PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Guo, SW; Zhen, YW; Wang, AR				Guo, Shewei; Zhen, Yingwei; Wang, Anran			Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						TBI; BMSCs; angiogenesis; neurological function	MARROW STROMAL CELLS; MONONUCLEAR-CELLS; CEREBRAL-ISCHEMIA; RATS; THERAPY; MICE; STROKE; DIFFERENTIATION; NEUROGENESIS; ATORVASTATIN	Traumatic brain injury (TBI) has emerged as a leading cause of mortality and morbidity worldwide. Transplantation of bone mesenchymal stem cells (BMSCs) has emerged as a promising treatment for various central nervous system diseases. This study aims to evaluate the effect of BMSCs transplantation by intravenous injection on neurological function and angiogenesis of the TBI mice. C57BL/6 male mice were randomly divided into four groups: control, sham, TBI, and BMSC. Functional neurological evaluation was performed 1, 4, 7, 14, and 21 days after TBI using neurological severity scores. The impairment of learning and memory in mice was evaluated 14 days after TBI by Morris water maze experiment. Mice were sacrificed 14 days after TBI, and then brain sections were stained by terminal deoxyribonucle-otidyl transferase (TDT)-mediated dUTP-digoxigenin nick end labeling staining to assess brain neuronal apoptosis. Immunohistochemistry was conducted to evaluate caspase-3 activity and identify vascular distribution and microvessel density. Protein and mRNA levels of vascular endothelial growth factor (VEGF) and angiogenin-1 (Ang-1) in brain tissues were analyzed by Western blot and quantitative real-time polymerase chain reaction, respectively. BMSCs transplantation promoted recovery of neurological function, ameliorated impairment of learning and memory, attenuated neuronal apoptosis, and diminished caspase-3 activation in mice after TBI. Also, BMSCs transplantation upregulated expressions of VEGF and Ang-1 and promoted the formation of microvessels in brain tissues after TBI. Our study demonstrated the important role of BMSCs transplantation in TBI mouse and indicated that the underlying mechanism was through promoting angiogenesis and improving neurological function. This provides a novel and effective strategy for cell-based therapy in the treatment of TBI.	[Guo, Shewei; Zhen, Yingwei; Wang, Anran] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Jianshe East Rd, Zhengzhou 450000, Henan, Peoples R China		Guo, SW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Jianshe East Rd, Zhengzhou 450000, Henan, Peoples R China.	gswfeicui@sohu.com					Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bao CF, 2015, CELL PHYSIOL BIOCHEM, V37, P901, DOI 10.1159/000430217; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Ding SG, 2006, HUM PATHOL, V37, P861, DOI 10.1016/j.humpath.2006.02.006; Fouillard L, 2007, LEUKEMIA, V21, P568, DOI 10.1038/sj.leu.2404550; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; James S, 2015, STEM CELL REP, V4, P1004, DOI 10.1016/j.stemcr.2015.05.005; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Malgieri A, 2010, INT J CLIN EXP MED, V3, P248; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Misra V, 2011, STEM CELLS BIOL REG, P143, DOI 10.1007/978-1-60761-965-9_7; Nandoe RDS, 2006, CELL TRANSPLANT, V15, P563, DOI 10.3727/000000006783981602; Pandya NM, 2006, VASC PHARMACOL, V44, P265, DOI 10.1016/j.vph.2006.01.005; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sandu N, 2010, MOL MED, V16, P433, DOI 10.2119/molmed.2010.00035; Sharma A, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/234095; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu BH, 2016, NEUROBIOL AGING, V39, P46, DOI 10.1016/j.neurobiolaging.2015.11.029; Yalvac ME, 2011, NEUROCHEM RES, V36, P2227, DOI 10.1007/s11064-011-0546-7; Yang B, 2011, J NEUROSCI RES, V89, P833, DOI 10.1002/jnr.22614; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	41	21	24	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2017	13						2757	2765		10.2147/NDT.S141534			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	FL7TD	WOS:000414452500001	29158675	gold, Green Submitted, Green Published			2022-02-06	
J	Hoffman, AN; Paode, PR; May, HG; Ortiz, JB; Kemmou, S; Lifshitz, J; Conrad, CD; Thomas, TC				Hoffman, Ann N.; Paode, Pooja R.; May, Hazel G.; Ortiz, J. Bryce; Kemmou, Salma; Lifshitz, Jonathan; Conrad, Cheryl D.; Thomas, Theresa Currier			Early and Persistent Dendritic Hypertrophy in the Basolateral Amygdala following Experimental Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						amygdala; comorbidity; plasticity; post-traumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; LATERAL FLUID PERCUSSION; CONDITIONED FEAR; GLUCOSE-UTILIZATION; RAT; HIPPOCAMPAL; NEURONS; CORTEX; PLASTICITY; GLUTAMATE	In the pathophysiology of traumatic brain injury (TBI), the amygdala remains understudied, despite involvement in processing emotional and stressful stimuli associated with anxiety disorders, such as post-traumatic stress disorder (PTSD). Because the basolateral amygdala (BLA) integrates inputs from sensory and other limbic structures coordinating emotional learning and memory, injury-induced changes in circuitry may contribute to psychiatric sequelae of TBI. This study quantified temporal changes in dendritic complexity of BLA neurons after experimental diffuse TBI, modeled by midline fluid percussion injury. At post-injury days (PIDs) 1, 7, and 28, brain tissue from sham and brain-injured adult, male rats was processed for Golgi, glial fibrillary acidic protein (GFAP), or silver stain and analyzed to quantify BLA dendritic branch intersections, activated astrocytes, and regional neuropathology, respectively. Compared to sham, brain-injured rats at all PIDs showed enhanced dendritic branch intersections in both pyramidal and stellate BLA neuronal types, as evidenced by Sholl analysis. GFAP staining in the BLA was significantly increased at PID1 and 7 in comparison to sham. However, the BLA was relatively spared from neuropathology, demonstrated by an absence of argyrophilic accumulation over time, in contrast to other brain regions. These data suggest an early and persistent enhancement of dendritic complexity within the BLA after a single diffuse TBI. Increased dendritic complexity would alter information processing into and through the amygdala, contributing to emotional symptoms post-TBI, including PTSD.	[Hoffman, Ann N.; Paode, Pooja R.; Ortiz, J. Bryce; Kemmou, Salma; Lifshitz, Jonathan; Conrad, Cheryl D.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [May, Hazel G.; Lifshitz, Jonathan; Thomas, Theresa Currier] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, 425 North 5th St,ABC-1 Bldg,Room 320, Phoenix, AZ 85004 USA; [May, Hazel G.; Lifshitz, Jonathan; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lifshitz, Jonathan; Thomas, Theresa Currier] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Hoffman, Ann N.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Hoffman, Ann N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [May, Hazel G.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England		Thomas, TC (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, 425 North 5th St,ABC-1 Bldg,Room 320, Phoenix, AZ 85004 USA.	theresathomas@email.arizona.edu	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Conrad, Cheryl/0000-0002-5924-2173	Arizona Biomedical Research Commission through the Arizona Department of Health Services [ADHS14-00003606]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052] Funding Source: NIH RePORTER	The authors thank Elizabeth Peck and Amanda Lisembee. Supported by the Arizona Biomedical Research Commission through the Arizona Department of Health Services (ADHS14-00003606), National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01 NS-065052), and Phoenix Children's Hospital Mission Support Funds.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; BOUZARTH WF, 1968, SURG GYNECOL OBSTETR, V126, P995; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; MCDONALD A J, 1992, P67; MCDONALD AJ, 1989, NEUROSCIENCE, V30, P405, DOI 10.1016/0306-4522(89)90261-3; MCDONALD AJ, 1992, BRAIN RES BULL, V28, P179, DOI 10.1016/0361-9230(92)90177-Y; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moreno N, 2007, J ANAT, V211, P151, DOI 10.1111/j.1469-7580.2007.00780.x; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ranft A, 2004, EUR J NEUROSCI, V20, P1276, DOI 10.1111/j.1460-9568.2004.03603.x; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Rumney B. M., 2014, 32 ANN NAT NEUR S SA; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Taylor SB, 2014, NEUROSCIENCE, V280, P231, DOI 10.1016/j.neuroscience.2014.09.029; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Uylings HBM, 2002, NETWORK-COMP NEURAL, V13, P397, DOI 10.1088/0954-898X/13/3/309; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	51	21	21	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					213	219		10.1089/neu.2015.4339			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100023	27306143	Green Published, Green Accepted			2022-02-06	
J	Khalili, H; Niakan, A; Ghaffarpasand, F				Khalili, Hosseinali; Niakan, Amin; Ghaffarpasand, Fariborz			Effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury: A historical cohort study	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury (TBI); Cerebrolysin; Functional recovery; Prognosis; Severe disability	NEUROTROPHIC TREATMENT; DOUBLE-BLIND; HEAD-INJURY; MODERATE; STROKE; RATS; EPIDEMIOLOGY; MANAGEMENT; APOPTOSIS; CELLS	Objective: To determine the effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury (TBI). Methods: This was a retrospective cohort study being performed during a 2-year period in a level I trauma center in Southern Iran including all the adult patients (>16 years) with severe disability (GOS of 2 and 3) 1-month after trauma. We excluded those with posttraumatic seizures and those with meningitis or current infections. Some patients received cerebrolysin (n = 65) and some did not (n = 64). Cerebrolysin was administered intravenously in 10 mL dosage daily for 30 days. Patients in two study groups were matched regarding the baseline characteristics including age, gender, GCS on admission, pupil reactivity and Rotterdam score. The administered cerebrolysin dosage was 10 mL intravenously daily for 30 days. The 3- and 6-month Glasgow Outcome Scale Extended (GOSE) was recorded. The outcome scales were compared between two study groups. Results: Overall we included 129 patients with severe disability 1-month after TBI. The baseline characteristics were comparable between groups. We found that GOSE at 3-month (p = 0.017) and 6-month (p = 0.009) was significantly higher in those receiving cerebrolysin. Cerebrolysin administration was associated with lower mortality rate, and higher good recovery after 6 month of therapy (p = 0.024). Cerebrolysin administration was also associated with higher favorable and lower unfavorable outcome (p = 0.043). Cerebrolysin was associated with higher seizure rate (p = 0.042). Conclusion: Cerebrolysin administration in patients with severe disability after TBI is associated with improved functional recovery, decreased mortality rate and increased favorable outcome. Seizure is important side effect of cerebrolysin administration in TBI patients. (C) 2016 Elsevier B.V. All rights reserved.	[Khalili, Hosseinali] Shiraz Univ Med Sci, Shiraz Trauma Res Ctr, Shiraz, Iran; [Niakan, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz, Iran; [Ghaffarpasand, Fariborz] Shiraz Univ Med Sci, Student Res Comm, Dept Neurosurg, Shiraz, Iran		Ghaffarpasand, F (corresponding author), Shiraz Univ Med Sci, Namazi Hosp, Neurosurg Dept Off, Namazi Sq, Shiraz 7197311351, Iran.	fariborz.ghaffarpasand@gmail.com	Ghaffarpasand, Fariborz/I-4204-2019; Khalili, Hosseinali/I-1087-2016; niakan, amin/A-6818-2019	Ghaffarpasand, Fariborz/0000-0002-1721-9987; Khalili, Hosseinali/0000-0002-3390-4212; niakan, amin/0000-0003-2644-8543	Shiraz University of Medical Sciences	We would like to acknowledge all the patients and their families who participated in this family with patience and fortitude. The study was supported by a grant from trauma research center of Shiraz University of Medical Sciences.	Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; Alvarez XA, 2008, J NEURAL TRANSM, V115, P683, DOI 10.1007/s00702-008-0024-9; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Boyce Vanessa S, 2014, Handb Exp Pharmacol, V220, P443, DOI 10.1007/978-3-642-45106-5_16; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Formichi P, 2012, J CELL MOL MED, V16, P2840, DOI 10.1111/j.1582-4934.2012.01615.x; Gauthier S, 2015, DEMENT GERIATR COGN, V39, P332, DOI 10.1159/000377672; Heydari ST, 2013, PUBLIC HEALTH, V127, P704, DOI 10.1016/j.puhe.2013.05.003; Heydari ST, 2013, CHIN J TRAUMATOL, V16, P84, DOI 10.3760/cma.j.issn.1008-1275.2013.02.003; Khalili H, 2016, WORLD NEUROSURG, V94, P120, DOI 10.1016/j.wneu.2016.06.122; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Muresanu DF, 2015, CNS NEUROL DISORD-DR, V14, P587, DOI 10.2174/1871527314666150430162531; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Taghipour M, 2006, J RES MED SCI, V11, P248; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Wong GKC, 2005, ACTA NEUROCHIR SUPPL, V95, P59; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061	32	21	22	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JAN	2017	152						34	38		10.1016/j.clineuro.2016.11.011			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EJ2AB	WOS:000393010900007	27871029				2022-02-06	
J	Khan, RS; Dine, K; Geisler, JG; Shindler, KS				Khan, Reas S.; Dine, Kimberly; Geisler, John G.; Shindler, Kenneth S.			Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							BROWN ADIPOSE-TISSUE; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MULTIPLE-SCLEROSIS; MOUSE MODEL; AXONAL LOSS; PROTEIN-2; DYSFUNCTION; UCP2; NEURODEGENERATION	The ability of novel mitochondrial uncoupler prodrug of 2,4-dinitrophenol (DNP), MP201, to prevent neuronal damage and preserve visual function in an experimental autoimmune encephalomyelitis (EAE) model of optic neuritis was evaluated. Optic nerve inflammation, demyelination, and axonal loss are prominent features of optic neuritis, an inflammatory optic neuropathy often associated with the central nervous system demyelinating disease multiple sclerosis. Currently, optic neuritis is frequently treated with high-dose corticosteroids, but treatment fails to prevent permanent neuronal damage and associated vision changes that occur as optic neuritis resolves, thus suggesting that additional therapies are required. MP201 administered orally, once per day, attenuated visual dysfunction, preserved retinal ganglion cells (RGCs), and reduced RGC axonal loss and demyelination in the optic nerves of EAE mice, with limited effects on inflammation. The prominent mild mitochondrial uncoupling properties of MP201, with slow elimination of DNP, may contribute to the neuroprotective effect by modulating the entire mitochondria's physiology directly. Results suggest that MP201 is a potential novel treatment for optic neuritis.	[Khan, Reas S.; Dine, Kimberly; Shindler, Kenneth S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Khan, Reas S.; Dine, Kimberly; Shindler, Kenneth S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Geisler, John G.] Mitochon Pharmaceut Inc, 970 Cross Lane, Blue Bell, PA USA		Shindler, KS (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.; Shindler, KS (corresponding author), Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.	kenneth.shindler@uphs.upenn.edu		Dine, Kimberly/0000-0001-5569-7261	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY019014]; Research to Prevent Blindness Physician Scientist AwardResearch to Prevent Blindness (RPB); F. M. Kirby Foundation	This work was supported by the National Institutes of Health grant EY019014; Research to Prevent Blindness Physician Scientist Award; and the F. M. Kirby Foundation. The authors thank Mitochon Pharmaceuticals, Inc. for providing MP201 for the studies reported in this manuscript.	Alemzadeh R, 2008, METABOLISM, V57, P1597, DOI 10.1016/j.metabol.2008.06.017; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barnstable CJ, 2016, J MOL NEUROSCI, V58, P461, DOI 10.1007/s12031-016-0728-5; Beck RW, 2008, ARCH OPHTHALMOL-CHIC, V126, P994, DOI 10.1001/archopht.126.7.994; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Beck RW, 2004, AM J OPHTHALMOL, V137, P77, DOI 10.1016/S0002-9394(02)00862-6; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Calvo-Rodriguez M, 2015, NEURAL REGEN RES, V10, P1371, DOI 10.4103/1673-5374.165219; Christensen CR, 2006, CLIN NUCL MED, V31, P193, DOI 10.1097/01.rlu.0000204199.33136.05; Chu ACY, 2009, FREE RADICAL BIO MED, V46, P810, DOI 10.1016/j.freeradbiomed.2008.12.015; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Cutting WC, 1933, J AMER MED ASSOC, V101, P193, DOI 10.1001/jama.1933.02740280013006; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Federico A., 2012, J NEUROL SCI, V15, P1; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; GEHRING PJ, 1969, TOXICOL APPL PHARM, V15, P574, DOI 10.1016/0041-008X(69)90060-X; Geisler JG, 2011, DIABETOLOGIA, V54, P237, DOI 10.1007/s00125-010-1932-4; Geisler J. G., 2016, ALZHEIMERS DEMENT, V16, pS1552; Geisler J. G., 2017, DIS MODIFYING EFFECT; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guy J, 1998, P NATL ACAD SCI USA, V95, P13847, DOI 10.1073/pnas.95.23.13847; HARRIS M, 1995, APERTURE, P1; Horner W D, 1941, Trans Am Ophthalmol Soc, V39, P405; Khan RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41768; Khan RS, 2014, INVEST OPHTH VIS SCI, V55, P5744, DOI 10.1167/iovs.14-14672; Khan RS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-3; Khan RS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00063; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kwok KHH, 2010, FREE RADICAL BIO MED, V49, P1023, DOI 10.1016/j.freeradbiomed.2010.06.017; Lee V., 2010, INVEST OPHTHALMOL, V52, P639; Lieven CJ, 2006, INVEST OPHTH VIS SCI, V47, P1477, DOI 10.1167/iovs.05-0921; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Nedergaard J, 1999, J BIOENERG BIOMEMBR, V31, P475, DOI 10.1023/A:1005400507802; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; PARASCANDOLA J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Porter RK, 2001, BBA-BIOENERGETICS, V1504, P120, DOI 10.1016/S0005-2728(00)00246-2; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P681, DOI 10.1167/iovs.06-0553; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; SKULACHEV VP, 1967, NATURE, V216, P718, DOI 10.1038/216718a0; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Su K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00169; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tainter ML, 1935, J AMER MED ASSOC, V105, P0332, DOI 10.1001/jama.1935.02760310006002; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Voss Elke, 2011, Ther Adv Neurol Disord, V4, P123, DOI 10.1177/1756285611398702; Wasilewska-Sampaio AP, 2005, FASEB J, V19, P1627, DOI 10.1096/fj.05-3812com; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Wu B, 2017, EXP NEUROL, V293, P83, DOI 10.1016/j.expneurol.2017.03.020; Wu ZF, 2010, J CLIN BIOCHEM NUTR, V46, P187, DOI 10.3164/jcbn.09-104-2; Zuo L, 2013, INVEST OPHTH VIS SCI, V54, P5097, DOI 10.1167/iovs.13-12157	70	21	21	1	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2017	2017								7180632	10.1155/2017/7180632			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EX4JV	WOS:000403201700001		Green Submitted, Green Published, gold			2022-02-06	
J	Kirkwood, MW; Peterson, RL; Baker, DA; Connery, AK				Kirkwood, Michael W.; Peterson, Robin L.; Baker, David A.; Connery, Amy K.			Parent satisfaction with neuropsychological consultation after pediatric mild traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; patient satisfaction; consumer satisfaction; concussion; pediatrics	POST-CONCUSSION SYMPTOMS; POSTCONCUSSION SYNDROME; SUBOPTIMAL EFFORT; CHILDREN; PATIENT; PERCEPTIONS; CARE; ADOLESCENTS; PREDICTORS; EXPERIENCE	Few studies have focused on consumer satisfaction following neuropsychological evaluation. We sought to examine parent satisfaction with neuropsychological consultation following a mild traumatic brain injury (TBI) in school-age children. We surveyed 71 parents of 8-to 17-year-olds participating in a prospective longitudinal study examining neuropsychological consultation as an intervention for persistent postconcussive symptoms. Children had sustained injuries between 2 and 12 months prior to enrollment. Neuropsychological consultation occurred on average 5 months post-injury. Parent satisfaction data were collected via telephone approximately 4 months after the neuropsychological consultation. The vast majority of parents were quite satisfied with the service (e.g., 94% overall satisfaction rate; 96% rated the service as good or excellent). Satisfaction rates were associated positively with time since injury and negatively with parental education. No other child, parent, or provider variable correlated with satisfaction. The results add to the relatively sparse literature on parent satisfaction with neuropsychological evaluation. A pressing future need in pediatric neuropsychology is to examine the satisfaction of other consumers of the service, including healthcare personnel, educators, and the child patients themselves.	Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA		Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, 13123 E 16th Ave, Aurora, CO 80045 USA.	michael.kirkwood@childrenscolorado.org			Children's Hospital Colorado Research Institute	The work was supported by the Children's Hospital Colorado Research Institute.	Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BENNETTLEVY J, 1994, CLIN NEUROPSYCHOL, V8, P219, DOI 10.1080/13854049408401559; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Bodin D, 2007, CLIN NEUROPSYCHOL, V21, P884, DOI 10.1080/13854040600888784; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Centers for Medicaid and Medicaid Services, 2012, HOSP CONS ASS HEALTH; Dillman DA, 2009, SOC SCI RES, V38, P3, DOI 10.1016/j.ssresearch.2008.03.007; Farmer J E, 1998, Appl Neuropsychol, V5, P194, DOI 10.1207/s15324826an0504_4; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Hilsabeck RC, 2014, ARCH CLIN NEUROPSYCH, V29, P131, DOI 10.1093/arclin/act084; King SM, 1996, DEV MED CHILD NEUROL, V38, P757, DOI 10.1111/j.1469-8749.1996.tb15110.x; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Peterson RL, 2015, J NEUROPSYCH CLIN N, V27, P280, DOI 10.1176/appi.neuropsych.14120373; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Shirley Eric D, 2013, J Bone Joint Surg Am, V95, pe69, DOI 10.2106/JBJS.L.01048; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Temple RO, 2006, ARCH CLIN NEUROPSYCH, V21, P371, DOI 10.1016/j.acn.2006.05.002; Tremont G, 2002, CLIN NEUROPSYCHOL, V16, P551, DOI 10.1076/clin.16.4.551.13902; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Westervelt HJ, 2007, CLIN NEUROPSYCHOL, V21, P263, DOI 10.1080/13854040500519745; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	32	21	21	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2017	23	3					273	283		10.1080/09297049.2015.1130219			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EO6YY	WOS:000396839600002	26739699				2022-02-06	
J	Nijsse, B; van Heugten, CM; van Mierlo, ML; Post, MWM; de Kort, PLM; Visser-Meily, JMA				Nijsse, Britta; van Heugten, Caroline M.; van Mierlo, Marloes L.; Post, Marcel W. M.; de Kort, Paul L. M.; Visser-Meily, Johanna M. A.			Psychological factors are associated with subjective cognitive complaints 2 months post-stroke	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; Rehabilitation; Cognitive complaints; Psychological factors	ANEURYSMAL SUBARACHNOID HEMORRHAGE; QUALITY-OF-LIFE; IMPAIRMENT HARMONIZATION STANDARDS; STROKE-CANADIAN STROKE; TRAUMATIC BRAIN-INJURY; MEMORY COMPLAINTS; NEUROLOGICAL DISORDERS; NATIONAL INSTITUTE; SELF-EFFICACY; CHRONIC PAIN	The aim of this study was to investigate which psychological factors are related to post-stroke subjective cognitive complaints, taking into account the influence of demographic and stroke-related characteristics, cognitive deficits and emotional problems. In this cross-sectional study, 350 patients were assessed at 2 months post-stroke, using the Checklist for Cognitive and Emotional consequences following stroke (CLCE-24) to identify cognitive complaints. Psychological factors were: proactive coping, passive coping, self-efficacy, optimism, pessimism, extraversion, and neuroticism. Associations between CLCE-24 cognition score and psychological factors, emotional problems (depressive symptoms and anxiety), cognitive deficits, and demographic and stroke characteristics were examined using Spearman correlations and multiple regression analyses. Results showed that 2 months post-stroke, 270 patients (68.4%) reported at least one cognitive complaint. Age, sex, presence of recurrent stroke(s), comorbidity, cognitive deficits, depressive symptoms, anxiety, and all psychological factors were significantly associated with the CLCE-24 cognition score in bivariate analyses. Multiple regression analysis showed that psychological factors explained 34.7% of the variance of cognitive complaints independently, and 8.5% (p < .001) after taking all other factors into account. Of all psychological factors, proactive coping was independently associated with cognitive complaints (p < .001), showing that more proactive coping related to less cognitive complaints. Because cognitive complaints are common after stroke and are associated with psychological factors, it is important to focus on these factors in rehabilitation programmes.	[Nijsse, Britta; de Kort, Paul L. M.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands; [van Mierlo, Marloes L.; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, POB 85500, NL-3508 GA Utrecht, Netherlands; [van Mierlo, Marloes L.; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, POB 85500, NL-3508 GA Utrecht, Netherlands; [van Mierlo, Marloes L.; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] De Hoogstr Rehabil, Utrecht, Netherlands		Visser-Meily, JMA (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, POB 85500, NL-3508 GA Utrecht, Netherlands.; Visser-Meily, JMA (corresponding author), Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	j.m.a.visser-meily@umcutrecht.nl	Post, Marcel/AAS-2502-2021		VSB foundation	This research project is funded by the VSB foundation and co-ordinated by ZonMw (Dutch Organization for Health Research and Development).	Aben I, 2002, STROKE, V33, P2391, DOI 10.1161/01.STR.0000029826.41672.2E; Aben L, 2011, CEREBROVASC DIS, V31, P566, DOI 10.1159/000324627; Antikainen R, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/s004060170060; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Bode C, 2008, PSYCHOL GEZONDH, V36, P81, DOI 10.1007/BF03077476; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Collin C, 1988, Int Disabil Stud, V10, P61; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; HANNINEN T, 1994, J AM GERIATR SOC, V42, P1; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Hopko DR, 2011, J CONSULT CLIN PSYCH, V79, P834, DOI 10.1037/a0025450; Koski L, 2013, CEREBROVASC DIS, V36, P6, DOI 10.1159/000352051; Lamb F, 2013, ARCH PHYS MED REHAB, V94, P1747, DOI 10.1016/j.apmr.2013.02.026; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Meijer R, 2006, INT J REHABIL RES, V29, P1, DOI 10.1097/01.mrr.0000175269.59788.41; Merlijn VPBM, 2005, PATIENT EDUC COUNS, V59, P126, DOI 10.1016/j.pec.2004.10.010; Narasimhalu K, 2013, EUR J NEUROL, V20, P547, DOI 10.1111/ene.12032; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niederehe G, 1998, PL S ADULT DEV AGING, P417; Passier PECA, 2012, NEUROREHABILITATION, V30, P137, DOI 10.3233/NRE-2012-0737; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Sanderman R., 1995, METEN PERSOONLIJKHEI; Sato T, 2005, J PSYCHOL, V139, P545, DOI 10.3200/JRLP.139.6.545-552; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schreurs PJG., 1993, UTRECHTSE COPING LIJ; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tielemans NS, 2014, INT J STROKE, V9, P818, DOI 10.1111/ijs.12127; Uijl SG, 2006, SEIZURE-EUR J EPILEP, V15, P242, DOI 10.1016/j.seizure.2006.02.009; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; van Heugten C, 2007, CLIN NEUROL NEUROSUR, V109, P257, DOI 10.1016/j.clineuro.2006.10.002; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; van Mierlo ML, 2014, INT J STROKE, V9, P148, DOI 10.1111/j.1747-4949.2012.00882.x; Verhage F, 1964, INTELLIGENTIE LEEFTI; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Winkens I, 2009, NEUROPSYCHOL REHABIL, V19, P64, DOI 10.1080/09602010801913650; Xiong YY, 2011, INT J GERIATR PSYCH, V26, P1144, DOI 10.1002/gps.2652	47	21	21	1	31	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	1					99	115		10.1080/09602011.2015.1065280			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EB0SL	WOS:000387055700007	26207868	Green Submitted			2022-02-06	
J	Salat, DH; Robinson, ME; Miller, DR; Clark, DC; McGlinchey, RE				Salat, David H.; Robinson, Meghan E.; Miller, Danielle R.; Clark, Dustin C.; McGlinchey, Regina E.			Neuroimaging of deployment-associated traumatic brain injury (TBI) with a focus on mild TBI (mTBI) since 2009	BRAIN INJURY			English	Article						Cortical thickness; diffusion tensor imaging; DTI; EEG; ERP: positron emission tomography; FA tractography; fcMRI; FDG; fMRI; fractional anisotropy; functional connectivity; functional magnetic resonance imaging; Glasgow Coma Scale: concussion; magnetic resonance imaging; MEG; MRI; neuroimaging; PET; TBI; Traumatic brain injury	WHITE-MATTER ABNORMALITIES; POSTTRAUMATIC-STRESS-DISORDER; COMMON DATA ELEMENTS; FUNCTIONAL CONNECTIVITY; BLAST EXPOSURE; MILITARY PERSONNEL; CORTICAL THICKNESS; COMBAT VETERANS; ALZHEIMERS-DISEASE; ENDURING FREEDOM	Objectives:, A substantial body of recent research has aimed to better understand the clinical sequelae,of military trauma through the application of advanced brain imaging procedures in Veteran populations. The primary objective of this review was to highlight:a portion of these recent studies to demonstrate how imaging tools can be used to understand millitary-associated brain injury; Methods: We focus here on the phenomenon Of mild traumatic brain injury (mTBI) given its high prevalence in the Veteran population and,current recognition of the need to better understand, the clinical implications. of this trauma. ThiS is intended to provide readers with an initial exposure to the field of neuroimaging of. mTBI with A brief introduction to the concept of traumatic brain injury, followed by a summary-of the major imaging techniques that have been applied to the study of mTBI. Results: Taken together, the collection of studies reviewed demonstrates a clear role.-for neuroimaging towards understanding the various neural consequences of mTBI as well as the clinical complications of such brain changes. Conclusions This information must be considered-in the-larger context of research into mTBI, including the potentially unique nature of blast exposure and the long-term consequences of mTBI.	[Salat, David H.; Robinson, Meghan E.; Clark, Dustin C.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 South Huntington Ave, Boston, MA 02130 USA; [Salat, David H.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Salat, David H.; Robinson, Meghan E.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Robinson, Meghan E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Miller, Danielle R.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Miller, Danielle R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [McGlinchey, Regina E.] Geriatr Res Educ & Clin Ctr, Boston, MA USA; [McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Salat, DH (corresponding author), VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 South Huntington Ave, Boston, MA 02130 USA.	salat@nmh.mgh.harvard.edu		Sullivan, Danielle R./0000-0002-0141-5887	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH019836] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019836] Funding Source: NIH RePORTER		Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Alexander MP, 1995, NEUROLOGY; Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Catafau AM, 2015, CLIN TRANSL IMAGING, V3, P39, DOI 10.1007/s40336-014-0098-3; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cifu DX, 2016, BRAIN INJURY, V30, P1397, DOI 10.1080/02699052.2016.1219065; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Farmer CF., 2016, UNDERSTANDING TREATM; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Franke LM, 2016, INT J PSYCHOPHYSIOL, V106, P21, DOI 10.1016/j.ijpsycho.2016.05.010; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Ibarra S., 2011, ENCY CLIN NEUROPSYCH, P325; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu J, 2016, J NEUROTRAUM, V33, P10, DOI 10.1089/neu.2014.3856; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller DR, 2016, BRAIN IMAGING BEHAV, V11, P1; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Pun PB, 2011, TRAUMAT INJUR NERV S, V29; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; TEASDALE G, 1974, LANCET, V2, P81; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Tsai YD, 2013, BRAIN INJURY, V27, P361, DOI 10.3109/02699052.2012.750738; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeh PH, 2016, HUM BRAIN MAPP	113	21	21	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1204	1219		10.1080/02699052.2017.1327672			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600007	28981347	hybrid			2022-02-06	
J	Shapiro, LA				Shapiro, Lee A.			Altered Hippocampal Neurogenesis during the First 7 Days after a Fluid Percussion Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						stem cells; hilar ectopic granule cells; doublecortin	DENTATE GRANULE CELLS; HILAR BASAL DENDRITES; STEM-CELLS; BORN; NEURONS; TRANSPLANTATION; PROLIFERATION; RECOVERY; GYRUS	Traumatic brain injury (TBI) is a devastating disorder causing negative outcomes in millions of people each year. Despite the alarming number of brain injuries and the long-term detrimental outcomes that can be associated with TBI, treatment options are lacking. Extensive investigation is underway, in hopes of identifying effective treatment strategies. Among the most state-of-the-art strategies is cell replacement therapy. TBI is a seemingly good candidate for cell replacement studies because there is often loss of neurons. However, translation of this therapy has not yet been successful. It is possible that a better understanding of endogenous neurogenic mechanisms after TBI could lead to more efficacious study designs using exogenous cell replacement strategies. Therefore, this study was designed to examine the number and migration of immature neurons at 1 and 7 d after a fluid percussion TBI. The results show that the number of immature neurons increases from 7 d after a fluid percussion injury (FPI), and there is ectopic migration of doublecortin (DCX+) immature neurons into the hilar region of the dentate gyrus. These results add important data to the current understanding of the endogenous neurogenic niche after TBI. Follow-up studies are needed to better understand the functional significance of elevated neurogenesis and aberrant migration into the hilus.	[Shapiro, Lee A.] Texas A&M Hlth Sci Ctr, Dept Surg, 702 SW HK Dodgen Loop, Temple, TX 76504 USA		Shapiro, LA (corresponding author), Texas A&M Hlth Sci Ctr, Dept Surg, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	lshapiro@medicine.tamhsc.edu					Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Arisi GM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0347-z; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Clausi MG, 2016, NEURAL REGEN RES, V11, P45, DOI 10.4103/1673-5374.175041; Darkazalli A, 2016, J NEUROTRAUMA; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pierce JP, 2005, EXP NEUROL, V196, P316, DOI 10.1016/j.expneurol.2005.08.007; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; Shapiro LA, 2005, NEUROSCIENCE, V136, P823, DOI 10.1016/j.neuroscience.2005.03.059; Shapiro LA, 2005, BRAIN RES, V1040, P81, DOI 10.1016/j.brainres.2005.01.098; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Shapiro LA, 2007, EUR J NEUROSCI, V26, P583, DOI 10.1111/j.1460-9568.2007.05662.x; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun D, 2016, NEURAL REGEN RES, V11, P18, DOI 10.4103/1673-5374.169605; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919	33	21	21	1	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1314	1318		10.1177/0963689717714099			5	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800017	28933222	gold, Green Published			2022-02-06	
J	Zhang, PJ; Ye, YQ; Qian, YH; Yin, BX; Zhao, JM; Zhu, SX; Zhang, L; Yan, MJ				Zhang, Pengju; Ye, Yongqi; Qian, Yuhang; Yin, Baoxin; Zhao, Jianmei; Zhu, Shunxing; Zhang, Li; Yan, Meijuan			The Effect of Pyrroloquinoline Quinone on Apoptosis and Autophagy in Traumatic Brain Injury	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Apoptosis; autophagy; electroencephalogram; pyrroloquinoline quinone; rat; traumatic brain injury	FLUID PERCUSSION INJURY; OXIDATIVE STRESS; RAT; PROTECTS; NEUROPROTECTION; ASTROCYTES; RECEPTOR; IMPROVES; HYPOXIA; DAMAGE	Background: Pyrroloquinoline quinone is an anionic, water-soluble compound with antioxidant characteristic. The role of pyrroloquinoline quinone in pharmacology and nutrition has attracted wide attention of researchers. Although a few experiments have confirmed that pyrroloquinoline quinone plays an obvious effective role in neuroprotection. There are few reports about the effect of pyrroloquinoline quinone on traumatic brain injury. Traumatic brain injury is one of the leading causes for adult disability and death. So far, there are no effective treatment methods for the injury because of its complex pathophysiology. Method: In the present study, a model of traumatic brain injury in rat was established to study the role of pyrroloquinoline quinone in central nervous system injury. Results: The results showed that the protein expression of cleaved-Caspase 3/Caspase 3 increased after traumatic brain injury and the expression decreased by treatment with 2mM pyrroloquinoline quinone. Terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining displayed that the TUNEL positive signals were up-regulated after traumatic brain injury and were down-regulated after treatment with 2mM pyrroloquinoline quinone. The protein expression of LC3II/LC3I or lysosome-associated membrane protein 2(LAMP2) was elevated after traumatic brain injury and reduced after administration with 2mM pyrroloquinoline quinone. Transmission electron microscopy showed that the number of autophagosomes increased markedly after traumatic brain injury and decreased on administration of 2mM pyrroloquinoline quinone. Electroencephalogram indicated that pyrroloquinoline quinone improved brain electrophysiological function after traumatic brain injury. The results of CCK-8 test showed that pyrroloquinoline quinone could increase the viability of primary astrocyte treated with Glutamate. Lactate dehydrogenase (LDH) assay demonstrated that pyrroloquinoline quinone decreased LDH content in primary astrocyte exposed to Glutamate. Conclusion: Pyrroloquinoline quinone could play a neuroprotective role after traumatic brain injury in rat, which might be associated with inhibiting apoptosis and autophagy caused by traumatic brain injury.	[Zhang, Pengju; Ye, Yongqi; Qian, Yuhang; Yin, Baoxin; Zhao, Jianmei; Zhu, Shunxing; Zhang, Li; Yan, Meijuan] Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China		Yan, MJ (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	ymz@ntu.edu.cn	yan, mei/AAA-1379-2022		National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31370803, 81101178]; Natural Scientific Foundation of Jiangsu Province [BK2011188]; Application Study Program of Nantong City [BK2013004]; Nantong University [10ZY013, 12B035]	This work was supported by the National Natural Scientific Foundation of China (31370803, 81101178), Natural Scientific Foundation of Jiangsu Province (BK2011188), Application Study Program of Nantong City (BK2013004), Early Pre-research Program of Nantong University (10ZY013), Doctoral Program of Nantong University (12B035).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Chen HY, 2015, APOPTOSIS, V20, P821, DOI 10.1007/s10495-015-1111-7; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; De Ford C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.413; Evans MK, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.412; Haque A, 2015, APOPTOSIS, V20, P986, DOI 10.1007/s10495-015-1126-0; Hu BY, 2014, J ETHNOPHARMACOL, V155, P1243, DOI 10.1016/j.jep.2014.07.009; Huang CF, 2016, PATHOL ONCOL RES, V22, P109, DOI 10.1007/s12253-015-9981-0; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Huang YQ, 2015, EXP THER MED, V10, P451, DOI 10.3892/etm.2015.2532; Jiang X, 2015, APOPTOSIS, V20, P1033, DOI 10.1007/s10495-015-1130-4; Kumar N, 2015, CHEM-BIOL INTERACT, V240, P278, DOI 10.1016/j.cbi.2015.08.027; Kuo YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143600; Lee SC, 2016, AM J TRANSPLANT; Li AH, 2013, J MOL NEUROSCI, V51, P208, DOI 10.1007/s12031-013-9994-7; Li FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147810; Li MM, 2015, APOPTOSIS, V20, P769, DOI 10.1007/s10495-015-1110-8; Lim EJ, 2015, APOPTOSIS, V20, P1087, DOI 10.1007/s10495-015-1135-z; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu ZB, 2016, INFLAMMATION, V39, P248, DOI 10.1007/s10753-015-0245-7; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P241, DOI 10.3177/jnsv.61.241; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Qin GQ, 2015, APOPTOSIS, V20, P1072, DOI 10.1007/s10495-015-1132-2; Qin JJ, 2015, TOXICOL LETT, V238, P70, DOI 10.1016/j.toxlet.2015.08.011; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Szydlowska K, 2010, J NEUROCHEM, V113, P904, DOI 10.1111/j.1471-4159.2010.06656.x; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Tiwari M, 2015, APOPTOSIS, V20, P1019, DOI 10.1007/s10495-015-1136-y; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Wang CC, 2013, J SURG RES, V185, P753, DOI 10.1016/j.jss.2013.07.002; Wang HQ, 2014, NEUROPHARMACOLOGY, V86, P9, DOI 10.1016/j.neuropharm.2014.06.018; Xiao YW, 2015, SEIZURE-EUR J EPILEP, V33, P29, DOI 10.1016/j.seizure.2015.10.005; Zhang LL, 2012, J NEUROTRAUM, V29, P851, DOI 10.1089/neu.2011.1882; Zhang Q, 2013, NEUROCHEM RES, V38, P1661, DOI 10.1007/s11064-013-1068-2; Zhang Q, 2011, TOXICOL APPL PHARM, V252, P62, DOI 10.1016/j.taap.2011.02.006; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003	43	21	21	2	15	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2017	16	6					724	736		10.2174/1871527316666170124164306			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FE8JR	WOS:000408451900011	28124619				2022-02-06	
J	Ziegler, D; Cravens, G; Poche, G; Gandhi, R; Tellez, M				Ziegler, Daniel; Cravens, George; Poche, Gerard; Gandhi, Raj; Tellez, Mark			Use of Transcranial Doppler in Patients with Severe Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						hypoperfusion; TBI; TCD; vasospasm	CEREBRAL BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; VASOSPASM; NIMODIPINE; ULTRASOUND; DIAGNOSIS; VELOCITY; SPASM	Severe traumatic brain injuries (TBI) are associated with a high rate of mortality and disability. Transcranial Doppler (TCD) sonography permits a noninvasive measurement of cerebral blood flow. The purpose of this study is to determine the usefulness of TCD in patients with severe TBI. TCD was performed, from April 2008 to April 2013, on 255 patients with severe TBI, defined as a Glasgow Coma Scale score of <= 8 on admission. TCD was performed on hospital days 1, 2, 3, and 7. Hypoperfusion was defined by having two out of three of the following: 1) mean velocity (Vm) of the middle cerebral artery <35cm/sec, 2) diastolic velocity (Vd) of the middle cerebral artery <20cm/sec, or 3) pulsatility index (PI) of >1.4. Vasospasm was defined by the following: Vm of the middle cerebral artery > 120 cm/sec and/or a Lindegaard index (LI) >3. One hundred fourteen (45%) had normal measurements. Of these, 92 (80.7%) had a good outcome, 6 (5.3%) had moderate disability, and 16 (14%) died, 4 from brain death. Seventy-two patients (28%) had hypoperfusion and 71 (98.6%) died, 65 from brain death, and 1 patient survived with moderate disability. Sixty-nine patients (27%) had vasospasm, 31 (44.9%) had a good outcome, 16 (23.2%) had severe disability, and 22 (31.9%) died, 13 from brain death. The vasospasm was detected on hospital day 1 in 8 patients, on day 2 in 23 patients, on day 3 in 22 patients, and on day 7 in 16 patients. Patients with normal measurements can be expected to survive. Patients with hypoperfusion have a poor prognosis. Patients with vasospasm have a high incidence of mortality and severe disability. TCD is useful in determining early prognosis.	[Ziegler, Daniel; Gandhi, Raj; Tellez, Mark] John Peter Smith Hosp, Dept Surg, 1500 South Main St, Ft Worth, TX 76104 USA; [Cravens, George; Poche, Gerard] John Peter Smith Hosp, Dept Neurosurg, Ft Worth, TX 76104 USA		Ziegler, D (corresponding author), John Peter Smith Hosp, Dept Surg, 1500 South Main St, Ft Worth, TX 76104 USA.	dziegler@jpshealth.org					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; CHAN KH, 1992, NEUROSURGERY, V30, P697; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; JENNETT B, 1975, LANCET, V1, P480; Kosty T, 2005, CRIT CARE NURS Q, V28, P122, DOI 10.1097/00002727-200504000-00005; Langham J., 2008, COCHRANE DB SYST REV, V4, P1; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MCINTOSH TK, 1992, J CEREBR BLOOD F MET, V12, P697, DOI 10.1038/jcbfm.1992.95; Moreno J, 2000, NEUROSURG FOCUS, V8, P8; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Sahuquillo J, 2000, REV NEUROLOGIA, V30, P401, DOI 10.33588/rn.3005.99063; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P6; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shroder M., 1995, J NEUROSURG, V82, P212; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; White R P, 1990, Neurosurg Clin N Am, V1, P401; WHITE RP, 1982, PHARMACOL THERAPEUT, V18, P313, DOI 10.1016/0163-7258(82)90035-3; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zubkov ZY, 2000, SURG NEUROL, V53, P126	40	21	21	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					121	127		10.1089/neu.2015.3967			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100015	26913374				2022-02-06	
J	An, CR; Jiang, XY; Pu, HJ; Hong, DD; Zhang, WT; Hu, XM; Gao, YQ				An, Chengrui; Jiang, Xiaoyan; Pu, Hongjian; Hong, Dandan; Zhang, Wenting; Hu, Xiaoming; Gao, Yanqin			Severity-Dependent Long-Term Spatial Learning-Memory Impairment in a Mouse Model of Traumatic Brain Injury	TRANSLATIONAL STROKE RESEARCH			English	Article						Traumatic brain injury; Long-term spatial learning-memory deficits; White matter injury; Hippocampus	WHITE-MATTER INTEGRITY; POSTTRAUMATIC-STRESS-DISORDER; VASCULAR COGNITIVE IMPAIRMENT; CONTROLLED CORTICAL IMPACT; HEAD-INJURY; RECOVERY; IMPROVES; DEFICITS; STROKE; DAMAGE	Traumatic brain injury (TBI) is a major cause of death and disability in young adults. Long-term mental disability often occurs in patients suffering moderate and severe TBI while not as frequent in the victims of mild TBI. To explore the potential mechanism underlying this severity-dependent cognitive deficit, we subjected C57/BL6 mice to different severities of controlled cortical impact (CCI) and assessed their learning-memory functions. The mice subjected to moderate and severe TBI exhibited significantly impaired long-term spatial learning-memory ability, which was accompanied by marked white matter injury and hippocampus damage. In contrast, long-term learning-memory deficits or structural abnormalities within the hippocampus or white matter were not significant in the case of mild TBI. According to a correlation analysis, the hippocampus or white matter injury severity was more relevant to Morris water maze outcome than tissue volume. This study revealed that long-term spatial learning-memory deficits are dependent on the severity of destruction in the white matter and hippocampus. Therapeutic strategies targeting both the white matter and hippocampus may be needed to improve the neurological functions in TBI victims.	[An, Chengrui; Jiang, Xiaoyan; Pu, Hongjian; Zhang, Wenting; Hu, Xiaoming; Gao, Yanqin] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [An, Chengrui; Jiang, Xiaoyan; Pu, Hongjian; Zhang, Wenting; Hu, Xiaoming; Gao, Yanqin] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China; [Jiang, Xiaoyan; Pu, Hongjian; Hong, Dandan; Hu, Xiaoming; Gao, Yanqin] Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA		Gao, YQ (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.; Gao, YQ (corresponding author), Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China.; Gao, YQ (corresponding author), Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA.	yqgao@shmu.edu.cn	Pu, Hongjian/AAW-3322-2020; Gao, Yanqin/I-6790-2016	Gao, Yanqin/0000-0002-4915-9819	Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81171149, 81371306, 81571285, 81471332]; Shanghai Committee of Science and Technology Support Program [14431907002]; American Heart Associat ion Scientist DevelopmentAmerican Heart Association [13SDG14570025]	This project was supported by the Chinese Natural Science Foundation grants 81171149, 81371306, 81571285 (to Dr. Gao), and 81471332 (to Dr. Zhang); the Shanghai Committee of Science and Technology Support Program 14431907002 (to Dr. Gao); and the American Heart Associat ion Scientist Development grant 13SDG14570025 (to Dr. Hu).	Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; d'Esterre CD, 2015, TRANSL STROKE RES, V6, P234, DOI 10.1007/s12975-015-0394-x; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harris AL, 2014, TRANSL STROKE RES, V5, P292, DOI 10.1007/s12975-013-0293-y; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Hill D, 2015, TRANSL STROKE RES, V6, P410, DOI 10.1007/s12975-015-0420-z; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kemmotsu N, 2011, EPILEPSIA, V52, P2257, DOI 10.1111/j.1528-1167.2011.03278.x; Khan MB, 2015, TRANSL STROKE RES, V6, P69, DOI 10.1007/s12975-014-0374-6; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; MAHUT H, 1982, J NEUROSCI, V2, P1214; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Pignataro G, 2014, TRANSL STROKE RES, V5, P145, DOI 10.1007/s12975-013-0308-8; Pringsheim T, 2014, NEUROLOGY, V83, P1661, DOI 10.1212/WNL.0000000000000929; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Sebastian V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00038; Sehba FA, 2014, TRANSL STROKE RES, V5, P660, DOI 10.1007/s12975-014-0368-4; Song MK, 2014, TRANSL STROKE RES, V5, P17, DOI 10.1007/s12975-013-0314-x; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Turner MJ, 2015, J NEUROIMMUNOL, V285, P4, DOI 10.1016/j.jneuroim.2015.05.018; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wong GKC, 2014, TRANSL STROKE RES, V5, P286, DOI 10.1007/s12975-013-0284-z; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Yuan L, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150129; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao H, 2014, TRANSL STROKE RES, V5, P128, DOI 10.1007/s12975-013-0286-x; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zuloaga KL, 2015, TRANSL STROKE RES, V6, P390, DOI 10.1007/s12975-015-0412-z	59	21	21	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	DEC	2016	7	6					512	520		10.1007/s12975-016-0483-5			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA1VJ	WOS:000386379800007	27539574				2022-02-06	
J	Chen, SL; Phang, I; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Chen, Suliang; Phang, Isaac; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Metabolic profile of injured human spinal cord determined using surface microdialysis	JOURNAL OF NEUROCHEMISTRY			English	Article						critical care unit; human; Kohonen self-organizing maps; microdialysis; prognosis; spinal cord injury	TRAUMATIC BRAIN-INJURY; PRESSURE EVALUATION; INTRASPINAL PRESSURE; PERFUSION-PRESSURE	The management of patients having traumatic spinal cord injury would benefit from understanding and monitoring of spinal cord metabolic states. We hypothesized that the metabolism of the injured spinal cord could be visualized using Kohonen self-organizing maps. Sixteen patients with acute, severe spinal cord injuries were studied. Starting within 72h of the injury, and for up to a week, we monitored the injury site hourly for tissue glucose, lactate, pyruvate, glutamate, and glycerol using microdialysis as well as intraspinal pressure and spinal cord perfusion pressure. A Kohonen map, which is an unsupervised, self-organizing topology-preserving neural network, was used to analyze 3366h of monitoring data. We first visualized the different spinal cord metabolic states. Our data show that the injured cord assumes one or more of four metabolic states. On the basis of their metabolite profiles, we termed these states near-normal, ischemic, hypermetabolic, and distal. We then visualized how patients' intraspinal pressure and spinal cord perfusion pressure affect spinal cord metabolism. This revealed that for more than 60% of the time, spinal cord metabolism is patient-specific; periods of high intraspinal pressure or low perfusion pressure are not associated with specific spinal cord metabolic patterns. Finally, we determined relationships between spinal cord metabolism and neurological status. Patients with complete deficits have shorter periods of near-normal spinal cord metabolic states (74% vs. 58 +/- 12%, p<0.01, mean +/- standard error) and more variable injury site metabolic responses (metabolism spread in 70 +/- 11 vs. 40 +/- 6 hexagons, p<0.05), compared with patients who have incomplete neurological deficits. We conclude that Kohonen maps allow us to visualize the metabolic responses of the injured spinal cord and may thus aid us in treating patients with acute spinal cord injuries.	[Chen, Suliang; Phang, Isaac; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, London, England; [Zoumprouli, Argyro] St George Hosp, Neurointens Care, London, England		Saadoun, S (corresponding author), St Georges Univ London, Room 1-234 Jenner Wing, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Zoumprouli, Argyro/0000-0003-0890-690X; Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176	Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation (Fletcher Fund); London Deanery	We thank St. George's Hospital, King's College Hospital and Hurstwood Park Neurological Centre neurosurgical departments helped recruit patients. The anesthetic, neuro-intensive care and operating theater staff at St. George's Hospital helped with data collection. The study was funded by Wings for Life Spinal Cord Research Foundation, Neurosciences Research Foundation (Fletcher Fund), and the London Deanery. The authors have no conflict of interest to declare.	Awad BI, 2015, WORLD NEUROSURG, V83, P120, DOI 10.1016/j.wneu.2013.01.042; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Cozzens JW, 2013, NEUROSURGERY, V72, P2, DOI 10.1227/NEU.0b013e3182772981; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	14	21	21	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2016	139	5					700	705		10.1111/jnc.13854			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	ED8QA	WOS:000389134800003	27664973	Green Accepted			2022-02-06	
J	Epstein, DJ; Legarreta, M; Bueler, E; King, J; McGlade, E; Yurgelun-Todd, D				Epstein, Daniel J.; Legarreta, Margaret; Bueler, Elliot; King, Jace; McGlade, Erin; Yurgelun-Todd, Deborah			Orbitofrontal cortical thinning and aggression in mild traumatic brain injury patients	BRAIN AND BEHAVIOR			English	Article						aggression; mild traumatic brain injury; morphometry; orbitofrontal cortex	VOXEL-BASED MORPHOMETRY; PREFRONTAL CORTEX; HEAD-INJURY; PREVALENCE; DISORDERS; RELIABILITY; DEPRESSION; VALIDITY; PERSONALITY; POPULATION	Introduction: Although mild traumatic brain injury (mTBI) comprises 80% of all TBI, the morphological examination of the orbitofrontal cortex (OFC) in relation to clinical symptoms such as aggression, anxiety and depression in a strictly mTBI sample has never before been performed. Objectives: The primary objective of the study was to determine if mTBI patients would show morphological differences in the OFC and if the morphology of this region would relate to clinical symptoms. Methods: Using structural images acquired in a 3T MRI machine, the cortical thickness and cortical volume (corrected for total brain volume) of the OFC was collected for healthy control (N = 27) subjects and chronic mTBI (N = 55) patients at least one year post injury. Also, during clinical interviews, measures quantifying the severity of clinical symptoms, including aggression, anxiety, and depression, were collected. Results: MTBI subjects displayed increased aggression, anxiety, and depression, and anxiety and depression measures showed a relationship with the number of mTBI in which the subject lost consciousness. The cortical thickness of the right lateral OFC displayed evidence of thinning in the mTBI group; however, after correction for multiple comparisons, this difference was no longer significant. Clinical measures were not significantly related with OFC morphometry. Conclusion: This study found increased aggression, anxiety, and depression, in the mTBI group as well as evidence of cortical thinning in the right lateral OFC. The association between clinical symptoms and the number of mTBI with loss of consciousness suggests the number and severity of mTBI may influence clinical symptoms long after injury. Future studies examining other brain regions involved in the production and regulation of affective processes and inclusion of subjects with well-characterized mood disorders could further elucidate the relationship between mTBI, brain morphology, and clinical symptoms.	[Epstein, Daniel J.; King, Jace; Yurgelun-Todd, Deborah] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84112 USA; [Epstein, Daniel J.; Legarreta, Margaret; Bueler, Elliot; King, Jace; McGlade, Erin; Yurgelun-Todd, Deborah] Cognit Neuroimaging Lab, Salt Lake City, UT USA; [Epstein, Daniel J.; Legarreta, Margaret; Bueler, Elliot; McGlade, Erin; Yurgelun-Todd, Deborah] Salt Lake City Rocky Mt MIRECC, Salt Lake City, UT USA; [McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Dept Psychiat, Salt Lake City, UT USA		Epstein, DJ (corresponding author), Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84112 USA.	Daniel.Epstein@utah.edu	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984; King, Jace/0000-0002-0206-0475	Veterans Health AdministrationUS Department of Veterans Affairs [5I01CX000253-02]; Veterans AffairsUS Department of Veterans Affairs [I01CX000253] Funding Source: NIH RePORTER	Veterans Health Administration - Merit Review Grant, (Grant / Award Number: '5I01CX000253-02')	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Blair RJR, 2001, J NEUROL NEUROSUR PS, V71, P727, DOI 10.1136/jnnp.71.6.727; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cady EB, 1996, MAGN RESON MED, V36, P878, DOI 10.1002/mrm.1910360610; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cirino PT, 2002, ASSESSMENT, V9, P145, DOI 10.1177/10791102009002005; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Faul M, 2010, TRAUMATIC BRAIN INJU; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gansler DA, 2009, PSYCHIAT RES-NEUROIM, V171, P145, DOI 10.1016/j.pscychresns.2008.03.007; Gerevich J, 2007, INT J METH PSYCH RES, V16, P124, DOI 10.1002/mpr.221; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Greve KW, 2001, BRAIN INJURY, V15, P255; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hoptman MJ, 2014, AM J PSYCHIAT, V171, P939, DOI 10.1176/appi.ajp.2014.13111553; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; IBM Corp Released, 2011, IBM SPSS STAT WIND V; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Liu CH, 2014, NEUROSCIENCE, V262, P190, DOI 10.1016/j.neuroscience.2013.12.058; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Panksepp J., 2004, INT REV SOC PSYCHOL, V17, P37; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Ratiu P, 2004, J NEUROTRAUM, V21, P637, DOI 10.1089/089771504774129964; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; Tu PC, 2012, PSYCHIAT RES-NEUROIM, V202, P206, DOI 10.1016/j.pscychresns.2011.07.011; Underhill HR, 2011, NEUROIMAGE, V54, P2052, DOI 10.1016/j.neuroimage.2010.10.065; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	84	21	21	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2016	6	12							e00581	10.1002/brb3.581			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EI7VL	WOS:000392712000013	28032004	Green Published, gold			2022-02-06	
J	Thompson, LL; Lyons, VH; McCart, M; Herring, SA; Rivara, FP; Vavilala, MS				Thompson, Leah L.; Lyons, Vivian H.; McCart, Melissa; Herring, Stanley A.; Rivara, Frederick P.; Vavilala, Monica S.			Variations in State Laws Governing School Reintegration Following Concussion	PEDIATRICS			English	Article							RECOMMENDATIONS; SYMPTOMS; CHILDREN; PREVALENCE; MANAGEMENT; KNOWLEDGE; STUDENT; SUPPORT; RETURN	OBJECTIVE: We sought to examine the prevalence, scope, and specificity of provisions abstract governing school reintegration in current state concussion laws. METHODS: State concussion laws as of May 2016 were independently assessed and classified by 2 trained coders. Statutes were classified as "Return-to-Learn" (RTL) laws if they contained language mandating institutional action at the state, district, or school level related to academic reintegration of youth who have sustained a concussion. All statutes classified as RTL laws were further analyzed to determine scope, required actions, and delineation of responsibility. RESULTS: RTL laws were uncommon, present in only 8 states. Most (75%) of these laws held schools responsible for RTL management but mandated RTL education for school personnel was less frequent, present in only one-quarter of the laws. None of the RTL laws provided guidance on support of students with persistent postconcussive symptoms, and only 1 recommended an evidence-based standard for RTL guidelines. CONCLUSIONS: Our review of state concussion laws indicates scant and vague legal guidance regarding RTL. These findings suggest an opportunity for legislative action on the issue of RTL, and reveal the need for better integration of laws and research, so that laws reflect existing best-practice recommendations and remain current as the evidence base develops.	[Thompson, Leah L.; Rivara, Frederick P.] Seattle Childrens Res Inst, Seattle, WA USA; [Lyons, Vivian H.; Rivara, Frederick P.; Vavilala, Monica S.] Harborview Injury Prevent & Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA; [Lyons, Vivian H.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Med Sports Hlth & Safety Inst, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Med Sports Concuss Program, Seattle, WA 98195 USA; [McCart, Melissa] Ctr Brain Injury Res & Training, Eugene, OR USA		Vavilala, MS (corresponding author), Harborview Injury Prevent & Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA.	vavilala@uw.edu	McCart, Melissa/AAN-1506-2020		Washington State Department of Health and Human Services Traumatic Brain Injury Council; Harborview Injury Prevention and Research Center; Seattle Children's Research Institute	This study was funded by the Washington State Department of Health and Human Services Traumatic Brain Injury Council, Harborview Injury Prevention and Research Center, and Seattle Children's Research Institute.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Blank NR, 2013, HEALTH AFFAIR, V32, P1282, DOI 10.1377/hlthaff.2013.0239; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Hatzenbuehler ML, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.2411; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Jones SE, 2008, J SCHOOL HEALTH, V78, P69, DOI 10.1111/j.1746-1561.2007.00272_1.x; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Lowrey KM, 2014, J BUSINESS TECH L, V10, P61; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rocky Mountain Hospital for Children, CONC MAN REAP; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Taber DR, 2015, J SCHOOL HEALTH, V85, P578, DOI 10.1111/josh.12288; The Center on Brain Injury Research and Training, OR CONC AW MAN PROGR; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zirkel PA, 2015, J SCH NURS, V31, P99, DOI 10.1177/1059840514521465; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	34	21	21	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2016	138	6							e20162151	10.1542/peds.2016-2151			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	ED5WX	WOS:000388924800047					2022-02-06	
J	Urban, JE; Weaver, AA; Lillie, EM; Maldjian, JA; Whitlow, CT; Stitzel, JD				Urban, Jillian E.; Weaver, Ashley A.; Lillie, Elizabeth M.; Maldjian, Joseph A.; Whitlow, Christopher T.; Stitzel, Joel D.			Evaluation of morphological changes in the adult skull with age and sex	JOURNAL OF ANATOMY			English	Article						aging; biomechanics; cranial fossa; morphometrics; skull; trauma	HYPEROSTOSIS FRONTALIS INTERNA; TRAUMATIC BRAIN-INJURY; MORPHOMETRIC-ANALYSIS; GEOMETRIC MORPHOMETRICS; INTRACRANIAL VOLUME; SHAPE CHANGES; HUMANS; FOSSA; SIZE	The morphology of the brain and skull are important in the evaluation of the aging human; however, little is known about how the skull may change with age. The objective of this study was to evaluate the morphological changes of the adult skull using three-dimensional geometric morphometric analysis of thousands of landmarks with the focus on anatomic regions that may be correlated with brain atrophy and head injury. Computed tomography data were collected between ages 20 and 100. Each scan was segmented using thresholding techniques. An atlas image of a 50th percentile skull was registered to each subject scan by computing a series of rigid, affine, and non-linear transformations between atlas space and subject space. Landmarks on the atlas skull were transformed to each subject and partitioned into the inner and outer cranial vault and the cranial fossae. A generalized Procrustes analysis was completed for the landmark sets. The coordinate locations describing the shape of each region were regressed with age to generate a model predicting the landmark location with age. Permutation testing was performed to assess significant changes with age. For the males, all anatomic regions reveal significant changes in shape with age except for the posterior cranial fossa. For the females, only the middle cranial fossa and anterior cranial fossa were found to change significantly in shape. Results of this study are important for understanding the adult skull and how shape changes may pertain to brain atrophy, aging, and injury.	[Urban, Jillian E.; Weaver, Ashley A.; Lillie, Elizabeth M.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Winston Salem, NC 27109 USA; [Urban, Jillian E.; Weaver, Ashley A.; Lillie, Elizabeth M.; Maldjian, Joseph A.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Winston Salem, NC USA; [Maldjian, Joseph A.; Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Univ, Translat Sci Inst, Winston Salem, NC 27109 USA		Urban, JE (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	jurban@wakehealth.edu	Stitzel, Joel/B-4045-2012; Weaver, Ashley/ABB-5845-2021	Stitzel, Joel/0000-0001-9762-3033; Weaver, Ashley/0000-0002-4383-0106; Maldjian, Joseph/0000-0002-6384-1072	National Highway Traffic Safety Administration [DTN22-09-H-00242]	Funding was provided by the National Highway Traffic Safety Administration under Cooperative Agreement Number DTN22-09-H-00242. Views expressed are those of the authors and do not represent the views of NHTSA. The authors would like to thank Callistus Nguyen for assistance with image segmentation, as well as Jaclyn Caccese and Mimin Meliyani for assistance in data collection.	Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Axelsson S, 2003, EUR J ORTHODONT, V25, P185, DOI 10.1093/ejo/25.2.185; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Chen SYY, 2000, EUR J ORTHODONT, V22, P205, DOI 10.1093/ejo/22.3.205; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Danelson KA, 2008, STAPP CAR C, V52, P59; De Groote I, 2011, J HUM EVOL, V60, P540, DOI 10.1016/j.jhevol.2010.09.009; Fakhry N, 2013, DYSPHAGIA, V28, P435, DOI 10.1007/s00455-013-9457-x; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fowles D, 2010, PROFILE OLDER AMERIC; FROST HM, 1996, BONE BIODYNAMICS, P315; Gayzik FS, 2011, ANN BIOMED ENG, V39, P2568, DOI 10.1007/s10439-011-0359-5; Gayzik FS, 2008, J BIOMECH, V41, P1545, DOI 10.1016/j.jbiomech.2008.02.006; Good P. I, 2000, SPRINGER SERIES STAT, V2; Gunz P, 2005, MODERN MORPHOMETERIC; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Harvati K, 2003, AM J PHYS ANTHROPOL, V120, P323, DOI 10.1002/ajpa.10122; Kanodia G, 2012, J NEUROSCI RURAL PRA, V3, P261, DOI 10.4103/0976-3147.102602; Marcus Jeffrey R, 2008, Eplasty, V8, pe20; May H, 2012, AM J HUM BIOL, V24, P812, DOI 10.1002/ajhb.22325; May H, 2010, ANAT REC, V293, P2007, DOI 10.1002/ar.21274; McIntyre GT, 2003, EUR J ORTHODONT, V25, P231, DOI 10.1093/ejo/25.3.231; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; ODDIE TH, 1966, J CLIN ENDOCR METAB, V26, P425, DOI 10.1210/jcem-26-4-425; Pirouzmand F, 2008, J CRANIOFAC SURG, V19, P27, DOI 10.1097/SCS.0b013e31815ca07a; Raikos A, 2011, ANN ANAT, V193, P453, DOI 10.1016/j.aanat.2011.05.004; Royle NA, 2013, MAGN RESON IMAGING, V31, P918, DOI 10.1016/j.mri.2013.01.012; She R, 2004, ANN CLIN LAB SCI, V34, P206; Slice DE, 2004, 2004012181 SAE; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9_1; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Weaver AA, 2014, J MORPHOL, V275, P1284, DOI 10.1002/jmor.20302; Weaver AA, 2014, J ANAT, V225, P246, DOI 10.1111/joa.12203	35	21	21	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	DEC	2016	229	6					838	846		10.1111/joa.12247			9	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anatomy & Morphology	ED2JK	WOS:000388670200009	25406956	Bronze, Green Published			2022-02-06	
J	Gao, L; Smielewski, P; Czosnyka, M; Ercole, A				Gao, Lei; Smielewski, Peter; Czosnyka, Marek; Ercole, Ari			Cerebrovascular Signal Complexity Six Hours after Intensive Care Unit Admission Correlates with Outcome after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						approximate entropy; autoregulation; complexity; ICP; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; RATE MULTISCALE ENTROPY; APPROXIMATE ENTROPY; INTRACRANIAL-PRESSURE; HEART-RATE; PHYSIOLOGICAL-COMPLEXITY; CRITICAL ILLNESS; VARIABILITY; HYPERTENSION; DISEASE	Disease states are associated with a breakdown in healthy interactions and are often characterized by reduced signal complexity. We applied approximate entropy (ApEn) analysis to investigate the correlation between the complexity of heart rate (ApEn-HR), mean arterial pressure (ApEn-MAP), intracranial pressure (ApEn-ICP), and a combined ApEn-product (product of the three individual ApEns) and outcome after traumatic brain injury. In 174 severe traumatic brain injured patients, we found significant differences across groups classified by the Glasgow Outcome Score in ApEn-HR (p = 0.007), ApEn-MAP (p = 0.02), ApEn-ICP (p = 0.01), ApEn-product (p = 0.001), and pressure reactivity index (PRx) (p = 0.004) in the first 6 h. This relationship strengthened in a 24 h and 72 h analysis (ApEn-MAP continued to correlate with death but was not correlated with favorable outcome). Outcome was dichotomized as survival versus death, and favorable versus unfavorable; the ApEn-product achieved the strongest statistical significance at 6 h (F = 11.0; p = 0.001 and F = 10.5; p = 0.001, respectively) and was a significant independent predictor of mortality and favorable outcome (p < 0.001). Patients in the lowest quartile for ApEn-product were over four times more likely to die (39.5% vs. 9.3%, p < 0.001) than those in the highest quartile. ApEn-ICP was inversely correlated with PRx (r=-0.39, p < 0.000001) indicating unique information related to impaired cerebral autoregulation. Our results demonstrate that as early as 6 h into monitoring, complexity measures from easily attainable vital signs, such as HR and MAP, in addition to ICP, can help triage those who require more intensive neurological management at an early stage.	[Gao, Lei] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Dept Anesthesia, Div Neurosurg, Cambridge, England; [Ercole, Ari] Univ Cambridge, Dept Anesthesia, Neurosci Crit Care Unit, Cambridge, England		Gao, L (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	lgao4@partners.org	Gao, Lei/AAL-1683-2020; Ercole, Ari/B-6288-2009	Gao, Lei/0000-0003-1476-1460; Ercole, Ari/0000-0001-8350-8093; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390] Funding Source: UKRI		Abasolo D, 2005, CLIN NEUROPHYSIOL, V116, P1826, DOI 10.1016/j.clinph.2005.04.001; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Bishop SM, 2012, ANESTHESIOLOGY, V117, P810, DOI 10.1097/ALN.0b013e31826a4aa2; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chon KH, 2009, IEEE ENG MED BIOL, V28, P18, DOI 10.1109/MEMB.2009.934629; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Gallagher R, 1999, SCIENCE, V284, P79, DOI 10.1126/science.284.5411.79; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hornero R, 2005, P ANN INT IEEE EMBS, P6157, DOI 10.1109/IEMBS.2005.1615900; JENNETT B, 1975, LANCET, V1, P480; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Norris PR, 2008, J CRIT CARE, V23, P399, DOI 10.1016/j.jcrc.2007.08.001; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Norris PR, 2009, ANN SURG, V250, P524, DOI [10.1097/SLA.0b013e181b8fb1f, 10.1097/SLA.0b013e3181b8fb1f]; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Pincus S, 2004, P NATL ACAD SCI USA, V101, P13709, DOI 10.1073/pnas.0405168101; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Sabeti M, 2009, ARTIF INTELL MED, V47, P263, DOI 10.1016/j.artmed.2009.03.003; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Srinivasan V, 2007, IEEE T INF TECHNOL B, V11, P288, DOI 10.1109/TITB.2006.884369; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	35	21	21	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2016	33	22					2011	2018		10.1089/neu.2015.4228			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EC4OL	WOS:000388112300004	26916703	Green Accepted			2022-02-06	
J	Antonenko, YN; Denisov, SS; Silachev, DN; Khailova, LS; Jankauskas, SS; Rokitskaya, TI; Danilina, TI; Kotova, EA; Korshunova, GA; Plotnikov, EY; Zorov, DB				Antonenko, Yuri N.; Denisov, Stepan S.; Silachev, Denis N.; Khailova, Ljudmila S.; Jankauskas, Stanislovas S.; Rokitskaya, Tatyana I.; Danilina, Tatyana I.; Kotova, Elena A.; Korshunova, Galina A.; Plotnikov, Egor Y.; Zorov, Dmitry B.			A leng-linker conjugate of fluorescein and triphenylphosphonium as mitochondria-targeted uncoupler and fluorescent neuroand nephroprotector	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Mitochondria; Mild uncoupler; Protonophore; Fluorescein; Membrane potential	TRAUMATIC BRAIN-INJURY; OXIDATIVE-PHOSPHORYLATION; LIPOPHILIC DICATIONS; ANTIOXIDANT SKQR1; SERUM PROTEINS; RHODAMINE 19; MEMBRANE; DINITROPHENOL; HOMEOSTASIS; DERIVATIVES	Background: Limited uncoupling of oxidative phosphorylation is known to be beneficial in various laboratory models of diseases. Linking a triphenyl-phosphonium cation to fluorescein through a decyl (C-10) spacer yields a fluorescent uncoupler, coined mitoFluo, that selectively accumulates in energized mitochondria (Denisov et al., Chem.Commun. 2014). Methods: Proton-transport activity of mitoFluo was tested in liposomes reconstituted with bacteriorhodopsin. To examine the uncoupling action on mitochondria, we monitored mitochondrial membrane potential in parallel with oxygen consumption. Neuro- and nephroprotecting activity was detected by a limb-placing test and a kidney ischemia/reperfusion protocol, respectively. Results: We compared mitoFluo properties with those of its newly synthesized analog having a short (butyl) spacer (C-4-mitoFluo). MitoFluo, but not C-4-mitoFluo, caused collapse of mitochondrial membrane potential resulting in stimulation of mitochondrial respiration. The dramatic difference in the uncoupling activity of mitoFluo and C-4-mitoFluo was in line with the difference in their protonophoric activity on a lipid membrane. The accumulation of mitoFluo in mitochondria was more pronounced than that of C-4-mitoFluo. MitoFluo decreased the rate of ROS production in mitochondria. MitoFluo was effective in preventing consequences of brain trauma in rats: it suppressed trauma-induced brain swelling and reduced a neurological deficit. Besides, mitoFluo attenuated acute kidney injury after ischemia/reperfusion in rats. Conclusions: A long alkyl linker was proved mandatory for mitoFluo to be a mitochondria- targeted uncoupler. MitoFluo showed high protective efficacy in certain models of oxidative stress-related diseases. General significance: MitoFluo is a candidate for developing therapeutic and fluorescence imaging agents to treat brain and kidney pathologies. (C) 2016 Elsevier B.V. All rights reserved.	[Antonenko, Yuri N.; Denisov, Stepan S.; Silachev, Denis N.; Khailova, Ljudmila S.; Jankauskas, Stanislovas S.; Rokitskaya, Tatyana I.; Danilina, Tatyana I.; Kotova, Elena A.; Korshunova, Galina A.; Plotnikov, Egor Y.; Zorov, Dmitry B.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Denisov, Stepan S.] Lomonosov Moscow State Univ, Fac Chem, Moscow 119991, Russia		Antonenko, YN (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia.	antonen@genebee.msu.ru	Jankauskas, Stanislovas/W-2744-2019; Denisov, Stepan/AAJ-4022-2020; Silachev, Denis N/C-9464-2012; Silachev, Denis/ABE-8515-2020; Zorov, Dmitry B./AAB-1738-2019; Rokitskaya, Tatyana/J-3541-2013; Plotnikov, Egor Y/F-8592-2019	Zorov, Dmitry B./0000-0003-0863-8490; Plotnikov, Egor Y/0000-0003-2838-3704; Rokitskaya, Tatyana/0000-0002-7719-1875; Jankauskas, Stanislovas/0000-0002-0843-5098; Denisov, Stepan/0000-0001-5460-940X; Silachev, Denis/0000-0003-0581-9755	Russian Science FoundationRussian Science Foundation (RSF) [16-14-10025]	The authors are grateful to Professor Vladimir Skulachev for valuable discussions. This work was financially supported by the Russian Science Foundation grant 16-14-10025.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Antonenko YN, 2015, BBA-BIOMEMBRANES, V1848, P995, DOI 10.1016/j.bbamem.2015.01.005; Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902; Antonenko YN, 2012, J BIOENERG BIOMEMBR, V44, P453, DOI 10.1007/s10863-012-9449-9; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Biasutto L, 2010, BBA-BIOENERGETICS, V1797, P189, DOI 10.1016/j.bbabio.2009.10.001; Blaikie FH, 2006, BIOSCIENCE REP, V26, P231, DOI 10.1007/s10540-006-9018-8; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; Dalla Via L, 2014, CURR PHARM DESIGN, V20, P253, DOI 10.2174/13816128113199990028; Denisov SS, 2014, CHEM COMMUN, V50, P15366, DOI 10.1039/c4cc04996a; Dikalov SI, 2016, CURR OPIN NEPHROL HY, V25, P73, DOI 10.1097/MNH.0000000000000198; DROBNICA L, 1979, BIOCHIM BIOPHYS ACTA, V585, P462, DOI 10.1016/0304-4165(79)90091-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng XX, 2015, P NATL ACAD SCI USA, V112, pE7073, DOI 10.1073/pnas.1521988112; Figarola JL, 2015, J BIOL CHEM, V290, P30321, DOI 10.1074/jbc.M115.686352; Fugit KD, 2014, J CONTROL RELEASE, V174, P88, DOI 10.1016/j.jconrel.2013.11.003; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; HAYASHI H, 1975, BIOCHIM BIOPHYS ACTA, V394, P145, DOI 10.1016/0005-2736(75)90213-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; HUANG KS, 1980, P NATL ACAD SCI-BIOL, V77, P323, DOI 10.1073/pnas.77.1.323; ILIVICKY J, 1969, BIOCHEM PHARMACOL, V18, P1389, DOI 10.1016/0006-2952(69)90252-4; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kalinovich AV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P620, DOI 10.1134/S0006297915050156; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Khailova LS, 2014, BBA-BIOENERGETICS, V1837, P1739, DOI 10.1016/j.bbabio.2014.07.006; Klotzsch E, 2015, P NATL ACAD SCI USA, V112, P130, DOI 10.1073/pnas.1415261112; KONISHI T, 1986, BIOCHIM BIOPHYS ACTA, V862, P278, DOI 10.1016/0005-2736(86)90229-4; Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krishna YR, 2011, CAN J GASTROENTEROL, V25, P157; Lardy H., 1967, METHOD ENZYMOL, V10, P94, DOI [DOI 10.1016/0076-6879(67)10018-9, 10.1016/0076-6879(67)10018-9]; LARIS PC, 1975, BIOCHIM BIOPHYS ACTA, V376, P415, DOI 10.1016/0005-2728(75)90163-2; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; OSORIO C, 1962, J PHYSIOL-LONDON, V163, P151, DOI 10.1113/jphysiol.1962.sp006963; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Perevoshchikova IV, 2008, BBA-BIOMEMBRANES, V1778, P2182, DOI 10.1016/j.bbamem.2008.04.008; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Severina II, 2007, BBA-BIOENERGETICS, V1767, P1164, DOI 10.1016/j.bbabio.2007.05.010; Shchepinova MM, 2014, BBA-BIOENERGETICS, V1837, P149, DOI 10.1016/j.bbabio.2013.09.011; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Silachev DN, 2014, BBA-GEN SUBJECTS, V1840, P3434, DOI 10.1016/j.bbagen.2014.09.002; Skulachev VP, 2010, BBA-BIOENERGETICS, V1797, P878, DOI 10.1016/j.bbabio.2010.03.015; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; STARKOV AA, 1994, FEBS LETT, V355, P305, DOI 10.1016/0014-5793(94)01211-3; Starkov AA, 2006, CHEM-BIOL INTERACT, V163, P133, DOI 10.1016/j.cbi.2006.08.015; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024; WOLFF J, 1961, J CLIN INVEST, V40, P1373, DOI 10.1172/JCI104368	64	21	23	0	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2016	1860	11	A				2463	2473		10.1016/j.bbagen.2016.07.014			11	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	DW7IR	WOS:000383824900013	27450891				2022-02-06	
J	Davis, G; Makdissi, M				Davis, Gavin; Makdissi, Michael			Use of video to facilitate sideline concussion diagnosis and management decision-making	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Football; Clinical management; Flowchart; Video analysis	HOCKEY LEAGUE NHL; HEAD; BLOWS	Objectives: Video analysis can provide critical information to improve diagnostic accuracy and speed of clinical decision-making in potential cases of concussion. The objective of this study was to validate a hierarchical flowchart for the assessment of video signs of concussion, and to determine whether its implementation could improve the process of game day video assessment. Design: Prospective cohort study. Methods: All impacts and collisions potentially resulting in a concussion were identified during 2012 and 2013 Australian Football League (AFL) seasons. Consensus definitions were developed for clinical signs associated with concussion. A hierarchical flowchart was developed based on the reliability and validity of the video signs of concussion. Ninety videos were assessed, with 45 incidents of clinically confirmed concussion, and 45 cases where no concussion was sustained. Each video was examined using the hierarchical flowchart, and a single response was given for each video based on the highest-ranking element in the flowchart. Results: No protective action, impact seizure, motor incoordination or blank/vacant look were the highest ranked video signs in almost half of the clinically confirmed concussions, but in only 8.8% of non-concussed individuals. The presence of facial injury, clutching at the head and slow to get up were the highest ranked sign in 77.7% of non-concussed individuals. Conclusions: This study suggests that the implementation of a flowchart model could improve timely assessment of concussion, and it identifies the video signs that should trigger automatic removal from play. (C) 2016 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Davis, Gavin; Makdissi, Michael] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Davis, Gavin] Austin Hosp, Dept Neurosurg, Heidelberg, Vic, Australia; [Davis, Gavin] Cabrini Hlth, Dept Neurosurg, Malvern, Vic, Australia; [Makdissi, Michael] Federat Univ, Australian Ctr Res Injury Sport & Its Prevent ACR, Ballarat, Vic, Australia; [Makdissi, Michael] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic 3086, Australia		Davis, G (corresponding author), Cabrini Med Ctr, Suite 53 Neurosurg, Malvern, Vic 3145, Australia.	gadavis@netspace.net.au		makdissi, michael/0000-0003-0334-7133			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gardner AJ, 2015, BRAIN INJURY, V17, P1; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Makdissi M, J SCI MED SPORT; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002	14	21	21	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	NOV	2016	19	11					898	902		10.1016/j.jsams.2016.02.005			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ED0PK	WOS:000388544200008	27117715				2022-02-06	
J	Hawryluk, GWJ; Phan, N; Ferguson, AR; Morabito, D; Derugin, N; Stewart, CL; Knudson, MM; Manley, G; Rosenthal, G				Hawryluk, Gregory W. J.; Phan, Nicolas; Ferguson, Adam R.; Morabito, Diane; Derugin, Nikita; Stewart, Campbell L.; Knudson, M. Margaret; Manley, Geoffrey; Rosenthal, Guy			Brain tissue oxygen tension and its response to physiological manipulations: influence of distance from injury site in a swine model of traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; oxygen monitor; optimal location; licox; in vivo	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; COMATOSE PATIENTS; PARTIAL-PRESSURE; INSPIRED OXYGEN; REACTIVITY; HYPEROXIA; THERAPY; HYPOXIA; PO2	OBJECTIVE The optimal site for placement of tissue oxygen probes following traumatic brain injury (TBI) remains unresolved. The authors used a previously described swine model of focal TBI and studied brain tissue oxygen tension (PbtO2) at the sites of contusion, proximal and distal to contusion, and in the contralateral hemisphere to determine the effect of probe location on PbtO2 and to assess the effects of physiological interventions on PbtO2 at these different sites. METHODS A controlled cortical impact device was used to generate a focal lesion in the right frontal lobe in 12 anesthetized swine. PbtO2 was measured using Licox brain tissue oxygen probes placed at the site of contusion, in pericontusional tissue (proximal probe), in the right parietal region (distal probe), and in the contralateral hemisphere. PbtO2 was measured during normoxia, hyperoxia, hypoventilation, and hyperventilation. RESULTS Physiological interventions led to expected changes, including a large increase in partial pressure of oxygen in arterial blood with hyperoxia, increased intracranial pressure (ICP) with hypoventilation, and decreased ICP with hyperventilation. Importantly, PbtO2 decreased substantially with proximity to the focal injury (contusion and proximal probes), and this difference was maintained at different levels of fraction of inspired oxygen and partial pressure of carbon dioxide in arterial blood. In the distal and contralateral probes, hypoventilation and hyperventilation were associated with expected increased and decreased PbtO2 values, respectively. However, in the contusion and proximal probes, these effects were diminished, consistent with,loss of cerebrovascular CO2 reactivity at and near the injury site. Similarly, hyperoxia led to the expected rise in PbtO2 only in the distal and contralateral probes, with little or no effect in the proximal and contusion probes, respectively. CONCLUSIONS PbtO2 measurements are strongly influenced by the distance from the site of focal injury. Physiological alterations, including hyperoxia, hyperventilation, and hypoventilation substantially affect PbtO2 values distal to the site of injury but have little effect in and around the site of contusion. Clinical interpretations of brain tissue oxygen measurements should take into account the spatial relation of probe position to the site of injury. The decision of where to place a brain tissue oxygen probe in TBI patients should also take these factors into consideration.	[Hawryluk, Gregory W. J.] Univ Utah, Dept Neurol Surg, Salt Lake City, UT USA; [Hawryluk, Gregory W. J.; Ferguson, Adam R.; Morabito, Diane; Derugin, Nikita; Manley, Geoffrey; Rosenthal, Guy] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Rm 101, San Francisco, CA 94110 USA; [Hawryluk, Gregory W. J.; Phan, Nicolas; Ferguson, Adam R.; Morabito, Diane; Derugin, Nikita; Manley, Geoffrey] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Knudson, M. Margaret] Univ Calif San Francisco, Dept Gen Surg, San Francisco, CA 94143 USA; [Phan, Nicolas] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neurol Surg, Toronto, ON, Canada; [Stewart, Campbell L.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Rosenthal, Guy] Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, Jerusalem, Israel		Manley, G (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Rm 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu		Ferguson, Adam/0000-0001-7102-1608	CDC grant R49 [CCR903697]; ONR grant [N00014002-1-0203]	We would like to thank Larry Carbone, DVM, PhD, and Ron Bairuther for their assistance with the large-animal studies. Kotaro Oshio MD, PhD, and Ken Monson, PhD, also made important contributions to the technical aspects of this study. This, work was supported by CDC grant R49, CCR903697, and ONR grant N00014002-1-0203.	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Andrade KC, 2006, ARQ NEURO-PSIQUIAT, V64, P895, DOI 10.1590/S0004-282X2006000600001; Bardt TF, 1998, ACT NEUR S, V71, P153; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; COLE SL, 1956, JAMA-J AM MED ASSOC, V161, P1454, DOI 10.1001/jama.1956.02970150022005; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Fandino J, 1999, ACTA NEUROCHIR, V141, P825, DOI 10.1007/s007010050383; Haitsma I, 2008, ACTA NEUROCHIR SUPPL, V102, P197, DOI 10.1007/978-3-211-85578-2_39; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Holzschuh M, 1998, BRAIN INJURY, V12, P191, DOI 10.1080/026990598122665; Hutchinson PJ, 2005, HEAD INJURY PATHOPHY, P216; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kiening KL, 1998, ACT NEUR S, V71, P172; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; Longhi L, 2002, ACT NEUR S, V81, P315; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; SCHNEIDER GH, 1995, ACTA NEUROCHIR, V134, P71, DOI 10.1007/BF01428507; Soustiel Jean F., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P131; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025	53	21	21	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2016	125	5					1217	1228		10.3171/2015.7.JNS15809			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DZ8FK	WOS:000386106100022	26848909				2022-02-06	
J	Pope, CN; Ross, LA; Stavrinos, D				Pope, Caitlin N.; Ross, Lesley A.; Stavrinos, Despina			Association Between Executive Function and Problematic Adolescent Driving	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						adolescent; executive function; driving; problematic driving outcomes; injury prevention	BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NOVICE DRIVERS; NORMATIVE DATA; CHILDREN; CRASHES; ADULTS; SAFETY; AGE	Objective: Motor vehicle collisions (MVCs) are one of the leading causes of injury and death for adolescents. Driving is a complex activity that is highly reliant on executive function (EF) to safely navigate through the environment. Little research has examined the efficacy of using self-reported EF measures for assessing adolescent driving risk. This study examined the Behavior Rating Inventory of Executive Function (BRIEF) questionnaire and performance-based EF tasks as potential predictors of problematic driving outcomes in adolescents. Methods: Forty-six adolescent drivers completed the (1) BRIEF, (2) Trail Making Test, (3) Backwards Digit Span, and (4) self-report on 3 problematic driving outcomes: the number of times of having been pulled over by a police officer, the number of tickets issued, and the number of MVCs. Results: Greater self-reported difficulty with planning and organization was associated with greater odds of having a MVC, whereas inhibition difficulties were associated with greater odds of receiving a ticket. Greater self-reported difficulty across multiple BRIEF subscales was associated with greater odds of being pulled over. Conclusion: Overall findings indicated that the BRIEF, an ecological measure of EF, showed significant association with self-reported problematic driving outcomes in adolescents. No relationship was found between performance-based EF measures and self-reported driving outcomes. The BRIEF could offer unique and quick insight into problematic driving behavior and potentially be an indicator of driving risk in adolescent drivers during clinical evaluations.	[Pope, Caitlin N.; Stavrinos, Despina] Univ Alabama Birmingham, Dept Psychol, 916 Bldg,19th St South, Birmingham, AL 35294 USA; [Ross, Lesley A.] Penn State Univ, Coll Hlth & Human Dev, Dept Human Dev & Family Studies, University Pk, PA 16802 USA		Stavrinos, D (corresponding author), Univ Alabama Birmingham, Dept Psychol, 916 Bldg,19th St South, Birmingham, AL 35294 USA.	dstavrin@uab.edu	Ross, Lesley/B-4842-2019; Pope, Caitlin N./W-7730-2019	Ross, Lesley/0000-0002-3794-158X; Pope, Caitlin N./0000-0003-1576-9763	Southeastern Transportation Research, Innovation, Development and Education (STRIDE) Center; Alabama Department of Transportation (ALDOT); Florida Department of Transportation (FDOT); University of Alabama at Birmingham; Edward R. Roybal Center for Translational Research in Aging and Mobility, National Institute on Aging at the National Institutes of Health [2 P30 AG022838]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG022838] Funding Source: NIH RePORTER	This work was supported, in part, by the Southeastern Transportation Research, Innovation, Development and Education (STRIDE) Center; Alabama Department of Transportation (ALDOT); Florida Department of Transportation (FDOT), University of Alabama at Birmingham Faculty Development Grant Program, and the Edward R. Roybal Center for Translational Research in Aging and Mobility, National Institute on Aging at the National Institutes of Health (2 P30 AG022838). The opinions, views, or comments expressed in this paper are those of the authors and do not necessarily represent the official positions of funding departments.	af Wahlberg AE, 2015, SAFETY SCI, V76, P67, DOI 10.1016/j.ssci.2015.02.020; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Alderson RM, 2010, J ABNORM CHILD PSYCH, V38, P497, DOI 10.1007/s10802-010-9387-0; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Beanland V, 2013, SAFETY SCI, V51, P127, DOI 10.1016/j.ssci.2012.06.021; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bonett DG, 2002, J EDUC BEHAV STAT, V27, P335, DOI 10.3102/10769986027004335; Boschloo A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00287; Centers for Disease Control and Prevention, 2013, WEB BAS INJ STAT QUE; Chan M, 2013, ACCIDENT ANAL PREV, V50, P147, DOI 10.1016/j.aap.2012.04.004; Eichelberger AH, 2015, J SAFETY RES, V55, P1, DOI 10.1016/j.jsr.2015.07.006; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Fisher DL, 2006, INJURY PREV, V12, P25, DOI 10.1136/ip.2006.012021; Garner AA, 2014, J ATTEN DISORD, V18, P496, DOI 10.1177/1087054711431699; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Guy SC, 2004, BRIEF SR BEHAV RATIN; HOLM S, 1979, SCAND J STAT, V6, P65; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Ker K, 2005, ACCIDENT ANAL PREV, V37, P305, DOI 10.1016/j.aap.2004.09.004; Laapotti S, 2001, ACCIDENT ANAL PREV, V33, P759, DOI 10.1016/S0001-4575(00)00090-7; Lee J.D., 2011, HDB DRIVING SIMULATI; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mantyla T, 2009, APPL NEUROPSYCHOL, V16, P11, DOI 10.1080/09084280802644086; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; McCartt AT, 2003, ACCIDENT ANAL PREV, V35, P311, DOI 10.1016/S0001-4575(02)00006-4; McDonald CC, 2015, J ADOLESCENT HEALTH, V57, pS15, DOI 10.1016/j.jadohealth.2015.02.013; O'Brien F, 2013, ACCIDENT ANAL PREV, V51, P238, DOI 10.1016/j.aap.2012.11.024; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Reimer B, 2006, BEHAV RES METHODS, V38, P314, DOI 10.3758/BF03192783; Rike PO, 2015, TRANSPORT RES F-TRAF, V29, P34, DOI 10.1016/j.trf.2015.01.004; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Roberts SE, 2008, ACCIDENT ANAL PREV, V40, P559, DOI 10.1016/j.aap.2007.08.017; Romer D, 2014, J ADOLESCENT HEALTH, V54, pS6, DOI 10.1016/j.jadohealth.2013.10.202; Rosenbloom T, 2008, ACCIDENT ANAL PREV, V40, P697, DOI 10.1016/j.aap.2007.09.007; Ross V, 2015, APPL NEUROPSYCH-ADUL, V22, P61, DOI 10.1080/23279095.2013.838958; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schiebener J, 2015, CHILD NEUROPSYCHOL, V21, P759, DOI 10.1080/09297049.2014.934216; SEAMAN MA, 1991, PSYCHOL BULL, V110, P577, DOI 10.1037/0033-2909.110.3.577; Shope JT, 2008, AM J PREV MED, V35, pS261, DOI 10.1016/j.amepre.2008.06.022; Tabibi Z, 2015, TRANSPORT RES F-TRAF, V34, P18, DOI 10.1016/j.trf.2015.07.015; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Wechsler D., 1999, MANUAL WECHSLER ABBR; Welburn SC, 2010, DEV SELF REPORT MEAS	63	21	22	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	NOV-DEC	2016	37	9					702	711		10.1097/DBP.0000000000000353			10	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	EC1IZ	WOS:000387859400005	27661394	Green Accepted			2022-02-06	
J	Tuominen, M; Stuart, MJ; Aubry, M; Kannus, P; Tokola, K; Parkkari, J				Tuominen, Markku; Stuart, Michael J.; Aubry, Mark; Kannus, Pekka; Tokola, Kari; Parkkari, Jari			Injuries in women's international ice hockey: an 8-year study of the World Championship tournaments and Olympic Winter Games	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PLAYERS; 7-YEAR; RATES; RISK; MENS	Background We report the incidence, type, mechanism and severity of ice hockey injuries in women's international ice hockey championships. Methods All injuries in the International Ice Hockey Federation World Women's Championship, World Women's under-18 Championship and Olympic Winter Games tournaments were analysed over an 8-year period using a strict injury definition, standardised reporting and team physician diagnosis. Results 168 injuries were recorded in 637 games over an 8-year period resulting in an injury rate (IR) of 6.4 per 1000 player-games and 22.0/1000 player-game hours. The IRs were 2.7/1000 player-games for the lower body, 1.4 for the upper body, 1.3 for the head and face and 0.9 for the spine and trunk. Contusion was the most common injury followed by a sprain. The most commonly injured site was the knee (48.6% of lower body injuries; IR 1.3/1000 player-games). The Medial collateral ligament sprain occurred in 37.1% and ACL rupture in 11.4% of knee injuries. A concussion (74.3%; IR 1.0/1000 player-games) was the most common head injury. Conclusions and recommendations The risk of injury to female ice hockey players at World Championship and Olympic tournaments was about half of that observed in the men's Championships. Full facial protection decreases the risk of lacerations and should be continued in all future female tournaments. More effective prevention strategies for knee, ankle and shoulder injuries are needed in women's ice hockey. Improved concussion education is necessary to promote more consistent diagnosis and return to play protocols.	[Tuominen, Markku] Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland; [Stuart, Michael J.] Mayo Clin, Dept Orthoped, Rochester, MN USA; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Kannus, Pekka; Tokola, Kari] UKK Inst, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Parkkari, Jari] UKK Inst, Tampere Res Ctr Sports Med, Tampere, Finland		Tuominen, M (corresponding author), Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland.	markku.tuominen@medisport.fi			International Ice Hockey Federation; Finnish Ministry of Education and Culture	This study was financially supported by The International Ice Hockey Federation and the Finnish Ministry of Education and Culture.	Agel J, 2010, CAN J SURG, V53, P319; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Junge A, 2007, BRIT J SPORT MED, V41, pI3, DOI 10.1136/bjsm.2007.036020; Langevoort G, 2007, SCAND J MED SCI SPOR, V17, P400, DOI 10.1111/j.1600-0838.2006.00587.x; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; LaPrade RF, 2014, BRIT J SPORT MED, V48, P4, DOI 10.1136/bjsports-2013-093020; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; Pasanen K, 2008, SCAND J MED SCI SPOR, V18, P49, DOI 10.1111/j.1600-0838.2007.00640.x; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688	15	21	21	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2016	50	22					1406	1412		10.1136/bjsports-2015-094647			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EC2XV	WOS:000387988700014	26153516				2022-02-06	
J	Jamall, OA; Feeney, C; Zaw-Linn, J; Malik, A; Niemi, MEK; Tenorio-Jimenez, C; Ham, TE; Jilka, SR; Jenkins, PO; Scott, G; Li, LM; Gorgoraptis, N; Baxter, D; Sharp, DJ; Goldstone, AP				Jamall, Omer A.; Feeney, Claire; Zaw-Linn, Joanna; Malik, Aysha; Niemi, Mari E. K.; Tenorio-Jimenez, Carmen; Ham, Timothy E.; Jilka, Sagar R.; Jenkins, Peter O.; Scott, Gregory; Li, Lucia M.; Gorgoraptis, Nikolaos; Baxter, David; Sharp, David J.; Goldstone, Anthony P.			Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injury	CLINICAL ENDOCRINOLOGY			English	Article							QUALITY-OF-LIFE; HYPOVITAMINOSIS-D; DEPRESSION; METAANALYSIS; DEMENTIA; DYSFUNCTION	Objectives Traumatic brain injury (TBI) is a major cause of long-term disability with variable recovery. Preclinical studies suggest that vitamin D status influences the recovery after TBI. However, there is no published clinical data on links between vitamin D status and TBI outcomes. The aim was to determine the (i) prevalence of vitamin D deficiency/insufficiency, and associations of vitamin D status with (ii) demographic factors and TBI severity, and with (iii) cognitive function, symptoms and quality of life, in adults after TBI. Design Retrospective audit of patients seen between July 2009 and March 2015. Serum vitamin D (25-hydroxy-cholecalciferol) was categorized as deficient (<40 nmol/l), insufficient (4070 nmol/l) or replete (>70 nmol/l). Patients A total of 353 adults seen in tertiary hospital clinic (75.4% lighter skinned, 74.8% male, age median 35.1 year, range 26.6-48.3 year), 0.3-56.5 months after TBI (74.5% moderate-severe). Measurements Serum vitamin D concentrations; Adden-brooke's Cognitive Examination (ACE-R), Beck Depression Inventory-II (BDI-II), SF-36 Quality of Life, Pittsburgh Sleep Quality Index. Results In total, 46.5% of patients after TBI had vitamin D deficiency and 80.2% insufficiency/deficiency. Patients with vitamin D deficiency had lower ACE-R scores than those of vitamin D replete (mean effect size +/- SEM 4.5 +/- 2.1, P = 0.034), and higher BDI-II scores than those of vitamin D insufficient (4.5 +/- 1.6, P = 0.003), correcting for age, gender, time since TBI and TBI severity. There was no association between vitamin D status and markers of TBI severity, sleep or quality of life. Conclusion Vitamin D deficiency is common in patients after TBI and associated with impaired cognitive function and more severe depressive symptoms.	[Jamall, Omer A.; Feeney, Claire; Zaw-Linn, Joanna; Malik, Aysha; Niemi, Mari E. K.; Tenorio-Jimenez, Carmen; Ham, Timothy E.; Jilka, Sagar R.; Jenkins, Peter O.; Scott, Gregory; Li, Lucia M.; Gorgoraptis, Nikolaos; Baxter, David; Sharp, David J.; Goldstone, Anthony P.] Hammersmith Hosp, Imperial Coll London, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Feeney, Claire; Tenorio-Jimenez, Carmen; Goldstone, Anthony P.] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Imperial Ctr Endocrinol, London, England; [Goldstone, Anthony P.] Hammersmith Hosp, Imperial Coll London, Div Brain Sci, Ctr Neuropsychopharmacol, London, England		Goldstone, AP (corresponding author), Hammersmith Hosp, Imperial Coll London, Div Brain Sci, Room E313,3rd Floor Burlington Danes Bldg, London W12 0NN, England.	tony.goldstone@imperial.ac.uk	Tenorio-Jimenez, Carmen/I-1550-2015; Sharp, David J/A-2119-2013	Tenorio-Jimenez, Carmen/0000-0002-1773-6036; Goldstone, Anthony/0000-0001-8179-7071; Niemi, Mari/0000-0003-0696-6175; Li, Lucia/0000-0001-7339-4854; Scott, Gregory/0000-0001-8063-5871; Gorgoraptis, Nikos/0000-0002-2588-9235	UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [26659]; Imperial College Healthcare Charity [7006/R21U]; Guarantors of Brain; Wellcome-GSK Imperial Translational Training Fellowship; Wellcome TrustWellcome TrustEuropean Commission; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [NIHR-RP-011-048]; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K023926/1] Funding Source: UKRI; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL13-Gorgoraptis] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K023926/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2013-21-010, NIHR-RP-011-048] Funding Source: researchfish	We thank Department of Chemical Pathology, Imperial College Healthcare NHS Trust, London, for performing hormone assays. CF is supported by UK Medical Research Council (ref. 26659) and Imperial College Healthcare Charity (ref. 7006/R21U), CT by Imperial College Healthcare Charity (ref. 7006/R21U), POJ by Guarantors of Brain, GS by Wellcome-GSK Imperial Translational Training Fellowship, LL by Wellcome Trust, NG by National Institute for Health Research (NIHR), DJS by National Institute for Health Research (NIHR, ref. NIHR-RP-011-048) and APG by UK Medical Research Council.	Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Ecemis GC, 2013, J ENDOCRINOL INVEST, V36, P622, DOI 10.3275/8898; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Groves NJ, 2014, ANNU REV NUTR, V34, P117, DOI 10.1146/annurev-nutr-071813-105557; Harris SS, 2006, J NUTR, V136, P1126, DOI 10.1093/jn/136.4.1126; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/BF02509538; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0; Kimura D, 1996, CURR OPIN NEUROBIOL, V6, P259, DOI 10.1016/S0959-4388(96)80081-X; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kuru P, 2015, RHEUMATOL INT, V35, P315, DOI 10.1007/s00296-014-3099-7; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Nice, 2014, NAT I HLTH CAR EXC G; Novack TA, 2000, BRAIN INJURY, V14, P987; Rajakumar K, 2008, OBESITY, V16, P90, DOI 10.1038/oby.2007.23; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; WEISSMAN MM, 1985, TRENDS NEUROSCI, V8, P416, DOI 10.1016/0166-2236(85)90145-6; Wiklund I, 1990, Scand J Prim Health Care Suppl, V1, P15	34	21	21	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	OCT	2016	85	4					636	644		10.1111/cen.13045			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DZ4IH	WOS:000385821400019	26921561	hybrid, Green Published			2022-02-06	
J	Zhang, H; Zhang, XN; Zhang, HL; Huang, L; Chi, QQ; Zhang, X; Yun, XP				Zhang, Hao; Zhang, Xiao-Nian; Zhang, Hui-Li; Huang, Liang; Chi, Qian-Qian; Zhang, Xin; Yun, Xiao-Ping			Differences in cognitive profiles between traumatic brain injury and stroke: A comparison of the Montreal Cognitive Assessment and Mini-Mental State Examination	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Montreal Cognitive Assessment; Mini-Mental State Examination; Cognitive impairment; Cognitive assessment; Brain injuries; Stroke		Purpose: To investigate the profiles of cognitive impairment through Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) in patients with chronic traumatic brain injury (TBI) or stroke and to evaluate the sensitivity of the two scales in patients with TBI. Methods: In this cohort study, a total of 230 patients were evaluated, including TBI group (n = 103) and stroke group (n = 127). The cognitive functions of two groups were evaluated by designated specialists using MoCA (Beijing version) and MMSE (Chinese version). Results: Compared with the patients with stroke, the patients with TBI received significantly lower score in orientation subtest and recall subtest in both tests. MoCA abnormal rates in the TBI group and stroke group were 94.17% and 86.61% respectively, while MMSE abnormal rates were 69.90% and 57.48%, respectively. In the TBI group, 87.10% patients with normal MMSE score had abnormal MoCA score and in the stroke group, about 70.37% patients with normal MMSE score had abnormal MoCA score. The diagnostic consistency of two scales in the TBI group and the stroke group were 72% and 69%, respectively. Conclusion: In our rehabilitation center, patients with TBI may have more extensive and severe cognitive impairments than patients with stroke, prominently in orientation and recall domain. In screening postTBI cognitive impairment, MoCA tends to be more sensitive than MMSE. (C) 2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.	[Zhang, Hao; Zhang, Xiao-Nian; Chi, Qian-Qian; Zhang, Xin] Capital Med Univ, Beijing Boai Hosp, Sch Rehabil, Neurorehabil Dept,China Rehabil Res Ctr, Beijing 100068, Peoples R China; [Zhang, Hui-Li; Yun, Xiao-Ping] Capital Med Univ, Beijing Boai Hosp, Sch Rehabil, Rehabil Evaluat Dept,China Rehabil Res Ctr, Beijing 100068, Peoples R China; [Huang, Liang] Huabei Oil Field Huayuan Hosp, Rehabil Dept, Hejian 062450, Hebei, Peoples R China		Yun, XP (corresponding author), Capital Med Univ, Beijing Boai Hosp, Sch Rehabil, Rehabil Evaluat Dept,China Rehabil Res Ctr, Beijing 100068, Peoples R China.	crrck3@sina.com			special basic research fund for Chinese central public research institutes [2013CZ-30, 2013CZ-41]	This study was supported by the special basic research fund for Chinese central public research institutes (No. 2013CZ-30, 2013CZ-41).	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grau-Olivares M, 2010, CEREBROVASC DIS, V30, P157, DOI 10.1159/000316059; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Li SC., 1989, CHIN J NEUROSURGERY, V5, P2; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Pendlebury ST, 2012, CEREBROVASC DIS, V34, P48, DOI 10.1159/000338905; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Xie SP, 1999, CHIN J EPIDEMIOL, V20, P299; Yang YC, 1987, CHINESE J NEUROSURGE, V3, P23; Zhao, 1989, SHANGHAI ARCH PSYCHI, V7, P108	28	21	24	0	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2016	19	5					271	274		10.1016/j.cjtee.2015.03.007			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1PV	WOS:000442111000006	27780506	Green Published, gold			2022-02-06	
J	Zuercher, P; Groen, JL; Aries, MJH; Steyerberg, EW; Maas, AIR; Ercole, A; Menon, DK				Zuercher, Patrick; Groen, Justus L.; Aries, Marcel J. H.; Steyerberg, Ewout W.; Maas, Andrew I. R.; Ercole, Ari; Menon, David K.			Reliability and Validity of the Therapy Intensity Level Scale: Analysis of Clinimetric Properties of a Novel Approach to Assess Management of Intracranial Pressure in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						clinimetrics; ICP; TIL scale; TBI	HYPOTHERMIA; MULTICENTER	We aimed to assess the reliability and validity of the Therapy Intensity Level scale (TIL) for intracranial pressure (ICP) management. We reviewed the medical records of 31 patients with traumatic brain injury (TBI) in two European intensive care units (ICUs). The ICP TIL was derived over a 4-day period for 4-h (TIL4) and 24-h epochs (TIL24). TIL scores were compared with historical schemes for TIL measurement, with each other, and with clinical variables. TIL24 scores in ICU patients with TBI were compared with two control groups: patients with extracranial trauma necessitating intensive care (Trauma_ICU; n = 20) and patients with TBI not needing ICU care (TBI_WARD; n = 19), to further determine the discriminative validity of the TIL for ICP-related ICU interventions. Interrater and intraobserver agreement were excellent for TIL4 and TIL24 (Cohen kappa: 0.98-0.99; intraclass correlation coefficient: 0.99-1; p < 0.0005). The mean + standard deviation (SD) TIL24 in the ICU TBI cohort was significantly higher than the Trauma_ICU patients and the TBI_WARD patients (8.2 +/- 3.2 vs. 2.2 +/- 0.9 and 0.1 +/- 0.1, respectively; p < 0.005 for both comparisons). Correlations between the TIL scale scores and historical TIL scores, between TIL24 and the Glasgow Coma Scale, and between a range of TIL metrics and summary measures of ICP over the 4-day period, were all highly significant (p < 0.01). The results were consistent with the expected direction. A linear mixed effect analysis, accounting for within-subjects repeated measures, showed strong correlation between TIL4 and 4-h ICP (p < 0.0000005). The TIL scale is a reliable measurement instrument with a high degree of validity for assessing the therapeutic intensity level of ICP management in patients with TBI.	[Zuercher, Patrick; Groen, Justus L.; Aries, Marcel J. H.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Zuercher, Patrick] Inselspital Bern, Univ Hosp, Dept Intens Care Med, Bern, Switzerland; [Groen, Justus L.] UMC Leiden, Dept Neurosurg, Leiden, Netherlands; [Aries, Marcel J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept PH, Ctr Med Decis Sci, Rotterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium		Zuercher, P (corresponding author), Inselspital Bern, Univ Hosp Bern, Dept Intens Care Med, Freiburgstr, CH-3010 Bern, Switzerland.	pz257@cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Groen, Justus/0000-0002-1251-4485			Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; de Vet H.C.W., 2011, MEASUREMENT MED PRAC, P338; JENNETT B, 1975, LANCET, V1, P480; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	19	21	21	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2016	33	19					1768	1774		10.1089/neu.2015.4266			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DY8KP	WOS:000385379100005	26866876	Green Accepted, Green Submitted			2022-02-06	
J	Zhao, JB; Chen, HD; Zhang, MJ; Zhang, YH; Qian, CF; Liu, Y; He, SX; Zou, YJ; Liu, HY				Zhao, Jinbing; Chen, Haodong; Zhang, Meijuan; Zhang, Yuhai; Qian, Chunfa; Liu, Yong; He, Shengxue; Zou, Yuanjie; Liu, Hongyi			Early expression of serum neutrophil gelatinase-associated lipocalin (NGAL) is associated with neurological severity immediately after traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						NGAL; Neurological severity; Traumatic brain injury	INTRACEREBRAL HEMORRHAGE; POTENTIAL ROLE; RENAL INJURY; RAT-BRAIN; IRON; BIOMARKER; CELLS; MEDIATOR; PROTEIN; MOUSE	Purpose: Intracranial bleeding and inflammatory reactions are common consequences of traumatic brain injury (TBI). Neutrophil gelatinase-associated lipocalin (NGAL), an iron-handling and acute phase protein, may participate in the pathogenesis of TBI. Therefore, we hypothesize that NGAL may be of high diagnostic and therapeutic relevance in the prognosis of TBI. Methods: 74 subjects were recruited in this study. 30 TBI patients receiving emergent operation were designated as severe TBI group (sTBI), 24 TBI patients receiving conservative treatment as mild TBI group (mTBI), while 20 age-matched healthy volunteers as healthy controls (CNT). We detected the expression and localization of NGAL in brain tissue by Q-PCR, western blotting, and immunofluorescence. Serum NGAL was evaluated by ELISA. Clinical manifestations and outcomes were measured by Glasgow Score (GCS), Trauma score (TS), Revised Trauma score (RTS), APACHEII, Sequential Organ Failure Assessment (SOFA), and Abbreviated Injury Scale (AIS) 85 at admission. Glasgow outcome score (GOS) and Karnofsky Performance Score (IKPS) were documented at discharge. Results: NGAL mRNA and protein levels in brain tissue from sTBI group were profoundly higher than control tissue. Double labeled NGAL with GFAP, NeuN and Iba-1 by immunofluroscence demonstrated that increased NGAL was mainly located in neurons. Compared to CNT and mTBI groups, serum NGAL were significantly increased in sTBI group (sTBI: 532.6 +/- 71.77 ng/ml vs. mTBI: 230.5 +/- 29.59 ng/ml, p < 0.01; sTBI: 532.6 71.77 ng/ml vs. CNT 178.0 +/- 19.83 ng/ml, p <0.01). Linear regression analysis indicated that there was a negative correlation between the NGAL levels and GCS (r = -0.427,p = 0.033), TS (r = -0.429,p = 0.032), RTS (r = -0.413, p = 0.040) in sTBI group. However, NGAL levels did not correlated with GOS and KPS scores. The NAGL cut-off value of 244.13 ng/ml yielded good sensitivity at 84% and specificity at 78.9%. Conclusion: NGAL may be a novel biomarker reflecting TBI severity, which increased obviously and negatively correlated with GCS, TS, and RTS scores; additionally, this characteristic of NGAL may be helpful in guiding clinical TBI therapeutic strategies. (C) 2016 Elsevier B.V. All rights reserved.	[Zhao, Jinbing; Zhang, Yuhai; Qian, Chunfa; Liu, Yong; He, Shengxue; Zou, Yuanjie; Liu, Hongyi] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, 264 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Haodong] Peoples Hosp Luhe, Dept Neurosurg, 9 Jiankang Lane, Nanjing 211500, Jiangsu, Peoples R China; [Zhang, Meijuan] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China		Zhao, JB; Liu, HY (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, 264 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	zjbbrain@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301049, 81571135]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [BK20130085]	This study was supported by the National Natural Science Foundation of China (Grants No. 81301049, 81571135), the Natural Science Foundation of Jiangsu Province of China (Grants No. BK20130085).	Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Chia WJ, 2011, NEUROCHEM INT, V59, P591, DOI 10.1016/j.neuint.2011.04.007; Chun BY, 2015, INVEST OPHTH VIS SCI, V56, P3691, DOI 10.1167/iovs.15-16851; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dong M, 2013, BRAIN RES, V1505, P86, DOI 10.1016/j.brainres.2013.02.008; Egashira Y, 2014, STROKE, V45, P2141, DOI 10.1161/STROKEAHA.114.005307; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; HRABARENEVEY S, 1989, ONCOGENE, V4, P601; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Jha Mithilesh Kumar, 2013, Immune Netw, V13, P289, DOI 10.4110/in.2013.13.6.289; Jin M, 2014, J CEREBR BLOOD F MET, V34, P1306, DOI 10.1038/jcbfm.2014.83; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowland J. B., 1997, GENOMICS, V45, P17; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Naude P. J., 2012, FASEB J; Ni W, 2015, J CEREBR BLOOD F MET, V35, P1454, DOI 10.1038/jcbfm.2015.52; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Wu L, 2015, J NEUROCHEM, V132, P622, DOI 10.1111/jnc.13023; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; Zhao JB, 2016, ACTA NEUROCHIR SUPPL, V121, P291, DOI 10.1007/978-3-319-18497-5_50; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zhao JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058730; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018	33	21	21	3	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2016	368						392	398		10.1016/j.jns.2016.07.060			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7SU	WOS:000382415700079	27538670				2022-02-06	
J	Sturdivant, NM; Smith, SG; Ali, SF; Wolchok, JC; Balachandran, K				Sturdivant, Nasya M.; Smith, Sean G.; Ali, Syed F.; Wolchok, Jeffrey C.; Balachandran, Kartik			Acetazolamide Mitigates Astrocyte Cellular Edema Following Mild Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							IN-VITRO; VOLUME REGULATION; AQUAPORIN 4; CULTURES; STRAIN; TISSUE; MICE; PATHOPHYSIOLOGY; MECHANISMS; ISCHEMIA	Non-penetrating or mild traumatic brain injury (mTBI) is commonly experienced in accidents, the battlefield and in full-contact sports. Astrocyte cellular edema is one of the major factors that leads to high morbidity post-mTBI. Various studies have reported an upregulation of aquaporin-4 (AQP4), a water channel protein, following brain injury. AZA is an antiepileptic drug that has been shown to inhibit AQP4 expression and in this study we investigate the drug as a therapeutic to mitigate the extent of mTBI induced cellular edema. We hypothesized that mTBI-mediated astrocyte dysfunction, initiated by increased intracellular volume, could be reduced when treated with AZA. We tested our hypothesis in a three-dimensional in vitro astrocyte model of mTBI. Samples were subject to no stretch (control) or one high-speed stretch (mTBI) injury. AQP4 expression was significantly increased 24 hours after mTBI. mTBI resulted in a significant increase in the cell swelling within 30 min of mTBI, which was significantly reduced in the presence of AZA. Cell death and expression of S100B was significantly reduced when AZA was added shortly before mTBI stretch. Overall, our data point to occurrence of astrocyte swelling immediately following mTBI, and AZA as a promising treatment to mitigate downstream cellular mortality.	[Sturdivant, Nasya M.; Smith, Sean G.; Wolchok, Jeffrey C.; Balachandran, Kartik] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Ali, Syed F.] US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA		Balachandran, K (corresponding author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.	kbalacha@uark.edu			National Science FoundationNational Science Foundation (NSF) [CMMI-1404716]; NSF Graduate Research FellowshipNational Science Foundation (NSF) [DGE-1450079]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA008748] Funding Source: NIH RePORTER	This work was supported by the National Science Foundation under grant no. CMMI-1404716 and by the NSF Graduate Research Fellowship Program under grant no. DGE-1450079. We would like to acknowledge Dr. Timothy Muldoon for the use of the multiphoton microscope in his laboratory. We also acknowledge Addison Walker for his assistance with the neonatal rat astrocyte harvest.	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/782424; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Danny Liang M. D., 2009, NEUROSURG FOCUS, V22; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; Guo FY, 2012, TRANSL STROKE RES, V3, P130, DOI 10.1007/s12975-011-0106-0; HANSON MA, 1981, J PHYSIOL-LONDON, V320, P113, DOI 10.1113/jphysiol.1981.sp013938; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hubbard JA, 2015, ASN NEURO, V7, DOI 10.1177/1759091415605486; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P418, DOI 10.1016/j.bmc.2007.12.038; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kamegawa A, 2016, MICROSCOPY-JPN, V65, P177, DOI 10.1093/jmicro/dfv368; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Katada R., 2012, AMERIAN J PATHOLOGY, P17; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lan Y.-L., 2015, ACTA NEUROLOGICA BEL, P1; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marmarou A, 2003, ACT NEUR S, V86, P7; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mendizabal A, 2015, J MECH BEHAV BIOMED, V45, P1, DOI 10.1016/j.jmbbm.2015.01.016; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; NINDS, 2015, TRAUM BRAIN INJ HOP; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Thrane A. S., 2011, PNAS, P86; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Wang F, 2014, NEUROTOXICOLOGY, V41, P54, DOI 10.1016/j.neuro.2014.01.002; Xiao M, 2014, CNS NEUROSCI THER, V20, P385, DOI 10.1111/cns.12267; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	60	21	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 14	2016	6								33330	10.1038/srep33330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV8QE	WOS:000383200700001	27623738	Green Published, gold			2022-02-06	
J	Hutchinson, EB; Schwerin, SC; Radomski, KL; Irfanoglu, MO; Juliano, SL; Pierpaoli, CM				Hutchinson, Elizabeth B.; Schwerin, Susan C.; Radomski, Kryslaine L.; Irfanoglu, Mustafa O.; Juliano, Sharon L.; Pierpaoli, Carlo M.			QUANTITATIVE MRI AND DTI ABNORMALITIES DURING THE ACUTE PERIOD FOLLOWING CCI IN THE FERRET	SHOCK			English	Article						Anisotropy; diffusion tensor imaging; microgliosis; T2 relaxometry; traumatic axonal injury	TRAUMATIC BRAIN-INJURY; COMMON DATA ELEMENTS; WHITE-MATTER INJURY; AXONAL INJURY; DIFFEOMORPHIC REGISTRATION; MOUSE MODEL; DIFFUSION; RAT	During the acute time period following traumatic brain injury (TBI), noninvasive brain imaging tools such as magnetic resonance imaging (MRI) can provide important information about the clinical and pathological features of the injury and may help predict long-term outcomes. In addition to standard imaging approaches, several quantitative MRI techniques including relaxometry and diffusion MRI have been identified as promising reporters of cellular alterations after TBI and may provide greater sensitivity and specificity for identifying brain abnormalities especially in mild TBI. However, for these imaging tools to be useful, it is crucial to define their relationship with the neurophysiological response to brain injury. Recently, a model of controlled cortical impact (CCI) has been developed in the ferret which has many advantages compared with rodent models (e.g., gyrencephalic cortex and high white matter volume). The objective of this study was to evaluate quantitative MRI metrics in the ferret CCI model, including T2 values and diffusion tensor imaging (DTI) metrics, during the acute time period. Longitudinal quantitative comparisons of in vivo MRI and DTI metrics were evaluated to identify abnormalities and characterize their spatial patterns in the ferret brain. Ex vivo MRI and DTI maps were then compared with histological staining for glial and neuronal abnormalities. The main findings of this article describe T2, diffusivity, and anisotropy markers of tissue change during the acute time period following mild TBI, and ex vivo analyses suggest that MRI and DTI markers are sensitive to subtle cellular alterations in this model. This was confirmed by comparison with immunohistochemistry, also showing altered markers in regions of MRI and DTI change.	[Hutchinson, Elizabeth B.; Irfanoglu, Mustafa O.; Pierpaoli, Carlo M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 13,Room 3W16,13 South Dr, Bethesda, MD 20892 USA; [Schwerin, Susan C.; Radomski, Kryslaine L.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Hutchinson, Elizabeth B.; Schwerin, Susan C.; Radomski, Kryslaine L.; Irfanoglu, Mustafa O.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA		Hutchinson, EB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 13,Room 3W16,13 South Dr, Bethesda, MD 20892 USA.	elizabeth.hutchinson@nih.gov	Pierpaoli, Carlo/E-1672-2011; Juliano, Sharon/AAO-1030-2020	Pierpaoli, Carlo/0000-0001-8558-4428; Radomski, Kryslaine/0000-0001-9624-623X; Schwerin, Susan/0000-0001-5435-2448; Hutchinson, Elizabeth/0000-0002-3374-5469	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089, ZIHEB000088] Funding Source: NIH RePORTER		Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373; Pierpaoli C, 2010, ISMRM 19 ANN M STOCK; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Schwerin S, 2014, 44 ANN M SOC NEUR WA; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	23	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2016	46	3		1			167	176		10.1097/SHK.0000000000000659			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DX3HG	WOS:000384263600024	27294688	Green Published			2022-02-06	
J	Oldham, JR; Munkasy, BA; Evans, KM; Wikstrom, EA; Buckley, TA				Oldham, Jessie R.; Munkasy, Barry A.; Evans, Kelsey M.; Wikstrom, Erik A.; Buckley, Thomas A.			Altered dynamic postural control during gait termination following concussion	GAIT & POSTURE			English	Article						Mild traumatic brain injury; Motor control; Center of pressure displacements; Center of pressure velocities	BALANCE CONTROL; STABILITY; MANAGEMENT; INITIATION; STATEMENT; MOVEMENT; DEFICITS; SPORT	Impaired postural control is a cardinal symptom following concussion. Planned gait termination (GT) is a non-novel, dynamic task that challenges postural control in individuals with neurological deficits, and it could be an impactful measure for identifying dynamic postural control impairments following concussion. Therefore, the purpose of this study was to assess acute post-concussion dynamic postural control utilizing a planned GT task. The concussion participants (n = 19, age: 19.0 +/- 0.8 years, height: 177.0 +/- 10.1 cm, weight: 83.3 +/- 20.0 kg) completed five planned GT trials during preseason baseline testing (Baseline) and on Day 1 post-concussion (Day-1). Healthy control participants (n = 19, age: 20.4 +/- 1.2 years, height: 173.8 +/- 8.9 cm, weight: 80.2 +/- 17.6 kg) completed the same trials a week apart. The dependent variables of interest included COP displacement and velocity in the mediolateral (ML) and anteroposterior (AP) axes during the three phases (braking, transitional, stabilization) of planned GT. There were significant interactions observed in both the braking ML and transitional AP displacement (p = 0.042, p = 0.030) and velocity (p = 0.027, p = 0.030). These results suggest a conservative post concussion motor control strategy during planned GT. Further, these results support the use of dynamic postural control tasks as measures of post-concussion impairments. (C) 2016 Elsevier B.V. All rights reserved.	[Oldham, Jessie R.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 541 South Coll Ave, Newark, DE 19716 USA; [Munkasy, Barry A.] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA 30460 USA; [Evans, Kelsey M.] Emory Univ, Dept Emergency Med, Sch Med, 49 Jesse Hill Jr Dr,Suite 126, Atlanta, GA 30303 USA; [Wikstrom, Erik A.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 311 Woollen Gym, Chapel Hill, NC 27599 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 541 South Coll Ave, Newark, DE 19716 USA.	Jroldham@udel.edu; Bmunkasy@georgiasouthern.edu; Kelsey.evans@emory.edu; Wikstrom@unc.edu; Tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Wikstrom, Erik/0000-0002-7260-0502; Oldham, Jessie/0000-0003-2801-2110	National Institute of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS070744-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	This study was supported by the National Institute of Health/National Institute of Neurological Disorders and Stroke (1R15NS070744-01A1). The funding source had no role in the study design, data collection and interpretation, or decision to submit this manuscript for publication.	Bishop M, 2006, NEUROSCI LETT, V397, P240, DOI 10.1016/j.neulet.2005.12.031; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2014, GAIT BIOMETRICS BASI, P141; Buckley TA, 2008, MOVEMENT DISORD, V23, P1274, DOI 10.1002/mds.22079; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Howell D., 2015, J BIOMECH; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Lee H.W., 2012, J AM CERAM SOC, V1, P1; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; NORLIN R, 1981, J PEDIATR ORTHOPED, V1, P261, DOI 10.1097/01241398-198111000-00004; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Rahn C., CLIN J SPORT MED, V25; Ryckewaert G, 2014, NEUROPHYSIOL CLIN, V44, P227, DOI 10.1016/j.neucli.2014.03.004; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Sparrow WA, 2005, GAIT POSTURE, V22, P362, DOI 10.1016/j.gaitpost.2004.11.005; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Zhang S, 2014, GAIT BIOMETRICS, P191	30	21	21	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	SEP	2016	49						437	442		10.1016/j.gaitpost.2016.07.327			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	DY1MF	WOS:000384858400073	27522565	Green Accepted, Green Submitted			2022-02-06	
J	Ritter, AC; Wagner, AK; Szaflarski, JP; Brooks, MM; Zafonte, RD; Pugh, MJV; Fabio, A; Hammond, FM; Dreer, LE; Bushnik, T; Walker, WC; Brown, AW; Johnson-Greene, D; Shea, T; Krellman, JW; Rosenthal, JA				Ritter, Anne C.; Wagner, Amy K.; Szaflarski, Jerzy P.; Brooks, Maria M.; Zafonte, Ross D.; Pugh, Mary Jo V.; Fabio, Anthony; Hammond, Flora M.; Dreer, Laura E.; Bushnik, Tamara; Walker, William C.; Brown, Allen W.; Johnson-Greene, Doug; Shea, Timothy; Krellman, Jason W.; Rosenthal, Joseph A.			Prognostic models for predicting posttraumatic seizures during acute hospitalization, and at 1 and 2 years following traumatic brain injury	EPILEPSIA			English	Article						Epilepsy; TBI Model System; Prognostic modeling; Risk factors; Craniectomy	RISK-FACTORS; DECOMPRESSIVE CRANIECTOMY; GENETIC-VARIATION; EPILEPSY; ASSOCIATIONS; REHABILITATION; COMPLICATIONS; MECHANISMS	Objective: Posttraumatic seizures (PTS) are well-recognized acute and chronic complications of traumatic brain injury (TBI). Risk factors have been identified, but considerable variability in who develops PTS remains. Existing PTS prognostic models are not widely adopted for clinical use and do not reflect current trends in injury, diagnosis, or care. We aimed to develop and internally validate preliminary prognostic regression models to predict PTS during acute care hospitalization, and at year 1 and year 2 postinjury. Methods: Prognostic models predicting PTS during acute care hospitalization and year 1 and year 2 post-injury were developed using a recent (2011-2014) cohort from the TBI Model Systems National Database. Potential PTS predictors were selected based on previous literature and biologic plausibility. Bivariable logistic regression identified variables with a p-value < 0.20 that were used to fit initial prognostic models. Multivariable logistic regression modeling with backward-stepwise elimination was used to determine reduced prognostic models and to internally validate using 1,000 bootstrap samples. Fit statistics were calculated, correcting for overfitting (optimism). Results: The prognostic models identified sex, craniotomy, contusion load, and pre-injury limitation in learning/remembering/concentrating as significant PTS predictors during acute hospitalization. Significant predictors of PTS at year 1 were subdural hematoma (SDH), contusion load, craniotomy, craniectomy, seizure during acute hospitalization, duration of posttraumatic amnesia, preinjury mental health treatment/psychiatric hospitalization, and preinjury incarceration. Year 2 significant predictors were similar to those of year 1: SDH, intraparenchymal fragment, craniotomy, craniectomy, seizure during acute hospitalization, and preinjury incarceration. Corrected concordance (C) statistics were 0.599, 0.747, and 0.716 for acute hospitalization, year 1, and year 2 models, respectively. Significance: The prognostic model for PTS during acute hospitalization did not discriminate well. Year 1 and year 2 models showed fair to good predictive validity for PTS. Cranial surgery, although medically necessary, requires ongoing research regarding potential benefits of increased monitoring for signs of epileptogenesis, PTS prophylaxis, and/or rehabilitation/social support. Future studies should externally validate models and determine clinical utility.	[Ritter, Anne C.; Brooks, Maria M.; Fabio, Anthony] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Ritter, Anne C.; Wagner, Amy K.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Epilepsy Ctr, UAB Stn, Birmingham, AL 35294 USA; [Zafonte, Ross D.] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA USA; [Pugh, Mary Jo V.] South Texas Vet Hlth Care Syst Polytrauma Rehabil, San Antonio, TX USA; [Pugh, Mary Jo V.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Bushnik, Tamara] NYU, Sch Med, Rusk Rehabil, New York, NY USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Shea, Timothy] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Krellman, Jason W.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Rosenthal, Joseph A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Brown, Allen W./0000-0001-7228-3351; Brooks, Maria/0000-0002-2030-7873; Bushnik, Tamara/0000-0003-3328-257X; Fabio, Anthony/0000-0002-6808-4939	NIDILRRUnited States Department of Health & Human Services [90DP0041, 90DP0038, 90DP0036, 90DP0033]; Polytrauma Rehabilitation Center Traumatic Brain Injury Model System; Department of Veterans Affairs (VA)US Department of Veterans Affairs; NIDILRRUnited States Department of Health & Human Services	The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) supported the collection of original data for this manuscript. The contents of this manuscript were developed under grants NIDILRR Grants 90DP0041 (AKW, ACR), NIDILRR 90DP0038 (JWK), 90DP0036 (FH), 90DP0033 (WCW), and the Polytrauma Rehabilitation Center Traumatic Brain Injury Model System (MJP). The Polytrauma Rehabilitation Center TBI Model System is a funded collaboration between the Department of Veterans Affairs (VA) and NIDILRR. NIDILRR is a Center within the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of the VA, NIDILRR, ACL, or HHS, and endorsement of this content by the Federal Government should not be assumed.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2012, EPILEPSY BEHAV, V24, P304, DOI 10.1016/j.yebeh.2012.04.128; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Harrell FE Jr, 2017, REGRESSION MODELING; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Keele NB, 2005, EPILEPSY BEHAV, V7, P325, DOI 10.1016/j.yebeh.2005.06.014; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; McDermott S, 2005, AM J MENT RETARD, V110, P48, DOI 10.1352/0895-8017(2005)110<48:POEIAW>2.0.CO;2; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Ramakrishnan Vivek, 2015, Surg Neurol Int, V6, P8, DOI 10.4103/2152-7806.149613; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Sills Graeme J, 2007, Epilepsy Curr, V7, P103, DOI 10.1111/j.1535-7511.2007.00189.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Weston J, 2015, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.00007286.PUB3; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	46	21	22	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2016	57	9					1503	1514		10.1111/epi.13470			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EB8QJ	WOS:000387655600025	27430564	Green Submitted			2022-02-06	
J	Sigakis, MJG; Leffert, LR; Mirzakhani, H; Sharawi, N; Rajala, B; Callaghan, WM; Kuklina, EV; Creanga, AA; Mhyre, JM; Bateman, BT				Sigakis, Matthew J. G.; Leffert, Lisa R.; Mirzakhani, Hooman; Sharawi, Nadir; Rajala, Baskar; Callaghan, William M.; Kuklina, Elena V.; Creanga, Andreea A.; Mhyre, Jill M.; Bateman, Brian T.			The Validity of Discharge Billing Codes Reflecting Severe Maternal Morbidity	ANESTHESIA AND ANALGESIA			English	Article							ADMINISTRATIVE DATA; ACCURACY; IDENTIFICATION; VALIDATION; DIAGNOSES	BACKGROUND: Discharge diagnoses are used to track national trends and patterns of maternal morbidity. There are few data regarding the validity of the International Classification of Diseases (ICD) codes used for this purpose. The goal of our study was to try to better understand the validity of administrative data being used to monitor and assess trends in morbidity. METHODS: Hospital stay billing records were queried to identify all delivery admissions at the Massachusetts General Hospital for the time period 2001 to 2011 and the University of Michigan Health System for the time period 2005 to 2011. From this, we identified patients with ICD-9-Clinical Modification (CM) diagnosis and procedure codes indicative of severe maternal morbidity. Each patient was classified with 1 of 18 different medical/obstetric categories (conditions or procedures) based on the ICD-9-CM code that was recorded. Within each category, 20 patients from each institution were selected at random, and the corresponding medical charts were reviewed to determine whether the ICD-9-CM code was assigned correctly. The percentage of correct codes for each of 18 preselected clinical categories was calculated yielding a positive predictive value (PPV) and 99% confidence interval (CI). RESULTS: The overall number of correctly assigned ICD-9-CM codes, or PPV, was 218 of 255 (86%; CI, 79%-90%) and 154 of 188 (82%; CI, 74%-88%) at Massachusetts General Hospital and University of Michigan Health System, respectively (combined PPV, 372/443 [84%; CI, 79-88%]). Codes within 4 categories (Hysterectomy, Pulmonary edema, Disorders of fluid, electrolyte and acid-base balance, and Sepsis) had a 99% lower confidence limit >= 75%. Codes within 8 additional categories demonstrated a 99% lower confidence limit between 74% and 50% (Acute respiratory distress, Ventilation, Other complications of obstetric surgery, Disorders of coagulation, Cardiomonitoring, Acute renal failure, Thromboembolism, and Shock). Codes within 6 clinical categories demonstrated a 99% lower confidence limit <50% (Puerperal cerebrovascular disorders, Conversion of cardiac rhythm, Acute heart failure [includes arrest and fibrillation], Eclampsia, Neurotrauma, and Severe anesthesia complications). CONCLUSIONS: ICD-9-CM codes capturing severe maternal morbidity during delivery hospitalization demonstrate a range of PPVs. The PPV was high when objective supportive evidence, such as laboratory values or procedure documentation supported the ICD-9-CM code. The PPV was low when greater judgment, interpretation, and synthesis of the clinical data (signs and symptoms) was required to support a code, such as with the category Severe anesthesia complications. As a result, these codes should be used for administrative research with more caution compared with codes primarily defined by objective data.	[Sigakis, Matthew J. G.; Sharawi, Nadir; Rajala, Baskar] Univ Michigan, Sch Med, Dept Anesthesiol, 1H247 UH,SPC 5048,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Leffert, Lisa R.; Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Div Obstet Anesthesia, Boston, MA 02114 USA; [Mirzakhani, Hooman] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Callaghan, William M.; Creanga, Andreea A.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Kuklina, Elena V.] Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div Heart Dis & Stroke Prevent, Atlanta, GA USA; [Mhyre, Jill M.] Univ Arkansas Med Sci, Dept Anesthesiol, Little Rock, AR 72205 USA		Sigakis, MJG (corresponding author), Univ Michigan, Sch Med, Dept Anesthesiol, 1H247 UH,SPC 5048,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	msigakis@med.umich.edu	Kuklina, Elena/AAF-3532-2020	Mirzakhani, Hooman/0000-0002-2290-4436	Intramural CDC HHS [CC999999] Funding Source: Medline		[Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; Berthelsen C L, 2000, Top Health Inf Manage, V21, P10; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Callaghan WM, 2014, OBSTET GYNECOL, V123, P978, DOI 10.1097/AOG.0000000000000218; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Centers for Disease Control and Prevention, 2016, CLASS DIS INT CLASS; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI 10.1016/j.ajog.2007.12.020; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Kilpatrick SJ, 2014, OBSTET GYNECOL, V124, P361, DOI 10.1097/AOG.0000000000000397; Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b; Lain SJ, 2012, MED CARE, V50, pE7, DOI 10.1097/MLR.0b013e31821d2b1d; McIsaac DI, 2015, ANESTHESIOLOGY, V123, P253, DOI 10.1097/ALN.0000000000000692; Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d; Neuman MD, 2015, ANESTHESIOLOGY, V123, P243, DOI 10.1097/ALN.0000000000000691; Pinyavat T, 2015, ANESTHESIOLOGY, V122, P55, DOI 10.1097/ALN.0000000000000467; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Romano PS, 2002, MED CARE, V40, P856, DOI 10.1097/00005650-200210000-00004; Ronsmans C, 2009, BEST PRACT RES CL OB, V23, P305, DOI 10.1016/j.bpobgyn.2009.01.001; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Severe Maternal Morbidity, 2016, SEVERE MATERNAL MORB; Wanderer JP, 2013, CRIT CARE MED, V41, P1844, DOI 10.1097/CCM.0b013e31828a3e24; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	28	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	2016	123	3					731	738		10.1213/ANE.0000000000001436			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DT9RA	WOS:000381838800025	27387839	Green Accepted			2022-02-06	
J	Hua, Z; Liu, LP; Shen, J; Cheng, K; Liu, AJ; Yang, J; Wang, LN; Qu, TY; Yang, HN; Li, Y; Wu, HY; Narouze, J; Yin, Y; Cheng, JG				Hua, Zhen; Liu, LiPing; Shen, Jun; Cheng, Katherine; Liu, Aijun; Yang, Jing; Wang, Lina; Qu, Tingyu; Yang, HongNa; Li, Yan; Wu, Haiyan; Narouze, John; Yin, Yan; Cheng, Jianguo			Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioidinduced Hyperalgesia	SCIENTIFIC REPORTS			English	Article							OPIOID-INDUCED HYPERALGESIA; TRAUMATIC BRAIN-INJURY; BONE-MARROW; STROMAL CELLS; NEUROPATHIC PAIN; ANALGESIC TOLERANCE; THERMAL HYPERALGESIA; NERVE INJURY; SPINAL-CORD; MECHANISMS	More than 240 million opioid prescriptions are dispensed annually to treat pain in the US. The use of opioids is commonly associated with opioid tolerance (OT) and opioid-induced hyperalgesia (OIH), which limit efficacy and compromise safety. The dearth of effective way to prevent or treat OT and OIH is a major medical challenge. We hypothesized that mesenchymal stem cells (MSCs) attenuate OT and OIH in rats and mice based on the understanding that MSCs possess remarkable anti-inflammatory properties and that both OT and chronic pain are associated with neuroinflammation in the spinal cord. We found that the development of OT and OIH was effectively prevented by either intravenous or intrathecal MSC transplantation (MSC-TP), which was performed before morphine treatment. Remarkably, established OT and OIH were significantly reversed by either intravenous or intrathecal MSCs when cells were transplanted after repeated morphine injections. The animals did not show any abnormality in vital organs or functions. Immunohistochemistry revealed that the treatments significantly reduced activation level of microglia and astrocytes in the spinal cord. We have thus demonstrated that MSC-TP promises to be a potentially safe and effective way to prevent and reverse two of the major problems of opioid therapy.	[Hua, Zhen; Liu, LiPing; Shen, Jun; Cheng, Katherine; Liu, Aijun; Yang, Jing; Wang, Lina; Wu, Haiyan; Narouze, John; Yin, Yan; Cheng, Jianguo] Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Pain Management, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hua, Zhen; Liu, LiPing; Shen, Jun; Cheng, Katherine; Liu, Aijun; Yang, Jing; Wang, Lina; Wu, Haiyan; Narouze, John; Yin, Yan; Cheng, Jianguo] Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA; Beijing Hosp, Dept Anesthesiol, 1 Dahua Rd, Beijing 100730, Peoples R China; [Qu, Tingyu; Yang, HongNa; Li, Yan] Univ Illinois, Coll Med, Inst Psychiat, Dept Psychiat, Chicago, IL USA		Cheng, JG (corresponding author), Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Pain Management, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Cheng, JG (corresponding author), Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chengj@ccf.org	aijun, liu/X-6413-2019; Cheng, Jianguo/I-1990-2019	Cheng, Jianguo/0000-0002-2318-0812	Department of DefenseUnited States Department of Defense [10669042]; Cleveland Clinic Anesthesiology Institute	This work is supported by grants from the Department of Defense (10669042) and Cleveland Clinic Anesthesiology Institute. We thank Richard Rosenquist, MD, and Daniel Sessler, MD, for commenting on an earlier version of the letter and David Brown, MD, for supporting the project, Yan Li, PhD, for assisting with MSC isolation and characterization, and Judith Drazba, PhD, for providing excellent Imaging Core Service.	[Anonymous], 2011, RELIEVING PAIN AM; Atoui R, 2012, EXPERT OPIN BIOL TH, V12, P1293, DOI 10.1517/14712598.2012.711307; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; BEITNERJOHNSON D, 1993, J NEUROCHEM, V61, P1766, DOI 10.1111/j.1471-4159.1993.tb09814.x; Bekhit MH, 2010, AM J THER, V17, P498, DOI 10.1097/MJT.0b013e3181ed83a0; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen G, 2015, J CLIN INVEST, V125, P3226, DOI 10.1172/JCI80883; Chu LF, 2012, PAIN, V153, P1583, DOI 10.1016/j.pain.2012.02.028; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; De Miguel MP, 2012, CURR MOL MED, V12, P574; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Eidson LN, 2013, J PAIN, V14, P393, DOI 10.1016/j.jpain.2012.12.010; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Guo W, 2011, STEM CELLS, V29, P1294, DOI 10.1002/stem.667; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Hosseini M, 2015, BIOL BLOOD MARROW TR, V21, P1537, DOI 10.1016/j.bbmt.2015.05.008; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Inoue M, 2003, GLIA, V44, P111, DOI 10.1002/glia.10285; Katsuno T, 2013, J CLIN BIOCHEM NUTR, V53, P170, DOI 10.3164/jcbn.13-68; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Kim EJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.2; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Liechty K. W., 2000, J AM COLL SURGEONS, V191, pS96, DOI DOI 10.1016/S1072-7515(00)00675-X; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Lu Y, 2004, ANESTH ANALG, V98, P414, DOI 10.1213/01.ANE.0000094334.12027.06; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Mao JR, 2002, J NEUROSCI, V22, P7650; Matsushita Y, 2013, CURR PHARM DESIGN, V19, P7355; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; Monsel A, 2014, ANESTHESIOLOGY, V121, P1099, DOI 10.1097/ALN.0000000000000446; Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Patel A., 2011, STEM CELLS CLONING A, V61; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Sanna MD, 2015, PAIN, V156, P1265, DOI 10.1097/j.pain.0000000000000164; Schafer S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0157-8; Shen J, 2013, PAIN MED, V14, P516, DOI 10.1111/pme.12057; Shen J, 2012, ANESTHESIOLOGY, V117, P365, DOI 10.1097/ALN.0b013e318260de41; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Sondergaard CS, 2010, ANN THORAC SURG, V90, P796, DOI 10.1016/j.athoracsur.2010.04.080; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Togel FE, 2010, NAT REV NEPHROL, V6, P179, DOI 10.1038/nrneph.2009.229; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vawda R, 2012, INDIAN J ORTHOP, V46, P10, DOI 10.4103/0019-5413.91629; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou QH, 2014, ACTA NEUROPSYCHIATR, V26, P218, DOI 10.1017/neu.2013.57	68	21	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 24	2016	6								32096	10.1038/srep32096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9VG	WOS:000381849800001	27554341	Green Published, gold			2022-02-06	
J	Banks, SD; Coronado, RA; Clemons, LR; Abraham, CM; Pruthi, S; Conrad, BN; Morgan, VL; Guillamondegui, OD; Archer, KR				Banks, Sarah D.; Coronado, Rogelio A.; Clemons, Lori R.; Abraham, Christine M.; Pruthi, Sumit; Conrad, Benjamin N.; Morgan, Victoria L.; Guillamondegui, Oscar D.; Archer, Kristin R.			Thalamic Functional Connectivity in Mild Traumatic Brain Injury: Longitudinal Associations With Patient-Reported Outcomes and Neuropsychological Tests	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Conference of the American-Congress-of-Rehabilitation-Medicine	OCT 25-30, 2015	Dallas, TX	Amer Congress Rehabil Med		Brain injuries; Functional neuroimaging; Magnetic resonance imaging; Neuropsychological tests; Rehabilitation; Thalamus	POSTTRAUMATIC-STRESS-DISORDER; FRONTOPARIETAL CONTROL-SYSTEM; RESTING-STATE FMRI; NETWORK CONNECTIVITY; COGNITIVE DECLINE; HEAD-INJURY; PAIN; CORTEX; SCHIZOPHRENIA; ACTIVATIONS	Objectives: (1) To examine differences in patient-reported outcomes, neuropsychological tests, and thalamic functional connectivity (FC) between patients with mild traumatic brain injury (mTBI) and individuals without mTBI and (2) to determine longitudinal associations between changes in these measures. Design: Prospective observational case-control study. Setting: Academic medical center. Participants: A sample (N=24) of 13 patients with mTBI (mean age, 39.3 +/- 14.0y; 4 women [31%]) and 11 age- and sex-matched controls without mTBI (mean age, 37.6 +/- 13.3y; 4 women [36%]). Interventions: Not applicable. Main Outcome Measures: Resting state FC (3T magnetic resonance imaging scanner) was examined between the thalamus and the default mode network, dorsal attention network, and frontoparietal control network. Patient-reported outcomes included pain (Brief Pain Inventory), depressive symptoms (Patient Health Questionnaire-9), posttraumatic stress disorder ([PTSD] Checklist - Civilian Version), and postconcussive symptoms (Rivermead Post-Concussion Symptoms Questionnaire). Neuropsychological tests included the Delis-Kaplan Executive Function System Tower test, Trails B, and Hotel Task. Assessments occurred at 6 weeks and 4 months after hospitalization in patients with mTBI and at a single visit for controls. Results: Student t tests found increased pain, depressive symptoms, PTSD symptoms, and postconcussive symptoms; decreased performance on Trails B; increased FC between the thalamus and the default mode network; and decreased FC between the thalamus and the dorsal attention network and between the thalamus and the frontoparietal control network in patients with mTBI as compared with controls. The Spearman correlation coefficient indicated that increased FC between the thalamus and the dorsal attention network from baseline to 4 months was associated with decreased pain and postconcussive symptoms (corrected P<.05). Conclusions: Findings suggest that alterations in thalamic FC occur after mTBI, and improvements in pain and postconcussive symptoms are correlated with normalization of thalamic FC over time. (C) 2016 by the American Congress of Rehabilitation Medicine	[Banks, Sarah D.; Coronado, Rogelio A.; Clemons, Lori R.; Abraham, Christine M.; Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg, Nashville, TN USA; [Abraham, Christine M.] Lehigh Univ, Dept Educ & Human Serv, Bethlehem, PA 18015 USA; [Pruthi, Sumit; Conrad, Benjamin N.; Morgan, Victoria L.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Conrad, Benjamin N.; Morgan, Victoria L.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, Nashville, TN USA		Archer, KR (corresponding author), Vanderbilt Orthopaed Inst, Med Ctr East, South Tower,Suite 4200,1215 21st Ave S, Nashville, TN 37232 USA.	kristin.archer@vanderbilt.edu		Coronado, Rogelio/0000-0002-7112-4903; Conrad, Benjamin/0000-0003-3755-6988	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075270] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54 HD083211] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS075270] Funding Source: Medline		Ab Aziz CB, 2006, MALAYS J MED SCI, V13, P11; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cai SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115573; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cauda F, 2010, J NEUROL NEUROSUR PS, V81, P806, DOI 10.1136/jnnp.2009.188631; Cetin MS, 2014, NEUROIMAGE, V97, P117, DOI 10.1016/j.neuroimage.2014.04.009; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cohen J., 1988, STAT POWER ANAL BEHA, P567; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cummiford CM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0934-0; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Delis DC., 2001, DELIS KAPLAN EXECUTI; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gerberding JL, 2003, REP C MILD TRAUM BRA, P9; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Ichesco E, 2016, EUR J PAIN      0115; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li R, 2013, AM J NEURORADIOL, V34, P340, DOI 10.3174/ajnr.A3197; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Melzack Ronald, 2005, Pain Pract, V5, P85, DOI 10.1111/j.1533-2500.2005.05203.x; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Militana AR, 2015, BRAIN IMAGING BEHAV; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Niesters M, 2014, BRAIN CONNECT, V4, P404, DOI 10.1089/brain.2014.0247; Onoda K, 2012, J COGNITIVE NEUROSCI, V24, P2186, DOI 10.1162/jocn_a_00269; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shulman GL, 1997, HUM BRAIN MAPP, V5, P317, DOI 10.1002/(SICI)1097-0193(1997)5:4<317::AID-HBM19>3.0.CO;2-A; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tu PC, 2013, SCHIZOPHR RES, V147, P339, DOI 10.1016/j.schres.2013.04.011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilcox CE, 2015, PAIN MED, V16, P2121, DOI 10.1111/pme.12785; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	72	21	22	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1254	1261		10.1016/j.apmr.2016.03.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200006	27085849	Green Accepted			2022-02-06	
J	McKinlay, A; Horwood, LJ; Fergusson, DM				McKinlay, Audrey; Horwood, L. John; Fergusson, David M.			Accuracy of Self-report as a Method of Screening for Lifetime Occurrence of Traumatic Brain Injury Events that Resulted in Hospitalization	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Head injury; Concussion; Self-report; Recall; Accuracy; Cohort; Prospective	NEUROPSYCHOLOGICAL FUNCTION; POSTCONCUSSION SYNDROME; PSYCHOSOCIAL OUTCOMES; SUBSTANCE-ABUSE; HEAD-INJURY; CHILDHOOD; CHILDREN; HEALTH; EPIDEMIOLOGY; ADOLESCENTS	Background Traumatic brain injury (TBI) occurs frequently during child and early adulthood, and is associated with negative outcomes including increased risk of drug abuse, mental health disorders and criminal offending. Identification of previous TBI for at-risk populations in clinical settings often relies on self-report, despite little information regarding self-report accuracy. This study examines the accuracy of adult self-report of hospitalized TBI events and the factors that enhance recall. Methods The Christchurch Health and Development Study is a birth cohort of 1265 children born in Christchurch, New Zealand, in 1977. A history of TBI events was prospectively gathered at each follow-up (yearly intervals 0-16, 18, 21, 25 years) using parental/self-report, verified using hospital records. Results At 25 years, 1003 cohort members were available, with 59/101 of all hospitalized TBI events being recalled. Recall varied depending on the age at injury and injury severity, with 10/11 of moderate/severe TBI being recalled. Logistic regression analysis indicated that a model using recorded loss of consciousness, age at injury, and injury severity, could accurately classify whether or not TBI would be reported in over 74% of cases. Conclusions This research demonstrates that, even when individuals are carefully cued, many instances of TBI will not recalled in adulthood despite the injury having required a period of hospitalization. Therefore, screening for TBI may require a combination of self-report and review of hospital files to ensure that all cases are identified.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Horwood, L. John; Fergusson, David M.] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Psychol Clin, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		Horwood, L./0000-0003-4881-1956; McKinlay, Audrey/0000-0001-9846-8514			Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Bruce D, 2000, PSYCHOL SCI, V11, P360, DOI 10.1111/1467-9280.00271; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Fergusson DM, 1998, J EMOT BEHAV DISORD, V6, P2, DOI 10.1177/106342669800600101; FERGUSSON DM, 1991, J CHILD PSYCHOL PSYC, V32, P257, DOI 10.1111/j.1469-7610.1991.tb00305.x; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2013, INT NEUROTRAUMA LETT, V33; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2014, J FAM VIOLENCE, V29, P391, DOI 10.1007/s10896-014-9591-8; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Youngblut JM, 2006, J PEDIATR PSYCHOL, V31, P608, DOI 10.1093/jpepsy/jsj066; Youngblut JM, 2008, J HEAD TRAUMA REHAB, V23, P92, DOI 10.1097/01.HTR.0000314528.85758.30	40	21	21	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2016	22	7					717	723		10.1017/S1355617716000497			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	DU8SQ	WOS:000382485100003	27265159				2022-02-06	
J	Zenisek, R; Millis, SR; Banks, SJ; Miller, JB				Zenisek, RyAnna; Millis, Scott R.; Banks, Sarah J.; Miller, Justin B.			Prevalence of below-criterion Reliable Digit Span scores in a clinical sample of older adults	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Dementia; Malingering/symptom validity testing; Assessment; Reliable Digit Span	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; DEMENTIA; MEMORY; VALIDATION; INVALIDITY; INDICATORS; SEVERITY	Objective: The Reliable Digit Span (RDS) is a well-validated embedded indicator of performance validity. An RDS score of <= 7 is commonly referenced as indicative of invalid performance; however, few studies have examined the classification accuracy of the RDS among individuals suspected for dementia. The current study evaluated performance of the RDS in a clinical sample of 934 non-litigating individuals presenting to an outpatient memory disorders clinic for assessment of dementia. Method: The RDS was calculated for each participant in the context of a comprehensive neuropsychological assessment completed as part of routine clinical care. Score distributions were examined to establish the base rate of below criterion performance for RDS cutoffs of <= 7, <= 6, and <= 5. One-way ANOVA was used to compare performance on a cognitive screening measure and informant reports of functional independence of those falling below and above cutoffs. Results: A cutoff score of <= 7 resulted in a high prevalence of below-criterion performance (29.7%), though an RDS of <= 6 was associated with fewer below-criterion scores (12.8%) and prevalence of an RDS of <= 5 was infrequent (4.3%). Those scoring below cutoffs performed worse on cognitive measures compared with those falling above cutoffs. Conclusions: Using the RDS as a measure of performance validity among individuals presenting with a possibility of dementia increases the risk of misinterpreting genuine cognitive impairment as invalid performance when higher cutoffs are used; lower cutoffs may be useful when interpreted in conjunction with other measures of performance validity.	[Zenisek, RyAnna] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Banks, Sarah J.; Miller, Justin B.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA		Miller, JB (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA.	millerj4@ccf.org		Miller, Justin B./0000-0002-4439-6604; Banks, Sarah/0000-0001-7536-2370	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM109025] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109025] Funding Source: NIH RePORTER		An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bortnik KE, 2013, APPL NEUROPSYCH-ADUL, V20, P233, DOI 10.1080/09084282.2012.695757; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Calderon J, 2001, J NEUROL NEUROSUR PS, V70, P157, DOI 10.1136/jnnp.70.2.157; Cohen J., 2013, STAT POWER ANAL BEHA; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gagnon LG, 2011, NEUROPSYCHOLOGY, V25, P226, DOI 10.1037/a0020919; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hales R.E., 2014, AM PSYCHIAT PUBLISHI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Johnson N, 2004, ALZ DIS ASSOC DIS, V18, P223; Kaplan E., 2001, BOSTON NAMING TEST; Kessels RPC, 2011, AGING CLIN EXP RES, V23, P487; Kiewel NA, 2012, CLIN NEUROPSYCHOL, V26, P965, DOI 10.1080/13854046.2012.694478; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Vogel Sally J, 2015, Alzheimers Dement (Amst), V1, P289, DOI 10.1016/j.dadm.2015.05.002; Walter J, 2014, CLIN NEUROPSYCHOL, V28, P1197, DOI 10.1080/13854046.2014.960454; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Wechsler D., 2008, WECHSLER ADULT INTEL; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	40	21	21	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2016	31	5					426	433		10.1093/arclin/acw025			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DU0LF	WOS:000381895200005	27193362	Green Published, Bronze			2022-02-06	
J	Skovira, JW; Kabadi, SV; Wu, JF; Zhao, ZR; DuBose, J; Rosenthal, R; Fiskum, G; Faden, AI				Skovira, Jacob W.; Kabadi, Shruti V.; Wu, Junfang; Zhao, Zaorui; DuBose, Joseph; Rosenthal, Robert; Fiskum, Gary; Faden, Alan I.			Simulated Aeromedical Evacuation Exacerbates Experimental Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						aeromedical evacuation; hypobaria; inflammation; neuronal cell death; traumatic brain injury	LIMITS MICROGLIAL ACTIVATION; NEUROINFLAMMATORY RESPONSE; IRAQI FREEDOM; NEURONAL LOSS; TRAUMA; NEURODEGENERATION; INFLAMMATION; ASSOCIATION; HYPEROXIA; OXYGEN	Aeromedical evacuation, an important component in the care of many patients with traumatic brain injury (TBI), particularly in war zones, exposes them to prolonged periods of hypobaria. The effects of such exposure on pathophysiological changes and outcome after TBI are largely unexplored. The objective of this study was to investigate whether prolonged hypobaria in rats subjected to TBI alters behavioral and histological outcomes. Adult male Sprague-Dawley rats underwent fluid percussion induced injury at 1.5-1.9 atmospheres of pressure. The effects of hypobaric exposure (6 h duration; equivalent to 0.75 atmospheres) at 6, 24, and 72 h, or 7 days after TBI were evaluated with regard to sensorimotor, cognitive, and histological changes. Additional groups were evaluated to determine the effects of two hypobaric exposures after TBI, representing primary simulated aeromedical evacuation (6 h duration at 24 h after injury) and secondary evacuation (10 h duration at 72 h after injury), as well as the effects of 100% inspired oxygen concentrations during simulated evacuation. Hypobaric exposure up to 7 days after injury significantly worsened cognitive deficits, hippocampal neuronal loss, and microglial/astrocyte activation in comparison with injured controls not exposed to hypobaria. Hyperoxia during hypobaric exposure or two exposures to prolonged hypobaric conditions further exacerbated spatial memory deficits. These findings indicate that exposure to prolonged hypobaria up to 7 days after TBI, even while maintaining physiological oxygen concentration, worsens long-term cognitive function and neuroinflammation. Multiple exposures or use of 100% oxygen further exacerbates these pathophysiological effects.	[Skovira, Jacob W.; Kabadi, Shruti V.; Wu, Junfang; Zhao, Zaorui; Fiskum, Gary; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [DuBose, Joseph] Univ Maryland, Sch Med, Program Trauma, Ctr Sustainment Trauma & Readiness Skills C STARS, Baltimore, MD 21201 USA; [Rosenthal, Robert] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA		Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.	afaden@anes.umm.edu		Faden, Alan I./0000-0003-0128-2348			Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Bridges E, 2010, AACN ADV CRIT CARE, V21, P260, DOI 10.1097/NCI.0b013e3181e67385; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Reno J, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1023; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rosenthal RE, 2005, HOSP MED, V66, P76; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1	30	21	21	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1292	1302		10.1089/neu.2015.4189			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100002	26593382				2022-02-06	
J	Haaland, KY; Sadek, JR; Keller, JE; Castillo, DT				Haaland, Kathleen Y.; Sadek, Joseph R.; Keller, Jenna E.; Castillo, Diane T.			Neurocognitive Correlates of Successful Treatment of PTSD in Female Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Executive functioning; Psychotherapy; Female; Trauma; PTSD; Veterans	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; MEMORY MALINGERING TOMM; EXECUTIVE FUNCTION; NEUROPSYCHOLOGICAL PERFORMANCE; MODIFICATION PROGRAM; INHIBITORY CONTROL; VERBAL MEMORY; ATTENTION; DEFICITS	Background: The influence of psychotherapy on neurocognition in post-traumatic stress disorder (PTSD) has not been examined methodically. This is despite evidence that pre-treatment learning and memory has been associated with treatment success and that executive function theories emphasize weak executive functions (especially inhibition/switching) are associated with PTSD. Objectives: To determine (1) if higher pre-treatment learning/memory, inhibition/switching, or both predict treatment success; and (2) if treatment success is associated with specific improvement in inhibition/switching and not learning/memory or working memory, another aspect of executive function. Methods: Pre-treatment neurocognition and neurocognitive changes (inhibition/switching, learning/memory, working memory) were examined in female veterans with PTSD. They were evaluated before and after 16-weeks of group psychotherapy for PTSD that included three counterbalanced modules (cognitive restructuring therapy, exposure therapy, skills training) with fidelity checks for therapist adherence. Results: Only pre-treatment learning/memory predicted better treatment outcome. Treatment success was associated with improvement in inhibition/switching only, even after controlling for mild traumatic brain injury, and changes in depressive symptoms, working memory, and learning/memory. Conclusions: Our finding that learning/memory predicted treatment success is consistent with previous studies. We extended these studies by showing that the effect was restricted to learning/memory, which is contrary to the executive function theory of PTSD. In contrast, the fact that only inhibition/switching significantly improved with better treatment success is consistent with its potential importance in maintaining PTSD symptoms. Future research should determine whether inhibition/switching abilities are a risk for development and maintenance of PTSD or whether such abilities have a broader reciprocal relationship with PTSD symptom change.	[Haaland, Kathleen Y.; Sadek, Joseph R.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Haaland, Kathleen Y.; Sadek, Joseph R.; Keller, Jenna E.; Castillo, Diane T.] New Mexico Vet Affairs Healthcare Syst, Albuquerque, NM USA; [Keller, Jenna E.] Biomed Res Inst New Mexico, Albuquerque, NM USA; [Castillo, Diane T.] VISN 17 Ctr Excellence, Waco, TX USA		Haaland, KY (corresponding author), Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA.	khaaland@unm.edu			Department of DefenseUnited States Department of Defense [PT074309, W81XWH-08-2-0022]; Department of Veterans AffairsUS Department of Veterans Affairs; Research Service at the NMVAHCS; Veterans Health AdministrationUS Department of Veterans Affairs	Study supported by the Department of Defense (D.C., grant number PT074309, Award number W81XWH-08-2-0022); Department of Veterans Affairs (K.Y.H., Career Scientist Award); and Research Service at the NMVAHCS (K.Y.H.), which approved the study design, but required no additional approvals. None of the authors had any potential conflicts of interest. This work was completed with support from the Veterans Health Administration. The views are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; [Anonymous], 2003, VA DOD CLIN PRACT GU; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Castillo DT, 2016, PSYCHOL TRAUMA-US, V8, P404, DOI 10.1037/tra0000111; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis DC., 2001, DELIS KAPLAN EXECUTI; DELIS DC, 2000, CVLT 2 MANUAL; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Foa E.B., 2007, PROLONGED EXPOSURE T; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Goodkind MS, 2016, INT J GERIATR PSYCH, V31, P334, DOI 10.1002/gps.4325; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Institutes of Medicine, 2008, TREATM POSTTR STRESS; Jakubowski, 1976, RESPONSIBLE ASSERTIV; Kuckertz JM, 2014, BEHAV RES THER, V63, P25, DOI 10.1016/j.brat.2014.09.002; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; PsychCorp, 2001, WECHSL TEST AD READ; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Resick P. A., 1993, COGNITIVE PROCESSING; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Stricker NH, 2015, J TRAUMA STRESS, V28, P102, DOI 10.1002/jts.22000; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Taylor CT, 2014, SOC COGN AFFECT NEUR, V9, P1379, DOI 10.1093/scan/nst128; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Wechsler D., 2008, WECHSLER ADULT INTEL; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	52	21	21	2	28	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2016	22	6					643	651		10.1017/S1355617716000424			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	DU8SM	WOS:000382484700007	27264618				2022-02-06	
J	Lin, M; He, HJ; Schifitto, G; Zhong, JH				Lin, Mu; He, Hongjian; Schifitto, Giovanni; Zhong, Jianhui			Simulation of Changes in Diffusion Related to Different Pathologies at Cellular Level After Traumatic Brain Injury	MAGNETIC RESONANCE IN MEDICINE			English	Article						Monte Carlo simulation; DTI; TBI; demyelination; edema; axonal injury	AMYLOID PRECURSOR PROTEIN; MONTE-CARLO SIMULATIONS; AXONAL INJURY; WHITE-MATTER; WATER DIFFUSION; CORPUS-CALLOSUM; HEAD-INJURY; RESTRICTED DIFFUSION; SPINAL-CORD; MILD	Purpose: The goal of the current study was to investigate tissue pathology at the cellular level in traumatic brain injury (TBI) as revealed by Monte Carlo simulation of diffusion tensor imaging (DTI)-derived parameters and elucidate the possible sources of conflicting findings of DTI abnormalities as reported in the TBI literature. Methods: A model with three compartments separated by permeable membranes was employed to represent the diffusion environment of water molecules in brain white matter. The dynamic diffusion process was simulated with a Monte Carlo method using adjustable parameters of intra-axonal diffusivity, axon separation, glial cell volume fraction, and myelin sheath permeability. The effects of tissue pathology on DTI parameters were investigated by adjusting the parameters of the model corresponding to different stages of brain injury. Results: The results suggest that the model is appropriate and the DTI-derived parameters simulate the predominant cellular pathology after TBI. Our results further indicate that when edema is not prevalent, axial and radial diffusivity have better sensitivity to axonal injury and demyelination than other DTI parameters. Conclusion: DTI is a promising biomarker to detect and stage tissue injury after TBI. The observed inconsistencies among previous studies are likely due to scanning at different stages of tissue injury after TBI. (C) 2015 Wiley Periodicals, Inc.	[Lin, Mu; He, Hongjian; Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Ctr Brain Imaging Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Schifitto, Giovanni] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Schifitto, Giovanni; Zhong, Jianhui] Univ Rochester, Med Ctr, Dept Imaging Sci, Rochester, NY 14642 USA		Zhong, JH (corresponding author), Zhejiang Univ, Ctr Brain Imaging Sci & Technol, Hangzhou, Zhejiang, Peoples R China.	jzhong@zju.edu.cn	Zhong, Jianhui/AAE-6061-2020		National High-Tech R.D Program (863 Program) of ChinaNational High Technology Research and Development Program of China [2012AA011603, 2012AA011602]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH099921]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401473]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH099921] Funding Source: NIH RePORTER	Grant sponsor: National High-Tech R.D Program (863 Program) of China; Grant numbers: 2012AA011603; 2012AA011602; Grant sponsor: National Institutes of Health; Grant number: R01-MH099921; Grant sponsor: National Natural Science Foundation of China; Grant number: 81401473.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Barzo P, 1997, ACT NEUR S, V70, P119; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BRISMAR T, 1981, ACTA PHYSIOL SCAND, V113, P167, DOI 10.1111/j.1748-1716.1981.tb06878.x; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Edgar JM, 2014, WHITE MATTER STRUCTU, P127; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fieremans E, 2008, J MAGN RESON, V190, P189, DOI 10.1016/j.jmr.2007.10.014; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Ford JC, 1997, MAGNET RESON MED, V37, P387, DOI 10.1002/mrm.1910370315; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; Harkins KD, 2012, MAGN RESON MED, V67, P793, DOI 10.1002/mrm.23053; Hossmann K-A, 1985, BRAIN EDEMA, P367; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ishiguri H, 1985, BRAIN EDEMA, P20; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landman BA, 2008, MAGN RESON IMAGING, V26, P790, DOI 10.1016/j.mri.2008.01.034; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nilsson M, 2010, J MAGN RESON, V206, P59, DOI 10.1016/j.jmr.2010.06.002; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/s0006-3495(98)77978-0; Peled S, 1999, MAGNET RESON MED, V42, P911; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Quirk JD, 2003, MAGNET RESON MED, V50, P493, DOI 10.1002/mrm.10565; Regan DG, 2000, EUR BIOPHYS J BIOPHY, V29, P221, DOI 10.1007/s002490000081; Regan DG, 2003, EUR BIOPHYS J BIOPHY, V31, P563, DOI 10.1007/s00249-002-0249-8; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sargon MF, 2007, INT J NEUROSCI, V117, P749, DOI 10.1080/00207450600910119; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spatz M, 2010, ACTA NEUROCHIR SUPPL, V106, P21, DOI 10.1007/978-3-211-98811-4_3; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; VANGELDEREN P, 1994, J MAGN RESON SER B, V103, P255, DOI 10.1006/jmrb.1994.1038; VONKEYSERLINGK DG, 1984, ANAT ANZEIGER, V157, P97; Waugh J., 1988, ADV MAGN RESON, P1; Webb S, 2003, MAGNET RESON MED, V49, P638, DOI 10.1002/mrm.10411; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Zhao FY, 2006, ACTA NEUROCHIR SUPPL, V96, P168	65	21	22	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	JUL	2016	76	1					290	300		10.1002/mrm.25816			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DY3MK	WOS:000384996900029	26256558	Green Accepted			2022-02-06	
J	Moro, N; Ghavim, SS; Harris, NG; Hovda, DA; Sutton, RL				Moro, Nobuhiro; Ghavim, Sima S.; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.			Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after experimental traumatic brain injury	BRAIN RESEARCH			English	Article						C-14-2DG; Controlled cortical impact; Fluoro-Jade B; Pyruvate; Rat	CONTROLLED CORTICAL IMPACT; CYTOCHROME-OXIDASE HISTOCHEMISTRY; PENTOSE-PHOSPHATE PATHWAY; CLOSED-HEAD INJURY; ETHYL PYRUVATE; HEMORRHAGIC-SHOCK; KETOGENIC DIET; EXTRACELLULAR GLUCOSE; SPREADING DEPRESSION; COGNITIVE DEFICITS	Experimental traumatic brain injury (TBI) is known to produce an acute increase in cerebral glucose utilization, followed rapidly by a generalized cerebral metabolic depression. The current studies determined effects of single or multiple treatments with sodium pyruvate (SP; 1000 mg/kg, i.p.) or ethyl pyruvate (EP; 40 mg/kg, i.p.) on cerebral glucose metabolism and neuronal injury in rats with unilateral controlled cortical impact (CCI) injury. In Experiment 1 a single treatment was given immediately after CCI. SP significantly improved glucose metabolism in 3 of 13 brain regions while EP improved metabolism in 7 regions compared to saline-treated controls at 24 h post-injury. Both SP and EP produced equivalent and significant reductions in dead/dying neurons in cortex and hippocampus at 24 h post-CCI. In Experiment 2 SP or EP were administered immediately (time 0) and at 1, 3 and 6 h post-CCI. Multiple SP treatments also significantly attenuated TBI-induced reductions in cerebral glucose metabolism (in 4 brain regions) 24 h post-CCI, as did multiple injections of EP (in 4 regions). The four pyruvate treatments produced significant neuroprotection in cortex and hippocampus 1 day after CCI, similar to that found with a single SP or EP treatment. Thus, early administration of pyruvate compounds enhanced cerebral glucose metabolism and neuronal survival, with 40 mg/kg of EP being as effective as 1000 mg/kg of SP, and multiple treatments within 6 h of injury did not improve upon outcomes seen following a single treatment. (C) 2016 Elsevier B.V. All rights reserved.	[Moro, Nobuhiro; Ghavim, Sima S.; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Moro, Nobuhiro; Ghavim, Sima S.; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 956901, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Sutton, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 956901, Los Angeles, CA 90095 USA.	moro.nobuhiro@nihon-u.ac.jp; sghavim@mednet.ucla.edu; ngharris@mednet.ucla.edu; dhovda@mednet.ucla.edu; rsutton@ucla.edu		Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1NS058489, NS091222, NS27544, U54HD087101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091222, P01NS058489, R01NS027544] Funding Source: NIH RePORTER	This work was supported by the UCLA Brain Injury Research Center and Awards PO1NS058489, NS091222, NS27544 and U54HD087101 from the National Institutes of Health (NIH). The content is the sole responsibility of the authors and does not necessarily represent official views of the NIH. NGH is a fellow of The Center for Neuroskills, Bakersfield, California.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Alvarez G, 2003, J NEUROSCI RES, V73, P260, DOI 10.1002/jnr.10648; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Conejo NM, 2007, NEUROSCIENCE, V145, P403, DOI 10.1016/j.neuroscience.2006.11.057; Das UN, 2006, MED SCI MONITOR, V12, pRA79; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1987, EXP NEUROL, V97, P391, DOI 10.1016/0014-4886(87)90099-9; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Izumi Y, 2010, NEUROSCI LETT, V478, P131, DOI 10.1016/j.neulet.2010.04.078; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kashiwagi A, 1997, DIABETES, V46, P2088, DOI 10.2337/diabetes.46.12.2088; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kim JB, 2005, BRAIN RES, V1060, P188, DOI 10.1016/j.brainres.2005.08.029; Kim TY, 2007, EXP NEUROL, V208, P159, DOI 10.1016/j.expneurol.2007.08.013; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lee JE, 2001, INSECTA KOREANA SUPP, V21, P1; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lee YJ, 2004, J APPL PHYSIOL, V96, P793, DOI 10.1152/japplphysiol.00797.2003; Mongan PD, 2003, J SURG RES, V112, P180, DOI 10.1016/S0022-4804(03)00148-3; Mongan PD, 2002, AM J PHYSIOL-HEART C, V283, pH1634, DOI 10.1152/ajpheart.01073.2001; Mongan PD, 2001, AM J PHYSIOL-HEART C, V281, pH854, DOI 10.1152/ajpheart.2001.281.2.H854; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sharma P, 2003, BRAIN RES, V992, P104, DOI 10.1016/j.brainres.2003.08.043; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tokumaru O, 2009, NEUROCHEM RES, V34, P775, DOI 10.1007/s11064-008-9871-x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yu YM, 2005, STROKE, V36, P2238, DOI 10.1161/01.STR.0000181779.83472.35; Zeng JY, 2007, ANESTHESIOLOGY, V107, P630, DOI 10.1097/01.anes.0000281898.01966.1e; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	63	21	21	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 1	2016	1642						270	277		10.1016/j.brainres.2016.04.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP7EI	WOS:000378661600031	27059390	Green Accepted			2022-02-06	
J	Tanweer, O; Frisoli, FA; Bravate, C; Harrison, G; Pacione, D; Kondziolka, D; Huang, PP				Tanweer, Omar; Frisoli, Fabio A.; Bravate, Crystal; Harrison, Gillian; Pacione, Donato; Kondziolka, Douglas; Huang, Paul P.			Tranexamic Acid for Treatment of Residual Subdural Hematoma After Bedside Twist-Drill Evacuation	WORLD NEUROSURGERY			English	Article						Bedside evacuation; Fibrinolyisis; Subdural hematoma; Tranexamic acid; Traumatic brain injury; Venous thromboembolism	PORT SYSTEM; SINGLE INSTITUTION; EXPERIENCE; MANAGEMENT	BACKGROUND: Management of nonemergent, nonacute subdural hematomas (SDHs) ranges from observation to burr-hole evacuation or craniotomy, but recurrence rates are high. We evaluated the safety and efficacy of tranexamic acid (TXA) for the treatment of residual SDHs after bedside twist-drill evacuation. METHODS: We performed a retrospective analysis of a prospectively maintained database from November 2013 to November 2014 for all patients who underwent placement of a bedside subdural evacuating port system (SEPS) followed by treatment with oral TXA (650 mg daily). All demographics, evidence of venous thromboembolism, and volumes of pertinent computed tomography were obtained. RESULTS: Twenty subdural hematomas in 14 patients met the inclusion criteria for this study. Most SDHs were mixed density. Mean SDH volume on presentation was 145.96 +/- 40.22 cm(3) with a mean midline shift of 9.44 +/- 4.84 mm. Mean volumes decreased to 80.00 +/- 31.96 cm(3) and midline shift improved to 4.44 +/- 3.29 mm after SEPS placement (P < 0.0001 and P = 0.0046). All patients were placed on TXA after their procedure. Mean follow-up with computed tomography was 92.1 +/- 27.5 days, and mean SDH volume at last follow-up was 7.41 +/- 15.54 cm(3) with a mean midline shift of 0.19 +/- 0.69 mm (P < 0.0001 and P = 0.0002). Percent volume reduction was significantly higher after TXA than after SEPS (91.31% vs. 40.74%; P < 0.0001). No increase or delayed recurrence of the SDH was noted during TXA treatment. All but 1 clinical presenting symptom improved at follow-up. No venous thromboembolisms were noted among the patients. CONCLUSIONS: In our pilot study, chronic SDH volumes were reduced by 40.74% after SEPS drainage. The residual volume was reduced by an additional 91.31% during oral TXA treatment. No patients developed delayed recurrence or expansion of their SDHs. Further prospective studies are needed to evaluate the role of TXA for adjunctive treatment of chronic SDHs.	[Tanweer, Omar; Frisoli, Fabio A.; Bravate, Crystal; Harrison, Gillian; Pacione, Donato; Kondziolka, Douglas; Huang, Paul P.] NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA		Frisoli, FA (corresponding author), NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA.	fabio.frisoli@nyumc.org		Huang, Paul/0000-0003-0563-921X			Asfora W T, 2001, S D J Med, V54, P495; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Balser D, 2013, NEUROL RES, V35, P233, DOI 10.1179/1743132813Y.0000000166; Chari A, 2014, J NEUROSURG, V121, P176, DOI 10.3171/2014.4.JNS131212; Cheriyan T, 2015, SPINE J, V15, P752, DOI 10.1016/j.spinee.2015.01.013; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Duncan CM, 2015, J ARTHROPLASTY, V30, P272, DOI 10.1016/j.arth.2014.08.022; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; FUJISAWA H, 1995, J NEUROL NEUROSUR PS, V59, P388, DOI 10.1136/jnnp.59.4.388; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; Kenning TJ, 2010, J NEUROSURG, V113, pA416, DOI 10.3171/2010.5.JNS1083; Neal MT, 2013, CLIN NEUROL NEUROSUR, V115, P658, DOI 10.1016/j.clineuro.2012.07.017; Park SH, 2011, CLIN NEUROL NEUROSUR, V113, P272, DOI 10.1016/j.clineuro.2010.11.014; Rughani AI, 2010, J NEUROSURG, V113, P609, DOI 10.3171/2009.11.JNS091244; Safain M, 2013, J NEUROSURG, V118, P694, DOI 10.3171/2012.11.JNS12689; Singla A, 2013, CLIN NEUROL NEUROSUR, V115, P425, DOI 10.1016/j.clineuro.2012.06.005; Suzuki M, 1998, ACTA NEUROCHIR, V140, P261, DOI 10.1007/s007010050093	19	21	24	3	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2016	91						29	33		10.1016/j.wneu.2016.03.062			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DS1OH	WOS:000380365000007	27032521				2022-02-06	
J	Vavilis, T; Delivanoglou, N; Aggelidou, E; Stamoula, E; Mellidis, K; Kaidoglou, A; Cheva, A; Pourzitaki, C; Chatzimeletiou, K; Lazou, A; Albani, M; Kritis, A				Vavilis, Theofanis; Delivanoglou, Nikoleta; Aggelidou, Eleni; Stamoula, Eleni; Mellidis, Kyriakos; Kaidoglou, Aikaterini; Cheva, Angeliki; Pourzitaki, Chryssa; Chatzimeletiou, Katerina; Lazou, Antigone; Albani, Maria; Kritis, Aristeidis			Oxygen-Glucose Deprivation (OGD) Modulates the Unfolded Protein Response (UPR) and Inflicts Autophagy in a PC12 Hypoxia Cell Line Model	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Oxygen-glucose deprivation; Unfolded protein response; Autophagy; Glucose-regulated proteins; Hypoxia; Chaperones	ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; CHAPERONE-MEDIATED AUTOPHAGY; FOCAL CEREBRAL-ISCHEMIA; GENE-EXPRESSION; RAT MODEL; DEATH; ACTIVATION; GRP78; NEUROPROTECTION	Hypoxia is the lack of sufficient oxygenation of tissue, imposing severe stress upon cells. It is a major feature of many pathological conditions such as stroke, traumatic brain injury, cerebral hemorrhage, perinatal asphyxia and can lead to cell death due to energy depletion and increased free radical generation. The present study investigates the effect of hypoxia on the unfolded protein response of the cell (UPR), utilizing a 16-h oxygen-glucose deprivation protocol (OGD) in a PC12 cell line model. Expression of glucose-regulated protein 78 (GRP78) and glucose-regulated protein 94 (GRP94), key players of the UPR, was studied along with the expression of glucose-regulated protein 75 (GRP75), heat shock cognate 70 (HSC70), and glyceraldehyde 3-phosphate dehydrogenase, all with respect to the cell death mechanism(s). Cells subjected to OGD displayed upregulation of GRP78 and GRP94 and concurrent downregulation of GRP75. These findings were accompanied with minimal apoptotic cell death and induction of autophagy. The above observation warrants further investigation to elucidate whether autophagy acts as a pro-survival mechanism that upon severe and prolonged hypoxia acts as a concerted cell response leading to cell death. In our OGD model, hypoxia modulates UPR and induces autophagy.	[Vavilis, Theofanis; Delivanoglou, Nikoleta; Aggelidou, Eleni; Stamoula, Eleni; Albani, Maria; Kritis, Aristeidis] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Med, Physiol Lab, Thessaloniki 54124, Greece; [Mellidis, Kyriakos; Lazou, Antigone] Aristotle Univ Thessaloniki, Sch Biol, Physiol Lab, Fac Sci, Thessaloniki 54124, Greece; [Kaidoglou, Aikaterini] Aristotle Univ Thessaloniki, Sch Med, Lab Histol Embryol & Anthropol, Fac Hlth Sci, Thessaloniki 54124, Greece; [Cheva, Angeliki] Gen Hosp Thessaloniki G Papanikolaou, Dept Pathol, Thessaloniki, Greece; [Pourzitaki, Chryssa] Aristotle Univ Thessaloniki, Pharmacol Lab, Sch Med, Fac Hlth Sci, Thessaloniki 54124, Greece; [Chatzimeletiou, Katerina] Aristotle Univ Thessaloniki, Human Reprod Unit, Sch Med, Papageorgiou Gen Hosp,Dept Obstet & Gynaecol 1, Thessaloniki 54124, Greece		Kritis, A (corresponding author), Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Med, Physiol Lab, Thessaloniki 54124, Greece.	kritis@med.auth.gr	Lazou, Antigone/L-3878-2014; Vavilis, Theofanis/D-1852-2016; Lazou, A./I-4511-2019; Kritis, Aristeidis/AAG-7474-2019	Vavilis, Theofanis/0000-0002-5658-4637; Lazou, A./0000-0002-7889-9648; Kritis, Aristeidis/0000-0002-2067-8842; CHEVA, ANGELIKI/0000-0002-5374-1772; Chatzimeletiou, katerina/0000-0001-9624-6352	Program for Basic Research Activity Enhancement of the Research Committee of Aristotle University [89337]; European Union/European Social Fund EPEAEK PYTHGORAS II [13]	The present work was supported by the Program for Basic Research Activity Enhancement of the Research Committee of Aristotle University (Project Number 89337), European Union/European Social Fund EPEAEK PYTHGORAS II (Project Number 13) as well as the yearly Laboratory of Physiology fund allocation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI M, 1993, J CEREBR BLOOD F MET, V13, P781, DOI 10.1038/jcbfm.1993.99; Balduini W, 2012, J MATERN-FETAL NEO M, V25, P119, DOI 10.3109/14767058.2012.663232; Balduini W, 2009, AUTOPHAGY, V5, P221, DOI 10.4161/auto.5.2.7363; Bando Y, 2003, EUR J NEUROSCI, V18, P829, DOI 10.1046/j.1460-9568.2003.02818.x; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Burbulla LF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.103; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Cavaliere F, 2001, NEUROCHEM INT, V38, P199, DOI 10.1016/S0197-0186(00)00087-5; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chatzimeletiou K, 2005, PRENATAL DIAG, V25, P919, DOI 10.1002/pd.1227; Chatzimeletiou K, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.161; Chiu BY, 2014, CELL MOL NEUROBIOL, V34, P825, DOI 10.1007/s10571-014-0059-4; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cui DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035324; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Hillion JA, 2005, J CEREBR BLOOD F MET, V25, P154, DOI 10.1038/sj.jcbfm.9600003; Hol EM, 2008, J MOL NEUROSCI, V34, P23, DOI 10.1007/s12031-007-0013-8; Jiang YF, 2012, NEUROSCI LETT, V516, P182, DOI 10.1016/j.neulet.2012.03.074; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang CH, 2008, AUTOPHAGY, V4, P82, DOI 10.4161/auto.5154; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Kashyap MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017757; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Kritis A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025950; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; LOWENSTEIN DH, 1991, NEURON, V7, P1053, DOI 10.1016/0896-6273(91)90349-5; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; MASSA SM, 1995, J NEUROSCI RES, V40, P807, DOI 10.1002/jnr.490400612; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mo ZT, 2012, ACTA PHARMACOL SIN, V33, P737, DOI 10.1038/aps.2012.35; Mo ZT, 2012, CELL BIOL INT, V36, P1043, DOI 10.1042/CBI20120229; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Olender T, 2013, ISR J CHEM, V53, P185, DOI 10.1002/ijch.201200094; Outeiro Tiago Fleming, 2007, Semin Pediatr Neurol, V14, P15, DOI 10.1016/j.spen.2006.11.005; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051469; Papadopoulou LC, 1996, BIOCHEM PHARMACOL, V52, P713, DOI 10.1016/0006-2952(96)00349-8; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Renaud J, 2014, NEUROTOX RES, V25, P110, DOI 10.1007/s12640-013-9439-7; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Xu F, 2012, NEUROSCI BULL, V28, P658, DOI 10.1007/s12264-012-1268-9; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	65	21	21	0	15	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JUL	2016	36	5					701	712		10.1007/s10571-015-0250-2			12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DN9LP	WOS:000377401400007	26239244				2022-02-06	
J	Delic, J; Alhilali, LM; Hughes, MA; Gumus, S; Fakhran, S				Delic, Joseph; Alhilali, Lea M.; Hughes, Marion A.; Gumus, Serter; Fakhran, Saeed			White Matter Injuries in Mild Traumatic Brain Injury and Posttraumatic Migraines: Diffusion Entropy Analysis	RADIOLOGY			English	Article							ABNORMALITIES	Purpose: To determine the performance of Shannon entropy (SE) as a diagnostic tool in patients with mild traumatic brain injury (mTBI) with posttraumatic migraines (PTMs) and those without PTMs on the basis of analysis of fractional anisotropy (FA) maps. Materials and Methods: The institutional review board approved this retrospective study, with waiver of informed consent. FA maps were obtained and neurocognitive testing was performed in 74 patients with mTBI (57 with PTM, 17 without PTM). FA maps were obtained in 22 healthy control subjects and in 20 control patients with migraine headaches. Mean FA and SE were extracted from total brain FA histograms and were compared between patients with mTBI and control subjects and between patients with and those without PTM. Mean FA and SE were correlated with clinical variables and were used to determine the areas under the receiver operating characteristic curve (AUCs) and likelihood ratios for mTBI and development of PTM. Results: Patients with mTBI had significantly lower SE (P < .001) and trended toward lower mean FA (P = .07) compared with control subjects. SE inversely correlated with time to recovery (TTR) (r = -0.272, P = .02). Patients with mTBI with PTM had significantly lower SE (P < .001) but not mean FA (P = .15) than did other patients with mTBI. SE provided better discrimination between patients with mTBI and control subjects than mean FA (AUC = 0.92; P = .01), as well as better discrimination between patients with mTBI with PTM and those without PTM (AUC = 0.85; P < .001). SE of less than 0.751 resulted in a 16.1 increased likelihood of having experienced mTBI and a 3.2 increased likelihood of developing PTM. Conclusion: SE more accurately reveals mTBI than mean FA, more accurately reveals those patients with mTBI who develop PTM, and inversely correlates with TTR.	[Delic, Joseph; Alhilali, Lea M.; Hughes, Marion A.; Gumus, Serter; Fakhran, Saeed] Univ Pittsburgh, Med Ctr, Div Neuroradiol, Dept Radiol, 200 Lothrop St,PUH 2nd Floor,Suite 201 East Wing, Pittsburgh, PA 15213 USA; [Alhilali, Lea M.] Barrow Neurol Inst, Div Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA		Alhilali, LM (corresponding author), Univ Pittsburgh, Med Ctr, Div Neuroradiol, Dept Radiol, 200 Lothrop St,PUH 2nd Floor,Suite 201 East Wing, Pittsburgh, PA 15213 USA.	lalhilali@sniweb.net					Alcaraz R, 2008, PHYSIOL MEAS, V29, P65, DOI 10.1088/0967-3334/29/1/005; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Altman DG, 1990, PRACTICAL STAT MED R, p[268, 352, 354, 417]; Baron EM, 2007, NEUROSURGERY, V60, P35, DOI 10.1227/01.NEU.0000215383.64386.82; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Cui JL, 2011, NEUROIMAGE, V54, P2125, DOI 10.1016/j.neuroimage.2010.10.018; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fozouni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076343; Guan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117707; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Metwalli Nader S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2260; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shannon CE, 1997, M D COMPUT, V14, P306; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964; Zhou T, 2009, IEEE ENG MED BIO, P3470, DOI 10.1109/IEMBS.2009.5334608	29	21	21	0	1	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2016	279	3					859	866		10.1148/radiol.2015151388			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DP8AG	WOS:000378719700024	26829524	Bronze			2022-02-06	
J	Kontos, AP; Reches, A; Elbin, RJ; Dickman, D; Laufer, I; Geva, AB; Shacham, G; DeWolf, R; Collins, MW				Kontos, Anthony P.; Reches, Amit; Elbin, R. J.; Dickman, Dalia; Laufer, Ilan; Geva, Amir B.; Shacham, Galit; DeWolf, Ryan; Collins, Michael W.			Preliminary evidence of reduced brain network activation in patients with post-traumatic migraine following concussion	BRAIN IMAGING AND BEHAVIOR			English	Article						Sport-related concussion; Brain network activation; Electroencephalography; Post-traumatic migraine	EVENT-RELATED POTENTIALS; HIGH-SCHOOL; RESPONSE-INHIBITION; EVOKED-POTENTIALS; RECOVERY; SPORT; IMPACT; OSCILLATIONS; IMPAIRMENT; PREDICTORS	Post-traumatic migraine (PTM) (i.e., headache, nausea, light and/or noise sensitivity) is an emerging risk factor for prolonged recovery following concussion. Concussions and migraine share similar pathophysiology characterized by specific ionic imbalances in the brain. Given these similarities, patients with PTM following concussion may exhibit distinct electrophysiological patterns, although researchers have yet to examine the electrophysiological brain activation in patients with PTM following concussion. A novel approach that may help differentiate brain activation in patients with and without PTM is brain network activation (BNA) analysis. BNA involves an algorithmic analysis applied to multichannel EEG-ERP data that provides a network map of cortical activity and quantitative data during specific tasks. A prospective, repeated measures design was used to evaluate BNA (during Go/NoGo task), EEG-ERP, cognitive performance, and concussion related symptoms at 1, 2, 3, and 4 weeks post-injury intervals among athletes with a medically diagnosed concussion with PTM (n=15) and without (NO-PTM) (n=22); and age, sex, and concussion history matched controls without concussion (CONTROL) (n=20). Participants with PTM had significantly reduced BNA compared to NO-PTM and CONTROLS for Go and NoGo components at 3 weeks and for NoGo component at 4 weeks post-injury. The PTM group also demonstrated a more prominent deviation of network activity compared to the other two groups over a longer period of time. The composite BNA algorithm may be a more sensitive measure of electrophysiological change in the brain that can augment established cognitive assessment tools for detecting impairment in individuals with PTM.	[Kontos, Anthony P.; DeWolf, Ryan; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Reches, Amit; Dickman, Dalia; Laufer, Ilan; Geva, Amir B.; Shacham, Galit] ElMindA Ltd, Tel Aviv, Israel; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310; Geva, Amir/0000-0003-3159-3673	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01 DC012332] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER		Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Brier MR, 2010, INT J PSYCHOPHYSIOL, V78, P215, DOI 10.1016/j.ijpsycho.2010.07.011; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buodo G, 2004, CEPHALALGIA, V24, P554, DOI 10.1111/j.1468-2982.2003.00716.x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen W, 2007, CEPHALALGIA, V27, P139, DOI 10.1111/j.1468-2982.2006.01256.x; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coppola G, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-20; Coppola G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-91; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fisher T, 2011, CLIN NEUROPHYSIOL, V122, P2390, DOI 10.1016/j.clinph.2011.05.010; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kawamata M, 2007, CLIN EEG NEUROSCI, V38, P193, DOI 10.1177/155005940703800403; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LINDEN RD, 1987, ELECTROEN CLIN NEURO, V66, P145; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Morlet D, 2014, CLIN NEUROPHYSIOL, V125, P500, DOI 10.1016/j.clinph.2013.05.032; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Wang W, 1998, CEPHALALGIA, V18, P261, DOI 10.1046/j.1468-2982.1998.1805261.x	44	21	22	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2016	10	2					594	603		10.1007/s11682-015-9412-6			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7JK	WOS:000382390000025	26091725	Green Accepted			2022-02-06	
J	Ritter, AC; Kammerer, CM; Brooks, MM; Conley, YP; Wagner, AK				Ritter, Anne C.; Kammerer, Candace M.; Brooks, Maria M.; Conley, Yvette P.; Wagner, Amy K.			Genetic variation in neuronal glutamate transport genes and associations with posttraumatic seizure	EPILEPSIA			English	Article						Traumatic brain injury; Epileptogenesis; Posttraumatic epilepsy; SLC1A1; SLC1A6	TRAUMATIC BRAIN-INJURY; CYSTEINE UPTAKE; EPILEPSY; EXPRESSION; HIPPOCAMPAL; EAAT4; REHABILITATION; EXCITOTOXICITY; LOCALIZATION; EAAT3/EAAC1	Objective: Posttraumatic seizures (PTS) commonly occur following severe traumatic brain injury (sTBI). Risk factors for PTS have been identified, but variability in who develops PTS remains. Excitotoxicity may influence epileptogenesis following sTBI. Glutamate transporters manage glutamate levels and excitatory neurotransmission, and they have been associated with both epilepsy and TBI. Therefore, we aimed to determine if genetic variation in neuronal glutamate transporter genes is associated with accelerated epileptogenesis and increased PTS risk after sTBI. Methods: Individuals (N = 253) 18-75 years of age with sTBI were assessed for genetic relationships with PTS. Single nucleotide polymorphisms (SNPs) within SLC1A1 and SLC1A6 were assayed. Kaplan-Meier estimates and log-rank statistics were used to compare seizure rates from injury to 3 years postinjury for SNPs by genotype. Hazard ratios (HRs) were estimated using Cox proportional hazards regression for SNPs significant in Kaplan-Meier analyses adjusting for known PTS risk factors. Results: Thirty-two tagging SNPs were examined (SLC1A1: n = 28, SLC1A6: n = 4). Forty-nine subjects (19.37%) had PTS. Of these, 18 (36.7%) seized within 7 days, and 31 (63.3%) seized between 8 days and 3 years post-TBI. With correction for multiple comparisons, genotypes at SNP rs10974620 (SLC1A1) were significantly associated with time to first seizure across the full 3-year follow-up (seizure rates: 77.1% minor allele homozygotes, 24.8% heterozygotes, 16.6% major allele homozygotes; p = 0.001). When seizure follow-up began day 2 postinjury, genotypes at SNP rs7858819 (SLC1A1) were significantly associated with PTS risk (seizure rates: 52.7% minor allele homozygotes, 11.8% heterozygotes, 21.1% major allele homozygotes; p = 0.002). After adjusting for covariates, we found that rs10974620 remained significant (p = 0.017, minor allele versus major allele homozygotes HR 3.4, 95% confidence interval [ CI] 1.3-9.3). rs7858819 also remained significant in adjusted models (p = 0.023, minor allele versus major allele homozygotes HR 3.4, 95% CI 1.1-10.5). Significance: Variations within SLC1A1 are associated with risk of epileptogenesis following sTBI. Future studies need to confirm findings, but variation within neuronal glutamate transporter genes may represent a possible pharmaceutical target for PTS prevention and treatment.	[Ritter, Anne C.; Brooks, Maria M.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ritter, Anne C.; Wagner, Amy K.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Kammerer, Candace M.] Univ Pittsburgh, Human Genet, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Hlth Promot & Human Genet, Pittsburgh, PA USA; [Conley, Yvette P.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Conley, Yvette/0000-0002-1784-6067; Kammerer, Candace M/0000-0002-2841-4761; Brooks, Maria/0000-0002-2030-7873	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048162, DODW81XWH-071-0701, NIH R01NR013342]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342, R01NR008424] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) R01HD048162, DODW81XWH-071-0701, and NIH R01NR013342. Thanks to Sandra Deslouches for support with genotyping and the subjects and their families for their generous participation. Thanks to the UPMC Trauma Registry for assisting with some elements of data collection.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Doi T, 2009, NEUROCHEM RES, V34, P1324, DOI 10.1007/s11064-009-9912-0; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Furuta A, 2003, AM J PATHOL, V163, P779, DOI 10.1016/S0002-9440(10)63705-4; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Hu WH, 2003, GLIA, V44, P13, DOI 10.1002/glia.10268; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Obrenovitch TP, 2000, INT J DEV NEUROSCI, V18, P281, DOI 10.1016/S0736-5748(99)00096-9; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Rakhade SN, 2008, EPILEPSIA, V49, P226, DOI 10.1111/j.1528-1167.2007.01310.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Stichter JP, 2010, J AUTISM DEV DISORD, V40, P1067, DOI [10.1007/s10803-010-0959-1, 10.1007/s10803-010-0961-7]; Wendland JR, 2009, ARCH GEN PSYCHIAT, V66, P408, DOI 10.1001/archgenpsychiatry.2009.6; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yamashita A, 2006, NEUROSCI RES, V55, P264, DOI 10.1016/j.neures.2006.03.007; Yi JH, 2007, BRAIN RES, V1154, P200, DOI 10.1016/j.brainres.2007.04.011; Zhang JP, 2014, 8TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2014), P1; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	45	21	22	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUN	2016	57	6					984	993		10.1111/epi.13397			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR8MD	WOS:000380151100018	27153812	Green Accepted, Bronze			2022-02-06	
J	Whiting, SW; Potenza, MN; Park, CL; Mckee, SA; Mazure, CM; Hoff, RA				Whiting, Seth W.; Potenza, Marc N.; Park, Crystal L.; Mckee, Sherry A.; Mazure, Carolyn M.; Hoff, Rani A.			Investigating Veterans' Pre-, Peri-, and Post-Deployment Experiences as Potential Risk Factors for Problem Gambling	JOURNAL OF BEHAVIORAL ADDICTIONS			English	Article						deployment experiences; gambling; military; veterans	SEEKING PATHOLOGICAL GAMBLERS; PSYCHIATRIC COMORBIDITY; GENDER-DIFFERENCES; SOCIAL SUPPORT; PREVALENCE; DISORDERS; MILITARY; HEALTH; AFGHANISTAN; BEHAVIOR	Background and aims: Gambling disorder and its comorbid diagnoses are observed at higher rates in military veterans than in the general population. A significant research gap exists regarding the relationships of veterans' life and service experiences to problematic gambling. The present study explored pre-, peri-, and post-deployment factors associated with problem gambling in veterans.Methods: Veterans of Operation Iraqi Freedom, Operation Enduring Freedom, and Operation New Dawn (n = 738; 463 males, and 275 females) completed questionnaires via structured telephone interview. We conducted bivariate and multinomial logistic regression analyses exploring associations among problem-gambling severity and socio-demographic variables, psychiatric comorbidities, and 10 scales of the Deployment Risk and Resilience Inventory measuring experiences pre-, peri-, and post-deployment. Results: Approximately 4.2% of veterans indicated at-risk or probable pathological gambling (ARPG) postdeployment (two or more DSM-IV criteria for pathological gambling). Bivariate analyses found more severe gambling in males, higher frequencies of post-traumatic stress disorder, substance dependence, traumatic brain injury, panic disorder, and depression in veterans with ARPG, and higher general harassment during deployment, and lower social support and more stressful life events post-deployment in those with ARPG. In multivariable models, both post-deployment factors remained significantly associated with ARPG. Discussion: The study suggests that problem gambling among veterans is related to service experiences, and particularly to life experiences post-deployment. Conclusions: Adverse service and life experiences and lack of social support may contribute to the risk of problem gambling in military veterans. Investigation of how Veterans Affairs clinical settings may serve veterans following deployment to prevent behavioral addictions is warranted.	[Whiting, Seth W.; Hoff, Rani A.] VISN 1 Mental Illness Res Educ & Clin Ctr MIRECC, Dept Vet Affairs, West Haven, CT USA; [Whiting, Seth W.; Potenza, Marc N.; Mckee, Sherry A.; Mazure, Carolyn M.; Hoff, Rani A.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Park, Crystal L.] Univ Connecticut, Dept Psychol, Storrs, CT USA		Hoff, RA (corresponding author), NEPEC-182,950 Campbell Ave, West Haven, CT 06416 USA.	Rani.hoff@va.gov					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Black DW, 1998, PSYCHIATR SERV, V49, P1434, DOI 10.1176/ps.49.11.1434; Boardman B., 2007, J SOCIO-ECON, V36, P789, DOI [10.1016/j.socec.2007.01.012, DOI 10.1016/J.SOCEC.2007.01.012]; BRAY RM, 1999, 1998 DEP DEFENSE SUR; Crockford DN, 1998, CAN J PSYCHIAT, V43, P43, DOI 10.1177/070674379804300104; Desai RA, 2008, SOC PSYCH PSYCH EPID, V43, P173, DOI 10.1007/s00127-007-0283-z; Edens EL, 2012, J GAMBL STUD, V28, P1, DOI 10.1007/s10899-011-9239-z; Ellenbogen S, 2007, J GAMBL STUD, V23, P133, DOI 10.1007/s10899-006-9048-y; Freimuth M., 2005, HIDDEN ADDICTIONS AS; George A., 2005, ADV PSYCHIAT TREATME, V11, P450, DOI [10.1192/apt.11.6.450, DOI 10.1192/APT.11.6.450]; Gerstein D., 1999, GAMBLING IMPACT BEHA; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; GRANT BF, 2000, ALCOHOL USE DISORDER; Grant JE, 2010, COMPR PSYCHIAT, V51, P115, DOI 10.1016/j.comppsych.2009.04.002; GRINOLS EL, 2004, GAMBLING AM COSTS BE; Gupta Rina, 1998, J Gambl Stud, V14, P319, DOI 10.1023/A:1023068925328; Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X; Jacobs D. F., 1989, J GAMBLING BEHAV, V5, P261, DOI [DOI 10.1007/BF01672427, 10.1007/BF01672427]; Kausch O, 2003, J SUBST ABUSE TREAT, V25, P263, DOI 10.1016/S0740-5472(03)00117-X; Kennedy CH, 2005, MIL MED, V170, P683, DOI 10.7205/MILMED.170.8.683; Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Ledgerwood DM, 2004, J NERV MENT DIS, V192, P711, DOI 10.1097/01.nmd.0000142021.71880.ce; Petry NM, 2009, AM J ADDICTION, V18, P402, DOI [10.1080/10550490903077861, 10.3109/10550490903077861]; Potenza MN, 2014, TRENDS COGN SCI, V18, P429, DOI 10.1016/j.tics.2014.03.007; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shaffer H J, 1994, J Gambl Stud, V10, P339, DOI 10.1007/BF02104901; Shaffer H J, 1996, J Gambl Stud, V12, P193, DOI 10.1007/BF01539174; Smith PH, 2014, J BEHAV ADDICT, V3, P214, DOI 10.1556/JBA.3.2014.4.2; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; TABER JI, 1987, INT J ADDICT, V22, P71, DOI 10.3109/10826088709027414; Toce-Gerstein M, 2003, ADDICTION, V98, P1661, DOI 10.1111/j.1360-0443.2003.00545.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; VOLBERG RA, 1994, AM J PUBLIC HEALTH, V84, P237, DOI 10.2105/AJPH.84.2.237; Westermeyer J, 2013, AM J ADDICTION, V22, P218, DOI 10.1111/j.1521-0391.2012.12011.x; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yaffee R.A., 1988, J GAMBLING BEHAVIOR, V4, P13, DOI DOI 10.1007/BF01043525	40	21	21	0	5	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-5871	2063-5303		J BEHAV ADDICT	J. Behav. Addict.	JUN	2016	5	2					213	220		10.1556/2006.5.2016.027			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DQ6UC	WOS:000379339700006	27156377	Green Published, gold, Green Accepted, Green Submitted			2022-02-06	
J	Williams, JM; Langdon, JL; McMillan, JL; Buckley, TA				Williams, Joshua M.; Langdon, Jody L.; McMillan, James L.; Buckley, Thomas A.			English professional football players concussion knowledge and attitude	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Concussion; Concussion recovery; Concussion reporting; Football; Mild traumatic brain injury; RoCKAS	CHRONIC TRAUMATIC ENCEPHALOPATHY; RUGBY UNION PLAYERS; HEAD-INJURY; RECURRENT CONCUSSION; NCAA CONCUSSION; PHYSICAL-ACTIVITY; SOCCER PLAYERS; ICE HOCKEY; EDUCATION; SPORT	Background: Concussions are a common pathology in football and multiple misconceptions exist amongst the players and managers. To address these misconceptions, and potentially reduce concussion associated sequela, effective educational interventions need to be developed. However, the current knowledge and attitude status must be ascertained to appropriately develop these interventions. The purpose of this study was to assess the concussion knowledge and attitude of English professional footballers. Methods: Twenty-six participants from one English Football League Championship club completed the study. A mixed methods approach included the Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS) and a semi-structured interview. The RoCKAS contains separate knowledge (0-25) and attitude (15-75) scores and was followed by a semi-structured interview consisting of concussion knowledge, attitude, and behavior related questions. Results: The mean score on the RoCKAS knowledge was 16.4 +/- 2.9 (range 11-22) and the attitude score was 59.6 +/- 8.5 (range 41-71). The interview responses identified inconsistencies between the RoCKAS and the intended behaviors, endorsing multiple concussion misconceptions, and revealed barriers to concussion reporting. Conclusion: The results of this study suggest that Championship Level English footballers have moderate concussion knowledge, safe attitudes, and good concussion symptom recognition when assessed with pen and paper questionnaires. However, within the semi-structured interview many respondents reported unsafe concussion behaviors despite accurately identifying the potential risks. Further, multiple barriers to concussion reporting were identified which included perceived severity of the injury, game situations, and the substitution rule. These findings can help form the foundation of educational interventions to potentially improve concussion reporting behaviors amongst professional footballers. (C) 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport.	[Williams, Joshua M.] Wagner Coll, Dept Intercoll Athlet, Staten Isl, NY 10301 USA; [Langdon, Jody L.; McMillan, James L.] Georgia So Univ, Sch Hlth & Kinesiol, Statesboro, GA 30460 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.	TBuckley@UDel.edu	Langdon, Jody/AAY-4638-2021; Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	Department of Health and Kinesiology at Georgia Southern University	This project was funded, in part, by the Department of Health and Kinesiology at Georgia Southern University. The data collection and analysis, manuscript write-up and submission, and the decision to submit to the Journal of Sport and Health Science were made by the research team independent of any influence by the funding department.	Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, WORLD NEUROSURG, V74, P224, DOI 10.1016/j.wneu.2010.07.023; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Gaughan J, 2013, DAILY MAIL; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; International Federation of Association Football, 2007, THE BIG COUNT; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; League AF, 2013, LAWS AUSTR FOOTBALL; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mihalik JP, 2014, J SPORT HEALTH SCI, V3, P307, DOI 10.1016/j.jshs.2014.07.005; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Overturf CD, 2012, NAT PRECEDINGS, P1; POSNER BM, 1992, EPIDEMIOLOGY, V3, P171, DOI 10.1097/00001648-199203000-00016; Price J, 2012, BRIT J SPORT MED, V46, P1000, DOI 10.1136/bjsports-2011-090687; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK., 2011, J ATHL TRAINING, V46, pS15; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Wright C., VINCENT KOMPANY PLAY; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	55	21	21	4	27	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	JUN	2016	5	2					197	204		10.1016/j.jshs.2015.01.009			8	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	DP3MO	WOS:000378398500015	30356509	gold, Green Published			2022-02-06	
J	da Costa, L; van Niftrik, CB; Crane, D; Fierstra, J; Bethune, A				da Costa, Leodante; van Niftrik, Christiaan Bas; Crane, David; Fierstra, Jorn; Bethune, Allison			Temporal Profile of cerebrovascular reactivity impairment, gray Matter Volumes, and Persistent symptoms after Mild Traumatic head injury	FRONTIERS IN NEUROLOGY			English	Article							BRAIN-INJURY; CEREBRAL AUTOREGULATION; BLOOD-FLOW; CT; SPECT; PATHOPHYSIOLOGY; METABOLISM; HISTORY; MODEL; MEG	Objective: Increased awareness around neurocognitive deficits after mild traumatic brain injury (mTBI) has progressed the search for objective, diagnostic, and monitoring tools, yet imaging biomarkers for mTBI and recovery are not established in clinical use. It has been suggested that mTBI impairs cerebrovascular reactivity (CVR) to CO2, which could be related to post-concussive syndrome (PCS). We investigate CVR evolution after mTBI using blood-oxygen-level dependent (BOLD) magnetic resonance imaging (MRI) and possible correlation with PCS. Methods: A prospective cohort of 25 mTBI patients and 18 matched controls underwent BOLD MRI CVR measurements. A subset of 19 mTBI patients underwent follow-up testing. Visits took place at a mean of 63 and 180 days after injury. Symptoms were assessed with the Sport Concussion Assessment Tool 2 (SCAT2). Symptoms, CVR and brain volume [ gray matter (GM), white matter (WM), and whole brain (WB)], age, and sex, were examined between groups and longitudinally within traumatic brain injury (TBI) patients. Results: Traumatic brain injury participants were 72% males, mean age being 42.7 years. Control participants were 61% with mean age of 38.7 years. SCAT2 scores tended to improve among those mTBI patients with follow-up visits (p = 0.07); however, they did not tend to recover to scores of the healthy controls. Brain volumes were not statistically different between groups at the first visit (WM p = 0.71; GM p = 0.36). In mTBI patients, there was a reduction in GM volume between visits 1 and 2 (p = 0.0046). Although mean CVR indexes were similar (WM p = 0.27; GM p = 0.36; and WB p = 0.35), the correlation between SCAT2 and CVR was negative in controls (WM-r = -0.59; p = 0.010; GM-r = -0.56; p = 0.016; brain-r = -0.58; p = 0.012) and weaker and positive in mTBI (brain-r = 0.4; p = 0.046; GM- r = 0.4; p = 0.048). SCAT2 correlated with GM volume (r = 0.5215, p = 0.0075) in mTBI but not in controls (r = 0.2945, p = 0.2355). Conclusion: There is a correlation between lower GM CVR indexes and lower performance on SCAT2 in patients with mTBI, which seems to be associated with more symptoms. This correlation seems to persist well beyond 120 days. mTBI may lead to a decrease in GM volume in these patients.	[da Costa, Leodante; Bethune, Allison] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [da Costa, Leodante] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [van Niftrik, Christiaan Bas; Fierstra, Jorn] Univ Zurich Hosp, Div Neurosurg, CH-8091 Zurich, Switzerland; [Crane, David] Sunnybrook Res Inst, Brain Sci Program, Toronto, ON, Canada		da Costa, L (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; da Costa, L (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada.	leo.dacosta@sunnybrook.ca		Fierstra, Jorn/0000-0001-6220-0727; van Niftrik, Christiaan/0000-0003-0930-8717			Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson-Barnes Victoria C, 2010, Continuum (Minneap Minn), V16, P17, DOI 10.1212/01.CON.0000391450.48225.73; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Devonshire IM, 2012, NEUROIMAGE, V59, P1997, DOI 10.1016/j.neuroimage.2011.09.050; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; GRAY BG, 1992, J NUCL MED, V33, P52; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Maggio P, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.280; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Paemeleire K, 2002, ACTA NEUROL BELG, V102, P153; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Thomas BP, 2013, NEUROIMAGE, V83, P505, DOI 10.1016/j.neuroimage.2013.07.005; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	21	21	1	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 11	2016	7								70	10.3389/fneur.2016.00070			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DL3JH	WOS:000375529600001	27242655	Green Accepted, gold, Green Published			2022-02-06	
J	Dyer, JR; Williams, R; Bombardier, CH; Vannoy, S; Fann, JR				Dyer, Joshua R.; Williams, Ryan; Bombardier, Charles H.; Vannoy, Steven; Fann, Jesse R.			Evaluating the Psychometric Properties of 3 Depression Measures in a Sample of Persons With Traumatic Brain Injury and Major Depressive Disorder	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; depression; outcomes research; patient outcomes; traumatic brain injuries	PATIENT HEALTH QUESTIONNAIRE-9; RANDOMIZED CONTROLLED-TRIAL; RATING-SCALE; HOSPITAL ANXIETY; DSM-IV; VALIDITY; SYMPTOMS; SEVERITY; SENSITIVITY; SERTRALINE	Objectives: To explore the psychometric properties of 3 widely used measures of depression in a sample of individuals with traumatic brain injury (TBI) and major depressive disorder and refine them to maximize efficiency. Design: Secondary analysis of data from a randomized controlled trial of cognitive-behavioral therapy for depression after TBI. Setting: Nationwide recruitment from community and clinical settings. Participants: One hundred adults within 10 years of complicated mild to severe TBI. Intervention: Telephone and in-person cognitive-behavioral therapy. Main Measures: Patient Health Questionnaire-9 (PHQ-9), Symptom Checklist-20, and Hamilton Depression Rating Scale. Results: We used Rasch rating scale analysis and multilevel modeling to investigate the 3 measures. Measurement properties of each of the depression measures were strong. We explored modifications to the rating scales to improve efficiency while retaining strong psychometric characteristics. Correlations among these revised measures were high. Treatment effects of each revised depression measure were compared using a multilevel model, and effect size estimates were comparable among the revised PHQ-9, Symptom Checklist-20, and Hamilton Depression Rating Scale. Conclusions: Although each of the 3 measures demonstrated adequate reliability, the efficiency of all 3 instruments was improved with rating scale analysis. The PHQ-9 required the fewest modifications and functions well as a measure of depression among those with TBI.	[Dyer, Joshua R.; Bombardier, Charles H.] Univ Washington, Sch Med, Dept Rehabil Med, Box 359740,325 9th Ave, Seattle, WA 98104 USA; [Fann, Jesse R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Williams, Ryan] Amer Inst Res, Chicago, IL USA; [Vannoy, Steven] Univ Massachusetts, Dept Counseling, Boston, MA USA; [Vannoy, Steven] Univ Massachusetts, Sch Psychol, Boston, MA USA		Dyer, JR (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 359740,325 9th Ave, Seattle, WA 98104 USA.	jdyer@u.washington.edu	vannoy, steven/W-2737-2019; Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD53736]; Department of Education, National Institute on Disability and Rehabilitation Research [H133G070016]	This study was supported by the National Institutes of Health (grant R21HD53736) and the Department of Education, National Institute on Disability and Rehabilitation Research (grant H133G070016). Trial registration: clinicaltrials.gov identifier: NCT00878150.	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; American Psychiatric Association, 2001, DIAGN STAT MAN MENT; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Babin PR, 2003, BRAIN INJURY, V17, P889, DOI 10.1080/0269905031000088595; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; BECH P, 1975, ACTA PSYCHIAT SCAND, V51, P161, DOI 10.1111/j.1600-0447.1975.tb00002.x; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; de Coster L, 2005, INT J GERIATR PSYCH, V20, P358, DOI 10.1002/gps.1290; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Faries D, 2000, J PSYCHIAT RES, V34, P3, DOI 10.1016/S0022-3956(99)00037-0; First Michael B, 2001, USERS GUIDE STRUCTUR; Guy W., 1976, CLIN GLOBAL IMPRESSI; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Linacre M, 2014, WINSTEPS RASCH MEASU; MAIER W, 1985, PHARMACOPSYCHIATRY, V18, P114, DOI 10.1055/s-2007-1017335; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Pinheiro J., 2020, NLME LINEAR NONLINEA; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Ruhe HG, 2005, COMPR PSYCHIAT, V46, P417, DOI 10.1016/j.comppsych.2005.03.001; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schwarzbold ML, 2014, REV BRAS PSIQUIATR, V36, P206, DOI 10.1590/1516-4446-2013-1308; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Williams RT, 2009, REHABIL PSYCHOL, V54, P198, DOI 10.1037/a0015529	46	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					225	232		10.1097/HTR.0000000000000177			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800014	26291629				2022-02-06	
J	Shadloo, B; Motevalian, A; Rahimi-Movaghar, V; Amin-Esmaeili, M; Sharifi, V; Hajebi, A; Radgoodarzi, R; Hefazi, M; Rahimi-Movaghar, A				Shadloo, Behrang; Motevalian, Abbas; Rahimi-Movaghar, Vafa; Amin-Esmaeili, Masoumeh; Sharifi, Vandad; Hajebi, Ahmad; Radgoodarzi, Reza; Hefazi, Mitra; Rahimi-Movaghar, Afarin			Psychiatric Disorders Are Associated with an Increased Risk of Injuries: Data from the Iranian Mental Health Survey (Iran MHS)	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Article						Injury; Mental health; Composite international diagnostic interview; Iran	TRAUMATIC BRAIN-INJURY; UNINTENTIONAL INJURY; MAJOR DEPRESSION; GLOBAL BURDEN; DRUG-USE; ALCOHOL; MEDICATION; SYMPTOMS; UPDATE	Background: Injuries and psychiatric disorders, notably both major public health concerns, are associated with a high burden and are believed to be bi-directionally correlated. Those inflicted with injuries face increased risks of mental illnesses. Psychiatric disorders may make the individual prone to injuries. The objective of the study was to assess the correlation of mental disorders with non-fatal injuries. Methods: A total of 7886 participants aged 15 to 64 yr were interviewed in a national household survey in 2011 in Iran. Composite International Diagnostic Interview (CIDI v2.1) was implemented to assess the prevalence of psychiatric disorders in the past twelve months. Injuries were assessed using Short Form Injury Questionnaire (SFIQ-7). Results: Injury was reported in 35.9% and 22.8% of participants in the past twelve and past three months, respectively. Using multivariate logistic regression analysis, mental disorders were significantly associated with injuries in the past three months (OR=1.6, 95% CI: 1.36-1.87), recurrent injuries (OR=1.7, 95% CI: 1.21-2.41) and road/traffic accidents (OR=2.4, 95% CI: 1.28-4.49). Conclusion: Psychiatric disorders were found to be associated with an increased risk of injuries. Early detection and treatment of mental illnesses can contribute to injury prevention.	[Shadloo, Behrang; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Shadloo, Behrang; Amin-Esmaeili, Masoumeh; Radgoodarzi, Reza; Hefazi, Mitra; Rahimi-Movaghar, Afarin] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Iranian Inst Reduct High Risk Behav, Tehran, Iran; [Motevalian, Abbas] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Sharifi, Vandad] Univ Tehran Med Sci, Psychiat & Psychol Res Ctr, Tehran, Iran; [Hajebi, Ahmad] Iran Univ Med Sci, Mental Hlth Res Ctr, Tehran Psychiat Inst, Tehran, Iran		Amin-Esmaeili, M (corresponding author), Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Iranian Inst Reduct High Risk Behav, Tehran, Iran.	m.aminesmaeeli@farabi.tums.ac.ir	Motevalian, Seyed Abbas/ABC-2213-2021; Rahimi-Movaghar, Vafa/L-6339-2019; Rahimi-Movaghar, Afarin/E-9505-2011; hajebi, ahmad/ABH-9175-2020; Sharifi, Vandad/J-2003-2019; Sharifi, Vandad/J-7884-2019; Rahimi-Movaghar, Vafa/T-7816-2017	Rahimi-Movaghar, Afarin/0000-0002-5761-1668; Shadloo, Behrang/0000-0003-1884-9371; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Motevalian, Seyed Abbas/0000-0002-0404-4495			Alaghband Rad J., 2003, MENTAL HLTH EFFECTS; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Cameron CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-114; Chen G, 2008, INJURY PREV, V14, P180, DOI 10.1136/ip.2007.016857; Dyster-Aas J, 2008, J TRAUMA, V64, P1349, DOI 10.1097/TA.0b013e318047e005; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Guillemont J, 2009, INT J INJ CONTROL SA, V16, P81, DOI 10.1080/17457300902836655; Hafezi-Nejad N, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041127; Haslam C, 2005, OCCUP ENVIRON MED, V62, P538, DOI 10.1136/oem.2004.016196; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Jahani MR, 2001, KOWSAR MED J, V5, P289; Kendrick D, 2001, PUBLIC HEALTH, V115, P103, DOI 10.1038/sj.ph.1900737; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McGee Kara, 2004, Inj Control Saf Promot, V11, P303, DOI 10.1080/156609704/233/327505; McGinty EE, 2013, INJURY PREV, V19, P32, DOI 10.1136/injuryprev-2011-040309; Motevalian S, 2004, HAKIM HLTH SYSTEMS R, V7, P1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Nordstrom DL, 2001, J TRAUMA, V51, P758, DOI 10.1097/00005373-200110000-00023; O'Donnell ML, 2009, J TRAUMA, V66, P470, DOI 10.1097/TA.0b013e31815d965e; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Palmu R, 2011, BURNS, V37, P601, DOI 10.1016/j.burns.2010.06.007; Patten SB, 2010, CAN J PSYCHIAT, V55, P313, DOI 10.1177/070674371005500507; Patterson DR, 2003, J BURN CARE REHABIL, V24, P347, DOI 10.1097/01.BCR.0000086070.91033.7F; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rahimi-Movaghar A., 2013, COCHRANE DB SYST REV, V1, P1; Rahimi-Movaghar Afarin, 2014, Iran J Psychiatry, V9, P96; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Sharif-Alhoseini M, 2012, CHIN J TRAUMATOL, V15, P145, DOI 10.3760/cma.j.issn.1008-1275.2012.03.003; Soderstrom CA, 2001, ACCIDENT ANAL PREV, V33, P771, DOI 10.1016/S0001-4575(00)00091-9; Tiesman HM, 2006, INJURY PREV, V12, P172, DOI 10.1136/ip.2006.011544; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Visser E, 2007, ACCIDENT ANAL PREV, V39, P556, DOI 10.1016/j.aap.2006.09.012; Wadsworth EJK, 2003, HUM PSYCHOPHARM CLIN, V18, P535, DOI 10.1002/hup.516; Watt K, 2006, J STUD ALCOHOL, V67, P14, DOI 10.15288/jsa.2006.67.14; Watt Kerrianne, 2006, Emerg Med Australas, V18, P108, DOI 10.1111/j.1742-6723.2006.00817.x	40	21	21	0	5	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	MAY	2016	45	5					623	635					13	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DY2PC	WOS:000384933500008	27398335				2022-02-06	
J	Song, SJ; Kong, XY; Acosta, S; Sava, V; Borlongan, C; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Borlongan, Cesar; Sanchez-Ramos, Juan			Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain repair; neurotrophic factors; cytokines; astrocytosis; microgliosis; neurogenesis; radial arm water maze	REVERSES COGNITIVE IMPAIRMENT; FACTOR G-CSF; NEUROGENESIS; ADULT; MACROPHAGES; PROLIFERATION; RECRUITMENT; DECREASES; RATS	Hematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF) represent a novel approach for treatment of traumatic brain injury (TBI). After mild controlled cortical impact (CCI), mice were treated with G-CSF (100g/kg) for 3 consecutive days. The primary behavioral endpoint was performance on the radial arm water maze (RAWM), assessed 7 and 14 days after CCI. Secondary endpoints included 1) motor performance on a rotating cylinder (rotarod), 2) measurement of microglial and astroglial response, 3) hippocampal neurogenesis, and 4) measures of neurotrophic factors (brain-derived neurotrophic factor [BDNF] and glial cell line-derived neurotrophic factor [GDNF]) and cytokines in brain homogenates. G-CSF-treated animals performed significantly better than vehicle-treated mice in the RAWM at 1 and 2 weeks but not on the rotarod. Cellular changes found in the G-CSF group included increased hippocampal neurogenesis as well as astrocytosis and microgliosis in both the striatum and the hippocampus. Neurotrophic factors GDNF and BDNF, elaborated by activated microglia and astrocytes, were increased in G-CSF-treated mice. These factors along with G-CSF itself are known to promote hippocampal neurogenesis and inhibit apoptosis and likely contributed to improvement in the hippocampal-dependent learning task. Six cytokines that were modulated by G-CSF treatment following CCI were elevated on day 3, but only one of them remained altered by day 7, and all of them were no different from vehicle controls by day 14. The pro- and anti-inflammatory cytokines modulated by G-CSF administration interact in a complex and incompletely understood network involving both damage and recovery processes, underscoring the dual role of inflammation after TBI. (c) 2016 Wiley Periodicals, Inc.	[Song, Shijie; Kong, Xiaoyuan; Sava, Vasyl; Sanchez-Ramos, Juan] James Haley Vet Adm Res Serv, Tampa, FL USA; [Song, Shijie; Borlongan, Cesar] Univ S Florida, Dept Neurol, 13220 Laurel Dr, Tampa, FL 33612 USA; [Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL USA		Sanchez-Ramos, J (corresponding author), Univ S Florida, Dept Neurol, 13220 Laurel Dr, Tampa, FL 33612 USA.	jsramos@health.usf.edu	Kaneko, Yuji/J-6447-2012; Sanchez-Ramos, Juan/O-7870-2014; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857	Veterans Administration Merit Review GrantUS Department of Veterans Affairs; Helen Ellis Research Endowment; Veterans AffairsUS Department of Veterans Affairs [I01BX004037, I01BX001407] Funding Source: NIH RePORTER	Contract grant sponsor: Veterans Administration Merit Review Grant (to S.S.); Contract grant sponsor: Helen Ellis Research Endowment (to J.S.-R.)	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Boku S, 2013, BIOCHEM BIOPH RES CO, V434, P779, DOI 10.1016/j.bbrc.2013.04.011; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen WF, 2011, PEDIATR RES, V70, P589, DOI 10.1203/PDR.0b013e3182324424; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Song SJ, 2014, J NEUROSCI RES, V92, P975, DOI 10.1002/jnr.23378; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Tang Y, 2015, MOL NEUROBIOL, DOI 10.1007/s12035-014-9070-5; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yamasaki R, 2010, J NEUROIMMUNOL, V229, P51, DOI 10.1016/j.jneuroim.2010.07.002; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	38	21	21	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY	2016	94	5					409	423		10.1002/jnr.23714			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6HT	WOS:000372892300006	26822127	Green Accepted			2022-02-06	
J	Steiner, ME; Berkstresser, BD; Richardson, L; Elia, G; Wang, F				Steiner, Mark E.; Berkstresser, Brant D.; Richardson, Lars; Elia, Greg; Wang, Frank			Full-Contact Practice and Injuries in College Football	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						football; injuries; injury exposures; concussions	HIGH-SCHOOL FOOTBALL; PROFESSIONAL RUGBY UNION; SURVEILLANCE SYSTEM; DATA-COLLECTION; RISK-FACTORS; TRAINING LOADS; LEAGUE PLAYERS; EPIDEMIOLOGY; IMPACT; DEFINITIONS	Background: Despite recent restrictions being placed on practice in college football, there are little data to correlate such changes with injuries. Hypothesis: Football injuries will correlate with a team's exposure to full-contact practice, total practice, and total games. Study Design: Descriptive epidemiological study. Methods: All injuries and athlete injury exposures (AE x Min = athletes exposed x activity duration in minutes) were recorded for an intercollegiate football team over 4 consecutive fall seasons. Weekly injuries and injury rates (injuries per athletic injury exposure) were correlated with the weekly exposures to full-contact practices, total practices, formal scrimmages, and games. Results: The preseason practice injury rate was over twice the in-season practice injury rate (P < 0.001). For preseason, injury exposures were higher for full-contact practice (P = 0.0166), total practices (P = 0.015), and scrimmages/games (P = 0.034) compared with in-season. Preseason and in-season practice injuries correlated with exposure to full-contact practice combined with scrimmages for preseason (P < 0.008) and full-contact practice combined with games for in-season (P = 0.0325). The game injury rate was over 6 times greater than the practice injury rate (P < 0.0001). Concussions constituted 14.5% of all injuries, and the incidence of concussions correlated with the incidence of all injuries (P = 0.0001). Strength training did not correlate with injuries. Conclusion: Decreased exposure to full-contact practice may decrease the incidence of practice injuries and practice concussions. However, the game injury rate was over 6 times greater than the practice injury rate and had an inverse correlation with full-contact practice.	[Steiner, Mark E.; Berkstresser, Brant D.; Richardson, Lars; Elia, Greg; Wang, Frank] Harvard Univ Hlth Serv, Cambridge, MA USA		Steiner, ME (corresponding author), Harvard Univ Hlth Serv, Dept Orthoped, 75 Mt Auburn St, Cambridge, MA 02138 USA.	msteiner@uhs.harvard.edu			Stryker Orthopedics; New England Baptist Research Department; DonJoy Orthopedics	The following authors declared potential conflicts of interest: Mark E. Steiner, MD, is a paid consultant for, and has patents and royalties from, Stryker Orthopedics; Greg Elia, MD, has received fees for participation in review activities from New England Baptist Research Department. The authors acknowledge and thank DonJoy Orthopedics for research funding, which made this project possible.	Adickes MS, 2004, SPORTS MED, V34, P201, DOI 10.2165/00007256-200434030-00005; Albright JP, 2004, AM J SPORT MED, V32, P1394, DOI 10.1177/0363546504264159; Anderson L, 2003, J STRENGTH COND RES, V17, P734; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; Bengtsson H, 2013, AM J SPORT MED, V41, P1505, DOI 10.1177/0363546513486769; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; Brink MS, 2010, BRIT J SPORT MED, V44, P809, DOI 10.1136/bjsm.2009.069476; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Brooks JHM, 2005, BRIT J SPORT MED, V39, P288, DOI 10.1136/bjsm.2004.013391; Camp Walter, 1894, FOOTBALL FACTS FIGUR; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DAGIAU RF, 1980, AM J SPORT MED, V8, P257, DOI 10.1177/036354658000800408; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Dupont G, 2010, AM J SPORT MED, V38, P1752, DOI 10.1177/0363546510361236; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gabbett TJ, 2007, J SPORT SCI, V25, P1507, DOI 10.1080/02640410701215066; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ, 2004, BRIT J SPORT MED, V38, P743, DOI 10.1136/bjsm.2003.008391; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Killen NM, 2010, J STRENGTH COND RES, V24, P2079, DOI 10.1519/JSC.0b013e3181ddafff; Kim J, 2011, REPORT REGARDING IVY; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; MILLER JOHN J., 2011, THE BIG SCRUM; Nichols EH, 1909, BOSTON MED SURG J, V160, P33, DOI 10.1056/NEJM190901141600201; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; Rogalski B, 2013, J SCI MED SPORT, V16, P499, DOI 10.1016/j.jsams.2012.12.004; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Steiner ME, 2005, AM J SPORT MED, V33, P1545, DOI 10.1177/0363546505275491; THOMPSON N, 1987, AM J SPORT MED, V15, P117, DOI 10.1177/036354658701500204; Thorndike Jr A, 1938, ATHLETIC INJURIES PR, P20	44	21	21	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2016	8	3					217	223		10.1177/1941738115626689			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8CM	WOS:000391283300002	26755741	Green Published			2022-02-06	
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Marsman, JBC; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Marsman, Jan-Bernard C.; Spikman, Jacoba M.; van der Naalt, Joukje			Brain network dysregulation, emotion, and complaints after mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						mild traumatic brain injury; emotion regulation; post-traumatic complaints; fMRI; brain networks	DEFAULT-MODE; POSTCONCUSSIVE SYMPTOMS; FUNCTIONAL CONNECTIVITY; HOSPITAL ANXIETY; SEX-DIFFERENCES; CONCUSSION; TASK; PREDICTORS; COMPONENTS; SYSTEM	ObjectivesTo assess the role of brain networks in emotion regulation and post-traumatic complaints in the sub-acute phase after non-complicated mild traumatic brain injury (mTBI). Experimental designFifty-four patients with mTBI (34 with and 20 without complaints) and 20 healthy controls (group-matched for age, sex, education, and handedness) were included. Resting-state fMRI was performed at four weeks post-injury. Static and dynamic functional connectivity were studied within and between the default mode, executive (frontoparietal and bilateral frontal network), and salience network. The hospital anxiety and depression scale (HADS) was used to measure anxiety (HADS-A) and depression (HADS-D). Principal ObservationsRegarding within-network functional connectivity, none of the selected brain networks were different between groups. Regarding between-network interactions, patients with complaints exhibited lower functional connectivity between the bilateral frontal and salience network compared to patients without complaints. In the total patient group, higher HADS-D scores were related to lower functional connectivity between the bilateral frontal network and both the right frontoparietal and salience network, and to higher connectivity between the right frontoparietal and salience network. Furthermore, whereas higher HADS-D scores were associated with lower connectivity within the parietal midline areas of the bilateral frontal network, higher HADS-A scores were related to lower connectivity within medial prefrontal areas of the bilateral frontal network. ConclusionsFunctional interactions of the executive and salience networks were related to emotion regulation and complaints after mTBI, with a key role for the bilateral frontal network. These findings may have implications for future studies on the effect of psychological interventions. Hum Brain Mapp 37:1645-1654, 2016. (c) 2016 Wiley Periodicals, Inc.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands; [Liemburg, Edith J.; Marsman, Jan-Bernard C.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, NL-9700 AB Groningen, Netherlands; [Liemburg, Edith J.; Marsman, Jan-Bernard C.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 AB Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands		van der Naalt, J (corresponding author), Hanzepl 1, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	de Hersenstichting [Ps2012-06]	Contract grant sponsor: de Hersenstichting; Contract grant number: Ps2012-06	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belleau EL, 2015, SOC COGN AFFECT NEUR, V10, P744, DOI 10.1093/scan/nsu117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coutinho JF, 2015, BRAIN IMAGI IN PRESS; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Manoliu A, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00930; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nielsen MB, 2014, SCAND J PSYCHOL, V55, P142, DOI 10.1111/sjop.12103; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Verhage F., 1964, THESIS NETHERLANDS; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	21	21	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	APR	2016	37	4					1645	1654		10.1002/hbm.23126			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DG7XH	WOS:000372296500026	26846195	Green Published			2022-02-06	
J	Morawska, MM; Buchele, F; Moreira, CG; Imbach, LL; Noain, D; Baumann, CR				Morawska, Marta M.; Buechele, Fabian; Moreira, Carlos Goncalves; Imbach, Lukas L.; Noain, Daniela; Baumann, Christian R.			Sleep Modulation Alleviates Axonal Damage and Cognitive Decline after Rodent Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						diffuse axonal damage; memory; sleep; traumatic brain injury	GAMMA-HYDROXYBUTYRIC ACID; AMYLOID PRECURSOR PROTEIN; EEG POWER SPECTRA; VIGILANCE STATES; MEMORY; DEPRIVATION; RATS; BETA; ACCUMULATION; IMPAIRMENT	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. It produces diffuse axonal injury (DAI), which contributes to cognitive impairment, but effective disease-modifying treatment strategies are missing. We have recently developed a rat model of closed skull TBI that reproduces human TBI consequences, including DAI and clinical sequelae such as memory impairment. Here, we investigated whether sleep modulation after trauma has an impact on DAI and memory outcome. We assessed cognition with the novel object recognition test and stained for amyloid precursor protein, a DAI marker. We found that both sleep induction and restriction acutely after TBI enhanced encephalographic slow-wave activity, markedly reduced diffuse axonal damage in the cortex and hippocampus, and improved memory impairment 2 weeks after trauma. These results suggest that enhancing slow-wave sleep acutely after trauma may have a beneficial disease-modifying effect in subjects with acute TBI.	[Morawska, Marta M.; Buechele, Fabian; Moreira, Carlos Goncalves; Imbach, Lukas L.; Noain, Daniela; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland		Morawska, MM (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	marta.morawska@usz.ch		Noain, Daniela/0000-0001-5482-7933; Morawska, Marta/0000-0003-1612-6786; Goncalves Moreira, Carlos/0000-0003-3197-3668; Imbach, Lukas/0000-0002-6135-8642; Buechele, Fabian/0000-0001-7091-1676; Baumann, Christian/0000-0003-3417-1978			Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buchele F, 2015, J NEUROTRAU IN PRESS; Cam E, 2013, EXP NEUROL, V247, P673, DOI 10.1016/j.expneurol.2013.03.003; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENTHOLZNER E, 1995, ANAESTHESIST, V44, P345, DOI 10.1007/s001010050163; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Gao B, 2008, CEREBROVASC DIS, V26, P413, DOI 10.1159/000151683; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hodor A, 2015, NEUROSCIENCE, V284, P18, DOI 10.1016/j.neuroscience.2014.08.061; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klein C, 2015, NEUROBIOL AGING, V36, P832, DOI 10.1016/j.neurobiolaging.2014.10.003; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LETTIERI JT, 1979, J PHARMACOL EXP THER, V208, P7; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meerlo P, 2004, SLEEP, V27, P899, DOI 10.1093/sleep/27.5.899; Nava F, 2001, EUR J PHARMACOL, V430, P261, DOI 10.1016/S0014-2999(01)01163-3; Plante DT, 2015, CLIN NEUROPHYSIOL; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TOBLER I, 1987, J COMP PHYSIOL A, V161, P449, DOI 10.1007/BF00603970; Tobler I, 1997, J NEUROSCI, V17, P1869; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	42	21	21	1	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 23	2016	36	12					3422	3429		10.1523/JNEUROSCI.3274-15.2016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH4HU	WOS:000372747100005	27013672	Green Published, Green Accepted, Bronze			2022-02-06	
J	Grech, LB; Kiropoulos, LA; Kirby, KM; Butler, E; Paine, M; Hester, R				Grech, Lisa B.; Kiropoulos, Litza A.; Kirby, Katherine M.; Butler, Ernest; Paine, Mark; Hester, Robert			Coping Mediates and Moderates the Relationship Between Executive Functions and Psychological Adjustment in Multiple Sclerosis	NEUROPSYCHOLOGY			English	Article						coping; multiple sclerosis; psychological adjustment; cognition; mediator moderator	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; DISABILITY STATUS; DEPRESSIVE SYMPTOMS; ECOLOGICAL VALIDITY; WORKING-MEMORY; VERBAL FLUENCY; ANXIETY; DYSFUNCTION	Objective: To identify the moderating and mediating relationship of different coping strategies between executive function and stress, depression and anxiety in people with multiple sclerosis (PwMS). Method: Participants were 107 people with relapsing remitting or secondary progressive multiple sclerosis who were administered tasks of executive function and completed self-report measures of stress, depression, anxiety, and coping. Results: An indirect relationship was found between executive function and psychosocial adjustment through maladaptive coping strategies: behavioral and mental disengagement, and substance abuse; adaptive coping strategies: acceptance, active, positive reinterpretation, and growth, as well as for an index of adaptive coping. In general, a relationship was found between better performance on tasks of executive function and psychosocial adjustment when adaptive coping strategies were low, as opposed to high, or maladaptive coping strategies were high, as opposed to low. Some unexpected findings are also discussed. Conclusion: Executive function and psychosocial adjustment is mediated and moderated by coping strategies used by PwMS. Well-preserved executive function provides relative protection from poorer adjustment in the presence of high maladaptive or low adaptive coping. PwMS who perform poorly on tasks of executive function benefit from using less cognitively demanding adaptive coping strategies to enhance adjustment outcomes and further research in this area would be advantageous to underpin effective intervention strategies.	[Grech, Lisa B.; Kiropoulos, Litza A.; Kirby, Katherine M.; Hester, Robert] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia; [Butler, Ernest] Monash Med Ctr, Dept Neurol, Melbourne, Vic, Australia; [Paine, Mark] St Vincents Hosp, Dept Neurol, Melbourne, Vic, Australia		Grech, LB (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia.	lbgrech@gmail.com	Hester, Robert/F-2097-2011	Hester, Robert/0000-0003-0982-8026; Kiropoulos, Litza/0000-0002-1921-5904			Aarstad AKH, 2011, EUR ARCH OTO-RHINO-L, V268, P907, DOI 10.1007/s00405-010-1417-6; Aikens JE, 1999, J BEHAV MED, V22, P127, DOI 10.1023/A:1018731415172; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Arnett PA, 2002, CLIN NEUROPSYCHOL, V16, P341, DOI 10.1076/clin.16.3.341.13852; Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Australian Bureau of Statistics, 2007, NAT SURV MENT HLTH; Balcer LJ, 2010, NEUROLOGY, V74, pS16, DOI 10.1212/WNL.0b013e3181dbb664; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Beatty WW, 1998, MULT SCLER, V4, P440, DOI 10.1191/135245898678919447; Bechara A., 2007, IOWA GAMBLING TASK P; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Brajkovic L, 2009, COLLEGIUM ANTROPOL, V33, P135; BROOKS NA, 1982, SOC SCI MED, V16, P2129, DOI 10.1016/0277-9536(82)90262-3; Brown RF, 2006, MULT SCLER J, V12, P465, DOI 10.1191/1352458506ms1296oa; Brown RF, 2009, PSYCHOL PSYCHOTHER-T, V82, P41, DOI 10.1348/147608308X345614; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cohen J., 2013, STAT POWER ANAL BEHA; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Corporation I. B. M., 2012, STAT PACKAGES SOCIAL; Crawford P., 2009, INT J MS CARE, V11, P167, DOI DOI 10.7224/1537-2073-11.4.167; Crigger NJ, 1996, ADV NURS SCI, V18, P37, DOI 10.1097/00012272-199603000-00005; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dougher M. J., 1994, ACCEPTANCE CHANGE CO, P125; Drew M, 2008, ARCH CLIN NEUROPSYCH, V23, P1, DOI 10.1016/j.acn.2007.09.005; Feinstein A, 2007, CLINICAL NEUROPSYCHIATRY OF MULTIPLE SCLEROSIS, 2ND EDITION, P1, DOI 10.1017/CBO9780511543760; Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; Folkman, 1984, HDB BEHAV MED, P282, DOI DOI 10.1016/S0002-7138(09)61635-6; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Genova HM, 2013, J CLIN EXP NEUROPSYC, V35, P631, DOI 10.1080/13803395.2013.806649; Goretti B, 2009, NEUROL SCI, V30, P15, DOI 10.1007/s10072-008-0009-3; Harrison T, 2004, WESTERN J NURS RES, V26, P266, DOI 10.1177/0193945903260188; Hayes, 2018, INTRO MEDIATION MODE; Hayes A. F., 2014, CAN YOUR PROCEDURES; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hayes S. C., 1994, ACCEPTANCE CHANGE CO, P125; Hayes S. C., 2003, EMPIRICALLY SUPPORTE, P4; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Higginson CI, 2000, ARCH CLIN NEUROPSYCH, V15, P185, DOI 10.1016/S0887-6177(99)00004-9; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x; Janssens ACJW, 2003, MULT SCLER, V9, P397, DOI 10.1191/1352458503ms930oa; Jobin C, 2010, WOMENS HEALTH, V6, P797, DOI 10.2217/WHE.10.69; Johnson W, 2009, INTELLIGENCE, V37, P613, DOI 10.1016/j.intell.2008.12.003; Jorm AF, 2004, INTELLIGENCE, V32, P7, DOI 10.1016/j.intell.2003.08.001; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Kehler MD, 2009, J BEHAV MED, V32, P150, DOI 10.1007/s10865-008-9186-z; Kessler E, 2005, GRIEF GRIEVING FINDI; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; Kroencke DC, 1999, MULT SCLER J, V5, P89, DOI 10.1191/135245899678847266; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAZARUS R, 1989, MANUAL HASSLES UPLIF; Lester K, 2007, J BEHAV MED, V30, P177, DOI 10.1007/s10865-007-9095-6; Lode K, 2009, MULT SCLER J, V15, P638, DOI 10.1177/1352458509102313; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; MacKinnon DP., 2008, ERLBAUM, DOI [DOI 10.1007/978-1-4842-0043-8_5, DOI 10.4324/9780203809556]; Makros J, 2003, J RELIG HEALTH, V42, P143, DOI 10.1023/A:1023681830716; McCabe M. P., 2004, PSYCHOL HEALTH MED, V9, P431, DOI DOI 10.1080/1354850042000267021; McCabe MP, 2009, PSYCHOL HEALTH MED, V14, P86, DOI 10.1080/13548500802017682; McCabe MP, 2004, J PSYCHOSOM RES, V56, P355, DOI 10.1016/S0022-3999(03)00132-6; McNulty K, 2004, REHABIL PSYCHOL, V49, P91, DOI 10.1037/0090-5550.49.2.91; Meyer-Moock S, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-58; Minden SL, 2014, NEUROLOGY, V82, P174, DOI 10.1212/WNL.0000000000000013; Mohr DC, 2000, NEUROLOGY, V55, P55, DOI 10.1212/WNL.55.1.55; Moran PJ, 2005, J BEHAV MED, V28, P35, DOI 10.1007/s10865-005-2561-0; Moreau T, 2009, EUR NEUROL, V62, P79, DOI 10.1159/000222777; Muthen L. K., 2012, MPLUS USERS GUIDE, V5th; Nada M., 2011, EGYPT J NEUROL PSYCH, V48, P71; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; O'Keefe DJ, 2003, HUM COMMUN RES, V29, P431, DOI 10.1093/hcr/29.3.431; Pakenham KI, 2006, PSYCHOL HEALTH, V21, P633, DOI 10.1080/14768320500422618; Pakenham KI, 2009, PSYCHOL HEALTH, V24, P373, DOI 10.1080/08870440701832592; PAKENHAM KI, 2001, PSYCHOL HEALTH MED, V6, P411, DOI DOI 10.1080/13548500126537; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2, DOI 10.1037/1089-2680.1.2.115, 10.1037/1089-2680.1.2.115]; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pozzilli C, 2012, J NEUROL, V259, P2319, DOI 10.1007/s00415-012-6492-8; Rabinowitz AR, 2009, NEUROPSYCHOLOGY, V23, P581, DOI 10.1037/a0016064; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Robertson I., 1994, TEST EVERYDAY ATTENT; ROSS HE, 1989, AM J DRUG ALCOHOL AB, V15, P429, DOI 10.3109/00952998908992802; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Salthouse TA, 1997, J GERONTOL B-PSYCHOL, V52, pP216, DOI 10.1093/geronb/52B.5.P216; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Smith A., 1991, SYMBOL DIGIT MODALIT; Somer E, 2010, MULT SCLER J, V16, P463, DOI 10.1177/1352458509358714; Sparrow EP, 2012, EXECUTIVE FUNCTION AND DYSFUNCTION: IDENTIFICATION, ASSESSMENT AND TREATMENT, P65; Spielberger C. D, 1983, STAI MANUAL STATE TR; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; SULLIVAN MJL, 1995, CAN J NEUROL SCI, V22, P228, DOI 10.1017/S0317167100039895; Summers M, 2008, J NEUROL NEUROSUR PS, V79, P955, DOI 10.1136/jnnp.2007.138685; Taylor AB, 2006, EDUC PSYCHOL MEAS, V66, P228, DOI 10.1177/0013164405278580; Tennen H, 2000, AM PSYCHOL, V55, P626, DOI 10.1037//0003-066X.55.6.626; Tennen H., 1999, COPING PSYCHOL WHAT, P279; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; vandenBosch RJ, 1997, COMPR PSYCHIAT, V38, P341, DOI 10.1016/S0010-440X(97)90930-5; Wallin MT, 2006, J REHABIL RES DEV, V43, P63, DOI 10.1682/JRRD.2004.09.0120; White J, 2012, J EPIDEMIOL COMMUN H, V66, P767, DOI 10.1136/jech-2011-200252; Wilder-Willis KE, 2002, SCHIZOPHR RES, V55, P259, DOI 10.1016/S0920-9964(01)00211-0; Wooldridge J. M, 2009, INTRO ECONOMETRICS M	117	21	21	0	36	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2016	30	3					361	376		10.1037/neu0000256			16	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DF0ZS	WOS:000371068800011	26618799				2022-02-06	
J	Liu, H; Mao, P; Wang, J; Wang, T; Xie, CH				Liu, Hao; Mao, Ping; Wang, Jia; Wang, Tuo; Xie, Chang-Hou			Azilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activity	NEUROCHEMISTRY INTERNATIONAL			English	Article						Neuroprotection; Azilsartan; eNOS; PPAR-gamma; Mitochondrial dysfunction	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; RAT CORTICAL-NEURONS; CEREBRAL-ISCHEMIA; GLUCOSE DEPRIVATION; OXIDATIVE STRESS; PROTECTS NEURONS; DOWN-REGULATION; CANDESARTAN; NEUROPROTECTION	Angiotensin II type 1 receptor (AT1-R) blockers protect against brain ischemia by mechanisms dependent on and independent of arterial blood pressure. However, the effects of AT1-R blockers on brain endothelial cell injury and detailed mechanisms remain unclear. The goal of this study is to investigate whether azilsartan, an AT1-R blocker, could attenuate oxidative injury in endothelial cells via regulating mitochondrial function and inflammatory responses. We found that treatment with azilsartan suppressed tert-butyl hydroperoxide (t-BHP)-induced oxidative damage in murine brain endothelial cells (mBECs) by increasing cell viability, decreasing lactate dehydrogenase (LDH) release and inhibiting cell apoptosis. Azilsartan significantly inhibited reactive oxygen species (ROS) generation and lipid peroxidation, but had no effect on antioxidant system. We also detected preserved mitochondrial function after azilsartan treatment, as evidenced by increased mitochondrial membrane potential (MMP), reduced cytochrome c release, preserved ATP synthesis and inhibited mitochondrial swelling. In addition, azilsartan differently regulated expression of inflammatory cytokines and increased the activation of endothelial nitric oxide synthase (eNOS). Pretreatment with eNOS inhibitor L-NIO partially prevented the azilsartan-induced regulation of cytokines and protection. Furthermore, azilsartan-induced protection in our in vitro model was shown to be associated with protein stability of peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Overall, our data suggest that the AT1-R blocker azilsartan may have therapeutic values in treating endothelial dysfunction associated neurological disorders through anti-oxidative and anti-inflammatory properties. (C) 2016 Elsevier Ltd. All rights reserved.	[Liu, Hao; Mao, Ping; Wang, Jia; Wang, Tuo; Xie, Chang-Hou] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, West Yanta Rd 277, Xian 710061, Shaanxi, Peoples R China		Liu, H (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, West Yanta Rd 277, Xian 710061, Shaanxi, Peoples R China.	liuhao_xjtu@126.com					Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Baker WL, 2011, ANN PHARMACOTHER, V45, P1506, DOI 10.1345/aph.1Q468; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Dai SH, 2014, INT J MOL MED, V34, P1159, DOI 10.3892/ijmm.2014.1876; Di J, 2014, CELL PHYSIOL BIOCHEM, V34, P1063, DOI 10.1159/000366321; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Forstermann U, 2011, BRIT J PHARMACOL, V164, P213, DOI 10.1111/j.1476-5381.2010.01196.x; Gajkowska B, 1997, FOLIA NEUROPATHOL, V35, P171; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hawkins BT, 2015, J CEREBR BLOOD F MET, V35, P985, DOI 10.1038/jcbfm.2015.9; Horiuchi M, 2010, J RENIN-ANGIO-ALDO S, V11, P1, DOI 10.1177/1470320309347793; Iwai M, 2007, AM J HYPERTENS, V20, P579, DOI 10.1016/j.amjhyper.2006.12.010; Kajiya T, 2011, J HYPERTENS, V29, P2476, DOI 10.1097/HJH.0b013e32834c46fd; Kim EJ, 2002, BRAIN RES, V941, P1, DOI 10.1016/S0006-8993(02)02480-0; Kozak A, 2009, STROKE, V40, P1870, DOI 10.1161/STROKEAHA.108.537225; Kurtz TW, 2008, AM J HYPERTENS, V21, P852, DOI 10.1038/ajh.2008.202; Li J., 2013, NEUROPHARMACOLOGY; Li JM, 2008, STROKE, V39, P2029, DOI 10.1161/STROKEAHA.107.503458; Li X, 2014, CELL PHYSIOL BIOCHEM, V34, P1227, DOI 10.1159/000366334; Lima CF, 2007, CHEM-BIOL INTERACT, V167, P107, DOI 10.1016/j.cbi.2007.01.020; Liu H, 2008, J HYPERTENS, V26, P1435, DOI 10.1097/HJH.0b013e3283013b6e; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo P, 2013, FEBS J, V280, P6114, DOI 10.1111/febs.12531; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Ogihara T, 2008, HYPERTENSION, V51, P393, DOI 10.1161/HYPERTENSIONAHA.107.098475; Ojima M, 2011, J PHARMACOL EXP THER, V336, P801, DOI 10.1124/jpet.110.176636; Ortiz PA, 2003, ACTA PHYSIOL SCAND, V179, P107, DOI 10.1046/j.1365-201X.2003.01207.x; Ostergren J, 2004, EXPERT OPIN PHARMACO, V5, P1589, DOI 10.1517/14656566.5.7.1589; Panahpour Hamdollah, 2014, Iranian Biomedical Journal, V18, P232, DOI 10.6091/ibj.13672.2014; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Perry CM, 2012, CLIN DRUG INVEST, V32, P621, DOI 10.2165/11209600-000000000-00000; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Saavedra JM, 2006, CELL MOL NEUROBIOL, V26, P1099, DOI 10.1007/s10571-006-9009-0; Schaefer KL, 2005, CANCER RES, V65, P2251, DOI 10.1158/0008-5472.CAN-04-3037; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.0000075777.18006.89; Volpe M, 2012, INTEGR BLOOD PRESS C, V5, P19, DOI 10.2147/IBPC.S13784; Wang R, 2014, CELL PHYSIOL BIOCHEM, V34, P854, DOI 10.1159/000366304; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Zhang JS, 2014, CELL PHYSIOL BIOCHEM, V34, P1137, DOI 10.1159/000366327; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061; Zhou YF, 2014, BRAIN RES BULL, V100, P14, DOI 10.1016/j.brainresbull.2013.10.013	55	21	22	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2016	94						48	56		10.1016/j.neuint.2016.02.005			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DI6ZT	WOS:000373649600006	26879328				2022-02-06	
J	Mofid, B; Soltani, Z; Khaksari, M; Shahrokhi, N; Nakhaee, N; Karamouzian, S; Ahmadinejad, M; Maiel, M; Khazaeli, P				Mofid, Behshad; Soltani, Zahra; Khaksari, Mohammad; Shahrokhi, Nader; Nakhaee, Nouzar; Karamouzian, Saeed; Ahmadinejad, Mehdi; Maiel, Masoud; Khazaeli, Payam			What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Diffuse axonal injury; Interleukin-1 beta; Interleukin-6; Progesterone; Transforming growth factor-beta 1; Oxidant activity	TRAUMATIC BRAIN-INJURY; SEX STEROID-HORMONES; CLINICAL-TRIAL; HEAD-INJURY; DAMAGE; NEUROPROTECTION; EXPRESSION; CONTUSION; EDEMA; S100B	To permit appropriate targeted therapy, the present clinical study was aimed to investigate the effects of progesterone on the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury (DAI). Forty-eight male DAI patients were divided into two groups (control and progesterone). Progesterone group received progesterone in dose of 1 mg/kg per 12 h for five days. The outcome was investigated using Extended Glasgow Outcome Scale (GOS-E) and functional independence measure (FIM). The markers of inflammation Iinterleukin-1 beta (IL-1 beta), IL-6, transforming growth factor-beta 1 (TGF-beta 1)], injury (brain protein of S-100B), and oxidant activity [malondialdehyde (MDA)] were evaluated in the serum of the patients. Higher GOS-E and FIM scores were observed in progesterone group at the six-month follow-up (P < 0.05 and P < 0.01, respectively). Meanwhile, a reduction in the serum levels of IL-1 beta, MDA and S-100B was noticed in progesterone group 24 h after injury (P < 0.05, P < 0.001 and P < 0.05, respectively), and there was an increase in serum levels of IL-6 and TGF-beta 1 (P < 0.01 and P < 0.05, respectively). Also, lower levels of MDA and S-100B, and higher levels of TGF-beta 1 were observed in progesterone group six days after injury (P < 0.05). According to these findings, progesterone may improve the outcome in DAI patients probably through modulation in the levels of cytokines, and reduction in the injury and oxidant activity. (C) 2016 Elsevier B.V. All rights reserved.	[Mofid, Behshad; Karamouzian, Saeed] Kerman Univ Med Sci, Dept Neurosurg, Kerman, Iran; [Soltani, Zahra; Khazaeli, Payam] Kerman Univ Med Sci, Afzalipour Sch Med, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Khaksari, Mohammad; Nakhaee, Nouzar] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Ahmadinejad, Mehdi] Kerman Univ Med Sci, Dept Intens Care Unit, Kerman, Iran; [Maiel, Masoud] Kerman Univ Med Sci, Dept Emergency Med, Kerman, Iran		Soltani, Z (corresponding author), Kerman Univ Med Sci, Afzalipour Sch Med, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran.	soltaniy@yahoo.com	Soltani, Zahra/AAC-1350-2019; Khazaeli, Payam/L-1837-2018; Shahrokhi, Nader/AAV-3747-2020; Haddad, Mohammad Khaksari/AAB-9025-2019; Nakhaee, Nouzar/AAZ-2677-2020; ahmadinejad, mehdi/AAK-1149-2020; khazaeli, Payam/AAP-5842-2021	Soltani, Zahra/0000-0002-8423-6189; Shahrokhi, Nader/0000-0002-0149-7819; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Nakhaee, Nouzar/0000-0001-5808-6503; khazaeli, Payam/0000-0001-8914-3187; Karamouzian, Saeid/0000-0001-6256-0941			Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Clarke D.D., 1999, BASIC NEUROCHEMISTRY, V6, P637; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Hanafy KA, 2012, NEUROTHERAPEUTICS, V9, P44, DOI 10.1007/s13311-011-0085-6; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Herrmann M, 2004, RESTOR NEUROL NEUROS, V22, P57; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mertsch K, 2001, NEUROSCI LETT, V314, P135, DOI 10.1016/S0304-3940(01)02299-6; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stein D., 2014, HDB CLIN NEUROL, V127, P433; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	73	21	22	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAR	2016	32						103	110		10.1016/j.intimp.2016.01.015			8	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	DF2QM	WOS:000371188900014	26803522	Green Accepted			2022-02-06	
J	Mollayeva, T; Mollayeva, S; Shapiro, CM; Cassidy, JD; Colantonio, A				Mollayeva, Tatyana; Mollayeva, Shirin; Shapiro, Colin M.; Cassidy, J. David; Colantonio, Angela			Insomnia in workers with delayed recovery from mild traumatic brain injury	SLEEP MEDICINE			English	Article						Insomnia; Traumatic brain injury; Concussion; Delayed recovery; Rehabilitation; Diagnostic modeling	OLDER-ADULTS; PSYCHIATRIC-DISORDERS; ASSESSING DEPRESSION; SLEEP DISTURBANCES; GENERAL-POPULATION; SEX-DIFFERENCES; RISK-FACTORS; PAIN; PREVALENCE; COMPLAINTS	Objective/Background/Aim: Insomnia has not been explored as it relates to recovery after mild traumatic brain injury (mTBI). We aimed to evaluate the prevalence of insomnia among Ontario workers with delayed recovery from mTBI, and its relationship with sociodemographic, TBI- and claim-related, behavioral, and clinical factors. Patients/Methods: This was a cross-sectional study carried out over a period of 24 months in a large rehabilitation hospital in Ontario. To assess the prevalence of insomnia, we used the Insomnia Severity Index (ISI). Data were collected from standardized questionnaires, insurer records, and clinical assessment at the time of recruitment. Bivariate associations were calculated using the Spearman's correlation coefficient or analysis of variance. We established stepwise multivariate linear regression models of factors associated with insomnia. Additional analyses, including the assessment of the internal consistency of the ISI, were performed. Results: Of the 94 participants diagnosed with mTBI, clinical insomnia was reported by 69.2%. The mean age was 45.20 +/- 9.94 years; 61.2% were men. No sex-related differences were observed in insomnia prevalence or severity. Insomnia was significantly associated with certain sociodemographic, claim-related, behavioral, and clinical variables. In the multivariable regression analysis, several determinants explained 53% of the insomnia variance. The internal consistency of the ISI, as measured by Cronbach's a, was 0.86. Conclusions: Insomnia is common in persons with delayed recovery from mTBI, and is significantly associated with potentially modifiable clinical and nonclinical variables. Care of persons with brain injury requires greater attention with regard to the diagnosis and management of insomnia and associated disorders. (C) 2015 Elsevier B.V. All rights reserved.	[Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Fac Med, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Mollayeva, Tatyana] Univ Toronto, Collaborat Program Neurosci, Toronto, ON, Canada; [Mollayeva, Tatyana] Toronto Rehab Univ Hlth Network, Toronto, ON, Canada; [Mollayeva, Shirin; Shapiro, Colin M.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Mollayeva, Shirin; Colantonio, Angela] Univ Toronto, Aquired Brain Injury Res Lab, Toronto, ON, Canada; [Mollayeva, Shirin; Shapiro, Colin M.] Youthdale Child & Adolescent Sleep Clin, Toronto, ON, Canada; [Shapiro, Colin M.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Cassidy, J. David] Univ Southern Denmark, Fac Hlth, Dept Sport Sci & Clin Biomech, Odense M, Denmark; [Cassidy, J. David] Univ Hlth Network, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Cassidy, J. David] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Mollayeva, T (corresponding author), Toronto Rehabil Inst, 550 Univ Ave,Rm 11207, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848; Mollayeva, Shirin/0000-0001-9612-8655	Toronto Rehabilitation Institute Scholarship; Ontario Graduate ScholarshipOntario Graduate Scholarship; Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Saunderson Family Chair in Acquired Brain Injury Research; Canadian Institutes of Health Research Grant -Institute for Gender and Health [CGW-126580]	Our study had no external funding source. The first author was supported by 2010/2011 Toronto Rehabilitation Institute Scholarship, the Ontario Graduate Scholarship 2012/2013, and the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research, Angela Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research and by the Canadian Institutes of Health Research Grant -Institute for Gender and Health (#CGW-126580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Brain Injury Association of America, 2012, AB BRAIN INJ; Casson RJ, 2014, CLIN EXP OPHTHALMOL, V42, P590, DOI 10.1111/ceo.12358; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; DeMartinis Nicholas A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P17, DOI 10.2174/187152707779940835; Drake CL, 2006, SLEEP MED CLIN, V1, P333, DOI 10.1016/j.jsmc.2006.06.005; Duckworth D, 1881, BRAIN, V4, P145; DUNLEAVY DL, 1972, BRIT J PSYCHIAT, V120, P663, DOI 10.1192/bjp.120.559.663; Edinger JD, 2008, SLEEP, V31, P599, DOI 10.1093/sleep/31.5.599; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Harland NJ, 2015, PHYSIOTHERAPY, V101, P50, DOI 10.1016/j.physio.2014.06.004; HARTMANN E, 1973, PSYCHOPHARMACOLOGIA, V33, P185, DOI 10.1007/BF00429087; Harvey AG, 2011, PRINCIPLES PRACTICE, P838; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jean-Louis G, 2008, J WOMENS HEALTH, V17, P15, DOI 10.1089/jwh.2006.0310; Kikuchi T, 2013, PSYCHIAT RES, V210, P127, DOI 10.1016/j.psychres.2013.05.007; KLINK ME, 1992, ARCH INTERN MED, V152, P1634, DOI 10.1001/archinte.152.8.1634; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Lichstein K. L., 2011, PRINCIPLES PRACTICE, P827, DOI DOI 10.1016/B978-1-4160-6645-3.00076-1; Lichstein KL, 2004, EPIDEMIOLOGY OF SLEEP AGE, GENDER, AND ETHNICITY, P1; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2013, ENCY SLEEP, V2, P330; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Morgan K, 2003, J SLEEP RES, V12, P231, DOI 10.1046/j.1365-2869.2003.00355.x; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Institutes of Health, 2005, J CLIN SLEEP MED, V1, P412; National Sleep Foundation, 2008, SLEEP AM POLL; NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037/0033-2909.101.2.259; NUNNALLY JC, 1978, PSYCHOMETRIC THEORY, P225; Ohayon MM, 2010, SLEEP MED, V11, P1010, DOI 10.1016/j.sleep.2010.02.018; Ohayon MM, 2005, SLEEP, V28, P981; Ohayon MM, 2001, J AM GERIATR SOC, V49, P360, DOI 10.1046/j.1532-5415.2001.49077.x; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; Popat RA, 2010, SLEEP MED, V11, P154, DOI 10.1016/j.sleep.2009.01.012; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI 10.1111/jsr.12102; Sosin DM, 1996, BRAIN INJURY, V10, P47; SPIELMAN AJ, 1999, SLEEP DISORDERS MED, P385; Stoffers D, 2014, BRAIN, V137, P610, DOI 10.1093/brain/awt329; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Sturzenegger C, 2004, J SLEEP RES, V13, P395, DOI 10.1111/j.1365-2869.2004.00422.x; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Vitiello MV, 2002, J PSYCHOSOM RES, V53, P555, DOI 10.1016/S0022-3999(02)00435-X; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; WHO, PROJ MORT BURD DIS 2; Wilson S, 2005, DRUGS, V65, P927, DOI 10.2165/00003495-200565070-00003; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	71	21	21	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAR	2016	19						153	161		10.1016/j.sleep.2015.05.014			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DM7EH	WOS:000376518600026	26358896				2022-02-06	
J	Sandsmark, DK; Kumar, MA; Woodward, CS; Schmitt, SE; Park, S; Lim, MM				Sandsmark, Danielle K.; Kumar, Monisha A.; Woodward, Catherine S.; Schmitt, Sarah E.; Park, Soojin; Lim, Miranda M.			Sleep Features on Continuous Electroencephalography Predict Rehabilitation Outcomes After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						seizure; continuous EEG; traumatic brain injury; rehabilitation; status epilepticus; modified Rankin Scale; sleep; electroencephalography	SEVERE HEAD-INJURY; UNITED-STATES; CLASSIFICATION; CONSCIOUSNESS; ANESTHESIA; DISORDERS; IMPACT; MEMORY; EEG	Objective: Sleep characteristics detected by electroencephalography (EEG) may be predictive of neurological recovery and rehabilitation outcomes after traumatic brain injury (TBI). We sought to determine whether sleep features were associated with greater access to rehabilitation therapies and better functional outcomes after severe TBI. Methods: We retrospectively reviewed records of patients admitted with severe TBI who underwent 24 or more hours of continuous EEG (cEEG) monitoring within 14 days of injury for sleep elements and ictal activity. Patient outcomes included discharge disposition and modified Rankin Scale (mRS). Results: A total of 64 patients underwent cEEG monitoring for a mean of 50.6 hours. Status epilepticus or electrographic seizures detected by cEEG were associated with poor outcomes (death or discharge to skilled nursing facility). Sleep characteristics were present in 19 (30%) and associated with better outcome (89% discharged to home/acute rehabilitation; P = .0002). Lack of sleep elements on cEEG correlated with a poor outcome or mRS > 4 at hospital discharge (P = .012). Of those patients who were transferred to skilled nursing/acute rehabilitation, sleep architecture on cEEG associated with a shorter inpatient hospital stay (20 days vs 27 days) and earlier participation in therapy (9.8 days vs 13.2 days postinjury). Multivariable analyses indicated that sleep features on cEEG predicted functional outcomes independent of admission Glasgow Coma Scale and ictal-interictal activity. Conclusion: The presence of sleep features in the acute period after TBI indicates earlier participation in rehabilitative therapies and a better functional recovery. By contrast, status epilepticus, other ictal activity, or absent sleep architecture may portend a worse prognosis. Whether sleep elements detected by EEG predict long-term prognosis remains to be determined.	[Sandsmark, Danielle K.; Kumar, Monisha A.] Univ Penn, Dept Neurol, 3400 Spruce St,3W Gates Bldg, Philadelphia, PA 19104 USA; [Woodward, Catherine S.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Woodward, Catherine S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Schmitt, Sarah E.] Med Univ S Carolina, Dept Neurol, Charleston, SC USA; [Park, Soojin] Columbia Univ, Dept Neurol, New York, NY USA; [Lim, Miranda M.] Vet Affairs Portland Hlth Care Syst, Dept Med, Div Pulm & Crit Care Med, Portland, OR USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Inst Occupat Hlth Sci, Portland, OR USA		Sandsmark, DK (corresponding author), Univ Penn, Dept Neurol, 3400 Spruce St,3W Gates Bldg, Philadelphia, PA 19104 USA.	danielle.sandsmark@uphs.upenn.edu		Schmitt, Sarah/0000-0003-1384-9794	VA Career Development Award [IK2 BX002712]; Veterans AffairsUS Department of Veterans Affairs [IK2BX002712] Funding Source: NIH RePORTER	This material is the result of the work supported with resources and the use of facilities at the VA Portland Health Care System, the VA Career Development Award IK2 BX002712, the American Sleep Medicine Foundation, and the Portland VA Research Foundation (MML). The contents do not represent the views of the US Department of Veterans Affairs or the US Government.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Cheliout-Heraut F, 2001, NEUROPHYSIOL CLIN, V31, P283, DOI 10.1016/S0987-7053(01)00270-2; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; JENNETT B, 1976, LANCET, V1, P1031; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Koenig MA, 2013, SEMIN NEUROL, V33, P121, DOI 10.1055/s-0033-1348962; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Marshall L., J NEUROSURG, V75, pS14; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; Schneider G, 2014, ANESTHESIOLOGY, V120, P819, DOI 10.1097/ALN.0000000000000151; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tung Avery, 2002, J Clin Monit Comput, V17, P37, DOI 10.1023/A:1015404803637; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Wright DW, 2015, NEW ENGL J MED, V372, P1766, DOI 10.1056/NEJMc1503138; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	33	21	23	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		101	107		10.1097/HTR.0000000000000217			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100003	26959664	Green Accepted			2022-02-06	
J	Vuletic, S; Bell, KR; Jain, S; Bush, N; Temkin, N; Fann, JR; Stanfill, KE; Dikmen, S; Brockway, JA; He, F; Ernstrom, K; Raman, R; Grant, G; Stein, MB; Gahm, GA				Vuletic, S.; Bell, K. R.; Jain, S.; Bush, N.; Temkin, N.; Fann, J. R.; Stanfill, K. E.; Dikmen, S.; Brockway, J. A.; He, F.; Ernstrom, K.; Raman, R.; Grant, G.; Stein, M. B.; Gahm, G. A.		CONTACT Investigators	Telephone Problem-Solving Treatment Improves Sleep Quality in Service Members With Combat-Related Mild Traumatic Brain Injury: Results From a Randomized Clinical Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						military; traumatic brain injury; sleep; problem-solving treatment; insomnia	POSTTRAUMATIC-STRESS-DISORDER; MILITARY PERSONNEL; VETERANS; INSOMNIA; HEALTH; CONCUSSION; SYMPTOMS; PAIN; DISTURBANCE; SEVERITY	Objective: Evaluate sleep quality, its correlates, and the effect of telephone-based problem-solving treatment (PST) in active duty postdeployment service members with mild traumatic brain injury (mTBI) Setting: Randomized clinical trial. Participants: Active duty service members with combat-related mTBI. Study design: Education-only (EO) and PST groups (N = 178 each) received printed study materials and 12 educational brochures. The PST group additionally received up to 12 PST telephone calls addressing participant-selected issues. Outcomes were evaluated postintervention (6 months) and at 12 months. Main Measure: Pittsburgh Sleep Quality Index. Results: Sleep quality was manifestly poor in both groups at baseline (Pittsburgh Sleep Quality Index = 12.5 +/- 4). Overall sleep quality was significantly different between the PST and EO groups at 6 months (P = .003) but not at 12 months. Longitudinally, PST significantly improved sleep quality at 6 months (P = .001) but not over the follow-up. Low sleep quality was associated with concussion symptoms, pain, depression, and posttraumatic stress disorder at all time points (P < .0001). Conclusions: Sleep disorders, common in postdeployment service members with mTBI, are strongly associated with the presence of pain, posttraumatic stress disorder, and depression. Telephone-based PST may be an effective therapeutic approach for reducing sleep disorders in this population. Research should focus on maintenance of treatment gains.	[Vuletic, S.; Bush, N.; Stanfill, K. E.; Gahm, G. A.] Natl Ctr Telehealth & Technol T2, Tacoma, WA USA; [Bell, K. R.; Temkin, N.; Dikmen, S.; Brockway, J. A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, N.; Dikmen, S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, N.; Fann, J. R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Fann, J. R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Bell, K. R.] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Jain, S.; He, F.; Ernstrom, K.; Raman, R.; Stein, M. B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, M. B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Grant, G.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Gahm, G. A.] Def Ctr Excellence DCoE, 4124 41st LP SE, Olympia, WA 98501 USA		Gahm, GA (corresponding author), Def Ctr Excellence DCoE, 4124 41st LP SE, Olympia, WA 98501 USA.	gregory.a.gahm.civ@mail.mil		Bush, Nigel/0000-0002-8137-7998; Bell, Kathleen/0000-0002-0928-2046	US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0159]	This research was supported by grant W81XWH-08-2-0159 from the US Army Medical Research and Materiel Command (USAMRMC). The authors are thankful to all study participants and their families; the CONTACT study team members: Wesley R. Cole, PhD (Womack Army Medical Center, Fort Bragg, North Carolina), Tessa Hart, PhD (Moss Rehabilitation Research Institute, Pennsylvania), Ariel J Lang, PhD, MPH (UCSD, La Jolla, California), Jef St. De Lore, MPH (University of Washington, Seattle, Washington), Jason Barber, MS (University of Washington, Seattle, Washington), Sara E. Fey-Hinckley, MA, LMFT, CBIS (University of Washington, Seattle, Washington), Jocelyn L. Savage, LICSW (University of Washington, Seattle, Washington), Michael Warren, MA (University of Washington, Seattle, Washington), Elissa Thomas (National Center for Telehealth and Technology, T2, Tacoma, Washington), Karina Boykin (National Center for Telehealth and Technology, T2, Tacoma, Washington); as well as Derek Smolensky, PhD, MPH (National Center for Telehealth and Technology, T2, Tacoma, Washington); and the Geneva Foundation (Tacoma, Washington), in particular Kasey Zink.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Babson KA, 2012, J TRAUMA STRESS, V25, P665, DOI 10.1002/jts.21757; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bell KR, 2015, CONTEMP CLIN TRIALS, V40, P54, DOI 10.1016/j.cct.2014.11.001; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Choe MC, 2015, SEMIN NEUROL, V35, P29, DOI 10.1055/s-0035-1544243; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; DePalma RG, 2015, BRAIN NEUROTRAUMA MO; Engdahl BE, 2000, BIOL PSYCHIAT, V47, P520, DOI 10.1016/S0006-3223(99)00201-2; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Ford ES, 2015, SLEEP MED, V16, P372, DOI 10.1016/j.sleep.2014.12.008; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garthus-Niegel S, 2015, J AFFECT DISORDERS, V172, P146, DOI 10.1016/j.jad.2014.10.003; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; HEFEZ A, 1987, AM J PSYCHIAT, V144, P344; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Miro J, 2016, EUR J PAIN, V20, P130, DOI 10.1002/ejp.704; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mustafa Masroor, 2005, Sleep Breath, V9, P57, DOI 10.1007/s11325-005-0016-z; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; *NAT SLEEP FDN, SLEEP AM POLL SLEEP; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Onen SH, 2001, J SLEEP RES, V10, P35, DOI 10.1046/j.1365-2869.2001.00240.x; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Reinsel RA, 2015, J CLIN SLEEP MED, V11, P1361, DOI 10.5664/jcsm.5264; Tello-Velasquez JR, 2015, CAD SAUDE PUBLICA, V31, P989, DOI 10.1590/0102-311X00010014; Riemann D, 2007, SLEEP MED, V8, pS15, DOI 10.1016/S1389-9457(08)70004-2; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Searle AK, 2015, INT J METH PSYCH RES, V24, P32, DOI 10.1002/mpr.1460; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sheehan DV, 2006, INT CLIN PSYCHOPH S3, V11, P89; Sivertsen B, 2015, PAIN, V156, P1433, DOI 10.1097/j.pain.0000000000000131; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	72	21	22	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		147	157		10.1097/HTR.0000000000000221			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100008	26959668				2022-02-06	
J	Yuan, Q; Wu, X; Cheng, HW; Yang, CH; Wang, YH; Wang, ES; Qiu, BH; Fei, ZM; Lan, Q; Wu, SR; Jiang, YZ; Feng, H; Liu, JF; Liu, K; Zhang, FY; Jiang, RC; Zhang, JM; Tu, Y; Wu, XH; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Cheng, Hongwei; Yang, Chaohua; Wang, Yuhai; Wang, Ersong; Qiu, Binghui; Fei, Zhimin; Lan, Qing; Wu, Sirong; Jiang, Yunzhao; Feng, Hua; Liu, Jingfang; Liu, Ke; Zhang, Fayun; Jiang, Rongcai; Zhang, Jianmin; Tu, Yue; Wu, Xuehai; Zhou, Liangfu; Hu, Jin			Is Intracranial Pressure Monitoring of Patients With Diffuse Traumatic Brain Injury Valuable? An Observational Multicenter Study	NEUROSURGERY			English	Article						Diffuse injury; Intracranial pressure monitoring; Outcome; Propensity score; Traumatic brain injury	SEVERE HEAD-INJURY; TOMOGRAPHIC SCAN CHARACTERISTICS; DECOMPRESSIVE CRANIECTOMY; LINEAR RELATIONSHIP; UNITED-STATES; CLASSIFICATION; MANAGEMENT; MORTALITY; PREDICTORS; DIAGNOSIS	BACKGROUND: Although intracranial pressure (ICP) monitoring of patients with severe traumatic brain injury (TBI) is recommended by the Brain Trauma Foundation, any benefits remain controversial. OBJECTIVE: To evaluate the effects of ICP monitoring on the mortality of and functional outcomes in patients with severe diffuse TBI. METHODS: Data were collected on patients with severe diffuse TBI (Glasgow Coma Scale [GCS] score on admission,9 and Marshall Class II-IV) treated from January 2012 to December 2013 in 24 hospitals (17 level I trauma centers and 7 level II trauma centers) in 9 Chinese provinces. We evaluated the impact of ICP monitoring on 6-month mortality and favorable outcome using propensity score-matched analysis after controlling for independent predictors of these outcomes. RESULTS: ICP monitors were inserted into 287 patients (59.5%). After propensity score matching, ICP monitoring significantly decreased 6-month mortality. ICP monitoring also had a greater impact on the most severely injured patients on the basis of head computed tomography data (Marshall computed tomography classification IV) and on patients with the lowest level of consciousness (GCS scores 3-5). After propensity score matching, monitoring remained nonassociated with a 6-month favorable outcome for the overall sample. However, monitoring had a significant impact on the 6-month favorable outcomes of patients with the lowest level of consciousness (GCS scores 3-5). CONCLUSION: ICP monitor placement was associated with a significant decrease in 6-month mortality after adjustment for the baseline risk profile and the monitoring propensity of patients with diffuse severe TBI, especially those with GCS scores of 3 to 5 or of Marshall computed tomography classification IV.	[Wu, Xing; Wu, Xuehai; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China; [Cheng, Hongwei] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Peoples R China; [Yang, Chaohua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610064, Peoples R China; [Wang, Yuhai] 101 Hosp Peoples Liberat Army, Dept Neurosurg, Wuxi, Peoples R China; [Wang, Ersong] Fudan Univ, Dept Neurosurg, Jinshan Hosp, Shanghai 200433, Peoples R China; [Qiu, Binghui] Southern Med Univ, Dept Neurosurg, South Hosp, Guangzhou, Guangdong, Peoples R China; [Fei, Zhimin] Shanghai Shu guang Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Lan, Qing] Soochow Univ, Dept Neurosurg, Affiliated Hosp 2, Suzhou, Peoples R China; [Wu, Sirong] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China; [Jiang, Yunzhao] Wuxi Third People Hosp, Dept Neurosurg, Wuxi, Peoples R China; [Feng, Hua] Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Liu, Jingfang] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Liu, Ke] Chongqing Emergency Med Ctr, Dept Neurosurg, Chongqing, Peoples R China; [Zhang, Fayun] Luqiao Hosp, Dept Neurosurg, Enze Med Ctr, Taizhou, Peoples R China; [Jiang, Rongcai] Tianjing Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Tu, Yue] Logist Univ Peoples Armed Police Force, Affiliated Hosp, Dept Neurosurg, Tianjin, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	hujin_dana@126.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471241, 81271375, 81171133]	This work was supported by the National Natural Science Foundation of China (grants 81471241, 81271375, and 81171133). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Figaji AA., 2012, CAN J NEUROL SCI, V39, P571; Figaji Anthony A, 2013, Can J Neurol Sci, V40, P433; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Wang D, 2004, J TRAUMA, V56, P972; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	39	21	23	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2016	78	3					361	368		10.1227/NEU.0000000000001050			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DE2DY	WOS:000370438000014	26891376	Bronze			2022-02-06	
J	Scheenen, ME; de Koning, ME; van der Horn, HJ; Roks, G; Yilmaz, T; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; de Koning, Myrthe E.; van der Horn, Harm J.; Roks, Gerwin; Yilmaz, Tansel; van der Naalt, Joukje; Spikman, Jacoba M.			Acute Alcohol Intoxication in Patients with Mild Traumatic Brain Injury: Characteristics, Recovery, and Outcome	JOURNAL OF NEUROTRAUMA			English	Article						alcohol; complaints; mild traumatic brain injury; outcome; recovery	GLASGOW COMA SCALE; ACUTE ETHANOL INTOXICATION; SYMPTOMS FOLLOWING MILD; PREDICTORS; IMPACT; LEVEL; MODEL; SCORE; AGE	A substantial number of patients (30% to 50%) sustains a mild traumatic brain injury (mTBI) while they are under the influence of alcohol. An acute alcohol intoxication (AAI) at the time of injury has been subject of research in severe TBI, but little is known about the relation between AAI and mTBI. This study aimed to describe the characteristics of this intoxicated subgroup and evaluate recovery and outcome in comparison to sober mTBI patients. We included 528 mTBI patients (Glasgow Coma Scale [GCS] score 13-15) admitted to two Level 1 trauma centers as part of a prospective follow-up study. We compared clinical characteristics, demographics, and injury mechanism between groups. Post-concussive complaints, mood disorders, and post-traumatic stress-related complaints were assessed at 2 weeks post-injury, and outcome at 6 months with the Glasgow Outcome Scale Extended (GOSE). Thirty-three percent of the mTBI patients were intoxicated. Results showed that the intoxicated group was younger (36 vs. 40 years; p=0.001) and were more frequently of male gender (78% vs. 60%; p<.001). The groups also differed in injury related characteristics, with intoxicated patients more frequently sustaining falls or violence-related injuries. The intoxicated group was assessed with a lower GCS score and had a higher hospital admission rate. However, at 2 weeks post-injury, intoxicated patients reported less complaints than the non-alcohol group and showed a better recovery at 6 months (average GOSE scores 7 vs. 7.3; p=0.030). We conclude that AAI in mTBI represents a characteristically different group, which has implications for prevention measures, as well as the course of recovery.	[Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Dept Neuropsychol, NL-9700 RB Groningen, Netherlands; [de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Roks, Gerwin; Yilmaz, Tansel] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418			ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gilman JM, 2008, J NEUROSCI, V28, P4583, DOI 10.1523/JNEUROSCI.0086-08.2008; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; IBM Corp, IBM SPSS STAT WIND V; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; Kaysen DL, 2010, J TRAUMA STRESS, V23, P523, DOI 10.1002/jts.20542; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Mahler SA, 2010, J EMERG MED, V39, P685, DOI 10.1016/j.jemermed.2009.05.016; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	21	22	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					339	345		10.1089/neu.2015.3926			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800003	26230219	Green Submitted			2022-02-06	
J	Kelestemur, T; Yulug, B; Caglayan, AB; Beker, MC; Kilic, U; Caglayan, B; Yalcin, E; Gundogdu, RZ; Kilic, E				Kelestemur, Taha; Yulug, Burak; Caglayan, Ahmet Burak; Beker, Mustafa Caglar; Kilic, Ulkan; Caglayan, Berrak; Yalcin, Esra; Gundogdu, Reyhan Zeynep; Kilic, Ertugrul			Targeting different pathophysiological events after traumatic brain injury in mice: Role of melatonin and memantine	NEUROSCIENCE LETTERS			English	Article						Memantine; Melatonin; Traumatic Brain Injury; DNA fragmentation	FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; CLOSED-HEAD INJURY; RECEPTOR INHIBITION; KINASE PATHWAYS; NMDA RECEPTOR; RAT STRIATUM; IN-VITRO; ACTIVATION; NEUROPROTECTION	The tissue damage that emerges during traumatic brain injury (TBI) is a consequence of a variety of pathophysiological events, including free radical generation and over-activation of N-methyl-D-aspartate-type glutamate receptors (NMDAR). Considering the complex pathophysiology of TBI, we hypothesized that combination of neuroprotective compounds, targeting different events which appear during injury, may be a more promising approach for patients. In this context, both NMDAR antagonist memantine and free radical scavenger melatonin are safe in humans and promising agents for the treatment of TBI. Herein, we examined the effects of melatonin administered alone or in combination with memantine on the activation of signaling pathways, injury development and DNA fragmentation. Both compounds reduced brain injury moderately and the density of DNA fragmentation significantly. Notably, melatonin/memantine combination decreased brain injury and DNA fragmentation significantly, which was associated with reduced p38 and ERK-1/2 phosphorylation. As compared with melatonin and memantine groups, SAM/INK-1/2 phosphorylation was also reduced in melatonin/memantine combined animals. In addition, melatonin, memantine and their combination decreased iNOS activity significantly. Here, we provide evidence that melatonin/memantine combination protects brain from traumatic injury, which was associated with decreased DNA fragmentation, p38 phosphorylation and iNOS activity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kelestemur, Taha; Caglayan, Ahmet Burak; Beker, Mustafa Caglar; Caglayan, Berrak; Yalcin, Esra; Gundogdu, Reyhan Zeynep; Kilic, Ertugrul] Univ Istanbul Medipol, Regenerat & Restorat Med Res Ctr, Dept Physiol, TR-34810 Istanbul, Turkey; [Yulug, Burak] Univ Istanbul Medipol, Dept Neurol, TR-34810 Istanbul, Turkey; [Kilic, Ulkan] Univ Istanbul Medipol, Dept Med Biol, TR-34810 Istanbul, Turkey		Kilic, E (corresponding author), Istanbul Medipol Univ, Dept Physiol, Ekinciler Cad 19, TR-34810 Istanbul, Turkey.	ekilic@medipol.edu.tr	Yulug, Burak/O-8322-2016; Yulug, Burak/AAD-3930-2022; Beker, Mustafa Caglar/ABH-2222-2020; Kilic, Ertugrul/W-4563-2018	Yulug, Burak/0000-0002-9704-6173; Kilic, Ertugrul/0000-0001-6494-8923; Beker, Mustafa/0000-0002-9476-8488; Kelestemur, Taha/0000-0003-3616-1204; Yalcin, Esra/0000-0002-1064-7989; Caglayan, Berrak/0000-0002-5072-132X; caglayan, ahmet burak/0000-0002-6242-3709	EMBO (European Molecular Biology Organization)European Molecular Biology Organization (EMBO); Turkish Academy of Sciences (TUBA)Turkish Academy of Sciences	This work was supported by EMBO (European Molecular Biology Organization) installation grant and Turkish Academy of Sciences (TUBA).	Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Babu CS, 2011, INT J DEV NEUROSCI, V29, P93, DOI 10.1016/j.ijdevneu.2010.08.001; Beker MC, 2015, ONCOTARGET, V6, P30604, DOI 10.18632/oncotarget.5773; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; El-Sherif Y, 2002, BRAIN RES, V945, P191, DOI 10.1016/S0006-8993(02)02752-X; Escames G, 2004, J NEUROENDOCRINOL, V16, P929, DOI 10.1111/j.1365-2826.2004.01250.x; Fukunaga K, 2002, J NEUROSCI RES, V70, P799, DOI 10.1002/jnr.10400; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Hermann DM, 2001, NEUROBIOL DIS, V8, P964, DOI 10.1006/nbdi.2001.0448; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kilic E, 1999, J CEREBR BLOOD F MET, V19, P511, DOI 10.1097/00004647-199905000-00005; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Kim YW, 2010, ANN NUCL MED, V24, P363, DOI 10.1007/s12149-010-0360-3; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Leon J, 1998, J NEUROENDOCRINOL, V10, P297, DOI 10.1046/j.1365-2826.1998.00203.x; Lipton SA, 2004, CELL DEATH DIFFER, V11, P18, DOI 10.1038/sj.cdd.4401344; Liu CH, 2009, BRAIN RES, V1282, P173, DOI 10.1016/j.brainres.2009.05.071; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Maroney AC, 1998, J NEUROSCI, V18, P104; Michinaga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102009; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Otani N, 2003, ACT NEUR S, V86, P287; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Otani N., 2011, NEUROSCI MED, V11, P208; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rao VLR, 2001, BRAIN RES, V911, P96; Reiter RJ, 2005, EXP BIOL MED, V230, P104; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; Robertson C. S., 2007, NITRIC OXIDE METABOL, P739; Turel MK, 2013, J CLIN NEUROSCI, V20, P593, DOI 10.1016/j.jocn.2012.06.009; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Watanabe T, 2010, J NEUROSCI RES, V88, P1908, DOI 10.1002/jnr.22346; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zubkov AY, 2000, STROKE, V31, P526, DOI 10.1161/01.STR.31.2.526	45	21	24	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 26	2016	612						92	97		10.1016/j.neulet.2015.11.043			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC8LU	WOS:000369471900016	26639427				2022-02-06	
J	Orhan, N; Yilmaz, CU; Ekizoglu, O; Ahishali, B; Kucuk, M; Arican, N; Elmas, I; Gurses, C; Kaya, M				Orhan, Nurcan; Yilmaz, Canan Ugur; Ekizoglu, Oguzhan; Ahishali, Bulent; Kucuk, Mutlu; Arican, Nadir; Elmas, Imdat; Gurses, Candan; Kaya, Mehmet			Effects of beta-hydroxybutyrate on brain vascular permeability in rats with traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Beta-hydroxybutyrate Blood-brain bather; Horseradish peroxidase; Occludin; Glucose transporter-1	FUNCTION IMPROVING AGENT; SPINAL-CORD BARRIER; NF-KAPPA-B; BLOOD-BRAIN; ENDOTHELIAL-CELLS; GLUCOSE-TRANSPORTER; CORTICAL CONTUSION; LIPID-PEROXIDATION; AQUAPORIN-4 EXPRESSION; HEMORRHAGIC-SHOCK	This study investigates the effect of beta-hydroxybutyrate (BHB) on blood-brain barrier (BBB) integrity during traumatic brain injury (TBI) in rats. Evans blue (EB) and horseradish peroxidase (HRP) were used as determinants of BBB permeability. Glutathione (GSH) and malondialdehyde (MDA) levels *ere estimated in the right (injury side) cerebral cortex of animals. The gene expression levels for occludin, glucose transporter (Glut)-1, aquaporin4 (AQP4) and nuclear factor-kappaB (NF-kappa B) were performed, and Glut-1 and NF-kappa B activities were analyzed. BHB treatment decreased GSH and MDA levels in intact animals and in those exposed to TBI (P<0.05). Glut-1 protein levels decreased in sham, BHB and TBI plus BHB groups (P<0.05). NF-kappa B protein levels increased in animals treated with BHB and/or exposed to TBI (P <0.05). The expression levels of occludin and AQP4 did not significantly change among experimental groups. Glut-1 expression levels increased in BHB treated and untreated animals exposed to TBI (P <0.05). While NF-kappa B expression levels increased in animals in TBI (P<0.01), a decrease was noticed in these animals upon BHB treatment (P <0.01). In animals exposed to TBI, EB extravasation was observed in the ipsilateral cortex regardless of BHB treatment. Ultrastructurally, BHB attenuated but did not prevent the presence of HRP in brain capillary endothelial cells of animals with TBI; moreover, the drug also led to the observation of the tracer when used in intact rats (P <0.01). Altogether, these results showed that BHB not only failed to provide overall protective effects on BBB in TBI but also led to BBB disruption in healthy animals. (C) 2015 Elsevier B.V. All rights reserved.	[Orhan, Nurcan] Istanbul Univ, Inst Expt Med, Dept Neurosci, Istanbul, Turkey; [Yilmaz, Canan Ugur; Kucuk, Mutlu] Istanbul Univ, Inst Expt Med, Dept Lab Anim Sci, Istanbul, Turkey; [Ekizoglu, Oguzhan; Arican, Nadir; Elmas, Imdat] Tepecik Training & Res Hosp, Dept Forens Med, Izmir, Turkey; [Ahishali, Bulent] Istanbul Univ, Istanbul Fac Med, Dept Histol & Embryol, Istanbul, Turkey; [Gurses, Candan] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey; [Yilmaz, Canan Ugur] Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey; [Kaya, Mehmet] Koc Univ, Sch Med, Dept Physiol, TR-34450 Istanbul, Turkey		Kaya, M (corresponding author), Koc Univ, Sch Med, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.	mehmetkaya@ku.edu.tr	Ekizoglu, Oguzhan/AAO-2704-2020; elmas, imdat/AAD-6054-2020; ARICAN, Nadir/G-2778-2012; Orhan, Nurcan/AAC-1954-2020	Ekizoglu, Oguzhan/0000-0002-0194-595X; ARICAN, Nadir/0000-0002-9736-0277; Ugur Yilmaz, Canan/0000-0002-0138-5163; Ahishali, Bulent/0000-0003-1275-3723	Istanbul UniversityIstanbul University [12610]	This study was supported by the Research Fund of Istanbul University (12610).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alluri H., 2015, METAB BRAIN DIS; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Beutler E, 1984, GLUTATHIONE RED CELL, Vthird; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Castejon OJ, 2013, FOLIA NEUROPATHOL, V51, P93, DOI 10.5114/fn.2013.35951; CEMAK I, 2000, J NEUROTRAUM, V17, P53; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Childs EW, 2005, SHOCK, V23, P565, DOI 10.1097/01.shk.0000164188.46364.2a; Chowdhury GMI, 2014, J CEREBR BLOOD F MET, V34, P1233, DOI 10.1038/jcbfm.2014.77; Cornford EM, 1996, J NEUROTRAUM, V13, P523, DOI 10.1089/neu.1996.13.523; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dore-Duffy P, 1999, MICROVASC RES, V57, P75, DOI 10.1006/mvre.1998.2112; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; HARIK SI, 1994, J APPL PHYSIOL, V77, P896, DOI 10.1152/jappl.1994.77.2.896; Ho CF, 2013, VET J, V198, P696, DOI 10.1016/j.tvjl.2013.09.069; Hoffman WH, 2009, BRAIN RES, V1254, P138, DOI 10.1016/j.brainres.2008.11.100; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huang XN, 2011, ANAT REC, V294, P46, DOI 10.1002/ar.21286; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening K. L., 1986, CLIN CHIM ACTA, V155, P275; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; Leite M, 2004, BRAIN RES BULL, V64, P139, DOI 10.1016/j.brainresbull.2004.06.005; Lin T, 2005, J TRAUMA, V59, P1191, DOI 10.1097/01.ta.0000188646.86995.9d; Manna P, 2014, J BIOL CHEM, V289, P11767, DOI 10.1074/jbc.M113.524645; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rains JL, 2012, CAN J PHYSIOL PHARM, V90, P1642, DOI 10.1139/y2012-131; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Shubert PJ, 1996, AM J OBSTET GYNECOL, V175, P56, DOI 10.1016/S0002-9378(96)70251-X; Stark B, 2000, EXP BRAIN RES, V131, P74, DOI 10.1007/s002219900300; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Tardif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE1205, DOI 10.1152/ajpendo.2001.281.6.E1205; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wang P, 2013, CELL PHYSIOL BIOCHEM, V32, P859, DOI 10.1159/000354488; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yosunkaya A, 2004, J TRAUMA, V56, P585, DOI 10.1097/01.TA.0000058119.60074.25; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	78	21	21	1	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2016	1631						113	126		10.1016/j.brainres.2015.11.038			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD7IK	WOS:000370096700011	26656066				2022-02-06	
J	Zhao, E; Tranovich, MJ; DeAngelo, R; Kontos, AP; Wright, VJ				Zhao, Emily; Tranovich, Michael J.; DeAngelo, Ron; Kontos, Anthony P.; Wright, Vonda J.			Chronic exercise preserves brain function in masters athletes when compared to sedentary counterparts	PHYSICIAN AND SPORTSMEDICINE			English	Article						Masters athletes; Neurocognitive decline; Aging; Cognition; Physical activity	PREDICTING BODY DENSITY; COGNITIVE FUNCTION; GENERALIZED EQUATIONS; WORKING-MEMORY; OLDER-ADULTS; FITNESS; HIPPOCAMPAL; PLASTICITY; IMPACT; CORTEX	Objective: Exercise is beneficial for both the body and the mind, and it has been associated with protective neurocognitive effects, such as increased levels of brain-derived neurotrophic factor and neurogenesis. These effects are linked to the attenuation of age-related mental decline and the preservation of mental capacities in older, physically active adults. This study evaluated whether masters athletes, a highly active population, have better cognitive function compared to age-matched non-athletes based on the Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) tool. Methods: Masters athletes and sedentary controls were recruited and screened for eligibility. All subjects were excluded if they had preexisting neurological diseases, psychiatric disorders, substance abuse disorders, learning disorders, and/or a history of traumatic brain injury, and in addition, control subjects were excluded if they performed >1h/week of aerobic exercise. All participants completed a health and activity survey which includes the SF-12 and the ImPACT neurocognitive test which measures verbal and visual memory as well as reaction time. Differences between masters athletes and the control population were determined by ImPACT score composites. Results: 51 pairs of athletes and non-athletes were analyzed. Athletes had significantly higher verbal memory scores (85.9 +/- 7.7 vs 79.9 +/- 13.9, p=0.01) and faster reaction times (0.71 +/- 0.12 vs 0.76 +/- 0.15s, p=0.04) on the ImPACT test. Athletes also scored significantly higher on the physical components summary score of the SF-12 (55.0 +/- 3.3 vs 51.8 +/- 6.7, p=0.004). Conclusion: Masters athletes performed better on verbal memory and reaction time test, as well as on physical function as evaluated by the SF-12, compared to non-athlete controls. Chronic physical activity may preserve neurocognitive processes and increase physical health, which are protective factors for the negative effects of the aging process.	[Zhao, Emily; Tranovich, Michael J.; Kontos, Anthony P.; Wright, Vonda J.] Univ Pittsburgh, Dept Orthopaed Surg, Kaufmann Med Bldg,Suite 1011 3471 Fifth Ave, Pittsburgh, PA 15213 USA; [DeAngelo, Ron] Univ Pittsburgh, Dept Sports Med, UPMC Sports Performance, Pittsburgh, PA USA; [Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Pittsburgh, PA USA		Zhao, E (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Kaufmann Med Bldg,Suite 1011 3471 Fifth Ave, Pittsburgh, PA 15213 USA.	zhaoe@upmc.edu		Kontos, Anthony/0000-0002-3749-4310			Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; British Columbia Ministry of Health, 1992, PHYS ACT READ QUEST; Bruce RA., 1972, EXERCISE TESTING TRA; Chappell NL, 2010, INT ENCY REHABILITAT; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Davenport MH, 2012, EXERC SPORT SCI REV, V40, P153, DOI 10.1097/JES.0b013e3182553430; Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fabre C, 2002, INT J SPORTS MED, V23, P415, DOI 10.1055/s-2002-33735; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Gordon BA, 2008, PSYCHOPHYSIOLOGY, V45, P825, DOI 10.1111/j.1469-8986.2008.00676.x; Gustafson D, 2008, EUR J PHARMACOL, V585, P163, DOI 10.1016/j.ejphar.2008.01.052; Hettich Thomas, 2010, J Spec Oper Med, V10, P48; Heyward V. H., 1998, PHYS FITNESS SPECIAL; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; ImPACT Applications Inc, 2011, IMM POSTC ASS TEST T; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Jansen A, 2009, CLIN NEUROL NEUROSUR, V111, P57, DOI 10.1016/j.clineuro.2008.08.005; Langdon KD, 2012, NEUROREHAB NEURAL RE, V26, P523, DOI 10.1177/1545968311425919; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lees SJ, 2004, CAN J APPL PHYSIOL, V29, P447, DOI 10.1139/h04-029; Leigey D, 2009, SPORTS HEALTH, V1, P508, DOI 10.1177/1941738109347979; Lovell MR, 2000, IMMEDIATE POSTCONCUS; Maki Y, 2012, J AM GERIATR SOC, V60, P505, DOI 10.1111/j.1532-5415.2011.03838.x; Reaburn P, 2008, EUR REV AGING PHYS A, V5, P31, DOI 10.1007/s11556-008-0029-2; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Szabo AN, 2011, NEUROPSYCHOLOGY, V25, P545, DOI 10.1037/a0022733; Trivedi J K, 2006, Indian J Psychiatry, V48, P10, DOI 10.4103/0019-5545.31613; Tsushima M, 2013, DIGEST DIS SCI, V58, P2673, DOI 10.1007/s10620-013-2668-z; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vehrs PR, 2007, MEAS PHYS EDUC EXERC, V11, P61, DOI 10.1080/10913670701294047; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Wroblewski A, 2010, MASTER ATHLETES MODE; Wroblewski AP, 2011, PHYSICIAN SPORTSMED, V39, P172, DOI 10.3810/psm.2011.09.1933; Zhao E, 2014, SPORTS HEALTH, V6, P63, DOI 10.1177/1941738113477832	43	21	22	0	41	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2016	44	1					8	13		10.1080/00913847.2016.1103641			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	DE5GS	WOS:000370660000002	26513012				2022-02-06	
J	Alder, J; Fujioka, W; Giarratana, A; Wissocki, J; Thakkar, K; Vuong, P; Patel, B; Chakraborty, T; Elsabeh, R; Parikh, A; Girn, HS; Crockett, D; Thakker-Varia, S				Alder, Janet; Fujioka, Wendy; Giarratana, Anna; Wissocki, Jenna; Thakkar, Keya; Vuong, Phung; Patel, Bijal; Chakraborty, Trisha; Elsabeh, Rami; Parikh, Ankit; Girn, Hartaj S.; Crockett, David; Thakker-Varia, Smita			Genetic and pharmacological intervention of the p75NTR pathway alters morphological and behavioural recovery following traumatic brain injury in mice	BRAIN INJURY			English	Article						Animal models; neurotrophic factors; learning and memory; locomotor function	MIDDLE CEREBRAL-ARTERY; NERVE GROWTH-FACTOR; TRKB MESSENGER-RNA; MOLECULE P75(NTR) LIGAND; REDUCES INFARCT SIZE; NEUROTROPHIC FACTOR; CELL-DEATH; DOPAMINERGIC-NEURONS; INCREASED EXPRESSION; FUNCTIONAL RECOVERY	Primary objective: Neurotrophin levels are elevated after TBI, yet there is minimal regeneration. It was hypothesized that the pro-neurotrophin/p75NTR pathway is induced more than the mature neurotrophin/Trk pathway and that interfering with p75 signalling improves recovery following TBI. Research design: Lateral Fluid Percussion (LFP) injury was performed on wildtype and p75 mutant mice. In addition, TrkB agonist 7,8 Dihydroxyflavone or p75 antagonist TAT-Pep5 were tested. Western blot and immunohistochemistry revealed biochemical and cellular changes. Morris Water Maze and Rotarod tests demonstrated cognitive and vestibulomotor function. Main outcomes and results: p75 was up-regulated and TrkB was down-regulated 1 day post-LFP. p75 mutant mice as well as mice treated with the p75 antagonist or the TrkB agonist exhibited reduced neuronal death and degeneration and less astrocytosis. The cells undergoing apoptosis appear to be neurons rather than glia. There was improved motor function and spatial learning in p75 mutant mice and mice treated with the p75 antagonist. Conclusions: Many of the pathological and behavioural consequences of TBI might be due to activation of the pro-neurotrophin/p75 toxic pathway overriding the protective mechanisms of the mature neurotrophin/Trk pathway. Targeting p75 can be a novel strategy to counteract the damaging effects of TBI.	[Alder, Janet; Fujioka, Wendy; Giarratana, Anna; Wissocki, Jenna; Thakkar, Keya; Vuong, Phung; Patel, Bijal; Chakraborty, Trisha; Elsabeh, Rami; Parikh, Ankit; Girn, Hartaj S.; Crockett, David; Thakker-Varia, Smita] Rutgers Robert Wood Johnson Med Sch, Piscataway, NJ USA		Thakker-Varia, S (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane West,Res Bldg 357A, Piscataway, NJ 08854 USA.	varia@rutgers.edu		Chakraborty, Trisha/0000-0003-4050-0600; Crockett, David Paul/0000-0002-8137-755X	New Jersey Commission on Brain Injury Research [08-3205 BIR-E-1]; Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship	The authors report no conflicts of interest. This study was supported by the New Jersey Commission on Brain Injury Research (08-3205 BIR-E-1) and an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship.	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bourikas D, 2010, MOL CELL NEUROSCI, V45, P363, DOI 10.1016/j.mcn.2010.07.009; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Catts VS, 2008, EUR J NEUROSCI, V28, P883, DOI 10.1111/j.1460-9568.2008.06390.x; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; Cragnolini AB, 2012, DEV NEUROBIOL, V72, P766, DOI 10.1002/dneu.20981; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Edalat Houri, 2013, Iranian Biomedical Journal, V17, P140, DOI 10.6091/ibj.1193.2013; Enomoto M, 2013, EXP NEUROL, V248, P170, DOI 10.1016/j.expneurol.2013.06.013; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Failla MD, 2015, NEUROREHABILITATION; Ferrer I, 1998, BRAIN PATHOL, V8, P253; Grabenstatter HL, 2014, J NEUROSCI RES, V92, P1307, DOI 10.1002/jnr.23402; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Gu Q, 2014, TOXICOL IN VITRO, V28, P469, DOI 10.1016/j.tiv.2014.01.007; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Higashi H, 2002, J NEUROSURG, V96, P117, DOI 10.3171/jns.2002.96.1.0117; Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9; HOVDA DA, 1990, ACT NEUR S, V51, P331; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Kim DH, 2005, NEUROCRIT CARE, V3, P71, DOI 10.1385/NCC:3:1:071; KNUSEL B, 1992, J NEUROSCI, V12, P4391; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; Koshimizu H, 2010, NEUROSCI LETT, V473, P229, DOI 10.1016/j.neulet.2010.02.055; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Levivier M, 1995, J NEUROSCI, V15, P7810, DOI 10.1523/jneurosci.15-12-07810.1995; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Liu Y, 1999, J NEUROSCI, V19, P4370; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.3.CO;2-S; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; McKay SE, 1996, DEVELOPMENT, V122, P715; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Montazeri F, 2013, J SPINAL CORD MED, V36, P231, DOI 10.1179/2045772312Y.0000000077; MUDO G, 1993, NEUROSCIENCE, V57, P901, DOI 10.1016/0306-4522(93)90036-F; Nygren J, 2006, J NEUROSCI RES, V84, P626, DOI 10.1002/jnr.20956; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patt S, 1999, EXP TOXICOL PATHOL, V51, P119, DOI 10.1016/S0940-2993(99)80084-0; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Ramos A, 2007, J NEUROSCI, V27, P1498, DOI 10.1523/JNEUROSCI.4806-06.2007; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P329; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tauris J, 2011, EUR J NEUROSCI, V33, P622, DOI 10.1111/j.1460-9568.2010.07556.x; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TSUKAHARA T, 1994, NEUROSURGERY, V34, P323, DOI 10.1227/00006123-199402000-00016; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Whiting M.D., 2006, COGNITIVE IMPAIRMENT; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Xie YY, 2003, DEV NEUROSCI-BASEL, V25, P65, DOI 10.1159/000071469; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005	117	21	21	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					48	65		10.3109/02699052.2015.1088963			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200008	26579945				2022-02-06	
J	Azouvi, P; Ghout, I; Bayen, E; Darnoux, E; Azerad, S; Ruet, A; Vallat-Azouvi, C; Pradat-Diehl, P; Aegerter, P; Charanton, J; Jourdan, C				Azouvi, Philippe; Ghout, Idir; Bayen, Eleonore; Darnoux, Emmanuelle; Azerad, Sylvie; Ruet, Alexis; Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Aegerter, Philippe; Charanton, James; Jourdan, Claire			Disability and health-related quality-of-life 4 years after a severe traumatic brain injury: A structural equation modelling analysis	BRAIN INJURY			English	Article						Traumatic brain injury; outcome; quality-of-life	PARIS-TBI; OUTCOME MEASURES; HEAD-INJURY; FOLLOW-UP; SCALE; VALIDITY; QOLIBRI; COHORT; REHABILITATION	Objectives: To assess predictors and indicators of disability and quality-of-life 4 years after severe traumatic brain injury (TBI), using structural equation modelling (SEM). Methods: The PariS-TBI study is a longitudinal multi-centre inception cohort study of 504 patients with severe TBI. Among 245 survivors, 147 patients were evaluated upon 4-year follow-up, and 85 completed the full assessment. Two outcome measures were analysed separately using SEM: the Glasgow Outcome Scale-extended (GOS-E), to measure disability, and the QOLIBRI, to assess quality-of-life. Four groups of variables were entered in the model: demographics; injury severity; mood and cognitive impairments; somatic impairments. Results: The GOS-E was directly significantly related to mood and cognition, injury severity, and somatic impairments. Age and education had an indirect effect, mediated by mood/cognition or somatic deficiencies. In contrast, the only direct predictor of QOLIBRI was mood and cognition. Age and somatic impairments had an indirect influence on the QOLIBRI. Conclusion: Although this study should be considered as explorative, it suggests that disability and quality-of-life were directly influenced by different factors. While disability appeared to result from an interaction of a wide range of factors, quality-of-life was solely directly related to psycho-cognitive factors.	[Azouvi, Philippe; Ruet, Alexis; Jourdan, Claire] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Azouvi, Philippe; Ruet, Alexis; Vallat-Azouvi, Claire; Jourdan, Claire] Univ Versailles St Quentin, EA HANDIReSP 4047, Versailles, France; [Ghout, Idir; Darnoux, Emmanuelle; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Univ Paris 06, Paris, France; [Darnoux, Emmanuelle; Charanton, James] CRFTC, Paris, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS SAMSAH, UGECAM IDF 92, Garches, France		Azouvi, P (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	philippe.azouvi@aphp.fr	RUET, Alexis/L-8726-2015; AEGERTER, Philippe/AAY-6003-2021	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [AOM04084]; Institut de Recherche en Sante Publique (IRESP); AP-HP (Departement de la Recherche Clinique et du Developpement)	The authors report no conflicts of interest. This study was funded by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004), grant number AOM04084, and from the Institut de Recherche en Sante Publique (IRESP). It was supported by AP-HP (Departement de la Recherche Clinique et du Developpement).	Azerad S., 2014, NEUROPSYCHOL REHABIL, V18, P1; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Dijkers M, 1999, AM J PHYS MED REHAB, V78, P286, DOI 10.1097/00002060-199905000-00022; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kline R, 2010, PRINCIPLES PRACTICE, V3rd Edn; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	21	21	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1665	1671		10.1080/02699052.2016.1201593			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800021	27740857				2022-02-06	
J	Bjugstad, KB; Rael, LT; Levy, S; Carrick, M; Mains, CW; Slone, DS; Bar-Or, D				Bjugstad, Kimberly B.; Rael, Leonard T.; Levy, Stewart; Carrick, Matthew; Mains, Charles W.; Slone, Denetta S.; Bar-Or, David			Oxidation-Reduction Potential as a Biomarker for Severity and Acute Outcome in Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							GLASGOW COMA SCALE; SEVERE HEAD-INJURY; REDOX STATUS; PREDICTION; STRESS; SERUM; EXPRESSION; DAMAGE; GFAP	There are few reliable markers for assessing traumatic brain injury (TBI). Elevated levels of oxidative stress have been observed in TBI patients. We hypothesized that oxidation-reduction potential (ORP) could be a potent biomarker in TBI. Two types of ORP were measured in patient plasma samples: the static state of oxidative stress (sORP) and capacity for induced oxidative stress (icORP). Differences in ORP values as a function of time after injury, severity, and hospital discharge were compared using ANOVAs with significance at p <= 0.05. Logit regression analyses were used to predict acute outcome comparing ORP, Injury Severity Score (ISS), Abbreviated Injury Scale (AIS), and Glasgow Coma Scale (GCS). Antioxidant capacity (icORP) on day 4 was prognostic for acute outcomes (p < 0.05). An odds ratio of 4.08 was associated with poor acute outcome when (icORP) > 7.25 mu C. IcORP was a better predictor than ISS, AIS, or GCS scores. sORP increased in those with the highest ISS values (p < 0.05). Based on these findings ORP is useful biomarker for severity and acute outcome in TBI patients. Changes in ORP values on day 4 after injury were themost prognostic, suggesting that patients' response to brain injury over time is a factor that determines outcome.	[Bjugstad, Kimberly B.; Rael, Leonard T.; Slone, Denetta S.; Bar-Or, David] Swedish Med Ctr, Dept Trauma Res, Englewood, CO 80113 USA; [Levy, Stewart] St Anthony Hosp, InterMt Neurosurg, Lakewood, CO 80228 USA; [Carrick, Matthew] Med Ctr Plano, Plano, TX 75075 USA; [Mains, Charles W.; Bar-Or, David] St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA; [Mains, Charles W.; Slone, Denetta S.; Bar-Or, David] Rocky Vista Univ, Dept Biomed Sci, Aurora, CO 80134 USA; [Mains, Charles W.; Bar-Or, David] Penrose St FrancisHealth Serv, Colorado Springs, CO 80907 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Dept Trauma Res, Englewood, CO 80113 USA.; Bar-Or, D (corresponding author), St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA.; Bar-Or, D (corresponding author), Rocky Vista Univ, Dept Biomed Sci, Aurora, CO 80134 USA.; Bar-Or, D (corresponding author), Penrose St FrancisHealth Serv, Colorado Springs, CO 80907 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020	Bjugstad, Kimberly/0000-0002-0473-5413	Trauma Research, LLC (Englewood, CO); Swedish Medical Center (Englewood, CO); St. Anthony Central Hospital (Denver, CO); Institute for Molecular Medicine (Englewood, CO)	The authors gratefully acknowledge the collection of patient samples and maintenance of patient records by Rachel Aumann, RN, and Anita Leyden, RN. This study was supported by Trauma Research, LLC (Englewood, CO), the Swedish Medical Center (Englewood, CO), St. Anthony Central Hospital (Denver, CO), and the Institute for Molecular Medicine (Englewood, CO).	Bains M., 2012, BIOCHIM BIOPHYS ACTA, V1822, P675; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bembea MM, 2015, CRIT CARE MED, V43, P2202, DOI 10.1097/CCM.0000000000001145; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Copeland A, 2014, J AM WATER WORKS ASS, V106, pE10, DOI 10.5942/jawwa.2014.106.0002; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Milic S, 2015, ENVIRON SCI TECHNOL, V49, P4245, DOI 10.1021/es5053396; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2015, ELECTROANAL, V27, P2567, DOI 10.1002/elan.201500178; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Spanidis Y, 2016, EXP THER MED, V11, P895, DOI 10.3892/etm.2016.2968; Spanidis Y, 2016, EXP THER MED, V11, P147, DOI 10.3892/etm.2015.2843; Spanidis Y, 2015, IN VIVO, V29, P595; Stagos D, 2015, REDOX REP, V20, P154, DOI 10.1179/1351000214Y.0000000118; Stagos D, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/204615; Stahel PF, 2012, BRIT J SURG, V99, P131, DOI 10.1002/bjs.7709; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TEASDALE G, 1974, LANCET, V2, P81; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vertuani S, 2004, CURR PHARM DESIGN, V10, P1677, DOI 10.2174/1381612043384655; VICTORIN K, 1974, J HYG-CAMBRIDGE, V72, P101, DOI 10.1017/S0022172400023263; VICTORIN K, 1972, J HYG-CAMB, V70, P313, DOI 10.1017/S0022172400022361; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; WHO (World Health Organization), 2011, GUIDELINES DRINKING, V4th, P1; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Yu L, 2014, NEUROL INDIA, V62, P498, DOI 10.4103/0028-3886.144439; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhi LZ, 2014, J CRIT CARE, V29, P1063, DOI 10.1016/j.jcrc.2014.06.013	50	21	21	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2016	2016								6974257	10.1155/2016/6974257			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DV0VV	WOS:000382639600001	27642494	Green Published, Green Submitted, gold			2022-02-06	
J	Brodsky, JR; Cusick, BA; Zhou, GW				Brodsky, Jacob R.; Cusick, Brandon A.; Zhou, Guangwei			Evaluation and management of vestibular migraine in children: Experience from a pediatric vestibular clinic	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Vestibular migraine; Migrainous vertigo; Migraine associated vertigo; Pediatric vertigo; Benign paroxysmal vertigo of childhood	BENIGN PAROXYSMAL VERTIGO; FOLLOW-UP; CHILDHOOD; DIZZINESS; THERAPY; MODULATION; NEURONS; IMPACT; RAT	Objective: Epidemiologic studies have shown Vestibular migraine (VM) to be the most common cause of vertigo in children, but little is known about the typical presentation and response to treatment of this disorder in the pediatric population. The aim of this study was to evaluate the diagnostic features and response to therapy of VM in children managed at a pediatric vestibular clinic. Methods: Twenty-eight patients <= 18 years old with a diagnosis of VM were identified from 208 patients seen at the Balance and Vestibular Program at Boston Children's Hospital from July 2012 July 2014, after excluding 12 patients with a history of major otologic or neurologic surgery, recent concussion, or additional vestibular disorders. Patients' electronic medical records and testing results were retrospectively reviewed. Results: Patients ranged in age from 9 to 18 years old (mean 14.48). All included patients met criteria for definite (n = 25) or probable (n = 3) VM as defined by the International Classification of Headache Disorders. Rotary chair (n = 17), caloric (n = 8), cervical vestibular evoked myogenic potential (n = 16), and video head impulse (n = 3) tests were normal. Medications effectively reduced reported vestibular symptoms in 88% of those treated with tricyclics (n = 8), 86% of those treated with cyprohepatadine (n = 7), 80% of those treated with topiramate (n = 5), 80% of those treated with triptans (n = 10), and 25% of those treated with gabapentin (n = 4). Conclusions: Vestibular migraine is a common cause of vertigo in the pediatric population that is frequently responsive to medical therapy. (C) 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Brodsky, Jacob R.; Cusick, Brandon A.; Zhou, Guangwei] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA USA; [Brodsky, Jacob R.; Zhou, Guangwei] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA		Brodsky, JR (corresponding author), Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA.	jacob.brodsky@childrens.harvard.edu		Brodsky, Jacob/0000-0001-9656-5855	Department of Otolaryngology and Communication Enhancement at Boston Children's Hospital	All financial support for this study was provided by the Department of Otolaryngology and Communication Enhancement at Boston Children's Hospital.	Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Akerman S, 2005, NEUROREPORT, V16, P1383, DOI 10.1097/01.wnr.0000175250.33159.a9; Baier B, 2009, J NEUROL, V256, P1447, DOI 10.1007/s00415-009-5132-4; Balaban CD, 2011, J VESTIBUL RES-EQUIL, V21, P315, DOI 10.3233/VES-2011-0428; BASSER LS, 1964, BRAIN, V87, P141, DOI 10.1093/brain/87.1.141; Batson Glenna, 2004, Paediatr Child Health, V9, P31; Batuecas-Caletrio A, 2013, EUR J PAEDIATR NEURO, V17, P397, DOI 10.1016/j.ejpn.2013.01.006; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; BOWER CM, 1995, ARCH OTOLARYNGOL, V121, P911; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Burstein R, 2011, J VESTIBUL RES-EQUIL, V21, P305, DOI 10.3233/VES-2012-0433; Carmona Sergio, 2009, Ther Clin Risk Manag, V5, P661; Celebisoy N, 2008, CEPHALALGIA, V28, P72, DOI 10.1111/j.1468-2982.2007.01474.x; Choung YH, 2003, INT J PEDIATR OTORHI, V67, P889, DOI 10.1016/S0165-5876(03)00136-8; DAgostino R, 1997, INT J PEDIATR OTORHI, V40, P133, DOI 10.1016/S0165-5876(97)00032-3; Dieterich M, 1999, J NEUROL, V246, P883, DOI 10.1007/s004150050478; Drigo P, 2001, BRAIN DEV-JPN, V23, P38, DOI 10.1016/S0387-7604(01)00175-9; Erbek SH, 2006, INT J PEDIATR OTORHI, V70, P1547, DOI 10.1016/j.ijporl.2006.04.001; Furman JM, 2005, J VESTIBUL RES-EQUIL, V15, P327; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Gelfand AA, 2013, CURR OPIN NEUROL, V26, P262, DOI 10.1097/WCO.0b013e32836085c7; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Gode S, 2010, HEADACHE, V50, P77, DOI 10.1111/j.1526-4610.2009.01496.x; Gottshall Kim R, 2005, Int Tinnitus J, V11, P81; Halberstadt AL, 2006, NEUROSCIENCE, V140, P1067, DOI 10.1016/j.neuroscience.2006.02.053; Hamilton SS, 2015, INT J PEDIATR OTORHI, V79, P1283, DOI 10.1016/j.ijporl.2015.05.033; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holland PR, 2009, CEPHALALGIA, V29, P1, DOI 10.1111/j.1468-2982.2009.02027.x; Hong SM, 2011, OTOLARYNG HEAD NECK, V144, P284, DOI 10.1177/0194599810391755; Johnson A, 2014, PEDIATR NEUROL, V51, P706, DOI 10.1016/j.pediatrneurol.2014.06.018; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; Khalmuratova R, 2010, J VESTIBUL RES-EQUIL, V20, P401, DOI 10.3233/VES-2010-0390; Koo JW, 2006, CEPHALALGIA, V26, P1310, DOI 10.1111/j.1468-2982.2006.01208.x; Krams B, 2011, CEPHALALGIA, V31, P439, DOI 10.1177/0333102410382797; Langhagen T, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00292; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Linde M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010610; Lindskog U, 1999, HEADACHE, V39, P33, DOI 10.1046/j.1526-4610.1999.3901033.x; Marano E, 2005, HEADACHE, V45, P325, DOI 10.1111/j.1526-4610.2005.05069.x; Marcelli V, 2006, BRAIN DEV-JPN, V28, P80, DOI 10.1016/j.braindev.2005.05.003; Marcelli V, 2010, HEADACHE, V50, P71, DOI 10.1111/j.1526-4610.2009.01454.x; Marcus DA, 2006, MED SCI MONITOR, V12, pPI1; Mikulec AA, 2012, AM J OTOLARYNG, V33, P121, DOI 10.1016/j.amjoto.2011.04.010; MIRA E, 1984, ACTA OTO-LARYNGOL, P271; Neuhauser H, 2003, NEUROLOGY, V60, P882, DOI 10.1212/01.WNL.0000049476.40047.A3; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2006, NEUROLOGY, V67, P1028, DOI 10.1212/01.wnl.0000237539.09942.06; O'Reilly R, 2012, LARYNGOSCOPE, V122, pS93, DOI 10.1002/lary.23809; O'Reilly RC, 2011, OTOLARYNG HEAD NECK, V144, P142, DOI 10.1177/0194599810393679; Obermann M, 2014, CEPHALALGIA, V34, P1053, DOI 10.1177/0333102414527650; Radtke A, 2012, NEUROLOGY, V79, P1607, DOI 10.1212/WNL.0b013e31826e264f; Ralli G, 2009, INT J PEDIATR OTORHI, V73, pS16, DOI 10.1016/S0165-5876(09)70004-7; Reploeg MD, 2002, OTOL NEUROTOL, V23, P364, DOI 10.1097/00129492-200205000-00024; Rosman NP, 2009, J CHILD NEUROL, V24, P155, DOI 10.1177/0883073808322338; Russell G, 1999, INT J PEDIATR OTORHI, V49, pS105, DOI 10.1016/S0165-5876(99)00143-3; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Stolte B, 2015, CEPHALALGIA, V35, P262, DOI 10.1177/0333102414535113; Vitkovic J, 2013, J NEUROL, V260, P3039, DOI 10.1007/s00415-013-7116-7; von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358; Zaleski A, 2015, OTOL NEUROTOL, V36, P295, DOI 10.1097/MAO.0000000000000665; Zhang DG, 2012, INT J PEDIATR OTORHI, V76, P107, DOI 10.1016/j.ijporl.2011.10.013; Zhou GW, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000037	64	21	22	0	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	JAN	2016	20	1					85	92		10.1016/j.ejpn.2015.09.011			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	DB5QQ	WOS:000368569100012	26521123				2022-02-06	
J	Frasnelli, J; Lague-Beauvais, M; LeBlanc, J; Alturki, AY; Champoux, MC; Couturier, C; Anderson, K; Lamoureuxe, J; Marcoux, J; Tinawi, S; Dagher, J; Maleki, M; Feyz, M; de Guise, E				Frasnelli, J.; Lague-Beauvais, M.; LeBlanc, J.; Alturki, A. Y.; Champoux, M. C.; Couturier, C.; Anderson, K.; Lamoureuxe, J.; Marcoux, J.; Tinawi, S.; Dagher, J.; Maleki, M.; Feyz, M.; de Guise, E.			Olfactory function in acute traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Craniocerebral trauma; Smell; Olfaction; Olfactory perception	GLASGOW COMA SCALE; HEAD-INJURY; POSTTRAUMATIC AMNESIA; ODOR IDENTIFICATION; GALVESTON ORIENTATION; DYSFUNCTION; DISCRIMINATION; ANOSMIA; RECOVERY; REHABILITATION	Objective: Traumatic brain injury (TBI) represents a significant public health problem and is associated with a high rate of mortality and morbidity. Although TBI is amongst the most common causes of olfactory dysfunction the relationship between injury severity and olfactory problems has not yet been investigated with validated and standardized methods in the first days following the TBI. Methods: We measured olfactory function in 63 patients admitted with TBI within the first 12 days following the trauma by means of the Sniffin' Sticks identification test (quantitative assessment) and a parosmia questionnaire (qualitative assessment). TBI severity was determined by means of the Glasgow Coma Scale (GCS) and by duration of post-traumatic amnesia (PTA) as measured by the Galveston Orientation and Amnesia Test. Results: Poor olfactory scores correlated with a longer amnesia period, but not with GCS scores. Further, we observed higher parosmia scores in assault victims than in victims of falls or motor vehicle collisions. Conclusions: We show that PTA is intimately related to olfactory problems following a TBI. Thus, a thorough evaluation of olfaction is essential in order to detect posttraumatic olfactory dysfunction and to take appropriate actions early on to help the individual deal with this impairment. (C) 2015 Elsevier B.V. All rights reserved.	[Frasnelli, J.] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Frasnelli, J.] Univ Quebec Trois Rivieres, Dept Anat, UQTR Chemosensory Neuroanat, Trois Rivieres, PQ GA9 5H7, Canada; [Lague-Beauvais, M.; LeBlanc, J.; Champoux, M. C.; Couturier, C.; Tinawi, S.; Dagher, J.; Feyz, M.] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ, Canada; [Anderson, K.; de Guise, E.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Lamoureuxe, J.] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Alturki, A. Y.; Marcoux, J.; Maleki, M.; de Guise, E.] McGill Univ, Ctr Hlth, Neurol & Neurosurg Dept, Montreal, PQ, Canada; [Tinawi, S.; Dagher, J.] McGill Univ, Ctr Hlth, Phys Med & Rehabil Serv, Montreal, PQ, Canada; [Alturki, A. Y.] King Fahad Med City, Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia		Frasnelli, J (corresponding author), Univ Quebec Trois Rivieres, Dept Anat, 3351 Blvd Forges, Trois Rivieres, PQ G9A 5H7, Canada.	johannes.a.frasnelli@uqtr.ca		Frasnelli, Johannes/0000-0002-8863-3982	Research Center of Sacre-Coeur Hospital, Montreal; University of Quebec in Trois-Rivieres; Natural Sciences and Engineering Research Council (Canada)Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec; University of Montreal; Research Institute of the McGill University Hospital Center	JF is supported by grants from the Research Center of Sacre-Coeur Hospital, Montreal, the University of Quebec in Trois-Rivieres, the Natural Sciences and Engineering Research Council (Canada), and the Fonds de Recherche du Quebec - Sante. EDG is supported by a start-up grant from the University of Montreal. We would like to thank the Research Institute of the McGill University Hospital Center for their support.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Auvray M, 2008, CONSCIOUS COGN, V17, P1016, DOI 10.1016/j.concog.2007.06.005; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo RM, 2000, CHEM SENSES, V25, P199, DOI 10.1093/chemse/25.2.199; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Frasnelli J, 2004, EUR ARCH OTO-RHINO-L, V261, P411, DOI 10.1007/s00405-003-0703-y; Frasnelli J, 2011, CHEM SENSES, V36, P405, DOI 10.1093/chemse/bjr001; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, ARCH OTOLARYNGOL, V136, P347, DOI 10.1001/archoto.2010.27; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Landis BN, 2010, LARYNGOSCOPE, V120, P1707, DOI 10.1002/lary.20955; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nordin S, 2007, RHINOLOGY, V45, P50; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sommer JB, 2013, J REHABIL MED, V45, P778, DOI 10.2340/16501977-1208; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	44	21	21	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JAN	2016	140						68	72		10.1016/j.clineuro.2015.11.013			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD7HI	WOS:000370093900011	26658033				2022-02-06	
S	Kalish, BT; Whalen, MJ		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Kalish, Brian T.; Whalen, Michael J.			Weight Drop Models in Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Mice; Closed head injury; Weight drop; Concussion; Cognitive deficits; Morris water maze; Diffuse injury; Mild traumatic brain injury	CLOSED-HEAD-INJURY; COLLEGIATE FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; TNF-ALPHA; ACETYLCHOLINESTERASE INHIBITOR; NEUROCOGNITIVE PERFORMANCE; COGNITIVE IMPAIRMENT; CEREBRAL CONCUSSION; MOUSE MODEL	Weight drop models in rodents have been used for several decades to advance our understanding of the pathophysiology of traumatic brain injury. Weight drop models have been used to replicate focal cerebral contusion as well as diffuse brain injury characterized by axonal damage. More recently, closed head injury models with free head rotation have been developed to model sports concussions, which feature functional disturbances in the absence of overt brain damage assessed by conventional imaging techniques. Here, we describe the history of development of closed head injury models in the first part of the chapter. In the second part, we describe the development of our own weight drop closed head injury model that features impact plus rapid downward head rotation, no structural brain injury, and long-term cognitive deficits in the case of multiple injuries. This rodent model was developed to reproduce key aspects of sports concussion so that a mechanistic understanding of how long-term cognitive deficits might develop will eventually follow. Such knowledge is hoped to impact athletes and war fighters and others who suffer concussive head injuries by leading to targeted therapies aimed at preventing cognitive and other neurological sequelae in these high-risk groups.	[Kalish, Brian T.] Boston Childrens Hosp, Dept Newborn Med, Boston, MA 02115 USA; [Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Boston, MA 02114 USA		Kalish, BT (corresponding author), Boston Childrens Hosp, Dept Newborn Med, Boston, MA 02115 USA.						Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	65	21	22	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						193	209		10.1007/978-1-4939-3816-2_12	10.1007/978-1-4939-3816-2		17	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500014	27604720				2022-02-06	
J	Rowe, RK; Ziebell, JM; Harrison, JL; Law, LM; Adelson, PD; Lifshitz, J				Rowe, Rachel K.; Ziebell, Jenna M.; Harrison, Jordan L.; Law, L. Matthew; Adelson, P. David; Lifshitz, Jonathan			Aging with Traumatic rain Injury: Effects of Age at Injury on Behavioral Outcome following Diffuse Brain Injury in Rats	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Concussion; Aging; Puberty; Behavior; Juvenile; Age at injury	HEAD-INJURY; LATE-ONSET; CHILDHOOD; RECOVERY; MODEL; ACTIVATION; PLASTICITY; MICROGLIA; CHILDREN; CORTEX	Development and aging are influenced by external factors with the potential to impact health throughout the life span. Traumatic brain injury (TBI) can initiate and sustain a lifetime of physical and mental health symptoms. Over 1.7 million TBIs occur annually in the USA alone, with epidemiology suggesting a higher incidence for young age groups. Additionally, increasing life spans mean more years to age with TBI. While there is ongoing research of experimental pediatric and adult TBI, few studies to date have incorporated animal models of pediatric, adolescent, and adult TBI to understand the role of age at injury across the life span. Here, we explore repeated behavioral performance between rats exposed to diffuse TBI at five different ages. Our aim was to follow neurological morbidities across the rodent life span with respect to age at injury. A single cohort of male Sprague Dawley rats (n = 69) was received at postnatal day (PND) 10. Subgroups of this cohort (n = 11-12/group) were subjected to a single moderate midline fluid percussion injury at age PND 17, PND 35, 2 months, 4 months, or 6 months. A control group of nave rats (n = 12) was assembled from this cohort. The entire cohort was assessed for motor function by beam walk at 1.5, 3, 5, and 7 months of age. Anxiety-like behavior was assessed with the open field test at 8 months of age. Cognitive performance was assessed using the novel object location task at 8, 9, and 10 months of age. Depression-like behavior was assessed using the forced swim test at 10 months of age. Age at injury and time since injury differentially influenced motor, cognitive, and affective behavioral outcomes. Motor and cognitive deficits occurred in rats injured at earlier developmental time points, but not in rats injured in adulthood. In contrast, rats injured during adulthood showed increased anxiety-like behavior compared to uninjured control rats. A single diffuse TBI did not result in chronic depression-like behaviors or changes in body weight among any groups. The interplay of age at injury and aging with an injury are translationally important factors that influence behavioral performance as a quality of life metric. More complete understanding of these factors can direct rehabilitative efforts and personalized medicine for TBI survivors. (C) 2016 S. Karger AG, Basel	[Rowe, Rachel K.; Ziebell, Jenna M.; Harrison, Jordan L.; Law, L. Matthew; Adelson, P. David; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Ziebell, Jenna M.; Harrison, Jordan L.; Law, L. Matthew; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA; [Harrison, Jordan L.; Adelson, P. David; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA; [Ziebell, Jenna M.] Univ Tasmania, Fac Hlth, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia		Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Translat Neurotrauma Res Program, Barrow Neurol Inst, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	jifshitz@email.arizona.edu	Adelson, David/W-2083-2019; Ziebell, Jenna/Y-4496-2019	Rowe, Rachel/0000-0002-9034-3159; Ziebell, Jenna/0000-0003-2497-4347	Arizona Alzheimer's Consortium; University of Arizona; College of Medicine - Phoenix; Barrow Neurological Institute at Phoenix Children's Hospital; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; Bisgrove Scholar award - Science Foundation Arizona; Bruce and Diane Halle Foundation; NIH fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31-NS090921]	The authors would like to thank Mr. Tony Romero and Mr. Mahir Qureshi for their technical assistance. The research reported in this paper was supported primarily by the Arizona Alzheimer's Consortium with matching funds from the University of Arizona, College of Medicine - Phoenix and Barrow Neurological Institute at Phoenix Children's Hospital. Partial support was provided by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01 NS-065052. Dr. Rachel K. Rowe was supported by the Bisgrove Scholar award funded by Science Foundation Arizona. Jordan L. Harrison was supported, in part, by the Bruce and Diane Halle Foundation and NIH fellowship F31-NS090921. L. Matthew Law was supported by the Bruce and Diane Halle Foundation.	Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cole W. R., 2016, TRANSLATIONAL RES TR; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Fann JR, 2013, MANAGEMENT ADULTS TR; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P158; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nagai T, 2012, J PHARMACOL SCI, V120, P213, DOI 10.1254/jphs.12142FP; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Ozen LJ, 2015, AGING NEUROPSYCHOL C, V22, P517, DOI 10.1080/13825585.2014.993584; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Scholten AC, 2016, J NEUROTRAUM; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Thomas S, 2000, ACT NEUR S, V76, P397; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang RS, 2015, BRAIN RES, V1629, P210, DOI 10.1016/j.brainres.2015.10.028; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	57	21	21	0	10	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2016	38	3					195	205		10.1159/000446773			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	DY7WK	WOS:000385339800004	27449121	Bronze			2022-02-06	
J	Smitherman, E; Hernandez, A; Stavinoha, PL; Huang, R; Kernie, SG; Diaz-Arrastia, R; Miles, DK				Smitherman, Emily; Hernandez, Ana; Stavinoha, Peter L.; Huang, Rong; Kernie, Steven G.; Diaz-Arrastia, Ramon; Miles, Darryl K.			Predicting Outcome after Pediatric Traumatic Brain Injury by Early Magnetic Resonance Imaging Lesion Location and Volume	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; cognitive function; MRI; outcome measures; pediatric brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; FUNCTIONAL RECOVERY; PROGNOSTIC VALUE; INTENSIVE-CARE; YOUNG-CHILDREN; MRI; STEM; CT; CLASSIFICATION	Brain lesions after traumatic brain injury (TBI) are heterogeneous, rendering outcome prognostication difficult. The aim of this study is to investigate whether early magnetic resonance imaging (MRI) of lesion location and lesion volume within discrete brain anatomical zones can accurately predict long-term neurological outcome in children post-TBI. Fluid-attenuated inversion recovery (FLAIR) MRI hyperintense lesions in 63 children obtained 6.2 +/- 5.6 days postinjury were correlated with the Glasgow Outcome Scale Extended-Pediatrics (GOS-E Peds) score at 13.5 +/- 8.6 months. FLAIR lesion volume was expressed as hyperintensity lesion volume index (HLVI)=(hyperintensity lesion volume / whole brain volume)x100 measured within three brain zones: zone A (cortical structures); zone B (basal ganglia, corpus callosum, internal capsule, and thalamus); and zone C (brainstem). HLVI-total and HLVI-zone C predicted good and poor outcome groups (p<0.05). GOS-E Peds correlated with HLVI-total (r=0.39; p=0.002) and HLVI in all three zones: zone A (r=0.31; p<0.02); zone B (r=0.35; p=0.004); and zone C (r=0.37; p=0.003). In adolescents ages 13-17 years, HLVI-total correlated best with outcome (r=0.5; p=0.007), whereas in younger children under the age of 13, HLVI-zone B correlated best (r=0.52; p=0.001). Compared to patients with lesions in zone A alone or in zones A and B, patients with lesions in all three zones had a significantly higher odds ratio (4.38; 95% confidence interval, 1.19-16.0) for developing an unfavorable outcome.	[Smitherman, Emily] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kernie, Steven G.; Miles, Darryl K.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Stavinoha, Peter L.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hernandez, Ana; Stavinoha, Peter L.] Childrens Med Ctr, Dept Neuropsychol, Dallas, TX 75235 USA; [Huang, Rong] Childrens Med Ctr, Clin Res, Dallas, TX 75235 USA		Miles, DK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Crit Care, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	darryl.miles@utsouthwestern.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Stavinoha, Peter L/0000-0002-3955-9579	Perot Brain and Nerve Injury Center at Children's Medical Center Dallas	The authors thank Dr. Michael Morriss for his assistance in the interpretation of neuroradiology results and Evin Shirley for her research coordinator support. This article was made possible through generous funding that supported the Perot Brain and Nerve Injury Center at Children's Medical Center Dallas.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Adelson PD, 2013, LANCET NEUROL, V12, P849, DOI 10.1016/S1474-4422(13)70205-9; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bakshi R, 1999, AM J NEURORADIOL, V20, P629; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bonnier C, 2007, J CHILD NEUROL, V22, P519, DOI 10.1177/0883073807302604; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Deng WB, 2010, NAT REV NEUROL, V6, P328, DOI 10.1038/nrneurol.2010.53; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Eder HG, 2000, CHILD NERV SYST, V16, P21, DOI 10.1007/s003810050005; Faul M, 2010, TRAUMATIC BRAIN INJU; Filippi M, 1997, NEUROLOGY, V49, P371, DOI 10.1212/WNL.49.2.371; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mullen E.M., 1995, MULLEN SCALES EARLY; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Pagni C A, 1975, J Neurosurg Sci, V19, P120; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Wechsler D., 2003, WECHLER INTELLIGENCE; Wechsler D., 2002, WPPSI 3 WECHSLER PRE; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Wright J., 2010, DEV NEUROSCI, V32; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	83	21	21	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					35	48		10.1089/neu.2014.3801			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200005	25808802	Green Published			2022-02-06	
J	Sullivan, KA; Berndt, SL; Edmed, SL; Smith, SS; Allan, AC				Sullivan, Karen A.; Berndt, Sara L.; Edmed, Shannon L.; Smith, Simon S.; Allan, Alicia C.			Poor sleep predicts subacute postconcussion symptoms following mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concussion; insomnia; mild traumatic brain injury; postconcussion symptoms; sleep	RANDOMIZED CONTROLLED-TRIALS; POST-CONCUSSION SYNDROME; DISTURBANCE; INSOMNIA; METAANALYSIS; POPULATION; COMPLAINTS; QUALITY; TBI; DISABILITY	The primary objective was to determine if poor sleep predicts postconcussion symptoms in the subacute period after mild traumatic brain injury (TBI). The impact of poor sleep pre- and post-injury was examined. The research design was cross-sectional. After screening to detect response invalidity, 61 individuals with a self-reported history of mild TBI 1-to-6 months prior answered an online fixed order battery of standardized questionnaires assessing their sleep (current and preinjury) and persistent postconcussion symptoms (Neurobehavioral Symptom Inventory, minus sleep, and fatigue items). The sleep measures were the Insomnia Severity Index, Epworth Sleepiness Scale, a single Likert-scale pre-injury sleep quality rating, and two PROMIS measures (sleep-related impairment and sleep disturbance). After controlling for the effects of preinjury sleep quality and demographics, the combination of the sleep measures made a significant contribution to the outcome (F[8,58]=4.013, p=.001, ). Only current sleep-related impairment (ss=.60, p<.05) made a significant and unique contribution to neurobehavioral symptoms. Preinjury sleep was not a predictor (ss=-.19, p>.05), although it contributed 3% of the variance in NSI scores after controlling for demographics. Sleep-related impairment is a modifiable factor. As a significant contributor to neurobehavioral symptoms, treatment for post-injury sleep-related impairment warrants further attention.	[Sullivan, Karen A.; Berndt, Sara L.; Edmed, Shannon L.; Smith, Simon S.; Allan, Alicia C.] Queensland Univ Technol, Sch Psychol & Counseling, Brisbane, Qld, Australia; [Sullivan, Karen A.; Edmed, Shannon L.; Smith, Simon S.; Allan, Alicia C.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Smith, Simon S.; Allan, Alicia C.] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Brisbane, Qld, Australia; [Smith, Simon S.] Queensland Univ Technol, CCHR, Brisbane, Qld, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045; Berndt, Sara/0000-0002-6844-2775			Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Ettenhofer ML, 2013, J INT NEUROPSYCH SOC, V19, P977, DOI 10.1017/S1355617713000763; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Johnson JA, 2016, SLEEP MED REV, V27, P20, DOI 10.1016/j.smrv.2015.07.001; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Naughton F, 2007, PAIN, V127, P243, DOI 10.1016/j.pain.2006.08.019; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Salmi L Rachid, 2014, Arch Phys Med Rehabil, V95, pS95, DOI 10.1016/j.apmr.2013.10.026; Salo P, 2010, SLEEP, V33, P1323, DOI 10.1093/sleep/33.10.1323; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tang NKY, 2015, SLEEP, V38, P1751, DOI 10.5665/sleep.5158; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003	53	21	21	2	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	6					426	435		10.1080/23279095.2016.1172229			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DX6XV	WOS:000384530300006	27183274				2022-02-06	
J	Togher, L; McDonald, S; Tate, R; Rietdijk, R; Power, E				Togher, Leanne; McDonald, Skye; Tate, Robyn; Rietdijk, Rachael; Power, Emma			The effectiveness of social communication partner training for adults with severe chronic TBI and their families using a measure of perceived communication ability	NEUROREHABILITATION			English	Article						Communication; communication partner; traumatic brain injury; clinical; rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE-COMMUNICATION; CONTROLLED-TRIAL; HEAD-INJURY; PEOPLE; QUESTIONNAIRE; INTERVENTIONS; INTEGRATION; EXPERIENCE; MANAGEMENT	BACKGROUND: Training for communication partners of people with traumatic brain injury (TBI) is efficacious when using blinded independent ratings of casual conversations measured in the clinic. However, the question remains as to whether participants with TBI and their significant other perceive changes to everyday social communication as a result of training. OBJECTIVE: To determine whether treatment focused on improving the conversational skills of everyday communication partners of people with severe TBI using a program called TBI Express resulted in improvements in perceived communicative ability as measured by the La Trobe Communication Questionnaire (LCQ). METHODS: Non randomized controlled trial comparing treatment of people with TBI together with communication partners (JOINT) with treatment of people with TBI without partner involvement (TBI SOLO) and a waitlist control group (CTRL) with follow-up at 6 months post-treatment. Forty-four outpatients from brain injury units in Sydney with severe chronic acquired brain injuries were recruited. A further 27 eligible outpatients refused to participate or could not be contacted. A total of 41 people completed treatment and 38 completed 6 month follow up assessment. The measure of perceived communication ability is the report of the participant with TBI and their partner on the LCQ. RESULTS: Communication partner training (JOINT) improved conversational performance relative to training the person with TBI alone and a waitlist control group on the LCQ. The TBI SOLO group improved in terms of report on the LCQ relative to the CONTROL group. Results were maintained at six months post-training. CONCLUSION: Training communication partners of people with chronic severe TBI using TBI Express led to perceived improvements in everyday communication ability by both the person with TBI and their family member.	[Togher, Leanne; Rietdijk, Rachael; Power, Emma] Univ Sydney, Fac Hlth Sci, Speech Pathol, Sydney, NSW 2006, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Fac Med, John Walsh Ctr Rehabil Res, Northern Clin Sch, Sydney, NSW 2006, Australia; [Togher, Leanne; McDonald, Skye; Tate, Robyn; Rietdijk, Rachael; Power, Emma] Ctr Res Excellence Brain Recovery, NHMRC, Sydney, NSW, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Speech Pathol, POB 170, Lidcombe, NSW 1825, Australia.	Leanne.togher@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748	NHMRCNational Health and Medical Research Council of Australia [402687]	We would like to acknowledge the contributions of the study participants, Dr Rob Heard for statistical advice, and Gaye Murrills, and the staff of the Brain Injury Rehabilitation Units at Liverpool Hospital, Royal Rehabilitation Centre Sydney and Westmead Hospital for their assistance with participant recruitment. The first author was supported by an NHMRC Senior Research Fellowship during the writing of this paper, and this project was funded by NHMRC Project Grant 402687.	Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Eggins S., 1997, ANAL CASUAL CONVERSA; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Grice H. P., 1975, SYNTAX SEMANTICS, P41; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; TATE RL, 1987, SCAND J REHABIL MED, V19, P19; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1998, COMMUNITY POLI UNPUB; Togher L, 2011, TBI EXPRESS SOCIAL C; TOGHER L, 2001, COMMUNICATION TRAINI; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200	38	21	22	0	20	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	3					243	255		10.3233/NRE-151316			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DM5PV	WOS:000376403300004	27030901				2022-02-06	
J	Truong, JQ; Ciuffreda, KJ				Truong, James Q.; Ciuffreda, Kenneth J.			Comparison of pupillary dynamics to light in the mild traumatic brain injury (mTBI) and normal populations	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); pupillometry; pupil light reflex; visual biomarker; parasympathetic system; sympathetic system		Purpose: To determine if mTBI adversely affects the pupillary light reflex (PLR).Methods: The PLR was evaluated in mTBI and compared to normal individuals under a range of test conditions. Nine pupil parameters (maximum, minimum and final pupil diameter, latency, amplitude and peak and average constriction and dilation velocities) and six stimulus conditions (dim pulse, dim step, bright pulse, bright step, bright red step and bright blue step) were assessed in 32 adults with mTBI (21-60 years of age) and compared to 40 normal (22-56 years of age). The Neuroptics, infrared, DP-2000 binocular pupillometer was used (30 Hz sampling rate; 0.05 mm resolution) with binocular stimulation and recording.Results: Different test conditions allowed for discrimination of different parameters. For any of the given six test conditions, five-to-eight of the nine pupillary parameters were statistically different (p < 0.05) between the two diagnostic groups. The most promising parameters for diagnostic differentiation were constriction latency, all pupillary diameters, average constriction velocity and peak dilation velocity.Conclusions: MTBI adversely affects the PLR. This suggests an impairment of the autonomic nervous system. The findings suggest the potential for quantitative pupillary dynamics to serve as an objective mTBI biomarker.	[Truong, James Q.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA		Truong, JQ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	james.q.truong@gmail.com					ALPERN M, 1963, J GEN PHYSIOL, V47, P265, DOI 10.1085/jgp.47.2.265; Bremner FD., 2011, INVEST OPHTHALMOL, V53, P7343; Brown CE., 1998, COEFFICIENT VARIATIO, DOI DOI 10.1007/978-3-642-80328-4_13; Cap?-Aponte JE., 2013, SPINE, V4, P1; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; Duke-Elder S., 1965, SYSTEM OPHTHALMOLOGY; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Goodman B, 2013, NEUROLOGY, V80, P265; Green D.M., 1966, SOCIETY; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; HUNG GK, 1988, OPHTHAL PHYSL OPT, V8, P327, DOI 10.1016/0275-5408(88)90183-4; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kardon R., 2011, ADLERS PHYSL EYE, P502; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL; Marcum JI., 1947, STAT THEORY TARGET D; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Orr JB, 2015, OPTOMETRY VISION SCI, V92, P834, DOI 10.1097/OPX.0000000000000627; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Selenow A., 1991, AMBLYOPIA BASIC CLIN; SEMMLOW JL, 1986, INVEST OPHTH VIS SCI, V27, P558; Stark L, 1968, NEUROLOGICAL CONTROL; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Tannen B., 1995, EYE MOVEMENT BASICS; TEASDALE G, 1974, LANCET, V2, P81; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; VA/DoD, 2009, CLIN PRACT GUID MAN, P7; Von Noorden GK, 1967, ATLAS OF STRABISMUS; Zasler N. D., 2012, BRAIN INJURY MED PRI; Zinn KM, 1972, THE PUPIL	37	21	21	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1378	1389		10.1080/02699052.2016.1195922			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900011	27541745				2022-02-06	
J	Yang, L; Guo, Y; Wen, D; Yang, L; Chen, Y; Zhang, G; Fan, Z				Yang, L.; Guo, Y.; Wen, D.; Yang, L.; Chen, Y.; Zhang, G.; Fan, Z.			Bone Fracture Enhances Trauma Brain Injury	SCANDINAVIAN JOURNAL OF IMMUNOLOGY			English	Article							GROUP BOX 1; MOBILITY GROUP BOX-1; COGNITIVE DEFICITS; INFLAMMATION; HMGB1; MICE; DYSFUNCTION; ACTIVATION; EXPRESSION; RELEASE	Traumatic brain injury (TBI) is one of the leading causes of mortality and morbidity in young individuals worldwide. However, the understanding of TBI at secondary phase remained obscure, and more knowledge of the pathophysiology of TBI is necessary. In this study, we examined the influence of bone fracture (BF) on TBI and investigated whether blocking high mobility group 1 (HMGB1) protein, an inflammatory mediator, could be effective to alleviate TBI. We found neurological severity was significantly increased by BF at 4days post-TBI with longer removal time of adhesive tape and higher percentage of left turn in the corner test compared to TBI treatment alone. Additionally, higher brain lesion volume and severer brain oedema in TBI+BF mice supports the negative effect of BF on TBI. HMGB1 level was significantly stimulated by BF, suggesting the important role of HMGB1 in the development of secondary TBI. Notably, ablation of HMGB1 significantly reduced this negative influence of BF on TBI. These results suggest that HMGB1 can be massively induced by the systemic immune activation triggered by BF, which in turn aggravates inflammation. Blocking HMGB1 reduced the inflammatory effect of BF and therefore helps lessen the severity of secondary TBI. In conclusion, these results provided the evidence that anti-HMGB1 may be an effective and feasible method to alleviate TBI.	[Yang, L.; Chen, Y.; Zhang, G.; Fan, Z.] Hebei Med Univ, Hosp 2, Dept Neurosurg, Shijiazhuang 050000, Peoples R China; [Guo, Y.] Hebei Univ, Dept Neurosurg, Affiliated Hosp, Baoding, Peoples R China; [Wen, D.] Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang 050000, Peoples R China; [Yang, L.] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Shijiazhuang 050000, Peoples R China		Yang, L (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Peoples R China.	yanglijun1981@163.com			Natural Science Foundation of Hebei Province, ChinaNatural Science Foundation of Hebei Province [H2015206201]	This project is supported by Natural Science Foundation of Hebei Province, China (Grant No. H2015206201).	Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Baethmann A, 1998, Curr Opin Anaesthesiol, V11, P193, DOI 10.1097/00001503-199804000-00013; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chen D, 2013, ACTA OTORHINOLARYNGO, V33, P398; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kang R, 2014, GASTROENTEROLOGY, V146, P1097, DOI 10.1053/j.gastro.2013.12.015; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McIntosh TK, 1996, LAB INVEST, V74, P315; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schaper F, 2014, MOL MED, V20, P72, DOI 10.2119/molmed.2014.00019; Schulze J, 2013, STROKE, V44, P246, DOI 10.1161/STROKEAHA.112.676072; Shen FX, 2011, J CEREBR BLOOD F MET, V31, P2343, DOI 10.1038/jcbfm.2011.97; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Woolbright BL, 2013, TOXICOL APPL PHARM, V273, P524, DOI 10.1016/j.taap.2013.09.023; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	21	21	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-9475	1365-3083		SCAND J IMMUNOL	Scand. J. Immunol.	JAN	2016	83	1					26	32		10.1111/sji.12393			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ2IF	WOS:000366927600004	26448486	Bronze			2022-02-06	
J	Zhang, QY; Li, ZK; Wu, SC; Li, XF; Sang, Y; Li, J; Niu, YH; Ding, H				Zhang, Qianying; Li, Zhike; Wu, Shuangchan; Li, Xiaofei; Sang, Ying; Li, Jian; Niu, Yunhui; Ding, Hong			Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway	FOOD & FUNCTION			English	Article							NRF2/HO-1 DEFENSE PATHWAY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; ANTIINFLAMMATORY ACTIVITY; IN-VITRO; ACTIVATION; REMYELINATION	Multiple sclerosis (MS) is a demyelinating disease occurring in the central nervous system. In the present study, we evaluated the function of myricetin on the alleviation of behavioral dysfunction and myelin protection in the cuprizone-induced demyelination model. Mice were daily fed with fodder including 0.2% cuprizone and were administrated myricetin (100 mg kg(-1)) by gavage administration for 5 weeks. The treatment of myricetin ameliorated hyper-locomotion and behavior impairment induced by cuprizone toxicity. With the administration of myricetin, the demyelinating lesion was lessened via increasing the LFB staining area and myelin phosphatide protein (MBP) expression. In addition, myricetin evidently promoted Nrf2 translocation in the nuclear fraction and enhanced the HO-1 and NQO1 expression levels. Our data revealed that myricetin may be a potential candidate for mitigating motor defects and demyelination in a cuprizone-induced mouse model via activating the Nrf2 pathway.	[Zhang, Qianying; Li, Zhike; Wu, Shuangchan; Li, Xiaofei; Sang, Ying; Li, Jian; Niu, Yunhui; Ding, Hong] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan, Hubei, Peoples R China		Ding, H (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan, Hubei, Peoples R China.	dinghong1106@whu.edu.cn					Acs P, 2013, J NEUROIMMUNOL, V262, P128, DOI 10.1016/j.jneuroim.2013.06.012; Alfieri A, 2013, FREE RADICAL BIO MED, V65, P1012, DOI 10.1016/j.freeradbiomed.2013.08.190; Biancotti JC, 2008, NEUROCHEM RES, V33, P2615, DOI 10.1007/s11064-008-9792-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; Bruck W, 2012, ACTA NEUROPATHOL, V124, P411, DOI 10.1007/s00401-012-1009-1; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Chang Y, 2015, J MED FOOD, V18, P516, DOI 10.1089/jmf.2014.3219; Cheng L, 2015, INT J CLIN EXP MED, V8, P10420; Chis IC, 2016, PHYSIOL INT, V103, P49, DOI 10.1556/036.103.2016.1.5; Cho BO, 2016, BIOSCI BIOTECH BIOCH, V80, P1520, DOI 10.1080/09168451.2016.1171697; Nunes AKD, 2016, EXP NEUROL, V275, P143, DOI 10.1016/j.expneurol.2015.10.013; Ding Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07002; Esteras N, 2016, BIOL CHEM, V397, P383, DOI 10.1515/hsz-2015-0295; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011; Gold R, 2012, CLIN IMMUNOL, V142, P44, DOI 10.1016/j.clim.2011.02.017; Guo Y, 2015, FREE RADICAL BIO MED, V88, P337, DOI 10.1016/j.freeradbiomed.2015.06.013; Hobbs CA, 2015, FOOD CHEM TOXICOL, V83, P283, DOI 10.1016/j.fct.2015.06.016; Hong C, 2014, INT J PHARMACEUT, V477, P251, DOI 10.1016/j.ijpharm.2014.10.044; Jhang KA, 2014, NEUROBIOL AGING, V35, P2465, DOI 10.1016/j.neurobiolaging.2014.05.020; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Krauthausen M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-109; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Li T, 2015, FREE RADICAL RES, V49, P1269, DOI 10.3109/10715762.2015.1066784; Licht-Mayer S, 2015, ACTA NEUROPATHOL, V130, P263, DOI 10.1007/s00401-015-1452-x; Liu JL, 2015, J NEUROCHEM, V135, P347, DOI 10.1111/jnc.13242; Lu SH, 2015, INT IMMUNOPHARMACOL, V29, P770, DOI 10.1016/j.intimp.2015.08.042; Mendes V, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/782504; Miljkovic D, 2013, ANTIOXID REDOX SIGN, V19, P2286, DOI 10.1089/ars.2012.5068; Miron VE, 2009, AM J PATHOL, V174, P1880, DOI 10.2353/ajpath.2009.080947; Orije J, 2015, NEUROIMAGE, V114, P128, DOI 10.1016/j.neuroimage.2015.04.012; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pasquali L, 2015, CLIN BIOCHEM, V48, P19, DOI 10.1016/j.clinbiochem.2014.09.024; Qin S, 2013, MOL NUTR FOOD RES, V57, P435, DOI 10.1002/mnfr.201200563; Semwal DK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020090; Shimizu H, 2015, BIOCHEM BIOPH RES CO, V457, P718, DOI 10.1016/j.bbrc.2015.01.059; Shinkai Y, 2016, TOXICOL APPL PHARM, V295, P37, DOI 10.1016/j.taap.2016.01.020; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; Suneetha A, 2016, J CHROMATOGR B, V1019, P15, DOI 10.1016/j.jchromb.2016.02.010; Tao L, 2014, BIOORG MED CHEM LETT, V24, P5385, DOI 10.1016/j.bmcl.2014.10.049; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Vakilzadeh G, 2015, MOL NEUROBIOL, V52, P130, DOI 10.1007/s12035-014-8857-8; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; Xie JH, 2015, FOOD CHEM, V186, P97, DOI 10.1016/j.foodchem.2014.06.106; Xu HY, 2014, EUR ARCH PSY CLIN N, V264, P121, DOI 10.1007/s00406-013-0414-3; Xu Haiyun, 2011, Front Behav Neurosci, V5, P31, DOI 10.3389/fnbeh.2011.00031; Xuan YH, 2015, NEUROCHEM INT, V90, P185, DOI 10.1016/j.neuint.2015.08.015; Xuan YH, 2014, NEUROCHEM INT, V69, P20, DOI 10.1016/j.neuint.2014.02.004; Yamamoto S, 2014, EUR J PHARMACOL, V741, P17, DOI 10.1016/j.ejphar.2014.07.040; Yang Y, 2015, CYTOKINE GROWTH F R, V26, P47, DOI 10.1016/j.cytogfr.2014.09.002; Zhang M, 2015, EXP BIOL MED, V240, P1183, DOI 10.1177/1535370214565975	56	21	21	3	26	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2042-6496	2042-650X		FOOD FUNCT	Food Funct.		2016	7	10					4332	4342		10.1039/c6fo00825a			11	Biochemistry & Molecular Biology; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Food Science & Technology	DZ9XT	WOS:000386236000022	27713953				2022-02-06	
J	Riganello, F; Cortese, MD; Arcuri, F; Quintieri, M; Dolce, G				Riganello, Francesco; Cortese, Maria D.; Arcuri, Francesco; Quintieri, Maria; Dolce, Giuliano			How Can Music Influence the Autonomic Nervous System Response in Patients with Severe Disorder of Consciousness?	FRONTIERS IN NEUROSCIENCE			English	Article						disorder of consciousness; vegetative state; autonomic nervous system; central autonomic network; heart rate variability; music therapy; entropy	HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; TIME-SERIES ANALYSIS; ARTIFICIAL-INTELLIGENCE; AUDITORY-STIMULATION; APPROXIMATE ENTROPY; NONPARAMETRIC-TESTS; RATE COMPLEXITY; CARE-UNIT; THERAPY	Activations to pleasant and unpleasant musical stimuli were observed within an extensive neuronal network and different brain structures, as well as in the processing of the syntactic and semantic aspects of the music. Previous studies evidenced a correlation between autonomic activity and emotion evoked by music listening in patients with Disorders of Consciousness (DoC). In this study, we analyzed retrospectively the autonomic response to musical stimuli by mean of normalized units of Low Frequency (nuLF) and Sample Entropy (SampEn) of Heart Rate Variability (HRV) parameters, and their possible correlation to the different complexity of four musical samples (i.e., Mussorgsky, Tchaikovsky, Grieg, and Boccherini) in Healthy subjects and Vegetative State/Unresponsive Wakefulness Syndrome (VS/UWS) patients. The complexity of musical sample was based on Formal Complexity and General Dynamics parameters defined by Imberty's semiology studies. The results showed a significant difference between the two groups for SampEn during the listening of Mussorgsky's music and for nuLF during the listening of Boccherini and Mussorgsky's music. Moreover, the VS/UWS group showed a reduction of nuLF as well as SampEn comparing music of increasing Formal Complexity and General Dynamics. These results put in evidence how the internal structure of the music can change the autonomic response in patients with DoC. Further investigations are required to better comprehend how musical stimulation can modify the autonomic response in DoC patients, in order to administer the stimuli in a more effective way.	[Riganello, Francesco; Cortese, Maria D.; Arcuri, Francesco; Quintieri, Maria; Dolce, Giuliano] Ist S Anna, Res Adv Neurorehabil, Crotone, Italy		Riganello, F (corresponding author), Ist S Anna, Res Adv Neurorehabil, Crotone, Italy.	f.riganello@istitutosantanna.it	Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020; Arcuri, Francesco/AAB-8718-2019; Cortese, Maria Daniela/AAB-9480-2022	Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; Arcuri, Francesco/0000-0002-7104-6378; Cortese, Maria Daniela/0000-0002-8524-6581			Aboy M, 2007, P ANN INT IEEE EMBS, P5943; Anand P., 1990, PSYCHOL MUSIC, V18, P150, DOI [10.1177/0305735690182004, DOI 10.1177/0305735690182004]; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Batchinsky AI, 2009, SHOCK, V32, P565, DOI 10.1097/SHK.0b013e3181a993dc; Behne Klaus-Ernst, 1986, HORERTYPOLOGIEN PSYC; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Berlyne, 1974, STUDIES NEW EXPT AES, P27; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Camm AJ, 1996, EUR HEART J, V17, P354; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; da Silva Sheila Ap F, 2014, Int Arch Med, V7, P27, DOI 10.1186/1755-7682-7-27; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; Ellis R. J., 2009, THESIS; Ellis RJ, 2010, MUSIC PERCEPT, V27, P317, DOI 10.1525/MP.2010.27.4.317; Etzel JA, 2006, INT J PSYCHOPHYSIOL, V61, P57, DOI 10.1016/j.ijpsycho.2005.10.025; Fukumoto M, 2010, INT J BIOMETRICS, V2, P124, DOI 10.1504/IJBM.2010.031792; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gabrielsson A, 2001, MUSIC SCI, V5, P123, DOI 10.1177/10298649020050S105; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; GUZZETTA CE, 1989, HEART LUNG, V18, P609; Hainsworth R., 1995, HEART RATE VAR, P3; Hajizadeh S., 2015, Applied Medical Informatics, V37, P11; Hanser SB, 2014, CARDIOL REV, V22, P37, DOI 10.1097/CRD.0b013e318291c5fc; Harrer G, 1968, Wien Med Wochenschr, V118, P966; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hodges D. A., 1980, HDB MUSIC PSYCHOL; Imberty M., 1997, MUSIC SCI, V1, P33; Imberty M., 1976, SIGNIFICATION MEANIN; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; Juslin P.N., 2010, HDB MUSIC EMOTION TH, P605, DOI [DOI 10.1093/ACPROF:OSO/9780199230143.003.0022, 10.1093/acprof:oso/9780199230143.003.0022]; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kawashima T, 2005, ANAT EMBRYOL, V209, P425, DOI 10.1007/s00429-005-0462-1; Kemper KJ, 2008, PEDIATR RES, V64, P105, DOI 10.1203/PDR.0b013e318174e6fb; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Khalfa S, 2008, INT J PSYCHOPHYSIOL, V68, P17, DOI 10.1016/j.ijpsycho.2007.12.001; Khandoker AH, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-3; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lee YC, 2011, IEEE ENG MED BIO, P1701, DOI 10.1109/IEMBS.2011.6090488; Lovric M., 2011, INT ENCY STAT SCI, DOI [DOI 10.1007/978-3-642-04898-2_420, 10.1007/978-3-642-04898-2_420]; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; Malliani A, 1999, NEWS PHYSIOL SCI, V14, P111, DOI 10.1152/physiologyonline.1999.14.3.111; Meyer, 2008, EMOTION MEANING MUSI; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Mukherjee S., 2015, CHAOS COMPLEXITY LEA, P243; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; O'Kelly J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00884; O'Kelly J, 2013, NORD J MUSIC THER, V22, P93, DOI 10.1080/08098131.2012.709269; Ockelford A., 2008, REVIEWARTICLE D HURO, P476, DOI DOI 10.1177/0305735608094506; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; Okumura Y, 2014, BRAIN INJURY, V28, P944, DOI 10.3109/02699052.2014.888477; Orini M, 2010, MED BIOL ENG COMPUT, V48, P423, DOI 10.1007/s11517-010-0592-3; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Papaioannou VE, 2006, J CRIT CARE, V21, P95, DOI 10.1016/j.jcrc.2005.12.007; Perez-Lloret S, 2014, NOISE HEALTH, V16, P279, DOI 10.4103/1463-1741.140507; Perrin F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01102; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Rauhe H., 1975, BEDINGUNGSZUSAMMENHA, V1975, P137; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riganello F, 2010, J PSYCHOPHYSIOL, V24, P112, DOI 10.1027/0269-8803/a000021; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Riganello F, 2008, J PSYCHOPHYSIOL, V22, P166, DOI 10.1027/0269-8803.22.4.166; Riganello F., 2014, EXP CLIN CARDIOL, V20, P5584; Riganello F, 2012, J PSYCHOPHYSIOL, V26, P178, DOI 10.1027/0269-8803/a000080; Riganello F, 2012, J REHABIL MED, V44, P495, DOI 10.2340/16501977-0975; Riordan WP, 2009, J SURG RES, V156, P283, DOI 10.1016/j.jss.2009.03.086; Roque AL, 2013, CLINICS, V68, P960, DOI 10.6061/clinics/2013(07)12; Roque AL, 2013, NOISE HEALTH, V15, P281, DOI 10.4103/1463-1741.113527; ROSENTHAL R, 1991, AM PSYCHOL, V46, P1086, DOI 10.1037/0003-066X.46.10.1086; Rosing H, 1985, MUSIK, V1985, P39; Ryan ML, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/416590; Scherlag BJ, 2006, CURR OPIN CARDIOL, V21, P51, DOI 10.1097/01.hco.0000198980.40390.e4; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; SMITH JD, 1990, COGNITION, V34, P279, DOI 10.1016/0010-0277(90)90007-7; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Tanizaki H, 1997, J APPL STAT, V24, P603, DOI 10.1080/02664769723576; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tillmann B, 2005, ANN NY ACAD SCI, V1060, P100, DOI 10.1196/annals.1360.007; Trappe Hans-Joachim, 2012, Int J Crit Illn Inj Sci, V2, P27, DOI 10.4103/2229-5151.94893; Umemura M, 1998, J Hum Ergol (Tokyo), V27, P30; VITZ PC, 1966, J EXP PSYCHOL, V71, P74, DOI 10.1037/h0022619; Voss A, 1996, CARDIOVASC RES, V31, P419; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Yen BS, 2010, IEEE INT SYMP CIRC S, P2239, DOI 10.1109/ISCAS.2010.5537211; ZIMMERMAN LM, 1988, HEART LUNG, V17, P560	98	21	24	1	39	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 10	2015	9								461	10.3389/fnins.2015.00461			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CY9KY	WOS:000366727000001	26696818	Green Published, gold			2022-02-06	
J	Hamada, SR; Gauss, T; Pann, J; Dunser, M; Leone, M; Duranteau, J				Hamada, Sophie Rym; Gauss, Tobias; Pann, Jakob; Duenser, Martin; Leone, Marc; Duranteau, Jacques			European trauma guideline compliance assessment: the ETRAUSS study	CRITICAL CARE			English	Article							DECISION-MAKING; CARE; MANAGEMENT; MORTALITY; VOLUME; COAGULOPATHY; TRANSFUSION; VENTILATION; THERAPY	Introduction: Haemorrhagic shock is the leading cause of preventable death in trauma patients. The 2013 European trauma guidelines emphasise a comprehensive, multidisciplinary, protocol-based approach to trauma care. The aim of the present Europe-wide survey was to compare 2015 practice with the 2013 guidelines. Methods: A group of members of the Trauma and Emergency Medicine section of the European Society of Intensive Care Medicine developed a 50-item questionnaire based upon the core recommendations of the 2013 guidelines, employing a multistep approach. The questionnaire covered five fields: care structure and organisation, haemodynamic resuscitation targets, fluid management, transfusion and coagulopathy, and haemorrhage control. The sampling used a two-step approach comprising initial purposive sampling of eminent trauma care providers in each European country, followed by snowball sampling of a maximum number of trauma care providers. Results: A total of 296 responses were collected, 243 (81 %) from European countries. Those from outside the European Union were excluded from the analysis. Approximately three-fourths (74 %) of responders were working in a designated trauma centre. Blunt trauma predominated, accounting for more than 90 % of trauma cases. Considerable heterogeneity was observed in all five core aspects of trauma care, along with frequent deviations from the 2013 guidelines. Only 92 (38 %) of responders claimed to comply with the recommended systolic blood pressure target, and only 81 (33 %) responded that they complied with the target pressure in patients with traumatic brain injury. Crystalloid use was predominant (n = 209; 86 %), and vasopressor use was frequent (n = 171, 76 %) but remained controversial. Only 160 respondents (66 %) declared that they used tranexamic acid always or often. Conclusions: This is the first European trauma survey, to our knowledge. Heterogeneity is significant across centres with regard to the clinical protocols for trauma patients and as to locally available resources. Deviations from guidelines are frequent, differ from region to region and are dependent upon specialty training. Further efforts are required to provide consensus guidelines and to improve their implementation across European countries.	[Hamada, Sophie Rym; Duranteau, Jacques] Hop Univ Paris Sud, Hop Bicetre, AP HP, Dept Anaesthesiol & Crit Care, F-94275 Le Kremlin Bicetre, France; [Gauss, Tobias] Hop Univ Paris Nord Val de Seine, Hop Beaujon, AP HP, Dept Anaesthesiol & Crit Care, F-92110 Clichy, France; [Pann, Jakob; Duenser, Martin] Salzburg Univ Hosp, Dept Anaesthesiol Perioperat & Gen Intens Care Me, A-5020 Salzburg, Austria; [Pann, Jakob; Duenser, Martin] Paracelsus Private Med Univ, A-5020 Salzburg, Austria; [Leone, Marc] Aix Marseille Univ, Hop Nord, Assistance Publ Hop Marseille, Dept Anaesthesiol & Crit Care, Marseille, France		Hamada, SR (corresponding author), Hop Univ Paris Sud, Hop Bicetre, AP HP, Dept Anaesthesiol & Crit Care, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	sophiehamada@hotmail.com	Tobias, Gauss/AAT-4949-2020; Leone, Marc/P-4835-2016	Leone, Marc/0000-0002-3097-758X			Brunkhorst FM, 2008, CRIT CARE MED, V36, P2719, DOI 10.1097/CCM.0b013e318186b6f3; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Cassell J, 2003, CRIT CARE MED, V31, P1263, DOI 10.1097/01.CCM.0000059318.96393.14; Chittawatanarat Kaweesak, 2014, Journal of the Medical Association of Thailand, V97, pS108; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; deMattos PC, 2012, MANAGE DECIS, V50, P1549, DOI 10.1108/00251741211266688; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dennison CR, 2007, CRIT CARE MED, V35, P2747, DOI 10.1097/01.CCM.0000287591.09487.70; European Society of Intensive Care Medicine (ESICM), 2015, NEW SURV ONL EUR TRA; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; Khan S, 2015, INTENS CARE MED, V41, P239, DOI 10.1007/s00134-014-3584-1; Leone M, 2004, INTENS CARE MED, V30, P984, DOI 10.1007/s00134-004-2172-1; Leone M, 2012, CRIT CARE MED, V40, P3189, DOI 10.1097/CCM.0b013e31826571f2; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI [10.1007/s00134-009-1738-3, 10.1097/CCM.0b013e3181cb0cdc]; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mohan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105445; Mohan D, 2010, CRIT CARE MED, V38, pS637, DOI 10.1097/CCM.0b013e3181f202c3; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae	25	21	25	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	DEC 8	2015	19								423	10.1186/s13054-015-1092-5			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0NI	WOS:000366102400001	26643471	Green Published, gold			2022-02-06	
J	Wen, L; Lou, HY; Xu, J; Wang, H; Huang, X; Gong, JB; Xiong, B; Yang, XF				Wen, Liang; Lou, Hai-Yan; Xu, Jun; Wang, Hao; Huang, Xin; Gong, Jiang-Biao; Xiong, Bin; Yang, Xiao-Feng			The impact of cranioplasty on cerebral blood perfusion in patients treated with decompressive craniectomy for severe traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; SINKING SKIN FLAP; PROSPECTIVE MULTICENTER; FLOW; CT; HEMODYNAMICS; MANAGEMENT		[Wen, Liang; Xu, Jun; Wang, Hao; Huang, Xin; Gong, Jiang-Biao; Yang, Xiao-Feng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Lou, Hai-Yan; Xiong, Bin] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com			Science Technology Department of Zhejiang Province [2014C33201]	The authors have reported no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This work was supported by the Science Technology Department of Zhejiang Province (2014C33201).	Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Erdogan E, 2003, NEUROL INDIA, V51, P479; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sarubbo S, 2014, NEURORADIOLOGY, V56, P237, DOI 10.1007/s00234-014-1318-2; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Won YD, 2008, ACTA NEUROCHIR SUPPL, V102, P15, DOI 10.1007/978-3-211-85578-2_3; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	20	21	26	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1654	1660		10.3109/02699052.2015.1075248			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800017	26513495				2022-02-06	
J	Guo, YJ; Liu, SM; Zhang, XH; Wang, LY; Gao, JG; Han, AQ; Hao, AJ				Guo, Yuji; Liu, Shangming; Zhang, Xianghong; Wang, Liyan; Gao, Jiangang; Han, Aiqing; Hao, Aijun			G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice	LABORATORY INVESTIGATION			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; FOCAL CEREBRAL-ISCHEMIA; CLOSED-HEAD INJURY; UP-REGULATION; MOUSE MODEL; CELL-DEATH; ACTIVATION; NEUROPROTECTION; RECOVERY	Granulocyte colony-stimulating factor (G-CSF) was investigated for its capacity to induce autophagy and related neuroprotective mechanisms in an acute spinal cord injury model. To accomplish this goal, we established a mouse spinal cord hemisection model to test the effects of recombinant human G-CSF. The results showed that autophagy was activated after spinal cord injury and G-CSF appears to induce a more rapid activation of autophagy within injured spinal cords as compared with that of non-treated animals. Apoptosis as induced in mechanically injured neurons with G-CSF treatment was enhanced after inhibiting autophagy by 3-methyladenine (3-MA), which partially blocked the neuroprotective effect of autophagy as induced by G-CSF. In addition, G-CSF inhibited the activity of the NF-kappa B signal pathway in neurons after mechanical injury. We conclude that G-CSF promotes autophagy by inhibiting the NF-kappa B signal pathway and protects neuronal structure after spinal cord injury. We therefore suggest that G-CSF, which rapidly induces autophagy after spinal cord injury to inhibit neuronal apoptosis, may thus provide an effective auxiliary therapeutic intervention for spinal cord injury.	[Guo, Yuji; Liu, Shangming; Zhang, Xianghong; Wang, Liyan; Hao, Aijun] Shandong Univ, Sch Med, Dept Histol & Embryol, Key Lab,Minist Educ Expt Teratol, Jinan 250012, Peoples R China; [Gao, Jiangang] Shandong Univ, Coll Life Sci, Inst Dev Biol, Jinan 250012, Peoples R China; [Han, Aiqing] Maternal & Children Hlth Hosp Jinan City, Dept Obstet, Jinan 250001, Shandong, Peoples R China		Han, AQ (corresponding author), Maternal & Children Hlth Hosp Jinan City, Dept Obstet, 2 Small Jingsan Rd, Jinan 250001, Shandong, Peoples R China.	haq6888@163.com; aijunhao@sdu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100919]; China postdoctoral science foundationChina Postdoctoral Science Foundation [2014170647]; postdoctoral science foundation of Shandong provinceChina Postdoctoral Science Foundation [201203050]; Scientific Research Foundation for Returned Scholars, Ministry of Education of ChinaScientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China [21300005451001]; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [BS2010YY041]; Natural Science Foundation of Shandong ProvinceNatural Science Foundation of Shandong Province [2012GSF11842, ZR2011HL070, ZR2015HM030]	This work is supported by the National Natural Science Foundation of China (grant no. 81100919); special financial grant from the China postdoctoral science foundation (2014170647); postdoctoral science foundation of Shandong province (201203050); the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (21300005451001); Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (BS2010YY041); Natural Science Foundation of Shandong Province (2012GSF11842; ZR2011HL070, ZR2015HM030).	An HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114607; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Bartolini A, 2011, NEUROBIOL DIS, V41, P640, DOI 10.1016/j.nbd.2010.11.013; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bethea JR, 1998, J NEUROSCI, V18, P3251; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Fan J, 2014, BRAIN RES, V1562, P76, DOI 10.1016/j.brainres.2014.03.019; Fujita S, 2015, J VASC SURG, V62, P1312, DOI 10.1016/j.jvs.2014.03.297; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Guo Y, 2013, NEUROSCIENCE, V238, P1, DOI 10.1016/j.neuroscience.2013.01.047; Guo YJ, 2014, J NEUROSCI RES, V92, P751, DOI 10.1002/jnr.23362; Henriques A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-25; Horner PJ, 2000, J NEUROSCI, V20, P2218; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kim J, 2013, NEUROBIOL DIS, V59, P80, DOI 10.1016/j.nbd.2013.07.011; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sanli AM, 2010, J CLIN NEUROSCI, V17, P1548, DOI 10.1016/j.jocn.2010.03.043; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shulak L, 2014, J VIROL, V88, P2927, DOI 10.1128/JVI.03406-13; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yamasaki R, 2010, J NEUROIMMUNOL, V229, P51, DOI 10.1016/j.jneuroim.2010.07.002; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	53	21	23	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	DEC	2015	95	12					1439	1449		10.1038/labinvest.2015.120			11	Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pathology	CX1LQ	WOS:000365458100010	26524416	Bronze			2022-02-06	
J	Lorente, L				Lorente, Leonardo			New Prognostic Biomarkers in Patients With Traumatic Brain Injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Biomarkers; Substance P; sCD40L; TIMP-1; Malondialdehyde; Cytokeratin-8; Brain Trauma	SOLUBLE CD40 LIGAND; SUBSTANCE-P; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; TISSUE FACTOR; LIPID-PEROXIDATION; HEAD-INJURY; IN-VIVO; CYTOKERATIN-18 FRAGMENTS; TACHYKININ RECEPTORS	Context: Traumatic brain injury (TBI) is a leading cause of death, disability, and resource consumption per year. There are two kinds of brain injury in TBI, primary and secondary injuries. Primary injury refers to the initial physical forces applied to the brain at the moment of impact. Secondary injury occurs over a period of hours or days following the initial trauma and results from the activation of different pathways such as inflammation, coagulation, oxidation, and apoptosis. Evidence Acquisition: This review focuses on new prognostic biomarkers of mortality in TBI patients related to inflammation, coagulation, oxidation, and apoptosis. Results: Recently circulating levels of substance P (SP), soluble CD40 ligand (sCD40L), tissue inhibitor of matrix metalloproteinases (TIMP)1, malondialdehyde (MDA), and cytokeratin (CK)-18 fragmented have been found to be associated with mortality in TBI patients. Substance P is a neuropeptide of the tachykinin family, mainly synthesized in the central and peripheral nervous system, with proinflammatory effects when binding to their neurokinin-1 receptor (NK1R). Soluble CD40 ligand, a member of the tumor necrosis factor (TNF) family that is released into circulation from activated platelets, exhibit proinflamatory, and procoagulant properties on binding to their cell surface receptor CD40. Matrix metalloproteinases (MMPs) are a family of zinc-containing endoproteinases involved neuroinflammation and TIMP-1 is the inhibitor of some of them. Malondialdehyde is an end-product formed during lipid peroxidation due to degradation of cellular membrane phospholipids, that is released into extracellular space and finally into the blood. Cytokeratin -18 is cleaved by the action of caspases during apoptosis, and CK-18 fragmented is released into the blood. Conclusions: Circulating levels of some biomarkers, such as SP, sCD40L, TIMP-1, MDA, and CK-18 fragmented, related to inflammation, coagulation, oxidation, and apoptosis have been recently associated with mortality in patients with TBI. These biomarkers could help in the prognostic classification of the patients and open new research lines in the treatment of patients with TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz de T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz de T, Spain.	lorentemartin@msn.com					Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chen R, 2013, EXP THER MED, V6, P1463, DOI 10.3892/etm.2013.1342; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Davi G, 2009, J ATHEROSCLER THROMB, V16, P707; De Swert KO, 2006, EUR J PHARMACOL, V533, P171, DOI 10.1016/j.ejphar.2005.12.066; Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; Ferroni P, 2007, CURR MED CHEM, V14, P2170; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; Gong DS, 2012, BRAIN INJURY, V26, P291, DOI 10.3109/02699052.2011.648710; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; Hu Shouxing, 1999, Hunan Yike Daxue Xuebao, V24, P56; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121739; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorente L, 2015, J CRIT CARE, V30, DOI [10.1016/j.jcrc.2015.03.023, 10.1016/j.jcrc.2014.09.012]; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109618; Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094318; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc12739; Lorente L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053741; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; Lukasik M, 2012, PLATELETS, V23, P132, DOI 10.3109/09537104.2011.597528; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MANTYH PW, 1989, P NATL ACAD SCI USA, V86, P5193, DOI 10.1073/pnas.86.13.5193; Mao De-Jun, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P177; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; de Lizarrondo SM, 2012, ARTERIOSCL THROM VAS, V32, P1477, DOI 10.1161/ATVBAHA.112.248773; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373, DOI 10.1002/jlb.63.3.373; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Moore DJ, 2012, CLIN DRUG INVEST, V32, P179, DOI 10.2165/11598610-000000000-00000; Munoz M, 2014, AMINO ACIDS, V46, P1727, DOI 10.1007/s00726-014-1736-9; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Parfieniuk-Kowerda A, 2014, LIVER INT, V34, P544, DOI 10.1111/liv.12297; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rasley A, 2002, GLIA, V37, P258, DOI 10.1002/glia.10034; Rodriguez JA, 2013, J THROMB HAEMOST, V11, P1464, DOI 10.1111/jth.12312; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Saniova B, 2006, CELL MOL NEUROBIOL, V26, P1475, DOI 10.1007/s10571-006-9033-0; Satake H, 2006, CURR DRUG TARGETS, V7, P963, DOI 10.2174/138945006778019273; Schaller B, 2002, Swiss Surg, V8, P145, DOI 10.1024/1023-9332.8.4.145; Sgier C, 2010, J VIRAL HEPATITIS, V17, P845, DOI 10.1111/j.1365-2893.2009.01251.x; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; Smrcka M, 2007, BRATISL MED J, V108, P144; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sumer S, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10106; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	110	21	23	0	14	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	DEC	2015	4	4							e30165	10.5812/atr.30165			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	CV9VO	WOS:000364635800006	26848476	Green Published, Green Submitted			2022-02-06	
J	Poulsen, MB; Damgaard, B; Zerahn, B; Overgaard, K; Rasmussen, RS				Poulsen, Mai Bang; Damgaard, Bodil; Zerahn, Bo; Overgaard, Karsten; Rasmussen, Rune Skovgaard			Modafinil May Alleviate Poststroke Fatigue A Randomized, Placebo-Controlled, Double-Blinded Trial	STROKE			English	Article						clinical trial; fatigue; randomized controlled trial; rehabilitation; stroke	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; MONTREAL COGNITIVE ASSESSMENT; EXCESSIVE DAYTIME SLEEPINESS; STROKE PATIENTS; MULTIPLE-SCLEROSIS; STATE-EXAMINATION; MENTAL FATIGUE; SEVERITY SCALE; METHYLPHENIDATE	Background and Purpose-Poststroke fatigue is common and reduces quality of life. Current evidence for intervention is limited, and this is the first placebo-controlled trial to investigate treatment of poststroke fatigue with the wakefulness promoting drug modafinil. Methods-The trial was randomized, double-blinded, and placebo-controlled. Patients were treated with 400-mg modafinil or placebo for 90 days. Assessments were done at inclusion, 30, 90, and 180 days. The primary end point was fatigue at 90 days measured by the Multidimensional Fatigue Inventory-20 general fatigue domain. Secondary end points included the Fatigue Severity Scale, the Montreal Cognitive Assessment, the modified Rankin Scale and the Stroke-specific quality of Life questionnaire. Adult patients with a recent stroke achieving a score of >= 12 on the Multidimensional Fatigue Inventory-20 general fatigue domain were consecutively included. Exclusion criteria were severe cognitive disabilities and contraindications for modafinil treatment. Results-One thousand one hundred twenty-one patients with stroke were screened and 41 patients included, 21 received modafinil. The primary end point, the Multidimensional Fatigue Inventory-20 general fatigue score, did not differ between groups. Patients in the modafinil group obtained better scores on the Fatigue Severity Scale (P=0.02) and in some subscales of the stroke-specific quality of life questionnaire (0.001<P<0.05), which were secondary outcomes. No serious adverse reactions were observed and there was no difference in blood pressure between groups. Conclusions-There were no significant differences between the 2 groups with regard to the primary end point. There were secondary significant outcomes that should be explored in future trials.	[Poulsen, Mai Bang; Overgaard, Karsten; Rasmussen, Rune Skovgaard] Herlev Univ Hosp, Dept Neurol, DK-2730 Herlev, Denmark; [Damgaard, Bodil] Herlev Univ Hosp, Dept Radiol, DK-2730 Herlev, Denmark; [Zerahn, Bo] Herlev Univ Hosp, Dept Clin Physiol, DK-2730 Herlev, Denmark; [Damgaard, Bodil] Hilleroed Univ Hosp, Dept Radiol, Hillerod, Denmark		Poulsen, MB (corresponding author), Herlev Hosp, Dept Neurol, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	maibang@gmail.com		Zerahn, Bo/0000-0002-3457-6249; Poulsen, Mai Bang/0000-0002-5525-0678; Rasmussen, Rune/0000-0002-5630-122X	Danish Ministry of Higher Education and Science; Department of Neurology at Herlev Hospital; Health Foundation; Research Council at Herlev Hospital; Merchant L.F. Foghts Foundation; Director Emil Hertz and wife Inger Hertz Foundation; Else and Mogens Wedell-Wedelsborgs Foundation; Boerge and Marie Kroghs Foundation; Soeren and Helene Hempels grant; Linex Foundation	The trial was supported by the Danish Ministry of Higher Education and Science, the Department of Neurology at Herlev Hospital, The Health Foundation, The Research Council at Herlev Hospital, Merchant L.F. Foghts Foundation, Director Emil Hertz and wife Inger Hertz Foundation, Else and Mogens Wedell-Wedelsborgs Foundation, Boerge and Marie Kroghs Foundation, Soeren and Helene Hempels grant and the Linex Foundation. The drugs used was not supplied by the manufacturer but bought from an independent pharmacy.	Andersen G, 2012, ACTA NEUROL SCAND, V125, P248, DOI 10.1111/j.1600-0404.2011.01557.x; Awudu GAH, 2014, DRUG SAFETY, V37, P661, DOI 10.1007/s40264-014-0201-8; Ballon JS, 2006, J CLIN PSYCHIAT, V67, P554, DOI 10.4088/JCP.v67n0406; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Brioschi A, 2009, EUR NEUROL, V62, P243, DOI 10.1159/000232927; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Choi-Kwon S, 2007, CEREBROVASC DIS, V23, P103, DOI 10.1159/000097045; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Karaiskos D, 2012, J NEUROPSYCH CLIN N, V24, P349, DOI 10.1176/appi.neuropsych.11110325; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kumar R, 2008, DRUGS, V68, P1803, DOI 10.2165/00003495-200868130-00003; Kutlubaev MA, 2015, INT J STROKE, V10, P280, DOI 10.1111/ijs.12428; Lerdal A, 2013, NEUROLOGY, V81, P1581, DOI 10.1212/WNL.0b013e3182a9f471; Lerdal A, 2011, INT J NURS STUD, V48, P1258, DOI 10.1016/j.ijnurstu.2011.02.019; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; Maribo Thomas, 2006, Ugeskr Laeger, V168, P2790; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mucke M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006788.pub3; Muus I, 2007, CLIN REHABIL, V21, P620, DOI 10.1177/0269215507075504; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Rush CR, 2002, BEHAV PHARMACOL, V13, P105, DOI 10.1097/00008877-200203000-00002; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Simon P, 1995, EUR NEUROPSYCHOPHARM, V5, P509, DOI 10.1016/0924-977X(95)00041-M; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Tseng BY, 2010, STROKE, V41, P2908, DOI 10.1161/STROKEAHA.110.596064; Urban KR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00038; van de Port IGL, 2007, CEREBROVASC DIS, V23, P40, DOI 10.1159/000095757; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647	42	21	21	3	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2015	46	12					3470	3477		10.1161/STROKEAHA.115.010860			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	CX2NS	WOS:000365534400018	26534969	Bronze			2022-02-06	
J	Yang, LM; Tang, J; Chen, QW; Jiang, B; Zhang, B; Tao, YH; Li, L; Chen, Z; Zhu, G				Yang, Liming; Tang, Jun; Chen, Qianwei; Jiang, Bing; Zhang, Bo; Tao, Yihao; Li, Lin; Chen, Zhi; Zhu, Gang			Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics	BRAIN RESEARCH			English	Article						Intracerebral hemorrhage; Hyperbaric oxygen; Preconditioning; Neuroinflammation; Microglia; Brain edema	SPINAL-CORD-INJURY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; ACTIVATION; EDEMA; INFLAMMATION; MODEL; CNS; NEURODEGENERATION	Intracerebral Hemorrhage (ICH) results in a detrimental neurologic disorder with complicated secondary brain injury. Hyperbaric oxygen preconditioning (HBOP) may be a safe and effective therapeutic method for ICH victims. Our previous studies have demonstrated that HBOP induces neuroprotection in cerebral ischemia and traumatic brain injury. This study aimed to investigate whether HBOP could alleviate neuroinflammation by regulating changes in microglia characteristics in a rat model of ICH. ICH was induced by autologous arterial blood injection, and animals were sacrificed at 12, 24, and 72 h post injury. We measured motor function and brain water content to evaluate the extent of inflammation. Fluoro-Jade C and TNF-alpha staining was used to characterize neuronal degeneration and neuroinflammatory cytokines, and immunofluorescence staining was performed for CD11b to show activated microglia and Iba-1 to show microglia. Our results indicate that motor dysfunction and brain water content are alleviated by HBOP, and Fluoro-Jade C staining demonstrates that neuron degeneration decreased in the HBOP group. The growth of Iba-1-positive microglia decreased in the HBOP group. Moreover, TNF-alpha was dynamically reduced in the HBOP group compared with the ICH group. CD11b-Iba-1 double staining demonstrated that the ratio of CD11b and Iba-1 was significantly decreased in the HBOP group. Overall, the data demonstrated that HBOP could significantly alleviate the ICH-induced neuroinflammation by regulating microglia characteristics changing. The phenomenon may propel the progress of the relation between microglia and HBOP and represent a novel target for ICH treatment. (C) 2015 Elsevier B.V. All rights reserved.	[Yang, Liming; Tang, Jun; Chen, Qianwei; Jiang, Bing; Zhang, Bo; Tao, Yihao; Li, Lin; Chen, Zhi; Zhu, Gang] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China		Zhu, G (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.	gangzhu6666@sina.com		Chen, Zhi/0000-0002-8404-4937	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81571116]; NSFCNational Natural Science Foundation of China (NSFC) [81371440]; National key basic research development program (973 Program) of China [2014CB541606]	This study was supported by the National Natural Science Foundation of China (NSFC, NO. 81571116), (NSFC, NO. 81371440), and 2014CB541606 from the National key basic research development program (973 Program) of China.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Cui GY, 2011, UNDERSEA HYPERBAR M, V38, P91; Geng CK, 2015, BRAIN RES, V1606, P68, DOI 10.1016/j.brainres.2015.01.029; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Hu S.L., 2014, MOL NEUROBIOL; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li N, 2013, STROKE, V44, P1144, DOI 10.1161/STROKEAHA.111.000056; Lu PG, 2012, NEUROL RES, V34, P944, DOI 10.1179/1743132812Y.0000000096; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Masuda T, 2010, BRAIN RES, V1355, P228, DOI 10.1016/j.brainres.2010.07.101; Matula C, 2000, STEREOT FUNCT NEUROS, V75, P142, DOI 10.1159/000048396; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Okauchi M, 2009, BRAIN RES, V1249, P229, DOI 10.1016/j.brainres.2008.10.035; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V102, P317, DOI 10.1007/978-3-211-85578-2_60; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V105, P113; Qu Y, 2007, J NEUROSURG, V106, P428, DOI 10.3171/jns.2007.106.3.428; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shin JA, 2014, BRAIN BEHAV IMMUN, V40, P143, DOI 10.1016/j.bbi.2014.03.013; Tang J., 2015, MOL NEUROBIOL; Tang Y, 2015, MOL NEUROBIOL, DOI 10.1007/s12035-014-9070-5; Tao YH, 2015, BRAIN RES, V1602, P127, DOI 10.1016/j.brainres.2015.01.025; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154; Yang J, 2013, LIFE SCI, V93, P1033, DOI 10.1016/j.lfs.2013.10.015; Yang Z, 2014, MOL IMMUNOL, V60, P109, DOI 10.1016/j.molimm.2014.03.005; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004	43	21	24	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 19	2015	1627						21	30		10.1016/j.brainres.2015.08.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY2HC	WOS:000366228400003	26301824				2022-02-06	
J	Chau, A; Salazar, AM; Krueger, F; Cristofori, I; Grafman, J				Chau, Aileen; Salazar, Andres M.; Krueger, Frank; Cristofori, Irene; Grafman, Jordan			The effect of claustrum lesions on human consciousness and recovery of function	CONSCIOUSNESS AND COGNITION			English	Article						Claustrum; Consciousness; Neurobehavioral function; Penetrating traumatic brain injury	PENETRATING HEAD-INJURY; BRAIN; SOFTWARE; EPILEPSY	Crick and Koch proposed that the claustrum plays a crucial role in consciousness. Their proposal was based on the structure and connectivity of the claustrum that suggested it had a role in coordinating a set of diverse brain functions. Given the few human studies investigating this claim, we decided to study the effects of claustrum lesions on consciousness in 171 combat veterans with penetrating traumatic brain injuries. Additionally, we studied the effects of claustrum lesions and loss of consciousness on long-term cognitive abilities. Claustrum damage was associated with the duration, but not frequency, of loss of consciousness, indicating that the claustrum may have an important role in regaining, but not maintaining, consciousness. Total brain volume loss, but not claustrum lesions, was associated with long-term recovery of neurobehavioral functions. Our findings constrain the current understanding of the neurobehavioral functions of the claustrum and its role in maintaining and regaining consciousness. (C) 2015 Elsevier Inc. All rights reserved.	[Chau, Aileen; Cristofori, Irene; Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Cristofori, Irene; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL 60208 USA		Chau, A (corresponding author), Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, 345 East Super St, Chicago, IL 60611 USA.	achau@ric.org; asalazar@starpower.net; fkrueger@gmu.edu; irene.cristofori@northwestem.edu; jgrafman@northwestern.edu		Cristofori, Irene/0000-0003-2339-1457	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	We thank our Vietnam veterans for their participation in the study. We are grateful to V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants. The National Naval Medical Center and the National Institute of Neurological Disorders and Stroke provided their facilities and supported the research. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; [Anonymous], 1960, ARMED FORCES QUALIFI; BRAAK H, 1982, ANAT EMBRYOL, V163, P447, DOI 10.1007/BF00305558; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Duffau H, 2007, J NEURO-ONCOL, V81, P327, DOI 10.1007/s11060-006-9236-8; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Kaplan E, 1983, BOSTON NAMING TEST; Koubeissi MZ, 2014, EPILEPSY BEHAV, V37, P32, DOI 10.1016/j.yebeh.2014.05.027; LEVIN HS, 1989, LANCET, V1, P1001; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Milardi D, 2015, CEREB CORTEX, V25, P406, DOI 10.1093/cercor/bht231; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Rahman FE, 2007, BRAIN RES, V1159, P94, DOI 10.1016/j.brainres.2007.05.011; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Remedios R., 2012, FRANC CRICK MEM C CA; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Smith JB, 2010, J NEUROSCI, V30, P16832, DOI 10.1523/JNEUROSCI.4438-10.2010; Smythies J, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00053; Smythies JR, 2014, CLAUSTRUM STRUCTURAL, V1st; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stiefel KM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00020; Tian F, 2011, BEHAV BRAIN RES, V216, P626, DOI 10.1016/j.bbr.2010.09.005; Torgerson C. M., 2014, FRONTIERS NEUROINFOR, V8; Torgerson C. M., 2014, HUMAN BRAIN MAPPING; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volz KG, 2010, CONSCIOUS COGN, V19, P829, DOI 10.1016/j.concog.2010.05.014; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	35	21	22	2	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	NOV	2015	36						256	264		10.1016/j.concog.2015.06.017			9	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	CQ3PX	WOS:000360516100024	26186439				2022-02-06	
J	Piao, C; Ranaivo, HR; Rusie, A; Wadhwani, N; Koh, S; Wainwright, MS				Piao, Chunshu; Ranaivo, Hantamalala Ralay; Rusie, Allison; Wadhwani, Nitin; Koh, Sookyong; Wainwright, Mark S.			Thrombin decreases expression of the glutamate transporter GLAST and inhibits glutamate uptake in primary cortical astrocytes via the Rho kinase pathway	EXPERIMENTAL NEUROLOGY			English	Article						Protease; Glutamate transporter; Kinases; Blood-brain barrier	BLOOD-BRAIN-BARRIER; PROTEASE-ACTIVATED RECEPTORS; TEMPORAL-LOBE; CULTURED ASTROCYTES; INJURY; SEIZURES; NEUROPROTECTION; HIPPOCAMPUS; EPILEPSY; CELLS	Astrocyte glutamate transporters GLAST and GLT1 play a key role in regulating neuronal excitation and their levels are altered in patients with epilepsy, and after traumatic brain injury. The mechanisms which regulate their expression are not well understood. We tested the hypothesis that exposure of astrocytes to high levels of thrombin, as may occur after a compromise of the blood-brain barrier, would reduce astrocyte glutamate transporter levels. In isolated rat cortical astrocytes we examined the effects of thrombin on the expression and function of glutamate transporters, and the signaling pathways involved in these responses by using Western blotting and selective inhibitors. Thrombin induced a selective decrease in the expression of GLAST but not GLT1, with a corresponding decrease in the capacity of astrocytes to take up glutamate. Activation of the thrombin receptor PAR-1 with an activating peptide induced a similar decrease in the expression of GLAST and compromise of glutamate uptake. The downregulation of GLAST induced by thrombin was mediated by the mitogen activated protein kinases p38 MAPK, ERK and JNK, but inhibition of these kinases did not prevent the decrease in glutamate uptake induced by thrombin. In contrast, inhibition of the Rho kinase pathway using the specific inhibitor, Y27632, suppressed both the decrease in the expression of GLAST and the decrease in glutamate uptake induced by thrombin. In hippocampal astrocyte cultures, thrombin caused a decrease in both GLAST and GLT1. In tissue resected from brains of children with intractable epilepsy, we found a decrease in the integrity of the blood-brain barrier along with a reduction in immunoreactivity for both transporters which was associated with an increase in cleaved thrombin and reactive astrogliosis. The in vitro results suggest a specific mechanism by which thrombin may lead to a compromise of astrocyte function and enhanced synaptic excitability after the blood-brain barrier is compromised. The human in vivo results provide indirect support evidence linking the compromise of the blood-brain barrier to thrombin-induced reduction in glutamate transporter expression and an increase in neuronal excitation. (C) 2015 Elsevier Inc All rights reserved.	[Piao, Chunshu; Ranaivo, Hantamalala Ralay; Rusie, Allison; Koh, Sookyong; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Div Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Div Crit Care, Feinberg Sch Med, Chicago, IL 60611 USA; [Piao, Chunshu; Ranaivo, Hantamalala Ralay; Rusie, Allison; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Feinberg Sch Med, Chicago, IL 60611 USA; [Wadhwani, Nitin] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Neurol, 225 E Chicago Ave,Mailstop 51, Chicago, IL 60611 USA.	m-wainwright@northwestern.edu		Wainwright, Mark/0000-0002-4736-7462	Lyndsey Whittingham Foundation; Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073768] Funding Source: NIH RePORTER	This work was supported by the Lyndsey Whittingham Foundation and by the Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program. The authors thank Bradley Scher for technical assistance.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abe K, 2003, NEUROSCI RES, V45, P25, DOI 10.1016/S0168-0102(02)00190-6; Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850; Anderson CM, 2000, GLIA, V32, P1; Barzo P, 1997, ACT NEUR S, V70, P243; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Choi MS, 2008, BRAIN RES BULL, V76, P368, DOI 10.1016/j.brainresbull.2008.02.031; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Donovan FM, 1997, J NEUROSCI, V17, P5316; Fang QH, 2006, AM J RESP CELL MOL, V35, P714, DOI 10.1165/rcmb.2005-0026OC; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Huynh THV, 2012, J MED CHEM, V55, P5403, DOI 10.1021/jm300345z; Isaeva E, 2012, ANN NEUROL, V72, P192, DOI 10.1002/ana.23587; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Koyama Y, 1996, GLIA, V16, P342, DOI 10.1002/(SICI)1098-1136(199604)16:4<342::AID-GLIA6>3.0.CO;2-1; KOYAMA Y, 1994, NEUROSCIENCE, V61, P1007, DOI 10.1016/0306-4522(94)90420-0; Lau CL, 2011, BRIT J PHARMACOL, V163, P533, DOI 10.1111/j.1476-5381.2011.01259.x; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Lin CC, 2011, EUR J PHARMACOL, V672, P180, DOI 10.1016/j.ejphar.2011.10.005; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2013, NEUROBIOL DIS, V50, P171, DOI 10.1016/j.nbd.2012.10.017; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Majumdar M, 1998, J BIOL CHEM, V273, P10099, DOI 10.1074/jbc.273.17.10099; Meli R, 2001, J NEUROCHEM, V79, P556, DOI 10.1046/j.1471-4159.2001.00617.x; Namekata K, 2008, MOL CELL BIOL, V28, P3273, DOI 10.1128/MCB.02159-07; Perez-Dominguez M, 2014, NEUROCHEM RES, V39, P1219, DOI 10.1007/s11064-014-1300-8; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Razafimanjato H, 2010, NEUROTOXICOLOGY, V31, P475, DOI 10.1016/j.neuro.2010.06.003; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Rohatgi T, 2004, NEUROSCIENTIST, V10, P501, DOI 10.1177/1073858404269955; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rossignol P, 2004, EXP CELL RES, V299, P279, DOI 10.1016/j.yexcr.2004.05.034; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rozyczka J, 2004, BRAIN PATHOL, V14, P406; Sarac S, 2009, APMIS, V117, P291, DOI 10.1111/j.1600-0463.2009.02443.x; Shikamoto Y, 1999, FEBS LETT, V463, P387, DOI 10.1016/S0014-5793(99)01657-9; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Swanson RA, 1997, J NEUROSCI, V17, P932; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Ulu MO, 2010, ACTA NEUROCHIR, V152, P845, DOI 10.1007/s00701-009-0548-2; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROSCIENCE, V277, P455, DOI 10.1016/j.neuroscience.2014.07.030; Vazquez-Juarez E, 2009, J NEUROCHEM, V111, P1398, DOI 10.1111/j.1471-4159.2009.06418.x; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246	62	21	22	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						288	300		10.1016/j.expneurol.2015.09.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW7BB	WOS:000365151800027	26391563				2022-02-06	
J	Seidl, JNT; Pastorek, NJ; Lillie, R; Rosenblatt, A; Troyanskaya, M; Miller, BI; Romesser, J; Lippa, S; Sim, AH; Linck, J				Seidl, Jennifer N. Travis; Pastorek, Nicholas J.; Lillie, Rema; Rosenblatt, Andrew; Troyanskaya, Maya; Miller, Brian I.; Romesser, Jennifer; Lippa, Sara; Sim, Anita H.; Linck, John			Factors Related to Satisfaction With Life in Veterans With Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						satisfaction with life; veterans; mild traumatic brain injury; concussion; social support	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; POLYTRAUMA CLINICAL TRIAD; CHRONIC PAIN; SOCIAL SUPPORT; ENDURING FREEDOM; SELF-EFFICACY; FOLLOW-UP; HEALTH; DISABILITY	Purpose/Objective: Satisfaction with life (SWL) is an important measure of outcome in rehabilitation. Previous research suggests that those with a history of traumatic brain injury (TBI), even mild TBI, report lower levels of life satisfaction when compared with the noninjured population. Although is it possible that TBI has a direct effect on SWL, various medical and psychosocial factors commonly affecting those recovering from TBI likely contribute to SWL. Research Method/Design: The present study aimed to identify factors related to SWL in 95 veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) with a history of mild TBI. Results: Regression analyses indicated that headache impact, pain interference, sleep quality, posttraumatic stress symptom severity, and social support were all significantly related to SWL. However, when secondary analyses were conducted including posttraumatic stress symptom severity as a covariate before the entry of other predictors, only sleep quality and social support remained significantly associated with SWL. Conclusions/Implications: These results indicate the importance of properly identifying and treating symptoms of posttraumatic stress in veterans with a history of mTBI, as posttraumatic stress symptoms appear to be strongly related to SWL in those with a history of mild TBI. Optimizing sleep quality and social support may also be important in improving SWL.	[Seidl, Jennifer N. Travis; Rosenblatt, Andrew] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Seidl, Jennifer N. Travis; Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, TBI Ctr Excellence, Houston, TX USA; [Pastorek, Nicholas J.] Michael E DeBakey VA Med Ctr, Rehabil Care Line, Houston, TX USA; [Pastorek, Nicholas J.; Troyanskaya, Maya] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Lillie, Rema] Mentis Neuro Rehabil, Houston, TX USA; [Miller, Brian I.] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX USA; [Miller, Brian I.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Romesser, Jennifer] VA Salt Lake City Healthcare Syst, Mental Hlth, Salt Lake City, UT USA; [Lippa, Sara] Walter Reed Natl Mil Med Ctr, Vet Brain Injury Ctr, Bethesda, MD USA; [Sim, Anita H.] Minneapolis VA Med Ctr, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Linck, John] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Norman, OK 73019 USA		Pastorek, NJ (corresponding author), 2002 Holcombe Blvd,RECL 117, Houston, TX 77007 USA.	nicholas.pastorek@va.gov		Pastorek, Nicholas/0000-0002-9290-380X			Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boals A, 2013, STRESS HEALTH, V29, P156, DOI 10.1002/smi.2443; Boonstra AM, 2013, QUAL LIFE RES, V22, P93, DOI 10.1007/s11136-012-0132-8; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; d'Ardenne P, 2005, J NERV MENT DIS, V193, P62, DOI 10.1097/01.nmd.0000149221.09294.92; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; De Diego EV, 2005, CEPHALALGIA, V25, P184, DOI 10.1111/j.1468-2982.2004.00820.x; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Groeger JA, 2004, J SLEEP RES, V13, P359, DOI 10.1111/j.1365-2869.2004.00418.x; Henderson JV, 2013, PAIN MED, V14, P1346, DOI 10.1111/pme.12195; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huxhold O, 2013, PSYCHOL AGING, V28, P3, DOI 10.1037/a0030170; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jean-Louis G, 2000, SLEEP, V23, P1115; Karatzias T, 2013, J MENT HEALTH, V22, P501, DOI 10.3109/09638237.2013.819418; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr S, 2004, INTERN MED J, V34, P403, DOI 10.1111/j.1444-0903.2004.00627.x; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; King D. W., 2003, MANUAL DEPLOYMENT RI; Lanteri-Minet M, 2005, PAIN, V118, P319, DOI 10.1016/j.pain.2005.09.010; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lemola S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071292, 10.1371/journal.pone.0082059]; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martelli MF, 2012, NEUROREHABILITATION, V31, P3, DOI 10.3233/NRE-2012-0770; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Money N., 2011, BEST PRACTICES IDENT; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rissanen T, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-202; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seligowski AV, 2012, APPL PSYCHOL-HLTH WE, V4, P261, DOI 10.1111/j.1758-0854.2012.01073.x; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stalnacke BM, 2011, NEUROPSYCH DIS TREAT, V7, P683, DOI 10.2147/NDT.S25321; Stovner LJ, 2008, J HEADACHE PAIN, V9, P139, DOI 10.1007/s10194-008-0038-6; Strine TW, 2008, SOC PSYCH PSYCH EPID, V43, P151, DOI 10.1007/s00127-007-0277-x; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tolin DF, 2010, PSYCHOL ASSESSMENT, V22, P729, DOI 10.1037/a0020973; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Wilder A, 2011, THER RECREAT J, V45, P268; Williams RM, 2012, J HEAD TRAUMA REHAB, V27, P261, DOI 10.1097/HTR.0b013e3182585cb6; World Health Organization, 2001, THE INTERNATIONAL CL; Yeung P, 2014, DISABIL REHABIL, V36, P63, DOI 10.3109/09638288.2013.777808	65	21	21	0	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2015	60	4					335	343		10.1037/rep0000064			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CX4YL	WOS:000365706800004	26618214				2022-02-06	
J	Stone, JD; Hill, MK; Pan, ZX; Novais, EN				Stone, Joseph D.; Hill, Mary K.; Pan, Zhaoxing; Novais, Eduardo N.			Open Reduction of Pediatric Femoral Neck Fractures Reduces Osteonecrosis Risk	ORTHOPEDICS			English	Article							TERM-FOLLOW-UP; DISPLACED FRACTURE; AVASCULAR NECROSIS; CHILDREN; FEMUR; HIP; COMPLICATIONS; ADOLESCENTS; CLASSIFICATION; DECOMPRESSION	Pediatric femoral neck fractures are rare injuries that are associated with a high risk of osteonecrosis of the femoral head. This study compared pediatric patients with fully displaced femoral neck fractures treated with either open reduction and internal fixation (ORIF) or closed reduction and internal fixation (CRIF). After institutional review board approval was obtained, the authors identified 53 patients who were treated for femoral neck fracture between 2003 and 2012. Inclusion criteria were as follows: (1) diagnosis of a fully displaced femoral neck fracture with no anatomic cortical contact; (2) age of at least 4 years; and (3) clinical/radiographic follow-up of at least 1 year. Medical records and radiographs were retrospectively reviewed. Excluded from the study were 16 patients who had fractures that were not fully displaced, 4 who were outside of the eligible age range, 1 who had insufficient radiographs, and 10 who had insufficient follow-up. Of the 22 patients included, 6 were treated with ORIF and 16 were treated with CRIF. Treatment groups were compared with Fisher's exact test for categorical outcome data and the Wilcoxon rank-sum test for continuous variables. There was a significantly (P=.051) greater occurrence of osteonecrosis after CRIF (50%) than after ORIF (0%). Further, patients who underwent ORIF had a higher (P=.009) quality of reduction, a higher (P=.046) rate of anatomic union, and fewer (P=.009) complications than those who underwent CRIF. Major complications occurred in significantly fewer (P=.015) hips after ORIF than after CRIF. No significant difference (P=.477) was seen between groups, according to the Ratliff assessment of final results. Fully displaced pediatric femoral neck fractures treated with ORIF had a significantly higher quality of reduction, with fewer complications, including osteonecrosis, than those treated with CRIF.	[Stone, Joseph D.; Hill, Mary K.; Pan, Zhaoxing; Novais, Eduardo N.] Childrens Hosp Colorado, Aurora, CO 80045 USA		Novais, EN (corresponding author), Childrens Hosp Colorado, 13123 E 16th Ave,Box 060, Aurora, CO 80045 USA.	eduardo.novais@childrenscolorado.org					Beaty JH, 2006, ORTHOP CLIN N AM, V37, P223, DOI 10.1016/j.ocl.2005.11.003; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; CANALE ST, 1990, ORTHOP CLIN N AM, V21, P341; Canale ST, 1995, AAOS INSTR COURS LEC, V44, P255; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P338; Colonna PC, 1929, AM J SURG, V6, P793, DOI [10.1016/S0002-9610(29)90726-1, DOI 10.1016/S0002-9610(29)90726-1, 10.1016/s0002-9610(29)90726-1]; Dendane MA, 2010, ORTHOP TRAUMATOL-SUR, V96, P161, DOI [10.1016/j.rcot.2010.02.004, 10.1016/j.otsr.2009.11.007]; Dhammi IK, 2005, J ORTHOP SCI, V10, P173, DOI 10.1007/s00776-004-0875-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; FORLIN E, 1992, J PEDIATR ORTHOPED, V12, P503, DOI 10.1097/01241398-199207000-00017; HEISER JM, 1980, CLIN ORTHOP RELAT R, P177; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; JONES RW, 1936, BRIT J SURG, V23, P787; LEUNG PC, 1986, J BONE JOINT SURG BR, V68, P537, DOI 10.1302/0301-620X.68B4.3733826; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Morsy HA, 2001, INJURY, V32, P45, DOI 10.1016/S0020-1383(00)00109-1; Ng GPK, 1996, INJURY, V27, P419, DOI 10.1016/0020-1383(96)00025-3; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; Sink EL, 2012, CLIN ORTHOP RELAT R, V470, P2220, DOI 10.1007/s11999-012-2343-2; Song KS, 2010, J BONE JOINT SURG BR, V92B, P1148, DOI 10.1302/0301-620X.92B8.24482; Song KS, 2001, J PEDIATR ORTHOP B, V10, P205, DOI 10.1097/00009957-200107000-00009; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; Yeranosian M, 2013, BONE JOINT J, V95B, P135, DOI 10.1302/0301-620X.95B1.30161	25	21	33	1	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	NOV	2015	38	11					E983	E990		10.3928/01477447-20151020-06			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	DA5JT	WOS:000367840100006	26558678				2022-02-06	
J	Bonsall, DR; Kim, H; Tocci, C; Ndiaye, A; Petronzio, A; McKay-Corkum, G; Molyneux, PC; Scammell, TE; Harrington, ME				Bonsall, David R.; Kim, Hyunji; Tocci, Catherine; Ndiaye, Awa; Petronzio, Abbey; McKay-Corkum, Grace; Molyneux, Penny C.; Scammell, Thomas E.; Harrington, Mary E.			Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1 beta: Investigating a Method for the Study of Fatigue in Laboratory Animals	PLOS ONE			English	Article							MESSENGER-RNA; DOUBLE-BLIND; BEHAVIORAL DEPRESSION; INFLAMMATORY MARKERS; BRAIN IL-1-BETA; CANCER PATIENTS; BASAL GANGLIA; MOUSE MODEL; SLEEP; METHYLPHENIDATE	Fatigue is a disabling symptom in patients with multiple sclerosis and Parkinson's Disease, and is also common in patients with traumatic brain injury, cancer, and inflammatory disorders. Little is known about the neurobiology of fatigue, in part due to the lack of an approach to induce fatigue in laboratory animals. Fatigue is a common response to systemic challenge by pathogens, a response in part mediated through action of the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). We investigated the behavioral responses of mice to IL-1 beta. Female C57Bl/6J mice of 3 ages were administered IL-1 beta at various doses i.p. Interleukin-1 beta reduced locomotor activity, and sensitivity increased with age. Further experiments were conducted with middle-aged females. Centrally administered IL-1 beta dose-dependently reduced locomotor activity. Using doses of IL-1 beta that caused suppression of locomotor activity, we measured minimal signs of sickness, such as hyperthermia, pain or anhedonia (as measured with abdominal temperature probes, pre-treatment with the analgesic buprenorphine and through sucrose preference, respectively), all of which are responses commonly reported with higher doses. We found that middle-aged orexin(-/-) mice showed equivalent effects of IL-1 beta on locomotor activity as seen in wild-type controls, suggesting that orexins are not necessary for IL-1 beta-induced reductions in wheel-running. Given that the availability and success of therapeutic treatments for fatigue is currently limited, we examined the effectiveness of two potential clinical treatments, modafinil and methylphenidate. We found that these treatments were variably successful in restoring locomotor activity after IL-1 beta administration. This provides one step toward development of a satisfactory animal model of the multidimensional experience of fatigue, a model that could allow us to determine possible pathways through which inflammation induces fatigue, and could lead to novel treatments for reversal of fatigue.	[Bonsall, David R.; Kim, Hyunji; Tocci, Catherine; Ndiaye, Awa; Petronzio, Abbey; McKay-Corkum, Grace; Molyneux, Penny C.; Harrington, Mary E.] Smith Coll, Neurosci Program, Northampton, MA 01063 USA; [Scammell, Thomas E.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA		Harrington, ME (corresponding author), Smith Coll, Neurosci Program, Northampton, MA 01063 USA.	mharring@smith.edu		Bonsall, David/0000-0002-2542-7559	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NR012845-01A1]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R21NR012845] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grant to MEH R21NR012845-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anforth HR, 1998, EUR CYTOKINE NETW, V9, P279; Anisman H, 2008, PSYCHOPHARMACOLOGY, V199, P231, DOI 10.1007/s00213-008-1166-z; Antle MC, 2012, NEUROPSYCHOPHARMACOL, V37, P2446, DOI 10.1038/npp.2012.103; Baker FC, 2005, AM J PHYSIOL-REG I, V288, pR998, DOI 10.1152/ajpregu.00615.2004; BARRETT J, 1993, SLEEP, V16, P93; Bluthe RM, 1997, PSYCHONEUROENDOCRINO, V22, P1, DOI 10.1016/S0306-4530(96)00042-X; Bower JE, 2015, ADV EXP MED BIOL, V862, P53, DOI 10.1007/978-3-319-16366-6_5; Bower JE, 2011, BRAIN BEHAV IMMUN, V25, P147, DOI 10.1016/j.bbi.2010.09.010; Bower JE, 2009, CLIN CANCER RES, V15, P5534, DOI 10.1158/1078-0432.CCR-08-2584; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Capuron L, 2012, ARCH GEN PSYCHIAT, V69, P1044, DOI 10.1001/archgenpsychiatry.2011.2094; Carmichael MD, 2006, AM J PHYSIOL-REG I, V291, pR1344, DOI 10.1152/ajpregu.00141.2006; CHAO CC, 1992, CLIN IMMUNOL IMMUNOP, V64, P161, DOI 10.1016/0090-1229(92)90194-S; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Clevenger L, 2012, BRAIN BEHAV IMMUN, V26, P1037, DOI 10.1016/j.bbi.2012.04.003; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; DUNN AJ, 1991, BRAIN RES BULL, V26, P539, DOI 10.1016/0361-9230(91)90092-X; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; Espana RA, 2007, SLEEP, V30, P1417, DOI 10.1093/sleep/30.11.1417; Felger JC, 2013, BRAIN BEHAV IMMUN, V31, P153, DOI 10.1016/j.bbi.2012.10.010; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457; Gaykema RPA, 2008, NEUROSCIENCE, V152, P273, DOI 10.1016/j.neuroscience.2007.10.042; Gaykema RPA, 2009, BRAIN BEHAV IMMUN, V23, P926, DOI 10.1016/j.bbi.2009.03.005; Gong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084391; Grossberg AJ, 2011, J NEUROSCI, V31, P11376, DOI 10.1523/JNEUROSCI.2311-11.2011; Harden LM, 2011, PSYCHONEUROENDOCRINO, V36, P608, DOI 10.1016/j.psyneuen.2010.09.003; Harrington ME, 2012, PROG NEUROBIOL, V99, P93, DOI 10.1016/j.pneurobio.2012.07.004; Ifuku M, 2014, EUR J NEUROSCI, V40, P3253, DOI 10.1111/ejn.12668; Ishizuka T, 2008, EUR J PHARMACOL, V578, P209, DOI 10.1016/j.ejphar.2007.09.009; Jean-Pierre P, 2010, CANCER-AM CANCER SOC, V116, P3513, DOI 10.1002/cncr.25083; Katafuchi T, 2003, NEUROSCIENCE, V120, P837, DOI 10.1016/S0306-4522(03)00365-8; Katafuchi T, 2006, ANN NY ACAD SCI, V1088, P230, DOI 10.1196/annals.1366.020; KENT S, 1992, P NATL ACAD SCI USA, V89, P9117, DOI 10.1073/pnas.89.19.9117; Kerr CW, 2012, J PAIN SYMPTOM MANAG, V43, P68, DOI 10.1016/j.jpainsymman.2011.03.026; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111/j.1460-9568.2008.06549.x; Konsman JP, 2000, EUR J NEUROSCI, V12, P4434, DOI 10.1046/j.0953-816X.2000.01319.x; Lattie EG, 2012, BRAIN BEHAV IMMUN, V26, P849, DOI 10.1016/j.bbi.2012.02.008; LAYE S, 1995, AM J PHYSIOL-REG I, V268, pR1327, DOI 10.1152/ajpregu.1995.268.5.R1327; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Liu LQ, 2012, BRAIN BEHAV IMMUN, V26, P706, DOI 10.1016/j.bbi.2012.02.001; MASOTTO C, 1992, BRAIN RES BULL, V28, P161, DOI 10.1016/0361-9230(92)90175-W; Matsuwaki T, 2014, BRAIN BEHAV IMMUN, V40, P166, DOI 10.1016/j.bbi.2014.03.015; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Mendonca DA, 2007, MOVEMENT DISORD, V22, P2070, DOI 10.1002/mds.21656; Minton O, 2011, J PAIN SYMPTOM MANAG, V41, P761, DOI 10.1016/j.jpainsymman.2010.06.020; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Nunes EJ, 2014, PSYCHOPHARMACOLOGY, V231, P727, DOI 10.1007/s00213-013-3285-4; Opp MR, 1998, LIFE SCI, V62, P923, DOI 10.1016/S0024-3205(98)00010-1; Ottenweller JE, 1998, PHYSIOL BEHAV, V63, P795, DOI 10.1016/S0031-9384(97)00539-8; Prommer E, 2012, AM J HOSP PALLIAT ME, V29, P483, DOI 10.1177/1049909111427029; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schoene C, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00081; Schrepf A, 2013, BRAIN BEHAV IMMUN, V30, pS126, DOI 10.1016/j.bbi.2012.07.022; Schwartz N, 2014, SCIENCE, V345, P535, DOI 10.1126/science.1253994; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Smith LB, 2014, BRAIN BEHAV IMMUN, V38, P66, DOI 10.1016/j.bbi.2013.12.022; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; SPADARO F, 1990, BRAIN BEHAV IMMUN, V4, P308, DOI 10.1016/0889-1591(90)90034-N; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; Spathis A, 2014, J CLIN ONCOL, V32, P1882, DOI 10.1200/JCO.2013.54.4346; Stringer EA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-93; Trotti LM, 2014, NEUROTHERAPEUTICS, V11, P68, DOI 10.1007/s13311-013-0236-z; Volkow N D, 2001, J Neurosci, V21, pRC121; Wang XS, 2008, CANCER, V113, P2102, DOI 10.1002/cncr.23820; Wang XS, 2015, GYNECOL ONCOL, V136, P446, DOI 10.1016/j.ygyno.2014.10.013; Weymann KB, 2014, BRAIN BEHAV IMMUN, V37, P84, DOI 10.1016/j.bbi.2013.11.003; Wood LJ, 2006, BIOL RES NURS, V8, P157, DOI 10.1177/1099800406290932; Worden LT, 2009, PSYCHOPHARMACOLOGY, V203, P489, DOI 10.1007/s00213-008-1396-0; Yamato M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090950; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142; Zombeck JA, 2013, COMPARATIVE MED, V63, P491	82	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140678	10.1371/journal.pone.0140678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	WOS:000363184600095	26469939	Green Published, gold, Green Submitted			2022-02-06	
J	Glang, A; Ettel, D; Todis, B; Gordon, WA; Oswald, JM; Vaughn, SL; Connors, SH; Brown, M				Glang, Ann; Ettel, Deborah; Todis, Bonnie; Gordon, Wayne A.; Oswald, Jennifer M.; Vaughn, Susan L.; Connors, Susan H.; Brown, Margaret			Services and Supports for Students with Traumatic Brain Injury: Survey of State Educational Agencies	EXCEPTIONALITY			English	Article							CHILDREN; SCHOOL; TBI; DISABILITY	Long-term follow-up studies conducted during the K-12 school years suggest that challenges related to childhood traumatic brain injury (TBI) tend to persist or worsen over time. A 1999 survey of State Directors of Special Education revealed that most states had emerging initiatives for children with TBI and were expanding their capacity to serve this growing population. To determine whether significant changes in patterns of identification and service delivery had occurred, State Directors and brain injury consumer organizations were surveyed. Survey results show some improvement, but significant gaps remain. Most state education administrators perceive a gap between incidence of childhood TBI and identification of students with TBI to receive special education services. Recommendations for policy changes and research are provided.	[Glang, Ann; Todis, Bonnie] Univ Oregon, Eugene, OR 97401 USA; [Ettel, Deborah] Eugene Sch Dist 4J, Eugene, OR USA; [Gordon, Wayne A.; Oswald, Jennifer M.] Icahn Sch Med Mt Sinai, Mt Sinai Brain Injury Res Ctr, New York, NY 10029 USA; [Vaughn, Susan L.; Connors, Susan H.] Brain Injury Assoc Amer, Vienna, Austria; [Brown, Margaret] Icahn Sch Med Mt Sinai, New York, NY 10029 USA		Glang, A (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, 99 West 10th Ave,Suite 370, Eugene, OR 97401 USA.	aglang@uoregon.edu			National Institute on Disability and Rehabilitation Research to Cincinnati Children's Hospital Medical Center; Center on Brain Injury Research and Training [H133B090010]; Brain Injury Research Center of Mount Sinai; Department of Rehabilitation Medicine of the Icahn School of Medicine at Mount Sinai [H133A120084]	This research was supported in part by funding from the National Institute on Disability and Rehabilitation Research to Cincinnati Children's Hospital Medical Center and the Center on Brain Injury Research and Training [H133B090010], the Brain Injury Research Center of Mount Sinai, and the Department of Rehabilitation Medicine of the Icahn School of Medicine at Mount Sinai [H133A120084].	Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cleary M., 2010, J SCH HLTH, V81, P1; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Faul M, 2010, TRAUMATIC BRAIN INJU; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Glang A, 1999, MAKING IEP PROCESS W; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gordon W. A., 2013, STATE STATES M ED NE; Henry KL, 2012, J YOUTH ADOLESCENCE, V41, P156, DOI 10.1007/s10964-011-9665-3; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Kozleski E., 2000, TEACHING EXCEPTIONAL, V32, P56; Markowitz J., 2001, TRAUMATIC BRAIN INJU; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang MT, 2014, CHILD DEV, V85, P722, DOI 10.1111/cdev.12138; Yeates KO, 2010, STUD NEUROPSYCHOL NE, P243; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	27	21	21	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0936-2835	1532-7035		EXCEPTIONALITY	Exceptionality	OCT 2	2015	23	4					211	224		10.1080/09362835.2014.986612			14	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	CU1VH	WOS:000363309300001					2022-02-06	
J	da Costa, L; Robertson, A; Bethune, A; MacDonald, MJ; Shek, PN; Taylor, MJ; Pang, EW				da Costa, Leodante; Robertson, Amanda; Bethune, Allison; MacDonald, Matt J.; Shek, Pang N.; Taylor, Margot J.; Pang, Elizabeth W.			Delayed and disorganised brain activation detected with magnetoencephalography after mild traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							DEFAULT-MODE NETWORKS; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; MEG; SPECT; PATHOPHYSIOLOGY; CONCUSSION; DISORDER; HISTORY; CORTEX	Background Awareness to neurocognitive issues after mild traumatic brain injury (mTBI) is increasing, but currently no imaging markers are available for mTBI. Advanced structural imaging recently showed microstructural tissue changes and axonal injury, mild but likely sufficient to lead to functional deficits. Magnetoencephalography (MEG) has high temporal and spatial resolution, combining structural and electrophysiological information, and can be used to examine brain activation patterns of regions involved with specific tasks. Methods 16 adults with mTBI and 16 matched controls were submitted to neuropsychological testing (Wechsler Abbreviated Scale of Intelligence (WASI); Conners; Alcohol Use Disorders Identification Test (AUDIT); Generalised Anxiety Disorder Seven-item Scale (GAD-7); Patient Health Questionnaire (PHQ-9); Symptom Checklist and Symptom Severity Score (SCAT2)) and MEG while tested for mental flexibility (Intra-Extra Dimensional set-shifting tasks). Three-dimensional maps were generated using synthetic aperture magnetometry beamforming analyses to identify differences in regional activation and activation times. Reaction times and accuracy between groups were compared using 2x2 mixed analysis of variance. Findings While accuracy was similar, patients with mTBI reaction time was delayed and sequence of activation of brain regions disorganised, with involvement of extra regions such as the occipital lobes, not used by controls. Examination of activation time showed significant delays in the right insula and left posterior parietal cortex in patients with mTBI. Conclusions Patients with mTBI showed significant delays in the activation of important areas involved in executive function. Also, more regions of the brain are involved in an apparent compensatory effort. Our study suggests that MEG can detect subtle neural changes associated with cognitive dysfunction and thus, may eventually be useful for capturing and tracking the onset and course of cognitive symptoms associated with mTBI.	[da Costa, Leodante; Bethune, Allison] Univ Toronto, Sunnybrook Hosp, Div Neurosurg, Toronto, ON, Canada; [da Costa, Leodante] Univ Toronto, Dept Med Imaging, Sunnybrook Hosp, Toronto, ON, Canada; [Robertson, Amanda; MacDonald, Matt J.; Taylor, Margot J.; Pang, Elizabeth W.] SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada; [Shek, Pang N.] Def Res & Dev Canada, Mil Med Sect, Toronto, ON, Canada; [Taylor, Margot J.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Taylor, Margot J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Pang, Elizabeth W.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada		da Costa, L (corresponding author), Sunnybrook Hlth Sci Ctr, Div Neurosurg, 2075 Bayview Ave Room A1-37, Toronto, ON M4N 3M5, Canada.	leo.dacosta@sunnybrook.ca		MacDonald, Matthew/0000-0002-2595-5941	Defence Research and Development Canada [W7719-135182/001/TOR]	This work was supported by funding from Defence Research and Development Canada (Contract #: W7719-135182/001/TOR) to MJT and EWPang.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Chau W, 2004, NEUROIMAGE, V23, P983, DOI 10.1016/j.neuroimage.2004.07.007; Conners CK, 2008, COMPREHENSIVE BEHAV; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Doesburg SM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00785; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dorion AA, 2002, NEUROPSYCHOLOGIA, V40, P946, DOI 10.1016/S0028-3932(01)00150-6; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Gau SSF, 2010, J CHILD PSYCHOL PSYC, V51, P838, DOI 10.1111/j.1469-7610.2010.02215.x; GRAY BG, 1992, J NUCL MED, V33, P52; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Kluetsch RC, 2014, ACTA PSYCHIAT SCAND, V130, P123, DOI 10.1111/acps.12229; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Pantelis C, 2009, SCHIZOPHR RES, V112, P104, DOI 10.1016/j.schres.2009.03.039; Perianez JA, 2004, NEUROIMAGE, V21, P687, DOI 10.1016/j.neuroimage.2003.10.008; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wechsler D., 2011, WECHSLER ABBREVIATED; World Health Organization, 2001, AUDIT ALCOHOL USE DI; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	43	21	21	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	SEP	2015	86	9					1008	1015		10.1136/jnnp-2014-308571			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	CO9IE	WOS:000359487500077	25324505	Green Published, hybrid			2022-02-06	
J	McIntosh, AS; Patton, DA				McIntosh, Andrew S.; Patton, Declan A.			Boxing headguard performance in punch machine tests	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PROFESSIONAL FOOTBALL; HEAD IMPACTS; CONCUSSION; BIOMECHANICS; INJURY; FACE	Background The paper presents a novel laboratory method for assessing boxing headguard impact performance. The method is applied to examine the effects of headguards on head impact dynamics and injury risk. Methods A linear impactor was developed, and a range of impacts was delivered to an instrumented Hybrid III head and neck system both with and without an AIBA (Association Internationale de Boxe Amateur)approved headguard. Impacts at selected speeds between 4.1 and 8.3 m/s were undertaken. The impactor mass was approximately 4 kg and an interface comprising a semirigid 'fist' with a glove was used. Results The peak contact forces were in the range 1.9-5.9 kN. Differences in head impact responses between the Top Ten AIBA-approved headguard and bare headform in the lateral and forehead tests were large and/or significant. In the 8.3 m/s fist-glove impacts, the mean peak resultant headform accelerations for bare headform tests was approximately 130 g compared with approximately 85 g in the forehead impacts. In the 6.85 m/s bare headform impacts, mean peak resultant angular head accelerations were in the range of 5200-5600 rad/s(2) and almost halved by the headguard. Linear and angular accelerations in 45 degrees forehead and 60 degrees jaw impacts were reduced by the headguard. Conclusions The data support the opinion that current AIBA headguards can play an important role in reducing the risk of concussion and superficial injury in boxing competition and training.	[McIntosh, Andrew S.; Patton, Declan A.] Federat Univ Australia, ACRISP, Ballarat, Vic 3353, Australia; [McIntosh, Andrew S.] McIntosh Consultancy & Res, Sydney, NSW, Australia		McIntosh, AS (corresponding author), Federat Univ Australia, ACRISP, POB 663, Ballarat, Vic 3353, Australia.	as.mcintosh@bigpond.com			IOC	The authors would like to thank the IOC for funding these projects, in particular Dr Torbjorn Soligard, who has been our point of contact; Cherine Fahmy and Professor Lars Engebretsen; RMS Crashlab staff, in particular-Drew Sherry, Colin Jackson, David Corless and Bruce Parker; and David Felice from Zoe's martial arts and boxing supplies in Sydney. Their assistance is gratefully acknowledged.	AIBA, 2013, AIBA OP BOX AOB COMP; Amateur International Boxing Association, 2013, REM HEADG EL MEN COM; American Society for Testing and Materials, 2012, F239709 ASTM; American Society for Testing and Materials, 2011, F144608 ASTM; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Dau N, 2006, AM SOC BIOM ANN M BL; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1113, DOI 10.1136/bjsports-2015-095093; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Nyquist GW, 1986, 30TH P STAPP CAR CRA, V30, P379; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pierce JD, 2006, J QUANT ANAL SPORTS, V2, DOI [10.2202/1559-0410.1030, 10.2202/1559-0410.1004]; PLANATH I, 1991, ACCIDENT ANAL PREV, V23, P95, DOI 10.1016/0001-4575(91)90039-8; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; SAE International, 1995, INSTR IMP TEST 1; Schneider DC, 1972, P 16 STAPP CAR CRASH, P186; Smith MS, 2006, J SPORT SCI MED, V5, P74; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Unterharnscheidt F, 2003, IMPACT MECH NEUROPAT, P1; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Yoganandan N, 1988, 32 STAPP CAR CRASH C, P45; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; [No title captured]	29	21	21	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2015	49	17					1108	1112		10.1136/bjsports-2015-095094			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CP3AW	WOS:000359750200005	26175022	Bronze			2022-02-06	
J	Schachar, RJ; Park, LS; Dennis, M				Schachar, Russell James; Park, Laura Seohyun; Dennis, Maureen			Mental Health Implications of Traumatic Brain Injury (TBI) in Children and Youth	JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						traumatic brain injury; mental illness; attention deficit hyperactivity disorder; children and adolescents	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; 1ST 6 MONTHS; POST-CONCUSSIVE SYMPTOMS; LONG-TERM DISABILITY; UNITED-STATES; HEAD-INJURY; PSYCHIATRIC-DISORDERS; PERSONALITY-CHANGE; SOCIAL OUTCOMES; PRE-INJURY	Traumatic brain injury (TBI) is the most common cause of death and disability in children and adolescents. Psychopathology is an established risk factor for, and a frequent consequence of, TBI. This paper reviews the literature relating psychopathology and TBI. Method: Selective literature review. Results: The risk of sustaining a TBI is increased by pre-existing psychopathology (particularly ADHD and aggression) and psychosocial adversity. Even among individuals with no psychopathology prior to the injury, TBI is frequently followed by mental illness especially ADHD, personality change, conduct disorder and, less frequently, by post-traumatic stress and anxiety disorders. The outcome of TBI can be partially predicted by pre-injury adjustment and injury severity, but less well by age at injury. Few individuals receive treatment for mental illness following TBI. Conclusion: TBI has substantial relevance to mental health professionals and their clinical practice. Available evidence, while limited, indicates that the risk for TBI in children and adolescents is increased in the presence of several, potentially treatable mental health conditions and that the outcome of TBI involves a range of mental health problems, many of which are treatable. Prevention and management efforts targeting psychiatric risks and outcomes are an urgent priority. Child and adolescent mental health professionals can play a critical role in the prevention and treatment of TBI through advocacy, education, policy development and clinical practice.	[Schachar, Russell James] Univ Toronto, Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Schachar, Russell James] Univ Toronto, Toronto Domin Bank Financial Grp, Dept Psychiat, Hosp Sick Children,Dept Psychiat,Fac Med, Toronto, ON, Canada; [Schachar, Russell James] Child & Adolescent Psychiat, Toronto, ON, Canada; [Park, Laura Seohyun] Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Hosp Sick Children, Program Neurosci & Mental Hlth, Res Inst,Dept Psychol,Dept Surg,Fac Med, Toronto, ON M5G 1X8, Canada		Schachar, RJ (corresponding author), Univ Toronto, Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada.	russell.schachar@sickkids.ca		Schachar, Russell/0000-0002-2015-4395	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Ontario Neurotrauma Foundation; Ontario Brain Institute; Ontario Research Development Foundation; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD35946, P01 HD35946-06]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1 HD04946]	Dr. Schachar is a consultant for Purdue Pharma, Eli Lilly Corp, Highland Therapeutics, and ehave and is supported by the Canadian Institutes of Health Research, National Institute for Neurological Diseases and Stroke, Ontario Neurotrauma Foundation, Ontario Brain Institute, and Ontario Research Development Foundation. Dr. Dennis is supported by the National Institute of Child Health and Human Development Grants P01 HD35946 & P01 HD35946-06, "Spina Bifida: Cognitive and Neurobiological Variability" and by National Institutes of Health Grant 1RO1 HD04946, "Social Outcomes in Pediatric Traumatic Brain Injury." This article is dedicated to the memory of our dear colleague and coauthor Dr. Maureen Dennis who recently deceased.	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; BIJUR P, 1988, AM J DIS CHILD, V142, P1307, DOI 10.1001/archpedi.1988.02150120061041; BIJUR PE, 1988, SOC SCI MED, V26, P839, DOI 10.1016/0277-9536(88)90176-1; Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), 2011, CAN ADHD PRACT GUID; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ERN.12.15, 10.1586/ern.12.15]; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Howard I, 2005, ETHNIC DIS, V15, pS5; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Pickering A, 2012, EMERG MED J, V29, P451, DOI 10.1136/emj.2010.094755; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Richards D, 2012, ACCIDENT ANAL PREV, V47, P16, DOI 10.1016/j.aap.2012.01.009; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Taylor H. G., 2015, J HEAD TRAUMA REHABI; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Visser SN, 2007, PEDIATRICS, V119, pS99, DOI 10.1542/peds.2006-2089O; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	96	21	21	1	25	CANADIAN ACAD CHILD & ADOLESCENT PSYCHIATRY	OTTAWA	701-141 LAURIER AVE W, OTTAWA, ONTARIO K1P 5J3, CANADA	1719-8429			J CAN ACAD CHILD ADO	J. Can. Acad. Child Adolesc. Psychiatry	FAL	2015	24	2					100	108					9	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	CR5KO	WOS:000361380800004	26379721				2022-02-06	
J	Yang, J; Korley, FK; Dai, M; Everett, AD				Yang, Jun; Korley, Frederick K.; Dai, Min; Everett, Allen D.			Serum neurogranin measurement as a biomarker of acute traumatic brain injury	CLINICAL BIOCHEMISTRY			English	Article						ELISA; Neurogranin; Biomarker; Traumatic brain injury	PROTEIN-KINASE-C; CALMODULIN-BINDING PROTEIN; NITRIC-OXIDE MODIFICATION; RAT-BRAIN; SYNAPTIC PLASTICITY; TERMINAL HYDROLASE; MESSENGER-RNA; SUBSTRATE; PHOSPHORYLATION; RC3/NEUROGRANIN	Objectives: Neurogranin (NRGN) is a small neuronal protein that plays an important role in synaptic signaling by regulating calmodulin (CaM) availability. In this study, we developed an ELISA to measure NRGN quantitatively in serum samples from a cohort of acute traumatic brain injury (TBI) patients and a non-TBI control cohort, and explored the potential value of NRGN as a circulating biomarker for TBI. Design and methods: Recombinant His-NRGN protein was used to develop mouse monoclonal capture and rabbit polyclonal detection antibodies, and they were used to develop a sandwich ELISA. After validation, we used this ELISA to measure serum samples from a cohort of typical adult acute TBI patients (N = 76 TBI cases) and non-TBI control patients (N = 150 controls). Results: The NRGN ELISA lower limit of detection was 0.055 ng/mL, lower limit of quantification was 0.2 ng/mL, and interassay CVs were <= 10.7%. The average recovery was 99.9% (range from 97.2-102%). Serum NRGN concentrations in TBI cases were significantly higher than in controls (median values were 0.18 ng/mL vs. 0.02 ng/mL, p <0.0001), but did not discriminate TBI cases with intracranial hemorrhage (p = 0.09). Conclusions: We have developed a highly sensitive and reproducible ELISA for measuring circulating NRGN in blood samples. Serum NRGN concentrations in acute TBI patients were significantly higher than in controls, indicating that NRGN could have utility as a circulating biomarker for acute TBI. This report provides evidence to support larger and controlled TBI clinical studies for NRGN validation and prediction of outcomes. (C) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Yang, Jun; Everett, Allen D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Korley, Frederick K.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21205 USA; [Dai, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA		Everett, AD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA.	aeveret3@jhmi.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30 NS050274] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS050274] Funding Source: NIH RePORTER		AlvarezBolado G, 1996, NEUROSCIENCE, V73, P565, DOI 10.1016/0306-4522(96)00061-9; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BAUDIER J, 1989, J BIOL CHEM, V264, P1824; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; COGGINS PJ, 1991, NEUROSCI RES COMMUN, V8, P49; de Arrieta CM, 1999, ENDOCRINOLOGY, V140, P335, DOI 10.1210/en.140.1.335; deArrieta CM, 1997, GENOMICS, V41, P243, DOI 10.1006/geno.1997.4622; DELOULME JC, 1991, FEBS LETT, V282, P183, DOI 10.1016/0014-5793(91)80473-G; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Goncalves C.A., 2010, CARDIOVASC PSYCHIAT, V2010, DOI [DOI 10.1155/2010/790431, 10.1155/2010/790431]; Guadano-Ferraz A, 2005, J COMP NEUROL, V493, P554, DOI 10.1002/cne.20774; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jin ZC, 2013, PROTEOMICS, V13, P2682, DOI 10.1002/pmic.201300064; Korley FK, 2014, ACAD EMERG MED, V21, P728, DOI 10.1111/acem.12417; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Kvartsberg H, 2014, ALZHEIMERS DEMENT, V19; Li GL, 2000, APMIS, V108, P98; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Mahoney CW, 1996, J BIOL CHEM, V271, P28798, DOI 10.1074/jbc.271.46.28798; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Ramakers GMJ, 1999, J BIOL CHEM, V274, P1873, DOI 10.1074/jbc.274.4.1873; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Schwartz J., 2014, CRIT CARE MED S, V42, pA1488, DOI [10.1097/01.ccm.0000458030.91776.65, DOI 10.1097/01.CCM.0000458030.91776.65]; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Sheu FS, 1996, J BIOL CHEM, V271, P22407, DOI 10.1074/jbc.271.37.22407; Singec I, 2004, J COMP NEUROL, V479, P30, DOI 10.1002/cne.20302; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Wu JF, 2003, J NEUROCHEM, V86, P1524, DOI 10.1046/j.1471-4159.2003.01963.x; Yang HM, 2004, MOL BRAIN RES, V129, P171, DOI 10.1016/j.molbrainres.2004.06.039	40	21	24	1	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	SEP	2015	48	13-14					843	848		10.1016/j.clinbiochem.2015.05.015			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	CR3UX	WOS:000361259700005	26025774	Green Accepted			2022-02-06	
J	Cross, DJ; Garwin, GG; Cline, MM; Richards, TL; Yarnykh, V; Mourad, PD; Ho, RJY; Minoshima, S				Cross, Donna J.; Garwin, Gregory G.; Cline, Marcella M.; Richards, Todd L.; Yarnykh, Vasily; Mourad, Pierre D.; Ho, Rodney J. Y.; Minoshima, Satoshi			Paclitaxel improves outcome from traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; MR imaging; Microtubule stabilization; Neurological function	ALZHEIMERS-DISEASE; HEAD-INJURY; AXONAL INJURY; ENCEPHALOPATHY; MICROTUBULES; TAXOL; PATHOLOGY; RISK; IRAQ	Pharmacologic interventions for traumatic brain injury (TBI) hold promise to improve outcome. The purpose of this study was to determine if the microtubule stabilizing therapeutic paclitaxel used for more than 20 years in chemotherapy would improve outcome after TBI. We assessed neurological outcome in mice that received direct application of paclitaxel to brain injury from controlled cortical impact (CCI). Magnetic resonance imaging was used to assess injury-related morphological changes. Catwalk Gait analysis showed significant improvement in the paclitaxel group on a variety of parameters compared to the saline group. MRI analysis revealed that paclitaxel treatment resulted in significantly reduced edema volume at site-of-injury (11.92+/-3.0 and 8.86+/-2.2 mm(3) for saline vs. paclitaxel respectively, as determined by T2-weighted analysis; p <= 0.05), and significantly increased myelin tissue preservation (9.45+/-0.4 vs. 8.95+/-0.3, p <= 0.05). Our findings indicate that paclitaxel treatment resulted in improvement of neurological outcome and MR imaging biomarkers of injury. These results could have a significant impact on therapeutic developments to treat traumatic brain injury. (C) 2015 Elsevier B.V. All rights reserved.	[Cross, Donna J.; Garwin, Gregory G.; Cline, Marcella M.; Richards, Todd L.; Yarnykh, Vasily] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Ho, Rodney J. Y.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Minoshima, Satoshi] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA		Cross, DJ (corresponding author), Univ Washington, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA.	dcross@uw.edu	Yarnykh, Vasiliy L./N-7635-2014; Yarnykh, Vasily/G-8757-2016; Yarnykh, Vasily/ABF-7873-2021	Yarnykh, Vasily/0000-0002-1583-8979; Cross, Donna/0000-0003-1918-2214; Minoshima, Satoshi/0000-0002-0043-3047; Cline, Marcella/0000-0002-9590-3725	Institute for Translational Health Sciences [UL1TR000423]; UW; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [UM1AI120176] Funding Source: NIH RePORTER	Support for this research was provided by the Institute for Translational Health Sciences pilot project grant opportunity (UL1TR000423) and the UW. Center on Human Development and Disability animal imaging and animal behavioral cores The authors would like to acknowledge Nathalie Martin and Abigail McClintic for their assistance with this project.	Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Alberts B., 1994, MOL BIOL CELL, V3rd ed; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Brunden KR, 2011, PHARMACOL RES, V63, P341, DOI 10.1016/j.phrs.2010.12.002; Carlson K, 2011, CLIN BREAST CANCER, V11, P73, DOI 10.1016/j.clbc.2011.03.006; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Diaz JF, 2003, J BIOL CHEM, V278, P8407, DOI 10.1074/jbc.M211163200; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein L.E., 2012, SCI TRANSL MED, V4; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Lou K, 2014, J MED CHEM, V57, P6116, DOI 10.1021/jm5005623; Lunn KF, 1997, J NEUROSCI, V17, P4921; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michaelis ML, 2002, J MOL NEUROSCI, V19, P289, DOI 10.1385/JMN:19:3:289; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Petrie EC, 2009, ARCH NEUROL-CHICAGO, V66, P632, DOI 10.1001/archneurol.2009.59; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Roberts G, 1969, BRAIN DAMAGE BOXERS; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Underhil HR, 2009, NEUROIMAGE, V47, P1568, DOI 10.1016/j.neuroimage.2009.05.075; Underhill HR, 2011, NEUROIMAGE, V54, P2052, DOI 10.1016/j.neuroimage.2010.10.065; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Yarnykh VL, 2012, MAGN RESON MED, V68, P166, DOI 10.1002/mrm.23224; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754	44	21	22	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 27	2015	1618						299	308		10.1016/j.brainres.2015.06.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP5XB	WOS:000359957600030	26086366	Green Accepted			2022-02-06	
J	Baldassarre, M; Smith, B; Harp, J; Herrold, A; High, WM; Babcock-Parziale, J; Pape, TLB				Baldassarre, Megan; Smith, Bridget; Harp, Jordan; Herrold, Amy; High, Walter M., Jr.; Babcock-Parziale, Judith; Pape, Theresa Louise-Bender			Exploring the Relationship Between Mild Traumatic Brain Injury Exposure and the Presence and Severity of Postconcussive Symptoms Among Veterans Deployed to Iraq and Afghanistan	PM&R			English	Article							POSTTRAUMATIC-STRESS-DISORDER; IDENTIFICATION TEST; ENDURING FREEDOM; HEALTH; SPECIFICITY; PREVALENCE; VALIDATION; DEPRESSION; COMPLAINTS; SEQUELAE	Objective: The aim of this study was to describe the association between mild traumatic brain injury (mTBI) and persisting postconcussive symptoms according to symptom category, number, and severity. Design: The study design was observational. Participants: The study sample comprised veterans (>= 18 years of age) deployed in Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) conflicts who had not received any treatment for mTBI in the 30 days preceding study enrollment. Methods: Veterans were interviewed and completed testing in a single day. The Standard TBI Diagnostic Interview and the Clinician-Administered PTSD Scale were used. Testing included the Neurobehavioral Symptom Inventory and a full neuropsychological battery. Gold standard classification methods were utilized to determine presence/absence of mTBI. For each of the 5 symptom outcomes, an adjusted multiple linear regression model (negative binomial count models) accounting for effects of socio-demographic variables and behavioral health conditions was used. Main Outcome Measures: Self-report of neurobehavioral symptoms categorized as affective, cognitive, somatic, and vestibular symptoms, in addition to the instruments specified above. Results: OEF/OIF veterans with mTBI, relative to veterans with no mTBI, were observed to have 30% more symptoms overall (P < .001), 34% more somatic symptoms (P < .001), 22% more cognitive symptoms (P = .008), 15% more affective symptoms (P = .017), and 59% more vestibular symptoms (P < .001). For adjusted models, variables significantly related to number of symptoms across all 4 symptom categories were anxiety (all P < .001) and insomnia (all P < .001). For the adjusted models, variables significantly related to symptom severity across all 4 symptom categories were insomnia (all P < .001), depression (P < .001-.05) and anxiety (all, P < .001). Conclusions: OEF/OIF veterans with mTBI, relative to veterans with no mTBI, have significantly more and significantly more severe persisting symptoms, with vestibular symptoms reported with the greatest frequency. After accounting for behavioral health conditions and socio-demographic factors, OEF/OIF veterans with mTBI compared to veterans without mTBI had significantly more cognitive, affective, vestibular, and somatic symptoms persisting 4.8 years after the mTBI event(s).	[Baldassarre, Megan; Smith, Bridget; Herrold, Amy; Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Ctr Management Complex Chron Care, Ctr Excellence, Hines, IL 60141 USA; [Baldassarre, Megan; Herrold, Amy; Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA; [Baldassarre, Megan] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Neuropsychol Serv, Lebanon, NH 03756 USA; [Smith, Bridget] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Smith, Bridget] Edward Hines Jr VA Hosp, Spinal Cord Injury QUERI, Dept Vet Affairs VA, Hines, IL USA; [Harp, Jordan; High, Walter M., Jr.] Univ Kentucky, Dept Psychol, Coll Med, Lexington, KY 40506 USA; [Herrold, Amy] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [High, Walter M., Jr.] Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [High, Walter M., Jr.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY USA; [Babcock-Parziale, Judith] Southern Arizona VA Hlth Care Syst 3 124, Tucson, AZ USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Off Med Educ, Chicago, IL 60611 USA		Baldassarre, M (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Ctr Management Complex Chron Care, Ctr Excellence, Hines, IL 60141 USA.	megan.baldassarre@gmail.com		Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans Affairs (VA), Office of Research and Development, Health services Research and Development (HSR&D) Service, Service Directed Research ProjectUS Department of Veterans Affairs [08-377]; Department of Veterans Affairs DisclosuresUS Department of Veterans Affairs; Department of Veterans AffairsUS Department of Veterans Affairs; VA HSRD; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	Disclosures related to this publication: grant, Department of Veterans Affairs (VA), Office of Research and Development, Health services Research and Development (HSR&D) Service, Service Directed Research Project #08-377; Disclosures related to this publication: grant, Department of Veterans Affairs; Disclosures related to this publication: grant, VA HSR&D	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1987, J ABNORM PSYCHOL, V96, P179, DOI 10.1037/0021-843X.96.3.179; Beck AT, 1988, MANUAL BECK ANXIETY; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King PR, 2012, J CLIN PSYCHOL MED S, V19, P376, DOI 10.1007/s10880-012-9345-9; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Long S, 1997, ADV QUANTATIVE TECHN; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; National Center for Injury Prevention and Control C. f. d. C. a. i. P., 2003, REP C MILD TRAUM BRA; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	55	21	22	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	AUG	2015	7	8					845	858		10.1016/j.pmrj.2015.03.003			14	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CQ1LU	WOS:000360360000006	25758529				2022-02-06	
J	Mohseni, S; Talving, P; Thelin, EP; Wallin, G; Ljungqvist, O; Riddez, L				Mohseni, Shahin; Talving, Peep; Thelin, Eric P.; Wallin, Goeran; Ljungqvist, Olle; Riddez, Louis			The Effect of beta-blockade on Survival After Isolated Severe Traumatic Brain Injury	WORLD JOURNAL OF SURGERY			English	Article							ORGAN DYSFUNCTION; HEAD-INJURY; OUTCOMES; CATECHOLAMINES; EPIDEMIOLOGY; PRINCIPLES; BLOCKERS; THERAPY; DEATH	Several North American studies have observed survival benefit in patients exposed to beta-blockers following traumatic brain injury (TBI). The purpose of this study was to evaluate the effect of beta-blockade on mortality in a Swedish cohort of isolated severe TBI patients. The trauma registry of an urban academic trauma center was queried to identify patients with an isolated severe TBI between 1/2007 and 12/2011. Isolated severe TBI was defined as an intracranial injury with an Abbreviated Injury Scale (AIS) a parts per thousand yen3 excluding extra-cranial injuries AIS a parts per thousand yen3. Multivariable logistic regression analysis was used to determine the effect of beta-blocker exposure on mortality. Also, a subgroup analysis was performed to investigate the risk of mortality in patients on pre-admission beta-blocker versus not and the effect of specific type of beta-blocker on the overall outcome. Overall, 874 patients met the study criteria. Of these, 33 % (n = 287) were exposed to beta-blockers during their hospital admission. The exposed patients were older (62 +/- A 16 years vs. 49 +/- A 21 years, p < 0.001), and more severely injured based on their admission GCS, ISS, and head AIS scores (GCS a parts per thousand currency sign8: 32 % vs. 28 %, p = 0.007; ISS a parts per thousand yen16: 71 % vs. 59 %, p = 0.001; head AIS a parts per thousand yen4: 60 % vs. 45 %, p < 0.001). The crude mortality was higher in patients who did not receive beta-blockers (17 % vs. 11 %, p = 0.007) during their admission. After adjustment for significant confounders, the patients not exposed to beta-blockers had a 5-fold increased risk of in-hospital mortality (AOR 5.0, CI 95 % 2.7-8.5, p = 0.001). No difference in survival was noted in regards to the type of beta-blocker used. Subgroup analysis revealed a higher risk of mortality in patients naive to beta-blockers compared to those on pre-admission beta-blocker therapy (AOR 3.0 CI 95 % 1.2-7.1, p = 0.015). beta-blocker exposure after isolated severe traumatic brain injury is associated with significantly improved survival. We also noted decreased mortality in patients on pre-admission beta-blocker therapy compared to patients naive to such treatment. Further prospective studies are warranted.	[Mohseni, Shahin; Wallin, Goeran; Ljungqvist, Olle] Orebro Univ Hosp, Div Acute Care Surg, Dept Surg, S-70185 Orebro, Sweden; [Mohseni, Shahin; Wallin, Goeran; Ljungqvist, Olle] Univ Orebro, S-70185 Orebro, Sweden; [Mohseni, Shahin; Riddez, Louis] Karolinska Univ Hosp Solna, Div Acute Care Surg & Trauma, Dept Surg, S-17176 Stockholm, Sweden; [Thelin, Eric P.] Karolinska Inst, Karolinska Univ Hosp Solna, Sect Neurosurg, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Talving, Peep] Tartu Univ Hosp, Dept Surg, EE-50406 Tartu, Estonia; [Talving, Peep] North Estonia Med Ctr, Dept Surg, Tallinn, Estonia		Talving, P (corresponding author), Tartu Univ Hosp, Dept Surg, Puusepa 8, EE-50406 Tartu, Estonia.	mohsenishahin@yahoo.com; peep.talving@ut.ee; eric.thelin@ki.se; goran.wallin@orebroll.se; olle.ljugqvist@ki.se; Louis.riddez@karolinska.se	Thelin, Eric Peter/K-2144-2012; Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015	Thelin, Eric Peter/0000-0002-2338-4364; Talving, Peep/0000-0002-9741-2073			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CLIFTON G L, 1989, Neurosurgical Review, V12, P465, DOI 10.1007/BF01790692; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Enderson BL, 2007, J TRAUMA, V62, P33; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kemp CD, 2008, AM SURGEON, V74, P866; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; Mayer SA, 2011, CRIT CARE MED, V39, P2330, DOI 10.1097/CCM.0b013e3182227238; MEYER JS, 1976, STROKE, V7, P158, DOI 10.1161/01.STR.7.2.158; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pryor JP, 2007, J TRAUMA, V62, P61; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	40	21	21	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2015	39	8					2076	2083		10.1007/s00268-015-3039-z			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CM4XW	WOS:000357690700032	25809062				2022-02-06	
J	Sajja, VSSS; Hubbard, WB; VandeVord, PJ				Sajja, Venkata Siva Sai Sujith; Hubbard, William B.; VandeVord, Pamela J.			SUBACUTE OXIDATIVE STRESS AND GLIAL REACTIVITY IN THE AMYGDALA ARE ASSOCIATED WITH INCREASED ANXIETY FOLLOWING BLAST NEUROTRAUMA	SHOCK			English	Article						Blast; inflammation; apoptosis; oxidative stress; trauma; anxiety; amygdala	TRAUMATIC BRAIN-INJURY; RAT MODEL; MICROGLIAL ACTIVATION; EXPRESSION; CONCUSSION; CONTUSION; VETERANS; PROTEINS; EXPOSURE; MICE	Behavioral symptoms, such as anxiety, are widely reported after blast overpressure (BOP) exposure. Amygdalar vulnerability to increasing magnitudes of BOP has not been investigated, and single exposures to blast have been limited to acute (<72 h) assessment. Rats were exposed to a single low, moderate, or high BOP (10, 14, or 24 psi) with an advanced blast simulator to test the susceptibility of the amygdala. Anxiety-like behavior was observed in the low-and moderate-pressure groups when subjected to the light/dark box assessment 7 days after the blast but not in high-pressure group. Immunohistochemistry was performed to measure apoptosis (cleaved caspase-3), neuronal loss (NeuN), reactive astrocytes (glial fibrillary acidic protein), microglia (Iba-1), and oxidative stress (CuZn superoxide dismutase). Slower progression of injury cascades was associated with a significant increase in anxiety, apoptosis, and astrogliosis in the low pressure group compared with others. A significant increase of CuZn superoxide dismutase in the low pressure group could be associated with neuroprotection from cell death caused by oxidative stress because neuronal loss was significant in the moderate-and high-but not the low-pressure group. Overall, this study demonstrated that overpressure as low as 10 psi can induce subacute anxiety, in addition to neuropathologic changes in the amygdala.	[Sajja, Venkata Siva Sai Sujith; Hubbard, William B.; VandeVord, Pamela J.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Res & Dev Serv, Salem, VA USA		VandeVord, PJ (corresponding author), 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	pvord@vt.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0207]; Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B1104-P]; Veterans AffairsUS Department of Veterans Affairs [I21RX001104] Funding Source: NIH RePORTER	This research was supported in part by the US Army Medical Research and Materiel Command (grant no. W81XWH-08-2-0207 to P.J.V.) and by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service (grant no. B1104-P to P.J.V.).	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Beschorner R, 2007, HISTOL HISTOPATHOL, V22, P515, DOI 10.14670/HH-22.515; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kliethermes CL, 2004, ALCOHOL CLIN EXP RES, V28, P1012, DOI 10.1097/01.ALC.0000131976.40428.8F; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kochanek PM, 2009, J NEUROTRAUM, V26, P813, DOI 10.1089/neu.2008.0893; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037	35	21	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2015	44			1			71	78		10.1097/SHK.0000000000000311			8	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DO3NA	WOS:000377687100012	25521536				2022-02-06	
J	Kerr, ZY; Littleton, AC; Cox, LM; DeFreese, JD; Varangis, E; Lynall, RC; Schmidt, JD; Marshall, SW; Guskiewicz, KM				Kerr, Zachary Y.; Littleton, Ashley C.; Cox, Leah M.; DeFreese, J. D.; Varangis, Eleanna; Lynall, Robert C.; Schmidt, Julianne D.; Marshall, Stephen W.; Guskiewicz, Kevin M.			Estimating Contact Exposure in Football Using the Head Impact Exposure Estimate	JOURNAL OF NEUROTRAUMA			English	Article						subconcussive impacts; traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; RECURRENT CONCUSSION; NCAA CONCUSSION; LEAGUE PLAYER; RISK; SYMPTOMS; ASSOCIATION; DEPRESSION; DISEASE; INJURY	Over the past decade, there has been significant debate regarding the effect of cumulative subconcussive head impacts on short and long-term neurological impairment. This debate remains unresolved, because valid epidemiological estimates of athletes' total contact exposure are lacking. We present a measure to estimate the total hours of contact exposure in football over the majority of an athlete's lifespan. Through a structured oral interview, former football players provided information related to primary position played and participation in games and practice contacts during the pre-season, regular season, and post-season of each year of their high school, college, and professional football careers. Spring football for college was also included. We calculated contact exposure estimates for 64 former football players (n=32 college football only, n=32 professional and college football). The head impact exposure estimate (HIEE) discriminated between individuals who stopped after college football, and individuals who played professional football (p<0.001). The HIEE measure was independent of concussion history (p=0.82). Estimating total hours of contact exposure may allow for the detection of differences between individuals with variation in subconcussive impacts, regardless of concussion history. This measure is valuable for the surveillance of subconcussive impacts and their associated potential negative effects.	[Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN 46202 USA; [Kerr, Zachary Y.; Littleton, Ashley C.; Lynall, Robert C.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Kerr, Zachary Y.; Cox, Leah M.; DeFreese, J. D.; Varangis, Eleanna; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Varangis, Eleanna] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Injury Prevent Ctr, Chapel Hill, NC USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Kerr, ZY (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	zkerr@datalyscenter.org	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Littleton, Ashley/0000-0001-6188-1284; Guskiewicz, Kevin/0000-0002-8682-2130; Kerr, Zachary/0000-0003-1423-1259; Varangis, Eleanna/0000-0002-2688-2297	National Football League Charities and National Football League Players' Association; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002479]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002479] Funding Source: NIH RePORTER	Funding/Support was provided by the National Football League Charities and National Football League Players' Association. Stephen W. Marshall is partly supported by grant R49CE002479 from the Centers for Disease Control and Prevention. Kevin Guskiewicz is a member of the NFL Head Neck and Spine Committee and the NFL Players' Association's Mackey-White Committee.	Broglio J., 2011, J BIOMECH, V44, P2673; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dick R, 2007, J ATHL TRAINING, V42, P221; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Piland SG, 2003, J ATHL TRAINING, V38, P104; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Sadek JR, 2004, NEUROPSYCHOLOGY, V18, P692, DOI 10.1037/0894-4105.18.4.692; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; USA Football, 2010, US FOOTB OV	25	21	21	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1083	1089		10.1089/neu.2014.3666			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000007	25603189	Green Published, Green Submitted			2022-02-06	
J	Maudsley, AA; Govind, V; Levin, B; Saigal, G; Harris, L; Sheriff, S				Maudsley, Andrew A.; Govind, Varan; Levin, Bonnie; Saigal, Gaurav; Harris, Leo; Sheriff, Sulaiman			Distributions of Magnetic Resonance Diffusion and Spectroscopy Measures with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; MR spectroscopy; traumatic brain injury; Z-score image analysis	WHITE-MATTER; ABNORMALITIES; TIME; DTI	Magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) studies have demonstrated that measures of altered metabolism and axonal injury can be detected following traumatic brain injury. The aim of this study was to characterize and compare the distributions of altered image parameters obtained by these methods in subjects with a range of injury severity and to examine their relative sensitivity for diagnostic imaging in this group of subjects. DTI and volumetric magnetic resonance spectroscopic imaging data were acquired in 40 subjects that had experienced a closed-head traumatic brain injury, with a median of 36d post-injury. Voxel-based analyses were performed to examine differences of group mean values relative to normal controls, and to map significant alterations of image parameters in individual subjects. The between-group analysis revealed widespread alteration of tissue metabolites that was most strongly characterized by increased choline throughout the cerebrum and cerebellum, reaching as much as 40% increase from control values for the group with the worse cognitive assessment score. In contrast, the between-group comparison of DTI measures revealed only minor differences; however, the Z-score image analysis of individual subject DTI parameters revealed regions of altered values relative to controls throughout the major white matter tracts, but with considerable heterogeneity between subjects and with a smaller extent than the findings for altered metabolite measures. The findings of this study illustrate the complimentary nature of these neuroimaging methods.	[Maudsley, Andrew A.; Govind, Varan; Saigal, Gaurav; Harris, Leo; Sheriff, Sulaiman] Univ Miami, Sch Med, Dept Radiol, Miami, FL 33136 USA; [Levin, Bonnie] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA		Maudsley, AA (corresponding author), Univ Miami, Sch Med, Dept Radiol, 1150 NW 14th St,Suite 713, Miami, FL 33136 USA.	AMaudsley@med.miami.edu		Govind, Varan/0000-0002-1205-5194; Maudsley, Andrew/0000-0001-7653-3063	National Institutes of Health research grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS055107, R01EB000822]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055107] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health research grants R01NS055107 and R01EB000822. We thank Dr. Mori for making available resources to perform the DTI analysis and Clara Morales for assistance with the study.	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Klimas A, 2013, CLIN IMAG, V37, P637, DOI 10.1016/j.clinimag.2013.01.013; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley A. A., 2008, TISSUE DEPENDENT ANA, P1604; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Watanabe M, 2013, RADIOLOGY, V266, P575, DOI 10.1148/radiol.12112420; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	31	21	21	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1056	1063		10.1089/neu.2014.3505			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000003	25333480	Green Published			2022-02-06	
J	Jimenez, N; Osorio, M; Ramos, JL; Apkon, S; Ebel, BE; Rivara, FP				Jimenez, Nathalia; Osorio, Marisa; Ramos, Jessica L.; Apkon, Susan; Ebel, Beth E.; Rivara, Frederick P.			Functional Independence After Inpatient Rehabilitation for Traumatic Brain Injury Among Minority Children and Adolescents	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Minority groups; Outcome; Rehabilitation	OUTCOMES; CARE; REGISTRY; QUALITY; TBI	Objective: To compare motor and cognitive functional independence scores between Hispanic, non-Hispanic black (NEB), and non-Hispanic white (NHW) children with traumatic brain injury (TBI) after discharge from inpatient rehabilitation. Design: Retrospective cohort study using the Uniform Data System for Medical Rehabilitation national dataset from the years 2002 to 2012. Setting: Inpatient rehabilitation units. Participants: Children (N=10,141) aged 6 months to 18 years who received inpatient rehabilitation for TBI. Interventions: Not applicable. Main Outcome Measures: Motor and cognitive functional independence after discharge from inpatient rehabilitation, adjusting for age, sex, admission function, length of stay, insurance, and region. Results: Inpatient rehabilitation therapy improved functional independence for all children. Younger age, lower admission functional independence scores, and Medicaid insurance were associated with lower functional independence at discharge. Hispanic and NHB children had lower discharge cognitive scores compared with NHW children; however, differences were small and were partially explained by insurance status and region. Children who received rehabilitation therapy at pediatric facilities had greater cognitive improvement. Conclusions: While racial/ethnic disparities are small, minority children are more likely to be younger, to have Medicaid, and to be cared for at nonpediatric facilities, factors that increase their risk for lower functional outcomes. (C) 2015 by the American Congress of Rehabilitation Medicine	[Jimenez, Nathalia] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Jimenez, Nathalia; Ebel, Beth E.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Osorio, Marisa; Apkon, Susan] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Ramos, Jessica L.; Ebel, Beth E.] Seattle Childrens Hosp, Ctr Divers & Hlth Equ, Seattle, WA USA; [Ebel, Beth E.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ebel, Beth E.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Jimenez, N (corresponding author), Dept Anesthesiol & Pain Med, Box 9824,4800 Sand Point Way NE, Seattle, WA 98105 USA.	nathalia.jimenez@seattlechildrens.org		Jimenez, Nathalia/0000-0002-6785-8330	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HDO7843-01]; National Center for Injury Prevention and Control, Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE 001021]; Seattle Children's Hospital Center for Diversity and Health Equity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER	Supported by the National Institute of Child Health and Human Development (grant no. 1K23HDO7843-01), the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (grant no. R49 CE 001021), and Seattle Children's Hospital Center for Diversity and Health Equity.	Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stallion A, 2007, J TRAUMA, V62, P1262; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	13	21	21	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2015	96	7					1255	1261		10.1016/j.apmr.2015.02.019			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CM5XN	WOS:000357762400010	25747552	Green Accepted			2022-02-06	
J	MacDonald, J; Duerson, D				MacDonald, James; Duerson, Drew			Reliability of a Computerized Neurocognitive Test in Baseline Concussion Testing of High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						AxonSports; computerized cognitive assessment tool; intraclass correlation coefficient; psychometrics	SPORT-RELATED CONCUSSION; RETEST RELIABILITY; PERFORMANCE; MANAGEMENT; AGE; ADOLESCENTS; STATEMENT; CHILDREN; BATTERY	Objective:Baseline assessments using computerized neurocognitive tests are frequently used in the management of sport-related concussions. Such testing is often done on an annual basis in a community setting. Reliability is a fundamental test characteristic that should be established for such tests. Our study examined the test-retest reliability of a computerized neurocognitive test in high school athletes over 1 year.Design:Repeated measures design.Setting:Two American high schools.Participants:High school athletes (N = 117) participating in American football or soccer during the 2011-2012 and 2012-2013 academic years.Interventions:All study participants completed 2 baseline computerized neurocognitive tests taken 1 year apart at their respective schools. The test measures performance on 4 cognitive tasks: identification speed (Attention), detection speed (Processing Speed), one card learning accuracy (Learning), and one back speed (Working Memory).Main Outcome Measures:Reliability was assessed by measuring the intraclass correlation coefficient (ICC) between the repeated measures of the 4 cognitive tasks. Pearson and Spearman correlation coefficients were calculated as a secondary outcome measure.Results:The measure for identification speed performed best (ICC = 0.672; 95% confidence interval, 0.559-0.760) and the measure for one card learning accuracy performed worst (ICC = 0.401; 95% confidence interval, 0.237-0.542). All tests had marginal or low reliability.Conclusions:In a population of high school athletes, computerized neurocognitive testing performed in a community setting demonstrated low to marginal test-retest reliability on baseline assessments 1 year apart. Further investigation should focus on (1) improving the reliability of individual tasks tested, (2) controlling for external factors that might affect test performance, and (3) identifying the ideal time interval to repeat baseline testing in high school athletes.Clinical Relevance:Computerized neurocognitive tests are used frequently in high school athletes, often within a model of baseline testing of asymptomatic individuals before the start of a sporting season. This study adds to the evidence that suggests in this population such testing may lack sufficient reliability to support clinical decision making.	[MacDonald, James; Duerson, Drew] Nationwide Childrens Hosp, Dept Pediat, Div Sports Med, Columbus, OH USA; [MacDonald, James] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		MacDonald, J (corresponding author), Nationwide Childrens Hosp, Dept Pediat, Div Sports Med, 5680 Venture Dr, Dublin, OH 43017 USA.	james.macdonald@nationwidechildrens.org	Macdonald, James/C-4701-2012	MacDonald, James/0000-0002-0432-0808	American Medical Society for Sports Medicine	Dr. MacDonald is supported in his research through an American Medical Society for Sports Medicine "Young Investigator" Grant.	ANASTASI A, 1998, PSYCHOL TESTING; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Centers for Disease Control and Prevention, FAQS BAS TEST YOUNG; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Darby D, VALIDITY AXON SPORTS; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; MacDonald J, 2012, CLIN J SPORT MED, V22, P187; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McDowell I, 2006, MEASURING HLTH GUIDE; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	30	21	21	0	38	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2015	25	4					367	372		10.1097/JSM.0000000000000139			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	CM2EK	WOS:000357492400010	25061807				2022-02-06	
J	Sonmez, A; Sayin, O; Gurgen, SG; Calisir, M				Sonmez, Atac; Sayin, Oya; Gurgen, Seren Gulsen; Calisir, Meryem			Neuroprotective effects of MK-801 against traumatic brain injury in immature rats	NEUROSCIENCE LETTERS			English	Article						Immature rats; Traumatic brain injury; MK-801; Hippocampus; BDNF; NGF; NMDAR; Cognition	D-ASPARTATE RECEPTORS; EXCITOTOXICITY; HIPPOCAMPUS; MECHANISMS; MODEL; ACID	Traumatic brain injury (TBI) is a major health problem in pediatric ages and also has major social, economic, and emotional outcomes, with diverse sequelae in many spheres of everyday life. We aimed to investigate the effect of MK-801, a competitive NMDA receptor antagonist, on hippocampal damage and behavioral deficits on 10-day-old rat pups subjected to contusion injury. The aims of the present study were to determine: (i) the short term effects of MK-801 on hippocampal BDNF, NGF and NMDA receptor immunoreactivity and neuron density in hippocampus (ii) long term effects of MK-801 on cognitive dysfunction following TBI in the immature rats. MK-801, was injected intraperitoneally at the doses of 1 mg/kg of body weight immediately after induction of traumatic injury. Hippocampal damage was examined by cresyl violet staining, BDNF, NGF and NMDAR receptor immunohistochemistry on P10 day and behavioral alterations were evaluated using elevated plus maze and novel object recognition tests two months after the trauma. Histopathological and immunohistochemical evaluations showed that treatment with a single dose of 1 mg/kg MK-801 (i.p.) significantly ameliorated the trauma induced hippocampal neuron loss and decreased BDNF, NGF and NMDAR expressions in CA1, CA3 and DG hippocampal brain regions. Additionally, treatment with MK-801 ameliorated anxiety and hippocampus dependent memory of animals subjected to trauma. These results show that acute treatment of MK-801 has a neuroprotective role against trauma induced hippocampal neuron loss and associated cognitive impairment in immature rats. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sonmez, Atac] Dokuz Eylul Univ, Fac Med, Dept Physiol, TR-35340 Izmir, Turkey; [Sayin, Oya] Dokuz Eylul Univ, Fac Med, Res Lab, TR-35340 Izmir, Turkey; [Gurgen, Seren Gulsen] Celal Bayar Univ, Fac Med, Dept Histol & Embriyol, Manisa, Turkey; [Calisir, Meryem] Dokuz Eylul Univ, Lab Anim Sci, Hlth Sci Inst, TR-35340 Izmir, Turkey		Sonmez, A (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Physiol, TR-35340 Izmir, Turkey.	atac.sonmez@deu.edu.tr	sayin, oya/O-9614-2019; Gurgen, Seren Gulsen/AAT-2326-2021; sayin, oya/O-9541-2019	sayin, oya/0000-0003-0879-9091; Calisir, Meryem/0000-0002-9890-8943			Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Cassol OJ, 2011, J NEUROIMMUNOL, V230, P48, DOI 10.1016/j.jneuroim.2010.08.026; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gurgen SG, 2013, NUTRITION, V29, P777, DOI 10.1016/j.nut.2012.11.004; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Phillips LL, 1997, J NEUROSCI RES, V49, P197; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	27	21	21	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 15	2015	597						137	142		10.1016/j.neulet.2015.05.001			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4HY	WOS:000356186100025	25943283				2022-02-06	
J	Egawa, EY; Kitamura, N; Nakai, R; Arima, Y; Iwata, H				Egawa, Edgar Y.; Kitamura, Narufumi; Nakai, Ryusuke; Arima, Yusuke; Iwata, Hiroo			A DNA hybridization system for labeling of neural stem cells with SPIO nanoparticles for MRI monitoring post-transplantation	BIOMATERIALS			English	Article						Neural cell; Stem cell; Nanoparticle; MRI (magnetic resonance imaging); In vitro test; Transplantation	IRON-OXIDE NANOPARTICLES; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TRANSPLANTATION; DIFFERENTIATION; MIGRATION; SURVIVAL; AGENTS	Neural stem cells (NSCs) demonstrate encouraging results in cell replacement therapy for neurodegenerative disorders and traumatic injury in the central nervous system. Monitor the survival and migration of transplanted cells would provide us important information concerning the performance and integration of the graft during the therapy time course. Magnetic resonance imaging (MRI) allow us to monitor the transplanted cells in a non-invasive way. The only requirement is to use an appropriate contrast agent to label the transplanted cells. Superparamagnetic iron oxide (SPIO) nanoparticles are one of the most commonly used contrast agent for MRI detection of transplanted cells. SPIO nanoparticles demonstrated to be suitable for labeling several types of cells including NSCs. However, the current methods for SPIO labeling are non-specific, depending mostly on electrostatic interactions, demanding relatively high SPIO concentration, and long incubation time, which can affect the viability of cells. In this study, we propose a specific and relatively fast method to label NSCs with SPIO nanoparticles via DNA hybridization. Two short single stranded DNAs (ssDNAs), oligo[dT](20) and oligo[dA](20) were conjugated with a lipid molecule and SPIO nanoparticle respectively. The labeling process comprises two simple steps; first the cells are modified to present oligo[dT](20) ssDNA on the cell surface, then the oligo[dA](20) ssDNA conjugated with SPIO nanoparticles are presented to the modified cells to allow the oligo[dT](20)-oligo[dA](20) hybridization. The method showed to be non-toxic at concentrations up to 50 mu g/mL oligo[dA](20)-SPIO nanoparticles. Presence of SPIO nanoparticles at cell surface and cell cytoplasm was verified by transmission electron microscopy (TEM). SPIO labeling via DNA hybridization demonstrated to not interfere on NSCs proliferation, aggregates formation, and differentiation. NSCs labeled with SPIO nanoparticles via DNA hybridization system were successfully detected by MRI in vitro as well in vivo. Cells transplanted into the rat brain striatum could be detected by MRI scanning up to 1 month post-transplantation. (C) 2015 Elsevier Ltd. All rights reserved.	[Egawa, Edgar Y.; Kitamura, Narufumi; Nakai, Ryusuke; Arima, Yusuke; Iwata, Hiroo] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan		Iwata, H (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	iwata@frontier.kuoyo-u.ac.jp	Egawa, Edgar Y/F-6034-2015	Egawa, Edgar Y/0000-0002-4017-4000; Nakai, Ryusuke/0000-0002-3531-2608	Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2306]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Antonelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078542; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bull E, 2014, INT J NANOMED, V9, P1641, DOI 10.2147/IJN.S48979; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Castro G, 2013, ISRN OPHTHALMOL, V26; Chen CCV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056125; Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Deng Xinyang, 2013, ScientificWorldJournal, V2013, P123731, DOI 10.1155/2013/123731; Deno S, 2014, BIOORGAN MED CHEM, V22, P350, DOI 10.1016/j.bmc.2013.11.023; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Futterer S, 2013, J PHARMACEUT BIOMED, V86, P151, DOI 10.1016/j.jpba.2013.08.005; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Jasmin, 2012, Methods Mol Biol, V906, P239, DOI 10.1007/978-1-61779-953-2_18; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Kitamura N, 2013, BIOORGAN MED CHEM, V21, P7175, DOI 10.1016/j.bmc.2013.08.063; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Lin G, 2009, GLIA, V57, P592, DOI 10.1002/glia.20788; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Lundberg C, 1997, EXP NEUROL, V145, P342, DOI 10.1006/exnr.1997.6503; Magnitsky S, 2008, ACAD RADIOL, V15, P1269, DOI 10.1016/j.acra.2008.05.003; Pardal R, 2012, ADV EXP MED BIOL, V741, P206, DOI 10.1007/978-1-4614-2098-9_14; Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080; Tang HL, 2013, CELL REPROGRAM, V15, P435, DOI 10.1089/cell.2012.0081; Teramura Y, 2010, BIOMATERIALS, V31, P2229, DOI 10.1016/j.biomaterials.2009.11.098; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Wen XH, 2014, BIOMATERIALS, V35, P4627, DOI 10.1016/j.biomaterials.2014.02.042; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Yoo J, 2013, J CELL BIOCHEM, V114, P743, DOI 10.1002/jcb.24427; Yu B, 2013, ARCH MED SCI, V9, P132, DOI 10.5114/aoms.2012.31438	38	21	22	0	55	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	54						158	167		10.1016/j.biomaterials.2015.03.017			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	CI2QD	WOS:000354591200016	25907049				2022-02-06	
J	Liu, HZ; Xiao, XF; Sun, CZ; Sun, D; Li, YY; Yang, MS				Liu, Huaizheng; Xiao, Xuefei; Sun, Chuanzheng; Sun, Dao; Li, Yayong; Yang, Mingshi			Systemic inflammation and multiple organ injury in traumatic hemorrhagic shock	FRONTIERS IN BIOSCIENCE-LANDMARK			English	Article						Systemic Inflammation; Multiple Organ Injury; Hemorrhagic Shock; Review	TOLL-LIKE RECEPTORS; FRESH WHOLE-BLOOD; BRAIN-INJURY; NA+/H+ EXCHANGER; HEPATIC-DYSFUNCTION; RURAL STATE; RESUSCITATION; MODEL; FAILURE; DEATHS	Traumatic hemorrhagic shock (HS) is a severe outcome of traumatic injury that accounts for numerous traumatic deaths. In the process of traumatic HS, both hemorrhage and trauma can trigger a complex cascade of posttraumatic events that are related to inflammatory and immune responses, which may lead to multiple organ injury or even death. From a mechanistic perspective, systemic inflammation and organ injury are involved coagulation, the complement system, impaired microcirculation and inflammatory signaling pathways. In this review, we discuss the systemic inflammation and multiple organ injury in post-traumatic HS.	[Liu, Huaizheng; Xiao, Xuefei; Sun, Chuanzheng; Sun, Dao; Li, Yayong; Yang, Mingshi] Cent S Univ, Xiangya Hosp 3, Emergency & Intens Care Ctr, Changsha 410013, Hunan, Peoples R China		Yang, MS (corresponding author), Cent S Univ, Xiangya Hosp 3, Emergency & Intens Care Ctr, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	lhz3385@yeah.net			Science and Technology Program from Hunan Science and Technology Burea [2012FJ4313]	This work was supported by Science and Technology Program from Hunan Science and Technology Burea (2012FJ4313).	Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Blasiole B, 2013, ANESTHESIOLOGY, V118, P649, DOI 10.1097/ALN.0b013e318280a42d; Bogren LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094225; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Catania R. A., 1999, Annals Academy of Medicine Singapore, V28, P120; Chai W, 2012, J SURG RES, V176, P210, DOI 10.1016/j.jss.2011.07.016; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; Esposito TJ, 2003, J TRAUMA, V54, P663, DOI 10.1097/01.TA.0000058124.78958.6B; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI 10.1517/14728220802600707 ; Frink M, 2007, ANN SURG, V246, P836, DOI 10.1097/SLA.0b013e318158fca0; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Harbrecht BG, 2002, J TRAUMA, V53, P517, DOI 10.1097/00005373-200209000-00020; Harbrecht BG, 2001, AM SURGEON, V67, P122; Hawksworth JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034224; Hostmann A, 2008, CRIT CARE, V12, DOI 10.1186/cc6772; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Kusumoto K, 2001, AM J PHYSIOL-HEART C, V280, pH738, DOI 10.1152/ajpheart.2001.280.2.H738; Lee TH, 2013, TRANSFUSION, V53, p72S, DOI 10.1111/trf.12039; Lu Jian, 2012, Zhonghua Wai Ke Za Zhi, V50, P655; Makley AT, 2010, J TRAUMA, V68, P305, DOI 10.1097/TA.0b013e3181cb4472; Marcu AC, 2007, J TRAUMA, V63, P662, DOI 10.1097/TA.0b013e31802e70d9; Matheson PJ, 2009, SURGERY, V146, P739, DOI 10.1016/j.surg.2009.06.037; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Moore FA, 1999, POSTINJURY MULTIPLE, P1427; Nattie E. E., 1995, REGULATION BREATHING, P473; Neal MD, 2009, J TRAUMA, V67, P476, DOI 10.1097/TA.0b013e3181ad66bb; Park KH, 2010, J KOREAN MED SCI, V25, P128, DOI 10.3346/jkms.2010.25.1.128; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Pfeifer R, 2013, CYTOKINE, V61, P585, DOI 10.1016/j.cyto.2012.10.022; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Tachon G, 2014, CRIT CARE MED, V42, P1433, DOI 10.1097/CCM.0000000000000223; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Vincenzi R, 2009, AM J SURG, V198, P407, DOI 10.1016/j.amjsurg.2009.01.017; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Wu DM, 2009, CRIT CARE MED, V37, P1994, DOI 10.1097/CCM.0b013e3181a0052e	49	21	23	1	16	FRONTIERS IN BIOSCIENCE INC	IRVINE	16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA	1093-9946	1093-4715		FRONT BIOSCI-LANDMRK	Front. Biosci.	JUN 1	2015	20						927	933		10.2741/4347			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH9LA	WOS:000354355900003	25961533				2022-02-06	
J	Griesbach, GS; Kreber, LA; Harrington, D; Ashley, MJ				Griesbach, Grace S.; Kreber, Lisa A.; Harrington, David; Ashley, Mark J.			Post-Acute Traumatic Brain Injury Rehabilitation: Effects on Outcome Measures and Life Care Costs	JOURNAL OF NEUROTRAUMA			English	Article						vascular injury; traumatic brain injury; rehabilitation; therapeutic approaches for the treatment of CNS injury; outcome measures	RATING-SCALE; HEALTH; TBI	Rehabilitation is the predominant post-acute treatment for patients with traumatic brain injury (TBI). We retrospectively evaluated the effectiveness of post-acute TBI rehabilitation by comparing outcome measures and life care cost with that of patients with cerebrovascular accident (CVA) who underwent a multidisciplinary rehabilitation program within the same facility. To better assess the effects of rehabilitation, we only included patients with no benefit limitations from the insurance carrier. Functional effectiveness was determined by comparing outcome scales, which included the Disability Rating Scale, Mayo Portland Inventory, Occupational Status Scale, Living Status Scale, and the Centre for Neuro Skills Scale. Cost-effectiveness was determined by having certified life care planners create separate cost projections from the admission and discharge patient files. This allowed us to compare cost projections with and without rehabilitation for each patient. Significant decreases in the cost projections, i.e., rehabilitation savings (RS), were found after rehabilitation for TBI. These RS were equivalent to those of patients with CVA. Likewise, equivalent improvements were found on all of the outcome scales for both brain injury groups. We also evaluated if the latency from TBI to admission in the rehabilitation program had an influence on outcome. Cost and functional effectiveness was more marked when rehabilitation was initiated within the first year after TBI. The effects of age of TBI were also evaluated. Although RS were most marked in younger patients, improvements in outcome measures were observed in all age groups after post-acute rehabilitation.	[Griesbach, Grace S.; Kreber, Lisa A.; Harrington, David; Ashley, Mark J.] Ctr Neuro Skills, Bakersfield, CA USA; [Griesbach, Grace S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Griesbach, GS (corresponding author), Ctr Neuro Skills, 16542 Ventura Blvd,Suite 500, Encino, CA 91436 USA.	ggriesbach@neuroskills.com					Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Ashley M.J., 2012, CEREBRUM, V8; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P761, DOI 10.1201/9781439849828-c23; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Blackwell DL, 2014, VITAL HLTH STAT, V10, P1; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; Griesbach G.S., HDB CLIN NE IN PRESS; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 2008, J HEAD TRAUMA REHAB, V23, P271, DOI 10.1097/01.HTR.0000336839.68585.0f; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Tal G, 2013, PEDIATR NEUROL, V48, P424, DOI 10.1016/j.pediatrneurol.2012.11.008; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	28	21	21	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					704	711		10.1089/neu.2014.3754			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200005	25496475				2022-02-06	
J	Benromano, T; Defrin, R; Ahn, AH; Zhao, J; Pick, CG; Levy, D				Benromano, T.; Defrin, R.; Ahn, A. H.; Zhao, J.; Pick, C. G.; Levy, D.			Mild closed head injury promotes a selective trigeminal hypernociception: Implications for the acute emergence of post-traumatic headache	EUROPEAN JOURNAL OF PAIN			English	Article							TRAUMATIC BRAIN-INJURY; FORMALIN TEST; SENSORY INNERVATION; COGNITIVE DEFICITS; PAIN; PREVALENCE; RATS; MICE	BackgroundHeadache is one of the most common symptoms following traumatic head injury. The mechanisms underlying the emergence of such post-traumatic headache (PTH) remain unknown but may be related to injury of deep cranial tissues or damage to central pain processing pathways, as a result of brain injury. MethodsA mild closed head injury in mice combined with the administration of cranial or hindpaw formalin tests was used to examine post-traumatic changes in the nociceptive processing from deep cranial tissues or the hindpaw. Histological analysis was used to examine post-traumatic pro-inflammatory changes in the calvarial periosteum, a deep cranial tissue. ResultsAt 48h after head injury, mice demonstrated enhanced nociceptive responses following injection of formalin into the calvarial periosteum, a deep cranial tissue, but no facilitation of the nociceptive responses following injection of formalin into an extracranial tissue, the hindpaw. Mice also showed an increase in the number of activated periosteal mast cells 48h following mild head trauma, suggesting an inflammatory response. ConclusionOur study demonstrates that mild closed head injury is associated with enhanced processing of nociceptive information emanating from trigeminal-innervated deep cranial tissues, but not from non-cranial tissues. Based on these finding as well as the demonstration of head injury-evoked degranulation of calvarial periosteal mast cells, we propose that inflammatory-evoked enhancement of peripheral cranial nociception, rather than changes in supraspinal pain mechanisms play a role in the initial emergence of PTH. Peripheral targeting of nociceptors that innervate the calvaria may be used to ameliorate PTH pain.	[Benromano, T.; Pick, C. G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Defrin, R.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Defrin, R.; Pick, C. G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Ahn, A. H.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Zhao, J.; Levy, D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA		Levy, D (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	dlevy1@bidmc.harvard.edu	Levy, Dan/AAF-1871-2021; Pick, Chaim/D-4789-2009		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077882, NS078263, AA020305]; National Headache Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078263, R21NS077882, R01NS086830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA020305] Funding Source: NIH RePORTER	This work is supported by NIH grants NS077882, NS078263 and AA020305 and the National Headache Foundation to Dr Levy.	Ahn A. H., 2008, NEUROSCIENCE M PLANN; CLAVELOU P, 1995, PAIN, V62, P295, DOI 10.1016/0304-3959(94)00273-H; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Fischer M, 2014, PAIN, V155, P511, DOI 10.1016/j.pain.2013.11.015; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Keidel M, 2006, HEADACHES, P863; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scher AI, 2014, CEPHALALGIA, V34, P83, DOI 10.1177/0333102413499644; Schueler M, 2013, PAIN, V154, P1622, DOI 10.1016/j.pain.2013.04.040; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; VOS BP, 1994, J NEUROSCI, V14, P2708; Zhao J, 2014, PAIN, V155, P1392, DOI 10.1016/j.pain.2014.04.019; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	24	21	21	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-3801	1532-2149		EUR J PAIN	Eur. J. Pain	MAY	2015	19	5					621	628		10.1002/ejp.583			8	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	CF6FW	WOS:000352653500005	25168788	Green Accepted			2022-02-06	
J	He, XH; Lakkaraju, SK; Hanscom, M; Zhao, ZR; Wu, JF; Stoica, B; MacKerell, AD; Faden, AI; Xue, FT				He, Xinhua; Lakkaraju, Sirish K.; Hanscom, Marie; Zhao, Zaorui; Wu, Junfang; Stoica, Bogdan; MacKerell, Alexander D., Jr.; Faden, Alan I.; Xue, Fengtian			Acyl-2-aminobenzimidazoles: A novel class of neuroprotective agents targeting mGluR5	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Traumatic brain injury; Metabotropic glutamate receptor; Neuroprotection; Computer-aided drug design; Positive allosteric modulator	POSITIVE ALLOSTERIC MODULATORS; TRAUMATIC BRAIN INJURY; SPINAL-CORD-INJURY; MOLECULAR-DYNAMICS; MACROMOLECULAR ENERGY; SITE-IDENTIFICATION; IMMUNE FUNCTION; IN-VIVO; DISCOVERY; ACTIVATION	Positive allosteric modulators (PAMs) of the metabotropic glutamate receptor 5 (mGluR5) are promising therapeutic agents for treating traumatic brain injury (TBI). Using computational and medicinal methods, the structure-activity relationship of a class of acyl-2-aminobenzimidazoles (1-26) is reported. The new compounds are designed based on the chemical structure of 3,3'-difluorobenzaldazine (DFB), a known mGluR5 PAM. Ligand design and prediction of binding affinities of the new compounds have been performed using the site identification by ligand competitive saturation (SILCS) method. Binding affinities of the compounds to the transmembrane domain of mGluR5 have been evaluated using nitric oxide (NO) production assay, while the safety of the compounds is tested. One new compound found in this study, compound 22, showed promising activity with an IC50 value of 6.4 mu M, which is similar to 20 fold more potent than that of DFB. Compound 22 represents a new lead for possible development as a treatment for TBI and related neurodegenerative conditions. (C) 2015 Elsevier Ltd. All rights reserved.	[He, Xinhua; Lakkaraju, Sirish K.; MacKerell, Alexander D., Jr.; Xue, Fengtian] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Hanscom, Marie; Zhao, Zaorui; Wu, Junfang; Stoica, Bogdan; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Hanscom, Marie; Zhao, Zaorui; Wu, Junfang; Stoica, Bogdan; Faden, Alan I.] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA		Xue, FT (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	fxue@rx.umaryland.edu	MacKerell, Alex/AAA-2560-2020; MacKerell, Alex/Y-2469-2019; STOICA, BOGDAN/H-9782-2013	MacKerell, Alex/0000-0001-8287-6804; STOICA, BOGDAN/0000-0002-2501-6434; Hanscom, Marie/0000-0001-8308-135X; Lakkaraju, Sirish Kaushik/0000-0003-1553-5780; Faden, Alan I./0000-0003-0128-2348; He, Xinhua/0000-0001-7826-2973	UMB Pilot & Exploratory Interdisciplinary Research (IDR); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA107331]; United States and Maryland Industrial Partnerships Award [5212]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA107331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R43GM109635] Funding Source: NIH RePORTER	This work was supported by the UMB Pilot & Exploratory Interdisciplinary Research (IDR), NIH grant CA107331 United States and Maryland Industrial Partnerships Award 5212. The authors acknowledge computer time and resources from the Computer Aided Drug Design (CADD) Center at the University of Maryland, Baltimore.	Allen M.P., 1989, J SOLUTION CHEM, V42, P105; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Engers DW, 2009, CHEMMEDCHEM, V4, P505, DOI 10.1002/cmdc.200800357; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Lakkaraju S. K., 2014, J CHEM THEORY COMPUT, P10; Lee JH, 2006, HETEROCYCLES, V70, P571; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; O'Brien JA, 2004, J PHARMACOL EXP THER, V309, P568, DOI 10.1124/jpet.103.061747; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pearlman DA, 2001, J MED CHEM, V44, P3417, DOI 10.1021/jm0100279; Pilyugin VS, 2004, RUSS J GEN CHEM+, V74, P738, DOI 10.1023/B:RUGC.0000039088.87053.eb; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Raman EP, 2013, J CHEM INF MODEL, V53, P3384, DOI 10.1021/ci4005628; Raman EP, 2011, J CHEM INF MODEL, V51, P877, DOI 10.1021/ci100462t; Ritzen A, 2009, BIOORG MED CHEM LETT, V19, P3275, DOI 10.1016/j.bmcl.2009.04.095; Rodriguez AL, 2010, MOL PHARMACOL, V78, P1105, DOI 10.1124/mol.110.067207; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharma S, 2009, J MED CHEM, V52, P4103, DOI 10.1021/jm900654c; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shim J., 2013, J PHYS CHEM B; Spranger M, 1996, NEUROSCIENTIST, V2, P293, DOI 10.1177/107385849600200515; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xue FT, 2014, CNS NEUROL DISORD-DR, V13, P558, DOI 10.2174/18715273113126660199; Zhao ZJ, 2007, BIOORG MED CHEM LETT, V17, P1386, DOI 10.1016/j.bmcl.2006.11.081	57	21	21	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAY 1	2015	23	9					2211	2220		10.1016/j.bmc.2015.02.054			10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CF6WZ	WOS:000352698700031	25801156	Green Accepted			2022-02-06	
J	Hu, JZ; Long, H; Wu, TD; Zhou, Y; Lu, HB				Hu, J. Z.; Long, H.; Wu, T. -D.; Zhou, Y.; Lu, H. -B.			THE EFFECT OF ESTROGEN-RELATED RECEPTOR alpha ON THE REGULATION OF ANGIOGENESIS AFTER SPINAL CORD INJURY	NEUROSCIENCE			English	Article						spinal cord injury; angiogenesis; estrogen receptor-related; receptor-alpha; XCT790.	PROLIFERATOR-ACTIVATED RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; GAMMA COACTIVATOR-1-ALPHA PGC-1-ALPHA; ERR-ALPHA; VASCULAR DISRUPTION; CONTUSION INJURY; VEGF RECEPTORS; BREAST-CANCER; RAT-BRAIN; EXPRESSION	Estrogen receptor-related receptor-alpha (ERR alpha) is an orphan member of the nuclear receptor superfamily that interacts with peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) to stimulate vascular endothelial growth factor (VEGF) expression and angiogenesis in a hypoxia-inducible factor-1 alpha-independent pathway. Although it is not regulated by any natural ligand, the action of ERR alpha can be blocked by the synthetic molecule XCT790. In the present study, Sprague-Dawley rats were randomly allocated to a sham group, injury-saline group or injury-XCT90 group. A modified Allen's weight-drop method was applied to induce the acute traumatic spinal cord injury (SCI) model in these rats, and an injection of XCT790 was administered every 24 h, starting half an hour after the SCI contusion. Histological analyses revealed that XCT790 significantly aggravated tissue damage and decreased the number of ERR alpha-positive cells at 1, 3 and 7 days after SCI. Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) analyses also indicated that XCT790 dramatically repressed the expression of ERR alpha, thus reducing the expression of VEGF and angiopoietin-2 (Ang-2) throughout the duration of the experiment, but the expression of PGC-1 alpha was not affected. Immunofluorescence analyses indicated that vascular density and endothelial cell proliferation were decreased in the injury-XCT90 group compared with the injury-saline group. These results suggest that ERR alpha is involved in mediating angiogenesis after SCI in the rat traumatic SCI model. (C) 2015 The Authors. Published by Elsevier Ltd. on behalf of IBRO.	[Hu, J. Z.; Long, H.; Wu, T. -D.; Zhou, Y.] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China; [Lu, H. -B.] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China		Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81371956]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110078]	This work was supported by grants from the National Natural Science Foundation of China (No. 81171698 and No. 81371956), and from Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078).	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bonnelye E, 2007, ENDOCRINOLOGY, V148, P1195, DOI 10.1210/en.2006-0962; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chen CW, 2010, NEUROCHEM RES, V35, P1111, DOI 10.1007/s11064-010-0162-y; Choi JS, 2007, J HISTOCHEM CYTOCHEM, V55, P821, DOI 10.1369/jhc.6A7139.2007; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dore-Duffy P, 2007, ANTIOXID REDOX SIGN, V9, P1363, DOI 10.1089/ars.2007.1713; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Durham-Lee JC, 2012, NEUROSCIENCE, V202, P454, DOI 10.1016/j.neuroscience.2011.09.058; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Liu XH, 2014, SPINE J, V14, P119, DOI 10.1016/j.spinee.2013.06.084; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Long HQ, 2012, MED HYPOTHESES, V79, P82, DOI 10.1016/j.mehy.2012.04.006; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Ning GZ, 2013, REGEN MED, V8, P271, DOI [10.2217/RME.13.26, 10.2217/rme.13.26]; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Ritz MF, 2010, CURR NEUROVASC RES, V7, P301, DOI 10.2174/156720210793180756; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang J, 2010, CELL PROLIFERAT, V43, P103, DOI 10.1111/j.1365-2184.2009.00659.x; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Yamazaki S., 2014, JAALD, Bulletin of the Japan Association of Agricultural Librarians and Information Specialists, P1; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638; Zhou Y, 2013, CHINESE MED J-PEKING, V126, P3897, DOI 10.3760/cma.j.issn.0366-6999.20130571	50	21	23	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 2	2015	290						570	580		10.1016/j.neuroscience.2015.01.067			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD3LG	WOS:000350979300051	25665753	hybrid			2022-02-06	
J	Dong, GC; Kuan, CY; Subramaniam, S; Zhao, JY; Sivasubramaniam, S; Chang, HY; Lin, FH				Dong, Guo-Chung; Kuan, Che-Yung; Subramaniam, Sadhasivam; Zhao, Jiong-Yao; Sivasubramaniam, Savitha; Chang, Hwan-You; Lin, Feng-Huei			A potent inhibition of oxidative stress induced gene expression in neural cells by sustained ferulic acid release from chitosan based hydrogel	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						TBI; Secondary brain injury; Hydrogel; Ferulic acid; Oxidative stress; Neuro-2a cells	TRAUMATIC BRAIN-INJURY; ANTIOXIDANT ENZYMES; COMPOSITE	Traumatic brain injury (TBI) is an extremely cataclysmic neurological disorder and the inhibition of oxidative stress following TBI could effectively protect the brain from further impairments. An injectable thermosensitive chitosan/gelatin/beta-Glycerol phosphate (C/G/GP) hydrogel for the controlled release of the phenolic antioxidant ferulic acid (FA) to inhibit the neurological oxidative stress was demonstrated. The C/G/GP hydrogel ensures an excellent clinical expediency with a gelation temperature of 32.6 degrees C and gelation time of 75.58 s. In-vitro cytotoxicity assays of C/G/GP hydrogel and FA have revealed an excellent biocompatibility with the Neuro-2a cells. 500 mu M of FA was considered to be an effective concentration to reduce the oxidative stress in Neuro-2a cells. TUNEL staining images evidenced that the H2O2 induced DNA fragmentation was comprehensively controlled after FA treatment. The mRNA gene expression profiles markedly authenticate the neuroprotectivity of FA by down-regulating ROS, inflammatory and apoptosis related markers. The outcomes of this study suggest that, C/G/GP hydrogel carrying ferulic acid could effectively protect further secondary traumatic brain injury associated impairments. (C) 2015 Elsevier B.V. All rights reserved.	[Dong, Guo-Chung; Kuan, Che-Yung; Subramaniam, Sadhasivam; Zhao, Jiong-Yao; Lin, Feng-Huei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan, Miaoli County, Taiwan; [Kuan, Che-Yung] Natl Chung Hsing Univ, Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan; [Zhao, Jiong-Yao; Chang, Hwan-You] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Sivasubramaniam, Savitha] Sree Sastha Inst Engn & Technol, Dept Biotechnol, Madras, Tamil Nadu, India		Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	double@ntu.edu.tw	Dong, Guo-Chung/E-3950-2010; Sadhasivam, Subramaniam/AAF-4545-2019	Dong, Guo-Chung/0000-0003-1159-1718; Kuan, Che-Yung/0000-0002-3349-3556			Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Cheng CY, 2008, BRAIN RES, V1209, P136, DOI 10.1016/j.brainres.2008.02.090; Cheng YH, 2011, PROCESS BIOCHEM, V46, P1670, DOI 10.1016/j.procbio.2011.05.017; Cheng YH, 2011, BIOMATERIALS, V32, P6953, DOI 10.1016/j.biomaterials.2011.03.065; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Faul M, 2010, TRAUMATIC BRAIN INJU; GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I; Hong Y, 2007, ACTA BIOMATER, V3, P23, DOI 10.1016/j.actbio.2006.06.007; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Li XY, 2012, INT J PHARMACEUT, V437, P110, DOI 10.1016/j.ijpharm.2012.08.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Nakata R, 2014, MAT SCI ENG C-MATER, V41, P59, DOI 10.1016/j.msec.2014.04.016; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Picone P, 2013, BIOL BULL-US, V224, P18, DOI 10.1086/BBLv224n1p18; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wang H, 2003, J NEUROCHEM, V87, P1527, DOI 10.1046/j.1471-4159.2003.02123.x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	25	21	22	5	52	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						691	699		10.1016/j.msec.2015.01.030			9	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	CC6YE	WOS:000350514100079	25686998				2022-02-06	
J	Nielson, DM; McKnight, CA; Patel, RN; Kalnin, AJ; Mysiw, WJ				Nielson, Dylan M.; McKnight, Curtis A.; Patel, Riddhi N.; Kalnin, Andrew J.; Mysiw, Walter J.			Preliminary Guidelines for Safe and Effective Use of Repetitive Transcraniat Magnetic Stimulation in Moderate to Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Case report; Depression; Rehabilitation; Transcranial magnetic stimulation	TREATMENT-RESISTANT DEPRESSION; RANDOMIZED CONTROLLED-TRIAL; SKULL PLATES; HEAD-INJURY; EFFICACY; SCALE; DISORDER; EXCITABILITY; SEIZURE; STATE	Transcranial magnetic stimulation has generated extensive interest within the traumatic brain injury (TBI) rehabilitation community, but little work has been done with repetitive protocols, which can produce prolonged changes in behavior. This is partly because of concerns about the safety of repetitive transcranial magnetic stimulation (rTMS) in subjects with TBI, particularly the risk of seizures. These risks can be minimized by careful selection of the rTMS protocol and exclusion criteria. In this article, we identify guidelines for safe use of rTMS in subjects with TBI based on a review of the literature and illustrate their application with a case study. Our subject is a 48-year-old man who sustained a severe TBI 5 years prior to beginning rTMS for the treatment of post-TBI depression. After a 4-week baseline period, we administered daily sessions of low-frequency stimulation to the right dorsolateral prefrontal cortex for 6 weeks. After stimulation, we performed monthly assessments for 3 months. The Hamilton Depression Rating Scale (HAMD) was our primary outcome measure. The stimulation was well tolerated and the patient reported no side effects. After 6 weeks of stimulation, the patient's depression was slightly improved, and these improvements continued through followup. At the end of follow-up, the patient's HAMD score was 49% of the average baseline score. (C) 2015 by the American Congress of Rehabilitation Medicine	[Nielson, Dylan M.; Patel, Riddhi N.; Mysiw, Walter J.] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA; [McKnight, Curtis A.] Ohio State Univ, Dept Psychiat, Wexner Med Ctr, Columbus, OH 43210 USA; [Kalnin, Andrew J.] Ohio State Univ, Dept Radiol, Wexner Med Ctr, Columbus, OH 43210 USA		Mysiw, WJ (corresponding author), 1818 Dodd Hall,480 Med Ctr Dr, Columbus, OH 43210 USA.	w.mysiw@osumc.edu	Nielson, Dylan/ABD-1615-2021	Nielson, Dylan/0000-0003-4613-6643	Department of Physical Medicine and Rehabilitation, Wexner Medical Center, The Ohio State University	Supported by the Department of Physical Medicine and Rehabilitation, Wexner Medical Center, The Ohio State University.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Epstein CM, 2006, CLIN NEUROPHYSIOL, V117, P2566, DOI 10.1016/j.clinph.2006.07.262; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M, 2010, TRAUMATIC BRAIN INJU; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Fitzgerald PB, 2009, NEUROPSYCHOPHARMACOL, V34, P1255, DOI 10.1038/npp.2008.233; Fitzgerald PB, 2013, SIDE EFFECTS RTMS TR; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hedlund J. L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hsu WY, 2011, EPILEPSY RES, V96, P231, DOI 10.1016/j.eplepsyres.2011.06.002; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2004, BIOL PSYCHIAT, V55, P398, DOI 10.1016/j.biopsych.2003.08.017; Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45; Kim L, 2011, ANN REHABIL MED-ARM, V35, P765, DOI 10.5535/arm.2011.35.6.765; Kito S, 2011, PSYCHIAT CLIN NEUROS, V65, P175, DOI 10.1111/j.1440-1819.2010.02183.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; McDonald WM, 2011, DEPRESS ANXIETY, V28, P973, DOI 10.1002/da.20885; Nowak DA, 2006, CLIN NEUROPHYSIOL, V117, P1631, DOI 10.1016/j.clinph.2006.03.017; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rotenberg A, 2007, CLIN NEUROPHYSIOL, V118, P2536, DOI 10.1016/j.clinph.2007.08.003; Rotenberg A, 2009, CLIN NEUROPHYSIOL, V120, P1417, DOI 10.1016/j.clinph.2009.05.004; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xia GH, 2008, INT J NEUROPSYCHOPH, V11, P119, DOI 10.1017/S1461145707007699	43	21	21	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4		2			S138	S144		10.1016/j.apmr.2014.09.010			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CE9RA	WOS:000352179900007	25281871				2022-02-06	
J	Lang, EW; Kasprowicz, M; Smielewski, P; Santos, E; Pickard, J; Czosnyka, M				Lang, Erhard W.; Kasprowicz, Magdalena; Smielewski, Peter; Santos, Edgar; Pickard, John; Czosnyka, Marek			Short pressure reactivity index versus long pressure reactivity index in the management of traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						brain monitoring; cerebral autoregulation; cerebrovascular reactivity; severe head injury; outcome; cerebral perfusion pressure; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW-VELOCITY; CAROTID-ARTERY-DISEASE; SEVERE HEAD-INJURY; CEREBROVASCULAR AUTOREGULATION; SPONTANEOUS OSCILLATIONS; INTRACRANIAL-PRESSURE; B-WAVES; HUMANS; CLASSIFICATION	OBJECT The pressure reactivity index (PRx) correlates with outcome after traumatic brain injury (TBI) and is used to calculate optimal cerebral perfusion pressure (CPPopt). The PRx is a correlation coefficient between slow, spontaneous changes (0.003-0.05 Hz) in intracranial pressure (ICP) and arterial blood pressure (ABP). A novel index the so-called long PRx (L-PRx)-that considers ABP and ICP changes (0.0008-0.008 Hz) was proposed. METHODS The authors compared PRx and L-PRx for 6-month outcome prediction and CPPopt calculation in 307 patients with TBI. The PRx- and L-PRx based CPPopt were determined and the predictive power and discriminant abilities were compared. RESULTS The PRx and L-PRx correlation was good (R = 0.7, p < 0.00001; Spearman test). The PRx, age, CPP, and Glasgow Coma Scale score but not L-PRx were significant fatal outcome predictors (death and persistent vegetative state). There was a significant difference between the areas under the receiver operating characteristic curves calculated for PRx and L-PRx (0.61 +/- 0.04 vs 0.51 +/- 0.04; z-statistic = -3.26, p = 0.011), which indicates a better ability by PRx than L-PRx to predict fatal outcome. The CPPopt was higher for L-PRx than for PRx, without a statistical difference (median CPPopt for L-PRx: 76.9 mm Hg, interquartile range [IQR] +/- 10.1 mm Hg; median CPPopt for PRx: 74.7 mm Hg, IQR +/- 8.2 mm Hg). Death was associated with CPP below CPPopt for PRx (chi(2) = 30.6, p < 0.00001), and severe disability was associated with CPP above CPPopt for PRx (chi(2) = 7.8, p = 0.005). These relationships were not statistically significant for CPPopt for L-PRx. CONCLUSIONS The PRx is superior to the L-PRx for TBI outcome prediction. Individual CPPopt for L-PRx and PRx are not statistically different. Deviations between CPP and CPPopt for PRx are relevant for outcome prediction; those between CPP and CPPopt for L-PRx are not. The PRx uses the entire B-wave spectrum for index calculation, whereas the L-PRX covers only one-third of it. This may explain the performance discrepancy.	[Lang, Erhard W.] Red Cross Hosp, Neurosurg Associates, D-34121 Kassel, Germany; [Kasprowicz, Magdalena] Heidelberg Univ, Dept Neurosurg, D-69115 Heidelberg, Germany; [Smielewski, Peter; Pickard, John; Czosnyka, Marek] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Santos, Edgar] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 1TN, England		Lang, EW (corresponding author), Red Cross Hosp, Neurosurg Associates, Bergmannstr 30, D-34121 Kassel, Germany.	keeflang@online.de	Santos, Edgar/AAV-2506-2021	Santos, Edgar/0000-0002-8976-5549; Kasprowicz, Magdalena/0000-0002-2271-7737; Smielewski, Peter/0000-0001-5096-3938	Polish Ministry of Science and Higher EducationMinistry of Science and Higher Education, Poland; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G0001237, G9439390] Funding Source: UKRI	DISCLOSURE The software for brain monitoring (ICM+) is licensed by the University of Cambridge (Cambridge Enterprise), and Drs. Smielewski and Czosnyka have financial interests in a part of the licensing fee. Dr. Czosnyka is a consultant for Codman J & J. Dr. Lang is a consultant for GMS Integra. Dr. Kasprowicz is the recipient of a scholarship funded by the Polish Ministry of Science and Higher Education.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; Diehl RR, 1997, STROKE, V28, P1289; DIEHL RR, 1996, FUNKTIONELLE DOPPLER; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Haubrich C, 2004, ACTA NEUROL SCAND, V109, P210, DOI 10.1034/j.1600-0404.2003.00210.x; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Lewis PM, 2008, ACTA NEUROCHIR, V150, P139, DOI 10.1007/s00701-007-1447-z; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mayer, 1876, SBER AKAD WISS WIEN, V74, P281; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oehm E, 2006, CEREBROVASC DIS, V22, P204, DOI 10.1159/000093810; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	32	21	23	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					588	594		10.3171/2014.10.JNS14602			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600014	25423266	Bronze			2022-02-06	
J	Schiehser, DM; Delano-Wood, L; Jak, AJ; Matthews, SC; Simmons, AN; Jacobson, MW; Filoteo, JV; Bondi, MW; Orff, HJ; Liu, L				Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Matthews, Scott C.; Simmons, Alan N.; Jacobson, Mark W.; Filoteo, J. Vincent; Bondi, Mark W.; Orff, Henry J.; Liu, Lin			Validation of the Modified Fatigue Impact Scale in Mild to Moderate Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; fatigue; Modified Fatigue Impact Scale; traumatic brain injury; validity	RELIABILITY	Objective: To evaluate the validity of the Modified Fatigue Impact Scale (MFIS) in veterans with a history of mild to moderate traumatic brain injury (TBI). Participants: Veterans (N = 106) with mild (92%) or moderate (8%) TBI. Setting: Veterans Administration Health System. Procedure: Factor structure, internal consistency, convergent validity, sensitivity, and specificity of the MFIS were examined. Results: Principal component analysis identified 2 viable MFIS factors: a Cognitive subscale and a Physical/Activities subscale. Item analysis revealed high internal consistency of the MFIS Total scale and subscale items. Strong convergent validity of the MFIS scales was established with 2 Beck Depression Inventory II fatigue items. Receiver operating characteristic curve analysis revealed good to excellent accuracy of the MFIS in classifying fatigued versus nonfatigued individuals. Conclusion: The MFIS is a valid multidimensional measure that can be used to evaluate the impact of fatigue on cognitive and physical functioning in individuals with mild to moderate TBI. The psychometric properties of the MFIS make it useful for evaluating fatigue and provide the potential for improving research on fatigue in this population.	[Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Matthews, Scott C.; Jacobson, Mark W.; Filoteo, J. Vincent; Bondi, Mark W.; Liu, Lin] VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Matthews, Scott C.; Simmons, Alan N.; Jacobson, Mark W.; Filoteo, J. Vincent; Bondi, Mark W.; Orff, Henry J.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Liu, Lin] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Delano-Wood, Lisa; Matthews, Scott C.; Simmons, Alan N.; Bondi, Mark W.; Orff, Henry J.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Schiehser, DM (corresponding author), Vet Affairs San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dschiehser@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	VA Career Development Awards; VA Merit AwardUS Department of Veterans Affairs	This study was supported by VA Career Development Awards (to D.M.S., L.D.W., and S.C.M.) and a VA Merit Award (to A.N.S.). The authors thank Russell Kim, Elisa Lanni, Norman Luc, Amber Gregory, Candice Colon, Ryan O'Connell, and Elena Kosheleva for their help with data collection and compilation. The authors also thank the patients, staff, and volunteers associated with the Veterans Affairs San Diego Healthcare System for their involvement in this study.	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Beck A., 1996, MANUAL BDI 2; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cohen J., 2013, STAT POWER ANAL BEHA; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU, P112; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Schiehser DM, 2013, PARKINSONISM RELAT D, V19, P335, DOI 10.1016/j.parkreldis.2012.11.013; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tatham, 1998, MULTIVARIATE DATA AN; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Whitehead L, 2009, J PAIN SYMPTOM MANAG, V37, P107, DOI 10.1016/j.jpainsymman.2007.08.019; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	23	21	21	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					116	121		10.1097/HTR.0000000000000019			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300014	24413076				2022-02-06	
J	Teng, SX; Katz, PS; Maxi, JK; Mayeux, JP; Gilpin, NW; Molina, PE				Teng, Sophie X.; Katz, Paige S.; Maxi, John K.; Mayeux, Jacques P.; Gilpin, Nicholas W.; Molina, Patricia E.			Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Alcohol; Neuroinflammation; Neurobehavior	MOBILITY GROUP BOX-1; INTERMITTENT ETHANOL EXPOSURE; FIBRILLARY ACIDIC PROTEIN; TOLL-LIKE RECEPTORS; OF-THE-LITERATURE; RECOGNITION MEMORY; DRUG-USE; MICROGLIAL ACTIVATION; PROFESSIONAL FOOTBALL; ALZHEIMERS-DISEASE	Traumatic brain injury (TBI) represents a leading cause of morbidity and mortality among young individuals. Alcohol abuse is a risk factor associated with increased TBI incidence. In addition, up to 26% of TBI patients engage in alcohol consumption after TBI. Limited preclinical studies have examined the impact of post-injury alcohol exposure on TBI recovery. The aim of this study was to determine the isolated and combined effects of TBI and alcohol on cognitive, behavioral, and physical recovery, as well as on associated neuroinflammatory changes. Male Sprague-Dawley rats (similar to 300 g) were subjected to a mild focal TBI by lateral fluid percussion (similar to 30 PSI, similar to 25 ms) under isoflurane anesthesia. On day 4 after TBI, animals were exposed to either sub-chronic intermittent alcohol vapor (95% ethanol 14 h on/10 h off; BAL similar to 200 mg/dL) or room air for 10 days. TBI induced neurological dysfunction reflected by an increased neurological severity score (NSS) showed progressive improvement in injured animals exposed to room air (TBI/air). In contrast, TBI animals exposed to alcohol vapor (TBI/alcohol) showed impaired NSS recovery throughout the 10-day period of alcohol exposure. Open-field exploration test revealed an increased anxiety-like behavior in TBI/alcohol group compared to TBI/air group. Additionally, alcohol-exposed animals showed decreased locomotion and impaired novel object recognition. Immunofluorescence showed enhanced reactive astrocytes, microglial activation, and HMGB1 expression localized to the injured cortex of TBI/alcohol as compared to TBI/air animals. The expression of neuroinflammatory markers showed significant positive correlation with NSS. These findings indicated a close relationship between accentuated neuroinflammation and impaired neurological recovery from post-TBI alcohol exposure. The clinical implications of long-term consequences in TBI patients exposed to alcohol during recovery warrant further investigation. (C) 2014 Elsevier Inc. All rights reserved.	[Molina, Patricia E.] Louisiana State Univ, Dept Physiol, Hlth Sci Ctr, New Orleans, LA 70112 USA; Louisiana State Univ, Alcohol & Drug Abuse Ctr Excellence, Hlth Sci Ctr, New Orleans, LA 70112 USA		Molina, PE (corresponding author), Louisiana State Univ, Dept Physiol, Alcohol & Drug Abuse Ctr Excellence, Hlth Sci Ctr, 1901 Perdido St Rm 7212, New Orleans, LA 70112 USA.	pmolin@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021; Gilpin, Nicholas/V-1266-2019	Molina, Patricia E./0000-0002-3598-384X; 	 [NIAAA-AA7577];  [AA018400];  [F30AA022838];  [LEQSF-EPS(2012)-PFUND-283]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K99AA018400, T32AA007577, F30AA022838, R00AA018400, R25AA021304] Funding Source: NIH RePORTER	This research was supported by grants NIAAA-AA7577, AA018400, F30AA022838, and LEQSF-EPS(2012)-PFUND-283.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Adams ZW, 2012, ADDICT BEHAV, V37, P848, DOI 10.1016/j.addbeh.2012.03.016; Alikunju S, 2011, BRAIN BEHAV IMMUN, V25, pS129, DOI 10.1016/j.bbi.2011.01.007; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asavarut Paladd, 2013, Acta Anaesthesiol Taiwan, V51, P28, DOI 10.1016/j.aat.2013.03.007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Baxter MG, 2010, BEHAV NEUROSCI, V124, P706, DOI 10.1037/a0021029; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Boyko M, 2011, BEHAV BRAIN RES, V223, P17, DOI 10.1016/j.bbr.2011.03.019; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Clark RE, 2000, J NEUROSCI, V20, P8853; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Franke H, 1997, ALCOHOL, V14, P445, DOI 10.1016/S0741-8329(96)00209-1; FREUND G, 1969, ARCH NEUROL-CHICAGO, V21, P315, DOI 10.1001/archneur.1969.00480150105013; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gilpin Nicholas W, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0929s44; Gonca S, 2005, CELL BIOL INT, V29, P169, DOI 10.1016/j.cellbi.2004.11.020; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hayakawa Kazuhide, 2013, Acta Neurochir Suppl, V118, P31, DOI 10.1007/978-3-7091-1434-6_5; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karlsson S, 2008, INTENS CARE MED, V34, P1046, DOI 10.1007/s00134-008-1032-9; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luan ZG, 2010, IMMUNOBIOLOGY, V215, P956, DOI 10.1016/j.imbio.2009.11.001; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; NAKASHIMA MN, 1995, CELL MOL NEUROBIOL, V15, P341, DOI 10.1007/BF02089944; Niranjan R, 2013, MOL NEUROBIOL, V48, P412, DOI 10.1007/s12035-013-8428-4; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Oscar-Berman M, 2012, NEUROPSYCHOL REV, V22, P154, DOI 10.1007/s11065-012-9198-x; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Riikonen J, 2002, ALCOHOL ALCOHOLISM, V37, P421, DOI 10.1093/alcalc/37.5.421; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Ruiz SM, 2013, ALCOHOL CLIN EXP RES, V37, P110, DOI 10.1111/j.1530-0277.2012.01862.x; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Whitaker AM, 2011, AM J PHYSIOL-REG I, V301, pR1529, DOI 10.1152/ajpregu.00035.2011; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang Qing-Wu, 2010, Front Biosci (Schol Ed), V2, P1081; Yang QW, 2010, J CEREBR BLOOD F MET, V30, P243, DOI 10.1038/jcbfm.2009.202; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	109	21	23	1	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2015	45						145	156		10.1016/j.bbi.2014.11.006			12	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	CC7BX	WOS:000350523800016	25489880	Green Accepted			2022-02-06	
J	Wang, D; Zhang, JJ				Wang, Dong; Zhang, Jianjun			Effects of hypothermia combined with neural stem cell transplantation on recovery of neurological function in rats with spinal cord injury	MOLECULAR MEDICINE REPORTS			English	Article						spinal cord injury; neural stem cells; transplantation; hypothermia; rat	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C RELEASE; MARROW STROMAL CELLS; PROTEIN-KINASE-II; MILD HYPOTHERMIA; BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; FLUID-PERCUSSION	The microenvironment of the injured spinal cord is hypothesized to be involved in driving the differentiation and survival of engrafted neural stem cells (NSCs). Hypothermia is known to improve the microenvironment of the injured spinal cord in a number of ways. To investigate the effect of NSC transplantation in combination with hypothermia on the recovery of rat spinal cord injury, 60 Sprague-Dawley female rats were used to establish a spinal cord hemisection model. They were divided randomly into three groups: A, spinal cord injury group; B, NSC transplantation group; and C, NSC transplantation + hypothermia group. At 1, 2, 4, 6 and 8 weeks post-injury, the motor function of all animals was evaluated using the Basso, Beattie and Besnaham locomotor scoring system and the inclined plane test. At 4 weeks post-transplantation, histological analysis and immunocytochemistry were performed. At 8 weeks post-transplantation, horseradish peroxidase nerve tracing and transmission electron microscopy were conducted to observe axonal regeneration. The outcome of hind limb motor function recovery in group C significantly surpassed that in group B at 4 weeks post-injury (P<0.05). Recovery was also observed in group A, but to a lesser degree. For the pathological sections no neural axonal were observed in group A. A few axon-like structures were observed in group B and more in group C. Horseradish peroxidase-labeled neurofibers and bromodeoxyuridine-positive cells were observed in the spinal cords of group C. Fewer of these cells were found in group B and fewer still in group A. The differences among the three groups were significant (P<0.05). Using transmission electron microscopy, newly formed nerve fibers and myelinated nerve fibers were observed in the central transverse plane in groups B and C, although these nerve fibers were not evident in group A. In conclusion, NSC transplantation promoted the recovery of hind limb function in rats, and combination treatment with hypothermia produced synergistic effects.	[Wang, Dong; Zhang, Jianjun] Tianjin Med Univ, Ctr Clin Coll 4, Dept Neurosurg, Tianjin 300140, Peoples R China; [Wang, Dong; Zhang, Jianjun] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China		Wang, D (corresponding author), Tianjin Med Univ, Ctr Clin Coll 4, Dept Neurosurg, 3 Zhongshan Rd, Tianjin 300140, Peoples R China.	dewangdong@163.com			Application Basis and Front Technology Projects of Tianjin (Science and Technology Foundation of Tianjin) [12JCYBJC18000]	This study was sponsored by the Application Basis and Front Technology Projects of Tianjin (Science and Technology Foundation of Tianjin, No. 12JCYBJC18000.	Arican N, 2006, INT J NEUROSCI, V116, P1249, DOI 10.1080/00207450600550303; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; BAKER AJ, 1991, STROKE, V22, P666, DOI 10.1161/01.STR.22.5.666; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Bhang SH, 2007, BIOCHEM BIOPH RES CO, V359, P40, DOI 10.1016/j.bbrc.2007.05.046; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Carvalho KAT, 2008, TRANSPL P, V40, P845, DOI 10.1016/j.transproceed.2008.02.054; Chen G, 2010, CHINESE MED J-PEKING, V123, P2424, DOI 10.3760/cma.j.issn.0366-6999.2010.17.025; CHURN SB, 1990, STROKE, V21, P1715, DOI 10.1161/01.STR.21.12.1715; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Furuya T, 2009, BRAIN RES, V1295, P192, DOI 10.1016/j.brainres.2009.07.087; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gressens P, 2008, BRAIN PATHOL, V18, P10, DOI 10.1111/j.1750-3639.2007.00095.x; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6; HANSEBOUT RR, 1985, CAN J NEUROL SCI, V12, P83, DOI 10.1017/S0317167100046758; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; HU BR, 1995, NEUROSCIENCE, V68, P1003, DOI 10.1016/0306-4522(95)00213-3; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; Hwang DH, 2014, J NEUROSCI, V34, P12788, DOI 10.1523/JNEUROSCI.5359-13.2014; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; Kobayashi MS, 2008, BRAIN RES REV, V58, P171, DOI 10.1016/j.brainresrev.2008.03.001; Kobbe P, 2009, UNFALLCHIRURG, V112, P1055, DOI 10.1007/s00113-009-1711-1; Ku JH, 2006, BJU INT, V98, P739, DOI 10.1111/j.1464-410X.2006.06395.x; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Kwon BK, 2008, SPINE J, V8, P859, DOI 10.1016/j.spinee.2007.12.006; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Li XH, 2014, ZHONGHUA CHUANG SHAN, V30, P500; LO EH, 1992, STROKE, V23, P889, DOI 10.1161/01.STR.23.6.889; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; Morino T, 2008, SPINAL CORD, V46, P425, DOI 10.1038/sj.sc.3102163; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Nguyen HP, 2010, ANESTHESIOLOGY, V113, P327, DOI 10.1097/ALN.0b013e3181dfd4f7; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Papadopoulos SM, 2002, J TRAUMA, V52, P323, DOI 10.1097/00005373-200202000-00019; ROKKAS CK, 1995, J THORAC CARDIOV SUR, V110, P27, DOI 10.1016/S0022-5223(05)80006-6; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; Shimohata T, 2007, J CEREBR BLOOD F MET, V27, P1463, DOI 10.1038/sj.jcbfm.9600450; Shimohata T, 2007, STROKE, V38, P375, DOI 10.1161/01.STR.0000254616.78387.ee; Sun Zhengang, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P165; SUTTON LN, 1991, STROKE, V22, P1567, DOI 10.1161/01.STR.22.12.1567; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Tohyama Y, 1998, EXP BRAIN RES, V122, P333, DOI 10.1007/s002210050521; Zausinger S, 2003, STROKE, V34, P1526, DOI 10.1161/01.STR.0000070841.31224.29; Zhao H, 2004, STROKE, V35, P572, DOI 10.1161/01.STR.0000110787.42083.58; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111; Zhao H, 2007, J NEUROSURG, V107, P636, DOI 10.3171/JNS-07/09/0636; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022	63	21	25	1	25	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAR	2015	11	3					1759	1767		10.3892/mmr.2014.2905			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CD2OA	WOS:000350917700028	25385306	Green Submitted, hybrid, Green Published			2022-02-06	
J	Yu, TS; Kim, A; Kernie, SG				Yu, Tzong-Shiue; Kim, Ahleum; Kernie, Steven G.			Donepezil Rescues Spatial Learning and Memory Deficits following Traumatic Brain Injury Independent of Its Effects on Neurogenesis	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GROWTH-FACTOR-I; PATTERN SEPARATION; MICE; RATS	Traumatic brain injury (TBI) is ubiquitous and effective treatments for it remain supportive largely due to uncertainty over how endogenous repair occurs. Recently, we demonstrated that hippocampal injury-induced neurogenesis is one mechanism underlying endogenous repair following TBI. Donepezil is associated with increased hippocampal neurogenesis and has long been known to improve certain aspects of cognition following many types of brain injury through unknown mechanisms. By coupling donepezil therapy with temporally regulated ablation of injury-induced neurogenesis using nestin-HSV transgenic mice, we investigated whether the pro-cognitive effects of donepezil following injury might occur through increasing neurogenesis. We demonstrate that donepezil itself enhances neurogenesis and improves cognitive function following TBI, even when injury-induced neurogenesis was inhibited. This suggests that the therapeutic effects of donepezil in TBI occur separately from its effects on neurogenesis.	[Kernie, Steven G.] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA		Kernie, SG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pediat, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Yu, Tzong-Shiue/0000-0003-4277-6213	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS083077]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS083077] Funding Source: NIH RePORTER	National Institutes of Health R21 NS083077, SK, TY, AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; Itou Y, 2011, HIPPOCAMPUS, V21, P446, DOI 10.1002/hipo.20761; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kotani S, 2008, CHEM-BIOL INTERACT, V175, P227, DOI 10.1016/j.cbi.2008.04.004; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	21	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118793	10.1371/journal.pone.0118793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	WOS:000350168700100	25714524	gold, Green Published, Green Submitted			2022-02-06	
J	Brucken, A; Kurnaz, P; Bleilevens, C; Derwall, M; Weis, J; Nolte, K; Rossaint, R; Fries, M				Bruecken, Anne; Kurnaz, Pinar; Bleilevens, Christian; Derwall, Matthias; Weis, Joachim; Nolte, Kay; Rossaint, Rolf; Fries, Michael			Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage	NEUROCRITICAL CARE			English	Article						Cardiopulmonary resuscitation; Hypoxia-ischemia, Brain; Reperfusion injury; Noble gases; Argon; Neuroprotective agents	TRAUMATIC BRAIN-INJURY; NOBLE-GAS ARGON; REDUCES NEUROHISTOPATHOLOGICAL DAMAGE; IN-VITRO MODEL; NEONATAL ASPHYXIA; XENON; RATS; NEUROPROTECTION; ISCHEMIA; PIGS	Argon at a dosage of 70 % is neuroprotective, when given 1 h after cardiac arrest (CA) in rats. We investigated if a neuroprotective effect of argon would also be observed, when administration was delayed. Twenty-four male Sprague-Dawley rats, weighing between 400 and 500 g were subjected to 7 min of CA and 3 min of cardiopulmonary resuscitation. Animals were randomized to receive either 1 h of 70 % argon ventilation 1 h (n = 8) or 3 h (n = 8) after return of spontaneous circulation or no argon treatment (n = 8). For all animals, a neurological deficit score (NDS) was calculated daily for 7 days following the experiment. On day 8, rats were re-anesthetized and transcardially perfused before brains were harvested for histopathological analyses. All animals survived. Control animals exhibited severe neurologic dysfunction at all time points as measured with the NDS. Argon-treated animals showed significant improvements in the NDS through all postoperative days, even when argon administration was delayed for 3 h. This was paralleled by a significant reduction in the neuronal damage index in the neocortex and the hippocampal CA 3/4 region in argon-treated animals, regardless of the timing of argon administration. However, animals of the delayed argon administration group additionally showed significant reductions in the basal ganglia in comparison with control animals. Our study demonstrates that a 1-h application of argon provided a significant reduction in histopathological damage, associated with a marked improvement in functional neurologic recovery even when treatment was delayed for 3 h. This is highly significant with regard to clinical situations, where argon treatment cannot be provided timely.	[Bruecken, Anne; Kurnaz, Pinar; Bleilevens, Christian; Derwall, Matthias; Rossaint, Rolf; Fries, Michael] Univ Hosp RWTH Aachen, Dept Anesthesiol, D-52074 Aachen, Germany; [Weis, Joachim; Nolte, Kay] Univ Hosp RWTH Aachen, Inst Neuropathol, D-52074 Aachen, Germany		Brucken, A (corresponding author), Univ Hosp RWTH Aachen, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	abruecken@ukaachen.de	Bleilevens, Christian/AAG-8034-2020; Weis, Joachim/G-1984-2014	Bleilevens, Christian/0000-0002-2104-1843; Weis, Joachim/0000-0003-3280-6773			Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Antonov A A, 2009, Aviakosm Ekolog Med, V43, P27; Arola OJ, 2013, CRIT CARE MED, V41, P2116, DOI 10.1097/CCM.0b013e31828a4337; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; David HN, 2013, N-S ARCH PHARMACOL, V386, P91, DOI 10.1007/s00210-012-0809-0; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Derwall M, 2009, MINERVA ANESTESIOL, V75, P37; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Idris AH, 1996, RESUSCITATION, V33, P69, DOI 10.1016/S0300-9572(96)01055-6; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ristagno G, 2014, SHOCK, V41, P72, DOI 10.1097/SHK.0000000000000049; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011; Soldatov P E, 1998, Aviakosm Ekolog Med, V32, P33; STARK RA, 1981, J APPL PHYSIOL, V51, P1355, DOI 10.1152/jappl.1981.51.5.1355; Yarin YM, 2005, HEARING RES, V201, P1, DOI 10.1016/j.heares.2004.09.015; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	30	21	22	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					112	120		10.1007/s12028-014-0029-1			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300015	25081369				2022-02-06	
J	Epstein, DS; Mitra, B; Cameron, PA; Fitzgerald, M; Rosenfeld, JV				Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.; Fitzgerald, Mark; Rosenfeld, Jeffrey V.			Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: Definition, incidence and outcomes	BRITISH JOURNAL OF NEUROSURGERY			English	Article						blood coagulation; brain injuries; coagulopathy; craniocerebral trauma; isolated head trauma; traumatic brain injury; wound and injuries	MASSIVE BLOOD-TRANSFUSION; FRESH-FROZEN PLASMA; TRANEXAMIC ACID; COAGULATION; PATHOGENESIS; EFFICACY; TRIAL	Background and objectives. Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and associated with poor outcomes. Among patients with iTBI, we aimed to select an appropriate definition of ATC, outline the incidence of ATC and examine clinical variables associated with ATC. Methods. A retrospective review of The Alfred Trauma Registry was conducted and patients with iTBI (head AIS [Abbreviated Injury Score] 3 and all other body regions AIS <3) were selected for analysis. The association of the international normalised ratio (INR) on arrival at hospital with the mortality on hospital discharge was explored, to select an appropriate clinical horizon to define ATC. The incidence of ATC was calculated using this definition. Injury and clinical variables measurable pre-hospital and immediately on arrival at the hospital were analysed to determine independent associations with ATC. Results. There were 1718 patients with iTBI included in the study. The overall mortality was 12%, but significantly greater when initial INR was measured at >= 1.3 (45.1%; p < 0.01). The proportion of patients with ATC, using this definition, was 7.7% (95% CI: 6.5-9.0). The pre-hospital variables independently associated with ATC in the setting of iTBI were age (OR 1.02,95% CI 1.01-1.03), shock index (SI) of >= 1 (OR 1.68,95% CI 1.01-2.79) and abnormal pupils (OR 8.33, 95% CI 4.50-15.89). The presence of at least two factors, of age >50 yrs, SI >= 1, or abnormal pupils, was 97.54% (95% Cl: 96.6-98.2) specific for ATC. Conclusions. An abnormal initial INR in the setting of iTBI was associated with poor outcomes, regardless of magnitude. The incidence of ATC appears too low to recommend empiric pro-coagulant management for all patients with iTBI. The subgroup of patients older than 50 yrs., with shock or abnormal size of pupils, may be considered for interventional trials of early treatment against ATC.	[Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3004, Australia; [Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cameron, Peter A.] Hamad Med Corp, Emergency Med, Doha, Qatar; [Fitzgerald, Mark] Alfred Hosp, Trauma Serv, Melbourne, Vic 3004, Australia; [Fitzgerald, Mark; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] USUHS, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD USA		Mitra, B (corresponding author), Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia.	b.mitra@alfred.org.au	Epstein, Daniel/AAQ-4181-2020; Mitra, Biswadev/AAC-3724-2019	Epstein, Daniel/0000-0003-2215-7749; Mitra, Biswadev/0000-0002-0508-2450; Cameron, Peter/0000-0002-1443-557X; Fitzgerald, Mark/0000-0003-0183-7761			Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gajic O, 2006, CRIT CARE MED, V34, pS170, DOI 10.1097/01.CCM.0000214288.88308.26; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gruen RL, 2011, LANCET, V377, P1052, DOI 10.1016/S0140-6736(11)60396-6; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mitra B, 2012, VOX SANG, V102, P324, DOI 10.1111/j.1423-0410.2011.01564.x; Mitra B, 2013, INJURY; Mitra B, 2012, INJURY, V43, P33, DOI 10.1016/j.injury.2011.10.011; Mitra B, 2011, RESUSCITATION, V82, P1208, DOI 10.1016/j.resuscitation.2011.04.007; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schierhout G, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000566, 10.1002/14651858. CD000566]; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Yuan S, 2007, THROMB RES, V120, P29, DOI 10.1016/j.thromres.2006.07.002; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	28	21	23	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2015	29	1					118	122		10.3109/02688697.2014.950632			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CE2KQ	WOS:000351644900033	25153987				2022-02-06	
J	Gando, S				Gando, Satoshi			Hemostasis and Thrombosis in Trauma Patients	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						trauma; traumatic brain injury; coagulopathy; fibrinolysis; disseminated intravascular coagulation; acute coagulopathy trauma shock; fat embolism syndrome	DISSEMINATED INTRAVASCULAR COAGULATION; MULTIPLE ORGAN DYSFUNCTION; SEVERE HEAD-INJURY; SERIAL LABORATORY EXAMINATION; CENTRAL-NERVOUS-SYSTEM; PROTEIN-C PATHWAY; BRAIN-INJURY; FAT-EMBOLISM; ACUTE COAGULOPATHY; TISSUE FACTOR	Hemostasis and thrombosis in trauma patients consist of physiological hemostasis for wound healing and the pathological reaction of disseminated intravascular coagulation (DIC). Whole body trauma, isolated brain injury, and fat embolism syndrome, if extremely severe, can cause DIC and affect a patient's prognosis. Shock-induced hyperfibrinolysis causes DIC with the fibrinolytic phenotype, contributing to oozing-type severe bleeding. If uncontrolled, this phenotype progresses to thrombotic phenotype at the late stage of trauma, followed by microvascular thrombosis, leading to organ dysfunction. Another type of pathological hemostatic change is acute coagulopathy of trauma shock (ACOTS), which gives rise to activated protein C-mediated systemic hypocoagulation, resulting in bleeding. ACOTS occurs only in trauma associated with shock-induced hypoperfusion and there is nothing to suggest DIC in this phenomenon. This review will provide information about the recent advances in hemostasis and thrombosis in trauma and will clarify the pathogeneses of the pathological processes observed in trauma patients.	[Gando, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med, Sapporo, Hokkaido 0608638, Japan		Gando, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med,Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	gando@med.hokudai.ac.jp	Gando, Satoshi/T-7407-2019	Gando, Satoshi/0000-0002-3525-0750			Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Arai F, 2007, ANESTHESIOLOGY, V107, P509, DOI 10.1097/01.anes.0000278898.62036.5f; Armstead VE, 1999, ANESTHESIOLOGY, V91, P1844, DOI 10.1097/00000542-199912000-00039; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; BERGENTZ SVEN-ERIK, 1961, ACTA CHIR SCAND, V122, P21; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Bouillon B, 2010, J TRAUMA, V68, P225, DOI 10.1097/TA.0b013e3181c42815; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chandler WL, 2010, AM J CLIN PATHOL, V134, P90, DOI 10.1309/AJCP3WPOYSKK6BFE; CLARK JA, 1980, J NEUROSURG, V52, P266, DOI 10.3171/jns.1980.52.2.0266; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Engelman DT, 1996, WORLD J SURG, V20, P5, DOI 10.1007/s002689900001; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Esmon CT, 1999, BEST PRACT RES CL HA, V12, P343, DOI 10.1053/beha.1999.0029; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; GANDO S, 1995, J TRAUMA, V39, P660, DOI 10.1097/00005373-199510000-00007; Gando S, 2013, J THROMB HAEMOST, V11, P826, DOI 10.1111/jth.12190; Gando S, 2012, J Thromb Haemost, V10, P2593; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gando S, 1990, Nihon Geka Gakkai Zasshi, V91, P17; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gando S, 2001, CRIT CARE MED, V29, P262, DOI 10.1097/00003246-200102000-00006; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618; Ito T, 2007, J THROMB HAEMOST, V5, P109, DOI 10.1111/j.1538-7836.2006.02255.x; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kao SJ, 2007, CLIN SCI, V113, P279, DOI 10.1042/CS20070011; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; LEVI M, 1993, JAMA-J AM MED ASSOC, V270, P975, DOI 10.1001/jama.270.8.975; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Marder VJ, 2006, HEMOSTASIS THROMBOSI, P1571; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; Mellor A, 2001, ANAESTHESIA, V56, P145, DOI 10.1046/j.1365-2044.2001.01724.x; Miller P, 2011, AM J FOREN MED PATH, V32, P291, DOI 10.1097/PAF.0b013e31822a6428; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Noel P, 2013, SEMIN HEMATOL, V50, P259, DOI 10.1053/j.seminhematol.2013.06.009; OKAJIMA K, 1994, AM J HEMATOL, V45, P16, DOI 10.1002/ajh.2830450104; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; Owings JT, 1997, SEMIN THROMB HEMOST, V23, P17; RISEBOROUGH EJ, 1976, CLIN ORTHOP RELAT R, P248; SALDEEN T, 1970, J TRAUM, V10, P273, DOI 10.1097/00005373-197004000-00001; SALDEEN T, 1970, J TRAUM, V10, P287, DOI 10.1097/00005373-197004000-00002; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Schrieber M, 2007, J TRAUMA, V63, P1261; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; SERCKHANSSEN A, 1965, ACTA PATHOL MIC SC, V65, P31, DOI 10.1111/apm.1965.65.1.31; Shier M R, 1980, Surg Annu, V12, P139; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; STUMP DC, 1990, SEMIN THROMB HEMOST, V16, P260, DOI 10.1055/s-2007-1002678; SUFFREDINI AF, 1989, NEW ENGL J MED, V320, P1165, DOI 10.1056/NEJM198905043201802; TAYLOR F, 1991, BLOOD, V78, P357, DOI 10.1182/blood.V78.2.357.357; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; TOVI D, 1973, ACTA NEUROL SCAND, V49, P152; Wu Xue-Hai, 2003, Chin J Traumatol, V6, P114; Yanagida Y, 2013, SURGERY, V154, P48, DOI 10.1016/j.surg.2013.02.004; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	99	21	23	0	16	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	FEB	2015	41	1					26	34		10.1055/s-0034-1398378			9	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	CA9HZ	WOS:000349234700005	25602698				2022-02-06	
J	Isaac, L; Main, KL; Soman, S; Gotlib, IH; Furst, AJ; Kinoshita, LM; Fairchild, JK; Yesavage, JA; Ashford, JW; Bayley, PJ; Adamson, MM				Isaac, Linda; Main, Keith L.; Soman, Salil; Gotlib, Ian H.; Furst, Ansgar J.; Kinoshita, Lisa M.; Fairchild, J. Kaci; Yesavage, Jerome A.; Ashford, J. Wesson; Bayley, Peter J.; Adamson, Maheen M.			The impact of depression on Veterans with PTSD and traumatic brain injury: A diffusion tensor imaging study	BIOLOGICAL PSYCHOLOGY			English	Article						Depression; PTSD; TBI; Emotion; DTI; Veterans	WHITE-MATTER ABNORMALITIES; ANTERIOR CINGULATE CORTEX; LATE-LIFE DEPRESSION; MAJOR DEPRESSION; PREFRONTAL CORTEX; EMOTION REGULATION; WORKING-MEMORY; DISORDER; STRESS; TRACTOGRAPHY	A significant proportion of military personnel deployed in support of Operation Enduring Freedom and Operation Iraqi Freedom were exposed to war-zone events associated with traumatic brain injury (TBI), depression (DEP) and posttraumatic stress disorder (PTSD). The co-occurrence of TBI, PTSD and DEP in returning Veterans has recently increased research and clinical interest. This study tested the hypothesis that white matter abnormalities are further impacted by depression. Of particular relevance is the uncinate fasciculus (UF), which is a key fronto-temporal tract involved in mood regulation, and the cingulum; a tract that connects to the hippocampus involved in memory integration. Diffusion tensor imaging (DTI) was performed on 25 patients with a combination of PTSD, TBI and DEP and 20 patients with PTSD and TBI (no DEP). Microstructural changes of white matter were found in the cingulum and UF. Fractional anisotropy (FA) was lower in Veterans with DEP compared to those without DEP. Published by Elsevier B.V.	[Isaac, Linda; Main, Keith L.; Soman, Salil; Furst, Ansgar J.; Ashford, J. Wesson; Bayley, Peter J.; Adamson, Maheen M.] Vet Affairs Palo Alto HealthCare Syst, War Related Illness & Injury Study Ctr, Palo Alto, CA 94304 USA; [Isaac, Linda; Main, Keith L.; Furst, Ansgar J.; Fairchild, J. Kaci; Yesavage, Jerome A.; Ashford, J. Wesson; Bayley, Peter J.; Adamson, Maheen M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Furst, Ansgar J.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Soman, Salil] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Gotlib, Ian H.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Kinoshita, Lisa M.; Fairchild, J. Kaci; Yesavage, Jerome A.] Vet Affairs Palo Alto HealthCare Syst, Palo Alto, CA USA		Isaac, L (corresponding author), Vet Affairs Palo Alto HealthCare Syst, War Related Illness & Injury Study Ctr, Palo Alto, CA 94304 USA.	lisaac@stanford.edu	Ashford, J. Wesson/D-3929-2009	Adamson, Maheen/0000-0002-1534-4063; Soman, Salil/0000-0002-5887-0717	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH059259] Funding Source: Medline		Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Benotsch EG, 2000, J ABNORM PSYCHOL, V109, P205, DOI 10.1037//0021-843X.109.2.205; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Brewin C. R., 2012, J ABNORM PSYCHOL, V118, P767; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Colloby SJ, 2011, J AFFECT DISORDERS, V135, P216, DOI 10.1016/j.jad.2011.07.025; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Demeyer I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065429; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Gross J. J., 2008, HDB EMOTIONS, V3, P497; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; Hedges DW, 2007, NEUROCASE, V13, P402, DOI 10.1080/13554790701851551; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horesh D, 2013, PSYCHIAT RES, V208, P265, DOI 10.1016/j.psychres.2012.12.004; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Joormann J, 2008, J ABNORM PSYCHOL, V117, P182, DOI 10.1037/0021-843X.117.1.182; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177; Lange G, 2013, MIL MED, V178, P705, DOI 10.7205/MILMED-D-13-00053; Li LJ, 2007, BRAIN RES, V1168, P124, DOI 10.1016/j.brainres.2007.06.094; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Oishi K., 2011, MRI ATLAS HUMAN WHIT, V2nd Edn.; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Runnals JJ, 2013, PAIN MED; Schecklmann M, 2011, PSYCHIAT RES-NEUROIM, V194, P378, DOI 10.1016/j.pscychresns.2011.01.016; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Sutker PB, 1996, PSYCHOL ASSESSMENT, V8, P18, DOI 10.1037/1040-3590.8.1.18; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 1939, MEASUREMENT ADULT IN; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Zhang AF, 2013, NEUROPSYCHOPHARMACOL, V38, P1451, DOI 10.1038/npp.2013.41; Zhang WH, 2008, NEUROIMAGE, V42, P771, DOI 10.1016/j.neuroimage.2008.04.241; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049; Zivin K., 2007, PSYCHIAT SERV, V63, P823	64	21	25	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	FEB	2015	105						20	28		10.1016/j.biopsycho.2014.12.011			9	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	CB8WH	WOS:000349912100002	25559772				2022-02-06	
J	Khodaie, B; Lotfinia, AA; Ahmadi, M; Lotfinia, M; Jafarian, M; Karimzadeh, F; Coulon, P; Gorji, A				Khodaie, Babak; Lotfinia, Ahmad Ali; Ahmadi, Milad; Lotfinia, Mahmoud; Jafarian, Maryam; Karimzadeh, Fariba; Coulon, Philippe; Gorji, Ali			Structural and functional effects of social isolation on the hippocampus of rats with traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Memory impairment; Brain trauma; Cell death; Neuronal damage; Cognition	SPREADING DEPRESSION; PHYSICAL-ACTIVITY; NEURONAL DEATH; HEART-DISEASE; RISK-FACTORS; CELL-DEATH; OPEN-FIELD; STRESS; STROKE; MILD	Social isolation has significant long-term psychological and physiological consequences. Both social isolation and traumatic brain injury (TBI) alter normal brain function and structure. However, the influence of social isolation on recovery from TBI is unclear. This study aims to evaluate if social isolation exacerbates the anatomical and functional deficits after TBI in young rats. juvenile male rats were divided into four groups; sham operated control with social contacts, sham control with social isolation, TBI with social contacts, and TBI with social isolation. During four weeks after brain injury in juvenile rats, we evaluated the animal behaviors by T-maze and open-field tests, recorded brain activity with electrocorticograms and assessed structural changes by histological procedures in the hippocampal dentate gyrus, CA1, and CA3 areas. Our findings revealed significant memory impairments and hyperactivity conditions in rats with TBI and social isolation compared to the other groups. Histological assessments showed an increase of the mean number of dark neurons, apoptotic cells, and caspase-3 positive cells in all tested areas of the hippocampus in TBI rats with and without social isolation compared to sham rats. Furthermore, social isolation significantly increased the number of dark cells, apoptotic neurons, and caspase-3 positive cells in the hippocampal CA3 region in rats with TBI. This study indicates the harmful effect of social isolation on anatomical and functional deficits induced by TBI in juvenile rats. Prevention of social isolation may improve the outcome of TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Khodaie, Babak; Lotfinia, Ahmad Ali; Ahmadi, Milad; Lotfinia, Mahmoud; Jafarian, Maryam; Karimzadeh, Fariba; Gorji, Ali] Khatam Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Khodaie, Babak; Lotfinia, Ahmad Ali; Ahmadi, Milad] Islamic Azad Univ, Karaj Branch, Fac Vet Med, Karaj, Iran; [Lotfinia, Mahmoud] Shahid Beheshti Med Univ, Sch Med, Tehran, Iran; [Coulon, Philippe; Gorji, Ali] Univ Munster, Epilepsy Res Ctr, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Klin & Poliklin Neurochirurg, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Inst Neurophysiol, D-48149 Munster, Germany		Gorji, A (corresponding author), Univ Munster, Epilepsy Res Ctr, Robert Koch Str 27a, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Coulon, Philippe/I-9214-2016; Meijer, Anna/K-5118-2016; Karimzadeh, Fathallah/ABA-6967-2021; Karimzadeh, Fariba/O-3897-2015	Coulon, Philippe/0000-0001-8350-5837; Karimzadeh, Fathallah/0000-0002-7561-5021; Karimzadeh, Fariba/0000-0002-8805-3486; Gorji, Ali/0000-0002-4557-3270	Shefa Neuroscience Center [25609]	This work was funded by the Shefa Neuroscience Center grant related to Dr-Thesis 25609.	Arranz Lorena, 2009, Rev Esp Geriatr Gerontol, V44, P137, DOI 10.1016/j.regg.2008.12.001; Barratt RL, 2011, CONTEMP NURSE, V39, P180, DOI 10.5172/conu.2011.180; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Boden-Albala B, 2005, NEUROLOGY, V64, P1888, DOI 10.1212/01.WNL.0000163510.79351.AF; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Charbonnier F, 2007, MOL NEUROBIOL, V35, P217, DOI 10.1007/s12035-007-0027-9; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Filipovic D, 2013, NEUROSCIENCE, V236, P47, DOI 10.1016/j.neuroscience.2013.01.033; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Garrido P, 2013, J NEURAL TRANSM, V120, P829, DOI 10.1007/s00702-012-0935-3; Gaskin Philip L R, 2014, Psychopharmacology (Berl), V231, P2533, DOI 10.1007/s00213-013-3424-y; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grant N, 2009, ANN BEHAV MED, V37, P29, DOI 10.1007/s12160-009-9081-z; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Huang E, 2013, BRAIN RES, V1529, P125, DOI 10.1016/j.brainres.2013.06.042; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; Ikeda A, 2008, STROKE, V39, P768, DOI 10.1161/STROKEAHA.107.496695; Inta D, 2013, J NEURAL TRANSM, V120, P1605, DOI 10.1007/s00702-013-1049-2; Jafarian M, 2010, NEUROSCIENCE, V169, P388, DOI 10.1016/j.neuroscience.2010.04.062; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jones CA, 2011, PSYCHOPHARMACOLOGY, V214, P269, DOI 10.1007/s00213-010-1931-7; Karimzadeh F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-76; Kherani ZS, 2008, ACTA NEUROPATHOL, V116, P447, DOI 10.1007/s00401-008-0386-y; Kurina LM, 2011, SLEEP, V34, P1519, DOI 10.5665/sleep.1390; Lapiz M D S, 2003, Neurosci Behav Physiol, V33, P13, DOI 10.1023/A:1021171129766; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moragrega I, 2003, BEHAV BRAIN RES, V147, P1, DOI 10.1016/S0166-4328(03)00112-8; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; O'Keefe LM, 2014, BEHAV BRAIN RES, V260, P162, DOI 10.1016/j.bbr.2013.10.047; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Reboucas RCR, 1997, PHYSIOL BEHAV, V62, P1159, DOI 10.1016/S0031-9384(97)00312-0; RINK A, 1995, AM J PATHOL, V147, P1575; ROBINSON N, 1969, J NEUROL NEUROSUR PS, V32, P317, DOI 10.1136/jnnp.32.4.317; Sachs M, 2007, NEUROBIOL DIS, V25, P27, DOI 10.1016/j.nbd.2006.08.013; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Spalletta G, 2006, MOL PSYCHIATR, V11, P984, DOI 10.1038/sj.mp.4001879; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Venna VR, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.128; Weil ZM, 2008, MOL PSYCHIATR, V13, P913, DOI 10.1038/mp.2008.70; Whitaker LR, 2013, NEURON, V77, P335, DOI 10.1016/j.neuron.2012.11.022; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	50	21	23	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2015	278						55	65		10.1016/j.bbr.2014.09.034			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AY5AQ	WOS:000347586300007	25264185				2022-02-06	
J	Vernau, BT; Grady, MF; Goodman, A; Wiebe, DJ; Basta, L; Park, Y; Arbogast, KB; Master, CL				Vernau, Brian T.; Grady, Matthew F.; Goodman, Arlene; Wiebe, Douglas J.; Basta, Luke; Park, Yong; Arbogast, Kristy B.; Master, Christina L.			Oculomotor and Neurocognitive Assessment of Youth Ice Hockey Players: Baseline Associations and Observations After Concussion	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CONVERGENCE INSUFFICIENCY; NEARPOINT; CHILDREN; MEMORY	Baseline scores on the King-Devick (K-D) Test, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Sport Concussion Assessment Tool 3 (SCAT3), and convergence were evaluated in youth hockey players. Worse K-D times were associated with worse ImPACT visual motor speed and reaction time. Eleven concussed athletes were retested, and there was a trend toward improved ImPACT and K-D times compared to baseline.	[Vernau, Brian T.; Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Dept Surg, Div Orthoped, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Grady, Matthew F.] Univ Penn, Perelman Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; [Goodman, Arlene] St Peters Sports Med Inst, Somerset, NJ USA; [Wiebe, Douglas J.; Basta, Luke] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Park, Yong] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Dept Pediat, Ctr Injury Res & Prevent,Div Emergency Med, Philadelphia, PA 19104 USA; [Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Master, CL (corresponding author), Childrens Hosp Philadelphia, Div Gen Pediat, Div Orthoped, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	masterc@email.chop.edu	Wiebe, Douglas J/Q-1168-2017	Arbogast, Kristy/0000-0002-1694-4562; Master, Christina/0000-0002-6717-4270			Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Rouse MW, 1998, OPTOMETRY VISION SCI, V75, P88, DOI 10.1097/00006324-199802000-00012; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2008, OPHTHAL EPIDEMIOL, V15, P24, DOI 10.1080/09286580701772037; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x	10	21	21	1	22	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JAN 2	2015	40	1			SI		7	11		10.1080/87565641.2014.971955			5	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CA6IR	WOS:000349015800002	25649773				2022-02-06	
J	Bor, N; Rubin, G; Rozen, N; Herzenberg, JE				Bor, Noam; Rubin, Guy; Rozen, Nimrod; Herzenberg, John E.			Chronic Anterior Monteggia Lesions in Children: Report of 4 Cases Treated With Closed Reduction by Ulnar Osteotomy and External Fixation	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						Monteggia fracture dislocation; external fixation; radial head dislocation; ulnar fracture	RADIAL-HEAD DISLOCATION; FRACTURE-DISLOCATIONS; MANAGEMENT; RECONSTRUCTION; ELBOW	Background: Chronic, subacute, and chronic Monteggia fracture dislocations of the elbow are challenging problems. The literature generally recommends complex open reconstructive procedures. We present an alternative, minimally invasive, percutaneous method with external fixation. Methods: This was a retrospective review of 4 cases presenting with chronic Monteggia lesions with anterior dislocation of the radial head. Results: Reduction of the radiocapitellar joint was successfully achieved in all patients after ulnar osteotomy and gradual correction using the Ilizarov external fixation. Open reduction or reconstruction of the radio-ulnar-capitellar joint and/or ligament was not undertaken. The patients were between 9 and 11 years of age at the time of injury. The time from injury to treatment was between 3 and 56 months. At follow-up of an average of 3.5 years (range, 2 to 6 y), all patients had full movement of the elbow and normal function of the forearm. Radiographically, all radial heads were well reduced and the ulnar osteotomy showed remodeling. Conclusions: The technique is relatively simple and avoids the risks and technical challenges of open osteotomies, open reduction, and ligament reconstruction. Gradual reduction of the radial head with the aid of an external fixation is a safe and effective method of treatment for chronic Monteggia lesions.	[Bor, Noam; Rubin, Guy; Rozen, Nimrod] Haemek Med Ctr, Dept Orthopaed Surg, Pediat Orthopaed Unit, Afula, Israel; [Bor, Noam; Rubin, Guy; Rozen, Nimrod] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Herzenberg, John E.] Sinai Hosp, Rubin Inst Adv Orthoped, Int Ctr Limb Lengthening, Baltimore, MD 21215 USA		Bor, N (corresponding author), 1 Saknai St, IL-18753 Afula, Israel.	noambor@yahoo.com	Rubin, Guy/AAN-8891-2020	Rubin, Guy/0000-0002-1032-7280			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Belangero WD, 2007, INT ORTHOP, V31, P151, DOI 10.1007/s00264-006-0153-4; Bell Tawse AJ, 1965, J BONE JOINT SURG BR, V47, P718; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; De Boeck H, 2000, CLIN ORTHOP RELAT R, P215; DeBoeck H, 1997, CLIN ORTHOP RELAT R, P94; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88, DOI 10.1302/0301-620X.87B1.14669; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; LINCOLN TL, 1994, J PEDIATR ORTHOPED, V14, P454, DOI 10.1097/01241398-199407000-00006; Lu XM, 2013, J PEDIATR ORTHOPED, V33, P398, DOI 10.1097/BPO.0b013e3182812762; Monteggia GB., 1814, INSTITUZIONI CHIRURG; Papandrea R, 2000, CLIN ORTHOP RELAT R, P115; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000156480.76450.04; Song KS, 2012, J ORTHOP TRAUMA, V26, P597, DOI 10.1097/BOT.0b013e3182548981; Wilkins KE, 2002, J PEDIATR ORTHOPED, V22, P548, DOI 10.1097/01.BPO.0000019211.02000.60	21	21	26	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN	2015	35	1					7	10		10.1097/BPO.0000000000000203			4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	AW3MC	WOS:000346189800003	24787311				2022-02-06	
J	Delahunty, SE; Delahunt, E; Condon, B; Toomey, D; Blake, C				Delahunty, Sinead E.; Delahunt, Eamonn; Condon, Brian; Toomey, David; Blake, Catherine			Prevalence of and Attitudes About Concussion in Irish Schools' Rugby Union Players	JOURNAL OF SCHOOL HEALTH			English	Article						health communication; concussion; rugby; adolescents	SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; KNOWLEDGE TRANSFER; FOOTBALL PLAYERS; MANAGEMENT; IMPLEMENTATION; PREVENTION; GUIDELINES; EDUCATION	BACKGROUNDYouth rugby players represent 45.2% (N=69,472) of the Irish rugby union playing population. The risk and consequences of concussion injury are of particular concern in these young athletes, but limited epidemiological data exists. This study investigated annual and lifetime prevalence of concussion in an Irish schoolboy rugby union cohort. METHODSAn anonymous cross-sectional survey of youth rugby players was conducted. Diagnosed concussion was defined as an incident where diagnosis was confirmed by a health professional or coach. Demographics, prevalence, and attitudes to concussion were collated. Data were analyzed with descriptive statistics, chi-square test, t-tests, Mann-Whitney tests, and logistic regression. RESULTSOverall, 304 youth (aged 12-18years) responded. Lifetime prevalence of diagnosed concussion was 19.4%, with annual (2010) prevalence 6.6%. Approximately 25.4% of players with diagnosed concussions returned to play without medical advice. Internal motivation (11.8%) was the predominant factor in feeling pressure to play while concussed. A desire for further concussion education was expressed by 89.5% of participants. CONCLUSIONSReform is required to prevent and manage concussion injuries among youth players in the rugby union, including mandatory education specific to concussion and implementation of return-to-play protocols. These findings have relevance for governing bodies, coaches, clinicians, schools, parents, and rugby union players.	[Delahunty, Sinead E.; Delahunt, Eamonn; Condon, Brian; Toomey, David; Blake, Catherine] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Hlth Sci Ctr, Dublin 4, Ireland		Delahunty, SE (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Hlth Sci Ctr, Dublin 4, Ireland.	sineaddelahunty@gmail.com; eamonn.delahunt@uccl.ie; bcondon89@gmail.com; cdavidtoomey2@gmail.com; cblake@uccl.ie	Blake, Catherine/M-6728-2016	Blake, Catherine/0000-0002-0600-629X; Delahunt, Eamonn/0000-0001-5449-5932			Ahmed O, 2013, J COMMUNITY INFORM; Australian Rugby, SMARTRUGBY; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bramley HP, 2011, CLIN PAEDIAT PHILA, DOI 10.1177/0009922811425233; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Covassion T, 2012, J SCH HLTH; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hart E, 2011, FAC SPORTS EX MED AN; Herring SA, 2011, MED SCI SPORTS EXERC, V43, P2412; Hollis SJ, 2011, BR J SPORTS MED, DOI 10.1136/bjsm.2011.085332; Immediate Post-concussive Assessment and Cognitive Testing (ImPACT) Applications Inc, IMPACT TEST; International Rugby Board (IRB), IRB CONC POST REC RE; International Rugby Board (IRB), IRB CONC GUID; Irish Rugby Football Union, 2009 2010 LANDM YEAR; Irish Rugby Football Union, GUID CONC RUGB UN; Irish Rugby Football Union, STOP REST INFORM RET; Irish Rugby Football Union, SAFE RUGB; Johnson LSM, 2011, J SCH HLTH, V82, P180; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; New Zealand Rugby Union, RUGBYSMART; O'Rourke KP, 2007, INJURY, V38, P104, DOI 10.1016/j.injury.2006.06.010; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; South African Rugby Union, BOKSMART; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Ulster Rugby, PLAY WELF SEM; US Department of Health and Human Services Centers for Disease Control and Prevention and National Center for Injury Prevention and Control Division of Injury Response, HEADS CONC YOUTH SPO; Viikari-Juntara E, 1996, SCAND J WORK ENV HEA, V22, P259; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278	44	21	23	1	60	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	JAN	2015	85	1					17	26		10.1111/josh.12219			10	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	AU7DP	WOS:000345761200003	25440449				2022-02-06	
J	Newsome, MR; Durgerian, S; Mourany, L; Scheibel, RS; Lowe, MJ; Beall, EB; Koenig, KA; Parsons, M; Troyanskaya, M; Reece, C; Wilde, E; Fischer, BL; Jones, SE; Agarwal, R; Levin, HS; Rao, SM				Newsome, Mary R.; Durgerian, Sally; Mourany, Lyla; Scheibel, Randall S.; Lowe, Mark J.; Beall, Erik B.; Koenig, Katherine A.; Parsons, Michael; Troyanskaya, Maya; Reece, Christine; Wilde, Elisabeth; Fischer, Barbara L.; Jones, Stephen E.; Agarwal, Rajan; Levin, Harvey S.; Rao, Stephen M.			Disruption of caudate working memory activation in chronic blast-related traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; fMRI; Cortical plasticity; Working memory; Concussion; Veteran	POSTTRAUMATIC-STRESS-DISORDER; BASAL GANGLIA; RESPONSE-INHIBITION; PARKINSONS-DISEASE; HEAD-INJURY; INDIVIDUAL-DIFFERENCES; INDUCED NEUROTRAUMA; MILITARY PERSONNEL; COGNITIVE FUNCTION; TEMPORAL DYNAMICS	Mild to moderate traumatic brain injury (TBI) due to blast exposure is frequently diagnosed in veterans returning from the wars in Iraq and Afghanistan. However, it is unclear whether neural damage resulting from blast TBI differs from that found in TBI due to blunt-force trauma (e.g., falls and motor vehicle crashes). Little is also known about the effects of blast TBI on neural networks, particularly over the long term. Because impairment in working memory has been linked to blunt-force TBI, the present functional magnetic resonance imaging (fMRI) study sought to investigate whether brain activation in response to a working memory task would discriminate blunt-force from blast TBI. Twenty-five veterans (mean age=29.8 years, standard deviation=6.01 years, 1 female) who incurred TBI due to blast an average of 4.2 years prior to enrollment and 25 civilians (mean age = 27.4 years, standard deviation=6.68 years, 4 females) with TBI due to blunt-force trauma performed the Sternberg Item Recognition Task while undergoing fMRI. The task involved encoding 1, 3, or 5 items in working memory. A group of 25 veterans (mean age=29.9 years, standard deviation=5.53 years, 0 females) and a group of 25 civilians (mean age = 27.3 years, standard deviation = 5.81 years, 0 females) without history of TBI underwent identical imaging procedures and served as controls. Results indicated that the civilian TBI group and both control groups demonstrated a monotonic relationship between working memory set size and activation in the right caudate during encoding, whereas the blast TBI group did not (p < 0.05, corrected for multiple comparisons using False Discovery Rate). Blast TBI was also associated with worse performance on the Sternberg Item Recognition Task relative to the other groups, although no other group differences were found on neuropsychological measures of episodic memory, inhibition, and general processing speed. These results could not be attributed to caudate atrophy or the presence of PTSD symptoms. Our results point to a specific vulnerability of the caudate to blast injury. Changes in activation during the Sternberg Item Recognition Task, and potentially other tasks that recruit the caudate, may serve as biomarkers for blast TBI. (C) 2015 The Authors. Published by Elsevier Inc.	[Newsome, Mary R.; Scheibel, Randall S.; Troyanskaya, Maya; Wilde, Elisabeth; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Res Serv Line, Houston, TX USA; [Newsome, Mary R.; Scheibel, Randall S.; Troyanskaya, Maya; Wilde, Elisabeth; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Durgerian, Sally] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Mourany, Lyla; Parsons, Michael; Reece, Christine; Rao, Stephen M.] Cleveland Clin, Neurol Inst, Schey Ctr Cognit Neuroimaging, 9500 Euclid Ave U10, Cleveland, OH 44195 USA; [Lowe, Mark J.; Beall, Erik B.; Koenig, Katherine A.; Jones, Stephen E.] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Fischer, Barbara L.] Wm S Middleton Mem Vet Affairs Hosp, GRECC, Madison, WI USA; [Agarwal, Rajan] Michael E DeBakey VA Med Ctr, Diagnost & Therapeut Care, Houston, TX USA; [Agarwal, Rajan] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA		Rao, SM (corresponding author), Cleveland Clin, Neurol Inst, Schey Ctr Cognit Neuroimaging, 9500 Euclid Ave U10, Cleveland, OH 44195 USA.	raos2@ccf.org	Rao, Stephen M/A-2460-2010; Koenig, Katherine/K-1564-2019	Rao, Stephen M/0000-0002-6463-7460; Koenig, Katherine/0000-0002-1504-7130; Durgerian, Sally/0000-0003-3931-9679	U.S Department of DefenseUnited States Department of Defense [W81XWH-08-2-0124, W81XWH-10-1-0609]; Department of Veterans Affairs, Veterans Health Administration, Office of Rehabilitation Research and Development, Traumatic Brain Injury Center of Excellence [B6812C]; Veterans AffairsUS Department of Veterans Affairs [I21RX001608] Funding Source: NIH RePORTER	This study was supported by grants from the U.S Department of Defense (W81XWH-08-2-0124, W81XWH-10-1-0609) and was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Rehabilitation Research and Development, Project #B6812C Traumatic Brain Injury Center of Excellence. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs. There are no potential conflicts of interest, including financial, between any of the authors and the work presented in this manuscript. We are grateful to the veterans taking part in the research. Thanks to laboratory members who provided helpful contributions: Gregory Vogt, Xiaodi Lin, Tricia Merkley, Rebecca Marsh, Brian Taylor, and Mark Walker.	Acheson DJ, 2009, PSYCHOL BULL, V135, P50, DOI 10.1037/a0014411; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Ashby FG, 2005, J COGNITIVE NEUROSCI, V17, P1728, DOI 10.1162/089892905774589271; Babor T.F., 2001, AUDIT THE ALCOHOL US; Baddeley A.D., 1986, WORKING MEMORY; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Delis D.C., 2000, CALIFORNIA VERBAL LE; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dretsch M. N., 2014, J NEUROTRAUMA; Erpelding N, 2013, PAIN, V154, P2060, DOI 10.1016/j.pain.2013.06.030; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gordon EM, 2015, CEREB CORTEX, V25, P336, DOI 10.1093/cercor/bht229; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hamster K., 1983, MULTILINGUAL APHASIA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; JOHNSONLAIRD PN, 1994, COGNITION, V50, P189, DOI 10.1016/0010-0277(94)90028-0; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levy R, 1997, J NEUROSCI, V17, P3870; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Marklund P, 2009, BRAIN, V132, P336, DOI 10.1093/brain/awn309; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Murty VP, 2011, NEUROIMAGE, V57, P1264, DOI 10.1016/j.neuroimage.2011.05.006; Ness V, 2013, NEUROPSYCHOLOGIA, V51, P2562, DOI 10.1016/j.neuropsychologia.2013.09.032; Nikolaidis A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00169; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; TEASDALE G, 1974, LANCET, V2, P81; Tian FH, 2014, NEUROIMAGE-CLIN, V4, P808, DOI 10.1016/j.nicl.2014.05.005; van Wingen GA, 2012, MOL PSYCHIATR, V17, P116, DOI 10.1038/mp.2011.110; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Wishart HA, 2011, J INT NEUROPSYCH SOC, V17, P174, DOI 10.1017/S1355617710001402; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	86	21	21	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2015	8						543	553		10.1016/j.nicl.2015.04.024			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI0LE	WOS:000373187100058	26110112	gold, Green Published			2022-02-06	
J	Norup, A; Mortensen, EL				Norup, Anne; Mortensen, Erik Lykke			Prevalence and Predictors of Personality Change After Severe Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Brain injuries; traumatic; Family members; Personality; Prevalence; Rehabilitation	BLUNT HEAD-INJURY; RELATIVES VIEW; DISTRESS; TRAITS	Objectives: To investigate the prevalence of personality change after severe brain injury; to identify predictors of personality change; and to investigate whether personality change is associated with distress in family members. Design: A longitudinal study of personality change. Setting: Rehabilitation unit. Participants: The study sample was composed of 22 pairs of patients with traumatic brain injury or nontraumatic brain injury (N=22) and their significant others (SOs). Interventions: Not applicable. Main Outcome Measures: An SO completed the observer version of the NEO Five Factor Inventory rating the patient at discharge from hospital and 1 year after injury. The SOs were also asked to complete the anxiety and depression scales of the Symptom Checklist-90-Revised, rating their own emotional condition and health-related quality of life (HRQOL) as assessed by the 4 mental scales of the Medical Outcomes Study 36-Item Short-Form Health Survey. Results: Of the sample, 59.1% experienced personality change after acquired brain injury, and the most dominant changes were observed in the personality traits of neuroticism, extraversion, and conscientiousness. Changes in neuroticism were most often observed in patients with frontal or temporal lesions. Generally, personality changes in patients were not associated with more distress and lower HRQOL in family members; however, change in patient agreeableness was associated with lower HRQOL on the role limitations-emotional scale. Conclusions: Personality change was observed in most patients with severe brain injury. Change in neuroticism was associated with frontal and temporal lesions. Generally, personality change was not associated with more distress and lower HRQOL in SOs. (C) 2015 by the American Congress of Rehabilitation Medicine	[Norup, Anne] Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, RUBRIC,Res Unit BRain Injury Rehabil Copenhagen, Glostrup, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark		Norup, A (corresponding author), Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	anne.norup@regionh.dk		Norup, Anne/0000-0002-5598-6116			Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bjorner JB, 1997, DANISH MANUAL SF36 H; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Costa PT, 1989, NEO  PIRNEOFFI MANUA; Derogatis LR, 2006, SCL90R MANUAL; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, pE14, DOI 10.1176/appi.neuropsych.23.2.E14; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Labbate L A, 1997, Ann Clin Psychiatry, V9, P27, DOI 10.3109/10401239709147771; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lishman W. A., 1997, ORGANIC PSYCHIAT; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; McCrae R.R., 2003, PERSONALITY ADULTHOO, V2nd; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; Norup A, 2013, THESIS U COPENHAGEN, Vdissertation; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Skovdahl Hansen H, 2004, NEO PI R MANUAL KLIN, P53; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062	27	21	22	2	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2015	96	1					56	62		10.1016/j.apmr.2014.08.009			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AY6EW	WOS:000347661100008	25193491				2022-02-06	
J	Prasanna, KL; Mittal, RS; Gandhi, A				Prasanna, K. L.; Mittal, R. S.; Gandhi, Ashok			Neuroendocrine dysfunction in acute phase of moderate-to-severe traumatic brain injury: A prospective study	BRAIN INJURY			English	Article						Endocrine; pituitary; traumatic brain injury	GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEAD-INJURY; PITUITARY DYSFUNCTION; PLASMA-CORTISOL; ADULT PATIENTS; FACTOR-I; HYPOPITUITARISM; ABNORMALITIES; REHABILITATION	Objectives: Most of the retrospective studies have demonstrated that traumatic brain injury mediated hypopituitarism could be more frequent than previously known. Therefore, this study has prospectively investigated pituitary function and their correlation with severity, pressure effect and Glasgow Outcome Scale in the acute phase of moderate-to-severe traumatic brain injury. Patients and methods: One hundred consecutive moderate-to-severe traumatic brain injury patients from August 2012 to November 2013 formed the study group. Apart from clinical assessment, non-contrast computed tomography of the head was performed on all patients on admission. The hormonal analysis (fT3, fT4, TSH, GH, Cortisol, Prolactin) was performed within 24 hours of traumatic brain injury and was repeated on the 7th day amongst the patients who survived. Results: Growth hormone was the most common hormone to decrease. Cortisol was the most common hormone to increase. Risk of pituitary insufficiency was increased in patients with severe traumatic brain injury, patients with increased intracranial pressure and who had low Glasgow Outcome Scale. Conclusion: Neuroendocrine dysfunction occurs often in the acute phase of moderate-to-severe traumatic brain injury, more commonly in patients with severe traumatic brain injury, patients with pressure effects and low Glasgow Outcome Scale. Hormonal analysis should be considered in patients with moderate-to-severe traumatic brain injury, so that appropriate hormonal replacement can be done to optimize the clinical outcome.	[Prasanna, K. L.; Mittal, R. S.; Gandhi, Ashok] SMS Med Coll & Hosp, Dept Neurosurg, Jaipur 302004, Rajasthan, India		Prasanna, KL (corresponding author), SMS Med Coll & Hosp, Dept Neurosurg, JLN Marg, Jaipur 302004, Rajasthan, India.	drprasannakl@yahoo.co.in					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BINNERTS A, 1992, AM J CLIN NUTR, V55, P918, DOI 10.1093/ajcn/55.5.918; BJORK S, 1989, ACTA PAEDIATR SCAND, P55; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Ceballos R, 1966, Ala J Med Sci, V3, P185; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; DANIEL PM, 1959, LANCET, V2, P927; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; DESAI D, 1989, J TRAUMA, V29, P719, DOI 10.1097/00005373-198906000-00003; EDWARDS OM, 1986, MEDICINE, V65, P281; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mahapatra A K, 2014, TXB HEAD INJURY, P1; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; ROSS R, 1991, CLIN ENDOCRINOL, V35, P47, DOI 10.1111/j.1365-2265.1991.tb03495.x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SCHNEIDER HJ, 2004, DTSCH ARZTEBL, V101, pA712; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; SOULES MR, 1979, SOUTHERN MED J, V72, P1592, DOI 10.1097/00007611-197912000-00029; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; Tandon A, 2009, ACTA NEUROCHIR, V151, P1411, DOI 10.1007/s00701-009-0444-9; TEASDALE G, 1974, LANCET, V2, P81; WARTOFSKY L, 1982, ENDOCR REV, V3, P164, DOI 10.1210/edrv-3-2-164; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209; ZIEGLER MG, 1990, CRIT CARE MED, V18, P253, DOI 10.1097/00003246-199003000-00001	47	21	22	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					336	342		10.3109/02699052.2014.955882			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000008	25671810				2022-02-06	
J	Sandry, J; DeLuca, J; Chiaravalloti, N				Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy			Working memory capacity links cognitive reserve with long-term memory in moderate to severe TBI: a translational approach	JOURNAL OF NEUROLOGY			English	Article						Brain injuries; Cognitive reserve; Memory Disorders; Cognition; Rehabilitation; Working memory	TRAUMATIC BRAIN-INJURY; INTELLECTUAL ENRICHMENT; MULTIPLE-SCLEROSIS; REHABILITATION; MAINTENANCE; SPEED	Traumatic brain injury (TBI) can have devastating negative consequences on an individuals' ability to remember information; however, there is variability among memory impairment resulting from TBI. Some individuals exhibit long-term memory (LTM) impairment while others do not. This variability has been explained, at least in part, by the theory of cognitive reserve (CR). The theory suggests that individuals who have spent significant time engaged in intellectually enriching activities (higher CR) are better able to withstand LTM impairment despite neurological injury. The cognitive mechanisms that underlie this relationship are not well-specified. Recent evidence suggests that working memory (WM) capacity may be one mediating variable that can help explain how/why cognitive reserve (CR) protects against LTM impairment. The present research tested this hypothesis in a sample of fifty moderate to severe TBI patients. Specific neuropsychological tests were administered to estimate CR, LTM and WM. The results were congruent with a recent theoretical model that implicates WM capacity as a mediating variable in the relationship between CR and LTM (Sobel's Z = 2.62, p = 0.009). These data corroborate recent findings in an alternate neurological population and suggest that WM is an underlying mechanism of CR. Additional research is necessary to establish whether (1) WM is an important individual difference variable to include in memory rehabilitation trials and (2) to determine whether rehabilitation and treatment strategies that specifically target WM may also lead to complimentary improvements on diagnostic tests of delayed LTM in TBI and other memory impaired populations.	[Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy] Kessler Fdn, W Orange, NJ 07052 USA; [Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [DeLuca, John] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA		Sandry, J (corresponding author), Kessler Fdn, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	jsandry@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	Northern NJ TBI Model Systems grant; US Department of Education-National Institute on Disability and Rehabilitation Research grant [H133P090009];  [H133A070037]	The authors wish to thank Dr. James F. Sumowski for helpful comments on an early draft of this manuscript. Study supported Northern NJ TBI Model Systems grant H133A070037 to NC. The contents of this article were also developed under the US Department of Education-National Institute on Disability and Rehabilitation Research grant H133P090009. However, the contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Berrigan LI, 2013, J INT NEUROPSYCH SOC, V19, P938, DOI 10.1017/S1355617713000696; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Constantinidou F, 2014, J INT NEUROPSYCH SOC, V20, P822, DOI 10.1017/S1355617714000678; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2005, PSYCHOLOGY; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; GRIGSBY J, 1994, J NEUROL, V241, P125; Harrison TL, 2013, PSYCHOL SCI; Hindle JV, 2014, PARKINSONISM RELAT D, V20, P1, DOI 10.1016/j.parkreldis.2013.08.010; Hoofien D, 2001, BRAIN INJURY, V15, P189; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Nunnari D, 2014, NEUROL SCI, P1; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Richter KM, 2015, NEUROREHAB NEURAL RE, V29, P33, DOI 10.1177/1545968314527352; Robertson IH, 1999, CURR OPIN NEUROL, V12, P703, DOI 10.1097/00019052-199912000-00008; Sandry J, 2014, J INT NEUROPSYCH SOC, V20, P868, DOI 10.1017/S1355617714000630; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P185, DOI 10.1016/j.jarmac.2012.06.003; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Steffener J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091196; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2013, MULT SCLER J, V19, P1122, DOI 10.1177/1352458513498834; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Trafimow D, 2006, GENET SOC GEN PSYCH, V132, P215, DOI 10.3200/MONO.132.3.215-240; Trafimow D, 2011, J GEN PSYCHOL, V138, P201, DOI 10.1080/00221309.2011.584584; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2014, COGNITIVE PSYCHOL, V71, P1, DOI 10.1016/j.cogpsych.2014.01.003; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; von Bastian Claudia C, 2014, Psychol Res, V78, P803, DOI 10.1007/s00426-013-0524-6; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726	44	21	21	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JAN	2015	262	1					59	64		10.1007/s00415-014-7523-4			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AZ4TM	WOS:000348216000007	25287019				2022-02-06	
J	Walthers, CM; Seidlits, SK				Walthers, Christopher M.; Seidlits, Stephanie K.			Gene Delivery Strategies to Promote Spinal Cord Repair	BIOMARKER INSIGHTS			English	Article						gene therapy; spinal cord; neurodegeneration	ADENOASSOCIATED VIRAL VECTOR; NEURAL STEM-CELLS; IMPROVES FUNCTIONAL RECOVERY; SUPPORTED LIPID-BILAYERS; IN-VIVO ELECTROPORATION; BLOOD-BRAIN-BARRIER; TRANSGENE EXPRESSION; NEUROTROPHIC FACTOR; LENTIVIRAL VECTORS; GROWTH-FACTOR	Gene therapies hold great promise for the treatment of many neurodegenerative disorders and traumatic injuries in the central nervous system. However, development of effective methods to deliver such therapies in a controlled manner to the spinal cord is a necessity for their translation to the clinic. Although essential progress has been made to improve efficiency of transgene delivery and reduce the immunogenicity of genetic vectors, there is still much work to be done to achieve clinical strategies capable of reversing neurodegeneration and mediating tissue regeneration. In particular, strategies to achieve localized, robust expression of therapeutic transgenes by target cell types, at controlled levels over defined time periods, will be necessary to fully regenerate functional spinal cord tissues. This review summarizes the progress over the last decade toward the development of effective gene therapies in the spinal cord, including identification of appropriate target genes, improvements to design of genetic vectors, advances in delivery methods, and strategies for delivery of multiple transgenes with synergistic actions. The potential of biomaterials to mediate gene delivery while simultaneously providing inductive scaffolding to facilitate tissue regeneration is also discussed.	[Walthers, Christopher M.; Seidlits, Stephanie K.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA		Seidlits, SK (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA.	seidlits@ucla.edu	Seidlits, Stephanie/D-4921-2014				Abdellatif AA, 2006, J NEUROSCI RES, V84, P553, DOI 10.1002/jnr.20968; Adams CF, 2013, NANOMED-NANOTECHNOL, V9, P737, DOI 10.1016/j.nano.2013.05.014; Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Ahn M, 2012, BRAIN RES, V1445, P11, DOI 10.1016/j.brainres.2012.01.045; Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208; An S, 2013, BIOMATERIALS, V34, P8949, DOI 10.1016/j.biomaterials.2013.07.060; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Aviles MO, 2011, DRUG DELIV TRANSL RE, V1, P91, DOI 10.1007/s13346-010-0011-1; Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035; Barateiro A, 2014, BBA-MOL CELL RES, V1843, P1917, DOI 10.1016/j.bbamcr.2014.04.018; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Benkhelifa-Ziyyat S, 2013, MOL THER, V21, P282, DOI 10.1038/mt.2012.261; Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Bevan AKK, 2014, DRUG DELIVERY BRAIN, P485; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Blits B, 2006, J NEUROTRAUM, V23, P508, DOI 10.1089/neu.2006.23.508; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3; Boehler RM, 2013, BIOMATERIALS, V34, P5431, DOI 10.1016/j.biomaterials.2013.04.009; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cameron AA, 2006, J NEUROSCI, V26, P2923, DOI 10.1523/JNEUROSCI.4390-05.2006; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Castle MJ, 2014, HUM GENE THER, V25, P705, DOI 10.1089/hum.2013.189; Cen JS, 2013, SPINE, V38, P1632, DOI 10.1097/BRS.0b013e31829dd58f; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chen MH, 2013, INT J CLIN EXP PATHO, V6, P2312; Chitty DW, 2012, J NEUROSCI METH, V205, P17, DOI 10.1016/j.jneumeth.2011.12.007; Chtarto A, 2003, GENE THER, V10, P84, DOI 10.1038/sj.gt.3301838; Clark ZJ, 2010, ANN NEUROSCI, V17, P142, DOI 10.5214/ans.0972-7531.1017310; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; Curinga GM, 2007, J NEUROCHEM, V102, P275, DOI 10.1111/j.1471-4159.2007.04530.x; De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112; De Laporte L, 2010, ACTA BIOMATER, V6, P2889, DOI 10.1016/j.actbio.2010.02.018; De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252; De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Dengler EC, 2013, J CONTROL RELEASE, V168, P209, DOI 10.1016/j.jconrel.2013.03.009; Desclaux M, 2015, J NEUROSCI RES, V93, P43, DOI 10.1002/jnr.23468; Doring A, 2011, EUR J IMMUNOL, V41, P813, DOI 10.1002/eji.201040912; Donnelly EM, 2012, CYTOTHERAPY, V14, P1235, DOI 10.3109/14653249.2012.714865; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eleftheriadou I, 2014, MOL THER, V22, P1285, DOI 10.1038/mt.2014.49; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Fagoe ND, 2014, GENE THER, V21, P242, DOI 10.1038/gt.2013.71; Foley CP, 2014, J CONTROL RELEASE, V196, P71, DOI 10.1016/j.jconrel.2014.09.018; Foust KD, 2008, HUM GENE THER, V19, P71, DOI 10.1089/hum.2007.104; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Franz S, 2012, EXP NEUROL, V235, P62, DOI 10.1016/j.expneurol.2011.01.015; Fujita Y, 2014, FRONT NEUROSCI, V8, P1; Garbossa D, 2012, NEUROSURG REV, V35, P293, DOI 10.1007/s10143-012-0385-2; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; Gerin CG, 2011, SYNAPSE, V65, P1255, DOI 10.1002/syn.20903; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Glorioso JC, 2004, ANNU REV MICROBIOL, V58, P253, DOI 10.1146/annurev.micro.58.030603.123709; Gonzalez AM, 2006, J GENE MED, V8, P901, DOI 10.1002/jgm.919; Gonzalez AM, 2009, J GENE MED, V11, P679, DOI 10.1002/jgm.1354; Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036; Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073; Haberman RP, 1998, GENE THER, V5, P1604, DOI 10.1038/sj.gt.3300782; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hayakawa K, 2015, J CONTROL RELEASE, V197, P1, DOI 10.1016/j.jconrel.2014.10.027; Hendriks WTJ, 2007, J NEUROSCI RES, V85, P3041, DOI 10.1002/jnr.21432; Hendriks WTJ, 2007, RESTOR NEUROL NEUROS, V25, P585; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Hermens WTJMC, 1998, BRAIN RES BULL, V47, P133, DOI 10.1016/S0361-9230(98)00042-2; Hirano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075896; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hou SP, 2012, J NEUROSCI, V32, P13206, DOI 10.1523/JNEUROSCI.5041-11.2012; Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/sj.mt.6300106; Houchin-Ray T, 2009, BIOTECHNOL BIOENG, V103, P1023, DOI 10.1002/bit.22311; Houchin-Ray T, 2009, J NEUROSCI RES, V87, P844, DOI 10.1002/jnr.21908; Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014; Hutson TH, 2012, GENE THER, V19, P49, DOI 10.1038/gt.2011.71; Hutson TH, 2014, METHODS MOL BIOL, V1162, P189, DOI 10.1007/978-1-4939-0777-9_16; Hyun J, 2013, STEM CELL TRANSL MED, V2, P690, DOI 10.5966/sctm.2013-0035; Jandial R, 2008, MOL THER, V16, P450, DOI 10.1038/sj.mt.6300402; Jeffery ND, 2009, J TISSUE ENG REGEN M, V3, P153, DOI 10.1002/term.139; Jin HL, 2011, SPINE, V36, P857, DOI 10.1097/BRS.0b013e3181e7f34b; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036; Kim E, 2014, ACS APPL MATER INTER, V6, P8288, DOI 10.1021/am5011095; Kim JS, 2012, GENE THER, V19, P329, DOI 10.1038/gt.2011.84; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Kusano K, 2010, BIOCHEM BIOPH RES CO, V393, P812, DOI 10.1016/j.bbrc.2010.02.088; Kwon EJ, 2008, J CONTROL RELEASE, V132, P230, DOI 10.1016/j.jconrel.2008.06.012; Kwon EJ, 2010, BIOMATERIALS, V31, P2417, DOI 10.1016/j.biomaterials.2009.11.086; Kwon I, 2008, PHARM RES, V25, P489, DOI 10.1007/s11095-007-9431-0; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; Lavdas AA, 2010, EXP NEUROL, V221, P206, DOI 10.1016/j.expneurol.2009.10.024; Lei YG, 2010, BIOMATERIALS, V31, P9106, DOI 10.1016/j.biomaterials.2010.08.016; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; Li Yan, 2014, World J Stem Cells, V6, P11, DOI 10.4252/wjsc.v6.i1.11; Liu JW, 2009, CHEM COMMUN, P5100, DOI 10.1039/b911472f; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; McIver SR, 2005, J NEUROSCI RES, V82, P397, DOI 10.1002/jnr.20626; Meunier A, 2008, J NEUROSCI METH, V167, P148, DOI 10.1016/j.jneumeth.2007.07.022; Mohan R, 2014, NEUROSCIENCE, V274, P318, DOI 10.1016/j.neuroscience.2014.05.045; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; Naidoo J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/595410; Nakajima H., 2014, NEUROPROTECTION REGE, V1, P193; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Negro-Demontel ML, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.47; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Papastefanaki F, 2007, BRAIN, V130, P2159, DOI 10.1093/brain/awm155; Park IK, 2007, J GENE MED, V9, P691, DOI 10.1002/jgm.1062; Park TE, 2015, BIOMATERIALS, V38, P61, DOI 10.1016/j.biomaterials.2014.10.068; Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437; Peel AL, 1997, GENE THER, V4, P16, DOI 10.1038/sj.gt.3300358; Pennant WA, 2014, SPINAL CORD, V52, P3, DOI 10.1038/sc.2013.106; Perez-Martinez FC, 2012, J ALZHEIMERS DIS, V31, P697, DOI 10.3233/JAD-2012-120661; Pickard MR, 2011, BIOMATERIALS, V32, P2274, DOI 10.1016/j.biomaterials.2010.12.007; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Qi YH, 2014, GENET MOL RES, V13, P1366, DOI 10.4238/2014.February.28.9; Qin LH, 1997, HUM GENE THER, V8, P2019, DOI 10.1089/hum.1997.8.17-2019; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rahim AA, 2009, GENE THER, V16, P509, DOI 10.1038/gt.2008.186; Rappa G, 2004, NEUROSCIENCE, V124, P823, DOI 10.1016/j.neuroscience.2003.11.030; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rosenberg JB, 2014, HUM GENE THER CL DEV, V25, P164, DOI 10.1089/humc.2013.239; Ruitenberg MJ, 2004, NEUROBIOL DIS, V15, P394, DOI 10.1016/j.nbd.2003.11.018; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p; Sareen D, 2014, J COMP NEUROL, V522, P2707, DOI 10.1002/cne.23578; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sato T, 2013, J NEUROSCI METH, V214, P170, DOI 10.1016/j.jneumeth.2013.01.014; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007; Seidlits SK, 2014, BIOMATERIALS AND REGENERATIVE MEDICINE, P431; Seidlits SK, 2013, EXPERT OPIN DRUG DEL, V10, P499, DOI 10.1517/17425247.2013.764864; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Seijffers R, 2014, P NATL ACAD SCI USA, V111, P1622, DOI 10.1073/pnas.1314826111; Sharp KG, 2013, EXP NEUROL, V248, P321, DOI 10.1016/j.expneurol.2013.06.023; Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016; Shaw A, 2014, BIOMEDICINES, V2, P14, DOI 10.3390/biomedicines2010014; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Shepard JA, 2012, BIOMATERIALS, V33, P7412, DOI 10.1016/j.biomaterials.2012.06.081; Shepard JA, 2010, J CONTROL RELEASE, V146, P128, DOI 10.1016/j.jconrel.2010.04.032; Shimamura M, 2005, J GENE MED, V7, P1468, DOI 10.1002/jgm.793; Shin DA, 2014, ACTA NEUROCHIR, V156, P297, DOI 10.1007/s00701-013-1963-y; Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Song HP, 2010, BIOMATERIALS, V31, P769, DOI 10.1016/j.biomaterials.2009.09.085; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Strappe PM, 2005, EUR J PHARM BIOPHARM, V61, P126, DOI 10.1016/j.ejpb.2005.06.006; Tang BL, 2007, CELL MOL NEUROBIOL, V27, P75, DOI 10.1007/s10571-006-9119-8; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a; Thomas AM, 2013, J CONTROL RELEASE, V170, P421, DOI 10.1016/j.jconrel.2013.06.013; Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014; Toyooka T, 2011, J NEUROTRAUM, V28, P607, DOI 10.1089/neu.2010.1520; Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002; Uchida K, 2012, SPINE, V37, P2125, DOI 10.1097/BRS.0b013e3182600ef7; van Gestel MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097639; Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057; Wallach Corey J, 2006, Spine J, V6, P107, DOI 10.1016/j.spinee.2005.05.002; Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036; Wang YX, 2012, BRAIN RES, V1448, P137, DOI 10.1016/j.brainres.2012.02.007; Wells DJ, 2004, GENE THER, V11, P1363, DOI 10.1038/sj.gt.3302337; Wolfe D, 2009, PAIN MED, V10, P1325, DOI 10.1111/j.1526-4637.2009.00720.x; Wu HF, 2013, BIOMATERIALS, V34, P1686, DOI 10.1016/j.biomaterials.2012.11.013; Yamaguchi M, 2013, ACS SYNTH BIOL, V3, P239; Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42; Yao L, 2012, DRUG DISCOV TODAY, V17, P998, DOI 10.1016/j.drudis.2012.05.009; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yip PK, 2006, HUM MOL GENET, V15, P3107, DOI 10.1093/hmg/ddl251; Yip PK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000399; Yoo M, 2014, J NEUROTRAUM, V31, P553, DOI 10.1089/neu.2013.2886; Yukawa Y, 2002, J NEUROTRAUM, V19, P1091, DOI 10.1089/089771502760341992; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-130; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003; Zhou HX, 2014, BRAIN RES, V1586, P46, DOI 10.1016/j.brainres.2014.08.048; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	209	21	22	0	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights		2015	10			1			11	29		10.4137/BMIMI.S20063			19	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	DB5UQ	WOS:000368579500002	25922572				2022-02-06	
J	Larsson, IM; Wallin, E; Kristofferzon, ML; Niessner, M; Zetterberg, H; Rubertsson, S				Larsson, Ing-Marie; Wallin, Ewa; Kristofferzon, Marja-Leena; Niessner, Marion; Zetterberg, Henrik; Rubertsson, Sten			Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome	RESUSCITATION			English	Article						Cardiac arrest; Therapeutic hypothermia; Prognostication; Biomarkers	NEURON-SPECIFIC ENOLASE; EUROPEAN RESUSCITATION COUNCIL; AMERICAN-HEART-ASSOCIATION; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS; S-100B; GUIDELINES; S100B; CARE	Aim of the study: To investigate serum levels of glial fibrillary acidic protein (GFAP) for evaluation of neurological outcome in cardiac arrest (CA) patients and compare GFAP sensitivity and specificity to that of more studied biomarkers neuron-specific enolas (NSE) and S100B. Method: A prospective observational study was performed in three hospitals in Sweden during 2008-2012. The participants were 125 CA patients treated with therapeutic hypothermia (TH) to 32-34 degrees C for 24 hours. Samples were collected from peripheral blood (n = 125) and the jugular bulb (n = 47) up to 108 hours post-CA. GFAP serum levels were quantified using a novel, fully automated immunochemical method. Other biomarkers investigated were NSE and S100B. Neurological outcome was assessed using the Cerebral Performance Categories scale (CPC) and dichotomized into good and poor outcome. Results: GFAP predicted poor neurological outcome with 100% specificity and 14-23% sensitivity at 24, 48 and 72 hours post-CA. The corresponding values for NSE were 27-50% sensitivity and for S100B 21-30% sensitivity when specificity was set to 100%. A logistic regression with stepwise combination of the investigated biomarkers, GFAP, did not increase the ability to predict neurological outcome. No differences were found in GFAP, NSE and S100B levels when peripheral and jugular bulb blood samples were compared. Conclusion: Serum GFAP increase in patients with poor outcome but did not show sufficient sensitivity to predict neurological outcome after CA. Both NSE and S100B were shown to be better predictors. The ability to predict neurological outcome did not increased when combining the three biomarkers. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Larsson, Ing-Marie; Wallin, Ewa; Rubertsson, Sten] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Kristofferzon, Marja-Leena] Univ Gavle, Fac Hlth & Occupat Studies, Dept Hlth & Caring Sci, SE-80176 Gavle, Sweden; [Kristofferzon, Marja-Leena] Uppsala Univ, Dept Publ Hlth & Caring Sci, SE-75122 Uppsala, Sweden; [Niessner, Marion] Roche Diagnost GmbH, Penzberg, Germany; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] Inst Neurol, London WC1N 3BG, England		Larsson, IM (corresponding author), Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, SE-75185 Uppsala, Sweden.	ing-marie.larsson@surgsci.uu.se		Kristofferzon, Marja-Leena/0000-0002-1864-5777	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish State Support for Clinical Research; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	The authors thank Birgit Klapperich, Roche Diagnostics GmbH, Penzberg, Germany for collaboration. The authors also thank Marie Sellert Rydberg, Dept. of Anaesthesia & Intensive Care Falun for collaboration and data collection and Elisabeth Pettersson, research assistants, Anaesthesiology & Intensive Care, Uppsala University. We also wish to thank the Department of Surgical Sciences, Anaesthesiology & Intensive Care, Uppsala University, for institutional grants, and The Uppsala University Hospital. The study was supported by grants from the Swedish Research Council, Swedish State Support for Clinical Research, the Knut and Alice Wallenberg Foundation.	Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; Cronberg T, 2013, RESUSCITATION, V84, P867, DOI 10.1016/j.resuscitation.2013.01.019; Cummins RO, 1997, RESUSCITATION, V34, P151, DOI 10.1016/S0300-9572(97)01112-X; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; JENNETT B, 1975, LANCET, V1, P480; Kamps MJA, 2013, INTENS CARE MED, V39, P1671, DOI 10.1007/s00134-013-3004-y; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lu-Emerson C, 2010, NEUROREHABILITATION, V26, P35, DOI 10.3233/NRE-2010-0534; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mlynash M, 2013, NEUROCRIT CARE, V19, P161, DOI 10.1007/s12028-013-9867-5; Mortberg E, 2011, ACTA ANAESTH SCAND, V55, P1132, DOI 10.1111/j.1399-6576.2011.02505.x; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Oddo M, 2014, CRIT CARE MED, V42, P1340, DOI 10.1097/CCM.0000000000000211; Oksanen T, 2009, RESUSCITATION, V80, P165, DOI 10.1016/j.resuscitation.2008.08.017; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Rana OR, 2013, INT J CARDIOL, V168, P1322, DOI 10.1016/j.ijcard.2012.12.016; Rundgren M, 2012, CRIT CARE, V16, DOI 10.1186/cc11244; Rundgren M, 2009, RESUSCITATION, V80, P784, DOI 10.1016/j.resuscitation.2009.03.025; Sandroni C, 2013, RESUSCITATION, V84, P1324, DOI 10.1016/j.resuscitation.2013.06.020; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Scolletta S, 2012, EXPERT REV CLIN PHAR, V5, P687, DOI [10.1586/ecp.12.64, 10.1586/ECP.12.64]; Shinozaki K, 2009, RESUSCITATION, V80, P870, DOI 10.1016/j.resuscitation.2009.05.005; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Sun Y, 2013, SCAND J CLIN LAB INV, V73, P601, DOI 10.3109/00365513.2013.830326; TEASDALE G, 1974, LANCET, V2, P81; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Zellner T, 2013, RESUSCITATION, V84, P1382, DOI 10.1016/j.resuscitation.2013.03.021; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263	37	21	24	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	DEC	2014	85	12					1654	1661		10.1016/j.resuscitation.2014.09.007			8	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	AW9UQ	WOS:000346603700010	25260722				2022-02-06	
J	Miller, TR; Steinbeigle, R; Wicks, A; Lawrence, BA; Barr, M; Barr, RG				Miller, Ted R.; Steinbeigle, Ryan; Wicks, Amy; Lawrence, Bruce A.; Barr, Marilyn; Barr, Ronald G.			Disability-Adjusted Life-Year Burden of Abusive Head Trauma at Ages 0-4	PEDIATRICS			English	Article						child abuse; DALY; Health Utilities Index; maltreatment; shaken baby syndrome; traumatic brain injury	QUALITY-OF-LIFE; OPERATIONAL CASE-DEFINITION; BRAIN-INJURY; CHILD MALTREATMENT; GLOBAL BURDEN; UNITED-STATES; HEALTH; CLASSIFICATION; ADOLESCENTS; DISEASES	OBJECTIVE: We estimated the disability-adjusted life-year (DALY) burden of abusive head trauma (AHT) at ages 0 to 4 years in the United States. METHODS: DALYs are computed by summing years of productive life that survivors lost to disability plus life-years lost to premature death. Surveying a convenience sample of 170 caregivers and pediatricians yielded health-related disability over time according to severity of AHT (measured with the Health Utilities Index, Mark 2). Incidence estimates for 2009 came from Vital Statistics for Mortality, Healthcare Cost and Utilization Program Kids' Inpatient Database for hospitalized survivors, and published ratios of 0.894 case treated and released and 0.340 case not diagnosed/treated while in the acute phase per survivor admitted. Survival probability over time after discharge came from published sources. RESULTS: An estimated 4824 AHT cases in 2009 included 334 fatalities within 30 days. DALYs per surviving child averaged 0.555 annually for severe AHT (95% confidence interval: 0.512-0.598) and 0.155 (95% confidence interval: 0.120-0.190) for other cases. Including life-years lost to premature mortality, estimated lifetime burden averaged 4.7 DALYs for mild AHT, 5.4 for moderate AHT, 24.1 for severe AHT, and 29.8 for deaths. On average, DALY loss per 30-day survivor included 7.6 years of lost life expectancy and 5.7 years lived with disability. Estimated burden of AHT incidents in 2009 was 69 925 DALYs or 0.017 DALYs per US live birth. CONCLUSIONS: AHT is extremely serious, often resulting in severe physical damage or death. The annual DALY burden several years after mild AHT exceeds the DALY burden of a severe burn.	[Miller, Ted R.; Lawrence, Bruce A.] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Steinbeigle, Ryan; Wicks, Amy; Barr, Marilyn] Natl Ctr Shaken Baby Syndrome, Farmington, UT USA; [Barr, Ronald G.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada		Miller, TR (corresponding author), Pacific Inst Res & Evaluat, 11720 Beltsville Dr,Suite 900, Calverton, MD 20705 USA.	miller@pire.org		Miller, Ted/0000-0002-0958-2639	Annie Casey Foundation; Canada Research Chair in Community Child Health Research	The authors' work was supported by grants from the Annie Casey Foundation (Drs Miller, Wicks, Steinbeigle, Lawrence, and Barr) and a Canada Research Chair in Community Child Health Research (Dr Barr). Neither funder was involved in decisions regarding design, analysis, or interpretation of study results. The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of the funders.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arias E., 2014, NATL VITAL STAT REPO, V62; Bourgeois FT, 2014, PEDIATRICS, V133, P78, DOI 10.1542/peds.2013-2567; Corso PS, 2011, AM J PUBLIC HEALTH, V101, P487, DOI 10.2105/AJPH.2010.196584; Drummond MF, 2007, METHODS EC EVALUATIO; Gold M., 1996, COST EFFECTIVENESS H; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; Miller T, 2013, QUAL LIFE RES, V22, P2293, DOI 10.1007/s11136-012-0321-5; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Prosser LA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-42; Roberts G, 2013, J PEDIATR-US, V163, P1008, DOI 10.1016/j.jpeds.2013.05.048; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wolke D, 2013, J PEDIATR-US, V163, P1020, DOI 10.1016/j.jpeds.2013.04.030; Xiang J, 2013, BRAIN INJURY, V27, P1555, DOI 10.3109/02699052.2013.831126	21	21	21	0	9	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2014	134	6					E1545	E1550		10.1542/peds.2014-1385			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	AU8KB	WOS:000345844200005	25404725				2022-02-06	
J	Chan, WP; Narducci, M; Gao, Y; Cheng, MY; Cheong, JH; George, AK; Cheam, DD; Leong, SC; Damalerio, MRB; Lim, RQ; Tsai, ML; Rahman, ARA; Park, MK; Kong, ZH; Prashanth, RJ; Je, M				Chan, Wai Pan; Narducci, Margarita; Gao, Yuan; Cheng, Ming-Yuan; Cheong, Jia Hao; George, Arup K.; Cheam, Daw Don; Leong, Siew Chong; Damalerio, Maria Ramona B.; Lim, Ruiqi; Tsai, Ming-Ling; Rahman, Abdur R. A.; Park, Mi Kyoung; Kong, Zhi Hui; Prashanth, Rao Jai; Je, Minkyu			A Monolithically Integrated Pressure/Oxygen/Temperature Sensing SoC for Multimodality Intracranial Neuromonitoring	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article; Proceedings Paper	9th IEEE Asian Solid-State Circuits Conference (A-SSCC)	NOV 11-13, 2013	Singapore, SINGAPORE	IEEE, IEEE SSCS Singapore, Singapore Semicond Ind Assoc		Capacitance to voltage converter (CVC); capacitive pressure sensor; electrochemical oxygen sensor; intracranial pressure (ICP); temperature sensor; traumatic brain injury (TBI)	SMART TEMPERATURE SENSOR; 3-SIGMA INACCURACY; DISSOLVED-OXYGEN; PRESSURE SENSOR; CMOS; COMPENSATION; MICROSYSTEM; WIRELESS; 10-BIT; INJURY	A fully integrated SoC for multimodality intracranial neuromonitoring is presented in this paper. Three sensors including a capacitive MEMS pressure sensor, an electrochemical oxygen sensor and a solid-state temperature sensor are integrated together in a single chip with their respective interface circuits. Chopper stabilization and dynamic element matching techniques are applied in sensor interface circuits to reduce circuit noise and offset. On-chip calibration is implemented for each sensor to compensate process variations. Measured sensitivity of the pressure, oxygen, and temperature sensors are 18.6 aF/mmHg, 194 pA/mmHg, and 2 mV/degrees C, respectively. Implemented in 0.18 mu m CMOS, the SoC occupies an area of 1.4 mm x 4 mm and consumes 166 W DC power. A prototype catheter for intracranial pressure (ICP) monitoring has been implemented and the performance has been verified with ex vivo experiment.	[Chan, Wai Pan; Narducci, Margarita; Gao, Yuan; Cheng, Ming-Yuan; Cheong, Jia Hao; Cheam, Daw Don; Leong, Siew Chong; Damalerio, Maria Ramona B.; Lim, Ruiqi; Tsai, Ming-Ling; Rahman, Abdur R. A.; Park, Mi Kyoung] ASTAR, Inst Microelect, Singapore 117685, Singapore; [George, Arup K.; Kong, Zhi Hui] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Prashanth, Rao Jai] Natl Inst Neurosci, Dept Neurosurg, Singapore 308433, Singapore; [Je, Minkyu] Daegu Gyeongbuk Inst Sci & Technol, Dept Informat & Commun Engn, Taegu 711873, South Korea		Chan, WP (corresponding author), ASTAR, Inst Microelect, Singapore 117685, Singapore.	gaoy@ime.a-star.edu.sg; zhkong@ntu.edu.sg; rao_jai@nni.com.sg; minkyu.je@dgist.ac.kr	Je, Minkyu/P-5960-2019; Je, Minkyu/G-3056-2016; Gao, Yuan/E-4502-2011; Je, Minkyu/Q-9864-2018	Je, Minkyu/0000-0003-4580-2771; Gao, Yuan/0000-0002-0832-2982; narducci, margarita/0000-0002-2639-8745; George, Arup/0000-0002-5851-7999	Science and Engineering Research Council of Agency for Science, Technology and Research (A*STAR), SingaporeAgency for Science Technology & Research (ASTAR) [102 148 0002]	This paper was approved by Guest Editor Zhihua Wang. This work was supported by the Science and Engineering Research Council of Agency for Science, Technology and Research (A*STAR), Singapore, under Grant 102 148 0002.	Abo AM, 1999, IEEE J SOLID-ST CIRC, V34, P599, DOI 10.1109/4.760369; Assaad RS, 2009, IEEE J SOLID-ST CIRC, V44, P2535, DOI 10.1109/JSSC.2009.2024819; Chai K. T. C., 2010, 2010 IEEE AS SOILD S, P1; CHAN WP, 2013, 2013 IEEE AS SOL STA, P89; Chen P, 2010, IEEE J SOLID-ST CIRC, V45, P600, DOI 10.1109/JSSC.2010.2040658; Cheong JH, 2011, IEEE T CIRCUITS-II, V58, P407, DOI 10.1109/TCSII.2011.2158255; Chitnis G, 2013, IEEE T BIO-MED ENG, V60, P250, DOI 10.1109/TBME.2012.2205248; Clark LC, 1959, US Patent, Patent No. 2913386; Cong P, 2009, IEEE J SOLID-ST CIRC, V44, P3631, DOI 10.1109/JSSC.2009.2035551; Cong P, 2008, SENSOR MATER, V20, P327; Faul M., 2010, CTR DIS CONTROL PREV; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hasan SMR, 2007, IEEE SENS J, V7, P814, DOI 10.1109/JSEN.2007.893236; Hong HC, 2007, IEEE J SOLID-ST CIRC, V42, P2161, DOI 10.1109/JSSC.2007.905237; KARAGOUNIS V, 1986, IEEE T BIO-MED ENG, V33, P108, DOI 10.1109/TBME.1986.325884; Lambrechts M., 1992, BIOSENSORS MICROELEC; Leung KN, 2003, IEEE J SOLID-ST CIRC, V38, P1691, DOI 10.1109/JSSC.2003.817256; Liao YT, 2012, IEEE J SOLID-ST CIRC, V47, P335, DOI 10.1109/JSSC.2011.2170633; Lou L., 2012, J MICROMECH MICROENG, V22, P1; Martin CS, 2012, SENSOR ACTUAT B-CHEM, V175, P111, DOI 10.1016/j.snb.2011.12.098; Melgaard J, 2011, IEEE T NEUR SYS REH, V19, P700, DOI 10.1109/TNSRE.2011.2171368; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narducci M, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/5/055007; Pertijs MAP, 2005, IEEE J SOLID-ST CIRC, V40, P2805, DOI 10.1109/JSSC.2005.858476; Sebastiano F, 2010, IEEE J SOLID-ST CIRC, V45, P2591, DOI 10.1109/JSSC.2010.2076610; Stangel K, 2001, IEEE J SOLID-ST CIRC, V36, P1094, DOI 10.1109/4.933466; Wang P, 2011, SENSOR ACTUAT B-CHEM, V153, P145, DOI 10.1016/j.snb.2010.09.075	27	21	21	1	27	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2014	49	11					2449	2461		10.1109/JSSC.2014.2345754			13	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering	AS6YD	WOS:000344404200008					2022-02-06	
J	Luo, H; Pace, E; Zhang, XG; Zhang, JS				Luo, Hao; Pace, Edward; Zhang, Xueguo; Zhang, Jinsheng			Blast-Induced Tinnitus and Spontaneous Firing Changes in the Rat Dorsal Cochlear Nucleus	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						blast exposure; tinnitus; traumatic brain injury (TBI); dorsal cochlear nucleus; spontaneous activity	NOISE-INDUCED HYPERACTIVITY; SPONTANEOUS NEURAL ACTIVITY; TRAUMATIC BRAIN-INJURY; INFERIOR COLLICULUS; ACOUSTIC TRAUMA; HEARING-LOSS; HOMEOSTATIC PLASTICITY; SOUND; EXPOSURE; DEGENERATION	Exposure to high-pressure blast shock waves is known to cause tinnitus. Although the underlying mechanisms may involve damage to structures in the ear and/or direct brain impact, which triggers a cascade of neuroplastic changes in both auditory and nonauditory centers, it remains unclear how the induced neuroplasticity manifests neuro-physiologically. This study investigates the influence of blast exposure on spontaneous firing rates (SFRs) in the dorsal cochlear nucleus (DCN) and its time course in rats with blast-induced tinnitus. Each rat was exposed to a single blast at 22 psi. Behavioral evidence of tinnitus was measured by using a gap-detection acoustic startle-reflex paradigm. SFRs were measured 1 day, 1 month, and 3 months after blast exposure. The results showed that nine rats with blast-induced tinnitus and hearing loss developed hyperactivity immediately and that the induced hyperactivity persisted in six rats with tinnitus at 1 month after blast exposure. At 3 months after blast exposure, however, the induced hyperactivity of four rats with tinnitus transitioned to hypoactivity. In addition, the 20-30-kHz, and >30-kHz regions in the DCN of rats with and without blast-induced tinnitus were more affected than other frequency regions at different recovery time points after blast exposure. These results demonstrate that the neural mechanisms underlying blast-induced tinnitus are substantially different from those underlying noise-induced tinnitus. (C) 2014 Wiley Periodicals, Inc.	[Luo, Hao; Pace, Edward; Zhang, Xueguo; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48201 USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, 5E-UHC,4201 St Antoine, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	Contract grant sponsor: Department of Defense, contract grant number: W81XWH-11-2-0031	AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Bilak M, 1997, EXP NEUROL, V147, P256, DOI 10.1006/exnr.1997.6636; Brozoski TJ, 2007, JARO-J ASSOC RES OTO, V8, P105, DOI 10.1007/s10162-006-0067-2; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Doiron B, 2011, J NEUROSCI, V31, P10579, DOI 10.1523/JNEUROSCI.1592-11.2011; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2013, HEARING RES, V295, P140, DOI 10.1016/j.heares.2012.01.005; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Geckle L., 2004, FORC HLTH PROT C ALB; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Kaltenbach JA, 1996, AUDIT NEUROSCI, V3, P57; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kaltenbach JA, 2006, HEARING RES, V216, P224, DOI 10.1016/j.heares.2006.01.002; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kim JN, 1997, HEARING RES, V103, P169, DOI 10.1016/S0378-5955(96)00173-6; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Langers DRM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00002; Lepczyk L, 2012, MIDW M ASS RES OT; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIBERMAN MC, 1979, ACTA OTO-LARYNGOL, V88, P161, DOI 10.3109/00016487909137156; LIBERMAN MC, 1984, HEARING RES, V16, P75, DOI 10.1016/0378-5955(84)90026-1; Llano DA, 2012, J NEUROSCI, V32, P16141, DOI 10.1523/JNEUROSCI.2499-12.2012; LOEB M, 1967, J ACOUST SOC AM, V42, P453, DOI 10.1121/1.1910600; Luo L, 2013, ASS RES OTO IN PRESS; Ma WLD, 2006, HEARING RES, V216, P176, DOI 10.1016/j.heares.2006.03.011; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Malmierca MS, 2002, J NEUROSCI, V22, P10891; Manzoor NF, 2013, HEARING RES, V295, P114, DOI 10.1016/j.heares.2012.04.003; Manzoor NF, 2012, J NEUROPHYSIOL, V108, P976, DOI 10.1152/jn.00833.2011; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; MCINTOSH AR, 1993, BRAIN RES, V627, P129, DOI 10.1016/0006-8993(93)90756-D; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Milbrandt JC, 2000, HEARING RES, V147, P251, DOI 10.1016/S0378-5955(00)00135-0; Mrena R, 2002, AUDIOL NEURO-OTOL, V7, P122, DOI 10.1159/000057660; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, NEUROSCIENCE, V192, P753, DOI 10.1016/j.neuroscience.2011.06.046; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Robertson D, 2013, HEARING RES, V295, P124, DOI 10.1016/j.heares.2012.02.002; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; Schaette R, 2006, EUR J NEUROSCI, V23, P3124, DOI 10.1111/j.1460-9568.2006.04774.x; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Whiting B, 2009, NEUROSCIENCE, V163, P1264, DOI 10.1016/j.neuroscience.2009.07.049; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; Zhang JS, 2006, J NEUROSCI RES, V84, P819, DOI 10.1002/jnr.20985; Zhang JS, 2013, HEARING RES, V295, P38, DOI 10.1016/j.heares.2012.05.007; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zhang JS, 2013, TINN RES IN INT C 14	73	21	21	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2014	92	11					1466	1477		10.1002/jnr.23424			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN4CJ	WOS:000340534900006	24938852				2022-02-06	
J	Das, M; Wang, CY; Bedi, R; Mohapatra, SS; Mohapatra, S				Das, Mahasweta; Wang, Chunyan; Bedi, Raminder; Mohapatra, Shyam S.; Mohapatra, Subhra			Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						TBI; LFPI; Brain; Magnetic micelle; Bio-distribution; Theranostic; DNA delivery	NUCLEIC-ACID DELIVERY; GENE DELIVERY; STEALTH LIPOSOMES; ZOLEDRONIC ACID; DRUG-DELIVERY; FLUORO-JADE; MAGNETOFECTION; NANOPARTICLES; CELLS; TRANSFECTION	Traumatic brain injury (TBI) causes significant mortality, long term disability and psychological symptoms. Gene therapy is a promising approach for treatment of different pathological conditions. Here we tested chitosan and polyethyleneimine (PEI)-coated magnetic micelles (CP-mag micelles or CPMMs), a potential MRI contrast agent, to deliver a reporter DNA to the brain after mild TBI (mTBI). CPMM-tomato plasmid (ptd) conjugate expressing a red-fluorescent protein (RFP) was administered intranasally immediately after mTBI or sham surgery in male SD rats. Evans blue extravasation following mTBI suggested CPMM-ptd entry into the brain via the compromised blood-brain barrier. Magnetofection increased the concentration of CPMMs in the brain. RFP expression was observed in the brain (cortex and hippocampus), lung and liver 48 h after mTBI. CPMM did not evoke any inflammatory response by themselves and were excreted from the body. These results indicate the possibility of using intranasally administered CPMM as a theranostic vehicle for mTBI. From the Clinical Editor: In this study, chitosan and PEI-coated magnetic micelles (CPMM) were demonstrated as potentially useful vehicles in traumatic brain injury in a rodent model. Magnetofection increased the concentration of CPMMs in the brain and, after intranasal delivery, CPMM did not evoke any inflammatory response and were excreted from the body. (C) 2014 Elsevier Inc. All rights reserved.	[Das, Mahasweta; Wang, Chunyan; Mohapatra, Shyam S.; Mohapatra, Subhra] Univ S Florida, Coll Med, Nanomed Res Ctr, Tampa, FL USA; [Das, Mahasweta; Bedi, Raminder; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Coll Med, Tampa, FL 33612 USA; [Wang, Chunyan; Mohapatra, Subhra] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA		Mohapatra, SS (corresponding author), Univ S Florida, Tampa, FL 33620 USA.	smohapat@health.usf.edu; smohapa2@health.usf.edu	Mohapatra, Shyam/C-2500-2012		Office of Naval Research grantOffice of Naval Research [N000140810914]; VA reintegration grant; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA152005] Funding Source: NIH RePORTER	The Office of Naval Research grant (N000140810914) to SSM and VA reintegration grant to SM.	Al-Deen FN, 2013, COLLOID SURFACE B, V102, P492, DOI 10.1016/j.colsurfb.2012.09.026; Brix G, 2008, MICROCIRCULATION, V15, P15, DOI 10.1080/10739680701410850; Caraglia M, 2012, CURR CANCER DRUG TAR, V12, P186, DOI 10.2174/156800912799277421; Caraglia M, 2013, MOL PHARMACEUT, V10, P1111, DOI 10.1021/mp3006215; Castillo B, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/218940; Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Duckworth EAM, 2005, BRAIN RES, V1042, P29, DOI 10.1016/j.brainres.2005.02.021; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Faul M, 2010, TRAUMATIC BRAIN INJU; Gersting SW, 2004, J GENE MED, V6, P913, DOI 10.1002/jgm.569; Guerra-Crespo M, 2003, J NEUROSCI METH, V127, P179, DOI 10.1016/S0165-0270(03)00125-0; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Leavey JA, CORNELL U ENV HLTH S; Lou YL, 2009, J BIOMED MATER RES A, V88A, P1058, DOI 10.1002/jbm.a.31961; Marra M, 2012, BIOTECHNOL ADV, V30, P302, DOI 10.1016/j.biotechadv.2011.06.018; McBain SC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/40/405102; Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Plank C, 2003, EXPERT OPIN BIOL TH, V3, P745, DOI 10.1517/eobt.3.5.745.21225; Plank C, 2003, BIOL CHEM, V384, P737, DOI 10.1515/BC.2003.082; Plank C, 2011, THER DELIV, V2, P717, DOI 10.4155/TDE.11.37; Repacholi MH, 1996, ELECTROMAGNETIC FIEL; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwerdt JI, 2012, CURR GENE THER, V12, P116; Vainauska D, 2012, MEDICINA-LITHUANIA, V48, P324; Wang CY, 2012, J CONTROL RELEASE, V163, P82, DOI 10.1016/j.jconrel.2012.04.030; Yang SY, 2008, ARTIF ORGANS, V32, P195, DOI 10.1111/j.1525-1594.2007.00526.x; Yun J, 2012, J CLIN NEUROSCI, V19, P875, DOI 10.1016/j.jocn.2011.12.016	32	21	21	0	29	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	OCT	2014	10	7					1539	1548		10.1016/j.nano.2014.01.003			10	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Research & Experimental Medicine	AR1AU	WOS:000343312100018	24486465	Green Accepted			2022-02-06	
J	Gilbert, M; Snyder, C; Corcoran, C; Norton, MC; Lyketsos, CG; Tschanz, JT				Gilbert, Mac; Snyder, Christine; Corcoran, Chris; Norton, Maria C.; Lyketsos, Constantine G.; Tschanz, JoAnn T.			The association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: the Cache County Dementia Progression Study	INTERNATIONAL PSYCHOGERIATRICS			English	Article						traumatic brain injury; dementia progression; functional ability; Alzheimer's disease	A-BETA DEPOSITION; HEAD-INJURY; VASCULAR FACTORS; RISK; COST	Background: There is limited research on factors that influence the rate of progression in Alzheimer's disease (AD). A history of traumatic brain injury (TBI) is associated with an increased risk for AD, but its role on the rate of dementia progression after the onset of AD has not been examined. Methods: A population-based cohort of 325 persons with incident AD was followed for up to 11 years. The sample was 65% female with a mean (SD) age of dementia onset = 84.4 (6.4) years. History of TBI was categorized as number, severity (with or without loss of consciousness), and timing in relation to dementia onset (within ten years or more than ten years). Cognition was assessed by the Consortium to Establish a Registry of AD battery, and functional ability was assessed by the Clinical Dementia Rating Sum of Boxes. Results: In linear mixed models, a history of TBI within ten years of onset showed faster progression of functional impairment (LR x(2) = 10.27, p = 0.006), while those with TBI more than ten years before dementia onset had higher scores on a measure of list learning (beta = 1.61, p = 0.003) and semantic memory (beta = 0.75, p = 0.0035). Conclusions: History of TBI and its recency may be a useful factor to predict functional progression in the course of AD.	[Gilbert, Mac; Snyder, Christine; Norton, Maria C.; Tschanz, JoAnn T.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Corcoran, Chris] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Corcoran, Chris; Norton, Maria C.; Tschanz, JoAnn T.] Utah State Univ, Ctr Epidemiol Studies, Logan, UT 84322 USA; [Norton, Maria C.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD USA		Tschanz, JT (corresponding author), Utah State Univ, Ctr Epidemiol Studies, 4450 Old Main Hill, Logan, UT 84322 USA.	joann.tschanz@usu.edu			NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG21136, R01AG11380]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021136, R01AG011380] Funding Source: NIH RePORTER	This project was supported by NIA grants R01AG21136 and R01AG11380. The authors are indebted to Dr. Ronald Munger for his unqualified support of the DPS. We also acknowledge the contributions of the following individuals whose activities have helped to ensure the success of the project: John C. S. Breitner, MD, MPH, Cara Brewer, BA, Tony Calvert, RN, BA, Michelle Carlson, PhD, Kimberly Graham, BA, Robert C. Green, MD, MPH, Hochang Ben Lee, MD, Jeanne-Marie Leoutsakos, PhD, Carol Leslie, MS, Lawrence S. Mayer, PhD, Michelle M. Mielke, PhD, Chiadi U. Onyike, MD, Roxane Pfister, MS, Georgiann Sanborn, MS, Nancy Sassano, PhD, Sarah Schwartz, MS, Ingmar Skoog, MD, Martin Steinberg, MD, Katherine Treiber, PhD, Yorghos Tripodis, PhD, Kathleen A. Welsh-Bohmer, PhD, Heidi Wengreen, PhD, RD, James Wyatt, and Peter P. Zandi, PhD, MPH. Finally, we thank the participants and their families for their participation and support.	American Psychiatric Association, 1987, DIAGNOSTIC AND STATI; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Herrmann N, 2010, CAN J PSYCHIAT, V55, P768, DOI 10.1177/070674371005501204; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Leoutsakos JMS, 2012, INT PSYCHOGERIATR, V24, P1561, DOI 10.1017/S104161021200049X; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; Mielke MM, 2011, J ALZHEIMERS DIS, V26, P127, DOI 10.3233/JAD-2011-110086; MORRIS JC, 1988, ANN NEUROL, V24, P17, DOI 10.1002/ana.410240105; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Singer J. D., 2003, APPLIED LONGITUDINAL; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tschanz JT, 2011, AM J GERIAT PSYCHIAT, V19, P532, DOI 10.1097/JGP.0b013e3181faec23; Tschanz JT, 2002, NEUROPSY NEUROPSY BE, V15, P28; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Werner CA, 2011, THE OLDER POPULATION	34	21	21	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	OCT	2014	26	10					1593	1601		10.1017/S1041610214000842			9	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Geriatrics & Gerontology; Psychiatry	AP0UZ	WOS:000341782100004	24831798	Green Accepted			2022-02-06	
J	Kaye, JL; Dunlop, BW; Iosifescu, DV; Mathew, SJ; Kelley, ME; Harvey, PD				Kaye, Joanna L.; Dunlop, Boadie W.; Iosifescu, Dan V.; Mathew, Sanjay J.; Kelley, Mary E.; Harvey, Philip D.			Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: Examining the convergence of performance-based measures and self-reports	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						PTSD; Depression; Neuropsychology; Psychiatric status rating scales; Functional outcome; Employment	TRAUMATIC BRAIN-INJURY; BIPOLAR DISORDER; OLDER PATIENTS; SCHIZOPHRENIA; VETERANS; PTSD; OUTCOMES; MEMORY; SCALE; DETERMINANTS	Individuals with posttraumatic stress disorder (PTSD) experience cognitive impairments and disability in everyday activities. In other neuropsychiatric disorders, impairments in cognition and functional capacity (i.e., the ability to perform everyday tasks) are associated with impairments in real-world functioning, independent of symptom severity. To date, no studies of functional capacity have been conducted in PTSD. Seventy-three women with moderate to severe PTSD underwent assessment with measures of cognition (MATRICS Consensus Cognitive Battery: MCCB), functional capacity (UCSD Performance-Based Skills Assessment-Brief: UPSA-B), PTSD (Clinician-Administered PTSD Scale and PTSD Symptom Scale Self-report (PSS-SR)), and depression (Montgomery Asberg Depression Rating Scale). Patients also reported their subjective level of disability (Sheehan Disability Scale). Over-reporting of symptom severity was assessed using six validity items embedded within the PSS-SR. Results indicated that on average PTSD patients manifested mild impairments on the functional capacity measure, performing about 1/3 standard deviation below healthy norms, and similar performance on the MCCB. Both clinician-rated and self-rated PTSD symptom severity correlated with self-reported disability but not with functional capacity. Self-reported disability did not correlate with functional capacity or cognition. Greater self-reported disability, depression, and PTSD symptoms all correlated with higher scores on the PSS-SR validity scale. The divergence between objective and subjective measures of disability suggests that individuals' distress, as indexed by symptom validity measures, may be impacting self-reports of disability. Future studies of disability should incorporate objective measures in order to obtain a broad perspective on functioning. (C) 2014 Elsevier Ltd. All rights reserved.	[Kaye, Joanna L.; Dunlop, Boadie W.; Kelley, Mary E.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Iosifescu, Dan V.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Mathew, Sanjay J.] Michael E Debakey VA Med Ctr, Houston, TX USA; [Mathew, Sanjay J.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Harvey, Philip D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Harvey, Philip D.] Bruce W Carter VA Med Ctr, Miami, FL USA		Harvey, PD (corresponding author), Univ Miami, Miller Sch Med, 1120 NW 14th St,Suite 1450, Miami, FL 33136 USA.	Philipdharvey1@cs.com	Iosifescu, Dan/L-3305-2019; Mathew, Sanjay J/J-2830-2014; Dunlop, Boadie/N-3362-2017	Iosifescu, Dan/0000-0002-2512-2835; Mathew, Sanjay J/0000-0002-2715-6641; Dunlop, Boadie/0000-0002-4653-0483; Harvey, Philip/0000-0002-9501-9366	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U19 MH069056]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH086690, U19MH069056] Funding Source: NIH RePORTER	This project was supported by a grant from National Institute of Mental Health (U19 MH069056). The NIMH had no role in the preparation of this paper.	Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bowie CR, 2008, BIOL PSYCHIAT, V63, P505, DOI 10.1016/j.biopsych.2007.05.022; Bowie CR, 2007, J PSYCHIATR RES, V41, P1012, DOI 10.1016/j.jpsychires.2006.08.003; Bowie CR, 2010, AM J PSYCHIAT, V167, P1116, DOI 10.1176/appi.ajp.2010.09101406; Bowie CR, 2006, AM J PSYCHIAT, V163, P418, DOI 10.1176/appi.ajp.163.3.418; Burdick KE, 2005, PSYCHIAT RES, V136, P43, DOI 10.1016/j.psychres.2004.12.009; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Depp CA, 2008, J CLIN PSYCHOPHARM, V28, P225, DOI 10.1097/JCP.0b013e318166dfed; Depp CA, 2009, J NERV MENT DIS, V197, P471, DOI 10.1097/NMD.0b013e3181ab5c9b; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Franklin CL, 2002, J PERS ASSESS, V79, P274, DOI 10.1207/S15327752JPA7902_10; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gildengers AG, 2007, AM J GERIAT PSYCHIAT, V15, P174, DOI 10.1097/JGP.0b013e31802dd367; Harvey PD, 2010, CURR DIR PSYCHOL SCI, V19, P249, DOI 10.1177/0963721410378033; Harvey PD, 2010, BIPOLAR DISORD, V12, P364, DOI 10.1111/j.1399-5618.2010.00831.x; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Leifker FR, 2009, SCHIZOPHR RES, V115, P82, DOI 10.1016/j.schres.2009.09.004; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; McKibbin C, 2004, J NERV MENT DIS, V192, P405, DOI 10.1097/01.nmd.0000130133.32276.83; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Sabbag S, 2012, SCHIZOPHR RES, V137, P190, DOI 10.1016/j.schres.2012.02.002; Sabbag S, 2011, SCHIZOPHR RES, V131, P250, DOI 10.1016/j.schres.2011.05.003; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2012, PSYCHIAT SERV, V63, P1072, DOI 10.1176/appi.ps.201100415; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Simonsen C, 2008, BIPOLAR DISORD, V10, P245, DOI 10.1111/j.1399-5618.2007.00492.x; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Twamley EW, 2002, AM J PSYCHIAT, V159, P2013, DOI 10.1176/appi.ajp.159.12.2013; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Williams, 1995, USERS GUIDE STRUCTUR; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	46	21	22	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	OCT	2014	57						51	57		10.1016/j.jpsychires.2014.06.002			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AO7RK	WOS:000341550100006	24974001	Green Accepted			2022-02-06	
J	Orfila, JE; Shimizu, K; Garske, AK; Deng, G; Maylie, J; Traystman, RJ; Quillinan, N; Adelman, JP; Herson, PS				Orfila, J. E.; Shimizu, K.; Garske, A. K.; Deng, G.; Maylie, J.; Traystman, R. J.; Quillinan, N.; Adelman, J. P.; Herson, P. S.			Increasing small conductance Ca2+-activated potassium channel activity reverses ischemia-induced impairment of long-term potentiation	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cardiac arrest; global cerebral ischemia; hippocampus long-term potentiation; mouse; small conductance Ca2+-activated potassium channels	TRANSIENT FOREBRAIN ISCHEMIA; HIPPOCAMPAL CA1 NEURONS; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; CLINICAL-TRIALS; NMDA RECEPTORS; CARDIAC-ARREST; SK2 CHANNELS	Global cerebral ischemia following cardiac arrest and cardiopulmonary resuscitation (CA/CPR) causes injury to hippocampal CA1 pyramidal neurons and impairs cognition. Small conductance Ca2+-activated potassium channels type 2 (SK2), expressed in CA1 pyramidal neurons, have been implicated as potential protective targets. Here we showed that, in mice, hippocampal long-term potentiation (LTP) was impaired as early as 3h after recovery from CA/CPR and LTP remained impaired for at least 30days. Treatment with the SK2 channel agonist 1-Ethyl-2-benzimidazolinone (1-EBIO) at 30min after CA provided sustained protection from plasticity deficits, with LTP being maintained at control levels at 30days after recovery from CA/CPR. Minimal changes in glutamate release probability were observed at delayed times after CA/CPR, implicating post-synaptic mechanisms. Real-time quantitative reverse transcriptase-polymerase chain reaction indicated that CA/CPR did not cause a loss of N-methyl-D-aspartate (NMDA) receptor mRNA at 7 or 30days after CA/CPR. Similarly, no change in synaptic NMDA receptor protein levels was observed at 7 or 30days after CA/CPR. Further, patch-clamp experiments demonstrated no change in functional synaptic NMDA receptors at 7 or 30days after CA/CPR. Electrophysiology recordings showed that synaptic SK channel activity was reduced for the duration of experiments performed (up to 30days) and that, surprisingly, treatment with 1-EBIO did not prevent the CA/CPR-induced loss of synaptic SK channel function. We concluded that CA/CPR caused alterations in post-synaptic signaling that were prevented by treatment with the SK2 agonist 1-EBIO, indicating that activators of SK2 channels may be useful therapeutic agents to prevent ischemic injury and cognitive impairments.	[Orfila, J. E.; Shimizu, K.; Garske, A. K.; Traystman, R. J.; Quillinan, N.; Herson, P. S.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA; [Deng, G.; Traystman, R. J.; Herson, P. S.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA; [Maylie, J.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Adelman, J. P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA		Herson, PS (corresponding author), Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA.	paco.herson@ucdenver.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS065855, NS080851]; Walter S. and Lucienne Driskill Foundation; AHA-Philips Resuscitation Fellowship [12POST11930031]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065855, R01NS080851] Funding Source: NIH RePORTER	This project was funded by NIH grants (NS065855 and NS080851), a Walter S. and Lucienne Driskill Foundation grant and an AHA-Philips Resuscitation Fellowship (12POST11930031).	Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; CREPEL V, 1993, J NEUROPHYSIOL, V69, P1774, DOI 10.1152/jn.1993.69.5.1774; Dai XN, 2007, NEUROPHARMACOLOGY, V52, P1124, DOI 10.1016/j.neuropharm.2006.11.012; Davies KD, 2007, BRAIN RES, V1158, P39, DOI 10.1016/j.brainres.2007.05.008; Davies KD, 2008, J BIOL CHEM, V283, P33138, DOI 10.1074/jbc.M803431200; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Di F. M., 2008, NEUROPHARMACOLOGY, V55, P353; Dos-Anjos S, 2009, NEUROCHEM INT, V54, P180, DOI 10.1016/j.neuint.2008.09.016; Gillardon F, 1999, NEUROSCIENCE, V93, P1219, DOI 10.1016/S0306-4522(99)00292-4; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; Hsu JC, 1998, J CEREBR BLOOD F MET, V18, P768, DOI 10.1097/00004647-199807000-00008; Hutchens MP, 2011, JOVE-J VIS EXP, DOI 10.3791/3116; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kofler J, 2004, J NEUROSCI METH, V136, P33, DOI 10.1016/j.jneumeth.2003.12.024; Li JM, 2013, BIOMED RES-TOKYO, V34, P75, DOI 10.2220/biomedres.34.75; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu ZA, 2010, BRAIN RES, V1361, P133, DOI 10.1016/j.brainres.2010.09.035; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Mori K, 1998, BRAIN RES, V795, P221, DOI 10.1016/S0006-8993(98)00295-9; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nagy D, 2011, NEUROPHARMACOLOGY, V61, P1026, DOI 10.1016/j.neuropharm.2011.07.005; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nunes B, 2003, RESUSCITATION, V57, P287, DOI 10.1016/S0300-9572(03)00033-9; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenkranz JA, 2009, J PHYSIOL-LONDON, V587, P115, DOI 10.1113/jphysiol.2008.158816; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Stackman RW, 2002, J NEUROSCI, V22, P10163; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Zhang L, 1997, J NEUROCHEM, V69, P1983	45	21	21	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	OCT	2014	40	8					3179	3188		10.1111/ejn.12683			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS1PL	WOS:000344052500005	25080203	Green Accepted			2022-02-06	
J	Petrini, K; Piwek, L; Crabbe, F; Pollick, FE; Garrod, S				Petrini, Karin; Piwek, Lukasz; Crabbe, Frances; Pollick, Frank E.; Garrod, Simon			Look at Those Two!: The Precuneus Role in Unattended Third-Person Perspective of Social Interactions	HUMAN BRAIN MAPPING			English	Article						biological motion; fMRI; granger causality; precuneus; social interaction	BIOLOGICAL MOTION PERCEPTION; DEFAULT MODE NETWORK; TRAUMATIC BRAIN-INJURY; FUNCTIONAL-ANATOMY; CINGULATE CORTEX; BASE-LINE; FMRI; SELF; CONNECTIVITY; COGNITION	Human beings often observe other people's social interactions without being a part of them. Whereas the implications of some brain regions (e.g. amygdala) have been extensively examined, the implication of the precuneus remains yet to be determined. Here we examined the implication of the precuneus in third-person perspective of social interaction using functional magnetic resonance imaging (fMRI). Participants performed a socially irrelevant task while watching the biological motion of two agents acting in either typical (congruent to social conventions) or atypical (incongruent to social conventions) ways. When compared to typical displays, the atypical displays elicited greater activation in the central and posterior bilateral precuneus, and in frontoparietal and occipital regions. Whereas the right precuneus responded with greater activation also to upside down than upright displays, the left precuneus did not. Correlations and effective connectivity analysis added consistent evidence of an interhemispheric asymmetry between the right and left precuneus. These findings suggest that the precuneus reacts to violations of social expectations, and plays a crucial role in third-person perspective of others' interaction even when the social context is unattended. Hum Brain Mapp 35:5190-5203, 2014. (c) 2014 Wiley Periodicals, Inc.	[Petrini, Karin] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Piwek, Lukasz; Crabbe, Frances; Pollick, Frank E.; Garrod, Simon] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland		Petrini, K (corresponding author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	k.petrini@ucl.ac.uk	Pollick, Frank/F-3186-2011; garrod, simon c/C-6837-2009	Pollick, Frank/0000-0002-7212-4622; Petrini, Karin/0000-0001-5354-5600	ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [RES-060-25-0010]	Contract grant sponsor: ESRC; Contract grant number: RES-060-25-0010	Aalto S, 2002, NEUROREPORT, V13, P67, DOI 10.1097/00001756-200201210-00018; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Bruneau EG, 2010, NEUROIMAGE, V52, P1704, DOI 10.1016/j.neuroimage.2010.05.057; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cloutier J, 2011, NEUROIMAGE, V57, P583, DOI 10.1016/j.neuroimage.2011.04.051; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Fink GR, 1996, J NEUROSCI, V16, P4275; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frankenstein UN, 2001, NEUROIMAGE, V14, P827, DOI 10.1006/nimg.2001.0883; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gitelman DR, 2002, NEUROIMAGE, V15, P970, DOI 10.1006/nimg.2001.1006; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Groen WB, 2010, CEREB CORTEX, V20, P1937, DOI 10.1093/cercor/bhp264; Henke K, 2003, NEUROPSYCHOLOGIA, V41, P863, DOI 10.1016/S0028-3932(03)00035-6; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kujala MV, 2012, HUM BRAIN MAPP, V33, P1753, DOI 10.1002/hbm.21317; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McDermott KB, 1999, MEMORY, V7, P661; McKay LS, 2012, NEUROIMAGE, V59, P1524, DOI 10.1016/j.neuroimage.2011.08.033; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Petrini K, 2010, J VISION, V10, DOI 10.1167/10.5.2; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Reid VM, 2009, DEV PSYCHOL, V45, P620, DOI 10.1037/a0015209; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roepstorff A., 2011, J NEUROSCI PSYCHOL E, V4, P1; Rose D, 2009, PERCEPTION, V38, P153, DOI 10.1068/p6279; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schilbach Leonhard, 2010, Nat Rev Neurosci, V11, P449, DOI 10.1038/nrn2805-c1; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shipley TF, 2003, PSYCHOL SCI, V14, P377, DOI 10.1111/1467-9280.24471; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065; Smith SM, 2012, NEUROIMAGE, V59, P1228, DOI 10.1016/j.neuroimage.2011.08.015; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Tsukiura T, 2002, J COGNITIVE NEUROSCI, V14, P922, DOI 10.1162/089892902760191144; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	84	21	22	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	OCT	2014	35	10					5190	5203		10.1002/hbm.22543			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AQ3CV	WOS:000342667400018	24824165	Green Accepted, Green Published			2022-02-06	
J	Elkon, B; Cambrin, JR; Hirshberg, E; Bratton, SL				Elkon, Benjamin; Cambrin, Jay Riva; Hirshberg, Eliotte; Bratton, Susan L.			Hyperglycemia: An Independent Risk Factor for Poor Outcome in Children With Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hyperglycemia; outcome; traumatic brain injury	TIGHT GLYCEMIC CONTROL; PEDIATRIC INTENSIVE-CARE; CRITICALLY-ILL PATIENTS; BLOOD-GLUCOSE; PERSISTENT HYPERGLYCEMIA; UNITED-STATES; HYPOTHERMIA; TRIAL; ASSOCIATION; RESUSCITATION	Objective: We sought 1) to describe the severity and duration of hyperglycemia among surviving and dying children after traumatic brain injury; 2) to evaluate whether persistent severe hyperglycemia (averaged blood glucose > 200 mg/dL [11 mmol/L] during the first 12 hr after injury) is independently associated with poor Glasgow Outcome Score; and 3) to evaluate different definitions and the prevalence of poor Glasgow Outcome Score to better understand measurement and potential hyperglycemia treatment evaluation. Design: Retrospective cohort. Setting: Level I American College of Surgery verified pediatric trauma center. Patients: Children admitted to intensive care with moderate-to-severe traumatic brain injury. Interventions: None. Measurements and Main Results: Time course for glucose changes was compared by survival and blood glucose groups. Twelve-hour averaged patient blood glucoses were categorized as persistent: severe hyperglycemia (> 200 mg/dL [11 mmol/L]), moderate hyperglycemia (161-200 mg/dL [9-11 mmol/L]), mild hyperglycemia (110-160 mg/dL [6-9 mmol/L]), normal glycemia (80-109 mg/dL [4-6 mmol/L]), or hypoglycemia (< 80 mg/dL [< 4 mmol/L]). Among 271 children, less than 1% had hypoglycemia and were excluded from further analysis. Seven percent had normal, 49% had mild, 24% had moderate, and 20% had severe blood glucose elevation. Among dying children (n = 44, 16%), the mean blood glucose at 20-24 hours after injury was significantly greater compared with survivors (150 vs 113 mg/dL [8 vs 6 mmol/L]) but by 29-32 hours, no longer significantly differed (112 vs 102 mg/dL [6 mmol/L]). Sixty-eight percent of children with severe blood glucose elevation had a poor outcome, whereas good outcomes at discharge occurred in 87% with mild or moderate blood glucose elevation. Severe blood glucose elevation was associated with a 3.5-fold increased adjusted odds ratio of poor outcome (95% CI, 1.2-10.3) compared with mild blood glucose elevation adjusted for injury severity and cardiorespiratory instability. Conclusions: Duration of severe blood glucose elevation (blood glucose > 200 mg/dL [11 mmol/L]) was brief but remained independently associated with poor outcome.	[Elkon, Benjamin; Hirshberg, Eliotte; Bratton, Susan L.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Cambrin, Jay Riva] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Hirshberg, Eliotte] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA		Bratton, SL (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.	susan.bratton@hsc.utah.edu	Bratton, Susan L./O-2353-2013; McMahon, Graham/D-3740-2009	Bratton, Susan L./0000-0002-4605-8078; McMahon, Graham/0000-0003-4288-6535	Hydrocephalus Association (Mentored-Young Investigator Award); NREF/AANS (Pediatric Neurosurgery Fellowship Grant) [CDC 1U01 DD000745-01]; AANS/CNS Section on Pediatric Neurological Surgery Research Grant; National Center on Birth Defects and Developmental DisabilitiesUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01DD000745] Funding Source: NIH RePORTER	Dr. Bratton serves as board member for the American Board of Pediatrics Critical Care Subboard (current chair), is employed by the University of Utah, and received support for travel from the Western Regional Pediatric Trauma Conference 2013. Dr. Riva-Cambrin is employed by the University of Utah and received grant support from Hydrocephalus Association (Mentored-Young Investigator Award). His institution received grant support from Hydrocephalus Association (Mentored-Young Investigator Award), NREF/AANS (Pediatric Neurosurgery Fellowship Grant), CDC 1U01 DD000745-01 (Spina Bifida Registry project), and AANS/CNS Section on Pediatric Neurological Surgery Research Grant (Risk Factors of Baclofen Pump Infection: A Multi-Centered Study). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; Christensen DW, 1997, PEDIATRICS, V99, P715; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; GRAF WD, 1995, ANN EMERG MED, V26, P312, DOI 10.1016/S0196-0644(95)70079-X; Hirshberg E, 2008, CHEST, V133, P1328, DOI 10.1378/chest.07-2702; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Legrand M, 2013, CRIT CARE, V17, DOI 10.1186/cc13133; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Mehari A, 2013, AM J RESP CRIT CARE, V187, P840, DOI 10.1164/rccm.201207-1222OC; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; Nadkarni VM, 2010, CIRCULATION, V122, P8276, DOI 10.1161/CIRCULATIONAHA.110.970921; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Traumatic Brain Injury in the United States, 2002, CDC MMWR SURVEILLANC; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	37	21	25	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2014	15	7					623	631		10.1097/PCC.0000000000000170			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AP3KR	WOS:000341975400013	24849146				2022-02-06	
J	Jabara, M; Bradley, J; Merrick, M				Jabara, Michael; Bradley, Jeffrey; Merrick, Michael			Is Stability of the Proximal Tibiofibular Joint Important in the Multiligament-injured Knee?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							POSTEROLATERAL CORNER; LIGAMENT INSTABILITIES; SURGICAL-MANAGEMENT; ACUTE DISLOCATION; RECONSTRUCTION; CLASSIFICATION; RELIABILITY; COMPARTMENT; VALIDITY; REPAIR	The incidence of proximal tibiofibular joint instability in the setting of the multiligament-injured knee has not been previously reported. The integrity of the proximal tibiofibular joint is required to perform a fibular-based, lateral-sided knee reconstruction. We report (1) the frequency of proximal tibiofibular joint instability in patients presenting with multiligament knee injuries and evaluate (2) our ability to restore stability to this joint, (3) patient-reported outcome scores, and (4) complications in patients surgically treated for proximal tibiofibular joint instability at the time of treatment of multiligament knee instability. From 2005 to 2013, 124 patients (129 knees) sustaining multiligament knee injuries with Grade 3 instability to at least two ligaments were treated at our institution. We defined proximal tibiofibular joint instability as a dislocated or dislocatable proximal tibiofibular joint at the time of surgery. These patients underwent surgery to restore proximal tibiofibular joint stability and ligament reconstruction or repair and were followed with routine clinical examination, radiographs, and subjective outcome measures, including Lysholm and IKDC scores. Minimum followup was 12 months (mean, 32 months; range, 12-61 months). Twelve knees (12 patients, 9% of 129 knees) showed proximal tibiofibular joint instability. Knee stability in 10 patients was restored to Grade 1 or less in all surgically treated ligaments. No proximal tibiofibular joint instability has recurred. No patients have complained of ankle stiffness or pain. In the ten patients with subjective scores, mean Lysholm score was 75 (range, 54-95) and mean IKDC score was 58 (range, 22-78). There were four complications: one failed posterolateral corner reconstruction, one proximal tibiofibular joint screw removal secondary to pain over the screw head, one deep infection treated with serial irrigation and d,bridements with graft retention, and one closed manipulation secondary to arthrofibrosis and loss of ROM. In the setting of multiligament-injured knees, our series demonstrated a 9% incidence of proximal tibiofibular joint instability. The technique we describe successfully restored stability to the proximal tibiofibular joint and resulted in satisfactory patient-reported outcomes with low complication rates.	[Jabara, Michael] Orthopaed Associates Michigan, Grand Rapids, MI 49503 USA; [Bradley, Jeffrey; Merrick, Michael] Grand Rapids Med Educ Partners, Orthoped Surg Residency Program, Grand Rapids, MI USA		Jabara, M (corresponding author), Orthopaed Associates Michigan, 230 Michigan,Suite 300, Grand Rapids, MI 49503 USA.	Michael.Jabara@oamichigan.com					Ahmad Riaz, 2008, J Med Case Rep, V2, P158, DOI 10.1186/1752-1947-2-158; Bicos J, 2006, SPORTS MED ARTHROSC, V14, P28, DOI 10.1097/00132585-200603000-00006; Briggs KK, 2006, J BONE JOINT SURG AM, V88A, P698, DOI 10.2106/JBJS.E.00339; Chhabra A, 2006, J BONE JOINT SURG AM, V88A, P2, DOI 10.2106/JBJS.F.00616; Engebretsen L, 2009, KNEE SURG SPORT TR A, V17, P1013, DOI 10.1007/s00167-009-0869-y; FALLON P, 1994, J ORTHOP TRAUMA, V8, P350, DOI 10.1097/00005131-199408000-00013; Fanelli GC, 2002, ARTHROSCOPY, V18, P703, DOI 10.1053/jars.2002.35142; Harvey GP, 1991, AM J KNEE SURG, V4, P151; Herscovici D Jr, 1992, J Orthop Trauma, V6, P116; Higgins LD, 2007, JOINT BONE SPINE, V74, P594, DOI 10.1016/j.jbspin.2007.01.036; Horst PK, 2010, KNEE SURG SPORT TR A, V18, P1452, DOI 10.1007/s00167-010-1049-9; HUGHSTON JC, 1976, J BONE JOINT SURG AM, V58, P173, DOI 10.2106/00004623-197658020-00002; HUGHSTON JC, 1976, J BONE JOINT SURG AM, V58, P159, DOI 10.2106/00004623-197658020-00001; Ibrahim SAR, 2008, ARTHROSCOPY, V24, P178, DOI 10.1016/j.arthro.2007.08.007; Ibrahim SAR, 2013, ARTHROSCOPY, V29, P733, DOI 10.1016/j.arthro.2012.11.021; Johnson Bryce A, 2007, Am J Orthop (Belle Mead NJ), V36, P439; LAMBERT KL, 1971, J BONE JOINT SURG AM, VA 53, P507, DOI 10.2106/00004623-197153030-00007; Levy BA, 2010, AM J SPORT MED, V38, P804, DOI 10.1177/0363546509352459; Levy BA, 2009, ARTHROSCOPY, V25, P430, DOI 10.1016/j.arthro.2009.01.008; Maffulli N, 2005, TECH KNEE SURG, V4, P126; Maffulli N, 2010, AM J SPORT MED, V38, P2294, DOI 10.1177/0363546510373472; Mariani P P, 1999, Am J Knee Surg, V12, P214; Miettinen H, 1999, ARCH ORTHOP TRAUM SU, V119, P358, DOI 10.1007/s004020050428; Nelaton A., 1874, ELEMENS PATHOLOGIE C, P292; OGDEN JA, 1974, CLIN ORTHOP RELAT R, P186; OGDEN JA, 1974, J BONE JOINT SURG AM, VA 56, P145, DOI 10.2106/00004623-197456010-00015; PARKES JC, 1973, J BONE JOINT SURG AM, VA 55, P177, DOI 10.2106/00004623-197355010-00019; Rajkumar P, 2002, INT J CLIN PRACT, V56, P556; Robinson Y, 2007, KNEE SURG SPORT TR A, V15, P199, DOI 10.1007/s00167-006-0147-1; Sekiya Jon K, 2003, J Am Acad Orthop Surg, V11, P120; Sreesobh K V, 2009, J Orthop Surg (Hong Kong), V17, P109; Stannard JP, 2005, AM J SPORT MED, V33, P881, DOI 10.1177/0363546504271208; Stannard JP, 2005, ARTHROSCOPY, V21, P1051, DOI 10.1016/j.arthro.2005.05.020; Tanner SM, 2007, CLIN J SPORT MED, V17, P75, DOI 10.1097/JSM.0b013e31802b4feb; van den Bekerom Michel P J, 2004, Acta Orthop Belg, V70, P604	35	21	21	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2014	472	9					2691	2697		10.1007/s11999-014-3574-1			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AM7LR	WOS:000340049200019	24664195	Green Published			2022-02-06	
J	Siegmund, GP; Guskiewicz, KM; Marshall, SW; DeMarco, AL; Bonin, SJ				Siegmund, Gunter P.; Guskiewicz, Kevin M.; Marshall, Stephen W.; DeMarco, Alyssa L.; Bonin, Stephanie J.			A Headform for Testing Helmet and Mouthguard Sensors that Measure Head Impact Severity in Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Validation; Repeatability	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; ACCELERATION; CONCUSSION; KINEMATICS; SYSTEM	A headform is needed to validate and compare helmet- and mouthguard-based sensors that measure the severity and direction of football head impacts. Our goal was to quantify the dynamic response of a mandibular load-sensing headform (MLSH) and to compare its performance and repeatability to an unmodified Hybrid III headform. Linear impactors in two independent laboratories were used to strike each headform at six locations at 5.5 m/s and at two locations at 3.6 and 7.4 m/s. Impact severity was quantified using peak linear acceleration (PLA) and peak angular acceleration (PAA), and direction was quantified using the azimuth and elevation of the PLA. Repeatability was quantified using coefficients of variation (COV) and standard deviations (SD). Across all impacts, PLA was 1.6 +/- A 1.8 g higher in the MLSH than in the Hybrid III (p = 0.002), but there were no differences in PAA (p = 0.25), azimuth (p = 0.43) and elevation (p = 0.11). Both headforms exhibited excellent or acceptable repeatability for PLA (HIII:COV = 2.1 +/- A 0.8%, MLSH:COV = 2.0 +/- A 1.2%, p = 0.98), but site-specific repeatability ranging from excellent to poor for PAA (HIII:COV = 7.2 +/- A 4.0%, MLSH:COV = 8.3 +/- A 5.8%, p = 0.58). Direction SD were generally < 1A degrees and did not vary between headforms. Overall, both headforms are similarly suitable for validating PLA in sensors that measure head impact severity in football players, however their utility for validating sensor PAA values varies with impact location.	[Siegmund, Gunter P.; DeMarco, Alyssa L.] MEA Forens Engineers & Scientists, Richmond, BC V7A 4S5, Canada; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Bonin, Stephanie J.] MEA Forens Engineers & Scientists, Laguna Hills, CA USA		Siegmund, GP (corresponding author), MEA Forens Engineers & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Siegmund, Gunter P/B-7003-2013	Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Siegmund, Gunter/0000-0003-2387-941X; DeMarco, Alyssa/0000-0002-3106-386X	National Football League (NFL); National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49-CE001495]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001495] Funding Source: NIH RePORTER	This study was funded by the National Football League (NFL). Author KMG approved the protocol and publication of these results on behalf of the NFL. The authors wish to acknowledge Chris Withnall and Michael Wonnacott of Biokinetics and Associates, and Dave Halstead and Elizabeth McCalley of Southern Impact Research Center (SIRC) for their assistance in refining the protocol and acquiring the data. SWM is partly supported by a grant R49-CE001495 from the National Center for Injury Prevention and Control. Author GPS owns shares in a forensic consulting company that may benefit from being associated with this study. Author KMG is a member of the NFL's Head, Neck and Spine Committee and Chair of the Subcommittee on Equipment and Playing Rules. The remaining authors declare no conflict of interest. Biokinetics and Associates Ltd. is the manufacturer of the MLSH headform and half of the data presented here was gathered in their lab. All tests at Biokinetics and Associates Ltd. were conducted under the supervision of author GPS, and they had no hand in post-processing these data.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; [Anonymous], 2013, 1583012013E ISO; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bortenschlager K., 2009, P 21 ESV C STUTTG GE; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Craig MJ, 2009, SAE INT J PASSEN CAR, V2, P587, DOI 10.4271/2009-01-0388; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Higgins M, 2007, J ATHL TRAINING, V42, P5; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kaleps I., 1988, HYBRID 3 GEOMETRICAL; Knox T, 2009, SAE INT J PASSENG CA, V1, P652; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Olvey SE, 2004, NEUROSURGERY, V54, P672, DOI 10.1227/01.NEU.0000108782.68099.29; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wonnacott M., 2010, 2010010136 SAE	26	21	21	0	31	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2014	42	9					1834	1845		10.1007/s10439-014-1052-2			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AN2DN	WOS:000340394100004	24920257				2022-02-06	
J	Taylor, JM; Kelley, B; Gregory, EJ; Berman, NEJ				Taylor, Jordan M.; Kelley, Brian; Gregory, Eugene J.; Berman, Nancy E. J.			Neuroglobin overexpression improves sensorimotor outcomes in a mouse model of traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Neuroglobin; Traumatic brain injury; Transgenic; Overexpression; Neuroprotective; Sensorimotor	CONTROLLED CORTICAL IMPACT; UP-REGULATION; EXPRESSION; MICE; CELLS; NEUROPROTECTION; PROTECTS; CYTOGLOBIN; RAT	There is a significant need for novel treatments that will improve traumatic brain injury (TBI) outcomes. One potential neuroprotective mechanism is to increase oxygen binding proteins such as neuroglobin. Neuroglobin has a high affinity for oxygen, is an effective free radical scavenger, and is neuroprotective within the brain following hypoxia and ischemia. The purpose of this study was to determine whether neuroglobin overexpression improves sensorimotor outcomes following TBI in transgenic neuroglobin overexpressing (NGB) mice. Additional study aims were to determine if and when an endogenous neuroglobin response occurred following TBI in wild-type (WT) mice, and in what brain regions and cell types the response occurred. Controlled cortical impact (CCI) was performed in adult (5 month) C57/BL6 WT mice, and NGB mice constitutively overexpressing neuroglobin via the chicken beta actin promoter coupled with the cytomegalovirus distal enhancer. The gridwalk task was used for sensorimotor testing of both WT and NGB mice, prior to injury, and at 2, 3, and 7 days post-TBI. NGB mice displayed significant reductions in the average number of foot faults per minute walking at 2,3, and 7 days post-TBI when compared to WT mice at each time point. Neuroglobin mRNA expression was assessed in the injured cortex of WT mice prior to injury, and at 1, 3, 7, and 14 days post-TBI using quantitative real time polymerase chain reaction (qRT-PCR). Neuroglobin mRNA was significantly increased at 7 days post-TBI. Immunostaining showed neuroglobin primarily localized to neurons and glial cells in the injured cortex and ipsilateral hippocampus of WT mice, while neuroglobin was present in all brain regions of NGB mice at 7 days post-TBI. These results showed that overexpression of neuroglobin reduced sensorimotor deficits following TBI, and that an endogenous increase in neuroglobin expression occurs during the subacute period. Increasing neuroglobin expression through novel therapeutic interventions during the acute period after TBI may improve recovery. (C) 2014 Elsevier B.V. All rights reserved.	[Taylor, Jordan M.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Kelley, Brian] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66160 USA; [Gregory, Eugene J.; Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Berman, NEJ (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Mailstop 3038,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	NBERMAN@kumc.edu			National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM103418]; University of Kansas Alzheimer's Disease Center [P30 AG035982]; Landon Center on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG035982] Funding Source: NIH RePORTER	This project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103418. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. This work was also supported by an award from the University of Kansas Alzheimer's Disease Center (P30 AG035982) and the Landon Center on Aging.	Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Fiocchetti M, 2013, BBA-PROTEINS PROTEOM, V1834, P1744, DOI 10.1016/j.bbapap.2013.01.015; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Jin KL, 2011, PHARMACOLOGY, V87, P81, DOI 10.1159/000322998; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Shang AJ, 2012, NEUROL RES, V34, P588, DOI 10.1179/1743132812Y.0000000052; Shang AJ, 2012, NEUROL SCI, V33, P551, DOI 10.1007/s10072-011-0772-4; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Tian SF, 2013, J BIOL CHEM, V288, P15988, DOI 10.1074/jbc.M112.428789; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhu YH, 2002, BLOOD, V100, P2494, DOI 10.1182/blood-2002-01-0280	29	21	26	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 8	2014	577						125	129		10.1016/j.neulet.2014.03.012			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN0XY	WOS:000340308500024	24642455	Green Accepted			2022-02-06	
J	Brickell, TA; Lange, RT; French, LM				Brickell, Tracey A.; Lange, Rael T.; French, Louis M.			Health-Related Quality of Life Within the First 5 Years Following Military-Related Concurrent Mild Traumatic Brain Injury and Polytrauma	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POST-CONCUSSION SYMPTOMS; MENTAL-HEALTH; SERVICE MEMBERS; PSYCHIATRIC DIAGNOSES; HEAD-INJURY; COMBAT; IRAQ; VETERANS	This study examined health-related quality of life within the first 5 years following concurrent mild traumatic brain injury (MTBI) and polytrauma. Participants were 167 U.S. service members who had sustained a MTBI who had completed a brief neurobehavioral evaluation within 3 months postinjury and at least one telephone follow-up interview at 6 (n = 46), 12 (n = 89), 24 (n = 54), 36 (n = 42), 48 (n = 30) or 60 months (n = 25) postinjury. Within the first 5years postinjury, service members reported ongoing headaches (67.4% to 92.0%), bodily pain (66.7% to 88.9%), medication use (71.7% to 92.0%), mental health treatment (28.3% to 60.0%), and the need for help with daily activities (18.5% to 40.0%). Problematic alcohol consumption was common within the first 24 months postinjury (23.9% to 29.2%). Many service members were working for pay (36.0% to 70.8%) though many reported a decline in work quality (16.0% to 30.4%). Despite ongoing symptom reporting, many service members reported that their medications were effective (43.3% to 80.0%), good/excellent health status (68.0% to 80.0%), and life satisfaction (79.6% to 90.5%). A minority reported suicidal or homicidal ideation (5.6% to 14.8%). Recovery from MTBI in a military setting is complex and multifaceted. Continued support and care for all service members who sustain a combat-related MTBI with polytrauma is recommended, regardless of the presence or absence of symptom reporting within the first few months postinjury.	[Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada		Brickell, TA (corresponding author), Def & Vet Brain Injury Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.		french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bradley CS, 2014, J UROLOGY, V191, P1327, DOI 10.1016/j.juro.2013.11.100; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CELLA DF, 1995, SEMIN ONCOL, V22, P73; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center D, 2012, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Goodwin L, 2012, J NERV MENT DIS, V200, P429, DOI 10.1097/NMD.0b013e31825322fe; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horesh D, 2013, PSYCHIAT RES, V208, P265, DOI 10.1016/j.psychres.2012.12.004; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Nestvold K, 2009, BRAIN INJ; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Weathers F. W., 1994, PTSD CHECKLIST CIVIL	57	21	21	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					827	838		10.7205/MILMED-D-13-00506			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UO	WOS:000340806700004	25102525	Bronze			2022-02-06	
J	Bayley, MT; Teasell, RW; Wolfe, DL; Gruen, RL; Eng, JJ; Ghajar, J; Tavender, E; Kua, A; Bragge, P				Bayley, Mark Theodore; Teasell, Robert William; Wolfe, Dalton Louis; Gruen, Russell Lindsay; Eng, Janice Jennifer; Ghajar, Jamshid; Tavender, Emma; Kua, Ailene; Bragge, Peter			Where to Build the Bridge Between Evidence and Practice?: Results of an International Workshop to Prioritize Knowledge Translation Activities in Traumatic Brain Injury Care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						guidelines; knowledge translation; rehabilitation; therapeutic approaches for the treatment of brain injury; traumatic brain injury	EMERGENCY-MEDICINE; RANDOMIZED-TRIALS; REHABILITATION; IMPLEMENTATION	Introduction: Treatment of patients with traumatic brain injury (TBI) should be based upon the strongest evidence to achieve optimal patient outcomes. Given the challenges, efforts involved, and delays in uptake of evidence into practice, priorities for knowledge translation (KT) should be chosen carefully. An international workshop was convened to identify KT priorities for acute and rehabilitation care of TBI and develop KT projects addressing these priorities. Methods: An expert panel of 25 neurotrauma clinicians, researchers, and KT scientists representing 4 countries examined 66 neurotrauma research topics synthesized from 2 neurotrauma evidence resources: Evidence Based Review of Acquired Brain Injury and Global Evidence Mapping projects. The 2-day workshop combined KT theory presentations with small group activities to prioritize topics using a modified Delphi method. Results: Four acute care topics and 3 topics in the field of rehabilitation were identified. These were focused into 3 KT project proposals: optimization of intracranial pressure and nutrition in the first week following TBI; cognitive rehabilitation following TBI; and vocational rehabilitation following TBI. Conclusion: Three high-priority KT projects were developed: the first combined 2 important topics in acute TBI management of intracranial pressure management and nutrition, and the other projects focused on cognitive rehabilitation and vocational rehabilitation.	[Bayley, Mark Theodore] Univ Hlth Network, Toronto Rehabil Inst, Brain & Spinal Cord Rehabil Program, Toronto, ON M5G 2A2, Canada; [Kua, Ailene] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Bayley, Mark Theodore] Univ Toronto, Fac Med, Toronto, ON, Canada; [Teasell, Robert William] Univ Western Ontario, Schulich Sch Med & Dent, Dept Phys Med & Rehabil, London, ON, Canada; [Teasell, Robert William] Lawson Hlth Res Inst, London, ON, Canada; [Wolfe, Dalton Louis] Lawson Hlth Res Inst, Aging Rehabil & Geriatr Care, London, ON, Canada; [Gruen, Russell Lindsay; Tavender, Emma; Bragge, Peter] Monash Univ, Melbourne, Vic 3004, Australia; [Gruen, Russell Lindsay] Alfred Hlth, Melbourne, Vic, Australia; [Eng, Janice Jennifer] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Ghajar, Jamshid] Weill Cornell Med Coll, New York, NY USA; [Tavender, Emma; Bragge, Peter] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Tavender, Emma] Cochrane Effect Practice & Org Care, Australian Satellite, Ottawa, ON, Canada		Bayley, MT (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Brain & Spinal Cord Rehabil Program, Room 3-131,550 Univ Ave, Toronto, ON M5G 2A2, Canada.	mark.bayley@uhn.ca		Bragge, Peter/0000-0003-0745-5131; Tavender, Emma/0000-0002-7230-712X; Eng, Janice/0000-0002-2093-0788; Bayley, Mark/0000-0001-7860-9463	Victorian Neurotrauma Initiative-a research program of the Transport Accident Commission; Monash UniversityMonash University; Ontario Neurotrauma Foundation	The project described in this article was funded through the Victorian Neurotrauma Initiative-a research program of the Transport Accident Commission and Monash University's Strategic Grants Scheme (lead chief investigator: Peter Bragge) and the Ontario Neurotrauma Foundation (lead chief investigator: Mark Bayley).	Access Economics, 2009, EC COST SPIN CORD IN, P115; Bayley MT, 2007, ARCH PHYS MED REHAB, V88, P526, DOI 10.1016/j.apmr.2007.01.005; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; Buchan H, 2004, MED J AUSTRALIA, V180, pS48; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Campbell MK, 1998, BMJ-BRIT MED J, V317, P1171, DOI 10.1136/bmj.317.7167.1171; Cranney A, 2008, OSTEOPOROSIS INT, V19, P1733, DOI 10.1007/s00198-008-0669-0; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Grimshaw JM, 2004, MED J AUSTRALIA, V180, pS50; Grimshaw JM, 2001, MED CARE, V39, pII2; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Lang ES, 2007, ACAD EMERG MED, V14, P915, DOI 10.1197/j.aem.2007.07.005; Lang ES, 2007, ACAD EMERG MED, V14, P919, DOI 10.1197/j.aem.2007.07.002; Lang ES, 2007, ANN EMERG MED, V49, P355, DOI 10.1016/j.annemergmed.2006.08.022; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McKenzie JE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-86; Priest JL, 2011, POPUL HEALTH MANAG, V14, P43, DOI 10.1089/pop.2010.0019; Ramsay CR, 2003, CLIN RADIOL, V58, P319, DOI 10.1016/S0009-9260(02)00524-X; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	28	21	22	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2014	29	4					268	276		10.1097/HTR.0000000000000053			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AM2AK	WOS:000339650300005	24984091				2022-02-06	
J	Colton, K; Yang, SM; Hu, PF; Chen, HH; Bonds, B; Scalea, TM; Stein, DM				Colton, Katharine; Yang, Shiming; Hu, Peter F.; Chen, Hegang H.; Bonds, Brandon; Scalea, Thomas M.; Stein, Deborah M.			Intracranial pressure response after pharmacologic treatment of intracranial hypertension	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; secondary insults; intracranial pressure; critical care documentation; automated documentation	7.2-PERCENT HYPERTONIC SALINE; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTENSIVE-CARE; MANNITOL; PROPOFOL; FENTANYL; SUFENTANIL; METABOLISM; SEDATION	BACKGROUND: The accepted treatment of increased intracranial pressure (ICP) in patients experiencing severe traumatic brain injury is multimodal and algorithmic, obscuring individual effects of treatment. Using continuous vital signs monitoring, we sought to measure treatment effect and ascertain the accuracy of manual data recording. METHODS: Patients older than 17 years, admitted and requiring ICP monitoring between 2008 and 2010 at a high-volume urban trauma center, were retrospectively evaluated. Timing and dose of ICP-directed therapy were recorded from paper and electronic medical records. ICP data were collected automatically at 6-second intervals and from manual charts. A statistical mixed model was applied to all data to account for multiple sampling. RESULTS: A total of 117 patients met inclusion criteria; 450 treatments were administered when nursing records indicate an ICP greater than 20 mm Hg, While 968 treatments were given when ICP was greater than 20 mm Hg by automated data. Pharmacologic treatments identified include hypertonic saline (HTS), mannitol, barbiturates, and dose escalations of propofol or fentanyl infusions. Treatment with HTS resulted in the largest ICP decrease of the treatments examined, with a 1-hour ICP reduction of 8.8/9.9 mm Hg (for a small/large dose) according to manual data and a reduction of 3.0/2.4 mm Hg according to automated data. Propofol and fentanyl escalations resulted in smaller but significant ICP reductions. Mannitol (n = 8) resulted in statistically insignificant trends down in the first hour but rebounded by the second hour after administration. The average ICP in the hour before medication administration was higher for barbiturates (27 mm Hg) and mannitol (32 mm Hg) than for the other interventions (18-19 mm Hg). CONCLUSION: ICP fell after administration of HTS, mannitol, or barbiturates and showed continued improvement after 2 hours. ICP fell initially after treatment with short-acting propofol and fentanyl but trended back up after 2 hours. Manually recorded data consistently overestimated treatment effectiveness. Automated data collection gives a more accurate assessment of patient status and responsiveness to treatment. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Colton, Katharine; Yang, Shiming; Hu, Peter F.; Chen, Hegang H.; Bonds, Brandon; Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD USA; [Colton, Katharine; Yang, Shiming; Hu, Peter F.; Chen, Hegang H.; Bonds, Brandon; Scalea, Thomas M.; Stein, Deborah M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Colton, Katharine] Duke Univ, Sch Med, Durham, NC USA		Colton, K (corresponding author), Duke Univ, Sch Med, 804 Remington Circle, Durham, NC 27705 USA.	krcolton@gmail.com	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	 [FA8650-11-2-6D06];  [FA8650-12-2-6D09];  [FA8650-13-2-6D15]	This study was funded in part by the grants FA8650-11-2-6D06, FA8650-12-2-6D09, and FA8650-13-2-6D15.	Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Becker DP, 1972, INTRACRANIAL PRESSUR, P309; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gugerty B., 2007, CHALLENGES OPPORTUNI; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Hravnak M, 2008, ARCH INTERN MED, V168, P1300, DOI 10.1001/archinte.168.12.1300; Hravnak M, 2011, CRIT CARE MED, V39, P65, DOI 10.1097/CCM.0b013e3181fb7b1c; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Lauer KK, 1997, CAN J ANAESTH, V44, P929, DOI 10.1007/BF03011963; LOUGHHEAD MG, 1988, MED J AUSTRALIA, V148, P458, DOI 10.5694/j.1326-5377.1988.tb139571.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MCGRAW CP, 1983, NEUROSURGERY, V13, P269, DOI 10.1227/00006123-198309000-00009; Mulligan Alison, 2010, Intensive Crit Care Nurs, V26, P196, DOI 10.1016/j.iccn.2010.03.002; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schrot RJ, 2002, LANCET, V359, P1633, DOI 10.1016/S0140-6736(02)08545-8; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; Subbe CP, 2007, INTENS CARE MED, V33, P619, DOI 10.1007/s00134-006-0516-8; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; Turner H B, 1988, J Neurosci Nurs, V20, P236; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; Wilson SJ, 2013, EMERG MED J, V30, P186, DOI 10.1136/emermed-2011-200499; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	38	21	23	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2014	77	1					47	53		10.1097/TA.0000000000000270			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AK4IY	WOS:000338389600012	24977754				2022-02-06	
J	Brenner, JS; Brooks, A; Demorest, RA; Halstead, ME; Kelly, AKW; Koutures, CG; LaBella, CR; LaBotz, M; Loud, KJ; Martin, SS; Moffatt, K				Brenner, Joel S.; Brooks, Alison; Demorest, Rebecca A.; Halstead, Mark E.; Kelly, Amanda K. Weiss; Koutures, Chris G.; LaBella, Cynthia R.; LaBotz, Michele; Loud, Keith J.; Martin, Stephanie S.; Moffatt, Kody		Council Sports Med Fittness	Reducing Injury Risk From Body Checking in Boys' Youth Ice Hockey	PEDIATRICS			English	Article						athletic injury; injury prevention; concussion; body checking	EMERGENCY-DEPARTMENTS; FACIAL INJURIES; HEAD IMPACTS; PLAYERS; RATES; CONCUSSION; RULES; FACE; AGGRESSION; SEVERITY	Ice hockey is an increasingly popular sport that allows intentional collision in the form of body checking for males but not for females. There is a two-to threefold increased risk of all injury, severe injury, and concussion related to body checking at all levels of boys' youth ice hockey. The American Academy of Pediatrics reinforces the importance of stringent enforcement of rules to protect player safety as well as educational interventions to decrease unsafe tactics. To promote ice hockey as a lifelong recreational pursuit for boys, the American Academy of Pediatrics recommends the expansion of nonchecking programs and the restriction of body checking to elite levels of boys' youth ice hockey, starting no earlier than 15 years of age.						Moffatt, Kody/0000-0001-5539-9969			Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernard D, 1993, SAFETY ICE HOCKEY, V2; Blake Tracy, 2012, Clin J Sport Med, V22, P377, DOI 10.1097/JSM.0b013e31826038e0; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; Bunn JW, 2008, PHYSICIAN SPORTSMED, V36, P76, DOI 10.3810/psm.2008.12.15; Comstock R.D., 2009, HIGH SCH RIO CONVENI; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano Michael D, 2011, Open Med, V5, pe57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris AW, 2012, CLIN J SPORT MED, V22, P455, DOI 10.1097/JSM.0b013e318259ed09; Hockey USA, 2011 2012 SEAS FIN R; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; Le Gall F, 2007, SCAND J MED SCI SPOR, V17, P564, DOI 10.1111/j.1600-0838.2006.00594.x; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Malenfant S, 2012, J SCI MED SPORT, V15, P463, DOI 10.1016/j.jsams.2012.03.003; Malina RM, 2005, MED SCI SPORT EXER, V37, P1044, DOI 10.1249/01.mss.0000171622.45134.cb; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McPherson MN, 2009, J ASTM INT, V6; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Smith A., 2009, J ASTM INT, V6; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; ThinkFirst Canada, 2011, POS STAT SAF HOCK; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Wattie N, 2010, CLIN J SPORT MED, V20, P113, DOI 10.1097/JSM.0b013e3181d2de78; Yard EE, 2006, J ATHL TRAINING, V41, P441	44	21	21	1	18	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2014	133	6					1151	1157		10.1542/peds.2014-0692			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AI8MY	WOS:000337172600066	24864185	Bronze			2022-02-06	
J	Lewandowski-Belfer, JJ; Patel, AV; Darracott, RM; Jackson, DA; Nordeen, JD; Freeman, WD				Lewandowski-Belfer, Julie J.; Patel, Alden V.; Darracott, Robert M.; Jackson, Daniel A.; Nordeen, Jerah D.; Freeman, W. David			Safety and Efficacy of Repeated Doses of 14.6 or 23.4 % Hypertonic Saline for Refractory Intracranial Hypertension	NEUROCRITICAL CARE			English	Article						Hypertonic saline; Hyperosmolar agents; Intracranial pressure; Osmotherapy; Intracranial hypertension; Serum sodium	TRAUMATIC BRAIN-INJURY; PRESSURE; MANAGEMENT; THERAPY	The efficacy of administering single bolus doses of 14.6 or 23.4 % hypertonic saline (HTS) to treat refractory intracranial hypertension has been demonstrated in the literature and has emerged as an important therapeutic option in treating these patients. However, many institutions lack experience with this therapy and there are few published studies evaluating the safety of repeated bolus dosing of HTS. A retrospective review of patients admitted between January 2008 and July 2012 was conducted to evaluate the use of repeated dosing of HTS in patients with refractory intracranial hypertension. The primary objective was to evaluate the safety of repeated dosing of HTS assessed by documented adverse effects such as central pontine myelinolysis (CPM) and severe fluctuations in serum sodium concentrations. Secondary objectives were to evaluate the efficacy of repeated dosing HTS in reducing intracranial pressure (ICP) and to compare the dose-response relationship of 14.6 and 23.4 % doses. Fifty-five patients were included for evaluation, each receiving an average of 8.9 (range 2-61) doses of HTS. A statistically significant increase in mean serum sodium concentration occurred with the administration of HTS (p < 0.0001). No cases of CPM were identified. The use of HTS was found to be effective based on decreases in ICP after administration (p < 0.0001, mean ICP reduction: 10.1 mmHg, range 3-23.6 mmHg). The efficacy of 23.4 % saline in decreasing ICP was not found to be significantly different than 14.6 % saline (p = 0.23). Repeat bolus dosing of 14.6 or 23.4 % HTS appears to be relatively safe and effective for treating refractory intracranial hypertension assuming there is frequent electrolyte monitoring and concomitant fluid management.	[Lewandowski-Belfer, Julie J.] Spectrum Hlth Butterworth, Dept Pharm, Grand Rapids, MI 49503 USA; [Lewandowski-Belfer, Julie J.; Patel, Alden V.; Darracott, Robert M.; Jackson, Daniel A.; Nordeen, Jerah D.] Mayo Clin, Dept Pharm, Jacksonville, FL 32224 USA; [Freeman, W. David] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Freeman, W. David] Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA; [Freeman, W. David] Mayo Clin, Dept Crit Care, Jacksonville, FL 32224 USA		Lewandowski-Belfer, JJ (corresponding author), Spectrum Hlth Butterworth, Dept Pharm, 100 Michigan NE, Grand Rapids, MI 49503 USA.	lewanjj@gmail.com; Patel.Alden@mayo.edu; Darracott.Robert@mayo.edu; Jackson.Daniel1@mayo.edu; Nordeen.Jerah@mayo.edu; freeman.william1@mayo.edu	Belfer, Julie/AAY-7497-2020	Freeman, M.D., William D./0000-0003-2326-0633; Belfer, Julie/0000-0002-9189-0752			Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Valentino Alden K, 2008, J Vasc Interv Neurol, V1, P113; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	17	21	22	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2014	20	3					436	442		10.1007/s12028-013-9907-1			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI7RH	WOS:000337092900012	24026522				2022-02-06	
J	Puschmann, TB; de Pablo, Y; Zanden, C; Liu, J; Pekny, M				Puschmann, Till B.; de Pablo, Yolanda; Zanden, Carl; Liu, Johan; Pekny, Milos			A Novel Method for Three-Dimensional Culture of Central Nervous System Neurons	TISSUE ENGINEERING PART C-METHODS			English	Article							IN-VITRO; REACTIVE ASTROCYTES; CNS SYNAPTOGENESIS; NEURITE OUTGROWTH; PORE-SIZE; SCAFFOLDS; CELLS; DIFFERENTIATION; CHOLESTEROL; MATRIX	Neuronal signal transduction and communication in vivo is based on highly complex and dynamic networks among neurons expanding in a three-dimensional (3D) manner. Studies of cell-cell communication, synaptogenesis, and neural network plasticity constitute major research areas for understanding the involvement of neurons in neurodegenerative diseases, such as Huntington's, Alzheimer's, and Parkinson's disease, and in regenerative neural plasticity responses in situations, such as neurotrauma or stroke. Various cell culture systems constitute important experimental platforms to study neuronal functions in health and disease. A major downside of the existing cell culture systems is that the alienating planar cell environment leads to aberrant cell-cell contacts and network formation and increased reactivity of cell culture-contaminating glial cells. To mimic a suitable 3D environment for the growth and investigation of neuronal networks in vitro has posed an insurmountable challenge. Here, we report the development of a novel electrospun, polyurethane nanofiber-based 3D cell culture system for the in vitro support of neuronal networks, in which neurons can grow freely in all directions and form network structures more complex than any culture system has so far been able to support. In this 3D system, neurons extend processes from their cell bodies as a function of the nanofiber diameter. The nanofiber scaffold also minimizes the reactive state of contaminating glial cells.	[Puschmann, Till B.; de Pablo, Yolanda; Pekny, Milos] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil,Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Zanden, Carl; Liu, Johan] Chalmers, SMIT Ctr, S-41296 Gothenburg, Sweden; [Zanden, Carl; Liu, Johan] Chalmers, Bionano Syst Lab, Dept Microtechnol & Nanosci MC2, S-41296 Gothenburg, Sweden; [Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia		Puschmann, TB (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil,Sahlgrenska Acad, Box 440, SE-40530 Gothenburg, Sweden.	till.puschmann@neuro.gu.se; milos.pekny@neuro.gu.se	de Pablo, Yolanda/AAD-1642-2019; Liu, Johan/O-3375-2019; Puschmann, Till/H-2901-2013	de Pablo, Yolanda/0000-0001-5208-2114; Puschmann, Till/0000-0003-4859-2482	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [11548]; ALF Gothenburg [11392]; AFA Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Hjarnfonden; Hagstromer's Foundation Millennium; Amlov's Foundation; E. Jacobson's Donation Fund; VINNOVA Health ProgramVinnova; Swedish Stroke Foundation; Swedish Society of Medicine; Free Mason Foundation; Chalmers University of Technology; NanoNet COST ActionEuropean Cooperation in Science and Technology (COST) [BM1002]; EUEuropean Commission [237956, 279017]	This work was supported by the Swedish Medical Research Council (11548), ALF Gothenburg (11392), AFA Research Foundation, Soderbergs Foundations, Sten A. Olsson Foundation for Research and Culture, Hjarnfonden, Hagstromer's Foundation Millennium, Amlov's Foundation, E. Jacobson's Donation Fund, VINNOVA Health Program, the Swedish Stroke Foundation, the Swedish Society of Medicine, the Free Mason Foundation, Chalmers University of Technology, NanoNet COST Action (BM1002), EU FP 7 Program Edu-Glia (237956), EU FP 7 Program TargetBraIn (279017).	Asefnejad A, 2011, INT J NANOMED, V6, P2375, DOI 10.2147/IJN.S15586; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Hu R, 2007, NEUROSCIENCE, V144, P1229, DOI 10.1016/j.neuroscience.2006.09.056; Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Jones EV, 2012, METHODS MOL BIOL, V814, P341, DOI 10.1007/978-1-61779-452-0_22; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Puschmann TB, 2014, J NEUROCHEM, V128, P878, DOI 10.1111/jnc.12519; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551; Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026; Steinmetz CC, 2006, J PHYSIOL-LONDON, V577, P249, DOI 10.1113/jphysiol.2006.117358; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21	32	21	21	0	38	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	JUN 1	2014	20	6					485	492		10.1089/ten.tec.2013.0445			8	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	AH2YE	WOS:000335987200004	24102451				2022-02-06	
J	Skoglund, K; Hillered, L; Purins, K; Tsitsopoulos, PP; Flygt, J; Engquist, H; Lewen, A; Enblad, P; Marklund, N				Skoglund, Karin; Hillered, Lars; Purins, Karlis; Tsitsopoulos, Parmenion P.; Flygt, Johanna; Engquist, Henrik; Lewen, Anders; Enblad, Per; Marklund, Niklas			The Neurological Wake-up Test Does not Alter Cerebral Energy Metabolism and Oxygenation in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Cerebral microdialysis; Brain tissue oxygenation; Jugular venous oxygenation; Neurological wake-up test; Brain energy metabolism; Interruption of sedation	RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; MECHANICALLY VENTILATED PATIENTS; POSITRON-EMISSION-TOMOGRAPHY; DAILY SEDATION INTERRUPTION; CRITICALLY-ILL PATIENTS; INTRACEREBRAL MICRODIALYSIS; NEUROCRITICAL CARE; PERFUSION-PRESSURE	The neurological wake-up test (NWT) is used to monitor the level of consciousness in patients with traumatic brain injury (TBI). However, it requires interruption of sedation and may elicit a stress response. We evaluated the effects of the NWT using cerebral microdialysis (MD), brain tissue oxygenation (PbtiO2), jugular venous oxygen saturation (SjvO(2)), and/or arterial-venous difference (AVD) for glucose, lactate, and oxygen in patients with severe TBI. Seventeen intubated TBI patients (age 16-74 years) were sedated using continuous propofol infusion. All patients received intracranial pressure (ICP) and cerebral perfusion pressure (CPP) monitoring in addition to MD, PbtiO2 and/or SjvO(2). Up to 10 days post-injury, ICP, CPP, PbtiO2 (51 NWTs), MD (49 NWTs), and/or SjvO(2) (18 NWTs) levels during propofol sedation (baseline) and NWT were compared. MD was evaluated at a flow rate of 1.0 mu L/min (28 NWTs) or the routine 0.3 mu L/min rate (21 NWTs). The NWT increased ICP and CPP levels (p < 0.05). Compared to baseline, interstitial levels of glucose, lactate, pyruvate, glutamate, glycerol, and the lactate/pyruvate ratio were unaltered by the NWT. Pathological SjvO(2) (< 50 % or > 71 %; n = 2 NWTs) and PbtiO2 (< 10 mmHg; n = 3 NWTs) values were rare at baseline and did not change following NWT. Finally, the NWT did not alter the AVD of glucose, lactate, or oxygen. The NWT-induced stress response resulted in increased ICP and CPP levels although it did not negatively alter focal neurochemistry or cerebral oxygenation in TBI patients.	[Skoglund, Karin; Hillered, Lars; Purins, Karlis; Tsitsopoulos, Parmenion P.; Flygt, Johanna; Engquist, Henrik; Lewen, Anders; Enblad, Per; Marklund, Niklas] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden		Marklund, N (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden.	niklas.marklund@neuro.uu.se	Lewen, Anders/A-5156-2013; Engquist, Henrik/S-1890-2016	Lewen, Anders/0000-0003-4925-1348; Engquist, Henrik/0000-0002-9826-1422; Marklund, Niklas/0000-0002-9797-5626; Hillered, Lars/0000-0002-2808-9292	Medical Faculty, Uppsala University, Uppsala, Sweden; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Ahlen Foundation; Selander Foundation; Uppsala University Hospital (ALF Funds)	We are grateful for the support of the neurocritical care unit staff at Uppsala University Hospital and Inger Stahl-Myllyaho and Dr. Tim Howells for their technical support. This study was supported by Grants from the Medical Faculty, Uppsala University, Uppsala, Sweden and the Swedish Research Council, The Swedish Brain Foundation, The Ahlen Foundation, The Selander Foundation, and the Uppsala University Hospital (ALF Funds).	Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Anifantaki S, 2009, J ADV NURS, V65, P1054, DOI 10.1111/j.1365-2648.2009.04967.x; Augustes R, 2011, ANAESTH INTENS CARE, V39, P401, DOI 10.1177/0310057X1103900310; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bucknall TK, 2008, CRIT CARE MED, V36, P1444, DOI 10.1097/CCM.0b013e318168f82d; Chesnut R M, 1995, New Horiz, V3, P366; Chieregato A, 2003, J NEUROL NEUROSUR PS, V74, P784, DOI 10.1136/jnnp.74.6.784; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grande PO, 2007, ACTA ANAESTH SCAND, V51, P1294, DOI 10.1111/j.1399-6576.2007.01475.x; Haitsma IK, 2007, PROG BRAIN RES, V161, P207, DOI 10.1016/S0079-6123(06)61014-5; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Helbok R, 2009, NEUROCRIT CARE, V11, P133, DOI 10.1007/s12028-009-9262-4; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson PJ, 2005, ACTA NEUROCHIR SUPPL, V95, P441; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kett-White R, 2002, ACT NEUR S, V81, P363; Koizumi H, 2008, ACT NEUR S, V102, P193, DOI 10.1007/978-3-211-85578-2_38; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mehta S, 2012, JAMA-J AM MED ASSOC, V308, P1985, DOI 10.1001/jama.2012.13872; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Prisco L, 2012, CRIT CARE, V16, DOI 10.1186/cc11891; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Purins K, 2011, CRIT CARE MED, V39, P512, DOI 10.1097/CCM.0b013e318206b824; Purins K, 2010, ACTA NEUROCHIR, V152, P681, DOI 10.1007/s00701-009-0532-x; Rao GSU, 2011, CURR OPIN ANESTHESIO, V24, P487, DOI 10.1097/ACO.0b013e32834a8965; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Schweickert WD, 2004, CRIT CARE MED, V32, P1272, DOI 10.1097/01.CCM.0000127263.54807.79; Skoglund K, 2009, NEUROCRIT CARE; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stover JF, 2012, CRIT CARE MED, V40, P338, DOI 10.1097/CCM.0b013e31823291bf; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wittbrodt ET, 2005, PHARMACOTHERAPY, V25, p3S, DOI 10.1592/phco.2005.25.5_Part_2.3S	70	21	23	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2014	20	3					413	426		10.1007/s12028-013-9876-4			14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI7RH	WOS:000337092900010	23934408				2022-02-06	
J	Fei, F; Rao, W; Zhang, L; Chen, BG; Li, J; Fei, Z; Chen, Z				Fei, F.; Rao, W.; Zhang, L.; Chen, B. -G.; Li, J.; Fei, Z.; Chen, Z.			DOWNREGULATION OF HOMER1B/C IMPROVES NEURONAL SURVIVAL AFTER TRAUMATIC NEURONAL INJURY	NEUROSCIENCE			English	Article						neurons; injury; receptors; glutamic acid; Homer1; RNAi	METABOTROPIC GLUTAMATE RECEPTORS; INDUCED OXIDATIVE STRESS; SPINAL DORSAL-HORN; BRAIN-INJURY; GENE-EXPRESSION; INDUCED APOPTOSIS; CORTICAL-NEURONS; LOOSE LIGATION; CELL-DEATH; IN-VITRO	Homer protein, a member of the post-synaptic density protein family, plays an important role in the neuronal synaptic activity and is extensively involved in neurological disorders. The present study investigates the role of Homer1b/c in modulating neuronal survival by using an in vitro traumatic neuronal injury model, which was achieved by using a punch device that consisted of 28 stainless steel blades joined together and produced 28 parallel cuts. Downregulation of Homer1b/c by specific siRNA significantly (p < 0.05) alleviated the cytoplasmic calcium levels and neuron lactate dehydrogenase release, and ultimately decreased the apoptotic rate after traumatic neuronal injury compared with non-targeting siRNA control treatment in cultured rat cortical neurons. Moreover, the expression of metabotropic glutamate receptor 1a (mGluR1a) was significantly (p < 0.05) reduced in the Homer1b/c siRNA-transfected neurons after injury. Therefore, Homer1b/c not only modulated the mGluR1a-inositol 1,4,5-triphosphate receptors-Ca2+ signal transduction pathway, but also regulated the expression of mGluR1a in mechanical neuronal injury. These findings indicate that the suppression of Homer1b/c expression potentially protects neurons from glutamate excitotoxicity after injury and might be an effective intervention target in traumatic brain injury. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Fei, F.; Chen, Z.] Fourth Mil Med Univ, Coll Basic Med, Dept Cell Biol, Xian 710032, Peoples R China; [Rao, W.; Zhang, L.; Li, J.; Fei, Z.] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Chen, B. -G.] Tongji Univ, Affiliated Shanghai East Hosp, Cent Lab, Shanghai 200120, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, 127 Changle Xi Rd, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn; znchen@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30930093]; research funds from the government [AWS11J008, 2012BAI11B02]; Program for Changjiang Scholars and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1053]	This work was supported by the National Natural Science Foundation of China (No. 30930093), research funds from the government (Nos. AWS11J008 and 2012BAI11B02), and Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1053).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; COPANI A, 1995, J NEUROCHEM, V64, P101; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Foa L, 2009, J NEUROCHEM, V108, P1, DOI 10.1111/j.1471-4159.2008.05726.x; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Hiroaki Y, 2002, BIOCHEM BIOPH RES CO, V295, P756, DOI 10.1016/S0006-291X(02)00738-6; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang WD, 2005, NEUROSCI LETT, V389, P46, DOI 10.1016/j.neulet.2005.07.014; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kammermeier PJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-1; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapanantasin S, 2006, SYNAPSE, V60, P406, DOI 10.1002/syn.20308; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mikoshiba K, 2006, J NEUROCHEM, V97, P1627, DOI 10.1111/j.1471-4159.2006.03985.x; Miletic G, 2005, NEUROSCI LETT, V386, P189, DOI 10.1016/j.neulet.2005.06.007; Miletic G, 2009, ANESTH ANALG, V109, P2000, DOI 10.1213/ANE.0b013e3181beea9b; Miyabe T, 2006, NEUROSCI LETT, V398, P296, DOI 10.1016/j.neulet.2006.01.011; Mukhin A, 1996, J NEUROSCI, V16, P6012; Obara I, 2013, PAIN, V154, P1932, DOI 10.1016/j.pain.2013.03.035; Obara Ilona, 2013, Front Psychiatry, V4, P39, DOI 10.3389/fpsyt.2013.00039; Rezvani K, 2012, J NEUROCHEM, V122, P24, DOI 10.1111/j.1471-4159.2012.07752.x; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Soloviev MM, 2000, J MOL BIOL, V295, P1185; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tappe-Theodor A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-38; Wagner KV, 2013, J NEUROSCI, V33, P3857, DOI 10.1523/JNEUROSCI.4333-12.2013; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yao YX, 2011, ANESTH ANALG, V113, P1501, DOI 10.1213/ANE.0b013e31822c0b98	50	21	25	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 16	2014	267						187	194		10.1016/j.neuroscience.2014.02.037			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF0KM	WOS:000334402700018	24607348				2022-02-06	
J	Gregorio, GW; Gould, KR; Spitz, G; van Heugten, CM; Ponsford, JL				Gregorio, Gisela Wolters; Gould, Kate R.; Spitz, Gershon; van Heugten, Caroline M.; Ponsford, Jennie L.			Changes in Self-Reported Pre- to Postinjury Coping Styles in the First 3 Years After Traumatic Brain Injury and the Effects on Psychosocial and Emotional Functioning and Quality of Life	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						TBI; quality of life; depression; psychological; anxiety; adaptation	PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; HEAD-INJURY; RECOVERY; REHABILITATION; ADJUSTMENT; HEALTH; STRATEGIES; PROGRAM	Objective: To examine the influence of self-reported preinjury coping on postinjury coping, psychosocial functioning, emotional functioning, and quality of life at 1 year following traumatic brain injury (TBI). Setting: Inpatient hospital and community. Participants: One hundred seventy-four participants with TBI. Design: Prospective, longitudinal design. Participants were assessed at 5 time points: after emerging from posttraumatic amnesia, and at 6, 12, 24, and 36 months postinjury. Main Measures: Coping Scale for Adults-Short Version; Quality of Life Inventory; Sydney Psychosocial Reintegration Scale; Hospital Anxiety and Depression Scale. Results: High preinjury use of nonproductive coping style predicted high use of nonproductive coping, more anxiety, and lower psychosocial functioning at 1 year postinjury. Increased use of nonproductive coping and decreased use of productive coping predicted poorer psychosocial outcome at 1 year post-TBI. Use of both productive and nonproductive coping decreased in the first 6 to 12 months post-TBI relative to preinjury. Unlike productive coping, nonproductive coping reached preinjury levels within 3 years postinjury. Conclusion: The findings support identification of individuals at risk of relying on nonproductive coping and poorer psychosocial outcome following TBI. In addition, the results emphasize the need to implement timely interventions to facilitate productive coping and reduce the use of nonproductive coping in order to maximize favorable long-term psychosocial outcome.	[Gregorio, Gisela Wolters; van Heugten, Caroline M.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Gould, Kate R.; Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Gould, Kate R.; Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Gould, Kate R.; Ponsford, Jennie L.] Alfred Hosp, Ctr Excellence Traumat Brain Injury Res, Natl Trauma Res Inst, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus, Clayton, Vic 3800, Australia.	Jennie.Ponsford@monash.edu	Spitz, Gershon/H-7755-2014; Gould, Kate Rachel/AAA-5511-2020	Spitz, Gershon/0000-0002-7810-1480; Gould, Kate Rachel/0000-0002-3564-7408			Access Economics Pty Ltd, 2009, EC COST SPIN CORD IN; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; Frisch M.B., 1994, QUALITY LIFE INVENTO; Frydenberg E, 1997, COPING SCALE ADULTS; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Helps Y, 2008, INJURY RES STAT SERI, V45; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Martz E., 2007, COPING CHRONIC ILLNE; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Snaith RP, 1994, HADS HOSP ANXIETY DE; Tan FES, 2008, BEST PRACTICES QUANT, P451, DOI DOI 10.4135/9781412995627.D36; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	21	21	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					E43	E53		10.1097/HTR.0b013e318292fb00			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100005	23835873	Green Published			2022-02-06	
J	Itzekson, Z; Maggio, N; Milman, A; Shavit, E; Pick, CG; Chapman, J				Itzekson, Zeev; Maggio, Nicola; Milman, Anat; Shavit, Efrat; Pick, Chaim G.; Chapman, Joab			Reversal of Trauma-Induced Amnesia in Mice by a Thrombin Receptor Antagonist	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						mTBI; Amnesia; Thrombin; PAR1; Hippocampus; Long term potentiation	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LONG-TERM POTENTIATION; BRAIN-INJURY; COGNITIVE DEFICITS; SEIZURES; MODEL; NEUROPROTECTION; CONSEQUENCES; EXCITABILITY; HIPPOCAMPUS	Minimal traumatic brain injury (mTBI) is associated with the existence of retrograde amnesia and microscopic bleeds containing activated coagulation factors. In an mTBI model, we report that thrombin induces amnesia through its receptor protease-activated receptor 1 (PAR-1). Thrombin activity was significantly elevated (32 %, p < 0.05) 5 min following mTBI compared to controls. Amnesia was assessed by the novel object recognition test in mTBI animals and in animals injected intracerebroventricularly (ICV) with either thrombin or a PAR-1 agonist 1 h after the acquisition phase. Saline-injected controls had a preference index of over 0.3 while mTBI animals and those injected with thrombin or the PAR-1 agonist spent equal time with both objects indicating no recall of the object presented to them 24 h previously (p < 0.05). Co-injecting a PAR-1 antagonist (SCH79797) completely blocked the amnestic effects of mTBI, thrombin, and the PAR-1 agonist. Long-term potentiation, measured in hippocampal slices 24 h after mTBI, ICV thrombin or the PAR-1 agonist, was significantly impaired and this effect was completely reversed by the PAR-1 antagonist. The results support a crucial role for PAR-1 in the generation of amnesia following mTBI, revealing a novel therapeutic target for the cognitive effects of brain trauma.	[Itzekson, Zeev; Shavit, Efrat; Chapman, Joab] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Itzekson, Zeev; Maggio, Nicola; Shavit, Efrat; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Milman, Anat; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel; [Milman, Anat] Tel Aviv Sourasky Med Ctr, Internal Med Dept B, IL-64239 Tel Aviv, Israel		Chapman, J (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel.	jchapman@post.tau.ac.il	Chapman, Joab/E-4598-2010	Maggio, Nicola/0000-0001-5041-2108; Milman, Anat/0000-0002-8551-4101			Aronovich R, 2005, IMMUNOBIOLOGY, V210, P781, DOI 10.1016/j.imbio.2005.10.010; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Beilin O, 2007, NEUROREPORT, V18, P581, DOI 10.1097/WNR.0b013e328091c1e6; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Feinsod M, 2012, WORLD NEUROSURG, V78, P371, DOI 10.1016/j.wneu.2011.12.007; Friedmann I, 2001, J NEUROIMMUNOL, V121, P12, DOI 10.1016/S0165-5728(01)00397-6; Friedmann I, 2001, J NEUROCHEM, V76, P641, DOI 10.1046/j.1471-4159.2001.00001.x; Friedmann I, 1999, FASEB J, V13, P533, DOI 10.1096/fasebj.13.3.533; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2013, NEUROBIOL DIS, V50, P171, DOI 10.1016/j.nbd.2012.10.017; Maggio N, 2012, HIPPOCAMPUS, V22, P267, DOI 10.1002/hipo.20893; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Shavit E, 2008, BRAIN, V131, P1113, DOI 10.1093/brain/awn005; Shavit E, 2011, J NEUROCHEM, V119, P460, DOI 10.1111/j.1471-4159.2011.07436.x; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	43	21	21	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2014	53	1					87	95		10.1007/s12031-013-0200-8			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AG2JN	WOS:000335242500010	24352712				2022-02-06	
J	Selassie, AW; Cao, Y; Church, EC; Saunders, LL; Krause, J				Selassie, Anbesaw W.; Cao, Yue; Church, Elizabeth C.; Saunders, Lee L.; Krause, James			Accelerated Death Rate in Population-Based Cohort of Persons With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						preexisting diseases; traumatic brain injury; postdischarge mortality; cumulative probability of death; low socioeconomic status	SPINAL-CORD-INJURY; LONG-TERM SURVIVAL; RISK-FACTORS; ALLOSTATIC LOAD; LATE MORTALITY; UNITED-STATES; HEAD-INJURY; OUTCOMES; TRENDS; CARE	Objectives: To determine the influence of preexisting heart, liver, kidney, cancer, stroke, and mental health problems and examine the influence of low socioeconomic status on mortality after discharge from acute care facilities for individuals with traumatic brain injury. Participants: Population-based retrospective cohort study of 33695 persons discharged from acute care hospital with traumatic brain injury in South Carolina, 1999-2010. Main Measures: Days elapsing from the dates of injury to death established the survival time (T). Data were censored at the 145th month. Multivariable Cox regression was used to examine the independent effect of the variables on death. Age-adjusted cumulative probability of death for each chronic disease of interest was plotted. Results: By the 70th month of follow-up, rate of death was accelerated from 10-fold for heart diseases to 2.5-fold for mental health problems. Adjusted hazard ratios for diseases of the heart (2.13), liver-renal (3.25), cancer (2.64), neurological diseases and stroke (2.07), diabetes (1.89), hypertension (1.43), and mental health problems (1.59) were highly significant (each with P < .001). Compared with persons with private insurance, the hazard ratio was significantly elevated with Medicaid (1.67), Medicare (1.54), and uninsured (1.27) (each with P < .001). Conclusion: Specific chronic diseases strongly influenced postdischarge mortality after traumatic brain injury. Low socioeconomic status as measured by the type of insurance elevated the risk of death.	[Selassie, Anbesaw W.] Med Univ S Carolina, Div Epidemiol & Biostat, Dept Publ Hlth Sci, Charleston, SC 29466 USA; [Cao, Yue; Saunders, Lee L.; Krause, James] Med Univ S Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC 29466 USA; [Church, Elizabeth C.] Med Univ S Carolina, Coll Med, Charleston, SC 29466 USA		Selassie, AW (corresponding author), Med Univ S Carolina, Div Epidemiol & Biostat, Dept Publ Hlth Sci, 135 Cannon St,Ste 303,MSC 835, Charleston, SC 29466 USA.	selassie@musc.edu		Church, Chandler/0000-0002-3614-5311	Department of Education, NIDRR grant [H133B090005]	This study is supported by a grant from the Department of Education, NIDRR grant number H133B090005 (PI: James Krause, PhD). The contents do not necessarily represent the policy of the Department of Education and should not be assumed as endorsement by the federal government. The authors recognize Mss Georgette Demian and Nicole Spivey from the South Carolina Department of Health and Environmental Control for their coordination of the abstraction process and for validating the accuracy of the medical record review report. Dr Linda Veldheer, Director of the Head and Spinal Cord Injury, Division of the South Carolina Department of Disabilities and Special Needs, assisted with data oversight for the project.	Allgulander C, 2000, AM J PSYCHIAT, V157, P244, DOI 10.1176/appi.ajp.157.2.244; Allison PD, 1995, SURVIVAL ANAL USING, P29; American Medical Association, 2009, INT CLASS DIS; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Bajaj JS, 2008, AM J GASTROENTEROL, V103, P1674, DOI 10.1111/j.1572-0241.2008.01814.x; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown AW, 2004, NEUROREHABILITATION, V19, P37; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; [Centers for Disease Control and Prevention National Center for Health Statistics], 2012, COMPR MORT FIL 1999; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Darlington GA, 1998, COLLINEARITY ENCY BI, P788; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferraris VA, 2010, J TRAUMA, V69, P645, DOI 10.1097/TA.0b013e3181d8941d; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gebhard F, 1998, SHOCK, V10, P237, DOI 10.1097/00024382-199810000-00002; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; Grunau GL, 2006, J CLIN EPIDEMIOL, V59, P274, DOI 10.1016/j.jclinepi.2005.08.007; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Kleinbaum DG, 1996, EVALUATING PROPORTIO, P130; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Krause JS, 2012, SPINAL CORD, V50, P784, DOI 10.1038/sc.2012.49; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P339, DOI 10.1016/j.apmr.2010.09.032; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Leahy R, 2012, COLLEGIUM ANTROPOL, V36, P11; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorelli DR, 2001, AM SURGEON, V67, P693; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Murphy SL, 2012, DEATHS PRELIMINARY D; Penman AD, 2008, COMPUT METH PROG BIO, V89, P50, DOI 10.1016/j.cmpb.2007.10.004; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Phillips LH, 2009, MUSCLE NERVE, V39, P1, DOI 10.1002/mus.21243; Prada SI, 2012, EVALUATION REV, V36, P133, DOI 10.1177/0193841X12442674; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; SAS Institute, 2009, STAT AN SOFTW VERS 9; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Seamon MJ, 2010, J TRAUMA, V69, P568, DOI 10.1097/TA.0b013e3181ec0867; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Selassie A, 2003, S CAROLINA TRAUMATIC; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2011, ARCH PHYS MED REHAB, V92, P1534, DOI 10.1016/j.apmr.2011.04.018; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Smedley BD, 2010, UNEQUAL TREATMENT, P125; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; The Economist Intelligence Unit, 2009, BREAK GLOB BURD CANC; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107	73	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					E8	E19		10.1097/HTR.0b013e3182976ad3			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100002	23835874				2022-02-06	
J	Theus, MH; Ricard, J; Glass, SJ; Travieso, LG; Liebl, DJ				Theus, M. H.; Ricard, J.; Glass, S. J.; Travieso, L. G.; Liebl, D. J.			EphrinB3 blocks EphB3 dependence receptor functions to prevent cell death following traumatic brain injury	CELL DEATH & DISEASE			English	Article						ephrins; Eph receptors; controlled cortical impact (CCI) injury; traumatic brain injury (TBI)	SPINAL-CORD-INJURY; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; UP-REGULATION; AXONAL REGENERATION; COMMISSURAL AXONS; WHITE-MATTER; LUNG-CANCER; ADULT CNS; RAT	Eph receptor tyrosine kinases and their membrane-bound ligands, ephrins, have a variety of roles in the developing and adult central nervous system that require direct cell-cell interactions; including regulating axon path finding, cell proliferation, migration and synaptic plasticity. Recently, we identified a novel pro-survival role for ephrins in the adult subventricular zone, where ephrinB3 blocks Eph-mediated cell death during adult neurogenesis. Here, we examined whether EphB3 mediates cell death in the adult forebrain following traumatic brain injury and whether ephrinB3 infusion could limit this effect. We show that EphB3 co-labels with microtubule-associated protein 2-positive neurons in the adult cortex and is closely associated with ephrinB3 ligand, which is reduced following controlled cortical impact (CCI) injury. In the complete absence of EphB3 (EphB3(-/-)), we observed reduced terminal deoxynucleotidyl transferase-dUTP nick end labeling (TUNEL), and functional improvements in motor deficits after CCI injury as compared with wild-type and ephrinB3(-/)-mice. We also demonstrated that EphB3 exhibits dependence receptor characteristics as it is cleaved by caspases and induces cell death, which is not observed in the presence of ephrinB3. Following trauma, infusion of pre-clustered ephrinB3-Fc molecules (eB3-Fc) into the contralateral ventricle reduced cortical infarct volume and TUNEL staining in the cortex, dentate gyrus and CA3 hippocampus of wild-type and ephrinB3(-/)-mice, but not EphB3(-/)-mice. Similarly, application of eB3-Fc improved motor functions after CCI injury. We conclude that EphB3 mediates cell death in the adult cortex through a novel dependence receptor-mediated cell death mechanism in the injured adult cortex and is attenuated following ephrinB3 stimulation.	[Theus, M. H.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Ricard, J.; Glass, S. J.; Travieso, L. G.; Liebl, D. J.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Liebl, DJ (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@med.miami.edu		Ricard, Jerome/0000-0002-9019-4165	Miami Project to Cure Paralysis; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291]; Department of DefenseUnited States Department of Defense [W81XWH-05-1-0061, NS064699]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049545, P50NS030291, F32NS064699] Funding Source: NIH RePORTER	We thank Dr. Mark Henkemeyer for his generous gift of the mutant mice. We also thank Jose Mier for assistance with animal husbandry. This work was supported by the Miami Project to Cure Paralysis, NIH/NINDS NS049545 (DJL), NS30291 (DJL), Department of Defense W81XWH-05-1-0061 (DJL) and NS064699 (MHT).	Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005; del Rio G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000463; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Figueroa JD, 2006, J NEUROSCI RES, V84, P1438, DOI 10.1002/jnr.21048; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Howard MA, 2003, HEARING RES, V178, P118, DOI 10.1016/S0378-5955(03)00068-6; Ji XD, 2011, CANCER RES, V71, P1156, DOI 10.1158/0008-5472.CAN-10-0717; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mehlen P, 2004, CELL MOL LIFE SCI, V61, P1854, DOI 10.1007/s00018-004-3467-7; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Omoto S, 2011, NEUROSCI RES, V69, P187, DOI 10.1016/j.neures.2010.12.004; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sobel RA, 2005, BRAIN PATHOL, V15, P35; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tulasne D, 2004, MOL CELL BIOL, V24, P10328, DOI 10.1128/MCB.24.23.10328-10339.2004; Willson CA, 2003, CELL TRANSPLANT, V12, P279, DOI 10.3727/000000003108746830; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	46	21	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	MAY	2014	5				SI				e1207	10.1038/cddis.2014.165			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AI9DN	WOS:000337229300007	24810043	Green Published, gold			2022-02-06	
J	Turner, AP; Sloan, AP; Kivlahan, DR; Haselkorn, JK				Turner, Aaron P.; Sloan, Alicia P.; Kivlahan, Daniel R.; Haselkorn, Jodie K.			Telephone Counseling and Home Telehealth Monitoring to Improve Medication Adherence: Results of a Pilot Trial Among Individuals With Multiple Sclerosis	REHABILITATION PSYCHOLOGY			English	Article						multiple sclerosis; medication adherence; motivational interviewing; self-management; telehealth	DISEASE-MODIFYING THERAPIES; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INJECTION ANXIETY; CHRONIC ILLNESS; PRIMARY-CARE; SELF-INJECT; ALCOHOL-DEPENDENCE; DEPRESSION	Objective: To evaluate the impact upon medication adherence of brief telephone-based counseling using principles of motivational interviewing and telehealth home monitoring. Design: Randomized controlled pilot trial of 19 veterans with multiple sclerosis (MS) currently prescribed disease modifying therapy (DMT) who endorsed missing doses. Follow-up was conducted at 1, 3, and 6 months. Results: Participants in the intervention condition reported better adherence relative to controls at 6-month follow-up [M (SD) = 1.3 (2.1) vs. 8.2 (12.3) past month missed doses]. All participants in the intervention condition completed all 3 telephone counseling sessions and 90% or greater rated the program as highly successful. Conclusion: Brief telephone counseling represents a promising mechanism for improving medication adherence. The primary components, motivational interviewing and home telehealth monitoring, provided complementary mechanisms for initiating and sustaining behavior change over time. The intervention was well tolerated and provided an opportunity to extend access and reduce barriers to care by bringing it into the homes of participants.	[Turner, Aaron P.; Sloan, Alicia P.; Kivlahan, Daniel R.; Haselkorn, Jodie K.] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Turner, Aaron P.; Sloan, Alicia P.; Haselkorn, Jodie K.] VA MS Ctr Excellence West, Seattle, WA USA; [Turner, Aaron P.; Kivlahan, Daniel R.] VA Ctr Excellence Subst Abuse Treatment & Educ, Seattle, WA USA; [Turner, Aaron P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Kivlahan, Daniel R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Haselkorn, Jodie K.] Univ Washington, VA Puget Sound Hlth Care Syst, VA MS Ctr Excellence West, Dept Rehabil Med, Seattle, WA 98195 USA; [Haselkorn, Jodie K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Turner, AP (corresponding author), VA Puget Sound Hlth Care Syst, Rehabil Care Serv, S-117-RCS,1660 S Columbian Way, Seattle, WA 98108 USA.	Aaron.Turner@med.va.gov	Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003; sloan, alicia/0000-0003-4891-3266			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; BEATTY WW, 1995, NEUROLOGY, V45, P718, DOI 10.1212/WNL.45.4.718; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bell KR, 2003, J HEAD TRAUMA REHAB, V18, P504, DOI 10.1097/00001199-200311000-00004; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bombardier CH, 2008, ARCH PHYS MED REHAB, V89, P1849, DOI 10.1016/j.apmr.2008.03.021; Bombardier CH, 2013, J CONSULT CLIN PSYCH, V81, P89, DOI 10.1037/a0031242; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bruce JM, 2010, ARCH CLIN NEUROPSYCH, V25, P39, DOI 10.1093/arclin/acp092; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; Clark NM, 2000, BMJ-BRIT MED J, V320, P572, DOI 10.1136/bmj.320.7234.572; Cook PF, 2007, AM J MED QUAL, V22, P445, DOI 10.1177/1062860607307990; Cook PF, 2009, J ASSOC NURSE AIDS C, V20, P316, DOI 10.1016/j.jana.2009.02.008; Cook PF, 2008, AM J MANAG CARE, V14, P841; Debanne SM, 1997, J AM GERIATR SOC, V45, P1352, DOI 10.1111/j.1532-5415.1997.tb02935.x; DelliFraine JL, 2008, J TELEMED TELECARE, V14, P62, DOI 10.1258/jtt.2007.070709; Department of Veterans Affairs. (Producer), 2013, VHA TEL SERV; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; DiIorio C, 2008, AIDS CARE, V20, P273, DOI 10.1080/09540120701593489; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; Fischer JS, 1999, MULT SCLER J, V5, P251, DOI 10.1177/135245859900500410; Fraser Cira, 2003, J Neurosci Nurs, V35, P163; Goodkin D, 1992, NATURAL HIST MULTIPL; Gottberg K, 2006, MULT SCLER J, V12, P605, DOI 10.1177/1352458505070660; Hadjimichael O, 1999, NEUROLOGY, V52, pA549; Halterman JS, 2011, J ASTHMA, V48, P523, DOI 10.3109/02770903.2011.576741; Hatzakis M, 2003, J REHABIL RES DEV, V40, P265; Haynes R B, 2002, Cochrane Database Syst Rev, pCD000011; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Haynes RB, 1996, LANCET, V348, P383; Heffner JL, 2010, J STUD ALCOHOL DRUGS, V71, P61, DOI 10.15288/jsad.2010.71.61; Holt C.S., 1990, BEHAV THER, V13, P213; Ingersoll KS, 2011, DRUG ALCOHOL DEPEN, V116, P177, DOI 10.1016/j.drugalcdep.2010.12.016; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller W.R., 2002, MOTIVATIONAL INTERVI; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Mohr D C, 1996, Mult Scler, V2, P222; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Mohr DC, 2005, MULT SCLER J, V11, P182, DOI 10.1191/1352458505ms1146oa; Mohr DC, 2002, J BEHAV THER EXP PSY, V33, P39, DOI 10.1016/S0005-7916(02)00011-3; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Mohr DC, 2005, ARCH GEN PSYCHIAT, V62, P1007, DOI 10.1001/archpsyc.62.9.1007; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Ogedegbe G, 2008, AM J HYPERTENS, V21, P1137, DOI 10.1038/ajh.2008.240; Pare G, 2007, J AM MED INFORM ASSN, V14, P269, DOI 10.1197/jamia.M2270; Pare G, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1357; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reid SC, 2005, J STUD ALCOHOL, V66, P833, DOI 10.15288/jsa.2005.66.833; Sabate E, 2003, ADHERENCE LONG TERM; Schwartz CE, 1999, NEUROLOGY, V52, P63, DOI 10.1212/WNL.52.1.63; Siegel SD, 2008, REHABIL PSYCHOL, V53, P73, DOI 10.1037/0090-5550.53.1.73; Solomon DH, 2012, ARCH INTERN MED, V172, P477, DOI 10.1001/archinternmed.2011.1977; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Stockl KM, 2010, AM J MANAG CARE, V16, P139; Stone VE, 2001, CLIN INFECT DIS, V33, P865, DOI 10.1086/322698; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Turner AP, 2007, MULT SCLER, V13, P1146, DOI 10.1177/1352458507078911; Turner AP, 2009, REHABIL PSYCHOL, V54, P116, DOI 10.1037/a0014460; Unverzagt FW, 2007, J INT NEUROPSYCH SOC, V13, P799, DOI 10.1017/S1355617707071020; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Vollmer TL, 2002, J REHABIL RES DEV, V39, P163; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams A, 2012, J ADV NURS, V68, P2515, DOI 10.1111/j.1365-2648.2012.05950.x; Williams RM, 2005, NEUROLOGY, V64, P75, DOI 10.1212/01.WNL.0000148480.31424.2A	75	21	21	0	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2014	59	2					136	146		10.1037/a0036322			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AJ7SQ	WOS:000337897800003	24708232				2022-02-06	
J	Yang, CC; Yuen, KM; Huang, SJ; Hsiao, SH; Tsai, YH; Lin, WC				Yang, Chi-Cheng; Yuen, Kit-Man; Huang, Sheng-Jean; Hsiao, Sheng-Huang; Tsai, Yi-Hsin; Lin, Wei-Chi			"Good-old-days" bias: A prospective follow-up study to examine the preinjury supernormal status in patients with mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Good-old-days bias; Mild traumatic brain injury; Postconcussion symptoms	MINOR HEAD-INJURY; POST-CONCUSSION SYNDROME; POSTCONCUSSION SYMPTOMS; NONCLINICAL SAMPLE; SEQUELAE; SPECTROSCOPY; EXPECTATION; PERSONALITY; ETIOLOGY; STRESS	Primary objective: Postconcussion symptoms (PCS) are common following mild traumatic brain injury (mTBI). A psychological misperception, the "good-old-days" bias, has been indicated as one of the influencing factors on symptom reporting after injury. To date, this response bias has only been examined in a small number of cross-sectional studies. This study thus prospectively evaluated the "good-old-days" bias in patients with mTBI. Research design: A prospective follow-up study. Method and procedures: Fifty-three patients with mTBI were recruited in this study. The PCS was evaluated by the modified Checklist of Postconcussion Symptoms (mCPCS) at 1 month post injury. Twenty-five patients were evaluated again at 3 months after injuries. In addition, 53 healthy participants were also evaluated for the PCS, and 23 of them underwent a second evaluation at 2 months after the first one. Main outcomes and results: Patients with mTBI showed significantly higher PCS reporting at 1 month post injury than healthy participants did, but not at 3 months post injury. Consistent with the "good-old-days" bias, patients remarkably underestimated their preinjury PCS at 1 month post injury. Interestingly, our results further revealed that this response bias diminished more at 3 months than at 1 month after mTBI. Conclusions: This study thus might be the first one to prospectively reveal the progression of the "good-old-days" bias in patients with mTBI.	[Yang, Chi-Cheng; Yuen, Kit-Man; Lin, Wei-Chi] Chang Gung Univ, Div Clin Psychol, Coll Med, Taoyuan, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Jin Shan Branch, New Taipei City, Taiwan; [Hsiao, Sheng-Huang] Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan; [Hsiao, Sheng-Huang] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Dept Neurosurg, New Taipei City, Taiwan		Yang, CC (corresponding author), Chang Gung Univ, Div Clin Psychol, Coll Med, Taoyuan, Taiwan.	ccyang@mail.cgu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2410-H-182-009-MY2]	This work was supported by the National Science Council of Taiwan [grant number NSC 101-2410-H-182-009-MY2].	Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Furnham A, 2004, BRIT J PSYCHOL, V95, P149, DOI 10.1348/000712604773952395; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hua M-S, 1986, WORD SEQUENCE LEARNI; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JENNETT B, 1975, LANCET, V1, P480; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levin H. S., 1983, PACED AUDITORY UNPUB; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R. M., 1996, NEUROPSYCHOLOGY, V6, P371; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yuen K. M., 2012, MODIFIED CHECK UNPUB	46	21	21	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 21	2014	36	4					399	409		10.1080/13803395.2014.903899			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AH0YS	WOS:000335847300006	24702428				2022-02-06	
J	Acker, SN; Partrick, DA; Ross, JT; Nadlonek, NA; Bronsert, M; Bensard, DD				Acker, Shannon N.; Partrick, David A.; Ross, James T.; Nadlonek, Nicole A.; Bronsert, Michael; Bensard, Denis D.			Blood component transfusion increases the risk of death in children with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; blood transfusion; anemia; children	CRITICALLY-ILL; PREDICTIVE FACTORS; CELL TRANSFUSIONS; ANEMIA; PLASMA; SHOCK	BACKGROUND Blood transfusion has been associated with worse outcomes in adult trauma patients with traumatic brain injury (TBI). However, the effects in injured children have not been evaluated. We hypothesize that blood transfusion is also associated with worse outcomes in children with TBI. METHODS A retrospective review of the trauma database at two Level I pediatric trauma centers was performed. We reviewed all patients 18 years and younger with TBI, who survived at least 24 hours, from 2002 to 2011. Exclusion criteria include those who underwent craniotomy, thoracotomy, exploratory laparotomy, and any orthopedic procedure. RESULTS A total of 1,607 children with TBI were included in the study population (mean age, 6.4 [5.7] years; 65% male), 178 of whom received a blood transfusion. Mean Injury Severity Score (ISS) was 16.5 (9.1). Patients who received a transfusion had a higher ISS than those who did not (26.7 vs. 15.3). After controlling for age, sex, ISS, Glasgow Coma Scale (GCS) score on presentation, and mechanism of injury, patients who received a blood transfusion were more likely to be admitted to the intensive care unit (p < 0.0001), less likely to survive to hospital discharge (p = 0.02), more likely to be discharged to a rehabilitation facility (p = 0.01) and be dependent on caretakers at follow-up (p < 0.0001), as well as more likely to develop urinary tract infection (p = 0.02) and bacteremia (p = 0.02) during their hospital stay. These differences in outcomes among those who did and did not receive a blood transfusion began to disappear in patients with a nadir hemoglobin of less than 8.0 g/dL. CONCLUSION Pediatric patients sustaining TBI who receive blood transfusion and do not require operative intervention have worse outcomes compared with patients who do not receive transfusion. This includes an increased risk of death. These data suggest that a transfusion trigger of hemoglobin level at 8.0 g/dL in injured children with TBI may be beneficial. LEVEL OF EVIDENCE Epidemiologic study, level III. Therapeutic study, level IV.	[Acker, Shannon N.; Partrick, David A.; Ross, James T.; Nadlonek, Nicole A.; Bensard, Denis D.] Childrens Hosp Colorado, Dept Pediat Surg, Aurora, CO USA; [Bronsert, Michael] Univ Colorado, Sch Med, Dept Surg Surg Outcomes & Appl Res, Aurora, CO 80045 USA; [Bensard, Denis D.] Denver Hlth & Hosp Author, Dept Surg, Denver, CO USA		Acker, SN (corresponding author), Univ Colorado, Sch Med, 12631 E 17th Ave,C302, Aurora, CO 80045 USA.	shannon.acker@ucdenver.edu					Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Armano R, 2005, CRIT CARE MED, V33, P2637, DOI 10.1097/01.CCM.0000185645.84802.73; Blajchman Morris A, 2002, Am J Ther, V9, P389, DOI 10.1097/00045391-200209000-00005; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Desmet L, 2004, CRIT CARE CLIN, V20, P299, DOI 10.1016/S0749-0704(03)00113-1; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Karam O, 2013, VOX SANG, V104, P342, DOI 10.1111/vox.12009; Lieberman L, 2013, TRANSFUSION, DOI [10.1111/trf.12249, DOI 10.1111/TRF. 12249]; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Morris KP, 2005, ARCH DIS CHILD, V90, P724, DOI 10.1136/adc.2004.062174; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; Pieracci FM, 2012, J PEDIATR SURG, V47, P1587, DOI 10.1016/j.jpedsurg.2012.02.011; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Rouette J, 2010, ANN SURG, V251, P421, DOI 10.1097/SLA.0b013e3181c5dc2e; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Vamvakas EC, 1998, ARCH PATHOL LAB MED, V122, P145; Vincent JL, 2006, CRIT CARE MED, V34, pS96, DOI 10.1097/01.CCM.0000214314.57109.CD; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Winn HR, 2004, YOUMANS NEUROLOGICAL, V5; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1	26	21	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2014	76	4					1082	1088		10.1097/TA.0000000000000095			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AE7FF	WOS:000334161500034	24662875				2022-02-06	
J	Baker, MS				Baker, Michael S.			Casualties of the Global War on Terror and Their Future Impact on Health Care and Society: A Looming Public Health Crisis	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DAMAGE CONTROL; MILITARY VETERANS; AIR TRANSPORT; IRAQ; EXPERIENCE; RESUSCITATION; TRANSFUSIONS; DIAGNOSES	This article is a primer to understand the medical advances and the future health care consequences of the current conflicts in the Middle East and Southwest Asia, known as the Global War on Terror. There have been significant advances in health care learned in caring for those injured by the conflict-often a polytrauma blast victim, but there are also very high incidence rates of the hidden injuries of war-traumatic brain injury, post-traumatic stress disorder, suicide, and depression. These lead to disruptive behaviors, homelessness, and family violence. Global War on Terror returnees are using medical services and applying for disability at higher rates than in previous conflicts. The costs for veterans' care may peak 30 to 40 years or longer following the conflict, and will inflict an enormous burden on services and resources. The effects of the war will linger for years and impact across generations because of the stress on families and children. We must mobilize government agencies, create public-private partnerships, and invest our resources now to mitigate the approaching tsunami of veterans' health care needs, the impact on our social services, and the devastating costs to society.	[Baker, Michael S.] John Muir Hosp, Dept Surg, Walnut Creek, CA 94598 USA; [Baker, Michael S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Baker, MS (corresponding author), John Muir Hosp, Dept Surg, Walnut Creek, CA 94598 USA.						[Anonymous], 2011, REFERENCE GUIDE ON C; [Anonymous], ITS NOT A CHARITY IT; [Anonymous], 2012, VA BENEFITS ACTIVITY; Baker M, 2013, ARMED FORCES JOURNAL; Barker DE, 2007, J AM COLL SURGEONS, V204, P784, DOI 10.1016/j.jamcollsurg.2006.12.039; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Beekley AC, 2007, SURG CLIN N AM, V87, P157, DOI 10.1016/j.suc.2006.09.008; BELLAMY RF, 1984, MIL MED, V149, P55; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bilmes LJ, CURRENT AND PROJECTE; Bilmes LJ, 2008, THE THREE TRILLION D; Blackbourne LH, 2008, CRIT CARE MED, V36, pS304, DOI 10.1097/CCM.0b013e31817e2854; Blimes Lk, 2013, THE FINANCIAL LEGACY; Blumenthal SM, STOPPING THE SURGE O; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Breggin P, MILITARY TO HOLD CON; Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Cannon JW, ADVANCED EN ROUTE CR; Cassels Caroline, 2009, YOUNG WOMEN VETERANS; Cesur R, 2011, NBER WORKING PAPER S; Clapesattle H, 1941, THE DOCTORS MAYO, P573; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Debusmann B, OUTSOURCED US WARS; Department of Defense, DEFENSE CASUALTY ANA; Dorlac GR, 2009, J TRAUMA, V66, pS164, DOI 10.1097/TA.0b013e31819cdf72; Duchesne JC, 2010, J TRAUMA, V69, P46, DOI 10.1097/TA.0b013e3181df91fa; Faison CF, 2012, PROC US NAV INST, V138, P64; Geiling J, 2012, MIL MED, V177, P1235, DOI 10.7205/MILMED-D-12-00031; Gerlock AA, 2004, MIL MED, V169, P470, DOI 10.7205/MILMED.169.6.470; Girard P, 2007, J SPEC OPER MED, V7, P55; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hildebrand F, 2004, INJURY, V35, P678, DOI 10.1016/j.injury.2004.03.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Householder M, 2012, QUADRUPLE AMPUTEE SO; Institute of Medicine, 2010, RETURNING HOME FROM; Jadick R, 2007, ON CALL IN HELL A DO; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Kennedy JF, 1963, 451 PROCLAMATION 356; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Lincoln A, 1865, SECOND INAUGURAL ADD; Litz B. T., 2009, PTSD RES Q, V20, P1; Loveland JA, 2004, BRIT J SURG, V91, P1095, DOI 10.1002/bjs.4641; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Miller CT, 2009, LOS ANGELES TIMES; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pellerin C, 2012, LANDSTUHL MEDICAL CE; Petrakis IL, 2011, AM J ADDICTION, V20, P185, DOI 10.1111/j.1521-0391.2011.00126.x; Purple Heart Homes, QUALITY OF LIFE SOLU; RIZZO J, 2013, NATL GEOGR, V223, P26; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sogomonyan F, 2010, TRAUMA FACED BY CHIL; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Stevens R, THE FORWARD RESUSCIT; Swords to Plowshares, 2011, VETERANS AND THEIR F; Tanielian T, 2008, INVISIBLE WOUNDS SUM; Tanielian T., 2008, INVISIBLE WOUNDS OF; Taylor DM, 2013, MIL MED, V178, P1196, DOI 10.7205/MILMED-D-13-00223; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; US Department of Labor, OFFICE OF WORKERS CO; Walters TJ, 2005, US ARMY MED DEP J, P42; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44; Williamson RB, 2009, PRELIMINARY FINDINGS; Yaeger D, 2006, J GEN INTERN MED, V21, pS65, DOI 10.1111/j.1525-1497.2006.00377.x	68	21	21	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2014	179	4					348	355		10.7205/MILMED-D-13-00471			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UK	WOS:000340806300001	24690957	Bronze			2022-02-06	
J	Murray, NG; Ambati, VNP; Contreras, MM; Salvatore, AP; Reed-Jones, RJ				Murray, Nicholas G.; Ambati, V. N. Pradeep; Contreras, Monica M.; Salvatore, Anthony P.; Reed-Jones, Rebecca J.			Assessment of oculomotor control and balance post-concussion: A preliminary study for a novel approach to concussion management	BRAIN INJURY			English	Article						Assessment; balance; concussion; eye tracking; post-concussion syndrome; vestibular; vision	STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; SPORT; ADAPTATION; RECOVERY; DEFICITS	Primary objective: Balance disturbances occur in similar to 30% of concussion injuries, with vestibular dysfunction reported as the main contributor. However, few have studied oculomotor control post-concussion to assess vestibular dysfunction. Research design: The current research measured the differences in oculomotor control between athletes post-concussion (PC) and athletes without concussion (NC) during an active balance control task. Methods: Nine PC and nine NC athletes wore a monocular eye tracking device, while balance tests were performed using the Nintendo WiiFit (R) soccer heading game. Average game scores, eye deviations from centre (Gaze Deviations) and gaze fixation (Percentage Time on Centre) were measured. Results: PC made significantly greater Gaze Deviations from centre compared to NC (p<0.001), however Percentage Time on Centre and game scores were not significantly different between groups. Correlations between gaze and balance within groups revealed a significant positive correlation in NC, while a significant negative correlation in PC. Conclusions: Results from this exploratory examination of oculomotor behaviour post-concussion revealed significant differences in gaze stability between athletes with a concussion and those without, suggesting vestibular involvement post-concussion. Assessment of oculomotor control during balance activities may provide further insight into dysfunction of the vestibular system following a concussion injury.	[Murray, Nicholas G.; Ambati, V. N. Pradeep] Univ Texas El Paso, Coll Hlth Sci, Interdisciplinary Hlth Sci PhD Program, El Paso, TX 79968 USA; [Contreras, Monica M.; Reed-Jones, Rebecca J.] Univ Texas El Paso, Coll Hlth Sci, Dept Kinesiol, El Paso, TX 79968 USA; [Salvatore, Anthony P.] Univ Texas El Paso, Coll Hlth Sci, Speech Language Pathol Program, El Paso, TX 79968 USA; [Reed-Jones, Rebecca J.] Univ Texas El Paso, Coll Hlth Sci, Phys Therapy Program, El Paso, TX 79968 USA		Reed-Jones, RJ (corresponding author), Univ Prince Edward Isl, Kinesiol Program, Dept Appl Human Sci, Fac Sci, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada.	rreedjones@upei.ca	Reed-Jones, Rebecca/L-2021-2019	Reed-Jones, Rebecca/0000-0002-2128-2671			Albright TD, 2000, CURR OPIN NEUROBIOL, V10, P612, DOI 10.1016/S0959-4388(00)00132-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], NCAA SPORTS MED HDB; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baron IS, 2007, BRAIN INJURY MED; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DeLong M R, 1984, Hum Neurobiol, V2, P235; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Kandel ER, 2000, PRINCIPLES NEURAL SC, P810; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Lanska DJ, 2000, NEUROLOGY, V55, P1201, DOI 10.1212/WNL.55.8.1201; Lovell M, 2006, SPORTS NEUROPSYCHOLO; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea MA, 2008, MILD TRAUMATIC BRAIN; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Mucha A, 2012, BRAIN INJURY PROFESS, V9, P12, DOI DOI 10.3109/02699052.2014.887144; NASHNER LM, 1982, J NEUROSCI, V2, P536; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Yamada M, 2011, GERIATR NURS, V32, P188, DOI 10.1016/j.gerinurse.2011.02.002	37	21	21	3	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					496	503		10.3109/02699052.2014.887144			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900014	24564740				2022-02-06	
J	Purcell, LK				Purcell, Laura K.			Sport-related concussion: Evaluation and management	PAEDIATRICS & CHILD HEALTH			English	Article						Adolescents; Children; Concussion; Return to learn; Return to play; Sport; Youth	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; PROTECTIVE EQUIPMENT; UNITED-STATES; CHILDREN; RECOVERY; PLAY; REHABILITATION; SYMPTOMS; RETURN	Concussion is a common injury among children and adolescents participating in organized sports and recreational activities. Any child or youth who sustains a concussion should be removed from play immediately and medically evaluated as soon as possible. Cognitive and physical rest are recommended to allow symptoms to resolve. Cognitive rest may require temporary school absence and/or a modified class work or homework load. After symptoms have completely resolved at rest and a full return to school is achieved, the student can progress through a medically supervised, stepwise exertion protocol to return to play. Everyone involved in child and youth sports must recognize the signs and symptoms of concussion, and ensure that any child or adolescent suspected of sustaining a concussion is properly evaluated and managed by qualified medical personnel. The present statement replaces a previous Canadian Paediatric Society position statement published in 2006 and revised in 2012.	[Purcell, Laura K.] Canadian Paediat Soc, Hlth Act Living & Sports Med Comm, Ottawa, ON K1G 4J8, Canada		Purcell, LK (corresponding author), Canadian Paediat Soc, 2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada.	info@cps.ca	Meijer, Anna/K-5118-2016				Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2013, GUIDELINES CONCUSSIO; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blume HK, 2012, PEDIATR REV, V33, P562, DOI 10.1542/pir.33-12-562; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW YOUR; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Leblanc John C, 2004, Paediatr Child Health, V9, P315; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sady MD, 2011, PHYS MED REH CLIN N, V22, pix; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thompson RS, 1996, NEW ENGL J MED, V335, P1680, DOI 10.1056/NEJM199611283352211	39	21	21	1	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	MAR	2014	19	3					153	158		10.1093/pch/19.3.153			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AC6KK	WOS:000332631400012	24665227	Green Published			2022-02-06	
J	Sarkar, K; Keachie, K; Nguyen, U; Muizelaar, JP; Zwienenberg-Lee, M; Shahlaie, K				Sarkar, Korak; Keachie, Krista; Nguyen, UyenThao; Muizelaar, J. Paul; Zwienenberg-Lee, Marike; Shahlaie, Kiarash			Computed tomography characteristics in pediatric versus adult traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; computed tomography; pediatric; adult; trauma	GLASGOW COMA SCALE; HEAD-INJURY; UNIQUE FEATURES; CLINICAL-TRIALS; CHILDREN; PREDICTION; CLASSIFICATION; BIOMECHANICS; VALIDATION; MANAGEMENT	Object. Traumatic brain injury (TBI) is a leading cause of injury, hospitalization, and death among pediatric patients. Admission CT scans play an important role in classifying TBI and directing clinical care, but little is known about the differences in CT findings between pediatric and adult patients. The aim of this study was to determine if radiographic differences exist between adult and pediatric TBI. Methods. The authors retrospectively analyzed TBI registry data from 1206 consecutive patients with nonpenetrating TBI treated at a Level 1 adult and pediatric trauma center over a 30-month period. Results. The distribution of sex, race, and Glasgow Coma Scale (GCS) score was not significantly different between the adult and pediatric populations; however, the distribution of CT findings was significantly different. Pediatric patients with TBI were more likely to have skull fractures (OR 3.21, p < 0.01) and epidural hematomas (OR 1.96, p < 0.01). Pediatric TBI was less likely to be associated with contusion, subdural hematoma, subarachnoid hemorrhage, or compression of the basal cisterns (p < 0.05). Rotterdam CT scores were significantly lower in the pediatric population (2.3 vs 2.6, p < 0.001). Conclusions. There are significant differences in the CT findings in pediatric versus adult TBI, despite statistical similarities with regard to clinical severity of injury as measured by the GCS. These differences may be due to anatomical characteristics, the biomechanics of injury, and/or differences in injury mechanisms between pediatric and adult patients. The unique characteristics of pediatric TBI warrant consideration when formulating a clinical trial design or predicting functional outcome using prognostic models developed from adult TBI data.	[Sarkar, Korak] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA; [Keachie, Krista; Muizelaar, J. Paul; Zwienenberg-Lee, Marike; Shahlaie, Kiarash] Univ Calif Davis, Sch Med, Dept Neurol Surg, Sacramento, CA 95817 USA; [Nguyen, UyenThao] Univ Calif Davis, Sch Med, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA		Shahlaie, K (corresponding author), Univ Calif Davis, Sch Med, Dept Neurol Surg, 4860 St,Ste 3740, Sacramento, CA 95817 USA.	kiarash.shahlaie@ucdmc.ucdavis.edu			National Center for Advancing Translational Sciences (NIH) [TR000002]	This project was supported by the National Center for Advancing Translational Sciences (NIH Grant No. TR000002).	Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 2007, J NEUROTRAUM, V24, pvii; Cadena G, 2012, J NEUROTRAUM, V29, pA41; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Litvack ZN, 2008, ACUTE BRAIN SPINAL C, P93; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; Reece RM, 2008, AM J PREV MED, V34, pS116, DOI 10.1016/j.amepre.2007.11.005; Roeder RA, 2011, J CRANIOFAC SURG, V22, P392, DOI 10.1097/SCS.0b013e318208ba30; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Wang NE, 2008, ANN EMERG MED, V52, P607, DOI 10.1016/j.annemergmed.2008.05.011; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023	34	21	22	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2014	13	3					307	314		10.3171/2013.12.PEDS13223			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AB8OC	WOS:000332048900013	24410128				2022-02-06	
J	White, RD; Harris, GD; Gibson, ME				White, Russell D.; Harris, George D.; Gibson, Margaret E.			Attention Deficit Hyperactivity Disorder and Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						attention deficit; hyperactivity disorder; athletes	SERIOUS CARDIOVASCULAR EVENTS; DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; CONSENSUS STATEMENT; RATING-SCALE; LIFE-SPAN; ADHD; CHILDREN; CONCUSSION; SPORT	Context: Attention deficit hyperactivity disorder (ADHD) is common in the general population, and many individuals with this condition participate in sports activity at all competition levels. Evidence Acquisition: Related studies were selected through literature searches of PubMed, MEDLINE, and Cochrane databases for the years 1991 to 2011. Key search terms were ADD, ADHD, sports, athletes, athletics, guidelines, NCAA, WADA, IOC, college, concussion, diagnosis, management, treatment, evaluation, return-to-play, pharmacotherapy, adult, adolescent, student, screening, injury, risk, neuropsychiatry, TBI, traumatic brain injury, and epidemiology. Study Design: Literature review. Results: ADHD usually has an early onset, with delayed diagnosis in some patients due to heterogeneous presentations. Suspected cases can be evaluated with available diagnostic tools and confirmed clinically. Athletes with ADHD may participate at all competition levels. Conclusion: Athletes with ADHD are able to participate at all competition levels by following published guidelines and requirements. Exercise benefits many athletes with ADHD. The relationship between ADHD and concussion syndromes is currently under investigation.	[White, Russell D.; Harris, George D.; Gibson, Margaret E.] Univ Missouri Kansas City, Kansas City, MO USA		White, RD (corresponding author), Univ Missouri Kansas City, Truman Med Ctr Lakewood, 7790 Lees Summit Rd, Kansas City, MO 64139 USA.	jockdoc2000@hotmail.com					AKINBAMI LJ, 1998, NCHS DATA BRIEF, V2011, P1; American Psychiatric Association, DSM 5 DEV; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 1980, DIAGN STAT MAN MENT; [Anonymous], 2011, NATL CTR HLTH STAT D, P70; Archer T, 2012, NEUROTOX RES, V21, P195, DOI 10.1007/s12640-011-9260-0; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; ATKINS MS, 1985, J ABNORM CHILD PSYCH, V13, P155, DOI 10.1007/BF00918379; Barbaresi W, 2002, ARCH PEDIAT ADOL MED, V156, P217, DOI 10.1001/archpedi.156.3.217; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, CLIN CHILD FAM PSYCH, V5, P89; Bidwell LC, 2011, PHARMACOL BIOCHEM BE, V99, P262, DOI 10.1016/j.pbb.2011.05.002; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Biederman J, 1998, J CLIN PSYCHIAT, V59, P4; Biederman J, 1996, ARCH GEN PSYCHIAT, V53, P437; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Biederman J, 2002, J ATTENTION DISOR S1, V6; Boschert S, 2011, FAMILY PRACTICE  JUL, P36; Bouchard R, 2002, CLIN J SPORT MED, V12, P209, DOI 10.1097/00042752-200207000-00003; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Cascade Elisa, 2008, Psychiatry (Edgmont), V5, P24; CDC-ADHD, DAT STAT NCBDDD; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; CLAUDE D, 1995, CAN J BEHAV SCI, V27, P226, DOI 10.1037/0008-400X.27.2.226; Clendenin Aaron A, 2005, J Atten Disord, V8, P79, DOI 10.1177/1087054705277166; Collett BR, 2003, J AM ACAD CHILD PSY, V42, P1015, DOI 10.1097/01.CHI.0000070245.24125.B6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Conant-Norville DO, 2005, CLIN SPORT MED, V24, P829, DOI 10.1016/j.csm.2005.05.007; CONNERS CK, 1969, AM J PSYCHIAT, V126, P884, DOI 10.1176/ajp.126.6.884; CONNERS CK, 2010, MANUAL CONNERS RATIN; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Dulcan MK, 1997, J AM ACAD CHILD PSY, V36, P1311; Dulk-Jacobs V, AD HD MED CHILDREN; Esfandiari A, 2011, CLIN SPORT MED, V30, P611, DOI 10.1016/j.csm.2011.03.002; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Greydanus DE, 2007, DM-DIS MON, V53, P70, DOI 10.1016/j.disamonth.2007.01.001; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Halperin JM, 2011, NEUROSCI BIOBEHAV R, V35, P621, DOI 10.1016/j.neubiorev.2010.07.006; Hamilton SS, 2008, AM FAM PHYSICIAN, V78, P861; Harel EH, 2003, CLIN PEDIATR, V42, P497, DOI 10.1177/000992280304200603; Hechtman L, 1992, PSYCHIATR CLIN N AM, V1, P553; Homer CJ, 2000, PEDIATRICS, V105, P1158; Hunt TN, 2010, MED SCI SPORT EXER, V42, P114, DOI 10.1249/01.MSS.0000386000.82770.27; Ingram S, 1999, MENT RETARD DEV D R, V5, P243, DOI 10.1002/(SICI)1098-2779(1999)5:3<243::AID-MRDD11>3.0.CO;2-D; International Olympic Committee, 2012, INT OL COMM ANT RUL; Iverson GL, 2004, NAT ASS SCH PSYCH AP; Kessler RC, 2005, BIOL PSYCHIAT, V57, P1442, DOI 10.1016/j.biopsych.2005.04.001; Kiluk BD, 2009, J ATTEN DISORD, V12, P499, DOI 10.1177/1087054708320400; Kitchen REC, DISORDERS ARE COMORB; Klein RG, ADIID LONG TERM OUTC; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2011, TXB TRAUMATIC BRAIN, P442; Mayo Clinic, HEATSTR RISK FACT; McCann B S, 2000, Semin Clin Neuropsychiatry, V5, P191, DOI 10.1053/scnp.2000.6730; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCGEE R, 1991, J AM ACAD CHILD PSY, V30, P224, DOI 10.1097/00004583-199103000-00010; National Federation of State High School Associations, SPORTS MED HDB; National Initiative for Children's Healthcare Quality, CAR CHILDR ADHD RES; National Institute of Mental Health, ATT DEF HYP DIS ADHD; National Institutes of Mental Health, ATT DEF HYP DIS ADHI; Office of Mental Health New York State, SCOR INSTR SNAP IV C; Perrin JM, 2008, PEDIATRICS, V122, P451, DOI 10.1542/peds.2008-1573; Perrin JM, 2001, PEDIATRICS, V108, P1033; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Polanczyk G, 1996, AM J PSYCHIAT, V53, P437; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Rowland AS, 2002, MENT RETARD DEV D R, V8, P162, DOI 10.1002/mrdd.10036; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Silva RR, 2010, CLIN PEDIATR, V49, P840, DOI 10.1177/0009922810368289; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Spencer T, 2008, PSYCHIAT CLIN N AM, P367; Swanson N, THESIS; Thaler NS, 2010, J CLIN EXP NEUROPSYC, V32, P929, DOI 10.1080/13803391003596488; Timimi S, 2004, BRIT J PSYCHIAT, V184, P8, DOI 10.1192/bjp.184.1.8; U.S. Department of Health and Human Services. U.S. Food and Drug Administration, FDA DRUG SAF COMM SA; US Department of Health & Human Resources U.S. Food and Drug Administration. FDA Drug, FDA DRUG DRUGF STIM; US Food and Drug Administration, 2006, DRUG SAF RISK MAN AD; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; WADA, 2011, MED INF SUPP DEC TUE; WebMD, ADHD IN TEENS; Wigal SB, 1998, PSYCHOPHARMACOL BULL, V34, P47; Wolraich ML, 1998, J ABNORM CHILD PSYCH, V26, P141, DOI 10.1023/A:1022673906401; Wolraich ML, 2005, PEDIATRICS, V115, P1734, DOI 10.1542/peds.2004-1959; Woodruff TJ, 2004, PEDIATRICS, V113, P1133; World Anti-Doping Agency (WADA), 2019, WORLD ANT COD	91	21	21	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2014	6	2					149	156		10.1177/1941738113484679			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V20EK	WOS:000214869700010	24587866	Green Published			2022-02-06	
J	Gueguen, C; Palmier, B; Plotkine, M; Marchand-Leroux, C; Bessson, VC				Gueguen, Cindy; Palmier, Bruno; Plotkine, Michel; Marchand-Leroux, Catherine; Bessson, Valerie C.			Neurological and Histological Consequences Induced by In Vivo Cerebral Oxidative Stress: Evidence for Beneficial Effects of SRT1720, a Sirtuin 1 Activator, and Sirtuin 1-Mediated Neuroprotective Effects of Poly(ADP-ribose) Polymerase Inhibition	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PREVENTS NAD(+) DEPLETION; SMALL-MOLECULE ACTIVATORS; PROMOTES CELL-SURVIVAL; DNA-DAMAGE; PARP-1 INHIBITION; ARTERY OCCLUSION; NEURONAL DEATH; RAT; RESVERATROL	Poly(ADP-ribose) polymerase and sirtuin 1 are both NAD+-dependent enzymes. In vitro oxidative stress activates poly(ADPribose) polymerase, decreases NAD(+) level, sirtuin 1 activity and finally leads to cell death. Poly(ADP-ribose) polymerase hyperactivation contributes to cell death. In addition, poly(ADP-ribose) polymerase inhibition restores NAD(+) level and sirtuin 1 activity in vitro. In vitro sirtuin 1 induction protects neurons from cell loss induced by oxidative stress. In this context, the role of sirtuin 1 and its involvement in beneficial effects of poly(ADP-ribose) polymerase inhibition were evaluated in vivo in a model of cerebral oxidative stress induced by intrastriatal infusion of malonate in rat. Malonate promoted a NAD(+) decrease that was not prevented by 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, at 4 and 24 hours. However, 3-aminobenzamide increased nuclear SIRT1 activity/expression ratio after oxidative stress. Malonate induced a neurological deficit associated with a striatal lesion. Both were reduced by 3-aminobenzamide and SRT1720, a sirtuin 1 activator, showing beneficial effects of poly(ADP-ribose) polymerase inhibition and sirtuin 1 activation on oxidative stress consequences. EX527, a sirtuin 1 inhibitor, given alone, modified neither the score nor the lesion, suggesting that endogenous sirtuin 1 was not activated during cerebral oxidative stress. However, its association with 3-aminobenzamide suppressed the neurological improvement and the lesion reduction induced by 3-aminobenzamide. The association of 3-aminobenzamide with SRT1720, the sirtuin 1 activator, did not lead to a better protection than 3-aminobenzamide alone. The present data represent the first demonstration that the sirtuin 1 activator SRT1720 is neuroprotective during in vivo cerebral oxidative stress. Furthermore sirtuin 1 activation is involved in the beneficial effects of poly(ADP-ribose) polymerase inhibition after in vivo cerebral oxidative stress.	[Gueguen, Cindy; Palmier, Bruno; Plotkine, Michel; Marchand-Leroux, Catherine; Bessson, Valerie C.] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Paris, France		Bessson, VC (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Paris, France.	valerie.besson@parisdescartes.fr	BESSON, VALERIE/AAZ-9989-2020; besson, valerie C/L-7388-2017; MARCHAND-LEROUX, Catherine/L-7453-2017	BESSON, VALERIE/0000-0002-1491-2380; besson, valerie C/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348	Universite Paris Descartes; Fondation des Gueules Cassees	This work was supported partly by Universite Paris Descartes and by a grant from the Fondation des Gueules Cassees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2011, BRAIN, V134, P1658, DOI 10.1093/brain/awr104; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Besson VC, 2003, FREE RADICAL RES, V37, P1201, DOI 10.1080/10715760310001612568; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Caito S, 2010, BIOCHEM BIOPH RES CO, V392, P264, DOI 10.1016/j.bbrc.2009.12.161; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Cosi C, 2000, AMINO ACIDS, V19, P229, DOI 10.1007/s007260070054; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Gupta YK, 2001, METHOD FIND EXP CLIN, V23, P241, DOI 10.1358/mf.2001.23.5.662120; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Paucard A, 2005, FUND CLIN PHARMACOL, V19, P57, DOI 10.1111/j.1472-8206.2004.00297.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	60	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87367	10.1371/journal.pone.0087367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	WOS:000331717900008	24586272	Green Published, gold, Green Submitted			2022-02-06	
J	Karamanos, E; Talving, P; Skiada, D; Osby, M; Inaba, K; Lam, L; Albuz, O; Demetriades, D				Karamanos, Efstathios; Talving, Peep; Skiada, Dimitra; Osby, Melanie; Inaba, Kenji; Lam, Lydia; Albuz, Ozgur; Demetriades, Demetrios			Is Prehospital Endotracheal Intubation Associated with Improved Outcomes in Isolated Severe Head Injury? A Matched Cohort Analysis	PREHOSPITAL AND DISASTER MEDICINE			English	Article						blood gas; endotracheal intubation; head injury; isolated; prehospital		Introduction: Prehospital endotracheal intubation (ETI) following traumatic brain injury in urban settings is controversial. Studies investigating admission arterial blood gas (ABG) patterns in these instances are scant. Hypothesis: Outcomes in patients subjected to divergent prehospital airway management options following severe head injury were studied. Methods: This was a retrospective propensity-matched study in patients with isolated TBI (head Abbreviated Injury Scale (AIS) >= 3) and Glasgow Coma Scale (GCS) score of <= 8 admitted to a Level 1 urban trauma center from January 1, 2003 through October 31, 2011. Cases that had prehospital ETI were compared to controls subjected to oxygen by mask in a one to three ratio for demographics, mechanism of injury, tachycardia/hypotension, Injury Severity Score, type of intracranial lesion, and all major surgical interventions. Primary outcome was mortality and secondary outcomes included admission gas profile, in-hospital morbidity, ICU length of stay (ICU LOS) and hospital length of stay (HLOS). Results: Cases (n = 55) and controls (n = 165) had statistically similar prehospital and in-hospital variables after propensity matching. Mortality was significantly higher for the ETI group (69.1% vs 55.2% respectively, P = .011). There was no difference in pH, base deficit, and pCO2 on admission blood gases; however the ETI group had significantly lower pO2 (187 (SD = 14) vs 213 (SD = 13), P = .034). There was a significantly increased incidence of septic shock in the ETI group. Patients subjected to prehospital ETI had a longer HLOS and ICU LOS. Conclusion: In isolated severe traumatic brain injury, prehospital endotracheal intubation was associated with significantly higher adjusted mortality rate and worsened admission oxygenation. Further prospective validation of these findings is warranted.	[Karamanos, Efstathios; Talving, Peep; Skiada, Dimitra; Osby, Melanie; Inaba, Kenji; Lam, Lydia; Albuz, Ozgur; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg Trauma Emergency Surg & Surg, Keck Sch Med, Los Angeles, CA 90033 USA		Karamanos, E (corresponding author), Univ Southern Calif, Dept Surg, Keck Sch Med, LAC USC Med Ctr,Div Acute Care Surg, 1200 North State St,Room 6341, Los Angeles, CA 90033 USA.	ef.karamanos@gmail.com	INABA, KENJI/AAC-8532-2020; Karamanos, Efstathios/AAU-8082-2020; Albuz, Ozgur/G-1480-2015; Talving, Peep/E-6015-2013	Karamanos, Efstathios/0000-0002-5118-4642; 			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bauer K, 2012, CRIT CARE NURS Q, V35, P281, DOI 10.1097/CNQ.0b013e3182542eb5; Bochicchio Grant V, 2003, Curr Opin Crit Care, V9, P524, DOI 10.1097/00075198-200312000-00010; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Dupanovic M, 2010, CURR OPIN ANESTHESIO, V23, P276, DOI 10.1097/ACO.0b013e3283360b4f; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; GRAHAM DI, 1971, LANCET, V1, P265; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Lossius HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9973; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	19	21	21	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	FEB	2014	29	1					32	36		10.1017/S1049023X13008947			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	VG1BE	WOS:000445148900007	24330753				2022-02-06	
J	Lin, TP; Adler, CH; Hentz, JG; Balcer, LJ; Galetta, SL; Devick, S				Lin, Tanya P.; Adler, Charles H.; Hentz, Joseph G.; Balcer, Laura J.; Galetta, Steven L.; Devick, Steve			Slowing of number naming speed by King-Devick Test in Parkinson's disease	PARKINSONISM & RELATED DISORDERS			English	Article						Parkinson's disease; Eye movements; Cognitive function	VISUALLY-GUIDED SACCADES; EYE-MOVEMENT CONTROL	Background: The King Devick (MD) test measures the speed of rapid number naming, and is postulated to require fast eye movements, attention, language, and possibly other aspects of cognitive functions. While used in multiple sports concussion studies, it has not been applied to the field of movement disorders. Methods: Forty-five Parkinson's disease (PD), 23 essential tremor (ET), and 65 control subjects were studied. Subjects performed two trials of reading out loud single-digit numbers separated by varying spacing on three test cards that were of different formats. The sum time of the faster trial was designated the MD score and compared across the three groups. Results: PD patients had higher (worse) MD scores, with longer reading times compared to ET and control subjects (66 s vs. 49 s vs. 52 s, p < 0.001, adjusting for age and gender). No significant difference was found between ET and control (Delta = -3 s, 95% CI: -10 to 4). Conclusions: This is the first study of the Ming Devick Test in Parkinson's disease. PD patients were found to have a slower rapid number naming speed compared to controls. This test may be a simple and rapid bedside tool for quantifying correlates of visual and cognitive function in Parkinson's disease. (C) 2013 Elsevier Ltd. All rights reserved.	[Lin, Tanya P.; Adler, Charles H.] Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA; [Hentz, Joseph G.] Mayo Clin, Coll Med, Dept Biostat, Scottsdale, AZ USA; [Balcer, Laura J.; Galetta, Steven L.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Devick, Steve] King Devick Test LLC, Oak Brook Terrace, IL USA		Adler, CH (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA.	cadler@mayo.edu	Adler, Charles/ABD-5276-2021		National Institute of Neurological Disorders and Stroke (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders) [U24 NS072026]; National Institute on Aging (Arizona Alzheimer's Disease Core Center)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG19610]; Arizona Department of Health Services (Arizona Alzheimer's Research Center) [211002]; Arizona Biomedical Research Commission [4001, 0011, 05901, 1001]; Mayo Clinic Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG019610] Funding Source: NIH RePORTER	The Arizona Parkinson's Disease Consortium and the Brain and Body Donation Program are supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05901 and 1001 to the Arizona Parkinson's Disease Consortium), and Mayo Clinic Foundation.	Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; Archibald NK, 2013, BRAIN, V136, P739, DOI 10.1093/brain/awt005; Chambers JM, 2010, NEUROPSYCHOLOGIA, V48, P887, DOI 10.1016/j.neuropsychologia.2009.11.006; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Helmchen C, 2012, MOVEMENT DISORD, V27, P1012, DOI 10.1002/mds.25042; MacAskill MR, 2012, NEUROPSYCHOLOGIA, V50, P3338, DOI 10.1016/j.neuropsychologia.2012.09.025; Marino S, 2010, NEUROL SCI, V31, P381, DOI 10.1007/s10072-009-0180-1; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; Terao Y, 2011, NEUROPSYCHOLOGIA, V49, P1794, DOI 10.1016/j.neuropsychologia.2011.03.002	12	21	21	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	FEB	2014	20	2					226	229		10.1016/j.parkreldis.2013.10.009			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB3IW	WOS:000331685500018	24269283	Green Accepted			2022-02-06	
J	Powers, KC; Kalmar, JM; Cinelli, ME				Powers, Kaley C.; Kalmar, Jayne M.; Cinelli, Michael E.			Dynamic stability and steering control following a sport-induced concussion	GAIT & POSTURE			English	Article						Concussion; Dynamic balance control; Steering; Temporal variability	TRAUMATIC BRAIN-INJURY; CENTER-OF-MASS; GAIT VARIABILITY; BALANCE CONTROL; OLDER-ADULTS; FALL RISK; HEAD; COORDINATION; DIRECTION; STRATEGIES	Loss of balance control is one of the cardinal symptoms following a concussion; however, the ability to detect the duration of these balance impairments seems to largely depend on task type and complexity. Typical balance assessment tools are simplistic and do not challenge dynamic balance control. Changing direction represents an internal perturbation that challenges the balance control system. The purpose of this study was to examine the effects of a concussion on dynamic stability and steering control. Nine male intercollegiate North American football players who experienced a concussion (CONC) were tested during the symptomatic phase (acute) and again once they had been cleared to return to play (RTP) while the controls (age-and position-matched teammates) were tested at a single time point coinciding with the acute phase testing of their matched injured player. All participants performed a steering task, requiring them to walk straight or turn in the direction of a visual cue located either 60 degrees or 45 degrees to the left or right of the centre line. CONC demonstrated increased swing time variability, segmental re-orientation variability, and the amount of time it took the centre of mass to reach the minimum lateral dynamic stability margin. These results suggest that CONC were more unstable and adopted a conservative gait strategy. Differences in the variability measures persisted even after the athlete was cleared to RTP. Overall, the findings reveal that intercollegiate football players with concussions have difficulty controlling temporal characteristics of gait, which cause dynamic instability to persist even at RTP. (C) 2013 Elsevier B.V. All rights reserved.	[Powers, Kaley C.; Kalmar, Jayne M.; Cinelli, Michael E.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada		Cinelli, ME (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, 75 Univ Ave,W Rm 501, Waterloo, ON N2L 3C5, Canada.	mcinelli@wlu.ca	Cinelli, Michael/ABE-7625-2020	Cinelli, Michael/0000-0002-5802-2590			Aruin A.S., 2002, J AUTOMATIC CONTROL, V12, P31, DOI [10.2298/JAC0201031A, DOI 10.2298/JAC0201031A]; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Grasso R, 1996, NEUROREPORT, V7, P1170, DOI 10.1097/00001756-199604260-00015; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hollands MA, 2004, EXP BRAIN RES, V154, P261, DOI 10.1007/s00221-003-1718-8; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; RIETDYK S, 1994, HUM MOVEMENT SCI, V13, P109, DOI 10.1016/0167-9457(94)90031-0; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; WINTER DA, 2004, BIOMECHANICS MOTOR C; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326	29	21	21	0	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2014	39	2					728	732		10.1016/j.gaitpost.2013.10.005			5	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	293NQ	WOS:000329979300011	24231441				2022-02-06	
J	Shetty, PK; Galeffi, F; Turner, DA				Shetty, Pavan K.; Galeffi, Francesca; Turner, Dennis A.			Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia	NEUROBIOLOGY OF DISEASE			English	Article						Nicotinamide; Hypoxia; Brain; Spreading depression; Hippocampus; PARP-1	MITOCHONDRIAL PERMEABILITY TRANSITION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NADH HYPEROXIDATION; HIPPOCAMPAL SLICES; OXIDATIVE STRESS; CELL-DEATH; PHARMACOLOGICAL TOOLS; ENERGY-METABOLISM; PROTECTS NEURONS	Prolonged hypoxia leads to irreversible loss of neuronal function and metabolic impairment of nicotinamide adenine dinucleotide recycling (between NAD(+) and NADH) immediately after reoxygenation, resulting in NADH hyperoxidation. We test whether the addition of nicotinamide (to enhance NAD(+) levels) or PARP-1 inhibition (to prevent consumption of NAD(+)) can be effective in improving either loss of neuronal function or hyperoxidation following severe hypoxic injury in hippocampal slices. After severe, prolonged hypoxia (maintained for 3 min after spreading depression) there was hyperoxidation of NADH following reoxygenation, an increased soluble NAD(+)/NADH ratio, loss of neuronal field excitatory post-synaptic potential (fEPSP) and decreased ATP content. Nicotinamide incubation (5 mM) 2 h prior to hypoxia significantly increased total NAD(H) content, improved neuronal recovery, enhanced ATP content, and prevented NADH hyperoxidation. The nicotinamide-induced increase in total soluble NAD(H) was more significant in the cytosolic compartment than within mitochondria. Prolonged incubation with PJ-34 (>1 h) led to enhanced baseline NADH fluorescence prior to hypoxia, as well as improved neuronal recovery, NADH hyperoxidation and ATP content on recovery from severe hypoxia and reoxygenation. In this acute model of severe neuronal dysfunction prolonged incubation with either nicotinamide or PJ-34 prior to hypoxia improved recovery of neuronal function, enhanced NADH reduction and ATP content, but neither treatment restored function when administered during or after prolonged hypoxia and reoxygenation. (C) 2013 Elsevier Inc All rights reserved.	[Shetty, Pavan K.; Galeffi, Francesca; Turner, Dennis A.] Duke Univ, Med Ctr, Res & Surg Serv, VAMC, Durham, NC 27710 USA		Shetty, PK (corresponding author), DUMC, Box 3807, Durham, NC 27710 USA.	shetty.p@duke.edu		Shetty, Pavan/0000-0002-6484-7417	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1AG037599]; VAMC Merit Review Award; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037599] Funding Source: NIH RePORTER	This research was supported by NIH Grant NIA RO1AG037599 and a VAMC Merit Review Award. We would also like to thank Dr. Shawn Acheson for helpful suggestions regarding this manuscript.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Assaly R, 2012, EUR J PHARMACOL, V675, P6, DOI 10.1016/j.ejphar.2011.11.036; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; DORA E, 1986, ANN NEUROL, V19, P536, DOI 10.1002/ana.410190604; Fiskum G, 2008, ANN NY ACAD SCI, V1147, P129, DOI 10.1196/annals.1427.026; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; Foster KA, 2008, NEUROBIOL AGING, V29, P598, DOI 10.1016/j.neurobiolaging.2006.11.006; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; KOGURE K, 1980, ANN NEUROL, V8, P278, DOI 10.1002/ana.410080310; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Paschen W, 2000, J NEUROCHEM, V75, P1675, DOI 10.1046/j.1471-4159.2000.0751675.x; Perez-Pinzon MA, 1998, BRAIN RES, V786, P165, DOI 10.1016/S0006-8993(97)01438-8; Perez-Pinzon MA, 1998, J CEREBR BLOOD F MET, V18, P215, DOI 10.1097/00004647-199802000-00013; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; ROSENTHAL M, 1995, J CEREBR BLOOD F MET, V15, P655, DOI 10.1038/jcbfm.1995.81; Shetty PK, 2012, NEUROBIOL DIS, V45, P177, DOI 10.1016/j.nbd.2011.08.002; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Yang J, 2002, MINI-REV MED CHEM, V2, P125, DOI 10.2174/1389557024605483; Yang J, 2004, PHARMACOL BIOCHEM BE, V78, P179, DOI 10.1016/j.pbb.2004.03.007; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002	45	21	24	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2014	62						469	478		10.1016/j.nbd.2013.10.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301SY	WOS:000330553600043	24184921	Green Accepted			2022-02-06	
J	Araujo, GC; Antonini, TN; Monahan, K; Gelfius, C; Klamar, K; Potts, M; Yeates, KO; Bodin, D				Araujo, Gabriel C.; Antonini, Tanya N.; Monahan, Kerry; Gelfius, Carl; Klamar, Karl; Potts, Michelle; Yeates, Keith O.; Bodin, Doug			The Relationship Between Suboptimal Effort and Post-Concussion Symptoms in Children and Adolescents With Mild Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Effort; Post-concussion symptoms; Mild traumatic brain injury; Children; Neuropsychology	ADULT INTELLIGENCE SCALE; DIGIT SPAN SUBTEST; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; TEST-PERFORMANCE; POOR EFFORT; TASK-FORCE; OUTCOMES; BIAS; RECOVERY	This retrospective chart review study explored the relationship between suboptimal effort and post-concussion symptoms in pediatric mild traumatic brain injury (mTBI). Participants were 382 clinically referred children and adolescents between 8 and 16 years of age who sustained an mTBI. Suboptimal effort was identified using reliable digit span and age-corrected scaled scores from the Numbers subtest of the Children's Memory Scale (CMS); 20% of the sample were classified as non-credible performers. Chi-square analyses and t-tests were used to examine differences in post-concussion symptoms and neuropsychological test performance between credible and non-credible performers. Linear regression was used to examine whether CMS Numbers performance predicted post-concussion symptoms after controlling for baseline symptoms and other relevant demographic-and injury-related factors. We found that non-credible performers presented with a greater number of post-concussion symptoms as compared with credible performers. Additionally, non-credible performers demonstrated comparatively poorer performance on neuropsychological tests of focused attention and processing speed. These results suggest that children and adolescents with mTBI who fail effort testing might have a greater tendency to exaggerate post-concussion symptoms and cognitive impairment. The clinical implications of these findings are discussed.	[Araujo, Gabriel C.; Antonini, Tanya N.; Monahan, Kerry; Yeates, Keith O.; Bodin, Doug] Nationwide Childrens Hosp, Dept Psychol & Neuropsychol, Columbus, OH 43205 USA; [Araujo, Gabriel C.; Antonini, Tanya N.; Monahan, Kerry; Gelfius, Carl; Klamar, Karl; Potts, Michelle; Yeates, Keith O.; Bodin, Doug] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Gelfius, Carl; Klamar, Karl; Potts, Michelle] Nationwide Childrens Hosp, Dept Phys Med & Rehabil, Columbus, OH 43205 USA		Bodin, D (corresponding author), Nationwide Childrens Hosp, Dept Psychol & Neuropsychol, 700 Childrens Dr, Columbus, OH 43205 USA.	Doug.Bodin@nationwidechildrens.org	Bodin, Doug/AAS-9534-2021; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Janusz JA, 2012, MILD TRAUMATIC BRAIN; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; KNIGHTS R, 1966, RES B, V20; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Pennington BF., 2010, PEDIAT NEUROPSYCHOLO; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Reitan R, 1985, HALSTEAD REITAN NEUR; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sosin DM, 1996, BRAIN INJURY, V10, P47; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; World Health Organization, 1992, INT CLASS DIS; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	56	21	21	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2014	28	5					786	801		10.1080/13854046.2014.896415			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AP4MM	WOS:000342051100007	24646066				2022-02-06	
J	De Maio, VJ; Joseph, DO; Tibbo-Valeriote, H; Cabanas, JG; Lanier, B; Mann, CH; Register-Mihalik, J				De Maio, Valerie J.; Joseph, Damilola O.; Tibbo-Valeriote, Holly; Cabanas, Jose G.; Lanier, Brian; Mann, Courtney H.; Register-Mihalik, Johna			Variability in Discharge Instructions and Activity Restrictions for Patients in a Children's ED Postconcussion	PEDIATRIC EMERGENCY CARE			English	Article						concussion; trauma; discharge instructions	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; RECURRENT CONCUSSION; SYMPTOMS; RECOVERY; RISK; ASSOCIATION; DEPRESSION	Objective The objective of this study was to describe discharge instructions given to school-aged patients evaluated in a children's emergency department (ED) following concussion. Methods This was a retrospective cohort study of children 6 to 18 years evaluated in a dedicated children's ED at a level I trauma center in 2008 following acute head trauma regardless of mechanism, identified by any of 27 International Classification of Disease, Ninth Revision diagnoses for head injury, concussion, or skull fracture. Included were those presentations consistent with the Zurich definition for concussion. Excluded were hospital admission, death before admission, evidence of intoxication, or structural abnormality on imaging. Univariate and multivariate analyses determined adjusted odds ratios (ORs) for receipt of concussion-specific discharge instructions and activity restrictions. Results Of 350 eligible patients, the 218 included patients were mostly male (68%) with mean age 12.8 (SD, 3.4) years. Injury characteristics included sports-related, 42%; fall, 23%; loss of consciousness, 33%; headache, 75%; dizziness, 29%; amnesia, 25%; and vomiting, 19%. Most patients underwent imaging (81%). Discharge characteristics included concussion stated in final diagnosis, 31%; concussion-specific instructions, 62%; and activity restrictions, 34%. Concussion-specific discharge instructions were more likely for loss of consciousness (OR, 1.7; 95% confidence interval [CI], 1.22-2.36), and activity restrictions were more likely for sport-related injury (OR, 1.31; 95% CI, 1.02-1.76) and amnesia (OR, 1.42; 95% CI, 1.01-1.98). Conclusions Most children meeting diagnostic criteria for concussion were discharged without concussion-specific diagnoses or activity restrictions. Given the risks associated with untimely return to both physical and cognitive activity after concussion, improved awareness and standardization of disposition are imperative for the management of these young patients in the ED.	[De Maio, Valerie J.; Tibbo-Valeriote, Holly; Lanier, Brian; Register-Mihalik, Johna] WakeMed Hlth & Hosp, Emergency Serv Inst, Raleigh, NC 27610 USA; [Cabanas, Jose G.] Austin Travis Cty Emergency Med Serv, Austin, TX USA		De Maio, VJ (corresponding author), WakeMed Hlth & Hosp, 3024 New Bern Ave,Suite G01, Raleigh, NC 27610 USA.	demaio@weppa.org	Meijer, Anna/K-5118-2016	Register-Mihalik, Johna/0000-0002-4229-4743			[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Faul M, 2010, TRAUMATIC BRAIN INJU; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Silverberg ND, 2012, J HEAD TRAUMA REHABI; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stevens PK, 2010, J TRAUMA NURS, V17, P174; Valentine V, 2012, AM FAM PHYSICIAN, V85, P100; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	37	21	21	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2014	30	1					20	25		10.1097/PEC.0000000000000058			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AH6ST	WOS:000336261700005	24365726				2022-02-06	
J	Dyer, K; das Nair, R				Dyer, Kerry; das Nair, Roshan			Talking about sex after traumatic brain injury: perceptions and experiences of multidisciplinary rehabilitation professionals	DISABILITY AND REHABILITATION			English	Article						Rehabilitation; sexuality; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURY; SEXUALITY; HEALTH; ISSUES; SATISFACTION; DYSFUNCTION; PREDICTORS; DISABILITY; ADJUSTMENT	Purpose: Research indicates that although 50-60% of people who have had a traumatic brain injury (TBI) experience changes in sexual functioning, sexuality issues remain largely unaddressed in rehabilitation. This study aimed to explore rehabilitation professionals' perceptions and experiences of discussing sexuality with service-users who have had a TBI. Method: Purposeful sampling was used to recruit 24 participants from two local National Health Service trusts and from a national charity. Four focus groups were conducted with pre-existing groups of professionals, using a semi-structured interview schedule. Focus group data were transcribed verbatim and analysed using thematic analysis. Results: Six main themes were derived from the analysis: (1) sexuality after TBI is a specialist issue; (2) sexuality is a sensitive subject; (3) practicalities of discussing sexuality; (4) roles and responsibilities; (5) dilemmas about risk and vulnerabilities; and (6) organisational and structural issues. Conclusions: Our findings suggest that a more proactive approach to addressing sexuality issues be taken by incorporating sexuality into assessments and by having sexuality information available for service-users. Support for professionals is also needed in the form of the development of policy, on-going training and supervision.	[Dyer, Kerry] Lincoln Univ, Inst Hlth Life & Social Sci, Lincoln, England; [das Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham NG7 2RD, England; [das Nair, Roshan] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2RD, England		Dyer, K (corresponding author), Lincoln Univ, Inst Hlth Life & Social Sci, Lincoln, England.	kerry_dyer@hotmail.co.uk		das Nair, Roshan/0000-0001-8143-7893			Annon JS., 1976, J SEX EDUC THER, V2, P1, DOI [10.1080/01614576.1976.11074483, DOI 10.1080/01614576.1976.11074483]; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Blackerby W, 1987, NATL HEAD INJURY FDN, V7, P8; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cellek S, 2012, NAT REV UROL, V9, P537, DOI 10.1038/nrurol.2012.134; Cote-Arsenault D, 1999, NURS RES, V48, P280; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Dattilo J, 2005, J HOLIST NURS, V23, P208, DOI 10.1177/0898010105275839; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Davis S., 2006, REHABILITATION USE T; *DEP HLTH, 2001, NAT STRAT SEX HLTH; Department of Health, 2010, HLTH LIV HLTH PEOPL; Ducharme S, 1991, SEX UPDATE, V4, P8; DUCHARME S, 1997, SEXUALITY SPINAL COR; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Earle S, 2001, J ADV NURS, V36, P433, DOI 10.1046/j.1365-2648.2001.01991.x; Gianotten WL, 2006, SEX RELATSH THER, V21, P303, DOI DOI 10.1080/14681990600754559; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; Glass CA, 1995, J MENT HEALTH, P251; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Guthrie C, 1999, J CLIN NURS, V8, P313, DOI 10.1046/j.1365-2702.1999.00253.x; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Harris AJR, 2004, J APPL RES INTELLECT, V17, P235, DOI 10.1111/j.1468-3148.2004.00211.x; Herson L, 1999, Rehabil Nurs, V24, P148; Hordern AJ, 2007, MED J AUSTRALIA, V186, P224, DOI 10.5694/j.1326-5377.2007.tb00877.x; HOUGH S, 1989, PSYCHOL REP, V65, P745, DOI 10.2466/pr0.1989.65.3.745; Jefferson, 1984, STRUCTURES SOCIAL AC, P346, DOI DOI 10.1017/CBO9780511665868; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Madriz E, 2000, HDB QUALITATIVE RES, V2, P835; Magnan Morris A, 2005, Medsurg Nurs, V14, P282; Marwick C, 1999, JAMA-J AM MED ASSOC, V281, P2132; MATOCHA LK, 1993, RES NURS HEALTH, V16, P371, DOI 10.1002/nur.4770160508; McCabe MP, 2000, SEX DISABIL, V18, P115, DOI 10.1023/A:1005562813603; McLaughlin J, 2005, SEX DISABIL, V23, P213, DOI 10.1007/s11195-005-8929-9; MEDLAR T, 1990, J HEAD TRAUMA REHAB, V5, P46; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Miller L., 1994, J COGNITIVE REHABILI, V12, P12; Nomejko A, 2011, POL J APP PSYCHOL, V9, P65; Northcott R, 2000, BR J OCCUP THER, V63, P412, DOI DOI 10.1177/030802260006300902; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Price B, 2010, CANC NURS PRACT, V9, P29; Rathus SA, 2005, HUMAN SEXUALITY WORL; Rubin Rona, 2005, Nurs Stand, V19, P33; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Shears S., 2010, SOC CARE NEURODISABI, V1, P4, DOI [10.5042/scn.2010.0597, DOI 10.5042/SCN.2010.0597]; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Taleporos G, 2002, SEX DISABIL, V20, P177, DOI 10.1023/A:1021493615456; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor B, 2007, SEX DISABIL, V25, P135, DOI 10.1007/s11195-007-9044-x; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; WATERHOUSE J, 1991, J ADV NURS, V16, P1048, DOI 10.1111/j.1365-2648.1991.tb03365.x; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Westcott H., 1994, EQUAL TERMS WORKING, P190; Wilkinson S, 1998, HEALTH PSYCHOL, V3, P329, DOI DOI 10.1177/135910539800300304; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2012, SEX DRAFT WORK DEF; Zinn W M, 1981, Int Rehabil Med, V3, P18	71	21	21	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	17					1431	1438		10.3109/09638288.2013.859747			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AN8XG	WOS:000340888500006	24286234	Green Accepted			2022-02-06	
J	Hutchison, MG; Comper, P; Meeuwisse, WH; Echemendia, RJ				Hutchison, Michael G.; Comper, Paul; Meeuwisse, Willem H.; Echemendia, Ruben J.			An observational method to code concussions in the National Hockey League (NHL): the heads-up checklist	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Ice hockey; Injury Prevention	YOUTH ICE HOCKEY; PROFESSIONAL FOOTBALL; VIDEO ANALYSIS; INJURY; BIOMECHANICS; RISK; MECHANISMS; AGREEMENT; CHECKING; IMPACTS	Background Development of effective strategies for preventing concussions is a priority in all sports, including ice hockey. Digital video records of sports events contain a rich source of valuable information, and are therefore a promising resource for analysing situational factors and injury mechanisms related to concussion. Aim To determine whether independent raters reliably agreed on the antecedent events and mechanisms of injury when using a standardised observational tool known as the heads-up checklist (HUC) to code digital video records of concussions in the National Hockey League (NHL). Methods The study occurred in two phases. In phase 1, four raters (2 naive and 2 expert) independently viewed and completed HUCs for 25 video records of NHL concussions randomly chosen from the pool of concussion events from the 2006-2007 regular season. Following initial analysis, three additional factors were added to the HUC, resulting in a total of 17 factors of interest. Two expert raters then viewed the remaining concussion events from the 2006-2007 season, as well as all digital video records of concussion events up to 31 December 2009 (n=174). Results For phase 1, the majority of the factors had a value of 0.6 or higher (8 of 15 factors for naive raters; 11 of 15 factors for expert raters). For phase 2, all the factors had a total percent agreement value greater than 0.8 and values of >0.65 for the expert raters. Conclusions HUC is an objective, reliable tool for coding the antecedent events and mechanisms of concussions in the NHL.	[Hutchison, Michael G.; Comper, Paul] Univ Toronto, David L MacIntosh Sport Med Clin, Fac Kinesiol & Phys Educ, Toronto, ON M5S 2W6, Canada; [Hutchison, Michael G.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 2W6, Canada; [Comper, Paul] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 2W6, Canada; [Meeuwisse, Willem H.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Meeuwisse, Willem H.] Univ Calgary, Hotchkiss Brain Inst, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Echemendia, Ruben J.] Univ Missouri, Kansas City, MO 64110 USA		Hutchison, MG (corresponding author), Univ Toronto, David L MacIntosh Sport Med Clin, Fac Kinesiol & Phys Educ, 55 Harbord St, Toronto, ON M5S 2W6, Canada.	michael.hutchison@utoronto.ca	Echemendia, Ruben/R-6939-2019		Ontario Neurotrauma Foundation (ONF); Pashby Sports Safety Fund	This study received funding by Ontario Neurotrauma Foundation (ONF) and The Pashby Sports Safety Fund. The organisations that contributed funds to the research had no role in the design of the study, the collection, analysis and interpretation of the data.	Andersen TE, 2004, AM J SPORT MED, V32, p69S, DOI 10.1177/0363546503262023; [Anonymous], MAC OS X VERS 10 5 8; Arnason A, 2004, AM J SPORT MED, V32, P1459, DOI 10.1177/0363546504262973; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; ETTLINGER CF, 1995, AM J SPORT MED, V23, P531, DOI 10.1177/036354659502300503; Fleiss Joseph L., 2004, MEASUREMENT INTERRAT; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; HARTMANN DP, 1977, J APPL BEHAV ANAL, V10, P103, DOI 10.1901/jaba.1977.10-103; HOUSE AE, 1981, J BEHAV ASSESS, V3, P37, DOI 10.1007/BF01321350; Hutchison MG, 2003, NAT UND RES C MARCH; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman EJ, 2003, NEUROSURGERY, V53, P12; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SILVER JR, 1988, SPORTS MED, V5, P328, DOI 10.2165/00007256-198805050-00005; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Viano DC, 2005, NEUROSURGERY, V56, P66	32	21	21	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					125	U133		10.1136/bjsports-2012-092059			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	276KK	WOS:000328749000014	23766437				2022-02-06	
J	Kamal, MA; Priyamvada, S; Anbazhagan, AN; Jabir, NR; Tabrez, S; Greig, NH				Kamal, Mohammad A.; Priyamvada, Shubha; Anbazhagan, Arivarasu N.; Jabir, Nasimudeen R.; Tabrez, Shams; Greig, Nigel H.			Linking Alzheimer's Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Alzheimer's disease; Anti-cholinesterase; Butyrylcholinesterase; Inflammation; Type 2 diabetes mellitus	GLYCATION END-PRODUCTS; GLUCAGON-LIKE PEPTIDE-1; NECROSIS-FACTOR-ALPHA; HUMAN SERUM BUTYRYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN; GROWTH-FACTOR EXPRESSION; A-BETA LEVELS; MOUSE MODEL; METABOLIC SYNDROME; ANIMAL-MODELS	Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two progressive and devastating health disorders afflicting millions of people worldwide. The probability and incidence of both have increased considerably in recent years consequent to increased longevity and population growth. Progressively more links are being continuously found between inflammation and central nervous system disorders like AD, Parkinson's disease, Huntington's disease, motor neuron disease, multiple sclerosis, stroke, traumatic brain injury and even cancers of the nervous tissue. The depth of the relationship depends on the timing and extent of anti- or pro-inflammatory gene expression. Inflammation has also been implicated in T2DM. Misfolding and fibrillization (of tissue specific and/or non-specific proteins) are features common to both AD and T2DM and are induced by as well as contribute to inflammation and stress (oxidative/glycation). This review appraises the roles of inflammation and abnormalities in the insulin signaling system as important shared features of T2DM and AD. The capacity of anti-cholinesterases in reducing the level of certain common inflammatory markers in particular if they may provide therapeutic potential to mitigate awry mechanisms leading to AD.	[Kamal, Mohammad A.; Jabir, Nasimudeen R.; Tabrez, Shams] King Abdulaziz Univ, King Fahd Med Res Ctr, Fundamental & Appl Biol Grp, Metabol & Enzymol Unit, Jeddah 21589, Saudi Arabia; [Priyamvada, Shubha; Anbazhagan, Arivarasu N.] Univ Illinois, Dept Med, Sect Digest Dis & Nutr, Chicago, IL 60612 USA; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH,Biomed Res Ctr, Baltimore, MD 21224 USA		Kamal, MA (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Fundamental & Appl Biol Grp, Metabol & Enzymol Unit, POB 80216, Jeddah 21589, Saudi Arabia.	meu.fabg@hotmail.com	Tabrez, Shams/H-9476-2012; Tabrez, Shams/H-7315-2019; Kamal, Mohammad Amjad/J-2918-2014; Rehumathbeevi, Jabir Nasimudeen/H-9483-2012	Tabrez, Shams/0000-0003-4550-415X; Tabrez, Shams/0000-0003-4550-415X; Kamal, Mohammad Amjad/0000-0003-0088-0565; Rehumathbeevi, Jabir Nasimudeen/0000-0001-8548-7986; Priyamvada, Shubha/0000-0002-7241-569X	Intramural Research Program of the National Institute on Aging, National Institutes of Health, Baltimore, MD, USA; Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois, Chicago, USA; deanship of scientific research at KSU [RGP-VPP-215]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311] Funding Source: NIH RePORTER	N.G. is supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. SP and NAA are grateful for support by the Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois, Chicago, USA. MAK, JNR and ST also extend their appreciation to the deanship of scientific research at KSU for funding the work through the research group project No- RGP-VPP-215.	ABBOTT CA, 1993, CLIN SCI, V85, P77, DOI 10.1042/cs0850077; Ahmed I, 2006, MT SINAI J MED, V73, P759; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Aleong R, 2008, CURR ALZHEIMER RES, V5, P33; Allam AR, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-28; Ando K, 1999, J NEUROSCI, V19, P4421; ARENDT T, 1984, LANCET, V1, P173; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Banks WA, 1997, PEPTIDES, V18, P1577, DOI 10.1016/S0196-9781(97)00238-6; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BASKIN DG, 1985, LIFE SCI, V36, P627, DOI 10.1016/0024-3205(85)90166-3; Becker RE, 2010, CURR ALZHEIMER RES, V7, P642; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Beeler N, 2009, BRAIN RES BULL, V80, P274, DOI 10.1016/j.brainresbull.2009.07.006; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Biessels GJ, 2004, EUR J PHARMACOL, V490, P1, DOI 10.1016/j.ejphar.2004.02.057; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Capsoni S, 2011, CNS NEUROL DISORD-DR, V10, P635, DOI 10.2174/187152711796235032; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chen GJ, 2003, J ALZHEIMERS DIS, V5, P209, DOI 10.3233/JAD-2003-5305; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Das UN, 2007, J NUTR BIOCHEM, V18, P701, DOI 10.1016/j.jnutbio.2007.01.002; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Eldor R, 2006, DIABETES RES CLIN PR, V74, pS3, DOI 10.1016/j.diabres.2006.06.004; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Gautam S, 2011, MOL GENET METAB, V102, P389, DOI 10.1016/j.ymgme.2010.12.012; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; Guo JT, 2002, J NEUROSCI, V22, P5900; Gupta A, 2003, INT J CLIN PRACT, V57, P36; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Hamer M, 2009, AGE, V31, P171, DOI 10.1007/s11357-009-9097-0; Hashim Y, 2001, DIABETOLOGIA, V44, P2227, DOI 10.1007/s001250100033; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Jellinger KA, 2006, J NEURAL TRANSM, V113, P1603, DOI 10.1007/s00702-006-0578-3; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525; Kamal MA, 2006, BBA-GEN SUBJECTS, V1760, P200, DOI 10.1016/j.bbagen.2005.10.003; Kamal MA, 2008, J NEURAL TRANSM, V115, P889, DOI 10.1007/s00702-008-0022-y; Kamal MA, 2008, NEUROCHEM RES, V33, P745, DOI 10.1007/s11064-007-9490-y; Kamal MA, 2006, J ALZHEIMERS DIS, V10, P43; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Kelley KW, 2013, BRAIN BEHAV IMMUN; Kennedy DJ, 2011, METAB SYNDR RELAT D, V9, P239, DOI 10.1089/met.2011.0003; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Koivisto AM, 2005, J NEUROGENET, V19, P155, DOI 10.1080/01677060600569721; Kumar S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-9; LAM K, 1994, J BIOL CHEM, V269, P20648; Laws SM, 2005, HUM MUTAT, V26, P29, DOI 10.1002/humu.20180; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Lue Lih-Fen, 2012, Int J Alzheimers Dis, V2012, P918680, DOI 10.1155/2012/918680; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Luo WM, 2006, J MED CHEM, V49, P2174, DOI 10.1021/JM050578P; Luo WM, 2005, J ORG CHEM, V70, P6171, DOI 10.1021/jo0503052; Luo WM, 2005, J MED CHEM, V48, P986, DOI 10.1021/jm049309+; MARKS JL, 1991, ADV EXP MED BIOL, V293, P459; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Milionis HJ, 2008, CNS SPECTRUMS, V13, P606, DOI 10.1017/S1092852900016886; Miyamoto Y, 2005, J NEUROSCI, V25, P1826, DOI 10.1523/jneurosci.3030-04.2005; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Nizri E, 2007, PHARMACOLOGY, V79, P42, DOI 10.1159/000097628; Nunomura A, 2012, NEUROTOX RES, V22, P231, DOI 10.1007/s12640-012-9331-x; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; PERRY EK, 1986, BRIT MED BULL, V42, P63, DOI 10.1093/oxfordjournals.bmb.a072100; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892; Priyadarshini M, 2012, CNS NEUROL DISORD-DR, V11, P482, DOI 10.2174/187152712800792767; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; RADA P, 1991, BRAIN RES, V550, P287, DOI 10.1016/0006-8993(91)91330-4; Rao AA, 2007, MED HYPOTHESES, V69, P1272, DOI 10.1016/j.mehy.2007.03.032; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reale M, 2012, CURR ALZHEIMER RES, V9, P447, DOI 10.2174/156720512800492549; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003; Rosenberg Paul B, 2006, MedGenMed, V8, P24; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smith U, 2007, J INTERN MED, V262, P142, DOI 10.1111/j.1365-2796.2007.01827.x; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Taepavarapruk P, 2010, J NEUROCHEM, V112, P1054, DOI 10.1111/j.1471-4159.2009.06524.x; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tam XHL, 2011, CLIN SCI, V120, P81, DOI 10.1042/CS20100256; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tobinick E, 2012, CURR ALZHEIMER RES, V9, P99, DOI 10.2174/156720512799015073; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Vetter SW, 2011, CLIN CHIM ACTA, V412, P2105, DOI 10.1016/j.cca.2011.07.022; Vidal CJ, 2005, CHEM-BIOL INTERACT, V157, P227, DOI 10.1016/j.cbi.2005.10.035; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Wortwein G, 1997, INT J DEV NEUROSCI, V15, P147, DOI 10.1016/S0736-5748(97)00002-6; Yamagishi S, 2005, MED HYPOTHESES, V64, P1205, DOI 10.1016/j.mehy.2005.01.016; Yamagishi S, 2003, INT J CLIN PHARM RES, V23, P129; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yu QS, 1999, J MED CHEM, V42, P1855, DOI 10.1021/jm980459s; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	139	21	22	0	19	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	2					338	346		10.2174/18715273113126660137			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AN8EL	WOS:000340835800018	24074448	Green Accepted			2022-02-06	
J	Sabati, M; Zhan, JP; Govind, V; Arheart, KL; Maudsley, AA				Sabati, Mohammad; Zhan, Jiping; Govind, Varan; Arheart, Kristopher L.; Maudsley, Andrew A.			Impact of Reduced k-Space Acquisition on Pathologic Detectability for Volumetric MR Spectroscopic Imaging	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MR spectroscopic imaging; parallel imaging; traumatic brain injury; undersampled acquisition; clinical equivalency	BRAIN; SENSE; RECONSTRUCTION; GRAPPA; PEPSI	PurposeTo assess the impact of accelerated acquisitions on the spectral quality of volumetric magnetic resonance spectroscopic imaging (MRSI) and to evaluate their ability in detecting metabolic changes with mild injury. Materials and MethodsThe implementation of a generalized autocalibrating partially parallel acquisition (GRAPPA) method for a high-resolution whole-brain echo planar SI (3D-EPSI) sequence is first described and the spectral accuracy of the GRAPPA-EPSI method is investigated using lobar and voxel-based analyses for normal subjects and patients with mild traumatic brain injuries (mTBI). The performance of GRAPPA was compared with that of fully encoded EPSI for five datasets collected from normal subjects at the same scanning session, as well as on 45 scans (20 normal subjects and 25 mTBI patients) for which the reduced k-space sampling was simulated. For comparison, a central k-space lower-resolution 3D-EPSI acquisition was also simulated. Differences in individual metabolites and metabolite ratio distributions of the mTBI group relative to those of age-matched control subjects were statistically evaluated using analyses divided into hemispheric brain lobes and tissue types. ResultsGRAPPA-EPSI with 16-minute scan time yielded robust and similar results in terms of MRSI quantitation, spectral fitting, and accuracy with that of fully sampled 3D-EPSI acquisitions and was more accurate than central k-space acquisition. Primary findings included high correlations (accuracy of 92.6%) between the GRAPPA and fully sampled results. ConclusionAlthough the reduced encoding method is associated with lower signal-to-noise ratio (SNR) that impacts the quality of spectral analysis, the use of the parallel imaging method can lead to the same diagnostic outcomes as the fully sampled data when using the sensitivity-limited volumetric MRSI. J. Magn. Reson. Imaging 2014;39:224-234. (c) 2013 Wiley Periodicals, Inc.	[Sabati, Mohammad; Zhan, Jiping; Govind, Varan; Maudsley, Andrew A.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Arheart, Kristopher L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA		Sabati, M (corresponding author), Univ Miami, Miller Sch Med, Dept Radiol, 1150 NW 14 St,Ste 713, Miami, FL 33136 USA.	msabati@med.miami.edu		Govind, Varan/0000-0002-1205-5194; Maudsley, Andrew/0000-0001-7653-3063	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS055107, R01EB000822]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB000822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055107] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health; Contract grant number: R01NS055107 and R01EB000822.	ADALSTEINSSON E, 1995, MAGNET RESON MED, V33, P461, DOI 10.1002/mrm.1910330402; Adalsteinsson E, 1998, MAGNET RESON MED, V39, P889, DOI 10.1002/mrm.1910390606; Andronesi OC, 2012, RADIOLOGY, V262, P647, DOI 10.1148/radiol.11110277; Bertolino A, 1998, NEUROPSYCHOPHARMACOL, V18, P1; Blaimer M, 2006, MAGN RESON MED, V56, P1359, DOI 10.1002/mrm.21071; Brown MA, 2004, MAGNET RESON MED, V52, P1207, DOI 10.1002/mrm.20244; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Dydak U, 2003, MAGN RESON MED, V50, P196, DOI 10.1002/mrm.10495; Dydak U, 2001, MAGN RESON MED, V46, P713, DOI 10.1002/mrm.1250; Ebel A, 2003, MAGN RESON IMAGING, V21, P113, DOI 10.1016/S0730-725X(02)00645-8; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gu M, 2009, MAGN RESON MED, V61, P267, DOI 10.1002/mrm.21838; Kurhanewicz J, 2000, NEOPLASIA, V2, P166, DOI 10.1038/sj.neo.7900081; Lin FH, 2007, MAGN RESON MED, V57, P249, DOI 10.1002/mrm.21119; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Mayer D, 2008, MAGN RESON MED, V59, P891, DOI 10.1002/mrm.21572; Otazo R, 2007, MAGN RESON MED, V58, P1107, DOI 10.1002/mrm.21426; Ozturk-Isik E, 2009, MAGN RESON IMAGING, V27, P1249, DOI 10.1016/j.mri.2009.05.028; POSSE S, 1994, RADIOLOGY, V192, P733, DOI 10.1148/radiology.192.3.8058941; Posse S, 2009, MAGN RESON MED, V61, P541, DOI 10.1002/mrm.21855; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.3.CO;2-J; Rueckert M, 2006, P 14 ANN M ISMRM SEA, P296; Signoretti S, 2002, ACT NEUR S, V81, P373; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Sodickson DK, 2000, MAGN RESON MED, V44, P243, DOI 10.1002/1522-2594(200008)44:2<243::AID-MRM11>3.3.CO;2-C; TEDESCHI G, 1995, NEUROLOGY, V45, P1384, DOI 10.1212/WNL.45.7.1384; Tsai SY, 2008, MAGN RESON MED, V59, P989, DOI 10.1002/mrm.21545; Zhu XP, 2007, MAGN RESON MED, V57, P815, DOI 10.1002/mrm.21217; Zierhut M, 2009, OCUL IMMUNOL INFLAMM, V17, P3, DOI 10.1080/09273940902797685	33	21	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JAN	2014	39	1					224	234		10.1002/jmri.24130			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	268QK	WOS:000328185400028	23559504	Green Accepted			2022-02-06	
J	Steenstrup, SE; Bere, T; Bahr, R				Steenstrup, Sophie E.; Bere, Tone; Bahr, Roald			Head injuries among FIS World Cup alpine and freestyle skiers and snowboarders: a 7-year cohort study	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Sporting Injuries; Epidemiology; Head Injuries; Ski Injuries	SYSTEMATIC VIDEO ANALYSIS; CRUCIATE LIGAMENT INJURY; CONSENSUS STATEMENT; INTERNATIONAL-CONFERENCE; CONCUSSION INCIDENCE; MECHANISMS; SPORTS; ZURICH; CROSS	Background Traumatic brain injury is the leading cause of death for skiers and snowboarders. Fatal head injuries have also occurred at the International Ski Federation (FIS) World Cup (WC) level. We therefore wanted to describe the risk of head injuries across disciplines and sex among WC skiers and snowboarders. Method We conducted retrospective interviews with FIS WC athletes at the end of seven consecutive seasons (2006-2013) to register injuries sustained during the competitive season. Head injuries were classified as head/face' injuries and did not include neck or cervical spine injuries. To calculate the exposure, we extracted data from the official FIS website for all WC competitions for each of the athletes interviewed. Results A total of 2080 injuries were reported during seven WC seasons. Of these, 245 (11.8%) were head/face injuries. Of the 245 head/face injuries reported, nervous system injuries/concussions were the most common (81.6%) and 58 of these were severe (23.7%). The injury incidence per 1000 competition runs was higher in freestyle (1.8, 95% CI 1.2 to 2.4) than in alpine skiing (0.9, 95% CI 0.6 to 1.2; risk ratio (RR) 2.05, 95% CI 1.25 to 3.46) and snowboard (1.0, 95% CI 0.6 to 1.3; RR 1.85, 95% CI 1.15 to 2.99). Women had a higher injury incidence (5.8, 95% CI 4.8 to 6.9) versus men (3.9, 95% CI 3.2 to 4.6; RR 1.48, 95% CI 1.15 to 1.90) throughout the season (per 100 athletes). Conclusions The majority of head/face injuries were nervous system injuries/concussions and one in four injuries was severe. Freestyle skiers had the highest overall head injury incidence. Across all disciplines, the injury incidence was higher in women than in men.	[Steenstrup, Sophie E.; Bere, Tone; Bahr, Roald] Norwegian Sch Sports Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway; [Bere, Tone] Aspetar, Doha, Qatar		Steenstrup, SE (corresponding author), Norwegian Sch Sports Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, PB 4014 Ulleval Stad, N-0806 Oslo, Norway.	s.e.steenstrup@nih.no	Bahr, Roald/B-6964-2014	Bahr, Roald/0000-0001-5725-4237	Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic Committee & Confederation of Sport; Norsk Tipping AS; International Ski Federation; Don Joy Orthotics (DJO)	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sports Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic Committee & Confederation of Sport and Norsk Tipping AS. The FIS Injury Surveillance System is supported by the International Ski Federation and has been established through a generous grant from Don Joy Orthotics (DJO).	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Bakken A, 2011, BRIT J SPORT MED, V45, P1315, DOI 10.1136/bjsports-2011-090527; Bere T, 2013, SCAND J MED SCI SPOR, DOI [10.1111/sms.12038, DOI 10.1111/SMS.12038.PUBLISHED]; Bere T, 2014, BRIT J SPORT MED, V48, P40; Bere T, 2013, AM J SPORT MED, V41, P1067, DOI 10.1177/0363546513479341; Bere T, 2011, BRIT J SPORT MED, V45, P1294, DOI 10.1136/bjsports-2011-090517; Bere T, 2011, AM J SPORT MED, V39, P1421, DOI 10.1177/0363546511405147; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Florenes TW, 2011, SCAND J MED SCI SPOR, V21, P196, DOI 10.1111/j.1600-0838.2009.01048.x; Florenes TW, 2010, BRIT J SPORT MED, V44, P803, DOI 10.1136/bjsm.2009.071159; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Major DH, 2014, BRIT J SPORT MED, V48, P18, DOI 10.1136/bjsports-2013-092573; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mecham MD, 1999, J APPL BIOMECH, V15, P27, DOI 10.1123/jab.15.1.27; Randjelovic S, 2014, BRIT J SPORT MED, V48, P31; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Russell K, 2013, CLIN J SPORT MED, V23, P172, DOI 10.1097/JSM.0b013e31827bd918; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Steenstrup SE, 2011, BRIT J SPORT MED, V45, P1310, DOI 10.1136/bjsports-2011-090528; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	32	21	26	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	1					41	+		10.1136/bjsports-2013-093145			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	272YX	WOS:000328500500009	24334504				2022-02-06	
J	Strigo, IA; Spadoni, AD; Lohr, J; Simmons, AN				Strigo, I. A.; Spadoni, A. D.; Lohr, J.; Simmons, A. N.			Too hard to control: compromised pain anticipation and modulation in mild traumatic brain injury	TRANSLATIONAL PSYCHIATRY			English	Article						concussion; dorsolateral prefrontal; emotion; imaging; PAG; post-traumatic stress	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MAJOR DEPRESSIVE DISORDER; INSULA ACTIVATION; BLAST EXPOSURE; WAR VETERAN; IRAQ; AFGHANISTAN; EMOTION; PTSD	Mild traumatic brain injury (MTBI) is a vulnerability factor for the development of pain-related conditions above and beyond those related to comorbid traumatic and emotional symptoms. We acquired functional magnetic resonance imaging (fMRI) on a validated pain anticipation task and tested the hypotheses that individuals with a reported history of MTBI, compared with healthy comparison subjects, would show increased brain response to pain anticipation and ineffective pain modulation after controlling for psychiatric symptoms. Eighteen male subjects with a reported history of blast-related MTBI related to combat, and eighteen healthy male subjects with no reported history of MTBI (healthy controls) underwent fMRI during an event-related experimental pain paradigm with cued high or low intensity painful heat stimuli. No subjects in either group met diagnostic criteria for current mood or anxiety disorder. We found that relative to healthy comparison subjects, after controlling for traumatic and depressive symptoms, participants with a reported history of MTBI showed significantly stronger activations within midbrain periaqueductual grey (PAG), right dorsolateral prefrontal cortex and cuneus during pain anticipation. Furthermore, we found that brain injury was a significant moderator of the relationship between anticipatory PAG activation and reported subjective pain. Our results suggest that a potentially disrupted neurocognitive anticipatory network may result from damage to the endogenous pain modulatory system and underlie difficulties with regulatory pain processing following MTBI. In other words, our findings are consistent with a notion that brain injury makes it more difficult to control acute pain. Understanding these mechanisms of dysfunctional acute pain processing following MTBI may help shed light on the underlying causes of increased vulnerability for the development of pain-related conditions in this population.	[Strigo, I. A.; Spadoni, A. D.; Lohr, J.; Simmons, A. N.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Strigo, I. A.; Spadoni, A. D.; Lohr, J.; Simmons, A. N.] Univ Calif San Diego, La Jolla, CA 92161 USA; [Strigo, I. A.] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92161 USA		Strigo, IA (corresponding author), Univ Calif San Diego, Dept Psychiat, 3350 La Jolla Village Dr,Bldg 13,MC 9151-B, La Jolla, CA 92161 USA.	istrigo@ucsd.edu	strigo, irina A/L-9882-2016; Simmons, Alan/A-9815-2008	strigo, irina A/0000-0002-8799-716X; Spadoni, Andrea/0000-0002-8367-6406; Simmons, Alan/0000-0003-3963-2112	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH080003]; Center of Excellence in Stress and Mental Health; Merit Grant; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K99MH080003, R00MH080003] Funding Source: NIH RePORTER	We are grateful to the National Institute of Mental Health (MH080003 to IAS), to the Veterans Administration via Center of Excellence in Stress and Mental Health to ANS and IAS, and Merit Grant to ANS for supporting this work and to Elena Kosheleva and Lindsay E Reinhardt for assisting with data collection.	Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chatterjee S., 2009, SENSITIVITY ANAL LIN, V327; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 1999, MEDULLA THALAMUS TXB, P183; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; First M., 1997, STRUCTURED CLIN INTE; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Gosselin N, 2012, J NEUROTRAUM, V29, P2625, DOI 10.1089/neu.2012.2312; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hayes AF, 2013, INTRO MEDLATION MODE; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Moeller-Bertram T, 2012, NEUROPHARMACOLOGY, V62, P586, DOI 10.1016/j.neuropharm.2011.04.028; Mohr C, 2008, PAIN, V139, P416, DOI 10.1016/j.pain.2008.05.020; Mutschler I, 2012, NEUROSCI LETT, V520, P204, DOI 10.1016/j.neulet.2012.03.095; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Staud R, 2012, EXPERT REV NEUROTHER, V12, P577, DOI [10.1586/ERN.12.41, 10.1586/ern.12.41]; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strigo IA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.15; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Taber KH, 2010, PTSD RES Q, V21, P1; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Warden DL, 2005, NEW ENGL J MED, V353, P633; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	70	21	21	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	JAN	2014	4								e340	10.1038/tp.2013.116			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	AJ2RL	WOS:000337507500002	24399043	gold, Green Published			2022-02-06	
J	Truong, JQ; Ciuffreda, KJ; Han, MHE; Suchoff, IB				Truong, James Q.; Ciuffreda, Kenneth J.; Han, M. H. Esther; Suchoff, Irwin B.			Photosensitivity in mild traumatic brain injury (mTBI): A retrospective analysis	BRAIN INJURY			English	Article						Contact lenses; neural adaptation; photophobia; photosensitivity; tinted lenses; traumatic brain injury; visual discomfort	DARK-ADAPTATION; VISUAL SYSTEM; EPIDEMIOLOGY; PHOTOPHOBIA; LIGHT	Primary objective: To determine whether photosensitivity (PS) changes over time and, if so, what factors may be related to the change; furthermore, to determine whether tint density changes over time, all in mild traumatic brain injury (mTBI). Design and methods: A retrospective analysis of 62 patient records (aged 18-40 years) with mTBI and PS was conducted. All charts were obtained from the SUNY/College of Optometry clinics from 2004-2011. Results: Fifty per cent demonstrated reduced PS over time, with most occurring after year 1 post-injury (40%). Promotion of PS reduction appears to be associated with the lack of spectacle tint usage (p = 0.01) and the use of contact lenses (p = 0.03). Inhibition of PS reduction appears to be associated with tinted lenses (p = 0.06), hyperacusis (p = 0.03), dry eye (p = 0.04), migraines (p = 0.03) and loss of consciousness at the time of injury (p = 0.05). Concerning tint density changes over time, 71% (p = 0.002) maintained the same degree over time, while 27% (p = 0.002) reduced and 2% waxed and waned. Conclusion: Neural adaptation to PS appears to be a long-term process. Tint usage may act to inhibit this adaptive process, while the use of contact lenses may act to promote it. These findings may provide guidance in the clinical management of photosensitivity in the mTBI population.	[Truong, James Q.; Ciuffreda, Kenneth J.; Han, M. H. Esther; Suchoff, Irwin B.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Truong, JQ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	james.q.truong@gmail.com					Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; CLARK W. E. LeGROS, 1949, DOCUMENTA OPHTHALMOL, V3, P57; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; DOWLING JE, 1967, SCIENCE, V155, P273, DOI 10.1126/science.155.3760.273; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; GALLIN PF, 1995, AM J OPHTHALMOL, V119, P202, DOI 10.1016/S0002-9394(14)73874-7; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; HAY JC, 1963, SCIENCE, V141, P167, DOI 10.1126/science.141.3576.167; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Kapoor N, 2009, MED MANAGEMENT ADULT, P407; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KOHLER I, 1962, SCI AM, V206, P62, DOI 10.1038/scientificamerican0562-62; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; MCCOLLOUGH C, 1965, AM J PSYCHOL, V78, P362, DOI 10.2307/1420571; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Reeves A., 2004, VISUAL NEUROSCIENCES, P851; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Suchoff IB, 2001, VISUAL VESTIBULAR CO; VIRSU V, 1977, EXP BRAIN RES, V27, P35; Walline Jeffrey J, 2007, Eye Contact Lens, V33, P317, DOI 10.1097/ICL.0b013e31804f80fb	28	21	21	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1283	1287		10.3109/02699052.2014.915989			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900008	24945993				2022-02-06	
J	Wilkins, SA; Shannon, CN; Brown, ST; Vance, EH; Ferguson, D; Gran, K; Crowther, M; Wellons, JC; Johnston, JM				Wilkins, Sara Anne; Shannon, Chevis N.; Brown, Steven T.; Vance, E. Haley; Ferguson, Drew; Gran, Kimberly; Crowther, Marshall; Wellons, John C., III; Johnston, James M., Jr.			Establishment of a multidisciplinary concussion program: impact of standardization on patient care and resource utilization Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; standardization; implementation analysis; trauma	SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; MANAGEMENT; STATEMENT	Object. Recent legislation and media coverage have heightened awareness of concussion in youth sports. Previous work by the authors' group defined significant variation of care in management of children with concussion. To address this variation, a multidisciplinary concussion program was established based on a uniform management protocol, with emphasis on community outreach via traditional media sources and the Internet. This retrospective study evaluates the impact of standardization of concussion care and resource utilization before and after standardization in a large regional pediatric hospital center. Methods. This retrospective study included all patients younger than 18 years of age evaluated for sports-related concussion between January 1, 2007, and December 31, 2011. Emergency department, sports medicine, and neurosurgery records were reviewed. Data collected included demographics, injury details, clinical course, Sports Concussion Assessment Tool-2 (SCAT2) scores, imaging, discharge instructions, and referral for specialty care. The cohort was analyzed comparing patients evaluated before and after standardization of care. Results. Five hundred eighty-nine patients were identified, including 270 before standardization (2007-2011) and 319 after standardization (2011-2012). Statistically significant differences (p < 0.0001) were observed between the 2 groups for multiple variables: there were more girls, more first-time concussions, fewer initial presentations to the emergency department, more consistent administration of the SCAT2, and more consistent supervision of return to play and return to think after adoption of the protocol. Conclusions. A combination of increased public awareness and legislation has led to a 5-fold increase in the number of youth athletes presenting for concussion evaluation at the authors' center. Establishment of a multidisciplinary clinic with a standardized protocol resulted in significantly decreased institutional resource utilization and more consistent concussion care for this growing patient population.	[Wilkins, Sara Anne; Brown, Steven T.; Johnston, James M., Jr.] Univ Alabama Birmingham, Dept Neurosurg, Div Neurosurg, Birmingham, AL 35233 USA; [Ferguson, Drew; Crowther, Marshall] Univ Alabama Birmingham, Dept Orthoped Surg, Div Sports Med, Birmingham, AL 35233 USA; [Gran, Kimberly] Vanderbilt Univ, Dept Emergency Med, Nashville, TN 37235 USA; [Shannon, Chevis N.; Vance, E. Haley; Wellons, John C., III] Vanderbilt Univ, Dept Neurosurg, Nashville, TN 37235 USA		Johnston, JM (corresponding author), Univ Alabama Birmingham, Childrens Alabama, Div Neurosurg, Sect Pediat Neurosurg, 1600 7th Ave S,Lowder 400, Birmingham, AL 35233 USA.	james.johnston@childrensal.org		Johnston, James/0000-0001-8564-1808			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Comstock RD, 2006, HIGH SCH RIO REPORTI; Comstock RD, 2011, HIGH SCH RIO REPORTI; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Toporek B, 2013, ED WEEK	15	21	21	0	14	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2014	13	1					82	89		10.3171/2013.10.PEDS13241			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	281GM	WOS:000329088000014	24236447				2022-02-06	
J	Fife, GP; O'Sullivan, DM; Pieter, W; Cook, DP; Kaminski, TW				Fife, Gabriel P.; O'Sullivan, David M.; Pieter, Willy; Cook, David P.; Kaminski, Thomas W.			Effects of Olympic-style taekwondo kicks on an instrumented head-form and resultant injury measures	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Head injuries; Martial Arts	PROFESSIONAL FOOTBALL; CONCUSSION; IMPACT; BIOMECHANICS	Objective The objective of this study was to assess the effect of taekwondo kicks and peak foot velocity (FVEL) on resultant head linear acceleration (RLA), head injury criterion (HIC15) and head velocity (HVEL). Methods Each subject (n=12) randomly performed five repetitions of the turning kick (TK), clench axe kick (CA), front leg axe kick, jump back kick (JB) and jump spinning hook kick (JH) at the average standing head height for competitors in their weight division. A Hybrid II Crash Test Dummy head was fitted with a protective taekwondo helmet and instrumented with a triaxial accelerometer and fixed to a height-adjustable frame. Resultant head linear acceleration, HVEL, FVEL data were captured and processed using Qualysis Track Manager. Results The TK (130.1151.67g) produced a higher RLA than the CA (54.95 +/- 20.08g, p<0.001, d=1.84) and a higher HIC15 than the JH (672.74 +/- 540.89 vs 300.19 +/- 144.35, p<0.001, ES=0.97). There was no difference in HVEL of the TK (4.73 +/- 1.67m/s) and that of the JB (4.43 +/- 0.78m/s; p=0.977, ES<0.01). Conclusions The TK is of concern because it is the most common technique and cause of concussion in taekwondo. Future studies should aim to understand rotational accelerations of the head.	[Fife, Gabriel P.] Yonsei Univ, Dept Phys Educ, Seoul 120749, South Korea; [Fife, Gabriel P.] Dong A Univ, Dept Phys Educ, Pusan, South Korea; [O'Sullivan, David M.] Chung Ang Univ, Dept Phys Educ, Anseong, South Korea; [O'Sullivan, David M.] Seoul Natl Univ, Dept Phys Educ, Seoul, South Korea; [Pieter, Willy] Keimyung Univ, Dept Taekwondo, Taegu, South Korea; [Cook, David P.] London S Bank Univ, Dept Acad Sport, London, England; [Kaminski, Thomas W.] Univ Delaware, Dept Hlth Nutr & Exercise Sci, Newark, DE USA		O'Sullivan, DM (corresponding author), Chung Ang Univ, Coll Sport Sci, Dept Phys Educ, 72-1 Naeri Daedeokmyeon, Gyeonggido Anseong 456756, South Korea.	tkd4@cau.ac.kr			National Athletic Trainers' Association; University of Delaware GUR Grant	National Athletic Trainers' Association and University of Delaware GUR Grant.	[Anonymous], 2008, WORLD TAEKW HEADQ; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Cohen JE, 2010, ISR MED ASSOC J, V12, P509; Foster KJ, 1977, P 21 STAPP CAR CRASH; Greenwald RM, 2001, J APPL BIOMECH, V17, P241, DOI 10.1123/jab.17.3.241; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hertzberg HE., 1969, P 13 STAPP CAR CRASH; Kazemi Mohsen, 2009, J Can Chiropr Assoc, V53, P144; Kim YK, 2011, J SPORT SCI MED, V10, P31; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leopold J., 1999, LOS ANGELES TIM 0111; Luk T.C., 2001, P 19 INT S BIOM SPOR, P166; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Highway Traffic Safety Administration, 2013, THOR ADV CRASH TEST; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pieter W, 1998, J ROY SOC HEALTH, V118, P272, DOI 10.1177/146642409811800512; Pieter W., 2009, COMBAT SPORTS MED, P263; PINTAR FA, 1990, 34TH P STAPP CAR CRA, P55; Queck C., 2009, STRAIGHTS TIMES 0711; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Scott MW, 1993, 930094 SAE; Spittle E. K., 1992, HYBRID 2 HYBRID 3 DU; Svenson MY., 1992, P INT IRCOBI C BIOM; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; World Taekwondo Federation News, 2010, WORLD TAEKWONDO FEDR	35	21	21	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2013	47	18					1161	+		10.1136/bjsports-2012-090979			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	255OK	WOS:000327249500007	22930694				2022-02-06	
J	Chen, BX; Grothe, C; Schaller, K				Chen, Bixia; Grothe, Christoph; Schaller, Karl			Validation of a new neurological score (FOUR Score) in the assessment of neurosurgical patients with severely impaired consciousness	ACTA NEUROCHIRURGICA			English	Article						Assessment; Coma; Consciousness; FOUR score; Glasgow coma scale; Outcome	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; BRAIN-STEM REFLEXES; PROGNOSTIC VALUE; PRACTICAL SCALE; MOTOR RESPONSE; PREDICTION; INNSBRUCK; SURVIVAL; TRAUMA	The Glasgow coma scale (GCS) was introduced as a scoring system for patients with impaired consciousness after traumatic brain injury (TBI). Since, it has become the worldwide standard in TBI assessment. The GCS has repeatedly been criticized for its several failures to reflect verbal reaction in intubated patients, and to test brain stem reflexes. Recently, the full outline of unresponsiveness (FOUR) score was introduced, which is composed of four clinically distinct categories of evaluation: eye reaction, motor function, brainstem reflexes and respiratory pattern. This study aims to validate the FOUR score in neurosurgical patients. FOUR score and GCS were assessed in a consecutive series of neurosurgical patients with severely impaired consciousness (GCS < 9). Their correlation with the 30-day Glasgow outcome score (GOS) was compared. Patients admitted for TBI, spontaneous intracranial hemorrhage (intracerebral hemorrhage, aneurysmal subarachnoid hemorrhage, cerebellar hemorrhage), or malignant middle cerebral artery infarction were included. We assessed a total of 101 patients (mean age = 64y, SD = 36.1y). The area under the curve (AUC) for mortality was 0.768 (P = 0.0001) for the FOUR Score, and 0.699 (P = 0.001) for the GCS. For poor outcome (GOS = 2-3) the FOUR score AUC was 0.683 (P = 0.018), the GCS AUC was 0.682 (P = 0.019). The FOUR score value for favorable outcome (GOS = 4-5) was 0.748 (P = 0.001), the corresponding GCS value was 0.704 (P = 0.002). The FOUR score was more robust than the GCS in predicting mortality after 30 days in neurosurgical patients with severely impaired consciousness. There was no relevant difference in predicting poor and good outcome.	[Chen, Bixia; Grothe, Christoph; Schaller, Karl] Univ Bonn, Med Ctr, Dept Neurosurg, Bonn, Germany; [Chen, Bixia] Univ Duisburg Essen, Med Ctr, Dept Neurosurg, Essen, Germany; [Schaller, Karl] Univ Geneva, Med Ctr, Dept Neurosurg, CH-1211 Geneva, Switzerland; [Schaller, Karl] Fac Med, Geneva, Switzerland; [Schaller, Karl] Univ Med Ctr, Dept Neurosurg, Fac Med, CH-1211 Geneva 4, Switzerland		Schaller, K (corresponding author), Univ Med Ctr, Dept Neurosurg, Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 4, Switzerland.	karl.schaller@hcuge.ch					Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; Alexandre A, 1982, J Neurosurg Sci, V26, P187; BENESCH CG, 1993, ARCH NEUROL-CHICAGO, V50, P1309, DOI 10.1001/archneur.1993.00540120024008; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Chan Betty, 1993, Journal of Emergency Medicine, V11, P579, DOI 10.1016/0736-4679(93)90312-U; de Sousa LCA, 2007, OTOL NEUROTOL, V28, P426; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Hirai S, 1996, NEUROSURGERY, V39, P441, DOI 10.1097/00006123-199609000-00002; JENNETT B, 1975, LANCET, V1, P480; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Parry-Jones AR, 2013, STROKE, V44, P1840, DOI 10.1161/STROKEAHA.113.001009; ROUT MW, 1971, BRIT MED J, V3, P7, DOI 10.1136/bmj.3.5765.7; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Schefold JC, 2009, RESUSCITATION, V80, P658, DOI 10.1016/j.resuscitation.2009.03.006; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; SUGIURA K, 1983, NEUROSURGERY, V12, P411, DOI 10.1227/00006123-198304000-00007; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Wijdicks Eelco F M, 2010, Pract Neurol, V10, P51, DOI 10.1136/jnnp.2009.200097; WIJDICKS EFM, 1994, ANN NEUROL, V35, P239, DOI 10.1002/ana.410350219; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 1998, J NEUROL NEUROSUR PS, V64, P117, DOI 10.1136/jnnp.64.1.117; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435; ZENTNER J, 1994, NEUROL RES, V16, P89	32	21	21	1	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2013	155	11					2133	2139		10.1007/s00701-013-1854-2			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236QZ	WOS:000325815600018	24013867	Green Published, Green Submitted			2022-02-06	
J	Jones, A				Jones, Alvin			Victoria Symptom Validity Test: Cutoff Scores for Psychometrically Defined Malingering Groups in a Military Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Victoria Symptom Validity Test; VSVT; Military sample; Malingering	TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; TEST-PERFORMANCE; REPEATABLE BATTERY; EFFORT INDEX; MILD; SPECIFICITY; SENSITIVITY; DYSFUNCTION; VALIDATION	The Victoria Symptom Validity Test (VSVT) is one of the least widely used tests to assess performance validity on tests of neurocognitive functioning, but a meta-analysis has suggested that it is one of the more effective validity tests. The current research examined cutoffs for several different scores derived from the VSVT in an active duty military sample composed primarily of mild TBI patients. The results are consistent with previous research and provide additional evidence that much higher cutoffs scores than originally recommended for the VSVT by the developers based on binomial probability theory can produce excellent classification and diagnostic statistics when a psychometrically defined non-malingering group is compared with two psychometrically defined malingering groups (Probable and Probable to Definite). The utility of the difference score between the Easy and Hard Items is supported by this research. The results also indicate that reaction times have some utility, but they are constrained by a lack of sensitivity.	Womack Army Med Ctr, Dept Brain Injury Med, Ft Bragg, NC 29310 USA		Jones, A (corresponding author), Womack Army Med Ctr, Dept Brain Injury Med, 2817 Riley Rd,Bldg 4-2817, Ft Bragg, NC 29310 USA.	alvin.jones2@us.army.mil					Allen LM, 2001, ARCH CLIN NEUROPSYCH, V16, P846; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Crawford JR, 2009, CLIN NEUROPSYCHOL, V23, P624, DOI 10.1080/13854040802524229; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Egeland J, 2003, J CLIN EXP NEUROPSYC, V25, P79, DOI 10.1076/jcen.25.1.79.13630; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Miller E, 1970, Cortex, V6, P121; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Randolph C., 1998, REPEATABLE BATTERY A; Sackett DL., 1991, CLIN EPIDEMIOLOGY BA, V2; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	55	21	21	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 1	2013	27	8					1373	1394		10.1080/13854046.2013.851740			22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	273KW	WOS:000328534700011	24161269				2022-02-06	
J	McCully, SP; Schreiber, MA				McCully, Sean P.; Schreiber, Martin A.			Traumatic Brain Injury and Its Effect on Coagulopathy	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						trauma; hemostasis; coagulopathy; traumatic brain injury	HEAD TRAUMA; COAGULATION; ABNORMALITIES; HEMORRHAGE; MILD	Polytraumatic injury results in tissue factor (TF) release from damaged cells. The acute coagulopathy of trauma (ACT) occurs early and results from significant tissue injury and tissue hypoperfusion. ACT is augmented by therapies resulting in acidemia, hypothermia, and hemodilution contributing to trauma-induced coagulopathy. Coagulopathy associated with traumatic brain injury (TBI) results from the interplay of numerous variables. Because of the high concentration of TF in brain tissue, TBI has been believed to be associated with a greater degree of coagulopathy compared with injury in other body systems. TBI has also recently been shown to cause platelet dysfunction. Platelet receptor inhibition prevents cellular initiation and amplification of the clotting cascade, limiting thrombin incorporation, and stabilization of clot to stop hemorrhage. Therefore, head injury in the presence of polytrauma does appear to augment ACT and warrants close monitoring and appropriate intervention.	[McCully, Sean P.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, TRIO, Portland, OR 97239 USA		McCully, SP (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L223, Portland, OR 97239 USA.	mccully@ohsu.edu					Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chu AJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/367284; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Goodnight S H Jr, 1977, Compr Ther, V3, P25; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; MACGEE EE, 1970, J NEUROSURG, V32, P578, DOI 10.3171/jns.1970.32.5.0578; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MCNICOL PL, 1994, ANAESTH INTENS CARE, V22, P659, DOI 10.1177/0310057X9402200603; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; PENICK G D, 1960, Int Rec Med, V173, P491; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schrieber M, 2007, J TRAUMA, V63, P1261; Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016; Silver J, 2005, TXB TRAUMATIC BRAIN, P27; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Sugawara T, 2009, STROKE, V40, P1530, DOI 10.1161/STROKEAHA.108.531699; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	45	21	26	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	NOV	2013	39	8					896	901		10.1055/s-0033-1357484			6	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	242ID	WOS:000326231500006	24114009				2022-02-06	
J	Wong, D; Dahm, J; Ponsford, J				Wong, Dana; Dahm, Jane; Ponsford, Jennie			Factor structure of the Depression Anxiety Stress Scales in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Anxiety; depression; Depression Anxiety Stress Scales; factor analysis; traumatic brain injury	PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; HOSPITAL ANXIETY; CLINICAL-SAMPLES; DASS	Primary objective: The Depression Anxiety Stress Scales (DASS) and its shorter version, the DASS21, demonstrate a consistent factor structure. However, when these scales are used with people with traumatic brain injury (TBI), it is possible that TBI symptoms that overlap with anxiety and depression (e. g. irritability, inertia, emotional lability) result in changes to the underlying structure. This study aimed to establish whether the factor structure of the DASS and DASS21 when used with individuals with TBI is consistent with the three scales designated in the manual. Methods and procedures: One hundred and twenty-three participants with mild-to-severe TBI completed the DASS. Main outcomes and results: The factor structure of the DASS was found to be consistent with the designated scales, with the exception of four items that cross-loaded weakly on multiple factors. However, the factor structure of the DASS21 did not correspond as closely to the designated depression, anxiety and stress scales, which appeared to be due to the fact that many of the highest loading items on the DASS were not included items in the DASS21. Conclusions: These results indicate that it may be preferable to use the full DASS, rather than the DASS21, with individuals with TBI.	[Wong, Dana; Dahm, Jane; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Wong, D (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia.	dana.wong@monash.edu		Wong, Dana/0000-0001-9619-1929	Monash UniversityMonash University; Transport Accident Commission (Victoria); National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The data reported in this study was collected as part of studies funded by Monash University, the Transport Accident Commission (Victoria) and the National Health and Medical Research Council. The funding sources had no role in study design or data analysis. The authors alone were responsible for the content and writing of the paper.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Dahm J, J AFFECTIVE IN PRESS; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Gloster AT, 2008, J AFFECT DISORDERS, V110, P248, DOI 10.1016/j.jad.2008.01.023; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Page AC, 2007, BRIT J CLIN PSYCHOL, V46, P283, DOI 10.1348/014466506X158996; Skilbeck C, 2011, BRAIN IMPAIR, V12, P22, DOI 10.1375/brim.12.1.22	17	21	21	1	21	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1377	1382		10.3109/02699052.2013.823662			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500006	23924030				2022-02-06	
J	Luo, Q; Xu, D; Roskos, T; Stout, J; Kull, L; Cheng, X; Whitson, D; Boomgarden, E; Gfeller, J; Bucholz, RD				Luo, Qian; Xu, Duo; Roskos, Tyler; Stout, Jeff; Kull, Lynda; Cheng, Xi; Whitson, Diane; Boomgarden, Erich; Gfeller, Jeffrey; Bucholz, Richard D.			Complexity Analysis of Resting State Magnetoencephalography Activity in Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						LZC; MEG; resting state; TBI	IMAGING APPROACH; TIME-SERIES; MILD; EEG; DYNAMICS; MEG	Diagnosis of mild traumatic brain injuries (TBIs) has been difficult because of the absence of obvious focal brain lesions, using conventional computed tomography (CT) or magnetic resonance imaging (MRI) scans, in a large percentage of TBIs. One useful measure that can characterize potential tissue and neural network damage objectively is Lempel-Ziv complexity (LZC) applied to magnetoencephalography (MEG) signals. LZC is a model-independent estimator of system complexity that estimates the number of different patterns in a sequence. We hypothesized that because of the potential network damage, TBIs would show a reduced level of complexity in regions that are impaired. We included 18 healthy controls and 18 military veterans with TBI in the study. Resting state MEG data were acquired, and the LZCs were analyzed across the whole brain. Our results indicated reduced complexity in multiple brain areas in TBI patients relative to the healthy controls. In addition, we detected several neuropsychological measures associated with motor responses, visual perception, and memory, correlated with LZC, which likely explains some of the cognitive deficits in TBI patients.	[Luo, Qian; Xu, Duo; Roskos, Tyler; Stout, Jeff; Kull, Lynda; Whitson, Diane; Boomgarden, Erich; Bucholz, Richard D.] St Louis Univ, Sch Med, Dept Neurosurg, St Louis, MO 63104 USA; [Cheng, Xi] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD USA; [Gfeller, Jeffrey] St Louis Univ, Dept Psychol, St Louis, MO 63104 USA		Luo, Q (corresponding author), St Louis Univ, Sch Med, Dept Neurosurg, 1320 South Grand Blvd,1st Floor,ODonnell Hall, St Louis, MO 63104 USA.	qluo2@slu.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0191]	The study is supported by the Department of Defense grant W81XWH-08-2-0191 granted to Dr R. Bucholz.	Abasolo D, 2006, PHYSIOL MEAS, V27, P241, DOI 10.1088/0967-3334/27/3/003; Mendez MA, 2012, J PSYCHOPHARMACOL, V26, P636, DOI 10.1177/0269881111408966; Anokhin AP, 2000, DEV PSYCHOBIOL, V36, P9, DOI 10.1002/(SICI)1098-2302(200001)36:1<9::AID-DEV2>3.0.CO;2-5; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fernandez A, 2011, CLIN NEUROPHYSIOL, V122, P2227, DOI 10.1016/j.clinph.2011.04.011; Fernandez A, 2009, BIOL PSYCHIAT, V65, P571, DOI 10.1016/j.biopsych.2008.10.046; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jelles B, 1999, CLIN NEUROPHYSIOL, V110, P1159, DOI 10.1016/S1388-2457(99)00013-9; Jeong J, 1998, MED ENG PHYS, V20, P669, DOI 10.1016/S1350-4533(98)00078-2; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; LUTZENBERGER W, 1995, BIOL CYBERN, V73, P477, DOI 10.1007/s004220050203; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MeyerLindenberg A, 1996, ELECTROEN CLIN NEURO, V99, P405, DOI 10.1016/S0013-4694(96)95699-0; Radhakrishnan N, 1998, IEEE ENG MED BIOL, V17, P89, DOI 10.1109/51.677174; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Substance Use Disorders Working Group, 2009, VA DOD CLIN PRACT GU; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	30	21	21	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1702	1709		10.1089/neu.2012.2679			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000002	23692211	Green Published			2022-02-06	
J	Arun, P; Abu-Taleb, R; Oguntayo, S; Wang, Y; Valiyaveettil, M; Long, JB; Nambiar, MP				Arun, Peethambaran; Abu-Taleb, Rania; Oguntayo, Samuel; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.			Acute Mitochondrial Dysfunction after Blast Exposure: Potential Role of Mitochondrial Glutamate Oxaloacetate Transaminase	JOURNAL OF NEUROTRAUMA			English	Article						adenosine triphosphate; blast exposure; glutamate oxaloacetate transaminase; mini citric acid cycle; mitochondrial dysfunction; pyruvate dehydrogenase; traumatic brain injury	TRAUMATIC BRAIN-INJURY; N-ACETYLASPARTATE; RAT-BRAIN; INDUCED NEUROTRAUMA; OVERPRESSURE; METABOLISM; SEVERITY; MODEL	Use of improvised explosive devices has significantly increased the incidence of traumatic brain injury (TBI) and associated neuropsychiatric deficits in the recent wars in Iraq and Afghanistan. Acute deleterious effects of single and repeated blast exposure can lead to long-term neurobiological effects and neuropsychiatric deficits. Using in vitro and in vivo shock tube models of blast-induced TBI, we studied changes in mitochondrial energy metabolism after blast exposure. Single and repeated blast exposures in vitro resulted in significant decreases in neuronal adenosine triphosphate (ATP) levels at 6h post-blast that returned towards normal levels by 24h. Similar changes in ATP also were observed in the cerebral cortices of mice subjected to single and repeated blast exposures. In neurons, mitochondrial glutamate oxaloacetate transaminase (GOT(2)) plays a critical role in metabolism and energy production. Proteomic analysis of brain cortices showed a significant decrease in GOT(2) levels 6h after repeated blast exposures, which was further confirmed by Western blotting. Western blot analysis of GOT(2) and pyruvate dehydrogenase in the cortex showed direct correlation only between GOT(2) and ATP levels. Activity of GOT(2) in the isolated cortical mitochondria also showed significant decrease at 6h supporting the results of proteomic and Western blot analyses. Knowing the significant role of GOT(2) in the neuronal mitochondrial energy metabolism, it is quite likely that the down regulation of GOT(2) after blast exposure is playing a significant role in mitochondrial dysfunction after blast exposure.	[Arun, Peethambaran; Abu-Taleb, Rania; Oguntayo, Samuel; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil					Arun P, 2012, INTERV MED APPL SCI, V4, P125, DOI 10.1556/IMAS.4.2012.3.2; Arun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033798; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; ERECINSKA M, 1988, J NEUROCHEM, V51, P892, DOI 10.1111/j.1471-4159.1988.tb01826.x; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Madhavarao CN, 2006, ADV EXP MED BIOL, V576, P49; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414	30	21	22	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1645	1651		10.1089/neu.2012.2834			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800005	23600763				2022-02-06	
J	Bosco, MA; Murphy, JL; Clark, ME				Bosco, Michelle A.; Murphy, Jennifer L.; Clark, Michael E.			Chronic Pain and Traumatic Brain Injury in OEF/OIF Service Members and Veterans	HEADACHE			English	Article						pain; traumatic brain injury; post deployment multisymptom disorder	OPERATIONS ENDURING FREEDOM; IRAQI-FREEDOM; HEAD-INJURY; POLYTRAUMA; BLAST; PREVALENCE; SOLDIERS; CARE; REHABILITATION; ENCEPHALOPATHY	The co-occurrence of chronic pain and traumatic brain injury (TBI) are 2 of the most common concerns among the Operations Enduring Freedom and Iraqi Freedom population and present unique challenges for evaluation and treatment. Previous research suggests that almost half the cohort report clinically significant pain, while up to 1 in 4 experiences some form of TBI. There is limited information regarding how TBI affects the presence and course of pain, and how pain impacts TBI and its symptoms. The present paper provides an overview of the range and degree of TBIs as well as a brief summary of current knowledge regarding the interaction between chronic pain and TBI, particularly in light of the numerous variables impacting it. Information on ways to best assess for and treat pain in the TBI population, including in those with multiple system injuries or associated affective symptoms, is provided. In addition, several innovative approaches for addressing the needs of this complex cohort of patients are described, which may stimulate further research and clinical innovation for this important subgroup.	[Bosco, Michelle A.; Murphy, Jennifer L.; Clark, Michael E.] James A Haley VA Hosp, Tampa, FL 33612 USA		Bosco, MA (corresponding author), James A Haley VA Hosp, Ctr Postdeployment Hlth & Educ, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	michelle.bosco@va.gov					[Anonymous], 2007, REP MIL TBI TASK FOR; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Buffum MD, 2007, J REHABIL RES DEV, V44, P315, DOI 10.1682/JRRD.2006.06.0064; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Godunsky JS, 2005, MIL MED, V170, P546; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hockenberry M.J., 2009, WONGS ESSENTIALS PED; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Leuthcke CA, 2011, J INT NEUROPSYCH SOC, V17, P1; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mersky H, 1994, INT ASS STUDY PAIN T, P226; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Veterans Affairs/Department of Defense, 2009, CLIN PRACT GUID MAN, P16; Veterans Health Administration, 2005, VHA HDB 2A, P1; Veterans Health Administration Epidemiology Program Post-Deployment Health Group's Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2012, UT OP END FREED OEF; Walker RL, 2008, NAT M VA HLTH SERV R; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Weiner DK, 2002, PERSISTENT PAIN IN OLDER ADULTS: INTERDISCIPLINARY GUIDE FOR TREATMENT, P18; Zoroya G, CTR WAR RELATED BRAI	36	21	21	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748			HEADACHE	Headache	OCT	2013	53	9					1518	1522		10.1111/head.12172			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	228AH	WOS:000325156600019	23848062				2022-02-06	
J	Cousar, JL; Conley, YP; Willyerd, FA; Sarnaik, AA; Puccio, AM; Empey, PE; Kochanek, PM; Bell, MJ; Okonkwo, DO; Clark, RSB				Cousar, J'mir L.; Conley, Yvette P.; Willyerd, F. Anthony; Sarnaik, Ajit A.; Puccio, Ava M.; Empey, Philip E.; Kochanek, Patrick M.; Bell, Michael J.; Okonkwo, David O.; Clark, Robert S. B.			Influence of ATP-Binding Cassette Polymorphisms on Neurological Outcome After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Blood-brain barrier; Head trauma; Membrane transporter; Multidrug resistance protein; Multidrug resistance-associated protein; P-Glycoprotein	P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; C3435T POLYMORPHISM; DRUG-TRANSPORTER; ABC TRANSPORTERS; GENETIC-FACTORS; MDR1 GENE; EPILEPSY; ASSOCIATION; BARRIER	As important mediators of solute transport at the blood-brain and blood-cerebrospinal fluid barriers, ATP-binding cassette (ABC) transporters (including ABCB1, ABCC1, and ABCC2), impact the bioavailability of drugs and endogenous substrates in the brain. While several ABCB1, ABCC1, and ABCC2 single nucleotide polymorphisms (SNPs) have been identified, their impact on outcome after traumatic brain injury (TBI) is unknown. ABCB1, ABCC1, and ABCC2 SNPs are associated with Glasgow Outcome Scale (GOS) score after TBI. DNA samples from 305 adult patients with severe TBI (Glasgow Coma Scale, GCS score a parts per thousand currency sign 8) were genotyped for tagging SNPs of ABCB1 (rs1045642; rs1128503), ABCC1 (rs212093; rs35621; rs4148382), and ABCC2 (rs2273697). For each SNP, patients were dichotomized based on presence of variant allele for multivariate analysis to determine associations with GOS assigned at 6 months adjusting for GCS, Injury Severity score, age, and patient sex. For ABCB1 rs1045642, patients homozygous for the T allele were less likely to be assigned poor outcome versus those possessing the C allele [CT/CC; odds of unfavorable GOS = 0.71(0.55-0.92)]. For ABCC1 rs4148382, patients homozygous for the G allele were less likely to be assigned poor outcome versus those possessing the A allele [AG/AA; odds of unfavorable GOS = 0.73(0.55-0.98)]. In this single-center study, patients homozygous for the T allele of ABCB1 rs1045642 or the G allele of ABCC1 rs4148382 were found to have better outcome after severe TBI. Further study is necessary to replicate these very preliminary findings and to determine whether these associations are due to central nervous system bioavailability of ABC transporter drug substrates commonly used in the management of TBI, brain efflux of endogenous solutes, or both.	[Cousar, J'mir L.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15260 USA; [Willyerd, F. Anthony] Childrens Hosp Pittsburgh, UPMC Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Sarnaik, Ajit A.] Univ Pediatricians, Detroit, MI 48201 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Clark, Robert S. B.] Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Clark, RSB (corresponding author), Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	cousarjr@uc.edu; yconley@pitt.edu; anthony.willyerd@chp.edu; asarnai@med.wayne.edu; puccioam@upmc.edu; pempey@pitt.edu; kochanekpm@ccm.upmc.edu; bellmj4@upmc.edu; okonkwodo@upmc.edu; clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Empey, Philip/L-9604-2019	Kochanek, Patrick M/0000-0002-2627-913X; Empey, Philip/0000-0001-7474-2339; Conley, Yvette/0000-0002-1784-6067	University of Pittsburgh School of Medicine Clinical Scientist Training Program; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS069247, P50 NS30318]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40686]; NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000146]; NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR008424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS069247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors would like to thank Sandra Deslouches for expert technical assistance. This work is supported by University of Pittsburgh School of Medicine Clinical Scientist Training Program (JLC); NINDS R01 NS069247 (RSBC, PEE), P50 NS30318 (DOO, AMP, YPC, PMK, RSBC); NICHD T32 HD40686 (AAS); NCATS KL2 TR000146 (PEE); and NINR R01 NR008424 (YPC).	Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Basic S, 2008, SEIZURE-EUR J EPILEP, V17, P524, DOI 10.1016/j.seizure.2008.01.003; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Budulac SE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-60; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Cotte S, 2009, BRAIN, V132, P2517, DOI 10.1093/brain/awp164; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Dey S, 2003, EXPERT OPIN BIOL TH, V3, P23, DOI 10.1517/eobt.3.1.23.20957; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Faul M, 2010, TRAUMATIC BRAIN INJU; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Haerian BS, 2011, PHARMACOGENOMICS, V12, P713, DOI 10.2217/PGS.10.212; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Hung CC, 2007, PHARMACOGENOMICS, V8, P1151, DOI 10.2217/14622416.8.9.1151; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Jedlitschky G, 2014, CURR PHARM DESIGN, V20, P1523, DOI 10.2174/13816128113199990460; JENNETT B, 1975, LANCET, V1, P480; Kim WJ, 2010, PHARMACOGENET GENOM, V20, P249, DOI 10.1097/FPC.0b013e328338073a; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ebid AHI, 2007, THER DRUG MONIT, V29, P305; Owen A, 2005, BRIT J CLIN PHARMACO, V59, P365, DOI 10.1111/j.1365-2125.2005.02229.x; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Siedlinski M, 2009, PHARMACOGENET GENOM, V19, P675, DOI 10.1097/FPC.0b013e32832f5eff; Spudich A, 2006, NAT NEUROSCI, V9, P487, DOI 10.1038/nn1676; Ufer M, 2009, PHARMACOGENET GENOM, V19, P353, DOI 10.1097/FPC.0b013e328329940b; van Assema DME, 2012, BRAIN, V135, P181, DOI 10.1093/brain/awr298	38	21	21	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	OCT	2013	19	2					192	198		10.1007/s12028-013-9881-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	221GB	WOS:000324644800009	23896815	Green Accepted			2022-02-06	
J	Liu, JH; Li, LD				Liu, Jianghong; Li, Linda			Parent-reported mild head injury history and behavioural performance in children at 6 years	BRAIN INJURY			English	Article						Behaviour; childhood; head injury; mild traumatic brain injury (MTBI)	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; PROBLEM-SOLVING SKILLS; PSYCHIATRIC-DISORDERS; CHINESE CHILDREN; SELF-REGULATION; EARLY-CHILDHOOD; ADOLESCENTS; OUTCOMES; SYMPTOMS	Objective: Mild head and brain injuries have gained increasing attention from health professionals and researchers. Little is known about mild injuries, which may not always be diagnosed or brought to medical attention. This study examines the associations between parent-reported history of mild head injury and behavioural problems in a large community-based sample of Chinese children. Method: Subjects included 725 children from China. Parents reported on children's head injury history and behaviour at age 6 years using the Chinese version of the Child Behavior Checklist. Mild head injury was defined as injury without loss of consciousness or hospitalization. Standardized T-scores were compared for each of the seven clinical sub-scales and three summary behavioural measures, adjusting for confounders. Logistic models were used to calculate odds ratios (ORs) between head injury and behavioural problems. Results: Parents reported that 97 children (14%) had a single injury and 70 (10%) had multiple injuries. Compared to the controls, head-injured children had worse behavioural outcomes and a higher prevalence of behavioural problems. Multiple injuries were associated with higher risk of certain internalizing and externalizing problems. Conclusion: Mild head injuries, especially incurred repeatedly, may still be a significant risk for adverse behaviours in children.	[Liu, Jianghong] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Liu, Jianghong] Univ Penn, Sch Med, Philadelphia, PA 19104 USA		Liu, JH (corresponding author), Univ Penn, Sch Nursing, 418 Curie Blvd,Room 426,Claire M Fagin Hall, Philadelphia, PA 19104 USA.	jhliu@nursing.upenn.edu		Li, Linda/0000-0001-5731-9643	National Institute of Environment Health Sciences (NIEHS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01-ES018858, K01-ES015 877, K02-ES019878-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K02ES019878, R01ES018858, K01ES015877] Funding Source: NIH RePORTER	Funding was provided by the National Institute of Environment Health Sciences (NIEHS, R01-ES018858; K01-ES015 877; K02-ES019878-01). The funders had no role in study design, data collection, data analysis, manuscript preparation and/or publication decision. The authors report no conflicts of interest.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Copeland SA, 2008, ANN NEUROL, V64, pS128; DAVIDSON LL, 1988, PEDIATRICS, V82, P644; Demellweek Colin, 2002, Pediatr Rehabil, V5, P81, DOI 10.1080/136384902320807194; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Hamilton NA, 2012, SEMINARS PEDIAT SURG, V19, P271; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Konrad KN, 2000, BRAIN INJURY, V14, P859; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Leung PWL, 2006, J CHILD PSYCHOL PSYC, V47, P970, DOI 10.1111/j.1469-7610.2005.01570.x; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li M, 2006, MED SCI SPORT EXER, V38, P2075, DOI 10.1249/01.mss.0000233802.54529.87; Liu JH, 2011, WORLD J PEDIATR, V7, P217, DOI 10.1007/s12519-011-0317-1; Liu JH, 2011, J ABNORM CHILD PSYCH, V39, P251, DOI 10.1007/s10802-010-9452-8; Liu JH, 2010, INT J EPIDEMIOL, V39, P668, DOI 10.1093/ije/dyp205; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Moore E, 2006, PARIS REV, P117; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	50	21	21	0	29	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1263	1270		10.3109/02699052.2013.804205			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800005	23875827	Green Accepted			2022-02-06	
J	McMullan, J; Rodriquez, D; Hart, KW; Lindsey, CJ; Vonderschmidt, K; Wayne, B; Branson, R				McMullan, Jason; Rodriquez, Dario; Hart, Kimberly Ward; Lindsey, Christopher J.; Vonderschmidt, Kay; Wayne, Beth; Branson, Richard			Prevalence of Prehospital Hypoxemia and Oxygen Use in Trauma Patients	MILITARY MEDICINE			English	Article							SUPPLEMENTAL OXYGEN; HYPEROXIA	Objective: This study estimates the prevalence of injured patients requiring prehospital supplemental oxygen based on existing recommendations, and determines whether actual use exceeds those recommendations. Patients and Methods: Prehospital oxygen use and continuous peripheral oxygen saturation measurements were prospectively collected on a purposive sample of injured civilians transported to an urban level 1 trauma center by paramedics. Structured chart review determined injury characteristics and outcomes. Supplemental oxygen administration indications were hypoxemia (peripheral oxygen saturation <= 90%), hemorrhagic shock (systolic blood pressure < 100 mmHg), or paramedic suspicion of traumatic brain injury. Results: Paramedics enrolled 224/290 screened subjects. Median (range) age was 34 (18-84) years, 48.7% were nonwhite, 75.4% were male, and Injury Severity Score was 5 (1-75). Half (54.5%) were admitted; 36.2% sustained a penetrating injury. None underwent prehospital endotracheal intubation. Hypoxemia occurred in 86 (38.4%), paramedics suspected traumatic brain injury in 22 (9.8%), and 20 (8.9%) were hypotensive. Any indication for supplemental oxygen (107/224 [47.8%, 95%CI 41.3%-54.3%]) and prehospital administration of oxygen (141/224 [62.9%, 95%CI 56.2%-69.2%]) was common. Many (35/141 [24.8%]) received oxygen without indication. Conclusions: On the basis of current guidelines, less than half of adult trauma patients have an indication for prehospital supplemental oxygen, yet is frequently administered in the absence of clinical indication.	[McMullan, Jason; Hart, Kimberly Ward; Lindsey, Christopher J.; Vonderschmidt, Kay; Wayne, Beth] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [Rodriquez, Dario] 88th Med Operat Squadron, Wright Patterson AFB, OH 45433 USA; [Branson, Richard] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA		McMullan, J (corresponding author), Univ Cincinnati, Dept Emergency Med, 231 Albert Sabin Way ML0769, Cincinnati, OH 45267 USA.		McMullan, Jason/ABB-9691-2020; Branson, Richard/ABD-7229-2020; Branson, Richard/K-4567-2019	McMullan, Jason/0000-0002-7656-7447; Branson, Richard/0000-0002-0912-3360; Lindsell, Christopher/0000-0002-3297-2811	U. S. Marine Corps System Command; U. S. Naval Medical Systems; Institutional Clinical and Translational Science Award, NIH/NCRR [5UL1RR026314-03]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	This study was funded by the U. S. Marine Corps System Command and U. S. Naval Medical Systems and supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 5UL1RR026314-03.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Branson RD, 2011, INTENS CARE MED, V37, P1, DOI 10.1007/s00134-010-2034-y; Cornet AD, 2012, ARCH INTERN MED, V172, P289, DOI 10.1001/archinternmed.2011.624; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Hale KE, 2008, EMERG MED J, V25, P773, DOI 10.1136/emj.2008.059287; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; *NAT ASS EM MED TE, 2007, PHTLS PREH TRAUM LIF; O'Driscoll BR, 2011, CLIN MED, V11, P372, DOI 10.7861/clinmedicine.11-4-372; Pancioli AM, 2002, ARCH INTERN MED, V162, P49, DOI 10.1001/archinte.162.1.49; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rubinson L, 2008, CHEST, V133, p32S, DOI 10.1378/chest.07-2691; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stockinger ZT, 2004, MIL MED, V169, P609, DOI 10.7205/MILMED.169.8.609; Wijesinghe M, 2011, INTERN MED J, V41, P618, DOI 10.1111/j.1445-5994.2010.02207.x	19	21	22	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	OCT	2013	178	10					1121	1125		10.7205/MILMED-D-13-00126			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7UD	WOS:000340805600013	24083926	Green Accepted, Bronze			2022-02-06	
J	Nyberg, J; Aberg, MAI; Toren, K; Nilsson, M; Ben-Menachem, E; Kuhn, HG				Nyberg, Jenny; Aberg, Maria A. I.; Toren, Kjell; Nilsson, Michael; Ben-Menachem, Elinor; Kuhn, H. Georg			Cardiovascular fitness and later risk of epilepsy A Swedish population-based cohort study	NEUROLOGY			English	Article							PHYSICAL-EXERCISE; KINDLING DEVELOPMENT; ADULTHOOD; CHILDHOOD; HEALTH; RATS; SUSCEPTIBILITY; ADOLESCENCE; COMORBIDITY; DEPRESSION	Objective: To analyze the associations between cardiovascular fitness at age 18 years and future risk of epilepsy. Methods: Population-based cohort study of Swedish male conscripts (n = 1,173,079) born in 1950-1987, who were followed for up to 40 years. Data on cardiovascular fitness were collected during conscription exams and linked with hospital registers to calculate later risk of epilepsy using Cox proportional hazard models controlling for several confounders, including familial factors. Results: Epilepsy was recorded in 6,796 individuals during the follow-up time. In fully adjusted models, low and medium cardiovascular fitness (compared with high) at age 18 years was associated with increased risk of future epilepsy (hazard ratio 1.79, 95% confidence interval 1.57-2.03; and hazard ratio 1.36, 95% confidence interval 1.27-1.45, respectively). The associations changed only marginally after adjustment for familial influences and prior severe traumatic brain injury, cerebrovascular disease, or diabetes. Conclusions: Low cardiovascular fitness early in life is associated with an increased risk of epilepsy later in adulthood. These results agree with previous results from animal models. We propose that behaviors that increase cardiovascular fitness may act as positive disease-modifiers for the development of epilepsy.	[Nyberg, Jenny; Aberg, Maria A. I.; Nilsson, Michael; Ben-Menachem, Elinor; Kuhn, H. Georg] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden; [Toren, Kjell] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Nilsson, Michael] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia		Ben-Menachem, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden.	Elinor.Ben-Menachem@neuro.gu.se	Aberg, Maria/R-4001-2016; Kuhn, Hans-Georg/L-8127-2014; NILSSON, MICHAEL/ABE-7821-2020	Kuhn, Hans-Georg/0000-0003-4247-5613; NILSSON, MICHAEL/0000-0002-8826-1621; Aberg, Maria/0000-0002-0323-1061	Martha Lundqvists Stiftelse; Wilhelm and Martina Lundgrens Stiftelse; Sten A Olsson Foundation for Research and Culture; Swedish Research Council for Worklife and Social Science (FAS); Swedish government under LUA/ALF; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission	Supported by grants from the Martha Lundqvists Stiftelse, Wilhelm and Martina Lundgrens Stiftelse, Sten A Olsson Foundation for Research and Culture, the Swedish Research Council for Worklife and Social Science (FAS), the Swedish government under the LUA/ALF agreement for biomedical research, and the Swedish Medical Research Council.	Aberg MAI, 2012, BRIT J PSYCHIAT, V201, P352, DOI 10.1192/bjp.bp.111.103416; Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; [Anonymous], 1997, GUID TREATM EP; Arida RM, 2007, PHYSIOL BEHAV, V90, P629, DOI 10.1016/j.physbeh.2006.11.016; Arida RM, 2009, NEUROSCI BIOBEHAV R, V33, P422, DOI 10.1016/j.neubiorev.2008.11.002; Arida RM, 1998, EPILEPSY RES, V30, P127, DOI 10.1016/S0920-1211(97)00102-2; Arida RM, 1999, EPILEPSY RES, V37, P45, DOI 10.1016/S0920-1211(99)00032-7; Ben-Menachem E, 2011, LAKEMEDELSBOKEN 2011; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; da Silva SG, 2011, INT J DEV NEUROSCI, V29, P861, DOI 10.1016/j.ijdevneu.2011.07.011; Daniels ZS, 2009, NEUROLOGY, V73, P658, DOI 10.1212/WNL.0b013e3181ab2b11; ERIKSEN HR, 1994, EPILEPSIA, V35, P1256, DOI 10.1111/j.1528-1157.1994.tb01797.x; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; FORSGREN L, 1992, EPILEPSIA, V33, P450, DOI 10.1111/j.1528-1157.1992.tb01690.x; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; Li XJ, 2008, SEIZURE-EUR J EPILEP, V17, P254, DOI 10.1016/j.seizure.2007.07.011; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Malina RM, 2001, AM J HUM BIOL, V13, P162, DOI 10.1002/1520-6300(200102/03)13:2<162::AID-AJHB1025>3.3.CO;2-K; McAuley JW, 2001, EPILEPSY BEHAV, V2, P592, DOI 10.1006/ebeh.2001.0271; McMurray RG, 2003, MED SCI SPORT EXER, V35, P1914, DOI 10.1249/01.MSS.0000093612.59984.0E; Nakken KO, 1999, EPILEPSIA, V40, P643, DOI 10.1111/j.1528-1157.1999.tb05568.x; Ni H, 2009, TOXICOL LETT, V191, P26, DOI 10.1016/j.toxlet.2009.07.028; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nordesjo LS, 1974, SWEDISH J DEFENCE ME, V10, P11; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Schober E, 2012, J PEDIAT, V160; Setkowicz Z, 2006, EPILEPSY RES, V71, P142, DOI 10.1016/j.eplepsyres.2006.06.002; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; St Germaine-Smith C, 2011, EPILEPSIA, V52, P2161, DOI 10.1111/j.1528-1167.2011.03292.x; Tutkun E, 2010, ACTA NEUROBIOL EXP, V70, P382; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 1967, INTS STAT CLASS DIS; World Health Organization, 1978, INT STAT CLASS DIS R	37	21	22	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 17	2013	81	12					1051	1057		10.1212/WNL.0b013e3182a4a4c0			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA0EK	WOS:000330767900009	24005340				2022-02-06	
J	Okon, EB; Streijger, F; Lee, JHT; Anderson, LM; Russell, AK; Kwon, BK				Okon, Elena B.; Streijger, Femke; Lee, Jae H. T.; Anderson, Lisa M.; Russell, Amy K.; Kwon, Brian K.			Intraparenchymal Microdialysis after Acute Spinal Cord Injury Reveals Differential Metabolic Responses to Contusive versus Compressive Mechanisms of Injury	JOURNAL OF NEUROTRAUMA			English	Article						compression; glucose; lactate; pyruvate; SCI	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-ARTERY OCCLUSION; BLOOD-FLOW; AMINO-ACIDS; TIME-COURSE; SUBARACHNOID HEMORRHAGE; EXTRACELLULAR GLUCOSE; VASCULAR CHANGES; MODEL	In animal models, spinal cord injury (SCI) is typically imparted by contusion alone (e.g., weight drop) or by compression alone (e.g., clip compression). In humans, however, the cord is typically injured by a combination of violent contusion followed by varying degrees of ongoing mechanical compression. Understanding how the combination of contusion and compression influences the early pathophysiology of SCI is important for the pre-clinical development of neuroprotective therapies that are applicable to the human condition. Disturbances in the metabolism of energy-related substrates such as lactate, pyruvate, and glucose are important aspects of secondary damage. In this study, we used a porcine model of traumatic SCI to determine the extent to which these metabolites were influenced by contusion followed by sustained compression, using the microdialysis technique. Following contusion injury, lactate and pyruvate levels near the epicenter both increased, while glucose remained quite stable. When the contusion injury was followed by sustained compression, we observed a transient rise in lactate, while pyruvate and glucose levels dropped rapidly, which may reflect decreased regional spinal cord blood flow. Furthermore, contusion with sustained compression produced a prolonged and dramatic increase in the lactate-pyruvate (L/P) ratio as a marker of tissue hypoxia, whereas after contusion injury alone, a transient and less significant elevation of the L/P ratio was observed. In this study, we demonstrate that disturbances in energy metabolism within the injured spinal cord vary greatly depending upon the biomechanical nature of the injury. Such differences are likely to be relevant to the applicability of novel therapies targeting specific aspects of the early secondary injury cascade after acute human SCI.	[Okon, Elena B.; Streijger, Femke; Lee, Jae H. T.; Anderson, Lisa M.; Russell, Amy K.; Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Int Collaborat Repair Discoveries ICORD, Vancouver, BC V5Z 1M9, Canada; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, CNOSP, Vancouver, BC V5Z 1M9, Canada		Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Blusson Spinal Cord Ctr, VGH, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@vch.ca		Okon, Elena/0000-0001-8568-5771	Best in Health Fund from the VGH and UBC Hospital Foundation	We thank Dr. Eric C. Sayre for his help with statistical data analysis. We also thank the veterinary medical team at the Centre for Comparative Medicine, and Stephanie Smith and Kate Orchard at the Jack Bell Research Center, for their help and advice. Dr. Kwan holds the Canada Research Chair in Spinal Cord Injury, and is supported by the Best in Health Fund from the VGH and UBC Hospital Foundation.	Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Backstrom T, 2001, EUR J VASC ENDOVASC, V22, P410, DOI 10.1053/ejvs.2001.1488; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; DYKSTRA KH, 1992, J NEUROCHEM, V58, P931, DOI 10.1111/j.1471-4159.1992.tb09346.x; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V41, P33, DOI 10.1007/BF00689554; GRIFFITHS IR, 1979, J NEUROSURG, V50, P353, DOI 10.3171/jns.1979.50.3.0353; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; HITCHON PW, 1990, J SPINAL DISORD, V3, P210; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KEARNEY P A, 1988, Journal of Neurotrauma, V5, P187, DOI 10.1089/neu.1988.5.187; Krueger H., 2010, EC BURDEN SPINAL COR; Kubota K, 2012, SPINE, V37, P1448, DOI 10.1097/BRS.0b013e31824ffda5; Kwon BK, 2002, SPINE, V27, P1504, DOI 10.1097/00007632-200207150-00005; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Navarro R, 2012, J NEUROTRAUM, V29, P499, DOI 10.1089/neu.2011.2076; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOYES DH, 1987, MED BIOL ENG COMPUT, V25, P335, DOI 10.1007/BF02447434; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; PALJARVI L, 1983, ACTA NEUROPATHOL, V60, P232, DOI 10.1007/BF00691871; Pellerin L., 1994, P NATL ACAD SCI USA, V91, P10; Poon PC, 2007, SPINE, V32, P2853, DOI 10.1097/BRS.0b013e31815b7e6b; Rabchevsky AG, 2003, J NEUROTRAUM, V20, P659, DOI 10.1089/089771503322144572; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Rivlin A. S., 1978, NEUROLOGY, V10, P38; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; SANDLER AN, 1976, J NEUROSURG, V45, P660, DOI 10.3171/jns.1976.45.6.0660; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sharma HS, 2011, J NEURAL TRANSM, V118, P155, DOI 10.1007/s00702-010-0514-4; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHUAIB A, 1990, NEUROSCI LETT, V112, P149, DOI 10.1016/0304-3940(90)90194-E; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stenken JA, 2010, AAPS J, V12, P73, DOI 10.1208/s12248-009-9163-7; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tholance Y, 2011, CLIN CHIM ACTA, V412, P647, DOI 10.1016/j.cca.2010.12.025; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vespa PM, 2005, CURR OPIN CRIT CARE, V11, P133, DOI 10.1097/01.ccx.0000155353.01489.58; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Wisniewski N, 2002, AM J PHYSIOL-ENDOC M, V282, pE1316, DOI 10.1152/ajpendo.00259.2001; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZHANG Y, 1993, SURG NEUROL, V39, P297, DOI 10.1016/0090-3019(93)90009-P	70	21	22	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2013	30	18					1564	1576		10.1089/neu.2013.2956			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	211EB	WOS:000323886600002	23768189				2022-02-06	
J	Andrews, PJD; Sinclair, LH; Harris, B; Baldwin, MJ; Battison, CG; Rhodes, JKJ; Murray, G; De Backer, D				Andrews, Peter J. D.; Sinclair, Louise H.; Harris, Bridget; Baldwin, Melissa J.; Battison, Claire G.; Rhodes, Jonathan K. J.; Murray, Gordon; De Backer, Daniel		Eurotherm3235Trial Collaborators	Study of therapeutic hypothermia (32 to 35 C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial): outcome of the pilot phase of the trial	TRIALS			English	Article						Traumatic brain injury; Therapeutic hypothermia; Randomized controlled trial; Feasibility	MILD HYPOTHERMIA; HEAD-INJURY; ADULTS; IMPACT; HYPERTENSION; PREVENTION; EFFICACY	Background: Clinical trials in traumatic brain injury (TBI) are challenging. Previous trials of complex interventions were conducted in high-income countries, reported long lead times for site setup and low screened-to-recruitment rates. In this report we evaluate the internal pilot phase of an international, multicentre TBI trial of a complex intervention to assess: design and implementation of an online case report form; feasibility of recruitment (sites and patients); feasibility and effectiveness of delivery of the protocol. Methods: All aspects of the pilot phase of the trial were conducted as for the main trial. The pilot phase had oversight by independent Steering and Data Monitoring committees. Results: Forty sites across 12 countries gained ethical approval. Thirty seven of 40 sites were initiated for recruitment. Of these, 29 had screened patients and 21 randomized at least one patient. Lead times to ethics approval (6.8 weeks), hospital approval (18 weeks), interest to set up (61 weeks), set up to screening (11 weeks), and set up to randomization (31.6 weeks) are comparable with other international trials. Sixteen per cent of screened patients were eligible. We found 88% compliance rate with trial protocol. Conclusion: The pilot data demonstrated good feasibility for this large international multicentre randomized controlled trial of hypothermia to control intracranial pressure. The sample size was reduced to 600 patients because of homogeneity of the patient group and we showed an optimized cooling intervention could be delivered.	[Andrews, Peter J. D.; Sinclair, Louise H.; Harris, Bridget; Battison, Claire G.; Rhodes, Jonathan K. J.] Univ Edinburgh, Dept Anaesthesia & Pain Management, Edinburgh, Midlothian, Scotland; [Baldwin, Melissa J.] NHS Lothian, Edinburgh EH1 3EG, Midlothian, Scotland; [Murray, Gordon] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [De Backer, Daniel] Univ Libre Brussels, Erasme Univ Hosp, B-1070 Brussels, Belgium		Andrews, PJD (corresponding author), Univ Edinburgh, Dept Anaesthesia & Pain Management, Edinburgh, Midlothian, Scotland.	p.andrews@ed.ac.uk	Forbes, John F/L-2558-2013; De Backer, Daniel/AAF-4177-2020	Forbes, John F/0000-0002-8255-3762; De Backer, Daniel/0000-0001-9841-5762; Murray, Gordon/0000-0001-9866-4734	European Society of Intensive Care Medicine (Pilot Phase); University of Edinburgh; NHS Lothian; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800803] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800803] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [11/01/30] Funding Source: researchfish	Funded by The European Society of Intensive Care Medicine (Pilot Phase) and sponsored by The University of Edinburgh and NHS Lothian.	Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Edwards P, 2005, LANCET, V365, P1957; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Klingmann I, 2009, IMPACT CLIN RES EURO; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Nilsson P, 2005, ACTA NEUROCHIR SUPPL, V95, P51; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300	20	21	28	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	SEP 3	2013	14								277	10.1186/1745-6215-14-277			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	213AI	WOS:000324024700001	24004918	gold, Green Published			2022-02-06	
J	Halpern, R; Gillard, P; Graham, GD; Varon, SF; Zorowitz, RD				Halpern, Rachel; Gillard, Patrick; Graham, Glenn D.; Varon, Sepideh F.; Zorowitz, Richard D.			Adherence Associated With Oral Medications in the Treatment of Spasticity	PM&R			English	Article							SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; MANAGEMENT; STROKE; PERSISTENCE	Objective: To examine adherence to badofen, tizanidine, and dantrolene (U.S. Food and Drug Administration-approved oral spasticity medications), and identified determinants of adherence. Design: A retrospective administrative claims data analysis that used medical and pharmacy claims data and enrollment information from a large, national U.S. health plan. Subjects and Methods: The subjects were commercial health plan members who initiated treatment on badofen, tizanidine, or dantrolene from January 1, 2004, through September 30, 2009, and who had stroke, spinal cord injury, traumatic brain injury, cerebral palsy, or multiple sclerosis. Descriptive and logistic regression statistical analyses were performed. Main Outcome Measurements: Outcomes were adherence, measured as continuous medication possession ratio (MPR) and as a binary indicator (MPR >= 0.80, adherent; MPR <0.80, nonadherent), change in oral spasticity medication, and use of nonoral spasticity therapy. Results: The study population included 2840 subjects. Adherence overall was poor: the range of mean unadjusted MPR values was 0.10-0.50, which indicated that, at best, the subjects were adherent to their index spasticity medications for 50% of their treatment periods. Unadjusted overall MPRs for badofen and tizanidine were 20.4% and 9.1%, respectively. Fewer than 5% of subjects changed oral spasticity medications. The results of logistic regression to identify determinants of adherence showed that subjects treated with tizanidine versus badofen had 37.4% lower odds of adherence and that subjects with traumatic brain injury versus stroke had 77.5% lower odds of adherence. The odds of adherence increased with age and with preindex contracture or decubitus ulcer. Conclusions: Adherence to oral spasticity medication was poor irrespective of index spasticity medication or condition. Results from this study indicated that physicians cannot assume that patients are adherent to prescribed oral spasticity medications. A more complete understanding of the reasons behind nonadherence is required.	[Halpern, Rachel] OptumInsight, Hlth Econ & Outcomes Res, Eden Prairie, MN 55344 USA; [Gillard, Patrick; Varon, Sepideh F.] Allergan Pharmaceut Inc, Global Hlth Outcomes Strategy & Res, Irvine, CA 92715 USA; [Graham, Glenn D.] Dept Vet Affairs, Washington, DC USA; [Zorowitz, Richard D.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Johns Hopkins Bayview Med Ctr, Baltimore, MD USA		Halpern, R (corresponding author), OptumInsight, Hlth Econ & Outcomes Res, 12125 Technol Dr, Eden Prairie, MN 55344 USA.	rachel.halpern@optum.com		Zorowitz, Richard/0000-0001-8938-786X	Allergan Inc, Irvine, CAAbbVieAllergan	Research support: Support was provided by Allergan Inc, Irvine, CA.	Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Burke DA, 2001, SPINAL CORD, V39, P274, DOI 10.1038/sj.sc.3101158; Centers for Disease Control and Prevention, 2011, STROK FACTS; Delgado MR, 2010, NEUROLOGY, V74, P336, DOI 10.1212/WNL.0b013e3181cbcd2f; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Esquenazi A., 2011, J CLIN OUTCOMES MANA, V18, P607; Fang Jing, 2012, Morbidity and Mortality Weekly Report, V61, P379; Faul M, 2010, TRAUMATIC BRAIN INJU; Gelber DA, 2001, STROKE, V32, P1841, DOI 10.1161/01.STR.32.8.1841; Haselkorn JK, 2005, J SPINAL CORD MED, V28, P167; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Lance JW, 1980, SPASTICITY DISORDERE; Moberg-Wolff EA, 2011, MEDSCAPE REFERENCE; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; PARZIALE JR, 1993, ORTHOPEDICS, V16, P801; Rabchevsky AG, 2011, NEUROTHERAPEUTICS, V8, P274, DOI 10.1007/s13311-011-0025-5; RxList, 2007, INT DRUG IND; Sabate E, 2003, ADHERENCE LONG TERM; Sajatovic M, 2009, COMPR PSYCHIAT, V50, P100, DOI 10.1016/j.comppsych.2008.06.008; Sikka R, 2005, AM J MANAG CARE, V11, P453; Simon O, 2010, EUR J PHYS REHAB MED, V46, P401; Simpson DM, 1997, MUSCLE NERVE, pS169; StataCorp LP, 2007, STAT 10 BAS REF MAN, V3; Vanek ZF, 2012, SPASTICITY INTRO PAT; Weidle PJ, 1999, J ACQ IMMUN DEF SYND, V22, P498; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728; Yelnik A. P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P746, DOI 10.1016/j.rehab.2009.09.005	31	21	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2013	5	9					747	756		10.1016/j.pmrj.2013.04.022			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	226MX	WOS:000325041600002	23648652				2022-02-06	
J	Klein, AM; Howell, K; Vogler, J; Grill, E; Straube, A; Bender, A				Klein, Anke-Maria; Howell, Kaitlen; Vogler, Jana; Grill, Eva; Straube, Andreas; Bender, Andreas			Rehabilitation Outcome of Unconscious Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						clinical course; recovery of consciousness; rehabilitation outcome; TBI	NEUROLOGIC PROGNOSIS; TERM OUTCOMES; LIFE; RESUSCITATION; CONSCIOUSNESS; EPIDEMIOLOGY; VALIDATION; PREDICTION; WITHDRAWAL; RECOVERY	Outcome prediction of traumatic brain injury (TBI) patients with severe disorders of consciousness (DOC) at the end of their time in an intensive care setting is important for clinical decision making and counseling of relatives, and constitutes a major challenge. Even the question of what constitutes an improved outcome is controversially discussed. We have conducted a retrospective cohort study for the rehabilitation dynamics and outcome of TBI patients with DOC. Out of 188 patients, 37.2% emerged from a minimally conscious state (MCS) and 16.5% achieved at least partial functional independence after a mean observation period of 107 days (range 1-399 days). This reflects that emergence from MCS is much easier to achieve than functional independence. Logistic regression analysis identified age and level of consciousness upon admission to neurorehabilitation as independent prognostic factors for both outcomes. The group who reached at least partial functional independence started to improve significantly more than the corresponding outcome group by post-injury week 7, and the average time to reach this functional status was 18 weeks. In contrast, the group who emerged from MCS started to improve after 6 weeks. The longest delay between brain injury and the beginning of functional improvement (measured by biweekly Functional Independence Measure [FIM] scores) still compatible with reaching at least partial functional independence was 18 weeks. In conclusion, despite a strong negative selection, a substantial proportion of severe TBI patients with DOC achieve functional improvements or at least emerge from MCS within the inpatient rehabilitation phase. In order to avoid self-fulfilling prophecies in decision making, it is important to be aware of the fact that the beginning of clinical improvement may take several months after brain injury. In this study, separation of both of the functional outcome groups started by 7 weeks post-injury.	[Klein, Anke-Maria; Howell, Kaitlen; Vogler, Jana; Straube, Andreas; Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Grill, Eva] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Grill, Eva] Univ Munich, Integrated Ctr Res & Treatment Vertigo Balance &, D-81377 Munich, Germany; [Bender, Andreas] Therapiezentrum Burgau, Dept Neurol, Burgau, Germany		Bender, A (corresponding author), Univ Munich, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	anbender@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Bender, Andreas/0000-0002-6328-7104	ZNS Hannelore Kohl Stiftung foundation [2011013]	This study was supported by a grant (#2011013) of the ZNS Hannelore Kohl Stiftung foundation.	Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bender A, 2012, J NEUROL, V259, P2481, DOI 10.1007/s00415-012-6573-8; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DUBROJA I, 1995, J NEUROL NEUROSUR PS, V58, P465, DOI 10.1136/jnnp.58.4.465; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Gabbe BJ, 2008, ANN SURG, V247, P854, DOI 10.1097/SLA.0b013e3181656d1e; Gabbe BJ, 2005, ACAD EMERG MED, V12, P751, DOI 10.1197/j.aem.2005.03.527; Geocadin RG, 2006, NEUROLOGY, V67, P105, DOI 10.1212/01.wnl.0000223335.86166.b4; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Grill E., 2013, ARCH PHYS MED REHABI; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Woischneck D, 1998, ACT NEUR S, V71, P138; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88	35	21	21	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1476	1483		10.1089/neu.2012.2735			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800002	23477301	Green Published			2022-02-06	
J	McLaughlin, KA; Glang, A; Beaver, SV; Gau, JM; Keen, S				McLaughlin, Karen A.; Glang, Ann; Beaver, Sherry Vondy; Gau, Jeff M.; Keen, Stacie			Web-Based Training in Family Advocacy	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adults; advocacy; caregiver; interactive; online; randomized trial; training; traumatic brain injury; Web-based	TRAUMATIC BRAIN-INJURY; INTERACTIVE MULTIMEDIA; INTERVENTION; REHABILITATION; SATISFACTION; INDIVIDUALS; PREDICTORS; DISTRESS; PROGRAM; SYSTEM	Objective: To examine the efficacy of an interactive multimedia intervention that teaches advocacy skills to people caring for a family member with traumatic brain injury. Participants: A total of 201 individuals (control, n = 97; treatment, n = 104) providing support to a family member with traumatic brain injury. Design: Randomized controlled study. Main Measures: Caregiver knowledge, skill application, behavioral intention, and overall life satisfaction. Intervention: The Brain Injury Partners program, a Web site focused on advocacy, communication skills, and resources for families affected by brain injury. Results: Univariate analyses revealed that compared with the control group, the Brain Injury Partners group reported statistically significant higher adjusted means for application, knowledge, and attitudes scales immediately postintervention and at follow-up. Satisfaction with life, assessed at follow-up but not posttest, was not significant. Discussion: This study demonstrated the effectiveness of a Web-based intervention to teach effective skills to caregivers advocating for a family member with traumatic brain injury.	[McLaughlin, Karen A.] Univ Oregon, Coll Educ, Eugene, OR 97403 USA; [Glang, Ann; Beaver, Sherry Vondy; Keen, Stacie] Oregon Ctr Appl Sci, Eugene, OR USA; [Gau, Jeff M.] Oregon Res Inst, Eugene, OR 97403 USA		McLaughlin, KA (corresponding author), Univ Oregon, Coll Educ, Eugene, OR 97403 USA.	kdurany@uoregon.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD46257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R44HD046257, R43HD046257] Funding Source: NIH RePORTER	This project was completed with funding from the National Institute of Child Health and Human Development (grant HD46257). The authors thank Donald Hood, John Seeley, PhD, and Carol Dennis, for their contributions to the program and evaluation, and McKay Moore Sohlberg, PhD, and Bonnie Todis, PhD, for their invaluable comments on revisions of this article.	AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; Albin R.W., 1996, POSITIVE BEHAV SUPPO, P81, DOI DOI 10.1177/108835760001500205; Boschen K, 2007, NEUROREHABILITATION, V22, P19; DeNavas-Walt C., 2010, US CENSUS BUREAU CUR; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Hood D, 2001, FAMILY ADVOCACY SKIL; Hood DR, 1999, C TRAUM BRAIN INJ 21; Horwitz R. C., 1998, FAMILIES SYSTEMS HLT, V16, P71; Irvine AB, 2003, J APPL GERONTOL, V22, P269, DOI 10.1177/0733464803022002006; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; LICHSTEIN KL, 1994, ADV BEHAV RES THER, V16, P1, DOI 10.1016/0146-6402(94)90001-9; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Malik-Hoegh S., 1994, BRAIN INJURY REHABIL, P393; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; McLaughlin KA, 2006, J MED SPEECH-LANG PA, V14, pXI; NORM, 1999, MULT IMP INC DAT NOR; Pew Research Center's Internet and American Life Project, HOM BROADB AD 2009; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Rempel RG., 1994, BRAIN INJURY REHABIL, P376; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Smith J E, 2000, Care Manag J, V2, P27; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wills J., 1996, REDEFINING FAMILY SU, P225; Ylvisaker M., 1998, COLLABORATIVE BRAIN; [No title captured]	40	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					341	348		10.1097/HTR.0b013e31824e1d43			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600080	22688211	Green Accepted			2022-02-06	
J	Yoshida, S; Kato, T; Higuchi, M; Yako, H; Chen, M; Kanno, N; Ueharu, H; Kato, Y				Yoshida, S.; Kato, T.; Higuchi, M.; Yako, H.; Chen, M.; Kanno, N.; Ueharu, H.; Kato, Y.			Rapid Transition of NESTIN-Expressing Dividing Cells from PROP1-Positive to PIT1-Positive Advances Prenatal Pituitary Development	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						NESTIN; PROP1; PIT1; pituitary; stem/progenitor cell	TRAUMATIC BRAIN-INJURY; STEM/PROGENITOR CELL; RAT PITUITARY; STEM-CELLS; POPULATION; PRX2	We recently reported that the quantitative and qualitative transition of stem/progenitor cells occurs by the acquisition of a novel mechanism in the terminal differentiation during postnatal development of the anterior pituitary. We hypothesised that this novel mechanism is an alteration of a cell supply system accompanying proliferation of the progenitor cells. In the present study, we examined the proliferation activities of progenitor cells by indication of the expression of Nestin, a marker of rapidly dividing progenitor cells, aiming to verify our hypothesis and to resolve another outstanding issue regarding whether the Nestin gene is expressed in the pituitary. We found that NESTIN-positive dividing cells certainly exist in the pituitary through all stages of development. Almost all of the PROP1-positive progenitor cells express Nestin in early embryonic pituitary development. Thereafter, Nestin-expressing dividing cells involved in the cell supply system transfer from PROP1-positive progenitor cells to committed progenitor cells, such as PIT1-positive cells, on neonatal pituitary development. Furthermore, our data, together with the findings of previous studies on cell lineage tracing analyses using Nestin-Cre mice derived by the central nervous system (CNS)-specific Nestin promoter, suggest that at least two regulation systems for Nestin-expression exist in the pituitary, with the majority of these not being CNS-specific.	[Yoshida, S.; Yako, H.; Chen, M.; Kanno, N.; Ueharu, H.; Kato, Y.] Meiji Univ, Grad Sch Agr, Div Life Sci, Tokyo, Kanagawa, Japan; [Kato, T.; Higuchi, M.; Kato, Y.] Meiji Univ, Inst Reprod & Endocrinol, Tokyo, Kanagawa, Japan; [Kato, Y.] Meiji Univ, Sch Agr, Dept Life Sci, Tokyo, Kanagawa, Japan		Kato, Y (corresponding author), Sch Agr, Dept Life Sci, Kanagawa, Japan.	yukato@isc.meiji.ac.jp		Higuchi, Masashi/0000-0003-2129-1065	MEXT of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [06454019, 21380184]; Institute of Science and Technology, Meiji University; Meiji University International Institute for BioResource Research (MUIIR)	We wish to thank Dr A. F. Parlow and the NIDDK for supplying us with the antibodies to the pituitary hormones. We also thank Dr S. Tanaka of Shizuoka University for providing the antibodies to human GH and ACTH. The present study was partially supported by Grants-in-Aid for Scientific Research (B) Numbers 06454019 and 21380184 and by the 'High-Tech Research Center' Project for Private Universities, a matching fund subsidy from the MEXT of Japan, and a Research Grant (A) to Y. Kato from the Institute of Science and Technology, Meiji University. This study was partly supported by Meiji University International Institute for BioResource Research (MUIIR).	Aihara M, 2004, LAB INVEST, V84, P1581, DOI 10.1038/labinvest.3700186; Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Chen M, 2013, CELL TISSUE RES, DOI 10.1007/s00441-013-1713-8; DAIKOKU S, 1981, ARCH HISTOL JAPON, V44, P103, DOI 10.1679/aohc1950.44.103; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Devnath S, 2008, J NEUROENDOCRINOL, V20, P687, DOI 10.1111/j.1365-2826.2008.01716.x; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Galichet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011443; Gautron L, 2009, NEUROENDOCRINOLOGY, V90, P19, DOI 10.1159/000220994; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Higuchi M, 2013, CELL TISSUE RES, V353, P27, DOI 10.1007/s00441-013-1632-8; Hunziker E, 2000, BIOCHEM BIOPH RES CO, V271, P116, DOI 10.1006/bbrc.2000.2611; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mitsuishi H, 2013, CELL TISSUE RES, DOI 10.1007/s00441-013-1686-7; Salehi F, 2008, J NEUROSURG, V108, P118, DOI 10.3171/JNS/2008/108/01/0118; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Susa T, 2012, J NEUROENDOCRINOL, V24, P1201, DOI 10.1111/j.1365-2826.2012.02336.x; Vankelecom H, 2010, GEN COMP ENDOCR, V166, P478, DOI 10.1016/j.ygcen.2009.11.007; VILAPORCILE E, 1972, Z ZELLFORSCH MIK ANA, V129, P328, DOI 10.1007/BF00307293; Weiss S, 2009, CLIN NEUROPATHOL, V28, P309; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yako H, 2013, CELL TISSUE RES CELL, DOI 10.1007/s00441-013-1717-4; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Yoshida S, 2009, BIOCHEM BIOPH RES CO, V385, P11, DOI 10.1016/j.bbrc.2009.05.027; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	37	21	21	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	SEP	2013	25	9					779	791		10.1111/jne.12077			13	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	202WD	WOS:000323250300002	23855824				2022-02-06	
J	Collins, NC; Molcho, M; Carney, P; McEvoy, L; Geoghegan, L; Phillips, JP; Nicholson, AJ				Collins, Niamh C.; Molcho, Michal; Carney, Peter; McEvoy, Linda; Geoghegan, Lourda; Phillips, Jack P.; Nicholson, Alf J.			Are boys and girls that different? An analysis of traumatic brain injury in children	EMERGENCY MEDICINE JOURNAL			English	Article							MORTALITY; PATTERN; APPRAISALS; RISK; AGE	Introduction The Phillips Report on traumatic brain injury (TBI) in Ireland found that injury was more frequent in men and that gender differences were present in childhood. This study determined when gender differences emerge and examined the effect of gender on the mechanism of injury, injury type and severity and outcome. Methods A national prospective, observational study was conducted over a 2-year period. All patients under 17 years of age referred to a neurosurgical service following TBI were included. Data on patient demographics, events surrounding injury, injury type and severity, patient management and outcome were collected from 'on-call' logbooks and neurosurgical admissions records. Results 342 patients were included. Falls were the leading cause of injury for both sexes. Boys' injuries tended to involve greater energy transfer and involved more risk-prone behaviour resulting in a higher rate of other (non-brain) injury and a higher mortality rate. Intentional injury occurred only in boys. While injury severity was similar for boys and girls, significant gender differences in injury type were present; extradural haematomas were significantly higher in boys (p=0.014) and subdural haematomas were significantly higher in girls (p=0.011). Mortality was 1.8% for girls and 4.3% for boys. Conclusions Falls were responsible for most TBI, the home is the most common place of injury and non-operable TBI was common. These findings relate to all children. Significant gender differences exist from infancy. Boys sustained injuries associated with a greater energy transfer, were less likely to use protective devices and more likely to be injured deliberately. This results in a different pattern of injury, higher levels of associated injury and a higher mortality rate.	[Collins, Niamh C.] James Connolly Mem Hosp, Dept Emergency Med, Dublin 15, Ireland; [Molcho, Michal] Natl Univ Ireland, Hlth Promot Res Ctr, Galway, Ireland; [Carney, Peter] Univ Coll Dublin, Geary Inst, Dublin 2, Ireland; [McEvoy, Linda; Phillips, Jack P.] Beaumont Hosp, Traumat Brain Injury Res Grp, Dublin 9, Ireland; [Geoghegan, Lourda] Publ Hlth Agcy Northern Ireland, Belfast, Antrim, North Ireland; [Nicholson, Alf J.] Childrens Univ Hosp, Dept Paediat Med, Dublin, Ireland		Collins, NC (corresponding author), James Connolly Mem Hosp, Dept Emergency Med, Dublin 15, Ireland.	nievoc@yahoo.co.uk					Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Consumer Safety Institute, 2000, DEATHS INJ DUE ACC V; Granie MA, 2010, ACCIDENT ANAL PREV, V42, P726, DOI 10.1016/j.aap.2009.10.022; Granie MA, 2009, SAFETY SCI, V47, P1277, DOI 10.1016/j.ssci.2009.03.010; Hillier LM, 1998, J PEDIATR PSYCHOL, V23, P229, DOI 10.1093/jpepsy/23.4.229; Kendrick D., 2007, COCHRANE DB SYST REV, V24; Klein KS, 2005, INJURY PREV, V11, P288, DOI 10.1136/ip.2004.007013; Molcho M, SLAN 2007 SURVEY LIF; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V76, P89, DOI 10.1006/jecp.2000.2572; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V77, P317, DOI 10.1006/jecp.2000.2595; Pearson J, 2009, ARCH DIS CHILD, V94, P524, DOI 10.1136/adc.2008.148403; Pearson J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-26; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; StataCorp, 2005, STAT STAT SOFTW REL; Unicef, 2001, LEAG TABL CHILD DEAT	15	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	AUG	2013	30	8					675	678		10.1136/emermed-2011-200496			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	301GH	WOS:000330520300016	22962053	hybrid, Green Published			2022-02-06	
J	Hwabejire, JO; Jin, G; Imam, AM; Duggan, M; Sillesen, M; Deperalta, D; Jepsen, CH; Lu, J; Li, YQ; deMoya, MA; Alam, HB				Hwabejire, John O.; Jin, Guang; Imam, Ayesha M.; Duggan, Michael; Sillesen, Martin; Deperalta, Danielle; Jepsen, Cecilie H.; Lu, Jennifer; Li, Yongqing; deMoya, Marc A.; Alam, Hasan B.			Pharmacologic modulation of cerebral metabolic derangement and excitotoxicity in a porcine model of traumatic brain injury and hemorrhagic shock	SURGERY			English	Article							MEMBRANE PHOSPHOLIPID DEGRADATION; PERMEABILITY TRANSITION PORE; CRITICALLY-ILL PATIENTS; OXYGEN DELIVERY; CELL-DEATH; RAT-BRAIN; K+-ATPASE; GLUTAMATE; GLYCEROL; INHIBITION	Background. Cerebral metabolic derangement and excitotoxicity play critical roles in the evolution of traumatic brain injury (TBI). We have shown previously that treatment with large doses of valproic acid (VPA) decreases the size of brain lesion. The goal of this experiment was to determine whether this effect was owing to metabolic modulation. Methods. Yorkshire swine (n = 9) underwent a protocol of computer-controlled TBI and 40% hemorrhage and were resuscitated randomly with either fresh frozen plasma equal to the volume of shed blood (FFP; n = 4) or VPA (300 mg/kg) and FFP (FFP+VPA; n = 5). Hemodynamics, brain oxygenation, and blood glucose were monitored continuously for 6 hours after resuscitation. Cerebral microdialysis was used to measure glucose, lactate, pyruvate, glutamate, and glycerol levels at baseline, 1 and 2 hours post-shock, post-resuscitation (PR), and at 2, 4, and 6 hours PR. Brain samples from the injured side were then separated into mitochondrial and cytosolic fractions, and activity of pyruvate dehydrogenase complex (PDH) was measured using a dipstick assay kit. Results. At baseline, there was no difference in brain lactate, pyruvate, glycerol, and glutamate concentrations between the groups. At all time points, there were no differences between the groups in brain oxygenation, cerebral perfusion pressure, or blood and brain glucose concentrations. After VPA infusion (PR time point), however, there was sustained decrease in lactate (0.91 +/- 0.47 vs 2.54 +/- 0.59 mmol/L; P < .01) and pyruvate (12.80 +/- 4.89 vs 46.25 +/- 9.22; P < .001) concentrations compared with the FFP alone group, implying superior glucose utilization for ATP production. There was also a decrease in concentrations of glutamate (6.64 +/- 3.68 vs 42.25 +/- 27.07 mmol/L; P = .02) and glycerol (19.20 +/- 6.76 vs 69.75 +/- 30.07 mmol/L; P = .01), in the FFP+VPA group, signifying lesser degree of excitotoxicity and brain damage, respectively. Brain PDH activity was greater in the mitochondrial fractions (5,984 +/- 504 adjusted volume intensity [INT] X mm(2) vs 4,332 +/- 1,055 INT X mm(2); P = .04) and lower in cytosolic fractions in the FFP+VPA group (1,597 +/- 1,395 vs 4,026 +/- 1,067 INT X mm(2); P = .03), indicating better mitochondrial membrane function and enhanced mitochondrial PDH retention. Conclusion. VPA treatment attenuates perturbation of post-traumatic cerebral metabolism by mitigating mitochondrial dysfunction, and decreases glutamate-mediated excitotoxic damage. These properties could explain its effectiveness in decreasing lesion size and post-traumatic cerebral edema.	[Hwabejire, John O.; Jin, Guang; Imam, Ayesha M.; Duggan, Michael; Sillesen, Martin; Deperalta, Danielle; Jepsen, Cecilie H.; Lu, Jennifer; Li, Yongqing; deMoya, Marc A.; Alam, Hasan B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Jin, Guang; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475	US Army Medical Research Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]	Funded by a grant from the US Army Medical Research Material Command GRANTT00521959 (to HBA).	Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Fei Zhou, 2003, Chin J Traumatol, V6, P270; Finkelstein E., 2006, INCIDENCE EC BURDEN; Frye RE, PYRUVATE DEHYDROGENA; Hall JE., 2006, TXB MED PHYSL; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Mitosciences, PYR DEH PDH ENZ ACT; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Mukhin A, 1996, J NEUROSCI, V16, P6012; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; US Centers for Disease Control and Prevention, INJ PREV CONTR TRAUM; US Centers for Disease Control and Prevention, SURV TRAUM BRAIN INJ; US Centers for Disease Control and Prevention, TRAUM BRAIN INJ US; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wang XQ, 2003, J CELL SCI, V116, P2099, DOI 10.1242/jcs.00420; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	39	21	24	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2013	154	2					234	243		10.1016/j.surg.2013.04.008			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	196UB	WOS:000322801800012	23889951				2022-02-06	
J	Osorio, MB; Kurowski, BG; Beebe, D; Taylor, HG; Brown, TM; Kirkwood, MW; Wade, SL				Osorio, Marisa B.; Kurowski, Brad G.; Beebe, Dean; Taylor, H. Gerry; Brown, Tanya M.; Kirkwood, Michael W.; Wade, Shari L.			Association of Daytime Somnolence With Executive Functioning in the First 6 Months After Adolescent Traumatic Brain Injury	PM&R			English	Article							BEHAVIOR RATING INVENTORY; SLEEP LATENCY TEST; SUBSTANCE USE; HEAD INJURY; SHORT-TERM; CHILDREN; DISORDERS; CONSEQUENCES; DISTURBANCES; PREVALENCE	Objective: To determine the relationship between severity of injury and self-reports and parent reports of daytime somnolence in adolescents after traumatic brain injury (TBI), and to determine the relationship between daytime somnolence and self-report and parent report of executive functioning in daily life. Design: Cross-sectional study conducted within the first 6 months (mean standard deviation 14.97 +/- 7.51 weeks) after injury. Partial correlation controlling for injury severity was used to examine the associations of TBI severity with daytime somnolence and the association of daytime somnolence with executive functioning. Setting: Outpatient visits at 3 children's hospitals and 2 general hospitals with pediatric trauma commitment. Participants: A total of 102 adolescents, 12-18 years old, who sustained moderate-to-severe TBI (n = 60) or complicated mild TBI (n = 42). Main Outcome Measurements: Parent-report Sleepiness Scale, Epworth Sleepiness Scale (youth report), Behavior Rating Inventory of Executive Function (BRIEF) (self-report and maternal report). Results: Adolescents who sustained moderate-to-severe TBI had increased daytime somnolence compared with those with complicated mild injuries in the parent report but not in the youth report. Based on the parent report, 51% of adolescents with moderate-to-severe TBI showed significant daytime somnolence compared with 22% of those with complicated mild TBI. The parent report of daytime somnolence was associated with executive dysfunction on both the BRIEF self-report and parent report; however, the youth report of daytime somnolence was associated only with the BRIEF self-report. Conclusions: The parent report of daytime somnolence correlated with TB I severity and predicted executive functioning difficulties of the teens in everyday circumstances. Although a correlation between daytime somnolence and executive dysfunction were also apparent on self-report, this did not differ based on injury severity. Teens tended to report fewer difficulties with executive function, which suggests that the teens have decreased awareness of their impairments.	[Osorio, Marisa B.] Univ Washington, Dept Phys Med & Rehabil, Div Pediat Rehabil Med, Seattle, WA 98145 USA; [Osorio, Marisa B.] Seattle Childrens Hosp, Seattle, WA 98145 USA; [Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Beebe, Dean; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Beebe, Dean] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA		Osorio, MB (corresponding author), Univ Washington, Dept Phys Med & Rehabil, Div Pediat Rehabil Med, POB 5371,M-S W-6847, Seattle, WA 98145 USA.	marisa.osorio@sealtlechildrens.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH073764]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); Colorado Traumatic Brain Injury Trust Fund Research Program; Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	Supported in part by National Institutes of Health grant R01-MH073764 from the National Institute of Mental Health and by a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program.	Anderson B, 2009, PEDIATRICS, V123, pE701, DOI 10.1542/peds.2008-1182; Babcock DA, 2011, PEDIATR CLIN N AM, V58, P543, DOI 10.1016/j.pcl.2011.03.001; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Beebe DW, 2012, CHILD NEUROPSYCHOL, V18, P313, DOI 10.1080/09297049.2011.602014; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Campbell IG, 2007, SLEEP, V30, P1677, DOI 10.1093/sleep/30.12.1677; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Clark DB, 2012, ADDICTION, V107, P206, DOI 10.1111/j.1360-0443.2011.03566.x; Dagys N, 2012, J CHILD PSYCHOL PSYC, V53, P660, DOI 10.1111/j.1469-7610.2011.02502.x; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Faul M, 2010, TRAUMATIC BRAIN INJU; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Grant JE, 2012, DRUG ALCOHOL DEPEN, V121, P159, DOI 10.1016/j.drugalcdep.2011.08.015; Gromov I, 2009, CHILD ADOL PSYCH CL, V18, P929, DOI 10.1016/j.chc.2009.04.004; Hanson KL, 2011, J CHILD ADOLES SUBST, V20, P135, DOI 10.1080/1067828X.2011.555272; Hasler BP, 2012, SLEEP MED REV, V16, P67, DOI 10.1016/j.smrv.2011.03.004; HODGES K, 1999, J CHILD FAM STUD, V8, P109; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; James JE, 2011, J ADOLESCENCE, V34, P665, DOI 10.1016/j.adolescence.2010.09.006; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Moore M, 2008, PAEDIATR RESPIR REV, V9, P114, DOI 10.1016/j.prrv.2008.01.001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Owens JA, 2005, SLEEP MED, V6, P63, DOI 10.1016/j.sleep.2004.07.015; Peterson RL, 2012, J HEAD TRAUMA REHABI; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Redline S, 2007, AM J RESP CRIT CARE, V176, P401, DOI 10.1164/rccm.200703-375OC; ROEHRS T, 1992, J CLIN NEUROPHYSIOL, V9, P63, DOI 10.1097/00004691-199201000-00007; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Talbot LS, 2010, EMOTION, V10, P831, DOI 10.1037/a0020138; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763	64	21	21	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUL	2013	5	7					554	562		10.1016/j.pmrj.2012.11.006			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	190PC	WOS:000322351700002	23375631	Green Accepted			2022-02-06	
J	Carlson, KF; Barnes, JE; Hagel, EM; Taylor, BC; Cifu, DX; Sayer, NA				Carlson, Kathleen F.; Barnes, Joan E.; Hagel, Emily M.; Taylor, Brent C.; Cifu, David X.; Sayer, Nina A.			Sensitivity and specificity of traumatic brain injury diagnosis codes in United States Department of Veterans Affairs administrative data	BRAIN INJURY			English	Article						Clinical coding; epidemiology; ICD-9-CM; public health surveillance; traumatic brain injury; validity	CASE ASCERTAINMENT; WAR VETERANS; HEAD-INJURY; VALIDITY; ACCURACY; AFGHANISTAN; PREVALENCE; IRAQ; CLAIMS; COSTS	Objective: To examine the validity of using International Classification of Diseases (ICD) diagnosis codes from United States Department of Veterans Affairs (VA) data to describe prevalence of traumatic brain injury (TBI) among military veterans. Methods: VA clinicians complete a standardized TBI evaluation to determine whether veterans' deployment exposures resulted in TBI. Clinician-confirmed cases and non-cases of TBI were used as recorded on the evaluation as the criterion standard against which to evaluate three series of TBI-related ICD diagnosis codes in national VA datasets. Focusing on codes used within VA, measures of validity were calculated and correlates of discordance examined, including patient characteristics, region and time. Secondarily, it was examined whether TBI codes can differentiate mild from more severe TBI cases. Results: Of 49 962 veterans with completed TBI evaluations, 29 534 (59%) received clinician-confirmed TBI diagnoses. Sensitivity of the VA series of codes was 70%, specificity was 82% and concordance was 75%. Concordance varied by region, but not by patient characteristics or time. Codes were not useful for distinguishing mild TBI. Conclusion: Estimates of TBI prevalence in military veterans are important for national programme development and resource distribution. Estimates derived from ICD diagnosis codes in administrative data should take potential misclassification into account.	[Carlson, Kathleen F.] Portland VA Med Ctr, Portland Ctr Study Chron Comorbid Mental & Phys D, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Barnes, Joan E.; Hagel, Emily M.; Taylor, Brent C.; Sayer, Nina A.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Taylor, Brent C.; Sayer, Nina A.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Cifu, David X.] Vet Hlth Adm, Phys Med & Rehabil Serv, Richmond, VA USA; [Cifu, David X.] Hunter Holmes McGuire VA Med Ctr, Phys Med & Rehabil Serv, Richmond, VA USA; [Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Sayer, Nina A.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA		Carlson, KF (corresponding author), Portland VA Med Ctr R&D 66, Portland Ctr Study Chron Comorbid Mental & Phys D, 3715 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kathleen.carlson@va.gov	Sayer, Nina/E-3249-2016; Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Cifu, David/0000-0003-1600-9387	United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development ServiceUS Department of Veterans Affairs [CDA 08-025]	This work was supported by a career development award from the United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (CDA 08-025). The opinions expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The authors report no conflicts of interest.	Abellera J, 2005, STATES ARE COLLECTIN; [Anonymous], 2009, FED REGISTER, V74, P11; Babcock-Parziale JL, 2012, 08377 SDR HSR D STUD; Bagalman E., 2011, TRAUMATIC BRAIN INJU; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; BIJUR PE, 1990, PEDIATRICS, V86, P337; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; De Coster C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-77; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Defense and Veterans Brain Injury Center, 2012, DOD NUMB TBI WORLDW; Department of Veterans Affairs Employee Education System, 2010, TRAUM BRAIN INJ IND; Department of Veterans Affairs. Office of Health Data and Informatics, 2010, FACT SHEET INT COD G; Department of Veterans Affairs. Office of Health Data and Informatics, 2009, FACT SHEET INT COD G; Department of Veterans Affairs. Office of Health Data and Informatics, 2008, FACT SHEET INT COD G; Department of Veterans Affairs. Office of Informatics and Analytics, 2011, FACT SHEED COD GUID; Department of Veterans Affairs Office of Rehabilitation Services, 2010, COMPR TBI EV; Department of Veterans Affairs Veterans Health Administration, 2012, VHA HDB; Department of Veterans Affairs VHA Support Services Center, COMPR TBI EV SUMM RE; Faul M, 2010, TRAUMATIC BRAIN INJU; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; Iverson G, 2007, BRAIN INJURY MED PRI; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelsey JL, 1996, METHODS OBSERVATIONA, P354; Kostylova A, 2005, INJURY PREV, V11, P186, DOI 10.1136/ip.2004.006585; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lix LM, 2008, J CLIN EPIDEMIOL, V61, P1250, DOI 10.1016/j.jclinepi.2008.02.002; McNaughton H, 2000, NEW ZEAL MED J, V113, P184; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Sigford B., 2008, NAT POL SYST CAR C E; Surjan G, 1999, INT J MED INFORM, V54, P77, DOI 10.1016/S1386-5056(98)00171-3; Tamblyn R, 2000, J CLIN EPIDEMIOL, V53, P183, DOI 10.1016/S0895-4356(99)00136-5; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; United States Department of Veterans Affairs, 2010, 2 VA IN TRAUM BRAIN; *US DEP HHS, 1989, INT CLASS DIS 9 REV; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; van Walraven C, 2011, J CLIN EPIDEMIOL, V64, P1054, DOI 10.1016/j.jclinepi.2011.01.001; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vose D., 2000, RISK ANAL QUANTITATI, V2nd ed.; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	53	21	21	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					640	650		10.3109/02699052.2013.771795			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500002	23514276				2022-02-06	
J	Conklin, HM; Ashford, JM; Di Pinto, M; Vaughan, CG; Gioia, GA; Merchant, TE; Ogg, RJ; Santana, V; Wu, SJ				Conklin, Heather M.; Ashford, Jason M.; Di Pinto, Marcos; Vaughan, Christopher G.; Gioia, Gerard A.; Merchant, Thomas E.; Ogg, Robert J.; Santana, Victor; Wu, Shengjie			Computerized assessment of cognitive late effects among adolescent brain tumor survivors	JOURNAL OF NEURO-ONCOLOGY			English	Article						Pediatric; Cancer; ImPACT	CONFORMAL RADIATION-THERAPY; WORKING-MEMORY PERFORMANCE; PEDIATRIC-PATIENTS; CHILDHOOD-CANCER; CHILDREN; MEDULLOBLASTOMA; ATTENTION; OUTCOMES	Advantages of computerized assessment of neuropsychological functions include improved standardization and increased reliability of response time variables. Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a computerized battery developed for monitoring recovery following mild brain injuries that assesses attention, memory and processing speed. Despite evidence that core areas of deficit among cancer survivors are those assessed by ImPACT, it has not previously been used with this population. Twenty four childhood brain tumor (BT) survivors treated with conformal radiation therapy (mean age = 15.7 +/- A 1.6; mean age at irradiation = 9.8 +/- A 2.5), twenty solid tumor (ST) survivors treated without CNS-directed therapy (mean age = 16.2 +/- A 1.8) and twenty healthy siblings (mean age = 15.1 +/- A 1.6 years) were administered an age modified version of ImPACT. Additional computerized measures of working memory and recognition memory were administered. Univariate ANOVAs revealed group differences (p < 0.05) on measures of recognition memory, spatial working memory, processing speed and reaction time, with BT survivors performing significantly worse than ST survivors and siblings. Pearson correlation coefficients revealed significant associations between ImPACT memory tasks and computerized forced choice recognition tasks (rs = 0.30-0.33, p < 0.05). Multiple surgical resections, hydrocephalus and CSF shunt placement most consistently predicted worse ImPACT performance using linear mixed models (p < 0.05). The ImPACT test battery demonstrated sensitivity to cognitive late effects experienced by some BT survivors with clinical predictors of performance consistent with the pediatric oncology literature. Correlations with measures of similar constructs provide evidence for convergent validity. Findings offer initial support for the utility of ImPACT for monitoring of cognitive late effects.	[Conklin, Heather M.; Ashford, Jason M.] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN 38105 USA; [Di Pinto, Marcos] Childrens Hosp Orange Cty, Dept Pediat Psychol, Orange, CA 92668 USA; [Vaughan, Christopher G.; Gioia, Gerard A.] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA; [Merchant, Thomas E.] St Jude Childrens Res Hosp, Div Radiat Oncol, Memphis, TN 38105 USA; [Ogg, Robert J.] St Jude Childrens Res Hosp, Div Translat Imaging Res, Memphis, TN 38105 USA; [Santana, Victor] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Wu, Shengjie] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA		Conklin, HM (corresponding author), St Jude Childrens Res Hosp, Dept Psychol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	heather.conklin@stjude.org	Conklin, Heather M/N-2696-2018; Merchant, Thomas E/N-3344-2018	Merchant, Thomas E/0000-0002-0412-6255	National Cancer Institute (St. Jude Cancer Center Support [CORE]) [P30 CA21765]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21 CA131616]; International Neuropsychological Society; American Lebanese Syrian Associated Charities (ALSAC)American Lebanese Syrian Associated Charities (ALSAC); Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17 CCU323352]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA131616, P30CA021765] Funding Source: NIH RePORTER	This work was supported in part by the National Cancer Institute (St. Jude Cancer Center Support [CORE] Grant number P30 CA21765), (H.C., grant number R21 CA131616); the International Neuropsychological Society (H.C., Rita Rudel Award); and the American Lebanese Syrian Associated Charities (ALSAC). Research and development of the pediatric and adolescent/midrange version of the ImPACT battery was provided by the Centers for Disease Control and Prevention (G.G., award number U17 CCU323352). We thank the patients and their families who volunteered their time to participate. Portions of this paper were presented at the annual meeting of the International Neuropsychological Society in Boston, Massachusetts, February, 2011. Dr. Gioia is a co-author of Pediatric ImPACT and in the future may receive royalties, but has no financial interest in the adolescent/midrange version presented here. The remaining authors declare that they have no conflict of interest.	Aukema EJ, 2009, INT J RADIAT ONCOL, V74, P837, DOI 10.1016/j.ijrobp.2008.08.060; Conklin HM, 2008, J CLIN ONCOL, V26, P3965, DOI 10.1200/JCO.2007.15.9970; Conklin HM, 2007, DEV NEUROPSYCHOL, V31, P103, DOI 10.1207/s15326942dn3101_6; Conklin HM, 2012, J INT NEUROPSYCH SOC, V18, P996, DOI 10.1017/S1355617712000793; Crom Deborah B, 2007, J Cancer Surviv, V1, P237, DOI 10.1007/s11764-007-0026-x; Dennis M, 1998, MED PEDIATR ONCOL, P25; Di Pinto M, 2012, INT J RADIAT ONCOL, V84, pE363, DOI 10.1016/j.ijrobp.2012.03.066; Filley CM, 2001, NEW ENGL J MED, V345, P425, DOI 10.1056/NEJM200108093450606; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Howarth RA, 2012, J INT NEUROPSYCH SOC, V28, P1; Kahalley LS, 2013, PSYCHO-ONCOLOGY, V22, P447, DOI 10.1002/pon.3021; Kirschen MP, 2008, BEHAV NEUROL, V20, P39, DOI [10.1155/2008/817253, 10.3233/BEN-2008-0216]; Krull KR, 2010, J CANCER SURVIV, V4, P210, DOI 10.1007/s11764-010-0123-0; Lovell MR, 2000, IMPACT; Mabbott DJ, 2008, NEUROPSYCHOLOGY, V22, P159, DOI 10.1037/0894-4105.22.2.159; Mabbott DJ, 2011, CANCER-AM CANCER SOC, V117, P5402, DOI 10.1002/cncr.26127; Maddrey AM, 2005, J NEURO-ONCOL, V72, P245, DOI 10.1007/s11060-004-3009-z; Merchant TE, 2004, J CLIN ONCOL, V22, P3156, DOI 10.1200/JCO.2004.11.142; Merchant TE, 2002, ONCOLOGY-NY, V16, P629; Merchant TE, 2009, J CLIN ONCOL, V27, P3691, DOI 10.1200/JCO.2008.21.2738; Mitby PA, 2003, CANCER-AM CANCER SOC, V97, P1115, DOI 10.1002/cncr.11117; Moore BD, 2005, J PEDIATR PSYCHOL, V30, P51, DOI 10.1093/jpepsy/jsi016; Mulhern Raymond K, 2004, Pediatr Rehabil, V7, P1, DOI 10.1080/13638490310001655528; Mulhern RK, 1999, ANN NEUROL, V46, P834, DOI 10.1002/1531-8249(199912)46:6<834::AID-ANA5>3.0.CO;2-M; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Netson KL, 2012, INT J RADIAT ONCOL, V84, P217, DOI 10.1016/j.ijrobp.2011.10.043; Reddick WE, 2000, MAGN RESON IMAGING, V18, P787, DOI 10.1016/S0730-725X(00)00182-X; Reeves CB, 2006, J PEDIATR PSYCHOL, V31, P272, DOI 10.1093/jpepsy/jsj019; RUTTER M, 1976, J CHILD PSYCHOL PSYC, V17, P35, DOI 10.1111/j.1469-7610.1976.tb00372.x; Sands SA, 2012, J CLIN ONCOL, V30, P943, DOI 10.1200/JCO.2011.35.7533; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Schultz KAP, 2007, J CLIN ONCOL, V25, P3649, DOI 10.1200/JCO.2006.09.2486; Wechsler D, 1999, ASSESSMENT	33	21	21	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	JUN	2013	113	2					333	340		10.1007/s11060-013-1123-5			8	Oncology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Neurosciences & Neurology	162CD	WOS:000320241100019	23525951	Green Accepted			2022-02-06	
J	Crepeau, AZ; Kerrigan, JF; Gerber, P; Parikh, G; Jahnke, H; Nakaji, P; Little, A; Chapmank, KE				Crepeau, Amy Z.; Kerrigan, John F.; Gerber, Paula; Parikh, Gunjan; Jahnke, Heidi; Nakaji, Peter; Little, Andrew; Chapmank, Kevin E.			Rhythmical and Periodic EEG Patterns Do Not Predict Short-term Outcome in Critically Ill Patients With Subarachnoid Hemorrhage	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Continuous EEG; ICU monitoring; Subarachnoid hemorrhage; Seizure	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; ELECTROGRAPHIC SEIZURES; INTRACEREBRAL HEMORRHAGE; INTEROBSERVER AGREEMENT; SUBCOMMITTEE; DISCHARGES; MORTALITY; PRESSURE	Introduction: Nonconvulsive seizures and nonconvulsive status epilepticus commonly occur in patients with aneurysmal subarachnoid hemorrhages. When continuous EEG is used in patients in the neuro-intensive care unit, rhythmical and periodic patterns of uncertain significance are frequently encountered. It is unknown how these findings impact patient outcome. Methods: Patients were enrolled from a single tertiary care center with subarachnoid hemorrhages secondary to ruptured intracranial aneurysm, and either a witnessed seizure or significantly impaired mental status. Prospective clinical, laboratory, imaging, and short-term outcome data were collected. Continuous EEG monitoring was performed and scored according to American Clinical Neurophysiology Society (ACNS) Subcommittee on Research Terminology for Continuous EEG Monitoring. Results: Sixty-eight patients were enrolled. Fifty-four had a poor-grade subarachnoid hemorrhage upon admission. Fifty-one patients had rhythmical or periodic patterns: 33 with periodic discharges and 38 with rhythmic delta activity. Four patients had unequivocal electrographic seizures. Patients did poorly in the short term: 14 died and 42 were severely disabled at discharge. In hospital, mortality was 19.6% in patients with rhythmical or periodic patterns and 23.5% in patients without. Age, female gender, and endovascular treatment had a positive correlation with the occurrence of periodic discharges. However, there was no correlation between rhythmical and periodic patterns and outcome. Discussion: Using the ACNS Research Terminology, it is shown that rhythmical and periodic patterns are very common in critically ill patients with subarachnoid hemorrhage. However, the presence and the abundance of these patterns did not predict short-term outcome in this prospective, single-center observational study. We were unable to show that rhythmical and periodic EEG patterns are an independent predictor for outcome relative to other clinical features. Large multicenter studies will be required to determine if these patterns independently predict outcome and to demonstrate the impact of treatment interventions that are directed at rhythmical and periodic continuous EEG patterns.	[Crepeau, Amy Z.; Kerrigan, John F.; Parikh, Gunjan; Jahnke, Heidi] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA; [Kerrigan, John F.] St Josephs Hosp, Barrow Neurol Inst, Clin Neurophysiol Sect, Phoenix, AZ USA; [Gerber, Paula] Providence Hosp, Neurodiagnost Lab, Portland, OR USA; [Jahnke, Heidi; Nakaji, Peter; Little, Andrew] St Josephs Hosp, Div Neurosurg, Barrow Neurol Inst, Phoenix, AZ USA; [Chapmank, Kevin E.] Childrens Hosp Colorado, Sect Pediat Neurol, Aurora, CO 80045 USA		Chapmank, KE (corresponding author), Childrens Hosp Colorado, 13123 East 16th Ave,B155, Aurora, CO 80045 USA.	kevin.chapman@childrenscolorado.org	Viani, Rafael/V-1196-2018; Parikh, Gunjan/AAS-1375-2020	Parikh, Gunjan/0000-0002-8447-1349			Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; DeGiorgio CM, 1996, EPILEPSIA, V37, P606, DOI 10.1111/j.1528-1157.1996.tb00623.x; Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006; Gerber PA, 2008, J CLIN NEUROPHYSIOL, V25, P241, DOI 10.1097/WNP.0b013e318182ed67; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Kaplan PW, 2000, NEUROPHYSIOL CLIN, V30, P377, DOI 10.1016/S0987-7053(00)00238-0; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; Mocco J, 2006, NEUROSURGERY, V59, P529, DOI 10.1227/01.NEU.0000228680.22550.A2; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Sutter R, 2011, EPILEPSIA, V52, P453, DOI 10.1111/j.1528-1167.2010.02888.x; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Waterhouse EJ, 1998, EPILEPSY RES, V29, P175, DOI 10.1016/S0920-1211(97)00071-5; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; WILLIAMS GW, 1985, NEUROLOGY, V35, P1714, DOI 10.1212/WNL.35.12.1714; Young GB, 1996, NEUROLOGY, V47, P83	27	21	21	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JUN	2013	30	3					247	254		10.1097/WNP.0b013e3182933d2f			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298TN	WOS:000330347500004	23733088				2022-02-06	
J	Perlick, DA; Straits-Troster, K; Strauss, JL; Norell, D; Tupler, LA; Levine, B; Luo, XD; Holman, C; Marcus, T; Dixon, LB; Dyck, DG				Perlick, Deborah A.; Straits-Troster, Kristy; Strauss, Jennifer L.; Norell, Diane; Tupler, Larry A.; Levine, Bruce; Luo, Xiaodong; Holman, Caroline; Marcus, Tara; Dixon, Lisa B.; Dyck, Dennis G.			Implementation of Multifamily Group Treatment for Veterans With Traumatic Brain Injury	PSYCHIATRIC SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PSYCHOMETRIC PROPERTIES; SERVICE MEMBERS; FAMILIES; IRAQ; AFGHANISTAN; THERAPY; SCHIZOPHRENIA; INTERVENTION	Objective: This study evaluated the initial efficacy and feasibility of implementing multifamily group treatment for veterans with traumatic brain injury (TBI). Methods: Veterans at two Veterans Affairs medical centers were prescreened by their providers for participation in an open trial of multifamily group treatment for TBI. Enrollment was limited to consenting veterans with a clinical diagnosis of TBI sustained during the Operation Enduring Freedom-Operation Iraqi Freedom era, a family member or partner consenting to participate, and a score >= 20 on the Mini-Mental State Examination. The nine-month (April 2010-March 2011) trial consisted of individual family sessions, an educational workshop, and bimonthly multifamily problem-solving sessions. Interpersonal functioning and symptomatic distress among veterans and family burden, empowerment, and symptomatic distress among families were assessed before and after treatment. Results: Providers referred 34 (58%) of 59 veterans screened for the study; of those, 14 (41%) met criteria and consented to participate, and 11 (32%) completed the study. Severity of TBI, insufficient knowledge about the benefits of family involvement, and access problems influenced decisions to exclude veterans or refuse to participate. Treatment was associated with decreased veteran anger expression (p <=.01) and increased social support and occupational activity (p <=.05), with effect sizes ranging from .6 to 1.0. Caregivers reported decreased burden (p <=.05) and increased empowerment (p <=.01). Conclusions: The results supported implementation of a randomized controlled trial, building in education at the provider and family level.	[Perlick, Deborah A.; Luo, Xiaodong] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Perlick, Deborah A.; Levine, Bruce; Holman, Caroline; Marcus, Tara] MIRECC, US Dept Vet Affairs VA, Bronx, NY USA; [Straits-Troster, Kristy; Tupler, Larry A.] Durham VA Med Ctr, Midatlantic Reg MIRECC, Durham, NC USA; [Strauss, Jennifer L.] Durham VA Med Ctr, Hlth Serv Res & Dev Serv, Durham, NC USA; [Strauss, Jennifer L.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Norell, Diane] Eastern Washington Univ, Dept Occupat Therapy, Cheney, WA 99004 USA; [Dixon, Lisa B.] Columbia Univ, Dept Psychiat, New York, NY USA; [Dixon, Lisa B.] New York State Psychiat Inst & Hosp, Ctr Practice Innovat, New York, NY 10032 USA; [Dyck, Dennis G.] Washington State Univ, Dept Psychol, Spokane, WA USA		Perlick, DA (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, 1 Gustave L Levy Pl, New York, NY 10029 USA.	deborah.perlick@va.gov			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0054]; Veterans Affairs Research Career Development AwardUS Department of Veterans Affairs [RCD 06-020]; Mental Illness, Research, Education and Clinical Centers; Veterans Integrated Service Networks 3 and 6	This study was supported by a Department of Defense award (W81XWH-08-2-0054) to Dr. Perlick, by a Veterans Affairs Research Career Development Award (RCD 06-020) to Dr. Strauss, and by the Mental Illness, Research, Education and Clinical Centers associated with Veterans Integrated Service Networks 3 and 6. The authors acknowledge the support and guidance of Claire Henderson, M. D., Katherine Taber, Ph.D., Robin Hurley, M. D., and Adrian Cristian, M.D.	Albright G, 2011, GAMES HLTH, V1, P9; [Anonymous], 1998, REH PERS TRAUM BRAIN; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bowling UB, 2008, PROF PSYCHOL-RES PR, V39, P451, DOI 10.1037/0735-7028.39.4.451; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dausch BM, 2012, AM J PSYCHIATR REHAB, V15, P5, DOI 10.1080/15487768.2012.655223; Dausch BM, 2009, J TELEMED TELECARE, V15, P211, DOI 10.1258/jtt.2009.081216; Deckersbach T, 2010, CNS NEUROSCI THER, V16, P298, DOI 10.1111/j.1755-5949.2009.00110.x; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KNIGHT RG, 1988, BRIT J CLIN PSYCHOL, V27, P279, DOI 10.1111/j.2044-8260.1988.tb00792.x; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; KOREN PE, 1992, REHABIL PSYCHOL, V37, P305, DOI 10.1037/h0079106; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; McDonell MG, 2007, COGNITIVE THER RES, V31, P785, DOI 10.1007/s10608-006-9098-6; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Mueser K. T., 1999, BEHAV FAMILY THERAPY; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Rotondi AJ, 2010, PSYCHIAT SERV, V61, P1099, DOI 10.1176/ps.2010.61.11.1099; Sautter FJ, 2011, PROF PSYCHOL-RES PR, V42, P63, DOI 10.1037/a0022323; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schmitter-Edgecombe M, 2012, ALZH ASS INT C VANC; Schumm JA, AM J FAMILY IN PRESS; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Straits-Troster KA, 2011, PSYCHOL TRAUMA-US, V3, P283, DOI 10.1037/a0024645; Straits-Troster K, 2013, PSYCHIAT SERVICES; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	41	21	22	0	17	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JUN	2013	64	6					534	540		10.1176/appi.ps.001622012			7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	255XF	WOS:000327272700007	23450320				2022-02-06	
J	Varsos, GV; de Riva, N; Smielewski, P; Pickard, JD; Brady, KM; Reinhard, M; Avolio, A; Czosnyka, M				Varsos, Georgios V.; de Riva, Nicolas; Smielewski, Peter; Pickard, John D.; Brady, Ken M.; Reinhard, Matthias; Avolio, Alberto; Czosnyka, Marek			Critical Closing Pressure During Intracranial Pressure Plateau Waves	NEUROCRITICAL CARE			English	Article						Critical closing pressure; Plateau waves; Intracranial pressure; Mathematical modeling; Wall tension	CEREBRAL BLOOD-VOLUME; COMMUNICATING HYDROCEPHALUS; ICP PATTERNS; FLOW; CIRCULATION; DEPENDENCE; CSF	Critical closing pressure (CCP) denotes a threshold of arterial blood pressure (ABP) below which brain vessels collapse and cerebral blood flow ceases. Theoretically, CCP is the sum of intracranial pressure (ICP) and arterial wall tension (WT). The aim of this study is to describe the behavior of CCP and WT during spontaneous increases of ICP, termed plateau waves, in order to quantify ischemic risk. To calculate CCP, we used a recently introduced multi-parameter method (CCPm) which is based on the modulus of cerebrovascular impedance. CCP is derived from cerebral perfusion pressure, ABP, transcranial Doppler estimators of cerebrovascular resistance and compliance, and heart rate. Arterial WT was estimated as CCPm-ICP. The clinical data included recordings of ABP, ICP, and transcranial Doppler-based blood flow velocity from 38 events of ICP plateau waves, recorded in 20 patients after head injury. Overall, CCPm increased significantly from 51.89 +/- A 8.76 mmHg at baseline ICP to 63.31 +/- A 10.83 mmHg at the top of the plateau waves (mean +/- A SD; p < 0.001). Cerebral arterial WT decreased significantly during plateau waves by 34.3 % (p < 0.001), confirming their vasodilatatory origin. CCPm did not exhibit the non-physiologic negative values that have been seen with traditional methods for calculation, therefore rendered a more plausible estimation of CCP. Rising CCP during plateau waves increases the probability of cerebral vascular collapse and zero flow when the difference: ABP-CCP (the "collapsing margin") becomes zero or negative.	[Varsos, Georgios V.; de Riva, Nicolas; Smielewski, Peter; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [de Riva, Nicolas] Univ Barcelona, Hosp Clin, Dept Anesthesiol, Barcelona, Spain; [Brady, Ken M.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Reinhard, Matthias] Univ Freiburg, Dept Neurol, D-79106 Freiburg, Germany; [Avolio, Alberto] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Varsos, GV (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Hills Rd, Cambridge CB2 0QQ, England.	gv249@cam.ac.uk; nderiva@clinic.ub.es; ps10011@cam.ac.uk; jdp1000@medschl.cam.ac.uk; kmbrady@texaschildrens.org; matthias.reinhard@uniklinik-freiburg.de; alberto.avolio@mq.edu.au; mc141@medschl.cam.ac.uk	de Riva, Nicolas/AAN-3347-2020	de Riva, Nicolas/0000-0003-2691-5770; Smielewski, Peter/0000-0001-5096-3938; Avolio, Alberto/0000-0002-8311-2010	National Institute of Health Research, Biomedical Research Centre (Neuroscience Theme), NIHR Senior Investigator Awards; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G0001237, G0001354, G1000183B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This study was supported by the National Institute of Health Research, Biomedical Research Centre (Neuroscience Theme), NIHR Senior Investigator Awards (JDP) and the Medical Research Council (Grants G0600986 and G9439390).	Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Avezaat CJJ, 1984, THESIS; Batorski L, 1989, INTRACRANIAL PRESSUR, VVII, P189; BRUNNER MJ, 1983, AM J PHYSIOL, V245, pH453, DOI 10.1152/ajpheart.1983.245.3.H453; Carrera E, 2011, EUR J NEUROL, V18, P711, DOI 10.1111/j.1468-1331.2010.03247.x; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Czosnyka M, 2012, NEUROL RES, V34, P17, DOI 10.1179/1743132811Y.0000000040; Daley ML, 2005, ACT NEUR S, V95, P327; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Gazzoli P, 2006, BRIT J NEUROSURG, V20, P348; GJERRIS F, 1982, ACTA NEUROCHIR, V64, P59, DOI 10.1007/BF01405619; HAYASHI M, 1985, J NEUROSURG, V63, P556, DOI 10.3171/jns.1985.63.4.0556; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; HAYASHI M, 1984, J NEUROSURG, V61, P30, DOI 10.3171/jns.1984.61.1.0030; HAYASHI M, 1985, J NEUROSURG, V62, P220, DOI 10.3171/jns.1985.62.2.0220; Kasprowicz M, 2012, NEUROCRIT CARE, V16, P213, DOI 10.1007/s12028-011-9653-1; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Lopez-Magana JA, 2009, J CEREB BLOOD FLOW M, V29, P1; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MATSUDA M, 1979, J NEUROSURG, V50, P483, DOI 10.3171/jns.1979.50.4.0483; Michel E, 1997, J CEREBR BLOOD F MET, V17, P1127, DOI 10.1097/00004647-199710000-00015; NICHOL J, 1951, AM J PHYSIOL, V164, P330, DOI 10.1152/ajplegacy.1951.164.2.330; Panerai R., 2011, PHYS MEAS, V32, P1; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Puppo Corina, 2012, Acta Neurochir Suppl, V114, P283, DOI 10.1007/978-3-7091-0956-4_55; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; Richards HK, 1999, ACTA NEUROCHIR, V141, P1221, DOI 10.1007/s007010050422; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Rosner MJ, 1999, CARE NEUROSURG INT, P57; Schmidt B, 1999, J CEREBR BLOOD F MET, V19, P990, DOI 10.1097/00004647-199909000-00006; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Varsos GV, 2013, J CEREBR BLOOD F MET, V33, P235, DOI 10.1038/jcbfm.2012.161	38	21	21	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2013	18	3					341	348		10.1007/s12028-013-9830-5			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	147II	WOS:000319159600008	23512327				2022-02-06	
J	Gauntlett-Gilbert, J; Wilson, S				Gauntlett-Gilbert, Jeremy; Wilson, Sarah			Veterans and chronic pain	BRITISH JOURNAL OF PAIN			English	Article						Back pain; chronic pain; headache; low back pain; pain management; phantom limb		1. Musculoskeletal problems are the commonest reason for medical discharge in all the British armed forces. By definition, these problems are chronic and resistant to treatment. 2. Pain is also common in veterans who have experienced severe injuries (polytrauma), often accompanied by post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) orpostconcussive syndrome. 3. In veterans seeking treatment for chronic pain, PTSD is common. There is also evidence for elevated levels of alcohol misuse in veterans who have been deployed to conflict. However, most veterans do not have pain, PTSD or alcohol problems. 4. Pain clinicians would benefit from training in meeting veterans' needs, in order to promote their engagement and successful treatment. This should include countering stereotypes, information about the military and support for the assessment and onward referral of PTSD and alcohol problems.	Univ Bath, Bath Ctr Pain Serv, Bath, Avon, England; Univ Bath, Dept Psychol, Bath, Avon, England		Gauntlett-Gilbert, J (corresponding author), Royal Natl Hosp Rheumat Dis NHS Fdn Trust, Bath Ctr Pain Serv, Bath BA1 1RL, Avon, England.	Jeremy.gauntlett-gilbert@rnhrd.nhs.uk		Wilson, Sarah/0000-0002-5040-4818	Royal National Hospital for Rheumatic Diseases NHS Foundation Trust	Authors are funded by the Royal National Hospital for Rheumatic Diseases NHS Foundation Trust.	Alschuler KN, 2012, EUR J PAIN, V16, P312, DOI 10.1016/j.ejpain.2011.06.010; Andrews B, 2009, J ABNORM PSYCHOL, V118, P767, DOI 10.1037/a0017203; Brewin CR, 2011, PSYCHOL MED, V41, P1733, DOI 10.1017/S003329171000231X; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Geary KG, 2002, OCCUP MED-OXFORD, V52, P85, DOI 10.1093/occmed/52.2.85; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Jeffreys MD, 2010, MIL MED, V175, P719, DOI 10.7205/MILMED-D-10-00054; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Ketz AK, 2008, ARCH PHYS MED REHAB, V89, P1127, DOI 10.1016/j.apmr.2007.11.037; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacGregor AJ, 2012, MIL MED, V177, P845, DOI 10.7205/MILMED-D-12-00021; McGeary D, 2011, J CLIN PSYCHOL MED S, V18, P155, DOI 10.1007/s10880-011-9236-5; Ministry of Defence, 2011, UK DEF STAT 2011; Ministry of Defence, 2013, Q AFGH IR AMP STAT; Ministry of Defence, OP HERR CAS FAT TABL; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Scottish Association for Mental Health, 2009, LIF FORC PRACT GUID; Shen-Gunther J, 2011, MIL MED, V176, P67, DOI 10.7205/MILMED-D-10-00109; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907	23	21	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2049-4637	2049-4645		BRIT J PAIN	Brit. J. Pain	MAY	2013	7	2					79	84		10.1177/2049463713482082			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VI0IC	WOS:000458462200005	26516504	Green Published			2022-02-06	
J	Wu, P; Zhao, YX; Haidacher, SJ; Wang, EY; Parsley, MO; Gao, JL; Sadygov, RG; Starkey, JM; Luxon, BA; Spratt, H; DeWitt, DS; Prough, DS; Denner, L				Wu, Ping; Zhao, Yingxin; Haidacher, Sigmund J.; Wang, Enyin; Parsley, Margaret O.; Gao, Junling; Sadygov, Rovshan G.; Starkey, Jonathan M.; Luxon, Bruce A.; Spratt, Heidi; DeWitt, Douglas S.; Prough, Donald S.; Denner, Larry			Detection of Structural and Metabolic Changes in Traumatically Injured Hippocampus by Quantitative Differential Proteomics	JOURNAL OF NEUROTRAUMA			English	Article						animal models; bioinformatics; mass spectrometry; proteomics; traumatic brain injury	TANDEM MASS-SPECTROMETRY; 2-DIMENSIONAL GEL-ELECTROPHORESIS; CONTROLLED CORTICAL IMPACT; HUMAN CEREBROSPINAL-FLUID; NEURAL STEM-CELLS; PROTEIN-KINASE-C; BRAIN-INJURY; GLUTAMATE RECEPTORS; CALCINEURIN SUBUNIT; NEUROTROPHIC FACTOR	Traumatic brain injury (TBI) is a complex and common problem resulting in the loss of cognitive function. In order to build a comprehensive knowledge base of the proteins that underlie these cognitive deficits, we employed unbiased quantitative mass spectrometry, proteomics, and bioinformatics to identify and quantify dysregulated proteins in the CA3 subregion of the hippocampus in the fluid percussion model of TBI in rats. Using stable isotope O-18-water differential labeling and multidimensional tandem liquid chromatography (LC)-MS/MS with high stringency statistical analyses and filtering, we identified and quantified 1002 common proteins, with 124 increased and 76 decreased. The Ingenuity Pathway Analysis (IPA) bioinformatics tool identified that TBI had profound effects on downregulating global energy metabolism, including glycolysis, the Krebs cycle, and oxidative phosphorylation, as well as cellular structure and function. Widespread upregulation of actin-related cytoskeletal dynamics was also found. IPA indicated a common integrative signaling node, calcineurin B1 (CANB1, CaNB alpha, or PPP3R1), which was downregulated by TBI. Western blotting confirmed that the calcineurin regulatory subunit, CANB1, and its catalytic binding partner PP2BA, were decreased without changes in other calcineurin subunits. CANB1 plays a critical role in downregulated networks of calcium signaling and homeostasis through calmodulin and calmodulin-dependent kinase II to highly interconnected structural networks dominated by tubulins. This large-scale knowledge base lays the foundation for the identification of novel therapeutic targets for cognitive rescue in TBI.	[Wu, Ping; Wang, Enyin; Gao, Junling] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Zhao, Yingxin; Haidacher, Sigmund J.; Denner, Larry] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Parsley, Margaret O.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Sadygov, Rovshan G.; Starkey, Jonathan M.; Luxon, Bruce A.; Spratt, Heidi] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Haidacher, Sigmund J.; Denner, Larry] Univ Texas Med Branch, Stark Diabet Ctr, Galveston, TX 77555 USA; [Zhao, Yingxin; Haidacher, Sigmund J.; Denner, Larry] Univ Texas Med Branch, McCoy Stem Cells & Diabet Mass Spectrometry Res L, Galveston, TX 77555 USA; [Zhao, Yingxin; Sadygov, Rovshan G.; Luxon, Bruce A.; Spratt, Heidi; Denner, Larry] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Zhao, Yingxin; Sadygov, Rovshan G.; Luxon, Bruce A.; Spratt, Heidi; Denner, Larry] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA		Denner, L (corresponding author), Univ Texas Med Branch, Div Endocrinol, 8-138 Med Res Bldg, Galveston, TX 77555 USA.	ladenner@utmb.edu	Prough, Donald S/G-5793-2013; Luxon, Bruce A/C-9140-2012	Prough, Donald S/0000-0001-7994-532X; Starkey, Jonathan/0000-0002-9083-6455	Department of the Army via the U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland [W81XWH-08-2-0137]; Miriam and Emmett McCoy Foundation; Coalition for Brain Injury Research; Moody Foundation; TIRR Foundation; John S. Dunn Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000071] Funding Source: NIH RePORTER	This work was supported by the Department of the Army (W81XWH-08-2-0137 to P.W .), via the U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland. The content of this work does not necessarily reflect the position or the policy of the U.S. government, and no official endorsement should be inferred. Other support for this study came from the Miriam and Emmett McCoy Foundation (L.D.), the Coalition for Brain Injury Research (P.W.), the Moody Foundation (P.W.), the TIRR Foundation (P.W.), and the John S. Dunn Research Foundation (P.W.).	Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Fukura H, 1996, J NEUROCHEM, V67, P1426; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Goshe MB, 2003, CURR OPIN BIOTECH, V14, P101, DOI 10.1016/S0958-1669(02)00014-9; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Heller M, 2003, J AM SOC MASS SPECTR, V14, P704, DOI 10.1016/S1044-0305(03)00207-1; Hoffrogge R, 2007, PROTEOMICS, V7, P33, DOI 10.1002/pmic.200600614; Hong Z, 2009, PROTEOM CLIN APPL, V3, P1072, DOI 10.1002/prca.200800234; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lehninger AL, 1970, BIOCH MOL BASIS CELL; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McNamara RK, 2005, HIPPOCAMPUS, V15, P675, DOI 10.1002/hipo.20089; Ohmitsu M, 1999, J BIOL CHEM, V274, P408, DOI 10.1074/jbc.274.1.408; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Palop JJ, 2011, METHODS MOL BIOL, V670, P245, DOI 10.1007/978-1-60761-744-0_17; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sadygov RG, 2010, J PROTEOME RES, V9, P4306, DOI 10.1021/pr100642q; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SHAPIRA Y, 1989, Neurological Research, V11, P169; Soares HD, 1995, J NEUROSCI, V15, P8223; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; Tao WA, 2003, CURR OPIN BIOTECH, V14, P110, DOI 10.1016/S0958-1669(02)00018-6; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; VENKATARAMANAN R, 1987, TRANSPLANT P, V19, P30; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Yang XY, 2009, BRAIN INJURY, V23, P830, DOI 10.1080/02699050903196670; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yoong LF, 2009, MOL CELL NEUROSCI, V41, P464, DOI 10.1016/j.mcn.2009.05.002; Zhao YX, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-15; Zhu WL, 2011, J NEUROCHEM, V117, P1075, DOI 10.1111/j.1471-4159.2011.07285.x; Zuberovic A, 2009, ELECTROPHORESIS, V30, P1836, DOI 10.1002/elps.200800714	83	21	21	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		775	788		10.1089/neu.2012.2391			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600009	22757692	Green Published			2022-02-06	
J	Bains, M; Cebak, JE; Gilmer, LK; Barnes, CC; Thompson, SN; Geddes, JW; Hall, ED				Bains, Mona; Cebak, John E.; Gilmer, Lesley K.; Barnes, Colleen C.; Thompson, Stephanie N.; Geddes, James W.; Hall, Edward D.			Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model	JOURNAL OF NEUROCHEMISTRY			English	Article						alpha-spectrin; calpain; neuroprotection; SNJ-1945; traumatic brain injury	ACID 5-METHOXY-3-OXAPENTYL ESTER; CEREBROSPINAL-FLUID; CORPUS-CALLOSUM; HEAD-INJURY; PROTEOLYSIS; NEURODEGENERATION; BREAKDOWN; DEGRADATION; MECHANISMS; RATS	The efficacy of the amphipathic ketoamide calpain inhibitor SNJ-1945 in attenuating calpain-mediated degradation of the neuronal cytoskeletal protein -spectrin was examined in the controlled cortical impact (CCI) traumatic brain injury (TBI) model in male CF-1 mice. Using a single early (15min after CCI-TBI) i.p. bolus administration of SNJ-1945 (6.25, 12.5, 25, or 50-mg/kg), we identified the most effective dose on -spectrin degradation in the cortical tissue of mice at its 24h peak after severe CCI-TBI. We then investigated the effects of a pharmacokinetically optimized regimen by examining multiple treatment paradigms that varied in dose and duration of treatment. Finally, using the most effective treatment regimen, the therapeutic window of -spectrin degradation attenuation was assessed by delaying treatment from 15min to 1 or 3h post-injury. The effect of SNJ-1945 on -spectrin degradation exhibited a U-shaped doseresponse curve when treatment was initiated 15min post-TBI. The most effective 12.5mg/kg dose of SNJ-1945 significantly reduced -spectrin degradation by similar to 60% in cortical tissue. Repeated dosing of SNJ-1945 beginning with a 12.5mg/kg dose did not achieve a more robust effect compared with a single bolus treatment, and the required treatment initiation was less than 1h. Although calpain has been firmly established to play a major role in post-traumatic secondary neurodegeneration, these data suggest that even brain and cell-permeable calpain inhibitors, when administered alone, do not show sufficient cytoskeletal protective efficacy or a practical therapeutic window in a mouse model of severe TBI. Such conclusions need to be verified in the human clinical situation.	[Bains, Mona; Cebak, John E.; Gilmer, Lesley K.; Barnes, Colleen C.; Thompson, Stephanie N.; Geddes, James W.; Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Hall, ED (corresponding author), Univ Kentucky, Med Ctr, SCoBIRC, Room B477,Biomed & Biol Sci Res Bldg,741 S Limest, Lexington, KY 40536 USA.	edhall@uky.edu	Thompson, Stephanie/AAB-8272-2020; Hall, Edward D/F-8930-2013	Thompson, Stephanie/0000-0002-9128-7515; 	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2P01 NS058484, 2P30 NS051220]; Kentucky Spinal Cord & Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058484, P30NS051220] Funding Source: NIH RePORTER	This study was supported by funding from the National Institute of Neurological Disorders and Stroke (2P01 NS058484, 2P30 NS051220) and the Kentucky Spinal Cord & Head Injury Research Trust. The authors have no conflicts of interest to declare in relation to the contents of this manuscript.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Bartus RT, 1997, NEUROSCIENTIST, V3, P314, DOI 10.1177/107385849700300513; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Oka T, 2006, NEUROSCIENCE, V141, P2139, DOI 10.1016/j.neuroscience.2006.05.060; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Shirasaki Y, 2008, BIOORG MED CHEM LETT, V18, P5174, DOI 10.1016/j.bmcl.2008.08.089; Shirasaki Y, 2006, J OCUL PHARMACOL TH, V22, P417, DOI 10.1089/jop.2006.22.417; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yoshikawa Y, 2010, AM J PHYSIOL-HEART C, V298, pH643, DOI 10.1152/ajpheart.00849.2009	29	21	21	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	APR	2013	125	1					125	132		10.1111/jnc.12118			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	112YR	WOS:000316631900013	23216523	Bronze			2022-02-06	
J	Bell, MJ; Kochanek, PM				Bell, Michael J.; Kochanek, Patrick M.			Pediatric Traumatic Brain Injury in 2012 The Year with New Guidelines and Common Data Elements	CRITICAL CARE CLINICS			English	Article						Pediatric TBI guidelines; Pediatric TBI common data elements; Evidenced-based medicine; Children; Severe traumatic brain injury	SEVERE HEAD-INJURY; ENDOTRACHEAL INTUBATION; DEXAMETHASONE THERAPY; HYPERTONIC SALINE; CLINICAL-TRIAL; CHILDREN; RECOMMENDATIONS; SURVIVAL; HYPERVENTILATION; HYPOTHERMIA	Pediatric Traumatic Brain Injury in 2012:The Year with New Guidelines and Common Data Elements Michael J. Bell and Patrick M. Kochanek Traumatic brain injury (TBI) remains the leading cause of death of children in the developing world. In 2012, several international efforts were completed to aid clinicians and researchers in advancing the field of pediatric TBI. The second edition of the Guidelines for the Medical Management of Traumatic Brain Injury in Infants, Children and Adolescents updated those published in 2003. This article highlights the processes involved in developing the Guidelines, contrasts the new guidelines with the previous edition, and delineates new research efforts needed to advance knowledge. The impact of common data elements within these potential new research fields is reviewed.	[Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA		Bell, MJ (corresponding author), Safar Ctr Resuscitat Res, Pediat Neurotrauma Ctr, 3434 5th Ave, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U44 NS070324, T32HD040686, U01 HD049981, R01 NS069247, R01 NS072308]; US ArmyUnited States Department of Defense [W81XWH-09-2-0187, W81XWH-10-0623]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD049981, T32HD040686, UG1HD049981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44NS070324, R01NS069247, R01NS072308, R01NS038087] Funding Source: NIH RePORTER	Both Drs Bell and Kochanek were selected by the Brain Trauma Foundation to develop the Guidelines for the Medical Management of Severe Traumatic Brain Injury for Infants, Children and Adolescents but were not compensated for their work. In addition, Dr Bell was selected by the National Institute of Neurological Disorders and Stroke to participate in development of the Common Data Elements for Pediatric TBI, but he was not compensated for his work. Dr Kochanek is supported by several Federal grants (U44 NS070324, T32HD040686 from the NIH and W81XWH-09-2-0187 and W81XWH-10-0623 from the US Army), as is Dr Bell (U01 HD049981, R01 NS069247, R01 NS072308 from the NIH).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS53; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS5; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS34; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS60; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS38; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Duhaime AC, 2012, J NEUROTRAUM, V29, P629, DOI 10.1089/neu.2011.1927; FANCONI S, 1988, INTENS CARE MED, V14, P163; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475	50	21	22	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	APR	2013	29	2					223	+		10.1016/j.ccc.2012.11.004			17	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125JJ	WOS:000317535800007	23537673	Green Accepted			2022-02-06	
J	Lakis, N; Corona, RJ; Toshkezi, G; Chin, LS				Lakis, Nelli; Corona, Robert J.; Toshkezi, Gentian; Chin, Lawrence S.			Chronic traumatic encephalopathy - neuropathology in athletes and war veterans	NEUROLOGICAL RESEARCH			English	Article						Chronic traumatic encephalopathy; Tau proteinopathy; Neurofibrillary tangles; Concussion; Traumatic brain injury; Dementia	PROGRESSIVE SUPRANUCLEAR PALSY; BRAIN-INJURY; HEAD-INJURY; DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; CONCUSSION; CORTEX	Objective: The neuropathologic findings of chronic traumatic encephalopathy (CTE) were first described almost 40 years after the first clinical reports. We reviewed the literature and describe the neuropathological findings seen primarily in professional athletes and more recently, in war veterans. Methods: We reviewed the literature of CTE concentrating on references that focused on the correlation of clinical findings with the neuropathologic changes. The pathobiology and proposed mechanisms of injury are described. Diagnostic modalities and various diagnostic criteria of CTE are reviewed. Results: We are beginning to understand the neuropathologic basis of CTE, which appears to be a consequence of repetitive mild brain injuries. There appear to be reproducible criteria for the post-mortem diagnosis of CTE and the neuropathologic findings are becoming more widely accepted. More research is required to elucidate the risk factors that predispose athletes and war veterans to CTE. There is also a need for more diagnostic markers and a method to assess CTE in patients prior to death. The neuropathologic findings of a progressive tauopathy including the presence of numerous neurofibrillary tangles (NFTs), rare neuritic plaques, and widespread expression of TDP-43 (transactive response [TAR] DNA binding protein 43) also require further study. Discussion: The potential prevalence of CTE, as well as the vulnerable populations involved, makes research into this topic crucial. Currently, a comprehensive neurological exam, neuropsychiatric assessment, and standard radiographic techniques such as conventional MRI are the mainstay of diagnosis. There is a pressing need for the prevention of CTE and the development of non-invasive diagnostic tests in order to develop therapies that may be of clinical use to athletes and blast injury veterans during their lifetimes.	[Lakis, Nelli; Corona, Robert J.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13078 USA; [Toshkezi, Gentian; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13078 USA		Chin, LS (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E,Adams St, Syracuse, NY 13078 USA.	chinl@upstate.edu					Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eggers AE, 2007, MED HYPOTHESES, V69, P852, DOI 10.1016/j.mehy.2007.01.074; Feany MB, 1996, J NEUROPATH EXP NEUR, V55, P53, DOI 10.1097/00005072-199601000-00006; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Galvin JE, 2011, NEUROLOGY, V76, P1797, DOI 10.1212/WNL.0b013e31821ccc83; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; HOF PR, 1992, ACTA NEUROPATHOL, V84, P45, DOI 10.1007/BF00427214; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Perl DP, 2003, J NEUROPATH EXP NEUR, V62, P381, DOI 10.1093/jnen/62.4.381; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Talavage TM, 2010, J NEUROTRAUMA; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Troncoso JC, 1996, NEUROBIOL AGING, V17, P365, DOI 10.1016/0197-4580(96)00028-0; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	77	21	21	3	49	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					290	299		10.1179/1743132813Y.0000000177			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104QW	WOS:000316010700010	23485056				2022-02-06	
J	Lien, E; Andersen, GL; Bao, YD; Gordish-Dressman, H; Skranes, JS; Vik, T; Blackman, JA				Lien, Espen; Andersen, Guro L.; Bao, Yongde; Gordish-Dressman, Heather; Skranes, Jon S.; Vik, Torstein; Blackman, James A.			Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; E GENOTYPE; ALZHEIMERS-DISEASE; APOE EPSILON-4; ASSOCIATION; ALLELE; POPULATION; RISK	Aim The aim of this study was to examine whether the presence of the apolipoprotein E (ApoE) allele APOE epsilon 4 is associated with less severe manifestations of cerebral palsy (CP), consistent with the suggested beneficial effect of this allele on neurodevelopment in children. Method ApoE genotyping was performed on buccal epithelial cells from 255 children (141 males 114 females; mean age 12y, SD 2y 3mo, range 917y) recorded in the Cerebral Palsy Register of Norway. The main outcome measure of CP severity was the Gross Motor Function Classification System (GMFCS). Secondary outcome measures were fine motor function, epilepsy, and the need for gastrostomy tube feeding (GTF). Results There was no association between the APOE epsilon 4 genotype and GMFCS levels (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.661.99). However, the APOE epsilon 4 genotype was more often present among children with epilepsy (OR 2.2; 95% CI 1.14.2) and/or receiving GTF (OR 2.7; 95% CI 1.16.6). Among children with unilateral CP, the presence of APOE epsilon 4 was associated with more severe fine motor impairment (OR 2.6; 95% CI 1.36.9). Interpretation Our main hypothesis that APOE epsilon 4 would have a protective effect on neurodevelopment was not supported. Instead, subgroup analyses suggested an adverse effect of the APOE epsilon 4 genotype on the developing brain after injury.	[Lien, Espen; Skranes, Jon S.; Vik, Torstein] Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Fac Med, N-7491 Trondheim, Norway; [Lien, Espen; Vik, Torstein] Univ Hosp Trondheim, Dept Paediat, St Olavs Hosp, Trondheim, Norway; [Andersen, Guro L.] Vestfold Hosp Trust, Cerebral Palsy Register Norway, Tonsberg, Norway; [Bao, Yongde] Univ Virginia, Sch Med, DNA Sci Core, Charlottesville, VA 22908 USA; [Gordish-Dressman, Heather] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Blackman, James A.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Blackman, James A.] Cerebral Palsy Int Res Fdn, Princeton Jct, NJ USA		Lien, E (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Fac Med, PB 8905, N-7491 Trondheim, Norway.	espen.lien@ntnu.no			National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD65826]; University of Virginia Children's Hospital; University of Virginia Pratt Research Fund; Health Authority of Central Norway; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD065826] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD65826), University of Virginia Children's Hospital Grant-in-Aid, the University of Virginia Pratt Research Fund, and the Health Authority of Central Norway. We would also like to thank Ms Jodi Darring at the University of Virginia, and Ms Sandra Julsen Hollung at the CPRN for their assistance, and all the children and their families who contributed to the study.	Aboud O, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-35; Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Kauffman MA, 2010, EPILEPSY RES, V90, P234, DOI 10.1016/j.eplepsyres.2010.05.007; [Anonymous], 2000, DEV MED CHILD NEUROL, V42, P816; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Blackman JA, 2009, J PEDIATR REHAB MED, V2, P67, DOI 10.3233/PRM-2009-0063; Braga LW, 2010, DEV MED CHILD NEUROL, V52, P666, DOI 10.1111/j.1469-8749.2009.03465.x; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Briellmann RS, 2000, NEUROLOGY, V55, P435, DOI 10.1212/WNL.55.3.435; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kumar T, 2002, HUM BIOL, V74, P137, DOI 10.1353/hub.2002.0006; Kuroda MM, 2007, PEDIATRICS, V119, P306, DOI 10.1542/peds.2006-1083; McMichael GL, 2008, HUM GENET, V124, P411, DOI 10.1007/s00439-008-0564-y; Meirelles Kalil Pessoa de B., 2000, J PEDIATR ORTHOPED, V20, P786; O'Callaghan ME, 2009, HUM GENET, V126, P149, DOI 10.1007/s00439-009-0638-5; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Stoknes M, 2012, EUR J PAEDIATR NEURO, V16, P56, DOI 10.1016/j.ejpn.2011.10.004; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	28	21	21	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	APR	2013	55	4					372	377		10.1111/dmcn.12086			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	108AF	WOS:000316262100016	23384326	Green Accepted			2022-02-06	
J	Oladunjoye, AO; Schrot, RJ; Zwienenberg-Lee, M; Muizelaar, JP; Shahlaie, K				Oladunjoye, Azeem O.; Schrot, Rudolph J.; Zwienenberg-Lee, Marike; Muizelaar, J. Paul; Shahlaie, Kiarash			Decompressive craniectomy using gelatin film and future bone flap replacement	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; cranioplasty; stroke; peridural scarring; traumatic brain injury; surgical technique	TRAUMATIC BRAIN-INJURY; ADHESION PREVENTIVE MATERIAL; CEREBRAL-ARTERY INFARCTION; SEVERE HEAD-INJURY; SURGICAL DECOMPRESSION; COLLAGEN MATRIX; TECHNICAL NOTE; CRANIOPLASTY; COMPLICATIONS; MULTICENTER	Object. Decompressive craniectomy plays an important role in the management of patients with traumatic brain injury (TBI) and stroke. Risks of decompressive craniectomy include those associated with cranioplasty, and may be related to adhesions that develop between the brain surface and overlying scalp and temporalis muscle. The authors report their institutional experience using a multilayered technique (collagen and gelatin film barriers) to facilitate safe and rapid cranioplasty following decompressive craniectomy. Methods. The authors conducted a retrospective chart review of 62 consecutive adult and pediatric patients who underwent decompressive craniectomy and subsequent cranioplasty between December 2007 and January 2011. Diagnoses included TBI, ischemic stroke, intraparenchymal hemorrhage, or subarachnoid hemorrhage. A detailed review of clinical charts was performed, including anesthesia records and radiographic study results. Results. The majority of patients underwent unilateral hemicraniectomy (n = 56), with indications for surgery including midline shift (n = 37) or elevated intracranial pressure (n = 25). Multilayered decompressive craniectomy was safe and easy to perform, and was associated with a low complication rate, minimal operative time, and limited blood loss. Conclusions. Decompressive craniectomy repair using an absorbable gelatin film barrier facilitates subsequent cranioplasty by preventing adhesions between intracranial contents and the overlying galea aponeurotica and temporalis muscle fascia. This technique makes cranioplasty dissection faster and potentially safer, which may improve clinical outcomes. The indications for gelatin film should be expanded to include placement in the epidural space after craniectomy. (http://thejns.org/doi/abs/10.3171/2013.1.JNS121475)	[Oladunjoye, Azeem O.; Schrot, Rudolph J.; Zwienenberg-Lee, Marike; Muizelaar, J. Paul; Shahlaie, Kiarash] Univ Calif Davis, Dept Neurol Surg, Sch Med, Sacramento, CA 95817 USA		Shahlaie, K (corresponding author), Univ Calif Davis, Dept Neurol Surg, Sch Med, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	kiarash.shahlaie@ucdmc.ucdavis.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bulters D, 2010, BRIT J NEUROSURG, V24, P75, DOI 10.3109/02688690903506135; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Danish SF, 2006, J NEUROSURG, V104, P16, DOI 10.3171/ped.2006.104.1.16; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Horaczek JA, 2008, NEUROSURGERY, V63, P176, DOI 10.1227/01.NEU.0000312707.25073.CB; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Huang X, 2010, INT J MED SCI, V7, P385; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsumura Goki, 2008, Asian Cardiovasc Thorac Ann, V16, P309; McCall TD, 2008, SURG NEUROL, V70, P92, DOI 10.1016/j.surneu.2007.04.007; McGhee MA, 1999, AM J OTOL, V20, P712; Missori P, 2008, SURG NEUROL, V70, P437, DOI 10.1016/j.surneu.2007.03.029; Miyake S, 2006, NEUROL MED-CHIR, V46, P104, DOI 10.2176/nmc.46.104; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nakagawa S, 2003, NEUROL MED-CHIR, V43, P120, DOI 10.2176/nmc.43.120; Narotam PK, 2004, SPINE, V29, P2861, DOI 10.1097/01.brs.0000148049.69541.ad; Nishizawa S, 1998, J Clin Neurosci, V5 Suppl, P78, DOI 10.1016/S0967-5868(98)90019-4; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Sade B, 2011, J NEUROSURG, V114, P714, DOI 10.3171/2010.7.JNS10460; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vakis A, 2006, CLIN NEUROL NEUROSUR, V108, P798, DOI 10.1016/j.clineuro.2005.11.026; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Yamagata Sen, 1993, Neurologia Medico-Chirurgica, V33, P582, DOI 10.2176/nmc.33.582; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	41	21	21	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2013	118	4					776	782		10.3171/2013.1.JNS121475			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	114BT	WOS:000316715700015	23394343				2022-02-06	
J	Turtzo, LC; Budde, MD; Gold, EM; Lewis, BK; Janes, L; Yarnell, A; Grunberg, NE; Watson, W; Frank, JA				Turtzo, L. Christine; Budde, Matthew D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Yarnell, Angela; Grunberg, Neil E.; Watson, William; Frank, Joseph A.			The evolution of traumatic brain injury in a rat focal contusion model	NMR IN BIOMEDICINE			English	Article						traumatic brain injury; controlled cortical impact; MRI; hemorrhage; autofluorescence	CONTROLLED CORTICAL IMPACT; GADOLINIUM OXIDE NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEURAL STEM-CELLS; SUPERFICIAL SIDEROSIS; HEAD-INJURY; VASCULAR DISRUPTION; FEMALE RATS; IN-VIVO	Serial MRI facilitates the in vivo analysis of the intra- and intersubject evolution of traumatic brain injury lesions. Despite the availability of MRI, the natural history of experimental focal contusion lesions in the controlled cortical impact (CCI) rat model has not been well described. We performed CCI on rats and MRI during the acute to chronic stages of cerebral injury to investigate the time course of changes in the brain. Female Wistar rats underwent CCI of their left motor cortex with a flat impact tip driven by an electromagnetic piston. In vivo MRI was performed at 7T serially over 6weeks post-CCI. The appearances of CCI-induced lesions and lesion-associated cortical volumes were variable on MRI, with the percentage change in cortical volume of the CCI ipsilateral side relative to the contralateral side ranging from 18% within 2h of injury on day 0 to a peak of 35% on day 1, and a trough of 28% by week 5/6, with an average standard deviation of +/- 14% at any given time point. In contrast, the percentage change in cortical volume of the ipsilateral side relative to the contralateral side in control rats was not significant (1 +/- 2%). Hemorrhagic conversion within and surrounding the CCI lesion occurred between days 2 and 9 in 45% of rats, with no hemorrhage noted on the initial scan. Furthermore, hemorrhage and hemosiderin within the lesion were positive for Prussian blue and highly autofluorescent on histological examination. Although some variation in injuries may be technique related, the divergence of similar lesions between initial and final scans demonstrates the inherent biological variability of the CCI rat model. Published 2012. This article is a US Government work and is in the public domain in the USA.	[Turtzo, L. Christine; Gold, Eric M.; Janes, Lindsay] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Turtzo, L. Christine; Budde, Matthew D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Frank, Joseph A.] NIH, Frank Lab, Bethesda, MD 20892 USA; [Yarnell, Angela; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Watson, William] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA		Turtzo, LC (corresponding author), NIH, Frank Lab, Bldg 10,Room B1N256 MSC 1074,10 Ctr Dr, Bethesda, MD 20892 USA.	l.turtzo@nih.gov; jafrank@helix.nih.gov	Frank, Joseph/W-2021-2019		Department of Defense through the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [300604-8.01-60855]; Intramural Research Program of the Clinical Center at the National Institutes of Health; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award #300604-8.01-60855) and from the Intramural Research Program of the Clinical Center at the National Institutes of Health.	Agudelo CA, 2011, TISSUE ENG PT A, V17, P2079, DOI [10.1089/ten.tea.2010.0482, 10.1089/ten.TEA.2010.0482]; Agudelo CA, 2012, BIOMATERIALS, V33, P2439, DOI 10.1016/j.biomaterials.2011.11.075; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Anderson SA, 2006, INVEST RADIOL, V41, P332, DOI 10.1097/01.rli.0000192420.94038.9e; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dierksen GA, 2010, ANN NEUROL, V68, P545, DOI 10.1002/ana.22099; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faucher L, 2012, ACS APPL MATER INTER, V4, P4506, DOI 10.1021/am3006466; Faucher L, 2011, CONTRAST MEDIA MOL I, V6, P209, DOI 10.1002/cmmi.420; Faul M, 2010, TRAUMATIC BRAIN INJU; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Giesel FL, 2006, INVEST RADIOL, V41, P868, DOI 10.1097/01.rli.0000246147.44835.4c; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kakeda S, 2010, ACAD RADIOL, V17, P871, DOI 10.1016/j.acra.2010.02.014; Kellermier H, 2009, NEUROPATHOLOGY, V29, P187, DOI 10.1111/j.1440-1789.2008.00943.x; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; MANDL AM, 1951, J EXP BIOL, V28, P576; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marti M, 2005, J NEUROSCI, V25, P9591, DOI 10.1523/JNEUROSCI.2546-05.2005; MCCLINTOCK MK, 1978, HORM BEHAV, V10, P264, DOI 10.1016/0018-506X(78)90071-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Nanda S, 2010, ANN CLIN BIOCHEM, V47, P275, DOI 10.1258/acb.2010.009226; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosell A, 2008, ACTA NEUROCHIR SUPPL, V105, P173; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Turtzo LC, 2010, FUTUR NEUROL, V5, P47, DOI 10.2217/FNL.09.66; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	78	21	21	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	APR	2013	26	4					468	479		10.1002/nbm.2886			12	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	107IK	WOS:000316209200014	23225324	Green Accepted			2022-02-06	
J	Crowe, LM; Catroppa, C; Babl, FE; Anderson, V				Crowe, Louise M.; Catroppa, Cathy; Babl, Franz E.; Anderson, Vicki			Executive function outcomes of children with traumatic brain injury sustained before three years	CHILD NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Executive function; Attention; Early brain injury; Cognitive development	PEDIATRIC HEAD-INJURY; GLASGOW COMA SCALE; YOUNG-CHILDREN; ATTENTION DEFICITS; FOLLOW-UP; INFANTS; CHILDHOOD; RECOVERY; AGE; MATURATION	Traumatic brain injury (TBI) is a common cause of disability in childhood. While the outcomes of TBI sustained in school years has been heavily researched, very little is known about the impact of TBI in infants and young children. The aim of this study was to investigate the impact of TBI on executive function (EF) in children who sustained a TBI before 3 years of age. A group of 55 children, 19 with a mild TBI, 16 children with a moderate-severe TBI, and 20 uninjured comparison children participated. The EF of children aged 3 to 6 years were compared using child-based measures of attentional control and information processing. Parents completed questionnaires rating their child's EF. Severity groups differed on the child-based EF measure of attentional control with children with TBI performing below the control group. There were no significant group differences for information processing or parent-rated EF. It appears that children who sustain a TBI before the age of 3 years display impairments in some areas of attentional control 34 years postinjury. The findings fit with the existing EF literature for older children.	[Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Psychol Sci, Melbourne, Vic, Australia; [Crowe, Louise M.; Catroppa, Cathy; Babl, Franz E.; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Babl, Franz E.; Anderson, Vicki] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia		Crowe, LM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Crowe, Louise/0000-0003-4619-9708	Foundation for Children; Victorian Government's Operational Infrastructure Support Program	This study was supported by a grant from the Foundation for Children and the Victorian Government's Operational Infrastructure Support Program.	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2009, DEV NEUROREHABIL, V12, P253, DOI 10.3109/17518420903086899; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Cohen J., 2013, STAT POWER ANAL BEHA; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dennis M, 1995, TRAUMATIC HEAD INJUR; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; Ennis Elaine, 2004, Pediatr Rehabil, V7, P205, DOI 10.1080/13638490410001703316; Espy KA, 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia G.A., 2002, BEHAV RATING INVENTO; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; Jacobs R., 2010, CORTEX; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kelly T P, 1999, Pediatr Rehabil, V3, P187; Korkman M., 2007, NEPSY 2; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Pickett W, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e365; Pink B.N., 2006, AUSTR NZ STANDARD CL; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Semsa H., 2008, PEDIATRICS, V121, pe1686; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D., 2002, WECHSLER PRESCHOOL P; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	63	21	21	0	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR 1	2013	19	2					113	126		10.1080/09297049.2011.651079			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	100DI	WOS:000315675600001	22384854				2022-02-06	
J	Govindarajan, S; McNeil, CJ; Lowry, JP; McMahon, CP; O'Neill, RD				Govindarajan, Sridhar; McNeil, Calum J.; Lowry, John P.; McMahon, Colm P.; O'Neill, Robert D.			Highly selective and stable microdisc biosensors for L-glutamate monitoring	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Glutamate; Biosensor; o-Phenylenediamine; Nafion; Selectivity; Stability	MODIFIED POLY(PHENYLENEDIAMINE)-COATED ELECTRODES; IN-VIVO; POLY(O-PHENYLENEDIAMINE) FILM; IMPEDANCE SPECTRA; BRUSH MODEL; OXIDASE; CARBON; POLYMER; ENZYME; NEUROTRANSMITTER	Glutamate mediates most of the excitatory synaptic transmission in the brain, and its abnormal regulation is considered a key factor underlying the appearance and progression of many neurodegenerative and psychiatric diseases. In this work, a microdisc-based amperometric biosensor for glutamate detection with highly enhanced selectivity and good stability is proposed. The biosensor utilizes the enzyme glutamate oxidase which was dip-coated onto 125 mu m diameter platinum discs. To improve selectivity, phosphatidylethanolamine was pre-coated prior to enzyme deposition, and electropolymerization of o-phenylenediamine was performed to entrap the enzyme within a polymer matrix. A variety of coating configurations were tested in order to optimize biosensor performance. For stability measurements, biosensors were biased continuously and calibration curves calculated each day for a period of 5-6 days. The optimized biosensors exhibited very high sensitivity (71 +/- 1 mA M-1 cm(-2)), low detection limit of similar to 2.5 mu M glutamate, selectivity (over 87% against ascorbic acid), very good temporal stability during continuous use, and a response time of <5 s. These biosensors are therefore good candidates for further development as devices for continuous monitoring during traumatic brain injury or neurosurgery. (c) 2013 Elsevier B.V. All rights reserved.	[Govindarajan, Sridhar] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McNeil, Calum J.] Newcastle Univ, Dept Clin Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lowry, John P.] NUIM, Dept Chem, Maynooth, Kildare, Ireland; [McMahon, Colm P.; O'Neill, Robert D.] Univ Coll Dublin, UCD Sch Chem & Chem Biol, Dublin, Ireland		Govindarajan, S (corresponding author), Swansea Univ, Coll Engn, Swansea SA2 8PP, W Glam, Wales.	sri.govindarajan@gmail.com; calum.mcneil@newcastle.ac.uk	O'Neill, Robert D/D-7290-2014; McNeil, Calum/G-8059-2011	O'Neill, Robert D/0000-0002-9606-5065; McNeil, Calum/0000-0002-8513-087X; Lowry, John/0000-0002-8957-6799; Govindarajan, Sridhar/0000-0002-0082-1429	Northern Brainwave Appeal	The authors would like to thank Prof. A.D. Mendelow and Mr. Patrick Mitchell (Consultant Neurosurgeons, Newcastle General Hospital, Newcastle upon Tyne, UK) for their help and invaluable advice. The authors would also like to thank Northern Brainwave Appeal for funding a part of this research.	Alvarez-Crespo SL, 1997, BIOSENS BIOELECTRON, V12, P739, DOI 10.1016/S0956-5663(97)00041-9; Bartlett PN, 1997, J ELECTROCHEM SOC, V144, P3705, DOI 10.1149/1.1838079; Basu AK, 2006, BIOSENS BIOELECTRON, V21, P1968, DOI 10.1016/j.bios.2005.09.011; BERNERS MOM, 1994, ANAL CHEM, V66, P2017, DOI 10.1021/ac00085a016; Boutelle MG, 1996, J MOL RECOGNIT, V9, P664, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<664::AID-JMR318>3.0.CO;2-U; Brown FO, 2003, ANALYST, V128, P700, DOI 10.1039/b300266g; Burmeister JJ, 2003, TRAC-TREND ANAL CHEM, V22, P498, DOI 10.1016/S0165-9936(03)00904-X; Camurri G, 2005, J ELECTROANAL CHEM, V585, P181, DOI 10.1016/j.jelechem.2005.08.016; Castillo J, 2005, BIOSENS BIOELECTRON, V20, P2116, DOI 10.1016/j.bios.2004.09.013; CENTONZE D, 1994, ELECTROANAL, V6, P423, DOI 10.1002/elan.1140060511; CHIBA K, 1987, J ELECTROANAL CHEM, V219, P117, DOI 10.1016/0022-0728(87)85034-9; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dingledine Raymond, 1999, P315; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Frost M, 2006, ANAL CHEM, V78, P7370, DOI 10.1021/ac069475k; Govindarajan S, 2009, ANAL LETT, V42, P739, DOI 10.1080/00032710902721972; GOYETTE MA, 1995, J ELECTROANAL CHEM, V382, P17, DOI 10.1016/0022-0728(94)03632-D; Hirano A, 2006, MINI-REV MED CHEM, V6, P1091, DOI 10.2174/138955706778560102; Jeong H, 2011, J NANOSCI NANOTECHNO, V11, P987, DOI 10.1166/jnn.2011.3079; KEMPSKI OS, 1994, ACTA NEUROCHIR, P7; Killoran SJ, 2008, ELECTROCHIM ACTA, V53, P7303, DOI 10.1016/j.electacta.2008.03.076; Lancelot E, 1998, PROG BRAIN RES, V116, P331, DOI 10.1016/S0079-6123(08)60446-X; Lang GG, 2006, ELECTROCHIM ACTA, V51, P1680, DOI 10.1016/j.electacta.2005.02.100; Lang GG, 2004, J ELECTROANAL CHEM, V572, P283, DOI 10.1016/j.jelechem.2003.11.052; LOWRY JP, 1994, ELECTROANAL, V6, P369, DOI 10.1002/elan.1140060504; LOWRY JP, 1994, ANAL CHEM, V66, P1754, DOI 10.1021/ac00082a025; MALITESTA C, 1990, ANAL CHEM, V62, P2735, DOI 10.1021/ac00223a016; McAteer K, 1996, ANALYST, V121, P773, DOI 10.1039/an9962100773; McMahon CP, 2007, BIOSENS BIOELECTRON, V22, P1466, DOI 10.1016/j.bios.2006.06.027; McMahon CP, 2006, ANALYST, V131, P68, DOI 10.1039/b511643k; McMahon CP, 2004, CHEM COMMUN, P2128, DOI 10.1039/b408051n; Murphy LJ, 1998, ANAL CHEM, V70, P2928, DOI 10.1021/ac971182r; Nakamura N, 2005, ANAL BIOANAL CHEM, V383, P660, DOI 10.1007/s00216-005-0033-6; O'Neill RD, 1998, CRIT REV NEUROBIOL, V12, P69, DOI 10.1615/CritRevNeurobiol.v12.i1-2.40; O'Neill RD, 2004, BIOSENS BIOELECTRON, V19, P1521, DOI 10.1016/j.bios.2003.12.004; O'Neill RD, 2008, TRAC-TREND ANAL CHEM, V27, P78, DOI 10.1016/j.trac.2007.11.008; Oldenziel WH, 2007, J NEUROSCI METH, V160, P37, DOI 10.1016/j.jneumeth.2006.08.003; Rothwell SA, 2010, ELECTROCHIM ACTA, V55, P1051, DOI 10.1016/j.electacta.2009.09.069; Rothwell SA, 2009, ANAL CHEM, V81, P3911, DOI 10.1021/ac900162c; Ryan MR, 1997, ANALYST, V122, P1419, DOI 10.1039/a704508e; Sanchez CO, 2002, J APPL POLYM SCI, V85, P2564, DOI 10.1002/app.10875; SASSO SV, 1990, ANAL CHEM, V62, P1111, DOI 10.1021/ac00210a004; Shang FJ, 2009, ANALYST, V134, P519, DOI 10.1039/b814317j; Smith Y, 2005, DOPAMINE AND GLUTAMATE IN PSYCHIATRIC DISORDERS, P65, DOI 10.1007/978-1-59259-852-6_3; WANG J, 1994, ANAL CHEM, V66, P1988, DOI 10.1021/ac00085a011; Weinberg RJ, 1999, BRAIN RES BULL, V50, P353, DOI 10.1016/S0361-9230(99)00102-1; Wu CC, 2004, ANAL CHIM ACTA, V505, P239, DOI 10.1016/j.aca.2003.10.073; Yogeswaran U, 2008, SENSOR ACTUAT B-CHEM, V130, P739, DOI 10.1016/j.snb.2007.10.040; Zhu WL, 2011, J NANOSCI NANOTECHNO, V11, P138, DOI 10.1166/jnn.2011.2673	50	21	21	2	57	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND		0925-4005		SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	MAR 1	2013	178						606	614		10.1016/j.snb.2012.12.077			9	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry; Instruments & Instrumentation	101BV	WOS:000315751100080		Green Accepted			2022-02-06	
J	Jones, L; Morris, R				Jones, Lisa; Morris, Reg			Experiences of adult stroke survivors and their parent carers: a qualitative study	CLINICAL REHABILITATION			English	Article						Stroke; carers; survivors; qualitative; parents	TRAUMATIC BRAIN-INJURY; INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS; FAMILY CAREGIVERS; INFORMAL CARERS; OF-LIFE; PSYCHOLOGY; PEOPLE; IMPACT; INTERVENTION; DEPRESSION	Objective: To explore the experiences of adult stroke survivors and their parent carers. Design: Qualitative methodology: interpretative phenomenological analysis. Setting: Six residential areas across England and south Wales. Participants: Six adult stroke survivors (aged 27-46), six mothers (aged 59-76) and five fathers (aged 55-76). Method: Semi-structured interviews to explore the relationship and interactions between parent and survivor prior to and after a stroke, with opportunities to explore both positive and negative changes. All interviews were transcribed and analysed by a six step interpretative phenomenological analysis process. Survivors, mothers and fathers were analysed as three separate groups and the results were synthesised. Results: Identical and interconnected themes emerged from the three groups, permitting synthesis into a single organising framework with four superordinate themes capturing the key issues for all three groups. The four superordinate themes were: 'emotional turmoil'; 'significance of parents'; 'negotiating independence versus dependence' and 'changed relationships'. Conclusions: Parents reported adjusting to caring with relative ease. Survivors did not adjust to being cared for with such ease and felt positioned in a child role. Balancing independence and dependence was a challenge for survivors and parents and is considered within a systemic theory framework. Implications for service developments and guidelines are considered.	[Jones, Lisa] Rookwood Hosp, Cardiff, S Glam, Wales; [Morris, Reg] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Jones, Lisa] Vale NHS Trust, Cardiff, S Glam, Wales		Morris, R (corresponding author), Cardiff Univ, Sch Psychol, 11th Floor,Tower Bldg,70 Pk Pl, Cardiff CF10, S Glam, Wales.	reg.morris@wales.nhs.uk		Morris, Reg/0000-0002-8250-9315	National Leadership and Innovation Agency for Health (Wales)	This research was undertaken in partial fulfilment of a doctor of clinical psychology programme funded by the National Leadership and Innovation Agency for Health (Wales).	Berg A, 2005, STROKE, V36, P639, DOI 10.1161/01.STR.0000155690.04697.c0; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Buckner L. J., 2007, VALUING CARERS CALCU; Bulley C, 2010, DISABIL REHABIL, V32, P1406, DOI 10.3109/09638280903531238; Buschenfeld K, 2009, DISABIL REHABIL, V31, P1643, DOI 10.1080/09638280902736338; CARNWATH TCM, 1987, BRIT MED J, V294, P409, DOI 10.1136/bmj.294.6569.409; Carter E.A., 1999, EXPANDED FAMILY LIFE; Cramer P, 2000, AM PSYCHOL, V55, P637, DOI 10.1037//0003-066X.55.6.637; Department of Health, 2005, NAT SERV FRAM LONG T; Draper P, 2007, J CLIN NURS, V16, P264, DOI 10.1111/j.1365-2702.2006.01575.x; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Evans R L, 1994, Disabil Rehabil, V16, P110; EVANS RL, 1987, ARCH PHYS MED REHAB, V68, P508; Gaugler JE, 2010, REHABIL PSYCHOL, V55, P108, DOI 10.1037/a0019023; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Gillespie David, 2011, Nurs Stand, V26, P39; Grant JS, 2004, REHABIL PSYCHOL, V49, P172, DOI 10.1037/0090-5550.49.2.172; Greenwood N, 2008, DISABIL REHABIL, V30, P1329, DOI 10.1080/09638280701602178; Greenwood N, 2010, MATURITAS, V66, P268, DOI 10.1016/j.maturitas.2010.03.017; Greenwood N, 2009, DISABIL REHABIL, V31, P337, DOI 10.1080/09638280802051721; Haley WE, 2009, STROKE, V40, P2129, DOI 10.1161/STROKEAHA.108.545269; Han B, 1999, STROKE, V30, P1478, DOI 10.1161/01.STR.30.7.1478; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Hunt D, 2004, DISABIL REHABIL, V26, P1000, DOI 10.1080/09638280410001702423; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; Mackenzie A, 2007, DISABIL REHABIL, V29, P111, DOI 10.1080/09638280600731599; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36; Molloy GJ, 2008, HEALTH PSYCHOL, V27, P286, DOI 10.1037/0278-6133.27.2.286; Morris R, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/534812; Murray J, 2003, BRIT J GEN PRACT, V53, P137; National Institute for Health and Clinical excellence, 2011, STROK QUAL STAND ADV; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Palmer S, 2003, REHABIL PSYCHOL, V48, P255, DOI 10.1037/0090-5550.48.4.255; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Robinson L, 2005, CLIN REHABIL, V19, P560, DOI 10.1191/0269215505cr787oa; ROLLAND JS, 1987, FAM PROCESS, V26, P203, DOI 10.1111/j.1545-5300.1987.00203.x; Segal D, 2010, INT J CHILD YOUTH FA, V1, P293, DOI 10.18357/ijcyfs13/420102093; Smith J.A., 2009, INTERPRETATIVE PHENO; Strudwick A, 2010, CLIN REHABIL, V24, P159, DOI 10.1177/0269215509343847; van Heugten C, 2006, J REHABIL MED, V38, P153, DOI 10.1080/16501970500441898; White CL, 2004, QUAL LIFE RES, V13, P625, DOI 10.1023/B:QURE.0000021312.37592.4f; Wongvatunyu S, 2008, QUAL HEALTH RES, V18, P1062, DOI 10.1177/1049732308320111; Yin R.K., 2009, CASE STUDY RES DESIG	51	21	21	0	19	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAR	2013	27	3					272	280		10.1177/0269215512455532			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	089FH	WOS:000314895100009	22850756				2022-02-06	
J	Miltiadous, P; Kouroupi, G; Stamatakis, A; Koutsoudaki, PN; Matsas, R; Stylianopoulou, F				Miltiadous, Panagiota; Kouroupi, Georgia; Stamatakis, Antonios; Koutsoudaki, Paraskevi N.; Matsas, Rebecca; Stylianopoulou, Fotini			Subventricular Zone-Derived Neural Stem Cell Grafts Protect Against Hippocampal Degeneration and Restore Cognitive Function in the Mouse Following Intrahippocampal Kainic Acid Administration	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Stem cell transplantation; Neural stem cell; Insulin-like growth factors; Experimental models; Cellular therapy	TEMPORAL-LOBE EPILEPSY; GROWTH-FACTOR-I; TRAUMATIC BRAIN-INJURY; IGF-I; PRECURSOR CELLS; GABAERGIC INTERNEURONS; NEUROLOGICAL DISORDERS; PROGENITOR CELLS; GENE THERAPIES; SCAR FORMATION	Temporal lobe epilepsy (TLE) is a major neurological disease, often associated with cognitive decline. Since approximately 30% of patients are resistant to antiepileptic drugs, TLE is being considered as a possible clinical target for alternative stem cell-based therapies. Given that insulin-like growth factor I (IGF-I) is neuroprotective following a number of experimental insults to the nervous system, we investigated the therapeutic potential of neural stem/precursor cells (NSCs) transduced, or not, with a lentiviral vector for overexpression of IGF-I after transplantation in a mouse model of kainic acid (KA)-induced hippocampal degeneration, which represents an animal model of TLE. Exposure of mice to the Morris water maze task revealed that unilateral intrahippocampal NSC transplantation significantly prevented the KA-induced cognitive decline. Moreover, NSC grafting protected against neurodegeneration at the cellular level, reduced astrogliosis, and maintained endogenous granule cell proliferation at normal levels. In some cases, as in the reduction of hippocampal cell loss and the reversal of the characteristic KA-induced granule cell dispersal, the beneficial effects of transplanted NSCs were manifested earlier and were more pronounced when these were transduced to express IGF-I. However, differences became less pronounced by 2 months postgrafting, since similar amounts of IGF-I were detected in the hippocampi of both groups of mice that received cell transplants. Grafted NSCs survived, migrated, and differentiated into neurons-including glutamatergic cells-and not glia, in the host hippocampus. Our results demonstrate that transplantation of IGF-I producing NSCs is neuroprotective and restores cognitive function following KA-induced hippocampal degeneration. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:185-198	[Miltiadous, Panagiota; Stamatakis, Antonios; Koutsoudaki, Paraskevi N.; Stylianopoulou, Fotini] Univ Athens, Fac Nursing, Dept Basic Sci, Biol Biochem Lab, Athens 11527, Greece; [Kouroupi, Georgia; Koutsoudaki, Paraskevi N.; Matsas, Rebecca] Hellenic Pasteur Inst, Lab Cellular & Mol Neurobiol, Athens, Greece		Stylianopoulou, F (corresponding author), Univ Athens, Fac Nursing, Dept Basic Sci, Biol Biochem Lab, 123 Papadiamantopoulou St, Athens 11527, Greece.	rmatsa@pasteur.gr; fstilian@nurs.uoa.gr	STYLIANOPOULOU, FOTINI/B-1403-2008; Stamatakis, A./J-5294-2019	Stamatakis, A./0000-0003-2480-5578; Koutsoudaki, Paraskevi N./0000-0003-4765-3730	framework of the Reinforcement Program of Human Research Manpower (PENED) [03ED82]; National and Community Funds; E.U. FP7 REGPOT Project Neurosign [264083]; Foundation BNP Paribas	The study is part of the 03ED82 research project, implemented within the framework of the Reinforcement Program of Human Research Manpower (PENED) and cofinanced by National and Community Funds (25% from the Greek General Secretariat for Research and Technology and 75% from E.U.-European Social Fund). R.M. acknowledges the support of E.U. FP7 REGPOT Project 264083 Neurosign and the Foundation BNP Paribas.	BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bjorklund A, 2010, PROG BRAIN RES, V184, P265, DOI 10.1016/S0079-6123(10)84014-2; Bluthe RM, 2005, J NEUROIMMUNOL, V169, P50, DOI 10.1016/j.jneuroim.2005.07.017; Boison D, 2009, NEUROTHERAPEUTICS, V6, P278, DOI 10.1016/j.nurt.2008.12.001; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Bondy CA, 2002, INT REV NEUROBIOL, V51, P189, DOI 10.1016/S0074-7742(02)51006-0; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; Chesik D, 2007, INT REV NEUROBIOL, V79, P203, DOI 10.1016/S0074-7742(07)79009-8; de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022; Fernandez AM, 2005, BRAIN RES REV, V50, P134, DOI 10.1016/j.brainresrev.2005.05.003; Florian C, 2006, LEARN MEMORY, V13, P465, DOI 10.1101/lm.249306; Gluckman PD, 1998, MOL CELL ENDOCRINOL, V140, P95, DOI 10.1016/S0303-7207(98)00035-5; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hartman NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015856; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Heinemann U, 2000, EPILEPSIA, V41, pS185, DOI 10.1111/j.1528-1157.2000.tb01579.x; Helmstaedter C, 2002, PROG BRAIN RES, V135, P439; HOLMES GL, 1991, DEV BRAIN RES, V64, P47, DOI 10.1016/0165-3806(91)90208-Z; Hurtado-Chong A, 2009, EUR J NEUROSCI, V30, P742, DOI 10.1111/j.1460-9568.2009.06870.x; INSAUSTI R, 2004, HUMAN NERVOUS SYSTEM; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kan EM, 2010, CURR MED CHEM, V17, P4492; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsimpardi L, 2008, STEM CELLS, V26, P1796, DOI 10.1634/stemcells.2007-0921; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kouroupi G, 2010, J NEUROCHEM, V115, P460, DOI 10.1111/j.1471-4159.2010.06939.x; Kuruba R, 2009, EPILEPSY BEHAV, V14, P65, DOI 10.1016/j.yebeh.2008.08.020; LAURBERG S, 1979, J COMP NEUROL, V184, P685, DOI 10.1002/cne.901840405; Li TF, 2007, BRAIN, V130, P1276, DOI 10.1093/brain/awm057; Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002; Liu Xin-Feng, 2004, J Stroke Cerebrovasc Dis, V13, P16, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.005; Loscher W, 2008, TRENDS NEUROSCI, V31, P62, DOI 10.1016/j.tins.2007.11.012; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Makri G, 2010, STEM CELLS, V28, P127, DOI 10.1002/stem.258; Miltiadous P, 2011, EXP NEUROL, V231, P223, DOI 10.1016/j.expneurol.2011.06.014; Miltiadous P, 2010, CELL MOL NEUROBIOL, V30, P347, DOI 10.1007/s10571-009-9457-4; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Parent JM, 2002, PROG BRAIN RES, V135, P121; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Rao MS, 2007, NEUROBIOL DIS, V27, P117, DOI 10.1016/j.nbd.2007.03.016; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Schwarz SC, 2010, TRANSL RES, V156, P155, DOI 10.1016/j.trsl.2010.07.002; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sequerra EB, 2010, CEREB CORTEX, V20, P2583, DOI 10.1093/cercor/bhq006; Shetty AK, 1999, EXP NEUROL, V158, P491, DOI 10.1006/exnr.1999.7107; Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313; Shetty AK, 2011, NEUROTHERAPEUTICS, V8, P721, DOI 10.1007/s13311-011-0064-y; Singleton JR, 1996, J BIOL CHEM, V271, P31791, DOI 10.1074/jbc.271.50.31791; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Torres-Aleman I, 2007, EXPERT OPIN THER TAR, V11, P1535, DOI 10.1517/14728222.11.12.1535; Turner RS, 1943, J COMP NEUROL, V79, P73, DOI 10.1002/cne.900790106; VONEIDA TJ, 1981, ANAT REC, V201, P91, DOI 10.1002/ar.1092010112; Waldau B, 2010, STEM CELLS, V28, P1153, DOI 10.1002/stem.446	64	21	24	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	MAR	2013	2	3					185	198		10.5966/sctm.2012-0074			14	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110FO	WOS:000316428200012	23417642	Green Published, gold			2022-02-06	
J	Li, Y; Song, JN; Liu, XB; Zhang, M; An, JY; Sun, P; Li, DD; Jin, T; Wang, JF				Li, Yu; Song, Jinning; Liu, Xiaobin; Zhang, Ming; An, Jiyang; Sun, Peng; Li, Dandong; Jin, Tao; Wang, Junfeng			High expression of STIM1 in the early stages of diffuse axonal injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Diffuse axonal injury; STIM1; SOCE; Calcium	TRAUMATIC BRAIN-INJURY; CALCIUM DYSREGULATION; TRPC CHANNELS; STORE; CRAC; DEPLETION; RELEASE; AXOTOMY; MODEL	Increased intracellular calcium ([Ca2+](i)) is a key pathological mechanism involved in secondary neuronal injury and cell death due to diffuse axonal injury (DAI). To date, this increased [Ca2+](i) is believed to be mainly caused by dysfunction of voltage-gated sodium channels and mechanoporation of the plasma membrane. Store-operated calcium entry (SOCE) is another source of Ca2+ influx, and stromal interaction molecule 1 (STIM1) is considered as a sensor and a regulator of SOCE. In this study, we established a DAI in vivo model in rats by lateral head rotation. Using immunohistochemistry, real-time RT-PCR and Western blot, we investigated STIM1 expression levels in the cerebral cortex of rats after lateral head rotational injury. Results revealed notably high STIM1 expression in neurons in the early stages (within 24 h) of DAI. STIM1 began to increase at 6 h post-injury (PI) peaked at 12 h PI, and then gradually decreased. At 2 days PI, STIM1 expression in the injury group showed no significant difference compared with that of the control group. These results indicate that abnormal SOCE may participate in Ca2+ overload of neurons in the early stages after DAI via enhanced STIM1 expression. (C) 2012 Elsevier B.V. All rights reserved.	[Li, Yu; Song, Jinning; Liu, Xiaobin; Zhang, Ming; An, Jiyang; Sun, Peng; Li, Dandong; Jin, Tao; Wang, Junfeng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China.	Jinnings@126.com		Li, Dan-Dong/0000-0003-4973-8818	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30471774]	This work was supported by the National Natural Science Foundation of China (Project 30471774).	BANIK NL, 1987, NEUROCHEM PATHOL, V7, P57, DOI 10.1007/BF02834292; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; He X.S., 2004, J CLIN NEUROSCI, V14, P8; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kachoei B.A., 2006, J NEUROPHYSIOL, V96, P2698; [刘晓斌 Liu Xiaobin], 2008, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V29, P595; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; McIntosh TK, 1996, LAB INVEST, V74, P315; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Skibinska-Kijek A, 2009, ACTA NEUROBIOL EXP, V69, P413; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Song JN, 2011, NEURAL REGEN RES, V6, P1530, DOI 10.3969/j.issn.1673-5374.2011.20.002; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	34	21	41	2	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 7	2013	1495						95	102		10.1016/j.brainres.2012.12.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085OQ	WOS:000314624500010	23261659				2022-02-06	
J	Wang, T; Chou, DYT; Ding, JY; Fredrickson, V; Peng, CY; Schafer, S; Guthikonda, M; Kreipke, C; Rafols, JA; Ding, YC				Wang, Tony; Chou, David Yu-Te; Ding, Jamie Y.; Fredrickson, Vance; Peng, Changya; Schafer, Steven; Guthikonda, Murali; Kreipke, Christian; Rafols, Jose A.; Ding, Yuchuan			Reduction of brain edema and expression of aquaporins with acute ethanol treatment after traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						blood-brain barrier; cognitive behavior; rat; motor behavior; ethanol; neuroprotection; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; MESSENGER-RNA; WATER CHANNELS; HEAD-INJURY; ALCOHOL; RATS; INTOXICATION; MODEL; PATHOPHYSIOLOGY; ASTROCYTES	Object. Previous studies have demonstrated that traumatic brain injury (TBI) causes brain edema by allowing excessive water passage through aquaporin (AQP) proteins. To establish the potential neuroprotective properties of ethanol as a post-TBI therapy, in the present study the authors determined the effect of ethanol on brain edema, AQP expression, and functional outcomes in a post-TBI setting. Methods. Adult male Sprague-Dawley rats weighing between 425 and 475 g received a closed head TBI in which Maramarou's impact-acceleration method was used. Animals were given a subsequent intraperitoneal injection of 0.5 g/kg or 1.5 g/kg ethanol at 60 minutes post-TBI and were killed 24 hours after TBI. Brains were subsequently examined for edema along with AQP mRNA and protein expression. Additional animals treated with either 0.5 g/kg or 1.5 g/kg ethanol at 60 minutes post-TBI were designated for cognitive and motor testing for 3 weeks. Results. Ethanol administration post-TBI led to significantly (p < 0.05) lower levels of brain edema as measured by brain water content. This downregulation in brain edema was associated with significantly (p < 0.05) reduced levels of AQP mRNA and protein expression as compared with TBI without treatment. These findings concur with cognitive studies in which ethanol-treated animals exhibited significantly (p < 0.05) faster radial maze completion times. Motor behavioral testing additionally demonstrated significant (p < 0.05) beneficial effects of ethanol, with treated animals displaying improved motor coordination when compared with untreated animals. Conclusions. The present findings suggest that acute ethanol administration after a TBI decreases AQP expression, which may lead to reduced cerebral edema. Ethanol-treated animals additionally showed improved cognitive and motor outcomes compared with untreated animals. (http://thejns.org/doi/abs/10.3171/2012.8.JNS12736)	[Wang, Tony; Chou, David Yu-Te; Fredrickson, Vance; Peng, Changya; Guthikonda, Murali; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA; [Schafer, Steven; Rafols, Jose A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Kreipke, Christian] Vet Adm Hosp, Detroit, MI USA; [Ding, Jamie Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA		Ding, YC (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, Lande Bldg,Room 48,550 E Canfield St, Detroit, MI 48201 USA.	yding@med.wayne.edu			Department of Neurological Surgery Fund; NIH NS Grant [39860]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER	This work was partially supported by the Department of Neurological Surgery Fund (Dr. Y. Ding) and NIH NS Grant No. 39860 (Dr. Rafols). The authors have no conflicts of interest.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; Ding YC, 2003, NEUROSCI LETT, V353, P173, DOI 10.1016/j.neulet.2003.09.055; Ding YC, 2002, BEHAV BRAIN RES, V132, P29, DOI 10.1016/S0166-4328(01)00405-3; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gerard HC, 2002, J RHEUMATOL, V29, P1827; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kreipke CW, 2007, NEUROL RES, V29, P388, DOI 10.1179/016164107X204710; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Moykkynen T, 2012, BASIC CLIN PHARMACOL, V111, P4, DOI 10.1111/j.1742-7843.2012.00879.x; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sorani MD, 2008, HUM MOL GENET, V17, P2379, DOI 10.1093/hmg/ddn138; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Wang F, 2012, STROKE, V43, P205, DOI 10.1161/STROKEAHA.111.629576; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zeng XW, 2012, BRAIN RES, V1437, P127, DOI 10.1016/j.brainres.2011.12.012	35	21	21	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2013	118	2					390	396		10.3171/2012.8.JNS12736			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	076DY	WOS:000313937900024	23198799				2022-02-06	
J	Jung, J; Shin, YH; Konishi, H; Lee, SJ; Kiyama, H				Jung, Junyang; Shin, Youn Ho; Konishi, Hiroyuki; Lee, Seo Jin; Kiyama, Hiroshi			Possible ATP release through lysosomal exocytosis from primary sensory neurons	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						ATP; Lysosomal exocytosis; Dorsal root ganglion; Vesicular nucleotide transporter	DORSAL-ROOT GANGLIA; NEUROTRANSMITTER RELEASE; ADENOSINE-TRIPHOSPHATE; CENTRAL SYNAPSES; SCHWANN-CELLS; QUINACRINE; RAT; ASTROCYTES; MECHANISM; NERVES	The adenosine triphosphate (ATP) plays important roles under physiological and pathological conditions such as traumatic brain injury, neuroinflammation and neuropathic pain. In the present study, we set out to study the role of lysosomal vesicles on ATP release from the dorsal root ganglion neurons. We found that the lysosomal vesicles, which contain the quinacrine-positive fluorescence and express the vesicular nucleotide transporter (VNUT), were localized within the soma and growth cone of the cultured dorsal root ganglion neurons. In addition, the number of the quinacrine staining was decreased by application of lysosomal exocytosis activators, and this decrease was suppressed by the metformin and vacuolin-1, which suppressed lysosomal exocytosis. Thus, these findings suggest that ATP release via the lysosomal exocytosis may be one of the pathways for ATP release in response to stimulation. (C) 2012 Elsevier Inc. All rights reserved.	[Jung, Junyang; Shin, Youn Ho; Lee, Seo Jin] Kyung Hee Univ, Dept Anat, Coll Med, Seoul 130701, South Korea; [Jung, Junyang; Konishi, Hiroyuki; Kiyama, Hiroshi] Nagoya Univ, Dept Funct Anat & Neurosci, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Jung, Junyang; Konishi, Hiroyuki; Kiyama, Hiroshi] Nagoya Univ, CREST, JST, Grad Sch Med,Showa Ku, Nagoya, Aichi 4668550, Japan		Kiyama, H (corresponding author), Nagoya Univ, Dept Funct Anat & Neurosci, Grad Sch Med, Showa Ku, 65 Tsurumaicho, Nagoya, Aichi 4668550, Japan.	Kiyama@med.nagoya-u.ac.jp	KONISHI, Hiroyuki/M-8871-2014; Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	CREST, JST, JapanJapan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This study was partially supported by CREST, JST, Japan and a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) from the Ministry of Education, Science, Sports and Culture of Japan.	ALUND M, 1979, BRAIN RES, V166, P121, DOI 10.1016/0006-8993(79)90654-1; Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Gonzales E, 2010, J HEPATOL, V52, P54, DOI 10.1016/j.jhep.2009.10.005; HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494, DOI 10.1113/jphysiol.1959.sp006157; IIJIMA T, 1983, CELL TISSUE RES, V230, P639, DOI 10.1007/BF00216207; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Liu GJ, 2003, NEUROREPORT, V14, P2079, DOI 10.1097/00001756-200311140-00014; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Matsuka Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-66; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Pankratov Y., 2002, J PHYSL, V512, P1702; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; RICHES DWH, 1983, BIOCHEM J, V212, P869, DOI 10.1042/bj2120869; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Soeda H, 1997, NEUROSCIENCE, V77, P1187, DOI 10.1016/S0306-4522(96)00465-4; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Sundler R, 1997, ACTA PHYSIOL SCAND, V161, P553, DOI 10.1046/j.1365-201X.1997.00262.x; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Takenouchi T, 2009, J IMMUNOL, V182, P2051, DOI 10.4049/jimmunol.0802577; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; WEISBLUM B, 1972, P NATL ACAD SCI USA, V69, P629, DOI 10.1073/pnas.69.3.629; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	38	21	21	0	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 11	2013	430	2					488	493		10.1016/j.bbrc.2012.12.009			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	080QH	WOS:000314257800008	23237805				2022-02-06	
J	Hellmich, HL; Rojo, DR; Micci, MA; Sell, SL; Boone, DR; Crookshanks, JM; DeWitt, DS; Masel, BE; Prough, DS				Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S.			Pathway Analysis Reveals Common Pro-Survival Mechanisms of Metyrapone and Carbenoxolone after Traumatic Brain Injury	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; COGNITIVE FUNCTION; MESSENGER-RNA; ALZHEIMERS; NEUROPROTECTION; GLUCOCORTICOIDS; IMPAIRMENT; INHIBITOR	Developing new pharmacotherapies for traumatic brain injury (TBI) requires elucidation of the neuroprotective mechanisms of many structurally and functionally diverse compounds. To test our hypothesis that diverse neuroprotective drugs similarly affect common gene targets after TBI, we compared the effects of two drugs, metyrapone (MT) and carbenoxolone (CB), which, though used clinically for noncognitive conditions, improved learning and memory in rats and humans. Although structurally different, both MT and CB inhibit a common molecular target, 11 beta hydroxysteroid dehydrogenase type 1, which converts inactive cortisone to cortisol, thereby effectively reducing glucocorticoid levels. We examined injury-induced signaling pathways to determine how the effects of these two compounds correlate with pro-survival effects in surviving neurons of the injured rat hippocampus. We found that treatment of TBI rats with MT or CB acutely induced in hippocampal neurons transcriptional profiles that were remarkably similar (i.e., a coordinated attenuation of gene expression across multiple injury-induced cell signaling networks). We also found, to a lesser extent, a coordinated increase in cell survival signals. Analysis of injury-induced gene expression altered by MT and CB provided additional insight into the protective effects of each. Both drugs attenuated expression of genes in the apoptosis, death receptor and stress signaling pathways, as well as multiple genes in the oxidative phosphorylation pathway such as subunits of NADH dehydrogenase (Complex1), cytochrome c oxidase (Complex IV) and ATP synthase (Complex V). This suggests an overall inhibition of mitochondrial function. Complex 1 is the primary source of reactive oxygen species in the mitochondrial oxidative phosphorylation pathway, thus linking the protective effects of these drugs to a reduction in oxidative stress. The net effect of the drug-induced transcriptional changes observed here indicates that suppressing expression of potentially harmful genes, and also, surprisingly, reduced expression of pro-survival genes may be a hallmark of neuroprotective therapeutic effects.	[Hellmich, Helen L.; Rojo, Daniel R.; Micci, Maria-Adelaide; Sell, Stacy L.; Boone, Deborah R.; Crookshanks, Jeanna M.; DeWitt, Douglas S.; Masel, Brent E.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Department of Anesthesiology; Moody Foundation; Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research	This study was supported by the Department of Anesthesiology, the Moody Foundation and the Moody Center for Traumatic Brain Injury and Spinal Cord Injury Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Aubrecht J, 1996, RES COMMUN MOL PATH, V94, P47; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BRODY TM, 1955, PHARMACOL REV, V7, P335; CAMPISI D, 1985, PHARMATHERAPEUTICA, V4, P166; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; DAVIES GJ, 1974, BRIT MED J, V3, P400, DOI 10.1136/bmj.3.5927.400; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gareri P, 2004, NEUROPHARMACOLOGY, V47, P1205, DOI 10.1016/j.neuropharm.2004.08.021; Gohil M, 2010, NAT BIOTECHNOL, V28, P249; Gomes E, 2007, MOL CELL BIOCHEM, V305, P179, DOI 10.1007/s11010-007-9542-2; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Jahn H, 2004, ARCH GEN PSYCHIAT, V61, P1235, DOI 10.1001/archpsyc.61.12.1235; Jahn H, 2003, SLEEP, V26, P823, DOI 10.1093/sleep/26.7.823; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6; Kasarskis A, 2011, PHARMACOGENOMICS, V12, P1695, DOI [10.2217/PGS.11.115, 10.2217/pgs.11.115]; KENNEDY JA, 1990, BRIT J ADDICT, V85, P1133; Khorasani MZ, 2009, PAK J PHARM SCI, V22, P349; Krugers HJ, 2000, STROKE, V31, P1162, DOI 10.1161/01.STR.31.5.1162; Laborie C, 2003, J NEUROENDOCRINOL, V15, P15, DOI 10.1046/j.1365-2826.2003.00859.x; Laborie C, 1995, NEUROENDOCRINOLOGY, V62, P601, DOI 10.1159/000127056; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Mahmud T, 1996, ARTHRITIS RHEUM, V39, P1998, DOI 10.1002/art.1780391208; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagayama S, 2001, LIFE SCI, V69, P2867, DOI 10.1016/S0024-3205(01)01362-5; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Pivato LS, 2006, J BIOCHEM MOL TOXIC, V20, P230, DOI 10.1002/jbt.20139; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Riepe MW, 1997, J CEREBR BLOOD F MET, V17, P257, DOI 10.1097/00004647-199703000-00002; Rogoz Z, 2007, PHARMACOL REP, V59, P588; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Rotllant D, 2002, EUR J NEUROSCI, V16, P693, DOI 10.1046/j.1460-9568.2002.02120.x; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; SAS Institute, 2004, SAS STAT 9 1 US GUID; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Srivastava S, 2011, CURR PHARM DESIGN, V17, P3418, DOI 10.2174/138161211798072526; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Whitehead D, 1997, J MOL ENDOCRINOL, V19, P291, DOI 10.1677/jme.0.0190291; YOUNG EA, 1994, ARCH GEN PSYCHIAT, V51, P701; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16	72	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53230	10.1371/journal.pone.0053230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	WOS:000313551500054	23326402	Green Submitted, Green Published, gold			2022-02-06	
J	Alhabdan, S; Zamakhshary, M; AlNaimi, M; Mandora, H; Alhamdan, M; Al-Bedah, K; Al-Enazi, S; Al-Habib, A				Alhabdan, Sultan; Zamakhshary, Mohammed; AlNaimi, Manal; Mandora, Hala; Alhamdan, Manal; Al-Bedah, Khalid; Al-Enazi, Salem; Al-Habib, Amro			Epidemiology of traumatic head injury in children and adolescents in a major trauma center in Saudi Arabia: implications for injury prevention	ANNALS OF SAUDI MEDICINE			English	Article							SEVERITY SCORE; BLUNT TRAUMA; BRAIN-INJURY; CHILDHOOD; IMPACT; MANAGEMENT; PATTERNS; OBESITY	BACKGROUND AND OBJECTIVES: Injury to the head is the most common affected body part in pediatric trauma and could be associated with deleterious consequences. It presents a challenge for developing countries since many injuries are preventable and there are few epidemiological data to support injury prevention programs. The current study aimed to determine demographic characteristics, etiology and outcome of head injury in the pediatric population and compare findings to international figures. DESIGN AND SETINGS: Retrospective review of consecutive cases registered in major trauma center database, Riyadh, from 2001 to 2009. PATIENTS AND METHODS: The database registry was limited to hospitalized patients following injury. Any head injury in a patient <= 18 years was included. RESULTS: Of 3796 patients identified, 1219 patients (32.1%) suffered head injury (mean age 8.6 years; males 78.4%). Children under 12 years comprised 66.3%. Motor vehicle crash (MVC) was the commonest cause (34.2%), followed by pedestrian injury (30.3%) and falls (28.4%). When stratified by age, falls (45.6%) were the most common etiology under 6 years while MVC was the leading cause in high school students (74.4%). The latter group had the lowest mean (SD) Glascow coma scale scores (8.58 [4.7]), highest mean injury severity scale scores (23.4 [21]), highest rate of craniotomy (7%) and highest mortality (20%). CONCLUSION: One third of pediatric trauma requiring hospital admission suffered head injury. Preschoolers and elementary school students were mostly affected. The striking incidence of pedestrian and fall injuries call for organized national prevention programs. Additionally, more attention should be directed to reduce MVC among high school students given their comparative high rate of severe injuries and deaths following trauma.	[Alhabdan, Sultan; Zamakhshary, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [AlNaimi, Manal; Mandora, Hala] King Abdul Aziz Med City, Dept Surg, Riyadh, Saudi Arabia; [Alhamdan, Manal; Al-Bedah, Khalid; Al-Enazi, Salem] King Abdullah Int Med Ctr, Riyadh, Saudi Arabia; [Al-Habib, Amro] King Saud Univ, Dept Surg, Riyadh 11472, Saudi Arabia		Al-Habib, A (corresponding author), King Saud Univ, Coll Med, Surg Dept 37, Riyadh 11472, Saudi Arabia.	amro.alhabib@gmail.com	Alhabib, Amro F/F-1778-2018	Zamakhshary, Mohammed/0000-0001-8870-8684			Abantanga FA, 1998, PEDIATR SURG INT, V13, P515, DOI 10.1007/s003830050387; Adesunkanmi ARK, 2000, INJURY, V31, P225, DOI 10.1016/S0020-1383(99)00236-3; [Anonymous], 2007, CENTRAL DEP STAT INF; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOULANGER BR, 1992, J TRAUMA, V33, P228, DOI 10.1097/00005373-199208000-00011; Brown CVR, 2006, J PEDIATR SURG, V41, P88, DOI 10.1016/j.jpedsurg.2005.10.012; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Brudvik C, 2000, INJURY, V31, P761, DOI 10.1016/S0020-1383(00)00093-0; Central Department for Statistics and Information, 2007, ANN STAT BOOKS; CIASTKO AR, 1983, CAN MED ASSOC J, V129, P532; Crankson SJ, 2006, PEDIATR SURG INT, V22, P641, DOI 10.1007/s00383-006-1715-7; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Emejulu JKC, 2010, NIGER J CLIN PRACT, V13, P276; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gofin R, 1999, J TRAUMA, V47, P15, DOI 10.1097/00005373-199907000-00004; Gresham L S, 2001, J Pediatr Nurs, V16, P79, DOI 10.1053/jpdn.2001.23148; IVAN LP, 1983, CAN MED ASSOC J, V128, P281; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Parker S ZB, 2004, DEV BEHAV PEDIAT HDB; Pomerantz WJ, 2010, PEDIATRICS, V125, P681, DOI 10.1542/peds.2009-2367; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rohana J, 1998, Med J Malaysia, V53, P217; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tamimi TM DM, 2003, LANCET, V7; UNICEF, STAT MON	29	21	21	0	3	K FAISAL SPEC HOSP RES CENTRE	RIYADH	PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA	0256-4947	1319-9226		ANN SAUDI MED	Ann. Saudi Med.	JAN-FEB	2013	33	1					52	56		10.5144/0256-4947.2013.52			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA3MW	WOS:000330997700012	23458942	Green Published, Green Submitted, gold			2022-02-06	
J	Greve, KW; Bianchini, KJ; Brewer, ST				Greve, Kevin W.; Bianchini, Kevin J.; Brewer, Steve T.			The Assessment of Performance and Self-report Validity in Persons Claiming Pain-related Disability	CLINICAL NEUROPSYCHOLOGIST			English	Article						Chromic pain; Malingering; Assessment	ADULT INTELLIGENCE SCALE; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; FAKE BAD SCALE; MIXED GROUP VALIDATION; VERBAL-LEARNING TEST; RELIABLE DIGIT SPAN; CLASSIFICATION ACCURACY; HEAD-INJURY; UNITED-STATES	One third of all people will experience spinal pain in their lifetime and half of these will experience chronic pain. Pain often occurs in the context of a legally compensable event with back pain being the most common reason for filing a Workers Compensation claim in the United States. When financial incentives to appear disabled exist, malingered pain-related disability is a potential problem. Malingering may take the form of exaggerated physical, emotional, or cognitive symptoms and/or under-performance on measures of cognitive and physical capacity. Essential to the accurate detection of Malingered Pain-related Disability is the understanding that malingering is an act of will, the goal of which is to increase the appearance of disability beyond that which would naturally arise from the injury in question. This paper will review a number of Symptom Validity Tests (SVTs) that have been developed to detect malingering in patients claiming pain-related disability and will conclude with a review of studies showing the diagnostic benefit of combining SVT findings from a comprehensive malingering assessment. The utilization of a variety of tools sensitive to the multiple manifestations of malingering increases the odds of detecting invalid claims while reducing the risk of rejecting a valid claim.	[Greve, Kevin W.; Bianchini, Kevin J.; Brewer, Steve T.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA 70002 USA		Greve, KW (corresponding author), Jefferson Neurobehav Grp, 2901 N I-10 Serv Rd East, Metairie, LA 70002 USA.	kgreve@uno.edu					Aguerrevere LE, 2009, CLIN NEUROPSYCHOL, V23, P567; Aguerrevere LE, 2011, J CLIN EXP NEUROPSYC, V33, P497, DOI 10.1080/13803395.2010.535503; Aguerrevere LE, 2008, ARCH CLIN NEUROPSYCH, V23, P831, DOI 10.1016/j.acn.2008.06.008; American Psychiatric Association, 2000, DIAGN STAT MAN, V4th ed; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Arnold G., 2007, ASSESSMENT FEIGNED C, P178; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Bagby R. M., 1991, J COUNSELING CLIN PS, V3, P496; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Ben-Porath Y., 2012, INTERPRETING MMPI 2; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Bianchini K. J., 2012, ACCURACY MODIF UNPUB; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1992, ARCH PHYS MED REHAB, V73, P377, DOI 10.1016/0003-9993(92)90013-M; BINDER LM, 1992, ARCH CLIN NEUROPSYCH, V7, P155, DOI 10.1016/0887-6177(92)90009-C; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BINDER LM, 1993, PORTLAND DIGIT RECOG; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; BOONE KB, 2007, ASSESSMENT MALINGERE, P27; BRADY JP, 1961, ARCH GEN PSYCHIAT, V4, P331; Bruns D., 2003, BATTERY HLTH IMPROVE; Butters N., 1980, ALCOHOLIC KORSAKOFFS; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; CHENGALUR SN, 1990, AM J PHYS MED REHAB, V69, P148, DOI 10.1097/00002060-199006000-00010; Curtis K. L., 2008, 36 ANN M INT NEUR SO; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Daubert SD, 2000, PSYCHOL ASSESSMENT, V12, P418, DOI 10.1037/1040-3590.12.4.418; DAWES RM, 1966, PSYCHOL BULL, V66, P63, DOI 10.1037/h0023584; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; DEARDORFF WW, 1993, PAIN, V54, P153, DOI 10.1016/0304-3959(93)90203-2; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fishbain DA, 1999, CLIN J PAIN, V15, P244, DOI 10.1097/00002508-199912000-00002; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Frederick RI, 2000, BEHAV SCI LAW, V18, P693, DOI 10.1002/bsl.432; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Frederick RI, 2009, ASSESSMENT, V16, P215, DOI 10.1177/1073191108325005; FRIEDMAN AF, 1983, J CONSULT CLIN PSYCH, V51, P629, DOI 10.1037/0022-006X.51.4.629; GATCHEL RJ, 1995, HEALTH PSYCHOL, V14, P415, DOI 10.1037/0278-6133.14.5.415; Gatchel RJ, 2004, AM PSYCHOL, V59, P795, DOI 10.1037/0003-066X.59.8.795; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K. W., 2012, COPING PSYCHIAT PSYC, P587, DOI DOI 10.1093/MED:PSYCH/9780195174113.003.0026; Greve K. W., 2009, ANN M AM AC CLIN NEU; Greve K. W., 2009, 29 ANN M NAT AC NEUR; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P850, DOI 10.1080/13854040802585055; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH PHYS MED REHAB, V84, P1233, DOI 10.1016/S0003-9993(03)00145-X; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; GROSSMAN LS, 1995, J PERS ASSESS, V64, P384, DOI 10.1207/s15327752jpa6402_17; GROSZ HJ, 1965, ARCH GEN PSYCHIAT, V13, P255; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Keller L. S., 1991, MMPI 2 MONOGRAPHS; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; LAWLIS GF, 1989, SPINE, V14, P511, DOI 10.1097/00007632-198905000-00007; Lechner DE, 1998, PHYS THER, V78, P867, DOI 10.1093/ptj/78.8.867; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 2003, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LUBIN B, 1984, AM PSYCHOL, V39, P451, DOI 10.1037/0003-066X.39.4.451; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; MARKS PA, 1963, ACTUARIAL DESCRIPTIO; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCusker PJ, 2003, INT J OFFENDER THER, V47, P585, DOI 10.1177/0306624X03254013; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Meyers J, 2000, TELEPHONY, V239, P7; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; MILLIS SR, 1997, M INT NEUR SOC BERG; Millon T., 1994, MILLON CLIN MULTIAXI; Millon T., 1997, MILLON CLIN MULTIAXI, V2nd ed.; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Morgan J., 2009, NEUROSPYCHOLOGY MALI; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; RETZLAFF P, 1991, J PERS ASSESS, V56, P466, DOI 10.1207/s15327752jpa5603_8; Reynolds CR, 1998, CRIT ISS NE, P261; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Robinson M E, 1993, J Occup Rehabil, V3, P45, DOI 10.1007/BF01076741; ROBINSON ME, 1989, PAIN, V37, P211, DOI 10.1016/0304-3959(89)90132-2; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Schoenberg MR, 2003, PSYCHOL ASSESSMENT, V15, P198, DOI 10.1037/1040-3590.15.2.198; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Slesinger D, 2002, ASSESSMENT, V9, P406, DOI 10.1177/1073191102238153; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SMITH GA, 1989, AM J PHYS MED REHAB, V68, P73, DOI 10.1097/00002060-198904000-00006; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; TAIT RC, 1990, PAIN, V40, P171, DOI 10.1016/0304-3959(90)90068-O; Tellegen, 2008, MMPI 2 RESTRUCTURED; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; [No title captured]	142	21	23	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 1	2013	27	1			SI		108	137		10.1080/13854046.2012.739646			30	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	106AU	WOS:000316114600008	23157188				2022-02-06	
J	Huang, Q; Dai, WM; Jie, YQ; Yu, GF; Fan, XF; Wu, A				Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Yu, Guo-Feng; Fan, Xiao-Feng; Wu, An			High concentrations of visfatin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome	PEPTIDES			English	Article						Visfatin; Intracerebral hemorrhage; Outcome; Mortality	COLONY-ENHANCING FACTOR; HUMAN FETAL MEMBRANES; CLONING; GROWTH; LEVEL; FAT	Higher plasma visfatin concentration has been associated with clinical outcomes of traumatic brain injury. No published information exists to date about change in plasma visfatin after intracerebral hemorrhage. This study included one hundred and twenty-eight healthy controls and 128 patients with intracerebral hemorrhage. The unfavorable outcome was defined as modified Rankin Scale score >2 at 6 months. The patients had higher plasma visfatin measurements than control subjects. Plasma visfatin levels were highly correlated with National Institutes of Health Stroke Scale score and plasma C-reactive protein levels in the patients. A multivariate analysis identified plasma visfatin level as an independent predictor for 6-month mortality and unfavorable outcome. According to receiver operating characteristic curve analysis, the predictive value of the plasma visfatin concentration was similar to National Institutes of Health Stroke Scale score. In a combined logistic-regression model, visfatin improved the predictive value of National Institutes of Health Stroke Scale score for 6-month unfavorable outcome. Thus, increased plasma visfatin level is associated with 6-month clinical outcomes after intracerebral hemorrhage. (C) 2012 Elsevier Inc. All rights reserved.	[Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Yu, Guo-Feng; Fan, Xiao-Feng; Wu, An] Quzhou Peoples Hosp, Dept Neurosurg, Quzhou 324100, Peoples R China		Yu, GF (corresponding author), Quzhou Peoples Hosp, Dept Neurosurg, 2 Zhongloudi Rd, Quzhou 324100, Peoples R China.	quzhouguofengyu@163.com					Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Haider DG, 2006, J CLIN ENDOCR METAB, V91, P1578, DOI 10.1210/jc.2005-2248; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; McGlothlin JR, 2005, BIOCHEM GENET, V43, P127, DOI 10.1007/s10528-005-1505-2; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Ognjanovic S, 2003, AM J OBSTET GYNECOL, V189, P1187, DOI 10.1067/S0002-9378(03)00591-X; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431	16	21	22	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2013	39						55	58		10.1016/j.peptides.2012.11.006			4	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	102IW	WOS:000315839300009	23174347				2022-02-06	
J	McBride, J; Zhao, X; Nichols, T; Vagnini, V; Munro, N; Berry, D; Jiang, Y				McBride, J.; Zhao, X.; Nichols, T.; Vagnini, V.; Munro, N.; Berry, D.; Jiang, Y.			Scalp EEG-Based Discrimination of Cognitive Deficits After Traumatic Brain Injury Using Event-Related Tsallis Entropy Analysis	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Biomedical signal processing; EEG; medical diagnosis; traumatic brain injury (TBI)	BIOPHYSICAL LINKAGE; ATTENTION; INDEX; TIME; TBI; MRI	Traumatic brain injury (TBI) is the leading cause of death and disability in children and adolescents in the U. S. This is a pilot study, which explores the discrimination of chronic TBI from normal controls using scalp EEG during a memory task. Tsallis entropies are computed for responses during an old-new memory recognition task. A support vector machinemodel is constructed to discriminate between normal andmoderate/severe TBI individuals using Tsallis entropies as features. Numerical analyses of 30 records (15 normal and 15 TBI) show amaximum discrimination accuracy of 93% (p-value = 7.8557E-5) using four features. These results suggest the potential of scalp EEG as an efficacious method for noninvasive diagnosis of TBI.	[McBride, J.; Zhao, X.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA; [Nichols, T.; Munro, N.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Vagnini, V.; Jiang, Y.] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA; [Berry, D.] Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA		Zhao, X (corresponding author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.	jmcbrid4@utk.edu; xzhao9@utk.edu; nicholstl@ornl.gov; tory.vagnini@gmail.com; munronb@ornl.gov; dtrb@pop.uky.edu; yjiang@uky.edu	Zhao, Xiaopeng/A-4419-2008	Zhao, Xiaopeng/0000-0003-1207-5379; JIANG, Yang/0000-0003-4589-0097	National Science FoundationNational Science Foundation (NSF) [CMMI-0845753]; Department of Behavioral Science, University of Kentucky College of Medicine	Manuscript received May 22, 2012; revised July 20, 2012 and September 1, 2012; accepted September 23, 2012. Date of publication October 10, 2012; date of current version December 14, 2012. This work was supported in part by the National Science Foundation under Grant CMMI-0845753 and in part by a pilot grant from the Department of Behavioral Science, University of Kentucky College of Medicine. Asterisk indicates corresponding author.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Bezerianos A, 2003, ANN BIOMED ENG, V31, P221, DOI 10.1114/1.1541013; Bishop C. M., 2008, NEURAL NETWORKS PATT, P295; Brain Trauma Foundation, 2011, FACTS TBI US; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Cerutti S., 2011, ADV METHODS BIOMEDIC, P357; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Fu SM, 2009, NEUROIMAGE, V48, P191, DOI 10.1016/j.neuroimage.2009.06.028; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Herron JE, 2004, NEUROIMAGE, V21, P302, DOI 10.1016/j.neuroimage.2003.09.039; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Leon-Carrion J, 2008, BRAIN INJURY, V22, P61, DOI 10.1080/02699050701824143; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Paul Danie B, 2006, J Clin Monit Comput, V20, P399, DOI 10.1007/s10877-006-9045-9; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sneddon R, 2005, CLIN EEG NEUROSCI, V36, P141, DOI 10.1177/155005940503600304; Sneddon R, 2007, PHYSICA A, V386, P101, DOI 10.1016/j.physa.2007.05.065; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tong S, 2002, PHYSICA A, V305, P619, DOI 10.1016/S0378-4371(01)00621-5; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; TYSZKA JM, 1994, ANN NEUROL, V35, P746, DOI 10.1002/ana.410350617; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; Van Egren L., 1996, CLIN ELECTROENCEPHAL, V27, P164; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zhang DD, 2010, IEEE T BIO-MED ENG, V57, P867, DOI 10.1109/TBME.2009.2029082	30	21	21	0	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JAN	2013	60	1	1				90	96		10.1109/TBME.2012.2223698			7	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	062CV	WOS:000312897600012	23070292				2022-02-06	
J	Mendez, MF; Owens, EM; Jimenez, EE; Peppers, D; Licht, EA				Mendez, Mario F.; Owens, Emily M.; Jimenez, Elvira E.; Peppers, Dominique; Licht, Eliot A.			Changes in personality after mild traumatic brain injury from primary blast vs. blunt forces	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; blast forces; blunt forces; personality	POSTTRAUMATIC-STRESS-DISORDER; SYSTEMS BEHAVIOR SCALE; POSTCONCUSSIVE SYMPTOMS; INTERPERSONAL-BEHAVIOR; SERVICE MEMBERS; MECHANISMS; INVENTORY; IRAQ; PTSD; TBI	Introduction: Injuries from explosive devices can cause blast-force injuries, including mild traumatic brain injury (mTBI). Objective: This study investigated changes in personality from blast-force mTBI in comparison to blunt-force mTBI. Methods: Clinicians and significant others assessed US veterans who sustained pure blast-force mTBI (n = 12), as compared to those who sustained pure blunt-force mTBI (n = 12). Inclusion criteria included absence of any mixed blast-blunt trauma and absence of post-traumatic stress disorder. Measures included the Interpersonal Measure of Psychopathy (IMP), the Big Five Inventory (BFI), the Interpersonal Adjectives Scale (IAS) and the Frontal Systems Behaviour Scale (FrSBe). Results: There were no group differences on demographic or TBI-related variables. Compared to the Blunt Group, the Blast Group had more psychopathy on the IM-P, with anger, frustration, toughness and boundary violations and tended to more neuroticism on the BFI. When pre-TBI and post-TBI assessments were compared on the IAS and FrSBe, only the patients with blast force mTBI had become more cold-hearted, aloof-introverted and apathetic. Conclusion: These results suggest that blast forces alone can cause negativistic behavioural changes when evaluated with selected measures of personality. Further research on isolated blast-force mTBI should focus on these personality changes and their relationship to blast over-pressure.	[Mendez, Mario F.; Owens, Emily M.; Jimenez, Elvira E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Mendez, Mario F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Mendez, Mario F.; Licht, Eliot A.] VA Greater Los Angeles Healthcare Ctr, Neurol Sect, Los Angeles, CA 90073 USA; [Peppers, Dominique] VA Greater Los Angeles Healthcare Ctr, Sect Phys Med & Rehabil, Los Angeles, CA 90073 USA		Mendez, MF (corresponding author), VA Greater Los Angeles Healthcare Ctr, Neurobehav Unit 691 116AF, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	mmendez@UCLA.edu			Veterans Affairs AdministrationUS Department of Veterans Affairs	This research was made possible by a grant from the Veterans Affairs Administration.	ALDEN LE, 1990, J PERS ASSESS, V55, P521, DOI 10.1207/s15327752jpa5503&4_10; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Foley J, 2006, INT J NEUROSCI, V116, P1377, DOI 10.1080/00207450500514334; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, pE14, DOI 10.1176/appi.neuropsych.23.2.E14; Heltemes KJ, 2012, INJURY; HENRY GK, 1994, J NEUROPSYCH CLIN N, V6, P58; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kosson DS, 1997, PSYCHOL ASSESSMENT, V9, P89, DOI 10.1037/1040-3590.9.2.89; Kozminski M, 2010, J AM OSTEOPATH ASSOC, V110, P514; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Labuschagne I, 2012, INT J NEUROPSYCHOPH, V15, P883, DOI 10.1017/S1461145711001489; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lew HL, 2008, CLIN PSYCHOL REV, V45, pxi; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mendez MF, 2008, INT J GERIATR PSYCH, V23, P1203, DOI 10.1002/gps.2019; Miller JD, 2011, ASSESSMENT, V18, P335, DOI 10.1177/1073191111411671; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruocco AC, 2007, BRAIN INJURY, V21, P1233, DOI 10.1080/02699050701716919; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stout JC, 2003, AM J GERIAT PSYCHIAT, V11, P683; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Vitacco MJ, 2010, PSYCHOL ASSESSMENT, V22, P638, DOI 10.1037/a0019780; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; WIGGINS JS, 1988, MULTIVAR BEHAV RES, V23, P517, DOI 10.1207/s15327906mbr2304_8; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215; Zolondek S, 2006, ASSESSMENT, V13, P470, DOI 10.1177/1073191106289861	68	21	22	1	50	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2013	27	1					10	18		10.3109/02699052.2012.722252			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300002	23252434				2022-02-06	
J	Wortzel, HS; Arciniegas, DB				Wortzel, Hal S.; Arciniegas, David B.			A Forensic Neuropsychiatric Approach to Traumatic Brain Injury, Aggression, and Suicide	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							FRONTAL-SUBCORTICAL CIRCUITS; POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER HYPERINTENSITIES; LONG-TERM DISABILITY; HEAD-INJURY; PSYCHIATRIC-DISORDERS; PREFRONTAL CORTEX; UNITED-STATES; NEUROPSYCHOLOGICAL OUTCOMES; INTRACRANIAL INJURY	Aggression is a common neuropsychiatric sequela of traumatic brain injury (TBI), one which interferes with rehabilitation efforts, disrupts social support networks, and compromises optimal recovery. Aggressive behavior raises critical safety concerns, potentially placing patients and care providers in harm's way. Such aggression may be directed outwardly, manifesting as assaultive behavior, or directed inwardly, resulting in suicidal behavior. Given the frequency of TBI and posttraumatic aggression and the potential medicolegal questions surrounding the purported causal relationships between the two, forensic psychiatrists need to understand and recognize posttraumatic aggression. They also must be able to offer cogent formulations about the relative contributions of neurotrauma versus other relevant neuropsychiatric factors versus combinations of both to any specific act of violence. This article reviews the relationships between TBI and aggression and discusses neurobiological and cognitive factors that influence the occurrence and presentation of posttraumatic aggression. Thereafter, a heuristic is offered that may assist forensic psychiatrists attempting to characterize the relationships between TBI and externally or internally directed violent acts.	[Wortzel, Hal S.] Denver Vet Med Ctr, VISN MIRECC 19, Mental Illness Res Educ & Clin Ctr, Denver, CO 80220 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Denver, CO USA		Wortzel, HS (corresponding author), Denver Vet Hosp, VISN MIRECC 19, 1055 Clermont St, Denver, CO 80220 USA.	hal.wortzel@ucdenver.edu					Aguilar EJ, 2008, PROG NEURO-PSYCHOPH, V32, P1673, DOI 10.1016/j.pnpbp.2008.06.016; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anisman H, 2008, J PSYCHIATR NEUROSCI, V33, P131; ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Arciniegas DB, 2002, CURR TREAT OPTION NE, V2, P169; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Austin MC, 2002, NEUROSCIENCE, V114, P807, DOI 10.1016/S0306-4522(02)00289-0; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Courville CB, 1950, PATHOLOGY CENTRAL NE, V3rd; Cummings JL, 1998, J PSYCHOSOM RES, V44, P627; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Department of Veterans Affairs Department of Defense, 2009, CLIN PRACT GUID MAN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Ehrlich S, 2005, J AFFECT DISORDERS, V86, P281, DOI 10.1016/j.jad.2005.01.007; Ernst C, 2009, PROG NEUROBIOL, V89, P315, DOI 10.1016/j.pneurobio.2009.09.001; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Gurdjian ES, 1975, IMPACT HEAD INJURY M; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helmick K., 2006, DEFENSE VETERANS BRA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Johnston JJE, 2007, EUR J EMERG MED, V14, P130, DOI 10.1097/MEJ.0b013e32801219a6; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr DCR, 2007, J ABNORM CHILD PSYCH, V35, P817, DOI 10.1007/s10802-007-9132-5; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mann JJ, 2000, ARCH GEN PSYCHIAT, V57, P729, DOI 10.1001/archpsyc.57.8.729; Marr A, 2002, CENTRAL NERVOUS SYST; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Matsuo K, 2010, NEUROSCI LETT, V469, P75, DOI 10.1016/j.neulet.2009.11.047; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Petrides M., 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Pompili M, 2007, EUR ARCH PSY CLIN N, V257, P494, DOI 10.1007/s00406-007-0755-x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reid WH, 2008, TXB VIOLENCE ASSESSM; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Skopp Nancy A, 2012, MSMR, V19, P7; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Tanielian T, 2012, INVISIBLE WOUNDS WAR; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Warnken W J, 1994, Violence Vict, V9, P153; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; YUDOFSKY SC, 1990, J CLIN PSYCHIAT, V51, P22; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	121	21	22	0	26	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2013	41	2					274	286					13	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	185CJ	WOS:000321942500013	23771941				2022-02-06	
J	Zielinski, MD; Smoot, DL; Stubbs, JR; Jenkins, DH; Park, MS; Zietlow, SP				Zielinski, Martin D.; Smoot, Dustin L.; Stubbs, James R.; Jenkins, Donald H.; Park, Myung S.; Zietlow, Scott P.			The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury	TRANSFUSION			English	Article							MASSIVE TRANSFUSION; THAWED PLASMA; BLOOD; MORTALITY; RATIO; PREDICTION; MORBIDITY; PRODUCTS; SURVIVAL	Background The rapid reversal of warfarin in the setting of traumatic brain injury (TBI) has been associated with improved outcomes. Until now, remote reversal of hypocoagulable states has not been possible in the prehospital environment. This manuscript describes the development and analysis of a prehospital plasma transfusion protocol to reverse warfarin at the earliest possible moment after TBI. Study Design and Methods A retrospective review of all TBI patients receiving plasma transfusion(s) in the prehospital environment for warfarin reversal between February 2009 and September 2010 was conducted. Thawed plasma was carried on every air ambulance flight centered at the main campus. Results A total of 2836 flights carried over 2500 units of thawed plasma throughout the study period. During this time, 16 patients received prehospital plasma resuscitation, five of who were on warfarin with a concurrent TBI. The median Injury Severity Score was 17 (8.5-27.5) with a median Glasgow Coma Score of 13 (8-15) and a mortality rate of 40%. A median of 2 (1.5-2.0) units of thawed plasma and 0 (0-0) units of RBCs were transfused en route. The pretransfusion point-of-care international normalized ratio improved from 3.1 (2.3-4.0) to 1.9 (1.3-3.6) upon trauma center admission (serum sample). One hundred percent of the transported, but unused, thawed plasma underwent subsequent transfusion prior to expiration. Conclusions Remote prehospital plasma transfusions effectively reverse anticoagulation secondary to warfarin administration in TBI patients. It is feasible to transfuse thawed plasma in the prehospital setting via remote damage control techniques without increasing waste. Prospective studies are needed to determine if this practice can improve outcomes in this population.	[Zielinski, Martin D.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA		Zielinski, MD (corresponding author), Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, 200 1st St SW, Rochester, MN 55905 USA.	zielinski.martin@mayo.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08 GM093133] Funding Source: Medline		Berns K S, 1998, Air Med J, V17, P105, DOI 10.1016/S1067-991X(98)90104-3; Blackbourne LH, 2011, J TRAUMA, V70, pS1, DOI 10.1097/TA.0b013e31821b587f; Borgman MA, 2011, VOX SANG, V101, P44, DOI 10.1111/j.1423-0410.2011.01466.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bussey HI, 1997, PHARMACOTHERAPY, V17, P861; de Biasi AR, 2011, TRANSFUSION, V51, P1925, DOI 10.1111/j.1537-2995.2010.03050.x; Derksen M, 2010, TRANSFUSION, V50, p265A; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Fatovich DM, 2009, J TRAUMA, V67, P910, DOI 10.1097/TA.0b013e3181815a26; Inaba K, 2010, ARCH SURG-CHICAGO, V145, P899, DOI 10.1001/archsurg.2010.175; Isaak E J, 2011, Immunohematology, V27, P61; Karafin MS, 2012, TRANSFUSION, V52, P2087, DOI 10.1111/j.1537-2995.2012.03574.x; Kim BD, 2012, J TRAUMA ACUTE CARE, V73, pS49, DOI 10.1097/TA.0b013e31826060ff; Krumrei NJ, 2012, J TRAUMA ACUTE CARE, V72, P211, DOI 10.1097/TA.0b013e318240507b; Maschoff P, 2009, TRANSFUSION, V49, p265A; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Vandromme MJ, 2010, J AM COLL SURGEONS, V210, P861, DOI 10.1016/j.jamcollsurg.2010.01.012; Zielinski MD, 2010, TRANSFUSION, V50, P2762, DOI 10.1111/j.1537-2995.2010.02806.x	22	21	21	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	JAN	2013	53			1	SI		59S	64S		10.1111/trf.12037			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	071SR	WOS:000313615000010	23301974				2022-02-06	
J	Boutte, AM; Yao, CP; Kobeissy, F; Lu, XCM; Zhang, ZQ; Wang, KK; Schmid, K; Tortella, FC; Dave, JR				Boutte, Angela M.; Yao, Changping; Kobeissy, Firas; Lu, Xi-Chun May; Zhang, Zhiqun; Wang, Kevin K.; Schmid, Kara; Tortella, Frank C.; Dave, Jitendra R.			Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury	ELECTROPHORESIS			English	Article						Biomarker; Penetrating ballistic-like brain injury; Proteomics; Systems biology; UCH-L1	C-TERMINAL HYDROLASE-L1; PROLIFERATION MARKER; BARRIER PERMEABILITY; METABOLIC CRISIS; RAT MODEL; BIOMARKER; SERUM; SUPPLEMENTATION; MICRODIALYSIS; INFLAMMATION	Proteomics and systems biology have significantly contributed to biomarker discovery in the field of brain injury. This study utilized 2D-DIGE-PMF-MS as a preliminary screen to detect biomarkers in a rat model of penetrating ballistic-like brain injury (PBBI). Brain-specific systems biology analysis of brain tissue identified 386 proteins having a fold change of more than 2, of which 321 proteins were increased and 65 were decreased 24 h after PBBI compared to sham controls. The majority of upregulated proteins were cytoskeletal (10.5%), nucleic acid binding (9.3%), or kinases (8.9%). Most proteins were involved in protein metabolism (22.7%), signal transduction (20.4%), and development (9.6%). Pathway analysis indicated that these proteins were involved in neurite outgrowth and cell differentiation. Semiquantitative Western blotting of 6, 24, 48, and 72 h after PBBI indicated ubiquitin carboxyl-terminal hydrolase isozyme L1 (a proposed traumatic brain injury biomarker in human clinical trials), tyrosine hydroxylase, and syntaxin-6 were found to be consistently elevated in brain tissue and cerebral spinal fluid after PBBI compared to sham controls. Combining proteomics and brain-specific systems biology can define underlying mechanisms of traumatic brain injury and provide valuable information in biomarker discovery that, in turn, may lead to novel therapeutic targets.	[Dave, Jitendra R.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Kobeissy, Firas; Zhang, Zhiqun; Wang, Kevin K.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA		Dave, JR (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jit.dave@amedd.army.mil	Kobeissy, Firas/E-7042-2017; Dave, Jitendra R/A-8940-2011	Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473	Banyan Biomarkers, Inc.	The authors have declared the following potential conflict of interest: Drs. Kevin K. W. Wang and Ronald L. Hayes, an executive officer at Banyan Biomarkers, Inc., own stock and receive royalties from Banyan Biomarkers, Inc., and as such may benefit financially as a result of the outcomes of this research or work reported in this publication.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Johnson VE, 2012, EXP NEUROL; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Liberatore GT, 1999, EXP NEUROL, V159, P565, DOI 10.1006/exnr.1999.7152; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Sun X, 2012, NEUROBIOL DIS, V45, P601, DOI 10.1016/j.nbd.2011.09.018; Thom M, 2005, J NEUROPATH EXP NEUR, V64, P194, DOI 10.1093/jnen/64.3.194; Todovov IT, 1998, LAB INVEST, V78, P73; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Villoslada P, 2012, J NEUROIMMUNOL, V248, P58, DOI 10.1016/j.jneuroim.2012.01.001; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Wharton SB, 2001, NEUROPATH APPL NEURO, V27, P305, DOI 10.1046/j.0305-1846.2001.00333.x; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]	53	21	21	2	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	DEC	2012	33	24			SI		3693	3704		10.1002/elps.201200196			12	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	057FT	WOS:000312548900012	23161467				2022-02-06	
J	Kazemi, H; Hashemi-Fesharaki, S; Razaghi, S; Najafi, M; Kolivand, PH; Kovac, S; Gorji, A				Kazemi, Hadi; Hashemi-Fesharaki, Sohrab; Razaghi, Soodeh; Najafi, Masomeh; Kolivand, Peir Hossein; Kovac, Stjepana; Gorji, Ali			Intractable epilepsy and craniocerebral trauma: Analysis of 163 patients with blunt and penetrating head injuries sustained in war	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Gunshot injury; Seizure; Metal fragments; Refractory epilepsy	POSTTRAUMATIC EPILEPSY; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; BRAIN-INJURY; RISK-FACTORS; OPERATION; RESECTION; CONFLICT	Post-traumatic epileptic seizure is a common complication of brain trauma including military injuries. We present clinical characteristics and correlates of post-traumatic epilepsy in 163 head-injured veterans suffering from intractable epilepsy due to blunt or penetrating head injuries sustained during the Iraq-Iran war. The medical records of 163 war veterans who were admitted by the Epilepsy Department of the Shefa Neuroscience Center between 2005 and 2009 were retrospectively reviewed. The mean follow-up period after developing epilepsy was 17.2 years. The time interval between the trauma and the first seizure was shorter and the seizure frequency was higher in epileptic patients suffering from penetrating head trauma. There was no difference in seizure type between epileptic patients traumatised by blunt or penetrating injury. Patients with seizure frequency of more than 30 per month mostly had simple partial seizure. Frontal and parietal semiologies were observed more frequently in patients with penetrating trauma, whereas patients with blunt trauma showed a higher temporal semiology. The most common brain lesion observed by CT scan was encephalomalacia followed by porencephaly and focal atrophy. There was no association between intracerebral retained fragments and different characteristic features of epilepsy. Patients with military brain injury carry a high risk of intractable post-traumatic epilepsy decades after their injury, and thus require a long-term medical follow-up. (c) 2012 Elsevier Ltd. All rights reserved.	[Gorji, Ali] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Kazemi, Hadi; Hashemi-Fesharaki, Sohrab; Razaghi, Soodeh; Najafi, Masomeh; Kolivand, Peir Hossein; Gorji, Ali] Shefa Neurosci Res Ctr, Tehran, Iran; [Kazemi, Hadi] Shahed Univ, Dept Pediat, Tehran, Iran; [Kovac, Stjepana] Univ Klinikum Munster, Klin & Poliklin Neurol, Munster, Germany		Gorji, A (corresponding author), Univ Munster, Inst Physiol 1, Robert Koch Str 27A, D-48149 Munster, Germany.	gorjial@uni-muenster.de		Kolivand, PirHossein/0000-0002-0532-4130			Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF., 1996, TREATMENT EPILEPSY P, P165; Ascroft PB, 1943, LANCET, V2, P211; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; Cukiert A, 1996, CAN J NEUROL SCI, V23, P114, DOI 10.1017/S0317167100038828; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Eftekhar B, 2009, J NEUROSURG, V110, P319, DOI 10.3171/2008.4.17519; Foerster O, 1930, BRAIN, V53, P99, DOI 10.1093/brain/53.2.99; Gorji A, 2001, NEUROSCI BIOBEHAV R, V25, P455, DOI 10.1016/S0149-7634(01)00025-2; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; Kazemi NJ, 1997, EPILEPSIA, V38, P670, DOI 10.1111/j.1528-1157.1997.tb01236.x; Langendorf F, 1997, EPILEPSY COMPREHENSI, P2469; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Soares HD, 1995, J NEUROSCI, V15, P8223; Splavski B, 1998, SURG NEUROL, V50, P194, DOI 10.1016/S0090-3019(98)00047-0; WEIDENHEIM KM, 1995, J NEUROPATH EXP NEUR, V54, P268, DOI 10.1097/00005072-199503000-00013; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869, DOI 10.1016/S0733-8619(18)30184-1	23	21	21	1	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2132	2135		10.1016/j.injury.2012.06.007			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600029	22763317				2022-02-06	
J	Kriz, PK; Comstock, RD; Zurakowski, D; Almquist, JL; Collins, CL; d'Hemecourt, PA				Kriz, Peter K.; Comstock, R. Dawn; Zurakowski, David; Almquist, Jon L.; Collins, Christy L.; d'Hemecourt, Pierre A.			Effectiveness of Protective Eyewear in Reducing Eye Injuries Among High School Field Hockey Players	PEDIATRICS			English	Article						girls' field hockey; eye injuries; protective eyewear; injury prevention; injury surveillance	LACROSSE; EPIDEMIOLOGY; HEAD; FACE	OBJECTIVE: To determine if injury rates differ among high school field hockey players in states that mandated protective eyewear (MPE) versus states with no protective eyewear mandate (no MPE). METHODS: We analyzed field hockey exposure and injury data collected over the 2009-2010 and 2010-2011 scholastic seasons from national and regional databases. RESULTS: Incidence of all head and face injuries (including eye injuries, concussion) was significantly higher in no-MPE states compared with MPE states, 0.69 vs 0.47 injuries per 1000 athletic exposures (incidence rate ratio [IRR] 1.47; 95% confidence interval [CI]: 1.04-2.15, P = .048). Players in the no-MPE group had a 5.33-fold higher risk of eye injury than players in the MPE group (IRR 5.33; 95% CI: 0.71-39.25, P = .104). There was no significant difference in concussion rates for the 2 groups (IRR 1.04; 95% CI: 0.63-1.75, P = .857). A larger percentage of injuries sustained by athletes in the no-MPE group required >10 days to return to activity (32%) compared with athletes in the MPE group (17%), but this difference did not reach statistical significance (P = .060). CONCLUSIONS: Among high school field hockey players, playing in a no-MPE state results in a statistically significant higher incidence of head and face injuries versus playing in an MPE state. Concussion rates among players in MPE and no-MPE states were similar, indicating that addition of protective eyewear did not result in more player-player contact injuries, challenging a perception in contact/collision sports that increased protective equipment yields increased injury rates. Pediatrics 2012;130:1069-1075	[Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch,Hasbro Childrens Hosp, Div Sports Med,Dept Orthoped,Injury Prevent Ctr, Providence, RI 02903 USA; [Comstock, R. Dawn; Collins, Christy L.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Comstock, R. Dawn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Zurakowski, David] Harvard Univ, Sch Med, Dept Anesthesia, Boston Childrens Hosp, Boston, MA 02115 USA; [d'Hemecourt, Pierre A.] Harvard Univ, Sch Med, Div Sports Med, Boston Childrens Hosp, Boston, MA USA; [Almquist, Jon L.] Fairfax Cty Publ Sch, Falls Church, VA USA		Kriz, PK (corresponding author), 2 Dudley St,Suite 200, Providence, RI 02905 USA.	peter_kriz@brown.edu			Prevent Blindness America (PBA) [701-5215]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE001172-01]; National Operating Committee on Standards for Athletic Equipment	Funded in part by Prevent Blindness America (PBA) grant 701-5215 and the Centers for Disease Control and Prevention grant R49/CE001172-01. The authors also acknowledge the generous research funding contributions of the National Operating Committee on Standards for Athletic Equipment. The content of this report is solely the responsibility of the authors and does not necessarily reflect the official views of Prevent Blindness America or the Centers for Disease Control and Prevention.	Amer Acad Pediat, 2004, OPHTHALMOLOGY, V111, P600, DOI 10.1016/j.ophtha.2003.12.027; American Optometric Association, SPORTS VIS EYE PROT; American Society for Testing and Materials International, F271309 ASTM INT; Browning DG, EYE FACE INJURIES FI; Dick R, 2007, J ATHL TRAINING, V42, P211; ELLIOTT AJ, 1984, BRIT MED J, V289, P21, DOI 10.1136/bmj.289.6436.21-a; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hendrickson CD, 2008, CLIN J SPORT MED, V18, P399, DOI 10.1097/JSM.0b013e318188b89d; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; International Federation of Sports Medicine, FIMS POS STAT EYE IN; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Meyers J, 2012, USA HOCKEY MAGAZ APR, V35, P26; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; National Center for Catastrophic Sport Injury Research, 1982, 28 NAT CTR CAT SPORT; National Federation of State High School Associations, PART FIG HIST; National Federation of State High School Associations, NFHS FIELD HOCK RUL; Prevent Blindness America, PREV EYE INJ; Vinger PF, MECH PREVENTION SPOR; Yard EE, 2006, J ATHL TRAINING, V41, P441; Zhang JX, 2016, HLTH PEOPL 2020, V2, P13	22	21	21	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2012	130	6					1069	1075		10.1542/peds.2012-1492			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	087YZ	WOS:000314802000056	23147982				2022-02-06	
J	Tanriverdi, F; De Bellis, A; Teksahin, H; Alp, E; Bizzarro, A; Sinisi, AA; Bellastella, G; Paglionico, VA; Bellastella, A; Unluhizarci, K; Doganay, M; Kelestimur, F				Tanriverdi, F.; De Bellis, A.; Teksahin, H.; Alp, E.; Bizzarro, A.; Sinisi, A. A.; Bellastella, G.; Paglionico, V. A.; Bellastella, A.; Unluhizarci, K.; Doganay, M.; Kelestimur, F.			Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity?	PITUITARY			English	Article						Meningitis; Pituitary; Hypopituitarism; Growth hormone; Autoimmunity	TRAUMATIC BRAIN-INJURY; GH REPLACEMENT THERAPY; SERUM IGF-I; GROWTH-HORMONE; ANTIPITUITARY ANTIBODIES; TUBERCULOUS MENINGITIS; SHEEHANS-SYNDROME; BODY-COMPOSITION; AMATEUR BOXERS; HYPOPITUITARISM	Previous case reports and retrospective studies suggest that pituitary dysfunction may occur after acute bacterial or viral meningitis. In this prospective study we assessed the pituitary functions, lipid profile and anthropometric measures in adults with acute bacterial or viral meningitis. Moreover, in order to investigate whether autoimmune mechanisms could play a role in the pathogenesis of acute meningitis-induced hypopituitarism we also investigated the anti-pituitary antibodies (APA) and anti-hypothalamus antibodies (AHA) prospectively. Sixteen patients (10 males, 6 females; mean +/- A SD age 40.9 +/- A 15.9) with acute infectious meningitis were included and the patients were evaluated in the acute phase, and at 6 and 12 months after the acute meningitis. In the acute phase 18.7% of the patients had GH deficiency, 12.5% had ACTH and FSH/LH deficiencies. At 12 months after acute meningitis 6 of 14 patients (42.8%) had GH deficiency, 1 of 14 patients (7.1%) had ACTH and FSH/LH deficiencies. Two of 14 patients (14.3%) had combined hormone deficiencies and four patients (28.6%) had isolated hormone deficiencies at 12 months. Four of 9 (44.4%) hormone deficiencies at 6 months were recovered at 12 months, and 3 of 8 (37.5%) hormone deficiencies at 12 months were new-onset hormone deficiencies. At 12 months there were significant negative correlations between IGF-I level vs. LDL-C, and IGF-I level vs. total cholesterol. The frequency of AHA and APA positivity was substantially high, ranging from 35 to 50% of the patients throughout the 12 months period. However there were no significant correlations between AHA or APA positivity and hypopituitarism. The risk of hypopituitarism, GH deficiency in particular, is substantially high in the acute phase, after 6 and 12 months of the acute infectious meningitis. Moreover we found that 6th month after meningitis is too early to make a decision for pituitary dysfunction and these patients should be screened for at least 12 months. In addition, the occurrence of AHA and APA positivity due to acute infectious meningitis was demonstrated for the first time. Further longer-term prospective investigations need to be carried out on a larger cohort of patients to understand the role of autoimmunity in the pathogenesis of late hypopituitarism after acute infectious meningitis.	[Tanriverdi, F.; Teksahin, H.; Unluhizarci, K.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [De Bellis, A.; Sinisi, A. A.; Bellastella, G.; Paglionico, V. A.; Bellastella, A.] Univ Naples 2, Dept Endocrinol, I-80131 Naples, Italy; [Alp, E.; Doganay, M.] Erciyes Univ, Sch Med, Dept Infect Dis, TR-38039 Kayseri, Turkey; [Bizzarro, A.] Univ Naples 2, Dept Immunol, I-80131 Naples, Italy		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021; Doganay, Mehmet/G-4250-2019	Doganay, Mehmet/0000-0003-3922-4901; DE BELLIS, Annamaria/0000-0002-0611-4506			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; AMATO G, 1993, J CLIN ENDOCR METAB, V77, P1671, DOI 10.1210/jc.77.6.1671; Bellastella G, 2010, J CLIN ENDOCR METAB, V95, P3750, DOI 10.1210/jc.2010-0551; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; De Bellis A, 2008, EUR J ENDOCRINOL, V158, P147, DOI 10.1530/EJE-07-0647; DRURY MI, 1968, BRIT MED J, V1, P842, DOI 10.1136/bmj.1.5595.842; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; HAGG E, 1978, ACTA MED SCAND, V203, P231; HASLAM RHA, 1969, AM J DIS CHILD, V118, P903, DOI 10.1001/archpedi.1969.02100040905017; JEW K, 1984, NEUROSURGERY, V14, P567, DOI 10.1227/00006123-198405000-00008; Karaca Z, 2011, PITUITARY, V14, P134, DOI 10.1007/s11102-010-0270-3; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kunitomi M, 2002, INT J OBESITY, V26, P361, DOI 10.1038/sj.ijo.0801899; KUPARI M, 1980, ACTA ENDOCRINOL-COP, V94, P433, DOI 10.1530/acta.0.0940433; LAM KSL, 1993, ANN INTERN MED, V118, P701, DOI 10.7326/0003-4819-118-9-199305010-00007; Lamberts SWJ, 1998, LANCET, V352, P127; LEVIN AR, 1959, BRIT MED J, V2, P1061, DOI 10.1136/bmj.2.5159.1061; LICHTENSTEIN MJ, 1982, J ENDOCRINOL INVEST, V5, P111, DOI 10.1007/BF03350501; Lynch C, 2007, BRIT J HOSP MED, V68, P272, DOI 10.12968/hmed.2007.68.5.23336; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Muraoka A, 1989, Nihon Naika Gakkai Zasshi, V78, P684; PAI KG, 1976, J PEDIATR-US, V88, P289, DOI 10.1016/S0022-3476(76)81002-5; Schaefer S, 2008, EUR J ENDOCRINOL, V158, P3, DOI 10.1530/EJE-07-0484; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2008, J ENDOCRINOL INVEST, V31, P489, DOI 10.1007/BF03346395; Tanriverdi F, 2005, GROWTH HORM IGF RES, V15, P231, DOI 10.1016/j.ghir.2005.03.005; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi Fatih, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P131, DOI 10.1586/14737167.6.2.131; Tanriverdi F, 2008, OBES METAB-MILAN, V4, P118; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; TUNKEL AR, 2005, PRINCIPLES PRACTICE, P1083	37	21	21	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	DEC	2012	15	4					579	588		10.1007/s11102-011-0371-7			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	034UM	WOS:000310898400017	22228382				2022-02-06	
J	Yu, WH; Dong, XQ; Hu, YY; Huang, M; Zhang, ZY				Yu, Wen-Hua; Dong, Xiao-Qiao; Hu, Yue-Yu; Huang, Man; Zhang, Zu-Yong			Ginkgolide B Reduces Neuronal Cell Apoptosis in the Traumatic Rat Brain: Possible Involvement of Toll-like Receptor 4 and Nuclear Factor Kappa B Pathway	PHYTOTHERAPY RESEARCH			English	Article						traumatic brain injury; ginkgolide B; toll-like receptor 4; nuclear factor kappa B; inflammatory cytokine; neuronal cell apoptosis	PLATELET-ACTIVATING-FACTOR; 5-YEAR DOUBLE-BLIND; ENDOTHELIAL-CELLS; MEMORY IMPAIRMENT; RANDOMIZED-TRIAL; ELDERLY-PEOPLE; UP-REGULATION; EGB 761(R); INJURY; PAF	Ginkgolide B (GB) has been demonstrated to have a variety of pharmacological actions. Accumulating evidence indicates that GB may exert a protective effect on brain injury. The study was designed to investigate the influence of GB on toll-like receptor 4 (TLR-4) and nuclear factor kappa B (NF-kappa B)-dependent inflammatory responses and neuronal cell apoptosis after traumatic brain injury (TBI). Wistar rats were subjected to 5, 10 and 20 mg/kg GB daily for 5 days, intraperitoneally, following TBI. Rats were sacrificed at hour 2, 6 and 12, as well as day 1, 2, 3 and 5 after TBI. The administration of 10 and 20 mg/kg GB could significantly (least-significant difference test: p<0.05) suppress gene expressions of TLR-4 and NF-kappa B, lessen concentrations of tumour necrosis factor a, interleukin-1 beta and interleukin-6, as well as reduce the number of apoptotic neuronal cells in traumatic rat brain tissues, but the administration of 5 mg/kg GB did not (p>0.05). However, a clear concentrationresponse relationship was not found. Thus, GB may inhibit TLR-4 and NF-kappa B-dependent inflammatory responses, and furthermore lessen neuronal cell apoptosis after TBI, which may support the use of GB for the treatment of TBI. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Yu, Wen-Hua; Dong, Xiao-Qiao; Zhang, Zu-Yong] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China; [Hu, Yue-Yu; Huang, Man] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Intens Care Unit, Hangzhou 310000, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310000, Zhejiang, Peoples R China.	dxqhyy@163.com			Traditional Chinese Medicine Department of Zhejiang Province [2011ZA077]	This work is financially supported by the Traditional Chinese Medicine Department of Zhejiang Province, No. 2011ZA077.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akiba S, 1998, BIOCHEM MOL BIOL INT, V46, P1243; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Andrieu S, 2008, CURR ALZHEIMER RES, V5, P406, DOI 10.2174/156720508785132271; ATTELLA MJ, 1989, EXP NEUROL, V105, P62, DOI 10.1016/0014-4886(89)90172-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bate C, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-4; Begley DJ, 2003, PROG DRUG RES, V61, P39; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; BRAQUET P, 1991, J ETHNOPHARMACOL, V32, P135, DOI 10.1016/0378-8741(91)90111-P; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Clark WM, 2001, STROKE, V32, P1000, DOI 10.1161/01.STR.32.4.1000; DeFeudis F. V., 2000, Current Drug Targets, V1, P25, DOI 10.2174/1389450003349380; Desouza IA, 2002, TOXICON, V40, P1709, DOI 10.1016/S0041-0101(02)00237-4; DESQUAND S, 1986, EUR J PHARMACOL, V127, P83, DOI 10.1016/0014-2999(86)90208-6; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DRIEU K, 1986, PRESSE MED, V15, P1455; Fang WR, 2010, EUR J PHARM SCI, V39, P8, DOI 10.1016/j.ejps.2009.10.002; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FOLDESFILEP E, 1987, BIOCHEM BIOPH RES CO, V148, P1412; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Guidetti C, 2001, J PHARM PHARMACOL, V53, P387, DOI 10.1211/0022357011775442; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hotter G, 1997, FREE RADICAL BIO MED, V22, P947, DOI 10.1016/S0891-5849(96)00494-7; Huang Jian-Ying, 2008, Zhongguo Yaolixue Tongbao, V24, P269; Ihl R, 2010, J NEUROL SCI, V299, P184, DOI 10.1016/j.jns.2010.08.033; KIMURA H, 1995, INT J RADIAT ONCOL, V33, P627, DOI 10.1016/0360-3016(95)00205-D; KLEIJNEN J, 1992, LANCET, V340, P1136, DOI 10.1016/0140-6736(92)93158-J; KURIHARA K, 1989, J ALLERGY CLIN IMMUN, V83, P83, DOI 10.1016/0091-6749(89)90480-6; Li R, 2009, J PHARMACOL SCI, V110, P362, DOI 10.1254/jphs.08275FP; Li SQ, 2007, CHINESE MED J-PEKING, V120, P1529, DOI 10.1097/00029330-200709010-00012; Ling NS, 2002, J HARBIN U COMMERCE, V18, P83; Liu BJ, 1996, CHINESE MED J-PEKING, V109, P467; Liu Yong-Gang, 2010, Zhong Yao Cai, V33, P578; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maclennan KM, 2002, PROG NEUROBIOL, V67, P235, DOI 10.1016/S0301-0082(02)00015-1; Nie Zhen-gui, 2004, Yaoxue Xuebao, V39, P415; Peng Shan-ying, 2010, Yaoxue Xuebao, V45, P1103; Qin B, 2005, CHINESE J INTEGRATED, V12, P17; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Schmidt H, 1996, J SURG RES, V60, P29, DOI 10.1006/jsre.1996.0006; Smith PF, 1996, J ETHNOPHARMACOL, V50, P131, DOI 10.1016/0378-8741(96)01379-7; van Dongen M, 2003, J CLIN EPIDEMIOL, V56, P367, DOI 10.1016/S0895-4356(03)00003-9; van Dongen MCJM, 2000, J AM GERIATR SOC, V48, P1183, DOI 10.1111/j.1532-5415.2000.tb02589.x; VARGAFTIG BB, 1983, TRENDS PHARMACOL SCI, V4, P341, DOI 10.1016/0165-6147(83)90433-9; VARGAFTIG BB, 1980, EUR J PHARMACOL, V65, P185, DOI 10.1016/0014-2999(80)90391-X; Vellas B, 2006, NEUROLOGY, V67, pS6, DOI 10.1212/WNL.67.9_suppl_3.S6; Wang JH, 2000, NEUROCHEM RES, V25, P613, DOI 10.1023/A:1007550801444; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Wu XM, 2009, J CELL MOL MED, V13, P4474, DOI 10.1111/j.1582-4934.2008.00551.x; Xia SH, 2007, CHINESE MED J-PEKING, V120, P922, DOI 10.1097/00029330-200705020-00013; Xiao QA, 2010, EUR J PHARMACOL, V647, P48, DOI 10.1016/j.ejphar.2010.08.002; Yang ZZ, 2011, J ETHNOPHARMACOL, V136, P117, DOI 10.1016/j.jep.2011.04.027; Zhang S, 2011, J CARDIOVASC PHARM, V57, P721, DOI 10.1097/FJC.0b013e31821a50a8; [张硕峰 Zhang Shuofeng], 2006, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V29, P836; Zhou Long-en, 2001, Yaoxue Xuebao, V36, P92	58	21	22	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	DEC	2012	26	12					1838	1844		10.1002/ptr.4662			7	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	056IP	WOS:000312481900012	22422608				2022-02-06	
J	Behnke, NMK; Redjal, HR; Nguyen, VT; Zinar, DM				Behnke, Nicole M. K.; Redjal, Hamid R.; Nguyen, Virginia T.; Zinar, Daniel M.			Internal Fixation of Diaphyseal Fractures of the Forearm: A Retrospective Comparison of Hybrid Fixation Versus Dual Plating	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						both-bone forearm fracture; intramedullary nailing; open reduction and internal fixation	MEDULLARY FIXATION; BONES; REFRACTURE; REMOVAL; ADULTS; PLATES; RADIUS; NAIL; ULNA	Objectives: To compare open reduction and internal fixation using dual plating to a hybrid fixation construct with intramedullary nailing of the ulna and plate fixation of the radius in both-bone forearm fractures. Design: Retrospective comparison study. Setting: Level I trauma center. Patients: A total of 56 skeletally mature individuals treated surgically for acute both-bone forearm fractures between July 2005 and December 2009. Monteggia, Galeazzi, and pathologic fractures, patients treated with external fixation and patients with traumatic brain injuries were excluded. Intervention: Twenty-seven patients were treated with dual plate fixation, and 29 patients were treated using a hybrid fixation construct. Main Outcome Measures: Time to union, range of motion as assessed using a Grace and Eversmann score, and presence of complications. Results: There was no significant difference in either time to union or Grace and Eversmann scores between the 2 groups. There was 1 nonunion in each of the 2 groups. Nine overall complications, outside nonunions, were reported: 5 in the dual plating group and 4 in the hybrid fixation group. Conclusions: Hybrid fixation, using open reduction and internal fixation with a plate-and-screw construct on the radius and closed-or minimally open-reduction and interlocked intramedullary fixation of the ulna, is an acceptable method for treating both-bone diaphyseal forearm fractures in skeletally mature patients.	[Behnke, Nicole M. K.; Redjal, Hamid R.; Zinar, Daniel M.] Harbor UCLA Med Ctr, Dept Orthopaed Surg, Torrance, CA 90509 USA; [Nguyen, Virginia T.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Behnke, NMK (corresponding author), Harbor UCLA Med Ctr, Dept Orthopaed Surg, 1000 W Carson Ave,2nd Floor,Box 422, Torrance, CA 90509 USA.	nmbehnke@gmail.com					ANDERSON LD, 1975, J BONE JOINT SURG AM, VA 57, P287, DOI 10.2106/00004623-197557030-00001; Beaupre GS, 1996, J ORTHOP TRAUMA, V10, P87, DOI 10.1097/00005131-199602000-00003; CHAPMAN MW, 1989, J BONE JOINT SURG AM, V71A, P159, DOI 10.2106/00004623-198971020-00001; Crenshaw AH, 1997, SURG TECHNIQUE FORES; Crenshaw Andrew H, 2002, Instr Course Lect, V51, P279; DELUCA PA, 1988, J BONE JOINT SURG AM, V70A, P1372, DOI 10.2106/00004623-198870090-00015; Droll KP, 2007, J BONE JOINT SURG AM, V89A, P2619, DOI 10.2106/JBJS.F.01065; Goldfarb CA, 2005, J BONE JOINT SURG BR, V87B, P374, DOI 10.1302/0301-620X.87B3; GRACE TG, 1980, J BONE JOINT SURG AM, V62, P433, DOI 10.2106/00004623-198062030-00013; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HADDEN WA, 1983, INJURY, V15, P44, DOI 10.1016/0020-1383(83)90162-6; Hertel R, 2006, ROCKWOOD GREENS FRAC, P965; HIDAKA S, 1984, J BONE JOINT SURG AM, V66A, P1241, DOI 10.2106/00004623-198466080-00012; Hong G, 2005, J ORTHOP TRAUMA, V19, P384, DOI 10.1097/01.bot.0000157911.76433.db; LABOSKY DA, 1990, J HAND SURG-AM, V15A, P294, DOI 10.1016/0363-5023(90)90112-5; LANGKAMER VG, 1991, INJURY, V22, P97, DOI 10.1016/0020-1383(91)90063-K; Lee YH, 2008, J BONE JOINT SURG AM, V90A, P1891, DOI 10.2106/JBJS.G.01636; Lindvall EM, 2006, J ORTHOP TRAUMA, V20, P157, DOI 10.1097/00005131-200603000-00001; MAREK FM, 1961, J BONE JOINT SURG AM, V43, P1099, DOI 10.2106/00004623-196143080-00003; Martin WN, 2002, INJURY, V33, P530, DOI 10.1016/S0020-1383(02)00029-3; MATTHEWS LS, 1982, J BONE JOINT SURG AM, V64, P14, DOI 10.2106/00004623-198264010-00003; McAuliffe JA, 1997, HAND CLIN, V13, P689; MIH AD, 1994, CLIN ORTHOP RELAT R, P256; Myers GJC, 2004, J BONE JOINT SURG BR, V86B, P581, DOI 10.1302/0301-620X.8684.13750; Rehman S, 2010, HAND CLIN, V26, P391, DOI 10.1016/j.hcl.2010.04.002; Reinhardt KR, 2008, J PEDIATR ORTHOPED, V28, P403, DOI 10.1097/BPO.0b013e31816d71f2; ROSSON J, 1991, J BONE JOINT SURG BR, V73, P283, DOI 10.1302/0301-620X.73B2.2005156; ROSSON JW, 1991, J BONE JOINT SURG BR, V73, P415, DOI 10.1302/0301-620X.73B3.1670441; SAGE FP, 1959, J BONE JOINT SURG AM, V41, P1489, DOI 10.2106/00004623-195941080-00010; SCHEMITSCH EH, 1992, J BONE JOINT SURG AM, V74A, P1068, DOI 10.2106/00004623-199274070-00014; Shah AS, 2010, J ORTHOP TRAUMA, V24, P440, DOI 10.1097/BOT.0b013e3181ca343b; Shea KG, 1997, HAND CLIN, V13, P737; SLATIS P, 1980, CAN J SURG, V23, P247; SMITH H, 1957, J BONE JOINT SURG AM, V39, P91, DOI 10.2106/00004623-195739010-00010; STREET DM, 1986, CLIN ORTHOP RELAT R, P219; TARR RR, 1986, CLIN ORTHOP RELAT R, P10; TARR RR, 1984, J BONE JOINT SURG AM, V66A, P65, DOI 10.2106/00004623-198466010-00010; UHTHOFF HK, 1994, J BONE JOINT SURG AM, V76A, P1507, DOI 10.2106/00004623-199410000-00010; Visna P, 2008, ACTA CHIR BELG, V108, P333, DOI 10.1080/00015458.2008.11680232; Weckbach A, 2006, ARCH ORTHOP TRAUM SU, V126, P309, DOI 10.1007/s00402-006-0122-9; Wei SY, 1999, J TRAUMA, V46, P1045, DOI 10.1097/00005373-199906000-00011; Wright RR, 1997, J ORTHOP TRAUMA, V11, P288, DOI 10.1097/00005131-199705000-00012; Zinar DM, 2006, FRACTURES, P157	43	21	23	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	NOV	2012	26	11					611	616		10.1097/BOT.0b013e31824aee8e			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	028WR	WOS:000310456200005	22487905				2022-02-06	
J	Bonneh-Barkay, D; Wang, GJ; LaFramboise, WA; Wiley, CA; Bissel, SJ				Bonneh-Barkay, Dafna; Wang, Guoji; LaFramboise, William A.; Wiley, Clayton A.; Bissel, Stephanie J.			Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						BRP-39; Chitinase-like proteins; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroimmunology; YKL-40	AUTOMATED IMAGE-ANALYSIS; REACTIVE ASTROCYTES; MULTIPLE-SCLEROSIS; YKL-40 EXPRESSION; DIFFERENTIAL EXPRESSION; CEREBROSPINAL-FLUID; SERUM-LEVELS; INFLAMMATION; DISEASE; INJURY	We previously reported that YKL-40, the human analog of mouse breast regression protein 39 ([BRP-39] chitinase 3-like 1), is elevated in the cerebrospinal fluid of patients with a variety of neuroinflammatory conditions, such as multiple sclerosis and traumatic brain injury. Expression of YKL-40 in the CNS was predominantly associated with reactive astrocytes in the vicinity of inflammatory lesions. Because previous studies have shown that reactive astrocytes play a critical role in limiting immune infiltration in the mouse model of experimental autoimmune encephalomyelitis, we explored the role of BRP-39 in regulating neuroinflammation in experimental autoimmune encephalomyelitis. Using BRP-39-deficient (BRP-39(-/-)) mice, we demonstrate the importance of BRP-39 in modulating the severity of clinical experimental autoimmune encephalomyelitis and CNS neuroinflammation. At disease onset, absence of BRP-39 had little effect on clinical disease or lymphocytic infiltrate, but by 14 days after immunization, differences in clinical scores were evident. By 28 days after immunization, BRP-39(-/-) mice showed more severe and persistent clinical disease than BRP-39(+/+) controls. Histopathological evaluation showed that BRP-39(-/-) mice had more marked lymphocytic and macrophage infiltrates and gliosis versus BRP-39(+/+) mice. These findings support the role of BRP-39 expression in limiting immune cell infiltration into the CNS and offer a new target to modulate neuroinflammation.	[Bonneh-Barkay, Dafna; Wang, Guoji; LaFramboise, William A.; Wiley, Clayton A.; Bissel, Stephanie J.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA		Bonneh-Barkay, D (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15213 USA.	dafnabb@yahoo.com			Pittsburgh Foundation;  [P30CA047904]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA047904] Funding Source: NIH RePORTER	This work was supported in part by a grant from The Pittsburgh Foundation John F. & Nancy A. Emmerling Fund for Medical Research to Dafna Bonneh-Barkay. This project used University of Pittsburgh Cancer Institute shared resources that are supported in part by award P30CA047904.	ADAMS CWM, 1989, J NEUROL SCI, V92, P291, DOI 10.1016/0022-510X(89)90144-5; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Bonneh-Barkay D, 2010, J BIOL CHEM, V27, P1215; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hung SL, 2002, J LEUKOCYTE BIOL, V72, P72; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Isse K, 2012, AM J TRANSPLANT, V12, P27, DOI 10.1111/j.1600-6143.2011.03797.x; Isse K, 2010, CLIN LIVER DIS, V14, P669, DOI 10.1016/j.cld.2010.07.004; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Johansen JS, 2006, DAN MED BULL, V53, P172; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Kaynar MY, 2005, J CLIN NEUROSCI, V12, P754, DOI 10.1016/j.jocn.2005.06.001; Koutroubakis IE, 2003, INT J COLORECTAL DIS, V18, P254, DOI 10.1007/s00384-002-0446-z; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Matsuura H, 2011, AM J RESP CELL MOL, V44, P777, DOI 10.1165/rcmb.2010-0081OC; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nikota JK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-39; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Rathcke CN, 2010, SCAND CARDIOVASC J, V44, P92, DOI 10.3109/14017430903402218; Singh SK, 2011, J BIOL CHEM, V286, P39893, DOI 10.1074/jbc.M111.257451; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Zhang W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-593	40	21	21	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	NOV	2012	71	11					948	958		10.1097/NEN.0b013e31826eaee7			11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	030CF	WOS:000310544800002	23041842	Green Accepted, Bronze			2022-02-06	
J	Genet, F; Chehensse, C; Jourdan, C; Lautridou, C; Denormandie, P; Schnitzler, A				Genet, Francois; Chehensse, Clement; Jourdan, Claire; Lautridou, Christine; Denormandie, Philippe; Schnitzler, Alexis			Impact of the Operative Delay and the Degree of Neurologic Sequelae on Recurrence of Excised Heterotopic Ossification in Patients With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						heterotopic ossification; recurrence; traumatic brain injury	SPINAL-CORD; BONE-FORMATION; HEAD-INJURY; ELBOW; RESECTION; HIP; REHABILITATION; STROKE; JOINT; KNEE	The timing of surgery with regard to recurrence risk after neurologic heterotopic ossification (HO) excision is still debated. This study investigated the association between recurrence risk after HO excision in traumatic brain injury (TBI) patients and (1) the operative delay and (2) the degree of neurologic sequelae (Garland status). A case-control study was performed. Patients who developed troublesome HO requiring surgery after TBI with (case, n = 16) or without recurrence (control, n = 64) were retrospectively included. Other matching criteria were sex and age at the time of surgery (+/- 4 years). The median delay for first HO surgery was 13.7 months (interquartile range: 9.0-37.1) for the case group and 13.2 months (interquartile range: 7.8-30.0) for the control group. No significant link was found between recurrence and operative delay (P = .54), even after inclusion of all matching factors (P = .53), or Garland status (P = .81). The inclusion of Garland status into the model did not change this result (P = .64). After TBI, no link was found between HO operative delay and recurrence. In spite of a common notion of a relationship between initial severity of TBI and HO development, no link was found between HO recurrence risk and the severity of sequelae.	[Genet, Francois; Chehensse, Clement; Jourdan, Claire; Schnitzler, Alexis] CHU R Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Denormandie, Philippe] CHU R Poincare, Serv Chirurg Orthoped, Garches, France		Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bld Raymond Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano Cara, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-33; Denormandie P, 1999, Chir Main, V18, P99; ENNEKING WF, 1972, CLIN ORTHOP RELAT R, P28; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Narmoneva DA, 2002, J ORTHOP RES, V20, P83, DOI 10.1016/S0736-0266(01)00076-6; ORZEL JA, 1985, J NUCL MED, V26, P125; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Rossier A B, 1973, Paraplegia, V11, P38; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; Sorriaux G, 2005, REV CHIR ORTHOP, V91, P415, DOI 10.1016/S0035-1040(05)84358-2; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TANAKA T, 1977, RADIOLOGY, V123, P217, DOI 10.1148/123.1.217; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	35	21	22	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					443	448		10.1097/HTR.0b013e31822b54ba			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200015	22495100				2022-02-06	
J	Kokjohn, TA; Maarouf, CL; Roher, AE				Kokjohn, Tyler A.; Maarouf, Chera L.; Roher, Alex E.			Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Amyloid-beta; Brain microvasculature; Brain microhemorrhages; Brain hypoperfusion	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; FLUID DRAINAGE PATHWAYS; BETA-PEPTIDE; A-BETA; PRECURSOR PROTEIN; PERFUSION SPECT; MICROVASCULAR PATHOLOGY; VENOUS THROMBOEMBOLISM	Here, we synthesize several lines of evidence supporting the hypothesis that at least one function of amyloid-beta is to serve as a part of the acute response to brain hemodynamic disturbances intended to seal vascular leakage. Given the resilient and adhesive physicochemical properties of amyloid, an abluminal hemostatic repair system might be highly advantageous, if deployed on a limited and short-term basis, in young individuals. However, in the aged, inevitable cardiovascular dysfunction combined with brain microvascular lesions may yield global chronic hypoperfusion that may lead to continuous amyloid deposition and consequential negative effects on neuronal viability. A large body of experimental evidence supports the hypothesis of an amyloid-beta rescue function gone astray. Preventing or inducing the removal of amyloid in Alzheimer's disease (AD) has been simultaneously successful and disappointing. Amyloid deposits clearly play major roles in AD, but they may not represent the preeminent factor in dementia pathogenesis. Successful application of AD preventative approaches may hinge on an accurate and comprehensive view of comorbidities, including cardiovascular disease, diabetes, and head trauma. (C) 2012 The Alzheimer's Association. All rights reserved.	[Kokjohn, Tyler A.; Maarouf, Chera L.; Roher, Alex E.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA; [Kokjohn, Tyler A.] Midwestern Univ, Dept Microbiol, Glendale, AZ USA		Roher, AE (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA.	alex.roher@bannerhealth.com			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG019795, R21 AG035078]; State of Arizona Alzheimer Disease Research Consortium; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG019795, R21AG035078] Funding Source: NIH RePORTER	This study was supported by the National Institute on Aging grants R01 AG019795 and R21 AG035078 and by the State of Arizona Alzheimer Disease Research Consortium. The authors thank Ian D. Daugs for assistance with the figures and Dr. Walter M. Kalback and Dr. Dean C. Luehrs for critical review of the manuscript.	[Anonymous], 2005, SHORT VERS LONG TERM; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2006, J ALZHEIMERS DIS, V10, P255; Atri A, 2005, NEURODEGENER DIS, V2, P305, DOI 10.1159/000092317; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2003, BRAIN RES REV, V43, P164, DOI 10.1016/S0165-0173(03)00206-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barlow DE, 2010, LANGMUIR, V26, P6549, DOI 10.1021/la9041309; Belohlavek M, 2009, J ULTRAS MED, V28, P1493, DOI 10.7863/jum.2009.28.11.1493; Bishop GM, 2004, BRAIN PATHOL, V14, P448; Bishop GM, 2002, DEV NEUROSCI-BASEL, V24, P184, DOI 10.1159/000065696; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2009, J NEUROL SCI, V283, P28, DOI 10.1016/j.jns.2009.02.328; Carlsson CM, 2010, J ALZHEIMERS DIS, V20, P711, DOI 10.3233/JAD-2010-100012; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; delaTorre JC, 1997, ANN NY ACAD SCI, V826, P75; Devanand DP, 2010, AM J GERIAT PSYCHIAT, V18, P959, DOI 10.1097/JGP.0b013e3181ec8696; Dickinson GH, 2009, J EXP BIOL, V212, P3499, DOI 10.1242/jeb.029884; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Fagan T, 2010, LILLY HALTS IDENTITY; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Freeman JS, 2010, J AM OSTEOPATH ASSOC, V110, pES2; GAZIANO JM, 2005, BRAUNWALDS HEART DIS, P1; Grammas P, 2004, J ALZHEIMERS DIS, V6, P275; Hanyu H, 2003, J NEUROL SCI, V209, P25, DOI 10.1016/S0022-510X(02)00456-2; HARDY JA, 1986, NEUROBIOL AGING, V7, P489, DOI 10.1016/0197-4580(86)90086-2; Henskens LHG, 2008, HYPERTENSION, V51, P62, DOI 10.1161/HYPERTENSIONAHA.107.100610; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Horani MH, 2003, CURR PHARM DESIGN, V9, P833, DOI 10.2174/1381612033455314; House E, 2004, J ALZHEIMERS DIS, V6, P291; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Imabayashi E, 2004, J NUCL MED, V45, P1450; Inoue S, 2001, INT REV CYTOL, V210, P121; Inzitari M, 2007, J NEUROL SCI, V257, P166, DOI 10.1016/j.jns.2007.01.026; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Kobayashi S, 2008, J NEUROL SCI, V264, P27, DOI 10.1016/j.jns.2007.07.015; Kogure D, 2000, J NUCL MED, V41, P1155; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Lowenson JD, 1999, METHOD ENZYMOL, V309, P89; Luchsinger JA, 2010, J NEUROL SCI, V299, P35, DOI 10.1016/j.jns.2010.08.063; Luo F, 2010, J PHARMACOL EXP THER, V335, P580, DOI 10.1124/jpet.110.172932; Maarouf CL, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-39; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; Matsuda H, 2002, EUR J NUCL MED MOL I, V29, P1502, DOI 10.1007/s00259-002-0930-2; Merkle DL, 1996, BLOOD COAGUL FIBRIN, V7, P650, DOI 10.1097/00001721-199609000-00011; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Mooradian AD, 1997, BRAIN RES REV, V23, P210, DOI 10.1016/S0165-0173(97)00003-9; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Nishimura T, 2007, ANN NUCL MED, V21, P15, DOI 10.1007/BF03033995; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Paris D, 2000, NEUROBIOL AGING, V21, P183, DOI 10.1016/S0197-4580(99)00111-6; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Paris D, 2010, INT J PEPT RES THER, V16, P23, DOI 10.1007/s10989-010-9198-8; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Raby CA, 1998, J NEUROCHEM, V71, P2505; Rhodin J, 2001, MICROCIRCULATION, V8, P207, DOI 10.1080/713774033; Robinson SR, 2009, REDOX REP, V14, P228, DOI 10.1179/135100009X12525712409931; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Roher AE, 1999, METHOD ENZYMOL, V309, P58; Roher Alex E., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P85, DOI 10.2174/1568013033358590; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P436, DOI 10.1016/j.jalz.2010.08.228; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Roher AE, 2011, J ALZHEIMERS DIS, V24, P315, DOI 10.3233/JAD-2011-101809; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SCHEIBEL AB, 1989, ANN MED, V21, P103, DOI 10.3109/07853898909149194; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Streitparth F, 2008, RADIOLOGE, V48, P175, DOI 10.1007/s00117-006-1443-y; Strobel G., 2008, FLURIZAN POSTMORTEM; Suo Z., 2004, Current Drug Targets - Inflammation and Allergy, V3, P105, DOI 10.2174/1568010043483953; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; Uro-Coste E, 2010, CLIN NEUROPATHOL, V29, P209; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Vasileyko V, 2010, ANN NY ACAD SCI, V1207, P58, DOI 10.1111/j.1749-6632.2010.05786.x; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Weir DR., 2009, NATL FOOTBALL LEAGUE; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weller RO, 2000, ANN NY ACAD SCI, V903, P110, DOI 10.1111/j.1749-6632.2000.tb06356.x; Wilcock DM, 2009, CNS NEUROL DISORD-DR, V8, P50, DOI 10.2174/187152709787601858; Wimo A, 2010, WORLD ALZHEIMER REPO; WONG GT, 2007, FDA DEEMS US ALZHEME; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Yang Y, 2011, PROG MOL BIOL TRANSL, V99, P241, DOI 10.1016/S1877-1173(11)99006-1; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	129	21	21	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260			ALZHEIMERS DEMENT	Alzheimers. Dement.	NOV	2012	8	6					574	583		10.1016/j.jalz.2011.05.2429			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	038KW	WOS:000311174600015	22047632	Green Accepted			2022-02-06	
J	Konigs, M; de Kieviet, JF; Oosterlaan, J				Konigs, Marsh; de Kieviet, Jorrit F.; Oosterlaan, Jaap			Post-traumatic amnesia predicts intelligence impairment following traumatic brain injury: a meta-analysis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CLOSED-HEAD INJURY; OF-THE-LITERATURE; INTELLECTUAL ABILITY; SHORT FORMS; RECOVERY; AGE; CHILDHOOD; SEVERITY; OUTCOMES; MEMORY	Context Worldwide, millions of patients with traumatic brain injury (TBI) suffer from persistent and disabling intelligence impairment. Post-traumatic amnesia (PTA) duration is a promising predictor of intelligence following TBI. Objectives To determine (1) the impact of TBI on intelligence throughout the lifespan and (2) the predictive value of PTA duration for intelligence impairment, using meta-analytic methods. Methods Electronic databases were searched for peer reviewed articles, published until February 2012. Studies reporting intelligence following TBI and injury severity by PTA duration were included. Meta-analytic methods generated effect sizes for full scale IQ (FSIQ), performance IQ (PIQ) and verbal IQ (VIQ), following mild TBI (PTA duration 1-24 h) and severe TBI (PTA duration >7 days), during the subacute phase of recovery (<= 6 months post-injury) and the chronic phase (>6 months post-injury). Meta-regression elucidated the predictive value of PTA duration for intelligence impairment. Results Patients with severe TBI exhibited large depressions in FSIQ in the subacute phase of recovery (d= -1.07, 95% CI to 1.52 to -0.62; p < 0.001), persisting into the chronic phase (d= -0.78, 95% CI -1.06 to -0.51; p < 0.001). PIQ was more severely affected than VIQ in the subacute phase (Q(1) =3.85; p < 0.05) but not in the chronic phase (Q(1) =0.03, p=0.87). Most importantly, longer PTA duration strongly predicted greater depressions of FSIQ and PIQ in the subacute phase (-0.76 <= beta s <= -0.73, Ps < 0.01) and FSIQ, PIQ and VIQ in the chronic phase (-0.80 <= beta s <= -0.61, Ps < 0.05). Conclusions PTA duration is a valuable predictor of intelligence impairment following TBI. Results support the routine assessment of PTA duration in clinical settings.	[Konigs, Marsh; de Kieviet, Jorrit F.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands		Konigs, M (corresponding author), Vrije Univ Amsterdam, FPP Dept Clin Neuropsychol, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	m.konigs@vu.nl		Konigs, Marsh/0000-0003-0200-0445	Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [022.003.010]	This work was supported by the Netherlands Organisation for Scientific Research (NWO) grant No 022.003.010. The funder had no role in the conductance of this study other than providing financial support.	Ahmed S, 2000, BRAIN INJURY, V14, P765; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; [Anonymous], 2008, SPSS STAT WIND COMP; [Anonymous], 2005, COMP MET VERS 2 COMP; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barker LA, 2010, NEUROPSYCHOLOGIA, V48, P2550, DOI 10.1016/j.neuropsychologia.2010.05.001; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cohen J., 2013, STAT POWER ANAL BEHA; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Ferri J, 2004, NEUROLOGIA, V19, P285; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; Guilmette TJ, 1999, ASSESSMENT, V6, P33, DOI 10.1177/107319119900600104; Hedges L.V., 1985, STAT METHODS META AN; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly J A, 1997, AAOHN J, V45, P439; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LUSKIN RC, 1991, AM J POLIT SCI, V35, P1032, DOI 10.2307/2111505; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; Persinger MA, 1995, PERCEPT MOTOR SKILL, V81, P1283, DOI 10.2466/pms.1995.81.3f.1283; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SILVERSTEIN AB, 1967, J CONSULT PSYCHOL, V31, P635, DOI 10.1037/h0025110; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tittle A, 2011, BRAIN INJURY, V25, P933, DOI 10.3109/02699052.2011.597042; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Tremont G, 1997, ARCH CLIN NEUROPSYCH, V12, P757, DOI 10.1016/S0887-6177(97)00049-8; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Verger K, 2000, BRAIN INJURY, V14, P495; Watt SE, 2006, BRAIN INJURY, V20, P1007, DOI 10.1080/02699050600909698; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D., 1949, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wechsler D., 1955, MANUAL WECHSLER ADUL; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Wells G., NEWCASTLE OTTAWA SCA; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P90, DOI 10.1017/S1355617707070129; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	61	21	21	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2012	83	11					1048	1055		10.1136/jnnp-2012-302635			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	020MG	WOS:000309813600006	22791900				2022-02-06	
J	Ma, XL; Sun, XL; Wan, CY; Ma, JX; Tian, P				Ma, Xin-Long; Sun, Xiao-Lei; Wan, Chun-You; Ma, Jian-Xiong; Tian, Peng			Significance of circulating endothelial progenitor cells in patients with fracture healing process	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						endothelial progenitor cell; fracture healing; neovascularization	OSTEOBLAST-LINEAGE CELLS; TRAUMATIC BRAIN-INJURY; BONE-MARROW; INDUCED MOBILIZATION; ACTIVATED PLATELETS; PRECURSOR CELLS; CD34(+) CELLS; STEM-CELLS; TRANSPLANTATION; THERAPY	Fracture healing is a complex bone formation process, and neovascularization may contribute to new bone regeneration. The circulating endothelial progenitor cell (EPC) mobilization and homing could involve in neovascularization and vasculogenesis. In this study, we investigate the changes of circulating EPC during bone fracture healing, and the possible contribution of EPCs to increased neovascularization and fracture healing. The number of circulating EPCs was monitored in twenty-four patients with long bone traumatic fracture within the first 48?h and at 3, 5, 10, and 14 days post-fracture. The mononuclear cells which isolated from peripheral blood were analyzed by flow cytometry. Peripheral blood counts of leukocytes and platelets were measured by hematology analyzer. The amount of peripheral EPCs significantly increased in patients with fracture compared to age-matched healthy control subjects within the first 48?h after injury, and peaked at 3 days post-fracture. There was no significant difference in the change trend of early EPCs between male and female, but the number of early EPCs was significantly greater in younger patients compared to older patients. A comparison of the EPCs levels between patients with severe injury (ISS?>?16) and patients with mild injury (ISS?=?16) revealed no statistically significant difference. The level of early EPCs was inverse correlation with the level of plate after fracture, but no correlation with the level of peripheral leucocytes. These findings suggest traumatic fracture may induce the mobilization of EPCs into the peripheral circulation. The increased EPCs may contribute to neovascularization and involve in fracture healing. (c) 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 30:18601866, 2012	[Ma, Xin-Long; Sun, Xiao-Lei; Wan, Chun-You; Tian, Peng] Tianjin Hosp, Tianjin 300211, Peoples R China; [Ma, Xin-Long; Ma, Jian-Xiong] Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin, Peoples R China		Tian, P (corresponding author), Tianjin Hosp, Tianjin 300211, Peoples R China.	tianpeng007@foxmail.com			Scientific Research Fund of Tianjin Public Health Bureau [10KG111]	This work was supported by funding from Scientific Research Fund of Tianjin Public Health Bureau (10KG111). The authors would like to thank Jing Yang and Shangkun Zhao for technical support.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083; Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7; Busse JW, 2002, CAN MED ASSOC J, V166, P437; Cobellis G, 2010, TRANSPL P, V42, P2816, DOI 10.1016/j.transproceed.2010.04.047; Condon ET, 2004, SURGERY, V135, P657, DOI 10.1016/j.surg.2003.10.012; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Eghbali-Fatourechi GZ, 2007, BONE, V40, P1370, DOI 10.1016/j.bone.2006.12.064; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Eguchi Masamichi, 2007, Clin Exp Nephrol, V11, P18, DOI 10.1007/s10157-006-0448-1; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gill M, 2001, CIRC RES, V88, P167; Grigoryan M, 2003, ACAD RADIOL, V10, P1267, DOI 10.1016/S1076-6332(03)00467-7; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kang HJ, 2001, BRIT J HAEMATOL, V113, P962, DOI 10.1046/j.1365-2141.2001.02694.x; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Kooistra BW, 2010, J ORTHOP TRAUMA, V24, pS71, DOI 10.1097/BOT.0b013e3181ca3fbd; Kuroda R, 2011, CELL TRANSPLANT, V20, P1491, DOI 10.3727/096368910X550189; Laing AJ, 2007, J BONE JOINT SURG BR, V89B, P116, DOI 10.1302/0301-620X.89B1.18222; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liew A, 2008, DIABETES OBES METAB, V10, P353, DOI 10.1111/j.1463-1326.2007.00754.x; Liew A, 2006, BIOESSAYS, V28, P261, DOI 10.1002/bies.20372; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Marsboom Glenn, 2008, Expert Rev Cardiovasc Ther, V6, P687, DOI 10.1586/14779072.6.5.687; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Masuda H, 2000, Hum Cell, V13, P153; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Morii T, 1994, Rinsho Ketsueki, V35, P649; Morshed S, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.G.01556; Murayama T, 2005, HANDB EXP PHARM, V170, P777; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Patil S, 2009, J ORTHOP RES, V27, P281, DOI 10.1002/jor.20572; Patschan SA, 2011, CRIT CARE, V15, DOI 10.1186/cc10100; Pihusch V, 2005, THROMB RES, V116, P233, DOI 10.1016/j.thromres.2004.12.010; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Quaranta N, 2011, ACTA OTO-LARYNGOL, V131, P347, DOI 10.3109/00016489.2010.536990; Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Terrace JD, 2007, STEM CELLS DEV, V16, P771, DOI 10.1089/scd.2007.0016; Tian B, 2010, CHINESE MED J-PEKING, V123, P2265, DOI 10.3760/cma.j.issn.0366-6999.2010.16.020; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wei HJ, 2011, J NEUROSCI RES, V89, P1822, DOI 10.1002/jnr.22696; Xie XX, 2011, MED HYPOTHESES, V76, P365, DOI 10.1016/j.mehy.2010.10.041; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035	59	21	25	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	NOV	2012	30	11					1860	1866		10.1002/jor.22134			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	015OL	WOS:000309455700023	22528744	Bronze			2022-02-06	
J	Max, JE; Wilde, EA; Bigler, ED; Thompson, WK; MacLeod, M; Vasquez, AC; Merkley, TL; Hunter, JV; Chu, ZD; Yallampalli, R; Hotz, G; Chapman, SB; Yang, TT; Levin, HS				Max, Jeffrey E.; Wilde, Elisabeth A.; Bigler, Erin D.; Thompson, Wesley K.; MacLeod, Marianne; Vasquez, Ana C.; Merkley, Tricia L.; Hunter, Jill V.; Chu, Zili D.; Yallampalli, Ragini; Hotz, Gillian; Chapman, Sandra B.; Yang, Tony T.; Levin, Harvey S.			Neuroimaging Correlates of Novel Psychiatric Disorders After Pediatric Traumatic Brain Injury	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						TBI; pediatric; psychiatric disorders; prospective; diffusion tensor imaging	1ST 6 MONTHS; HEAD-INJURY; CHILDREN; ADOLESCENTS; ANXIETY; RELIABILITY; MRI; SEGMENTATION; SCHEDULE; VALIDITY	Objective: To study magnetic resonance imaging (MRI) correlates of novel (new-onset) psychiatric disorders (NPD) after traumatic brain injury (TBI) and orthopedic injury (OI). Method: Participants were 7 to 17 years of age at the time of hospitalization for either TBI or OI. The study used a prospective, longitudinal, controlled design with standardized psychiatric assessments conducted at baseline (reflecting pre-injury function) and 3 months post-injury. MRI assessments including diffusion tensor imaging (DTI) derived fractional anisotropy (FA), volumetric measures of gray and white matter regions, volumetric measures of lesions, and cortical thickness were conducted. Injury severity was assessed by standard clinical scales. The outcome measure was the presence of an NPD identified during the first 3 months after injury. Results: There were 88 participants (TBI, 44; 01, 44). NPD occurred more frequently in the TBI (21/44; 48%) versus the OI (6/44; 14%) group (Fisher's exact test, p = .001). NPD in TBI participants was not related to injury severity. Multivariate analysis of covariance of the relationship between FA in hypothesized regions of interest (bilateral frontal and temporal lobes, bilateral centrum semiovale, bilateral uncinate fasciculi) and NPD and group (TBI versus OI) was significant, and both variables (NPD, p < .05; group, p < .001) were jointly significantly related to FA. NPD was not significantly related to volumetric measures of white or gray matter structures, volumetric measures of lesions, or cortical thickness measures. Conclusions: Lowered white matter integrity may be more important in the pathophysiology of NPD than indices of gray matter or white matter atrophic changes, macroscopic lesions, and injury severity. J. Am. Acad. Child Adolesc. Psychiatry, 2012;51(11):1208-1217.	[Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Max, Jeffrey E.; Thompson, Wesley K.; Yang, Tony T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Wilde, Elisabeth A.; MacLeod, Marianne; Vasquez, Ana C.; Merkley, Tricia L.; Hunter, Jill V.; Chu, Zili D.; Yallampalli, Ragini; Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA; [Hunter, Jill V.; Chu, Zili D.] Texas Childrens Hosp, Houston, TX 77030 USA; [Bigler, Erin D.; Merkley, Tricia L.] Brigham Young Univ, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Salt Lake City, UT USA; [Bigler, Erin D.] Utah Brain Inst, Salt Lake City, UT USA; [Hotz, Gillian] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Chapman, Sandra B.] Univ Texas Dallas, Richardson, TX 75083 USA		Max, JE (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu	Merkley, Tricia L./AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800, R01MH085734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research has been supported by the National Institute of Mental Health grant K-08 MH01800 (J.E.M.) and the National Institute of Neurological Disorders and Stroke (NINDS) grant NS-21889 (H.S. L.).	Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gerring J, 2000, BRAIN INJURY, V14, P205; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Little R. J., 2019, STAT ANAL MISSING DA, V793; Max J.E., 2011, TXB TRAUMATIC BRAIN, P438; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, J NEUROPSYC IN PRESS; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Moos RH, 1994, LIFE STRESSORS SOCIA; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Netsch T, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P718, DOI 10.1109/ICCV.2001.937595; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; TEASDALE G, 1974, LANCET, V2, P81; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	41	21	23	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	NOV	2012	51	11					1208	1217		10.1016/j.jaac.2012.08.026			10	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	035IF	WOS:000310939300012	23101746	Green Accepted			2022-02-06	
J	Gregson, BA; Rowan, EN; Mitchell, PM; Unterberg, A; McColl, EM; Chambers, IR; McNamee, P; Mendelow, AD				Gregson, Barbara A.; Rowan, Elise N.; Mitchell, Patrick M.; Unterberg, Andy; McColl, Elaine M.; Chambers, Iain R.; McNamee, Paul; Mendelow, A. David			Surgical trial in traumatic intracerebral hemorrhage (STITCH(Trauma)): study protocol for a randomized controlled trial	TRIALS			English	Article						Head injury; Traumatic intracerebral hemorrhage; Hematoma; Early surgery	HEMATOMAS; SURGERY	Background: Intracranial hemorrhage occurs in over 60% of severe head injuries in one of three types: extradural (EDH); subdural (SDH); and intraparenchymal (TICH). Prompt surgical removal of significant SDH and EDH is established and widely accepted. However, TICH is more common and is found in more than 40% of severe head injuries. It is associated with a worse outcome but the role for surgical removal remains undefined. Surgical practice in the treatment of TICHs differs widely around the world. The aim of early surgery in TICH removal is to prevent secondary brain injury. There have been trials of surgery for spontaneous ICH (including the STICH II trial), but none so far of surgery for TICH. Methods/Design: The UK National Institutes of Health Research has funded STITCH(Trauma) to determine whether a policy of early surgery in patients with TICH improves outcome compared to a policy of initial conservative treatment. It will include a health economics component and carry out a subgroup analysis of patients undergoing invasive monitoring. This is an international multicenter pragmatic randomized controlled trial. Patients are eligible if: they are within 48 h of injury; they have evidence of TICH on CT scan with a confluent volume of attenuation significantly raised above that of the background white and grey matter that has a total volume >10 mL; and their treating neurosurgeon is in equipoise. Patients will be ineligible if they have: a significant surface hematoma (EDH or SDH) requiring surgery; a hemorrhage/contusion located in the cerebellum; three or more separate hematomas fulfilling inclusion criteria; or severe pre-existing physical or mental disability or severe co-morbidity which would lead to poor outcome even if the patient made a full recovery from the head injury. Patients will be randomized via an independent service. Patients randomized to surgery receive surgery within 12 h. Both groups will be monitored according to standard neurosurgical practice. All patients have a CT scan at 5 days (+/-2 days) to assess changes in hematoma size. Follow-up is by postal questionnaire at 6 and 12 months. The recruitment target is 840 patients.	[Gregson, Barbara A.; Rowan, Elise N.; Mitchell, Patrick M.; Mendelow, A. David] Newcastle Univ, Neurosurg Trials Unit, Newcastle Upon Tyne NE2 4AE, Tyne & Wear, England; [Unterberg, Andy] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; [McColl, Elaine M.] Newcastle CTU, Sch Med, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chambers, Iain R.] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [McNamee, Paul] Univ Aberdeen, Hlth Econ Res Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland		Rowan, EN (corresponding author), Newcastle Univ, Neurosurg Trials Unit, 3-4 Claremont Terrace, Newcastle Upon Tyne NE2 4AE, Tyne & Wear, England.	e.n.rowan@ncl.ac.uk	McColl, Elaine/V-9906-2019; Abdullah, J/C-2828-2011; Mendelow, Alexander/AAW-2878-2021	McColl, Elaine/0000-0001-8300-3204; Abdullah, J/0000-0002-0258-7410; Gregson, Barbara/0000-0003-4868-9137	NIHR Health Technology Assessment program [07/37/16]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0501444] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0501444] Funding Source: UKRI	This project is funded by the NIHR Health Technology Assessment program (project number 07/37/16). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA program, NIHR, NHS, or the Department of Health.	Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; D'Avella D, 2001, J Neurosurg Sci, V45, P29; Fairbank J, 2005, BRIT MED J, V330, P1485; Marion DW, 2006, NEUROSURGERY, V58, P655; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Mendelow AD, 2005, LANCET, V365, P387; Mendelow AD, 2003, ACTA NEUROCHIR, V145, P679, DOI 10.1007/s00701-003-0063-9; Mendelow AD, 2003, ACTA NEUROCHIR WIEN, P681; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Prasad K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000200.pub2, 10.1002/14651858.CD002244.pub3]; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	16	21	24	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	OCT 16	2012	13								193	10.1186/1745-6215-13-193			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	032SW	WOS:000310740400001	23072576	Green Published, gold			2022-02-06	
J	Piatt, JH; Neff, DA				Piatt, Joseph H., Jr.; Neff, Daniel A.			Hospital care of childhood traumatic brain injury in the United States, 1997-2009: a neurosurgical perspective Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						children; infant; Kids' Inpatient Database; mortality rate; neurosurgery; traumatic brain injury; epidemiological study	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; INSURANCE STATUS; PEDIATRIC TRAUMA; HEAD-INJURY; EMERGENCY-DEPARTMENT; RACIAL DISPARITIES; TARGETED THERAPY; SEVERITY SCORES; RISK-FACTORS	Object. The goal in this paper was to study hospital care for childhood traumatic brain injury (TBI) in a nationwide population base. Methods. Data were acquired from the Kids' Inpatient Database (KID) for the years 1997, 2000, 2003, 2006, and 2009. Admission for TBI was defined by any ICD-9-CM diagnostic code for TBI. Admission for severe TBI was defined by a principal diagnostic code for TBI and a procedural code for mechanical ventilation; admissions ending in discharge home alive in less than 4 days were excluded. Results. Estimated raw and population-based rates of admission for all TBI, for severe TBI, for death from severe TBI, and for major and minor neurosurgical procedures fell steadily during the study period. Median hospital charges for severe TBI rose steadily, even after adjustment for inflation, but estimated nationwide hospital charges were stable. Among 14,932 actual admissions for severe TBI captured in the KID, case mortality was stable through the study period, at 23.9%. In a multivariate analysis, commercial insurance (OR 0.86, CI 0.77-0.95; p = 0.004) and white race (OR 0.78, CI 0.70-0.87; p < 0.0005) were associated with lower mortality rates, but there was no association between these factors and commitment of resources, as measured by hospital charges or rates of major procedures. Increasing median income of home ZIP code was associated with higher hospital charges and higher rates of major and minor procedures. Only 46.8% of admissions for severe TBI were coded for a neurosurgical procedure of any kind. Fewer admissions were coded for minor neurosurgical procedures than anticipated, and the state-by-state variance in rates of minor procedures was twice as great as for major procedures. Possible explanations for the "missing ICP monitors" are discussed. Conclusions. Childhood brain trauma is a shrinking sector of neurosurgical hospital practice. Racial and economic disparities in mortality rates were confirmed in this study, but they were not explained by available metrics of resource commitment. Vigilance is required to continue to supply neurosurgical expertise to the multidisciplinary care process. (http://thejns.org/doi/abs/10.3171/2012.7.PEDS11532)	[Piatt, Joseph H., Jr.] Alfred I DuPont Hosp Children, Div Neurosurg, Wilmington, DE 19803 USA; [Neff, Daniel A.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Neff, Daniel A.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA		Piatt, JH (corresponding author), Alfred I DuPont Hosp Children, Div Neurosurg, 1600 Rockland Rd, Wilmington, DE 19803 USA.	jpiatt@nemours.org		Piatt, Joseph/0000-0002-9332-8376			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alban RF, 2010, AM SURGEON, V76, P1108; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Epstein D, 2011, PEDIATRICS, V127, pE588, DOI 10.1542/peds.2010-0394; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Falcone RA, 2007, J PEDIATR SURG, V42, P172, DOI 10.1016/j.jpedsurg.2006.09.015; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hostetler SG, 2005, PEDIATR EMERG CARE, V21, P420, DOI 10.1097/01.pec.0000169430.68325.a0; Howard I, 2005, ETHNIC DIS, V15, pS5; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; KINGMA J, 1994, PERCEPT MOTOR SKILL, V78, P915, DOI 10.2466/pms.1994.78.3.915; KINGMA J, 1994, PERCEPT MOTOR SKILL, V78, P939, DOI 10.2466/pms.1994.78.3.939; Lopez AM, 2006, PEDIATR CRIT CARE ME, V7, P2, DOI 10.1097/01.PCC.0000192319.55850.81; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Martin CA, 2010, AM J SURG, V199, P210, DOI 10.1016/j.amjsurg.2009.05.001; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Peter JC, 2010, CHILD NERV SYST, V26, P201, DOI 10.1007/s00381-009-1030-4; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; RUTLEDGE R, 1995, J TRAUMA, V38, P590, DOI 10.1097/00005373-199504000-00022; Sabharwal S, 2007, J PEDIATR ORTHOPED, V27, P690, DOI 10.1097/BPO.0b013e3181425653; Salim A, 2008, AM SURGEON, V74, P1088; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wall SP, 2005, ACAD EMERG MED, V12, P862, DOI 10.1197/j.aem.2005.05.003	48	21	21	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2012	10	4					257	267		10.3171/2012.7.PEDS11532			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	015YX	WOS:000309485300003	22900487				2022-02-06	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			Temperature effects on brain tissue in compression	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury (TBI); Body temperature; Room temperature; Ogden model; Compression	MODEL; BEHAVIOR; STRETCH; INJURY	Extensive research has been carried out for at least 50 years to understand the mechanical properties of brain tissue in order to understand the mechanisms of traumatic brain injury (TBI). The observed large variability in experimental results may be due to the inhomogeneous nature of brain tissue and to the broad range of test conditions. However, test temperature is also considered as one of the factors influencing the properties of brain tissue. In this research, the mechanical properties of porcine brain have been investigated at 22 degrees C (room temperature), and at 37 degrees C (body temperature) while maintaining a constant preservation temperature of approximately 4-5 degrees C. Unconfined compression tests were performed at dynamic strain rates of 30 and 50 s(-1) using a custom made test apparatus. There was no significant difference (p = 0.8559-0.9290) between the average engineering stresses of the brain tissue at the two different temperature conditions. The results of this study should help to understand the behavior of brain tissue at different temperature conditions, particularly in unconfined compression tests. (C) 2012 Elsevier Ltd. All rights reserved.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	Badar.Rashid@ucdconnect.ie; michel.destrade@nuigalway.ie; michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017; Destrade, Michel/O-5825-2019	Gilchrist, Michael D/0000-0003-1765-429X; Destrade, Michel/0000-0002-6266-1221	Irish Research Council for Science, Engineering and Technology (IRCSET), IrelandIrish Research Council for Science, Engineering and Technology	The authors thank John Gahan, Tony Dennis and Pat McNally for their assistance in machining components and developing electronic circuits for the experimental setup. This work was supported for the first author by a Postgraduate Research Scholarship awarded by the Irish Research Council for Science, Engineering and Technology (IRCSET), Ireland.	Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Huang CY, 2009, J BIOMECH, V42, P546, DOI 10.1016/j.jbiomech.2008.11.013; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney D.F., 1990, INT C BIOM IMP; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; TAKHOUNTS EG, 1999, P 27 INT WORKSH, P141; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang L, 2001, Stapp Car Crash J, V45, P369	31	21	22	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	OCT	2012	14						113	118		10.1016/j.jmbbm.2012.04.005			6	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	073SB	WOS:000313761700012	23022565	Green Submitted			2022-02-06	
J	Singh, R; Squires, J; Fromkin, JB; Berger, RP				Singh, Ranjodh; Squires, Janet; Fromkin, Janet B.; Berger, Rachel P.			Assessing the use of follow-up skeletal surveys in children with suspected physical abuse	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Skeletal survey; child physical abuse	TRAUMATIC BRAIN-INJURY; INFANTS; FRACTURES; BRUISE; SERUM	BACKGROUND: Child physical abuse is an important cause of morbidity and mortality in young children. The skeletal survey (SS) is considered a mandatory part of the evaluation for suspected physical abuse in young children. Literature suggests that a follow-up SS performed 10 to 21 days after the initial SS can provide important additional information, but previous studies evaluating the follow-up SS have been small and included very selective patient populations. METHODS: A retrospective descriptive study of a consecutive sample of children who underwent an initial SS and a follow-up SS at a single children's hospital during a 7-year period. Data on demographics, clinical presentation, results, and effect of the follow-up SS on clinical diagnosis were collected. RESULTS: Of the 1470 children who underwent an initial SS, 11% (169 of 1470 children) also underwent a follow-up SS. The mean age of the children who underwent both an initial SS and a follow-up SS was 5.8 months. Fourteen percent of the follow-up SS identified previously unrecognized fractures; all of which were healing. There were eight children in whom the information obtained from the follow-up SS resulted in a diagnosis of definite physical abuse; all eight children were younger than 12 months, and in six of these cases, the initial SS did not demonstrate any fractures. CONCLUSION: Only a small proportion of children who undergo an initial SS also undergo a follow-up SS. The relatively high proportion of follow-up SS that demonstrated previously unrecognized fracture(s), the young age of children undergoing the follow-up SS, and the high morbidity and mortality of unrecognized/missed child physical abuse in this age group suggest that the follow-up SS should be a routine part of the evaluation of child physical abuse. (J Trauma Acute Care Surg. 2012; 73: 972-976. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Squires, Janet; Fromkin, Janet B.; Berger, Rachel P.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Singh, Ranjodh] Univ Pittsburgh, Pittsburgh, PA 15224 USA		Berger, RP (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, 4417 Penn Ave, Pittsburgh, PA 15224 USA.	Rachel.Berger@chp.edu			Pediatric Clinical and Translational Research Center at the Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center; University of PittsburghUniversity of Pittsburgh	R. Singh received funding from the Summer Student Research Training Program of the Pediatric Clinical and Translational Research Center at the Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center and the Brackenridge Summer Fellowship of the University of Pittsburgh. The remaining authors declare no conflicts of interest.	Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; Bennett Berkeley L, 2011, BMC Res Notes, V4, P354, DOI 10.1186/1756-0500-4-354; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Campbell KA, 2006, ARCH PEDIAT ADOL MED, V160, P1241, DOI 10.1001/archpedi.160.12.1241; Day Fiona, 2006, J Clin Forensic Med, V13, P55, DOI 10.1016/j.jcfm.2005.08.001; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Hamilton-Giachritsis CE, 2005, J FAM PSYCHOL, V19, P619, DOI 10.1037/0893-3200.19.4.619; Hansen KK, 2009, CHILD ABUSE NEGLECT, V33, P278, DOI 10.1016/j.chiabu.2008.10.002; Harlan SR, 2009, PEDIATR RADIOL, V39, P962, DOI 10.1007/s00247-009-1313-7; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Nimkin K, 2001, RADIOL CLIN N AM, V39, P843, DOI 10.1016/S0033-8389(05)70314-6; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Pierce MC, 2009, PEDIATR EMERG CARE, V25, P845, DOI 10.1097/PEC.0b013e3181c06217; Sonik A, 2010, CHILD ABUSE NEGLECT, V34, P804, DOI 10.1016/j.chiabu.2010.03.002; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; Talvik I, 2008, ACTA PAEDIATR, V97, P782, DOI 10.1111/j.1651-2227.2008.00778.x; US Department of Health and Human Services Administration for Children Youth and Families, 2010, CHILD MALTR 2009; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Zimmerman S, 2005, CHILD ABUSE NEGLECT, V29, P1075, DOI 10.1016/j.chiabu.2004.08.012	24	21	21	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73	4					972	976		10.1097/TA.0b013e31825a773d			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	029OL	WOS:000310505100030	22902733	Green Accepted			2022-02-06	
J	Yang, CC; Hua, MS; Lin, WC; Tsai, YH; Huang, SJ				Yang, Chi-Cheng; Hua, Mau-Sun; Lin, Wei-Chi; Tsai, Yi-Hsin; Huang, Sheng-Jean			Irritability following traumatic brain injury: Divergent manifestations of annoyance and verbal aggression	BRAIN INJURY			English	Article						Irritability; traumatic brain injury; annoyance; verbal aggression	SCALE	Primary objectives: To evaluate irritability following traumatic brain injury. Research design: A prospective study was conducted at a level I trauma centre. Methods and procedures: One hundred and forty-four participants, which included 80 healthy subjects and 64 patients suffering from TBI, were recruited. Irritability was assessed by the National Taiwan University Irritability Scale (NTUIS) from patients themselves and their families. Main outcomes and results: the results showed 14.8% of patients and 29.4% of their families reported patients' problems of irritability. Meanwhile, both self-reported and family-reported irritability post-injury were significantly higher than those reported by the healthy subjects. When evaluating two sub-components of irritability, respectively, both family- and self-reported post-injury annoyance were significantly higher than the pre-injury one, while the self-reported post-injury verbal aggression was not. Conclusions: TBI patients have remarkable problems of irritability after injuries. Specifically, the results showed that annoyance might be the main characteristic of irritability in TBI patients and patients themselves might be unaware of their verbal aggression post-injury. Hence, it is merited to pay more attention to the annoyance of the patients with TBI and to the reports from significant caregivers when evaluating TBI patients' irritability in clinical settings.	[Yang, Chi-Cheng; Lin, Wei-Chi] Chang Gung Univ, Dept Occupat Therapy, Clin Psychol Program, Tao Yuan, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Tsai, Yi-Hsin] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Jin Shan Branch, New Taipei City, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei, Taiwan		Yang, CC (corresponding author), Chang Gung Univ, Dept Occupat Therapy, Clin Psychol Program, Tao Yuan, Taiwan.	ccyang@mail.cgu.edu.tw; sjhuang1@ntu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2410-H-182-012-MY2]	This study is supported by the National Science Council of Taiwan (NSC 99-2410-H-182-012-MY2).	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Alderman N, 2004, SCI PRACT NEUROPSYCH, P269; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BENDIG AW, 1962, J CONSULT PSYCHOL, V26, P200, DOI 10.1037/h0048664; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Craig KJ, 2008, PSYCHIAT RES, V159, P367, DOI 10.1016/j.psychres.2007.03.002; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; HARRIS JA, 1995, BEHAV RES THER, V33, P991, DOI 10.1016/0005-7967(95)00038-Y; JENNETT B, 1975, LANCET, V1, P480; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Spielberger C D, 1995, Issues Compr Pediatr Nurs, V18, P207, DOI 10.3109/01460869509087271; Stuss D., 1991, AWARENESS DEFICIT BR, P63; VANGOOZEN SHM, 1994, AGGRESSIVE BEHAV, V20, P79, DOI 10.1002/1098-2337(1994)20:2<79::AID-AB2480200202>3.0.CO;2-K; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Yang CC, 2011, BRAIN IMPAIR, V12, P200	26	21	21	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1185	1191		10.3109/02699052.2012.666374			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600003	22571629				2022-02-06	
J	Belousov, AB; Wang, YF; Song, JH; Denisova, JV; Berman, NE; Fontes, JD				Belousov, Andrei B.; Wang, Yongfu; Song, Ji-Hoon; Denisova, Janna V.; Berman, Nancy E.; Fontes, Joseph D.			Neuronal gap junctions play a role in the secondary neuronal death following controlled cortical impact	NEUROSCIENCE LETTERS			English	Article						Gap junctions; Connexin 36; Traumatic brain injury; Glutamate; Neuronal death	GLOBAL-ISCHEMIA; CELL-DEATH; IN-VIVO; INJURY; VULNERABILITY; MECHANISMS; GLUTAMATE; CONNEXINS; INCREASES; STROKE	In the mammalian CNS, excessive release of glutamate and overactivation of glutamate receptors are responsible for the secondary (delayed) neuronal death following neuronal injury, including ischemia, traumatic brain injury (TBI) and epilepsy. Recent studies in mice showed a critical role for neuronal gap junctions in NMDA receptor-mediated excitotoxicity and ischemia-mediated neuronal death. Here, using controlled cortical impact (CCI) in adult mice, as a model of TBI, and Fluoro-jade B staining for analysis of neuronal death, we set to determine whether neuronal gap junctions play a role in the CCI-mediated secondary neuronal death. We report that 24 h post-CCI, substantial neuronal death is detected in a number of brain regions outside the injury core, including the striatum. The striatal neuronal death is reduced both in wild-type mice by systemic administration of mefloquine (a relatively selective blocker of neuronal gap junctions) and in knockout mice lacking connexin 36 (neuronal gap junction protein). It is also reduced by inactivation of group II metabotropic glutamate receptors (with LY341495) which, as reported previously, control the rapid increase in neuronal gap junction coupling following different types of neuronal injury. The results suggest that neuronal gap junctions play a critical role in the CO-induced secondary neuronal death. (c) 2012 Elsevier Ireland Ltd. All rights reserved.	[Belousov, Andrei B.; Wang, Yongfu; Song, Ji-Hoon; Denisova, Janna V.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Berman, Nancy E.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Fontes, Joseph D.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA		Belousov, AB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, 2146 W 39th Ave, Kansas City, KS 66160 USA.	abelousov@kumc.edu		Fontes, Joseph/0000-0003-4796-343X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS064256, R21 NS076925]; University of Kansas Medical Center funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064256, R21NS076925] Funding Source: NIH RePORTER	This research was supported by NIH (R01 NS064256 and R21 NS076925) and the University of Kansas Medical Center funds to A.B.B. Core support was provided by NIH HD002528.	Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Garrett FG, 2008, NEURON GLIA BIOL, V4, P295, DOI 10.1017/S1740925X09990093; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Park WM, 2011, J NEUROSCI, V31, P5909, DOI 10.1523/JNEUROSCI.6787-10.2011; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; Vaccari JCDR, 2007, J NEUROPHYSIOL, V98, P2878, DOI 10.1152/jn.00362.2007; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Xu LL, 2004, J LIQ CHROMATOGR R T, V27, P1627, DOI 10.1081/JLC-120034096	20	21	21	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 22	2012	524	1					16	19		10.1016/j.neulet.2012.06.065			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	000LA	WOS:000308386600004	22781494	Green Accepted			2022-02-06	
J	Bellastella, A; Bizzarro, A; Colella, C; Bellastella, G; Sinisi, AA; De Bellis, A				Bellastella, Antonio; Bizzarro, Antonio; Colella, Caterina; Bellastella, Giuseppe; Sinisi, Antonio A.; De Bellis, Annamaria			Subclinical diabetes insipidus	BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article						subclinical central diabetes insipidus; autoimmunity; AVPcAb; isohormonal therapy	VASOPRESSIN-CELL ANTIBODIES; POSTERIOR PITUITARY-FUNCTION; LYMPHOCYTIC HYPOPHYSITIS; MAGNETIC-RESONANCE; TRANSSPHENOIDAL SURGERY; ADRENOCORTICAL FAILURE; SPONTANEOUS REMISSION; ADDISONS-DISEASE; NATURAL-HISTORY; AUTOIMMUNE	Subclinical central diabetes insipidus (CDI) can be the outcome of a number of diseases that affect the hypothalamus-infundibulum-post hypophysis axis. One of the most common forms of subclinical CDI is linked to an autoimmune pathogenesis even if other causes may be also responsible. Among these, pregnancy, traumatic and surgical brain injury and some infiltrative, vascular, infectious and neoplastic diseases have been reported with increasing frequency. The natural history of autoimmune CDI seems to evolve through 4 functional stages according to the presence of antibodies to vasopressin-secreting cells (AVPcAb) and the relationship between their behavior overtime, the variations of posterior pituitary function and the characteristics of hypothalamic-hypophyseal region on magnetic resonance imaging. This staging is of crucial importance for the therapeutic strategy, taking into account that some stages could be still reversible. Several medical treatments have been suggested to interrupt the progression toward clinical CDI but the results are still discussed. (C) 2011 Elsevier Ltd. All rights reserved.	[Bellastella, Antonio; Colella, Caterina; Bellastella, Giuseppe; Sinisi, Antonio A.; De Bellis, Annamaria] Univ Naples 2, Dept Cardiothorac & Resp Sci, Monaldi Hosp, I-80131 Naples, Italy; [Bizzarro, Antonio] Univ Naples 2, Dept Clin & Expt Med & Surg, I-80131 Naples, Italy		Bellastella, A (corresponding author), Univ Naples 2, Dept Cardiothorac & Resp Sci, Monaldi Hosp, Via Leonardo Bianchi, I-80131 Naples, Italy.	antonio.bellastella@unina2.it		DE BELLIS, Annamaria/0000-0002-0611-4506			Abe T, 2008, BRAIN TUMOR PATHOL, V25, P59, DOI 10.1007/s10014-008-0234-8; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aleksandrov N, 2010, J OBSTET GYNAECOL CA, V32, P225, DOI 10.1016/S1701-2163(16)34448-6; Ananthakrishnan S, 2009, ENDOCR PRACT, V15, P377, DOI 10.4158/EP09090.RA; Atmaca H, 2007, EUR J ENDOCRINOL, V156, P563, DOI 10.1530/EJE-06-0727; Bellastella A, 2003, EUR J ENDOCRINOL, V149, P363, DOI 10.1530/eje.0.1490363; Betterle C, 1997, J CLIN ENDOCR METAB, V82, P932, DOI 10.1210/jc.82.3.932; BETTERLE C, 1993, CLIN ENDOCRINOL, V39, P35, DOI 10.1111/j.1365-2265.1993.tb01748.x; BHAN GL, 1982, POSTGRAD MED J, V58, P165, DOI 10.1136/pgmj.58.677.165; Bihan H, 2007, MEDICINE, V86, P259, DOI 10.1097/MD.0b013e31815585aa; BOTTAZZO GF, 1986, IMMUNOL REV, V94, P137, DOI 10.1111/j.1600-065X.1986.tb01168.x; Bueno JAS, 2005, EUR J OBSTET GYN R B, V118, P251, DOI 10.1016/j.ejogrb.2004.04.036; CACCIARI E, 1990, ARCH DIS CHILD, V65, P1199, DOI 10.1136/adc.65.11.1199; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; DAVIDSON JM, 1984, AM J PHYSIOL, V246, P105; DAVISON JM, 1988, J CLIN INVEST, V81, P798, DOI 10.1172/JCI113386; De Bellis A, 2005, BEST PRACT RES CL EN, V19, P67, DOI 10.1016/j.beem.2004.11.007; De Bellis A, 1999, J CLIN ENDOCR METAB, V84, P3047, DOI 10.1210/jc.84.9.3047; De Bellis A, 2002, J CLIN ENDOCR METAB, V87, P3825, DOI 10.1210/jc.87.8.3825; De Bellis A, 2001, J CLIN ENDOCR METAB, V86, P675, DOI 10.1210/jc.86.2.675; De Bellis A, 2004, IMMUNOENDOCRINOLOGY, P439; De Bellis A, 2011, CONTEMP ENDOCRINOL S, P547, DOI 10.1007/978-1-60327-478-4_33; DEBELLIS A, 1993, J CLIN ENDOCR METAB, V76, P1002, DOI 10.1210/jc.76.4.1002; DEBELLIS A, 1995, HORM RES, V44, P142, DOI 10.1159/000184614; DEBELLIS A, 1994, CLIN ENDOCRINOL, V40, P173; DIAMOND MP, 1987, SOUTHERN MED J, V80, P773, DOI 10.1097/00007611-198706000-00026; Dogan M., 2008, Experimental Oncology, V30, P324; Domiciano DS, 2010, ACTA REUMATOL PORT, V35, P232; Silva CMD, 2008, ARQ NEURO-PSIQUIAT, V66, P415, DOI 10.1590/S0004-282X2008000300028; DURR JA, 1987, NEW ENGL J MED, V316, P1070, DOI 10.1056/NEJM198704233161707; Edouard T, 2009, HORM RES, V72, P57, DOI 10.1159/000224342; Eisenbarth GS, 1998, WILLIAMS TXB ENDOCRI, P1651; El-Hennawy A S, 2003, J Matern Fetal Neonatal Med, V14, P349, DOI 10.1080/713606703; Ellidokuz E, 2006, J OBSTET GYNAECOL RE, V32, P602, DOI 10.1111/j.1447-0756.2006.00464.x; EPSTEIN S, 1971, BRIT MED J, V2, P267, DOI 10.1136/bmj.2.5756.267; Falorni A, 2002, ENDOCRIN METAB CLIN, V31, P369, DOI 10.1016/S0889-8529(01)00010-X; Fatourechi V, 2001, MAYO CLIN PROC, V76, P413; Finken MJJ, 2011, HORM RES PAEDIAT, V76, P22, DOI 10.1159/000324115; Fluteau-Nadler S, 1998, PRESSE MED, V27, P1095; Hansen LK, 1997, TRENDS ENDOCRIN MET, V8, P363, DOI 10.1016/S1043-2760(97)00157-4; Hensen J, 1999, CLIN ENDOCRINOL, V50, P431, DOI 10.1046/j.1365-2265.1999.00666.x; HIETT AK, 1990, OBSTET GYNECOL, V76, P982; Hime M C, 1978, Obstet Gynecol Surv, V33, P375, DOI 10.1097/00006254-197806000-00001; Hsu Y-J, ACTA NEUROLOGICA SCA, V107, P382; Huang CH, 2005, AM J KIDNEY DIS, V45, P197, DOI 10.1053/j.ajkd.2004.09.033; Imura H, 1993, NEW ENGL J MED; Inaba H, 2010, MED PRIN PRACT, V19, P79, DOI 10.1159/000252841; IWASAKI Y, 1991, NEW ENGL J MED, V324, P522, DOI 10.1056/NEJM199102213240803; Jennifer AL, 2007, ENDOCRINOL METAB, V3, P489; Kaijvama H, 2004, J RHEUMATOL, V31, P1218; Kalelioglu I, 2007, PITUITARY, V10, P87, DOI 10.1007/s11102-007-0006-1; KALLEN BAJ, 1995, EUR J ENDOCRINOL, V132, P144, DOI 10.1530/eje.0.1320144; Knip M, 2002, HORM RES, V57, P6, DOI 10.1159/000053305; KUCHARCZYK J, 1989, AM J ROENTGENOL, V152, P153, DOI 10.2214/ajr.152.1.153; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; Lethagen AL, 2002, J CLIN ENDOCR METAB, V87, P1177, DOI 10.1210/jc.87.3.1177; LINDER N, 1986, AM J PERINAT, V3, P165, DOI 10.1055/s-2007-999859; Maghnie M, 1997, AM J NEURORADIOL, V18, P1749; Maghnie M, 2000, NEW ENGL J MED, V343, P998, DOI 10.1056/NEJM200010053431403; Marchand I, 2011, J CLIN ENDOCRINOLOGY; MARCOCCI C, 1991, J CLIN ENDOCR METAB, V72, P209, DOI 10.1210/jcem-72-1-209; Matsui K, 1979, Horumon To Rinsho, V27, P891; MCCONNELL EM, 1953, ANAT RECORD, V115, P175, DOI 10.1002/ar.1091150204; MCLEOD JF, 1993, J CLIN ENDOCR METAB, V77, pA599, DOI 10.1210/jcem.77.3.8370682; MILLER M, 1970, ANN INTERN MED, V73, P721, DOI 10.7326/0003-4819-73-5-721; Molitch ME, 1998, SEMIN PERINATOL, V22, P457, DOI 10.1016/S0146-0005(98)80026-8; MOSES AM, 1992, AM J NEURORADIOL, V13, P1273; NAGAE A, 1994, J INTERN MED, V235, P75, DOI 10.1111/j.1365-2796.1994.tb01035.x; Nagasaki K, 2009, ENDOCR J, V56, P721, DOI 10.1507/endocrj.K09E-045; Nemergut EC, 2005, J NEUROSURG, V103, P448, DOI 10.3171/jns.2005.103.3.0448; OHSHIMA K, 1989, J ENDOCRINOL INVEST, V12, P713, DOI 10.1007/BF03350038; Pivonello R, 2003, J CLIN ENDOCR METAB, V88, P1629, DOI 10.1210/jc.2002-020791; Ray J G, 1998, Obstet Gynecol Surv, V53, P450, DOI 10.1097/00006254-199807000-00025; Rittig S, 2002, J CLIN ENDOCR METAB, V87, P3351, DOI 10.1210/jc.87.7.3351; Rivera Juan-Andres, 2006, Pituitary, V9, P35, DOI 10.1007/s11102-006-6598-z; Robinson AG, 2008, WILLIAMS TXB ENDOCRI, P263; SCHERBAUM WA, 1983, DEUT MED WOCHENSCHR, V108, P1053, DOI 10.1055/s-2008-1069691; SCHERBAUM WA, 1983, LANCET, V1, P897; Scherbaum WA, 1987, BAILLIERE CLIN IMMUN, P237; Scherbaum WA, 1982, ENDOCRINOLOGY S, V110, P84; Shin JH, 2001, KOREAN J RADIOL, V2, P222, DOI 10.3348/kjr.2001.2.4.222; Sills ES, 1995, J MATERN FETAL MED, V4, P81; Smith D, 2002, J CLIN ENDOCR METAB, V87, P4564, DOI 10.1210/jc.2002-020090; THOMPSON CJ, 1987, Q J MED, V65, P853; Tubridy N, 2001, J NEUROL NEUROSUR PS, V71, P798, DOI 10.1136/jnnp.71.6.798; Verbalis J, 1984, DIABETES INSIPIDUS M, P247; VERREES M, 2004, NEUROSURG FOCUS, V16, P1; Vomacka Zdenek, 1993, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V135, P17; WILLIAMS DJ, 1993, CLIN ENDOCRINOL, V38, P595, DOI 10.1111/j.1365-2265.1993.tb02140.x; Xue J, 2009, RHEUMATOL INT, V29, P1213, DOI 10.1007/s00296-008-0774-6; Yamazaki M, 2010, INTERNAL MED, V49, P1885, DOI 10.2169/internalmedicine.49.3381; Yaun X-Q, 1991, FRONT NEUROENDOCRIN, V12, P209	93	21	22	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1521-690X			BEST PRACT RES CL EN	Best Pract. Res. Clin. Endoc. Metab.	AUG	2012	26	4					471	483		10.1016/j.beem.2011.11.008			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	994FY	WOS:000307917500008	22863389				2022-02-06	
J	Khalili, MA; Anvari, M; Hekmati-Moghadam, SH; Sadeghian-Nodoushan, F; Fesahat, F; Miresmaeili, SM				Khalili, Mohammad Ali; Anvari, Morteza; Hekmati-Moghadam, Sayyed H.; Sadeghian-Nodoushan, Fatemeh; Fesahat, Farzaneh; Miresmaeili, Sayyed M.			Therapeutic Benefit of Intravenous Transplantation of Mesenchymal Stem Cells After Experimental Subarachnoid Hemorrhage in Rats	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Apoptosis; mesenchymal stem cell; rat; subarachnoid hemorrhage; transplantation	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; STROKE; GROWTH; DIFFERENTIATE; ANGIOGENESIS; REPLACEMENT; ASTROCYTES; EXPRESSION; FOREBRAIN	Background: Subarachnoid hemorrhage (SAH) usually occurs when an aneurysm ruptures and bleeds into the subarachnoid space. However, no information is available regarding the therapeutic potency of transplanted mesenchymal stem cells (MSCs) for SAH. Therefore, our aim was to investigate whether MSC transplantation therapy may cause stem cell activation and improve neurologic functional recovery after induction of SAH. Methods: Female rats were divided into 2 groups of SAH plus phosphate-buffered saline (PBS; control) and SAH plus MSCs (experimental). Both control and experimental groups received PBS or injection of 3 x 10(6) male rat MSCs labeled with bromodeoxyuridine (BrdU) into the tail vein 24 hours after SAH. All animals were killed 14 days after SAH. A behavioral test (Neurological Severity Score) was performed at 1, 7, and 14 days after SAH. Immunohistochemistry was used to identify MSCs and the cells derived from MSCs in brains with SAH. Terminal deoxynucleotidyltransferase mediated dUTP-biotin nick-end labeling was used to identify apoptotic cells. Results: Significant functional recovery (P<.05) was found in SAH animals infused with MSCs compared with other rats. Significantly more BrdU-positive cells were located in the parietal lobe of MSC-treated than in PBS-treated animals. MSCs were also seen to differentiate into glial cells (GFAP), neurons (Neu-N), and endothelial cells (vWF), thereby enhancing neuroplastic effects in the injured brain. Significantly fewer apoptotic cells were found in insulted cerebral tissue in SAH plus MSC rats when compared with other groups. Conclusions: Intravenously transplanted MSCs improve functional recovery, reduce apoptosis, and enhance neuroplastic effects after SAH in animal models. This is a promising novel procedure to repair central nervous system damage after SAH, and may provide a new way to induce plasticity in the injured brain cells.	[Khalili, Mohammad Ali; Anvari, Morteza; Sadeghian-Nodoushan, Fatemeh; Fesahat, Farzaneh] Shahid Sadoughi Univ Med Sci, Res & Clin Ctr Infertil, Yazd, Iran; [Hekmati-Moghadam, Sayyed H.] Shahid Sadoughi Univ Med Sci, Dept Pathol, Yazd, Iran; [Miresmaeili, Sayyed M.] Yazd Acad Ctr Educ, Culture & Res Higher Educ Inst, Yazd, Iran		Khalili, MA (corresponding author), Shahid Sadoughi Univ Med Sci, Res & Clin Ctr Infertil, Yazd, Iran.	khalili59@hotmail.com	Hekmatimoghaddam, Seyedhossein/Q-8258-2017; anvari, morteza/AAV-3080-2020; fesahat, farzaneh/AAF-4822-2020	Hekmatimoghaddam, Seyedhossein/0000-0001-9859-3753; miresmaeili, seyed mohsen/0000-0001-8623-2889	Shahid Sadoughi University of Medical Sciences, Yazd, Iran	This study was supported by a research grant from Shahid Sadoughi University of Medical Sciences, Yazd, Iran. The authors would like to thank Mehrdad Soleimani and Fatemeh Mousavi for their technical assistance and Nasrin Shekrariz for secretarial support.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; CLOWER BR, 1994, ANAT REC, V240, P104, DOI 10.1002/ar.1092400110; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Hanabusa K, 2005, BRAIN RES, V36, P853; Khalili MA, 1998, MED J IR IRAN, V2, P25; Khalili MA, 2001, MED J IR IRAN, V5, P93; Kondziolka D, 2008, NEUROSURG FOCUS, V24, P1; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Li Y, 2001, CELL TRANSPLANT, V10, P31; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; VANHOUTTE PM, 1985, CIRCULATION, V72, P728, DOI 10.1161/01.CIR.72.4.728; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054	30	21	24	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057			J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2012	21	6					445	451		10.1016/j.jstrokecerebrovasdis.2010.10.005			7	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	977JZ	WOS:000306656600003	21282068				2022-02-06	
J	Pal, D; Gupta, RK; Agarwal, S; Yadav, A; Ojha, BK; Awasthi, A; Rathore, RKS; Pandey, CM; Narayana, PA				Pal, Deepa; Gupta, Rakesh K.; Agarwal, Shruti; Yadav, Abhishek; Ojha, Bal K.; Awasthi, Ashish; Rathore, Ram K. S.; Pandey, Chandra M.; Narayana, Ponnada A.			Diffusion tensor tractography indices in patients with frontal lobe injury and its correlation with neuropsychological tests	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Tractography; Frontal lobe injury; Fractional anisotropy; Mean diffusivity; Neuropsychological test	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; WHITE-MATTER; CORPUS-CALLOSUM; HEAD-INJURIES; MILD; SEQUELAE; STATE; NEUROPATHOLOGY; DEGENERATION	Objectives: Diffusion tensor tractography (DTT) was performed to quantify diffuse axonal injury (DAI) in major white matter (WM) fiber bundles (FBs) of patients with frontal lobe injury and to correlate these changes with neuropsychological tests (NPT) at 6 month follow-up. Patients and Methods: DTT was performed in 21 patients with moderate traumatic brain injury (TBI) within week and after 6 month follow-up, and in controls. DTI indices were calculated from the entire FBs in patients as well as controls. Bonferroni multiple comparisons Post hoc test was performed for determining the changes in DTI indices. Paired t-test was performed between DTI indices at baseline and follow-up. Pearson's correlation was performed between NPT scores and DTI indices. Results: Significant changes in DTI indices were observed in some of the FBs as compared to controls which incompletely recovered at 6 month follow-up. DTI indices of different WM FBs correlated significantly with some of the NPT. Conclusion: We conclude that DTT based quantification helps in assessment of DAI in patients with moderate frontal lobe injury. Some of the FBs recover partially at 6 month follow-up and correlate with NPT scores. (C) 2011 Elsevier B.V. All rights reserved.	[Gupta, Rakesh K.] Sanjay Gandhi Postgrad Inst Med Sci, MRI Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India; [Awasthi, Ashish; Pandey, Chandra M.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Biostat, Lucknow 226014, Uttar Pradesh, India; [Agarwal, Shruti; Rathore, Ram K. S.] Indian Inst Technol, Dept Math & Stat, Kanpur 208016, Uttar Pradesh, India; [Ojha, Bal K.] Chhatrapati Shahuji Maharaj Med Univ, Dept Neurosurg, Lucknow, Uttar Pradesh, India; [Narayana, Ponnada A.] Univ Texas Med Sch, Dept Diagnost & Intervent Imaging, Houston, TX USA		Gupta, RK (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, MRI Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India.	rgupta@sgpgi.ac.in	Awasthi, Ashish/Y-5915-2019; Awasthi, Ashish/P-3966-2018	Awasthi, Ashish/0000-0002-9308-9782; Awasthi, Ashish/0000-0002-9308-9782; Agarwal, Shruti/0000-0003-0902-5354	Indian Council of Medical Research, New Delhi, IndiaIndian Council of Medical Research (ICMR); Department of Science and technology, New Delhi, IndiaDepartment of Science & Technology (India)	Deepa Pal and Abhishek Yadav acknowledge the financial assistance from the Indian Council of Medical Research, New Delhi, India. Ashish Awasthi acknowledges the financial assistance from Department of Science and technology, New Delhi, India.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barron KD, 2004, J NEUROL SCI, V220, P119, DOI 10.1016/j.jns.2004.03.009; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bendszus M, 2004, EXP NEUROL, V188, P171, DOI 10.1016/j.expneurol.2004.03.025; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DHIMAN RK, 1995, J GASTROEN HEPATOL, V10, P14, DOI 10.1111/j.1440-1746.1995.tb01041.x; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ramalingaswamy P, 1974, MANUAL INDIAN ADAPTA, P20; Rathore RK, 2011, MAGN RESON IMAGING; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Silver JM, 2005, TXB TRAUMATIC BRAIN, P3; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Trivedi R, 2009, PEDIATR RES, V66, P636, DOI 10.1203/PDR.0b013e3181bbc6b5; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	43	21	22	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2012	114	6					564	571		10.1016/j.clineuro.2011.12.002			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	969GY	WOS:000306044900008	22209144				2022-02-06	
J	Schneider, JW; Goetsch, SC; Leng, XY; Ludwig, SM; Russell, JL; Yang, CP; Zhang, QJ				Schneider, Jay W.; Goetsch, Sean C.; Leng, Xiuyu; Ludwig, Sara M.; Russell, Jamie L.; Yang, Cui-Ping; Zhang, Qing-Jun			Coupling Hippocampal Neurogenesis to Brain pH through Proneurogenic Small Molecules That Regulate Proton Sensing G Protein-Coupled Receptors	ACS CHEMICAL NEUROSCIENCE			English	Article						Small molecules; acidosis; G protein-coupled receptors; hippocampal neurogenesis; traumatic brain injury	NEURONAL DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; EXERCISE; INJURY; RAT; IDENTIFICATION; PROLIFERATION; ACIDOSIS; DISEASE	Acidosis, a critical aspect of central nervous system (CNS) pathophysiology and a metabolic corollary of the hypoxic stem cell niche, could be an expedient trigger for hippocampal neurogenesis and brain repair. We recently tracked the function of our isoxazole stem cell-modulator small molecules (Isx) through a chemical biology-target discovery strategy to GPR68, a proton (pH) sensing G protein-coupled receptor with no known function in brain. Isx and GPR68 coregulated neuronal target genes such as Bex1 (brain-enriched X-linked protein-1) in hippocampal neural progenitors (HCN cells), which further amplified GPR68 signaling by producing metabolic acid in response to Isx. To evaluate this proneurogenic small molecule/proton signaling circuit in vivo, we explored GPR68 and BEX1 expression in brain and probed brain function with Isx. We localized proton-sensing GPR68 to radial processes of hippocampal type 1 neural stem cells (NSCs) and, conversely, localized BEX1 to neurons. At the transcriptome level, Isx demonstrated unrivaled proneurogenic activity in primary hippocampal NSC cultures. In vivo, Isx pharmacologically targeted type 1 NSCs, promoting neurogenesis in young mice, depleting the progenitor pool without adversely affecting hippocampal learning and memory function. After traumatic brain injury, cerebral cortical astrocytes abundantly expressed GPR68, suggesting an additional role for proton-GPCR signaling in reactive astrogliosis. Thus, probing a novel proneurogenic synthetic small molecule's mechanism-of-action, candidate target, and pharmacological activity, we identified a new GPR68 regulatory pathway for integrating neural stem and astroglial cell functions with brain pH.	[Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA		Schneider, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, NB 11-200F,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jay.schneider@utsouthwestern.edu			American Heart Association-Jon Holden DeHaan Cardiac Myogenesis Research Network; NIH/NHLBI U01 Progenitor Cell Biology Consortium [HL100401]; LoneStar Heart, Inc. Sponsored Research Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL100401] Funding Source: NIH RePORTER	Funding for these studies was derived from the American Heart Association-Jon Holden DeHaan Cardiac Myogenesis Research Network, NIH/NHLBI U01 Progenitor Cell Biology Consortium (HL100401), and a LoneStar Heart, Inc. Sponsored Research Agreement to J.W.S.	AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Carter BD, 2006, EMBO REP, V7, P382, DOI 10.1038/sj.embor.7400675; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Chen YJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-39; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chu Xiang-Ping, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P288; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dioum EM, 2011, P NATL ACAD SCI USA, V108, P20713, DOI 10.1073/pnas.1118526109; Everts HB, 2002, IUBMB LIFE, V53, P295, DOI 10.1080/15216540213465; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Huang CW, 2007, MOL CELL NEUROSCI, V36, P195, DOI 10.1016/j.mcn.2007.06.010; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Nation DA, 2011, MED HYPOTHESES, V76, P847, DOI 10.1016/j.mehy.2011.02.034; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; Rishton Gilbert M, 2008, Recent Pat CNS Drug Discov, V3, P200, DOI 10.2174/157488908786242425; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Russell J. L., 2012, ACS CHEM BI IN PRESS; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Selwood D, 2012, CHEM BIOL DRUG DES, V79, P1, DOI 10.1111/j.1747-0285.2011.01273.x; SHERMAN DR, 1987, P NATL ACAD SCI USA, V84, P3209, DOI 10.1073/pnas.84.10.3209; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Warashina M, 2006, ANGEW CHEM INT EDIT, V45, P591, DOI 10.1002/anie.200503089; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Xu Y, 1996, GENOMICS, V35, P397, DOI 10.1006/geno.1996.0377; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Zhang L, 2011, DIFFERENTIATION, V81, P233, DOI 10.1016/j.diff.2011.02.005	44	21	21	0	19	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUL	2012	3	7					557	568		10.1021/cn300025a			12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	975VO	WOS:000306539800009	22860225	Green Published			2022-02-06	
J	Shiner, B; Drake, RE; Watts, BV; Desai, RA; Schnurr, PP				Shiner, Brian; Drake, Robert E.; Watts, Bradley V.; Desai, Rani A.; Schnurr, Paula P.			Access to VA Services for Returning Veterans With PTSD	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-GUARD SOLDIERS; MENTAL-HEALTH TREATMENT; TRAUMATIC BRAIN-INJURY; MEDICAL-CARE; AFGHANISTAN VETERANS; ADMINISTRATIVE DATA; MILITARY PERSONNEL; ENDURING FREEDOM; IRAQI FREEDOM	Objective: In order to understand access to treatment services for post-traumatic stress disorder (PTSD) in the Veterans Health Administration (VHA), we reviewed existing literature to estimate the proportion of Iraq and Afghanistan veterans who have used VHA services. Methods: We reviewed studies regarding the prevalence of PTSD among Iraq and Afghanistan War veterans to estimate the need for treatment. We then compared need to Veterans Affairs utilization in order to estimate the proportion accessing care. Results: Access to VHA services is high, with 58% of the estimated population of Iraq and Afghanistan veterans accessing some PTSD-related service. However, there is insufficient information about the quality of these services. Conclusions: The Veterans Affairs has been successful in providing access to treatment services for Iraq and Afghanistan Veterans with PTSD. Additional studies are needed to further characterize the quality of services provided.	[Shiner, Brian] VA Med Ctr, White River Jct, VT 05009 USA; [Drake, Robert E.] Dartmouth Psychiat Res Ctr, Lebanon, NH 03766 USA; [Watts, Bradley V.] VA Natl Ctr, Patient Safety Field Off, White River Jct, VT 05009 USA; [Desai, Rani A.] VA Northeast Program Evaluat Ctr, West Haven, CT 06516 USA; [Schnurr, Paula P.] VA Natl Ctr, PTSD Execut Div, White River Jct, VT 05009 USA		Shiner, B (corresponding author), VA Med Ctr, 215 Main St, White River Jct, VT 05009 USA.		Drake, Robert/AAS-3310-2020		VA-New England Early Career Development Award [V1CDA2010-03]	This work was supported by a VA-New England Early Career Development Award to Dr. Shiner (V1CDA2010-03).	Abt Associates, 2006, ACTIVE DUTY HEALTH S; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ANDERSON HR, 1983, J EPIDEMIOL COMMUN H, V37, P180, DOI 10.1136/jech.37.3.180; [Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Blanchard EB, 1996, BEHAV RES THER, V34, P775, DOI 10.1016/0005-7967(96)00038-1; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2007, PSYCHOL SERV, V76, P27281; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Engelhard IM, 2007, BRIT J PSYCHIAT, V191, P140, DOI 10.1192/bjp.bp.106.034884; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frayne SM, 2010, AM J MED QUAL, V25, P42, DOI 10.1177/1062860609346347; Friedman MJ, 2004, NEW ENGL J MED, V351, P75, DOI 10.1056/NEJMe048129; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Helmer DA, 2007, J OCCUP ENVIRON MED, V49, P475, DOI 10.1097/JOM.0b013e318042d682; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Institute of Medicine, 2006, IMPROVING THE QUALIT; Institute of Medicine Committee on Quality of Healthcare in America, 2001, CROSSING THE QUALITY; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Lindley S, 2010, ANN NY ACAD SCI, V1208, P104, DOI 10.1111/j.1749-6632.2010.05692.x; Martin C, 2007, NATION, V285, P2; Mattocks KM, 2010, J WOMENS HEALTH, V19, P2159, DOI 10.1089/jwh.2009.1892; MCFARLANE AC, 1988, J NERV MENT DIS, V176, P30, DOI 10.1097/00005053-198801000-00004; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; Meis LA, 2010, J FAM PSYCHOL, V24, P560, DOI 10.1037/a0020925; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Norris FH, 2004, ASSESSING PSYCHOLOGI; Ouimette P., 2008, TRAUMATOLOGY, V14, P51, DOI [10.1177/1534765608320330, DOI 10.1177/1534765608320330]; Pincus HA, 2007, AM J PSYCHIAT, V164, P712, DOI 10.1176/appi.ajp.164.5.712; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2008, INVISIBLE WOUNDS WAR, P35; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rundell JR, 2006, GEN HOSP PSYCHIAT, V28, P352, DOI 10.1016/j.genhosppsych.2006.04.006; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Schell TL, 2008, INVISIBLE WOUNDS OF; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Stecker T, 2010, PATIENT PREFER ADHER, V4, P45; Thornicroft G, 2011, OXFORD TEXTBOOK OF C; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Watkins Katherine E, 2010, J Healthc Qual, V32, P33, DOI 10.1111/j.1945-1474.2010.00109.x; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	73	21	21	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2012	177	7					814	822		10.7205/MILMED-D-12-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33NZ	WOS:000209026800009	22808888	Bronze			2022-02-06	
J	Xia, L; Jiang, ZL; Wang, GH; Hu, BY; Ke, KF				Xia, Lei; Jiang, Zheng-Lin; Wang, Guo-Hua; Hu, Bao-Yin; Ke, Kai-Fu			Treatment with ginseng total saponins reduces the secondary brain injury in rat after cortical impact	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						ginseng total saponins; traumatic brain injury; oxidative stress; nitrative stress; inflammatory response; neuronal apoptosis	SUPPRESSING OXIDATIVE STRESS; NF-KAPPA-B; PANAX-GINSENG; RED GINSENG; HEAD-INJURY; PC12 CELLS; HIPPOCAMPAL-NEURONS; MOTOR-PERFORMANCE; INDUCED APOPTOSIS; GINSENOSIDES	The present study was designed to investigate the neuroprotective effect of ginseng total saponins (GTSs) and its underlying mechanisms in a rat model of traumatic brain injury (TBI). Rats were injected with GTSs (20 mg/kg, i.p.) or vehicle for 14 days after TBI. Neurological functions were determined using beam balance and prehensile traction tests at 114 days after trauma. Brain samples were extracted at 1 day after trauma for determination of water content, Nissl staining, enzyme-linked immunosorbent assay, immunohistochemistry, terminal deoxynucleotidyl transferase-mediated biotin-dUTP nick end labeling, and measurement of oxidative stress variables and inflammatory cytokines. Moreover, the dose response of the neuroprotective effect and time window of the efficacy of GTSs were also determined. We found that treatment of GTSs 1) improved the neurological function with an effective dosage of 580 mg/kg and an efficacy time window of 36 hr after TBI; 2) reduced brain water content and neuronal loss in the hippocampal CA3 area; 3) increased the activity of superoxide dismutase and decreased the activity of nitric oxide synthase and the amount of malondialdehyde and nitric oxide; 4) down-regulated interleukin-1 beta, interleukin-6, and tumor necrosis factor-a and upregulated interleukin-10 in the cortical area surrounding the injured core; and 5) inhibited the apoptotic cell death and expression of caspase-3 and bax and raised the expression of bcl-2. These findings suggest that administration of GTSs after TBI could reduce the secondary injury through inhibiting oxidative and nitrative stress, attenuating inflammatory response, and reducing apoptotic cell death. (c) 2012 Wiley Periodicals, Inc.	[Xia, Lei; Jiang, Zheng-Lin; Wang, Guo-Hua; Hu, Bao-Yin] Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong 226001, Jiangsu, Peoples R China; [Xia, Lei] Nanjing Med Univ, Dept Neurol, Huaian Peoples Hosp 1, Huaian, Peoples R China; [Ke, Kai-Fu] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China		Jiang, ZL (corresponding author), Nantong Univ, Dept Neuropharmacol, Inst Naut Med, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn			Administration of Science and Technology of Nantong [S2008011]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Contract grant sponsor: Administration of Science and Technology of Nantong; Contract grant number: S2008011; Contract grant sponsor: Priority Academic Program Development of Jiangsu Higher Education Institutions.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Chen LM, 2008, J ASIAN NAT PROD RES, V10, P439, DOI 10.1080/10286020801892292; Chen XC, 2005, ACTA PHARMACOL SIN, V26, P56, DOI 10.1111/j.1745-7254.2005.00019.x; Chen XC, 2003, EUR J PHARMACOL, V473, P1, DOI 10.1016/S0014-2999(03)01945-9; Cho WCS, 2006, EUR J PHARMACOL, V550, P173, DOI 10.1016/j.ejphar.2006.08.056; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; DEGRABA TJ, 1994, J CEREBR BLOOD F MET, V14, P262, DOI 10.1038/jcbfm.1994.33; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; JIANG S, 2003, J APOPLEXY NERVOUS D, V20, P415; JIANG ZL, 2001, CHIN J APPL PHYSL, V17, P105; Joo SS, 2006, FOOD SCI BIOTECHNOL, V15, P244; Kiefer D, 2003, AM FAM PHYSICIAN, V68, P1539; Kim KR, 2010, BIOL PHARM BULL, V33, P604, DOI 10.1248/bpb.33.604; Kim ND, 2007, PHARMAZIE, V62, P933, DOI 10.1691/ph.2007.12.7533; Li N, 2007, J ETHNOPHARMACOL, V111, P458, DOI 10.1016/j.jep.2006.12.015; Li XY, 2010, CLIN EXP PHARMACOL P, V37, P199, DOI 10.1111/j.1440-1681.2009.05286.x; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lim JH, 1997, NEUROSCI RES, V28, P191, DOI 10.1016/S0168-0102(97)00041-2; Lin WM, 2007, J NEURAL TRANSM-SUPP, P105; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Lopez MVN, 2007, BBA-GEN SUBJECTS, V1770, P1308, DOI 10.1016/j.bbagen.2007.06.008; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Park EK, 2004, INT ARCH ALLERGY IMM, V133, P113, DOI 10.1159/000076383; Park JS, 2009, J NEUROIMMUNOL, V209, P40, DOI 10.1016/j.jneuroim.2009.01.020; Park JK, 2005, LIFE SCI, V76, P1013, DOI 10.1016/j.lfs.2004.10.011; Park J, 2009, AFR J BIOTECHNOL, V8, P3682; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rudakewich M, 2001, PLANTA MED, V67, P533, DOI 10.1055/s-2001-16488; Samukawa K, 2008, BIORHEOLOGY, V45, P689, DOI 10.3233/BIR-2008-0516; Shen LH, 2003, NEUROSCI LETT, V344, P1, DOI 10.1016/S0304-3940(03)00318-5; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Soares HD, 1995, J NEUROSCI, V15, P8223; Tu LH, 2009, CELL MOL NEUROBIOL, V29, P1257, DOI 10.1007/s10571-009-9421-3; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Xie JT, 2006, EUR J PHARMACOL, V532, P201, DOI 10.1016/j.ejphar.2006.01.001; Yang Xiao-feng, 2005, Chin J Traumatol, V8, P96; Ye RD, 2008, BIOL PHARM BULL, V31, P1923, DOI 10.1248/bpb.31.1923; Ye RD, 2009, NEUROSCI RES, V64, P306, DOI 10.1016/j.neures.2009.03.016; Yoo YI, 2009, FOOD SCI BIOTECHNOL, V18, P262; Zhang B, 1998, J Stroke Cerebrovasc Dis, V7, P1, DOI 10.1016/S1052-3057(98)80015-3; Zhang YF, 2008, EUR J PHARMACOL, V586, P90, DOI 10.1016/j.ejphar.2007.12.037; Zhao HF, 2009, BRAIN RES, V1256, P111, DOI 10.1016/j.brainres.2008.12.031; 姜正林, 2000, 中华航海医学杂志, V7, P28	57	21	22	0	12	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	JUL	2012	90	7					1424	1436		10.1002/jnr.22811			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	939YQ	WOS:000303857400013	22434648				2022-02-06	
J	Julien, C; Marcouiller, F; Bretteville, A; El Khoury, NB; Baillargeon, J; Hebart, SS; Planel, E				Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel			Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation	PLOS ONE			English	Article							NEURONAL CELL-DEATH; COLD-WATER STRESS; ALZHEIMERS-DISEASE; IN-VIVO; NEUROFIBRILLARY PATHOLOGY; PROTEIN PHOSPHATASE-2A; PHOSPHORYLATION SITES; INHIBITION; HYPOTHERMIA; KINASE	Dimethyl sulfoxide (DMSO) is widely used as a solvent or vehicle for biological studies, and for treatment of specific disorders, including traumatic brain injury and several forms of amyloidosis. As Alzheimer's disease (AD) brains are characterized by deposits of beta-amyloid peptides, it has been suggested that DMSO could be used as a treatment for this devastating disease. AD brains are also characterized by aggregates of hyperphosphorylated tau protein, but the effect of DMSO on tau phosphorylation is unknown. We thus investigated the impact of DMSO on tau phosphorylation in vitro and in vivo. One hour following intraperitoneal administration of 1 or 2 ml/kg DMSO in mice, no change was observed in tau phosphorylation. However, at 4 ml/kg, tau was hyperphosphorylated at AT8 (Ser(202)/Thr(205)), PHF-1 (Ser(396)/Ser(404)) and AT180 (Thr(231)) epitopes. At this dose, we also noticed that the animals were hypothermic. When the mice were maintained normothermic, the effect of 4 ml/kg DMSO on tau hyperphosphorylation was prevented. On the other hand, in SH-SY5Y cells, 0.1% DMSO induced tau hyperphosphorylation at AT8 and AT180 phosphoepitopes in normothermic conditions. Globally, these findings demonstrate that DMSO can induce tau hyperphosphorylation indirectly via hypothermia in vivo, and directly in vitro. These data should caution researchers working with DMSO as it can induce artifactual results both in vivo and in vitro.	[Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada; [Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Quebec, Ctr Hosp, Ctr Rech, Axe Neurosci, Quebec City, PQ, Canada		Julien, C (corresponding author), Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada.	carl.julien@crchul.ulaval.ca; emmanuel@planel.org	Hebert, Sebastien S./Q-2729-2017; Julien, Carl/AAU-5309-2021	Hebert, Sebastien/0000-0002-0391-9325; Planel, Emmanuel/0000-0001-5128-0565	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-106423, PCN-102993]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [354722]; Fonds de la recherche en sante du QuebecFonds de la Recherche en Sante du Quebec [16205, 20048]; Alzheimer Society of Canada; Alzheimer Society of Saskatchewan	This work was supported by grants to EP from the Canadian Institute of Health Research (MOP-106423, PCN-102993) (www.cihr-irsc.gc.ca), the Natural Sciences and Engineering Research Council of Canada (354722) (www.nserc-crsng.gc.ca), the Fonds de la recherche en sante du Quebec (16205, 20048) (www.frsq.gouv.qc.ca). CJ was supported by Postdoctoral Awards from the Alzheimer Society of Canada and the Alzheimer Society of Saskatchewan (www.alzheimer.ca). NBEK was supported by a Doctoral Award from the Alzheimer Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTLAND PD, 1966, P SOC EXP BIOL MED, V123, P853; ASHWOODS.MJ, 1967, ANN NY ACAD SCI, V141, P45, DOI 10.1111/j.1749-6632.1967.tb34865.x; Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; CAUJOLLE F, 1964, CR HEBD ACAD SCI, V258, P2224; de Oliveira ACP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-2; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; FARRANT J, 1964, J PHARM PHARMACOL, V16, P472, DOI 10.1111/j.2042-7158.1964.tb07496.x; Feng Q, 2005, NEUROSCI LETT, V388, P13, DOI 10.1016/j.neulet.2005.06.022; Goedert M, 1996, ANN NY ACAD SCI, V777, P121, DOI 10.1111/j.1749-6632.1996.tb34410.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Goldbaum O, 2002, GLIA, V40, P271, DOI 10.1002/glia.10119; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Mailliot C, 2000, ANN NY ACAD SCI, V920, P107; Martins DF, 2011, J PAIN, V12, P315, DOI 10.1016/j.jpain.2010.06.007; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Pegg David E, 2007, Methods Mol Biol, V368, P39; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Pohjanvirta R, 2002, FOOD CHEM TOXICOL, V40, P1023, DOI 10.1016/S0278-6915(02)00067-4; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Regelson W, 1997, ANN NY ACAD SCI, V826, P348, DOI 10.1111/j.1749-6632.1997.tb48485.x; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Roller J, 2010, LANGENBECK ARCH SURG, V395, P387, DOI 10.1007/s00423-010-0603-8; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Villarreal JS, 2006, NEUROBIOL LEARN MEM, V85, P44, DOI 10.1016/j.nlm.2005.08.005; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Watanabe E, 2000, BIOL PHARM BULL, V23, P838; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; WOOD DC, 1975, ANN NY ACAD SCI, V243, P7, DOI 10.1111/j.1749-6632.1975.tb25339.x; Zhu GC, 2006, TRANSPLANT P, V38, P3307, DOI 10.1016/j.transproceed.2006.10.114	50	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40020	10.1371/journal.pone.0040020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	WOS:000305892100174	22768202	gold, Green Published, Green Submitted			2022-02-06	
J	Ahnstedt, H; Stenman, E; Cao, L; Henriksson, M; Edvinsson, L				Ahnstedt, H.; Stenman, E.; Cao, L.; Henriksson, M.; Edvinsson, L.			Cytokines and growth factors modify the upregulation of contractile endothelin ETA and ETB receptors in rat cerebral arteries after organ culture	ACTA PHYSIOLOGICA			English	Article						basic fibroblast growth factor; endothelin receptors; epidermal growth factor; interleukin-1 ss; platelet-derived growth factor; tumour necrosis factor-a	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; B RECEPTORS; ISCHEMIC-STROKE; MEK/ERK PATHWAY; SMOOTH-MUSCLE; MEDIATED CONTRACTION; MESSENGER-RNA; DOUBLE-BLIND; BLOOD-FLOW	Aim: Experimental cerebral ischaemia and organ culture of cerebral arteries induce an increased endothelin ETB receptormediated contraction. The aim of this study was to examine whether cytokines and growth factors, known to be activated in ischaemia, can influence the expression and function of endothelin receptors after organ culture. Methods: Rat middle cerebral arteries were cultured for 24h at 37 degrees C in humidified 5% CO2 and air in culture medium alone, or with tumour necrosis factor-a (TNF-alpha), interleukin-1 beta (IL-1 beta), platelet-derived growth factor (PDGF), epidermal growth factor (EGF) or basic fibroblast growth factor (bFGF). Concentrationresponse curves were obtained for sarafotoxin 6c (ETB receptor agonist) and endothelin-1 (here ETA receptor agonist, because of ETB receptor desensitization). The receptor mRNA expression was examined by real-time PCR and the protein expression by immunohistochemistry and Western blot. Results: Tumour necrosis factor-a (100ngmL-1) and EGF (20ngmL-1) potentiated the ETB receptormediated contraction (increase in pEC50 without change in Emax). bFGF (10ngmL-1) and IL-1 beta (10ngmL-1) induced an enhanced ETA receptormediated contraction. bFGF (10ngmL-1) significantly increased the ETB mRNA level, and EGF (20ngmL-1) increased the ETA receptor protein. Increased ETB receptor mRNA and protein level also were observed after treatment with IL-1 beta (10ngmL-1). Conclusion: This study shows that TNF-a, IL-1 beta, EGF and bFGF can modify the expression and function of endothelin receptors during organ culture. Because there is similar receptor upregulation in experimental stroke, the effect of cytokines and growth factors on endothelin receptor upregulation is an interesting aspect to study in vivo.	[Ahnstedt, H.; Stenman, E.; Cao, L.; Henriksson, M.; Edvinsson, L.] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, SE-22184 Lund, Sweden		Ahnstedt, H (corresponding author), Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Solvegatan 17,BMC A13, SE-22184 Lund, Sweden.	Hilda.Ahnstedt@med.lu.se		Edvinsson, Lars/0000-0002-1805-1346			Adner M, 1996, BRIT J PHARMACOL, V119, P1159, DOI 10.1111/j.1476-5381.1996.tb16018.x; Ansar S, 2008, STROKE, V39, P185, DOI 10.1161/STROKEAHA.107.487827; Ansar S, 2009, J NEUROSURG, V111, P978, DOI 10.3171/2007.3.16738; Armstead WM, 2011, NEUROL RES, V33, P133, DOI 10.1179/016164111X12881719352174; BARONE FC, 1995, J CARDIOVASC PHARM, V26, pS404; BARONE FC, 1994, J CEREBR BLOOD F MET, V14, P337, DOI 10.1038/jcbfm.1994.41; Bhardwaj A, 2000, J CEREBR BLOOD F MET, V20, P499, DOI 10.1097/00004647-200003000-00008; Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; Chuquet J, 2002, STROKE, V33, P3019, DOI 10.1161/01.STR.0000039401.48915.9F; Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005; Dai XL, 2006, EXP BIOL MED, V231, P746; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duan Shu-Rong, 2008, Zhonghua Yi Xue Za Zhi, V88, P3337; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Evans NJ, 2008, CAN J PHYSIOL PHARM, V86, P526, DOI 10.1139/Y08-050; Evans NJ, 2008, BIOPHYS J, V95, P483, DOI 10.1529/biophysj.107.119206; Gregan B, 2004, J BIOL CHEM, V279, P27679, DOI 10.1074/jbc.M403601200; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Henriksson M, 2004, BRIT J PHARMACOL, V142, P1155, DOI 10.1038/sj.bjp.0705803; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Kreipke CW, 2011, NEUROL RES, V33, P208, DOI 10.1179/016164111X12881719352570; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Larsen CC, 2011, J NEUROSURG, V114, P1143, DOI 10.3171/2010.6.JNS1018; Leseth KH, 1999, NEUROREPORT, V10, P2355, DOI 10.1097/00001756-199908020-00025; Lodge NJ, 1995, EUR J PHARMACOL, V287, P279, DOI 10.1016/0014-2999(95)00494-7; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Maddahi A, 2011, J CEREBR BLOOD F MET, V31, P144, DOI 10.1038/jcbfm.2010.62; Maddahi A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-14; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Patel TR, 1996, J CEREBR BLOOD F MET, V16, P950, DOI 10.1097/00004647-199609000-00019; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Renner O, 2003, MOL BRAIN RES, V113, P44, DOI 10.1016/S0169-328X(03)00085-8; Sabri M, 2011, STROKE, V42, P1454, DOI 10.1161/STROKEAHA.110.604728; Sauvageau S, 2006, EXP BIOL MED, V231, P840; Sauvageau S, 2009, PULM PHARMACOL THER, V22, P311, DOI 10.1016/j.pupt.2009.01.006; Stenman E, 2002, STROKE, V33, P2311, DOI 10.1161/01.STR.0000028183.04277.32; Stenman E, 2007, EUR J PHARMACOL, V570, P142, DOI 10.1016/j.ejphar.2007.05.049; Tatlisumak T, 1998, STROKE, V29, P850, DOI 10.1161/01.STR.29.4.850; Thampatty BP, 2011, NEUROCRIT CARE, V15, P19, DOI 10.1007/s12028-011-9508-9; Thorin E, 2010, ADV PHARMACOL, V60, P1, DOI [10.1016/B978-0-12-385061-4.00001-5, 10.1016/S1054-3589(10)60009-9]; Uddman E, 1999, EUR J PHARMACOL, V376, P223, DOI 10.1016/S0014-2999(99)00381-7; UMEMURA K, 1995, EUR J PHARMACOL, V275, P17, DOI 10.1016/0014-2999(94)00725-M; Vatter H, 2007, J NEUROSURG, V107, P121, DOI 10.3171/JNS-07/07/0121; Vatter H, 2007, NEUROSURGERY, V60, P1100, DOI 10.1227/01.NEU.0000255471.75752.4B; Wang J, 2007, CURR TOP MED CHEM, V7, P1364; Watts SW, 2010, AM J PHYSIOL-REG I, V298, pR254, DOI 10.1152/ajpregu.00584.2009; White LR, 2000, EUR J PHARMACOL, V406, P117, DOI 10.1016/S0014-2999(00)00642-7; Xu CB, 2002, BIOCHEM PHARMACOL, V64, P497, DOI 10.1016/S0006-2952(02)01189-9	54	21	22	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	JUN	2012	205	2					266	278		10.1111/j.1748-1716.2011.02392.x			13	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	930CU	WOS:000303115100009	22145714				2022-02-06	
J	Watkins, AC; Vedula, GV; Horan, J; Dellicarpini, K; Pak, SW; Daly, T; Samstein, B; Kato, T; Emond, JC; Guarrera, JV				Watkins, A. C.; Vedula, G. V.; Horan, J.; Dellicarpini, K.; Pak, S. -W.; Daly, T.; Samstein, B.; Kato, T.; Emond, J. C.; Guarrera, J. V.			The deceased organ donor with an "open abdomen": proceed with caution	TRANSPLANT INFECTIOUS DISEASE			English	Article						Pseudomonas aeruginosa; donor-derived infection; multidrug-resistant bacteria; solid organ transplantation	RESISTANT PSEUDOMONAS-AERUGINOSA; EXTENDED CRITERIA; INFECTIONS; EXPERIENCE; CLOSURE; IMPACT	In solid organ transplantation, the disparity between donor supply and patients awaiting transplant continues to increase. The organ shortage has led to relaxation of historic contraindications to organ donation. A large percentage of deceased organ donors have been subjected to traumatic injuries, which can often result in intervention that leads to abdominal packing and intensive care unit resuscitation. The donor with this "open abdomen" (OA) presents a situation in which the risk of organ utilization is difficult to quantify. There exists a concern for the potential of a higher risk for both bacterial and fungal infections, including multidrug-resistant (MDR) pathogens because of the prevalence of antibiotic use and critical illness in this population. No recommendations have been established for utilization of organs from these OA donors, because data are limited. Herein, we report a case of a 21-year-old donor who had sustained a gunshot wound to his abdomen, resulting in a damage-control laparotomy and abdominal packing. The donor subsequently suffered brain death, and the family consented to organ donation. A multiorgan procurement was performed with respective transplantation of the procured organs (heart, liver, and both kidneys) into 4 separate recipients. Peritoneal swab cultures performed at the time of organ recovery grew out MDR Pseudomonas aeruginosa on the day after procurement, subsequently followed by positive blood and sputum cultures as well. All 4 transplant recipients subsequently developed infections with MDR P. aeruginosa, which appeared to be donor-derived with similar resistance patterns. Appropriate antibiotic coverage was initiated in all of the patients. Although 2 of the recipients died, mortality did not appear to be clearly associated with the donor-derived infections. This case illustrates the potential infectious risk associated with organs from donors with an OA, and suggests that aggressive surveillance for occult infections should be pursued.	[Watkins, A. C.; Vedula, G. V.; Samstein, B.; Kato, T.; Emond, J. C.; Guarrera, J. V.] Columbia Univ, Div Abdominal Organ Transplantat, Dept Med, Med Ctr, New York, NY USA; [Horan, J.] Columbia Univ, Div Infect Dis, Dept Med, Med Ctr, New York, NY USA; [Dellicarpini, K.] New York Organ Donor Network, New York, NY USA; [Pak, S. -W.; Daly, T.] Columbia Univ, Div Cardiothorac Surg, Dept Surg, Med Ctr, New York, NY USA		Guarrera, JV (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Liver Dis & Transplantat, 622 W 168th St,PH 14 Ctr,Room 202, New York, NY 10032 USA.	jjg46@columbia.edu	Samstein, Benjamin/AAJ-5846-2020	Samstein, Benjamin/0000-0002-3934-2564			Abikhaled JA, 1997, AM SURGEON, V63, P1109; Alkofer B, 2006, SEMIN LIVER DIS, V26, P221, DOI 10.1055/s-2006-947292; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Barker DE, 2000, J TRAUMA, V48, P201, DOI 10.1097/00005373-200002000-00001; Blumberg E, 2010, SESS INF DIS SOC AM; Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Fridkin SK, 1999, CLIN CHEST MED, V20, P303, DOI 10.1016/S0272-5231(05)70143-X; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Kubak BM, 2009, J HEART LUNG TRANSPL, V28, P260, DOI 10.1016/j.healun.2008.11.911; Lopez-Navidad A, 2003, CLIN TRANSPLANT, V17, P308, DOI 10.1034/j.1399-0012.2003.00119.x; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Orlando G, 2009, TRANSPL INFECT DIS, V11, P442, DOI 10.1111/j.1399-3062.2009.00412.x; Subramonia S, 2009, WORLD J SURG, V33, P931, DOI 10.1007/s00268-009-9947-z	15	21	22	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273			TRANSPL INFECT DIS	Transpl. Infect. Dis.	JUN	2012	14	3					311	315		10.1111/j.1399-3062.2011.00712.x			5	Immunology; Infectious Diseases; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Transplantation	956FY	WOS:000305076700014	22283979				2022-02-06	
J	Zhao, YQ; Wu, HL; Wang, XL; Li, JG; Zhang, S				Zhao, Yongqing; Wu, Huili; Wang, Xueling; Li, Jianguo; Zhang, Sai			Clinical epidemiology of posttraumatic epilepsy in a group of Chinese patients	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Traumatic brain injury; Posttraumatic epilepsy; Epidemiology; Risk factor	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SEIZURES	Objective: To explore the incidence, types of onset, and risk factors of posttraumatic epilepsy (PTE). Methods: This is a retrospective follow-up study of patients discharged from the Affiliated Hospital of the Medical College of the Chinese People's Armed Police Forces between September 2004 and September 2008 with a diagnosis of traumatic brain injury (TBI). Results: Complete clinical information was available on 2826 patients. Of the 2826 TBI patients, 141 developed PTE, providing an incidence rate of 5.0%. Twenty-four cases (0.8%) had posttraumatic seizures (PTS), of which 16 (66.7%) continued to experience after the acute phase of their TBI, accounting for 5.0% of the total PTE cases. A total of 125 cases (88.7%) were diagnosed as presenting with late-stage seizures, occurring from 10 days to three years after TBI (93/141 (66.0%) presented within six months after the TBI, 14/141 (9.9%) between six and twelve months, 22/141 (15.7%) between one and two years and only 12/141 (8.5%) between two and three years after the TBI. The severity of PTE was rated mild, medium, and severe in 3.6%, 6.9%, and 17% of the TBI patients. Multiple regression analysis was carried out to identify factors contributing to the risk of developing PTE. Five parameters contributed to the model: Older age, greater severity of brain injury, abnormal neuroimaging, surgical treatment, and early-stage seizures. Conclusion: Age, severity of brain injury, neuroimaging results, treatment methods, and early-stage seizures are independent risk factors of PTE. (C) 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Zhao, Yongqing; Wu, Huili; Wang, Xueling; Li, Jianguo; Zhang, Sai] Chinese Peoples Armed Police Forces, Hosp Med Coll, Comprehens Epilepsy Ctr, Neurol & Neurosurg Ctr, Tianjin 300162, Peoples R China		Zhao, YQ (corresponding author), Chinese Peoples Armed Police Forces, Hosp Med Coll, Comprehens Epilepsy Ctr, Neurol & Neurosurg Ctr, Tianjin 300162, Peoples R China.	yongqing6509@yahoo.com.cn			Medical College of Chinese People's Armed Police Forces	This work was financially supported by the Doctor Fund of the Medical College of Chinese People's Armed Police Forces.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Chengyun D, 2006, CHIN J NEUROSURG, V22, P541; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; HAUSER WA, 1984, NEUROLOGY, V34, P746, DOI 10.1212/WNL.34.6.746; Hillbom E., 1959, ACTA PSYCHIAT NEUROL, V34, P7; Jyoti A, 2009, NEUROSCI LETT, V453, P86, DOI 10.1016/j.neulet.2009.01.082; Qifu T, 2006, EPILEPSY SURG, P538; Schutze M, 1999, ZBL NEUROCHIR, V60, P163; Shengyu Y, 2000, DIAGNOSIS TREATMENT, P133; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Zhongcheng W, 1998, NEUROSURGERY, P365	17	21	24	0	10	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	JUN	2012	21	5					322	326		10.1016/j.seizure.2012.02.007			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948RT	WOS:000304521000003	22425008	Bronze			2022-02-06	
J	Bir, C; VandeVord, P; Shen, YM; Raza, W; Haacke, EM				Bir, Cynthia; VandeVord, Pamela; Shen, Yimin; Raza, Waqar; Haacke, E. Mark			Effects of variable blast pressures on blood flow and oxygen saturation in rat brain as evidenced using MRI	MAGNETIC RESONANCE IMAGING			English	Article						MRI; Blast; Neurotrauma; Rat model	INJURY	It has been recognized that primary blast waves may result in neurotrauma in soldiers in theater. A new type of contrast used in magnetic resonance imaging (MRI), susceptibility-weighted imaging (SWI), has been developed that is based on the different susceptibility levels in diverse tissues and can detect decreases in cerebral blood flow (CBF) using inferred oxygen saturation changes in tissue. In addition, a continuous arterial spin-labeled (ASL) MRI sequence was used as a direct measure of regional CBF within the brain tissue. Animals were subjected to whole-body blast exposures of various overpressures within a gas-driven shock tube. When exposed to low levels of overpressure, most rats demonstrated no obvious changes between pre- and postexposure in the conventional MR images. CBF changes measured by SWI and ASL were significantly higher for the overpressure exposed groups as compared to the sham group and tended to increase with pressure increases at the highest two pressures. In the hippocampus, all blast animals had a reduction in the CBF consistently in the range of 0-27%. In summary, low levels of primary blast pressure exposure demonstrated a significant physiologic effect to the brain up to 72 h postexposure. (C) 2012 Elsevier Inc. All rights reserved.	[Bir, Cynthia; VandeVord, Pamela; Haacke, E. Mark] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [VandeVord, Pamela] Wayne State Univ, Res & Dev Serv, John D Dingell VA Med Ctr, Detroit, MI 48201 USA; [Shen, Yimin; Raza, Waqar; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA		Bir, C (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.	cbir@wayne.edu		Bir, Cynthia/0000-0002-0777-0951	United States Office of Naval ResearchOffice of Naval Research [N000140810585]	This research was supported by the United States Office of Naval Research Award Number N000140810585.	Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Haacke EM, 2007, MAGN RESON MED, V58, P463, DOI 10.1002/mrm.21358; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wycliffe ND, 2004, J MAGN RESON IMAGING, V20, P372, DOI 10.1002/jmri.20130; Zoroya G, 2005, US TODAY	16	21	21	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X			MAGN RESON IMAGING	Magn. Reson. Imaging	MAY	2012	30	4					527	534		10.1016/j.mri.2011.12.003			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	929ST	WOS:000303086700007	22285875				2022-02-06	
J	Ley, EJ; Singer, MB; Clond, MA; Ley, HC; Mirocha, J; Bukur, M; Margulies, DR; Salim, A				Ley, Eric J.; Singer, Matt B.; Clond, Morgan A.; Ley, Heidi C.; Mirocha, James; Bukur, Marko; Margulies, Daniel R.; Salim, Ali			Admission heart rate is a predictor of mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Heart rate; trauma; mortality; sympathetic hyperactivity; beta blocker	RELATIVE BRADYCARDIA; TRAUMA	BACKGROUND: The association between admission heart rate (AHR) and mortality after trauma can assist initial emergency department triage and resuscitation. In addition, increased AHR is often associated with sympathetic hyperactivity which may require targeted treatment. We determined whether AHR was a predictor for mortality in trauma patients. METHODS: The Los Angeles County Trauma System Database was queried for all injured patients admitted between 1998 and 2005 (n = 147,788). Traumatic brain injury (TBI) patients (head Abbreviated Injury Scale score >= 3) were excluded. Demographics were compared at various AHR subgroups (<50, 50-59, 60-69, 70-79, 80-89, 90-99, 100-109, and >= 110). Mortality was compared at various AHR ranges, and logistic regression was performed to determine significance. RESULTS: After exclusions, 103,799 trauma patients requiring admission were identified; overall mortality was 1.4%. AHR 80 to 89 demonstrated a statistically significant lower mortality (0.5%) compared with all other AHR ranges, except AHR 70 to 79 (0.6%). In trauma patients who required admission, AHR 70 to 79 and 80 to 89 were predictors of lower mortality. Mortality for 22,232 moderate to severely injured patients was 5.5% and AHR 80 to 89 demonstrated a statistically lower mortality (2.0%) than all other AHR ranges, except AHR 70 to 79 (1.9%). After moderate to severe trauma, AHR <60 and >= 100 were associated with significantly higher mortality. CONCLUSION: Mortality after trauma increases outside the AHR range of 70 to 89 beats per minute. AHR ranges previously considered "normal" were associated with significantly increased mortality. Prospective research is required to evaluate if resuscitation goals should target heart rate at the 70 to 89 range. (J Trauma. 2012;72:943-947. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Ley, Eric J.; Singer, Matt B.; Clond, Morgan A.; Ley, Heidi C.; Mirocha, James; Bukur, Marko; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	eric.ley@cshs.org		Clond, Morgan/0000-0002-3036-4193; Bukur, Marko/0000-0002-1850-7147			Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Benarroch EE, 2009, NEUROLOGY, V73, P236, DOI 10.1212/WNL.0b013e3181aebd43; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; BRESLOW MJ, 1991, CRIT CARE MED, V19, P1566, DOI 10.1097/00003246-199112000-00021; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; Cancio LC, 2008, J TRAUMA, V64, pS51, DOI 10.1097/TA.0b013e3181608c21; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Demetriades D, 1998, J TRAUMA, V45, P534, DOI 10.1097/00005373-199809000-00020; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Fonseca RB, 2005, J TRAUMA, V59, P884, DOI 10.1097/01.ta.0000187653.64300.f5; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Fujiura Y, 2001, J CLIN EPIDEMIOL, V54, P495, DOI 10.1016/S0895-4356(00)00323-1; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; Ley EJ, 2011, J TRAUMA, V71, P1689, DOI 10.1097/TA.0b013e31823cc5df; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Ley EJ, 2009, J TRAUMA, V67, P1051, DOI 10.1097/TA.0b013e3181bba222; Malhotra A, 2005, J TRAUMA, V59, P889; Pryor JP, 2007, J TRAUMA, V62, P61; Reunanen A, 2000, J INTERN MED, V247, P231, DOI 10.1046/j.1365-2796.2000.00602.x; Thomas I, 2004, BMJ-BRIT MED J, V328, P451, DOI 10.1136/bmj.328.7437.451; van der Poll T., 2001, SEPSIS, V4, P159, DOI DOI 10.1023/A:1011463006351; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	24	21	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					943	947		10.1097/TA.0b013e3182465527			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	925TO	WOS:000302784600032	22491609				2022-02-06	
J	Skotak, M; Wang, F; Chandra, N				Skotak, Maciej; Wang, Fang; Chandra, Namas			An in vitro injury model for SH-SY5Y neuroblastoma cells: Effect of strain and strain rate	JOURNAL OF NEUROSCIENCE METHODS			English	Article						In vitro TBI model; Strain and strain rate effect; Viability scale; Stretch induced injury	TRAUMATIC BRAIN-INJURY; MECHANICALLY INDUCED TRAUMA; STRETCH INJURY; SLICE CULTURES; NEURAL TRAUMA; LIVING BRAIN; CALCIUM; NEURONS; SYSTEM; DEFORMATION	There is a great need to have in vitro cell injury model wherein a wide range of strain (6) and strain rate ((epsilon)over dot) can be precisely and independently applied. Such a model will enable exploration of various biomechanical loading conditions cells normally encounter during either blunt or blast impact-induced traumatic brain injuries (TBIs). In combination with a highly automated data acquisition and analysis system, this method can quickly generate a large data set of experimental results to yield identification of bio-mechanical and chemical sequelae following injury. A proper understanding of these sequelae will enable the discovery of the time window of opportunity available for pharmacological interventions. In this study we present such an injury model, a modified version of the Cultured Axonal Injury (CAI) device, and demonstrate its efficacy through viability of SH-SY5Y cells at different ranges of strain (0-140%) and strain rate (15-68 s(-1)). We identified three different regimes in the stretch-induced dose-response of curves of SH-SY5Y cells, with a very sharp decline from live to dead in a narrow range of strain (30-55%). The effect of strain rate is minimal when the final strain in the cells was fixed at 50%. The model further shows that time-after-injury plays a vital role in the determination of recovery-deterioration pathways and the biological selection depends on the severity of initial injury. These data point out the initial strain level is vital to the cell fate and emphasize the need to study the various mechanisms triggered by different magnitudes of initial injuries. (C) 2012 Elsevier B.V. All rights reserved.	[Skotak, Maciej; Wang, Fang; Chandra, Namas] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA		Chandra, N (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	nchandra2@unl.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294	US Army Research Office "Army-UNL Center of Trauma Mechanics" [W911NF-08-10483]; College of Engineering	Financial support under the US Army Research Office project "Army-UNL Center of Trauma Mechanics" (Contract No. W911NF-08-10483) is gratefully acknowledged. Partial financial support provided by the College of Engineering is acknowledged. We are grateful to Dr. Douglas Smith (University of Pennsylvania) for helpful comments during development of the injury model.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cargill RS, 1999, BIOMATERIALS, V20, P2417, DOI 10.1016/S0142-9612(99)00169-6; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Decressac M., NEUROBIOL AGING; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Engel DC, 2005, NEUROPHARMACOLOGY, V49, P985, DOI 10.1016/j.neuropharm.2005.05.021; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; OLIVER JD, 1992, J AM SOC NEPHROL, V3, P214; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Slemmer JE, 2004, NEUROBIOL DIS, V15, P563, DOI 10.1016/j.nbd.2003.11.027; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Stroetz RW, 2001, J APPL PHYSIOL, V90, P2361, DOI 10.1152/jappl.2001.90.6.2361; WINSTON FK, 1989, J APPL PHYSIOL, V67, P397, DOI 10.1152/jappl.1989.67.1.397; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	39	21	21	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 30	2012	205	1					159	168		10.1016/j.jneumeth.2012.01.001			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	911AB	WOS:000301688600017	22257521				2022-02-06	
J	Bernocchi, P; Scalvini, S; Tridico, C; Borghi, G; Zanaboni, P; Masella, C; Glisenti, F; Marzegalli, M				Bernocchi, Palmira; Scalvini, Simonetta; Tridico, Caterina; Borghi, Gabriella; Zanaboni, Paolo; Masella, Cristina; Glisenti, Fulvio; Marzegalli, Maurizio			Healthcare Continuity From Hospital to Territory in Lombardy: TELEMACO Project	AMERICAN JOURNAL OF MANAGED CARE			English	Article							RESPIRATORY-FAILURE PATIENTS; CHRONIC HEART-FAILURE; DISEASE; METAANALYSIS; MANAGEMENT; TRIAL; QUESTIONNAIRE; TELEMEDICINE; TELEHEALTH; ASSISTANCE	Objectives: To verify implementation and use of TELEMACO (TELEMedicina Ai piccoli COmunilombardi; http://www.telemaco.regione.lombardia.it/), which provides specialized continuity of care with innovative healthcare services in remote areas of the Lombardy region of Italy; to design a network in the territory for sharing of continuityof- care programs; and to allow the relevant health authorities to collect cost data to establish a model for sustainable pricing for implementing these services. Methods: TELEMACO provides home-based telemanagement services for patients with chronic heart failure and chronic obstructive pulmonary disease (COPD), as well as second-opinion teleconsultations in cardiology, dermatology, diabetology, and pulmonology for general practitioners and second-opinion teleconsultations on digital images in cases of traumatic brain injury and stroke. A total of 2 service centers, 10 cardiology and pneumology departments, 30 specialists, 176 general practitioners, 40 nurses, 2 emergency departments, and 2 consultant hospitals were involved. Results: A total of 166 patients with chronic heart failure and 474 patients with COPD were enrolled. There were 4830, 51, and 44 second-opinion teleconsultations for cardiologic, dermatologic, and diabetic conditions, respectively. There were 147 second-opinion teleconsultations on digital images, 68 for stroke, and 79 for traumatic brain injury. Implementation of TELEMACO introduced innovations on working methods and provided evidence to the health authorities for allocating funds for such services. Conclusions: TELEMACO provided evidence that there is a growing need for home management of patients using telemedicine, a common and efficacious approach that can ensure care continuity, especially in chronic diseases.	[Bernocchi, Palmira; Scalvini, Simonetta] Fdn Salvatore Maugeri, IRCCS, Telemed Serv, Ctr Lumezzane, I-25066 Lumezzane, Brescia, Italy; [Tridico, Caterina] San Carlo Borromeo Hosp, Hlth Directorate, Milan, Italy; [Borghi, Gabriella] CEFRIEL, Milan, Italy; [Zanaboni, Paolo; Masella, Cristina] Politecn Milan, Dept Management Econ & Ind Engn, I-20133 Milan, Italy; [Glisenti, Fulvio] Hlth Telemat Network, Brescia, Italy; [Marzegalli, Maurizio] San Carlo Borromeo Hosp, Dept Cardiol, Milan, Italy		Bernocchi, P (corresponding author), Fdn Salvatore Maugeri, IRCCS, Telemed Serv, Ctr Lumezzane, Via Giuseppe Mazzini 129, I-25066 Lumezzane, Brescia, Italy.	palmira.bernocchi@fsm.it	scalvini, simonetta/ABG-9872-2020; Bernocchi, Palmira/R-6523-2019; Scalvini, Simonetta/AAB-8992-2020; Bernocchi, Palmira/AAB-8661-2020	scalvini, simonetta/0000-0001-7387-505X; Scalvini, Simonetta/0000-0001-7387-505X; Bernocchi, Palmira/0000-0003-0875-2007	Ministry of Health, Ministry of Innovation and Technologies and Lombardy region [VII/19768]; INTESA ISTITUZIONALE di PROGRAMMA tra il Governo della Repubblica Italiana e la regione Lombardia II Atto integrativo dell accordo di programma Quadro in Materia di Societa dell Informazione nella regione Lombardia; Ministry of Health [E1,600,000.00]; Ministry of Innovation and Technologies [450,000.00]; Lombardy regionRegione Lombardia [E1,386,084.86]	Ministry of Health, Ministry of Innovation and Technologies and Lombardy region: regional Law 11/2004; DGR No VII/19768 of 10/12/2004 and INTESA ISTITUZIONALE di PROGRAMMA tra il Governo della Repubblica Italiana e la regione Lombardia II Atto integrativo dell accordo di programma Quadro in Materia di Societa dell Informazione nella regione Lombardia. Funding received for the TELEMACO Project is summarized as follows: Funding from Ministry of Health: E1,600,000.00. Funding from Ministry of Innovation and Technologies: 450,000.00. Funding from Lombardy region E1,386,084.86. Total: E3,436,084.86.	Backman W, 2010, J ROY SOC MED, V103, P442, DOI 10.1258/jrsm.2010.100301; Beretta L, 2007, RHEUMATOLOGY, V46, P296, DOI 10.1093/rheumatology/kel221; Bove AA, 2011, AM HEART J, V161, P351, DOI 10.1016/j.ahj.2010.11.008; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Glisenti Fulvio, 2005, Monaldi Arch Chest Dis, V64, P139; Hines PA, 2010, NURS ECON, V28, P74; Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039; Martinelli Giovanna, 2005, Monaldi Arch Chest Dis, V64, P140; McLean S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d120; Moffatt JJ, 2010, AUST HEALTH REV, V34, P276, DOI 10.1071/AH09794; Peake SL, 2007, CURR OPIN CRIT CARE, V13, P720, DOI 10.1097/MCC.0b013e3282f1bb21; Pezzella FR, 2009, STROKE, V40, P2557, DOI 10.1161/STROKEAHA.108.534495; Polisena J, 2010, J TELEMED TELECARE, V16, P120, DOI 10.1258/jtt.2009.090812; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Roccaforte R, 2005, EUR J HEART FAIL, V7, P1133, DOI 10.1016/j.ejheart.2005.08.005; Rygh E M, 2007, Rural Remote Health, V7, P766; Scalvini S, 2005, J TELEMED TELECARE, V11, P325, DOI 10.1258/135763305774472051; Scalvini S, 2009, TELEMED J E-HEALTH, V15, P261, DOI 10.1089/tmj.2008.0109; Sibbald Bonnie, 2007, J Health Serv Res Policy, V12, P110; Taylor P, 1998, J TELEMED TELECARE, V4, P63, DOI 10.1258/1357633981931948; TEASDALE G, 1974, LANCET, V2, P81; Vitacca M, 2009, EUR RESPIR J, V33, P411, DOI 10.1183/09031936.00005608; Vitacca M, 2010, TELEMED J E-HEALTH, V16, P299, DOI 10.1089/tmj.2009.0115; While A, 2011, INT J NURS STUD, V48, P1302, DOI 10.1016/j.ijnurstu.2011.02.020; Zanaboni P, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-238	25	21	21	1	19	MANAGED CARE & HEALTHCARE COMMUNICATIONS LLC	PLAINSBORO	666 PLAINSBORO RD, STE 300, PLAINSBORO, NJ 08536 USA	1088-0224			AM J MANAG CARE	Am. J. Manag. Care	MAR	2012	18	3					E101	E108					8	Health Care Sciences & Services; Health Policy & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; General & Internal Medicine	001EH	WOS:000308442600009	22435961				2022-02-06	
J	Blyth, T; Scott, A; Bond, A; Paul, E				Blyth, Tanya; Scott, Amanda; Bond, Annabelle; Paul, Eldho			A comparison of two assessments of high level cognitive communication disorders in mild traumatic brain injury	BRAIN INJURY			English	Article						Assessment; closed head injury; cognitive; language	STATUS EXAMINATION COGNISTAT	Primary objectives: Individuals with traumatic brain injury (TBI) frequently encounter cognitive communication disorders. Deficits can be subtle but can seriously influence an individual's ability to achieve life goals. Feedback from rehabilitation facilities indicated that high level cognitive communication disorders are not consistently identified in the acute setting. This study aimed to compare the cognitive communication results from two screening assessments, the Cognistat and the Cognitive Linguistic Quick Test (CLQT), in participants with a mild traumatic brain injury and to relate these findings to a range of prognostic indicators. Methods: Eighty-three adults post-TBI (16-81 years; 79.5% males) were recruited at an acute trauma centre. The language components of the two tests were analysed. Main outcomes and results: The CLQT identified more participants with an impairment in language than the Cognistat, 19.3% compared to 1.2% (p < 0.001). No clinical variables relating to the participants' brain injury were found to be associated with language impairment. Conclusions: This study found that the CLQT identified more individuals with high level cognitive communication deficits than the Cognistat in the acute setting.	[Blyth, Tanya; Scott, Amanda] The Alfred, Speech Pathol Dept, Melbourne, Vic, Australia; [Bond, Annabelle] The Alfred, Occupat Therapy Dept, Melbourne, Vic, Australia; [Paul, Eldho] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia		Blyth, T (corresponding author), The Alfred, POB 315, Prahran, Vic 3181, Australia.	t.blyth@alfred.org.au		Paul, Eldho/0000-0003-1263-7255	Royal Automobile Club of Victoria; Sir Edmund Herring Scholarship	This research was funded by the Royal Automobile Club of Victoria with the Sir Edmund Herring Scholarship.	Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bergeron E, 2003, EUR J TRAUMA, V29, P85; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; Doninger NA, 2006, REHABIL PSYCHOL, V51, P281, DOI 10.1037/0090-5550.51.4.281; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hinchliffe FJ, 2001, TRAUMATIC BRAIN INJU, P199; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lynch WJ, 2002, J HEAD TRAUMA REHAB, V17, P66, DOI 10.1097/00001199-200202000-00009; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Morarty J, 2005, 6 WORLD C BRAIN INJ; Mueller J., 2007, COGNISTAT MANUAL; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P1; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Tate RL, 2008, AUSTR NZ J PUBLIC HL, V22, P419; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Ylvisaker M, 2000, LANGUAGE INTERVENTIO, P745	24	21	21	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					234	240		10.3109/02699052.2012.654587			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100004	22372411				2022-02-06	
J	Li, DR; Zhang, F; Wang, Y; Tan, XH; Qiao, DF; Wang, HJ; Michiue, T; Maeda, H				Li, Dong-Ri; Zhang, Fu; Wang, Yao; Tan, Xiao-Hui; Qiao, Dong-Fang; Wang, Hui-Jun; Michiue, Tomomi; Maeda, Hitoshi			Quantitative analysis of GFAP- and S100 protein-immunopositive astrocytes to investigate the severity of traumatic brain injury	LEGAL MEDICINE			English	Article						Forensic pathology; Brain injury; Astrocyte; Glial fibrillary acidic protein; S100 protein; Immunohistochemistry	DIFFUSE AXONAL INJURY; FIBRILLARY ACIDIC PROTEIN; DELAYED NEURONAL DEATH; DURET HEMORRHAGE; WHITE-MATTER; RAT-BRAIN; EDEMA; EXPRESSION; HERNIATION; ISCHEMIA	Previous studies have shown that diffuse cortical astrocyte damage is seen in acute deaths due to brain injury and mechanical asphyxiation. The present study quantitatively investigated the number of astrocytes that showed GFAP- and S100-protein immunopositivity in the cerebral white matter and hippocampus at the sites distant from primary injury with regard to survival time, complication, and the immediate cause of death of brain injury cases. Autopsy cases of brain injury (8-48 h postmortem) comprising acute/subacute deaths (survival time, <3/6 h-3 days; n = 27/42) and delayed deaths (survival time >3 days) with/without complications (n = 30/22) were examined. Delayed death cases with complications were subdivided into those in which the immediate cause of death had been determined as cerebral dysfunction (n = 22) and those that had been determined as due to fatal complications (n = 8). For controls, natural deaths from pneumonias (n = 12) and sudden cardiac deaths (n = 27) were used. In brain injury cases, the numbers of astrocytes in the cerebral white matter and hippocampal CA4 region were significantly lower for subacute death and delayed death without complications (p < 0.05-0.001). Delayed death with fatal complications showed a significant increase in the number of astrocytes (p < 0.05). Among delayed death cases, the numbers of astrocytes were higher in the cases with fatal complications than in those without complications and with non-fatal complications, although the latter cases showed large variations in the numbers of these astrocytes. These findings suggest that critical brain injury causes acute death without evident astrocyte pathology and that subacute death is associated with progressive brain damage accompanied by an astrocyte loss. In delayed death cases, the numbers astrocytes might be closely related to the severity of posttraumatic brain injury. GFAP and S100-immunopositivity might be useful for elucidating the cause and process of deaths due to brain injury. (C) 2012 Published by Elsevier Ireland Ltd.	[Li, Dong-Ri; Zhang, Fu; Wang, Yao; Tan, Xiao-Hui; Qiao, Dong-Fang; Wang, Hui-Jun] So Med Univ, Dept Forens Med, Guangzhou 510515, Guangdong, Peoples R China; [Li, Dong-Ri; Michiue, Tomomi; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Osaka 5458585, Japan		Wang, HJ (corresponding author), So Med Univ, Dept Forens Med, Guangzhou 510515, Guangdong, Peoples R China.	lidongri0828@hotmail.com					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; AMADUCCI L, 1981, NEUROSCI LETT, V21, P27, DOI 10.1016/0304-3940(81)90052-5; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Baldwin SA, 1996, GLIA, V16, P266; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Jenkins LW, 1982, RECENT PROGR STUDY T, P525; Kakinuma Y, 1998, NAT MED, V4, P1078, DOI 10.1038/2070; Kamijo Y, 2005, AM J EMERG MED, V23, P908, DOI 10.1016/j.ajem.2005.07.014; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Kubo Shin-Ichi, 1998, Journal of Medical Investigation, V44, P109; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2006, Legal Medicine, V8, P78, DOI 10.1016/j.legalmed.2005.09.002; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; LONG DM, 1966, J NEUROPATH EXP NEUR, V25, P373, DOI 10.1097/00005072-196607000-00003; Nelson LR, 1982, COMP ANIMAL HEAD INJ, P117; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; Oehmichen M, 2006, FORENSIC NEUROPATHOL, P7; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; Privat Alain, 1995, P3; Stewart W, 2004, FORENSIC SCI INT, V146, P125, DOI 10.1016/j.forsciint.2004.06.025; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; Swanson RA, 1997, GLIA, V21, P142, DOI 10.1002/(SICI)1098-1136(199709)21:1<142::AID-GLIA16>3.0.CO;2-S; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Walz W, 2000, GLIA, V31, P95, DOI 10.1002/1098-1136(200008)31:2<95::AID-GLIA10>3.0.CO;2-6; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	42	21	22	1	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAR	2012	14	2					84	92		10.1016/j.legalmed.2011.12.007			9	Medicine, Legal; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Biomedical Social Sciences	902KU	WOS:000301037800005	22301378				2022-02-06	
J	Miller, AC; Odenkirchen, J; Duhaime, AC; Hicks, R				Miller, A. Cate; Odenkirchen, Joanne; Duhaime, Ann-Christine; Hicks, Ramona			Common Data Elements for Research on Traumatic Brain Injury: Pediatric Considerations	JOURNAL OF NEUROTRAUMA			English	Article						assessment tools; bioinformatics; CDE; clinical trials; database; meta-analysis; pediatrics; rehabilitation; research; TBI	PSYCHOLOGICAL HEALTH; OUTCOME MEASURES; WORKING GROUP; RECOMMENDATIONS	Traumatic brain injury (TBI) is a significant global health problem, with a notably high incidence in children and adolescents. Despite the prevalence of TBI and the disabilities that often follow, research on which to base effective treatment is limited by several challenges, including but not limited to the complexity and heterogeneity of TBI. Even when rigorous methods are employed, the utility of the research may be limited by difficulties in comparing findings across studies resulting from the use of different measures to assess similar TBI study variables. Standardization of definitions and data elements is an important step toward accelerating the process of data sharing that will ultimately lead to a stronger evidence base for treatment advances. To address this need, recommendations for common data elements (CDEs) for research on TBI were developed through a 2009 national initiative. To ensure that the TBI CDE recommendations are relevant to pediatric populations, the National Institute on Disability and Rehabilitation Research (NIDRR) and the National Institute of Neurological Disorders and Stroke (NINDS) called for a review of the original recommendations. Following the process used for the original initiative, multidisciplinary work groups composed of pediatric TBI experts were formed (Demographics and Clinical Assessment; Biomarkers; Neuroimaging; and Outcomes Assessment). Recommendations for modifications and additions to the original CDEs were developed by the work groups, vetted at a 2010 workshop and further refined in preparation for publication. The pediatric considerations for TBI CDEs are described in a series of articles in this journal. This article describes the efforts leading to this pediatric CDE initiative and the CDE review and development process. It concludes with general recommendations for future iterations of the CDE initiative.	[Miller, A. Cate] US Dept Educ, Natl Inst Disabil & Rehabil Res, Washington, DC 20202 USA; [Odenkirchen, Joanne; Hicks, Ramona] NINDS, NIH, Bethesda, MD 20892 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Boston, MA 02114 USA		Miller, AC (corresponding author), US Dept Educ, Natl Inst Disabil & Rehabil Res, 400 Maryland Ave SW, Washington, DC 20202 USA.	cate.miller@ed.gov			National Institute for Disability and Rehabilitation Research of the United States Department of Education (NIDRR/DoE); National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NINDS/NIH)	We gratefully acknowledge the working group members and chairpersons for their dedication of time and expertise to this initiative. Support for the workshop came from the National Institute for Disability and Rehabilitation Research of the United States Department of Education (NIDRR/DoE) and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NINDS/NIH)	Alexander MS, 2009, SPINAL CORD, V47, P582, DOI 10.1038/sc.2009.18; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Faul M, 2010, TRAUMATIC BRAIN INJU; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; National Institute of Neurological Disorders and Stroke, 2010, NINDS COMM DAT EL TR; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	14	21	22	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	4					634	638		10.1089/neu.2011.1932			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	901SQ	WOS:000300987500003	22091862	Green Published			2022-02-06	
J	Vincent, AS; Roebuck-Spencer, T; Lopez, MS; Twillie, DA; Logan, BW; Grate, SJ; Friedl, KE; Schlegel, RE; Gilliland, K				Vincent, Andrea S.; Roebuck-Spencer, Tresa; Lopez, Mary S.; Twillie, David A.; Logan, Bret W.; Grate, Stephen J.; Friedl, Karl E.; Schlegel, Robert E.; Gilliland, Kirby			Effects of Military Deployment on Cognitive Functioning	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; PERFORMANCE; IRAQ; MOOD; ANAM; WAR; AFGHANISTAN; VALIDATION; DECREMENTS	Military deployment poses many risks for cognitive functioning. When deployed individuals are compared to a nondeployed control group, there is some evidence that deployment may be associated with declines in cognitive functioning. The current study examined cognitive performance before and following deployment in a large sample of active duty military personnel (N = 8,002) who reported no traumatic brain injury (TBI). Cognition was assessed using the Automated Neuropsychological Assessment Metrics version 4 TBI Military (ANAM4 TBI-MIL) battery, a computer-based battery of tests measuring attention, processing speed, and general cognitive efficiency. Pre- and postdeployment scores were compared using repeated measures analyses. Although statistically significant differences were observed for all tests (with 5 of 7 tests demonstrating performance improvement), effect sizes were very small for all but I test, indicating that performance differences had minimal clinical significance. Likewise, determination of change for individuals using reliable change indices revealed that a very small percentage (<3%) of this presumed healthy sample showed meaningful decline in cognition following deployment. Analyses indicated that despite risks for cognitive decline while in theater, deployment had minimal to no lasting effect on cognition as measured by ANAM4 TBI-Mil upon return from deployment.	[Vincent, Andrea S.; Roebuck-Spencer, Tresa; Schlegel, Robert E.; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA; [Lopez, Mary S.] US Army Bavaria Med Dept Act BMEDDAC, Rose Barracks, Vilseck, Germany; [Twillie, David A.; Logan, Bret W.] Blanchfield Army Community Hosp, Ft Campbell, KY 42223 USA; [Grate, Stephen J.; Friedl, Karl E.] USA, Telemed & Adv Res Ctr, Med Res & Mat Command, Ft Detrick, MD 21702 USA		Vincent, AS (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 3200 Marshall Ave,Suite 260, Norman, OK 73072 USA.		Friedl, Karl/M-1803-2019	Friedl, Karl/0000-0002-3134-8427	DoDUnited States Department of Defense; Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick [W8IXWH-07-2-0097]	This data analysis was conducted by the Cognitive Science Research Center (CSRC) at the University of Oklahoma and is made possible by a DoD Grant awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD, under contract number W8IXWH-07-2-0097.	Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bradshaw D, 2007, US ARMY TRAUMATIC BR; Brunner HI, 2007, ARTHRIT RHEUM-ARTHR, V57, P1174, DOI 10.1002/art.23005; Casscells SW, 2008, MEMORANDUM BASELINE; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cohen J., 1988, STAT POWER BEHAV SCI; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Harris WC, 2005, MIL PSYCHOL, V17, P115, DOI 10.1207/s15327876mp1702_4; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane RL, 1996, J INT NEUROPSYCH SOC, V2, P68; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kay GG, 1997, ARCH INTERN MED, V157, P2350, DOI 10.1001/archinte.157.20.2350; Labutta RJ, 2007, USE AUTOMATED NEUROP; Lieberman HR, 2005, AVIAT SPACE ENVIR MD, V76, pC7; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McDiarmid MA, 2004, J TOXICOL ENV HEAL A, V67, P277, DOI 10.1080/15287390490273541; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2002, NEUROLOGY, V58, pA210; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Woodard J., 2002, J INT NEUROPSYCHOLOG, V8, P175	45	21	21	0	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2012	177	3					248	255		10.7205/MILMED-D-11-00156			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	906CW	WOS:000301323500003	22479911	Bronze			2022-02-06	
J	Argandona, EG; Bengoetxea, H; Ortuzar, N; Bulnes, S; Rico-Barrio, I; Lafuente, JV				Argandona, Enrike G.; Bengoetxea, Harkaitz; Ortuzar, Naiara; Bulnes, Susana; Rico-Barrio, Irantzu; Vicente Lafuente, Jose			Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit	CURRENT NEUROVASCULAR RESEARCH			English	Article						Angioglioneurins; environmental enrichment; neurogliovascular unit; neuroprotection; neurorestoration; VEGF	RAT VISUAL-CORTEX; TRAUMATIC BRAIN-INJURY; EXPERIENCE-DEPENDENT PLASTICITY; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; ENVIRONMENTAL ENRICHMENT; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; CEREBRAL-CORTEX; NERVOUS-SYSTEM	Brain postnatal development is modulated by adaptation and experience. Experience-mediated changes increase neuronal activity leading to increased metabolic demands that involve adaptive changes including ones at the microvascular network. Therefore, vascular environment plays a key role in central nervous system (CNS) development and function in health and disease. Trophic factors are crucial in CNS development and cell survival in adults. They participate in protection and proliferation of neuronal, glial and endothelial cells. Among the most important molecules are: the proangiogenic vascular endothelial growth factor (VEGF), the neurotrophin brain derived neurotrophic factor (BDNF), insulin growth factor (IGF-I) and the glycoprotein erythropoietin (EPO). We propose the term angioglioneurins to define molecules acting on the three components of the neurogliovascular unit. We have previously reported the effects of environmental modifications on the three components of the neurogliovascular unit during the postnatal development. We have also described the main role played by VEGF in the experience-induced postnatal changes. Angioglioneurin administration, alone or in combination with other neuroprotective strategies such as environmental enrichment, has been proposed as a non-invasive therapeutic strategy against several CNS diseases.	[Argandona, Enrike G.] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland; [Bengoetxea, Harkaitz; Ortuzar, Naiara; Bulnes, Susana; Rico-Barrio, Irantzu; Vicente Lafuente, Jose] Univ Basque Country UPV EHU, Lab Expt Neurosci LaNCE, Dept Neurosci, E-48940 Leioa, Spain		Argandona, EG (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Rue Albert Gockel 1, CH-1700 Fribourg, Switzerland.	enrique.argandona@unifr.ch	Bulnes, Susana/F-4130-2016; Bulnes, Susana/AAJ-3381-2020; Bengoetxea, Harkaitz/AAD-5751-2021; Rico Barrio, Irantzu/H-6757-2015; Lafuente, Jose-Vicente/O-6395-2014	Bulnes, Susana/0000-0002-9059-0758; Rico Barrio, Irantzu/0000-0003-4908-1182; Lafuente, Jose-Vicente/0000-0001-7246-0987	Basque GovernmentBasque Government [MV-2010-1-23]	This work has been supported by the Basque Government grant MV-2010-1-23. NO is predoctoral fellow from the Spanish Government and IRB is predoctoral fellow from the Gangoiti foundation.	Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Angely CJ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-26; Argandona E. G., 2011, 8 INT BRAIN RES ORG, V2, p[992, F1000]; Argandona EG, 2005, DEV BRAIN RES, V156, P158, DOI 10.1016/j.devbraines.2005.02.007; Argandona EG, 2003, DEV BRAIN RES, V141, P63, DOI 10.1016/S0165-3806(02)00643-0; Argandona EG, 1996, BRAIN RES, V732, P43, DOI 10.1016/0006-8993(96)00485-4; Argandona EG, 2009, J ANAT, V215, P132, DOI 10.1111/j.1469-7580.2009.01103.x; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; BEDI KS, 1989, J ANAT, V167, P71; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bengoetxea H, 2008, CEREB CORTEX, V18, P1630, DOI 10.1093/cercor/bhm190; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Bezard E, 2003, J NEUROSCI, V23, P10999; BLACK JE, 1987, NEUROSCI LETT, V83, P351, DOI 10.1016/0304-3940(87)90113-3; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BORGES S, 1978, J COMP NEUROL, V180, P277, DOI 10.1002/cne.901800207; Briner A, 2010, J COMP NEUROL, V518, P1711, DOI 10.1002/cne.22297; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Briones TL, 2009, J NEUROTRAUM, V26, P613, DOI 10.1089/neu.2008.0707; Bugg JM, 2011, NEUROBIOL AGING, V32, P506, DOI 10.1016/j.neurobiolaging.2009.03.008; Caleo M, 2002, NEUROSCIENTIST, V8, P52, DOI 10.1177/107385840200800110; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Chauvet C, 2011, NEUROSCIENCE, V184, P88, DOI 10.1016/j.neuroscience.2011.03.068; Choi BH, 2007, J NEUROSURG-SPINE, V7, P54, DOI 10.3171/SPI-07/07/054; COMERY TA, 1995, NEUROBIOL LEARN MEM, V63, P217, DOI 10.1006/nlme.1995.1025; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; CRAGG BG, 1967, NATURE, V215, P251, DOI 10.1038/215251a0; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Davis A E, 2000, Crit Care Nurs Q, V23, P1; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; FIFKOVA E, 1970, J COMP NEUROL, V140, P431, DOI 10.1002/cne.901400404; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Franklin TB, 2006, BRAIN RES, V1095, P1, DOI 10.1016/j.brainres.2006.04.025; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; GREENOUGH WT, 1986, BRAIN RES, V380, P136, DOI 10.1016/0006-8993(86)91437-X; Grunfeld JF, 2007, EXP NEUROL, V204, P260, DOI 10.1016/j.expneurol.2006.11.002; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Hawkins BT, 2003, PHARMACOL REV, V57, P173; Hebb, 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Herring A, 2008, BRAIN PATHOL, V18, P32, DOI 10.1111/j.1750-3639.2007.00094.x; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee SH, 2007, J NEUROPHYSIOL, V97, P4380, DOI 10.1152/jn.01217.2006; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lojovich JM, 2010, J HEAD TRAUMA REHAB, V25, P184, DOI 10.1097/HTR.0b013e3181dc78cd; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Naka F, 2005, BRAIN DEV-JPN, V27, P275, DOI 10.1016/j.braindev.2004.07.006; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nikolaev E, 2002, BRAIN RES, V957, P91, DOI 10.1016/S0006-8993(02)03606-5; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Ortuzar N, 2010, ACTA NEUROCHIR SUPPL, V106, P55, DOI 10.1007/978-3-211-98811-4_9; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Petrosini L, 2009, BRAIN RES REV, V61, P221, DOI 10.1016/j.brainresrev.2009.07.002; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; RICCIO RV, 1985, NEUROSCIENCE, V16, P1027, DOI 10.1016/0306-4522(85)90113-7; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Sathasivam S, 2008, NEUROSCI RES, V62, P71, DOI 10.1016/j.neures.2008.06.008; Saucier DM, 2010, BEHAV BRAIN RES, V214, P48, DOI 10.1016/j.bbr.2010.04.039; Segovia G, 2009, J NEURAL TRANSM, V116, P1007, DOI 10.1007/s00702-009-0214-0; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Shoykhet M, 2005, J NEUROPHYSIOL, V94, P3987, DOI 10.1152/jn.00569.2005; SIREVAAG AM, 1988, DEV BRAIN RES, V43, P299, DOI 10.1016/0165-3806(88)90107-1; SIREVAAG AM, 1991, BRAIN RES, V540, P273, DOI 10.1016/0006-8993(91)90517-Y; SIREVAAG AM, 1987, BRAIN RES, V424, P320, DOI 10.1016/0006-8993(87)91477-6; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Solerte SB, 2005, DEMENT GERIATR COGN, V19, P1, DOI 10.1159/000080963; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Thiriet N, 2008, BRAIN RES, V1222, P31, DOI 10.1016/j.brainres.2008.05.030; Tieman SB, 2004, BRAIN RES, V998, P100, DOI 10.1016/j.brainres.2003.11.023; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Yao HS, 2005, NEUROSCIENTIST, V11, P206, DOI 10.1177/1073858404272404; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	125	21	23	0	12	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	FEB	2012	9	1					72	81					10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	888YK	WOS:000300040400009	22272767				2022-02-06	
J	Maguen, S; Madden, E; Lau, KM; Seal, K				Maguen, Shira; Madden, Erin; Lau, Karen M.; Seal, Karen			The impact of head injury mechanism on mental health symptoms in veterans: Do number and type of exposures matter?	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; AUDIT-C; AFGHANISTAN; IRAQ; DEPLOYMENT	This study examined the association between screening results for mental health problems and the number and type of head injuries in 1,082 Iraq and Afghanistan War veterans who received population-based screening for traumatic brain injury at a Veterans Administration health care facility. Nearly one third of all veterans reported multiple types of head injuries (median = 1 among those with any head injury, range = 16 types of head injury). Veterans reporting multiple head injury mechanisms had 6 times the odds of screening positive for posttraumatic stress disorder (PTSD), adjusted odds ratio (OR) = 6.15, 95% confidence interval (CI) [4.4, 8.7], p < .001, over 4 times the odds of screening positive for depression, adjusted OR = 4.09, 95% CI [2.8, 5.9], p < .001, and about twice the odds of screening positive for alcohol misuse, adjusted OR = 1.64, 95% CI [1.19, 2.3], p = .003, compared to those without head injuries. Veterans reporting a blast plus another head injury mechanism had higher odds of screening positive for all mental health outcomes than any other group (e.g., compared to no head injury group): PTSD, adjusted OR = 6.52, 95% CI [4.6, 9.3], p < .001; depression, adjusted OR = 4.42, 95% CI [3.0, 6.4], p < .001; alcohol misuse, adjusted OR =1.59, 95% CI [1.14, 2.2], p = .006. Given their association with a variety of mental health outcomes, number and type of head injury mechanism should be considered as part of any postdeployment evaluation.	[Maguen, Shira; Madden, Erin; Lau, Karen M.; Seal, Karen] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Maguen, Shira] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Seal, Karen] Univ Calif San Francisco, Dept Med, San Francisco, CA USA		Maguen, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA.	Shira.Maguen@va.gov					Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Dougall AL, 2000, J CONSULT CLIN PSYCH, V68, P290, DOI 10.1037/0022-006X.68.2.290; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141	19	21	21	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	FEB	2012	25	1					3	9		10.1002/jts.21669			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	897VA	WOS:000300685800002	22354503				2022-02-06	
J	Mumford, N; Duckworth, J; Thomas, PR; Shum, D; Williams, G; Wilson, PH				Mumford, Nick; Duckworth, Jonathan; Thomas, Patrick R.; Shum, David; Williams, Gavin; Wilson, Peter H.			Upper-limb virtual rehabilitation for traumatic brain injury: A preliminary within-group evaluation of the elements system	BRAIN INJURY			English	Article						Virtual rehabilitation; traumatic brain injury; augmented feedback; elements; movement rehabilitation; motor control; virtual reality; upper-limb; motor learning	COGNITIVE FUNCTION; MOTOR IMPAIRMENT; ARM FUNCTION; REALITY; SEVERITY; RECOVERY; EXERCISE; VALIDITY; ENVIRONMENTS; POSTSTROKE	Aim: The aim of this study was to assess the efficacy of the Elements virtual reality (VR) system for rehabilitation of upper-limb function in patients with traumatic brain injury (TBI). Methods: Using a within-group design, patients were tested three times, each 4 weeks apart: Pre-intervention 1 and 2 and Post-intervention. During intervention, participants received 12 1-hour training sessions over 4 weeks in addition to their usual care. Five males and four females aged 18-48 years with severe TBI were recruited. The Elements system consisted of a 100-cm tabletop LCD, camera tracking system, tangible user interfaces (i.e. graspable objects of basic shape) and software. The system provided two modes of interaction with augmented feedback: goal-directed and exploratory. Upper-limb performance was assessed using system-rated measures (movement speed, accuracy and efficiency) and standardized tests. Results: Planned comparisons revealed little change in performance over the pre-test period apart from an increase in movement speed. There were significant training effects, with large effect sizes on all measures except the nuts-and-bolts task. Conclusions: These preliminary findings support the results of an early case study of the Elements system, further demonstrating that VR training is a viable adjunct to conventional physical therapy in facilitating motor learning in patients with TBI.	[Wilson, Peter H.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic 3065, Australia; [Mumford, Nick; Wilson, Peter H.] RMIT Univ, Discipline Psychol, Melbourne, Vic, Australia; [Duckworth, Jonathan] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Thomas, Patrick R.] Griffith Univ, Sch Educ & Profess Studies, Brisbane, Qld 4111, Australia; [Thomas, Patrick R.; Shum, David] Griffith Univ, Behav Basis Hlth Program, Brisbane, Qld 4111, Australia; [Shum, David] Griffith Univ, Griffith Hlth Inst, Sch Psychol, Brisbane, Qld 4111, Australia; [Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia		Wilson, PH (corresponding author), Australian Catholic Univ, Sch Psychol, 115 Victoria Parade, Melbourne, Vic 3065, Australia.	peterh.wilson@acu.edu.au	Wilson, Peter H./E-2881-2018; Shum, David/A-3914-2008	Wilson, Peter H./0000-0003-3747-0287; Shum, David/0000-0002-4810-9262; Williams, Gavin/0000-0003-2758-7473	Australian Research CouncilAustralian Research Council [LP0562622]; Australia Council for the Arts	We wish to acknowledge the invaluable contribution of another member of the broader Elements project, Mr Ross Eldridge from the School of Electrical and Computer Engineering, RMIT University. This research was supported under Australian Research Council's Linkage Projects funding scheme (Project Number LP0562622) and the Australia Council for the Arts under the Synapse Scheme.	Adamovich SV, 2004, P ANN INT IEEE EMBS, V26, P4936; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Bialocerkowski AE, 2003, HAND CLIN, V19, P449, DOI 10.1016/S0749-0712(02)00148-8; Boian R, 2002, VIRTUAL REALITY BASE, P64; Bordens Kenneth, 2008, RES DESIGN METHODS P; CASTANEDA MB, 1993, J MANAGE, V19, P707; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook Lysandra, 2005, Work, V25, P279; Cox J., 2006, J HAND THER, V19, P444, DOI [10.1197/j.ht.2006.07.011, DOI 10.1197/J.HT.2006.07.011]; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eastridge D, 2005, BEHAV INTERVENT, V20, P77, DOI 10.1002/bin.175; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Goodwin C. J, 2005, RES PSYCHOL METHODS; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; HEBERT R, 1988, AGE AGEING, V17, P293, DOI 10.1093/ageing/17.5.293; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Holden M., 1999, NEUROLOGY REPORT, V23, P57; Holden MK, 2007, IEEE T NEUR SYS REH, V15, P36, DOI 10.1109/TNSRE.2007.891388; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Holden MK, 2001, ST HEAL T, V81, P192; HOLDEN MK, 2001, NEUROLOGY REPORT, V25, P129; Holden MK, 2002, J NEUROL PHYS THER, V26, P62, DOI DOI 10.1097/01253086-200226020-00003; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Karnezis IA, 2002, J BONE JOINT SURG BR, V84B, P967, DOI 10.1302/0301-620X.84B7.12673; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kuttuva M, 2006, CYBERPSYCHOL BEHAV, V9, P148, DOI 10.1089/cpb.2006.9.148; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Linden A, 2005, ACTA NEUROL SCAND, V111, P48, DOI 10.1111/j.1600-0404.2004.00356.x; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; MCCARRON LT, 1997, MCCARRON ASSESSMENT; McCrea PH, 2002, DISABIL REHABIL, V24, P534, DOI 10.1080/09638280110115393; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Mitchell M.L., 2007, RES DESIGN EXPLAINED, V6th ed.; Mumford N, 2008, P ANN C VIRT REH VAN; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Piron L, 2005, PRESENCE-TELEOP VIRT, V14, P732, DOI 10.1162/105474605775196580; Piron L, 2004, MED INFORM INTERNET, V29, P119, DOI 10.1080/14639230410001723428; Piron L, 2003, ST HEAL T, V94, P265; Piron L, 2007, P ANN C VIRT REH VEN; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Platz T, 2005, ARM ARM REHABILITATI; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rochette A., 1997, CANADIAN J OCCUPATIO, V64, P270, DOI [10.1177/000841749706400504, DOI 10.1177/000841749706400504]; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Toschlog EA, 2003, AM SURGEON, V69, P491; Triffitt PD, 1998, J BONE JOINT SURG AM, V80A, P41, DOI 10.2106/00004623-199801000-00008; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Walker AJ, 2005, BRAIN INJURY, V19, P1237, DOI 10.1080/02699050500309411; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Waller SM, 2008, HUM MOVEMENT SCI, V27, P749, DOI 10.1016/j.humov.2008.03.006; Weigelt M, 2009, ACTA PSYCHOL, V132, P68, DOI 10.1016/j.actpsy.2009.06.005; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; WILSON BA, 1998, COMPREHENSIVE CLIN P, P463; Wilson PH, 2006, P 5 INT WORKSH VIRT; Woollacott, 2007, MOTOR CONTROL TRANSL; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	71	21	21	1	34	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2012	26	2					166	176		10.3109/02699052.2011.648706			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	897NP	WOS:000300658200005	22360522				2022-02-06	
J	Oluigbo, CO; Wilkinson, CC; Stence, NV; Fenton, LZ; McNatt, SA; Handler, MH				Oluigbo, Chima O.; Wilkinson, C. Corbett; Stence, Nicholas V.; Fenton, Laura Z.; McNatt, Sean A.; Handler, Michael H.			Comparison of outcomes following decompressive craniectomy in children with accidental and nonaccidental blunt cranial trauma Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						decompressive craniectomy; nonaccidental trauma; children; outcome; mortality	CEREBRAL PERFUSION-PRESSURE; SHAKEN BABY SYNDROME; BRAIN-INJURY; HEAD-INJURY; INTRACRANIAL-PRESSURE; OPHTHALMOLOGIC FINDINGS; YOUNG-CHILDREN; INFANTS; IMPACT; PATHOPHYSIOLOGY	Object. The goal of this study was to compare clinical outcomes following decompressive craniectomy performed for intracranial hypertension in children with nonaccidental, blunt cranial trauma with outcomes of decompressive craniectomy in children injured by other mechanisms. Methods. All children in a prospectively acquired database of trauma admissions who underwent decompressive craniectomy over a 9-year span, beginning January 1, 2000, are the basis for this study. Clinical records and neuro-imaging studies were systematically reviewed. Results. Thirty-seven children met the inclusion criteria. Nonaccidental head trauma was the most common mechanism of injury (38%). The mortality rate in patients with abusive brain injury (35.7%) was significantly higher (p < 0.05) than in patients with other causes of traumatic brain injury (4.3%). Children with inflicted head injuries had a 12-fold increase in the odds of death and 3-fold increase in the odds of a poor outcome (King's Outcome Scale for Closed Head Injury score of 1,2, or 3). Conclusions. Children with nonaccidental blunt cranial trauma have significantly higher mortality following decompressive craniectomy than do children with other mechanisms of injury. This understanding can be interpreted to mean either that the threshold for decompression should be lower in children with nonaccidental closed head injury or that decompression is unlikely to alter the path to a fatal outcome. If decompressive craniectomy is to be effective in reducing mortality in the setting of nonaccidental blunt cranial trauma, it should be done quite early. (http://thejns.org/doi/abs/10.3171/2011.11.PEDS09449)	[Wilkinson, C. Corbett] Childrens Hosp, Dept Neurosurg, Aurora, CO 80045 USA; Childrens Hosp, Dept Pediat Neuroradiol, Aurora, CO 80045 USA; Univ Colorado, Aurora, CO USA		Wilkinson, CC (corresponding author), Childrens Hosp, Dept Neurosurg, 13123 E 16th Ave, Aurora, CO 80045 USA.	Wilkinson.Charles@tchden.org	Oluigbo, Chima/E-3788-2011	Maliawan, Sri/0000-0003-2389-3481; Oluigbo, Chima/0000-0002-7851-3792			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; Feldman KW, 1997, CHILD ABUSE NEGLECT, V21, P199, DOI 10.1016/S0145-2134(96)00145-7; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Golden N, 2005, J CLIN NEUROSCI, V12, P235, DOI 10.1016/j.jocn.2004.11.001; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Monro A., 1783, OBSERVATIONS STRUCTU, P2; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Saternus KS, 2000, FORENSIC SCI INT, V109, P203, DOI 10.1016/S0379-0738(00)00144-4; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410	37	21	21	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2012	9	2					125	132		10.3171/2011.11.PEDS09449			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	882SC	WOS:000299583200004	22295915				2022-02-06	
J	Ordonez, C; Navarro, A; Perez, C; Martinez, E; del Valle, E; Tolivia, J				Ordonez, Cristina; Navarro, Ana; Perez, Cristina; Martinez, Eva; del Valle, Eva; Tolivia, Jorge			Gender differences in apolipoprotein D expression during aging and in Alzheimer disease	NEUROBIOLOGY OF AGING			English	Article						Apolipoprotein D; Aging; Alzheimer disease; Human; Frontal cortex; Entorhinal cortex; Hippocampus; Immunohistochemistry	RNA TISSUE DISTRIBUTION; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; PARAFFIN SECTIONS; PERIPHERAL-NERVE; BREAST-CANCER; LIFE-SPAN; D GENE; CORTEX; BRAIN	Apolipoprotein D (Apo D) is a lipocalin expressed in a wide variety of mammalian tissues. Different studies have shown that this protein is upregulated in the central nervous system (CNS) in several neuropathological conditions, after traumatic brain injury and in aging. The Apo D promoter shows 3 estrogen response elements and it has been shown that its expression is influenced by estrogens in breast cyst fluid. The aim of this work is to study the possible relationship between gender and Apo D expression in human hippocampus and in the entorhinal and frontal cortices during aging and Alzheimer's disease (AD). We visualized Apo D immunohistochemically and then performed a quantification of the chromogen signal strength. Our findings show that Apo D expression is influenced by age, Braak stage, and sex. In most of the studied areas, Apo D expression is increased with age in women but not in men, and in AD progression in both genders. Apo D is always expressed by neurons with no signs of degeneration or death. (C) 2012 Elsevier Inc. All rights reserved.	[Ordonez, Cristina; Navarro, Ana; Perez, Cristina; Martinez, Eva; del Valle, Eva; Tolivia, Jorge] Univ Oviedo, Fac Biol & Med, Dpt Morfol & Biol Celular, E-33006 Oviedo, Spain		Tolivia, J (corresponding author), Univ Oviedo, Fac Biol & Med, Dpt Morfol & Biol Celular, Julian Claveria S-N, E-33006 Oviedo, Spain.	jtolivia@uniovi.es	Martinez-Pinilla, Eva/C-7907-2013; Navarro, Ana/N-2092-2014; Tolivia, Jorge/D-2248-2010; del Valle, Eva/D-6820-2012	Martinez-Pinilla, Eva/0000-0002-0572-0926; Navarro, Ana/0000-0001-6206-6505; Tolivia, Jorge/0000-0001-8984-8849; del Valle, Eva/0000-0002-7959-4790	MECEuropean Commission; FEDEREuropean Commission [SAF2007-64076/]	This work was supported by a MEC and FEDER (SAF2007-64076/) grant. CO was a predoctoral fellow from "Gobierno del Principado de Asturias" Spain (BP05-064). CP and EM were predoctoral fellows from "Ministerio de Educacion y Ciencia" Spain (AP-2004-0854 and AP-2005-3815).	Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; BISHOP RE, 1995, J BIOL CHEM, V270, P23097, DOI 10.1074/jbc.270.39.23097; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Brinton RD, 2004, CNS DRUGS, V18, P405, DOI 10.2165/00023210-200418070-00001; Desai PP, 2005, NEUROBIOL DIS, V20, P574, DOI 10.1016/j.nbd.2005.04.012; DIEZITZA I, 1994, AM J PATHOL, V144, P310; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Glockner F, 2003, NEUROSCIENCE, V122, P103, DOI 10.1016/S0306-4522(03)00529-3; Henderson VW, 2009, SEMIN REPROD MED, V27, P283, DOI 10.1055/s-0029-1216281; Hu CY, 2001, J NEUROCYTOL, V30, P209, DOI 10.1023/A:1012797623620; Kalman J, 2000, NEUROL RES, V22, P330; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; MCCONATH.WJ, 1973, FEBS LETT, V37, P178, DOI 10.1016/0014-5793(73)80453-3; Navarro A, 1998, NEUROSCI LETT, V254, P17, DOI 10.1016/S0304-3940(98)00639-9; Navarro A, 1999, J HISTOTECHNOL, V22, P305, DOI 10.1179/his.1999.22.4.305; Navarro A, 2003, EXP NEUROL, V184, P697, DOI 10.1016/S0014-4886(03)00315-7; Navarro A, 2008, HISTOL HISTOPATHOL, V23, P995, DOI 10.14670/HH-23.995; Navarro A, 2010, AGE, V32, P85, DOI 10.1007/s11357-009-9117-0; Ong WY, 1997, NEUROSCIENCE, V79, P359, DOI 10.1016/S0306-4522(96)00608-2; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; PATEL SC, 1995, NEUROREPORT, V6, P653, DOI 10.1097/00001756-199503000-00017; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1995, MOL CELL ENDOCRINOL, V109, P225, DOI 10.1016/0303-7207(95)03506-3; PROVOST PR, 1990, J LIPID RES, V31, P2057; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; REUSCHE E, 1991, PATHOL RES PRACT, V187, P1045, DOI 10.1016/S0344-0338(11)81084-8; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sanchez D, 2000, INT J DEV BIOL, V44, P349; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SIMARD J, 1992, ENDOCRINOLOGY, V130, P1115, DOI 10.1210/en.130.3.1115; SMITH KM, 1990, J LIPID RES, V31, P995; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; Suresh S, 1998, J NEUROCHEM, V70, P242; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43	42	21	22	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580			NEUROBIOL AGING	Neurobiol. Aging	FEB	2012	33	2							433.e11	10.1016/j.neurobiolaging.2011.01.010			10	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	863NR	WOS:000298171800054	21429623				2022-02-06	
J	Ohayon, S; Boyko, M; Saad, A; Douvdeyani, A; Gruenbaum, BF; Melamed, I; Shapira, Y; Teichberg, VI; Zlotnik, A				Ohayon, Sharon; Boyko, Matthew; Saad, Amit; Douvdeyani, Amos; Gruenbaum, Benjamin F.; Melamed, Israel; Shapira, Yoram; Teichberg, Vivian I.; Zlotnik, Alexander			Cell-Free DNA as a Marker for Prediction of Brain Damage in Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; brain edema; CFD; neurological performance; TBI	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; AMYLOID PRECURSOR PROTEIN; EXPERIMENTAL-MODELS; BLOOD GLUTAMATE; ANIMAL-MODELS; PLASMA DNA; EDEMA; MILD; MICE	Traumatic brain injury (TBI) is a major cause of morbidity and mortality, and early predictors of neurological outcomes are of great clinical importance. Cell free DNA (CFD), a biomarker used for the diagnosis and monitoring of several diseases, has been implicated as a possible prognostic indicator after TBI. The purpose of this study was to determine the pattern and timing of CFD) levels after TBI, and whether a relationship exists between the level of CFD and brain edema and neurological outcomes. Thirty-nine Sprague Dawley rats were randomly assigned to two groups: rats in group 1 (sham group) were anesthetized and had a scalp incision without TBI, and rats in group 2 were anesthetized and had a scalp incision with TBI which was induced by using a weight drop model that causes diffuse brain injury. A neurological severity score (NSS) was assessed at 1, 24, and 48 h after TBI. CFD was measured via blood samples drawn at t=0 (baseline), 12, 24, 48, 72, and 120h after TBI. At 48h after TBI, brain edema was determined in a subgroup of 11 rats by calculating the difference between rats' wet and dry brain weight. The significance of comparisons between and within groups (CFD levels, brain water content, and NSS) were determined using the Kruskal-Wallis, Mann-Whitney and Student t test. The correlation between CFD levels and the NSS, as well as between CFD levels and the extent of brain edema, was calculated using the Spearman and Pearson tests, respectively. Compared with baseline levels, the CFD) levels in rats subjected to TBI were significantly increased at 24 and 48h after TBI (p<0.01 and p<0.05, respectively). A positive correlation was demonstrated between CFD) levels 24 h following TBI and the extent of brain edema (r = 0.63, p<0.05), as well as between CFD levels and the NSS (r = 0.79, p<0.005). In this study, we demonstrated an increase in CFD levels after TBI, as well as a correlation between CFD levels and brain edema and NSS. CFD levels may provide a quick, reliable, and simple prognostic indicator of neurological outcome in animals after TBI. Its role in humans has not been clearly elucidated, but has potentially significant clinical implications.	[Ohayon, Sharon; Boyko, Matthew; Gruenbaum, Benjamin F.; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Douvdeyani, Amos] Ben Gurion Univ Negev, Dept Clin Biochem, Div Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Melamed, Israel] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurosurg, IL-84105 Beer Sheva, Israel; [Saad, Amit] Univ Haifa, Dept Philosophy, IL-31999 Haifa, Israel; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il		Boyko, Matthew/0000-0003-3116-1643; Douvdevani, Amos/0000-0002-0197-6481			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hayasaki K, 1997, ACT NEUR S, V70, P75; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Kawamata T, 1997, ACT NEUR S, V70, P191; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lo YMD, 2000, CLIN CHEM, V46, P319; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Park DS, 1998, J NEUROSCI, V18, P830; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Povlishock JT, 1999, ACT NEUR S, V73, P15; Prieto R, 2009, NEUROCIRUGIA, V20, P225; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vaz R, 1998, ACTA NEUROCHIR, V140, P76, DOI 10.1007/s007010050061; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	46	21	21	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					261	267		10.1089/neu.2011.1938			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300006	22149927				2022-02-06	
J	Adams, RS; Corrigan, JD; Larson, MJ				Adams, Rachel; Corrigan, John; Larson, Mary			Alcohol Use After Combat-Acquired Traumatic Brain Injury: What We Know and Don't Know	JOURNAL OF SOCIAL WORK PRACTICE IN THE ADDICTIONS			English	Article						alcohol use; combat-acquired injury; military deployment; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SUBSTANCE USE DISORDERS; MENTAL-HEALTH PROBLEMS; MILITARY PERSONNEL; SERVICE MEMBERS; PRIMARY-CARE; DRUG-USE; VETERANS; ABUSE	Military personnel engage in unhealthy alcohol use at rates higher than their same-age civilian peers, resulting in negative consequences for the individual and jeopardized force readiness for the armed services. Among those returning from combat deployment, unhealthy drinking might be exacerbated by acute stress reactions and injury, including traumatic brain injury (TBI). Combat-acquired TBI is common among personnel in current conflicts. Although research suggests that impairment due to TBI leads to an increased risk for unhealthy drinking and consequences among civilians, there has been little research to examine whether TBI influences drinking behaviors among military personnel. This article examines TBI and drinking in both civilian and military populations and discusses implications for clinical care and policy.	[Adams, Rachel] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Corrigan, John] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Larson, Mary] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,Mailstop 035, Waltham, MA 02254 USA		Adams, RS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,Mailstop 035, Waltham, MA 02254 USA.	radams@brandeis.edu	Adams, Rachel/AAH-4653-2020		National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31 AA021030]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA007567]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01 DA030150]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007567, F31AA021030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA030150] Funding Source: NIH RePORTER	The authors would like to acknowledge the following: Ms. Adams conducted this research with predoctoral fellowship dissertation support from a Ruth L. Kirschstein National Research Service Award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA; F31 AA021030) and an institutional training grant from NIAAA (T32 AA007567). Dr. Larson's work was supported by a grant from the National Institute on Drug Abuse (R01 DA030150). Ms. Adams acknowledges the support of her dissertation committee, Drs. Mary Jo Larson (chair), Constance M. Horgan, Grant Ritter, John D. Corrigan, and Robert M. Bray, as well as guidance provided by Dr. Laura S. Lorenz.	Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P14; Otto J. L., 2010, Medical Surveillance Monthly Report, V17, P2; Babor T.F., 2001, AUDIT THE ALCOHOL US; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bell NS, 2004, ALCOHOL CLIN EXP RES, V28, P1890, DOI 10.1097/01.ALC.0000148102.89841.9B; Bigler ED, 2007, BRAIN INJURY MED PRI, P201; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Bray RM., 2009, DEP DEFENSE; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown JM, 2010, MIL MED, V175, P101, DOI 10.7205/MILMED-D-09-00080; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CASTRO CA, 2000, INT REV ARMED FORCES, V73, P191; Centers for Disease Control and Prevention and National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Defense and Veterans Brain Injury Center, 2010, DEP DEF COD GUID TRA; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2011, NEW TOOLK HELPS PROV; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2011, COOCC COND TOOLK MIL; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2010, CAS MAN CONC MILD TB; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Department of Defense, 1985, 10106 DEP DEF; Department of Defense, 2009, DEP DEF NUMB TRAUM B; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Deployment Health Clinical Center, 2011, TRAUMATIC BRAIN INJU; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Federman EB, 2000, MIL PSYCHOL, V12, P205, DOI 10.1207/S15327876MP1203_3; Ferrier-Auerbach AG, 2009, ADDICT BEHAV, V34, P625, DOI 10.1016/j.addbeh.2009.03.027; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; FRENCH LM, 2010, MILITARY NEUROPSYCHO, P101; FRENCH LM, 2009, THE JOURNAL OF HEAD, V24, P1; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; GORDON WA, 1998, THE JOURNAL OF HEAD, V13, P39; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Helmick K., 2011, MIL HLTH SYST C NAT; Helmick K., 2011, HOT TOPICS TREATMENT; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; HIBBARD MR, 1998, THE JOURNAL OF HEAD, V13, P24; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, J HEAD TRAUMA REHAB, V24, P299, DOI 10.1097/HTR.0b013e3181afbc20; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Institute of Medicine, 2008, GULF WAR HLTH, V7; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Institute of Medicine, 2008, GULF WAR HLTH, V1; Institute of Medicine, 2010, GULF WAR HLTH; IVINS BJ, 2009, THE JOURNAL OF HEAD, V24, P24; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; JENSEN GB, 1993, LANCET, V342, P1201; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kochanek PM, 2007, BRAIN INJURY MED PRI, P81; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; MCKINLAY A, 2009, THE JOURNAL OF HEAD, V24, P221; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; MITTENBERG W, 2000, THE JOURNAL OF HEAD, V15, P783; *NAT I ALC AB ALC, 2005, NIH PUB; Office of the Deputy Under Secretary of Defense, 2007, DEM 2007 PROF MIL CO; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Ong AL, 2008, MIL MED, V173, P871, DOI 10.7205/MILMED.173.9.871; Pogoda TK, 2009, AM J PHYS MED REHAB, V88, P1043, DOI 10.1097/PHM.0b013e3181c1eef5; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Pueschel M., 2010, NEW MHS PROGR SHOWC; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Center for Substance Abuse Research (CESAR), 2009, MIL PERS MOR LIK BIN; The Management of Substance Use Disorders Working Group, 2009, VA DOD CLIN PRACT GU; The TRICARE Management Activity, 2009, EV TRICARE PROGR FIS; Thurman DJ., 1995, GUIDELINES SURVEILLA; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; VERMA NP, 1992, CLIN ELECTROENCEPHAL, V23, P147, DOI 10.1177/155005949202300310; WALKER R, 2007, THE JOURNAL OF HEAD, V22, P360; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	109	21	21	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1533-256X	1533-2578		J SOC WORK PRACT ADD	J. Soc. Work Pract. Addict.		2012	12	1			SI		28	51		10.1080/1533256X.2012.647580			24	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	V82HU	WOS:000212309700003	22485074	Green Accepted			2022-02-06	
J	Alao, A; Selvarajah, J; Razi, S				Alao, Adekola; Selvarajah, Jennifer; Razi, Syed			THE USE OF CLONIDINE IN THE TREATMENT OF NIGHTMARES AMONG PATIENTS WITH CO-MORBID PTSD AND TRAUMATIC BRAIN INJURY	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						clonidine; nightmares; PTSD; traumatic brain injury; norepinephrine	POSTTRAUMATIC-STRESS-DISORDER; NOREPINEPHRINE	Objective: To describe the successful treatment of PTSD associated nightmares in two patients with PTSD. Case Summaries: The report of the successful use of clonidine to treat PTSD associated nightmares among two Veterans following combat exposure. Discussion: Clonidine, a centrally acting alpha-agonist agent used to treat hypertension, stimulates alpha-adrenoreceptors in the brain stem. This action results in reduced sympathetic outflow from the central nervous system. We hypothesize that this central mechanism of action is why clonidine may be more effective in treating nightmares among patients with PTSD when compared with other agents. Conclusion: Clonidine should be considered as an alternative in the treatment of nightmares among patients with PTSD. (Int'l. J. Psychiatry in Medicine 2012;44:165-169)	VA Med Ctr, Syracuse, NY USA; SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA		Selvarajah, J (corresponding author), SUNY Upstate Med Univ, Dept Psychiat, 750 E Adams St, Syracuse, NY 13210 USA.	Selvaraj@upstate.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Aurora RN, 2010, J CLIN SLEEP MED, V6, P389; Byers MG, 2010, J CLIN PSYCHOPHARM, V30, P225, DOI 10.1097/JCP.0b013e3181dac52f; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; MELLMAN TA, 1995, BIOL PSYCHIAT, V38, P174, DOI 10.1016/0006-3223(94)00238-X; Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; Yehuda R, 1998, BIOL PSYCHIAT, V44, P56, DOI 10.1016/S0006-3223(98)80007-3	10	21	21	0	13	BAYWOOD PUBL CO INC	AMITYVILLE	26 AUSTIN AVE, PO BOX 337, AMITYVILLE, NY 11701 USA	0091-2174			INT J PSYCHIAT MED	Int. J. Psychiatr. Med.		2012	44	2					165	169		10.2190/PM.44.2.g			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	082XR	WOS:000314427800007	23413663				2022-02-06	
J	Beyer, JA; Rowson, S; Duma, SM				Beyer, Jeffrey A.; Rowson, Steven; Duma, Stefan M.			Concussions Experienced by Major League Baseball Catchers and Umpires: Field Data and Experimental Baseball Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Mild traumatic brain injury; Linear; Rotational; Angular; Acceleration; Impact; Biomechanics	TRAUMATIC BRAIN-INJURY; HEAD ACCELERATIONS; FOOTBALL; EPIDEMIOLOGY; RISK	Some reports have shown that head injuries in baseball may comprise up to 18.5% of all competitive sports-related head injuries. The objective of this study was to evaluate the response of catcher and umpire masks to impacts at these different regions to discover the impact conditions that represent the greatest risk of injury. A series of 10 events in which a catcher or umpire in Major League Baseball, who experienced a foul ball to the mask that resulted in a concussion, were analyzed through video and data on pitch characteristics. It was found that the impacts were distributed across the face, and the median plate speed was approximately 38 m/s (84 mph). To determine the relative severity of each identified impact location, an instrumented Hybrid III head outfitted with a catcher or umpire mask was impacted with baseballs. Testing at 27 and 38 m/s (60 and 84 mph) suggested that impacts to the center-eyebrow and chin locations were the most severe. Peak linear and rotational accelerations were found to be lower than the suggested injury thresholds. While impacts to a mask result in head accelerations which are near or below levels commonly associated with the lower limits for head injury, the exact injury mechanism is unclear, as concussions are still experienced by the mask wearers.	[Beyer, Jeffrey A.; Rowson, Steven; Duma, Stefan M.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA		Rowson, S (corresponding author), Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012; Duma, Stefan/A-8368-2012	Rowson, Steven/0000-0002-3227-0596; 			Adair R. K., 1990, PHYS TODAY, V43, P103; Agel J, 2007, J ATHL TRAINING, V42, P241; Albert J., 2010, J STAT ED, V18, P1; Albert J, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1279; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Brooks D., 2011, BROOKSBASEBALL NET P; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hardy, 2003, P INT RES C BIOM IMP; HEALD JH, 1994, AM SOC TEST MATER, V1229, P223, DOI 10.1520/STP12816S; Jones I. S., 1984, HEAD IMPACT TOLERANC; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Melvin J. W., 1984, BASEBALL IMPACTS DUM; NOCSAE, 2010, 02410M10B NOCSAE DOC; NOCSAE, 2009, 02198M09 NOCSAE DOC; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2010, CLIN J SPORT MED, V20, P344, DOI 10.1097/JSM.0b013e3181ed7e50; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Versace J, 1971, SAE TECHNICAL PAPER; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	31	21	21	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		150	159		10.1007/s10439-011-0412-4			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700014	22012084				2022-02-06	
J	Caglio, M; Latini-Corazzini, L; D'Agata, F; Cauda, F; Sacco, K; Monteverdi, S; Zettin, M; Duca, S; Geminiani, G				Caglio, M.; Latini-Corazzini, L.; D'Agata, F.; Cauda, F.; Sacco, K.; Monteverdi, S.; Zettin, M.; Duca, S.; Geminiani, G.			Virtual navigation for memory rehabilitation in a traumatic brain injured patient	NEUROCASE			English	Article						Memory rehabilitation; Computer-based training; Virtual reality; Traumatic brain injury; fMRI	EPISODIC MEMORY; HIPPOCAMPAL; ALZHEIMERS; MODERATE; SCORES	The use of 3D video games in memory rehabilitation has been explored very little. A virtual navigation task allows participants to encode the spatial layout of the virtual environment and activate areas involved in memory processing. We describe the rehabilitation of a 24-year-old man with traumatic brain injury presenting memory deficits, and evaluate the efficacy of a navigational training program measuring neuropsychological changes and fMRI modification cerebral activations. Memory improvement appears to be present both after navigational training and in follow-up testing. Furthermore, fMRI data suggest that this training may increase activation of the hippocampal and parahippocampal brain regions. The results suggest that intensive training in virtual navigational tasks may result in an enhancement of memory function in brain-damaged adults.	[Caglio, M.; Latini-Corazzini, L.; D'Agata, F.; Cauda, F.; Sacco, K.; Zettin, M.; Geminiani, G.] Univ Turin, Dept Psychol, I-10123 Turin, Italy; [D'Agata, F.; Cauda, F.; Sacco, K.; Duca, S.; Geminiani, G.] Koelliker Hosp, CCS fMRI, Turin, Italy; [Monteverdi, S.; Zettin, M.] Puzzle Rehabil Ctr, Turin, Italy		Caglio, M (corresponding author), Univ Turin, Dept Psychol, Via 14, I-10123 Turin, Italy.	marcella.caglio@unito.it	Cauda, Franco/G-5021-2010; Sacco, Katiuscia/J-2133-2012; D'Agata, Federico/ABG-8839-2021	Cauda, Franco/0000-0003-1526-8475; Sacco, Katiuscia/0000-0002-9660-5236; D'Agata, Federico/0000-0001-9432-0248	University of Turin; 'Progetto Lagrange-Fondazione C.R.T.', Turin, Italy	Marcella Caglio was supported by a doctoral grant from the University of Turin and the 'Progetto Lagrange-Fondazione C.R.T.', Turin, Italy. The manuscript is original, previously unpublished, and not under concurrent consideration elsewhere. We confirm that the requirements of authorship have been met and that there is no conflict of interests. We thank Stephan Cooper for checking the English.	Annoni J. M., 1992, DISABILITY REHABILIT, V14, P23; Brooks BM, 1999, NEUROPSYCHOL REHABIL, V9, P63, DOI 10.1080/713755589; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; CAPITANI E, 1988, DEV NEUROPSYCHOL, V4, P325, DOI 10.1080/87565648809540416; CARLESIMO GA, 1993, INT J NEUROSCI, V73, P1, DOI 10.3109/00207459308987206; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Fernandez G, 1998, J NEUROSCI, V18, P1841; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Henke K, 1999, J COGNITIVE NEUROSCI, V11, P682, DOI 10.1162/089892999563643; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rosen W. G., 1996, ADAS ALZHEIMERS DIS; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Spiers HJ, 2007, NEUROSCIENCE, V149, P7, DOI 10.1016/j.neuroscience.2007.06.056; Spinnler H. A., 1987, ITALIAN J ENV PSYCHO, V9, P233; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005; Woollett K, 2008, HIPPOCAMPUS, V18, P981, DOI 10.1002/hipo.20465	26	21	26	0	23	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2012	18	2					123	131		10.1080/13554794.2011.568499			9	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	920JP	WOS:000302400900006	22352998				2022-02-06	
J	Cloots, RJH; van Dommelen, JAW; Geers, MGD				Cloots, R. J. H.; van Dommelen, J. A. W.; Geers, M. G. D.			A tissue-level anisotropic criterion for brain injury based on microstructural axonal deformation	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury (TBI); Diffuse axonal injury (DAI); Brain injury criterion; Axons; Neurons; Finite element method	PREFRONTAL CORTEX; HEAD-INJURY; PYRAMIDAL NEURONS; WHITE-MATTER; SOMAL SIZE; MODEL; SCHIZOPHRENIA; STRETCH; SYSTEM; MECHANISMS	Different length scales from micrometers to several decimeters play an important role in diffuse axonal injury. The kinematics at the head level result in local impairments at the cellular level. Finite element methods can be used for predicting brain injury caused by a mechanical loading of the head. Because of its oriented microstructure, the sensitivity of brain tissue to a mechanical load can be expected to be orientation dependent. However, the criteria for injury that are currently used at the tissue level in finite element head models are isotropic and therefore do not consider this orientation dependence, which might inhibit a reliable assessment of injury. In this study, an anisotropic brain injury criterion is developed that is able to describe the effects of the oriented microstructure based on micromechanical simulations. The effects of both the main axonal direction and of local deviations from this direction are accounted for. With the anisotropic criterion for brain injury, computational head models will be able to account for aspects of diffuse axonal injury at the cellular level and can therefore more reliably predict injury. (C) 2011 Elsevier Ltd. All rights reserved.	[Cloots, R. J. H.; van Dommelen, J. A. W.; Geers, M. G. D.] Eindhoven Univ Technol, Mat Technol Inst, NL-5600 MB Eindhoven, Netherlands		van Dommelen, JAW (corresponding author), Eindhoven Univ Technol, Mat Technol Inst, POB 513, NL-5600 MB Eindhoven, Netherlands.	j.a.w.v.dommelen@tue.nl	Geers, Marc G.D./E-4385-2014	Geers, Marc G.D./0000-0002-0009-6351	Dutch Technology Foundation STWTechnologiestichting STW; applied science division of NWONetherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs	This work has been supported by the Dutch Technology Foundation STW, applied science division of NWO and the Technology Program of the Ministry of Economic Affairs.	Abaqus, 2010, AB 6 10 MAN; Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Alberts B., 1994, MOL BIOL CELL, V3rd ed; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Braitenberg V., 1998, CORTEX STAT GEOMETRY; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cloots R.J.H., 2010, P IRCOBI C HANN GERM, P119; Cloots R.J.H., MULTISCALE MEC UNPUB; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; DRUCKER DC, 1952, Q APPL MATH, V10, P157, DOI 10.1090/qam/48291; FENSTERMACHER JD, 1970, EXP NEUROL, V27, P101, DOI 10.1016/0014-4886(70)90205-0; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Highley JR, 2003, BRIT J PSYCHIAT, V183, P414, DOI 10.1192/bjp.183.5.414; HILL R, 1948, PROC R SOC LON SER-A, V193, P281, DOI 10.1098/rspa.1948.0045; HILL R, 1979, MATH PROC CAMBRIDGE, V85, P179, DOI 10.1017/S0305004100055596; Hutsler JJ, 2003, BRAIN LANG, V86, P226, DOI 10.1016/S0093-934X(02)00531-X; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Khoshgoftar Mehdi, 2007, American Journal of Applied Sciences, V4, P918, DOI 10.3844/ajassp.2007.918.924; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kouznetsova V, 2001, COMPUT MECH, V27, P37, DOI 10.1007/s004660000212; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Liu C, 1997, ACTA MATER, V45, P2397, DOI 10.1016/S1359-6454(96)00349-7; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; National Highway Traffic Safety Administration (NHTSA), 1972, OCC CRASH PROT HEAD; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Nolte J., 2002, HUMAN BRAIN INTRO IT; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Takhounts EG, 2003, STAPP CAR CRASH J, V47, P51; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; [No title captured]	50	21	24	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161			J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2012	5	1					41	52		10.1016/j.jmbbm.2011.09.012			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	873QX	WOS:000298899200005	22100078				2022-02-06	
J	Hall, RCW; Hall, RCW				Hall, Ryan C. W.; Hall, Richard C. W.			Compensation Neurosis: A Too Quickly Forgotten Concept?	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							EXCESSIVE COGNITIVE SYMPTOMS; TRAUMATIC BRAIN-INJURY; ACCIDENT NEUROSIS; HEAD-INJURY; COGNIFORM CONDITION; PROPOSED DIAGNOSES; QUANTITATIVE EEG; BASE RATES; DISORDER; PTSD	There has been great debate concerning the existence and meaning of compensation neurosis. It is included in the International Classification of Diseases (ICD)-9 and -10 but not listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). On the eve of publication of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), we re-examine the history and concept of compensation neurosis and conceptually update the condition to reflect current psychiatric thought. We consider its utility as a diagnostic entity for forensic evaluations and its components as they relate to exaggeration in injury claims. We also discuss how compensation neurosis differs from malingering and factitious disorder.	[Hall, Ryan C. W.; Hall, Richard C. W.] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL 32816 USA; [Hall, Ryan C. W.; Hall, Richard C. W.] Univ S Florida, Dept Psychiat, Tampa, FL USA		Hall, RCW (corresponding author), 2500 W Lake Mary Blvd,Suite 219, Lake Mary, FL 32746 USA.	rcwh@live.com					Allaz AF, 1998, GEN HOSP PSYCHIAT, V20, P91, DOI 10.1016/S0163-8343(97)00127-8; American Academy of Psychiatry and the Law, 2005, ETH GUID PRACT FOR P; American Psychiatric Association, 2011, JUST CRIT S IN PRESS; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, DSM 5 DEV J 02 CONV; American Psychiatric Association, DSM 5 DEV; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association, 2010, DSM 5 DEV; American Psychiatric Association, 2011, DSM 5 DEV PERS DIS; American Psychiatric Association, 2012, DSM 5 DEV B 01 DEL D; [Anonymous], FACTITIOUS DISORDER; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bellamy R, 1997, CLIN ORTHOP RELAT R, P94; Blanchard EB, 1996, BEHAV RES THER, V34, P1, DOI 10.1016/0005-7967(95)00058-6; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Bracha HS, 2008, ARCH GEN PSYCHIAT, V65, P115, DOI 10.1001/archgenpsychiatry.2007.14; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; FISHBAIN DA, 1988, PAIN, V32, P197, DOI 10.1016/0304-3959(88)90068-1; Goetz CG, 2007, NEUROLOGY, V69, P103, DOI 10.1212/01.wnl.0000265061.46526.77; Hall R. C. W, 2012, NEW PERSPECTIVES FAK, P255; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hall RCW, 2007, J FORENSIC SCI, V52, P717, DOI 10.1111/j.1556-4029.2007.00434.x; Hall RCW, 2006, GEN HOSP PSYCHIAT, V28, P525, DOI 10.1016/j.genhosppsych.2006.08.011; KENNEDY F, 1946, COMPENSATION MED, V1, P19; Lees-Haley PR, 2004, ARCH CLIN NEUROPSYCH, V19, P333, DOI 10.1016/j.acn.2003.12.004; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVY A, 1992, Brain Injury, V6, P401, DOI 10.3109/02699059209008136; Mayou R, 1996, BRIT J PSYCHIAT, V168, P399, DOI 10.1192/bjp.168.4.399; McHugh PR, 2007, J ANXIETY DISORD, V21, P211, DOI 10.1016/j.janxdis.2006.09.003; McNally RJ, 2007, J ANXIETY DISORD, V21, P192, DOI 10.1016/j.janxdis.2006.09.005; MENDELSON G, 1995, J PSYCHOSOM RES, V39, P695, DOI 10.1016/0022-3999(94)00154-W; MENDELSON G, 1984, INT J LAW PSYCHIAT, V7, P179, DOI 10.1016/0160-2527(84)90031-1; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Reid WH, 2008, J PSYCHIATR PRACT, V14, P122, DOI 10.1097/01.pra.0000314320.25286.bf; RESNICK PJ, 1995, POSTTRAUMATIC STRESS, P117; Strasburger LH, 1997, AM J PSYCHIAT, V154, P448; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; WEIGHILL VE, 1983, J PSYCHOSOM RES, V27, P97, DOI 10.1016/0022-3999(83)90085-5; WESSELY S, 1995, J PSYCHOSOM RES, V39, P659, DOI 10.1016/0022-3999(95)00067-S; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Winckler P, 1998, Versicherungsmedizin, V50, P219; WOODYARD JE, 1982, ANN ROY COLL SURG, V64, P191; World Health Organization, 1992, ICD 10 CLASS MENT BE, P222; World Health Organization, 2008, COMP NEUR INT CLASS, V1, P80	54	21	22	0	7	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793			J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2012	40	3					390	398					9	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	021QE	WOS:000309899600011	22960922				2022-02-06	
J	Huisinga, JM; Filipi, ML; Stergiou, N				Huisinga, Jessie M.; Filipi, Mary L.; Stergiou, Nicholas			Supervised Resistance Training Results in Changes in Postural Control in Patients with Multiple Sclerosis	MOTOR CONTROL			English	Article						exercise; motor control; rehabilitation; strength training	TIME-SERIES ANALYSIS; CEREBRAL CONCUSSION; IMPROVES STRENGTH; EXERCISE; PERFORMANCE; MOBILITY; BALANCE; WALKING; ADULTS; FATIGUE	Postural disturbances are one of the first reported symptoms in patients with Multiple Sclerosis (MS). The purpose of this study was to investigate the effect of supervised resistance training on postural control in MS patients. Postural control was assessed using amount of sway variability [Root Mean Square (RMS)] and temporal structure of sway variability [Lyapunov Exponent (LyE)] from 15 MS patients. Posture was evaluated before and after completion of three months of resistance training. There were significant differences between MS patients pretraining and healthy controls for both LyE (p = .000) and RMS = .002), but no differences between groups after training. There was a significant decrease in RMS (p = .025) and a significant increase in LyE (p = .049) for MS patients pre- to posttraining. The findings suggested that postural control of MS patients could be affected by a supervised resistance training intervention.	[Huisinga, Jessie M.; Stergiou, Nicholas] Univ Nebraska, Nebraska Biomech Core Facil, Omaha, NE 68182 USA; [Filipi, Mary L.] Univ Nebraska Med Ctr, Coll Nursing, Omaha, NE 68198 USA; [Stergiou, Nicholas] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA		Huisinga, JM (corresponding author), Univ Nebraska, Nebraska Biomech Core Facil, Omaha, NE 68182 USA.				MARS Foundation in Ames, IA; Clinical Research Center at the University of Nebraska Medical Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K25 HD047194]; Nebraska Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K25HD047194] Funding Source: NIH RePORTER	This work was supported by the MARS Foundation in Ames, IA, by the Clinical Research Center at the University of Nebraska Medical Center, the National Institutes of Health (K25 HD047194), and the Nebraska Research Initiative.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Barrett C, 2002, AUST J PHYSIOTHER, V48, P215, DOI 10.1016/S0004-9514(14)60226-9; Buchanan JJ, 2001, EXP BRAIN RES, V139, P482, DOI 10.1007/s002210100798; Cakit BD, 2010, AM J PHYS MED REHAB, V89, P446, DOI 10.1097/PHM.0b013e3181d3e71f; Cameron MH, 2008, SOMATOSENS MOT RES, V25, P113, DOI 10.1080/08990220802131127; Cattaneo D, 2007, CLIN REHABIL, V21, P771, DOI 10.1177/0269215507077602; Cattaneo D, 2009, MULT SCLER, V15, P59, DOI 10.1177/1352458508096874; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Chung LH, 2008, MED SCI SPORT EXER, V40, P1717, DOI 10.1249/MSS.0b013e31817e32a3; Dalgas U, 2008, MULT SCLER J, V14, P35, DOI 10.1177/1352458507079445; DeBolt LS, 2004, ARCH PHYS MED REHAB, V85, P290, DOI 10.1016/j.apmr.2003.06.003; Delignieres D, 2003, J MOTOR BEHAV, V35, P86, DOI 10.1080/00222890309602124; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Franklin B.A., 2000, ACSMS GUIDELINES EXE; Frzovic D, 2000, ARCH PHYS MED REHAB, V81, P215, DOI 10.1053/apmr.2000.0810215; Fulk George D, 2005, J Neurol Phys Ther, V29, P34; Giesser B, 2007, MULT SCLER, V13, P224, DOI 10.1177/1352458506070663; Gutierrez GM, 2005, ARCH PHYS MED REHAB, V86, P1824, DOI 10.1016/j.apmr.2005.04.008; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; JONES DA, 1987, J PHYSIOL-LONDON, V391, P1; Karst Gregory M, 2005, J Neurol Phys Ther, V29, P170; Kuo AD, 1998, EXP BRAIN RES, V122, P185, DOI 10.1007/s002210050506; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kyvelidou A, 2010, ARCH PHYS MED REHAB, V91, P1593, DOI 10.1016/j.apmr.2010.06.027; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Lockhart T, 2008, ERGONOMICS, V51, P1860, DOI 10.1080/00140130802567079; Motl RW, 2006, RES NURS HEALTH, V29, P597, DOI 10.1002/nur.20161; NELSON SR, 1995, ANN OTO RHINOL LARYN, V104, P62, DOI 10.1177/000348949510400110; Newell K. M., 1997, DEGREES FREEDOM DEV, P63; Newell K. M., 1997, APPL NONLINEAR DYNAM, P63; Newman MA, 2007, MULT SCLER, V13, P113, DOI 10.1177/1352458506071169; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Romberg A, 2004, NEUROLOGY, V63, P2034, DOI 10.1212/01.WNL.0000145761.38400.65; RUTHERFORD OM, 1986, EUR J APPL PHYSIOL O, V55, P100, DOI 10.1007/BF00422902; Ryushi Tomoo, 2000, Journal of Physiological Anthropology and Applied Human Science, V19, P143, DOI 10.2114/jpa.19.143; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; Snook EM, 2009, NEUROREHAB NEURAL RE, V23, P108, DOI 10.1177/1545968308320641; Sosnoff JJ, 2010, ARCH PHYS MED REHAB, V91, P93, DOI 10.1016/j.apmr.2009.09.013; Soyuer F, 2006, NEUROL RES, V28, P555, DOI 10.1179/016164105X49373; Sprott J.C., 1998, CHAOS DATAS ANAL PRO; Stergiou N, 2004, INNOVATIVE ANAL HUMA, P63; Van Emmerik REA, 2010, GAIT POSTURE, V32, P608, DOI 10.1016/j.gaitpost.2010.09.002; Weiss A, 2000, AM J PHYS MED REHAB, V79, P369, DOI 10.1097/00002060-200007000-00009; White LJ, 2004, SPORTS MED, V34, P1077, DOI 10.2165/00007256-200434150-00005; White LJ, 2004, MULT SCLER J, V10, P668, DOI 10.1191/1352458504ms1088oa; Yamada N, 1995, HUM MOVEMENT SCI, V14, P711, DOI 10.1016/0167-9457(95)00032-1	51	21	21	1	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1087-1640	1543-2696		MOTOR CONTROL	Motor Control	JAN	2012	16	1					50	63		10.1123/mcj.16.1.50			14	Neurosciences; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Sport Sciences	911FH	WOS:000301702200004	22402220				2022-02-06	
J	Mommsen, P; Bradt, N; Zeckey, C; Andruszkow, H; Petri, M; Frink, M; Hildebrand, F; Krettek, C; Probst, C				Mommsen, Philipp; Bradt, Nikolas; Zeckey, Christian; Andruszkow, Hagen; Petri, Max; Frink, Michael; Hildebrand, Frank; Krettek, Christian; Probst, Christian			Comparison of helicopter and ground Emergency Medical Service: A retrospective analysis of a German rescue helicopter base	TECHNOLOGY AND HEALTH CARE			English	Article						Emergency medical service; air rescue; ground ambulance; mission times; time sensitive diagnosis	TRAUMA PATIENTS; POLYTRAUMATIZED PATIENTS; VENTRICULAR-ARRHYTHMIAS; AMBULANCE TRANSPORT; AIR AMBULANCE; TIME; MORTALITY; IMPACT; ASSOCIATION; SURVIVAL	Background: In consideration of rising cost pressure in the German health care system, the usefulness of helicopter emergency medical service (HEMS) in terms of time- and cost-effectiveness is controversially discussed. The aim of the present study was to investigate whether HEMS is associated with significantly decreased arrival and transportation times compared to ground EMS. Methods: In a retrospective study, we evaluated 1,548 primary emergency missions for time sensitive diagnoses (multiple trauma, traumatic brain and burn injury, heart-attack, stroke, and pediatric emergency) performed by a German HEMS using the medical database, NADIN, of the German Air Rescue Service. Arrival and transportation times were compared to calculated ground EMS times. Results: HEMS showed significantly reduced arrival times at the scene in case of heart-attack, stroke and pediatric emergencies. In contrast, HEMS and ground EMS showed comparable arrival times in patients with multiple trauma, traumatic brain and burn injury due to an increased flight distance. HEMS showed a significantly decreased transportation time to the closest centre capable of specialist care in all diagnosis groups (p < 0.001). Conclusions: The results of the present study indicate the time-effectiveness of German air ambulance services with significantly decreased transportation times.	[Mommsen, Philipp; Bradt, Nikolas; Zeckey, Christian; Andruszkow, Hagen; Petri, Max; Frink, Michael; Hildebrand, Frank; Krettek, Christian; Probst, Christian] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany		Mommsen, P (corresponding author), Hannover Med Sch, Trauma Dept, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mommsen.philipp@mh-hannover.de	Hildebrand, Frank/J-3176-2017; Mommsen, Philipp/ABC-3510-2020	Krettek, Christian/0000-0001-9807-0020			Biewener A, 2005, UNFALLCHIRURG, V108, P370, DOI 10.1007/s00113-005-0928-x; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Diaz MA, 2005, J TRAUMA, V58, P148, DOI 10.1097/01.TA.0000124264.43941.41; Frink M, 2007, UNFALLCHIRURG, V110, P334, DOI 10.1007/s00113-006-1222-2; Gries A, 2008, ANAESTHESIST, V57, P562, DOI 10.1007/s00101-008-1373-3; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Hacke W, 1999, NEUROLOGY, V53, pS3; Hacke W, 2004, LANCET, V363, P768; Hata N, 2006, INTERNAL MED, V45, P45, DOI 10.2169/internalmedicine.45.1399; Hohnloser SH, 2003, CIRCULATION, V107, P941, DOI 10.1161/01.CIR.0000054211.00668.9B; Hotvedt R, 1996, LANCET, V347, P1362, DOI 10.1016/S0140-6736(96)91010-7; Knobloch Karsten, 2009, Air Med J, V28, P146, DOI 10.1016/j.amj.2008.11.004; Kurola J, 2002, ACTA ANAESTH SCAND, V46, P779, DOI 10.1034/j.1399-6576.2002.460704.x; Larson JT, 2004, J TRAUMA, V56, P89, DOI 10.1097/01.TA.0000061163.35582.A5; Lechleuthner A, 1994, Eur J Emerg Med, V1, P159; Milavetz JJ, 1998, J AM COLL CARDIOL, V31, P1246, DOI 10.1016/S0735-1097(98)00088-6; Murphy M S, 1997, Air Med J, V16, P73, DOI 10.1016/S1067-991X(97)90018-3; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; Schlechtriemen I, 2002, UNFALLCHIRURG, V105, P974, DOI 10.1007/s00113-002-0515-3; Shatney CH, 2002, J TRAUMA, V53, P817, DOI 10.1097/00005373-200211000-00002; Sollid S, 2003, J NEUROTRAUM, V20, P309, DOI 10.1089/089771503321532897	25	21	22	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0928-7329	1878-7401		TECHNOL HEALTH CARE	Technol. Health Care		2012	20	1					49	56		10.3233/THC-2011-0655			8	Health Care Sciences & Services; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Engineering	068BW	WOS:000313340500005	22297713				2022-02-06	
J	Roebuck-Spencer, TM; Vincent, AS; Twillie, DA; Logan, BW; Lopez, M; Friedl, KE; Grate, SJ; Schlegel, RE; Gilliland, K				Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Twillie, David A.; Logan, Bret W.; Lopez, Mary; Friedl, Karl E.; Grate, Stephen J.; Schlegel, Robert E.; Gilliland, Kirby			Cognitive Change Associated with Self-Reported Mild Traumatic Brain Injury Sustained During the OEF/OIF Conflicts	CLINICAL NEUROPSYCHOLOGIST			English	Article						Military deployment; Mild traumatic brain injury; Computerized testing; ANAM; Military TBI	POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TEST; HEAD-INJURY; IRAQ-WAR; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; SPORTS CONCUSSION; DIAGNOSIS THREAT; ENDURING FREEDOM; TEST-PERFORMANCE	Traumatic brain injury (TBI) has received much attention due to high rates of this injury in Service Members returning from the Iraq/Afghanistan conflicts. This study examined cognitive performance in Service Members tested with ANAM prior to and following deployment. The sample was divided into a control group (n = 400) reporting no TBI injury prior to or during most recent deployment, and a group who self-reported a TBI injury (n = 502) during most recent deployment. This latter group was divided further based on self-report of post-concussion symptoms at post-deployment testing. All three groups performed similarly at pre-deployment. The group reporting TBI with active symptoms performed worst at post-deployment and included the highest percentage of individuals showing significant decline in cognitive performance over time (30.5%). A small sample of symptomatic individuals with a non-TBI reported injury did not demonstrate similar declines in performance, suggesting that active symptoms alone cannot account for these findings. Of those reporting a TBI injury during deployment, 70% demonstrated no significant change in cognitive performance compared with baseline. Although the exact etiology of observed declines is uncertain, findings indicate that individuals who self-report TBI during deployment with active symptomatology at post-deployment are at greatest risk for declines in cognitive performance. These individuals can be identified using self-report and brief computer-based testing. Importantly, the majority of active-duty individuals reporting TBI during deployment do not present with lasting significant cognitive impairment, a finding consistent with the civilian literature on mild TBI.	[Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Schlegel, Robert E.; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA; [Twillie, David A.; Logan, Bret W.] Blanchfield Army Community Hosp, Ft Campbell, KY USA; [Lopez, Mary] US Army Bavaria Med Dept Act BMEDDAC, Vilseck, Germany; [Friedl, Karl E.; Grate, Stephen J.] USA, Telemed & Adv Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA			tresa@ou.edu	Friedl, Karl/M-1803-2019	Friedl, Karl/0000-0002-3134-8427	DoDUnited States Department of Defense; Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH-07-2-0097]; ANAM	This data analysis was conducted by the Center for the Study of Human Operator Performance (C-SHOP) at the University of Oklahoma and is made possible by a DoD Grant awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD under Contract Number W81XWH-07-2-0097.; The University of Oklahoma (OU) holds the exclusive license for the Automated Neuropsychological Assessment Metrics (ANAM). The Cognitive Science Research Center (formerly C-SHOP) at OU is responsible for research and development of ANAM. VistaLifeSciences holds the exclusive license for ANAM commercialization. Author Friedl is a co-inventor on United States Patent 7,837,472 and has received royalties in connection with this patent. Authors Gilliland and Schlegel have standard university royalty agreements for the sale of ANAM. No other authors of this manuscript receive funds or salary support from ANAM sales.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Johnson D. R., 2009, NAT AC NEUR NEW ORL; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Marr A., 2004, CENTRAL NERVOUS SYST; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent A. S., MILITARY ME IN PRESS; Vincent A. S., 2010, NAT AC NEUR C; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	41	21	21	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	3					473	489		10.1080/13854046.2011.650214			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	936ER	WOS:000303574200164	22268558				2022-02-06	
J	da Silva, SG; de Almeida, AA; Araujo, BHS; Scorza, FA; Cavalheiro, EA; Arida, RM				da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Silva Araujo, Bruno Henrique; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao; Arida, Ricardo Mario			Early physical exercise and seizure susceptibility later in life	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Exercise; Development; Brain; Plasticity; Seizure; Epilepsy	TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; ENVIRONMENTAL ENRICHMENT; PREADOLESCENT CHILDREN; KINDLING DEVELOPMENT; ALZHEIMERS-DISEASE; ADOLESCENT PERIOD; SPATIAL MEMORY; OLD-AGE; EPILEPSY	We conducted a study to examine whether physical exercise undertaken during the period of postnatal brain development could modify seizure susceptibility later in life. Male Wistar rats aged 21 postnatal days (P21) were divided into two groups: exercise and control. Animals in the exercise group were submitted to daily exercise on the treadmill between P21 and P60. Running time and speed gradually increased over this period, reaching a maximum of 18 m/min for 60min. After the final exercise session (P60), animals from exercise group were maintained non-trained for 90 days. This "period without stimulus" was used to observe the influence of early physical exercise on susceptibility to seizures induced by the pilocarpine model of epilepsy at P150. The results showed that the exercise program undertaken during the period of postnatal brain development delayed the onset and reduced the intensity of pilocarpine-induced motor symptoms in midlife rats. These findings suggest that early exercise interferes positively in the later ictogenesis process, and support the hypothesis that physical activity in early life may build a neural reserve against brain disorders. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Arida, Ricardo Mario] Univ Fed Sao Paulo UNIFESP, Dept Fisiol, BR-04023900 Sao Paulo, Brazil; [Silva Araujo, Bruno Henrique; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao] Univ Fed Sao Paulo UNIFESP, Dept Neurol & Neurosurg, BR-04023900 Sao Paulo, Brazil		da Silva, SG (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Rua Botucatu 862,Ed Ciencias Biomed,5 Andar, BR-04023900 Sao Paulo, Brazil.	sergio.gomes@unifesp.br; arida.nexp@epm.br	Scorza, Fulvio/C-7048-2013; Arida, Ricardo Mario/P-7408-2016; Cavalheiro, Esper A/I-3084-2016; Arida, Ricardo M/E-2667-2013; Neurociencia, Inct/I-1011-2013; da Silva, Sergio Gomes/F-1847-2013; Cavalheiro, Esper/N-3985-2019; Torres, Bruno/P-9975-2019; Cavalheiro, Esper A/F-4325-2014; Araujo, Bruno/B-8741-2013; de Almeida, Alexandre/E-8771-2016	Scorza, Fulvio/0000-0002-0694-8674; Arida, Ricardo Mario/0000-0002-7771-6133; Cavalheiro, Esper A/0000-0002-0854-3582; Arida, Ricardo M/0000-0002-0908-3274; da Silva, Sergio Gomes/0000-0002-9650-809X; Cavalheiro, Esper/0000-0002-0854-3582; Torres, Bruno/0000-0003-0012-4217; Cavalheiro, Esper A/0000-0002-0854-3582; Araujo, Bruno/0000-0003-0012-4217; de Almeida, Alexandre/0000-0002-9045-7826	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Cooperacao Interinstitucional de Apoio a Pesquisa sobre o Cerebro (CInAPCe); Instituto Nacional de Neurociencia Translacional (INNT) (Brazil)	This study was supported by research grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Cooperacao Interinstitucional de Apoio a Pesquisa sobre o Cerebro (CInAPCe) and Instituto Nacional de Neurociencia Translacional (INNT) (Brazil).	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Arida RM, 2007, PHYSIOL BEHAV, V90, P629, DOI 10.1016/j.physbeh.2006.11.016; Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Arida RM, 2010, EPILEPSY BEHAV, V17, P432, DOI 10.1016/j.yebeh.2010.01.013; Arida RM, 1998, EPILEPSY RES, V30, P127, DOI 10.1016/S0920-1211(97)00102-2; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Barnett JH, 2006, PSYCHOL MED, V36, P1053, DOI 10.1017/S0033291706007501; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; da Silva SG, 2010, NEUROCHEM INT, V57, P492, DOI 10.1016/j.neuint.2010.07.001; da Silva SG, 2010, BRAIN DEV-JPN, V32, P137, DOI 10.1016/j.braindev.2008.12.012; Dawson KS, 2007, BRAIN INJURY, V21, P943, DOI 10.1080/02699050701553171; Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583; ERIKSEN HR, 1994, EPILEPSIA, V35, P1256, DOI 10.1111/j.1528-1157.1994.tb01797.x; ESQUIVEL E, 1991, ELECTROEN CLIN NEURO, V79, P127, DOI 10.1016/0013-4694(91)90050-E; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Gomes da Silva S, HIPPOCAMPUS IN PRESS; Graves AB, 1996, BRIT J PSYCHIAT, V169, P86, DOI 10.1192/bjp.169.1.86; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Lores-Arnaiz S, 2007, BEHAV BRAIN RES, V184, P117, DOI 10.1016/j.bbr.2007.06.024; Middleton LE, 2010, J AM GERIATR SOC, V58, P1322, DOI 10.1111/j.1532-5415.2010.02903.x; Nakken KO, 1999, EPILEPSIA, V40, P643, DOI 10.1111/j.1528-1157.1999.tb05568.x; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Pai MC, 2005, EPILEPSIA, V46, P7, DOI 10.1111/j.0013-9580.2005.461003.x; Racine RJ, 1972, CLIN NEUROPHYSIOL, V32, P281, DOI DOI 10.1016/0013-4694(72)90177-0; Raine A, 2003, AM J PSYCHIAT, V160, P1627, DOI 10.1176/appi.ajp.160.9.1627; Richards M, 2003, SOC SCI MED, V56, P785, DOI 10.1016/S0277-9536(02)00075-8; Riviere S, 2001, J Nutr Health Aging, V5, P295; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Setkowicz Z, 2006, EPILEPSY RES, V71, P142, DOI 10.1016/j.eplepsyres.2006.06.002; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; Vancini RL, 2010, EPILEPSY BEHAV, V19, P504, DOI 10.1016/j.yebeh.2010.09.007; Werz MA, 2005, EPILEPSY BEHAV, V6, P98, DOI 10.1016/j.yebeh.2004.11.008; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	45	21	21	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2011	29	8					861	865		10.1016/j.ijdevneu.2011.07.011			5	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	858DC	WOS:000297775100011	21840389				2022-02-06	
J	Tseng, WC; Shih, HM; Su, YC; Chen, HW; Hsiao, KY; Chen, IC				Tseng, Wei-Chun; Shih, Hong-Mo; Su, Yi-Chun; Chen, Hong-Wen; Hsiao, Kuang-Yu; Chen, I-Chuan			The Association Between Skull Bone Fractures and Outcomes in Patients With Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Mortality; Risk factors; Skull bone fracture; Subarachnoid hemorrhage; Subdural hemorrhage	MODERATE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; HYPOTENSION; SCAN; EPIDEMIOLOGY; MULTICENTER; PROGRESSION; PREDICTORS; MORTALITY	Background: In traumatic brain injury (TBI), computed tomography (CT) provides a good assessment of anatomic pathologic findings and the prognostic value of CT characteristics has been well discussed. However, few studies have focused on skull bone fracture and its clinical prognostic importance. Hence, this study aims to evaluate the effects of skull bone fracture on patients with severe TBI admitted to the emergency unit. Methods: We reviewed the medical records of patients with isolated severe TBI admitted to the emergency unit of a university hospital from July 2003 to June 2008. Patients were divided into two groups based on the presence of skull bone fracture identified by the CT scan while in the emergency unit. Mann-Whitney U test and a Student's t test were used to identify the differences between the two groups, whereas logistic regression was applied to determine any significant differences found in the statistical analysis. Results: A total of 197 patients were signed up in our study. Based on the presence of skull bone fracture on CT scan at emergency department, 92 patients (46.7%) comprised the skull bone fracture group and 59 patients (64.1%) of these died. One hundred five patients (53.3%) comprised the nonskull bone fracture group, of which 33 patients (31.4%) died. There is significant difference between the two groups (p = 0.004). Conclusion: This study shows that skull bone fracture is a mortality risk factor for patients with isolated severe blunt TBI.	[Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Puzih City 613, Chiayi County, Taiwan; Chang Gung Univ, Coll Med, Dept Med, Gueishan Township, Taoyuan County, Taiwan		Chen, IC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sec,Jiapu Rd, Puzih City 613, Chiayi County, Taiwan.	giomacky@gmail.com		Shih, Hong-Mo/0000-0001-7732-3594			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bjerke HS, 2000, J TRAUMA, V48, P1037; Castellan N. J, 1988, NONPARAMETRIC STAT B; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, ACT NEUR S, V81, P81; Shapiro MB, 2002, J TRAUMA, V53, P236; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	28	21	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1611	1614		10.1097/TA.0b013e31823a8a60			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400029	22182871				2022-02-06	
J	Bennett, S; Ward, M; Moreau, K; Fortin, G; King, J; MacKay, M; Plint, A				Bennett, Susan; Ward, Michelle; Moreau, Katherine; Fortin, Gilles; King, Jim; MacKay, Morag; Plint, Amy			Head injury secondary to suspected child maltreatment: Results of a prospective Canadian national surveillance program	CHILD ABUSE & NEGLECT			English	Article						Child maltreatment; Head injury; Surveillance; Abuse; Incidence	SHAKEN-BABY-SYNDROME; TRAUMATIC BRAIN-INJURY; CHANGE KNOWLEDGE; ABUSE	Objective: We sought to determine the incidence, clinical features, and demographic profile of head injury secondary to suspected child maltreatment (abuse or neglect) in Canada to help inform the development and evaluation of prevention programs for abusive head injuries. Methods: From March 1, 2005 to February 28, 2008, an average of 2,545 paediatricians and paediatric subspecialists were surveyed monthly through the established network of the Canadian Paediatric Surveillance Program. We calculated incidence rates using the number of confirmed cases over the product of the duration of the study (3 years) and population estimates by age group. Results: There were 220 confirmed cases of head injury from suspected child maltreatment. The annual incidence rate was 14.1 per 100,000 for children less than 1 year of age and 1.4 per 100,000 for those less than 15 years. Seventy three percent (141) of cases involved infants less than 12 months of age and 52% (100) of cases involved infants less than 6 months of age. Seventy-five percent (165) of cases presented to the emergency room. With regard to outcome, 12% (27) of cases resulted in death and 45% (75) of survivors had neurological sequelae at discharge. Thirty percent (67) of all cases, as well as, 30% (8) of deaths were previously known to child welfare authorities. Conclusion: This study provides an estimate of the rate of head injury secondary to suspected child maltreatment in Canada. The young age and poor medical outcomes of those involved highlights the need for prevention efforts that are implemented early in life. Given that a significant percentage of injured infants and children were already known to child welfare authorities, the study also highlights the need to establish and evaluate additional preventive efforts for parents and caregivers already in the child welfare system. (C) 2011 Elsevier Ltd. All rights reserved.	[Bennett, Susan] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Psychiat, Ottawa, ON K1H 8L1, Canada; [Bennett, Susan; Ward, Michelle; King, Jim; Plint, Amy] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Moreau, Katherine] Childrens Hosp Eastern Ontario, Clin Res Unit, Res Inst, Ottawa, ON K1H 8L1, Canada; [Fortin, Gilles] Univ Montreal, Dept Pediat Neurol, Montreal, PQ H3C 3J7, Canada; [MacKay, Morag] European Child Safety Alliance, Birmingham B15 1RP, W Midlands, England		Bennett, S (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Psychiat, Ottawa, ON K1H 8L1, Canada.		Plint, Amy/AAE-2250-2020				Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Barr RG, 2008, AM J PREV MED, V34, pS106, DOI 10.1016/j.amepre.2008.01.021; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; Dias Mark S, 2005, Pediatrics, V115, pe470, DOI 10.1542/peds.2004-1896; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; Goulet C, 2009, JOGNN-J OBST GYN NEO, V38, P7, DOI 10.1111/j.1552-6909.2008.00301.x; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; King WJ, 2003, CAN MED ASSOC J, V168, P155; Public Health Agency of Canada, 2010, CAN INC STUD REP CHI; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REECE RM, 2003, INFLICTED CHILDHOOD; Sibert JR, 2002, CHILD ABUSE NEGLECT, V26, P267, DOI 10.1016/S0145-2134(01)00324-6; *STAT CAN, 2003, CAN SOC INF MAN SYST; Tolliday F., 2010, COMMUNITIES CHILDREN, V5, P31	21	21	21	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	NOV	2011	35	11					930	936		10.1016/j.chiabu.2011.05.018			7	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	859XV	WOS:000297910000004	22099143				2022-02-06	
J	Graumann, U; Ritz, MF; Hausmann, O				Graumann, Ursula; Ritz, Marie-Francoise; Hausmann, Oliver			Necessity for Re-Vascularization after Spinal Cord Injury and the Search for Potential Therapeutic Options	CURRENT NEUROVASCULAR RESEARCH			English	Article						Angiogenic factors; angiogenesis; blood vessels; cell-based therapy; re-vascularization; spinal cord injury	ENDOTHELIAL PROGENITOR CELLS; HEPATOCYTE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; IN-VITRO; CONTUSION INJURY; LESIONAL EXPRESSION; FUNCTIONAL RECOVERY; VENTRAL HORN; TGF-BETA	Disruption of the blood-spinal cord barrier (BSCB) and microvascular changes leading to reduction of blood supply represent hallmarks of spinal cord secondary injury causing further deterioration of the traumatized patient. Injury to the blood vessels starts with prominent hemorrhage and generation of inflammation. Furthermore, spinal cord ischemia and extravasation of blood components contribute to edema formation resulting in death of neural cells. Endogenous attempts of re-vascularization have been observed although these newly formed vessels display morphological and functional abnormalities. The unfavorable regulation of angiogenic and counterregulatory anti-angiogenic factors during the complicated course of vessel remodeling after SCI is suspected to participate in the failure of re-vascularization and vessel stabilization. Repression of the expression of angiogenic factors such as vascular endothelial growth factor-A (VEGF-A), placental growth factor (PlGF), angiopoietin-1 (Ang1), and platelet-derived growth factor-BB (PDGF-BB) contributes to vessel regression. Therefore, therapeutic applications of angiogenic factors following SCI are promising strategies to restore blood flow in the lesion.	[Ritz, Marie-Francoise] Pharmacenter, Brain Tumor Biol Lab, Dept Biomed, CH-4056 Basel, Switzerland; [Graumann, Ursula] Spinal Injury Res, Swiss Parapleg Res, CH-6207 Nottwil, Switzerland; [Hausmann, Oliver] Hirslanden Clin St Anna, Neuro & Spine Ctr, CH-6006 Luzern, Switzerland		Ritz, MF (corresponding author), Pharmacenter, Brain Tumor Biol Lab, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	marie-francoise.ritz@unibas.ch					Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; BUCKLEYSTURROCK A, 1989, J CELL PHYSIOL, V138, P70, DOI 10.1002/jcp.1041380111; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Cai XX, 2009, STEM CELL REV REP, V5, P437, DOI 10.1007/s12015-009-9097-6; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Choi JS, 2007, J HISTOCHEM CYTOCHEM, V55, P821, DOI 10.1369/jhc.6A7139.2007; Finney MR, 2010, CYTOTHERAPY, V12, P67, DOI 10.3109/14653240903300658; Frontczak-Baniewicz M, 2006, NEUROENDOCRINOL LETT, V27, P539; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; George J, 2005, CARDIOVASC RES, V68, P299, DOI 10.1016/j.cardiores.2005.06.022; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Graumann U, 2010, CURR NEUROVASC RES, V7, P144, DOI 10.2174/156720210791184907; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; Javaherian K, 2002, J BIOL CHEM, V277, P45211, DOI 10.1074/jbc.M206358200; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kang CE, 2010, J NEUROTRAUM, V27, P2041, DOI 10.1089/neu.2010.1345; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Li XL, 2008, J NEUROL SCI, V268, P163, DOI 10.1016/j.jns.2007.12.005; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Liu Y, 2007, J PATHOL, V212, P12, DOI 10.1002/path.2155; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Mueller CA, 2007, EXP NEUROL, V208, P228, DOI 10.1016/j.expneurol.2007.07.020; Mueller CA, 2003, J NEUROTRAUM, V20, P1007, DOI 10.1089/089771503770195858; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rieckmann P, 2003, NAT MED, V9, P828, DOI 10.1038/nm0703-828; Ritz MF, 2010, CURR NEUROVASC RES, V7, P301, DOI 10.2174/156720210793180756; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Sasaki H, 2009, SPINE, V34, P249, DOI 10.1097/BRS.0b013e3181913cde; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Shimamura M, 2007, BRAIN RES, V1151, P188, DOI 10.1016/j.brainres.2007.03.022; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Xiyang YB, 2009, J NEUROTRAUM, V26, P275, DOI 10.1089/neu.2007.0374; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zeng X, 2011, CELL TANSPL IN PRESS; Zorner B, 2010, ANN NY ACAD SCI, V1198, pE22, DOI 10.1111/j.1749-6632.2010.05566.x	77	21	21	1	14	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026			CURR NEUROVASC RES	Curr. Neurovasc. Res.	NOV	2011	8	4					334	341		10.2174/156720211798121007			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	883FE	WOS:000299618800008	22023610				2022-02-06	
J	Rieder, C; Jansen, P				Rieder, Cornelia; Jansen, Petra			No Neuropsychological Consequence in Male and Female Soccer Players after a Short Heading Training	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						heading training; acute head impacts; neuropsychological measurements; headache; concussion	SEX-DIFFERENCES; CONCUSSION SYMPTOMS; SPORTS; TRAUMA; PERFORMANCE; FREQUENCY; RECOVERY	The impact of heading on neuropsychological performance is a subject of controversy. In this experimental study, a controlled group design was used to investigate the possible effects of a short heading training session on neuropsychological performance. Ninety-one participants matched by age, sex, and intelligence were assigned to one of the following groups: A heading-training group, a placebo control group, and a waiting control group. All participants completed a neuropsychological test battery for attention and working memory (D2 Test, Benton Visual Retention Test, Paced Auditory Serial Addition Task Test). After 1 week, they received heading training, football (e.g., soccer) training without heading, or no training. Immediately after this training, the neuropsychological tests were conducted again. There was no neuropsychological deficit which could only be attributed to the heading training. However, within the heading group, women complained more about headache than men.	[Rieder, Cornelia; Jansen, Petra] Univ Regensburg, Inst Sport Sci, D-93047 Regensburg, Germany		Jansen, P (corresponding author), Univ Regensburg, Inst Sport Sci, D-93047 Regensburg, Germany.	petra.jansen@psk.uni-regensburg.de					Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; BENTON AL, 1950, AMA ARCH NEUROL PSY, V64, P699, DOI 10.1001/archneurpsyc.1950.02310290095010; BENTON AL, 1996, BENTON TEST; Brickenkamp R., 2002, TEST D2 AUFMERKSAMKE; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dvorak J, 2000, AM J SPORT MED, V28, pS3; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; FREYTAG HW, 1979, ARCH PSYCHIAT NERVEN, V227, P109; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan S. E., 1996, AM J SPORTS MED, V24, P105; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Lambourne K, 2010, MED SCI SPORT EXER, V42, P1396, DOI 10.1249/MSS.0b013e3181cbee11; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCaffrey RJ, 2001, ARCH CLIN NEUROPSYCH, V16, P9, DOI 10.1016/S0887-6177(99)00055-4; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Oswald W D., 1987, ZAHLEN VERBINDUNGS T, V2; Poeck K., 2006, NEUROLOGIE; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Reitan R.M., 1956, TRAIL MAKING TEST MA; Rieder C., 2010, BRENNPUNKTE SPORTWIS, P63; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Rutherford A., 2007, FOCUS COGNITIVE DISO, P181; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Talavage TM, 2010, J NEUROTRAUMA; VERNON PA, 1993, PERS INDIV DIFFER, V14, P35, DOI 10.1016/0191-8869(93)90172-Y; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wechsler D., 1964, MESSUNG INTELLIGENZ; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	44	21	21	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2011	26	7					583	591		10.1093/arclin/acr055			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	836FF	WOS:000296094800002	21750329	Bronze, Green Published			2022-02-06	
J	van Pelt, ED; de Kloet, A; Hilberink, SR; Lambregts, SAM; Peeters, E; Roebroeck, ME; Catsman-Berrevoets, CE				van Pelt, E. Danielle; de Kloet, Arend; Hilberink, Sander R.; Lambregts, Susanne A. M.; Peeters, Els; Roebroeck, Marije E.; Catsman-Berrevoets, Coriene E.			The incidence of traumatic brain injury in young people in the catchment area of the University Hospital Rotterdam, The Netherlands	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Brain injury; Trauma; Children; Adolescents; Incidence; Netherlands	GLASGOW COMA SCALE; MINOR HEAD TRAUMA; CHILDREN; EPIDEMIOLOGY; ADOLESCENTS	Background: Traumatic brain injuiy (TBI) is in the developed countries the most common cause of death and disability in childhood. Aim: The purpose of this study is to estimate the incidence of TBI for children and young people in an urbanised region of the Netherlands and to describe relevant characteristics of this group. Methods: Patients, aged 1 month - 24 years who presented with traumatic brain injury at the Erasmus University Hospital (including the Sophia Children's Hospital) in 2007 and 2008 were included in a retrospective study. Data were collected by means of diagnosis codes and search terms for TBI in patient records. The incidence of TBI in the different referral areas of the hospital for standard, specialised and intensive patient care was estimated. Results: 472 patients met the inclusion criteria. The severity of the Injury was classified as mild in 342 patients, moderate in 50 patients and severe in 80 patients. The total incidence of traumatic brain injury in the referral area of the Erasmus University Hospital was estimated at 113.9 young people per 100.000. The incidence for mild traumatic brain injury was estimated at 104.4 young people, for moderate 6.1 and for severe 3.4 young people per 100.000. Conclusion: The ratio for mild, moderate and severe traumatic brain injury in children and young people was 33.7-1.8-1.In the mild TBI group almost 17% of the patients reported sequelae. The finding that 42% of them had a normal brain CT scan at admission underwrites the necessity of careful follow up of children and young people with mild TBI. (C) 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[van Pelt, E. Danielle; Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, NL-3015 GJ Rotterdam, Netherlands; [de Kloet, Arend] Sophia Rehabil & Hague Univ, The Hague, Netherlands; [Hilberink, Sander R.; Lambregts, Susanne A. M.; Roebroeck, Marije E.] Erasmus Univ Hosp, Dept Rehabil Med & Physiotherapy, Rotterdam, Netherlands; [Peeters, Els] Haga Hosp, The Hague, Netherlands; [Peeters, Els] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands		Catsman-Berrevoets, CE (corresponding author), Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, Dr Molewaterpl 60, NL-3015 GJ Rotterdam, Netherlands.	c.catsman@erasmusmc.nl					Aarsen FK, 2006, CANCER-AM CANCER SOC, V106, P396, DOI 10.1002/cncr.21612; Cnossen MH, 2010, DEV MED CHILD NEUROL, V52, P394, DOI 10.1111/j.1469-8749.2009.03580.x; Curtain RP, 2006, PEDIATR NEUROL, V34, P329, DOI 10.1016/j.pediatrneurol.2005.08.033; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Dutch Healthcare Authority, 2010, DUTCH HEALTHC AUTH; Dutch Society of Neurology, 2010, GUID ASS TREATM PAT; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Erasmus University Medical Centre Rotterdam, 2007, ER U MED CTR ROTT AN; Gillett J, 2004, NEUROREHABILITATION, V19, P207; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnston MV, 2003, EUR J PAEDIATR NEURO, V7, P105, DOI 10.1016/S1090-3798(03)00039-4; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McDougall J, 2006, BRAIN INJURY, V20, P1189, DOI 10.1080/02699050600975541; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meerhoff S R, 2000, Ned Tijdschr Geneeskd, V144, P1915; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Statistics Netherlands, 2010, POP BAS FIG; TEASDALE G, 1974, LANCET, V2, P81; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; Vermunt LCAC, 2009, BRIT J CLIN PSYCHOL, V48, P195, DOI 10.1348/014466508X391094; YOSHIDA M, 1979, SURG NEUROL, V12, P115	36	21	21	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	NOV	2011	15	6					519	526		10.1016/j.ejpn.2011.05.005			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	862YB	WOS:000298128900008	21855375				2022-02-06	
J	Zeng, GW; Wang, GP; Guan, FX; Chang, KL; Jiao, HL; Gao, WQ; Xi, SM; Yang, B				Zeng, Guangwei; Wang, Gongping; Guan, Fangxia; Chang, Keliang; Jiao, Hongliang; Gao, Wanqin; Xi, Shoumin; Yang, Bo			Human amniotic membrane-derived mesenchymal stem cells labeled with superparamagnetic iron oxide nanoparticles: the effect on neuron-like differentiation in vitro	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Amniotic membrane; Mesenchymal stem cells; Neuron-like differentiation; Superparamagnetic iron oxide nanoparticles	TRAUMATIC BRAIN-INJURY; UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; ADIPOSE-TISSUE; MODEL; TRANSPLANTATION; MIGRATION; SURVIVAL; THERAPY	Mesenchymal stem cells (MSCs) have the potential for self-renewal and multipotential differentiation to regenerate damaged tissues or recover functional absence in diseases. Superparamagnetic iron oxide nanoparticles (SPIONs) are used as contrast agents in magnetic resonance imaging (MRI) for labeling cells in vitro and for tracking SPION-labeled cells after transplantation in vivo. Human amniotic membrane-derived mesenchymal stem cells (hAM-dMSCs) have the capacity for neuron-like differentiation that could be used to cure central nervous system (CNS) diseases. The study investigated the impacts of cytotoxicity of SPIONs on neuron-like differentiation of hAM-dMSCs in both single (1x) and multiple (4x) SPIONs-labeled methods. hAM-dMSCs could be efficiently labeled at safe concentrations of SPIONs (a parts per thousand currency sign14 mu g/ml) without significantly affecting their viability (> 80% after a MTT assay), special surface antigens (CD29, CD44, CD90, CD105 through flow cytometry), and neuron-like differentiation (nestin and neuron-specific enolase through immunocytochemistry and reverse transcription polymerase chain reaction). Compared with multiple (4x) SPION-labeled methods, a single (1x) SPION-labeled method avoided multiple SPION-labeled hAM-dMSCs and minimized the impact of cytotoxicity of SPIONs on neuron-like differentiation of hAM-dMSCs. Under safe concentrations of SPIONs, a single (1x) SPION-labeled method provided appropriate viability for SPIONs-labeled hAM-dMSCs and facilitated the MRI evaluation of hAM-dMSCs after transplantation.	[Zeng, Guangwei; Chang, Keliang; Jiao, Hongliang; Yang, Bo] Zhengzhou Univ, Hosp 1, Dept Neurosurg, Zhengzhou 450052, Henan Province, Peoples R China; [Zeng, Guangwei] Henan Univ Sci & Technol, Hosp 1, Dept Plast Reconstruct & Burns Surg, Luoyang 471003, Henan Province, Peoples R China; [Wang, Gongping] Henan Univ Sci & Technol, Hosp 1, Dept Onchol, Luoyang 471003, Henan Province, Peoples R China; [Guan, Fangxia] Zhengzhou Univ, Dept Bioengn, Zhengzhou 450001, Henan Province, Peoples R China; [Gao, Wanqin] Henan Univ Sci & Technol, Hosp 1, Dept Radiol, Luoyang 471003, Henan Province, Peoples R China; [Xi, Shoumin] Henan Univ Sci & Technol, Dept Pharmacol, Sch Med, Luoyang 471003, Henan Province, Peoples R China		Yang, B (corresponding author), Zhengzhou Univ, Hosp 1, Dept Neurosurg, Zhengzhou 450052, Henan Province, Peoples R China.	zgwnw11@126.com			Health Department of Henan Province, People's Republic of China [200702003, 2005018]	This research was supported by Henan Medical Science and Technology Research Projects of Health Department of Henan Province, People's Republic of China (No. 200702003); Henan Medical Technological Innovation Projects of Health Department of Henan Province, People's Republic of China (No. 2005018).	Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Brohlin M, 2009, NEUROSCI RES, V64, P41, DOI 10.1016/j.neures.2009.01.010; Chalmers J.J., 2007, MAGNETIC CELL SEPARA, P32; Chao YX, 2009, J NEUROIMMUNOL, V216, P39, DOI 10.1016/j.jneuroim.2009.09.003; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Daldrup-Link HE, 2005, RADIOLOGY, V234, P197, DOI 10.1148/radiol.2341031236; Fallahi-Sichani M, 2007, CELL BIOL INT, V31, P299, DOI 10.1016/j.cellbi.2006.11.011; Han K, 2008, CELL PROLIFERAT, V41, P709, DOI 10.1111/j.1365-2184.2008.00553.x; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Ishige I, 2009, INT J HEMATOL, V90, P261, DOI 10.1007/s12185-009-0377-3; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Khoo MLM, 2008, STEM CELLS DEV, V17, P883, DOI 10.1089/scd.2007.0185; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LI GX, 2006, ZHENGZHOU DAXUE XUEB, V412, P244; Lu FZ, 2005, J LAB CLIN MED, V146, P271, DOI 10.1016/j.lab.2005.07.003; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Marcus AJ, 2008, J CELL MOL MED, V12, P1256, DOI 10.1111/j.1582-4934.2008.00180.x; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Song SJ, 2007, STEM CELLS DEV, V16, P747, DOI 10.1089/scd.2007.0027; Wang Gong-ping, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P926; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205; Zhao P, 2005, TRANSPLANTATION, V79, P528, DOI 10.1097/01.TP.0000149503.92433.39	24	21	24	0	23	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	NOV	2011	357	1-2					331	341		10.1007/s11010-011-0904-4			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834EF	WOS:000295941500036	21625950				2022-02-06	
J	FitzGerald, DB; Crosson, BA				FitzGerald, David B.; Crosson, Bruce A.			Diffusion weighted imaging and neuropsychological correlates in adults with mild traumatic brain injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Diffusion tensor imaging; Mild traumatic brain injury; Neuropsychological testing; Neurophysiological testing	COMMON DATA ELEMENTS; WHITE-MATTER INJURY; AXONAL INJURY; ABNORMALITIES; DYSFUNCTION; INTEGRITY	Diffusion Tensor Imaging (DTI) is increasingly being used as a research tool in mild Traumatic Brain Injury (mTBI). This article reviews the concepts of diffusion tensor imaging, neuropsychological testing and results to date when applied to mTBI in adults. DTI is being used in conjunction with neuropsychological and electrophysiological measures to provide improved structural/functional correlations of mTBI. Future directions and applications of DTI in mTBI research are suggested. Published by Elsevier B.V.	[FitzGerald, David B.] N Florida S Georgia Vet Hlth Syst, Neurol Serv 127, Gainesville, FL 32608 USA; [FitzGerald, David B.; Crosson, Bruce A.] Brain Rehabil Res Ctr, Rehabil Res & Dev Serv RR&D, Off Res & Dev, Dept Vet Affairs, Gainesville, FL USA; [FitzGerald, David B.] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA; [Crosson, Bruce A.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA		FitzGerald, DB (corresponding author), N Florida S Georgia Vet Hlth Syst, Neurol Serv 127, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	dfitzger@massmed.org	Crosson, Bruce A/L-3128-2013		Veterans Health AdministrationUS Department of Veterans Affairs [B6698W, B6364S]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21-DC009247, R01-DC007387]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC007387, R21DC009247] Funding Source: NIH RePORTER	Dr. FitzGerald is sponsored by Veterans Health Administration RR&D Career Development award B6698W.; Dr. Crosson is sponsored by Veterans Health Administration RR&D grant B6364S and NIH grants R21-DC009247 and R01-DC007387.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; CDC, 2010, INJ PREV CONTR TRAUM; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones DK, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P37, DOI 10.1016/B978-0-12-374709-9.00003-1; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	41	21	23	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		79	85		10.1016/j.ijpsycho.2011.02.011			7	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600009	21338633				2022-02-06	
J	Irie, F; Le Brocque, R; Kenardy, J; Bellamy, N; Tetsworth, K; Pollard, C				Irie, Fumiko; Le Brocque, Robyne; Kenardy, Justin; Bellamy, Nicholas; Tetsworth, Kevin; Pollard, Cliff			Epidemiology of Traumatic Epidural Hematoma in Young Age	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Epidemiology; Traumatic epidural hematoma; Young age group	BRAIN-INJURY; EXTRADURAL HEMATOMAS; HEAD-INJURY; CHILDREN; MANAGEMENT; INTUBATION; CRANIECTOMY; EXPERIENCE; AUSTRALIA; INFANTS	Background: Epidural hematoma (EDH) is a major traumatic brain injury and a potentially life-threatening condition, with the mortality rate in the young age group varying across studies. The aim of this analysis was to investigate the magnitude of traumatic EDH in young patients aged 0 year to 24 years in Queensland, Australia. Methods: Study patients presented to the emergency department of 14 public hospitals participating in the Queensland Trauma Registry during 2005 to 2007 and were diagnosed and admitted for treatment of EDH. Age group comparisons were performed for demographic, injury, treatment, operation details, and outcome-related variables. Results: We identified 224 young patients with traumatic EDH. The most frequent cause of injury was a fall in the 0 year to 9 years age groups and road traffic crash in those aged 10 years to 24 years. Almost 81% of the EDH cases were due to accidental injury, 17% due to assault, with the remainder due to self-harm and undetermined intent. Skull fracture was present in 75% of the study patients. Neurosurgical operations were performed on 40%. The overall Injury Severity Score adjusted in-hospital mortality rate was 4.8%. The odds of in-hospital mortality was 2.5 (95% confidence interval, 0.8-8.2) compared with older patients (25-64 years). Conclusions: The results indicate that the Injury Severity Score adjusted in-hospital mortality rates for young patients with EDH were 4.8%. Given the limited information on morbidity resulting from EDH, further analysis to examine modifiable factors for better management and to evaluate survivor's long-term health outcomes via a longitudinal follow-up study is warranted.	[Irie, Fumiko; Le Brocque, Robyne; Bellamy, Nicholas; Tetsworth, Kevin; Pollard, Cliff] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med CONROD, Brisbane, Qld, Australia; [Tetsworth, Kevin; Pollard, Cliff] Royal Brisbane Womens Hosp, Brisbane, Qld, Australia		Irie, F (corresponding author), Univ Queensland, RBWH, Edith Cavell Bldg, Herston, Qld 4029, Australia.	f.irie@uq.edu.au	Tetsworth, Kevin/A-8005-2013; Kenardy, Justin/F-2085-2010; Le Brocque, Robyne/F-4848-2010; Kenardy, Justin A/H-6603-2014	Tetsworth, Kevin/0000-0002-3069-4141; Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450	Motor Accident Insurance Commission (MAIC); Queensland Health (QH); QTR; Trauma Registry Nurse Coordinators	We acknowledge the support and contributions of the Motor Accident Insurance Commission (MAIC), Queensland Health (QH), core QTR staff, and Trauma Registry Nurse Coordinators, and all the clinical, administrative, and managerial staff at each of the hospitals where the QTR is located.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Aitken L, 2006, QUEENSLAND TRAUMA RE; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Beni-Adani L, 1999, J TRAUMA, V46, P306, DOI 10.1097/00005373-199902000-00018; Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Browne GJ, 2002, PEDIATR EMERG CARE, V18, P86, DOI 10.1097/00006565-200204000-00006; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Dallow N, 2010, QUEENSLAND TRAUMA RE; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; De Souza M, 2007, J TRAUMA, V63, P370, DOI 10.1097/TA.0b013e318124a95b; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DOSSANTOS ALM, 1994, PEDIATR NEUROSURG, V21, P50; Ehrlich PF, 2004, J PEDIATR SURG, V39, P1376, DOI 10.1016/j.jpedsurg.2004.05.010; Finkelhor D, 2005, CHILD MALTREATMENT, V10, P5, DOI 10.1177/1077559504271287; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Glaeser P, 2000, JAMA-J AM MED ASSOC, V283, P797, DOI 10.1001/jama.283.6.797; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; HELFER RE, 1977, PEDIATRICS, V60, P533; Irie F, 2010, INJURY, V41, P964, DOI 10.1016/j.injury.2009.09.002; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lee ACW, 1997, J PAEDIATR CHILD H, V33, P446; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; Maggi G, 1998, J Neurosurg Sci, V42, P95; Marion DW, 2006, NEUROSURGERY, V58, P655; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; PASAOGLU A, 1990, ACTA NEUROCHIR, V106, P136, DOI 10.1007/BF01809456; PILLAY R, 1995, S AFR MED J, V85, P672; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shugerman RP, 1996, PEDIATRICS, V97, P664; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202	45	21	22	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					847	853		10.1097/TA.0b013e3182032c9a			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	833ZT	WOS:000295925700019	21336188				2022-02-06	
J	Ross, EH; Hoaken, PNS				Ross, Erin H.; Hoaken, Peter N. S.			Executive Cognitive Functioning Abilities of Male First Time and Return Canadian Federal Inmates	CANADIAN JOURNAL OF CRIMINOLOGY AND CRIMINAL JUSTICE			English	Article						executive cognitive functioning; adult male inmates; forensic rehabilitation; recidivism	FRONTAL-LOBE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; CORRECTIONAL TREATMENT; AGGRESSIVE-BEHAVIOR; NEUROPSYCHOLOGICAL FUNCTION; ANTISOCIAL-BEHAVIOR; PASSIVE-AVOIDANCE; VIOLENT BEHAVIOR; DECISION-MAKING; REHABILITATION	A primary goal of forensic rehabilitation programming for incarcerated offenders is to eliminate or, at the very least, decrease rates of recidivism. However, repeat offending continues to occur, and studies suggest that reductions in recidivism brought about by programs are modest. Indeed, a series of studies suggests decreases in recidivism ranging between only 7% and 14%. While several factors have been identified as potential contributors to criminal behaviour, one notion that has garnered much attention is that an individual may be predisposed to criminality if s/he has deficits in executive cognitive functioning. At this time, the link between executive functioning and antisocial behaviour is largely unquestioned. However, it remains uncertain whether executive deficits may be even more profound in offenders who have served multiple terms of imprisonment. Using a cross sectional design, 93 Canadian federal inmates, categorized as either first timers (n = 56) or return inmates (n = 37) were tested on a battery of executive cognitive-functioning measures. In keeping with our hypotheses, return inmates showed more severe and pervasive patterns of executive dysfunction. These results suggest that improved focus on ameliorating ECF deficits of offenders may further assist in decreasing recidivism.	[Ross, Erin H.; Hoaken, Peter N. S.] Univ Western Ontario, Dept Psychol, London, ON N6A 3K7, Canada		Ross, EH (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 3K7, Canada.						ANDREWS DA, 1990, CRIMINOLOGY, V28, P369, DOI 10.1111/j.1745-9125.1990.tb01330.x; Anstiss B, 2003, NEW ZEAL J PSYCHOL, V32, P84; Antonio R.Damasio, 1995, HDB MEMORY DISORDERS; Aos S., 2006, EVIDENCE BASED PUBLI; Bechara A, 1998, J NEUROSCI, V18, P428; Blud L, 2003, LEGAL CRIMINOL PSYCH, V8, P69, DOI 10.1348/135532503762871255; Broomhall L., 2005, PSYCHIAT PSYCHOL LAW, V12, P367, DOI DOI 10.1375/PPLT.12.2.367; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Chen CY, 2005, NEUROREPORT, V16, P1213, DOI 10.1097/00001756-200508010-00016; Chen M. Keith, 2007, AM LAW ECON REV, V9, P3, DOI DOI 10.1093/ALER/AHM006; Clarke R. V. G., 1993, ADV CRIMINOLOGICAL T; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Correctional Service Canada, 2004, PROGR DESCR REINT PR; Correctional Service Canada, 2007, AB IN; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dowden C, 2000, CAN J CRIMINOL, V42, P449, DOI 10.3138/cjcrim.42.4.449; Enns RA, 2006, J OFFENDER REHABIL, V44, P43, DOI 10.1300/J076v44n04_04; Fillmore MT, 2004, ADDICTION, V99, P1237, DOI 10.1111/j.1360-0443.2004.00805.x; Fishbein D, 2000, CRIM JUSTICE BEHAV, V27, P139, DOI 10.1177/0093854800027002001; Friendship C, 2003, LEGAL CRIMINOL PSYCH, V8, P103, DOI 10.1348/135532503762871273; Gendreau P., 1999, REPORT CORRECTIONS R; Giancola PR, 2006, J PSYCHOPATHOL BEHAV, V28, P211, DOI 10.1007/s10862-005-9015-4; Giancola PR, 1998, J ABNORM PSYCHOL, V107, P629, DOI 10.1037/0021-843X.107.4.629; Giancola PR, 2004, J ABNORM PSYCHOL, V113, P541, DOI 10.1037/0021-843X.113.4.541; GIANCOLA PR, 1994, J ABNORM PSYCHOL, V103, P832, DOI 10.1037/0021-843X.103.4.832; Grigsby J, 2002, NEUROEPIDEMIOLOGY, V21, P213, DOI 10.1159/000065638; Hawkins KA, 2000, AGGRESS VIOLENT BEH, V5, P147, DOI 10.1016/S1359-1789(98)00033-0; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1981, MANUAL WISCONSIN CAR; HEATON RK, 2005, WISCONSIN CARD SORTI; HELMERS KF, 1995, PERS INDIV DIFFER, V19, P927, DOI 10.1016/S0191-8869(95)00107-7; Hoaken PNS, 2007, AGGRESSIVE BEHAV, V33, P412, DOI 10.1002/ab.20194; Hollin CR, 2008, CRIM JUSTICE BEHAV, V35, P269, DOI 10.1177/0093854807312234; Ishikawa SS, 2001, J ABNORM PSYCHOL, V110, P423, DOI 10.1037/0021-843X.110.3.423; Jackson D. N., 2003, MULTIDIMENSIONAL APT; Kahokehr A, 2004, J GERIATR PSYCH NEUR, V17, P68, DOI 10.1177/0891988704264536; Kiehl KA, 2000, BIOL PSYCHIAT, V48, P210, DOI 10.1016/S0006-3223(00)00834-9; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koski L, 2001, NEUROPSYCHOLOGIA, V39, P268, DOI 10.1016/S0028-3932(00)00110-X; KRIESHOK TS, 1985, J COUNS DEV, V64, P87, DOI 10.1002/j.1556-6676.1985.tb01016.x; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lindman HR, 1974, ANAL VARIANCE COMPLE; Lipsey MW, 2007, ANNU REV LAW SOC SCI, V3, P297, DOI 10.1146/annurev.lawsocsci.3.081806.112833; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Marceau R, 2008, J OFFENDER REHABIL, V47, P41, DOI 10.1080/10509670801940409; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Mcguire, 2002, OFFENDER REHABILITAT; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Motiuk Larry, 1993, FORUM CORRECTIONAL R, V5; Nagin DS, 2004, J QUANT CRIMINOL, V20, P295, DOI 10.1007/s10940-004-5866-1; NEWMAN JP, 1990, PERS INDIV DIFFER, V11, P1101, DOI 10.1016/0191-8869(90)90021-I; Olvera RL, 2005, BIPOLAR DISORD, V7, P57, DOI 10.1111/j.1399-5618.2004.00167.x; Osterman Karin, 2006, CONT RES AGGRESSION; Paschall MJ, 2002, AGGRESS VIOLENT BEH, V7, P215, DOI 10.1016/S1359-1789(00)00044-6; PATTERSON CM, 1987, J PERS SOC PSYCHOL, V52, P565, DOI 10.1037/0022-3514.52.3.565; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; PETRIDES M, 1990, NEUROPSYCHOLOGIA, V28, P137, DOI 10.1016/0028-3932(90)90096-7; Phillips L.H., 2008, EXECUTIVE FUNCTION F; Proctor A, 2008, NEUROREHABILITATION, V23, P529; Raaijmakers MAJ, 2008, J ABNORM CHILD PSYCH, V36, P1097, DOI 10.1007/s10802-008-9235-7; Roberts AC, 1998, PREFRONTAL CORTEX EX; Romero J., 2003, PSYCHOL SPAIN, V7, P77; Ross EH, 2010, CRIM JUSTICE BEHAV, V37, P656, DOI 10.1177/0093854810363104; Royall DR, 2000, NEUROEPIDEMIOLOGY, V19, P293, DOI 10.1159/000026268; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Seguin JR, 2004, J ABNORM PSYCHOL, V113, P603, DOI 10.1037/0021-843X.113.4.603; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tong LSJ, 2008, PSICOTHEMA, V20, P20; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; UCHIYAMA CL, 1994, ARCH CLIN NEUROPSYCH, V9, P215, DOI 10.1016/0887-6177(94)90027-2; Valliant P. M, 2001, J OFFENDER REHABILIT, DOI [10.1300/J076v33n03_02, DOI 10.1300/J076V33N03_02]; Valliant PM, 2003, PSYCHOL REP, V92, P299, DOI 10.2466/PR0.92.1.299-306; VERNON PA, 1985, INTELLIGENCE, V9, P357, DOI 10.1016/0160-2896(85)90020-0; West R, 1999, J GERONTOL B-PSYCHOL, V54, pP34, DOI 10.1093/geronb/54B.1.P34; WILKINSON J, 2005, HOWARD J, V44, P70, DOI DOI 10.1111/J.1468-2311.2005.00356.X; Wilson S, 2003, LEGAL CRIMINOL PSYCH, V8, P83, DOI 10.1348/135532503762871264; Wood Jacqueline N, 2003, Behav Cogn Neurosci Rev, V2, P97; Wormith JS, 2007, CRIM JUSTICE BEHAV, V34, P879, DOI 10.1177/0093854807301552; Wykes T, 1999, SCHIZOPHRENIA BULL, V25, P291, DOI 10.1093/oxfordjournals.schbul.a033379; Yechiam E, 2008, PSYCHON B REV, V15, P44, DOI 10.3758/PBR.15.1.44; [No title captured]	88	21	21	0	21	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	1707-7753	1911-0219		CAN J CRIMINOL CRIM	Can. J. Criminol. Crim. Justice	OCT	2011	53	4					377	403		10.3138/cjccj.53.4.377			27	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	871ZM	WOS:000298776200001					2022-02-06	
J	Lancioni, GE; O'Reilly, MF; Singh, NN; Sigafoos, J; Buonocunto, F; Sacco, V; Colonna, F; Navarro, J; Lanzilotti, C; de Pace, C; Megna, M; Oliva, D				Lancioni, Giulio E.; O'Reilly, Mark F.; Singh, Nirbhay N.; Sigafoos, Jeff; Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa; de Pace, Claudia; Megna, Marisa; Oliva, Doretta			Communication opportunities via special messaging technology for two post-coma persons with multiple disabilities	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Messaging technology; Microswitches; Acquired brain injury; Emergence from minimally conscious state	TRAUMATIC BRAIN-INJURY; MINIMALLY CONSCIOUS STATE; ASSISTIVE TECHNOLOGY; REHABILITATION; PEOPLE; INDIVIDUALS; IMPAIRMENTS; MOTOR; EMERGENCE; RECOVERY	This study extended the assessment of a special messaging technology with two additional post-coma adults who had emerged from a minimally conscious state, but showed multiple disabilities including profound motor and communication impairments. For each participant, the study involved an ABAB design, in which the A represented baseline phases and the B represented intervention phases with the special messaging technology. The technology involved a net-book computer provided with specific software, a global system for mobile communication (GSM) modem, microswitches, and prerecorded verbal lists of persons' names and messages. Both participants learned to send out and receive (listen to) messages independently during the intervention, thus providing clear support for previous data in the area. They sent out means of about three and 17 messages and received means of about two and six messages per 20- and 30-min session, respectively. The positive impact of the technology was discussed in relation to previous data in this area and the possibility of helping post-coma persons with multiple disabilities engage in basic communication with distant partners. (C) 2011 Elsevier Ltd. All rights reserved.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Singh, Nirbhay N.] ONE Res Inst, Midlothian, VA USA; [Sigafoos, Jeff] Victoria Univ Wellington, Wellington, New Zealand; [Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa] S Raffaele Rehabil Ctr, Ceglie Messapica, Italy; [Oliva, Doretta] Lega F DOro Res Ctr, Osimo, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Megna, Marisa/ABE-8907-2020; Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Navarro solano, Jorge/0000-0003-1508-6727; Megna, Marisa/0000-0002-8486-103X; Lancioni, Giulio/0000-0002-6515-5690			Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Durando J, 2008, J VISUAL IMPAIR BLIN, V102, P40, DOI 10.1177/0145482X0810200105; Egan J, 2006, BRAIN INJURY, V20, P1283, DOI 10.1080/02699050601049692; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Greig CA, 2008, TOP STROKE REHABIL, V15, P307, DOI 10.1310/tsr1504-307; Hagen C, 1998, LEVELS COGNITIVE FUN; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Lancioni G, 2011, DEV NEUROREHABIL, V14, P8, DOI 10.3109/17518423.2010.519760; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Lancioni GE, 2010, BRAIN INJURY, V24, P1236, DOI 10.3109/02699052.2010.506857; Lancioni GE, 2010, RES DEV DISABIL, V31, P777, DOI 10.1016/j.ridd.2010.02.001; Lancioni GE, 2009, RES DEV DISABIL, V30, P1459, DOI 10.1016/j.ridd.2009.07.006; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sohlberg MM, 2003, BRAIN INJURY, V17, P609, DOI 10.1080/0269905031000070189; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Todis B, 2005, BRAIN INJURY, V19, P389, DOI 10.1080/02699050400003957; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105	32	21	21	2	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	SEP-OCT	2011	32	5					1703	1708		10.1016/j.ridd.2011.02.025			6	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	799UC	WOS:000293310600034	21440412				2022-02-06	
J	Lv, LQ; Hou, LJ; Yu, MK; Ding, XH; Qi, XQ; Lu, YC				Lv, Li-Quan; Hou, Li-Jun; Yu, Ming-Kun; Ding, Xue-Hua; Qi, Xiang-Qian; Lu, Yi-Cheng			Hyperbaric Oxygen Therapy in the Management of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury: A Report of 6 Cases	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Case report: Hyperbaric oxygen therapy; Paroxysmal sympathetic hyperactivity; Rehabilitation; Traumatic brain injuries	INTRACRANIAL-PRESSURE; DYSAUTONOMIA	Lv L-Q, Hou L-J, Yu M-K, Ding X-H, Qi X-Q, Lu Y-C. Hyperbaric oxygen therapy in the management of paroxysmal sympathetic hyperactivity after severe traumatic brain injury: a report of 6 cases. Arch Phys Med Rehabil 2011;92:1515-8. Paroxysmal sympathetic hyperactivity (PSH) after severe brain injury is detrimental to the recovery of patients. Pharmacologic management of PSH is difficult and efficacy is unpredictable or incomplete. This report presents 6 cases of PSH after extremely severe traumatic brain injury in which hyperbaric oxygen therapy (HBOT) controlled paroxysmal autonomic changes and posturing in the early subacute phase after limited success with conventional medication regimens. Thus, HBOT may present an option for the management of PSH in addition to pharmacologic therapy. Potential mechanisms for these effects are discussed.	[Lv, Li-Quan; Hou, Li-Jun; Yu, Ming-Kun; Ding, Xue-Hua; Qi, Xiang-Qian; Lu, Yi-Cheng] Second Mil Med Univ, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai Changzheng Hosp, Shanghai, Peoples R China		Hou, LJ (corresponding author), 415 Feng Yang Rd, Shanghai 200003, Peoples R China.	neuro_hlj@yahoo.com.cn			National Natural Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30600635]	Supported by the National Natural Foundation of China (grant no. 30600635).	ARTRU F, 1976, EUR NEUROL, V14, P310, DOI 10.1159/000114753; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Eschenfelder CC, 2008, CEREBROVASC DIS, V25, P193, DOI 10.1159/000113856; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; MILLER JD, 1971, ARCH NEUROL-CHICAGO, V24, P210, DOI 10.1001/archneur.1971.00480330038003; Ostrowski RP, 2006, ACTA NEUROCHIR SUPPL, V96, P188; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; SUKOFF MH, 1982, NEUROSURGERY, V10, P29, DOI 10.1227/00006123-198201000-00006; Voigt C, 2008, ACTA NEUROCHIR SUPPL, V102, P441, DOI 10.1007/978-3-211-85578-2_86; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	23	21	25	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2011	92	9					1515	1518		10.1016/j.apmr.2011.01.014			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	826YG	WOS:000295390900024	21620375				2022-02-06	
J	Bourdeaux, CP; Brown, JM				Bourdeaux, Chris P.; Brown, Jules M.			Randomized Controlled Trial Comparing the Effect of 8.4% Sodium Bicarbonate and 5% Sodium Chloride on Raised Intracranial Pressure after Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Brain edema; Intracranial hypertension; Sodium bicarbonate; Saline solution; Hypertonic; Acidosis	CEREBRAL EDEMA; INFUSION	Hypertonic sodium chloride solutions are routinely used to control raised intracranial pressure (ICP) after traumatic brain injury but have the potential to cause a hyperchloremic metabolic acidosis. Sodium bicarbonate 8.4% has previously been shown to reduce ICP and we have therefore conducted a randomized controlled trial to compare these two solutions. Patients with severe traumatic brain injury were randomly allocated to receive an equiosmolar dose of either 100 ml of sodium chloride 5% or 85 ml of sodium bicarbonate 8.4% for each episode of intracranial hypertension. ICP and blood pressure were measured continuously. Arterial pCO(2), sodium, chloride, osmolality, and pH were measured at intervals. We studied 20 episodes of intracranial hypertension in 11 patients. Treatments with 8.4% sodium bicarbonate and 5% sodium chloride reduced raised ICP effectively with a significant fall in ICP from baseline at all time points (P < 0.001). There was no significant difference in ICP with time between those episodes treated with 5% sodium chloride or 8.4% sodium bicarbonate, P = 0.504. Arterial pH was raised after treatment with 8.4% sodium bicarbonate. An equiosmolar infusion of 8.4% sodium bicarbonate is as effective as 5% sodium chloride for reduction of raised ICP after traumatic brain injury when infused over 30 min.	[Bourdeaux, Chris P.; Brown, Jules M.] Frenchay Hosp, Intens Care Unit, Bristol BS16 1LE, Avon, England		Brown, JM (corresponding author), Frenchay Hosp, Intens Care Unit, Frenchay Pk Rd, Bristol BS16 1LE, Avon, England.	jules.brown@nbt.nhs.uk			Frenchay Hospital	We are grateful to Paul White from the University of the West of England for his help with the statistical analysis. This study was supported by a small grant from the Frenchay Hospital anaesthetic department research fund.	Bourdeaux C, 2010, NEUROCRIT CARE, V13, P24, DOI 10.1007/s12028-010-9368-8; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; YOUNG RSK, 1984, ACTA NEUROPATHOL, V65, P124, DOI 10.1007/BF00690465	8	21	21	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2011	15	1					42	45		10.1007/s12028-011-9512-0			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	789XI	WOS:000292552100007	21298358				2022-02-06	
J	Merzagora, AC; Schultheis, MT; Onaral, B; Izzetoglu, M				Merzagora, Anna C.; Schultheis, Maria T.; Onaral, Banu; Izzetoglu, Meltem			FUNCTIONAL NEAR-INFRARED SPECTROSCOPY-BASED ASSESSMENT OF ATTENTION IMPAIRMENTS AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						fNIR; attention; traumatic brain injury; NIRS; TBI	POSITRON-EMISSION-TOMOGRAPHY; COGNITIVE-CONTROL; HEAD-INJURY; MEMORY; ACTIVATION; TIME; PET; REHABILITATION; AROUSAL	A frequent consequence of traumatic brain injury (TBI) is cognitive impairment, which results in significant disruption of an individual's everyday living. To date, most clinical rehabilitation interventions still rely on behavioral observation, with little or no quantitative information about physiological changes produced at the brain level. Functional brain imaging has been extensively used in the study of cognitive impairments following TBI. However, its applications to rehabilitation have been limited. This is due in part to the expensive or invasive nature of these modalities. The objective of this study is to apply functional near-infrared spectroscopy (fNIR) to the assessment of attention impairments following TBI. fNIR provides a localized measure of prefrontal hemodynamic activation, which is susceptible to TBI, and it does so in a noninvasive, affordable and wearable way, thus partially overcoming the limitations of other modalities. Participants included 5 TBI subjects and 11 healthy controls. Brain activation measurements were collected during a target categorization task. Significant differences were found in the hemodynamic response between healthy and TBI subjects. In particular, the elicited responses exhibited reduced amplitude in the TBI group. Overall, the results provide first evidence of the ability of fNIR to reveal differences between TBI and healthy subjects in an attention task. fNIR is therefore a promising neuroimaging technique in the field of neurorehabilitation. The use of fNIR in neurorehabilitation applications would benefit from its noninvasiveness and cost-effectiveness and the neurophysiological information obtained through the evaluation of the hemodynamic activation could provide invaluable information to guide the choice of intervention.	[Merzagora, Anna C.; Schultheis, Maria T.; Onaral, Banu; Izzetoglu, Meltem] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA		Merzagora, AC (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	a.merzagora@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Alloway K. D., 2007, MED NEUROSCIENCE; Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Butti Michele, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1944; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Conners C, 1999, ADHD ADULTS CHILDREN; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Harrison-Felix C., 1996, DESCRIPTIVE FINDINGS, P1; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Izzetoglu K., 2003, 36th Hawaii International Conference on Systems Sciences; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; Kennan RP, 2002, NEUROIMAGE, V16, P587, DOI 10.1006/nimg.2002.1060; Kim YH, 2004, YONSEI MED J, V45, P241, DOI 10.3349/ymj.2004.45.2.241; Kirkby BS, 1996, NEUROPSYCHOLOGIA, V34, P689; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pessoa L, 2003, J NEUROSCI, V23, P3990; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUFF RM, 1985, J CLIN EXP NEUROPSYC, V7, P645; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3	46	21	21	0	9	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	JUL	2011	4	3					251	260		10.1142/S1793545811001551			10	Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Optics; Radiology, Nuclear Medicine & Medical Imaging	V27YK	WOS:000208648300007					2022-02-06	
J	Piilgaard, H; Witgen, BM; Rasmussen, P; Lauritzen, M				Piilgaard, Henning; Witgen, Brent M.; Rasmussen, Peter; Lauritzen, Martin			Cyclosporine A, FK506, and NIM811 ameliorate prolonged CBF reduction and impaired neurovascular coupling after cortical spreading depression	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral blood flow; migraine; mitochondria; spreading depression; traumatic brain injury	MITOCHONDRIAL PERMEABILITY TRANSITION; NITRIC-OXIDE SYNTHASE; MIGRAINE AURA; REACTIVITY; DEPOLARIZATION; INHIBITION; HEMOGLOBIN; MECHANISMS; ISCHEMIA; PATHWAY	Cortical spreading depression (CSD) is associated with mitochondrial depolarization, increasing intracellular Ca2+, and the release of free fatty acids, which favor opening of the mitochondrial permeability transition pore (mPTP) and activation of calcineurin (CaN). Here, we test the hypothesis that cyclosporine A (CsA), which blocks both mPTP and CaN, ameliorates the persistent reduction of cerebral blood flow (CBF), impaired vascular reactivity, and a persistent rise in the cerebral metabolic rate of oxygen (CMRO2) following CSD. In addition to CsA, we used the specific mPTP blocker NIM811 and the specific CaN blocker FK506. Cortical spreading depression was induced in rat frontal cortex. Electrocortical activity was recorded by glass microelectrodes, CBF by laser Doppler flowmetry, and tissue oxygen tension with polarographic microelectrodes. Electrocortical activity, basal CBF, CMRO2, and neurovascular and neurometabolic coupling were unaffected by all three drugs under control conditions. NIM811 augmented the rise in CBF observed during CSD. Cyclosporine A and FK506 ameliorated the persistent decrease in CBF after CSD. All three drugs prevented disruption of neurovascular coupling after CSD; the rise in CMRO2 was unchanged. Our data suggest that blockade of mPTP formation and CaN activation may prevent persistent CBF reduction and vascular dysfunction after CSD. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1588-1598; doi: 10.1038/jcbfm.2011.28; published online 23 March 2011	[Lauritzen, Martin] Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark; [Piilgaard, Henning; Witgen, Brent M.; Rasmussen, Peter; Lauritzen, Martin] Univ Copenhagen, Panum Inst, Ctr Hlth Aging, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark		Lauritzen, M (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark.	marlau03@glo.regionh.dk	Ernst-Rasmussen, Peter Bonde/B-8203-2013	Ernst-Rasmussen, Peter Bonde/0000-0003-1761-4562; Lauritzen, Martin/0000-0002-1517-1131	Lundbeck Foundation via the Lundbeck Foundation Centre for Neurovascular Signalling (LU-CENS); NOVO Nordisk FoundationNovo Nordisk FoundationNovocure Limited; Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); NORDEA foundation for Center for Healthy Aging; Foundation LeducqLeducq Foundation	This study was supported by the Lundbeck Foundation via the Lundbeck Foundation Centre for Neurovascular Signalling (LU-CENS), the NOVO Nordisk Foundation, the Danish Medical Research Council, the NORDEA foundation for Center for Healthy Aging, and Foundation Leducq.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Busija DW, 2008, PROG NEUROBIOL, V86, P379, DOI 10.1016/j.pneurobio.2008.09.008; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Enager P, 2009, J CEREBR BLOOD F MET, V29, P976, DOI 10.1038/jcbfm.2009.23; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23, DOI 10.1152/ajpheart.1995.269.1.H23; FLORENCE G, 1994, AM J PHYSIOL, V266, pR1136, DOI 10.1152/ajpregu.1994.266.4.R1136; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Gabbott PLA, 1997, BRAIN RES, V747, P352, DOI 10.1016/S0006-8993(96)01376-5; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Hazelton JL, 2009, J NEUROSCI RES, V87, P1250, DOI 10.1002/jnr.21921; Hoffmeyer HW, 2007, J CEREBR BLOOD F MET, V27, P575, DOI 10.1038/sj.jcbfm.9600372; Kruger H, 1996, NEUROREPORT, V7, P2733; LACOMBE P, 1992, EXP NEUROL, V117, P278, DOI 10.1016/0014-4886(92)90137-F; LAURITZEN M, 1990, J CEREBR BLOOD F MET, V10, P115, DOI 10.1038/jcbfm.1990.14; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Ruiz F, 2000, EUR J PHARMACOL, V404, P29, DOI 10.1016/S0014-2999(00)00584-7; Scheckenbach KEL, 2006, EXP NEUROL, V202, P449, DOI 10.1016/j.expneurol.2006.07.007; Seitz I, 2004, J CEREBR BLOOD F MET, V24, P526, DOI 10.1097/00004647-200405000-00006; Sierra-Paredes G, 2008, CNS NEUROSCI THER, V14, P36, DOI 10.1111/j.1527-3458.2008.00036.x; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sukhotinsky I, 2010, J CEREBR BLOOD F MET, V30, P1168, DOI 10.1038/jcbfm.2009.285; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	40	21	21	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2011	31	7					1588	1598		10.1038/jcbfm.2011.28			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	786FD	WOS:000292287800011	21427730	Green Published, Bronze			2022-02-06	
J	Smith, AM; Stuart, MJ; Greenwald, RM; Benson, BW; Dodick, DW; Emery, CA; Finnoff, JT; Mihalik, JP; Roberts, WO; Sullivan, CA; Meeuwisse, WH				Smith, Aynsley M.; Stuart, Michael J.; Greenwald, Richard M.; Benson, Brian W.; Dodick, David W.; Emery, Carolyn A.; Finnoff, Jonathan T.; Mihalik, Jason P.; Roberts, William O.; Sullivan, Carol-Anne; Meeuwisse, Willem H.			Proceedings From the Ice Hockey Summit on Concussion: A Call to Action	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; hockey	SPORTS-RELATED CONCUSSION; NEURON-SPECIFIC ENOLASE; RETURN-TO-PLAY; HIGH-SCHOOL; INJURY PREVENTION; BODY-CHECKING; HEAD-INJURIES; RECURRENT CONCUSSION; RULE INFRACTIONS; NORTH-AMERICAN	Objective: The objective of this proceeding is to integrate the concussion in sport literature and sport science research on safety in ice hockey to develop an action plan to reduce the risk, incidence, severity, and consequences of concussion in ice hockey. Methods: A rationale paper outlining a collaborative action plan to address concussions in hockey was posted for review two months prior to the Ice Hockey Summit: Action on Concussion. Focused presentations devoted specifically to concussion in ice hockey were presented during the Summit and breakout sessions were used to develop strategies to reduce concussion in the sport. This proceedings and a detailed scientific review (a matrix of solutions) were written to disseminate the evidence-based information and resulting concussion reduction strategies. The manuscripts were reviewed by the authors, advisors and contributors to ensure that the opinions and recommendations reflect the current level of knowledge on concussion in hockey. Results: Six components of a potential solution were articulated in the Rationale paper and became the topics for breakout groups that followed the professional, scientific lectures. Topics that formed the core of the action plan were: metrics and databases; recognizing, managing, and return to play; hockey equipment and ice arenas; prevention and education; rules and regulations; and expedient communication of the outcomes. The attendees in breakout sessions identified action items for each section. The most highly ranked action items were brought to a vote in the open assembly, using an Audience Response System (ARS). The strategic planning process was conducted to assess: Where are we at?; Where must we get to?; and What strategies are necessary to make progress on the prioritized action items? Conclusions: Three prioritized action items for each component of the solution and the percentage of the votes received are listed in the body of this proceeding.	[Smith, Aynsley M.; Stuart, Michael J.; Finnoff, Jonathan T.] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA; [Greenwald, Richard M.] SIMBEX, LCC, Lebanon, NH USA; [Benson, Brian W.; Emery, Carolyn A.; Meeuwisse, Willem H.] Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; [Dodick, David W.] Mayo Clin, Coll Med, Scottsdale, AZ USA; [Mihalik, Jason P.] Univ N Carolina, Chapel Hill, NC USA; [Roberts, William O.] Univ Minnesota, St Paul, MN 55108 USA; [Sullivan, Carol-Anne] Ontario Neurotrauma Fdn, Toronto, ON, Canada		Smith, AM (corresponding author), Mayo Clin, Ctr Sports Med, 200 1st St SW, Rochester, MN 55905 USA.	smith.aynsley@mayo.edu	Wiese-Bjornstal, Diane M./L-1408-2019; Emery, Carolyn/AAI-2761-2020	Wiese-Bjornstal, Diane M./0000-0003-4824-3311; Roberts, William O/0000-0003-4517-4330; Mihalik, Jason/0000-0001-6085-8322	Team Wendy; Johannson-Gund Endowment; Hockey Equipment Certification Council; International Ice Hockey Federation; Ontario Neurotrauma Foundation; USA Hockey	Partially support by the Team Wendy and the Johannson-Gund Endowment.; Joint sponsors are the Hockey Equipment Certification Council, International Ice Hockey Federation, Ontario Neurotrauma Foundation, and USA Hockey.	Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], FACTS PREV TIPS; [Anonymous], 2009, BRIT J SPORT MED, V43, pi85; ASHARE A, 2009, SAFETY ICE HOCKEY, V5; ASHARE AB, 2000, SAFETY ICE HOCKEY, V3; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BAZARIAN J, BLOOD TEST BRAIN INJ; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernard D, 2004, AM SOC TEST MATER, V1446, P152, DOI 10.1520/STP11616S; Bernstein R., 2006, CODE UNWRITTEN RULES; BISHOP PJ, 2009, J ASTM INT, V6, P5; BISHOP PJ, 2009, J ASTM INT, V6, P4; Bloom GA, 2004, AM SOC TEST MATER, V1446, P12, DOI 10.1520/STP11605S; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CASTALDI CR, 1993, SAFETY ICE HOCKEY, V2; CASTALDI CR, 1989, SAFETY ICE HOCKEY, V1; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Ciavarro C, 2008, COMPUT HUM BEHAV, V24, P2862, DOI 10.1016/j.chb.2008.04.011; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Coulson NR, 2009, AM SOC TEST MATER, V1516, P141, DOI 10.1520/JAI101890; Crawford BJ, 2004, AM SOC TEST MATER, V1446, P26, DOI 10.1520/STP11606S; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; CUSIMANO M, 2002, CAN J NEUROL SCI, V29, pS23; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; Dorsch KD, 2007, PSYCHOL SPORT EXERC, V8, P585, DOI 10.1016/j.psychsport.2006.06.003; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; FAUGHT BE, 2009, J ASTM INT, V6; Ferrara Michael S., 2001, J Athl Train, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fraser K, 2010, FINAL CALL; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Gilbert WD, 2000, AM SOC TEST MATER, V1341, P291, DOI 10.1520/STP15246S; Gioia G., 2008, BRAIN INJURY PROFESS, V4, P14; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gladwell M., 2000, TIPPING POINT LITTLE; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; GOODMAN D, 2004, STP, V1446, P11; Gordon KE, 2010, CLIN J SPORT MED, V20, P405, DOI 10.1097/JSM.0b013e318202de6b; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead PD, 2000, AM SOC TEST MATER, V1341, P93, DOI 10.1520/STP15230S; *INJ PREV CONTR TR, HEADS CONC YOUTH SPO; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; LaPrade RF, 2000, AM SOC TEST MATER, V1341, P124, DOI 10.1520/STP15234S; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; LINK A, 2008, ROCHESTER YOUTH  JAN; LINK A, 2007, HOCKEY ED PROGRA NOV; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; MARCOTTE G, 1993, STP, V1212, P100; Mariconda J, 2004, AM SOC TEST MATER, V1446, P135, DOI 10.1520/STP11614S; Matheson GO, 2010, CLIN J SPORT MED, V20, P399, DOI 10.1097/JSM.0b013e318203114c; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCPHERSON MN, 2009, J ASTM INT, V28, P6; *MEDSC, ERR IS HUM BUILD SAF; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; *MN HOCK HEP, 2010, HOCK ED PROGR; Montelpare W, 2010, INT J SPORTS SCI COA, V5, P61; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; MUELLER F, 2002, 19 ANN REPORT NATL C; PEARSALL DJ, 2004, SAFETY ICE HOCKEY, V4; Pocket SCAT2, 2009, BR J SPORTS MED, V43, pi89; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Roberts WO, 2010, CLIN J SPORT MED, V20, P318, DOI 10.1097/JSM.0b013e3181e6301d; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Rousseau P, 2008, J ASTM INT, V6, P152; RUDOLPH M, 1989, STP, V1050, P35; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; SCAPINELLO R, 2006, LINES NOT SO TALL TA; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Smith AM, 2000, AM SOC TEST MATER, V1341, P199, DOI 10.1520/STP15240S; Smith AM., 2009, J ASTM INT, V6, P1; SMITH AM, 1999, POWER PLAY MENTAL TO; SMITH AM, ZERO TOLERANCE CONCU; SMITH MD, 1975, CAN REV SOC ANTHROP, V12, P72; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; STJOHN A, ANATOMY NASCAR CRASH; Stuart MJ, 2009, CLIN J SPORT MED, V19, P494, DOI 10.1097/JSM.0b013e3181c0aaa4; Stuart MJ, 2004, AM SOC TEST MATER, V1446, P52, DOI 10.1520/STP11608S; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; STUART MJ, 2008, J ASTM INT, V5, P10; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2000, AM SOC TEST MATER, V1341, P150, DOI 10.1520/STP15236S; Tegner Y, 2000, AM SOC TEST MATER, V1341, P165, DOI 10.1520/STP15237S; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Visek A, 2005, SPORT PSYCHOL, V19, P178, DOI 10.1123/tsp.19.2.178; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Watson RC, 1996, CLIN J SPORT MED, V6, P108, DOI 10.1097/00042752-199604000-00008; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; WILLIAMSON IJS, 2009, J ASTM INT, V6, P3; HEADS HOCKEY	136	21	21	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2011	21	4					281	287		10.1097/JSM.0b013e318225bc15			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	786DY	WOS:000292284700001	21847809				2022-02-06	
J	Feng, JF; Van, KC; Gurkoff, GG; Kopriva, C; Olszewski, RT; Song, M; Sun, SF; Xue, M; Neale, JH; Yuen, PW; Lowe, DA; Zhou, J; Lyeth, BG				Feng, Jun-Feng; Van, Ken C.; Gurkoff, Gene G.; Kopriva, Christina; Olszewski, Rafal T.; Song, Minsoo; Sun, Shifeng; Xue, Man; Neale, Joseph H.; Yuen, Po-Wai; Lowe, David A.; Zhou, Jia; Lyeth, Bruce G.			Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Glutamate; N-acetylaspartylglutamate (NAAG); Hippocampus; Morris water maze	LATERAL FLUID-PERCUSSION; TRAUMATIC BRAIN-INJURY; METABOTROPIC GLUTAMATE RECEPTORS; ACUTE NEURONAL DEGENERATION; N-ACETYLASPARTYLGLUTAMATE; NAALADASE INHIBITION; BEHAVIORAL DEFICITS; FLUORO-JADE; RAT; RELEASE	Traumatic brain injury (TBI) leads to a rapid and excessive increase in glutamate concentration in the extracellular milieu, which is strongly associated with excitotoxicity and neuronal degeneration. N-acetylaspartylglutamate (NAAG), a prevalent peptide neurotransmitter in the vertebrate nervous system, is released along with glutamate and suppresses glutamate release by actions at pre-synaptic metabotropic glutamate autoreceptors. Extracellular NAAG is hydrolyzed to N-acetylaspartate and glutamate by peptidase activity. In the present study PGI-02776, a newly designed di-ester prodrug of the urea-based NAAG peptidase inhibitor ZJ-43, was tested for neuroprotective potential when administered intraperitoneally 30 min after lateral fluid percussion TBI in the rat. Stereological quantification of hippocampal CA2-3 degenerating neurons at 24 h post injury revealed that 10 mg/kg PGI-02776 significantly decreased the number of degenerating neurons (p<0.05). Both average latency analysis of Morris water maze performance and assessment of 24-hour memory retention revealed significant differences between sham-TBI and TBI-saline. In contrast, no significant difference was found between sham-TBI and PGI-02776 treated groups in either analysis indicating an improvement in cognitive performance with PGI-02776 treatment. Histological analysis on day 16 post-injury revealed significant cell death in injured animals regardless of treatment. In vitro NAAG peptidase inhibition studies demonstrated that the parent compound (ZJ-43) exhibited potent inhibitory activity while the mono-ester (PGI-02749) and di-ester (PGI-02776) prodrug compounds exhibited moderate and weak levels of inhibitory activity, respectively. Pharmacokinetic assays in uninjured animals found that the di-ester (PGI-02776) crossed the blood-brain barrier. PGI-02776 was also readily hydrolyzed to both the mono-ester (PGI-02749) and the parent compound (ZJ-43) in both blood and brain. Overall, these findings suggest that post-injury treatment with the ZJ-43 prodrug PGI-02776 reduces both acute neuronal pathology and longer term cognitive deficits associated with TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Feng, Jun-Feng; Van, Ken C.; Gurkoff, Gene G.; Kopriva, Christina; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Olszewski, Rafal T.; Neale, Joseph H.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Song, Minsoo; Yuen, Po-Wai; Lowe, David A.; Zhou, Jia] PsychoGenics Inc, Tarrytown, NY 10591 USA; [Sun, Shifeng; Xue, Man] Pharmaron Inc, Irvine, CA 92618 USA; [Feng, Jun-Feng] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200027, Peoples R China		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	 [NIHNS61352];  [NIHNS38080];  [NIHNS29995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, R01NS038080, R43NS061352] Funding Source: NIH RePORTER	This research was supported by NIHNS61352 (JZ), NIHNS38080 (JHN) and NIHNS29995 (BGL).	BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Bzdega T, 1997, J NEUROCHEM, V69, P2270; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU; Ghadge GD, 2003, P NATL ACAD SCI USA, V100, P9554, DOI 10.1073/pnas.1530168100; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P699, DOI 10.1002/hipo.20429; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Luthi-Carter R, 1998, P NATL ACAD SCI USA, V95, P3215, DOI 10.1073/pnas.95.6.3215; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schweitzer C, 2000, NEUROPHARMACOLOGY, V39, P1700, DOI 10.1016/S0028-3908(99)00265-8; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Wroblewska B, 2006, J NEUROCHEM, V96, P1071, DOI 10.1111/j.1471-4159.2005.03569.x; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhang W, 2006, J NEUROL SCI, V247, P217, DOI 10.1016/j.jns.2006.05.052; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	43	21	22	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 13	2011	1395						62	73		10.1016/j.brainres.2011.04.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	788DQ	WOS:000292426000008	21565332	Green Accepted			2022-02-06	
J	Galton, C; Deem, S; Yanez, ND; Souter, M; Chesnut, R; Dagal, A; Treggiari, M				Galton, Christopher; Deem, Steven; Yanez, N. David; Souter, Michael; Chesnut, Randall; Dagal, Armagan; Treggiari, Miriam			Open-Label Randomized Trial of the Safety and Efficacy of a Single Dose Conivaptan to Raise Serum Sodium in Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Conivaptan; Hyponatremia; Intracranial pressure; Sodium; Arginine vasopressin; Vasopressin-receptor antagonists; Human; Clinical trial	ARGININE-VASOPRESSIN V-1; RECEPTOR ANTAGONIST; HYPONATREMIA; EXPRESSION; EDEMA	Background Conivaptan is an arginine-vasopressin-receptor antagonist approved for the treatment of hyponatremia. We hypothesized that administration of conivaptan to normonatremic patients with traumatic brain injury (TBI) is safe and could reduce intracranial pressure (ICP). Methods Open-label, randomized, controlled trial enrolling 10 subjects within 24 h of severe TBI to receive a single 20 mg dose of conivaptan (n = 5) or usual care (n = 5). The primary endpoint was the evaluation of the safety profile defined by serum sodium increases averaging > 1 mEq/h when measured every 4 h and any adverse events. Secondary endpoints were 48-h serum sodium, sodium load, change in ICP, and urine output. Results Ten patients were included in the intention-to-treat analysis. Three patients (2 conivaptan, 1 usual care group) experienced brief sodium increases averaging > 1 mEq/h, with no patients achieving Na > 160 mEq/l. There were no drug-related serious adverse events. At 48 h, the mean sodium was 142 +/- A 6 mEq/l (conivaptan) and 144 +/- A 10 mEq/l (usual care, P = 0.71). 48-h sodium load was 819 +/- A 724 mEq in the conivaptan and 1,137 +/- A 1,165 mEq in the usual care group (P = 0.62). At 4 h, serum sodium was higher (P = 0.02) and ICP was lower (P = 0.046) in the conivaptan compared with usual care group. 24-h but not 48-h urine output was different between the two groups (P < 0.01 and P = 0.20, respectively). Conclusions These data suggest that a single dose conivaptan is safe in non-hyponatremic patients with severe TBI and may reduce ICP. Further studies are needed to establish the effect of conivaptan on clinically relevant endpoints, and its role in the management of intracranial hypertension.	[Treggiari, Miriam] Univ Washington, Sch Med, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; [Galton, Christopher] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Deem, Steven; Souter, Michael; Dagal, Armagan; Treggiari, Miriam] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Yanez, N. David] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Souter, Michael; Chesnut, Randall; Treggiari, Miriam] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Treggiari, Miriam] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA		Treggiari, M (corresponding author), Univ Washington, Sch Med, Harborview Med Ctr, Dept Anesthesiol, Box 359724,325 9th Ave, Seattle, WA 98104 USA.	treggmm@uw.edu	Souter, Michael/ABE-1890-2020	Chesnut, Randall/0000-0001-6377-3666	AstellasAstellas Pharmaceuticals	Financial support for this investigator initiated study was provided by Astellas. The sponsor had no role in the design, interpretation, and reporting of the study findings.	ADLER S, 1995, BRAIN RES, V679, P135, DOI 10.1016/0006-8993(95)00245-L; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Dhar R, 2011, NEUROCRIT CARE, V14, P97, DOI 10.1007/s12028-010-9366-x; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Kozniewska E, 2008, J PHYSIOL PHARMACOL, V59, P109; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; LLUCH S, 1984, J PHARMACOL EXP THER, V228, P749; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Naidech AM, 2010, NEUROCRIT CARE, V13, P57, DOI 10.1007/s12028-010-9379-5; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; SUZUKI Y, 1994, J AUTONOM NERV SYST, V49, pS129; SUZUKI Y, 1992, J NEUROSURG, V77, P424, DOI 10.3171/jns.1992.77.3.0424; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; TSUGANE S, 1994, LIFE SCI, V54, pPL241, DOI 10.1016/0024-3205(94)00424-2; Wright WL, 2009, NEUROCRIT CARE, V11, P6, DOI 10.1007/s12028-008-9152-1	17	21	21	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2011	14	3					354	360		10.1007/s12028-011-9525-8			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	759FT	WOS:000290226800005	21409494				2022-02-06	
J	Dardier, V; Bernicot, J; Delanoe, A; Vanberten, M; Fayada, C; Chevignard, M; Delaye, C; Laurent-Vannier, A; Dubois, B				Dardier, Virginie; Bernicot, Josie; Delanoe, Anaig; Vanberten, Melanie; Fayada, Catherine; Chevignard, Mathilde; Delaye, Corinne; Laurent-Vannier, Anne; Dubois, Bruno			Severe traumatic brain injury, frontal lesions, and social aspects of language use: A study of French-speaking adults	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Severe traumatic brain injury; Frontal lesion; Pragmatics; Metapragmatics; Language production; Language comprehension; Requests; Communication	CLOSED-HEAD-INJURY; EXECUTIVE DYSFUNCTION; DAMAGED PATIENTS; VERBAL FLUENCY; YOUNG-CHILDREN; MIND; ABILITY; IMPAIRMENT; DISCOURSE; REQUESTS	The purpose of this study was to gain insight into the social (pragmatic) aspects of language use by French-speaking individuals with frontal lesions following a severe traumatic brain injury. Eleven participants with traumatic brain injury performed tasks in three areas of communication: production (interview situation), comprehension (direct requests, conventional indirect requests, and hints), and metapragmatic knowledge. The results of the patients pointed out some strengths (turn-taking in production, and request comprehension, including hints and the speaker's intention) and some weaknesses (topic maintenance in production and metapragmatic knowledge). The patients' good comprehension of requests and their difficulty expressing metapragmatic knowledge suggest that they differ from controls in how they "explain the world": their knowledge of the event sequence was not based on verbally expressible knowledge about the relationship between the structural characteristics of a request utterance and those of its social production context. The pragmatic skills of persons with traumatic brain injury seem to vary across tasks: these individuals have specific strengths and weaknesses in different domains. In addition, marked interindividual differences were noted among the patients: three of them had only one weak point, topic maintenance. These interindividual differences were not systematically linked to performance on executive function tests, but lesion unilaterality (right or left) seems to help preserve patients' pragmatic and metapragmatic skills. The discussion stresses the need to take each patient's strengths and weaknesses into account in designing remediation programs. Learning outcomes: As a result of this activity, the reader will be able to explain the social/pragmatic aspects of language in typical and atypical participants with TBI. As a result of this activity, the reader will be able to identify social/pragmatic weaknesses and strengths. (C) 2011 Elsevier Inc. All rights reserved.	[Bernicot, Josie] Univ Poitiers, CNRS, Ctr Rech Apprentissage & Cognit, CeRCA MSHS, F-86000 Poitiers, France; [Dardier, Virginie; Delanoe, Anaig] Univ Europeenne Bretagne Rennes 2, Ctr Rech Psychol Cognit & Commun EA 1285, F-35043 Rennes, France; [Vanberten, Melanie] Ctr Med & Peciagog Rennes Beaulieu, F-35700 Rennes, France; [Fayada, Catherine; Dubois, Bruno] Groupement hosp Univ Est Federat Maladies Syst Ne, Hop La Pitie Salpetriere, F-75651 Paris, France; [Chevignard, Mathilde; Delaye, Corinne; Laurent-Vannier, Anne] Hop Natl St Maurice, Serv Reeducat Pathol Neurol Acquises, F-94415 St Maurice, France		Bernicot, J (corresponding author), Univ Poitiers, CNRS, Ctr Rech Apprentissage & Cognit, CeRCA MSHS, Betiment A5-5,Rue Theodore Lefebvre, F-86000 Poitiers, France.	virginie.dardier@uhb.fr; josie.bernicot@univ-poitiers.fr; melanie.vanberten@laposte.net; catherine.fayada@psl.ap-hop-paris.fr; m.chevignard@hopital-saint-maurice.fr; c.delaye@hopital-saint-maurice.fr; a.laurentvannier@hopital-saint-maurice.fr; b.dubois@psl.aphp.fr					ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Austin JL., 1962, DO THINGS WORDS, V2; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bechara A, 1999, J NEUROSCI, V19, P5473; BERNICOT J, 1987, CAH PSYCHOL COGN, V7, P267; Bernicot J, 2001, INT J LANG COMM DIS, V36, P245; BERNICOT J, 1991, INT J BEHAV DEV, V14, P285, DOI 10.1177/016502549101400303; BERNICOT J, 1994, EUR J PSYCHOL EDUC, V9, P311, DOI 10.1007/BF03172904; BERNICOT J, 2001, PSYCHOL INTERACTION, V13, P139; Bernicot J, 2007, J PRAGMATICS, V39, P2115, DOI 10.1016/j.pragma.2007.05.009; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BRADY M, 2006, J NEUROLINGUIST, V19, P39; BROOKS DN, 1984, CLOSED HEAD INJURY P; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Champagne M, 2003, BRAIN COGNITION, V53, P152, DOI 10.1016/S0278-2626(03)00099-X; Champagne M, 2004, BRAIN LANG, V91, P172, DOI 10.1016/j.bandl.2004.06.089; Champagne M, 2002, BRAIN LANG, V83, P214; Champagne-Lavau M, 2010, J NEUROLINGUIST, V23, P285, DOI 10.1016/j.jneuroling.2009.08.009; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Chantraine Y, 1998, J NEUROLINGUIST, V11, P21, DOI 10.1016/S0911-6044(98)00003-7; CHAPMAN SB, 1999, BRAIN DAM B, P235; CLYNE M, 1998, CONCISE ENCY PRAGMAT; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cutica I, 2006, BRAIN LANG, V98, P12, DOI 10.1016/j.bandl.2006.01.001; Deloche G, 1997, TEST DENOMINATION OR; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); FOLDI NS, 1987, BRAIN LANG, V31, P88, DOI 10.1016/0093-934X(87)90062-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLEASON JB, 2001, DEV LANGUAGE; Grice H. P., 1975, SYNTAX SEMANTICS, P41; HALLIDAY MAK, 1975, SHORT INTRO FUNCTION; HARDEN WD, 1995, J COMMUN DISORD, V28, P247, DOI 10.1016/0021-9924(94)00012-O; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Joanette Y, 2004, PROTOCOLE MONTREAL E; Joanette Y., 1990, RIGHT HEMISPHERE VER; KACZMAREK BLJ, 1984, BRAIN LANG, V21, P52, DOI 10.1016/0093-934X(84)90035-X; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Landry SH, 2004, DEV NEUROPSYCHOL, V26, P707, DOI 10.1207/s15326942dn2603_4; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Mazaux J.-M., 1981, ECHELLE EVALUATION A; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S., 2002, AWARENESS SOCIAL INF; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; MULLER F, 2009, CORTEX, P1; Myers P.S., 1999, RIGHT HEMISPHERE DAM; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Noveck IA, 2004, PALG STUD PRAGM LANG, P1, DOI 10.1057/9780230524125; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Penn C, 1999, BRAIN LANG, V68, P535, DOI 10.1006/brln.1999.2127; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; Penn C, 2010, APHASIOLOGY, V24, P288, DOI 10.1080/02687030902958399; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prutting C., 1983, PRAGMATIC ASSESSMENT, P29; Reilly J, 2005, PERSPECTIVES ON LANGUAGE AND LANGUAGE DEVELOPMENT, P303, DOI 10.1007/1-4020-7911-7_22; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Searle J. R., 1969, SPEECH ACTS ESSAY PH; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; STEMMER B, 1994, BRAIN LANG, V47, P1, DOI 10.1006/brln.1994.1040; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Turkstra LS, 2001, J COMMUN DISORD, V34, P151, DOI 10.1016/S0021-9924(00)00046-0; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; van Daal J, 2004, J SPEECH LANG HEAR R, V47, P1411, DOI 10.1044/1092-4388(2004/105); Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Verschueren Jef., 1999, UNDERSTANDING PRAGMA; WEYLMAN ST, 1989, BRAIN LANG, V36, P580, DOI 10.1016/0093-934X(89)90087-4; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; [No title captured]	99	21	22	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAY-JUN	2011	44	3					359	378		10.1016/j.jcomdis.2011.02.001			20	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	770KV	WOS:000291086300008	21458824				2022-02-06	
J	Apori, AA; Herr, AE				Apori, Akwasi A.; Herr, Amy E.			Homogeneous Immunosubtraction Integrated with Sample Preparation Enabled by a Microfluidic Format	ANALYTICAL CHEMISTRY			English	Article							CEREBROSPINAL-FLUID; CAPILLARY-ELECTROPHORESIS; POLYACRYLAMIDE-GELS; PROTEIN-LEVELS; S100 PROTEIN; SERUM; S-100; IMMUNOASSAYS; DISEASE; INJURY	Immunosubtraction is a powerful and resource-intensive laboratory medicine assay that reports both protein mobility and binding specificity. To expedite and automate this electrophoretic assay, we report on advances to the electrophoretic immunosubtraction assay by introducing a homogeneous, not heterogeneous, format with integrated sample preparation. To accomplish homogeneous immunosubtraction, a step-decrease in separation matrix pore-size at the head of a polyacrylamide gel electrophoresis (PAGE) separation channel enables "subtraction" of target analyte when capture antibody is present (as the large immune-complex is excluded from PAGE), but no subtraction when capture antibody is absent. Inclusion of sample preparation functionality via small pore size polyacrylamide membranes is also key to automated operation (i.e., sample enrichment, fluorescence sample labeling, and mixing of sample with free capture antibody). Homogeneous sample preparation and assay operation allows on-the-fly, integrated subtraction of one to multiple protein targets and reuse of each device. Optimization of the assay is detailed which allowed for similar to 95% subtraction of target with 20% non-specific extraction of large species at the optimal antibody antigen ratio, providing conditions needed for selective target identification. We demonstrate the assay on putative markers of injury and inflammation in cerebrospinal fluid (CSF), an emerging area of diagnostics research, by rapidly reporting protein mobility and binding specificity within the sample matrix. We simultaneously detect S100B and C-reactive protein, suspected biomarkers for traumatic brain injury (TBI), in similar to 2 min. Lastly, we demonstrate S100B detection (65 nM) in raw human CSF with an estimated lower limit of detection of 3.25 nM, within the clinically relevant concentration range for detecting TBI in CSF. Beyond the novel CSF assay introduced here, a fully automated immunosubtraction assay would impact a spectrum of routine but labor and time-intensive laboratory medicine assays.	[Apori, Akwasi A.; Herr, Amy E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA		Herr, AE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aeh@berkeley.edu		Herr, Amy/0000-0002-6906-2985	Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-1-2118]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2OD007294]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD007294] Funding Source: NIH RePORTER	This material is based upon work supported by the Defense Advanced Research Projects Agency (DARPA) under Award N66001-09-1-2118 and the National Institutes of Health through the NIH Director's New Innovator Award Program (AEH, 1DP2OD007294). A.A.A. is a National Defense Science and Engineering Graduate (NDSEG) Fellow and UNCF/Merck Fellow. A.E.H. is an Alfred P. Sloan Foundation Research Fellow in chemistry.	AGUZZI F, 1977, B I SIEROTER MILAN, V56, P212; Beyor N, 2009, ANAL CHEM, V81, P3523, DOI 10.1021/ac900060r; Bienvenu J, 1998, CLIN CHEM, V44, P599; Bossuyt X, 1998, CLIN CHEM, V44, P760; CATON JE, 1973, ABSTR PAP AM CHEM S, P31; Clark R, 1998, ELECTROPHORESIS, V19, P2479, DOI 10.1002/elps.1150191421; CZERNICKI Z, 2009, BRAIN EDEMA, V14, P247; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Hatch AV, 2006, ANAL CHEM, V78, P4976, DOI 10.1021/ac0600454; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Herr AE, 2005, ANAL CHEM, V77, P585, DOI 10.1021/ac0489768; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Hickman JL, 2004, CUR CLIN NEUROL, P571; Hou CL, 2010, ANAL CHEM, V82, P3343, DOI 10.1021/ac100182j; Hutchison CA, 2009, NAT REV NEPHROL, V5, P621, DOI 10.1038/nrneph.2009.151; Infante JR, 2000, TUMOR BIOL, V21, P38, DOI 10.1159/000030109; Irani D.N, 2009, CEREBROSPINAL FLUID; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Keren DF, 1999, ARCH PATHOL LAB MED, V123, P126; Keren DF, 2003, PROTEIN ELECTROPHORE; Kunihara T, 2001, J THORAC CARDIOV SUR, V122, P1019, DOI 10.1067/mtc.2001.115151; Marshall T, 1999, ELECTROPHORESIS, V20, P1307, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1307::AID-ELPS1307>3.3.CO;2-G; Mussack T, 2006, CLIN BIOCHEM, V39, P349, DOI 10.1016/j.clinbiochem.2005.12.007; NEILSEN PK, 2007, NURSING CARE PEDIAT; Nygaard O, 1997, CLIN CHEM, V43, P541; Otto M, 1997, J NEUROL, V244, P566, DOI 10.1007/s004150050145; PALFREY SM, 1999, CLIN APPL CAPILLARY, P39; Paquette DM, 2001, ELECTROPHORESIS, V22, P2391, DOI 10.1002/1522-2683(200107)22:12<2391::AID-ELPS2391>3.0.CO;2-B; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Sun XH, 2008, ANAL CHEM, V80, P5126, DOI 10.1021/ac800322f; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Tsakadze NL, 1998, J NEUROCHEM, V71, pS72; Woodward S, 2002, Br J Nurs, V11, P47; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	36	21	21	1	23	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700			ANAL CHEM	Anal. Chem.	APR 1	2011	83	7					2691	2698		10.1021/ac103219x			8	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	741TM	WOS:000288887700041	21375345	Green Accepted			2022-02-06	
J	Griffin, GD				Griffin, Gerald Dieter			The Injured Brain: TBI, mTBI, the Immune System, and Infection: Connecting the Dots	MILITARY MEDICINE			English	Article							BACTERIAL TRANSLOCATION; BARRIER; STROKE; PERMEABILITY; ACTIVATION	Traumatic brain injury or stroke causes profound suppression of the cellular immune system and short- and long-term psychological sequelae. Infection is also a common result and is likely caused by bacterial translocation from the gut. Both the bacterial translocation from the gut and the ensuing pneumonia and sepsis are ameliorated by adoptive immune therapy. Huge health care costs are incurred by brain trauma and its sequelae in our soldiers, athletes, and general population. Diffusion tensor imaging and adoptive immune therapy should become standards of care to follow the injured brain serially as it heals and as the immune suppression and infections are overcome. Brain infrastructure healing is retarded by a suppressed immune system, and the blood brain barrier's response to trauma offers opportunity for adoptive immune therapy to enhance microglial-directed neuronal repair and maintenance.	BiobancUSA, Monterey, CA 93940 USA		Griffin, GD (corresponding author), BiobancUSA, 5 Lower Ragsdale,Suite 100, Monterey, CA 93940 USA.		Griffin, Gerald Dieter/R-7186-2019				Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; BRATHWAITE CEM, 1993, J TRAUMA, V34, P586, DOI 10.1097/00005373-199304000-00017; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; GAUTREAUX MD, 1994, INFECT IMMUN, V62, P2874, DOI 10.1128/IAI.62.7.2874-2884.1994; GAUTREAUX MD, 1995, INFECT IMMUN, V63, P3827, DOI 10.1128/IAI.63.10.3827-3834.1995; Hartl R, 1997, ACT NEUR S, V70, P240; Huber JD, 2006, AM J PHYSIOL-HEART C, V290, pH732, DOI 10.1152/ajpheart.00747.2005; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; MacFie J, 2004, BRIT MED BULL, V71, P1, DOI 10.1093/bmb/ldh029; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; Oztuna V, 2004, J ORTHOP TRAUMA, V18, P92; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; TANIELIAN T, 2008, MG7201CCF RAND CORP; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Tuosto L, 1994, EUR J IMMUNOL, V24, P1061, DOI 10.1002/eji.1830240508; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Wilckens T, 1997, IMMUNOL TODAY, V18, P418, DOI 10.1016/S0167-5699(97)01111-0; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706	26	21	23	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2011	176	4					364	368		10.7205/MILMED-D-10-00021			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825BO	WOS:000295246100004	21539156	Bronze			2022-02-06	
J	Guillamondegui, OD; Richards, JE; Ely, EW; Jackson, JC; Archer-Swygert, K; Norris, PR; Obremskey, WT				Guillamondegui, Oscar D.; Richards, Justin E.; Ely, E. Wesley; Jackson, James C.; Archer-Swygert, Kristin; Norris, Patrick R.; Obremskey, William T.			Does Hypoxia Affect Intensive Care Unit Delirium or Long-Term Cognitive Impairment After Multiple Trauma Without Intracranial Hemorrhage?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-25, 2010	Boston, MA	Amer Assoc Surg Trauma (AAST)		Hypoxia; Delirium; Cognitive impairment; Traumatic brain injury	BRAIN-INJURY; RISK-FACTORS; SURVIVORS; OUTCOMES; DECLINE	Background: Within the traumatic brain injury population, outcomes are affected by hypoxic events in the early injury period. Previous work shows a high prevalence of cognitive deficits in patients with multiple injuries who do not have intracranial hemorrhage identified on admission head computed tomography scan. We hypothesize that intensive care unit (ICU) delirium and long-term cognitive impairment (LTCI) are more likely in patients who have a hypoxic event within the first 48 hours of ICU admission. Methods: A total of 173 patients with multiple injuries (Injury Severity Score [ISS] > 15) who presented to a Level I trauma center from July 2006 to July 2007 were enrolled in a study on long-term cognitive deficit. Ninety-seven patients required ICU management and all had continuous oxygen saturation data collected. The Confusion Assessment Method for the ICU was collected twice a day on all patients in ICU. Of the total enrolled population, 108 (62%) were evaluated 12 months after discharge by neuropsychological tests. Cognitive impairment was defined as having 2 neuropsychological test scores, 1.5 standard deviations below the mean or 1 neuropsychological test score, and 2 standard deviations below the mean. Demographic data, ISS, initial 24-hour blood requirements, presence of hypoxia (SpO(2) <90% and <85%) or hypotension (systolic blood pressure <90 mm Hg), emergency department (ED) pulse, Glasgow Coma Scale score, ventilator and ICU days were recorded. Significant univariate identification of clinical variables was used for multivariate analysis. Results: Fifty-five of 97 ICU patients (57%) were Confusion Assessment Method-ICU positive for delirium and 59 of 108 (55%) demonstrated cognitive impairment at 12-month follow-up. There was no significant association between hypoxia and ICU delirium (74.5% vs. 74%; p = 0.9) or LTCI (89% vs. 83%; p = 0.5). Ventilator days (8.7 +/- 8.9 vs. 2.9 +/- 4.6; p < 0.0001), ED pulse (109 +/- 28.5 vs. 94 +/- 22.8; p = 0.01), and blood transfusions (10 U +/- 10.8 U vs. 5 U +/- 5.3 U; p = 0.015) were significant independent predictors of delirium. Ventilator days (odds ratio, 1.16; 95% confidence interval, 1.05-1.29; p = 0.004) and ED pulse (odds ratio, 1.02; 95% confidence interval, 1.00-1.04; p = 0.03) remained significant predictors of ICU delirium after adjusting for ISS, hypoxic state, blood transfusions, and ED blood pressure. Among ED Glasgow Coma Scale score (10.5 +/- 5.1 vs. 11.4 +/- 5.5; p = 0.7), ISS (33.3 +/- 10.1 vs. 32.2 +/- 9.0; p = 0.5), ventilator days (6.5 +/- 7.5 vs. 6.2 +/- 8.8; p = 0.4), blood transfusions (8.1 +/- 6.8 vs. 9.4 +/- 8.1; p = 0.4), and delirium (62% vs. 62.5%; p = 0.9), there were no significant univariate associations with LTCI. Conclusions: Hypoxic events in the ICU do not have a direct correlation with ICU delirium or LTCI in the patients with multiple injuries without evidence of intracranial hemorrhage.	[Guillamondegui, Oscar D.; Norris, Patrick R.] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Richards, Justin E.; Archer-Swygert, Kristin; Obremskey, William T.] Vanderbilt Univ, Med Ctr, Div Orthopaed Trauma, Dept Orthopaed & Rehabil, Nashville, TN USA; [Ely, E. Wesley; Jackson, James C.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care Med, Nashville, TN USA; [Guillamondegui, Oscar D.] Tennessee Valley Healthcare Syst Nashville VA, Nashville, TN USA		Guillamondegui, OD (corresponding author), 1211 21st Ave S,404 Med Arts Bldg, Nashville, TN 37212 USA.	oscar.guillamondegui@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Angles EM, 2008, AM J SURG, V196, P864, DOI 10.1016/j.amjsurg.2008.07.037; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Control NCfIPa, 2003, REP C MILD TRAUM BRA; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2004, INTENS CARE MED, V30, P2009, DOI 10.1007/s00134-004-2422-2; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Norris PR, 2010, J HEALTHC ENG, V1, P315, DOI 10.1260/2040-2295.1.3.315; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	21	21	25	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2011	70	4					910	913		10.1097/TA.0b013e3182114f18			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	750OV	WOS:000289558700031	21610396				2022-02-06	
J	Ramanathan, DM; Wardecker, BM; Slocomb, JE; Hillary, FG				Ramanathan, Deepa M.; Wardecker, Britney M.; Slocomb, Julia E.; Hillary, Frank G.			Dispositional optimism and outcome following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; dispositional optimism; psychological distress; cognitive ability; functional outcome	QUALITY-OF-LIFE; GLASGOW COMA SCALE; ARTERY BYPASS-SURGERY; HEAD-INJURY; COPING STRATEGIES; SOCIAL SUPPORT; SEVERITY; VARIABLES; RECOVERY; MODERATE	Objective: Despite vast literature examining the predictors of patient outcome following traumatic brain injury (TBI), the complicated relationship between personality and psychological, cognitive and functional outcomes remains poorly understood. The present study examined the relationship between the personality trait of dispositional optimism (DO) and outcome after moderate and severe TBI in the context of a proposed theoretical model. Methods: Forty-five individuals who had sustained moderate-to-severe TBI were recruited through mailings and completed the Symptom Checklist Questionnaire-90 Revised (SCL-90-R), the Telephone Interview for Cognitive Status (TICS), the Craig Handicap Assessment Reporting Technique (CHART) and the Life Orientation Test-Revised (LOT-R). Analyses were conducted to test a model predicting the relationship between personality and patient outcome after TBI. Results: DO was significantly correlated with psychological distress, but did not predict functional outcome. In addition, two significant mediating relationships were demonstrated: (1) psychological distress was shown to mediate the relationship between dispositional optimism and cognitive ability and (2) cognitive ability mediated the relationship between psychological distress and functional outcome. Conclusion: These findings illustrate that higher levels of DO in individuals sustaining moderate-to-severe TBI are related to better psychological functioning which in turn predicts improved cognitive and functional outcomes.	[Ramanathan, Deepa M.; Wardecker, Britney M.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Slocomb, Julia E.; Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Ramanathan, DM (corresponding author), Penn State Univ, Dept Psychol, 610 Moore Bldg, University Pk, PA 16802 USA.	deepar@psu.edu	Hillary, Frank/AAN-8622-2021	Ramanathan-Elion, Deepa/0000-0001-7723-7346; Wardecker, Britney/0000-0003-2168-538X			AFFLECK G, 2001, OPTIMISM PESSIMISM I; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; CARVER CS, 1987, COGNITIVE THER RES, V11, P449, DOI 10.1007/BF01175355; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CURBOW B, 1993, J BEHAV MED, V16, P423, DOI 10.1007/BF00844815; Dancy BL, 2004, NURS OUTLOOK, V52, P234, DOI 10.1016/j.outlook.2004.04.012; DEROGATIS LR, 1977, SCL 90 ADM ACORING P; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; ELSADR W, 1992, JAMA-J AM MED ASSOC, V267, P954, DOI 10.1001/jama.267.7.954; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FITZGERALD TE, 1993, J BEHAV MED, V16, P25, DOI 10.1007/BF00844753; Fleming J, 1999, BRAIN INJURY, V13, P417; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GIBB MA, 2004, THESIS RAND AFRIKAAN; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KAMENSIEGEL L, 1991, HEALTH PSYCHOL, V10, P229, DOI 10.1037/0278-6133.10.4.229; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MARSHALL GN, 1992, J PERS SOC PSYCHOL, V62, P1067, DOI 10.1037/0022-3514.62.6.1067; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; ODDY M, 1984, CLOSED HEAD INJURY; Pais-Ribeiro J, 2007, EPILEPSY BEHAV, V11, P33, DOI 10.1016/j.yebeh.2007.04.010; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Riskind J. H., 1996, J COGNITIVE PSYCHOTH, V10, P105; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schou I, 2005, PSYCHO-ONCOLOGY, V14, P718, DOI 10.1002/pon.896; Schweizer K, 1999, PSYCHOL REP, V84, P627, DOI 10.2466/PR0.84.2.627-636; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; Seligman MEP., 1975, HELPLESSNESS DEPRESS; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; TAYLOR SE, 1992, J PERS SOC PSYCHOL, V63, P460, DOI 10.1037/0022-3514.63.3.460; Taylor SE, 1991, HLTH PSYCHOL; TENNEN H, 1992, CAN J BEHAV SCI, V24, P186, DOI 10.1037/h0078709; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vogenthaler D R, 1987, Brain Inj, V1, P113; Whiteneck GG, 1992, GUIDE USE CHART CRAI; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	65	21	21	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2011	25	4					328	337		10.3109/02699052.2011.554336			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600002	21314277				2022-02-06	
J	Strong, CAH; Tiesma, D; Donders, J				Strong, Carrie-Ann H.; Tiesma, David; Donders, Jacobus			Criterion Validity of the Delis-Kaplan Executive Function System (D-KEFS) Fluency Subtests After Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychological assessment; Executive functioning; Verbal fluency; Design fluency; Classification accuracy; Clinical utility	CARD SORTING TEST; FRONTAL-LOBE LESIONS; TEST-PERFORMANCE; DESIGN FLUENCY; OLDER-ADULTS; PREDICTION; IMPAIRMENTS; DYSFUNCTION; DISEASE; MEMORY	The performance of 65 patients with complicated mild severe traumatic brain injury was evaluated on the Verbal and Design Fluency subtests of the Delis-Kaplan Executive Function System (D-KEFS), and compared with that of 65 demographically matched healthy controls. There were statistically significant group differences on Letter Fluency and Category Switching but not on any of the Design Fluency tasks. Combined, these two Verbal Fluency subtests had a classification accuracy of 65.39%, associated with a likelihood ratio of 1.87. The impact of length of coma on Letter Fluency performance but not Category Switching was mediated at least in part by processing speed. The findings suggest modest criterion validity of some of the D KEFS Verbal Fluency subtests in the assessment of patients with complicated mild severe traumatic brain injury. (JINS, 2011, 17, 230-237)	[Strong, Carrie-Ann H.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [Tiesma, David] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson P., 2008, EXECUTIVE FUNCTIONS; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; DELIS DC, 2001, DELISKAPLAN EXECUTIV; DOWNES JJ, 1993, BRAIN, V116, P887, DOI 10.1093/brain/116.4.887; Green P., 2003, GREENS WORD MEMORY T; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Houston WS, 2005, J INT NEUROPSYCH SOC, V11, P863, DOI 10.1017/S1355617705051015; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JUDY PA, 2010, J INT NEUROPSYCH SOC, V16, P640; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kramer JH, 2007, J INT NEUROPSYCH SOC, V13, P386, DOI 10.1017/S1355617707070567; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; MCDONALD S, 2008, EXECUTIVE FUNCTIONS; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Nemoto T, 2005, BEHAV NEUROL, V16, P217, DOI 10.1155/2005/386932; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Reitan R.M., 1993, HALSTEADREITAN NEURO; Ruff RM, 1988, RUFF FIGURAL FLUENCY; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Strong CAH, 2008, J CLIN EXP NEUROPSYC, V30, P885, DOI 10.1080/13803390701858224; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 1988, CONTINUOUS VISUAL ME; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205	45	21	22	1	23	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2011	17	2					230	237		10.1017/S1355617710001451			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	738DY	WOS:000288620900003	21122190				2022-02-06	
J	Ueno, T; Ohori, Y; Ito, J; Hoshikawa, S; Yamamoto, S; Nakamura, K; Tanaka, S; Akai, M; Tobimatsu, Y; Ogata, T				Ueno, T.; Ohori, Y.; Ito, J.; Hoshikawa, S.; Yamamoto, S.; Nakamura, K.; Tanaka, S.; Akai, M.; Tobimatsu, Y.; Ogata, T.			Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury	SPINAL CORD			English	Article						biomarker; pNF-H; minocycline; spinal cord injury	TRAUMATIC BRAIN-INJURY; SERUM BIOMARKER; DEATH; RECOVERY; ENOLASE; BLOOD; MODEL; RATS	Study design: An in vivo study in a rat model of acute spinal cord contusion. Objectives: To assess the efficacy of novel therapies for acute spinal cord injury (SCI), methods to evaluate accurately the effects of these therapies should be developed. Although neurological examination is commonly used for this purpose, unstable clinical conditions and the spontaneous recovery of neurological function in the acute and subacute phases after injury make this measurement unreliable. Recent studies have reported that the phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H), a new biomarker for axonal degeneration, can be measured in serum samples in experimental SCI animals. Therefore, we aimed to investigate the use of plasma pNF-H as an indicator of the efficacy of minocycline, a neuroprotective drug, for treating SCI. Setting: This study was carried out at Saitama, Japan. Methods: Spinal cord injured rats received either minocycline or saline intraperitoneally. The plasma pNF-H levels and functional hind limb score were determined after the injury. Results: Minocycline treatment reduced plasma pNF-H levels at 3 and 4 days post-injury (dpi). Rats with lower plasma pNF-H levels at 3 dpi had higher hind limb motor score at 28 dpi. Conclusions: pNF-H levels may serve as a biomarker for evaluating the efficacy of therapies for SCI. Spinal Cord (2011) 49, 333-336; doi:10.1038/sc.2010.116; published online 31 August 2010	[Ueno, T.; Ohori, Y.; Ito, J.; Hoshikawa, S.; Yamamoto, S.; Ogata, T.] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Ueno, T.; Ohori, Y.; Ito, J.; Nakamura, K.; Tanaka, S.] Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Akai, M.; Tobimatsu, Y.] Natl Rehabil Ctr Persons Disabil, Rehabil Hosp, Tokorozawa, Saitama, Japan		Ogata, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, 4-1 Namiki, Tokorozawa, Saitama, Japan.	ogata-toru@rehab.go.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414			BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Marquardt G, 2009, ACTA NEUROCHIR, V151, P1439, DOI 10.1007/s00701-009-0408-0; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	16	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAR	2011	49	3					333	336		10.1038/sc.2010.116			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	730ZH	WOS:000288075600004	20805831	Bronze			2022-02-06	
J	Wang, YB; Liu, J; Yang, ZX				Wang, Yan-Bin; Liu, Jing; Yang, Zhao-Xu			Effects of intestinal mucosal blood flow and motility on intestinal mucosa	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article						Traumatic brain injury; Intestinal mucosa barrier; Stress; Intestinal mucosa blood flow; Intestinal motility	EXPERIMENTAL ACUTE-PANCREATITIS; BARRIER FUNCTION; TRAUMA PATIENTS; RATS; PERMEABILITY; STRESS; INJURY; RESTRAINT; INHIBITION; ACTIVATION	AIM: To investigate the role of intestinal nnucosal blood flow (IMBF) and motility in the damage of intestinal mucosal barrier in rats with traumatic brain injury. METHODS: Sixty-four healthy male Wistar rats were divided randomly into two groups: traumatic brain injury (TBI) group (n = 32), rats with traumatic brain injury; and control group (n = 32), rats with sham-operation. Each group was divided into four subgroups (n = 8) as 6, 12, 24 and 48 h after operation. Intestinal motility was measured by the propulsion ratio of a semi-solid colored marker (carbon-ink). IMBF was measured with the laser-Doppler technique. Endotoxin and D-xylose levels in plasma were measured to evaluate the change of intestinal mucosal barrier function following TBI. RESULTS: The level of endotoxin was significantly higher in TBI group than in the control group at each time point (0.382 +/- 0.014 EU/mL vs 0.102 +/- 0.007 EU/mL, 0.466 +/- 0.018 EU/mL vs 0.114 +/- 0.021 EU/mL, 0.478 +/- 0.029 EU/mL vs 0.112 +/- 0.018 EU/mL and 0.412 +/- 0.036 EU/mL vs 0.108 +/- 0.011 EU/mL, P < 0.05). D-xylose concentrations in plasma in TBI group were significantly higher than in the control group (6.68 +/- 2.37 mmol/L vs 3.66 +/- 1.07 mmol/L, 8.51 +/- 2.69 mmol /L vs 3.15 +/- 0.95 mmol/L, 11.68 +/- 3.24 mmol/L vs 3.78 +/- 1.12 mmol/L and 10.23 +/- 2.83 mmol/L vs 3.34 +/- 1.23 mmol/ L, P < 0.05). The IMBF in TBI group was significantly lower than that in the control group (38.5 +/- 2.8 PU vs 45.6 +/- 4.6 PU, 25.2 +/- 3.1 PU vs 48.2 +/- 5.3 PU, 21.5 +/- 2.7 PU vs 44.9 +/- 2.8 PU, 29. 4 +/- 3.8 PU vs 46.7 +/- 3.2 PU) (P < 0.05). Significant decelerations of intestinal propulsion ratio in TBI groups were found compared with the control group (0.48% +/- 0.06% VS 0.62% +/- 0.03%, 0.37% +/- 0.05% VS 0.64% +/- 0.01%, 0.39% +/- 0.07% VS 0.63% +/- 0.05% and 0.46% +/- 0.03% VS 0.65% +/- 0.02%) (P < 0.05). CONCLUSION: The intestinal mucosal permeability is increased obviously in TBI rats. Decrease of intestinal motility and IMBF occur early in TBI, both are important pathogenic factors for stress-related damage of the intestinal mucosal barrier in TBI. (C) 2011 Baishideng. All rights reserved.	[Liu, Jing] Beijing Dianli Hosp, Dept Neurol, Beijing 100073, Peoples R China; [Wang, Yan-Bin; Yang, Zhao-Xu] Capital Med Univ, Dept Gastroenterol, Beijing Tiantan Hosp, Beijing 100050, Peoples R China		Liu, J (corresponding author), Beijing Dianli Hosp, Dept Neurol, Beijing 100073, Peoples R China.	maogou0806@sina.com					Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; Ballabeni V, 2002, LIFE SCI, V71, P2025, DOI 10.1016/S0024-3205(02)01966-5; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P336, DOI 10.1590/S0102-86502005000400013; CHEN CL, 2008, DISAN JUNYI DAXUE XU, V30, P1434; Dervenis Christos, 2003, J Hepatobiliary Pancreat Surg, V10, P415, DOI 10.1007/s00534-002-0727-5; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Farhadi A, 2007, WORLD J GASTROENTERO, V13, P3027, DOI 10.3748/wjg.v13.i22.3027; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; GANGAROSA EJ, 1977, POSTGRAD MED, V62, P113, DOI 10.1080/00325481.1977.11714583; Kawano S, 2000, J GASTROEN HEPATOL, V15, pD1; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; Leveau P, 1996, INT J PANCREATOL, V20, P119; Li S, 2008, WORLD J GASTROENTERO, V14, P3254, DOI 10.3748/wjg.14.3254; Liu ZH, 2009, WORLD J GASTROENTERO, V15, P5732, DOI 10.3748/wjg.15.5732; MacFie J, 2000, NUTRITION, V16, P606, DOI 10.1016/S0899-9007(00)00249-5; Ogawa M, 1998, PANCREAS, V16, P312, DOI 10.1097/00006676-199804000-00017; RAYBOULD HE, 1988, AM J PHYSIOL, V255, pG242, DOI 10.1152/ajpgi.1988.255.2.G242; Schwarz M, 2000, SURGERY, V127, P427, DOI 10.1067/msy.2000.104116; Shi HL, 2003, ZHONGGUO XINGWEI YIX, V12, P251; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Sun YJ, 2008, WORLD J GASTROENTERO, V14, P5868, DOI 10.3748/wjg.14.5868; Tominaga G, 1998, J TRAUMA, V44, P1035; Tsukada F, 2002, BIOL PHARM BULL, V25, P122, DOI 10.1248/bpb.25.122; Tsukada F, 2001, BIOL PHARM BULL, V24, P488, DOI 10.1248/bpb.24.488; Tsukada F, 2001, BIOL PHARM BULL, V24, P1332, DOI 10.1248/bpb.24.1332; WANG YB, 2007, ZHONGHUA XIAOHUA ZAZ, V27, P103, DOI DOI 10.3760/J.ISSN:0254-1432.2007.02.008; WANG YB, 2007, ZHONGGUO SHIYAN DONG, V15, P220; Wang ZT, 2004, WORLD J GASTROENTERO, V10, P1619, DOI 10.3748/wjg.v10.i11.1619; WANG ZJ, 1985, GASTROINTESTINAL HOR, P2; XU XZ, 2000, ZHONGGUO WEIZHONGBIN, V6, P362	31	21	26	0	4	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	FEB 7	2011	17	5					657	661		10.3748/wjg.v17.i5.657			5	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	725EJ	WOS:000287627700015	21350716	Green Published, hybrid			2022-02-06	
J	Nelson, NG; McKenzie, LB				Nelson, Nicolas G.; McKenzie, Lara B.			Mountain Biking-Related Injuries Treated in Emergency Departments in the United States, 1994-2007	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						National Electronic Injury Surveillance System; injury; mountain bike; outdoor; emergency department	RACING INJURIES; BIKERS	Background: Injury research on mountain biking has been mostly limited to examining professional riders and off-road biking. Mountain bikes represent the largest segment of bike sales in the United States. Recreational mountain bike use is popular and understudied. Purpose: To describe the scope, distribution, and trends of mountain bike-related injuries treated in US emergency departments. Study Design: Descriptive epidemiologic study. Methods: A retrospective analysis was conducted with data from the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission for patients aged >= 8 years from 1994 through 2007. Sample weights provided by the system were used to calculate national estimates of mountain bike-related injuries based on 4624 cases. Bivariate comparisons between categorical variables were assessed with injury proportion ratios and 95% confidence intervals. Results: Nationwide, an estimated 217 433 patients were treated for mountain bike-related injuries in US emergency departments from 1994 to 2007, an average of 15 531 injuries per year. The annual number of injuries decreased 56%, from a high of 23 177 in 1995 to 10 267 in 2007 (P<.001). The most common injuries were upper extremity fractures (10.6%) and shoulder fractures (8.3%). Patients aged 14 to 19 years sustained a greater proportion of traumatic brain injuries (8.4%) than did patients aged 8 to 13 years and >= 20 years combined (4.3%). A greater proportion of female riders (6.1%) than male riders (4.5%) were hospitalized. Conclusion: Mountain bike-related injuries decreased from 1994 to 2007. Upper extremity fractures were the most common injury. Girls and women may be more likely than boys and men to sustain more severe injuries requiring hospitalization. Despite the decline over the past decade, more can be done to improve safety and reduce injuries in this popular recreational activity.	[McKenzie, Lara B.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Lara.McKenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			*AM SPORTS DAT INC, 2008, 2008 SUP SPORTS PART, V3; *AM SPORTS DAT INC, 2008, 2008 SUP SPORTS PART; Apsingi S, 2006, AM J SPORT MED, V34, P487, DOI 10.1177/0363546505279917; Carmont MR, 2008, BRIT MED BULL, V85, P101, DOI 10.1093/bmb/ldn009; CHOW TK, 1993, WESTERN J MED, V159, P145; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Frauscher F, 2001, RADIOLOGY, V219, P427, DOI 10.1148/radiology.219.2.r01ma42427; Gassner R, 1999, INT J ORAL MAX SURG, V28, P188; Gassner RJ, 1999, J TRAUMA, V47, P50, DOI 10.1097/00005373-199907000-00011; Gaulrapp H, 2001, KNEE SURG SPORT TR A, V9, P48, DOI 10.1007/s001670000145; *INT OL COMM, 2000, GAMES 38 OL MOUNT BI; Jeys LM, 2001, BRIT J SPORT MED, V35, P197, DOI 10.1136/bjsm.35.3.197; Kroneke EL, 2008, CLIN J SPORT MED, V18, P38, DOI 10.1097/JSM.0b013e318160c044; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Kronisch RL, 1996, AM J SPORT MED, V24, P88, DOI 10.1177/036354659602400116; Kronisch RL, 2002, CLIN J SPORT MED, V12, P158, DOI 10.1097/00042752-200205000-00003; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Mitterberger M, 2008, CLIN J SPORT MED, V18, P49, DOI 10.1097/JSM.0b013e31815c042f; Muller KE, 2008, DENT TRAUMATOL, V24, P522, DOI 10.1111/j.1600-9657.2008.00660.x; *NAT BIK DEAL ASS, 2008 NBDA STATP LOOK; Nehoda H, 2001, INJURY, V32, P285, DOI 10.1016/S0020-1383(00)00193-5; PFEIFFER RP, 1995, SPORTS MED, V19, P311, DOI 10.2165/00007256-199519050-00002; PFEIFFER RP, 1994, CLIN SPORT MED, V13, P207; Rajapaske BN, 1996, NEW ZEAL MED J, V109, P147; Rivara FP, 1997, J FAM PRACTICE, V44, P481; Schroeder T., 2001, NEISS SAMPLE DESIGN; U. S. Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; *US BUR CENS, INT EST US POP AG SE; *US BUR CENS, NAT POP EST 2000S; *US CYCL, MOUNT BIK; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	32	21	21	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	FEB	2011	39	2					404	409		10.1177/0363546510383478			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	717EI	WOS:000287025700027	21076012				2022-02-06	
J	Rosa, CM; Luigi, B; Antonio, D; Nicoletta, A; Gloria, L; Marco, G				Rosa, Calvi Maria; Luigi, Beretta; Antonio, Dell'Acqua; Nicoletta, Anzalone; Gloria, Licini; Marco, Gemma			Early Prognosis After Severe Traumatic Brain Injury With Minor or Absent Computed Tomography Scan Lesions	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head injury; Coma; MRI; Prognosis; Diffuse axonal injury	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; CONSENSUS CONFERENCE; STEM LESIONS; COMA; CLASSIFICATION; DEFINITIONS; FEATURES; FAILURE; STATE	Background: To assess the prognostic value of corpus callosum lesions (CCL) and brain stem lesions (BSL) in diffuse axonal injury (DAI) patients. Methods: From December 1989 to December 2008, 102 consecutive patients with pure DAI were admitted to our neurosurgical intensive care unit. Age, gender, Acute Physiology and Chronic Health Evaluation score, Glasgow Coma Score (GCS), pupillary light reactivity on admission, brain magnetic resonance imaging (MRI) 24 hours to 72 hours after trauma and sepsis, shock, adult respiratory distress syndrome, renal failure, neurosurgery, high intracranial pressure during the 6 months posttrauma were studied with multiple logistic regression, and Cox's proportional hazards, respectively, considering the Glasgow Outcome Scale and the time to recovery of consciousness as outcome variables. Results: Four variables predicted unfavorable Glasgow Outcome Scale (likelihood ratio p < 0.0001; Area Under the Receiver Operator Curve (AUROC) = 0.92; Naglekerke's R-2 = 0.64; Goodness-of-Fit p = 0.8679): age (5-year odds ratio [OR], 1.44; 95% CI, 1.14-1.82; p = 0.002), bilateral absence of light reflexes (OR, 11.11; 95% CI, 2.19-57.67; p = 0.004), multiplicity of CCL (OR, 29.23; 95% CI, 7.06-121.01; p < 0.001), and multiplicity of BSL (OR, 9.43; 95% CI, 2.44-36.42; p = 0.001). Four variables affected time to recovery of consciousness: age (hazard ratio, 0.98; 95% CI, 0.97-0.99; p = 0.009), bilateral absence of light reflexes (hazard ratio, 0.51; 95% CI, 0.27-0.97; p = 0.041), multiplicity of CCL (hazard ratio, 0.40; 95% CI, 0.25-0.66; p = 0.001), and total GCS on admission (hazard ratio, 1.45; 95% CI, 1.23-1.71; p < 0.001). Conclusions: In DAI patients, bad outcome is predicted by age, bilateral absence of pupillary light reflexes, multiplicity of CCL, and BSL on MRI. Time to recovery of consciousness is predicted by age, bilateral absence of light reflexes, multiplicity of CCL on MRI, and GCS on admission.	[Rosa, Calvi Maria; Luigi, Beretta; Antonio, Dell'Acqua; Gloria, Licini; Marco, Gemma] Ist Sci San Raffaele, Dept Head & Neck Anesthesia & Intens Care, I-20132 Milan, Italy; [Nicoletta, Anzalone] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy		Marco, G (corresponding author), Ist Sci San Raffaele, Dept Head & Neck Anesthesia & Intens Care, Via Olgettina 60, I-20132 Milan, Italy.	gemma.marco@hsr.it	anzalone, nicoletta/I-8752-2018	anzalone, nicoletta/0000-0002-4249-2723; Gemma, Marco/0000-0002-9543-3831			ADAMS JH, 1984, LANCET, V2, P1420; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BERETTA L, 1994, INTRACRANIAL PRESSUR, V9, P284; Beretta L, 2010, J NEUROTRAUM, V27, P509, DOI 10.1089/neu.2009.1054; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GODERSKY JC, 1990, ACT NEUR S, V51, P311; JANIN Y, 2000, TXB CRITICAL CARE, P1037; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; WONG CW, 1993, SURG NEUROL, V39, P37, DOI 10.1016/0090-3019(93)90107-C; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	24	21	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2011	70	2					447	451		10.1097/TA.0b013e3182095e14			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	719FV	WOS:000287187700042	21307746				2022-02-06	
J	Lankford, A				Lankford, Adam			Could Suicide Terrorists Actually Be Suicidal?	STUDIES IN CONFLICT & TERRORISM			English	Article							TRAUMATIC BRAIN-INJURY; POPULATION; ATTACKS; BOMBERS	For years, it has been widely agreed on that suicide terrorists are not suicidal individuals, and that behaviorally, they are more similar to noble soldiers who are willing to sacrifice themselves for a cause. However, upon closer examination, it appears that the foundation of this conventional wisdom is extraordinarily shaky. There are many reasons to think that both event-based and psychological risk factors for suicide may drive the behavior of suicide terrorists. Furthermore, there is growing evidence that more than 75 individual suicide terrorists have exhibited these classic suicidal traits. Given the power that the stigma of suicide may have to deter future suicide terrorists, it is critical that governments, scholars, and practitioners examine this issue once again.	Univ Alabama, Dept Criminal Justice, Tuscaloosa, AL 35487 USA		Lankford, A (corresponding author), Univ Alabama, Dept Criminal Justice, POB 870320, Tuscaloosa, AL 35487 USA.	Adam.Lankford@ua.edu					Al-San'ani Abu M., 2006, MEMRI TV        0504; ALZAHAR M, 2006, MEMRI TV        0406; American Foundation for Suicide Prevention, 2010, RISK FACT SUIC; [Anonymous], 2010, FOX NEWS        0318; [Anonymous], 2007, FOX NEWS        0924; [Anonymous], 2007, BBC NEWS        0129; [Anonymous], 2009, TIMES ONLINE    1106; [Anonymous], 2006, SUNDAY TRIBUNE  0917; [Anonymous], 2009, BBC NEWS        0204; BAER R, 2008, CULT SUICIDE BOMBER, V2; BAER R, 2005, CULT SUICIDE BOMBER; BBC News, 2008, BBC NEWS        0404; Berko A., 2007, PATH PARADISE INNER, P7; Berko Anat, 2005, Violence Vict, V20, P603, DOI 10.1891/088667005780927467; Berko A, 2008, CONTEMP TERROR STUD, P146; Byman Daniel, 2010, ATLANTIC MAGAZIN JUL; Caplan B, 2006, PUBLIC CHOICE, V128, P91, DOI 10.1007/s11127-006-9046-8; CHARNY I, 2007, FIGHTING SUICIDE BOM; CNN, 1997, CNN             1112; CNN, 2008, CNN             0203; Dao James, 2009, NY TIMES        1105; Davies Christie, 2000, DURKHEIMS SUICIDE CE; DUNCAN S, 2004, WAR DIFFERENT KIND M; Durkheim E., 1897, SUICIDE ETUDE SOCIOL; EVANS G, 1988, ENCY SUICIDE; Fair Christine, 2007, CARNEGIE ENDOWM 1019; FARBER ML, 1968, THEORY SUICIDE; Fatah Sonya, 2001, GLOBE MAIL      0507; GAMBETTA D, 2005, MAKING SENSE SUICIDE; Grossman D., 1995, KILLING PSYCHOL COST; Hafez MM, 2006, PERSPECT SER, P3; HOFFMAN BRUCE, 2006, INSIDE TERRORISM, VExpanded; Iraq Body Count, 2005, DOSS CIV CAS 2003 20; Israeli R, 1997, TERROR POLIT VIOLENC, V9, P96, DOI 10.1080/09546559708427418; JACOBSON P, 2001, TELEGRAPH       0819; Kruglanski AW, 2009, POLIT PSYCHOL, V30, P331, DOI 10.1111/j.1467-9221.2009.00698.x; Lankford A., 2009, HUMAN KILLING MACHIN; Lankford A, 2010, AGGRESS VIOLENT BEH, V15, P334, DOI 10.1016/j.avb.2010.06.001; Lester, 2003, HATING 1 PERSON PLUR; LESTER D, 1997, MAKING SENSE SUICIDE; Lester David, 2004, STUDIES CONFLICT TER, V27, P290; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Maris R., 1981, PATHWAYS SUICIDE SUR; McGirk Tim, 2004, TIME            0802; Merari A, 2010, TERROR POLIT VIOLENC, V22, P87, DOI 10.1080/09546550903409312; *NAT I MENT HLTH, 2009, SUIC US STAT PREV; National Consortium for the Study of Terrorism and Responses to Terrorism (START), 2010, GLOB TERR DAT; Nelson Soraya Sarhaddi, 2007, NATL PUBLIC RAD 1015; Ohnuki-Tierney Emiko, 2006, KAMIKAZE DIARIES REF, pxvi; Pape R., 2005, DYING WIN STRATEGIC; Pastor LH, 2004, PSYCHIAT ANN, V34, P701, DOI 10.3928/0048-5713-20040901-15; Pedahzur A., 2005, SUICIDE TERRORISM; Post JM, 2009, PSYCHIATRY, V72, P13, DOI 10.1521/psyc.2009.72.1.13; Rowley CK, 2006, PUBLIC CHOICE, V128, P1, DOI 10.1007/s11127-006-9042-z; Rubin Barry, 2002, ANTIAMERICAN TERRORI, P149; Shneidman Edwin S., 1979, SUICIDE THEORY CLIN; Slackman Michael, 2006, NY TIMES        0206; Speckhard A, 2006, STUD CONFL TERROR, V29, P429, DOI 10.1080/10576100600698550; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Townsend E, 2007, SUICIDE LIFE-THREAT, V37, P35, DOI 10.1521/suli.2007.37.1.35; Tyson Ann S., 2007, WASHINGTON POST 0102; U.S. Army, 2010, TOT ARM SUIC CY2001; UN Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; Warrick Joby, 2010, WASHINGTON POST 0318; Yellow Ribbon Suicide Prevention Program, 2009, WARN SIGNS RISK FACT	65	21	21	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1057-610X	1521-0731		STUD CONFL TERROR	Stud. Confl. Terror.		2011	34	4					337	366	PII 934984933	10.1080/1057610X.2011.551721			30	International Relations; Political Science	Social Science Citation Index (SSCI)	International Relations; Government & Law	738XH	WOS:000288675400004					2022-02-06	
J	McCrory, P				McCrory, Paul			Future Advances and Areas of Future Focus in the Treatment of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Sports concussion; Athletic injuries; Chronic traumatic encephalopathy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; NATIONAL-FOOTBALL-LEAGUE; RUGBY UNION FOOTBALL; PROFESSIONAL FOOTBALL; HEAD-INJURIES; RECURRENT CONCUSSION; PLAYERS; DEPRESSION; ENCEPHALOPATHY; RISK	The occurrence and management of sports concussion provokes more debate and concern than virtually all other sports injuries combined. In the past 3 decades, clinicians have gone from mostly anecdotal strategies to an international consensus based approach and the early evolution of evidence-based practice. There is increasing engagement by mainstream neuroscientists in this field, which had previously been dominated by sports team physicians. However, the interchange has largely taken place in the media rather than through scientific journals. Legislators have proposed regulatory measures that restrict medical management of concussion in ways that apply to no other medical condition. This paper examines some of the key areas that are likely to be the focus of research in the next few years.	[McCrory, Paul] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Parkville, Vic 3010, Australia; [McCrory, Paul] Univ Melbourne, Brain Res Inst, Parkville, Vic 3010, Australia		McCrory, P (corresponding author), Univ Melbourne, Ctr Hlth Exercise & Sports Med, Parkville, Vic 3010, Australia.	paulmccr@bigpond.net.au	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568	National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Australian Research CouncilAustralian Research Council; International Rugby Board; Victorian Department of Health; Australian Sports Commission; International Olympic Commission; Federation Internationale de Football Association; CogState Inc.	the author has received research funding and conference support from the National Health & Medical Research Council of Australia, the Australian Research Council, the International Rugby Board, Victorian Department of Health, Australian Sports Commission, the International Olympic Commission, Federation Internationale de Football Association, and CogState Inc.	Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blatter JS, 2010, SCAND J MED SCI SPOR, V20, DOI 10.1111/j.1600-0838.2010.01114.x; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dietze PM, 2008, MED J AUSTRALIA, V189, P479, DOI 10.5694/j.1326-5377.2008.tb02138.x; Dvorak J, 2009, BRIT J SPORT MED, V43, P317, DOI 10.1136/bjsm.2009.059618; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; HERRING S, 2006, MED SCI SPORTS EXERC, V38, P395, DOI DOI 10.1249/01.MSS.0000202025.48774.31; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, pV, DOI 10.1097/00001199-199804000-00001; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, J SCI MED SPORT, V5, P169, DOI 10.1016/S1440-2440(02)80002-0; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 2000, MED J AUSTRALIA, V172, P217, DOI 10.5694/j.1326-5377.2000.tb123912.x; McIntosh A, 2005, RUGBY HEADGEAR STUDY; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Peretti-Watel P, 2003, ADDICTION, V98, P1249, DOI 10.1046/j.1360-0443.2003.00490.x; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sullivan SJ, 2008, BRIT J SPORT MED, V42, P175, DOI 10.1136/bjsm.2007.039297; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Weiss MR, 2005, RES Q EXERCISE SPORT, V76, pS71, DOI 10.1080/02701367.2005.10599291; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	64	21	21	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					201	+		10.1016/j.csm.2010.08.002			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	691XR	WOS:000285114800018	21074093				2022-02-06	
S	Tang, JY; Ai, JL; Macdonald, RL		Zhang, JH; Colohan, A		Tang, Jingyang; Ai, Jinglu; Macdonald, R. Loch			Developing a Model of Chronic Subdural Hematoma	INTRACEREBRAL HEMORRHAGE RESEARCH: FROM BENCH TO BEDSIDE	Acta Neurochirurgica Supplementum		English	Article; Book Chapter						Chronic subdural hematoma; Acute subdural hematoma; Subdural hygroma; Animal models; Mild traumatic brain injury	SURGICAL-TREATMENT; PHYSIOPATHOGENESIS; RECURRENCE; HEMORRHAGE; PATHOLOGY; GROWTH; ORIGIN	Chronic subdural hematoma (CSDH) is a common neurosurgical condition that has a high incidence in the increasing elderly population of many countries. Pathologically, it is defined as a persistent liquefied hematoma in the subdural space more than 3 weeks old that is generally encased by a membraneous capsule. CSDHs likely originate after minor head trauma, with a key factor in its development being the potential for a subdural cavity to permit its expansion within, which is usually due to craniocerebral disproportion. The pathogenesis of CSDH has been attributed to osmotic or oncotic pressure differences, although measurements of these factors in the CSDH fluid do not support this theory. Current belief is that CSDH arises from recurrent bleeding in the subdural space, caused by a cycle of local angiogenesis, inflammation, coagulation and ongoing fibrinolysis. However, because of a lack of detailed knowledge about the precise mechanisms, treatment is often limited to surgical interventions that are invasive and often prone to recurrence. Thus, it is possible that an easily reproducible and representative animal model of CSDH would facilitate research in the pathogenesis of CSDH and aid with development of treatment options.	[Tang, Jingyang; Ai, Jinglu; Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON, Canada		Macdonald, RL (corresponding author), St Michaels Hosp, Div Neurosurg, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca		AI, JINGLU/0000-0001-7414-0207			AIKAWA H, 1987, J NEUROSURG, V67, P710, DOI 10.3171/jns.1987.67.5.0710; APFELBAUM RI, 1974, J NEUROSURG, V40, P336, DOI 10.3171/jns.1974.40.3.0336; Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; FUJISAWA H, 1991, SURG NEUROL, V35, P441, DOI 10.1016/0090-3019(91)90177-B; Fujisawa H, 2006, NEUROL MED-CHIR, V46, P333, DOI 10.2176/nmc.46.333; Gardner W.J., 1932, ARCH NEUROL PSYCHIAT, V27, P847; GLOVER D, 1976, J NEUROSURG, V45, P393, DOI 10.3171/jns.1976.45.4.0393; GOLDEN J, 1994, CLIN NEUROPATHOL, V13, P12; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; Killeffer JA, 2000, NEUROSURG CLIN N AM, V11, P407, DOI 10.1016/S1042-3680(18)30102-5; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Labadie E L, 1974, Can J Neurol Sci, V1, P222; LABADIE EL, 1976, J NEUROSURG, V45, P382, DOI 10.3171/jns.1976.45.4.0382; Lee KS, 1998, BRAIN INJURY, V12, P901; Lee Kyeong-Seok, 1997, Journal of Korean Medical Science, V12, P353; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Stoodley M, 2000, NEUROSURGERY, V46, P1193, DOI 10.1097/00006123-200005000-00034; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Virchow R., 1857, VERH PHYS MED GES WU, V7, P134; WATANABE S, 1972, J NEUROSURG, V37, P552, DOI 10.3171/jns.1972.37.5.0552; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Yamashima T, 2000, NEUROSURG CLIN N AM, V11, P413, DOI 10.1016/S1042-3680(18)30103-7	25	21	21	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, A-1201 VIENNA, AUSTRIA	0065-1419		978-3-7091-0692-1	ACTA NEUROCHIR SUPPL	Acta Neurochir. Suppl.		2011	111						25	29		10.1007/978-3-7091-0693-8_5	10.1007/978-3-7091-0693-8		5	Medicine, Research & Experimental; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Research & Experimental Medicine; Neurosciences & Neurology	BGT35	WOS:000324076300005	21725727				2022-02-06	
J	Zlotnik, A; Ohayon, S; Gruenbaum, BF; Gruenbaum, SE; Mohar, B; Boyko, M; Klin, Y; Sheiner, E; Shaked, G; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Ohayon, Sharon; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Mohar, Boaz; Boyko, Matthew; Klin, Yael; Sheiner, Eyal; Shaked, Gad; Shapira, Yoram; Teichberg, Vivian I.			Determination of Factors Affecting Glutamate Concentrations in the Whole Blood of Healthy Human Volunteers	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						glutamate; neurotoxicity; traumatic brain injury; glutamate-pyruvate transaminase (GPT); glutamate-oxaloacetate transaminase (GOT)	MONOSODIUM L-GLUTAMATE; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; AMINO-ACIDS; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; PLASMA GLUTAMATE; ISCHEMIC-STROKE; BRAIN	Background: Abnormally high concentrations of glutamate in brain fluids have been shown to be neurotoxic and correlate with a poor neurological outcome following traumatic brain injury (TBI). Since brain fluid glutamate can be reduced by scavenging blood glutamate, the purpose of this study was to investigate factors that may potentially influence levels of blood glutamate, glucose, and the enzymes glutamate-pyruvate transaminase (GPT) and glutamate-oxaloacetate transaminase (GOT) in healthy individuals. Methods: Factors that were examined included age, gender, time of last meal or drink, and recent consumption of coffee. A total of 112 healthy volunteers between 18 and 70 years of age participated in the study. The average participant was 38 years old, and the sample consisted of 48 males and 64 females. Five milliliters of venous blood was collected from participants' cubital vein and blood glutamate, glucose, GOT and GPT levels were determined. Participants were then asked to complete a questionnaire addressing their gender, age, time of last meal, time of last drink, and whether coffee was consumed within the last 6 hours. Results: Blood glutamate concentrations were significantly higher in males than in females (P < 0.001) and may be due to effects of estrogen and progesterone. Concentrations of GOT were significantly higher in males than in females (P < 0.01). Concentrations of GPT were significantly higher in males than in females (P < 0.01). There were no other significant differences demonstrated. Conclusions: Understanding the factors that affect blood glutamate levels may give new insight into mechanisms that protect the brain from excess glutamate and result in a better neurological outcome following TBI.	[Zlotnik, Alexander; Ohayon, Sharon; Gruenbaum, Benjamin F.; Boyko, Matthew; Shapira, Yoram] Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Sheiner, Eyal] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Shaked, Gad] Soroka Univ, Dept Gen Surg, Med Ctr, Beer Sheva, Israel; [Mohar, Boaz; Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	Mohar, Boaz/H-6398-2011; SHEINER, EYAL/F-1488-2012	Mohar, Boaz/0000-0002-8613-2869; Boyko, Matthew/0000-0003-3116-1643			Andreadou E, 2008, IN VIVO, V22, P137; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Koura SS, 1998, ACT NEUR S, V71, P244; Liang Z, 2002, J NEUROCHEM, V80, P807, DOI 10.1046/j.0022-3042.2002.00779.x; MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552; Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Reeds PJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE413, DOI 10.1152/ajpendo.1996.270.3.E413; Sailasuta N, 2008, MAGN RESON IMAGING, V26, P667, DOI 10.1016/j.mri.2007.06.007; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Slooter AJC, 1999, J NEUROL NEUROSUR PS, V67, P779, DOI 10.1136/jnnp.67.6.779; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; STEGINK LD, 1985, AM J CLIN NUTR, V42, P220, DOI 10.1093/ajcn/42.2.220; STEGINK LD, 1983, J NUTR, V113, P1851, DOI 10.1093/jn/113.9.1851; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tsai PJ, 2000, J NUTR, V130, p1002S, DOI 10.1093/jn/130.4.1002S; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	33	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2011	23	1					45	49		10.1097/ANA.0b013e3181f82a8f			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	692FC	WOS:000285137200009	21248494				2022-02-06	
J	Kaufman, NA; Beare, JE; Tan, AA; Vitek, MP; McKenna, SE; Hoane, MR				Kaufman, Nicholas A.; Beare, Jason E.; Tan, Arlene A.; Vitek, Michael P.; McKenna, Suzanne E.; Hoane, Michael R.			COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Therapy; Recovery of function; Amnesia; Treatment; FPI	TRAUMATIC BRAIN-INJURY; SYSTEM INFLAMMATORY RESPONSE; CLOSED-HEAD INJURY; NICOTINAMIDE TREATMENT; FUNCTIONAL RECOVERY; INTRACEREBRAL HEMORRHAGE; MICROGLIAL ACTIVATION; MIMETIC PEPTIDES; CONTUSION INJURY; APOE GENOTYPE	COG1410, a small, novel ApoE-mimetic peptide derived from the receptor binding region of apolipoprotein E (ApoE), has been classified as anti-inflammatory in nature and improves motor, sensorimotor, and cognitive dysfunction following cortical contusion injury (CCI). In order to further examine COG1410's preclinical efficacy on cognitive recovery, the present study evaluated COG1410 following moderate fluid percussion injury (FPI). Animals were prepared with a moderate, unilateral FPI over the hippocampus. Following FPI, animals received a regimen of five doses of COG1410 or vehicle at 2 and 4 h (1.0 mg/kg, i.v.) followed by additional doses administered 24, 48, and 72 h (1.0 mg/kg, i.p.). Prior to injury, animals were trained for 4 days (4 trials/day) in the Morris water maze (MWM) and then tested for retrograde amnesia on post-FPI day 11 and then on a working memory task on day 18. Testing for motor dysfunction on the tapered balanced beam began on day 2 post-FPI. Administration of this regimen of COG1410 significantly improved retention of memory in the retrograde amnesia test compared to vehicle post-FPI. However. COG1410 did not significantly improve acquisition of working memory in the MWM. Motor dysfunction on the tapered beam post-FPI was improved in the COG1410-treated group compared to vehicle treatment. Cortical lesion analysis revealed that the COG1410-treated animals demonstrated significantly less tissue loss compared to vehicle-treated animals. The results of this study suggest that COG1410 significantly limited the behavioral dysfunction and tissue loss associated with FPI and demonstrated continued preclinical efficacy for TBI. (C) 2010 Elsevier B.V. All rights reserved.	[Kaufman, Nicholas A.; Beare, Jason E.; Tan, Arlene A.; Hoane, Michael R.] So Illinois Univ, Restorat Neurosci Lab, Dept Psychol, Ctr Integrat Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Vitek, Michael P.; McKenna, Suzanne E.] Cognosci Inc, Res Triangle Pk, NC USA; [Vitek, Michael P.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA; [Vitek, Michael P.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA		Hoane, MR (corresponding author), So Illinois Univ, Restorat Neurosci Lab, Dept Psychol, Ctr Integrat Res Cognit & Neural Sci, Life Sci 2,MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu	; Beare, Jason/D-2870-2016	Vitek, Michael/0000-0001-8140-8048; Beare, Jason/0000-0003-3988-1223; Hoane, Michael/0000-0001-7779-2657	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44NS048689, R44AG020473]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS048689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R44AG020473] Funding Source: NIH RePORTER	Funding provided by Cognosci Inc. grants R44NS048689 and R44AG020473 from the NIH. Special thanks to Andrea Quigley, Keith Gregory, and Sarah Heck for technical assistance. Cognosci, Inc. has filed for patent protection for COG1410.	Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Colton CA, 2002, NEUROBIOL AGING, V23, P777, DOI 10.1016/S0197-4580(02)00016-7; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schallert T, 2005, BEHAV LAB RAT, P129; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Wang H, 2009, ANAESTH INTENS CARE, V37, P38, DOI 10.1177/0310057X0903700111; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249	47	21	25	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	DEC 10	2010	214	2					395	401		10.1016/j.bbr.2010.06.017			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	643SJ	WOS:000281318700030	20600347	Green Accepted			2022-02-06	
J	Iaci, JF; Ganguly, A; Finklestein, SP; Parry, TJ; Ren, JM; Saha, S; Sietsma, DK; Srinivas, M; Vecchione, AM; Caggiano, AO				Iaci, Jennifer F.; Ganguly, Anindita; Finklestein, Seth P.; Parry, Tom J.; Ren, JingMei; Saha, Subhash; Sietsma, Dana K.; Srinivas, Maya; Vecchione, Andrea M.; Caggiano, Anthony O.			Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke	NEUROPHARMACOLOGY			English	Article						Neuregulin; Ischemia; GGF2; MCAO; Recovery	EXTENDED THERAPEUTIC WINDOW; PLASMINOGEN-ACTIVATOR; TRAUMATIC BRAIN; ANIMAL-MODELS; NEUREGULIN-1; NEUROPROTECTION; LOCALIZATION; WIDESPREAD; INHIBITION; EXPRESSION	Neuregulins are a family of growth factors essential for normal cardiac and nervous system development. The EGF-like domain of neuregulins contains the active site which binds and activates signaling cascades through ErbB receptors. A neuregulin-1 gene EGF-like fragment demonstrated neuroprotection in the transient middle cerebral artery occlusion (MCAO) stroke model and drastically reduced infarct volume (Xu et al., 2004). Here we use a permanent MCAO rat model to initially compare two products of the neuregulin-1 gene and also assess levels of recovery with acute versus delayed time to treatment. In the initial study full-length glial growth factor 2 (GGF2) and an EGF-like domain fragment were compared with acute intravenous delivery. In a second study GGF2 only was delivered starting at 24 h, 3 days or 7 days after permanent ischemia was induced. In both studies daily intravenous administration continued for 10 days. Recovery of neurological function was assessed using limb placing and body swing tests. GGF2 had similar functional improvements compared to the EGF-like domain fragment at equimolar doses, and a higher dose of GGF2 demonstrated more robust functional improvements compared to a lower dose. GGF2 improved sensorimotor recovery with all treatment paradigms, even enhancing recovery of function with a delay of 7 days to treatment. Histological assessments did not show any associated reduction in infarct volume at either 48 h or 21 days post-ischemic event. Neurorestorative effects of this kind are of great potential clinical importance, given the difficulty of delivering neuroprotective therapies within a short time after an ischemic event in human patients. If confirmed by additional work including additional data on mechanism(s) of improved outcome with verification in other stroke models, one can make a compelling case to bring GGF2 to clinical trials as a neurorestorative approach to improving outcome following stroke injury. (C) 2010 Elsevier Ltd. All rights reserved.	[Iaci, Jennifer F.; Ganguly, Anindita; Parry, Tom J.; Saha, Subhash; Srinivas, Maya; Vecchione, Andrea M.; Caggiano, Anthony O.] Acorda Therapeut Inc, Hawthorne, NY 10532 USA; [Finklestein, Seth P.; Ren, JingMei; Sietsma, Dana K.] Biotrofix Inc, Waltham, MA 02451 USA		Iaci, JF (corresponding author), Acorda Therapeut Inc, 15 Skyline Dr, Hawthorne, NY 10532 USA.	jiaci@acorda.com					Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bin Kwon O, 2008, P NATL ACAD SCI USA, V105, P15587, DOI 10.1073/pnas.0805722105; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Buonanno A., 2008, NOVART FDN SYMP, V289, P177; BUONANNO A, 2008, NOVART FDN SYMP, V289, P193; Buonanno Andres, 2008, Novartis Found Symp, V289, P165; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chen Yong-jun, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1771; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1602/neurorx.1.1.36; COMELLI MC, 1993, NEUROSCIENCE, V55, P473, DOI 10.1016/0306-4522(93)90517-J; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; DERYCK M, 1992, BRAIN RES, V573, P44; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Di Segni A, 2005, J MOL NEUROSCI, V26, P57, DOI 10.1385/JMN:26:1:057; Dimayuga FO, 2003, J NEUROIMMUNOL, V136, P67, DOI 10.1016/S0165-5728(03)00003-1; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; FINKLESTEIN SP, 1990, STROKE, V21, P122; Fischbach GD, 2007, NEURON, V54, P495, DOI 10.1016/j.neuron.2007.05.009; Flores AI, 2000, J NEUROSCI, V20, P7622; Foley Norine C, 2003, Top Stroke Rehabil, V10, P1; Furlan Anthony J., 2003, Curr Treat Options Cardiovasc Med, V5, P171, DOI 10.1007/s11936-003-0001-4; Heiss WD, 1998, J CEREBR BLOOD F MET, V18, P1298, DOI 10.1097/00004647-199812000-00004; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Komjati K, 2004, INT J MOL MED, V13, P373; LEMKE G, 2006, SCI STKE, pPE11; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li Q, 2002, EXP NEUROL, V177, P531, DOI 10.1006/exnr.2002.7994; Li YG, 2007, BRAIN RES, V1184, P277, DOI 10.1016/j.brainres.2007.09.037; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Loeb JA, 2007, NEUROLOGY, V68, pS38, DOI 10.1212/01.wnl.0000275231.97764.43; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mauler F, 2005, J CEREBR BLOOD F MET, V25, P451, DOI 10.1038/sj.jcbfm.9600038; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Neddens Jorg, 2009, Commun Integr Biol, V2, P261; Price CJS, 2006, STROKE, V37, P1749, DOI 10.1161/01.STR.0000226980.95389.0b; Que M, 1999, NEUROSCI LETT, V273, P77, DOI 10.1016/S0304-3940(99)00598-4; Redecker C, 2002, J CEREBR BLOOD F MET, V22, P1463, DOI 10.1097/01.WCB.0000034149.72481.BD; RUDD A, 2002, HOSP PHARM, V9, P5; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; Tamura A, 1986, No To Shinkei, V38, P747; Tan Kiat T, 2003, Curr Atheroscler Rep, V5, P245, DOI 10.1007/s11883-003-0046-6; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; ter Laak MP, 2000, J NEUROSCI RES, V60, P237, DOI 10.1002/(SICI)1097-4547(20000415)60:2<237::AID-JNR13>3.0.CO;2-5; Wahlgren N G, 2000, J Stroke Cerebrovasc Dis, V9, P32, DOI 10.1053/jscd.2000.19320; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x	60	21	22	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC	2010	59	7-8					640	649		10.1016/j.neuropharm.2010.07.017			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	682XN	WOS:000284436400011	20691195				2022-02-06	
J	Klein, AH; Wendroth, SM; Drewes, LR; Andrews, MT				Klein, Amanda H.; Wendroth, Scott M.; Drewes, Lester R.; Andrews, Matthew T.			SMALL-VOLUME D-beta-HYDROXYBUTYRATE SOLUTION INFUSION INCREASES SURVIVABILITY OF LETHAL HEMORRHAGIC SHOCK IN RATS	SHOCK			English	Article						Hibernation; melatonin; hemorrhage; ketone; hypothermia; fluid resuscitation	TRAUMATIC BRAIN-INJURY; KETONE-BODIES; ISCHEMIA-REPERFUSION; THERAPEUTIC IMPLICATIONS; MELATONIN PRODUCTION; PULMONARY APOPTOSIS; FREE-RADICALS; HIBERNATION; ISCHEMIA/REPERFUSION; MODEL	A small-volume therapeutic approach based on the biochemistry of hibernating mammals was evaluated to test the hypothesis that passive hypothermia and systemic administration of D-beta-hydroxybutyrate (D-BHB) plus melatonin will increase survival of animals subjected to hemorrhagic shock ([HS] 60% blood loss). Anesthetized Sprague-Dawley male rats (320 +/- 23 g) underwent controlled loss of 60% blood volume. Rats were instrumented to measure mean arterial pressure, body temperature (T-b), and heart rate. A passive decrease in rat T-b in response to HS significantly increased survival over animals maintained at 37 degrees C (n = 5-6). Infusion of 4 M D-BHB, at a volume of only 5.5% of the total blood removed, significantly prolonged survival to a mean of 3 h compared with 90 min using equal osmolar 4 M NaCl (n = 6). In experiments where the shed blood was returned after 1 h of 60% blood loss, 4% fluid replacement with 4 M D-BHB plus 43 mM melatonin significantly prolonged survival up to 10 days after blood return compared with 4 M NaCl plus 43 mM melatonin and other control solutions (n = 10). We conclude that a slow decrease in animal T-b resulting from 60% blood loss, combined with infusion of 4 M D-BHB plus 43 mM melatonin, was beneficial for long-term survival after return of shed blood. This HS therapy is designed as a portable low-volume solution for further evaluation in a large-animal model and is ultimately intended for use in HS patients by first responders.	[Klein, Amanda H.; Wendroth, Scott M.; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Drewes, Lester R.] Univ Minnesota, Sch Med, Dept Biochem & Mol Biol, Duluth, MN 55812 USA		Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, 1035 Kirby Dr, Duluth, MN 55812 USA.	mandrews@d.umn.edu	Drewes, Lester R/X-9794-2018	Drewes, Lester R/0000-0002-7440-0387	Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W911NF-05-1-0432, W911NF-06-0088]	This study was supported by the Defense Advanced Research Projects Agency (contracts W911NF-05-1-0432 and W911NF-06-0088).	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alam HB, 2006, SURGERY, V140, P307, DOI 10.1016/j.surg.2006.03.015; Alam HB, 2004, J TRAUMA, V57, P961, DOI 10.1097/01.TA.0000149549.72389.3F; Alam HB, 2001, J AM COLL SURGEONS, V193, P255, DOI 10.1016/S1072-7515(01)01004-3; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Bardutzky J, 2005, J CEREBR BLOOD F MET, V25, P968, DOI 10.1038/sj.jcbfm.9600095; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cervantes M, 2008, J PINEAL RES, V45, P1, DOI 10.1111/j.1600-079X.2007.00551.x; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Dutton Richard P, 2007, Anesthesiol Clin, V25, P23, DOI 10.1016/j.atc.2006.11.007; Engel FL, 1943, J EXP MED, V77, P397, DOI 10.1084/jem.77.5.397; Fukudome EY, 2009, CRIT CARE MED, V37, pS265, DOI 10.1097/CCM.0b013e3181aa60ac; HARKNESS JE, 1995, BIOL MED RABBITS ROD; HAUPTMAN JG, 1989, AM J PHYSIOL, V257, pR439, DOI 10.1152/ajpregu.1989.257.2.R439; Henry PG, 2007, J NEUROCHEM, V101, P1505, DOI 10.1111/j.1471-4159.2007.04514.x; HIRAIDE A, 1991, EUR SURG RES, V23, P250, DOI 10.1159/000129160; Institute of Medicine and Committee on Fluid Resuscitation for Combat Casualties, 1999, FLUID RES STAT SCI T; Kacmaz A, 2005, SURG TODAY, V35, P744, DOI 10.1007/s00595-005-3027-2; KATAYAMA M, 1994, JPEN-PARENTER ENTER, V18, P442, DOI 10.1177/0148607194018005442; Koustova E, 2003, SURGERY, V134, P267, DOI 10.1067/msy.2003.245; Larkin JE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P577, DOI 10.1086/375436; Lin T, 2005, J TRAUMA, V59, P1191, DOI 10.1097/01.ta.0000188646.86995.9d; LITTLE JR, 1981, NEUROSURGERY, V9, P34, DOI 10.1227/00006123-198107000-00006; Lomas-Niera JL, 2005, SHOCK, V24, P33, DOI 10.1097/01.shk.0000191411.48719.ab; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; MOORE TJ, 1976, AM J PHYSIOL, V230, P619, DOI 10.1152/ajplegacy.1976.230.3.619; Reiter RJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Reiter RJ, 2003, CARDIOVASC RES, V58, P10, DOI 10.1016/S0008-6363(02)00827-1; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; SCOFIELD RF, 1983, METABOLISM, V32, P1009, DOI 10.1016/0026-0495(83)90144-0; Sener G, 2002, J UROLOGY, V167, P2624, DOI 10.1016/S0022-5347(05)65048-3; Spaniol Joseph R, 2007, J Trauma Nurs, V14, P152; STANTON TL, 1986, J EXP ZOOL, V239, P247, DOI 10.1002/jez.1402390212; Suckow MA, 1998, LAB RAT; Tan DX, 2005, ENDOCRINE, V27, P149, DOI 10.1385/ENDO:27:2:149; Taylor JH, 2004, SHOCK, V21, P58, DOI 10.1097/01.shk.0000101674.49265.93; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Yildirim A, 2009, INT J MORPHOL, V27, P519, DOI 10.4067/S0717-95022009000200036	45	21	21	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	DEC	2010	34	6					565	572		10.1097/SHK.0b013e3181e15063			8	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	680LW	WOS:000284234400004	20386494				2022-02-06	
J	Sacho, RH; Vail, A; Rainey, T; King, AT; Childs, C				Sacho, Raphael H.; Vail, Andy; Rainey, Timothy; King, Andrew T.; Childs, Charmaine			The Effect of Spontaneous Alterations in Brain Temperature on Outcome: A Prospective Observational Cohort Study in Patients with Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain; mortality; outcome; pupil responses; temperature; traumatic brain injury	SEVERE HEAD-INJURY; INTENSIVE-CARE; HYPOTHERMIA; HYPERTHERMIA; HEMORRHAGE; GUIDELINES; MANAGEMENT; PYREXIA; OXYGEN; FEVER	There are few prospective studies reporting the effect of spontaneous temperature changes on outcome after severe traumatic brain injury (TBI). Where studies have been conducted, results are based on systemic rather than brain temperature per se. However, body temperature is not a reliable surrogate for brain temperature. Consequently, the effect of brain temperature changes on outcome in the acute phase after TBI is not clear. Continuous intraparenchymal brain temperature was measured in consecutive admissions of severe TBI patients during the course of the first 5 days of admission to the intensive care unit (ICU). Patients received minimal temperature altering therapy during their ICU stay. Logistic regression was used to explore the relationship between the initial, the 24-h mean, and the 48-h mean brain temperature with outcome for mortality at 30 days and outcome at 3 months. Multifactorial analysis was performed to account for potential confounders. At the 24-h time point, brain temperature within the range of 36.5 degrees C to 38 degrees C was associated with a lower probability of death (10-20%). Brain temperature outside of this range was associated with a higher probability of death and poor 3-month neurological outcome. After adjusting for other predictors of outcome, low brain temperature was independently associated with a worse outcome. Lower brain temperatures (below 37 degrees C) are independently associated with a higher mortality rate after severe TBI. The results suggest that, contrary to current opinion, temperatures within the normal to moderate fever range during the acute post-TBI period do not impose an additional risk for a poor outcome after severe TBI.	[Sacho, Raphael H.; King, Andrew T.] Salford Royal NHS Fdn Trust, Dept Neurosurg, Salford, Lancs, England; [Vail, Andy] Univ Manchester, Hlth Methodol Res Grp, Manchester M13 9PL, Lancs, England; [Sacho, Raphael H.; Rainey, Timothy; King, Andrew T.; Childs, Charmaine] Univ Manchester, Brain Injury Res Grp, Manchester M13 9PL, Lancs, England		Childs, C (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr, Block E3A Level 3,Engn Dr 1, Singapore 117574, Singapore.	Raphael.Sacho@postgrad.manchester.ac.uk; charmaine_childs@nuhs.edu.sg	King, Andrew/AAR-1656-2020; Childs, Charmaine/G-9928-2012	Vail, Andy/0000-0001-8274-2726; King, Andrew/0000-0002-6546-7248			ACKERMAN D, 1980, J PHYSIOL-LONDON, V307, P59, DOI 10.1113/jphysiol.1980.sp013423; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; HAYWARD JN, 1969, BRAIN RES, V16, P417, DOI 10.1016/0006-8993(69)90236-4; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Jurkovich GJ, 2007, SURG CLIN N AM, V87, P247, DOI 10.1016/j.suc.2006.10.003; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kirk D, 2009, CRIT CARE, V13, DOI 10.1186/cc7898; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion D, 2008, NEUROSURGERY, V62, P872; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; MCILVOY L, 2004, J NEUROSCI NURS, P9; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; SACHO RH, 2008, BRIT J NEUROSURG, P1; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	36	21	23	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2010	27	12					2157	2164		10.1089/neu.2010.1384			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	691PN	WOS:000285093400005	20822465				2022-02-06	
J	Evans, HL; Zonies, DH; Warner, KJ; Bulger, EM; Sharar, SR; Maier, RV; Cuschieri, J				Evans, Heather L.; Zonies, David H.; Warner, Keir J.; Bulger, Eileen M.; Sharar, Sam R.; Maier, Ronald V.; Cuschieri, Joseph			Timing of Intubation and Ventilator-Associated Pneumonia Following Injury	ARCHIVES OF SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; POSTTRAUMATIC PNEUMONIA; NOSOCOMIAL PNEUMONIA; RISK-FACTORS; COMPLICATIONS; OUTCOMES; FIELD; RESUSCITATION	Hypothesis: In an emergency medical system with established rapid-sequence intubation protocols, prehospital (PH) intubation of patients with trauma is not associated with a higher rate of ventilator-associated pneumonia (VAP) than emergency department (ED) intubation. Design: Retrospective observational cohort. Setting: Level I trauma center. Patients: Adult patients with trauma intubated in a PH or an ED setting from July 1, 2007, through July 31, 2008. Main Outcome Measures: Diagnosis of VAP by means of bronchoscopic alveolar lavage or clinical assessment when bronchoscopic alveolar lavage was impossible. Secondary outcomes included time to VAP, length of hospitalization, and in-hospital mortality. Results: Of 572 patients, 412 (72.0%) underwent PH intubation. The ED group was older than the PH group (mean ages, 46.4 vs 39.1 years; P < .001) and had a higher incidence of blunt injury (142 [88.8%] vs 322 [78.2%]; P = .002). The mean (SD) lowest recorded ED systolic blood pressure was lower in the ED group (102.8 [1.9] vs 111.4 [1.2] mm Hg; P < .001), despite similar mean injury severity scores in both groups (27.2 [0.7] vs 27.0 [1.1]; P = .94). There was no difference in the mean rate of VAP (30 [18.8%] vs 71 [17.2%]; P = .66) or mean time to diagnosis (8.1 [1.2] vs 7.8 [1.0] days; P = .89). Logistic regression analysis identified history of drug abuse, lowest recorded ED systolic blood pressure, and injury severity score as 3 independent factors predictive of VAP. Conclusions: Prehospital intubation of patients with trauma is not associated with higher risk of VAP. Further investigation of intubation factors and the incidence and timing of aspiration is required to identify potentially modifiable factors to prevent VAP.	[Evans, Heather L.; Zonies, David H.; Warner, Keir J.; Bulger, Eileen M.; Maier, Ronald V.; Cuschieri, Joseph] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Sharar, Sam R.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA		Evans, HL (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, Campus Box 359796,325 9th Ave, Seattle, WA 98104 USA.	hlevans@uw.edu	Evans, Heather L/B-7620-2008; Zonies, David/B-6497-2011; Evans, Heather/F-9113-2014	Evans, Heather/0000-0002-3661-0666			Bard MR, 2006, J TRAUMA, V61, P1441, DOI 10.1097/01.ta.0000245981.22931.43; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Brown DL, 2001, J TRAUMA, V51, P1207, DOI 10.1097/00005373-200112000-00034; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bulger EM, 2002, J EMERG MED, V23, P183, DOI 10.1016/S0736-4679(02)00490-0; COBB LA, 1975, CIRCULATION, V52, P223; Cook DJ, 1998, JAMA-J AM MED ASSOC, V279, P1605, DOI 10.1001/jama.279.20.1605; COPASS MK, 1984, AM J SURG, V148, P20, DOI 10.1016/0002-9610(84)90284-8; Croce MA, 1995, J TRAUMA, V39, P1134, DOI 10.1097/00005373-199512000-00022; Croce MA, 2003, J TRAUMA, V54, P724, DOI 10.1097/01.TA.0000054643.54218.C5; Croce MA, 2001, AM SURGEON, V67, P105; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; DEMLING RH, 1988, CRIT CARE MED, V16, P573, DOI 10.1097/00003246-198806000-00001; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Eckert MJ, 2004, J TRAUMA, V57, P750, DOI 10.1097/01.TA.0000147499.73570.12; Griffin R, 2009, J BURN CARE RES, V30, P395, DOI 10.1097/BCR.0b013e3181a28966; Hadjizacharia P, 2009, J TRAUMA, V66, P491, DOI 10.1097/TA.0b013e3181622b9b; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Karch SB, 1996, AM J EMERG MED, V14, P617, DOI 10.1016/S0735-6757(96)90073-X; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858	28	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	NOV	2010	145	11					1041	1046		10.1001/archsurg.2010.239			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	680KK	WOS:000284230600009	21079091	Bronze			2022-02-06	
J	McMahon, CG; Kenny, R; Bennett, K; Little, R; Kirkman, E				McMahon, C. Geraldine; Kenny, RoseAnne; Bennett, Katherine; Little, Rod; Kirkman, Emrys			The Effect of Acute Traumatic Brain Injury on the Performance of Shock Index	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Brain injuries; Trauma; Hemorrhagic shock; Shock index	HEMORRHAGIC-SHOCK; VITAL SIGNS; RESPONSES; RATS; RESUSCITATION; STIMULATION; HYPOVOLEMIA; BRADYCARDIA; MORPHINE; DEATHS	Background: Shock index (SI) is recognized to be a more reliable early indicator of hemorrhage than traditional vital signs. Acute traumatic brain injury (TBI) can be associated with autonomic uncoupling and may therefore alter the reliability of SI in patients with combined TBI and peripheral hemorrhage. The aim of this study was to evaluate the performance of SI when acute TBI of mild and moderate severity were associated with progressive simple hemorrhage. Methods: This study was undertaken in a laboratory setting. Brian injury was induced using the lateral fluid percussion model in anesthetized rats. The fluid percussion device delivered an applied cortical pressure of 1.2 atm and 1.8 atm, producing mild and moderate TBI, respectively. Control animals underwent identical procedures but with no applied cortical pressure. Hemorrhage was induced 10 minutes after brain injury, at a rate of 2% of blood volume per minute until 40% blood volume was withdrawn. Results: The SI response to increasing volume of hemorrhage was unaltered when control and mild TBI groups were compared (test of interaction p = 0.39). There was a 50% mortality rate observed 20 to 60 minutes after hemorrhage in the moderate TBI group. The SI response to hemorrhage in the moderate TBI group compared with the control group became significantly different at 40% blood volume loss (test of interaction p = 0.048). Comparison of the SI response with hemorrhage between survivors and nonsurvivors of moderate TBI revealed a significant difference (p = 0.007). SI was markedly attenuated in the presence of increasing hemorrhage in the nonsurvivor subgroup of moderate TBI. Conclusions: SI significantly underestimated underlying hemorrhage in the presence of acute TBI of moderate severity where attenuation of the biphasic heart rate and blood pressure response was also most pronounced.	[McMahon, C. Geraldine] St James Hosp, Dept Emergency Med, Trinity Coll, Dublin, Ireland; [Kenny, RoseAnne] Trinity Coll Dublin, Dept Geriart Med, Inst Neurosci, Dublin, Ireland; [Bennett, Katherine] Trinity Coll Dublin, Dept Pharmacol & Therapeut, Trinity Med Sch, Dublin, Ireland; [Little, Rod] Univ Manchester, Manchester, Lancs, England		McMahon, CG (corresponding author), St James Hosp, Dept Emergency Med, Trinity Coll, Dublin, Ireland.	gmcmahon@stjames.ie	McMahon, C Geraldine/M-8684-2019	McMahon, C Geraldine/0000-0002-9870-3104	Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	Funding received from Medical Research Council, UK, as part of the North West Injury Research Program Grant.	Allgower M, 1968, Ger Med Mon, V13, P14; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Barcroft H, 1944, LANCET, V1, P489; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; ELEBUTE EA, 1978, CLIN SCI MOL MED, V54, P431, DOI 10.1042/cs0540431; Evans RG, 2001, CLIN EXP PHARMACOL P, V28, P479, DOI 10.1046/j.1440-1681.2001.03473.x; FEUERSTEIN G, 1986, CIRC SHOCK, V19, P293; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; LITTLE RA, 1995, J ACCID EMERG MED, V12, P1; LITTLE RA, 1990, UPDATE INTENSIVE CAR, P505; Mackway-Jones K, 1999, J TRAUMA, V47, P481, DOI 10.1097/00005373-199909000-00008; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Nakasone Y, 2007, CARDIOVASC INTER RAD, V30, P861, DOI 10.1007/s00270-007-9131-5; OBERG B, 1973, ACTA PHYSIOL SCAND, V88, P8, DOI 10.1111/j.1748-1716.1973.tb05429.x; Ohnishi M, 1998, J TRAUMA, V45, P1024, DOI 10.1097/00005373-199812000-00009; RADY MY, 1992, RESUSCITATION, V23, P227, DOI 10.1016/0300-9572(92)90006-X; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; REDFERN WS, 1984, Q J EXP PHYSIOL CMS, V69, P763, DOI 10.1113/expphysiol.1984.sp002867; SECHER NH, 1984, CIRC SHOCK, V14, P267; TIMMS RJ, 1981, PFLUG ARCH EUR J PHY, V391, P49, DOI 10.1007/BF00580694; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1991, CIRC SHOCK, V35, P231	31	21	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2010	69	5					1169	1175		10.1097/TA.0b013e3181cc8889			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	678VK	WOS:000284110100040	20571456				2022-02-06	
J	Pantaleo, N; Chadwick, W; Park, SS; Wang, LY; Zhou, Y; Martin, B; Maudsley, S				Pantaleo, Nick; Chadwick, Wayne; Park, Sung-Soo; Wang, Liyun; Zhou, Yu; Martin, Bronwen; Maudsley, Stuart			The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Central neurological disorders; substance P; neurokinin A; neurokinin B; neurotherapeutics; receptor-ligand systems; tachykinin	SUBSTANCE-P-LIKE; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID LEVELS; MESENCEPHALIC DOPAMINERGIC-NEURONS; AMYOTROPHIC-LATERAL-SCLEROSIS; FREE MAGNESIUM CONCENTRATION; DISEASE CEREBRAL-CORTEX; PRIMARY SENSORY NEURONS; CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION	Our understanding of the complex signaling neurophysiology of the central nervous system has facilitated the exploration of potential novel receptor-ligand system targets for disorders of this most complex organ. In recent years, many relatively neglected receptor-ligand systems have been re-evaluated with respect to their ability to potently modulate discrete tracts in the central nervous system. One such system is the tachykinin (previously neurokinin) system. The multiple heptahelical G protein-coupled receptors and neuropeptide ligands that comprise this system may be significantly involved in more central nervous systems actions than previously thought, including sleep disorders, amyotrophic lateral sclerosis, Alzheimer's disease and Machado-Joseph disease. The development of our understanding of the role of the tachykinin receptor-ligand system in higher order central functions is likely to allow the creation of more specific and selective tachykinin-related neurotherapeutics.	[Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Biomed Res Ctr, Neurosci Lab,NIH, Baltimore, MD 21224 USA; [Martin, Bronwen] NIA, Metab Unit, Clin Invest Lab, NIH, Baltimore, MD 21224 USA		Maudsley, S (corresponding author), NIA, Receptor Pharmacol Unit, Biomed Res Ctr, Neurosci Lab,NIH, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Pantaleo, Nick/AAE-4452-2021; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	NIH, National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000915, ZIAAG000325, ZIAAG000917, ZIAAG000319, ZIAAG000318] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging. The authors have no conflicts of scientific interest with respect to the manuscript.	Ahmed MM, 2004, NEUROSCIENCE, V126, P639, DOI 10.1016/j.neuroscience.2004.04.024; Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Amadoro G, 2007, NEUROPHARMACOLOGY, V52, P1366, DOI 10.1016/j.neuropharm.2007.01.020; ARMSTRONG DM, 1989, NEUROSCIENCE, V31, P663, DOI 10.1016/0306-4522(89)90431-4; Augood SJ, 1996, NEUROSCIENCE, V72, P1023, DOI 10.1016/0306-4522(95)00595-1; Barker R, 1996, REV NEUROSCIENCE, V7, P187; BEAL MF, 1987, NEUROLOGY, V37, P1205, DOI 10.1212/WNL.37.7.1205; Bondy B, 2003, BIOL PSYCHIAT, V53, P538, DOI 10.1016/S0006-3223(02)01544-5; BONNER TI, 1987, MOL BRAIN RES, V2, P243, DOI 10.1016/0169-328X(87)90031-3; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; BURGUNDER JM, 1989, NEUROSCIENCE, V32, P323, DOI 10.1016/0306-4522(89)90081-X; CADIEUX A, 1986, NEUROSCIENCE, V19, P605, DOI 10.1016/0306-4522(86)90285-X; Calvo N, 1996, BRAIN RES, V740, P323, DOI 10.1016/S0006-8993(96)00879-7; Chadwick W, 2008, TRENDS NEUROSCI, V31, P504, DOI 10.1016/j.tins.2008.07.005; CHANG MM, 1971, NATURE-NEW BIOL, V232, P86, DOI 10.1038/newbio232086a0; Chen LW, 1998, BRAIN RES, V780, P150, DOI 10.1016/S0006-8993(97)01062-7; Chen LW, 2004, CURR DRUG TARGETS, V5, P197, DOI 10.2174/1389450043490596; COOPER PE, 1981, BRAIN RES, V218, P219, DOI 10.1016/0006-8993(81)91302-0; CRAMER H, 1989, EUR NEUROL, V29, P1, DOI 10.1159/000116366; CRYSTAL HA, 1982, J NEUROCHEM, V38, P1781, DOI 10.1111/j.1471-4159.1982.tb06665.x; Cui QL, 2008, NEUROSCI RES, V60, P162, DOI 10.1016/j.neures.2007.10.007; Dawson LA, 2008, NEUROPSYCHOPHARMACOL, V33, P1642, DOI 10.1038/sj.npp.1301549; De Laurentiis A, 2003, REGUL PEPTIDES, V111, P91, DOI 10.1016/S0167-0115(02)00258-6; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; ERSPAMER V, 1962, BRIT J PHARM CHEMOTH, V19, P337, DOI 10.1111/j.1476-5381.1962.tb01198.x; FERRANTE RJ, 1986, NEUROSCI LETT, V71, P283, DOI 10.1016/0304-3940(86)90634-8; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; Furuta T, 2000, J COMP NEUROL, V426, P279, DOI 10.1002/1096-9861(20001016)426:2<279::AID-CNE9>3.0.CO;2-F; Furuta T, 2004, J COMP NEUROL, V473, P43, DOI 10.1002/cne.20087; GAI WP, 1991, BRAIN, V114, P2253, DOI 10.1093/brain/114.5.2253; GARCIARILL E, 1987, BRAIN RES BULL, V18, P731, DOI 10.1016/0361-9230(87)90208-5; GERARD NP, 1993, REGUL PEPTIDES, V43, P21, DOI 10.1016/0167-0115(93)90404-V; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GILLBERG PG, 1982, BRAIN RES, V250, P394, DOI 10.1016/0006-8993(82)90439-5; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; HALLIDAY GM, 1990, NEUROSCIENCE, V39, P81, DOI 10.1016/0306-4522(90)90223-Q; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Herpter I, 2003, WORLD J BIOL PSYCHIA, V4, P56, DOI 10.3109/15622970309167952; ITO H, 1995, ACTA NEUROPATHOL, V89, P513; KAGE R, 1988, J NEUROCHEM, V50, P1412, DOI 10.1111/j.1471-4159.1988.tb03024.x; KALRA PS, 1994, BRAIN RES, V662, P178, DOI 10.1016/0006-8993(94)90810-9; KANGAWA K, 1983, BIOCHEM BIOPH RES CO, V114, P533, DOI 10.1016/0006-291X(83)90813-6; Kart E, 2004, PEPTIDES, V25, P1959, DOI 10.1016/j.peptides.2004.07.003; Kashiba H, 1997, NEUROSCIENCE, V76, P299; KIEFER R, 1993, EUR J NEUROSCI, V5, P775, DOI 10.1111/j.1460-9568.1993.tb00929.x; KIMURA S, 1983, P JPN ACAD B-PHYS, V59, P101, DOI 10.2183/pjab.59.101; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; KOWALL NW, 1993, REGUL PEPTIDES, V46, P174, DOI 10.1016/0167-0115(93)90028-7; Kramer JH, 2003, EXP BIOL MED, V228, P665, DOI 10.1177/153537020322800604; Kramer MS, 2004, NEUROPSYCHOPHARMACOL, V29, P385, DOI 10.1038/sj.npp.1300260; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Krasnova IN, 2000, NEUROSCIENCE, V95, P113; KRAUSE JE, 1987, P NATL ACAD SCI USA, V84, P881, DOI 10.1073/pnas.84.3.881; Kurtz MM, 2002, GENE, V296, P205, DOI 10.1016/S0378-1119(02)00861-2; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lieb K, 1997, J IMMUNOL, V159, P4952; Lieb K, 2002, NEUROPSYCHOPHARMACOL, V27, P1041, DOI 10.1016/S0893-133X(02)00369-X; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; Liu HT, 1999, P NATL ACAD SCI USA, V96, P5286, DOI 10.1073/pnas.96.9.5286; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; MAI JK, 1986, NEUROSCIENCE, V17, P709, DOI 10.1016/0306-4522(86)90041-2; Malcangio M, 2000, EUR J NEUROSCI, V12, P397, DOI 10.1046/j.1460-9568.2000.00946.x; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; MARKSTEINER J, 1992, NEUROSCIENCE, V51, P107, DOI 10.1016/0306-4522(92)90475-H; MARKSTEINER J, 1992, J COMP NEUROL, V317, P341, DOI 10.1002/cne.903170403; Marriott I, 2000, J IMMUNOL, V165, P182, DOI 10.4049/jimmunol.165.1.182; Marriott I, 2001, J NEUROIMMUNOL, V114, P131, DOI 10.1016/S0165-5728(00)00466-5; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; MARTIN FC, 1993, J NEUROIMMUNOL, V42, P53, DOI 10.1016/0165-5728(93)90212-H; MARTIN JB, 1984, NEUROLOGY, V34, P1059, DOI 10.1212/WNL.34.8.1059; Matsuishi T, 1999, J NEURAL TRANSM, V106, P943, DOI 10.1007/s007020050214; Matsuishi T, 1996, J NEUROL SCI, V142, P107, DOI 10.1016/0022-510X(96)00159-1; MAUBORGNE A, 1983, BRAIN RES, V268, P167, DOI 10.1016/0006-8993(83)90403-1; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Maudsley S, 1998, BRIT J PHARMACOL, V124, P675, DOI 10.1038/sj.bjp.0701889; MAUDSLEY S, 1995, BRIT J PHARMACOL, V116, pP444; MAUDSLEY S, 1993, BRIT J PHARMACOL, V110, pP175; Maudsley S, 2007, CURR ALZHEIMER RES, V4, P3, DOI 10.2174/156720507779939850; McCluskey LP, 2001, J NEUROIMMUNOL, V116, P136, DOI 10.1016/S0165-5728(01)00295-8; McCutcheon JE, 2008, EUR J NEUROSCI, V27, P683, DOI 10.1111/j.1460-9568.2008.06043.x; McIntosh TK, 1996, LAB INVEST, V74, P315; Morcuende S, 2003, EUR J NEUROSCI, V18, P1828, DOI 10.1046/j.1460-9568.2003.02911.x; NEWBOLD P, 1995, BRIT J PHARMACOL, V114, P570, DOI 10.1111/j.1476-5381.1995.tb17177.x; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; OHKUBO H, 1991, ANN NY ACAD SCI, V632, P53, DOI 10.1111/j.1749-6632.1991.tb33094.x; Pae CU, 2009, EXPERT OPIN PHARMACO, V10, P1561, DOI 10.1517/14656560902988510; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Phenna S, 1996, BRIT J PHARMACOL, V119, P315, DOI 10.1111/j.1476-5381.1996.tb15988.x; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Pompei P, 2001, J HISTOCHEM CYTOCHEM, V49, P1469, DOI 10.1177/002215540104901114; Preston Z, 2000, NEUROSCI LETT, V284, P89, DOI 10.1016/S0304-3940(00)00968-X; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUIGLEY BJ, 1991, NEUROSCIENCE, V41, P41, DOI 10.1016/0306-4522(91)90199-X; REGOLI D, 1994, PHARMACOL REV, V46, P551; Richfield EK, 2002, MOVEMENT DISORD, V17, P327, DOI 10.1002/mds.10032; RIMON R, 1984, BIOL PSYCHIAT, V19, P509; Rosler N, 2001, J NEURAL TRANSM, V108, P231, DOI 10.1007/s007020170091; Rupniak NMJ, 2000, NEUROPHARMACOLOGY, V39, P1413, DOI 10.1016/S0028-3908(00)00052-6; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Russell IJ, 2002, RHEUM DIS CLIN N AM, V28, P329, DOI 10.1016/S0889-857X(01)00006-0; Salthun-Lassalle B, 2005, MOL PHARMACOL, V68, P1214, DOI 10.1124/mol.105.015453; Sankhala KK, 2009, EXPERT OPIN DRUG MET, V5, P1607, DOI 10.1517/17425250903451675; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SCHEDLOWSKI M, 1995, PSYCHONEUROENDOCRINO, V20, P103, DOI 10.1016/0306-4530(94)00048-4; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; Shughrue PJ, 1996, J COMP NEUROL, V372, P395; Silva RAD, 2000, SYNAPSE, V38, P243, DOI 10.1002/1098-2396(20001201)38:3<243::AID-SYN3>3.0.CO;2-G; SIVAM SP, 1992, J NEUROCHEM, V59, P2278; Sonomura T, 2007, EUR J NEUROSCI, V26, P3093, DOI 10.1111/j.1460-9568.2007.05923.x; Spooren W, 2005, NAT REV DRUG DISCOV, V4, P967, DOI 10.1038/nrd1905; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; TATEMOTO K, 1985, BIOCHEM BIOPH RES CO, V128, P947, DOI 10.1016/0006-291X(85)90138-X; TENOVUO O, 1984, BRAIN RES, V303, P113, DOI 10.1016/0006-8993(84)90217-8; VAEROY H, 1988, PAIN, V32, P21, DOI 10.1016/0304-3959(88)90019-X; Van Belle S, 2002, CANCER-AM CANCER SOC, V94, P3032, DOI 10.1002/cncr.10516; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; von Euler US, 1931, J PHYSIOL-LONDON, V72, P74, DOI 10.1113/jphysiol.1931.sp002763; Weiss DW, 1996, BEHAV MED, V22, P5, DOI 10.1080/08964289.1996.9933760; Whitty CJ, 1997, J COMP NEUROL, V382, P394; Willis M, 2007, BRAIN RES, V1143, P199, DOI 10.1016/j.brainres.2007.01.080; WOIE K, 1993, CIRC RES, V73, P839, DOI 10.1161/01.RES.73.5.839; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yew DT, 1999, EXP GERONTOL, V34, P117, DOI 10.1016/S0531-5565(98)00017-5; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006; Zachrisson O, 1998, MOL BRAIN RES, V60, P291, DOI 10.1016/S0169-328X(98)00191-0; Zhang X, 2008, NEUROPHARMACOLOGY, V54, P1143, DOI 10.1016/j.neuropharm.2008.03.005; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	135	21	21	0	7	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	NOV	2010	9	5					627	635		10.2174/187152710793361504			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	685HW	WOS:000284620800011	20632965	Green Accepted			2022-02-06	
J	Moon, RJ; Sutton, T; Wilson, PM; Kirkham, FJ; Davies, JH				Moon, Rebecca Jane; Sutton, Timothy; Wilson, Peter Murray; Kirkham, Fenella Jane; Davies, Justin Huw			Pituitary Function at Long-Term Follow-Up of Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						growth hormone deficiency; pituitary; traumatic brain injury	QUALITY-OF-LIFE; GROWTH-HORMONE DEFICIENCY; BODY-COMPOSITION; REFERENCE CURVES; INTENSIVE-CARE; HYPOPITUITARISM; CHILDREN; PREVALENCE; INSUFFICIENCY; RELIABILITY	Pituitary dysfunction is a recognized sequela of traumatic brain injury (TBI), occurring in 10-83% of adult patients, but there are few data on the prevalence or natural history in childhood. Our objective was to determine pituitary function in children and young adults at least 4 years after TBI requiring pediatric intensive care unit (PICU) admission. The effects of TBI and hypopituitarism on height, adiposity, and quality of life (QOL) were also evaluated. Unselected patients discharged from the regional PICU with TBI (age<18 years at injury) from 1999-2004 were recruited. Blood and urine samples were collected for baseline pituitary function testing. Height and weight were measured. Adiposity was assessed by mid-upper arm and waist circumferences, and body fat percentage estimation using four-site skinfold thickness and bioelectrical impedance. Auxology and adiposity data were compared to local age-and sex-matched healthy control data. QOL questionnaires (PedsQL 4.0 and QOL-AGHDA) were completed. Twenty subjects (median age 16.7 years, range 9.2-23.3 years, 13 male) of 127 who were eligible agreed to participate at a median of 6.8 years (range 4.2-10.3 years) since TBI. Markers of injury were higher in those recruited than those who were not. Biochemical evidence of hypopituitarism was identified in only one case, possibly related to comorbid pre-existing attention deficit-hyperactivity disorder. Height, weight, and adiposity were similar to healthy controls. Poor QOL was seen in patients with chronic functional deficits or comorbidities. Overall, pituitary dysfunction was less prevalent than in previous studies in adults and children. The results of this study do not support the use of routine endocrine evaluation of children following TBI.	[Wilson, Peter Murray; Davies, Justin Huw] Southampton Univ Hosp NHS Trust, Paediat Intens Care Unit, Southampton SO16 6YD, Hants, England		Davies, JH (corresponding author), Southampton Univ Hosp NHS Trust, Paediat Intens Care Unit, Tremona Rd, Southampton SO16 6YD, Hants, England.	justin.davies@suht.swest.nhs.uk	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958; Davies, Justin/0000-0001-7560-6320	Pfizer Ltd.Pfizer	Peer-review funding from Pfizer Ltd. grant scheme contributed to funding of this study.	Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Benvenga S, 2004, AM J MED, V116, P767, DOI 10.1016/j.amjmed.2003.12.038; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Faraone SV, 2008, J AM ACAD CHILD PSY, V47, P994, DOI [10.1097/CHI.0b013e31817e0ea7, 10.1097/CHI.ObO13e31817eOea7]; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gandrud LM, 2004, GROWTH HORM IGF RES, V14, P185, DOI 10.1016/j.ghir.2003.11.003; Gasco V, 2008, PITUITARY, V11, P121, DOI 10.1007/s11102-008-0110-x; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 1996, J CLIN ENDOCR METAB, V81, P3323, DOI 10.1210/jc.81.9.3323; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goldman M, 1997, PEDIATR NEUROL, V17, P339, DOI 10.1016/S0887-8994(97)00168-9; Hoeck HC, 1999, GROWTH HORM IGF RES, V9, P18, DOI 10.1054/ghir.1998.0085; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; JENNETT B, 1975, LANCET, V1, P480; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pesce M., 2007, NELSON TXB PEDIAT, V18th ed, P2943; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4251, DOI 10.1210/jc.2009-0779; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Stanley TL, 2009, J CLIN ENDOCR METAB, V94, P4875, DOI 10.1210/jc.2009-1369; Stouthart PJHM, 1999, J PEDIATR ENDOCR MET, V12, P335; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	53	21	21	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2010	27	10					1827	1835		10.1089/neu.2010.1408			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	665OZ	WOS:000283046600007	20684673				2022-02-06	
J	Ekmark-Lewen, S; Lewen, A; Meyerson, BJ; Hillered, L				Ekmark-Lewen, Sara; Lewen, Anders; Meyerson, Bengt J.; Hillered, Lars			The Multivariate Concentric Square Field Test Reveals Behavioral Profiles of Risk Taking, Exploration, and Cognitive Impairment in Mice Subjected to Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; functional outcome; mouse; Multivariate Concentric Square Field Test; traumatic brain injury	WATER MAZE PERFORMANCE; CORTICAL IMPACT MODEL; MUS-MUSCULUS-MUSCULUS; 2 LABORATORY STRAINS; MOTOR DEFICITS; RATS; MOUSE; RESPONSES; STRATEGIES; OUTCOMES	There is a need for more efficient tests to evaluate functional outcome following experimental traumatic brain injury (TBI), reflecting deficits in cognitive, sensory, and motor functions that are seen in TBI patients. The Multivariate Concentric Square Field (TM) (MCSF) test is a relatively new behavioral model that measures exploration, risk taking, risk assessment, and shelter seeking, all of which are evolutionarily-conserved strategies for survival. The multivariate design enables scoring of different functional domains in a single test situation, with a free choice of optional environmental settings. Furthermore, repeated trials permits cognitive effects to be measured. In the present study, 11 anesthetized C57BL6 mice received controlled cortical injury (CCI) (0.5mm and 3.3 m/sec) over the right parietal cerebral cortex or sham surgery (n - 12). Naive mice (n 12) not subjected to any surgical procedure were also included. The animals were evaluated in the MCSF test at 2 and 7 days post-surgery, and behavioral profiles were analyzed. The results revealed differences in risk taking and explorative behavior between the sham animals and the animals subjected to trauma. Animals subjected to trauma were characterized by taking more risks and had a higher level of exploration activity, but they sought less shelter. Repeated exposure to the MCSF caused a general decrease in activity in the naive and sham group, while a more specific behavioral impairment was seen in injured mice, suggesting cognitive dysfunction. We submit that the MCSF test is a useful complementary tool for functional outcome evaluation in experimental TBI.	[Ekmark-Lewen, Sara; Lewen, Anders; Hillered, Lars] Uppsala Univ, Dept Neurosci, Univ Uppsala Hosp, SE-75185 Uppsala, Sweden; [Meyerson, Bengt J.] Uppsala Univ, Biomed Ctr, Dept Neurosci, Div Pharmacol, SE-75185 Uppsala, Sweden		Ekmark-Lewen, S (corresponding author), Uppsala Univ, Dept Neurosci, Univ Uppsala Hosp, SE-75185 Uppsala, Sweden.	Sara.Ekmark-Lewen@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Hillered, Lars/0000-0002-2808-9292	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; Swedish Brain Foundation; Ahlen Foundation; Uppsala University Hospital	This work was supported by grants from the Swedish Medical Research Council, the Swedish Brain Foundation, the Ahlen Foundation, and Uppsala University Hospital.	Alsio J, 2009, GENES BRAIN BEHAV, V8, P193, DOI 10.1111/j.1601-183X.2008.00464.x; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Augustsson H, 2005, PHYSIOL BEHAV, V84, P265, DOI 10.1016/j.physbeh.2004.12.002; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; CLAUSEN F, 2001, 31 ANN M SOC NEUR SA; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Johansson E., 2006, MULTI MEGAVARIATE 1; Karlsson O, 2009, TOXICOL SCI, V112, P185, DOI 10.1093/toxsci/kfp196; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marques JM, 2008, PHYSIOL BEHAV, V93, P139, DOI 10.1016/j.physbeh.2007.08.006; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Meyerson BJ, 2006, BEHAV BRAIN RES, V168, P100, DOI 10.1016/j.bbr.2005.10.020; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Roman E, 2007, BEHAV BRAIN RES, V183, P195, DOI 10.1016/j.bbr.2007.06.009; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; Roman E, 2009, BEHAV BRAIN RES, V205, P249, DOI 10.1016/j.bbr.2009.08.020; Roos MW, 2003, BRAIN RES, V961, P15, DOI 10.1016/S0006-8993(02)03829-5; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002	44	21	21	1	8	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1643	1655		10.1089/neu.2009.0953			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500011	20578827				2022-02-06	
J	Eastman, CL; Verley, DR; Fender, JS; Temkin, NR; D'Ambrosio, R				Eastman, Clifford L.; Verley, Derek R.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo			ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Posttraumatic epilepsy; Neocortical epilepsy; Trauma; Screening; In vivo; EEG; Partial seizure; Pharmacoresistance; Fluid percussion injury; Remission; Bootstrap	COMPLEX PARTIAL SEIZURES; FLUID PERCUSSION INJURY; ANTIEPILEPTIC DRUGS; CROSS-TOLERANCE; BRAIN-INJURY; MODEL; RESISTANCE; IDENTIFICATION; LEVETIRACETAM; PROGRESSION	The use of electrocorticography (ECoG) with etiologically realistic epilepsy models promises to facilitate the discovery of better anti-epileptic drugs (AEDs). However, this novel approach is labor intensive, and must be optimized. To this end, we employed rostral parasagittal fluid percussion injury (rpFPI) in the adolescent rat, which closely replicates human contusive closed head injury and results in posttraumatic epilepsy (PTE). We systematically examined variables affecting the power to detect anti-epileptic effects by ECoG and used a non-parametric bootstrap strategy to test several different statistics, study designs, statistical tests, and impact of non-responders. We found that logarithmically transformed data acquired in repeated-measures experiments provided the greatest statistical power to detect decreases in seizure frequencies of preclinical interest with just 8 subjects and with up to similar to 40% non-responders. We then used this optimized design to study the anti-epileptic effects of acute exposure to halothane, and chronic (1 week) exposures to carbamazepine (CBZ) and valproate (VPA) 1 month post-injury. While CBZ was ineffective in all animals, VPA induced, during treatment, a progressive decrease in seizure frequency in animals primarily suffering from non-spreading neocortical seizures, but was ineffective in animals with a high frequency of spreading seizures. Halothane powerfully blocked all seizure activity. The data show that rpFPI and chronic ECoG can conveniently be employed for the evaluation of AEDs, suggest that VPA may be more effective than CBZ to treat some forms of PTE, and support the theory that pharmacoresistance may depend on the severity of epilepsy. The data also demonstrate the utility of chronic exposures to experimental drugs in preclinical studies and highlight the need for greater attention to etiology in clinical studies of AEDs. (C) 2010 Elsevier Inc. All rights reserved.	[Eastman, Clifford L.; Verley, Derek R.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98104 USA; [D'Ambrosio, Raimondo] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98104 USA; [D'Ambrosio, Raimondo] Univ Washington, Sch Med, Reg Epilepsy Ctr, Seattle, WA 98104 USA		D'Ambrosio, R (corresponding author), Harborview Med Ctr, UW Dept Neurosurg, Box 359915,325 9th Ave, Seattle, WA 98104 USA.	raid@u.washington.edu	Verley, Derek/J-4550-2015	Verley, Derek/0000-0002-2670-6568	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS053928]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053928] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health [NS053928 to RD]. We thank Drs. Shahin Hakimian, John W. Miller and Emilio Perucca for helpful discussion and review of the manuscript.	Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; BALISH M, 1991, EPILEPSIA, V32, P642, DOI 10.1111/j.1528-1157.1991.tb04703.x; Bancaud J, 1992, Adv Neurol, V57, P3; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; BEGHI E, 1992, EPILEPSIA, V33, P45; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Bethmann K, 2007, EPILEPSIA, V48, P816, DOI 10.1111/j.1528-1167.2007.00980.x; Blum DE, 1996, NEUROLOGY, V47, P260, DOI 10.1212/WNL.47.1.260; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DELGADOESCUETA AV, 1982, NEW ENGL J MED, V306, P1337, DOI 10.1056/NEJM198206033062205; DELGADOESCUETA AV, 1983, NEW ENGL J MED, V308, P1576, DOI 10.1056/NEJM198306303082607; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Efron B, 1998, INTRO BOOTSTRAP, V2nd; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Gilliam F, 2004, NEUROLOGY, V63, pS9, DOI 10.1212/WNL.63.10_suppl_4.S9; Grabenstatter HL, 2005, EPILEPSIA, V46, P8, DOI 10.1111/j.0013-9580.2005.13404.x; Haut SR, 2005, EPILEPSIA, V46, P146, DOI 10.1111/j.0013-9580.2005.29004.x; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; JUULJENSEN P, 1986, INTRACTABLE EPILEPSY, P5; Karceski S, 2005, EPILEPSY BEHAV, V7, pS1, DOI 10.1016/j.yebeh.2005.06.001; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Klein PM, 2009, EPILEPSIA, V50, P385; Kraus J, 2000, HEAD INJURY, P1; Krupp E, 2000, EXP NEUROL, V162, P278, DOI 10.1006/exnr.1999.7343; Kwan P, 2003, NEUROLOGY, V60, pS2, DOI 10.1212/WNL.60.11_suppl_4.S2; LANGENDORF FG, 2008, EPILEPSY COMPREHENSI, P2537; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; LOSCHER W, 1995, EPILEPSIA, V36, P929, DOI 10.1111/j.1528-1157.1995.tb01637.x; Loscher W, 2002, CNS DRUGS, V16, P669; Luders H O, 1992, Adv Neurol, V57, P149; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; Mattson RH, 1996, NEUROLOGY, V47, P68, DOI 10.1212/WNL.47.1.68; Meldrum B, 2002, EPILEPSY RES, V50, P33, DOI 10.1016/S0920-1211(02)00066-9; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Murao Kohei, 2002, J Anesth, V16, P34, DOI 10.1007/s540-002-8092-0; Nissinen J, 2007, EPILEPSY RES, V73, P181, DOI 10.1016/j.eplepsyres.2006.10.003; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; Rogawski Michael A, 2008, Epilepsy Curr, V8, P127, DOI 10.1111/j.1535-7511.2008.00272.x; ROPPER AH, 1986, ANN NEUROL, V19, P98, DOI 10.1002/ana.410190124; Schmidt D, 2002, EPILEPSY RES, V50, P71, DOI 10.1016/S0920-1211(02)00070-0; Schmidt D, 2009, EPILEPSY CURR, V9, P47, DOI 10.1111/j.1535-7511.2008.01289.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; Stables James P., 2002, Epilepsia, V43, P1410, DOI 10.1046/j.1528-1157.2002.06702.x; Tatum WO, 2001, J CLIN NEUROPHYSIOL, V18, P14, DOI 10.1097/00004691-200101000-00004; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; van Vliet EA, 2008, EPILEPSIA, V49, P1151, DOI 10.1111/j.1528-1167.2007.01516.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; White H.S., 1998, NEUROPHARMACOLOGY ME, P27; White HS, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s7.10.x; White HS, 2002, NEUROLOGY, V59, pS7, DOI 10.1212/WNL.59.9_suppl_5.S7; Williams PA, 2007, NEUROSCIENCE, V149, P943, DOI 10.1016/j.neuroscience.2007.07.067; WILLIAMSON PD, 1986, EPILEPSIA, V27, pS46, DOI 10.1111/j.1528-1157.1986.tb05740.x; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413; Zhang ZJ, 2003, EPILEPSIA, V44, P1487, DOI 10.1111/j.0013-9580.2003.34803.x	67	21	21	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2010	224	2					369	388		10.1016/j.expneurol.2010.04.013			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	631II	WOS:000280339600007	20420832	Green Accepted, Green Submitted			2022-02-06	
J	Georgoff, P; Meghan, S; Mirza, K; Stein, SC				Georgoff, Patrick; Meghan, Sudha; Mirza, Kasim; Stein, Sherman C.			Geographic Variation in Outcomes from Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Epidemiology; Mortality; Outcomes; Traumatic brain injury	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; MULTIMODALITY EVOKED-POTENTIALS; SAN-DIEGO-COUNTY; COMPUTERIZED-TOMOGRAPHY; INTRACRANIAL-PRESSURE; EARLY PREDICTION; PROGNOSTIC VALUE; INTENSIVE-CARE; SUBARACHNOID HEMORRHAGE	BACKGROUND: Recent reports have documented a wide range of outcomes after treatment of severe traumatic brain injury at trauma centers throughout the world. METHODS: In an effort to test the contribution of geography to treatment outcome, we compared case series published from 1975 to 2009. Trauma centers were divided into those from the United States, other developed countries, and the developing world. We pooled data on mortality rates using meta-analytic techniques, and corrected for temporal trends and other covariates using meta-regression. RESULTS: Our search yielded 231 case series, totaling more than 121,000 cases. There was a decrease in mortality over time in all three geographic locales. The small advantage the United States had versus other high and moderate income countries tended to decrease over time, whereas low income countries reported significantly greater mortality, and their rates decreased more slowly over time. CONCLUSIONS: Low income countries have the highest mortality rates in treating patients with severe closed traumatic brain injury. The lower intensity of treatment appears to be the largest contributor to the discrepancy, and other possible causes are discussed.	[Georgoff, Patrick; Meghan, Sudha; Mirza, Kasim; Stein, Sherman C.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Stein, SC (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	sherman.stein@uphs.upenn.edu					Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; ANDERSON DW, 1983, PUBLIC HEALTH REP, V98, P475; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; Auer L, 1979, Acta Neurochir Suppl (Wien), V28, P171; Baguley I, 2000, BRAIN INJURY, V14, P505; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Benzer A, 1995, Anasthesiol Intensivmed Notfallmed Schmerzther, V30, P231, DOI 10.1055/s-2007-996481; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; BRAIN TRAUM FD, 2000, J NEUROTRAUM, V17, P563; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; BROWNE LA, 1977, IRISH MED J, V70, P197; BUCHMANN B, 1992, J TRAUMA, V32, P459, DOI 10.1097/00005373-199204000-00009; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BULLIET M, 2005, NY POST, P3; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Douglas IS, 2005, LANCET, V365, P212; Dunn LT, 2000, BRIT J NEUROSURG, V14, P219; EDDY VA, 1995, AM SURGEON, V61, P24; EDNA TH, 1983, ACTA NEUROCHIR, V69, P15, DOI 10.1007/BF02055848; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Einarson TR, 1997, CLIN THER, V19, P559, DOI 10.1016/S0149-2918(97)80140-3; Eker C, 2000, BRAIN INJURY, V14, P605; El-Gindi S., 2001, REV ESPANOLA NEUROPS, V3, P3; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Enderson BL, 2007, J TRAUMA, V62, P33; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; ESPERSEN JO, 1982, ACTA NEUROCHIR, V65, P81, DOI 10.1007/BF01405444; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2004, ACT NEUR S, V89, P101; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FELDMAN Z, 1991, LANCET, V337, P1451, DOI 10.1016/0140-6736(91)93137-X; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GALBRAITH S, 1977, SCOT MED J, V22, P129, DOI 10.1177/003693307702200208; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GIBSON RM, 1989, LANCET, V2, P369; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Goosen J, 2003, INJURY, V34, P704, DOI 10.1016/S0020-1383(03)00153-0; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Gujral IB, 2006, BRAIN INJURY, V20, P283, DOI 10.1080/02699050500488058; Habbema J D, 1979, Acta Neurochir Suppl (Wien), V28, P158; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1979, Int Anesthesiol Clin, V17, P133, DOI 10.1097/00004311-197917020-00006; JENNETT B, 1976, LANCET, V1, P1031; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jin PHPFK, 2008, J NEUROTRAUM, V25, P1003, DOI 10.1089/neu.2007.0463; Joshipura MK, 2008, WORLD J SURG, V32, P1613, DOI 10.1007/s00268-008-9634-5; Joshipura MK, 2003, INJURY, V34, P686, DOI 10.1016/S0020-1383(03)00163-3; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KAGAN RJ, 1994, AM SURGEON, V60, P394; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Kim Y, 2000, J TRAUMA, V48, P280, DOI 10.1097/00005373-200002000-00014; KING JT, 1995, J NEUROSURG, V83, P403, DOI 10.3171/jns.1995.83.3.0403; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KLEIN DG, 1999, NURS CLIN N AM, V11, P209; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lane PL, 2000, CAN J SURG, V43, P442; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; LIU HM, 1995, J TRAUMA, V38, P330, DOI 10.1097/00005373-199503000-00003; Lobato R D, 1979, Acta Neurochir Suppl (Wien), V28, P70; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; Lu J, 2005, ACT NEUR S, V95, P281; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; McSwain NE, 2004, J TRAUMA, V57, P8; Miller J D, 1979, Acta Neurochir Suppl (Wien), V28, P86; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY GD, 1986, STAT MED, V5, P103, DOI 10.1002/sim.4780050202; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nathens A B, 2001, Adv Surg, V35, P61; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; Oakley PA, 2004, INJURY, V35, P379, DOI 10.1016/S0020-1383(03)00096-2; Odebode TO, 2008, NIGER J CLIN PRACT, V11, P265; Ogungbo B, 2004, J AM COLL SURGEONS, V198, P852, DOI 10.1016/j.jamcollsurg.2004.02.003; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; Peden M., 2004, WORLD REPORT ROAD TR; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Pillai SV, 2003, NEUROL INDIA, V51, P345; Price D J, 1979, Acta Neurochir Suppl (Wien), V28, P179; Pryor JP, 2003, J TRAUMA, V55, P442; Raja IA, 2001, WORLD J SURG, V25, P1230; Ramesh VG, 2008, J CLIN NEUROSCI, V15, P1110, DOI 10.1016/j.jocn.2007.08.033; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Richard K E, 1979, Acta Neurochir Suppl (Wien), V28, P66; RIMEL RW, 1981, RESUSCITATION, V9, P75, DOI 10.1016/0300-9572(81)90036-8; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Rudnik A, 1992, Acta Neurochir Suppl (Wien), V55, P33; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shavelle R, 2000, J Insur Med, V32, P163; Siddiqui Arshad A, 2004, J Coll Physicians Surg Pak, V14, P173; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2001, Eur J Emerg Med, V8, P215, DOI 10.1097/00063110-200109000-00009; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Sundbarg G, 1989, Brain Inj, V3, P283, DOI 10.3109/02699058909029641; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Sutton A.J., 2000, METHODS METAANALYSIS; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Tsementzis S A, 1979, Acta Neurochir Suppl (Wien), V28, P78; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581; Winchell RJ, 1998, J TRAUMA, V45, P104; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; [No title captured]; [No title captured]	248	21	22	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG-SEP	2010	74	2-3					331	345		10.1016/j.wneu.2010.03.025			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	792WM	WOS:000292781100037	21492567				2022-02-06	
J	Ho, KM; Burrell, M; Rao, S				Ho, Kwok M.; Burrell, Maxine; Rao, Sudhakar			Extracranial injuries are important in determining mortality of neurotrauma	CRITICAL CARE MEDICINE			English	Article						hypoxia; injury severity; outcome; prognosis; prediction; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERITY SCORE; HEAD-INJURY; SURVIVAL; LINKAGE	Objective: This study aimed to assess the significance of extracranial injuries, as measured by Injury Severity Score, on 6-mo and 9-yr mortality of neurotrauma. Design: Retrospective linked data cohort study. Setting: A major neurotrauma center in Western Australia. Patients: Six hundred eighty-three adult neurotrauma patients. Measurements and Main Results: Data were first used to validate the largest published international neurotrauma "extended" mortality prognostic model, in which extracranial injuries are considered significant if the patient has hypoxemia or hypotension on admission. Logistic and Cox regression, incorporating bootstrap techniques to adjust for overfitting, were used to assess the significance of Injury Severity Score in determining 6-mo and 9-yr mortality, respectively. Among a total of 683 patients admitted between 1994 and 2002, 636 (93.1%) had extracranial injuries. The international neurotrauma "extended" mortality prognostic model was poorly calibrated and underestimated the observed mortality (slope and intercept of the calibration curve were 2.14 and 0.35, respectively) when applied to our patients. Incorporating Injury Severity Score into the model improved its calibration. Injury Severity Score accounted for 11% of the variability and was the third most important factor after Marshall computed tomographic grading (17.8%) and pupil reactivity (14.5%) in determining 6-mo mortality. There was a notable increase in mortality between 6-mo (19.2%) and 24-mo follow-up (25.8%). Injury Severity Score remained important and accounted for 9.2% of the variability in determining 9-yr mortality after the injury. Conclusions: Hypotension and hypoxemia on admission were inadequate markers of extracranial injuries; incorporating more comprehensive extracranial injury assessment by the Injury Severity Score to the standard neurologic prognostic factors improved the accuracy of predictions on mortality after neurotrauma. (Crit Care Med 2010; 38:1562-1568)	[Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Burrell, Maxine; Rao, Sudhakar] Royal Perth Hosp, Trauma Serv, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia		Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004	BUPA; Medical Research Foundation of Royal Perth Hospital	The BUPA and Medical Research Foundation of Royal Perth Hospital funded the data linkage process involved in this study. No funding was received from the National Institutes of Health, Wellcome Trust, HHMI, or others.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brenneman FD, 1997, J TRAUMA, V42, P773, DOI 10.1097/00005373-199705000-00003; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Harrell FE Jr, 2017, REGRESSION MODELING; Ho KM, 2007, J CLIN EPIDEMIOL, V60, P746, DOI 10.1016/j.jclinepi.2006.10.017; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; LI G, 2009, CHEST           1016; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P373; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Williams TA, 2006, ANAESTH INTENS CARE, V34, P307, DOI 10.1177/0310057X0603400316	22	21	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2010	38	7					1562	1568		10.1097/CCM.0b013e3181e2ccd8			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	612RL	WOS:000278920000008	20526198				2022-02-06	
J	Reavenall, S; Blake, H				Reavenall, Sarah; Blake, Holly			Determinants of physical activity participation following traumatic brain injury	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						barriers; brain injury; determinants; physical activity	NOTTINGHAM EXTENDED ACTIVITIES; GENERAL HEALTH QUESTIONNAIRE; SPINAL-CORD-INJURY; DAILY LIVING SCALE; SELF-EFFICACY; EXERCISE BEHAVIOR; PSYCHOSOCIAL PREDICTORS; ACTIVITY PATTERNS; SOCIAL SUPPORT; BARRIERS	Aims: The objective of the study described in this article was to establish the environmental, social, or personal determinants associated with physical activity participation in people with traumatic brain injury (TBI). Methods: A multi-centre cross-sectional questionnaire survey using a convenience sample was used at eight community day centres for brain injured populations. The participants were 63 individuals with traumatic brain injury (51 male, 12 female). Physical activity participation was based on the proportion of participants achieving the level of physical activity recommended for health (30 mins moderate activity, most days of the week). Standardized measures were used to assess activities of daily living (Extended Activities of Daily Living Scale), self-efficacy (Self-Efficacy for Exercise Scale), social support (Social Support for Exercise Scale) and mood (General Health Questionnaire-12). Findings: Over half the participants were not active enough for health benefit. Active participants were more independent in activities of daily living (t = -2.21, P < 0.05), had greater self-efficacy for exercise (t = -3.02, P < 0.05) and were more educated (chi(2)= 5.61, P < 0.05) than inactive participants. Logistic Regression showed self-efficacy for exercise to be the only significant predictor of physical activity participation (beta = 0.32, OR 1.03, P < 0.05). Conclusions: Self-efficacy predicted physical activity participation. Efforts to increase self-efficacy among brain injured participants may encourage activity participation in those who are able and this warrants further investigation.	[Reavenall, Sarah] Univ Hosp Birmingham NHS Fdn Trust, New Queen Elizabeth Hosp, Burns Ctr, Birmingham, W Midlands, England; [Blake, Holly] Queens Med Ctr, Fac Med & Hlth Sci, Div Nursing, Nottingham, England		Blake, H (corresponding author), Queens Med Ctr, Fac Med & Hlth Sci, Div Nursing, Nottingham, England.	Holly.Blake@nottingham.ac.uk	Blake, Holly/B-8855-2008	Blake, Holly/0000-0003-3080-2306			Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Blake H, 2009, PHYS ACTIVITY REHABI; Blake H, 2008, INT J THER REHABIL, V15, P180, DOI 10.12968/ijtr.2008.15.4.29037; Bulley C, 2008, INT J HEALTH PROMOT, V46, P4, DOI 10.1080/14635240.2008.10708121; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Chipperfield JG, 2008, GERONTOLOGIST, V48, P349, DOI 10.1093/geront/48.3.349; Dawes H, 2009, PHYS ACTIVITY REHABI; *DEP HLTH, 2005, CHOOS ACT PHYS ACT A; *DEP HLTH, 2004, CHOOS HLTH; *DEP HLTH, 2004, HLTH SURV ENGL 2003; *DEP HLTH, 2004, AT LEAST 5 WEEK EV I; Department of Health, 2009, BE ACT BE HLTH PLAN; Department of Health, 2005, NAT SERV FRAM LONG T; Donath S, 2001, AUST NZ J PSYCHIAT, V35, P231, DOI 10.1046/j.1440-1614.2001.00869.x; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Elsworth C, 2010, J SPORT SCI IN PRESS; Elsworth C, 2009, INT J THER REHABIL, V16, P17, DOI 10.12968/ijtr.2009.16.1.37936; Elsworth C, 2009, CLIN REHABIL, V23, P171, DOI 10.1177/0269215508098895; Emmons KM, 2007, HEALTH EDUC BEHAV, V34, P315, DOI 10.1177/1090198106288011; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Gleeson-Kreig JM, 2006, DIABETES EDUCATOR, V32, P69, DOI 10.1177/0145721705284285; Goldberg D., 1988, USERS GUIDE GEN HLTH; GOMPERTZ P, 1994, CLIN REHABIL, V8, DOI DOI 10.1177/026921559400800401; Hankins M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-355; Harnirattisai T, 2005, NURS RES, V54, P97; Harwood RH, 2002, DISABIL REHABIL, V24, P371, DOI 10.1080/09638280110101541; Hassett LM, 2008, COCHRANE DB SYST REV, V2, P1; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Heller T., 2003, J GERONTOL SOC WORK, V38, P161, DOI [DOI 10.1300/J083V38N01_03, 10.1300/J083v38n01_03]; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; Jacob KS, 1997, PSYCHOL MED, V27, P1215, DOI 10.1017/S0033291796004436; Jones KD, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-67; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; KING AC, 1995, CIRCULATION, V91, P2596, DOI 10.1161/01.CIR.91.10.2596; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lee S. L., 2008, Q ACTIVE FINAL REPOR; Levins SM, 2004, PHYS THER, V84, P496, DOI 10.1093/ptj/84.6.496; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nicholl CR, 2002, MULT SCLER, V8, P372, DOI 10.1191/1352458502ms827oa; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Okubadejo AA, 1997, EUR RESPIR J, V10, P1572, DOI 10.1183/09031936.97.10071572; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Piperidou Eleana, 2008, Br J Community Nurs, V13, P271; Plasqui G, 2004, OBES RES, V12, P688, DOI 10.1038/oby.2004.80; Resnick B, 2000, NURS RES, V49, P154, DOI 10.1097/00006199-200005000-00007; Resnick Barbara, 2004, J Nurs Meas, V12, P235, DOI 10.1891/106137404780954579; Rimmer JH, 2008, J REHABIL RES DEV, V45, P315, DOI 10.1682/JRRD.2007.02.0042; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rogers LQ, 2008, SUPPORT CARE CANCER, V16, P19, DOI 10.1007/s00520-007-0293-0; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Sharpe PA, 2008, AM J HEALTH BEHAV, V32, P701, DOI 10.5555/ajhb.2008.32.6.701; Simonavice EM, 2008, PERCEPT MOTOR SKILL, V107, P946, DOI 10.2466/PMS.107.3.946-950; Steptoe A, 2000, PREV MED, V31, P183, DOI 10.1006/pmed.2000.0688; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Vissers M, 2008, J REHABIL MED, V40, P461, DOI 10.2340/16501977-0191; Wallace LS, 2000, PREV MED, V31, P494, DOI 10.1006/pmed.2000.0736; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Williams DM, 2008, ANN BEHAV MED, V36, P186, DOI 10.1007/s12160-008-9054-7; World Health Organization, 2007, INT CLASS FUNCT DIS; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	70	21	21	1	1	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	JUL	2010	17	7					360	367		10.12968/ijtr.2010.17.7.48893			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V05FH	WOS:000213858000006		Green Submitted, Green Accepted			2022-02-06	
J	Lima, FB; Bethea, CL				Lima, F. B.; Bethea, C. L.			Ovarian steroids decrease DNA fragmentation in the serotonin neurons of non-injured rhesus macaques	MOLECULAR PSYCHIATRY			English	Article						apoptosis; TUNEL; estrogen; progesterone; serotonin; dorsal raphe nucleus	TRAUMATIC BRAIN-INJURY; APOPTOTIC CELL-DEATH; PROGESTIN RECEPTORS; MESSENGER-RNA; RAPHE NEURONS; ESTROGEN; NEUROPROTECTION; MECHANISMS; EXPRESSION; ISCHEMIA	We previously found that ovarian steroids promote neuroprotection in serotonin neurons by decreasing the expression of pro-apoptotic genes and proteins in the dorsal raphe nucleus of rhesus macaques, even in the absence of overt injury. In this study, we questioned whether these actions would lead to a reduction in DNA fragmentation in serotonin neurons. Ovariectomized (OVX) rhesus monkeys were implanted with silastic capsules that were empty (placebo) or containing estradiol (E), progesterone (P) or estradiol and progesterone (E+P) for 1 month. In all animals, eight levels of the dorsal raphe nucleus in a rostral-to-caudal direction were immunostained using the terminal deoxynucleotidyl transferase nick end labeling (TUNEL) method. Two staining patterns were observed, which are referred to as type I, with complete dark staining of the nucleus, and type II, with peripheral staining in the perinuclear area. A montage of the dorsal raphe was created at each level with a Marianas Stereology Microscope and Slidebook 4.2, and the TUNEL-positive cells were counted. In direct comparison with OVX animals, P treatment and E+P treatment significantly reduced the total number of TUNEL-positive cells (Mann-Whitney test, both treatments P = 0.04) and E+P treatment reduced the number of TUNEL-positive cells per mm(3) (Mann-Whitney test, P = 0.04). Double immunocytochemistry for TUNEL and tryptophan hydroxylase (TPH) indicated that DNA fragmentation was prominent in serotonin neurons. These data suggest that in the absence of ovarian steroids, a cascade of gene and protein expression leads to an increase in DNA fragmentation in serotonin neurons. Conversely, ovarian steroids have a neuroprotective role in the non-injured brain and prevent DNA fragmentation and cell death in serotonin neurons of nonhuman primates. Molecular Psychiatry (2010) 15, 657-668; doi: 10.1038/mp.2009.97; published online 13 October 2009	[Lima, F. B.; Bethea, C. L.] Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR 97006 USA; [Bethea, C. L.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA		Bethea, CL (corresponding author), Oregon Natl Primate Res Ctr, Div Reprod Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	betheac@ohsu.edu	Lima, Fernanda B/G-3670-2015	Lima, Fernanda B/0000-0002-9177-0814	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH 62677]; Oregon National Primate Research Center [U54-HD18185, RR00163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD018185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS061800] Funding Source: NIH RePORTER	We are deeply grateful to the dedicated staff of the Division of Animal Resources, including the staff of the Departments of Surgery and Pathology, for their expertise and helpfulness in all aspects of monkey management. We especially thank Dr Jessica Henderson for cutting the midbrain brain blocks and organizing the sections. We are indebted to the Endocrine Services Laboratory for radioimmunoassay of steroid hormones. This research was supported by the National Institutes of Health Grants MH 62677 ( to CLB), and Grants U54-HD18185 and RR00163 in support of the Oregon National Primate Research Center.	Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Benninghoff J, 2002, J NEURAL TRANSM, V109, P947, DOI 10.1007/s007020200078; Bethea CL, 2006, J PSYCHIATR NEUROSCI, V31, P105; Bethea CL, 2005, NEUROSCIENCE, V132, P151, DOI 10.1016/j.neuroscience.2004.11.022; BETHEA CL, 1994, NEUROENDOCRINOLOGY, V60, P50, DOI 10.1159/000126719; BETHEA CL, 1993, NEUROENDOCRINOLOGY, V57, P1, DOI 10.1159/000126334; Bethea CL, 2002, FRONT NEUROENDOCRIN, V23, P41, DOI 10.1006/frne.2001.0225; Bethea CL, 2008, J NEUROCHEM, V105, P1129, DOI 10.1111/j.1471-4159.2008.05213.x; Bethea CL, 2008, MOL NEUROBIOL, V38, P199, DOI 10.1007/s12035-008-8042-z; Brinton RD, 2005, ANN NY ACAD SCI, V1052, P57, DOI 10.1196/annals.1347.005; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Corasaniti MT, 2005, NEUROTOXICOLOGY, V26, P893, DOI 10.1016/j.neuro.2005.01.019; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Faubel S., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P269, DOI 10.2174/1568008054863754; Frey Benicio N, 2008, Menopause Int, V14, P123, DOI 10.1258/mi.2008.008019; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1998, NEUROREPORT, V9, P593, DOI 10.1097/00001756-199803090-00006; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Gorman AM, 1998, NEUROREPORT, V9, pR49, DOI 10.1097/00001756-199807130-00001; Gundlah C, 2001, MOL BRAIN RES, V91, P14, DOI 10.1016/S0169-328X(01)00108-5; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; ISACSON O, 1993, TRENDS NEUROSCI, V16, P306, DOI 10.1016/0166-2236(93)90104-T; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krantic S, 2007, PROG NEUROBIOL, V81, P179, DOI 10.1016/j.pneurobio.2006.12.002; Lu NZ, 2003, MOL PSYCHIATR, V8, P353, DOI 10.1038/sj.mp.4001243; Lu NZ, 2002, NEUROPSYCHOPHARMACOL, V27, P12, DOI 10.1016/S0893-133X(01)00423-7; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Manji H K, 2001, Psychopharmacol Bull, V35, P5; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; Paxinos G., 2000, RHESUS MONKEY BRAIN; Peter ME, 1997, P NATL ACAD SCI USA, V94, P12736, DOI 10.1073/pnas.94.24.12736; Piantadosi CA, 1997, EXP NEUROL, V147, P103, DOI 10.1006/exnr.1997.6584; Reddy AP, 2005, PSYCHOPHARMACOLOGY, V180, P125, DOI 10.1007/s00213-005-2154-1; RINK A, 1995, AM J PATHOL, V147, P1575; Schmidt PJ, 2000, AM J OBSTET GYNECOL, V183, P414, DOI 10.1067/mob.2000.106004; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shughrue PJ, 1997, ENDOCRINOLOGY, V138, P5476, DOI 10.1210/en.138.12.5476; Simpkins JW, 2005, CELL MOL LIFE SCI, V62, P271, DOI 10.1007/s00018-004-4382-2; Singh M, 2006, EXP BIOL MED, V231, P514; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; TEJANIBUTT SM, 1995, NEUROREPORT, V6, P1207, DOI 10.1097/00001756-199505300-00033; Tokuyama Y, 2008, NEUROSCIENCE, V154, P720, DOI 10.1016/j.neuroscience.2008.03.056; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Yao MZ, 2007, J NEUROSCI, V27, P1422, DOI 10.1523/JNEUROSCI.2382-06.2007; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009	62	21	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	JUN	2010	15	6					657	668		10.1038/mp.2009.97			12	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	599DZ	WOS:000277891800009	19823180	Bronze, Green Accepted			2022-02-06	
J	Lippi, G; Cervellin, G				Lippi, Giuseppe; Cervellin, Gianfranco			Disseminated Intravascular Coagulation in Trauma Injuries	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						Trauma; hemostasis; coagulation; disseminated intravascular coagulation	PROTEIN-C PATHWAY; HEAD-INJURY; BRAIN-INJURY; SEVERITY SCORE; EARLY COAGULOPATHY; TISSUE FACTOR; POSTTRAUMA COAGULATION; ORGAN DYSFUNCTION; COMBAT CASUALTIES; IMPROVES ACCURACY	Physical injuries, especially road traffic injuries, are a leading cause of death and morbidity worldwide, ranking fifth among the leading causes of death in the United States. Immediate and early trauma deaths are mainly determined by primary brain injuries and/or hemorrhages, whereas late mortality is caused by secondary brain injuries, host defense failure, and superimposed complications including also disseminated intravascular coagulation (DIC). Trauma patients are particularly susceptible to the early development of coagulopathy, and the most severely injured patients are coagulopathic on hospital admission. The zenith of the problem is typically seen in patients with head injuries and in those who are massively injured and transfused. The resulting coagulopathy is characterized by nonsurgical bleeding from mucosal lesions, serosal surfaces, and wound and vascular access sites. DIC associated with traumatic injury results from multiple independent but interplaying mechanisms, involving tissue trauma, shock, and inflammation. As such, the multifaceted derangement of hemostasis occurring after massive traumatic injuries, especially those involving the brain, is mainly sustained by release of procoagulants (fats, phospholipids) and constitutive tissue factor from the injured tissue into the circulation, associated with a systemic inflammatory response that also promotes tissue factor hyperexpression on monocytes and the other cells. The excessive, non-wound-related thrombin generation is insufficiently antagonized by physiological anticoagulant pathways and amplified by impaired endogenous fibrinolysis. The resulting burst of systemic thrombin generation, coupled with platelet hyperaggregability, shock, hypothermia, and tissue hypoperfusion, further contribute to the development of DIC and microvascular bleeding.	[Lippi, Giuseppe] Azienda Osped Univ Parma, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43126 Parma, Italy; [Cervellin, Gianfranco] Azienda Osped Univ Parma, UO Pronto Soccorso & Med Urgenza, I-43126 Parma, Italy		Lippi, G (corresponding author), Azienda Osped Univ Parma, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, Via Gramsci 14, I-43126 Parma, Italy.	glippi@ao.pr.it	Lippi, Giuseppe/X-7198-2018	Lippi, Giuseppe/0000-0001-9523-9054			AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chatzizisis YS, 2008, EUR J INTERN MED, V19, P568, DOI 10.1016/j.ejim.2007.06.037; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; DEHAVEN H, 1952, SITE FREQUENCY DANGE; DRAYER BP, 1975, JAMA-J AM MED ASSOC, V231, P174, DOI 10.1001/jama.231.2.174; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; *EUR COMM, HLTH STAT ATL MORT E; Franchini M, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-4; Gadzhiev M R, 1991, Zh Vopr Neirokhir Im N N Burdenko, P8; Gando S, 1998, THROMB HAEMOSTASIS, V79, P1111; Gando S, 1997, CRIT CARE MED, V25, P1820, DOI 10.1097/00003246-199711000-00019; Gando S, 2006, SEMIN THROMB HEMOST, V32, P48, DOI 10.1055/s-2006-933340; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Heron MP, NATL VITAL STAT REPO; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kushimoto S, 2008, THROMB HAEMOSTASIS, V100, P1099, DOI 10.1160/TH08-05-0306; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; MENENDEZ LR, 1995, CLIN ORTHOP RELAT R, P185; Mirdad TM, 2000, E AFR MED J, V77, P663; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pitts SR, 2008, NATL HLTH STAT REPOR, V7, P1; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Schrieber M, 2007, J TRAUMA, V63, P1261; Sethi D, 2007, J EPIDEMIOL COMMUN H, V61, P842, DOI 10.1136/jech.2007.063081; Soderstrom CA, 1997, J TRAUMA, V43, P925; STRINCHINI A, 1974, LANCET, V2, P957; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEASDALE G, 1974, LANCET, V2, P81; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; van der Poll T, 2001, SEMIN THROMB HEMOST, V27, P639, DOI 10.1055/s-2001-18868; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; World Health Organization (WHO), 2004, INT CLASS EXT CAUS I; YAMAMOTO H, 1995, J ORTHOP TRAUMA, V9, P449, DOI 10.1097/00005131-199505000-00016; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zhu YJ, 2009, CHIN J TRAUMATOL, V12, P203, DOI 10.3760/cma.j.issn.1008-1275.2009.04.003	56	21	22	1	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	JUN	2010	36	4					378	387		10.1055/s-0030-1254047			10	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	605HI	WOS:000278338100003	20614390				2022-02-06	
J	Moines, LESM; Allen, DN; Puente, AE; Neblina, C				Moines, Liza E. San Miguel; Allen, Daniel N.; Puente, Antonio E.; Neblina, Cris			Validity of the WISC-IV Spanish for a Clinically Referred Sample of Hispanic Children	PSYCHOLOGICAL ASSESSMENT			English	Article						WISC-IV Spanish; Hispanic children; learning disabilities; ADHD; Puerto Rican children	TRAUMATIC BRAIN-INJURY; HIGH-FUNCTIONING AUTISM; CRITERION VALIDITY; INTELLIGENCE SCALE; ADOLESCENTS; PROFILES; EDITION	The Wechsler Intelligence Scale for Children (WISC) is the most commonly used intelligence test for children. Five years ago, a Spanish version of the WISC-IV was published (WISC-IV Spanish: Wechsler. 2005). hut a limited amount of published information is available regarding its utility when assessing clinical samples. The current study included 107 children who were Spanish speaking and of Puerto Rican descent that had been administered the WISC-IV Spanish. They were subdivided into a clinical sample of 35 children with diagnoses of various forms of brain dysfunction (primarily learning disability. attention-deficit/hyperactivity disorder, and epilepsy) and a comparison group made up of 72 normal children who were part of the WISC-IV Spanish version standardization sample. Comparisons between these groups and the standardization sample were performed for the WISC-IV Spanish index and subtest scores. Results indicated that the clinical sample performed worse than the comparison samples on the Working Memory and Processing Speed Indexes, although findings varied to some extent depending on whether the clinical group was compared with the normal comparison group or the standardization sample. These findings provide support for the criterion validity of the WISC-IV Spanish when it is used to assess a clinically referred sample with brain dysfunction.	[Moines, Liza E. San Miguel] Univ Puerto Rico, Sch Med, Neurol Sect, Child Neurol Program, San Juan, PR 00936 USA; [Allen, Daniel N.; Neblina, Cris] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Puente, Antonio E.] Univ N Carolina, Dept Psychol, Wilmington, NC USA		Moines, LESM (corresponding author), Univ Puerto Rico, Sch Med, Neurol Sect, Child Neurol Program, Med Sci Campus, San Juan, PR 00936 USA.	lsanmiguel@rcm.upr.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; *AM ED RES ORG AM, 1999, STAND ED PSYCH TEST; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ARDILA A, 1992, NEUROPSYCHOLOGICAL E; Braden J. P., 2007, J PSYCHOEDUCATIONAL, V25, P292, DOI [10.1177/0734282907302955, DOI 10.1177/0734282907302955]; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Goldstein G, 2008, NEUROPSYCHOLOGY, V22, P301, DOI 10.1037/0894-4105.22.3.301; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; Mayes Susan Dickerson, 2006, J Atten Disord, V9, P486, DOI 10.1177/1087054705283616; Puente AE., 1998, WISC 3 CLIN USE INTE, P227, DOI [10.1016/B978-012564930-8/50012-7, DOI 10.1016/B978-012564930-8/50012-7]; RAIFORD SE, 2008, 4 PEARS ASS; Renteria L, 2008, CLIN NEUROPSYCHOL, V22, P455, DOI 10.1080/13854040701336428; Siegel DJ, 1996, J AUTISM DEV DISORD, V26, P389, DOI 10.1007/BF02172825; SOLANTO M, 2008, J ABNORMAL CHILD PSY, V36, P129; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 2005, WECHSLER INTELLIGENC; Weiss L. G., 2006, WISC 4 ADV CLIN INTE; WEISS LG, 2008, 6 PEARS ASS	27	21	23	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2010	22	2					465	469		10.1037/a0018895			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	609OF	WOS:000278665600026	20528073				2022-02-06	
J	Schatz, P; Neidzwski, K; Moser, RS; Karpf, R				Schatz, Philip; Neidzwski, Katherine; Moser, Rosemarie Scolaro; Karpf, Robin			Relationship Between Subjective Test Feedback Provided by High-School Athletes During Computer-Based Assessment of Baseline Cognitive Functioning and Self-Reported Symptoms	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						baseline assessment; concussion; concussion symptoms; ImPACT; neuropsychological testing	CONCUSSION; RELIABILITY; PERFORMANCE; RECOVERY; NOISE	Subjective feedback about distractions or problems encountered during computerized assessment was provided by 538 out of a pool of 1659 high-school athletes who completed baseline testing using ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing). Three types of feedback were included: (a) environmental, (b) computer-based (mechanical), and (c) instruction-based (associated with difficulty understanding test instructions). One-way analyses of variance were conducted and revealed relationships between greater symptom reporting and any type of feedback, environmental feedback, and instruction-based feedback. Increased symptom reporting was noted for female students. Additional relationships were noted between providing computer-based feedback and faster reaction time; and between history of concussion and providing instruction-based feedback. Athletes endorsing more symptoms at baseline scored significantly worse on ImPACT, as reflected in decreased visual memory performance. Results suggest that feedback provided during computerized assessment may yield information about symptom reporting and test-taking style, which may also be of particular interpretive utility when athletes minimize their symptoms.	[Schatz, Philip; Neidzwski, Katherine] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Moser, Rosemarie Scolaro] RSM Psychol Ctr LLC, Lawrenceville, NJ USA; [Karpf, Robin] Lawrenceville Sch, Lawrenceville, NJ USA		Schatz, P (corresponding author), St Josephs Univ, Dept Psychol, 222 Post Hall,5600 City Ave, Philadelphia, PA 19131 USA.	pschatz@sju.edu		Schatz, Philip/0000-0002-6222-6545			BADDELEY A, 1993, J EXP PSYCHOL LEARN, V19, P862, DOI 10.1037/0278-7393.19.4.862; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; BARTRAM D, 1984, J OCCUP PSYCHOL, V57, P221, DOI 10.1111/j.2044-8325.1984.tb00164.x; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Chen Z, 2006, J EXP PSYCHOL HUMAN, V32, P1452, DOI 10.1037/0096-1523.32.6.1452; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corneil BD, 1996, J NEUROSCI, V16, P8193; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; IVERSON G, 2004, J INT NEUROPSYCH SOC, V10, P1; IVERSON GL, 2003, NORMATIVE DATA FOXPR; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Lovell MR, 2007, IMPACT VERSION 6 0 C; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; Macken WJ, 2009, PSYCHON B REV, V16, P139, DOI 10.3758/PBR.16.1.139; PIERCE RC, 1963, J CONSULT PSYCHOL, V27, P536, DOI 10.1037/h0038844; Podell K, 2004, STUD NEUROPSYCHOL DE, P375; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; SPACE LG, 1981, BEHAV RES METH INSTR, V13, P595, DOI 10.3758/BF03202072; Trimmel M, 2006, ERGONOMICS, V49, P202, DOI 10.1080/00140130500434986; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wechsler D., 1955, MANUAL WECHSLER ADUL; WEINSTEIN ND, 1974, J APPL PSYCHOL, V59, P548, DOI 10.1037/h0037338; WILSON SL, 1991, MICROCOMPUTERS CLIN, P79; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	34	21	21	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2010	25	4					285	292		10.1093/arclin/acq022			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	600KL	WOS:000277984600003	20363733	Bronze			2022-02-06	
J	Bergquist, TF; Thompson, K; Gehl, C; Pineda, JM				Bergquist, Thomas F.; Thompson, Kelsey; Gehl, Carissa; Pineda, Jorge Munoz			Satisfaction Ratings After Receiving Internet-Based Cognitive Rehabilitation in Persons with Memory Impairments After Severe Acquired Brain Injury	TELEMEDICINE JOURNAL AND E-HEALTH			English	Article						technology; telecommunications; telemedicine	PATIENT SATISFACTION; TELEREHABILITATION; CARE; TELEMEDICINE; FEASIBILITY; STROKE; HOME	Objective: This study looked at patient satisfaction with an Internet-based cognitive rehabilitation program, which has been previously shown to be associated with functional improvements. Materials and Methods: Fourteen individuals with documented traumatic brain injury and memory impairments completed this study. Participants completed 60 sessions of Internet-based cognitive rehabilitation: 30 sessions of an active calendar intervention and 30 sessions of a control diary intervention. A four-question satisfaction questionnaire (responses were generated using a seven-point Likert scale) was completed after 30 sessions and again after 60 sessions. Results: No significant differences in satisfaction were found between time of assessment and treatment condition. In addition, a higher level of calendar use prior to beginning the study was associated with greater satisfaction at study completion. Conclusion: These results suggest that persons with traumatic brain injury are not only willing to use the Internet to receive cognitive rehabilitation treatment, but are generally highly satisfied with the treatment. Further, individuals with some baseline compensatory strategies may be particularly well suited to this method of treatment.	[Bergquist, Thomas F.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Thompson, Kelsey] St Olaf Coll, Northfield, MN 55057 USA; [Gehl, Carissa] Iowa City VAMC, Iowa City, IA USA; [Pineda, Jorge Munoz] Gustavus Adolphus Coll, St Peter, MN 56082 USA		Bergquist, TF (corresponding author), Mayo Clin, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	bergquist.thomas@mayo.edu		Gehl, Carissa/0000-0003-4370-0624	National Institute for Disability and Rehabilitation Research (NIDRR)	This research was supported by a TBI Model System grant from the National Institute for Disability and Rehabilitation Research (NIDRR).	Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Day SX, 2002, J COUNS PSYCHOL, V49, P499, DOI 10.1037/0022-0167.49.4.499; Gustke SS, 2000, TELEMED J, V6, P5, DOI 10.1089/107830200311806; Holden D, 2008, TELEMED J E-HEALTH, V14, P381, DOI 10.1089/tmj.2007.0054; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; Lai JCK, 2004, J TELEMED TELECARE, V10, P199, DOI 10.1258/1357633041424340; Locke Dona E C, 2008, J Support Oncol, V6, P383; Mair F, 2000, BMJ-BRIT MED J, V320, P1517, DOI 10.1136/bmj.320.7248.1517; Nieves JE, 2009, J TELEMED TELECARE, V15, P51, DOI 10.1258/jtt.2008.080706; Piron L, 2008, J TELEMED TELECARE, V14, P257, DOI 10.1258/jtt.2008.080304; Randolph C., 1998, RBANS MANUAL REPEATA; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Williams TL, 2001, TELEMED J E-HEALTH, V7, P293, DOI 10.1089/15305620152814700; Wright BA., 1983, PHYS DISABILITY PSYC; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	23	21	21	2	10	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627			TELEMED J E-HEALTH	Telemed. J. e-Health	MAY	2010	16	4					417	423		10.1089/tmj.2009.0118			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	601ZI	WOS:000278107000042	20420542				2022-02-06	
J	Bottari, C; Dassa, C; Rainville, C; Dutil, E				Bottari, Carolina; Dassa, Clement; Rainville, Constant; Dutil, Elisabeth			A Generalizability Study of the Instrumental Activities of Daily Living Profile	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Brain injuries; Cognition; Psychometrics; Rehabilitation	TRAUMATIC BRAIN-INJURY; RELIABILITY; IMPAIRMENTS; COGNITION; DEFICITS; MODERATE; OUTCOMES; CONTEXT; DAMAGE	Objective: To establish generalizability estimates of the Instrumental Activities of Daily Living (IADL) Profile when administered to persons with a moderate or severe traumatic brain injury (TB!) within their home and community environment. Design: Generalizability theory was used to estimate generalizability and dependability coefficients as well as the relative contribution of identified sources of measurement error to total measurement error. Decision studies were used to enable the investigators to determine the optimal measurement design. Setting: The IADL Profile was administered in subjects' homes and community environments. Participants: Convenience sample of adults with a moderate or severe TBI (N=30, aged 16-65y). Interventions: Not applicable. Main Outcome Measures: IADL Profile scores include 6 factor scores (going to the grocery store/shopping for groceries, having a meal with guests/cleaning up, putting on outdoor clothing, obtaining information, making a budget, and preparing a hot meal) and I total score. Results: The greatest sources of measurement error were the subject-item interactions (3-random-facet design) and the subject-rater interactions (2-random-facet design). One hundred percent of generalizability coefficients of factor scores indicated acceptable to excellent reliability. Indices of dependability confirmed that 1 evaluator could reliably score the tool on a single occasion after having received a 3-day training workshop. Conclusions: The IADL Profile administered to persons with a moderate or severe TB I provides occupational therapists with a reliable set of measures of IADL independence capable of both capturing and analyzing the complex interactions between personal and environmental factors.	[Bottari, Carolina; Dutil, Elisabeth] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Dassa, Clement] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Rainville, Constant] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Bottari, Carolina; Rainville, Constant; Dutil, Elisabeth] Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada; [Dassa, Clement] Interdisciplinary Res Grp Hlth, Montreal, PQ, Canada		Bottari, C (corresponding author), Univ Montreal, Ecole Readaptat, 7077 Parc, Montreal, PQ, Canada.	carolina.bottari@umontreal.ca			Fonds de la recherche en sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec [6623]; Association quebecoise d'etablissements de sante et de services sociaux; Association des etablissements de readaptation du Quebec; Societe d'assurance automobile du Quebec; Quebec Rehabilitation Research Network; Canadian Occupational Therapy Foundation	Supported by the Fonds de la recherche en sante du Quebec (FRSQ) (grant no. 6623). The study was financed pursuant to a jointly cooperative arrangement between the FRSQ, the Association quebecoise d'etablissements de sante et de services sociaux, the Association des etablissements de readaptation du Quebec, the Societe d'assurance automobile du Quebec, and the Quebec Rehabilitation Research Network. Also supported by the Canadian Occupational Therapy Foundation.	BAIN D, 1996, EVALUER VOS EVALUATI, P125; Bao S, 2009, HUM FACTORS, V51, P292, DOI 10.1177/0018720809340273; Benson D.F., 1986, FRONTAL LOBES; Bottari C., 2008, BRAIN INJ S1, V22, P33; BOTTARI C, 2009, BRAIN INJURY, V23, P1; Bottari C, 2001, PERCEPTION EXPERTS C; BOTTARI C, 2008, BRAIN INJ S1, V22, P34; Bottari C., 2006, AUST OCCUP THER J, V53, P98, DOI DOI 10.1111/J.1440-1630.2006.00547.X; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Brennan R.L., 2001, GEN THEORY; Brentnall J, 2009, OTJR-OCCUP PART HEAL, V29, P63, DOI 10.3928/15394492-20090301-01; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; CARDINET J, 1985, ASSURER MESURE; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Crocker L., 1986, INTRO CLASSICAL MODE; CRONBACH LJ, 1972, MULTIFACET CONCEPT O, P1; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; DUTIL E, 1990, Occupational Therapy in Health Care, V7, P7, DOI 10.1080/J003v07n01_03; Dutil E, 2005, ADL PROFILE DESCRIPT; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fisher AG, 2003, ASSESSMENT MOTOR PRO, V1; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; GERVAIS N, 1995, COMP PROFIL AVQ MESU; Gitlin LN, 2003, GERONTOLOGIST, V43, P628, DOI 10.1093/geront/43.5.628; Golden CJ, 1978, STROOP COLOR WORD TE; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Humphreys GW, 1998, COGN NEUROPSYCHOL, V15, P771; KASINDI G, 1998, COMP DEUX OUTILS SER; Klein Sheryl, 2008, Can J Occup Ther, V75, P69; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Le Thiec F., 1999, Annales de Readaptation et de Medecine Physique, V42, P1, DOI 10.1016/S0168-6054(99)80030-0; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN INTRO; Martin K, 2009, PEDIATR PHYS THER, V21, P261, DOI 10.1097/PEP.0b013e3181b13bca; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Pedhazur E. J., 1991, MEASUREMENTS DESIGN; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; RAINVILLE C, 2005, COMMUNICATION DEMENC, P137; Rempfer MV, 2003, PSYCHIAT RES, V117, P103, DOI 10.1016/S0165-1781(02)00318-9; ROGERS JC, 1982, AM J OCCUP THER, V36, P709, DOI 10.5014/ajot.36.11.709; Rousseau J., 1994, CANADIAN J OCCUPATIO, V61, P149, DOI DOI 10.1177/000841749406100304; ROUSSEAU J, 1994, CANADIAN J OCCUPATIO, V61, P159, DOI DOI 10.1177/000841749406100305; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Vangeneugden T, 2005, BIOMETRICS, V61, P295, DOI 10.1111/j.0006-341X.2005.031040.x; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Zalla T, 2001, NEUROPSYCHOLOGIA, V39, P759, DOI 10.1016/S0028-3932(01)00019-7; [No title captured]	64	21	21	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2010	91	5					734	742		10.1016/j.apmr.2009.12.023			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	594LK	WOS:000277539000010	20434611				2022-02-06	
J	Kesmezacar, H; Sarikaya, IA				Kesmezacar, Hayrettin; Sarikaya, Ilker Abdulah			The results of conservatively treated simple elbow dislocations	ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA			English	Article						Dislocations/therapy/complications; elbow joint/injuries; joint instability	MEDIAL COLLATERAL LIGAMENT; RADIAL HEAD; INSTABILITY; JOINT; FRACTURE; EXCISION; SUBLUXATION; STABILITY; REPAIR; ADULT	Objectives: Closed reduction followed by short-time immobilization is the generally accepted treatment for simple elbow dislocations. However, the number of studies concerning the results of this method is limited. In this study, the clinical and radiographic results of conservatively treated simple elbow dislocations were retrospectively evaluated. Methods: The study included 21 patients (16 males, 5 females) who underwent closed reduction and immobilization for simple elbow dislocations. Simple dislocations were defined as non-fracture dislocations and dislocations accompanied by minor avulsion fractures that did not require additional surgery or immobilization. The mean age of the patients at the time of injury was 35 years (range 16 to 59 years). All the patients had posterior dislocations. Eleven patients (52.4%) had minor avulsion fractures. Following closed reduction, a plaster splint and hinged brace were used in four (19.1%) and 17 (81%) patients, respectively. Incremental active and passive motions were started at the end of the first week in patients in whom a brace was used. The mean duration of brace use was 27 +/- 16 days. Patients using a plaster splint were immobilized for three weeks. The patients were assessed clinically with respect to range of motion, instability, and neurologic findings after a mean follow-up period of 34 months (range 12 to 99 months). Functional assessments included the Mayo Elbow Performance Score (MEPS) and the Broberg-Morrey Functional Rating Index (BMFRI). Standard elbow anteroposterior and lateral radiographs were examined for concentric reduction and signs of degeneration and heterotopic ossification. Results: Compared to the normal side, the degrees of flexion, extension, flexion arc, and pronation were significantly decreased in dislocated elbows (p<0.05), while the degrees of supination and rotational arc were similar. There was no muscular atrophy. Four patients (19.1%) had residual instability and six patients (28.6%) had mild to moderate neurological complaints that were primarily related to the ulnar nerve. Three patients complained of mild pain, and one patient complained of moderate pain at ::est. Radiographic assessment showed mild degeneration in three patients (14.3%), and mild to moderate heterotopic ossification in 14 patients (66.7%). Patients with and without heterotopic ossification did not differ significantly with respect to the values of joint ranee of motion. The mean MEPS and BMFRI scores were 96.9 and 97.7, respectively. The scores of both systems were excellent in 20 patients (95.2%) and moderate in one patient (4.8%). The majority of the patients (81%) reported complaints about their elbows including sensation of stiffness in the elbow, pain during strenuous work or sports activities, and limitation of movement. Only four patients (19.1%) reported a feeling of full recovery. Conclusion: Although closed reduction with short-term immobilization is a universally accepted method for simple elbow dislocations with excellent functional scores, it is associated with significant limitations in joint movements and a great majority of patients do not consider themselves fully recovered.	[Kesmezacar, Hayrettin; Sarikaya, Ilker Abdulah] Istanbul Univ, Cerrahpasa Med Fac, Dept Orthoped & Traumatol, TR-34303 Istanbul, Turkey		Kesmezacar, H (corresponding author), Istanbul Univ, Cerrahpasa Tip Fak, Ortopedi & Travmatol Anabilim Dali, TR-34303 Istanbul, Turkey.	hkesmezacar@yahoo.com					Ahmad CS, 2004, AM J SPORT MED, V32, P1607, DOI 10.1177/0363546503263149; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; CROMACK P I, 1961, Aust N Z J Surg, V30, P212, DOI 10.1111/j.1445-2197.1961.tb03112.x; Duckworth AD, 2008, J SHOULDER ELB SURG, V17, P276, DOI 10.1016/j.jse.2007.06.006; DURIG M, 1979, J BONE JOINT SURG AM, V61, P239, DOI 10.2106/00004623-197961020-00012; Eygendaal D, 2000, J BONE JOINT SURG AM, V82A, P555, DOI 10.2106/00004623-200004000-00010; HABERNEK H, 1992, CLIN ORTHOP RELAT R, P226; Jensen SL, 2003, J BONE JOINT SURG BR, V85B, P1006, DOI 10.1302/0301-620X.85B7.14405; Jeon In-Ho, 2008, Keio Journal of Medicine, V57, P99, DOI 10.2302/kjm.57.99; JOHANSSON O, 1962, Acta Chir Scand Suppl, VSuppl 287, P1; JOSEFSSON PO, 1987, J BONE JOINT SURG AM, V69A, P605, DOI 10.2106/00004623-198769040-00018; JOSEFSSON PO, 1984, J BONE JOINT SURG AM, V66A, P927, DOI 10.2106/00004623-198466060-00014; JOSEFSSON PO, 1989, CLIN ORTHOP RELAT R, P126; JOSEFSSON PO, 1986, ACTA ORTHOP SCAND, V57, P537, DOI 10.3109/17453678609014788; KING T, 1953, J BONE JOINT SURG BR, V35, P50, DOI 10.1302/0301-620X.35B1.50; Kini MC, 1940, J BONE JOINT SURG, V22, P107; LANSINGER K, 1984, ARCH ORTHOP TRAUMA S, V102, P183; LINSCHEI.RL, 1965, J AMER MED ASSOC, V194, P1171, DOI 10.1001/jama.194.11.1171; LINSCHEID RL, 1993, ELBOW ITS DISORDERS, P441; Maripuri SN, 2007, INJURY, V38, P1254, DOI 10.1016/j.injury.2007.02.040; McKee MD, 2003, J SHOULDER ELB SURG, V12, P391, DOI 10.1016/S1058-2746(03)00027-2; MEHLHOFF TL, 1988, J BONE JOINT SURG AM, V70A, P244, DOI 10.2106/00004623-198870020-00013; Micic I, 2009, INT ORTHOP, V33, P1141, DOI 10.1007/s00264-008-0624-x; MORREY BF, 1991, CLIN ORTHOP RELAT R, P187; MORREY BF, 1983, AM J SPORT MED, V11, P315, DOI 10.1177/036354658301100506; MORREY BF, 1993, ELBOW ITS DISORDERS, V2, P86; NEVIASER JS, 1977, SOUTHERN MED J, V70, P172, DOI 10.1097/00007611-197702000-00013; O'Driscoll S W, 2001, Instr Course Lect, V50, P89; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; ODRISCOLL SW, 1992, CLIN ORTHOP RELAT R, P186; Osborne G, 1966, J Bone Joint Surg Br, V48, P340; PROTZMAN RR, 1978, J BONE JOINT SURG AM, V60, P539, DOI 10.2106/00004623-197860040-00019; Ring D, 2000, CLIN ORTHOP RELAT R, P44; Ross G, 1999, AM J SPORT MED, V27, P308, DOI 10.1177/03635465990270030701; ROYLE SG, 1991, CLIN ORTHOP RELAT R, P201; SCHWAB GH, 1980, CLIN ORTHOP RELAT R, P42	36	21	21	0	14	TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY	ISTANBUL	TIP FAKULTESI ORTOPEDI VE TRAVMATOLOJI KLINIGI, ISTANBUL, TOPKAPI 34390, TURKEY	1017-995X			ACTA ORTHOP TRAUMATO	Acta Orthop. Traumatol. Turc.	MAY-JUN	2010	44	3					199	205		10.3944/AOTT.2010.2400			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	690WB	WOS:000285038400006	21088460	gold, Green Submitted			2022-02-06	
J	Fitzharris, M; Bowman, D; Ludlow, K				Fitzharris, Michael; Bowman, Diana; Ludlow, Karinne			Factors associated with return-to-work and health outcomes among survivors of road crashes in Victoria	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH			English	Article						accidents; disability; pain; quality of life; wounds; injuries; compensation	SPINAL-CORD-INJURY; TRAUMATIC BRAIN INJURY; COMPENSATION; DETERMINANTS; DISABILITY; EMPLOYMENT; PREDICTION; SEVERITY; ACCIDENT; LIFE	Objective: To explore the relationships between injury, disability, work role and return-to-work outcomes following admission to hospital as a consequence of injury sustained in a road crash Design and setting: Prospective cohort study of patients admitted to an adult trauma centre and two metropolitan teaching hospitals in Victoria, Australia Participants were interviewed in hospital, 2.5 and eight months post-discharge Participants: Participants were 60 employed and healthy adults aged 18 to 59 years admitted to hospital in the period February 2004 to March 2005 Results: Despite differences in health between the lower extremity fracture and non-fracture groups eight months post-crash the proportions having returned to work was approximately 90% Of those returning to work, 44% did so in a different role After adjustment for baseline parameters, lower extremity injuries were associated with a slower rate of return to work (HR. 0 31, 95%CI 0 16-0 58) as was holding a manual occupation (HR 0 16, 95 %CI 0 09-0 57) There were marked differences in physical health between and within the injury groups at both follow-up periods Conclusions: These results demonstrate that both injury type and severity and the nature of ones occupation have a considerable influence on the rate and pattern of return to work following injury Further, persisting disability has a direct influence on the likelihood of returning to work The implications of these findings and the types of data required to measure outcome post-injury are discussed	[Fitzharris, Michael; Bowman, Diana] Monash Univ, Accid Res Ctr, Clayton, Vic 3800, Australia; [Bowman, Diana] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Ludlow, Karinne] Monash Univ, Fac Law, Clayton, Vic 3800, Australia		Fitzharris, M (corresponding author), Monash Univ, Accid Res Ctr, Clayton, Vic 3800, Australia.			Ludlow, Karinne/0000-0002-3179-1349; Fitzharris, Michael/0000-0002-3691-6868	MUARC Foundation; Monash UniversityMonash University; MUARC Doctoral Students Research Fund (DSRF)	The data collected here was done so as part of the first author's PhD candidature at Monash University under the supervision of Professor Brian Fildes, Dr Judith Charlton and Professor Claes Tingvall During this time Michael Fitzharns was a Research Fellow in the Department of Trauma Surgery, The Alfred. the National Trauma Research Institute and the Department of Emergency Medicine, Southern Health The authors gratefully acknowledge the significant contribution of each participant as well as that of the treating nursing and medical staff of the hospitals involved The authors wish to thank Professor Thomas Kossmann, Professor Johannes Wenzel and Dr Pam Rosenganen for supporting the study Thanks also to Louise Nuzgemeyer RN, Manager, Trauma Registry, The Alfred. Michelle Sratze RN & Claire Sage RN. Trauma Care-Coordinators, The Alfred, and Metz Lindsay RN, Southern Health, for vital support without which this research would not be possible Michael Fitzharns acknowledges the financial contribution of the MUARC Foundation and Monash University for providing stipend funding and the MUARC Doctoral Students Research Fund (DSRF) for supporting this research activity The views expiessed are those of the authors and do not necessarily represent those of Monash University, the Accident Research Centre, the MUARC Foundation, Alfred Health or Southern Health.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; *ASS ADV AUT MED, 1998, ABBR INJ SCAL AIS 19; Australian Bureau of Statistics, 1995, 43990 AUSTR BUR STAT; Babor TF, 2001, AUDIT ALCOHOL USE DI; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; Bryant RA., 2000, ACUTE STRESS DISORDE; BUTLER RJ, 1995, IND LABOR RELAT REV, V48, P452, DOI 10.2307/2524774; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Castellan N. J, 1988, NONPARAMETRIC STAT B; Fitzharris Michael, 2007, Traffic Inj Prev, V8, P309, DOI 10.1080/15389580701216533; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Krause N, 2001, AM J IND MED, V40, P464, DOI 10.1002/ajim.1116; Leduc BE, 2002, DISABIL REHABIL, V24, P196, DOI 10.1080/09638280110067603; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Matthews LR, 2005, INT J PSYCHOL, V40, P339, DOI 10.1080/00207590444000320; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; MORRIS JA, 1991, J TRAUMA, V31, P827, DOI 10.1097/00005373-199106000-00014; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; TEASDALE G, 1974, LANCET, V2, P81; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Ware J., 2001, SF 36 PHYS MENTAL HL; World Health Organization, 2002, COMM LANG FUNCT DIS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Yasuda S, 2002, NEUROREHABILITATION, V17, P177; [No title captured]; [No title captured]; [No title captured]; [No title captured]	41	21	21	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1326-0200	1753-6405		AUST NZ J PUBL HEAL	Aust. N. Z. Publ. Health	APR	2010	34	2					153	159		10.1111/j.1753-6405.2010.00500.x			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	586WE	WOS:000276944800010	23331359				2022-02-06	
J	Groh, GI; Wirth, MA; Rockwood, CA				Groh, Gordon I.; Wirth, Michael A.; Rockwood, Charles A., Jr.			Results of treatment of luxatio erecta (inferior shoulder dislocation)	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Luxatio erecta; inferior shoulder dislocation; results of treatment	INSTABILITY	Hypothesis: Traumatic inferior shoulder dislocation (luxatio erecta) injuries are rare, comprising less than 0.5% of all shoulder dislocations. Few cases have been reported, and the outcome of treatment has been ill defined. Materials and methods: Between 1968 and 2000, 18 patients (20 shoulders) with luxatio erecta were evaluated at our institution. Two patients (2 shoulders) were lost to follow-up, leaving 16 patients (18 shoulders) for long-term follow-up (average, 9 years). Associated injuries included peripheral nerve injury, humeral fracture, acromial fracture, and rotator cuff tear. All patients were initially managed with closed reduction, which was successful in 9 shoulders. The remaining 9 shoulders required operative treatment. Results: Patients were evaluated with respected to pain, function, range of motion, strength, and patient satisfaction, according to the University of California at Los Angeles Rating Scale. Overall, 13 of the 16 patients were graded as good or excellent. Patients treated with closed reduction or operative treatment compared favorably in terms of improvements in ratings for pain, strength, motion, and the ability to perform work and sports. Discussion: Our experience suggests that treatment of luxatio erecta is largely successful, with good or excellent results obtained in 83% of the shoulders. Half of the patients evaluated, required only closed reduction as their definitive treatment. Operative treatment is typically indicated for associated displaced humeral head fractures or patients with recurrent instability. Recurrent instability appears to be more likely in patients with a previous history of dislocation. Associated neurologic or vascular injury did not affect the final outcome. Level of evidence: Level IV; Case Series; Therapeutic Study (C) 2010 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Groh, Gordon I.] Blue Ridge Bone & Joint Clin, Asheville, NC 28801 USA; [Wirth, Michael A.; Rockwood, Charles A., Jr.] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthopaed, San Antonio, TX 78229 USA		Groh, GI (corresponding author), Blue Ridge Bone & Joint Clin, 129 McDowell, Asheville, NC 28801 USA.	ggroh@brbj.com	Groh, Gordon/AAH-8571-2020	Groh, Gordon/0000-0001-7994-225X			ADAR R, 1980, J TRAUMA, V21, P323; AMSTUTZ HC, 1981, CLIN ORTHOP RELAT R, P7; BURKHEAD WZ, 1992, J BONE JOINT SURG AM, V74A, P890, DOI 10.2106/00004623-199274060-00010; DAVIDS JR, 1990, CLIN ORTHOP RELAT R, P144; Garcia R, 2006, J TRAUMA, V60, P1132, DOI 10.1097/01.ta.0000217246.64718.02; GARDHAM JRC, 1979, INJURY, V11, P155, DOI 10.1016/S0020-1383(79)80014-5; Mallon W J, 1990, J Orthop Trauma, V4, P19; Nho SJ, 2006, J ORTHOP TRAUMA, V20, P419, DOI 10.1097/00005131-200607000-00010; Nutton RW, 1997, J BONE JOINT SURG BR, V79B, P73, DOI 10.1302/0301-620X.79B1.7225; Rockwood CA, 1996, FRACTURES ADULTS, P1193; Sewecke Jeffrey J, 2006, Am J Orthop (Belle Mead NJ), V35, P578; Tornetta P 3rd, 1993, Orthop Rev, V22, P855; Tsuchida T, 2001, J SHOULDER ELB SURG, V10, P595, DOI 10.1067/mse.2001.115987; Wirth MA, 1996, J BONE JOINT SURG AM, V78A, P246, DOI 10.2106/00004623-199602000-00012; Yamamoto Tetsuji, 2003, Am J Orthop (Belle Mead NJ), V32, P601	15	21	22	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	APR	2010	19	3					423	426		10.1016/j.jse.2009.07.062			4	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	582SW	WOS:000276620100014	19836975				2022-02-06	
J	Karam, YR; Traynelis, VC				Karam, Youssef R.; Traynelis, Vincent C.			Occipital Condyle Fractures	NEUROSURGERY			English	Article						Basilar cranial fracture; Cranial trauma; Craniovertebral junction; Occipital condyle; Occipitocervical fusion	COLLET-SICARD-SYNDROME; CLOSED-HEAD-INJURY; OCCIPITOATLANTOAXIAL COMPLEX; CRANIOVERTEBRAL JUNCTION; FORGOTTEN CONDYLE; LIGAMENT INJURY; CT; TRAUMA; BIOMECHANICS; MORPHOLOGY	OBJECTIVE: The anatomy, clinical presentation, radiologic evaluation, treatment, and outcome of occipital condyle fractures are reviewed. METHODS: We review and discuss the literature on occipital condyle fractures. RESULTS: Occipital condyle fractures are best diagnosed with computed tomography. The neurologic presentation is variable. The majority of these injuries may be treated non-operatively, but an occipitocervical fusion is necessary to restore stability across the craniovertebral junction. CONCLUSION: Occipital condyle fractures are a rare but serious injury that requires prompt diagnosis and treatment.	[Karam, Youssef R.; Traynelis, Vincent C.] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA		Traynelis, VC (corresponding author), Rush Univ, Med Ctr, Dept Neurosurg, 1725 W Harrison 1115, Chicago, IL 60612 USA.	vincent_traynelis@rush.edu					Alcelik I, 2006, J BONE JOINT SURG BR, V88B, P665, DOI 10.1302/0301-620X.88B5.16598; ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; Aran E, 2001, NEUROCIRUGIA, V12, P517; BELL C, 1817, MIDDLESEX HOSP J, P4469; BLACKSIN MF, 1995, AM J ROENTGENOL, V165, P1201, DOI 10.2214/ajr.165.5.7572503; Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; Bloom AI, 1996, PEDIATR RADIOL, V26, P786, DOI 10.1007/BF01396202; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BUCHOLZ RW, 1979, J BONE JOINT SURG AM, V61, P248, DOI 10.2106/00004623-197961020-00014; Chen JY, 2006, EMERG RADIOL, V12, P192, DOI 10.1007/s10140-006-0471-2; Chou CW, 2008, J CLIN NEUROSCI, V15, P920, DOI 10.1016/j.jocn.2007.03.014; CLAYMAN DA, 1994, AM J NEURORADIOL, V15, P1309; COHEN A, 1991, Pediatric Emergency Care, V7, P24, DOI 10.1097/00006565-199102000-00007; Cottalorda J, 1996, J PEDIATR ORTHOP B, V5, P61, DOI 10.1097/01202412-199605010-00013; Dashti R, 2007, EUR SPINE J, V16, pS261, DOI 10.1007/s00586-006-0270-1; De Wyngaert R, 2006, EMERG RADIOL, V13, P79, DOI 10.1007/s10140-006-0516-6; Demisch S, 1998, CLIN NEUROL NEUROSUR, V100, P44, DOI 10.1016/S0303-8467(97)00111-X; DESAI SS, 1990, J TRAUMA, V30, P240, DOI 10.1097/00005373-199002000-00023; DVORAK J, 1988, J ORTHOP RES, V6, P452, DOI 10.1002/jor.1100060317; Erol FS, 2007, YONSEI MED J, V48, P120, DOI 10.3349/ymj.2007.48.1.120; Freeman BJC, 2005, INJURY, V36, P207, DOI 10.1016/j.injury.2004.05.026; HAAS LL, 1957, RADIOLOGY, V69, P546, DOI 10.1148/69.4.546; HARRIS MB, 1993, J SPINAL DISORD, V6, P5; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; LEVENTHAL MR, 1992, ORTHOPEDICS, V15, P944; LEVINE AM, 1989, CLIN ORTHOP RELAT R, P53; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; Liu JK, 2004, SURG NEUROL, V61, P255, DOI 10.1016/S0090-3019(03)00422-1; Miyazaki C, 2000, CLIN NEUROL NEUROSUR, V102, P255, DOI 10.1016/S0303-8467(00)00109-8; Muthukumar N, 2002, J CLIN NEUROSCI, V9, P580, DOI 10.1054/jocn.2001.1067; Noble ER, 1996, AM J NEURORADIOL, V17, P507; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; Payer M, 2004, J CLIN NEUROSCI, V11, P211, DOI 10.1016/j.jocn.2003.02.010; Rhoton AL, 2000, NEUROSURGERY, V47, pS155, DOI 10.1097/00006123-200009001-00017; Rhoton AL, 2000, NEUROSURGERY, V47, pS195, DOI 10.1097/00006123-200009001-00020; Schrodel MH, 2002, SKULL BASE-INTERD AP, V12, P93, DOI 10.1055/s-2002-31571-1; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Shin H, 2006, J NEUROSURG-SPINE, V4, P137, DOI 10.3171/spi.2006.4.2.137; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; STANDRING S, 2005, GRAYS ANATOMY, P463; STROOBANTS J, 1994, J NEUROSURG, V81, P137, DOI 10.3171/jns.1994.81.1.0137; Tubbs RS, 2000, J NEUROSURG, V92, P197, DOI 10.3171/spi.2000.92.2.0197; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; Vishteh AG, 1999, J NEUROSURG, V90, P91, DOI 10.3171/spi.1999.90.1.0091; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; WHITE AA, 1978, ORTHOP CLIN N AM, V9, P867; WIESEL S, 1978, ORTHOP CLIN N AM, V9, P969; WIESEL S W, 1979, Spine, V4, P187, DOI 10.1097/00007632-197905000-00001; YOUNG WF, 1994, NEUROSURGERY, V34, P257, DOI 10.1227/00006123-199402000-00008	51	21	21	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2010	66	3		S			A56	A59		10.1227/01.NEU.0000365751.84075.66			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	559BY	WOS:000274796000009	20173528				2022-02-06	
J	Newberry, A; Sherwood, P; Hricik, A; Bradley, S; Kuo, J; Crago, E; Hoffman, LA; Given, BA				Newberry, Alyssa; Sherwood, Paula; Hricik, Allison; Bradley, Sarah; Kuo, Jein; Crago, Elizabeth; Hoffman, Leslie A.; Given, Barbara A.			Understanding Recruitment and Retention in Neurological Research	JOURNAL OF NEUROSCIENCE NURSING			English	Article							COGNITIVE STATUS EXAMINATION; MENTAL-STATE-EXAMINATION; CAREGIVERS; CANCER; CHALLENGES; STRATEGIES; SURVIVORS; CAPACITY	Cognitive deficits in participants and the abrupt and traumatic way in which many neurological conditions present are two examples of the unique challenges in recruiting and retaining participants with neurological injury for research studies. The purpose of this investigation was to identify obstacles to recruitment and retention in three ongoing research studies. These Studies involve persons with neurological disorders across the continuum of care, from those newly diagnosed and with emergent presentation to those with more established chronic neurological conditions. For this analysis, we evaluated the effectiveness of the strategies employed to improve participation rates. The first study was a project funded by the National Institutes of Health designed to identify biomarkers of vasospasm in persons (n = 496) with aneurysmal subarachnoid hemorrhage who presented to the neurovascular intensive care unit (National Institute of Nursing Research, RO1 NR004339). The purpose of the second study was to examine biobehavioral interactions in family caregivers (n = 59) of persons with a primary malignant brain tumor recruited in the community setting. The third project involved recruiting persons (n = 1,019) within an outpatient neurosurgical center to participate in a research registry. To determine differential effectiveness of strategies, consent and attrition rates were calculated at serial points over time in three studies, and recruitment and retention strategies were compared. Sentinel time points in participants' disease trajectories played a key role in determining whether those who were approached to participate gave consent and were retained, particularly in the Studies involving persons with aneurysmal subarachnoid hemorrhage (consent = 85%; retention = 89%) and persons with primary malignant brain tumors and their caregivers (consent = 68%; retention = 83%). In addition, several specific recruiter and interviewer training techniques were associated with higher recruitment and retention. Targeted strategies to improve participation rates are vital for neuroscience nurses involved in any aspect of clinical research, including those Who Conduct Studies, assist with data collection, and recruit potential participants.	[Newberry, Alyssa; Sherwood, Paula; Hricik, Allison; Bradley, Sarah; Kuo, Jein; Crago, Elizabeth; Hoffman, Leslie A.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Given, Barbara A.] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA		Newberry, A (corresponding author), Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA.	agn8@pitt.edu			 [R01 CA 118711001];  [R01 NR004339-06]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA118711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004339, R01NR011044] Funding Source: NIH RePORTER	The authors acknowledge the following Studies: "Mind-Body Interactions in Neuro-Oncology Caregiving" (Sherwood, principal investigator; Grant R01 CA 118711001) and "The Role of 20-Hete on Vasospasm-Induced Ischemia After SAH" (Hoffman, principal investigator; Grant R01 NR004339-06).	Adams J, 1997, CONTROL CLIN TRIALS, V18, P14, DOI 10.1016/S0197-2456(96)00132-8; Aitken Leanne, 2003, Int J Nurs Pract, V9, P338, DOI 10.1046/j.1440-172X.2003.00449.x; Connell CM, 2001, ALZ DIS ASSOC DIS, V15, P137, DOI 10.1097/00002093-200107000-00005; Dancy BL, 2004, NURS OUTLOOK, V52, P234, DOI 10.1016/j.outlook.2004.04.012; Dilworth-Anderson P, 2005, ALZ DIS ASSOC DIS, V19, P256, DOI 10.1097/01.wad.0000190803.11340.66; Given Barbara, 2002, Oncol Nurs Forum, V29, P949, DOI 10.1188/02.ONF.949-956; GIVEN BP, 1993, FAMILY HOME CARE CAN; GIVEN BP, 1998, FAMILY HOME CARE CAN; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kim SYH, 2006, BEHAV SCI LAW, V24, P469, DOI 10.1002/bsl.702; Krupp W, 2000, ACTA NEUROCHIR, V142, P233, DOI 10.1007/s007010050030; Murphy MR, 2007, RES NURS HEALTH, V30, P347, DOI 10.1002/nur.20186; Northouse LL, 2006, RES NURS HEALTH, V29, P199, DOI 10.1002/nur.20128; Ott CD, 2006, CANCER NURS, V29, P21, DOI 10.1097/00002820-200601000-00004; Ransom S, 2006, RES NURS HEALTH, V29, P190, DOI 10.1002/nur.20129; Sadler GR, 2007, CONTEMP CLIN TRIALS, V28, P423, DOI 10.1016/j.cct.2006.11.006; Roper BL, 1996, NEUROPSY NEUROPSY BE, V9, P54; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; Smith SD, 2008, TOP STROKE REHABIL, V15, P593, DOI 10.1310/tsr1506-593; Sullivan-Bolyai S, 2007, WESTERN J NURS RES, V29, P486, DOI 10.1177/0193945907299658; Tansey CM, 2007, INTENS CARE MED, V33, P2051, DOI 10.1007/s00134-007-0817-6; Thompson EE, 1996, J CONSULT CLIN PSYCH, V64, P861, DOI 10.1037/0022-006X.64.5.861	22	21	21	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	FEB	2010	42	1					47	57		10.1097/JNN.0b013e3181c1fdd9			11	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	552RQ	WOS:000274311500007	20187349	Green Accepted			2022-02-06	
J	Cosentino, G; Giglia, G; Palermo, A; Panetta, ML; Lo Baido, R; Brighina, F; Fierro, B				Cosentino, G.; Giglia, G.; Palermo, A.; Panetta, M. L.; Lo Baido, R.; Brighina, F.; Fierro, B.			A case of post-traumatic complex auditory hallucinosis treated with rTMS	NEUROCASE			English	Article						Auditory hallucinosis; rTMS; Functional disruption; Therapeutic role of TMS; Right posterior temporal region	TRANSCRANIAL MAGNETIC STIMULATION; MUSICAL HALLUCINATIONS; ACQUIRED DEAFNESS; FRONTOTEMPORAL DEMENTIA; SCHIZOPHRENIA; TINNITUS; DEPRESSION; METABOLISM; APHASIA; CORTEX	Previous studies of auditory hallucinations in schizophrenia found that the hallucinations were reduced by the application of transcranial magnetic stimulation (rTMS). Here we describe a case of traumatic brain injury associated with continuous music hallucinations. An MRI scan showed a structural lesion of the right temporal pole and a PET scan indicated a hyperactive area of the posterior right temporal lobe. We hypothesized that rTMS applied to the right temporal area would reduce this activity and the corresponding hallucinations. The patient's music hallucinations were significantly reduced by rTMS treatment. A PET scan following treatment also indicated that rTMS treatment reduced brain activity in the right temporal lobe. This case provides initial evidence that rTMS may be a successful treatment of syndromes associated with hyperactive brain areas.	[Cosentino, G.; Palermo, A.; Panetta, M. L.; Lo Baido, R.; Brighina, F.; Fierro, B.] Univ Palermo, Dept Clin Neurosci, Palermo, Italy; [Giglia, G.] Casa Cura R Pacis, San Cataldo CL, Sicily, Italy		Brighina, F (corresponding author), Univ Palermo, Dept Clin Neurosci, Palermo, Italy.	fbrighina@unipa.it	Brighina, Filippo/K-9864-2016; Giglia, Giuseppe/M-7100-2016	Brighina, Filippo/0000-0001-5875-3126; Giglia, Giuseppe/0000-0001-5616-3595			AIZENBERG D, 1986, J NERV MENT DIS, V174, P309, DOI 10.1097/00005053-198605000-00008; BERRIOS GE, 1990, BRIT J PSYCHIAT, V156, P188, DOI 10.1192/bjp.156.2.188; Boellaard R, 2004, J NUCL MED, V45, P1519; Brighina F, 2003, NEUROSCI LETT, V336, P131, DOI 10.1016/S0304-3940(02)01283-1; Burt T, 2002, INT J NEUROPSYCHOPH, V5, P73, DOI 10.1017/S1461145702002791; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; d'Alfonso AAL, 2002, J NEUROPSYCH CLIN N, V14, P77, DOI 10.1176/appi.neuropsych.14.1.77; Daniele O, 2003, J NEUROL, V250, P761, DOI 10.1007/s00415-003-1080-6; Evers S, 2004, J NEUROL SCI, V227, P55, DOI 10.1016/j.jns.2004.08.004; Finocchiaro C, 2006, NEUROCASE, V12, P317, DOI 10.1080/13554790601126203; Griffiths TD, 2000, BRAIN, V123, P2065, DOI 10.1093/brain/123.10.2065; Halpern AR, 2001, ANN NY ACAD SCI, V930, P179, DOI 10.1111/j.1749-6632.2001.tb05733.x; HAMMEKE TA, 1983, J NEUROL NEUROSUR PS, V46, P570, DOI 10.1136/jnnp.46.6.570; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Hoffman RE, 2000, LANCET, V355, P1073, DOI 10.1016/S0140-6736(00)02043-2; Horacek J, 2007, NEUROPSYCHOBIOLOGY, V55, P132, DOI 10.1159/000106055; LENNOX G, 1988, BRIT J PSYCHIAT, V153, P713, DOI 10.1192/bjp.153.5.713b; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; Londero A, 2006, NEUROPHYSIOL CLIN, V36, P145, DOI 10.1016/j.neucli.2006.08.001; Miller BL, 2000, BRIT J PSYCHIAT, V176, P458, DOI 10.1192/bjp.176.5.458; Miller BL, 1998, NEUROLOGY, V51, P978, DOI 10.1212/WNL.51.4.978; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Rossi S, 2007, J NEUROL NEUROSUR PS, V78, P857, DOI 10.1136/jnnp.2006.105007; Schielke E, 2000, NEUROLOGY, V55, P454, DOI 10.1212/WNL.55.3.454; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; THEODORE WH, 1988, NEUROLOGY, V38, P1201, DOI 10.1212/WNL.38.8.1201; Thie JA, 2004, J NUCL MED, V45, P1431; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994	29	21	21	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2010	16	3					267	272	PII 918839701	10.1080/13554790903456191			6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	602FQ	WOS:000278124300006	20104391				2022-02-06	
J	Demakis, GJ; Hammond, FM; Knotts, A				Demakis, George J.; Hammond, Flora M.; Knotts, Allison			Prediction of Depression and Anxiety 1 Year After Moderate-Severe Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						anxiety; depression; Personality Assessment Inventory; traumatic brain injury	DISABILITY RATING-SCALE; PERSONALITY-ASSESSMENT INVENTORY; HEAD-INJURY; IMPAIRED AWARENESS; POPULATION; DISORDERS; COMMUNITY; PEOPLE	This study examined three scales of the Personality Assessment Inventory (PAI; Anxiety, Anxiety-Related Disorders, and Depression) in 88 participants 1 year after they suffered a moderate-severe traumatic brain injury (TBI). Participants were all enrolled in the federally funded Traumatic Brain Injury Model System project at Carolinas Rehabilitation. The following variables were assessed at the time of injury: age, sex, employment and marital status, and length of loss of consciousness. Disability status, using the Disability Rating Scale (DRS), was assessed at the time of discharge from the rehabilitation hospital. A series of three linear regression analyses found that these variables significantly predicted scores on the Anxiety and Anxiety-Related Disorders scales, which accounted for 14% and 17.7% of the variance, respectively. The variables did not significantly predict scores on the Depression scale. Within each regression analysis, DRS was consistently and negatively related to each PAI scale, such that greater disability was associated with better psychological functioning. Such seemingly paradoxical findings are discussed in terms of anosognosia or poor awareness of psychological functioning among those with greater disability 1 year after TBI.	[Demakis, George J.] Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA; [Hammond, Flora M.; Knotts, Allison] Carolinas HealthCare Syst, Carolinas Rehabil, Charlotte, NC USA		Demakis, GJ (corresponding author), Univ N Carolina, Dept Psychol, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	gdemakis@uncc.edu					Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; CORCORAN C, 2005, TXB TRAUMATIC BRAIN, P213; Deb S, 1999, AM J PSYCHIAT, V156, P374; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Flashman L., 2005, TXB TRAUMATIC BRAIN, P353; Fleming J, 1999, BRAIN INJURY, V13, P417; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Leung K L, 2005, Work, V25, P333; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Morey, 1991, PERSONALITY ASSESSME; Morey LC, 2006, DIFFERENTIATING NORM, P451; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	35	21	23	0	6	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	3					183	189	PII 926372433	10.1080/09084282.2010.499752			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	643VQ	WOS:000281328100004	20799109				2022-02-06	
J	Hansen, TS; Jakobsen, D				Hansen, Trine S.; Jakobsen, Daniela			A decision-algorithm defining the rehabilitation approach: 'Facial oral tract therapy'(R)	DISABILITY AND REHABILITATION			English	Article						Rehabilitation research; therapeutic methods; practice guideline	TRAUMATIC BRAIN-INJURY; HYPOTHESIS-ORIENTED ALGORITHM; BLACK-BOX; SWALLOWING DISORDERS; CHIN-TUCK; STROKE; COORDINATION; PATIENT; INTERVENTIONS; PSYCHOTHERAPY	Aim. The aim of this study was to describe and define the rehabilitation approach: 'Facial Oral Tract Therapy' (F.O.T.T.)(R). Method. We defined the content and process of the rehabilitation approach (F.O.T.T.)(R) in a decision-algorithm supported by a manual with supplementary material. The algorithm was developed by a research occupational therapist and an F.O.T.T.(R) senior instructor. We used an inductive approach combining existing knowledge from: F.O.T.T.(R) instructors, therapists trained in using the F.O.T.T.(R) approach, and existing literature. A group of F.O.T.T.(R) instructors and the originator of the treatment approach Mrs. Kay Coombes has given comments to and approved the algorithm. Result. The algorithm consist of five flowcharts: 'one assessment' chart guiding the therapist in the examination of the patient and four 'treatment charts', one for each of the four areas of F.O.T.T.(R): swallowing and eating; oral hygiene; breathing, voice, and speech articulation; facial expression, giving guidance on interventions. The algorithm outlines all important components in the treatment that the therapist should decide to use or not to use in the intervention. The algorithm is supported by a manual with criteria of when to use which components. Conclusion. This algorithm is designed to be a practical guideline to therapists using F.O.T.T.(R) in clinical practice and in educational settings. The use of this algorithm may support standardization of F.O.T.T.(R) and thereby promote and maintain the quality in the treatment. This in turn will facilitate research that addresses F.O.T.T.(R) and outcomes.	[Hansen, Trine S.; Jakobsen, Daniela] Univ Copenhagen, Hvidovre Hosp, Brain Injury Unit, Dept Neurorehabil, DK-2760 Hvidovre, Denmark; [Hansen, Trine S.; Jakobsen, Daniela] Univ Copenhagen, Hvidovre Hosp, Dept Occupat Therapy, DK-2760 Hvidovre, Denmark		Hansen, TS (corresponding author), Univ Copenhagen, Hvidovre Hosp, Brain Injury Unit, Dept Neurorehabil, Kettegaard Alle 30,2650, DK-2760 Hvidovre, Denmark.	trine.schow@gmail.com					Addis ME, 1999, CLIN PSYCHOL-SCI PR, V6, P430, DOI 10.1093/clipsy/6.4.430; Affolter F., 1991, PERCEPTION INTERACTI; AFFOLTER F, 2000, CLIN IMPLICATIONS; Alaverdashvili M, 2008, BEHAV BRAIN RES, V188, P281, DOI 10.1016/j.bbr.2007.11.007; *ARCOS, FAC OR TRACT THER FO; Ayuse T, 2006, J ORAL REHABIL, V33, P402, DOI 10.1111/j.1365-2842.2005.01586.x; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; BOBATH B, 1978, HEMIPLEGIA EVALUATIO; Calhoun KS, 1998, J CONSULT CLIN PSYCH, V66, P151, DOI 10.1037/0022-006X.66.1.151; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll KM, 2002, CLIN PSYCHOL-SCI PR, V9, P396, DOI 10.1093/clipsy/9.4.396; COOMBES K, 2001, FACIAL ORAL TRACT TH; COOMBES KFO, 2008, IADH MAGAZINE; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; DAVIES PM, 2000, STEPS FOLLOW; DAVIES PM, 1994, STARTING AGAIN EARLY; De Mayo T, 2005, J ORAL REHABIL, V32, P487, DOI 10.1111/j.1365-2842.2005.01453.x; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; ECHTERNACH JL, 1989, PHYS THER, V69, P559, DOI 10.1093/ptj/69.7.559; FRANK JS, 1990, PHYS THER, V70, P855, DOI 10.1093/ptj/70.12.855; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; HARRINGTON R, 1975, J AM GERIATR SOC, V23, P254, DOI 10.1111/j.1532-5415.1975.tb00314.x; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; HENRY WP, 1993, J CONSULT CLIN PSYCH, V61, P434, DOI 10.1037/0022-006X.61.3.434; *IB, THEOR ASS; *IB, THEOR ASS CLIN PRACT; KATHLEEN M, 2002, CLIN PSYCHOL-SCI PR, V9, P396; KJAERSGAARD A, 2005, MUND SVAELG; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; LOGEMANN JA, 1983, EVALUATION TREATMENT, V2; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; MARTIN BJW, 1994, J APPL PHYSIOL, V76, P714, DOI 10.1152/jappl.1994.76.2.714; MAYSTON M, 2001, NEUROLOGICAL PHYSIOT; Miller R M, 1999, Phys Med Rehabil Clin N Am, V10, P925; MONCHER FJ, 1991, CLIN PSYCHOL REV, V11, P247, DOI 10.1016/0272-7358(91)90103-2; MULDER T, 1993, BAILLIERE CLIN NEUR, V2, P1; Mulder Theo, 2001, Neural Plasticity, V8, P131, DOI 10.1155/NP.2001.131; Nezu A. M., 2008, EVIDENCE BASED OUTCO; Nudo Randolph J, 2006, NeuroRx, V3, P420; Nudo Randolph J, 2003, Phys Med Rehabil Clin N Am, V14, pS57, DOI 10.1016/S1047-9651(02)00054-2; Nudo RJ, 2007, BRAIN INJURY MED PRI, P913; NUSSERMULLER B, 2004, THERAPIE FACIO ORALE; *NUSSERMULLERBU, 2007, THERAPIE FACIO ORALE, V2; NUSSERMULLERBUS.R, 2007, KONSENSUSEMPFEHLUNGE; Raine S, 2006, PHYSIOTHER RES INT, V11, P4, DOI 10.1002/pri.35; Rothstein JM, 2003, PHYS THER, V83, P455, DOI 10.1093/ptj/83.5.455; ROTHSTEIN JM, 1986, PHYS THER, V66, P1388, DOI 10.1093/ptj/66.9.1388; Rozet I, 2007, BEST PRACT RES-CLIN, V21, P465, DOI 10.1016/j.bpa.2007.07.001; Sataloff RT, 2007, OTOLARYNG CLIN N AM, V40, P909, DOI 10.1016/j.otc.2007.05.002; Schenkman M, 2006, PHYS THER, V86, P1681, DOI 10.2522/ptj.20050260; Seidl RO, 2007, CLIN REHABIL, V21, P686, DOI 10.1177/0269215507076393; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Talbot Ana, 2005, Gerodontology, V22, P77, DOI 10.1111/j.1741-2358.2005.00049.x; Tinetti ME, 2008, J AM GERIATR SOC, V56, P730, DOI 10.1111/j.1532-5415.2007.01627.x; TINETTI ME, 1989, SEMIN NEUROL, V9, P39, DOI 10.1055/s-2008-1041303; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; WELCH MV, 1993, ARCH PHYS MED REHAB, V74, P178; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146; World Health Organization, WHO INT CLASS FUNCT; World Health Organization, 2006, INT CLASS FUNCT DIS	64	21	21	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2010	32	17					1447	1460		10.3109/09638280903556482			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	636QX	WOS:000280755100008	20624108				2022-02-06	
J	Noe, E; Ferri, J; Colomer, C; Moliner, B; Chirivella, J				Noe, E.; Ferri, J.; Colomer, C.; Moliner, B.; Chirivella, J.			APOE genotype and verbal memory recovery during and after emergence from post-traumatic amnesia	BRAIN INJURY			English	Article						APOE; post-traumatic amnesia; traumatic brain injury; rehabilitation; memory	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E POLYMORPHISM; HEAD-INJURY; ASSOCIATION; EPSILON-4; COGNITION; MODERATE; SCALE	Objective: To determine if APOE genotype is linked to memory function after moderate-severe traumatic brain injury (TBI). Methods: Eighty-two patients in post-traumatic amnesia (PTA) and 107 patients who had emerged from PTA were selected from 239 consecutive patients admitted to the facility. Verbal memory assessments, including the Spanish version of the California Verbal Learning Test and the Working-Memory Index of the WAIS-III, were conducted immediately after PTA resolution or during the first week after admission for patients who were out of PTA. Both groups were reassessed 6 months after inclusion in a multidisciplinary rehabilitation programme. Results: Patients with the APOE-epsilon 4 allele (n = 17 in the PTA group and n = 9 in the out of PTA group) entered rehabilitation at a more impaired level, but made remarkable progress during follow-up. Fifty-five patients from the initial sample emerged from PTA during the follow-up period. Age, GOAT at admission and chronicity, but not APOE genotype or initial trauma severity, were significant predictors of emergence from PTA. Conclusions: APOE genotype seems to be associated with the trajectory of cognitive recovery after TBI, but does not play a determinant role in the efficacy of memory rehabilitation in this population.	[Noe, E.; Ferri, J.; Colomer, C.; Moliner, B.; Chirivella, J.] Hosp Valencia Mar, Serv Dano Cerebral Hosp NISA, FIVAN, Valencia 46011, Spain		Noe, E (corresponding author), Hosp Valencia Mar, Serv Dano Cerebral Hosp NISA, FIVAN, C Rio Tajo N 1, Valencia 46011, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; BENEDET MJ, 1999, TEST APRENDIZAJE VER; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mueller SG, 2008, NEUROIMAGE, V42, P42, DOI 10.1016/j.neuroimage.2008.04.174; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WECHSLER D, 1999, ESCALA INTELIGENCIA, V3; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460	30	21	22	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	6					886	892		10.3109/02699051003724952			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700011	20377344				2022-02-06	
J	Semrud-Clikeman, M				Semrud-Clikeman, Margaret			Pediatric Traumatic Brain Injury: Rehabilitation and Transition to Home and School	APPLIED NEUROPSYCHOLOGY			English	Article						children; rehabilitation; TBI; treatment	COGNITIVE REHABILITATION; HEAD-INJURY; FAMILY INTERVENTION; YOUNG-CHILDREN; BEHAVIOR; TBI; RECOMMENDATIONS; RECOVERY; OUTCOMES; DAMAGE	The purpose of this review is to provide a summary of the empirical research on rehabilitation in pediatric traumatic brain injury (TBI). Studies of the effectiveness of interventions with children with TBI are hampered by difficulty with combining subjects with various levels of TBI, problems with random assignment to treatment groups, and varying age levels at injury. While these are areas of concern, there are emerging studies that indicate both applied behavioral analysis (ABA) and positive behavioral interventions are helpful to many children. For some children, ABA is not successful, and a shift to positive behavioral interventions has been found to be helpful. Transitions to home and school can be difficult particularly if there are family issues that predated the injury. This review provides additional information for the pediatric neuropsychologist to assist with transition to school and home. Studies utilizing the Internet for family interventions have revealed promising results. This review suggests that additional studies as to the efficacy of interventions following TBI are needed particularly to evaluate outcomes after initial recovery and at follow-up. In addition, this review suggests that an important role for pediatric neuropsychologists is to provide support for schools and families through therapy and inservices for school personnel on TBI.	[Semrud-Clikeman, Margaret] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Semrud-Clikeman, Margaret] Michigan State Univ, Dept Psychiat, E Lansing, MI 48824 USA		Semrud-Clikeman, M (corresponding author), Michigan State Univ, Dept Psychol, 321 A W Fee Hall, E Lansing, MI 48824 USA.	semrudcl@msu.edu	Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X			ALLEN K, 1994, REHABIL PSYCHOL, V39, P30; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; BERGLAND MM, 1996, ACQUIRED BRAIN INJUR, P17; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CARTER RR, 1985, COGNITIVE REHABILITA, V3, P14; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 2009, NEUROPSYCHOLOGY, V23, P20; COHEN SB, 1996, ACQUIRED BRAIN INJUR, P126; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Conoley JC, 1996, J LEARN DISABIL-US, V29, P662, DOI 10.1177/002221949602900610; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DEPOMPEI R, 1993, STAFF DEV CLIN INTER, P229; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Fischer, 2004, NEUROPSYCHOL ASSESSM; Fyffe CE, 2004, J APPL BEHAV ANAL, V37, P401, DOI 10.1901/jaba.2004.37-401; Jutai Jeffrey W, 2003, Top Stroke Rehabil, V10, P77; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; MAEGDEN J, 2007, PEDIATRIC NEUROPSYCH; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rosen CD, 1986, HEAD TRAUMA ED REINT; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Semrud-Clikeman M., 2005, HDB SCH NEUROPSYCHOL, P425; Semrud-Clikeman M., 2009, CHILD NEUROPSYCHOLOG; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wilson B. A., 2005, EFFECTIVENESS REHABI, P143; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 1993, Seminars in Speech and Language, V14, P74, DOI 10.1055/s-2008-1064160; ZENICUS A, 1989, BRAIN INJURY, V3, P67	49	21	21	0	24	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					116	122	PII 922181819	10.1080/09084281003708985			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800007	20467952				2022-02-06	
J	Zgaljardic, DJ; Temple, RO				Zgaljardic, Dennis J.; Temple, Richard O.			Neuropsychological Assessment Battery (NAB): Performance in a Sample of Patients with Moderate-to-Severe Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						neuropsychological assessment; postacute; rehabilitation; traumatic brain injury	SCREENING MODULE; COGNITIVE IMPAIRMENT; REHABILITATION; VALIDITY; SCORES	The Neuropsychological Assessment Battery (NAB; Stern White, 2003) is a comprehensive test battery that assesses five cognitive domains (Attention, Language, Memory, Spatial, and Executive Functions). The purpose of the current descriptive study was to present data on the index and primary test scores from the five main NAB cognitive modules in a sample of patients with moderate-to-severe traumatic brain injury (TBI) admitted to a residential postacute rehabilitation program. Twenty patients were administered all five main NAB modules upon recommendation from the NAB Screening module. The sample performed significantly worse than normal on tests that assess selective and divided attention, psychomotor speed, verbal memory, and cognitive flexibility. The largest proportion of patients performing below an established impairment cutoff (10th percentile) occurred on the Numbers and Letters, List Learning, Story Learning, Daily Living Memory, and Categories Tests. Significant performance decrements were not observed on any indices or tests from the Language or Spatial cognitive domain modules. The pattern of performance on the NAB demonstrated by the current sample is consistent with the neuropsychological profile observed in postacute patients with moderate-to-severe TBI without focal deficits (e.g., aphasia), demonstrating its relative sensitivity in this patient population. A comparison between the current study sample and a related clinical sample from the NAB standardization data is discussed.	[Zgaljardic, Dennis J.] Transit Learning Ctr, Dept Neuropsychol, Galveston, TX 77550 USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Galveston, TX USA; [Temple, Richard O.] CORE Hlth Care, Dripping Springs, TX USA		Zgaljardic, DJ (corresponding author), Transit Learning Ctr, Dept Neuropsychol, 1528 Postoff St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org			Moody Endowment	This work was supported by the Moody Endowment. We gratefully acknowledge Jason Levinson, MA, for assistance with data collection, and Kimberly Wildes, DrPH, MA, and Renee Pearcy for editorial assistance.	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Cahn-Weiner DA, 2009, EPILEPTIC DISORD, V11, P222, DOI 10.1684/epd.2009.0265; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Grohman K, 2004, EXP CLIN PSYCHOPHARM, V12, P200, DOI 10.1037/1064-1297.12.3.200; Iverson GL, 2007, APPL NEUROPSYCHOL, V14, P178, DOI 10.1080/09084280701508952; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lynch WJ, 2004, J HEAD TRAUMA REHAB, V19, P180, DOI 10.1097/00001199-200403000-00009; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Wechsler D., 1981, WAIS R MANUAL; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	16	21	23	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	4					283	288	PII 930971379	10.1080/09084282.2010.525118			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	693AE	WOS:000285196200007	21154042				2022-02-06	
S	Zhang, ZQ; Larner, SF; Kobeissy, F; Hayes, RL; Wang, KKW		Yan, Q		Zhang, Zhiqun; Larner, Stephen F.; Kobeissy, Firas; Hayes, Ronald L.; Wang, Kevin K. W.			Systems Biology and Theranostic Approach to Drug Discovery and Development to Treat Traumatic Brain Injury	SYSTEMS BIOLOGY IN DRUG DISCOVERY AND DEVELOPMENT: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Biomarkers; Brain injury; Theranostics; Systems biology	SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; IDENTIFICATION; PROTEOME; RATS	Traumatic brain injury is a significant disease affecting 1.4 to 2 million patients every year in the USA. Currently, there are no FDA-approved therapeutic remedies to treat TBI despite the fact that there have been over 200 clinical drug trials, all which have failed. These drugs used the traditional single drug-to-target approach of drug discovery and development. An alternative based upon the advances in genomics, proteomics, bioinformatic tools, and systems biology software has enabled us to use a Systems Biology-based approach to drug discovery and development for TBI. It focuses on disease-relevant converging pathways as potential therapeutic intervention points and is accompanied by downstream biomarkers that allow for the tracking of drug targeting and appears to correlate with disease mitigation. When realized, one is able to envision that a companion diagnostic will be codeveloped along the therapeutic compound. This "theranostic" approach is perfectly positioned to align with the emerging trend toward "personalized medicine".	[Zhang, Zhiqun; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA; [Kobeissy, Firas; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, McKnight Brain Inst, Gainesville, FL 32611 USA		Zhang, ZQ (corresponding author), Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA.		Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473			Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005; CAMPAGNE F, 2004, SCI STKE, pI11; Chen S. S., 2007, DATA MINING BIOMEDIC, P1; Hinman LM, 2006, PHARMACOGENOMICS J, V6, P375, DOI 10.1038/sj.tpj.6500392; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Katz Russell, 2004, NeuroRx, V1, P189, DOI 10.1007/BF03206602; Kobeissy FH, 2008, EXPERT REV PROTEOMIC, V5, P293, DOI 10.1586/14789450.5.2.293; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Nickerson D, 2005, P ANN INT IEEE EMBS, P6096, DOI 10.1109/IEMBS.2005.1615884; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vitzthum F, 2005, J PROTEOME RES, V4, P1086, DOI 10.1021/pr050080b; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Warner S, 2004, SCIENTIST, V18, P38	22	21	22	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-60761-799-0	METHODS MOL BIOL	Methods Mol. Biol.		2010	662						317	329		10.1007/978-1-60761-800-3_16	10.1007/978-1-60761-800-3		13	Biochemical Research Methods; Biochemistry & Molecular Biology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology	BRH19	WOS:000282703900016	20824479				2022-02-06	
J	Vaccari, JPD; Marcillo, A; Nonner, D; Dietrich, WD; Keane, RW				Vaccari, Juan Pablo de Rivero; Marcillo, Alex; Nonner, Doris; Dietrich, W. Dalton; Keane, Robert W.			Neuroprotective effects of bone morphogenetic protein 7 (BMP7) treatment after spinal cord injury	NEUROSCIENCE LETTERS			English	Article						Bone morphogenetic protein 7; Spinal cord injury; Glutamate excitotoxicity; MAPK signaling	TRAUMATIC BRAIN-INJURY; INTRACISTERNAL OSTEOGENIC PROTEIN-1; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; CORTICAL-NEURONS; CROSS-TALK; STROKE; KINASE; NMDA	Bone morphogenetic protein 7 (BMP7) has been shown to ameliorate reduced dendritic growth induced by glutamate excitotoxicity in neuronal tissue cultures and/or provide an enhancement of functional recovery in central nervous system (CNS) injury. BMP7 expression is modulated by spinal cord injury (SCI), but the molecular mechanisms involved in neuroprotection have not been clearly defined. Here, we show that BMP7 treatment of rats subjected to mild cervical SCI significantly increased the pro-survival mitogen-activated protein kinase-38 (MAPK-38) pathway and levels of N-methyl-D-aspartate receptor I (NMDAR-1) resulting in a significant increase in neuronal sparing in the ventral horn of the spinal cord. Moreover, BMP7 was neuroprotective against glutamate-mediated excitotoxicity in cultured cortical neurons. These studies show that BMP7 administration may be used as a therapeutic strategy to reduce the damaging excitotoxic effects following SCI. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Nonner, Doris; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Vaccari, Juan Pablo de Rivero; Marcillo, Alex; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Vaccari, Juan Pablo de Rivero; Marcillo, Alex; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA		Keane, RW (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave, Miami, FL 33136 USA.	rkeane@miami.edu	de Rivero Vaccari, Juan Pablo/H-5718-2019; de Rivero Vaccari, Juan Pablo/ABE-3248-2020	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834	Department of DefenseUnited States Department of Defense [USAMRMC X81XWH-05-1-0001]	This work was supported by Department of Defense grant: USAMRMC X81XWH-05-1-0001. We thank David Molnar and Dr. Juan Carlos de Rivero Vaccari for technical assistance.	BENARDETE EA, 2009, BRAIN RES; BRAMLETT HD, 2005, INT J NEUROPROT NEUR, V1, P165; Brown KM, 2004, DEV BRAIN RES, V152, P61, DOI 10.1016/j.devbrainres.2004.06.001; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chaverneff F, 2009, J NEUROCHEM, V109, P733, DOI 10.1111/j.1471-4159.2009.05990.x; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Cox S, 2004, BRAIN RES, V1010, P55, DOI 10.1016/j.brainres.2004.02.068; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Enzmann GU, 2005, EXP NEUROL, V195, P293, DOI 10.1016/j.expneurol.2005.04.021; Esquenazi S, 2002, EXP NEUROL, V176, P41, DOI 10.1006/exnr.2002.7906; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gazzerro E, 2007, CURR OPIN PHARMACOL, V7, P325, DOI 10.1016/j.coph.2007.01.003; Haddad JJ, 2005, PROG NEUROBIOL, V77, P252, DOI 10.1016/j.pneurobio.2005.10.008; Haghighi SS, 2000, SPINAL CORD, V38, P733, DOI 10.1038/sj.sc.3101074; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hu MC, 2004, J BIOL CHEM, V279, P12051, DOI 10.1074/jbc.M310526200; JANTAS D, 2009, NEUROCHEM RES; Kawamata T, 1998, NEUROREPORT, V9, P1441, DOI 10.1097/00001756-199805110-00035; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; McAdoo DJ, 1997, J NEUROTRAUM, V14, P507, DOI 10.1089/neu.1997.14.507; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Ren JM, 2000, NEUROPHARMACOLOGY, V39, P860, DOI 10.1016/S0028-3908(99)00261-0; Repici M, 2009, NEUROSCIENCE, V159, P94, DOI 10.1016/j.neuroscience.2008.11.049; Ryu BR, 1999, J NEUROBIOL, V39, P536, DOI 10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; Timmer J, 2005, DEV BIOL, V285, P1, DOI 10.1016/j.ydbio.2005.05.039; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	35	21	22	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 20	2009	465	3					226	229		10.1016/j.neulet.2009.09.013			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	510CY	WOS:000271066800006	19765637				2022-02-06	
J	Alexander, T; Fuller, G; Hargovan, P; Clarke, DL; Muckart, DJ; Thomson, SR				Alexander, T.; Fuller, G.; Hargovan, P.; Clarke, D. L.; Muckart, D. J.; Thomson, S. R.			An audit of the quality of care of traumatic brain injury at a busy regional hospital in South Africa	SOUTH AFRICAN JOURNAL OF SURGERY			English	Article							HEAD-INJURIES; MANAGEMENT; EMERGENCY; ACCIDENT	Access to care by a dedicated neurosurgical unit is limited in the developing world, and the vast majority of patients who sustain a head injury are managed by general surgeons. Prevention of secondary brain injury is paramount. While the principles of management are relatively straightforward, delivering this care may be difficult. This audit looks at the spectrum of head injuries presenting to a busy regional hospital and attempts to measure the quality of care offered to these patients. Patients and methods. The audit includes three separate sections. The first is a prospective audit of all patients with a traumatic brain injury presenting to the Accident and Emergency (AE) department at Edendale Hospital, Pietermaritzburg, over a 2-month period, The next two sub-audits consist of a random review of referral letters and AE clerking notes to assess the quality of care received by these patients. A total of 25 referral letters and 28 AE inpatient notes were randomly chosen for review and compared with agreed standardised markers for quality of care. Results. Over the 2 months October and November 2007, 150 patients with a head injury were seen in the AE department. Of these 117 were male. A total of 76 were discharged home after investigation with a head injury warning chart, 49 were admitted to the general wards, 11 were admitted to the surgical intensive care unit, 10 were referred to the neurosurgical centre in Durban, and 4 died in the AE department. Of the 10 who needed advanced neurosurgical care, 3 required urgent burr-holes before referral. One of these patients died. All the remaining 9 patients who were transferred to the neurosurgery unit survived. The referral letters and AE clerking notes revealed major deficits. Conclusion. Traumatic brain injury is a common problem. Only a small subset of patients require specialised neurosurgical care. Although many patients with intracranial injury can tolerate the delay associated with transfer, some cases are acute and urgent intervention by non-neurosurgeons is needed. Prevention of secondary brain injury is poorly understood and not prioritised. This situation needs to be improved. The introduction of formalised standard referral and management sheets may help to improve care.	[Alexander, T.; Fuller, G.; Hargovan, P.] Edendale Hosp, Dept Accid & Emergency, Pietermaritzburg, South Africa; [Clarke, D. L.; Muckart, D. J.; Thomson, S. R.] Univ KwaZulu Natal, Dept Gen Surg, Durban, South Africa		Alexander, T (corresponding author), Edendale Hosp, Dept Accid & Emergency, Pietermaritzburg, South Africa.			Clarke, Damian/0000-0002-8467-1455			Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Cohn SM, 2007, J TRAUMA, V62, P951, DOI 10.1097/01.ta.0000260131.79063.50; FISHER RB, 1990, BRIT MED J, V300, P1560, DOI 10.1136/bmj.300.6739.1560; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JACOBSON S, 1993, J TRAUMA, V35, P491, DOI 10.1097/00005373-199309000-00032; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Myburgh J A, 1999, Crit Care Resusc, V1, P55; Nadvi SS, 1997, S AFR MED J, V87, P1669; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; O'Connor AE, 2001, NEW ZEAL MED J, V114, P443; Pitts LH, 1998, J TRAUMA, V44, P989; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; Thomson R, 1994, Qual Health Care, V3, P86, DOI 10.1136/qshc.3.2.86; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004; WALLACE SA, 1994, J ACCID EMERG MED, V11, P33; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	21	21	23	0	4	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0038-2361	2078-5151		S AFR J SURG	South Afr. J. Surg.	NOV	2009	47	4					120	+					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	547DK	WOS:000273865600004	20141069				2022-02-06	
J	Bagiella, E				Bagiella, Emilia			Clinical Trials in Rehabilitation: Single or Multiple Outcomes?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Clinical trials as topic; Rehabilitation	END-POINTS	Bagiella E. Clinical trials in rehabilitation: single or multiple outcomes? Arch Phys Med Rebabil 2009;90 (11 Suppl 1):S17-21. In clinical trials, the choice of the primary outcome affects the study design, the sample size calculations, the data analysis, and the interpretation of the study results. Most importantly, it may determine the future of the intervention being studied. In several clinical and rehabilitation settings, a single primary outcome measure is often not sufficient to reflect the effect of an intervention because attention is focused on multiple aspects of patients' recovery. In stroke and traumatic brain injuries trials, for example, functional recovery is as important as cognitive recovery. Thus, a trial with a functional scale alone as the primary outcome would not be informative a out the effectiveness of the intervention on cognitive functions. From the methodologic point of view, the choice of multiple primary outcomes presents several challenges, including selecting a measure, among several, to be used for sample size calculations; dealing with multiple comparisons; and interpreting the results. In this article, we discuss a global test procedure that allows investigators to use several binary measures as primary outcomes in a clinical trial. This procedure offers an efficient solution under very reasonable assumptions, avoids loss of power caused by multiple comparisons, has greater statistical power than any single outcome measure, and is easily interpreted and of direct clinical interest.	Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA		Bagiella, E (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, 722 W 168th St, New York, NY 10032 USA.	eb51@columbia.edu					Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Hardin James W., 2003, GEN ESTIMATING EQUAT, DOI [10.1201/b13880, DOI 10.1201/B13880]; MEIER P, 1975, BIOMETRICS, V31, P511, DOI 10.2307/2529434; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; POCOCK SJ, 1987, BIOMETRICS, V43, P487, DOI 10.2307/2531989; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; POCOCK SJ, 1997, CONTROL CLIN TRIALS, V18, P546; Rao C.R., 1999, LINEAR MODELS LEAST; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tilley BC, 1999, ARTHRITIS RHEUM, V42, P1879, DOI 10.1002/1529-0131(199909)42:9<1879::AID-ANR12>3.0.CO;2-1; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136	13	21	21	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2009	90	11		1			S17	S21		10.1016/j.apmr.2009.08.133			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	520XE	WOS:000271882100004	19892070				2022-02-06	
J	Uswatte, G; Qadri, LH				Uswatte, Gitendra; Qadri, Laura Hobbs			A Behavioral Observation System for Quantifying Arm Activity in Daily Life After Stroke	REHABILITATION PSYCHOLOGY			English	Article						arm; observation; rehabilitation; treatment outcome; stroke	INDUCED MOVEMENT THERAPY; UPPER-EXTREMITY; REHABILITATION; ACCELEROMETRY; VALIDITY	Objective: Evaluate psychometric properties of the Functional Arm Activity Behavioral Observation System (FAABOS) for measuring hemiparetic arm use. Participants and Measures: All participants acquired their brain injury > 1 year prior to study entry; most had mild-to-moderate upper-extremity hemiparesis. In Study 1, 9 stroke survivors wore accelerometers and were videotaped for 15 min in the hospital or at home after they were asked to behave as usual. In Study 2, 1 traumatic brain injury and 8 stroke survivors wore accelerometers and were videotaped at home for 3 days with a motion-triggered camera. Observers independently rated 15-min segments of the Study I and 2 videotapes in 2-s blocks with a 4-step arm-activity coding scheme. Results: Interrater reliability was excellent; the mean Cohen's K in each study was >= .84. For data from both studies combined, validity was supported by a strong correlation between amount of hemiparetic arm functional activity, as determined by the observers, and the ratio of hemiparetic to other arm movement, as determined by accelerometry. Conclusion: FAABOS reliably and validly quantifies amount of spontaneous hemiparetic arm activity outside the laboratory.	[Uswatte, Gitendra; Qadri, Laura Hobbs] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Uswatte, Gitendra] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA		Uswatte, G (corresponding author), Univ Alabama Birmingham, Dept Psychol, 1530 3rd Ave S,CH415, Birmingham, AL 35294 USA.	guswatte@uab.edu	Uswatte, Gitendra/C-4913-2009		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053750] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD034273] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD053750-01A2, R01 HD053750-02, HD34273, HD053750, R01 HD034273, R01 HD053750] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133G050222] Funding Source: Medline		Bakeman R., 1986, OBSERVING INTERACTIO; Bowman MH, 2006, NEUROREHABILITATION, V21, P167; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J., 2013, STAT POWER ANAL BEHA; Elliott TR, 2002, REHABIL PSYCHOL, V47, P131, DOI 10.1037//0090-5550.47.2.131; Merbitz C, 1996, Assist Technol, V8, P121; Schasfoort FC, 2003, PAIN, V101, P79, DOI 10.1016/S0304-3959(02)00298-1; Smith EE., 1981, CATEGORIES CONCEPTS; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 2006, NEUROREHABILITATION, V21, P93; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2005, REHABIL PSYCHOL, V50, P34, DOI 10.1037/0090-5550.50.1.34; Uswatte G, 2000, STROKE, V31, P662, DOI 10.1161/01.STR.31.3.662; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; USWATTE G, NEW FRONTIE IN PRESS; USWATTE G, 2009, ASSESSMENT REHABILIT, P121; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; World Health Organization, 2007, INT CLASS FUNCT DIS	22	21	21	0	28	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2009	54	4					398	403		10.1037/a0017501			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	526YF	WOS:000272331600006	19929121	Green Accepted			2022-02-06	
J	Roberts, DJ; Goralski, KB; Renton, KW; Julien, LC; Webber, AM; Sleno, L; Volmer, DA; Hall, RI				Roberts, Derek J.; Goralski, Kerry B.; Renton, Kenneth W.; Julien, Lisa C.; Webber, Adam M.; Sleno, Lekha; Volmer, Dietrich A.; Hall, Richard I.			Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3-and 6-glucuronide in the human brain	CRITICAL CARE MEDICINE			English	Article						blood-brain barrier; inflammation; morphine; morphine-3-glucuronide; morphine-6-glucuronide; P-glycoprotein; multidrug resistance protein	P-GLYCOPROTEIN EXPRESSION; NECROSIS-FACTOR-ALPHA; BARRIER TRANSPORT; MEDIATED TRANSPORT; MORPHINE-6-GLUCURONIDE; MORPHINE-3-GLUCURONIDE; PHARMACOKINETICS; MICRODIALYSIS; MICE; RAT	Objective: In animals, central nervous system inflammation increases drug accumulation in the brain partly due to a loss of central nervous system drug efflux transporter function at the blood-brain barrier. To determine whether a similar loss of active drug efflux occurs in humans after acute inflammatory brain injury. Design: Observational human pharmacokinetic study. Setting: Medical-surgical-neurosurgical intensive care unit at a university-affiliated, Canadian tertiary care center. Patients: Patients with acute inflammatory brain injury, including subarachnoid hemorrhage (n = 10), intracerebral and/or intraventricular hemorrhage (n = 4), or closed head trauma (n = 2) who received morphine intravenously after being fitted with cerebrospinal fluid ventriculostomy and peripheral arterial catheters. Interventions: We correlated the cerebrospinal fluid distribution of morphine, morphine-3-glucuronide, and morphine-6-glucuronide with the cerebrospinal fluid and plasma concentration of the proinflammatory cytokine interleukin-6 and the passive marker of blood-brain barrier permeability, albumin. Measurements and Main Results: Acute brain injury produced a robust inflammatory response in the central nervous system as reflected by the elevated concentration of interleukin-6 in cerebrospinal fluid. Penetration of morphine metabolites into the central nervous system increased in proportion to the neuroinflammatory response as demonstrated by the positive correlation between cerebrospinal fluid interleukin-6 exposure and the area under the curve cerebrospinal fluid/plasma ratio for morphine-3-glucuronide (r = .49, p < .001) and morphine-6-glucuronide (r = .51, p < .001). In contrast, distribution of morphine into the brain was not linked with cerebrospinal fluid interleukin-6 exposure (r = .073, p = .54). Albumin concentrations in plasma and cerebrospinal fluid were consistently in the normal range, indicating that the physical integrity of the blood-brain barrier was likely undisturbed. Conclusions: Our results suggest that central nervous system inflammation following acute brain injury may selectively inhibit the activity of specific drug efflux transporters within the blood-brain barrier. This finding may have significant implications for patients with neuroinflammatory conditions when administered centrally acting drugs normally excluded from the brain by such transporters. (Crit Care Med 2009; 37:2767-2774)	[Roberts, Derek J.; Julien, Lisa C.; Webber, Adam M.; Hall, Richard I.] Dalhousie Univ, Div Crit Care Med, Halifax, NS, Canada; Dalhousie Univ, Dept Med, Halifax, NS, Canada; Dalhousie Univ, Dept Anesthesia, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada; Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Roberts, Derek J.; Goralski, Kerry B.; Renton, Kenneth W.; Hall, Richard I.] Dalhousie Univ, Dept Pharmacol, Fac Med, Halifax, NS B3H 4H7, Canada; [Goralski, Kerry B.] Dalhousie Univ, Coll Pharm, Fac Hlth Profess, Halifax, NS B3H 3J5, Canada; [Sleno, Lekha] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada; [Volmer, Dietrich A.] MRC, Elsie Widdowson Lab, Cambridge, England		Hall, RI (corresponding author), Dalhousie Univ, Div Crit Care Med, Halifax, NS, Canada.	RIHall@Dal.Ca	Roberts, Derek J./L-6229-2019; Volmer, Dietrich/G-7900-2012	Roberts, Derek J./0000-0001-6111-6291; Volmer, Dietrich/0000-0003-2820-1480; Goralski, Kerry/0000-0003-0040-5879	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Dalhousie Medical Research Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105960396] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U105960396] Funding Source: researchfish	Support for this investigation was afforded, in part, by the Canadian Institutes of Health Research and the Dalhousie Medical Research Foundation.	BARTLETT SE, 1994, LIFE SCI, V54, P687, DOI 10.1016/0024-3205(94)00552-4; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bourasset F, 2003, J NEUROCHEM, V86, P1564, DOI 10.1046/j.1471-4159.2003.01990.x; Bouw MR, 2001, BRIT J PHARMACOL, V134, P1796, DOI 10.1038/sj.bjp.0704406; Bouw R, 2001, ACTA ANAESTH SCAND, V45, P390, DOI 10.1034/j.1399-6576.2001.045003390.x; DeVries HE, 1997, PHARMACOL REV, V49, P143; Ederoth P, 2004, BRIT J CLIN PHARMACO, V57, P427, DOI 10.1046/j.1365-2125.2003.02032.x; Faura CC, 1998, PAIN, V74, P43, DOI 10.1016/S0304-3959(97)00142-5; Goralski KB, 2003, BRIT J PHARMACOL, V139, P35, DOI 10.1038/sj.bjp.0705227; Hamabe W, 2007, J PHARMACOL SCI, V105, P353, DOI 10.1254/jphs.FP0071287; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Huwyler J, 1996, BRIT J PHARMACOL, V118, P1879, DOI 10.1111/j.1476-5381.1996.tb15619.x; King M, 2001, NAT NEUROSCI, V4, P268, DOI 10.1038/85115; LABELLA FS, 1979, BRAIN RES, V174, P263, DOI 10.1016/0006-8993(79)90849-7; Letrent SP, 1998, PHARMACEUT RES, V15, P599, DOI 10.1023/A:1011938112599; Lotsch J, 2000, LIFE SCI, V66, P2393, DOI 10.1016/S0024-3205(00)00569-5; Lotsch J, 2002, J NEUROCHEM, V83, P241, DOI 10.1046/j.1471-4159.2002.01177.x; Meineke I, 2002, BRIT J CLIN PHARMACO, V54, P592, DOI 10.1046/j.1365-2125.2002.t01-1-01689.x; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Osuka K, 1998, ACTA NEUROCHIR, V140, P943, DOI 10.1007/s007010050197; Roberts DJ, 2008, EXPERT OPIN DRUG MET, V4, P1245, DOI 10.1517/17425255.4.10.1245 ; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Skarke C, 2004, ANESTHESIOLOGY, V101, P1394; Theron D, 2003, BIOCHEM PHARMACOL, V66, P579, DOI 10.1016/S0006-2952(03)00340-X; Thompson SJ, 2000, ANESTHESIOLOGY, V92, P1392, DOI 10.1097/00000542-200005000-00030; van de Wetering K, 2007, MOL PHARMACOL, V72, P387, DOI 10.1124/mol.107.035592; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498; Xie RJ, 2000, BRIT J PHARMACOL, V131, P1784, DOI 10.1038/sj.bjp.0703759	32	21	21	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2009	37	10					2767	2774		10.1097/CCM.0b013e3181b755d5			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OU	WOS:000270234700013	19865006				2022-02-06	
J	Mauritz, W; Leitgeb, J; Wilbacher, I; Majdan, M; Janciak, I; Brazinova, A; Rusnak, M				Mauritz, Walter; Leitgeb, Johannes; Wilbacher, Ingrid; Majdan, Marek; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin			Outcome of brain trauma patients who have a Glasgow Coma Scale score of 3 and bilateral fixed and dilated pupils in the field	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						brain injury; fixed and dilated; Glasgow Coma Scale; Glasgow Outcome Scale; pupils; traumatic	INJURY; MANAGEMENT; REACTIVITY; IMPACT; CARE	Objective To investigate the outcome of brain trauma patients who had a Glasgow Coma Scale score (GCS) of 3 and bilateral fixed and dilated pupils (BFDP) in the field. Methods Between January 2001 and December 2005, 13 European centres enrolled patients with severe brain trauma. Data sets of all patients who had a GCS of 3 as well as BFDP were analysed. Patients were classified according to the Glasgow Outcome Scale, 12 months after trauma as 'good' (Glasgow Outcome Scale of 5 or 4) or 'poor' functional recovery; relevant data for these two groups were compared. Variables that showed differences in univariate analyses (chi(2) and Wilcoxon-Mann-Whitney tests) were then used as covariates in logistic regression models. A P value of less than 0.05 was considered significant. Results Ninety-two (78%) of 1172 patients had a GCS of 3 and BFDP; eight had 'good', 84 had 'poor' recovery. We found no significant differences in sex (79% male), age (median 32 years), and trauma mechanisms. Trauma was significantly less severe, probability of survival significantly higher (0.48 vs. 0.23) in the 'good' group. Only one of 39 patients who had closed basal cisterns on the first computed tomography scan, and none of the patients with midline shift greater than 15 mm had good outcomes. Logistic regression revealed that age, trauma severity, and status of basal cisterns on the first computed tomography scan were the factors determining outcomes. Conclusion Patients with a GCS of 3 and BFDP in the field should be resuscitated aggressively, especially if the trauma seems to be not too severe. European Journal of Emergency Medicine 16:153-158 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Mauritz, Walter; Leitgeb, Johannes; Wilbacher, Ingrid; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin] INRO, A-1080 Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Buehler, Dept Anaesthesiol & Intens Care Med, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia		Mauritz, W (corresponding author), INRO, Molkergasse 4-3, A-1080 Vienna, Austria.	walter.mauritz@igeh.org	Brazinova, Alexandra/C-4265-2016; Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712			BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CLUSMANN H, 2001, J NEUROL NEUROSURG P, V71; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz W, 2003, CLIN RES REGUL AFF, V20, P81, DOI 10.1081/CRP-120018744; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sousa J, 2002, NEUROL INDIA, V50, P430; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4	18	21	21	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0969-9546			EUR J EMERG MED	Eur. J. Emerg. Med.	JUN	2009	16	3					153	158		10.1097/MEJ.0b013e32832a0864			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	444GC	WOS:000265967700011	19282759				2022-02-06	
J	O'Phelan, KH; Park, D; Efird, JT; Johnson, K; Albano, M; Beniga, J; Green, DM; Chang, CWJ				O'Phelan, Kristine H.; Park, Dalnam; Efird, Jimmy T.; Johnson, Katherine; Albano, Melanie; Beniga, Juliet; Green, Deborah M.; Chang, Cherylee W. J.			Patterns of Increased Intracranial Pressure After Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Proceedings Paper	5th Annual Meeting of the Neurocritical-Care-Society	NOV 01, 2007	Las Vegas, NV	Neurocrit Care Soc		Intracranial pressure; Traumatic brain injury; Intracranial hypertension	HYPERTONIC SALINE; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; MANNITOL; RESUSCITATION; EDEMA	Secondary brain injury due to increased intracranial pressure (ICP) contributes to post-traumatic morbidity and mortality. Although it is often taught that increased ICP begins early after traumatic brain injury, some patients develop increased ICP after the first 3 days post-injury. We examined our data to describe temporal patterns of increased ICP. This is a retrospective review of prospectively collected physiologic and demographic data. Seventy-seven patients were included. We identified four patterns of increased ICP: beginning within 72 h (early), beginning after 72 h (late), early increases with resolution, and then a second rise after 72 h (bimodal), and continuously increased ICP. Late increases in ICP occur in 17% of this cohort. Peak day of swelling was day 7 for the "late" rise group and day 4 for the other patients with increased ICP. Forty-four percent of patients showed enlargement of cerebral contusions on follow-up imaging at 24 h post-injury. Late rises in ICP were not rare in this cohort. This is clinically relevant as it may impact decisions about ICP monitor removal. Differences between groups in age, CT patterns of injury, fluid therapy, osmotic use, and fever were not statistically significant.	Neuroscience Inst, Queens Med Ctr, Honolulu, HI 96813 USA; [O'Phelan, Kristine H.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [O'Phelan, Kristine H.; Park, Dalnam; Johnson, Katherine; Albano, Melanie; Beniga, Juliet; Green, Deborah M.; Chang, Cherylee W. J.] Queens Med Ctr, Inst Neurosci, Honolulu, HI 96813 USA; [O'Phelan, Kristine H.; Green, Deborah M.; Chang, Cherylee W. J.] Univ Hawaii, Dept Med, John A Burns Sch Med, Honolulu, HI 96813 USA; [O'Phelan, Kristine H.; Green, Deborah M.; Chang, Cherylee W. J.] Univ Hawaii, Dept Surg, John A Burns Sch Med, Honolulu, HI 96813 USA; [Efird, Jimmy T.] Cincinnati Childrens Hosp, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA		O'Phelan, KH (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1120 NW 14th St,CRB 1358, Miami, FL 33136 USA.	kophelan@med.miami.edu	Chang, Cherylee/ABG-2080-2020	Green-LaRoche, MD, Deborah/0000-0001-8158-0788			ADAMS JH, 1992, HEAD INJURY GREENFIE; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; BUXTON RL, 1970, LANCET, V2, P498; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; DOSTAL PCV, 1998, CRIT CARE, V2; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kohta M, 2007, J CLIN NEUROSCI, V14, P167, DOI 10.1016/j.jocn.2006.01.042; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155	24	21	21	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2009	10	3					280	286		10.1007/s12028-008-9183-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	449KG	WOS:000266328900005	19165634				2022-02-06	
J	Scales, DC; Riva-Cambrin, J; Le, TL; Pinto, R; Cook, DJ; Granton, JT				Scales, Damon C.; Riva-Cambrin, Jay; Le, Thao Lan; Pinto, Ruxandra; Cook, Deborah J.; Granton, John T.		Canadian Critical Care Trials Grp	Prophylaxis against venous thromboembolism in neurointensive care patients: Survey of Canadian practice	JOURNAL OF CRITICAL CARE			English	Article						Critical care; Neurosurgery; Venous thromboembolism; Venous thrombosis; Anticoagulants; Intracranial hemorrhage; Survey	DEEP-VEIN THROMBOSIS; TRAUMATIC BRAIN-INJURY; NEUROSURGICAL PATIENTS; SUBARACHNOID HEMORRHAGE; COMPRESSION STOCKINGS; RESPONSE RATES; MAJOR TRAUMA; DOUBLE-BLIND; PREVENTION; ENOXAPARIN	Purpose: Although anticoagulant thromboprophylaxis reduces the incidence of venous thromboembolism in critically ill patients, it may increase the risk of devastating bleeding complications in neurosurgical patients. For this population, anticoagulant thromboprophylaxis remains controversial and randomized controlled studies are sparse. Our goal was to establish sufficient clinical equipoise to facilitate future research in this area. Materials and Methods: We conducted a survey of Canadian neurosurgeons and neurointensivists to better understand current practice. We developed a novel self-administered questionnaire on anticoagulant thromboprophylaxis for different neurosurgical subgroups using illustrative clinical scenarios. The instrument was evaluated for clinical sensibility by 20 nurses, neurosurgeons, and intensivists and then mailed to Canadian neurosurgeons (Canadian Neurosurgery Society) and intensivists (Canadian Critical Care Society). Results: The response rate after 3 mailings was 50% for neurosurgeons (66/132) and 49% for intensivists (94/193). Most respondents reported use of anticoagulant thromboprophylaxis for neurosurgical patients, although the timing varied considerably. Use of anticoagulant thromboprophylaxis (ever) ranged from 60% for traumatic intracranial hemorrhage after decompressive craniotomy to 90% for traumatic spinal injury. The responses were comparable between specialties. Conclusions: Most Canadian physicians reported using anticoagulant thromboprophylaxis after neurosurgery, although practice patterns differed as to when and for whom. Future research should quantify the benefits and risks in relation to the time of initiation in different neurosurgical subgroups. Our results suggest there is equipoise regarding the use of anticoagulation thromboprophylaxis in neurosurgical patients. Therefore randomized controlled trials are justifiable and needed to guide clinicians. (C) 2009 Elsevier Inc. All rights reserved.	[Scales, Damon C.; Pinto, Ruxandra; Granton, John T.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Scales, Damon C.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Riva-Cambrin, Jay] Primary Childrens Med Ctr, Dept Neurosurg, Salt Lake City, UT 84113 USA; [Riva-Cambrin, Jay] Univ Utah, Salt Lake City, UT 84112 USA; [Le, Thao Lan] George Mason Univ, Fairfax, VA 22030 USA; [Cook, Deborah J.] St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada; [Cook, Deborah J.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Cook, Deborah J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Granton, John T.] Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada; [Granton, John T.] Univ Hlth Network, Dept Crit Care, Toronto, ON M5G 2C4, Canada		Scales, DC (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.	damon.scales@utoronto.ca		Le, Thao Lan/0000-0003-3299-7450			Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; *AM ASS NEUR SURG, GUID MAN SEV HEAD IN; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Attia J, 2001, ARCH INTERN MED, V161, P1268, DOI 10.1001/archinte.161.10.1268; *CAMBR U, 1982, JUDGM UNC HEUR BIAS; CERRATO D, 1978, J NEUROSURG, V49, P378, DOI 10.3171/jns.1978.49.3.0378; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Hammond FM, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199802000-00007; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; SAWAYA R, 1992, J NEURO-ONCOL, V14, P119; Siironen J, 2003, J NEUROSURG, V99, P953, DOI 10.3171/jns.2003.99.6.0953; VALLADARES JB, 1980, NEUROSURGERY, V6, P138, DOI 10.1227/00006123-198002000-00004; Wurm G, 2004, CLIN NEUROL NEUROSUR, V106, P97, DOI 10.1016/j.clineuro.2004.01.006	21	21	21	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	JUN	2009	24	2					176	184		10.1016/j.jcrc.2009.03.010			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458CR	WOS:000266991700004	19501306				2022-02-06	
J	Broglio, SP; Monk, A; Sopiarz, K; Cooper, ER				Broglio, Steven P.; Monk, Annette; Sopiarz, Kay; Cooper, Earl R.			The influence of ankle support on postural control	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Postural balance; Sports injuries; Cerebral concussion	MILD HEAD-INJURY; ATHLETIC TAPE; CONCUSSION; STABILITY; EXERCISE; METAANALYSIS; PERFORMANCE; INVERSION; MOTION	Postural control assessments are commonly administered to athletes as part of a pre-season screening. Establishing a baseline level of function permits the clinician to compare post-injury results to normal functioning during the return to play decision-making process. In the athletic setting, follow-Lip tests may be completed on the sideline immediately following injury. We sought to examine the effect of commonly administered external ankle joint support on postural control using the balance error scoring system (BESS) and the NeuroCom sensory organization test (SOT). Nineteen volunteers free from balance issues completed three sessions with varied ankle support: bilateral prophylactic ankle taping, laced bracing device, or barefoot. Each session included an initial balance assessment on the BESS and SOT, a 20 min treadmill walk, and post-walk balance test. Fewer errors, indicating improved balance, were committed on the BESS during the barefoot condition than the braced ankle condition (p = 0.044) at the pre-walk assessment. During the post-walk assessment, fewer errors were committed during the barefoot condition compared to the braced ankle condition (p = 0.034) and the taped ankle condition (p = 0.037). All ankle support conditions showed similar improvements in balance between the pre and post-walk assessments on the BESS (p<0.001) and SOT composite balance score (p = 0.009). These findings indicate that ankle support devices may influence postural control on the BESS, but not on the NeuroCom SOT. Clinicians using the BESS as a balance assessment device at multiple time points should be consistent in the application of ankle support devices. Published by All rights reserved.	[Broglio, Steven P.; Monk, Annette; Sopiarz, Kay] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Cooper, Earl R.] Georgia Coll, Dept Kinesiol, Milledgeville, GA 31061 USA		Broglio, SP (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	broglio@uiuc.edu		Cooper, Earl/0000-0003-1132-4644			BENNELL KL, 1994, J ORTHOP SPORT PHYS, V20, P287, DOI 10.2519/jospt.1994.20.6.287; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cordova ML, 2000, J ORTHOP SPORT PHYS, V30, P170, DOI 10.2519/jospt.2000.30.4.170; Cordova ML, 2002, J ATHL TRAINING, V37, P446; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; FEUERBACH JW, 1993, J ORTHOP SPORT PHYS, V17, P149, DOI 10.2519/jospt.1993.17.3.149; Gravlee JR, 2007, AM FAM PHYSICIAN, V75, P342; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heit E.J., 1996, J SPORT REHABIL, V5, P206; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Kinzey SJ, 1997, J ATHL TRAINING, V32, P300; Manfroy PP, 1997, AM J SPORT MED, V25, P156, DOI 10.1177/036354659702500203; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; MYBURGH KH, 1984, AM J SPORT MED, V12, P441, DOI 10.1177/036354658401200607; Pederson TS, 1997, J ATHL TRAINING, V32, P29; Perrin D., 1995, ATHLETIC TAPING BRAC; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Riemann BL, 2000, J ATHL TRAINING, V35, P19; ROVERE GD, 1988, AM J SPORT MED, V16, P228, DOI 10.1177/036354658801600305; Simoneau GG, 1997, J ATHL TRAINING, V32, P141; TROPP H, 1984, AM J SPORT MED, V12, P185, DOI 10.1177/036354658401200302; VALOVICH TC, 2002, USE STANDARDIZED ASS; Wilkerson GB, 2002, J ATHL TRAINING, V37, P436; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	29	21	23	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2009	12	3					388	392		10.1016/j.jsams.2007.12.010			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	448IN	WOS:000266256400010	18550434				2022-02-06	
J	Wagshul, ME; Kelly, EJ; Yu, HJ; Garlick, B; Zimmerman, T; Egnor, MR				Wagshul, Mark E.; Kelly, Erin J.; Yu, Hui Jing; Garlick, Barbara; Zimmerman, Tom; Egnor, Michael R.			Resonant and notch behavior in intracranial pressure dynamics	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article; Proceedings Paper	50th Meeting of the Society-for-Research-into-Hydrocephalus-and-Spina-Bifida	AUG 30-SEP 02, 2006-2008	Cambridge, ENGLAND	Soc Res Hydrocephalus & Spina Bifida		intracranial pressure; compliance; notch filter; resonance; transfer function; pulse pressure; pulsatility	CEREBROSPINAL-FLUID FLOW; CSF PULSE-WAVE; HEAD-INJURED PATIENTS; CEREBRAL BLOOD-FLOW; PHASE-CONTRAST MR; SYSTEMS-ANALYSIS; HYDROCEPHALUS PATIENTS; MATHEMATICAL-MODEL; STROKE VOLUME; FORM ANALYSIS	Object. The intracranial pulse pressure is often increased when neuropathology is present, particularly in cases of increased intracranial pressure (ICP) such as occurs in hydrocephalus. This pulse pressure is assumed to originate from arterial blood pressure oscillations enterin g the cranium; the fact that there is a coupling between the arterial blood pressure and the ICP is undisputed. In this study, the nature of this coupling and how it changes under conditions of increased ICP are investigated. Methods. In 12 normal dogs, intracarotid and parenchymal pulse pressure were measured and their coupling was characterized using amplitude and phase transfer function analysis. Mean intracranial ICP was manipulated via infusions of isotonic saline into the spinal subarachnoid space, and changes in transfer function were monitored. Results. Under normal conditions, the ICP wave led the arterial wave, and there was a minimum in the pulse pressure amplitude near the frequency of the heart rate. Under conditions of decreased intracranial compliance, the ICP wave began to lag behind the arterial wave and increased significantly in amplitude. Most interestingly, in many animals the Pulse pressure exhibited a minimum in amplitude at a mean pressure that coincided with the transition from a leading to lagging ICP wave. Conclusions. This transfer function behavior is characteristic of a resonant notch system. This may represent a component of the intracranial Windkessel mechanism, which protects the microvasculature from arterial pulsatility. The impairment of this resonant notch system may play a role in the altered pulse pressure in conditions such as hydrocephalus and traumatic brain swelling. New models of intracranial dynamics are needed for understanding the frequency-sensitive behavior elucidated in these studies and could open a path for development of new therapies that are geared toward addressing the pulsation dysfunction in pathological conditions, such as hydrocephalus and traumatic brain injury, affecting ICP and flow dynamics. (DOI: 10.3171/2009.1.PEDS08109)	[Wagshul, Mark E.] SUNY Stony Brook, Hlth Sci Ctr, Dept Radiol, Stony Brook, NY 11794 USA; [Wagshul, Mark E.; Egnor, Michael R.] SUNY Stony Brook, Dept Neurosurg, Stony Brook, NY 11794 USA; [Wagshul, Mark E.; Yu, Hui Jing] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Kelly, Erin J.] Toshiba Amer Med Syst, Div MR Imaging, Tustin, CA USA; [Garlick, Barbara] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11794 USA		Wagshul, ME (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Radiol, L4-109 Stony Brook, Stony Brook, NY 11794 USA.	mark.wagshul@stonybrook.edu	Yu, Hui Jing/A-1619-2013	Yu, Hui Jing/0000-0003-0662-9670			Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Bakker SLM, 2002, ACTA NEUROL SCAND, V106, P123, DOI 10.1034/j.1600-0404.2002.01329.x; Bateman GA, 2005, NEURORADIOLOGY, V47, P741, DOI 10.1007/s00234-005-1418-0; Bateman GA, 2003, NEURORADIOLOGY, V45, P65, DOI 10.1007/s00234-002-0901-0; Bergsneider M, 1998, ACT NEUR S, V71, P266; Bilfinger TV, 2000, ANN THORAC SURG, V69, P480, DOI 10.1016/S0003-4975(99)01083-8; BRADLEY WG, 1986, RADIOLOGY, V159, P611, DOI 10.1148/radiology.159.3.3704142; Bradley WG, 1996, RADIOLOGY, V198, P523, DOI 10.1148/radiology.198.2.8596861; Bradley WG, 2002, MAYO CLIN PROC, V77, P507, DOI 10.4065/77.6.507; Chopp M, 1980, Biomed Sci Instrum, V16, P149; de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6; de Marco G, 2004, J COMPUT ASSIST TOMO, V28, P247, DOI 10.1097/00004728-200403000-00015; Dixon GR, 2002, MAYO CLIN PROC, V77, P509, DOI 10.4065/77.6.509; Egeler-Peerdeman SM, 1998, ACT NEUR S, V71, P340; Egnor M, 2003, PEDIATR NEUROSURG, V38, P273, DOI 10.1159/000069826; Egnor M, 2002, PEDIATR NEUROSURG, V36, P281, DOI 10.1159/000063533; Egnor M, 2001, PEDIATR NEUROSURG, V35, P284, DOI 10.1159/000050440; Eide PK, 2007, PEDIATR NEUROSURG, V43, P472, DOI 10.1159/000108790; Eide PK, 2006, ACTA NEUROCHIR, V148, P1151, DOI 10.1007/s00701-006-0896-0; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Eide PK, 2006, ACTA NEUROCHIR, V148, P21, DOI 10.1007/s00701-005-0654-8; Eide PK, 2005, PEDIATR NEUROSURG, V41, P122, DOI 10.1159/000085868; FOLTZ EL, 1981, SURG NEUROL, V15, P283, DOI 10.1016/S0090-3019(81)80009-2; FOLTZ EL, 1984, INTRACRANIAL PRESSUR, V6, P337; Foss T, 2007, DEMENT GERIATR COGN, V23, P47, DOI 10.1159/000096683; FRIDEN HG, 1983, NEUROSURGERY, V13, P351, DOI 10.1227/00006123-198310000-00002; GREITZ D, 1993, ACTA RADIOL, V34, P1; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Henry-Feugeas MC, 2001, INVEST RADIOL, V36, P146, DOI 10.1097/00004424-200103000-00003; HIRAI O, 1984, SURG NEUROL, V21, P67, DOI 10.1016/0090-3019(84)90404-X; Kahlon B, 2007, NEUROSURGERY, V60, P124, DOI 10.1227/01.NEU.0000249208.04344.A3; KASUGA Y, 1987, J NEUROSURG, V66, P907, DOI 10.3171/jns.1987.66.6.0907; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kim DS, 1999, CHILD NERV SYST, V15, P461, DOI 10.1007/s003810050440; Kim J, 2007, AM J NEURORADIOL, V28, P983; Klinge P, 2005, NEUROSURGERY, V57, P40, DOI 10.1227/01.NEU.0000168187.01077.2F; Lang EW, 2003, J NEUROSURG, V98, P214, DOI 10.3171/jns.2003.98.1.0214; Lewis SB, 1998, CLIN EXP PHARMACOL P, V25, P947, DOI 10.1111/j.1440-1681.1998.tb02350.x; LIN ES, 1991, BRIT J ANAESTH, V66, P476, DOI 10.1093/bja/66.4.476; Luetmer PH, 2002, NEUROSURGERY, V50, P534, DOI 10.1097/00006123-200203000-00020; MATSUMOTO T, 1994, CHILD NERV SYST, V10, P91, DOI 10.1007/BF00302770; Miyati T, 2003, EUR RADIOL, V13, P1019, DOI 10.1007/s00330-002-1697-3; MUNROE J, 1783, OBSERVATIONS STRUCTU; NITTA M, 1982, NEUROCHIRURGIA, V25, P186; Peters T.M, 1998, FOURIER TRANSFORM BI; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1985, CHILD NERV SYST, V1, P248, DOI 10.1007/BF00272020; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; PORTNOY HD, 1986, CHILD NERV SYST, V2, P107, DOI 10.1007/BF00270834; PORTNOY HD, 1986, INTRACRANIAL PRESSUR, V6, P256; QUENCER RM, 1990, NEURORADIOLOGY, V32, P371, DOI 10.1007/BF00588471; Ramirez RW, 1985, FFT FUNDAMENTALS CON; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; SAGAWA K, 1990, J MOL CELL CARDIOL, V22, P253, DOI 10.1016/0022-2828(90)91459-K; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SKLAR FH, 1977, J NEUROSURG, V47, P670, DOI 10.3171/jns.1977.47.5.0670; SKLAR FH, 1984, INTRACRANIAL PRESSUR, V6, P323; Tenti G, 2002, PEDIATR NEUROSURG, V37, P221, DOI 10.1159/000065400; URSINO M, 1991, IEEE T BIO-MED ENG, V38, P795, DOI 10.1109/10.83592; URSINO M, 1988, ANN BIOMED ENG, V16, P379, DOI 10.1007/BF02364625; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; WHITE DN, 1979, J NEUROL SCI, V42, P11, DOI 10.1016/0022-510X(79)90150-3; Winfield H., 1989, ART ELECT, V2nd; Zou R, 2008, J NEUROS-PEDIATR, V2, P83, DOI 10.3171/PED/2008/2/7/083	66	21	21	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2009	3	5					354	364		10.3171/2009.1.PEDS08109			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics; Surgery	437QJ	WOS:000265501700004	19409013				2022-02-06	
J	Chen-Roetling, J; Li, Z; Chen, M; Awe, OO; Regan, RF				Chen-Roetling, Jing; Li, Zhi; Chen, Mai; Awe, Olatilewa O.; Regan, Raymond F.			Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway	NEUROPHARMACOLOGY			English	Article						Cell culture; Free radical; Hemoglobin toxicity; Intracerebral hemorrhage; Mouse; Oxidative stress	SIGNAL-REGULATED KINASE; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; PROTEIN-KINASE; IN-VITRO; FOREBRAIN ISCHEMIA; TIN-MESOPORPHYRIN; NEURONS; INDUCTION	Hemoglobin breakdown produces an iron-dependent neuronal injury after experimental CNS hemorrhage that may be attenuated by heme oxygenase (HO) inhibitors. The HO enzymes are phosphoproteins that are activated by phosphorylation in vitro. While testing the effect of kinase inhibitors in cortical cell cultures, we observed that HO activity was consistently decreased by the MEK inhibitor U0126. The present study tested the hypothesis that MEK/ERK pathway inhibitors reduce HO activity and neuronal vulnerability to hemoglobin. The MEK inhibitors U0126 and SL327 and the ERK inhibitor FR180204 reduced baseline culture HO activity by 35-50%, without altering the activity of recombinant HO-1 or HO-2; negative control compounds U0124 and FR180289 had no effect. Hemoglobin exposure for 16 h produced widespread neuronal injury, manifested by release of 59.2 +/- 7.8% of neuronal lactate dehydrogenase and a twelve-fold increase in malondialdehyde; kinase inhibitors were highly protective. HO-1 induction after hemoglobin treatment was also decreased by U0126, SL327, and FR180204. These results suggest that reduction in HO activity may contribute to the protective effect of MEK and ERK inhibitors against heme-mediated neuronal injury. (C) 2009 Elsevier Ltd. All rights reserved.	[Chen-Roetling, Jing; Li, Zhi; Chen, Mai; Awe, Olatilewa O.; Regan, Raymond F.] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA		Regan, RF (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, 1020 Sansom St,Thompson Bldg Room 239, Philadelphia, PA 19107 USA.	Raymond.Regan@jefferson.edu	LI, Zhi/Q-4790-2018	LI, Zhi/0000-0003-4422-4914	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050662]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050662] Funding Source: NIH RePORTER	Funding for this study was provided by a grant from the National Institutes of Health (NS050662).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Benvenisti-Zarom L, 2006, NEUROSCI LETT, V398, P230, DOI 10.1016/j.neulet.2006.01.003; Boehning D, 2003, NEURON, V40, P129, DOI 10.1016/S0896-6273(03)00596-8; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen-Roetling J, 2008, CURR NEUROVASC RES, V5, P193, DOI 10.2174/156720208785425684; Chen-Roetling J, 2006, BIOCHEM BIOPH RES CO, V350, P233, DOI 10.1016/j.bbrc.2006.09.036; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Geijsen N, 2000, FEBS LETT, V471, P83, DOI 10.1016/S0014-5793(00)01373-9; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Gong Y, 2006, ACTA NEUROCHIR SUPPL, V96, P232; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; Koeppen AH, 2002, J NEUROPATH EXP NEUR, V61, P689, DOI 10.1093/jnen/61.8.689; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Kress GJ, 2002, J NEUROSCI, V22, P5848; LETARTE PB, 1993, J NEUROSURG, V79, P252, DOI 10.3171/jns.1993.79.2.0252; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Panahian N, 1999, J NEUROCHEM, V72, P1187; Parfenova H, 2008, CURR PHARM DESIGN, V14, P443, DOI 10.2174/138161208783597380; Qu Y, 2007, J NEUROSURG, V106, P428, DOI 10.3171/jns.2007.106.3.428; Regan RF, 1998, J NEUROCHEM, V70, P77; Regan RF, 2000, NEUROSCI LETT, V282, P1, DOI 10.1016/S0304-3940(00)00817-X; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; Salinas M, 2004, FEBS LETT, V578, P90, DOI 10.1016/j.febslet.2004.10.077; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Scherle PA, 2000, J BIOL CHEM, V275, P37086, DOI 10.1074/jbc.M006168200; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Takizawa S, 1998, J CEREBR BLOOD F MET, V18, P559, DOI 10.1097/00004647-199805000-00011; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; Wagner KR, 2000, CELL MOL BIOL, V46, P597; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	47	21	25	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	APR	2009	56	5					922	928		10.1016/j.neuropharm.2009.01.022			7	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	441MY	WOS:000265774500010	19371583	Green Accepted, Green Submitted			2022-02-06	
J	Hartig, W; Reichenbach, A; Voigt, C; Boltze, J; Bulavina, L; Schuhmann, MU; Seeger, J; Schusser, GF; Freytag, C; Grosche, J				Haertig, Wolfgang; Reichenbach, Andreas; Voigt, Cornelia; Boltze, Johannes; Bulavina, Larysa; Schuhmann, Martin U.; Seeger, Johannes; Schusser, Gerald F.; Freytag, Christiane; Grosche, Jens			Triple fluorescence labelling of neuronal, glial and vascular markers revealing pathological alterations in various animal models	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Multiple fluorescence labelling; Potato lectin; Rat; Triple transgenic mouse; Horse small intestine; NeuN; HuC/D	FIBRILLARY ACIDIC PROTEIN; BLOOD-BRAIN-BARRIER; FOCAL CEREBRAL-ISCHEMIA; ENTERIC NERVOUS-SYSTEM; GENE-PRODUCT 9.5; ALZHEIMERS-DISEASE; LECTIN HISTOCHEMISTRY; GLUTAMINE-SYNTHETASE; MYENTERIC PLEXUS; NEUROENDOCRINE CELLS	The simultaneous detection of glia, vessels and neurons facilitates insights into the complex chemoarchitecture of the central nervous system. Here, we present a simple, robust and versatile approach for the carbocyanine triple fluorescence labelling of neuronal, vascular and glial markers. The usefulness of this procedure is shown for rat brain tissue under physiological conditions, after traumatic brain injury caused by controlled cortical impact injury, and after stroke following middle cerebral artery occlusion. Moreover, the versatility of the method is verified by its application to sections from old triple transgenic mice with age-dependent P-amyloidosis and tau hyperphosphorylation in the hippocampus, modelling neuropathological alterations in Alzheimer's disease. To exemplify the usefulness of the approach for analysis of the enteric nervous system, it was applied to whole mounts from the horse intestine. The biotinylated lectin from potato (Solanum tuberosum) is presented as an excellent tool to detect both vessels and microglia. Furthermore, this lectin revealed macrophages after experimental insults, and senile plaques in aged triple transgenic mice. A large portion of astroglia was demonstrated by immunolabelling of glial fibrillary acidic protein. Neurons were detected by monoclonal antibodies directed against neuronal nuclei and, in horse tissues, mouse-anti-HuC/D recognizing a conserved nuclear protein. Confocal laser-scanning microscopy elucidated spatial relationships of the relevant markers and their pathological alterations after experimental insults and in transgenic mice with Alzheimer-like lesions. (C) 2008 Elsevier B.V. All rights reserved.	[Haertig, Wolfgang; Reichenbach, Andreas; Voigt, Cornelia; Freytag, Christiane; Grosche, Jens] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Voigt, Cornelia; Schuhmann, Martin U.] Univ Leipzig, Clin & Polyclin Neurosurg, D-04103 Leipzig, Germany; [Voigt, Cornelia; Boltze, Johannes; Bulavina, Larysa] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany; [Boltze, Johannes] Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany; [Schuhmann, Martin U.] Univ Tubingen, Dept Neurosurg, Univ Hosp, D-72076 Tubingen, Germany; [Seeger, Johannes; Freytag, Christiane] Univ Leipzig, Dept Anat Histol & Embryol, Fac Vet Med, D-04103 Leipzig, Germany; [Schusser, Gerald F.; Freytag, Christiane] Univ Leipzig, Large Anim Clin Internal Med, Fac Vet Med, D-04103 Leipzig, Germany; [Grosche, Jens] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, D-04103 Leipzig, Germany		Hartig, W (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany.	hartig@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017	Boltze, Johannes/0000-0003-3956-4164			ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Bazwinsky I, 2008, J CHEM NEUROANAT, V35, P158, DOI 10.1016/j.jchemneu.2007.10.003; Betz T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2114788; BIGNAMI A, 1979, EXP EYE RES, V28, P63; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BJORKLUND H, 1985, NEUROSCI LETT, V54, P363, DOI 10.1016/S0304-3940(85)80061-6; Brulport M, 2007, HEPATOLOGY, V46, P861, DOI 10.1002/hep.21745; Byers MR, 2004, MICROSC RES TECHNIQ, V65, P295, DOI 10.1002/jemt.20130; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Cornford Eain M, 2005, NeuroRx, V2, P27, DOI 10.1602/neurorx.2.1.27; DAMJANOV I, 1987, NEUROSURGERY, V20, P722, DOI 10.1227/00006123-198705000-00008; DERMIETZEL R, 1991, INT REV CYTOL, V127, P57; Derouiche A, 1996, J ANAT, V189, P363; Dobrenis K, 1998, METHODS, V16, P320, DOI 10.1006/meth.1998.0688; DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ERIKSDOTTERNILSSON M, 1986, J NEUROSCI METH, V17, P275, DOI 10.1016/0165-0270(86)90128-7; ERIKSDOTTERNILSSON M, 1987, EXP BRAIN RES, V69, P155; Franciosi S, 2007, J NEUROSCI METH, V163, P76, DOI 10.1016/j.jneumeth.2007.02.020; GABELLA G, 1981, NEUROSCIENCE, V6, P425, DOI 10.1016/0306-4522(81)90135-4; Ganns D, 2006, HISTOL HISTOPATHOL, V21, P41, DOI 10.14670/HH-21.41; GERSHON MD, 1978, J COMP NEUROL, V180, P467, DOI 10.1002/cne.901800305; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; HALLERMAYER K, 1984, BRAIN RES, V295, P1, DOI 10.1016/0006-8993(84)90810-2; Halliday GM, 1996, NEUROSCI LETT, V209, P29, DOI 10.1016/0304-3940(96)12592-1; HANANI M, 1994, CELL TISSUE RES, V278, P153; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Harkany T, 2002, NEUROREPORT, V13, P767, DOI 10.1097/00001756-200205070-00007; Hartig W, 2003, J COMP NEUROL, V465, P1, DOI 10.1002/cne.10789; HARTIG W, 1995, J NEUROCYTOL, V24, P507, DOI 10.1007/BF01179976; Hartig W, 2001, BRAIN RES, V899, P123, DOI 10.1016/S0006-8993(01)02211-9; Horn AK, 2008, J COMP NEUROL, V507, P1317, DOI 10.1002/cne.21598; HUBER G, 1984, J NEUROSCI, V4, P151; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobs K, 1997, J COMP NEUROL, V387, P255, DOI 10.1002/(SICI)1096-9861(19971020)387:2<255::AID-CNE7>3.0.CO;2-#; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kiatipattanasakul W, 1998, ACTA NEUROPATHOL, V95, P261, DOI 10.1007/s004010050796; Kozireski-Chuback D, 1999, DEV BRAIN RES, V115, P201, DOI 10.1016/S0165-3806(99)00062-0; KRUM JM, 1991, EXP NEUROL, V111, P152, DOI 10.1016/0014-4886(91)90002-T; Lin WM, 1997, NEUROREPORT, V8, P2999, DOI 10.1097/00001756-199709290-00002; LIU J, 1995, NEUROLOGY, V45, P544, DOI 10.1212/WNL.45.3.544; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; MANNOJI H, 1986, ACTA NEUROPATHOL, V71, P341, DOI 10.1007/BF00688060; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; Meyer W, 2008, ANN ANAT, V190, P264, DOI 10.1016/j.aanat.2007.11.004; MINAMIKAWA T, 1987, HISTOCHEMISTRY, V87, P317, DOI 10.1007/BF00492584; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pardridge William M, 2003, Methods Mol Med, V89, P385; PERLMUTTER LS, 1990, BRAIN RES, V508, P13, DOI 10.1016/0006-8993(90)91111-S; Phillips RJ, 2004, ANAT EMBRYOL, V209, P19, DOI 10.1007/s00429-004-0426-x; Phillips RJ, 2004, J NEUROSCI METH, V133, P99, DOI 10.1016/j.jneumeth.2003.10.004; Piccinini M, 1996, BIOCHEM J, V318, P711, DOI 10.1042/bj3180711; Pike CJ, 1996, EXP NEUROL, V139, P167, DOI 10.1006/exnr.1996.0091; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rosario ER, 2006, J NEUROSCI, V26, P13384, DOI 10.1523/JNEUROSCI.2514-06.2006; Ruhl A, 2004, NEUROGASTROENT MOTIL, V16, P44, DOI 10.1111/j.1743-3150.2004.00474.x; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Schusser GF, 1997, J AM VET MED ASSOC, V210, P928; Seeger G, 1997, J NEUROSCI RES, V48, P465, DOI 10.1002/(SICI)1097-4547(19970601)48:5<465::AID-JNR7>3.0.CO;2-C; SIMIONESCU M, 1974, J CELL BIOL, V60, P128, DOI 10.1083/jcb.60.1.128; SMITT PAES, 1993, ACTA HISTOCHEM, V95, P13, DOI 10.1016/S0065-1281(11)80381-8; SPICER SS, 1992, J HISTOCHEM CYTOCHEM, V40, P1, DOI 10.1177/40.1.1370305; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; THEILEN H, 1992, J CEREBR BLOOD F MET, V12, P347, DOI 10.1038/jcbfm.1992.47; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Van Damme EJM, 2004, PLANT J, V37, P34, DOI 10.1046/j.1365-313X.2003.01929.x; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; WESSENDORF MW, 1992, HISTOCHEMISTRY, V98, P81, DOI 10.1007/BF00716998; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8	86	21	21	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	MAR	2009	37	2					128	138		10.1016/j.jchemneu.2008.10.003			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	411BR	WOS:000263623300009	19028564				2022-02-06	
J	Sokol, RZ				Sokol, Rebecca Z.			Endocrinology of Male Infertility: Evaluation and Treatment	SEMINARS IN REPRODUCTIVE MEDICINE			English	Article						Male infertility; hypogonadism; testosterone; luteinizing hormone; follicle-stimulating hormone	FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; TRAUMATIC BRAIN-INJURY; ANDROGEN-RECEPTOR GENE; KLINEFELTER-SYNDROME; HYPOGONADOTROPIC HYPOGONADISM; FREE TESTOSTERONE; CANCER INCIDENCE; AZOOSPERMIC MEN; SEX-DIFFERENCES	A normal functioning reproductive endocrine system is a prerequisite for normal male fertility. Any disruption of the delicately coordinated interaction between the components of the hypothalamic-pituitary-testicular axis may lead to hypogonadism and/or infertility. The goal of the clinical evaluation is to determine if the patient has an abnormality of testosterone production or action, the etiology of the abnormality, and if hormone therapy will correct the infertility. Based on a careful history, physical examination, and evaluation of the hormones of the reproductive axis, the physician will ascertain if the patient's hypogonadism is (1) prepubertal or postpubertal in onset; (2) the result of an abnormality in the hypothalamic-pituitary axis, the testes, or the androgen receptor; or (3) associated with another underlying medical condition. This information will place the patient into one of four diagnostic categories: hypogonadotropic hypogonadism, testicular failure, 5 alpha-reductase deficiency, or androgen resistance. Within each category are disorders with identifiable pathogenic mechanisms. Recent studies have added to these lists and have provided insights into the molecular basis and inheritance patterns of several of these endocrinopathies.	[Sokol, Rebecca Z.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA		Sokol, RZ (corresponding author), Womens & Childrens Hosp, 1240 N Mission Rd,Room 8K3, Los Angeles, CA 90033 USA.	rsokol@usc.edu					ATTIA AM, 2006, COCHRANE DB SYST REV, V1; BAIN J, 1988, FERTIL STERIL, V49, P123; Bayrak A, 2005, FERTIL STERIL, V84, P181, DOI 10.1016/j.fertnstert.2005.01.102; Bhagavath B, 2006, FERTIL STERIL, V85, P706, DOI 10.1016/j.fertnstert.2005.08.044; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bojesen A, 2006, J CLIN ENDOCR METAB, V91, P1254, DOI 10.1210/jc.2005-0697; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bouloux P, 2002, FERTIL STERIL, V77, P270, DOI 10.1016/S0015-0282(01)02973-9; Bouloux PMG, 2003, J ANDROL, V24, P604; Bunin GR, 1998, J NEUROSURG, V89, P547, DOI 10.3171/jns.1998.89.4.0547; CARRUTHERS M, 2004, ANDROGEN DEFICIENCY; Catlin DH, 1996, J MASS SPECTROM, V31, P397; CILENTO BG, 2007, MALE REPROD DYSFUNCT, P161; Davis-Dao CA, 2007, J CLIN ENDOCR METAB, V92, P4319, DOI 10.1210/jc.2007-1110; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Dowsing AT, 1999, LANCET, V354, P640, DOI 10.1016/S0140-6736(98)08413-X; FINKEL DM, 1985, NEW ENGL J MED, V313, P651, DOI 10.1056/NEJM198509123131102; Foresta C, 2005, FERTIL STERIL, V84, P654, DOI 10.1016/j.fertnstert.2005.03.055; Fukagai T, 2005, UROLOGY, V65, DOI 10.1016/j.urology.2004.09.017; Geschwind DH, 2000, MENT RETARD DEV D R, V6, P107, DOI 10.1002/1098-2779(2000)6:2<107::AID-MRDD4>3.0.CO;2-2; Ghazi AAM, 2003, J ENDOCRINOL INVEST, V26, P84, DOI 10.1007/BF03345128; Gillam MP, 2006, ENDOCR REV, V27, P485, DOI 10.1210/er.2005-9998; Giltay JC, 2004, FERTIL STERIL, V81, P693, DOI 10.1016/j.fertnstert.2003.07.030; Goldstone AP, 2008, FRONT HORM RES, V36, P37, DOI 10.1159/000115336; Goodman-Gruen D, 2000, DIABETES CARE, V23, P912, DOI 10.2337/diacare.23.7.912; GRIFFIN JE, 1992, NEW ENGL J MED, V326, P611; HAMMAR M, 1990, SCAND J UROL NEPHROL, V24, P17, DOI 10.3109/00365599009180353; Hammoud AO, 2006, J ANDROL, V27, P619, DOI 10.2164/jandrol.106.000125; Handelsman DJ, 2007, J CLIN ENDOCR METAB, V92, P4505, DOI 10.1210/jc.2007-1431; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HASLE H, 1995, BRIT J CANCER, V71, P416, DOI 10.1038/bjc.1995.85; HAUSER R, 1995, FERTIL STERIL, V63, P631, DOI 10.1016/S0015-0282(16)57437-8; HOFFMAN AR, 1982, NEW ENGL J MED, V307, P1237, DOI 10.1056/NEJM198211113072003; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Hughes IA, 2001, ENDOCRINOLOGY, V142, P3281, DOI 10.1210/en.142.8.3281; Hultborn R, 1997, ANTICANCER RES, V17, P4293; Ismail AAA, 2001, ANN CLIN BIOCHEM, V38, P596, DOI 10.1258/0004563011900993; Jarow JP, 2005, ANN NY ACAD SCI, V1061, P208, DOI 10.1196/annals.1336.023; Kamischke A, 2003, J ANDROL, V24, P41; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; KLIESCH S, 1994, EUR J ENDOCRINOL, V131, P347, DOI 10.1530/eje.0.1310347; Kolb BA, 2000, FERTIL STERIL, V74, P234, DOI 10.1016/S0015-0282(00)00641-5; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; LEWIS AS, 2008, PITUITARY       0413; LEY SB, 1985, J CLIN ENDOCR METAB, V61, P746, DOI 10.1210/jcem-61-4-746; Liu PY, 2003, HUM REPROD UPDATE, V9, P9, DOI 10.1093/humupd/dmg002; Liu PY, 1999, HUM REPROD, V14, P1540, DOI 10.1093/humrep/14.6.1540; LONGCOPE C, 1984, J CLIN ENDOCR METAB, V58, P1089, DOI 10.1210/jcem-58-6-1089; Lue YH, 2005, ENDOCRINOLOGY, V146, P4148, DOI 10.1210/en.2005-0278; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marchetti Francesco, 2005, Birth Defects Res C Embryo Today, V75, P112, DOI 10.1002/bdrc.20040; Meikle AW, 1996, J CLIN ENDOCR METAB, V81, P1832, DOI 10.1210/jc.81.5.1832; Melmed S, 2008, J CLIN ENDOCR METAB, V93, P331, DOI 10.1210/jc.2007-1409; Meschede D, 1997, MOL HUM REPROD, V3, P419, DOI 10.1093/molehr/3.5.419; Murialdo G, 2002, J ENDOCRINOL INVEST, V25, P650, DOI 10.1007/BF03345093; Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Pavlovich CP, 2001, J UROLOGY, V165, P837, DOI 10.1016/S0022-5347(05)66540-8; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Raman JD, 2002, J UROLOGY, V167, P624, DOI 10.1016/S0022-5347(01)69099-2; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Ross JL, 2008, AM J MED GENET A, V146A, P708, DOI 10.1002/ajmg.a.32232; Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326; Schiff JD, 2005, J CLIN ENDOCR METAB, V90, P6263, DOI 10.1210/jc.2004-2322; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Simpson JL, 2003, GENET MED, V5, P460, DOI 10.1097/01.GIM.0000095626.54201.D0; SKARIN G, 1982, J CLIN ENDOCR METAB, V55, P723, DOI 10.1210/jcem-55-4-723; SOKOL RZ, 1982, FERTIL STERIL, V37, P425; SOKOL RZ, 1981, J CLIN ENDOCR METAB, V52, P929, DOI 10.1210/jcem-52-5-929; SOKOL RZ, 1997, INFERTILITY CONTRACE, P547; SOKOL RZ, 1997, INFERTILITY MALE, P10; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; Stikkelbroeck NMML, 2001, J CLIN ENDOCR METAB, V86, P5721, DOI 10.1210/jc.86.12.5721; Swerdloff RS, 2000, J CLIN ENDOCR METAB, V85, P4500, DOI 10.1210/jc.85.12.4500; Swerdlow AJ, 2001, ANN HUM GENET, V65, P177, DOI 10.1017/S0003480001008569; Thomas NS, 2003, HUM REPROD UPDATE, V9, P309, DOI 10.1093/humupd/dmg028; Tong S, 2003, CLIN ENDOCRINOL, V58, P115, DOI 10.1046/j.1365-2265.2003.01686.x; Trarbach EB, 2005, J ENDOCRINOL, V187, P361, DOI 10.1677/joe.1.06103; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vernaeve V, 2004, HUM REPROD, V19, P1135, DOI 10.1093/humrep/deh253; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Whitten SJ, 2006, FERTIL STERIL, V86, P1664, DOI 10.1016/j.fertnstert.2006.05.042; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; Zitzmann M, 2006, FERTIL STERIL, V86, P339, DOI 10.1016/j.fertnstert.2005.12.058	85	21	22	0	7	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1526-8004	1526-4564		SEMIN REPROD MED	Semin. Reprod. Med.	MAR	2009	27	2					149	158		10.1055/s-0029-1202303			10	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	413YY	WOS:000263832300007	19247916				2022-02-06	
J	Blanchet, S; Paradis-Giroux, AA; Pepin, M; Mckerral, M				Blanchet, Sophie; Paradis-Giroux, Andree-Anne; Pepin, Michel; Mckerral, Michelle			Impact of divided attention during verbal learning in young adults following mild traumatic brain injury	BRAIN INJURY			English	Article						Episodic memory; attention; executive processes; mild head injury	EVENT-RELATED POTENTIALS; HEAD-INJURY; EPISODIC MEMORY; OLDER-ADULTS; RETRIEVAL; SYMPTOMS; PERFORMANCE; TOMOGRAPHY; CONCUSSION; STRATEGY	Primary objective: The goal of the present study was to assess the impact of mild traumatic brain injury (MTBI) on episodic memory performance in relation to attentional and executive control processes in young adults. Research design/methods: A verbal memory paradigm manipulating attentional load (full attention or divided attention) and semantic congruency between pairs of category-target words during encoding was administrated to 13 individuals with MTBI and 12 normal control participants. Environmental supports during retrieval (free recall, cued recall and recognition modes) were also manipulated. Main outcomes and results: Results show that recall performances of individuals with MTBI were similar to those of controls when words were encoded under full attention. In contrast, individuals with MTBI performed worse than control participants when encoding under divided attention, whatever the semantic link between pairs of words. Conclusions: By using a sensitive test, one was able to objectively measure subtle impairments in memory performance, suggesting a diminished availability of attentional resources after MTBI. Young adults' learning of verbal material under divided attention might be compromised by the reduction of cognitive resources following MTBI. These findings are also discussed in light of different factors that can influence cognitive performance.	[Blanchet, Sophie; Paradis-Giroux, Andree-Anne; Pepin, Michel] Inst Readaptat Deficience Phys Quebec, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ G1M 2S8, Canada; [Blanchet, Sophie; Paradis-Giroux, Andree-Anne; Pepin, Michel] Univ Laval, Sch Psychol, Quebec City, PQ, Canada; [Mckerral, Michelle] Ctr Readaptat Lucie Bruneau, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Mckerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada		Blanchet, S (corresponding author), Inst Readaptat Deficience Phys Quebec, Ctr Interdisciplinary Res Rehabil & Social Integr, 525 Blvd Hamel Est, Quebec City, PQ G1M 2S8, Canada.	sophie.blanchet@rea.ulaval.ca		Paradis-Giroux, Andree-Anne/0000-0003-0527-6439			Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Anderson ND, 1998, PSYCHOL AGING, V13, P405, DOI 10.1037/0882-7974.13.3.405; BADDELEY A, 1984, J EXP PSYCHOL GEN, V113, P518, DOI 10.1037/0096-3445.113.4.518; Baddeley A.D., 1986, WORKING MEMORY; BADDELEY AD, 1996, J EXPT PSYCHOL A, V49, P5, DOI DOI 10.1080/713755608; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BERSTAIN M, 2002, J INT NEUROPSYCH SOC, V8, P673; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Bouchard S, 1996, CAN J AGING, V15, P500, DOI 10.1017/S0714980800009387; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Conners CK., 1995, CONNERS CONTINUOUS P; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Desrochers A, 2000, CAN J EXP PSYCHOL, V54, P274, DOI 10.1037/h0087347; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DUBORD S, 2000, B PSYCHOL, V53, P185; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; FAVREAU M, 1980, SEMANTIC CATEGORY NO; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Guerin F, 2006, NEUROREHABILITATION, V21, P295; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iidaka T, 2000, J COGNITIVE NEUROSCI, V12, P267, DOI 10.1162/089892900562093; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCauley S. R., 2007, J CLIN EXPT NEUROPSY, V25, P1; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Moscovitch M., 1990, MODULAR DEFICITS ALZ, P1; Moscovitch M., 1994, NEUROPSYCHOLOGY, V8, P524; Naveh-Benjamin M, 2004, PSYCHON B REV, V11, P1067, DOI 10.3758/BF03196738; Naveh-Benjamin M, 2003, MEM COGNITION, V31, P1021, DOI 10.3758/BF03196123; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; PAIVIO A, 1975, PSYCHOL LEARN MOTIV, P179; PEPIN M, 2004, TIFA VERSION EXPT 1; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Raskin SA, 1997, BRAIN INJURY, V11, P587, DOI 10.1080/026990597123287; Regard M., 1981, THESIS U VICTORIA; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, LEXAMEN CLINIQUE PSY; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Signoret J. L, 1991, BATTERIE EFFICIENCE, V144; Toglia MP, 1997, PERCEPT MOTOR SKILL, V84, P976, DOI 10.2466/pms.1997.84.3.976; Tulving E., 1983, ELEMENTS EPISODIC ME; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANDERLINDEN M, 1987, QUESTIONNAIRE AUTO; WECHSLER D, 1997, MEM 3 ECHELLE CLIN M, V3; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	63	21	21	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	2					111	122	PII 908462980	10.1080/02699050802649688			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403LD	WOS:000263083200005	19191090				2022-02-06	
J	Carlson, NE; Brenner, LA; Wierman, ME; Harrison-Felix, C; Morey, C; Gallagher, S; Ripley, D				Carlson, N. E.; Brenner, L. A.; Wierman, M. E.; Harrison-Felix, C.; Morey, C.; Gallagher, S.; Ripley, D.			Hypogonadism on admission to acute rehabilitation is correlated with lower functional status at admission and discharge	BRAIN INJURY			English	Article						Endocrine dysfunction; physical function; testosterone; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TESTOSTERONE REPLACEMENT; SEX-HORMONES; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; COGNITIVE FUNCTION; INFECTED MEN; HYPOPITUITARISM; PERFORMANCE; STRENGTH	Primary objective: To investigate the association between hormone levels and functional status during acute TBI rehabilitation. Research design: Retrospective cohort study of 43 men with moderate-to-severe TBI admitted to an acute rehabilitation unit during a 1 year period. Methods and procedures: Labs were drawn on admission, including total and free testosterone (T), prolactin, adrenocorticotropin hormone (ACTH), cortisol, thyroid stimulating hormone (TSH), free thyroxine (fT4) and insulin-like growth factor (IGF-1). Functional Independence Measure (FIM) scores were obtained at admission and discharge. Main outcome and results: Associations between admission hormone levels and the main outcomes, admission and discharge FIM scores, were assessed using linear regression. Lower total and free T-levels at admission were associated with lower total FIM scores at admission (p 0.038) and discharge (p 0.046). Higher cortisol levels at admission were significantly associated with lower admission (p = 0.012) and discharge (p = 0.036) scores on the cognitive-FIM. Prolactin, TSH, fT4 and IGF-1 were not correlated with functional status. Conclusions: In men, lower total and free T-levels at admission to acute rehabilitation correlate with lower admission and discharge FIM scores. These data support the need for studies to investigate the impact of physiological testosterone therapy on outcomes during and post-rehabilitation.	[Carlson, N. E.] Univ Colorado Denver, Dept Biostat & Informat, Aurora, CO 80045 USA; [Brenner, L. A.] VA VISN 19 Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Brenner, L. A.; Harrison-Felix, C.; Morey, C.; Ripley, D.] Craig Hosp, Rocky Mt Reg Traumat Brain Injury Syst, Englewood, CO USA; [Wierman, M. E.] Univ Colorado, Dept Psychiat, Denver, CO USA; [Brenner, L. A.] Univ Colorado, Dept Neurol, Denver, CO USA; [Brenner, L. A.; Harrison-Felix, C.] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO USA; [Wierman, M. E.] Univ Colorado, Sch Med, Dept Med, Denver, CO USA; [Wierman, M. E.] Denver VA Med Ctr, Res Serv, Denver, CO USA; [Gallagher, S.] Childrens Hosp, Denver, CO 80218 USA		Carlson, NE (corresponding author), Univ Colorado Denver, Dept Biostat & Informat, 17000 E 17th PL,MS C245, Aurora, CO 80045 USA.	nichole.carlson@ucdenver.edu	Brenner, Lisa A./AAG-2442-2019	Ripley, David/0000-0002-5349-1830			Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3155, DOI 10.1210/jc.83.9.3155; Bhasin S, 2000, JAMA-J AM MED ASSOC, V283, P763, DOI 10.1001/jama.283.6.763; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; CLARK JDA, 1992, CLIN ENDOCRINOL, V36, P481, DOI 10.1111/j.1365-2265.1992.tb02249.x; Clark MJ, 2008, AM J PHYS MED REHAB, V87, P281, DOI 10.1097/PHM.0b013e318168bbec; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Eskelinen Seija I, 2007, Endocr Pract, V13, P743; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Grinspoon S, 2000, ANN INTERN MED, V133, P348, DOI 10.7326/0003-4819-133-5-200009050-00010; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEE SC, 1994, BRAIN INJURY, V8, P571; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mateo JM, 2008, NEUROBIOL LEARN MEM, V89, P582, DOI 10.1016/j.nlm.2007.11.002; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Mohamad MJ, 2007, NEUROENDOCRINOL LETT, V28, P182; Molitch ME, 2001, ENDOCRIN METAB CLIN, V30, P585, DOI 10.1016/S0889-8529(05)70203-6; O'Connor DB, 2001, NEUROPSYCHOLOGIA, V39, P1385, DOI 10.1016/S0028-3932(01)00067-7; Okun MS, 2002, ARCH NEUROL-CHICAGO, V59, P1750, DOI 10.1001/archneur.59.11.1750; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; REICHLIN S, 1992, WILLIAMS TXB ENDOCRI, P174; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS579; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Stanworth RD, 2008, CLIN INTERV AGING, V3, P25; *STAT U NEW YORK B, 1997, UN DAT SYST MED REH; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury Model Systems National Data Center, 2007, TRAUM BRAIN INJ MOD; Wolf OT, 2002, HORM BEHAV, V41, P259, DOI 10.1006/hbeh.2002.1770; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Yaffe K, 2002, J AM GERIATR SOC, V50, P707, DOI 10.1046/j.1532-5415.2002.50166.x; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426	47	21	21	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	4					336	344	PII 909972518	10.1080/02699050902788535			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	425MY	WOS:000264643000008	19330595				2022-02-06	
J	Chaudhuri, K; Malham, GM; Rosenfeld, JV				Chaudhuri, Krishanu; Malham, Gregory M.; Rosenfeld, Jeffrey V.			Survival of trauma patients with coma and bilateral fixed dilated pupils	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Glasgow Coma Score; Pupillary status; Traumatic brain injury; Pre-hospital; Outcome	SEVERE HEAD-INJURY; BRAIN-INJURY; SCALE SCORE; GLASGOW; ASSOCIATION; REACTIVITY; HEMATOMA; FIELD	Background: Survival of patients with severe trauma presenting with Glasgow Coma Score (GCS) 3 and bilateral fixed dilated pupils is uncertain. Pre-hospital management of these patients affects the true measurement of the GCS and other factors may affect pupillary status. Patients and methods: A retrospective review was undertaken of all patients who were classified GCS 3 and had bilateral fixed dilated pupils on admission to a Level I Adult Trauma Centre between July 2001 and March 2005. Pre-hospital assessment, hospital interventions and outcomes were determined. Results: Ninety-three patients fulfilled the criteria for inclusion into the study. There were 6 survivors who were all less than 28 years of age, had at least one GCS score above 3 in the pre-hospital phase and were more likely to have had an evacuable mass lesion on CT brain scan and undergo craniotomy. Of the 6 surviving patients, none had significant thoracoabdominal injuries. Four of the survivors had Glasgow Outcome Score (COS) of 4 or 5. Time to hospital, mechanism of injury and pre-hospital haemodynamic parameters had no significant effect on Survival. Of the 57 patients who were GCS 3 at the scene of the accident, post-basic resuscitation and on admission, none survived. Conclusion: Pre-hospital GCS scores, prior to the effects of intubation, sedation and paralysis should be given more attention when assessing prognosis in patients who are GCS 3 on admission. Trauma patients with GCS 3 persisting from the scene with bilaterally fixed dilated pupils have no appreciable chance of Survival. Further interventions such as ICU admission and surgery may not be warranted. Physicians may need to consider stopping treatment and discussing organ donation. (C) 2008 Elsevier Ltd. All rights reserved.	[Chaudhuri, Krishanu; Malham, Gregory M.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Malham, Gregory M.; Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia		Rosenfeld, JV (corresponding author), Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia.	j.rosenfeld@alfred.org.au	Rosenfeld, Jeffrey V/B-7249-2011				Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; GOETTING MG, 1991, ANN EMERG MED, V20, P55, DOI 10.1016/S0196-0644(05)81119-9; Gray AT, 1997, ARCH NEUROL-CHICAGO, V54, P579, DOI 10.1001/archneur.1997.00550170055014; He DM, 2007, J ORAL MAXIL SURG, V65, P713, DOI 10.1016/j.joms.2006.09.006; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; RITTER AM, 2002, NEUROSURGERY, V51, P848; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sousa J, 2002, NEUROL INDIA, V50, P430; Stein SC, 2004, J TRAUMA, V56, P457, DOI 10.1097/01.TA.0000112354.87333.F3; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TEASDALE G, 1974, LANCET, V2, P81; Thompson D., 2000, DRUG DELIV TECHNOL, V2, P34; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4	25	21	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2009	40	1					28	32		10.1016/j.injury.2008.09.004			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	407TA	WOS:000263386000004	19070839				2022-02-06	
J	Greiffenstein, M				Greiffenstein, Manfred F.			Clinical Myths of Forensic Neuropsychology	CLINICAL NEUROPSYCHOLOGIST			English	Article						Myths; Neuropsychology; Forensic; Clinical folklore	TRAUMATIC BRAIN-INJURY; REPEATED ADMINISTRATIONS; BATTERY; VALIDITY; MEMORY	Clinical myths and lore are unfounded beliefs that still influence practice decisions. I examine the validity of six beliefs commonly encountered in forensic neuropsychology practice: the admissibility of test batteries; avoidance of practice effects; forewarning insures good effort; average deficits in bright persons; 15% chronic impairment in mild brain injury; and examiner bias causing malingering. I show these beliefs are invalid because of material misunderstandings of case law and literature, falsification by empirical findings, and lack of authoritative sources. The benefits, costs, and persistence of clinical myths are discussed.	Psychol Syst Inc, Royal Oak, MI 48073 USA		Greiffenstein, M (corresponding author), Psychol Syst Inc, 32121 Woodward,Suite 201, Royal Oak, MI 48073 USA.	mfgreiff@comcast.net					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Buss D.M, 2005, HDB EVOLUTIONARY PSY; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHAPMAN LJ, 1969, J ABNORM PSYCHOL, V74, P271, DOI 10.1037/h0027592; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; DODRILL CB, 1975, J NERV MENT DIS, V161, P185, DOI 10.1097/00005053-197509000-00006; FOX DD, 1995, J CLIN PSYCHOL, V51, P42, DOI 10.1002/1097-4679(199501)51:1<42::AID-JCLP2270510108>3.0.CO;2-Z; Galbraith John Kenneth, 1958, AFFLUENT SOC; Greiffenstein M., 2008, TXB CLIN NEUROPSYCHO, P905; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HORTON AM, 1992, PERCEPT MOTOR SKILL, V75, P257, DOI 10.2466/PMS.75.4.257-258; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; Johnson JL, 1998, PERCEPT MOTOR SKILL, V87, P152, DOI 10.2466/pms.1998.87.1.152; KAUFMAN AS, 1994, ENCY HUMAN INTELLIGE, V2, P828; KOLATA G, 2006, NY TIMES        1122; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; MCCREA M, 2007, NEW EVIDENCE BASE DI; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; McNally R, 2005, AM J PSYCHOL, V118, P152; MELTON GB, 1997, PSYCHOL EVALUATIONS; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; Morgan J. E., 2008, TXB CLIN NEUROPSYCHO; Nisbett R., 1980, HUMAN INFERENCE STRA; Paauw D S, 1999, J Am Board Fam Pract, V12, P143; Posthuma A., 2002, AM J FORENSIC PSYCH, V20, P21; PUTNAM SH, 1992, PSYCHOL ASSESSMENT, V4, P312; Reed JE, 1996, BEHAV SCI LAW, V14, P315, DOI 10.1002/(SICI)1099-0798(199622)14:3<315::AID-BSL242>3.0.CO;2-X; Reitan RM, 1996, ARCH CLIN NEUROPSYCH, V11, P573, DOI 10.1016/0887-6177(95)00037-2; REITAN RM, 2002, J FORENSIC NEUROPSYC, V3, P275; ROGERS R, 1983, J PSYCHIAT LAW, V11, P443, DOI 10.1177/009318538301100404; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Russell EW, 2007, ARCH CLIN NEUROPSYCH, V22, P787, DOI 10.1016/j.acn.2007.06.006; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Shatz M W, 1981, J Clin Neuropsychol, V3, P171, DOI 10.1080/01688638108403123; Storm J, 2000, PSYCHOL ASSESSMENT, V12, P158, DOI 10.1037/1040-3590.12.2.158; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Suhr JA, 2002, ARCH CLIN NEUROPSYCH, V17, P69, DOI 10.1016/S0887-6177(00)00102-5; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Theisen ME, 1998, ASSESSMENT, V5, P85, DOI 10.1177/107319119800500110; VANDERPLOEG RD, 1994, CLIN GUIDE NEUROPSYC, P1; Wechsler, 1997, WECHSLER ADULT INTEL; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wong J. L., 1998, INT J REHABILITATION, V4, P153, DOI [10.1023/A:1022954629505, DOI 10.1023/A:1022954629505]; WORTMAN CB, 1989, J CONSULT CLIN PSYCH, V57, P349, DOI 10.1037/0022-006X.57.3.349; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	52	21	22	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	2					286	296	PII 793945250	10.1080/13854040802104873			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	399LS	WOS:000262802000007	18609338				2022-02-06	
J	Holm, S; Schonberger, M; Poulsen, I; Caetano, C				Holm, Sara; Schonberger, Michael; Poulsen, Ingrid; Caetano, Carla			Patients' and relatives' experience of difficulties following severe traumatic brain injury: The sub-acute stage	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Subjective experience; Traumatic brain injury; European Brain Injury Questionnaire; Quality of Life; Sub-acute treatment	SEVERE HEAD-INJURY; QUALITY-OF-LIFE; FUNCTIONAL INDEPENDENCE MEASURE; GLASGOW OUTCOME SCALE; SUBJECTIVE EXPERIENCE; CLOSE RELATIVES; REHABILITATION; AWARENESS; ADULTS; DISABILITY	The present study aimed to (1) identify the difficulties most frequently reported by individuals with severe traumatic brain injury (TBI) at the time of discharge from a sub-acute rehabilitation brain injury unit as well as difficulties reported by their relatives, (2) compare patients' and relatives' reports of patient difficulties, and (3) explore the role of injury severity, disability and other factors on subjective experience of difficulties. The primary measure was the European Brain Injury Questionnaire (EBIQ) administered to patients and to one of their close relatives at discharge. Results from 52 patients and 50 relatives indicate that the most frequent complaints in both groups related to somatic and cognitive problems. Relatives reported significantly more difficulties than patients on all subscales of the EBIQ. However, the level of complaints in both patients and relatives was low compared to other studies using the EBIQ. Furthermore, the effects of injury severity and general level of functioning had limited impact on the subjective experience of difficulties. Implications of these findings, specifically as they pertain to the sub-acute stage are discussed.	[Holm, Sara; Poulsen, Ingrid] Univ Copenhagen, Hvidovre Hosp, Brain Injury Unit, DK-2650 Hvidovre, Denmark; [Schonberger, Michael] Monash Univ, Sch Psychol Psychiat & Psychol Med, Melbourne, Vic 3004, Australia; [Schonberger, Michael] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Caetano, Carla] Univ Copenhagen, Ctr Rehabil Brain Injury, DK-1168 Copenhagen, Denmark		Holm, S (corresponding author), 354 Hvidovre Hosp, Dept Neurol Rehabil, Kettegard 30, DK-2650 Hvidovre, Denmark.	sara_holm@hotmail.com	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X			Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1999, REHABILITATION ADULT, P131; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lustig D., 2003, J APPL REHABIL COUS, V34, P30; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale T W, 1995, Appl Neuropsychol, V2, P116; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Williams WH, 1999, NEUROPSYCHOL REHABIL, V9, P421, DOI 10.1080/096020199389482; Wilson BA, 2002, J HEAD TRAUMA REHAB, V17, P542, DOI 10.1097/00001199-200212000-00006	30	21	21	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2009	19	3					444	460	PII 902917230	10.1080/09602010802296402			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	435UO	WOS:000265369000006	18815939				2022-02-06	
J	Kilov, AM; Togher, L; Grant, S				Kilov, Andrea M.; Togher, Leanne; Grant, Susan			Problem solving with friends: Discourse participation and performance of individuals with and without traumatic brain injury	APHASIOLOGY			English	Article							QUALITY-OF-LIFE; COMMUNICATION ACTIVITIES; PEOPLE; SATISFACTION; IMPAIRMENT; SKILLS	Background: Traumatic brain injury (TBI) is a leading cause of hospitalisation and disability worldwide. There is general consensus in the literature reporting poor communication and social outcomes for individuals with TBI. While the literature is extensive in describing cognitive communication difficulties manifesting in the discourse of individuals with TBI, it does not include genres that represent everyday interactions. Furthermore, there are very few studies in the literature that explore interactions of individuals with TBI and their friends, even though it is common for individuals with TBI to lose friends within the first year of their injury. Aims: To explore discourse participation and performance of individuals with and without TBI in a shared problem-solving task with their friends. Methods Procedures: Ten participants with severe TBI were matched with ten control participants for sex, age, and education. Participants problem-solved names and functions of unfamiliar objects with their friends. The resulting discourse was transcribed, divided into moves, and analysed for its generic structure potential (GSP) within a systemic functional linguistics approach. The number of moves contributed by each participant (participation) and frequencies of moves assigned to generic structural elements (performance) were tallied and then statistically analysed. Results Outcomes: There was no significant difference in discourse participation and performance between participants with and without TBI. Individuals with and without TBI mostly talked about the task, gave thesis propositions, offered the possible function of the object, and gave rationales for their decisions. These may be obligatory (not optional) elements of problem-solving discourse. Individuals without TBI used significantly more tangential and unrelated talk, which may be indicative of more frequent and successful attempts to engage in social chat, even in a goal-driven activity. Conclusions: Competent discourse participation and performance is possible for individuals with TBI when they engage in meaningful interactions with friends. Problem solving may be a useful therapy genre for maximising communication outcomes of individuals with TBI, as it encourages the involvement of friends and elicits social chat as well as other creative language options.	[Kilov, Andrea M.; Togher, Leanne; Grant, Susan] Univ Sydney, Lidcombe, NSW 2141, Australia		Kilov, AM (corresponding author), Univ Sydney, Cumberland Campus C42,75 E St, Lidcombe, NSW 2141, Australia.	a_kilov@hotmail.com	Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Bloom R. L., 1994, DISCOURSE ANAL APPL; Bonduelle M, 1995, HUM REPROD, V10, P3327, DOI 10.1093/oxfordjournals.humrep.a135914; Butt D., 2000, USING FUNCTIONAL GRA; Cherney L. R., 1998, ANAL DISCOURSE COMMU; COELHO C, 1995, DISCOURSE ANAL APPL, P95; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Cools C, 1998, INT J REHABIL RES, V21, P323, DOI 10.1097/00004356-199809000-00007; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Davidson B, 2003, APHASIOLOGY, V17, P243, DOI 10.1080/729255457; Eggins S., 1997, ANAL CASUAL CONVERSA; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gangoiti L., 2004, REHABILITATION, V38, P313; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Halliday M., 2004, INTRO FUNCTIONAL GRA; HALLIDAY MAK, 1995, DISCOURSE SOC SYSTEM; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hemmeter ML, 2000, TOP EARLY CHILD SPEC, V20, P56, DOI 10.1177/027112140002000110; Hwang B, 2000, J AUTISM DEV DISORD, V30, P331, DOI 10.1023/A:1005579317085; JENNETT B, 1977, INTRO NEUROSURGERY; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; KAZDIN AE, 1992, METHODOLOGICAL ISSUE; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Marshall RC, 2003, BRAIN INJURY, V17, P589, DOI 10.1080/0269905031000088496; Martin J. R., 1984, LANGUAGE STUDIES CHI, P21; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; MCDONALD S, 1999, COMMUNICATION DISORD, P338; Nolte J, 1998, HUMAN BRAIN INTRO IT; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Poynton C., 1985, LANGUAGE GENDER MAKI; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rosenthal M, 1999, REHABILITATION ADULT; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SNOW P, 1999, 22 ANN BRAIN IMP C S; Snow PC, 2000, BRAIN INJURY, V14, P397; Stubbs Michael, 1983, DISCOURSE ANAL SOCIO; Tannen Deborah, 2005, CONVERSATIONAL STYLE; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1998, THESIS U SYDNEY AUST; Warren L, 1996, J REHABIL RES DEV, V33, P404; World Health Organization, 2001, ICF INT CLASS FUNCT; [No title captured]	50	21	21	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2009	23	5					584	605	PII 794611250	10.1080/02687030701855382			22	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	427RC	WOS:000264795400004					2022-02-06	
J	Shigaki, CL; Johnstone, B; Schopp, LH				Shigaki, Cheryl L.; Johnstone, Brick; Schopp, Laura H.			Financial and vocational outcomes 2 years after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Brain injuries; cost of illness; social security; employment; financial support	QUALITY-OF-LIFE; EMPLOYMENT; WORK; RETURN	Purpose. To determine outcomes for persons with traumatic brain injury (TBI) in terms of employment status, income and public assistance received at 2 years after injury. Method. This study was part of a non-experimental, longitudinal survey. Participants included 49 persons with new TBI from one US national Traumatic Brain Injury Model Systems centre. Main outcome measures included employment status, earned monthly income and monthly income from public sources, at the time of injury and at 2-years follow-up. Results. At 2-year follow-up, individuals with TBI reported higher levels of employment and earned income than was previously reported for 1-year post-injury, but continued to experience declines relative to pre-injury baseline. Frequency and amount of major public agency payments continued to be increased relative to baseline. Conclusions. The costs associated with brain injury remain high for individuals, families and society, as those with TBI move into the more chronic phase of recovery.	[Shigaki, Cheryl L.; Johnstone, Brick; Schopp, Laura H.] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA		Shigaki, CL (corresponding author), Univ Missouri, Dept Hlth Psychol, 1 Hosp Dr,DC116-88, Columbia, MO 65212 USA.	shigakic@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	National Institute on Disability and Rehabilitation Research [H133A980008]; US Department of EducationUS Department of Education	This study was completed as part of the Missouri Model Brain Injury System, funded by the National Institute on Disability and Rehabilitation Research (#H133A980008), US Department of Education. Opinions expressed do not reflect those of NIDRR or the Department of Education. The authors thank Ashley Sherman, M. A., and John Hewett, Ph.D. for their statistical assistance. I would also like to thank Kelly Lora Franklin for her assistance with managing references and editorial support in the preparation of this manuscript.	[Anonymous], 1998, REH PERS TRAUM BRAIN; Bell GD, 1998, B AM METEOROL SOC, V79, pS1, DOI 10.1175/1520-0477-79.5s.S1; *CDC, 1999, TRAUM BRAIN INJ US; *CDCP, TRAUM BRAIN INJ FACT; CRISP R, 1992, J REHABIL, V58, P27; FINKELSTEIN E, 2006, CDCP RTI INT PAC I R; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MILLIS S, 2004, WINTER, V10, P8; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *US GOV PRESS OFF, 2007, PRESS OFF FACT SHEET; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	18	21	21	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2009	31	6					484	489	PII 905995375	10.1080/09638280802240449			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	434RW	WOS:000265292800006	19034724				2022-02-06	
J	Ghalenoui, H; Saidi, H; Azar, M; Yahyavi, ST; Razavi, HB; Khalatbari, M				Ghalenoui, Hossein; Saidi, Hossein; Azar, Mazyar; Yahyavi, Seyyed; Razavi, Hamid; Khalatbari, Mahmoudreza			Near-Infrared Laser Spectroscopy as a Screening Tool for Detecting Hematoma in Patients with Head Trauma	PREHOSPITAL AND DISASTER MEDICINE			English	Article						closed head trauma; intracranial hematoma; near infrared spectroscopy		Introduction: Among imaging techniques, computed tomography (CT) is a reliable method for detecting intracranial hematomas in patients with head trauma, but it is not generally available in special circumstances like prehospital situations and harsh conditions such as those following an earthquake. Objective: The objective of this study is to determine if near-infrared spectroscopy (NIRS) is useful for performing CT scans on patients with closed head trauma that present to medical centers that do not have the ability to perform a CT scan or in prehospital or harsh situations. Near-infrared spectroscopy and CT scan were compared according to sensitivity and specificity. Methods: This was an observational, prospective study. One hundred forty-eight patients admitted to Rasool Akram General Hospital in Tehran, Iran with head injuries during a one-month period were studied using NIRS and CT. The observational, prospective study was conducted and sensitivity, specificity, positive and negative predictive values of NIRS were calculated. Chi-square and Kappa analysis was performed, and a Rvalue <0.05 was considered significant. Results: According to the CT scan findings, 54 (36.5%) of the patients developed intracranial hematoma. The NIRS examination showed that 69 patients (46.6%) might have intracranial hematoma. The number of true negatives was 73 and the number of false negatives was six patients. The sensitivity and specificity of NIRS examination was 88.9% and 77.7%, respectively. Conclusions: This study speculates that NIRS may be a useful screening tool to detect intracranial hematoma. This capability could be useful in special situations like in a deprived area, medical centers without CT scan capabilities, prehospital situations, and in harsh conditions like those after an earthquake or other disasters that causes increased numbers of victims with closed head trauma.	[Ghalenoui, Hossein; Azar, Mazyar; Khalatbari, Mahmoudreza] Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Saidi, Hossein] IUMS, Dept Emergency Med, Tehran, Iran; [Yahyavi, Seyyed; Razavi, Hamid] IUMS, Res Comm, Tehran, Iran		Yahyavi, ST (corresponding author), 11,Boostan 4,Pasdaran St, Tehran, Iran.	seyyedtaha@yahoo.com	saidi, hossein/T-6299-2019; Yahyavi, Seyyedtaha/AAO-9966-2021	Yahyavi, Seyyedtaha/0000-0001-9733-2068; Saidi, Hossein/0000-0002-6648-0284; Azar, Maziar/0000-0003-4486-4487			AUSMAN JI, 1993, J NEUROSURG, V79, P810, DOI 10.3171/jns.1993.79.6.0810; BAUMGARTNER RW, 1995, J CLIN ULTRASOUND, V23, P89, DOI 10.1002/jcu.1870230205; Bein B, 2006, CRIT CARE, V10, DOI 10.1186/cc3980; BRAZY JE, 1986, PEDIATRICS, V108, P983; Daubeney PEF, 1996, ANN THORAC SURG, V61, P930, DOI 10.1016/0003-4975(95)01186-2; Ferrari M, 1986, Adv Exp Med Biol, V200, P203; Francis SV, 2005, J CLIN NEUROSCI, V12, P291, DOI 10.1016/j.jocn.2004.06.009; Goldberg S, 2001, PROC SPIE, V4432, P310, DOI 10.1117/12.447155; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Hennes HJ, 1997, P SOC PHOTO-OPT INS, V3194, P42; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KURTH CD, 1995, ANESTHESIOLOGY, V82, P74, DOI 10.1097/00000542-199501000-00011; Litscher G, 2003, INTERNET J NEUROMONI, V3; MCCORMICK PW, 1991, CRIT CARE MED, V19, P89, DOI 10.1097/00003246-199101000-00020; Owen-Reece H, 1999, BRIT J ANAESTH, V82, P418, DOI 10.1093/bja/82.3.418; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; VANBEL F, 1993, PEDIATRICS, V92, P365; WYATT JS, 1993, CLIN PERINATOL, V20, P369, DOI 10.1016/S0095-5108(18)30398-1	20	21	21	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	DEC	2008	23	6					558	561		10.1017/S1049023X00006415			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V82KD	WOS:000212315800015	19557974				2022-02-06	
J	da Silva, PSL; Reis, ME; Aguiar, VE				Lucas da Silva, Paulo Sergio; Reis, Maria Eunice; Aguiar, Vania Euzebio			Value of Repeat Cranial Computed Tomography in Pediatric Patients Sustaining Moderate to Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Children; CT scan; Traumatic brain injury; Glasgow Coma Scale; Pediatric intensive care unit	MINIMAL HEAD-INJURY; INTRACRANIAL INJURY; CLINICAL-EFFICACY; CHILDREN; UTILITY; MANAGEMENT; RADIATION; COHORT; SCAN	Background: Repeat head computed tomography (CT) is standard practice for traumatic brain injury (TBI) at many centers. The few studies available in children remain unclear over the value of repeat CT within 24 hours to 48 hours of lesion in such patients. The purpose of the present study was to assess the value of repeat cranial CT in children presenting moderate or severe TBI. Methods: A retrospective study performed within a pediatric intensive care unit between January 2000 and December 2006. All patients with moderate and severe TBI who survived the first 24 hours after admission were included. Clinical data collected included age, lesion mechanism, time between first and second CTs, disease severity score at admission, and Glasgow Coma Scale (GCS) both at admission and (lay of repeat CT. Results: A total of 63 children were assessed whose mean age was 72 months (48-112). The time between the first and the second CT scans averaged 25.78 hours +/- 13.75 hours (range, 6-48 hours). The reasons for ordering repeat CT scans were divided as follows: follow-up (78%), neurologic deterioration (20.4%.), and increased intracranial pressure (1.6%). The change on the follow-tip CT scan was compared with the GCS score. The GCS score was improved in 66.6% of patients, remained the same in 15.9%, and worsened in 17.5%. The appearance on the CT scans was better, the same or worse in 41.3%, 34.9%, and 23.8% of patients, respectively. There was a significant association between GCS and changes in findings on repeat CT (OR = 34.5, confidence interval [5.98-199.04], p = 0.000009). The positive and negative predictive values were 82% and 89%, respectively. One patient with a worsened GCS required surgical intervention based on the repeat CT scan. Conclusion: An unchanged or improving neurologic examination in children sustaining moderate or severe TBI who are appropriately monitored may be adequate to exclude the possibility of neurosurgical intervention and, hence, repeat head CT scan.	[Lucas da Silva, Paulo Sergio; Reis, Maria Eunice; Aguiar, Vania Euzebio] Hosp Servidor Publ Municipal, Dept Pediat, Pediat Intens Care Unit, Sao Paulo, Brazil		da Silva, PSL (corresponding author), Rua Aroeiras 30 Ap 22, BR-09090000 Sao Paulo, Brazil.	psls.nat@terra.com.br	Silva, Paulo Sergio L/P-5182-2018				*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Dharap SB, 2005, INJURY, V36, P412, DOI 10.1016/j.injury.2004.06.020; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Gruen JP, 1996, SURG CLIN N AM, V76, P905, DOI 10.1016/S0039-6109(05)70487-4; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; HURST JM, 1992, J TRAUMA, V33, P582, DOI 10.1097/00005373-199210000-00015; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LOBATO RD, 1997, ACTA NEUROCHIR WIEN, V139, P395; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stearley H E, 1998, Am J Crit Care, V7, P282; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	26	21	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2008	65	6					1293	1297		10.1097/TA.0b013e318156866c			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	383WV	WOS:000261706000019	19077616				2022-02-06	
J	Craig, M; Bir, C; Viano, D; Tashman, S				Craig, Matthew; Bir, Cynthia; Viano, David; Tashman, Scott			Biomechanical response of the human mandible to impacts of the chin	JOURNAL OF BIOMECHANICS			English	Article						Mandible; Impact biomechanics; Response corridors	HUMAN TEMPOROMANDIBULAR-JOINT; PROFESSIONAL FOOTBALL; CONCUSSION; CORRIDORS; INJURIES; FRACTURE; BONE	The purpose of this study was to determine the force-time and force-displacement response of the human mandible under direct loading at the chin. Sub-fracture response of the mandible and temporomandibular joint (TMJ) were analyzed from 10 cadavers that were impacted at the chin with a 2.8-kg mass at drop heights of 300, 400 and 500 mm and a 5.2-kg mass at 500 mm. Motion of radio-opaque markers adhered to the surface of the bone was recorded at 1000 Hz by a bi-planar X-ray and converted to three-dimensional coordinates. Peak force ranged from 0.90 to 4.54kN causing chin displacement of 1.2-4.4 mm. A bi-linear response was observed with stiffness of 475.1 +/- 199.8 kN/m for chin displacement resulting from loading up to 0.6 kN and 2381.6 +/- 495.7 kN/m for loads from 0.6 to 3.25 kN. This defines the biomechanical response of the mandible for chin motion under impact loading. The response of different segments of the mandible and TMJ are also documented. Force-time and force-displacement response corridors for the mandible can be used for finite element model and/or the development and validation of a biomechanical surrogate. (c) 2008 Elsevier Ltd. All rights reserved.	[Craig, Matthew; Bir, Cynthia; Viano, David] Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA; [Tashman, Scott] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA		Bir, C (corresponding author), Wayne State Univ, Ctr Bioengn, 818 W Hancock, Detroit, MI 48202 USA.	cbir@wayne.edu	Tashman, Scott/A-8951-2011; Tashman, Scott/X-4724-2018	Tashman, Scott/0000-0003-0534-3785; Tashman, Scott/0000-0003-0534-3785; Bir, Cynthia/0000-0002-0777-0951			Beek M, 2001, J DENT RES, V80, P876, DOI 10.1177/00220345010800030601; Bir C, 2004, J BIOMECH, V37, P73, DOI 10.1016/S0021-9290(03)00238-0; BYARS EF, 1970, 1970 ASME WINT ANN M; Giesen EBW, 2003, CLIN BIOMECH, V18, P358, DOI 10.1016/S0268-0033(03)00018-4; Hardy W N, 2001, Stapp Car Crash J, V45, P1; HODGSON VR, 1967, AM J ANAT, V120, P113, DOI 10.1002/aja.1001200109; Hopper R. H., 1994, P 38 STAPP CAR CRASH; Hu K, 2003, MED ENG PHYS, V25, P107, DOI 10.1016/S1350-4533(02)00191-1; Hubbard RP, 1973, HUMAN IMPACT RESPONS, P129; HUELKE DF, 1983, J ORAL MAXIL SURG, V41, P241, DOI 10.1016/0278-2391(83)90266-5; KING AI, 1995, J TRAUMA, V38, P564, DOI 10.1097/00005373-199504000-00016; Kroell CK, 1971, P 15 STAPP CAR CRASH; Lai WFT, 1998, J OROFAC PAIN, V12, P153; Maltese Matthew R, 2002, Stapp Car Crash J, V46, P321; MELVIN J, 1989, HYBRID, V3, P453; MELVIN J, 1995, P 39 STAPP CAR CRASH; NAHUM AM, 1975, LARYNGOSCOPE, V85, P140, DOI 10.1288/00005537-197501000-00011; NAHUM AM, 1968, P 12 STAPP CAR CRASH; Newman J. A., 1984, P 28 STAPP CAR CRASH; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PRETI G, 1982, J PROSTHET DENT, V47, P445, DOI 10.1016/S0022-3913(82)80099-1; SCHNEIDER DC, 1972, P 16 STAPP CAR CRASH; Stemper B D, 2001, Biomed Sci Instrum, V37, P239; Tanaka E, 2001, J ORAL REHABIL, V28, P273, DOI 10.1111/j.1365-2842.2001.tb01677.x; Tashman S, 2003, J BIOMECH ENG-T ASME, V125, P238, DOI 10.1115/1.1559896; Unnewehr M, 2003, INT J LEGAL MED, V117, P326, DOI 10.1007/s00414-003-0391-6; WALILKO TJ, 2004, THESIS WAYNE STATE U; Wheeldon JA, 2006, J BIOMECH, V39, P375, DOI 10.1016/j.jbiomech.2004.11.014	30	21	21	2	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	OCT 20	2008	41	14					2972	2980		10.1016/j.jbiomech.2008.07.020			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	373PZ	WOS:000260985700012	18805529				2022-02-06	
J	Pickering, C; Hagglund, M; Szmydynger-Chodobska, J; Marques, F; Palha, JA; Waller, L; Chodobski, A; Fredriksson, R; Lagerstrom, MC; Schioth, HB				Pickering, Chris; Hagglund, Maria; Szmydynger-Chodobska, Joanna; Marques, Fernanda; Palha, Joana A.; Waller, Linn; Chodobski, Adam; Fredriksson, Robert; Lagerstrom, Malin C.; Schioth, Helgi B.			The Adhesion GPCR GPR125 is specifically expressed in the choroid plexus and is upregulated following brain injury	BMC NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; GENOME; GENERATION; EVOLUTION; BINDING; FAMILY; CELLS; GENE	Background: GPR125 belongs to the family of Adhesion G protein-coupled receptors (GPCRs). A single copy of GPR125 was found in many vertebrate genomes. We also identified a Drosophila sequence, DmCG15744, which shares a common ancestor with the entire Group III of Adhesion GPCRs, and also contains Ig, LRR and HBD domains which were observed in mammalian GPR125. Results: We found specific expression of GPR125 in cells of the choroid plexus using in situ hybridization and protein-specific antibodies and combined in situ/immunohistochemistry co-localization using cytokeratin, a marker specific for epithelial cells. Induction of inflammation by LPS did not change GPR125 expression. However, GPR125 expression was transiently increased ( almost 2-fold) at 4 h after traumatic brain injury (TBI) followed by a decrease ( approximately 4-fold) from 2 days onwards in the choroid plexus as well as increased expression ( 2-fold) in the hippocampus that was delayed until 1 day after injury. Conclusion: These findings suggest that GPR125 plays a functional role in choroidal and hippocampal response to injury.	[Pickering, Chris; Lagerstrom, Malin C.] Uppsala Univ, Dept Neurosci, BMC, Div Dev Genet, SE-75124 Uppsala, Sweden; [Szmydynger-Chodobska, Joanna; Chodobski, Adam] Brown Univ, Warren Alpert Med Sch, Dept Clin Neurosci, Providence, RI 02903 USA; [Marques, Fernanda; Palha, Joana A.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, P-4710057 Braga, Portugal		Pickering, C (corresponding author), Uppsala Univ, Dept Neurosci, BMC, Div Dev Genet, Box 593, SE-75124 Uppsala, Sweden.	chris.pickering@neuro.uu.se; maria.hagglund@neuro.uu.se; joanna_szmydynger-chodobska@brown.edu; fmarques@ecsaude.uminho.pt; japalha@ecsaude.uminho.pt; Linn.Waller.2968@student.uu.se; adam_chodobski@brown.edu; robert.fredriksson@neuro.uu.se; malin.lagerstrom@neuro.uu.se; helgi.schioth@neuro.uu.se	Marques, Fernanda/D-4238-2012; Fredriksson, Robert/AAH-3921-2019; Palha, Joana Almeida/C-2745-2009; Schioth, Helgi/AAQ-7239-2020	Marques, Fernanda/0000-0002-3612-1870; Fredriksson, Robert/0000-0002-2810-3226; Palha, Joana Almeida/0000-0002-8866-368X; Pickering, Chris/0000-0002-6630-7852	Hjarnfonden (Brain Research Foundation); Swedish Research Foundation; Novo NordiskNovo Nordisk; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-49479]; FEDER/Portuguese Foundation for Science and TechnologyPortuguese Foundation for Science and TechnologyEuropean Commission [POCTI/SAU-NEU/56618/2004]; FCTPortuguese Foundation for Science and TechnologyEuropean Commission; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	The authors wish to thank Anders Hellstrom and Julie Sarri for technical assistance. ML was supported by Hjarnfonden (Brain Research Foundation). Studies were supported by grants from the Swedish Research Foundation and Novo Nordisk to HBS and TBI studies were supported by grant NS-49479 from the NIH to AC. JAP studies were supported by grant POCTI/SAU-NEU/56618/2004 from FEDER/Portuguese Foundation for Science and Technology (FCT). FM has a PhD fellowship from FCT.	Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; BROCKLEHURST G, 1979, ANN ROY COLL SURG, V61, P349; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Emerich DF, 2005, BIOESSAYS, V27, P262, DOI 10.1002/bies.20193; Endo H, 1998, BRAIN RES, V793, P297, DOI 10.1016/S0006-8993(98)00042-0; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Felsenstein J, 2005, PHYLIP PHYLOGENY INF; Ferrand-Drake M, 1999, NEUROSCIENCE, V93, P537, DOI 10.1016/S0306-4522(99)00181-5; Fredriksson R, 2005, ANN NY ACAD SCI, V1040, P89, DOI 10.1196/annals.1327.011; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fridmanis D, 2007, MOL PHYLOGENET EVOL, V43, P864, DOI 10.1016/j.ympev.2006.11.007; Gard AL, 2004, NEUROSCIENCE, V127, P43, DOI 10.1016/j.neuroscience.2004.03.065; Harmar AJ, 2001, GENOME BIOL, V2; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kudo S, 2007, ONCOL REP, V18, P785; Kwakkenbos MJ, 2006, FASEB J, V20, P2582, DOI 10.1096/fj.06-6500fje; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lagerstrom MC, 2006, PLOS COMPUT BIOL, V2, P493, DOI 10.1371/journal.pcbi.0020054; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Marques F, 2007, NEUROSCIENCE, V144, P424, DOI 10.1016/j.neuroscience.2006.09.029; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Sousa JC, 2007, NEUROBIOL AGING, V28, P713, DOI 10.1016/j.neurobiolaging.2006.03.015; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yamamoto Y, 2004, ONCOGENE, V23, P3889, DOI 10.1038/sj.onc.1207495	43	21	21	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	OCT 3	2008	9								97	10.1186/1471-2202-9-97			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	363HD	WOS:000260257500001	18834514	gold, Green Published			2022-02-06	
J	Kincaid, MS				Kincaid, M. Sean			Transcranial Doppler ultrasonography: a diagnostic tool of increasing utility	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						carotid endarterectomy; cerebral vasospasm; ischemic stroke; migraine; patent foramen ovale; sickle cell; transcranial Doppler ultrasonography; traumatic brain injury	PATENT FORAMEN OVALE; CAROTID-ARTERY STENOSIS; TISSUE-PLASMINOGEN ACTIVATOR; FULMINANT HEPATIC-FAILURE; TRAUMATIC BRAIN-INJURY; SICKLE-CELL-DISEASE; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; DYNAMIC CEREBRAL AUTOREGULATION; ATRIAL SEPTAL ANEURYSM; ACADEMY-OF-NEUROLOGY	Purpose of review Since its introduction in 1982, transcranial Doppler ultrasonography has become an important diagnostic and monitoring tool in patients with surgical disease. It has applications in the perioperative period, as well as in the intensive care unit. It is therefore appropriate for the anesthesiologist to maintain an understanding of its current utility. Recent findings Transcranial Doppler has an established role in diagnosing cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage and for guiding transfusion therapy in children with sickle cell disease. It has application in the preoperative evaluation of patients with cerebrovascular disease, as well as that of an intraoperative monitor in carotid endarterectomy and carotid stenting. It is useful for detecting right-to-left shunts in settings in which transesophageal echocardiography is not desirable. Its value in settings such as traumatic brain injury, hepatic failure, and migraine headache has yet to be fully clarified. Summary Although there are several settings in which transcranial Doppler has well established usefulness, there are many more in which it is likely valuable, such as traumatic brain injury, ischemic stroke, and fulminant hepatic failure. Further research is needed in these fields to elucidate the exact role for transcranial Doppler.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Anesthesiol, Seattle, WA 98104 USA		Kincaid, MS (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Anesthesiol, Seattle, WA 98104 USA.	kincaid@u.washington.edu					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1986, NEURORADIOLOGY, V28, P11, DOI 10.1007/BF00341759; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abdo A, 2003, TRANSPLANT P, V35, P1859, DOI 10.1016/S0041-1345(03)00592-X; Ackerstaff RGA, 2005, J VASC SURG, V41, P618, DOI 10.1016/j.jvs.2005.01.034; Ackerstaff RGA, 2000, STROKE, V31, P1817, DOI 10.1161/01.STR.31.8.1817; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Arauz A, 2006, CEREBROVASC DIS, V22, P150, DOI 10.1159/000093244; Ardizzone G, 2004, TRANSPLANT P, V36, P3060, DOI 10.1016/j.transproceed.2004.11.014; Barbut D, 1996, STROKE, V27, P87, DOI 10.1161/01.STR.27.1.87; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Belvis R, 2006, J NEUROIMAGING, V16, P133, DOI 10.1111/j.1552-6569.2006.00021.x; BRASS LM, 1990, STROKE, V21, P484, DOI 10.1161/01.STR.21.3.484; Burch CM, 1996, J NEUROIMAGING, V6, P8, DOI 10.1111/jon1996618; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Carod-Artal FJ, 2006, CEPHALALGIA, V26, P934, DOI 10.1111/j.1468-2982.2006.01156.x; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Chernyshev OY, 2005, STROKE, V36, P32, DOI 10.1161/01.STR.0000150496.27584.e3; Czosnyka M, 2003, ACT NEUR S, V86, P581; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Domitrz I, 2007, HEADACHE, V47, P1311, DOI 10.1111/j.1526-4610.2006.00724.x; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; Ederle J, 2006, EUR J RADIOL, V60, P3, DOI 10.1016/j.ejrad.2006.05.021; Estrera AL, 2005, J THORAC CARDIOV SUR, V129, P277, DOI 10.1016/j.jtcvs.2004.08.052; FRANCIS CW, 1995, ULTRASOUND MED BIOL, V21, P419, DOI 10.1016/0301-5629(94)00119-X; Gao S, 2004, STROKE, V35, P2832, DOI 10.1161/01.STR.0000147035.31297.b6; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; Hadani M, 1999, INTENS CARE MED, V25, P822, DOI 10.1007/s001340050958; Halliday A, 2004, LANCET, V363, P1491; HALSEY JH, 1992, STROKE, V23, P1583, DOI 10.1161/01.STR.23.11.1583; HERZIG R, 2004, REV BIOMED PAP MED F, V148, P119; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Iguchi Y, 2008, J NEUROL NEUROSUR PS, V79, P253, DOI 10.1136/jnnp.2007.123414; JORGENSEN LG, 1993, EUR J VASCULAR SURG, V7, P370, DOI 10.1016/S0950-821X(05)80252-X; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Komoribayashi N, 2006, J CEREBR BLOOD F MET, V26, P878, DOI 10.1038/sj.jcbfm.9600244; Komotar RJ, 2006, NEUROSURGERY, V59, P284, DOI 10.1227/01.NEU.0000223340.89958.8D; Laman DM, 2002, J VASC SURG, V36, P278, DOI 10.1067/mva.2002.125796; Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Markus HS, 2005, STROKE, V36, P971, DOI 10.1161/01.STR.0000162717.62684.40; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Mazumdar M, 2007, PEDIATRICS, V120, pe1107, DOI 10.1542/peds.2006-2002; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; MOLLER JT, 1993, ANESTHESIOLOGY, V78, P445, DOI 10.1097/00000542-199303000-00007; Molloy J, 1999, STROKE, V30, P1440, DOI 10.1161/01.STR.30.7.1440; Moritz S, 2007, ANESTHESIOLOGY, V107, P563, DOI 10.1097/01.anes.0000281894.69422.ff; NAYLOR AR, 1991, BRIT J SURG, V78, P1264, DOI 10.1002/bjs.1800781038; Naylor AR, 2000, J VASC SURG, V32, P750, DOI 10.1067/mva.2000.108007; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; Ogasawara K, 2007, J NEUROSURG, V107, P1130, DOI 10.3171/JNS-07/12/1130; Orlandi G, 2005, ARCH NEUROL-CHICAGO, V62, P1208, DOI 10.1001/archneur.62.8.1208; PIEPGRAS DG, 1988, J NEUROSURG, V68, P532, DOI 10.3171/jns.1988.68.4.0532; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; Puppo C, 2008, NEUROCRIT CARE, V8, P344, DOI 10.1007/s12028-008-9069-8; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Reisman M, 2005, J AM COLL CARDIOL, V45, P493, DOI 10.1016/j.jacc.2004.10.055; RILES TS, 1994, J VASC SURG, V19, P206, DOI 10.1016/S0741-5214(94)70096-6; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Sastry S, 2006, J AM COLL CARDIOL, V48, P686, DOI 10.1016/j.jacc.2006.02.074; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Sloan M. A., 1997, NEW TRENDS CEREBRAL, P221; SLOAN MA, 1989, NEUROLOGY, V39, P1514, DOI 10.1212/WNL.39.11.1514; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; SLOAN MA, 1994, STROKE, V25, P2187, DOI 10.1161/01.STR.25.11.2187; Soustiel JF, 2002, STROKE, V33, P72, DOI 10.1161/hs0102.100484; Spence JD, 2005, STROKE, V36, P2373, DOI 10.1161/01.STR.0000185922.49809.46; Sreeram GM, 2004, J CARDIOTHOR VASC AN, V18, P548, DOI 10.1053/j.jvca.2004.07.010; Sviri GE, 2006, NEUROSURGERY, V59, P360, DOI 10.1227/01.NEU.0000223502.93013.6E; Tan H, 2001, Chin J Traumatol, V4, P156; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tofteng F, 2004, METAB BRAIN DIS, V19, P207, DOI 10.1023/B:MEBR.0000043970.34533.04; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Vernieri F, 2001, STROKE, V32, P1552, DOI 10.1161/01.STR.32.7.1552; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WILCOX WD, 1983, J PEDIATR-US, V102, P294, DOI 10.1016/S0022-3476(83)80546-0; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong KSL, 2005, EUR NEUROL, V53, P132, DOI 10.1159/000085569; Wozniak MA, 1996, J NEUROIMAGING, V6, P87, DOI 10.1111/jon19966287	95	21	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0952-7907			CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2008	21	5					552	559		10.1097/ACO.0b013e32830edc0b			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	398ER	WOS:000262715900005	18784478				2022-02-06	
J	Weant, KA; Sasaki-Adams, D; Dziedzic, K; Ewend, M				Weant, Kyle A.; Sasaki-Adams, Deanna; Dziedzic, Kathryn; Ewend, Matthew			ACUTE RELATIVE ADRENAL INSUFFICIENCY AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE	NEUROSURGERY			English	Article						Adrenal insufficiency; Aneurysmal subarachnoid hemorrhage; Brain injury; Steroids	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOSPASM; MEDICAL PROGRESS; FREE CORTISOL; SEPTIC SHOCK; NITRIC-OXIDE; HYDROCORTISONE	OBJECTIVE: The hypothalamic-pituitary-adrenal axis is an important part of the body's natural response to acute illness. Adrenal insufficiency has the potential to lead to hemodynamic instability and electrolyte imbalances, limit the body's ability to respond to stress, and worsen overall clinical outcome. in this case series, we describe 16 patients evaluated for acute adrenal insufficiency after aneurysmal subarachnoid hemorrhage. CLINICAL PRESENTATION: Over a 2-year period, the medical records of 16 patients admitted to the adult neurosurgery service for aneurysmal subarachnoid hemorrhage who were nonresponsive to vasopressor therapy and received cosyntropin for the evaluation of adrenal insufficiency within 14 days of their event were reviewed. INTERVENTION: The median baseline cortisol in this population was 22.5 mu g/dL, with a poststimulation cortisol level of 31 mu g/dL. Of the population surveyed, a total of 11 patients met the preestablished criteria for adrenal insufficiency, 3 with baseline cortisol levels of less than 15 mu g/dL and 11 with poststimulation concentration changes of less than 9 mu g/dL. Baseline serum cortisol concentrations were significantly correlated with hospital stay (P = 0.045), intensive care unit stay (P = 0.005), and ventilator days (P = 0.006). CONCLUSION: To date, this is the only investigation evaluating the incidence of acute relative adrenal insufficiency in this population. In our cohort, 69% of the patients met the preestablished criteria for relative adrenal insufficiency. The impact of low-dose corticosteroid therapy in this population also needs review, as it could have significant implications for the management of cerebral vasospasm.	[Weant, Kyle A.] Univ Kentucky Healthcare, Serv Pharm, Lexington, KY 40536 USA; [Weant, Kyle A.] Univ Kentucky, Coll Pharm, Dept Pharm Practice & Sci, Lexington, KY USA; [Sasaki-Adams, Deanna; Ewend, Matthew] Univ N Carolina, Div Neurol Surg, Chapel Hill, NC USA; [Dziedzic, Kathryn] Univ N Carolina Hosp, Dept Pharm, Chapel Hill, NC USA; [Dziedzic, Kathryn] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA		Weant, KA (corresponding author), Univ Kentucky Healthcare, Serv Pharm, 800 Rose St,H109A, Lexington, KY 40536 USA.	kawean2@email.uky.edu		Weant, Kyle/0000-0003-0835-7955			ADAMS JH, 1966, J NEUROL NEUROSUR PS, V29, P545, DOI 10.1136/jnnp.29.6.545; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alhashemi JA, 2001, BRIT J ANAESTH, V86, P138, DOI 10.1093/bja/86.1.138; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DANIEL PM, 1959, LANCET, V2, P927; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI [10.1007/s00134-007-0934-2, 10.1097/01.CCM.0000298158.12101.41]; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; KASSELL NF, 1984, STROKE, V15, P566, DOI 10.1161/01.STR.15.3.566; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Marik PE, 2003, CRIT CARE MED, V31, P141, DOI 10.1097/00003246-200301000-00022; MORAN JL, 1994, INTENS CARE MED, V20, P489, DOI 10.1007/BF01711901; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sehba FA, 2005, J NEUROSURG, V102, P1094, DOI 10.3171/jns.2005.102.6.1094; Sehba FA, 2004, NEUROSURGERY, V55, P671, DOI 10.1227/01.NEU.0000134557.82423.B2; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Sesmilo Gemma, 2007, Hormones (Athens), V6, P132; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173	34	21	23	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2008	63	4					645	649		10.1227/01.NEU.0000325728.50939.15			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	367UR	WOS:000260578600014	18824943				2022-02-06	
J	Zhao, XR; Gorin, FA; Berman, RF; Lyeth, BG				Zhao, Xueren; Gorin, Fredric A.; Berman, Robert F.; Lyeth, Bruce G.			Differential Hippocampal Protection when Blocking Intracellular Sodium and Calcium Entry during Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	International Symposium on Traumatic Brain Injury Research Priorities	OCT 13-16, 2005	Johnstown, PA	John P Murtha Neursci & Pain Inst, Natl Brain Injury Res, Treatments & Training Fdn, Brain Injury Assoc Amer		astrocyte; glia; hippocampus; ion exchangers; lateral fluid percussion injury; neuronal degeneration; sodium; traumatic brain injury	FATTY-ACID EFFLUX; NA+-H+ EXCHANGE; LATERAL FLUID-PERCUSSION; EXCITATORY AMINO-ACIDS; SENSING ION CHANNELS; CEREBRAL-CORTEX; NEURONAL DEGENERATION; NA+/CA2+ EXCHANGE; HYPOXIC/HYPOGLYCEMIC INJURY; ARBITRARY PARTICLES	This study investigated the contributions of the reverse mode of the sodium-calcium exchanger (NCX) and the type 1 sodium-proton antiporter (NHE-1) to acute astrocyte and neuronal pathology in the hippocampus following fluid percussion traumatic brain injury (TBI) in the rat. KB-R7943, EIPA, or amiloride, which respectively inhibit NCX, NHE-1, or NCX, NHE-1, and ASIC1a (acid-sensing ion channel type 1a), was infused intraventricularly over a 60-min period immediately prior to TBI. Astrocytes were immunostained for glial fibrillary acidic protein (GFAP), and degenerating neurons were identified by Fluoro-Jade staining at 24 h after injury. Stereological analysis of the CA2/3 sub-regions of the hippocampus demonstrated that higher doses of KB-R7943 (2 and 20 nmoles) significantly reduced astrocyte GFAP immunoreactivity compared to vehicle-treated animals. EIPA (2-200 nmoles) did not alter astrocyte GFAP immunoreactivity. Amiloride (100 nmoles) significantly attenuated the TBI-induced acute reduction in astrocyte GFAP immunoreactivity. Of the three compounds examined, only amiloride (100 nmoles) reduced hippocampal neuronal degeneration assessed with Fluoro-Jade. The results provide additional evidence of acute astrocyte pathology in the hippocampus following TBI, while suggesting that activation of NHE-1 and the reverse mode of NCX contribute to both astrocyte and neuronal pathology following experimental TBI.	[Zhao, Xueren; Berman, Robert F.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gorin, Fredric A.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039090, R01NS045136, R01NS029995, R01NS040489] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS029995, R01 NS045136-04, NS40489, NS45136, NS39090, NS29995, R01 NS029995-13, R01 NS045136] Funding Source: Medline		Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; ANDREEVA N, 1992, NEUROSCIENCE, V49, P175, DOI 10.1016/0306-4522(92)90085-G; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Bondarenko A, 2001, GLIA, V34, P143, DOI 10.1002/glia.1049; Breder J, 2000, NEUROPHARMACOLOGY, V39, P1779, DOI 10.1016/S0028-3908(00)00027-7; BRIERLEY GP, 1994, J BIOENERG BIOMEMBR, V26, P519, DOI 10.1007/BF00762736; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Castejon OJ, 1998, BRAIN INJURY, V12, P409, DOI 10.1080/026990598122539; Chattou S, 2000, J MOL CELL CARDIOL, V32, P1181, DOI 10.1006/jmcc.2000.1151; Cho JH, 2008, J NEUROPHYSIOL, V99, P426, DOI 10.1152/jn.00940.2007; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1994, PROG NEUROBIOL, V44, P377, DOI 10.1016/0301-0082(94)90033-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ENKVIST MOK, 1989, GLIA, V2, P397, DOI 10.1002/glia.440020602; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Jenkins L.W., 1984, RECENT PROGR STUDY T, P523; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kempski O, 1990, Adv Neurol, V52, P39; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1992, ASTROCYTES PHARM FUN; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; MacGregor DG, 2003, J NEUROCHEM, V85, P1402, DOI 10.1046/j.1471-4159.2003.01772.x; Magistretti PJ, 1996, CEREB CORTEX, V6, P50, DOI 10.1093/cercor/6.1.50; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NELSON LR, 1982, HEAD INJURY BASIC CL, P117; NOBLE LJ, 1992, J NEUROTRAUM, V9, P255, DOI 10.1089/neu.1992.9.255; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Phillis JW, 1999, BRAIN RES, V839, P199, DOI 10.1016/S0006-8993(99)01705-9; Phillis JW, 2000, BRAIN RES, V884, P155, DOI 10.1016/S0006-8993(00)02938-3; Phillis JW, 1998, BRAIN RES, V812, P297, DOI 10.1016/S0006-8993(98)00984-6; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Pilitsis JG, 2001, BRAIN RES, V913, P156, DOI 10.1016/S0006-8993(01)02760-3; Pilitsis JG, 2001, BRAIN RES, V916, P192, DOI 10.1016/S0006-8993(01)02896-7; Rogister F, 2001, EUR J MED CHEM, V36, P597, DOI 10.1016/S0223-5234(01)01247-8; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P319, DOI 10.1016/S0028-3908(98)00198-1; SIEGL PKS, 1984, P NATL ACAD SCI-BIOL, V81, P3238, DOI 10.1073/pnas.81.10.3238; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Silver IA, 1997, GLIA, V21, P35, DOI 10.1002/(SICI)1098-1136(199709)21:1<35::AID-GLIA4>3.0.CO;2-0; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Takahashi M, 1997, J EXP BIOL, V200, P401; VIGNE P, 1983, BIOCHEM BIOPH RES CO, V116, P86, DOI 10.1016/0006-291X(83)90384-4; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Wangemann P, 1996, HEARING RES, V94, P94, DOI 10.1016/0378-5955(96)00008-1; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	63	21	24	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2008	25	10					1195	1205		10.1089/neu.2008.0635			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	370XK	WOS:000260796200008	18847376	Green Published, Green Accepted			2022-02-06	
J	Mangus, BE; Shen, LY; Helmer, SD; Maher, J; Smith, RS				Mangus, Barry E.; Shen, Luke Y.; Helmer, Stephen D.; Maher, Janae; Smith, R. Stephen			Taser and Taser associated injuries: A case series	AMERICAN SURGEON			English	Article							OCULAR INJURY	Taser devices were introduced in 1974 and are increasingly used by law enforcement agencies. Taser use theoretically reduces the risk of injury and death by decreasing the use of lethal force. We report a spectrum of injuries sustained by four patients subdued with Taser devices. Injuries identified in our review included: 1) a basilar skull fracture, right subarachnoid hemorrhage, and left-sided epidural hemorrhage necessitating craniotomy; 2) a concussion, facial laceration, comminuted nasal fracture, and orbital floor fracture; 3) penetration of the outer table and cortex of the cranium by a Taser probe with seizure-like activity reported by the officer when the Taser was activated; and 4) a forehead hematoma and laceration. The Taser operator's manual states that these devices are designed to incapacitate a target from a safe distance without causing death or permanent injury. However, individuals may be exposed to the potential for significant injury. These devices represent a new mechanism for potential injury. Trauma surgeons and law enforcement agencies should be aware of the potential danger of significant head injuries as a result of loss of neuromuscular control.	[Mangus, Barry E.; Shen, Luke Y.; Helmer, Stephen D.; Maher, Janae; Smith, R. Stephen] Univ Kansas, Sch Med, Dept Surg, Wichita, KS 67214 USA; [Smith, R. Stephen] Via Christi Reg Med Ctr, Div Trauma, Wichita, KS USA		Smith, RS (corresponding author), Roanoke Mem Hosp, Dept Surg, 1906 Belleview Ave, Roanoke, VA 24014 USA.	rssmith@carifon.com		Helmer, Stephen/0000-0002-8760-7950			Chen SL, 2006, CLIN EXP OPHTHALMOL, V34, P378, DOI 10.1111/j.1442-9071.2006.01228.x; Jenkinson Emma, 2006, J Clin Forensic Med, V13, P229, DOI 10.1016/j.jcfm.2005.11.006; KORNBLUM RN, 1991, J FORENSIC SCI, V36, P434; Maier A., 2005, HUMAN EFFECTIVENES 1; Ng W, 2005, AM J OPHTHALMOL, V139, P713, DOI 10.1016/j.ajo.2004.11.039; ORDOG GJ, 1987, ANN EMERG MED, V16, P73, DOI 10.1016/S0196-0644(87)80292-5; *TASER INT, GEN INF; TUTTLE S, 2007, TASER ELECT CONTROL; TASER ELECT DEVICE D	9	21	21	0	1	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	SEP	2008	74	9					862	865					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	344NC	WOS:000258933400020	18807679				2022-02-06	
J	Monnerie, H; Le Roux, PD				Monnerie, Hubert; Le Roux, Peter D.			Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: The role of cysteine proteases	EXPERIMENTAL NEUROLOGY			English	Article						calpain; cathepsin; cerebral cortex; excitotoxicity; GABA; CAD; glutamate; neuron	CALPAIN-MEDIATED CLEAVAGE; CULTURED CORTICAL-NEURONS; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; MESSENGER-RNA; CATHEPSIN-L; HIPPOCAMPAL-NEURONS; TRANSIENT ISCHEMIA; 67-KDA ISOFORM; I ACTIVATION	Brain cell vulnerability to neurologic insults varies greatly, depending on their neuronal subpopulation. Among cells that Survive a pathological insult such as ischemia or brain trauma, some may undergo morphological and/or biochemical changes that could compromise brain function. We previously reported that Surviving cortical GABAergic neurons exposed to glutamate in vitro displayed an NMDA receptor (NMIDAR)-mediated alteration in the levels of the GABA synthesizing enzyme glutamic acid decarboxylase (GAD65/67) [Monnerie, H., Le Roux, R, 2007. Reduced dendrite growth and altered glutamic acid decarboxylase (GAD) 65- and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro. Exp. Neurol. 205,367-382]. In this study, we examined the mechanisms by which glutamate excitotoxicity Caused a change in cortical GABAergic neurons' GAD protein levels. Removing extracellular Calcium prevented the NMDAR-mediated decrease in GAD protein levels, measured using Western blot techniques, whereas inhibiting calcium entry through voltage-gated calcium channels had no effect. Glutamate's effect on GAD protein isoforms was significantly attenuated by preincubation with the cysteine protease inhibitor N-Acetyl-L-Leucyl-L-Leucyl-norleucinal (ALLN). Using class-specific protease inhibitors, we observed that ALLN's effect resulted from the blockade of calpain and cathepsin protease activities. Cell-free proteolysis assay confirmed that both proteases were involved in glutamate-induced alteration in GAD protein levels. Together these results suggest that glutamate-induced excitotoxic stimulation of NMDAR in Cultured cortical neurons leads to altered GAD protein levels from GABAergic neurons through intracellular Calcium increase and protease activation including calpain and cathepsin. Biochemical alterations in Surviving cortical GABAergic neurons in various disease states may contribute to the altered balance between excitation and inhibition that is often observed after injury. (C) 2008 Elsevier Inc. All rights reserved.	[Monnerie, Hubert; Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA		Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, 330 S 9th St,4th Floor, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu					Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Akashiba H, 2006, J NEUROCHEM, V99, P733, DOI 10.1111/j.1471-4159.2006.04100.x; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BAO J, 1995, J BIOL CHEM, V270, P6464, DOI 10.1074/jbc.270.12.6464; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; BRORSON JR, 1995, STROKE, V26, P1259, DOI 10.1161/01.STR.26.7.1259; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V62, P1989; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; Hajimohammadreza I, 1997, J NEUROCHEM, V69, P1006; HIWASA T, 1990, CARCINOGENESIS, V11, P75, DOI 10.1093/carcin/11.1.75; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI12978; Kohda Y, 1996, BIOCHEM BIOPH RES CO, V228, P616, DOI 10.1006/bbrc.1996.1706; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Manor D, 1996, NEUROCHEM RES, V21, P1031, DOI 10.1007/BF02532413; Monnerie H, 2007, EXP NEUROL, V205, P367, DOI 10.1016/j.expneurol.2007.02.007; NAJLERAHIM A, 1992, EXP NEUROL, V118, P352, DOI 10.1016/0014-4886(92)90193-T; NAJLERAHIM A, 1992, EXP BRAIN RES, V90, P332; NAKAMURA Y, 1991, NEUROSCI LETT, V130, P195, DOI 10.1016/0304-3940(91)90395-A; Namchuk M, 1997, J BIOL CHEM, V272, P1548, DOI 10.1074/jbc.272.3.1548; Neder L, 2002, CELL MOL NEUROBIOL, V22, P689, DOI 10.1023/A:1021852907068; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Olney J W, 1986, Adv Neurol, V44, P857; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; RIBAK CE, 1979, SCIENCE, V205, P211, DOI 10.1126/science.109922; Sheng M, 2000, NAT NEUROSCI, V3, P633, DOI 10.1038/76576; Shetty AK, 2000, J NEUROSCI, V20, P8788; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; TECOMA ES, 1989, NEUROLOGY, V39, P676, DOI 10.1212/WNL.39.5.676; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tsuchiya K, 1999, EXP NEUROL, V155, P187, DOI 10.1006/exnr.1998.6988; WANG KKW, 1990, TRENDS PHARMACOL SCI, V11, P139, DOI 10.1016/0165-6147(90)90060-L; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yoshida M, 2002, ACTA NEUROPATHOL, V104, P267, DOI 10.1007/s00401-002-0554-4; Yoshiyama Y, 2000, NEUROSCI LETT, V290, P125, DOI 10.1016/S0304-3940(00)01326-4; Zakharov VV, 2007, J NEUROCHEM, V101, P1539, DOI 10.1111/j.1471-4159.2007.04452.x; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078	56	21	25	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	SEP	2008	213	1					145	153		10.1016/j.expneurol.2008.05.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	344QX	WOS:000258943500018	18599042				2022-02-06	
J	Timaru-Kast, R; Meissner, A; Heimann, A; Hoelper, B; Kempski, O; Alessandri, B				Timaru-Kast, Ralph; Meissner, Anke; Heimann, Axel; Hoelper, Bernd; Kempski, Oliver; Alessandri, Beat			Acute Subdural Hematoma in Pigs: Role of Volume on Multiparametric Neuromonitoring and Histology	JOURNAL OF NEUROTRAUMA			English	Article						acute subdural hematoma; intracranial pressure (ICP); microdialysis; neuromonitoring; neurotransmitters; pig; ptiO2; SEP; somatosensory evoked potentials; tissue oxygen tension; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; MATURATION-DEPENDENT RESPONSE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; FELINE BRAIN; MICRODIALYSIS; MODEL	Traumatic brain injury (TBI) is often complicated by acute subdural hemorrhage (ASDH) with a high mortality rate. The pathophysiological mechanisms behind such an injury type and the contribution of blood to the extent of an injury remain poorly understood. Therefore, the goals of this study were to establish a porcine ASDH model in order to investigate pathomechanisms of ASDH and to compare effects induced by blood or sheer volume. Thus, we infused 2, 5, and 9 mL of blood (up to 15% of intracranial volume), and we compared a 5-mL blood and paraffin oil volume to separate out effects of extravasated blood on brain tissue. An extended neuromonitoring was applied that lasted up to 12 h after injury and included intracranial pressure (ICP), cerebral perfusion pressure (CPP), tissue oxygen concentration (ptiO(2)), biochemical markers (glutamate, lactate), somatosensory evoked potentials (SEP), brain water content, and histological assessment (Lesion Index [LI]). Volume-dependent changes were detected mainly during the first hours after injury. ICP increased to significant levels (p < 0.05) of 36.89 +/- 1.59, 15.52 +/- 0.48, and 11.25 +/- 0.35 mm Hg after 9, 5, and 2 mL of subdural blood, respectively (sham, 4.85 +/- 0.06 mm Hg). The ptiO(2) dropped drastically after 9 mL of subdural blood without recovery in both hemispheres to below 20% of baseline, but was affected little after 2 and 5 mL in the acute monitoring period (maximal drop to 71% of baseline). Later, 5 mL of blood led to a significant increase of ptiO2 compared to 2 mL ipsilaterally (p < 0.05). Glutamate and lactate showed a comparable pattern with a long-lasting increase after 9 mL of blood and short-lasting changes after 2 and 5 mL. The two smaller volumes caused an increased brain swelling (2 mL, 80.60 +/- 0.34%; 5 mL, 81.20 +/- 0.66%; p < 0.05 vs. sham), a significant LI (sham, 6.4 +/- 1.4; 2 mL, 30.0 +/- 0.95; 5 mL, 32.1 +/- 1.2; p < 0.05 vs. sham), and a reduced SEP amplitude (5 mL, p < 0.05 vs. baseline) at the end of the experiment. A 9-mL led to herniation during the experiment causing dramatical brain swelling and acute histological damage. Comparison of blood volume with paraffin oil showed no significance, indicating that volume alone determines the acute pathophysiological processes leading to a rapidly developing histological damage. Additional effects due to blood contact with brain tissue (e.g., inflammation) may be detected only at later time points (< 12 h).	[Timaru-Kast, Ralph; Meissner, Anke; Heimann, Axel; Hoelper, Bernd; Kempski, Oliver; Alessandri, Beat] Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Rheinland Pfalz, Germany		Alessandri, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Langenbeckstr 1, Mainz, Rheinland Pfalz, Germany.	alessandri@nc-patho.klinik.uni-mainz.de		Heimann, Axel/0000-0003-2510-3228	Schwerpunkt Neurowissenschaften Mainz; Deutsche Forschungsgemeinschaft, DFGGerman Research Foundation (DFG) [KE338/6-2]	We gratefully thank A. Ehlert, M. Malzahn, and L. Kopacz for their excellent technical assistance. The study was supported by Schwerpunkt Neurowissenschaften Mainz (to R.T.) and by a grant of Deutsche Forschungsgemeinschaft, DFG (KE338/6-2; to B. A. and O.K.). The data shown in the paper are part of the inaugural dissertations of Anke Meissner and Ralph Timaru-Kast.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Alessandri B, 1999, ACT NEUR S, V75, P25; ALESSANDRI B, 2006, J NEUROTRAUMA, V23; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BULLOCK R, 1990, ACT NEUR S, V51, P274; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bullock R, 1997, HEAD INJURY PATHOPHY, P121; Chiari P, 2000, J HEART LUNG TRANSPL, V19, P675, DOI 10.1016/S1053-2498(00)00127-3; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Kempski O, 1990, Adv Neurol, V52, P219; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kiening KL, 1998, ACT NEUR S, V71, P172; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marion DW, 2006, NEUROSURGERY, V58, P655; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; ORLIN JR, 1992, ACTA NEUROCHIR, V118, P146, DOI 10.1007/BF01401300; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Reilly P, 1997, HEAD INJURY PATHOPHY; SARRAFZADEH A, 2000, NEUROSURG FOCUS, V15, pE2; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; Server A, 2001, ACTA RADIOL, V42, P254; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhang H, 2001, CLIN CHEM, V47, P1458; ZWETNOW NN, 1993, ACTA NEUROCHIR, V121, P58, DOI 10.1007/BF01405184; [No title captured]	53	21	22	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2008	25	9					1107	1119		10.1089/neu.2008.0517			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	360JX	WOS:000260054900007	18771396				2022-02-06	
J	Klementiev, B; Novikova, T; Korshunova, I; Berezin, V; Bock, E				Klementiev, B.; Novikova, T.; Korshunova, I.; Berezin, V.; Bock, E.			The NCAM-derived P2 peptide facilitates recovery of cognitive and motor function and ameliorates neuropathology following traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adult rat; motor and cognitive deficit; NCAM; neuropathology; traumatic brain injury	CELL-ADHESION MOLECULE; CEREBRAL-ARTERY OCCLUSION; HOMOPHILIC BINDING-SITE; LONG-TERM-MEMORY; DENTATE GYRUS; SOCIAL RECOGNITION; BEHAVIORAL RECOVERY; NEURITE OUTGROWTH; MIMETIC PEPTIDES; NERVOUS-SYSTEM	The neural cell adhesion molecule (NCAM) plays a crucial role during development and regeneration of the nervous system, mediating neuronal differentiation, survival and plasticity. Moreover, NCAM regulates learning and memory. A peptide termed P2, corresponding to a 12-amino-acid sequence in the second immunoglobulin (Ig)-like module of NCAM, represents the natural cis-binding site for the first NCAM Ig module. The P2 peptide targets NCAM, thereby inducing a number of intracellular signaling events leading to the stimulation of neurite outgrowth and promotion of neuronal survival in vitro. The present study evaluated the effect of the P2 peptide on functional and histological outcomes following traumatic brain injury inflicted by a cortical cryogenic lesion. Lesioned rats were injected subcutaneously with P2 peptide, 5 mg/kg daily for 15 days beginning 2 h after injury. This treatment significantly improved postlesion recovery of motor and cognitive function, reduced neuronal degeneration, protected cells against oxidative stress, and increased reactive astrogliosis and neuronal plasticity in the sublesional area. P2 appeared rapidly in blood and cerebrospinal fluid after subcutaneous administration and remained detectable in blood for up to 5 h. The results suggest that P2 has therapeutic potential for the treatment of traumatic brain injury.	[Klementiev, B.; Novikova, T.; Korshunova, I.] ENKAM Pharmaceut AS, Copenhagen, Denmark; [Klementiev, B.] Univ Copenhagen, Panum Inst, Prot Lab, Dept Neurosci & Pharmacol,Sch Med, DK-2200 Copenhagen, Denmark		Klementiev, B (corresponding author), Univ Copenhagen, Panum Inst, Prot Lab, Dept Neurosci & Pharmacol,Sch Med, Blegdamsvej 3C,Bldg 6-2, DK-2200 Copenhagen, Denmark.	klement@plab.ku.dk		Korshunova, Irina/0000-0003-1921-6170			Andersen MB, 1997, PHARMACOL BIOCHEM BE, V56, P719, DOI 10.1016/S0091-3057(96)00414-5; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; BENOWITZ LI, 1990, MOL BRAIN RES, V8, P17, DOI 10.1016/0169-328X(90)90004-W; Berezin V, 2004, J MOL NEUROSCI, V22, P33, DOI 10.1385/JMN:22:1-2:33; Berezin V, 2000, Curr Opin Drug Discov Devel, V3, P605; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Burman OHP, 2000, APPL ANIM BEHAV SCI, V67, P241, DOI 10.1016/S0168-1591(99)00120-3; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; COTMAN CW, 1981, PHYSIOL REV, V61, P684, DOI 10.1152/physrev.1981.61.3.684; Covolan L, 2000, HIPPOCAMPUS, V10, P169, DOI 10.1002/(SICI)1098-1063(2000)10:2<169::AID-HIPO6>3.0.CO;2-W; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Ditlevsen DK, 2007, EUR J NEUROSCI, V25, P1678, DOI 10.1111/j.1460-9568.2007.05436.x; Emery DL, 2000, J COMP NEUROL, V424, P521; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HAKIM AM, 1987, CAN J NEUROL SCI, V14, P557; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hinsby AM, 2004, J NEUROCHEM, V91, P694, DOI 10.1111/j.1471-4159.2004.02772.x; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Hotta N, 2005, MOL BRAIN RES, V133, P71, DOI 10.1016/j.molbrainres.2004.09.027; Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Krushel LA, 1999, J BIOL CHEM, V274, P2432, DOI 10.1074/jbc.274.4.2432; Larsen E, 2006, ONCOGENE, V25, P2425, DOI 10.1038/sj.onc.1209284; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Li SZ, 2005, BIOCHEMISTRY-US, V44, P5034, DOI 10.1021/bi0480133; Liu JL, 1998, J NEUROSCI, V18, P7768; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MILLER PD, 1994, J NEUROSCI, V14, P4217; NG SC, 1988, NEURON, V1, P133, DOI 10.1016/0896-6273(88)90197-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedersen MV, 2004, J NEUROSCI RES, V75, P55, DOI 10.1002/jnr.10812; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Penkowa M, 2006, J NEUROSCI RES, V83, P974, DOI 10.1002/jnr.20790; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Popik P, 1998, PROG BRAIN RES, V119, P415; Povlsen GK, 2003, NEUROCHEM RES, V28, P127, DOI 10.1023/A:1021660531484; Prediger RDS, 2005, NEUROBIOL AGING, V26, P957, DOI 10.1016/j.neurobiolaging.2004.08.012; Reier P J, 1988, Adv Neurol, V47, P87; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; RUDGE JS, 1990, J NEUROSCI, V10, P3594; SAWYER TF, 1984, BEHAV NEUROSCI, V98, P908, DOI 10.1037/0735-7044.98.5.908; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.0.CO;2-1; SCHOEN SW, 1994, EXP NEUROL, V127, P106, DOI 10.1006/exnr.1994.1084; SEKIGUCHI R, 1991, PHYSIOL BEHAV, V50, P1253, DOI 10.1016/0031-9384(91)90591-B; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Soroka V, 2002, J BIOL CHEM, V277, P24676, DOI 10.1074/jbc.M109694200; Stepanichev MY, 2003, BRAIN RES BULL, V61, P197, DOI 10.1016/S0361-9230(03)00118-7; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	82	21	21	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUN	2008	27	11					2885	2896		10.1111/j.1460-9568.2008.06245.x			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	313BV	WOS:000256717000009	18540884				2022-02-06	
J	Mittrach, R; Grill, E; Walchner-Bonjean, M; Scheuringer, M; Boldt, C; Huber, EO; Stucki, G				Mittrach, Rene; Grill, Eva; Walchner-Bonjean, Monika; Scheuringer, Monika; Boldt, Christine; Huber, Erika Omega; Stucki, Gerold			Goals of physiotherapy interventions can be described using the International Classification of Functioning, Disability and Health	PHYSIOTHERAPY			English	Article						physical therapy (speciality); documentation; rehabilitation; treatment outcome; goals; lCF	ICF CORE SET; EARLY INPATIENT REHABILITATION; TRAUMATIC BRAIN-INJURY; PHYSICAL-THERAPY; MENTAL PRACTICE; STROKE; IDENTIFICATION; ARTHROPLASTY; FACILITIES; CATEGORIES	Objective To provide an example of how goals of physiotherapy interventions and their typical patterns can be described using the International Classification of Functioning, Disability and Health (ICF). Design Cross-sectional study. Setting Acute hospital. Participants One hundred patients with neurological, musculoskeletal or cardiopulmonary conditions requiring physiotherapy interventions in University Hospital Zurich between January 2003 and October 2003. Main outcome measures The case record form consisted of two parts: a standardised questionnaire for functioning and health of the patient; and a standardised record form for physiotherapy interventions. Both parts were based on the ICF Results The mean age of the subjects was 58.2 years (standard deviation 15.9), the median age was 60.5 years and 44% were female. The most frequent intervention goals in patients with neurological conditions were: muscle power functions; muscle tone functions; control of voluntary movement functions; changing basic body position; maintaining a body position; and transferring oneself. The most frequent intervention goals for cardiopulmonary patients were: functions of the cardiovascular system; and respiration functions. The most frequent intervention goals in patients with musculoskeletal conditions were: sensation of pain; stability of joint functions; muscle power functions; muscle tone functions; and muscle endurance functions. Conclusion By using the lCF as a framework and linguistic support, intervention goals can serve as standardised documentation for physiotherapy interventions, their evaluation and planning. (C) 2007 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.	[Stucki, Gerold] Univ Munich, Dept Phys Med & Rehabil, D-81377 Munich, Germany; [Mittrach, Rene; Grill, Eva; Walchner-Bonjean, Monika; Scheuringer, Monika; Boldt, Christine; Stucki, Gerold] Univ Munich, IHRS, WHO FIC Collaborating Ctr DIMDI, ICF Res Branch, Munich, Germany; [Huber, Erika Omega] Univ Zurich Hosp, Dept Rheumatol, Zurich, Switzerland; [Huber, Erika Omega] Univ Zurich Hosp, Inst Med Phys, Zurich, Switzerland; [Stucki, Gerold] Swiss Parapleg Res, Nottwil, Switzerland		Stucki, G (corresponding author), Univ Munich, Dept Phys Med & Rehabil, Marchioninistr 15, D-81377 Munich, Germany.	gerold.stucki@med.uni-muenchen.de	Grill, Eva/D-1875-2010; Grill, Eva/AAF-8104-2020; Scheuringer, Monika/C-2306-2013	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Scheuringer, Monika/0000-0001-7196-3419			Bitar AA, 2005, ARCH PHYS MED REHAB, V86, pS56, DOI 10.1016/j.apmr.2004.12.015; Boldt C, 2005, DISABIL REHABIL, V27, P375, DOI 10.1080/09638280400013982; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Edwards MJ, 2003, DISABIL REHABIL, V25, P405, DOI 10.1080/0963828031000062642; Ewert T, 2005, DISABIL REHABIL, V27, P367, DOI 10.1080/09638280400014014; Finger ME, 2006, PHYS THER, V86, P1203, DOI 10.2522/ptj.20050134; Grill E, 2005, DISABIL REHABIL, V27, P447, DOI 10.1080/09638280400014048; Grill E, 2005, DISABIL REHABIL, V27, P361, DOI 10.1080/09638280400013974; HAYES SH, 1986, ARCH PHYS MED REHAB, V67, P319; Higgs J, 2001, J Interprof Care, V15, P79; Jette DU, 2005, PHYS THER, V85, P238, DOI 10.1093/ptj/85.3.238; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, PHYS THER, V81, P1455, DOI 10.1093/ptj/81.8.1455; Pomeroy VM, 2001, CLIN REHABIL, V15, P67, DOI 10.1191/026921501675454995; Stoll T, 2005, DISABIL REHABIL, V27, P381, DOI 10.1080/09638280400013990; Stucki G, 2005, DISABIL REHABIL, V27, P353, DOI 10.1080/09638280400014105; STUCKI G, 1997, RHEUMATOLOGY; van der Peijl ID, 2004, ANN THORAC SURG, V77, P1535, DOI 10.1016/j.athoracsur.2003.10.091; Wade DT, 2003, CLIN REHABIL, V17, P1, DOI 10.1191/0269215503cr578ed; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; World Health Organization, 2007, INT STAT CLASS DIS H; World Health Organization, 2007, INT CLASS FUNCT DIS; ZIMMERMAN JR, 1998, REHABILITATION MED P, P1677	27	21	24	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0031-9406			PHYSIOTHERAPY	Physiotherapy	JUN	2008	94	2					150	157		10.1016/j.physio.2007.08.006			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	313MO	WOS:000256744900009					2022-02-06	
J	Alvarez, XA; Sampedro, C; Figueroa, J; Tellado, I; Gonzalez, A; Garcia-Fantini, M; Cacabelos, R; Muresanu, D; Moessler, H				Anton Alvarez, X.; Sampedro, Carolina; Figueroa, Jesus; Tellado, Ivan; Gonzalez, Andres; Garcia-Fantini, Manuel; Cacabelos, Ramon; Muresanu, Dafin; Moessler, Herbert			Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury	JOURNAL OF NEURAL TRANSMISSION			English	Article						Cerebrolysin; EEG power ratio; quantitative EEG; qEEG slowing; cognitive performance; traumatic brain injury	DOUBLE-BLIND; ALZHEIMERS-DISEASE; ALPHA; DEFICITS; SERUM; HEAD; ELECTROENCEPHALOGRAPHY; PERFORMANCE; COGNITION; CHILDREN	Changes in quantitative EEG (qEEG) recordings over a 1-year period and the effects of Cerebrolysin (Cere) on qEEG slowing and cognitive performance were investigated in postacute moderate-severe traumatic brain injury (TBI) patients. Time-related changes in qEEG activity frequency bands (increases of alpha and beta, and reductions of theta and delta relative power) and in qEEG slowing (reduction of EEG power ratio) were statistically significant in patients with a disease progress of less than 2 years at baseline, but not in those patients having a longer disease progress time. Slowing of qEEG activity was also found to be significantly reduced in TBI patients after 1 month of treatment with Cere and 3 months later. Therefore, Cere seems to accelerate the time-related reduction of qEEG slowing occurring in untreated patients. The decrease of qEEG slowing induced by Cere correlated with the improvement of attention and working memory. Results of this exploratory study suggest that Cere might improve the functional recovery after brain injury and encourage the conduction of further controlled clinical trials.	[Anton Alvarez, X.; Sampedro, Carolina; Figueroa, Jesus; Tellado, Ivan; Gonzalez, Andres; Cacabelos, Ramon] EuroEspes Biomed Res Ctr, Dept Neuropharmacol, Bergondo 15166, A Coruna, Spain; [Garcia-Fantini, Manuel] Hosp Juan Canalejo, La Coruna, Spain; [Muresanu, Dafin] Univ Cluj, Neurol Clin, Cluj Napoca, Romania; [Moessler, Herbert] EBEWE Pharma, Unterach, Austria		Alvarez, XA (corresponding author), EuroEspes Biomed Res Ctr, Dept Neuropharmacol, Bergondo 15166, A Coruna, Spain.	xantonal@yahoo.es	Muresanu, Fior-Dafin/AAI-8120-2021				AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213; ALBRECHT E, 1993, ADV BIOSCI, V87, P341; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P281; Alvarez XA, 2006, EUR J NEUROL, V13, P43, DOI 10.1111/j.1468-1331.2006.01222.x; Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; Alvarez XA, 1999, METHOD FIND EXP CLIN, V21, P633; Alvarez XA, 1999, 1ST INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA, P233; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P315; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Bae CY, 2000, J AM GERIATR SOC, V48, P1566, DOI 10.1111/j.1532-5415.2000.tb03865.x; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Boado RJ, 1999, NEUROSCI RES, V34, P217, DOI 10.1016/S0168-0102(99)00056-5; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Cacabelos R, 1996, ANN NY ACAD SCI, V777, P399, DOI 10.1111/j.1749-6632.1996.tb34452.x; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Funke M, 1998, J NEURAL TRANSM-SUPP, P385; Gschanes A, 1998, J NEURAL TRANSM-SUPP, P313; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P351; HutterPaier B, 1996, J NEURAL TRANSM-SUPP, P267; JENNETT B, 1975, LANCET, V1, P480; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lombardi VRM, 1999, METHOD FIND EXP CLIN, V21, P331, DOI 10.1358/mf.1999.21.5.541910; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Magnoni S, 2003, J NEUROTRAUM, V20, P251, DOI 10.1089/089771503321532833; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; NAGATA K, 1989, ELECTROEN CLIN NEURO, V72, P16, DOI 10.1016/0013-4694(89)90027-8; Overall J E, 1992, J Geriatr Psychiatry Neurol, V5, P220; Panisset M, 2002, J NEURAL TRANSM, V109, P1089, DOI 10.1007/s007020200092; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reinprecht I, 1999, HISTOCHEM J, V31, P394; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Ruether E, 2002, J NEURAL TRANSM-SUPP, P265; Ruether E, 2001, INT CLIN PSYCHOPHARM, V16, P253, DOI 10.1097/00004850-200109000-00002; SALETU B, 1995, INT J CLIN PHARM TH, V33, P249; Satou T., 1994, JPN PHARMACOL THER, V22, P205; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schwab M, 1998, J NEURAL TRANSM-SUPP, P299; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; TEASDALE G, 1974, LANCET, V2, P81; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039	56	21	21	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAY	2008	115	5					683	692		10.1007/s00702-008-0024-9			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	308ZY	WOS:000256430700004	18273537				2022-02-06	
J	Morgan, AT; Sell, D; Ryan, M; Raynsford, E; Hayward, R				Morgan, Angela Tamsin; Sell, Deborah; Ryan, Martina; Raynsford, Elizabeth; Hayward, Richard			Pre and post-surgical dysphagia outcome associated with posterior fossa tumour in children	JOURNAL OF NEURO-ONCOLOGY			English	Article						infratentorial neoplasm; posterior fossa tumour; brain tumour; cerebellum; child; dysphagia	TRAUMATIC BRAIN-INJURY; PEDIATRIC-PATIENTS; DYSARTHRIA; RESECTION; MUTISM	Background Swallowing impairment (dysphagia) has been reported as a possible sequela following surgical removal of posterior fossa tumours (PFT). Dysphagia may result in aspiration of food/fluid leading to respiratory tract infection, placing the patient at considerable health risk. No prospective studies have investigated dysphagia pre and post-surgical removal of PFT. The present study aimed to document the presence, severity and characteristics of dysphagia pre and post-surgical resection of PFT, and to determine whether children were managing a normal oral diet (i.e. a measure of functional swallowing ability) at two months post-surgery. Methods Dysphagia was assessed using a clinical bedside evaluation in 11 participants (8 M; aged 3 years 6 months to 13 years 5 months) pre (within 3-5 days) and post-surgery (within 1-2 weeks). Return to normal oral feeding was documented at two months post-surgery via a parent telephone interview. Results and conclusion No participant had dysphagia pre-surgically. Seventy three percent (8/11) had dysphagia at 1-2 weeks post-surgery, primarily characterized by impaired lip closure (8/8), poor mastication (8/8), and inefficient oral transit (8/8). Whilst dysphagia severity was largely mild (6/8) in presentation, data suggest that assessment and monitoring of this disorder may be required in the acute phase post-surgery. Overall however, prognosis appeared positive, with 75% (6/8) of participants managing a full oral diet at 2 months post-surgery.	[Morgan, Angela Tamsin] Murdoch Childrens Res Inst, Language & Literacy Grp, Parkville, Vic 3052, Australia; [Sell, Deborah; Ryan, Martina; Raynsford, Elizabeth] Great Ormond St Hosp Sick Children, Speech Pathol Dept, London WC1N 3JH, England		Morgan, AT (corresponding author), Murdoch Childrens Res Inst, Language & Literacy Grp, 50 Flemington Rd, Parkville, Vic 3052, Australia.	angela.morgan@mcri.edu.au	Morgan, Angela/J-5235-2017	Morgan, Angela/0000-0003-1147-7405; Sell, Debbie/0000-0002-2488-5881			Aarsen FK, 2004, NEUROLOGY, V62, P1311, DOI 10.1212/01.WNL.0000120549.77188.36; Catsman-Berrevoets CE, 1999, J NEUROL NEUROSUR PS, V67, P755, DOI 10.1136/jnnp.67.6.755; Cornwell Petrea L, 2003, Pediatr Rehabil, V6, P67; Cornwell PL, 2003, J CLIN NEUROSCI, V10, P506, DOI 10.1016/S0967-5868(03)00077-8; Hanif Ghazala, 2004, J Coll Physicians Surg Pak, V14, P150; Huber JF, 2007, J CHILD NEUROL, V22, P848, DOI 10.1177/0883073807303995; Ibrahim K, 2004, SEIZURE-EUR J EPILEP, V13, P108, DOI 10.1016/S1059-1311(03)00083-9; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; Morgan A, 2005, J MED SPEECH-LANG PA, V13, P109; Morgan A, 2004, J HEAD TRAUMA REHAB, V19, P226, DOI 10.1097/00001199-200405000-00004; Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; MORGAN AT, 2007, DEV NEUROREHABIL, V15, P1; Newman LA, 2006, CHILD NERV SYST, V22, P1296, DOI 10.1007/s00381-006-0065-z; POLLACK IF, 1995, NEUROSURGERY, V37, P885, DOI 10.1227/00006123-199511000-00006; Reilly S, 1996, J PEDIATR-US, V129, P877, DOI 10.1016/S0022-3476(96)70032-X	16	21	22	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	MAY	2008	87	3					347	354		10.1007/s11060-008-9524-6			8	Oncology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Neurosciences & Neurology	285VU	WOS:000254805100014	18209951				2022-02-06	
J	Coster, WJ; Haley, SM; Ni, P; Dumas, HM; Fragala-Pinkham, MA				Coster, Wendy J.; Haley, Stephen M.; Ni, Pengsheng; Dumas, Helene M.; Fragala-Pinkham, Maria A.			Assessing self-care and social function using a computer adaptive testing version of the pediatric evaluation of disability inventory	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						outcome assessment (health care); pediatrics; rehabilitation	ITEM RESPONSE THEORY; TRAUMATIC BRAIN INJURY; INPATIENT REHABILITATION; CHILDREN; MOBILITY; OUTCOMES; YOUTH; PEDI; LIKELIHOOD; SCALES	Objective: To examine score agreement, validity, precision, and response burden of a prototype computer adaptive testing (CAT) version of the self-care and social function scales of the Pediatric Evaluation of Disability Inventory compared with the full-length version of these scales. Design: Computer simulation analysis of cross-sectional and longitudinal retrospective data; cross-sectional prospective study. Setting: Pediatric rehabilitation hospital, including inpatient acute rehabilitation, day school program, outpatient clinics; community-based day care, preschool, and children's homes. Participants: Children with disabilities (n=469) and 412 children with no disabilities (analytic sample); 38 children with disabilities and 35 children without disabilities (cross-validation sample). Interventions: Not applicable. Main Outcome Measures: Summary scores from prototype CAT applications of each scale using 15-, 10-, and 5-item stopping rules; scores from the full-length self-care and social function scales; time (in seconds) to complete assessments an respondent ratings of burden. Results: Scores from both computer simulations and field administration of the prototype CATs were highly consistent with scores from full-length administration (r range, .94-99). Using computer simulation of retrospective data, discriminant validity, and sensitivity to change of the CATs closely approximated that of the full-length scales, especially when the 15- and 10-item stopping rules were applied. In the cross-validation study the time to administer both CATs was 4 minutes, compared with over 16 minutes to complete the full-length scales. Conclusions: Self-care and social function score estimates from CAT administration are highly comparable with those obtained from full-length scale administration, with small losses in validity and precision and substantial decreases in administration time.	[Coster, Wendy J.] Boston Univ, Sargent Coll, Dept Occupat Therapy & Rehabil Counseling, Boston, MA 02215 USA; [Haley, Stephen M.] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA USA; [Dumas, Helene M.; Fragala-Pinkham, Maria A.] Franciscan Hosp Children, Res Ctr Children Special Hlth Care Needs, Boston, MA USA		Coster, WJ (corresponding author), Boston Univ, Sargent Coll, Dept Occupat Therapy & Rehabil Counseling, 635 Commonwealth Ave, Boston, MA 02215 USA.	wjcoster@bu.edu	Fragala-Pinkham, Maria/AAY-4354-2020	Ni, Pengsheng/0000-0003-1774-2185	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD052318, R43HD042388, K02HD045354] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43 HD42388-01, R41 HD052318-01A1, K02 HD45354-01A1, R41 HD052318, R43 HD042388, K02 HD045354] Funding Source: Medline		ANDRICH D, 1998, RASCH MODELS MEASURE; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; BUTLER C, 1995, DEV MED CHILD NEUROL, V37, P753; Dijkers MP, 2003, ARCH PHYS MED REHAB, V84, P384, DOI 10.1053/apmr.2003.50006; Dumas H M, 2001, Pediatr Rehabil, V4, P177, DOI 10.1080/13638490210121720; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Dumas HM, 2001, BRAIN INJURY, V15, P891, DOI 10.1080/02699050110065691; DUMAS HM, 2001, PHYS OCCUP THER PEDI, V21, P17; Embretson S.E., 2013, ITEM RESPONSE THEORY; Engelbert RH, 1997, PEDIAT PHYS THER, V9, P18; FELDMAN AB, 1990, PHYS THER, V70, P602, DOI 10.1093/ptj/70.10.602; Fischer GH, 1995, RASCH MODELS FDN REC; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Haley SM, 2005, ARCH PHYS MED REHAB, V86, P932, DOI 10.1016/j.apmr.2004.10.032; Haley SM, 2001, PHYS THER, V81, P1425, DOI 10.1093/ptj/81.8.1425; HALEY SM, 1992, PEDIAT EVALUATION DI; Haley SM, 1993, PHYS MED REH CLIN N, V4, P529, DOI [10.1016/S1047-9651(18)30568-0, DOI 10.1016/S1047-9651(18)30568-0]; Hambleton RK., 1991, FUNDAMENTALS ITEM RE; HARIHARAN S, 1990, J EDUC MEAS, V27, P361; Hays RD, 2000, MED CARE, V38, P28; Iyer LV, 2003, PHYS THER, V83, P888, DOI 10.1093/ptj/83.10.888; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Ketelaar M, 2001, PHYS THER, V81, P1534, DOI 10.1093/ptj/81.9.1534; Kothari DH, 2003, PHYS THER, V83, P776, DOI 10.1093/ptj/83.9.776; Lollar DJ, 2000, ARCH PHYS MED REHAB, V81, pS46, DOI 10.1053/apmr.2000.20624; Ludlow L H, 2000, J Outcome Meas, V4, P482; Ludlow LH, 1996, EDUC PSYCHOL MEAS, V56, P122, DOI 10.1177/0013164496056001008; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MISLEVY RJ, 1986, J EDUC STAT, V11, P3, DOI 10.2307/1164846; Msall ME, 2002, PEDIATRICS, V109, P317, DOI 10.1542/peds.109.2.317; Muthen B. O., 1998, MPLUS USERS GUIDE, V7th; Nichols DS., 1996, PEDIATR PHYS THER, V8, P15, DOI DOI 10.1097/00001577-199600810-00004; Nordmark E, 2000, DEV MED CHILD NEUROL, V42, P245, DOI 10.1017/S0012162200000426; Norrlin S, 2003, ACTA PAEDIATR, V92, P204; Ostensjo S, 2003, DEV MED CHILD NEUROL, V45, P603, DOI 10.1017/S0012162203001105; Revicki DA, 1997, QUAL LIFE RES, V6, P595, DOI 10.1023/A:1018420418455; TJUR T, 1982, SCAND J STAT, V9, P23; Tsai PY, 2002, CHILD NERV SYST, V18, P48, DOI 10.1007/s00381-001-0531-6; van der Linden W.J., 1997, HDB MODERN ITEM RESP; Wainer H., 2000, COMPUTERIZED ADAPTIV; Ware JE, 2000, MED CARE, V38, P73; WARM TA, 1989, PSYCHOMETRIKA, V54, P427, DOI 10.1007/BF02294627; Wright FV, 1993, CAN J REHABIL, V7, P41; Wu M. L., 1998, CONQUEST COMPUTER SO	45	21	22	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2008	89	4					622	629		10.1016/j.apmr.2007.09.053			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	289IG	WOS:000255047600005	18373991	Green Accepted			2022-02-06	
J	Gong, SW; Lee, HP; Lu, C				Gong, S. W.; Lee, H. P.; Lu, C.			Computational simulation of the human head response to non-contact impact	COMPUTERS & STRUCTURES			English	Article						impact biomechanics; finite element model; multibody system; ATB model; human head; traumatic brain injury; head injury criterion (HIC)	FINITE-ELEMENT MODELS	This paper deals with the human head response to a sudden motion without direct contact with another solid object, i.e. to non-contact impact. A computational simulation approach is presented for this study, which is accomplished by the integration of a coated articulated total body (ATB) model with a finite element (FE) head model. The present approach includes two major aspects: one is to simulate the sudden motion of the human head with the whole body by means of the ATB model; and the other is to predict the head deformation and stress induced by the sudden motion through using the FE head model. The agreement between the simulation results and the published experimental data [Wismans J, Hermans J. MADYMO 3D simulations of hybrid III dummy sled tests. In: Backailis SH, Mertz HJ, editors. Hybrid III: the first human-like crash test dummy, SAE PT-44; 1994. p. 735-49; Nahum AM, Smith R, War CC. Intracranial pressure dynamic during head injury. In: 21st Stapp car crash conference proceedings, SAE 770922; 1977] is obtained. The intracranial pressure response and the head stress response are then predicted using the present approach. The correlation between the head motion and the brain stresses are also explored. In addition, the head injury induced by the non-contact impact is evaluated. (C) 2007 Elsevier Ltd. All rights reserved.	[Gong, S. W.; Lee, H. P.; Lu, C.] Inst High Performance Comp, Singapore 117528, Singapore; [Lee, H. P.] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore		Gong, SW (corresponding author), Inst High Performance Comp, 1 Sci Pk Rd,01-01 Capricorn,Singapore Sci Pk 2, Singapore 117528, Singapore.	gongsw@ihpc.a-star.edu.sg	LU, Chun/A-4653-2010; Lee, Heow Pueh/I-7834-2014	LU, Chun/0000-0001-7941-4879; Lee, Heow Pueh/0000-0002-4380-3888			Advani SH, 1982, HUMAN BODY DYNAMICS; Fox B, 1999, IEEE T BIO-MED ENG, V46, P1199, DOI 10.1109/10.790496; Gadd C, 1961, NATL RES COUNCIL PUB, P141; GOLDSMITH W, 1972, BIOMECHANICS ITS F O, P585; Gong SW, 2007, IEEE T BIO-MED ENG, V54, P956, DOI 10.1109/TBME.2006.889158; Gong SW, 1999, INT J IMPACT ENG, V22, P397, DOI 10.1016/S0734-743X(98)00058-X; Gong SW, 1996, AIAA J, V34, P1619, DOI 10.2514/3.13280; GONG SW, 2005, P 20 C INT SOC BIOM, P938; GONG SW, 2000, P 71 SHOCK VIBR S AR; HERMANN LR, 1968, CPIA PUBLICATION, V177; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; HUAINING C, 1998, ARTICULATED TOTAL BO; JOHN OH, 2006, LS DYNA THEORY MANUA; Johnson EAC, 2005, J BIOMECH, V38, P39, DOI 10.1016/j.jbiomech.2004.03.018; KENNER VH, 1973, J BIOMECH, V6, P1, DOI 10.1016/0021-9290(73)90032-8; Kleinberger M, 1998, DEV IMPROVED INJURY; Koenig H., 1998, MODERN COMPUTATIONAL; LAM KY, 1999, P NAV TECHN SEM PLAT, V5, P1; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Livermore Software Technology Corporation, 2003, LS DYNA KEYW US MAN; MCHENRY BG, 2004, 2004 ATB US C; *MSC SOFTW CORP, 2002, MSC DYTRAN US MAN; Nahum A, 1977, 21 STAPP CAR CRASH C; OGLESBY DB, 1998, P 69 SHOCK VIBR S ST; OMMAYA A, 1984, BIOMECHANICS TRAUMA; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1995, J NEUROTRAUM, V12, P247; Shabana A.A., 2001, COMPUTATIONAL DYNAMI; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; *TNO, 2001, MAD V6 0 TNO AUT; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Walz F., 2004, TRAUMA BIOMECHANICS; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; WISMANS J, 1994, HYBRID, V3, P735; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; ZHOU C, 1995, THESIS WAYNE STATE U; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	37	21	22	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-7949	1879-2243		COMPUT STRUCT	Comput. Struct.	APR	2008	86	7-8					758	770		10.1016/j.compstruc.2007.06.003			13	Computer Science, Interdisciplinary Applications; Engineering, Civil	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	297FO	WOS:000255602700014					2022-02-06	
J	Liu, WP; Jiang, XD; Fu, XF; Cui, SJ; Du, MX; Cai, YQ; Xu, RX				Liu, Wenpeng; Jiang, Xiaodan; Fu, Xiafei; Cui, Shaojie; Du, Mouxuan; Cai, Yingqian; Xu, Ruxiang			Bone marrow stromal cells can be delivered to the site of traumatic brain injury via intrathecal transplantation in rabbits	NEUROSCIENCE LETTERS			English	Article						bone marrow stromal cells; traumatic brain injury; transplantation; green fluorescent protein	NEURAL PRECURSOR CELLS; FUNCTIONAL RECOVERY; SPINAL-CORD; GENE-TRANSFER; STEM-CELLS; RAT-BRAIN; MIGRATION; THERAPY; REPAIR	Recent studies suggest that bone marrow stromal cells (BMSCs) are promising grafts for treatment of traumatic brain injury (TBI). Neural precursor cells (NPCs) have been detected in the site of cervical cord injury following intrathecal injection by lumbar puncture. So, this study is designed to determine whether BMSCs (after intrathecal administration by lumbar puncture) could also migrate to the TBI site. The cells were cultured in vitro and transfected with adenovirus green fluorescent protein (Ad-GFP), and then transplanted intrathecally or intravenously into an autologous rabbit model of TBI. The labeled, grafted cells were identified in the injured cerebral tissue using fluorescence microscopy. Results showed that the intrathecal protocol was more efficient than the intravenous one. And motor dysfunction was improved after autologous transplantation of BMSCs. This study suggests another attractive minimally invasive option for treating TBI. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Liu, Wenpeng; Jiang, Xiaodan; Du, Mouxuan; Cai, Yingqian; Xu, Ruxiang] So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Peoples R China; [Fu, Xiafei] So Med Univ, Zhujiang Hosp, Dept Obstet & Gynecol, Guangzhou, Peoples R China; [Cui, Shaojie] 306 Hosp Peoples Liberat Army, Dept Neurosurg, Beijing, Peoples R China		Xu, RX (corresponding author), So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Peoples R China.	zhanghuimeng1688@sina.com; 1wp88899@hotmail.com					Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Bakshi A, 2006, J NEUROTRAUM, V23, P55, DOI 10.1089/neu.2006.23.55; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fukunaga A, 2003, ACTA NEUROCHIR, V145, P473, DOI 10.1007/s00701-003-0038-x; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kretz A, 2003, MOL THER, V7, P659, DOI 10.1016/S1525-0016(03)00062-5; Kruger GM, 2002, CELL, V110, P399, DOI 10.1016/S0092-8674(02)00899-1; Lacza Z, 2003, BRAIN RES PROTOC, V11, P145, DOI 10.1016/S1385-299X(03)00039-4; Lepore AC, 2005, BRAIN RES, V1045, P206, DOI 10.1016/j.brainres.2005.03.050; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Miyaguchi K, 2000, BRAIN RES BULL, V51, P195, DOI 10.1016/S0361-9230(99)00217-8; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rao MS, 2000, PROG BRAIN RES, V128, P273; Seledtsov VI, 2005, BIOMED PHARMACOTHER, V59, P415, DOI 10.1016/j.biopha.2005.01.012; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; STEVE SWH, 2002, EXP NEUROL, V177, P360; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594	24	21	24	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 28	2008	434	2					160	164		10.1016/j.neulet.2007.12.067			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	288EC	WOS:000254968000002	18325665				2022-02-06	
J	Cornielje, H; Velema, JP; Finkenfluge, H				Cornielje, Huib; Velema, Johan P.; Finkenfluge, Harry			Community based rehabilitation programmes: monitoring and evaluation in order to measure results	LEPROSY REVIEW			English	Article							TRAUMATIC BRAIN-INJURY; CLASSIFICATION; PROJECTS	Although community Based Rehabilitation has now formally existed for almost 30 years, few papers have been written about the results of this approach. The authors hope to contribute With this paper towards methodologies that will help to Measure results of community Based Rehabilitation programmes. The importance of establishing - prior to the development of Community Based Rehabilitation - an extensive baseline has not been extensively covered as the importance of it is almost self-evident: vel the lack of baseline data often severely hampers the possibility of being able to measure the effects of Community Based Rehabilitation. The article places considerable importance on management information systems and monitoring, since it is believed that evaluation will greatly benefit from both the existence of baseline data as well as a well-developed and well-implemented information system. The present article emphasises the need for participatory processes in the development of baseline data and information systems. Four key areas for measuring CBR are highlighted: people, power, public society and partnerships. Finally, a tool is presented in order to evaluate (or monitoring and evaluation) systematically.	[Cornielje, Huib] Enablement, NL-2402 PX Alphen Aan Den Rijn, Netherlands; [Velema, Johan P.] Leprosy Mission Int, Evaluat & Monitoring Network, NL-7301 BD Apeldoorn, Netherlands; [Finkenfluge, Harry] Erasmus MC Univ Med Ctr Rotterdam, Inst Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands		Cornielje, H (corresponding author), Enablement, Langenhorst 36, NL-2402 PX Alphen Aan Den Rijn, Netherlands.	h.cornielje@enablement.nl	Cornielje, Huib/AAY-9441-2021				BOYCE W, 2000, ASIA PACIFIC DISABIL, V11, P69; BOYCE W, 2001, ASIA PACIFIC DISABIL, V12, P3; Cornielje H, 2002, LEPROSY REV, V73, P47; Cornielje H, 2000, LEPROSY REV, V71, P472; CORNIELJE H, 1999, RES INFORM REHABILIT; Evans PJ, 2001, SOC SCI MED, V53, P333, DOI 10.1016/S0277-9536(00)00321-X; Finkenflugel H, 2005, INT J REHABIL RES, V28, P187, DOI 10.1097/00004356-200509000-00001; Finkenflugel H, 2008, DISABIL REHABIL, V30, P348, DOI 10.1080/09638280701257288; Khasnabis C, 2008, LEPROSY REV, V79, P17; Kusek J.Z., 2004, 10 STEPS RESULTS BAS; MCLAREN P, 1998, INDICATORS DISABILIT; Powell BA, 2002, DISASTERS, V26, P175, DOI 10.1111/1467-7717.00199; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Thomas M, 2008, LEPROSY REV, V79, P10; Thomas MJ, 2003, LEPROSY REV, V74, P175; Velema JP, 2008, LEPROSY REV, V79, P65; Velema JP, 2008, DISABIL REHABIL, V30, P396, DOI 10.1080/09638280701256272; Velema JP, 2003, DISABIL REHABIL, V25, P1252, DOI 10.1080/09638280310001599970; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Wirz S, 2002, INT J REHABIL RES, V25, P163, DOI 10.1097/00004356-200209000-00001; World Health Organization, 1997, WHOQOL MEAS QUAL LIF	22	21	21	0	3	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518	2162-8807		LEPROSY REV	Lepr. Rev.	MAR	2008	79	1					36	49					14	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	341LD	WOS:000258715100006	18540236				2022-02-06	
J	Horner, MD; Selassie, AW; Lineberry, L; Ferguson, PL; Labbate, LA				Horner, Michael D.; Selassie, Anbesaw W.; Lineberry, Lee; Ferguson, Pamela L.; Labbate, Lawrence A.			Predictors of psychological symptoms 1 year after traumatic brain injury: A population-based, epidemiological study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; brain damage; chronic; depression; epidemiologic studies,follow-up studies; mood disorders	NATIONAL PROBABILITY SAMPLE; AMERICAN DRINKING PRACTICES; PSYCHIATRIC-DISORDERS; AXIS-I; DEPRESSION; REHABILITATION; QUESTIONNAIRE; INDIVIDUALS; OUTPATIENTS; CONCUSSION	Objective: To examine self-reported psychological symptoms 1 year after traumatic brain injury (TBI) in a populationbased sample. Participants: There were 1560 adults who had sustained TBI. Design: A telephone survey with questions about recent mood and anxiety symptoms, and diagnoses since TBI. Polychotomous logistic regression with 3 response levels (probable, possible, and no mood or anxiety symptoms) identified predictors of psychological symptoms. Results: Overall, 40% of participants had clinically significant mood or anxiety symptoms-12.6% with probable symptoms and 27.5% with possible symptoms. Main risk factors for probable symptoms included younger age, poor physical functioning, inadequate social support, and being a white woman. Other risk factors included being retired or unemployed, and pre-TBI psychiatric disorder or multiple concussions. Conclusions: These findings suggest the need for careful screening of persons with TBI who are at particular risk of developing psychological symptoms, and persons who have recently sustained TBI and their families to be educated about the possibility of developing such symptoms.	[Horner, Michael D.; Labbate, Lawrence A.] Ralph H Johnson Dept Vet Affairs Med Ctr, Mental Hlth Serv, Charleston, SC 29401 USA; [Horner, Michael D.; Labbate, Lawrence A.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Selassie, Anbesaw W.; Lineberry, Lee; Ferguson, Pamela L.] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA		Horner, MD (corresponding author), Ralph H Johnson Dept Vet Affairs Med Ctr, Mental Hlth Serv 116, 109 Bee St, Charleston, SC 29401 USA.	hornermd@musc.edu					ALLISON PD, 1991, LOGISTIC REGRESSION, P48; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BARRERA M, 1983, AM J COMMUN PSYCHOL, V11, P133; Beck A., 1996, BECK DEPRESSION INVE; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P642; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; *CDCP, 2003, BEH RISK FACT SURV S; Center for Injury Research and Policy of The Johns Hopkins University School of Public Health, 1997, ICDMAP 90 SOFTW; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; DARLINGTON GA, 1998, ENCY BIOSTATISTICS, P788; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jorge R, 2002, NEUROREHABILITATION, V17, P311; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LAWRENCE RH, 1995, J AGING HEALTH, V7, P74, DOI 10.1177/089826439500700104; LEAVY RL, 1983, J COMMUNITY PSYCHOL, V11, P3, DOI 10.1002/1520-6629(198301)11:1<3::AID-JCOP2290110102>3.0.CO;2-E; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MCCAFFREY RJ, 1987, INT J CLIN NEUROPSYC, V9, P174; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Moore J. C, 1988, J OFF STAT, V4, P155; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SAS Institute Inc, 2006, STAT AN SOFTW; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; STOKES ME, 1995, CATEGORICAL DATA ANA, P241; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; WARE JE, 1994, SF36 PHYS MENTAL HLT; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	49	21	22	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2008	23	2					74	83		10.1097/01.HTR.0000314526.01006.c8			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	280KW	WOS:000254426700002	18362761				2022-02-06	
J	Langley, J; Kypri, K; Cryer, C; Davie, G				Langley, John; Kypri, Kypros; Cryer, Colin; Davie, Gabrielle			Assessing the validity of potential alcohol-related non-fatal injury indicators	ADDICTION			English	Article						alcohol; bias; case ascertainment; face validity; indicators; injury	TRAUMATIC BRAIN-INJURY; NEW-ZEALAND; TRENDS; RATES	Aim To assess critically the face validity of the World Health Organization's (WHO's) International Guide for Monitoring Alcohol Consumption and Related Harm (MACRH) for deriving indicators, for the purposes of developing non-fatal alcohol-related injury indicators in New Zealand. Design MACRH's five solutions for deriving indicators are: (i) use only alcohol-specific cases; (ii) identify subsets of events known to be highly alcohol-related; (iii) utilize control indicators that are rarely alcohol-related; (iv) estimate alcohol attributable fractions (AAFs) and adjust indicators accordingly; and (v) develop composite indicators. These were assessed in terms of their face validity with particular reference to New Zealand. Findings There are significant face validity issues with each of the five options. Solution 4 offers the greatest promise, provided that: (i) valid AAFs can be derived and they are updated regularly; and (ii) appropriate adjustment is made for extraneous influences on the estimates of alcohol-related harm. To date, the latter has not been carried out. Conclusions Most potential sources of data on alcohol-related harm are subject to extraneous influences, which vary over time and space. While the attempt by WHO to offer solutions to this problem is laudable, the solutions do not address the problem adequately. MACRH guidelines need to be revised to include criteria for a valid outcome indicator.	[Langley, John; Kypri, Kypros; Cryer, Colin; Davie, Gabrielle] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand		Langley, J (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, POB 913, Dunedin, New Zealand.	john.langley@ipru.otago.ac.nz	Kypri, Kypros/D-2809-2009	Kypri, Kypros/0000-0002-9657-9904; Davie, Gabrielle/0000-0001-5466-5364			Alsop J, 2001, ACCIDENT ANAL PREV, V33, P353, DOI 10.1016/S0001-4575(00)00049-X; Boufous S, 2007, INJURY PREV, V13, P211, DOI 10.1136/ip.2006.014654; CHIKRITZHS T, 2003, AUSTR ALCOHOL INDICA; Connor J, 2004, EPIDEMIOLOGY, V15, P337, DOI 10.1097/01.ede.0000120045.58295.86; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; CONNOR J, 2005, ALAC OCCASIONAL PUBL, V32; Cryer C, 2006, INJURY PREV, V12, P202, DOI 10.1136/ip.2006.011635; Cryer C, 2002, PUBLIC HEALTH, V116, P257, DOI 10.1038/sj.ph.1900878; CRYER C, 2003, INT COLLABORATIVE EF; Cryer C, 2006, CHARTBOOK NZ INJURY; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Haworth N., 1997, 120 MON U ACC RES CT; *IRTAD, 2007, ORG EC COOP DEV; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Langley J, 2000, AUSTR EPIDEMIOLOGIST, V7, P5; Langley John, 2003, Traffic Inj Prev, V4, P291, DOI 10.1080/714040487; Lyons R A, 2006, Int J Inj Contr Saf Promot, V13, P63, DOI 10.1080/17457300500258682; Lyons Ronan A, 2005, Int J Inj Contr Saf Promot, V12, P207, DOI 10.1080/17457300500172776; Ridolfo B., 2001, QUANTIFICATION DRUG; Roberts I, 1996, BRIT MED J, V313, P1239, DOI 10.1136/bmj.313.7067.1239; Rosman DL, 2001, ACCIDENT ANAL PREV, V33, P81, DOI 10.1016/S0001-4575(00)00018-X; Shepherd J, 2005, INJURY PREV, V11, P324, DOI 10.1136/ip.2005.09761; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Stockwell T, 2000, J SUBST ABUSE, V12, P139, DOI 10.1016/S0899-3289(00)00046-8; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; WHO, 2000, INT GUID MON ALC CON; Winter, 1995, QUANTIFICATION DRUG	28	21	22	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0965-2140			ADDICTION	Addiction	MAR	2008	103	3					397	404		10.1111/j.1360-0443.2007.02089.x			8	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	259TU	WOS:000252964600009	18190665				2022-02-06	
J	Reid, WM; Hamm, RJ				Reid, Wendy M.; Hamm, Robert J.			Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						animal study; atomoxetine; dopamine; fluid-percussion injury; morris water maze; norepinephrine; traumatic brain injury	ATTENTION DEFICIT/HYPERACTIVITY DISORDER; WATER MAZE PERFORMANCE; FRONTAL-CORTEX DAMAGE; WORKING-MEMORY; PREFRONTAL CORTEX; RAT; NOREPINEPHRINE; DOPAMINE; RECOVERY; DEFICITS	Catecholaminergic neurotransmission is regionally altered following injury, and drugs aimed at these systems offer promising avenues for post - traumatic brain injury ( TBI) pharmacotherapies. Atomoxetine is a selective norepinephrine transporter ( NET) inhibitor currently indicated for treatment of attention-deficit hyperactivity disorder ( ADHD). The current study was designed to test the efficacy of atomoxetine in treating cognitive deficits following experimental TBI in animals and to determine an optimal dose and therapeutic window for drug treatment. Sprague-Dawley rats were subjected to lateral fluid-percussion injury ( L-FPI) of moderate severity ( 2.08 atm +/- 0.05). Two experiments were performed. In the first study, atomoxetine ( 0.3, 1, 3, or 9 mg/ kg) or vehicle was administered daily on post-injury days ( PID) 1 - 15. Cognitive assessment was performed using the Morris water maze on PID 11 - 15. L-FPI resulted in significant cognitive impairment when compared to Sham-Injury. Treatment with lower doses of atomoxetine ( 0.3, 1, and 3 mg/ kg) significantly attenuated the cognitive deficits in injured animals. Treatment with the higher dosage ( 9 mg/ kg) of atomoxetine resulted in animals that were not significantly different than injured-vehicle treated animals. The optimal response was achieved using 1 mg/ kg atomoxetine. In the second study, treatment with atomoxetine ( 1 mg/ kg) or vehicle was delayed for 11 days post-injury. Rats were administered atomoxetine daily for 15 days, and cognitive assessment was performed on PID 25 - 29. In this study, treatment with atomoxetine ( 1 mg/ kg) did not result in improved cognitive performance. In conclusion, this is the first study to show low-dose atomoxetine initiated early after experimental TBI results in improved cognition.	[Reid, Wendy M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA		Reid, WM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Box 980709,Med Coll Virginia Campus,1101 E Marsha, Richmond, VA 23284 USA.	murdockwm@vcu.edu					Baranova AI, 2006, J NEUROTRAUM, V23, P1233, DOI 10.1089/neu.2006.23.1233; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; D'Sa C, 2002, BIPOLAR DISORD, V4, P183, DOI 10.1034/j.1399-5618.2002.01203.x; DELLO RC, 2004, J NEUROINFLAMM, V1, P1; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; Emery DL, 2000, J COMP NEUROL, V424, P521; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1981, P W PHARMACOL SOC, V24, P15; Forsyth RJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003984.pub2; Foster DJ, 2006, ARCH PHYS MED REHAB, V87, P216, DOI 10.1016/j.apmr.2005.08.131; Fujinaka T, 2003, NEUROL RES, V25, P35, DOI 10.1179/016164103101201094; GEHLERT DR, 1993, NEUROSCI LETT, V157, P203, DOI 10.1016/0304-3940(93)90737-6; Gladstone DJ, 2000, CAN J NEUROL SCI, V27, P97; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; GOLDSTEIN LB, 1990, BRAIN RES, V508, P305, DOI 10.1016/0006-8993(90)90413-6; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; KOLB B, 1992, J NEUROSCI, V12, P2321; Laifenfeld D, 2002, J NEUROCHEM, V83, P1054, DOI 10.1046/j.1471-4159.2002.01215.x; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Madrigal JLM, 2005, J NEUROSCI RES, V81, P390, DOI 10.1002/jnr.20481; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Mattiuz EL, 2003, DRUG METAB DISPOS, V31, P88, DOI 10.1124/dmd.31.1.88; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PRASAD MR, 1995, RESTOR NEUROL NEUROS, V9, P65; Ripley DL, 2006, J HEAD TRAUMA REHAB, V21, P85, DOI 10.1097/00001199-200601000-00010; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; SUTHERLAND RJ, 1982, NEUROSCI LETT, V32, P125, DOI 10.1016/0304-3940(82)90261-0; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V9, P1; Swanson CJ, 2006, NEUROPHARMACOLOGY, V50, P755, DOI 10.1016/j.neuropharm.2005.11.022; Tzavara ET, 2006, MOL PSYCHIATR, V11, P187, DOI 10.1038/sj.mp.4001763; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WHITING MD, 2004, PHYS REHABIL MED, V16, P273; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	57	21	22	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2008	25	3					248	256		10.1089/neu.2007.0389			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	282PJ	WOS:000254579400008	18352838				2022-02-06	
J	Vickery, CD; Sepehri, A; Evans, CC				Vickery, Chad D.; Sepehri, Arash; Evans, Clea C.			Self-esteem in an acute stroke rehabilitation sample: a control group comparison	CLINICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; SOCIAL SUPPORT; VALIDATION; SCALE	Objective: To compare ratings of self-esteem and depressive mood in a sample of stroke survivors in an acute inpatient rehabilitation setting to those of a matched control group. Design: Stroke survivors (n=80) were matched on age and education to a group of neurologically intact community-dwelling control participants. Between-group analysis compared mean ratings of self-esteem and depressive measures. Within-group correlational analyses explored the relationship between self-esteem and mood. Between-group comparison of the correlations between self-esteem and mood explored differences in the strength of association between these constructs. Regression analyses explored the relationship of self-esteem measures after controlling for depressive mood. Main measures: Visual Analogue Self-Esteem Scale, Rosenberg Self-Esteem Scale, Geriatric Depression Scale. Results: Stroke survivors rated significantly lower mean levels of self-esteem- on the Visual Analogue Self-Esteem Scale (37 versus 41) and the Rosenberg Self-Esteem Scale (21 versus 24) than the control group. Stroke survivors also rated higher mean levels of depressive mood on the Geriatric Depression Scale (9 versus 6). Significantly higher correlations between self-esteem and mood ratings were noted in the stroke group than in the control group. Lower self-esteem ratings do not appear to be a byproduct of depressive mood. Conclusions: Self-esteem is negatively impacted by stroke and is strongly, but independently, associated with depressive mood. Clinicians may better facilitate the emotional adjustment of the survivor by considering this facet of psychological impact and intervening to address self-esteem.	[Vickery, Chad D.] Methodist Rehabil Ctr, Neuropsychol Dept, Jackson, MS 39216 USA		Vickery, CD (corresponding author), Methodist Rehabil Ctr, Neuropsychol Dept, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	chadvickery@hotmail.com					Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; BRINKMANN JR, 1979, PHYS THER, V59, P859, DOI 10.1093/ptj/59.7.859; Brown JD, 2001, COGNITION EMOTION, V15, P615; Brumfitt SM, 1999, BRIT J CLIN PSYCHOL, V38, P387, DOI 10.1348/014466599162980; Chang AM, 1999, J CLIN NURS, V8, P477, DOI 10.1046/j.1365-2702.1999.0196a.x; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Fung LCL, 2006, J CLIN NURS, V15, P505, DOI 10.1111/j.1365-2702.2006.01328.x; Heatherton TF, 2000, J PERS SOC PSYCHOL, V78, P725, DOI 10.1037/0022-3514.78.4.725; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; Koehler M L, 1989, Rehabil Nurs, V14, P9; KRAVETZ S, 1995, BRAIN INJURY, V9, P131, DOI 10.3109/02699059509008186; Li L, 1998, J SOC PSYCHOL, V138, P13, DOI 10.1080/00224549809600349; Lincoln NB, 1997, CLIN REHABIL, V11, P114, DOI 10.1177/026921559701100204; Ng JYY, 2000, PERCEPT MOTOR SKILL, V91, P107; OVERHOLSER JC, 1993, REHABIL PSYCHOL, V38, P187, DOI 10.1037/h0080296; Penninx BWJH, 1998, HEALTH PSYCHOL, V17, P551, DOI 10.1037/0278-6133.17.6.551; PYSZCZYNSKI T, 1985, PERS SOC PSYCHOL B, V11, P179, DOI 10.1177/0146167285112006; Rosenberg M., 1979, CONCEIVING SELF; RULE B G, 1989, Clinical Gerontologist, V9, P37; Schroevers MJ, 2003, SOC SCI MED, V57, P375, DOI 10.1016/S0277-9536(02)00366-0; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; VICKERY CD, UNPUB PSYCHOMETRIC C; VICKERY CD, IN PRESS REHABIL PSY; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Westin L, 1997, J INTERN MED, V242, P239, DOI 10.1046/j.1365-2796.1997.00203.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	28	21	23	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2008	22	2					179	187		10.1177/0269215507080142			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	276NV	WOS:000254150100008	18212038				2022-02-06	
J	Davis, LM; Rho, JM; Sullivan, PG				Davis, Laurie M.; Rho, Jong M.; Sullivan, Patrick G.			UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: Correlations to dietary modulations	EPILEPSIA			English	Article						Calorie reduction; Fasting; Free fatty acids; Mitochondria; Reactive oxygen species; Trauma; Ketogenic diet	OXIDATIVE STRESS; BRAIN	Uncoupling proteins (UCP) translocate protons from the mitochondrial intermembrane space to the matrix, thereby "uncoupling" electron transport from the production of ATP. It has been shown that these proteins are highly expressed in animals maintained on the ketogenic diet (KD). Although the exact mechanism remains unclear, it is known that these proteins are activated within a protective antireactive oxygen species (ROS) mechanism by free fatty acids (FFA). In our current studies, mitochondrial samples were probed for the presence of UCP2, which is the most ubiquitously expressed UCP isoform. We found that both traumatic brain injury and fasting upregulated the expression of UCP2, with a synergistic upregulation in fasted injured animals. We then used mitochondria from fasted naive animals to screen a number of FFA for their activation of uncoupling as well as their ability to reduce ROS. We found that arachidonic acid (AA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), palmitoleic acid, myristic acid, and butyric acid increased mitochondrial uncoupling when added after oligomycin. These FFA, along with oleic acid, also reduced ROS in mitochondria incubated with oligomycin. In order to correlate our data to KD and fasting, both of which have been shown to be neuroprotective after neurologic insult, we determined the serum levels of FFA in KD and fasted animals using gas chromatography/mass spectroscopy. We also determined brain and cerebrospinal fluid (CSF) FFA levels from fasted animals.	[Davis, Laurie M.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Davis, Laurie M.; Sullivan, Patrick G.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY USA; [Rho, Jong M.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Rho, Jong M.] St Josephs Hosp, Phoenix, AZ USA		Sullivan, PG (corresponding author), 741 S Limestone,375 BBSRB, Lexington, KY 40536 USA.	patsullivan@uky.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS48191]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048191] Funding Source: NIH RePORTER	This work has been supported by NIH grant NS48191 to P. G. Sullivan.	Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145; Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114; Kiec-Wilk B, 2005, J PHYSIOL PHARMACOL, V56, P149; LANE N, 2006, POWER SEX SUICIDE MI; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nicholls DG, 2002, BIOENERGETICS; Patel M, 2003, NEUROSCIENCE, V118, P431, DOI 10.1016/S0306-4522(02)00979-X; Sleven H, 2006, NEUROCHEM INT, V48, P75, DOI 10.1016/j.neuint.2005.10.002; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543	12	21	23	0	5	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0013-9580			EPILEPSIA	Epilepsia		2008	49			8			117	119		10.1111/j.1528-1167.2008.01854.x			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	374QW	WOS:000261059800035	19049607	Green Accepted, Bronze			2022-02-06	
J	Hessen, E; Anderson, V; Nestvold, K				Hessen, Erik; Anderson, Vicki; Nestvold, Knut			MMPI-2 profiles 23 years after paediatric mild traumatic brain injury	BRAIN INJURY			English	Article						long-term TBI outcome; mild paediatric head injury; mTBI; MMPI-2; post-concussive syndrome	MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; CHILDREN; ADOLESCENTS; CLASSIFICATION; SCALE	Primary objective: Research suggest that post-concussive syndrome after mild traumatic brain injury (mTBI) is more common than chronic cognitive impairment. The aim of this study was to investigate very long-term outcome of subjective complaints after paediatric mTBI. Research design: The study was a follow-up 23 years after a prospective head injury study at a general hospital in Norway. Methods and procedures: Forty-one patients were assessed with the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) 23 years after sustaining mTBI as children. Main outcomes and results: A good overall outcome was found with scores close to the normative mean, average length of education and normal employment rate. However, the children that sustained complicated mTBI showed slightly more pathological scores, typical for mild post-concussive syndrome. The most important predictors of poor outcome were skull fracture and a combination of post-traumatic amnesia 30 minutes and EEG pathology within 24 hours after TBI. No influence of pre- and post-injury risk factors on current MMPI-2 profiles was evident. Conclusions: The results give support for the notion of potentially differential impact of uncomplicated vs complicated mTBI. The findings suggest that children and adolescents sustaining complicated mTBI may be at risk of developing subtle chronic symptoms typical of post-concussive syndrome.	[Hessen, Erik; Nestvold, Knut] Akershus Univ Hosp, Dept Neurol, Oslo, Norway; [Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia; [Hessen, Erik] Univ Oslo, Dept Psychol, Cognit Dev Res Unit, N-0316 Oslo, Norway		Hessen, E (corresponding author), Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway.	erik.hessen@nevropsykologi.no					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; BUTCHER JN, 2004, MMPI 2; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; CROWE L, UNPUB PEDIATRICS; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DIKMEN SS, 1989, NEUROBEHAVIORAL RECO, P229; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; GEENE RL, 2000, MMPI 2 INTERPRETIVE; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; *HOU COMM SEL COMM, 2001, 3 REP HEAD INJ REH; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JENNETT B, 1975, LANCET, V1, P480; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1989, PSYCHIAT MED, V7, P11; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; *STAT SENTR, 2001, STAT NORW; Tellier A, 1999, BRAIN INJURY, V13, P463; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	51	21	21	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	1					39	50		10.1080/02699050701846179			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400006	18183508				2022-02-06	
J	Salim, A; Martin, M; Brown, C; Inaba, K; Browder, T; Rhee, P; Teixeira, PGR; Demetriades, D				Salim, Ali; Martin, Matthew; Brown, Carlos; Inaba, Kenji; Browder, Timothy; Rhee, Peter; Teixeira, Pedro G. R.; Demetriades, Demetrios			The presence of the adult respiratory distress syndrome does not worsen mortality or discharge disability in blunt trauma patients with severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						adult respiratory distress syndrome; traumatic brain injury; trauma; morbidity; mortality; disability	ACUTE LUNG INJURY; NEUROGENIC PULMONARY-EDEMA; SEVERE HEAD-INJURY; COMBAT CASUALTIES; RISK-FACTORS; INSUFFICIENCY; IDENTIFICATION; COMPLICATIONS; CARE	Purpose: To evaluate the prevalence of the acute respiratory distress syndrome (ARDS) among blunt trauma patients with severe traumatic brain injury (TBI) and to determine if ARDS is associated with higher mortality, morbidity and worse discharge outcome. Methods: Blunt trauma patients with TBI (head abbreviated injury score {AIS} >= 4) who developed predefined ARDS criteria between January 2000 and December 2004 were prospectively collected as part of an ongoing ARDS database. Each patient in the TBI + ARDS group was matched with two control TBI patients based on age, injury severity score (ISS) and head AIS. Outcomes including complications, mortality and discharge disability were compared between the two groups. Results: Among 362 TBI patients, 28 (7.7%) developed ARDS. There were no differences between the two groups with respect to age, sex, ISS, Glasgow coma score (GCS), head, abdomen and extremity AIS. The TBI + ARDS group had significantly more patients with chest AIS >= 3 (57.1% versus 32.1%, p = 0. 03). There was no difference with respect to overall mortality between the TBI + ARDS group (50.0%) and the TBI group (51.8%) (OR 0.79: 95% Cl 0.31-2.03, p=0.63). There was no significant difference with respect to discharge functional capacity between the two groups. There were significantly more overall complications in the TBI + ARDS group (42.9%) compared to the TBI group (16.1%) (OR 3.66: 95% CI 1.19-11.24, p=0.02). The TBI + ARDS group had an overall mean intensive care unit (ICU) length of stay of 15.6 days, versus 8.4 days in the TBI group (p < 0.01). The TBI + ARDS group had significantly higher hospital charges than the TBI group ($210,097 versus $115,342, P < 0.01). Conclusion: The presence of ARDS was not associated with higher mortality or worse discharge disability. It was, however, associated with higher hospital morbidity, longer ICU and hospital length of stay. (c) 2007 Elsevier Ltd. All rights reserved.	[Salim, Ali; Martin, Matthew; Brown, Carlos; Inaba, Kenji; Browder, Timothy; Rhee, Peter; Teixeira, Pedro G. R.; Demetriades, Demetrios] Univ So Calif, Los Angeles Cty Med Ctr, Univ So Calif Keck Sch Med, Div Trauma & Crit Ctr,Dept Surg, Los Angeles, CA 90033 USA		Salim, A (corresponding author), LAC USC, Med Ctr, 1200 N State St,Rm 9900, Los Angeles, CA 90033 USA.	asalim@surgery.usc.edu	Martin, Matthew/B-2676-2014; INABA, KENJI/AAC-8532-2020; Teixeira, Pedro/H-2239-2011	Martin, Matthew/0000-0002-9169-9069; Teixeira, Pedro/0000-0002-7258-7977			BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BRATTON SL, 1997, NEUROSURGERY, V41, P1214; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; DOYLE RL, 1995, AM J RESP CRIT CARE, V152, P1818, DOI 10.1164/ajrccm.152.6.8520742; Eberhard LW, 2000, CRIT CARE MED, V28, P125, DOI 10.1097/00003246-200001000-00021; FULTON RL, 1975, SURG GYNECOL OBSTET, V140, P179; GARCIAURIA J, 1981, J NEUROSURG, V54, P632, DOI 10.3171/jns.1981.54.5.0632; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; KATSURADA K, 1973, SURGERY, V73, P191; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; MARTIN AM, 1969, ANN SURG, V170, P30, DOI 10.1097/00000658-196907000-00004; Martin M, 2005, J TRAUMA, V59, P1107, DOI 10.1097/01.ta.0000188633.94766.d0; Mascia L, 1998, INTENS CARE MED, V24, P1115, DOI 10.1007/s001340050727; MCCLELLAN MD, 1989, J APPL PHYSIOL, V67, P1185, DOI 10.1152/jappl.1989.67.3.1185; Miller PR, 2002, AM SURGEON, V68, P845; Navarrete-Navarro P, 2001, INTENS CARE MED, V27, P1133, DOI 10.1007/s001340100955; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Salim A, 2006, ARCH SURG-CHICAGO, V141, P655, DOI 10.1001/archsurg.141.7.655; SIMMONS RL, 1969, ANN SURG, V170, P39, DOI 10.1097/00000658-196907000-00005; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Valta P, 1999, CRIT CARE MED, V27, P2367, DOI 10.1097/00003246-199911000-00008; Weisman SJ, 1939, SURGERY, V6, P722	26	21	24	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2008	39	1					30	35		10.1016/j.injury.2007.06.015			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	264GE	WOS:000253274700004	17920066				2022-02-06	
J	Sherman, TE; Rapport, LJ; Ryan, KA				Sherman, Tanya E.; Rapport, Lisa J.; Ryan, Kelly A.			Awareness of deficit in multiple sclerosis	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; IMPACT SCALE MSIS-29; SELF-REPORT; CONSEQUENCES; METAMEMORY; IMPAIRMENT; PREDICTORS; PROFILES; SYMPTOMS	The present study examined awareness of deficits among individuals with multiple sclerosis (MS). A total of 74 pairs of persons with MS and their significant others participated. Awareness of cognitive deficit was measured by discrepancy scores between patient reports of their cognitive abilities and objective test results. Awareness of functional deficit was measured by the discrepancy between the patient and significant other reports of the functional abilities of the patient. Results suggest that about one third of MS patients have diminished awareness of their cognitive and/or functional deficits. Unawareness of deficit was more common among patients with secondary-progressive MS than among those with relapse-remitting MS. Executive dysfunction was strongly associated with unawareness of cognitive deficits but not unawareness of functional deficits. Unawareness of cognitive deficits and unawareness of functional deficits appear to be tapping different aspects of unawareness of deficit.	[Sherman, Tanya E.] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA; [Sherman, Tanya E.; Rapport, Lisa J.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Rapport, Lisa J.; Ryan, Kelly A.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA		Sherman, TE (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Rm 555,261 Mack Blvd, Detroit, MI 48201 USA.	tsherman@dmc.org		Rapport, Lisa/0000-0001-8014-9523			Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Benedict RHB, 2004, J NEUROIMAGING, V14, p36S, DOI 10.1111/j.1552-6569.2004.tb00277.x; Benito-Leon J, 2002, EUR J NEUROL, V9, P497, DOI 10.1046/j.1468-1331.2002.00450.x; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; BOYLE EA, 1991, ARCH NEUROL-CHICAGO, V48, P1150, DOI 10.1001/archneur.1991.00530230058022; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Charcot JM, 1877, LECT DIS NERVOUS SYS, P157; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Cottrell SS, 1926, J NEUROL PSYCHOPATHO, V7, P1; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DELIS DC, 2000, CVLT2 CALIFORINA VER; Diaz-Olavarrieta C, 1999, J NEUROPSYCH CLIN N, V11, P51, DOI 10.1176/jnp.11.1.51; Duke LM, 2002, NEUROPSYCHOLOGY, V16, P359, DOI 10.1037//0894-4105.16.3.359; Fidell L.S., 2000, USING MULTIVARIATE S; Fishman I, 2004, J NEUROPSYCH CLIN N, V16, P350, DOI 10.1176/appi.neuropsych.16.3.350; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Heaton R.K., 1981, WISCONSIN CARD SORTI; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hoogervorst ELJ, 2001, NEUROLOGY, V56, P934, DOI 10.1212/WNL.56.7.934; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; KNIGHT RG, 1992, NEUROPSYCHOLOGY DEGE, P131; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McGuigan C, 2004, J NEUROL NEUROSUR PS, V75, P266; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; O'Brien R A, 1995, Sch Inq Nurs Pract, V9, P323; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Provinciali L, 1999, ACTA NEUROL SCAND, V100, P156; *PSYCH CORP, 1997, WAIS3 WMS3 TECHN MAN; RABINS PV, 1986, BRAIN, V109, P585, DOI 10.1093/brain/109.4.585; Rabins PV, 1990, NEUROBEHAVIORAL ASPE, P180; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; REGARD M, 1981, UNPUB COGNITIVE RIGI; RON MA, 1989, PSYCHOL MED, V19, P887, DOI 10.1017/S0033291700005602; Ryan KA, 2007, CLIN NEUROPSYCHOL, V21, P239, DOI 10.1080/13854040600582460; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherman TE, 2007, MULT SCLER, V13, P238, DOI 10.1177/1352458506070754; Smith, 1973, SYMBOL DIGIT MODALIT; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Spreen O, 1991, COMPENDIUM NEUROPSYC; SURRIDGE D, 1969, BRIT J PSYCHIAT, V115, P749, DOI 10.1192/bjp.115.524.749; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Zakzanis KK, 2000, ARCH CLIN NEUROPSYCH, V15, P115, DOI 10.1016/S0887-6177(98)00157-7	51	21	21	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	3					301	311		10.1080/13803390701380617			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	269NJ	WOS:000253655500004	17852617				2022-02-06	
J	Nicholson, KL; Mansbach, RS; Menniti, FS; Balster, RL				Nicholson, Katherine L.; Mansbach, Robert S.; Menniti, Frank S.; Balster, Robert L.			The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101 606 in rats and rhesus monkeys	BEHAVIOURAL PHARMACOLOGY			English	Article						CP-101 606; drug discrimination; monkey; N-methyl-D-aspartate; phencyclidine; rat self-ad ministration; traxprodil	RECEPTOR NR2B SUBUNIT; TRAUMATIC BRAIN-INJURY; NMDA RECEPTORS; IN-VITRO; CHANNEL; KETAMINE; DRUG; STEREOISOMERS; PHARMACOLOGY; BLOCKER	Development of N-methyl-D-aspartate (NMDA) antagonists for a variety of disorders has been hindered by their production of phencyclidine (PCP)-like psychological effects and abuse potential. There is, however, evidence to suggest that this problem might be mitigated by targeting NMDA receptors subtypes, in particular, those containing the NR2B subunit. To further test this hypothesis, the NR2B selective antagonist CP-101 606 (traxoprodil) was evaluated in two animal models: drug discrimination, a model of the subjective effects of drugs in humans, and self-administration, which evaluates the reinforcing properties of the drug. In the first study, CP-101 606 (3-300 mu g/kg/infusion) was tested for intravenous self-administration in rhesus monkeys experienced in PCP (5.6pg/kg/infusion, intravenously) self-administration. In the second study, CP-1 01 606 was tested for production of PCP-like discriminative stimulus effects in rats (3-56 mg/ kg, intraperitoneally) and rhesus monkeys (0.3-5.6 mg/kg intravenously). Evidence was obtained for reinforcing effects of at least one dose of CP-1 01 606 in all four monkeys. In rats, CP-101 606 produced more than 80% mean PCP-lever selection (2.0 mg/kg, intraperitoneally) but, unlike PCP itself, the dose producing the highest level of substitution was accompanied by more than 50% suppression of response rates. In monkeys, CP-101 606 produced more than 90% PCP-lever selection (0.1 mg/kg intramuscularly) in three of four animals at doses that did not significantly decrease rates of responding. The data show that CP-101606 has some PCP-like discriminative stimulus effects in rats and monkeys and functions as a positive reinforcer in monkeys. These results suggest that inhibition of NR2B subunit containing NMDA receptors plays a role in the production of the subjective effects and abuse potential associated with many subtype-nonselective NMDA receptor antagonists such as PCR.	Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Somaxon Pharmaceut, San Diego, CA USA; CNS Discovery, Pfizer Global Res & Dev, Groton, CT USA		Nicholson, KL (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, PO Box 980613, Richmond, VA 23298 USA.			Menniti, Frank/0000-0003-2612-9534	NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA-01442, R01 DA001442-30, R01 DA001442] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA001442] Funding Source: NIH RePORTER		ATOR NA, 1987, PHARMACOL BIOCHEM BE, V27, P391, DOI 10.1016/0091-3057(87)90588-0; BALSTER RL, 1995, BEHAV PHARMACOL, V6, P577; BALSTER RL, 1994, DRUG ALCOHOL DEPEN, V35, P211, DOI 10.1016/0376-8716(94)90076-0; BALSTER RL, 1991, BRIT J ADDICT, V86, P1549; BALSTER RL, 1990, COMP PERCEPTION, V1, P127; BALSTER RL, 1996, HANDB EXP PHARM, V118, P233; Bandyopadhyay S, 2006, EPILEPSY RES, V72, P127, DOI 10.1016/j.eplepsyres.2006.07.013; Bath CP, 1996, EUR J PHARMACOL, V299, P103, DOI 10.1016/0014-2999(95)00846-2; Beardsley PM, 2002, BEHAV PHARMACOL, V13, P583, DOI 10.1097/00008877-200211000-00007; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Brackett RL, 2000, NEUROPHARMACOLOGY, V39, P407, DOI 10.1016/S0028-3908(99)00151-3; BRADY KT, 1982, PHARMACOL BIOCHEM BE, V17, P291, DOI 10.1016/0091-3057(82)90083-1; BRADY KT, 1982, SCIENCE, V215, P178, DOI 10.1126/science.6274022; BRADY KT, 1982, J PHARMACOL EXP THER, V220, P56; Brimecombe JC, 1997, P NATL ACAD SCI USA, V94, P11019, DOI 10.1073/pnas.94.20.11019; BULLOCK R, 1999, ANN NY ACAD SCI, V890, P551; Chaperon F, 2003, BEHAV PHARMACOL, V14, P477, DOI 10.1097/01.fbp.0000091471.79060.ed; Chazot PL, 2004, CURR MED CHEM, V11, P389, DOI 10.2174/0929867043456061; Chazot PL, 2002, NEUROPHARMACOLOGY, V42, P319, DOI 10.1016/S0028-3908(01)00191-5; CHENARD BL, 1995, J MED CHEM, V38, P3138, DOI 10.1021/jm00016a017; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; De Vry J, 2003, BEHAV PHARMACOL, V14, P229, DOI 10.1097/00008877-200305000-00007; DERLET RW, 1990, PHARMACOL BIOCHEM BE, V36, P745, DOI 10.1016/0091-3057(90)90071-O; Di X, 1997, STROKE, V28, P2244, DOI 10.1161/01.STR.28.11.2244; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Dyker AG, 1999, STROKE, V30, P986, DOI 10.1161/01.STR.30.5.986; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; GRIFFITHS RR, 1979, CLIN PHARMACOL THER, V25, P611; Guscott MR, 2003, EUR J PHARMACOL, V476, P193, DOI 10.1016/S0014-2999(03)02182-4; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; HOLTZMAN SG, 1990, MODERN METHODS PHARM, V6, P193; JACKSON A, 1988, PSYCHOPHARMACOLOGY, V96, P87, DOI 10.1007/BF02431538; KEW JN, 1996, J PHYSL, V15, P761; Klein M, 1999, ANN NY ACAD SCI, V890, P515, DOI 10.1111/j.1749-6632.1999.tb08033.x; Koek W, 1999, PHARMACOL BIOCHEM BE, V64, P275, DOI 10.1016/S0091-3057(99)00055-6; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kundrotiene J, 2004, J NEUROTRAUM, V21, P83, DOI 10.1089/089771504772695977; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LANNES B, 1991, NEUROSCI LETT, V128, P177, DOI 10.1016/0304-3940(91)90255-R; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; McAllister KH, 1996, EUR J PHARMACOL, V314, P307, DOI 10.1016/S0014-2999(96)00576-6; Menniti F, 1997, EUR J PHARMACOL, V331, P117, DOI 10.1016/S0014-2999(97)10092-9; Merchant RE, 1999, ANN NY ACAD SCI, V890, P42, DOI 10.1111/j.1749-6632.1999.tb07979.x; Monaghan DT, 1997, J PHARMACOL EXP THER, V280, P614; MONYER H, 1992, NATURE, V256, P1217; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Nankai M, 1998, PROG NEURO-PSYCHOPH, V22, P35, DOI 10.1016/S0278-5846(97)00180-2; Nicholson KL, 1997, BEHAV PHARMACOL, V8, P396; Nicholson KL, 1999, PSYCHOPHARMACOLOGY, V146, P49, DOI 10.1007/s002130051087; Nicholson KL, 1998, BEHAV PHARMACOL, V9, P231; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PARSONS CG, 1995, NEUROPHARMACOLOGY, V34, P1239, DOI 10.1016/0028-3908(95)00092-K; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; ROGAWSKI MA, 1993, TRENDS PHARMACOL SCI, V14, P325, DOI 10.1016/0165-6147(93)90005-5; Sharma TA, 1999, J PHARMACOL EXP THER, V289, P1041; SLIFER BL, 1983, J PHARMACOL EXP THER, V225, P522; SLIFER BL, 1985, SUBST ALCOHOL ACTION, V5, P273; Smith Paul F, 2003, Curr Opin Investig Drugs, V4, P826; Steece-Collier K, 2000, EXP NEUROL, V163, P239, DOI 10.1006/exnr.2000.7374; Taniguchi K, 1997, BRIT J PHARMACOL, V122, P809, DOI 10.1038/sj.bjp.0701445; Tsuchida E, 1997, J NEUROTRAUM, V14, P409, DOI 10.1089/neu.1997.14.409; Wessell RH, 2004, NEUROPHARMACOLOGY, V47, P184, DOI 10.1016/j.neuropharm.2004.03.011; WILLETTS J, 1988, EUR J PHARMACOL, V146, P167, DOI 10.1016/0014-2999(88)90498-0; Witkin JM, 1997, J PHARMACOL EXP THER, V280, P46; YAMAKURA T, 1993, NEUROREPORT, V4, P687, DOI 10.1097/00001756-199306000-00021; Young A. M., 1986, BEHAV ANAL DRUG DEPE, P9; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428	70	21	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0955-8810			BEHAV PHARMACOL	Behav. Pharmacol.	DEC	2007	18	8					731	743		10.1097/FBP.0b013e3282f14ed6			13	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	236DM	WOS:000251283200004	17989511				2022-02-06	
J	Jacobsson, LJ; Westerberg, M; Lexell, J				Jacobsson, L. J.; Westerberg, M.; Lexell, J.			Demographics, injury characteristics and outcome of traumatic brain injuries in northern Sweden	ACTA NEUROLOGICA SCANDINAVICA			English	Article						accidental falls; accidents; traffic; brain; injuries; Glasgow Outcome Scale; rehabilitation	GLASGOW-COMA-SCALE; CHRONIC SUBDURAL-HEMATOMA; HEAD-INJURIES; FOLLOW-UP; EPIDEMIOLOGY; MORTALITY; WORSE	Objectives - To describe demographics, injury characteristics and outcome of traumatic brain injury (TBI) in northern Sweden over 10 years. Materials and methods - Data were retrospectively collected on those individuals (n = 332) in Norrbotten, northern Sweden, with a TBI who had been transferred for neurosurgical care from 1992 to 2001. Results - A majority were older men with a mild TBI and an acute or chronic subdural hematoma following a fall. Younger individuals were fewer but had more often a severe TBI from a traffic accident. Most individuals received post-acute care and brain injury rehabilitation. A majority had a moderate or severe disability, but many were discharged back home with no major changes in their physical or social environment. Conclusions - Our data confirm the relationship between age, cause of injury, injury severity and outcome in relation to TBI and underscore the need for prevention as well as the importance of TBI as a cause of long-term disability.	Univ Lund Hosp, Dept Rehabil, S-22185 Lund, Sweden; Kalix Hosp, Dept Gen Med, Med Rehabil Sect, Kalix, Sweden; Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden; Lulea Univ Technol, Dept Business Adm & Social Sci, S-95187 Lulea, Sweden		Lexell, J (corresponding author), Univ Lund Hosp, Dept Rehabil, Orupssjukhuset, S-22185 Lund, Sweden.	jan.lexell@skane.se	Westerberg, Mats/C-3300-2012	Westerberg, Mats/0000-0001-5464-9292; Lexell, Jan/0000-0001-5294-3332; Jacobsson, Lars/0000-0002-1127-1178			Alaranta H, 2000, Wien Med Wochenschr, V150, P444; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; Eker C, 2000, BRAIN INJURY, V14, P605; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Harmon RL, 1996, BRAIN INJURY, V10, P139, DOI 10.1080/026990596124638; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; JENNETT B, 1975, LANCET, V1, P480; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Kannus P, 2001, J CLIN EPIDEMIOL, V54, P597, DOI 10.1016/S0895-4356(00)00346-2; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sundbarg G, 1989, Brain Inj, V3, P283, DOI 10.3109/02699058909029641; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	33	21	21	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	NOV	2007	116	5					300	306		10.1111/j.1600-0404.2007.00896.x			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218BC	WOS:000249990000004	17922723				2022-02-06	
J	Mazzeo, AT; Bullock, R				Mazzeo, Anna Teresa; Bullock, Ross			Monitoring brain tissue oxymetry: Will it change management of critically ill neurologic patients?	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						brain oxygenation; tissue oxygen tension; cerebral ischemia; neuromonitoring; traumatic brain injury	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; OXYGEN-TENSION; CARBON-DIOXIDE; PARTIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; SUBSTRATE DELIVERY; ANEURYSM SURGERY; METABOLISM; PH	Based on the assumption that brain ischemia and hypoxia are central causes of brain damage, the maintenance of an adequate tissue oxygenation is a primary objective in the field of neurocritical care. Thus, monitoring brain tissue oxymetry, allowing the possibility to discriminate between normal and critically impaired tissue oxygenation, is recognized as an essential part of the management of the neurological critically ill patient. The clinical usefulness of this neuromonitoring tool in the area of neurosciences (traumatic brain injury, aneurysm surgery, arteriovenous malformation resection, brain tumors) is discussed. Monitoring brain tissue oxymetry not only allows the detection of impending cerebral ischemia, thus providing the clinician with essential information for the management and correction of harmful intracerebral events, but it also helps in understanding the pathophysiology of neuro-injury. It can also be used as a "surrogate end point" to evaluate putative therapies, targeting therapy towards improved cerebral oxygenation. As brain tissue oxygenation correlates closely with outcome, several outcome categories have been differentiated, aiding in predicting prognosis after injury. The rationale for monitoring brain tissue oxygenation is to provide essential information about oxygen supply and utilization in this specific tissue bed, thus reducing secondary brain damage and improving neurological outcome. (C) 2007 Elsevier B.V. All rights reserved.	Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Messina, Italy; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Neurosci Intens Care Unit, Richmond, VA 23298 USA		Mazzeo, AT (corresponding author), Viale Regina Margherita 59, I-98121 Messina, Italy.	annateresainazzeo@unime.it		Mazzeo, Anna Teresa/0000-0002-8454-7243			Baunach S, 1998, ACT NEUR S, V71, P241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Critchley GR, 1998, NEUROL RES, V20, pS44; CRUICKSHANK GS, 1994, ACT NEUR S, V60, P375; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fandino J, 1999, ACTA NEUROCHIR, V141, P825, DOI 10.1007/s007010050383; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gupta A K, 2002, J Postgrad Med, V48, P218; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Hoelper BM, 2003, NEUROSURGERY, V52, P970, DOI 10.1227/01.NEU.0000053033.98317.A3; Hoffman WE, 1997, NEUROSURGERY, V40, P294, DOI 10.1097/00006123-199702000-00012; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jodicke A, 2003, J NEUROSURG, V98, P515, DOI 10.3171/jns.2003.98.3.0515; JOHNSON BA, 1991, CRIT CARE MED, V19, P1432, DOI 10.1097/00003246-199111000-00021; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KAYAMA T, 1991, J NEUROSURG, V74, P55, DOI 10.3171/jns.1991.74.1.0055; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Menzel M, 2003, J NEUROSURG ANESTH, V15, P33, DOI 10.1097/00008506-200301000-00006; Pennings FA, 2003, J NEUROSURG ANESTH, V15, P1, DOI 10.1097/00008506-200301000-00001; Scheufler KM, 2004, TRANSFUS APHER SCI, V31, P45, DOI 10.1016/j.transci.2004.06.001; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Siegemund M, 1999, INTENS CARE MED, V25, P1044, DOI 10.1007/s001340051011; Stiefel MF, 2004, J NEUROSURG, V101, P594, DOI 10.3171/jns.2004.101.4.0594; Stocchetti N, 1998, ACT NEUR S, V71, P162; Szelenyi A, 2002, NEUROL RES, V24, P555, DOI 10.1179/016164102101200528; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 1998, J NEUROTRAUM, V15, P813, DOI 10.1089/neu.1998.15.813; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825; Zauner A, 1998, NEUROL RES, V20, pS85; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	54	21	21	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2007	261	1-2					1	9		10.1016/j.jns.2007.04.026			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216JO	WOS:000249874500001	17537460				2022-02-06	
J	Dirette, DK; Plaisier, BR				Dirette, Diane K.; Plaisier, Brian R.			The development of self-awareness of deficits from 1 week to 1 year after traumatic brain injury: Preliminary findings	BRAIN INJURY			English	Article						self-awareness; time post-injury; severity of injury; deficit factors	IMPAIRED AWARENESS; REHABILITATION; SEVERITY	Primary objective: To examine the process of recovery of self- awareness with consideration for the variables of severity of injury and deficit factors. Research design: A longitudinal, descriptive design was used. Methods and procedures: Eighteen participants and their significant others were interviewed using the Awareness Questionnaire at 1 week, 1 month, 4 months and 1 year post- injury. Main outcomes and results: Participants differed in self- awareness according to severity of injury, deficit factors and time post- injury. Overall, participants with mild TBI demonstrated better self- awareness. There was a significant interaction effect between severity of injury and time post- injury. Reduced self- awareness of cognitive deficits was noted for the participants with moderate and severe TBI. Conclusions: Time post- injury, severity of injury and deficit factors are confounding variables in the study of self- awareness.	Western Michigan Univ, Dept Occupat Therapy, Kalamazoo, MI 49008 USA; Bronson Methodist Hosp, Kalamazoo, MI USA		Dirette, DK (corresponding author), Western Michigan Univ, Dept Occupat Therapy, 1903 W Michigan Ave, Kalamazoo, MI 49008 USA.	diane.dirette@wmich.edu					BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; COETZER BR, 2002, J COGNITIVE REHABILI, V4, P46; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Garmoe W, 2005, J HEAD TRAUMA REHAB, V20, P348, DOI 10.1097/00001199-200507000-00006; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; LAATSCH L, 2001, J COGNITIVE REHA SPR, P10; McWilliams S, 1991, BRIT J OCCUPATIONAL, V54, P246; Munro B., 2005, STAT METHODS HLTH RE; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rimel RW, 1990, REHABILITATION ADULT, P8; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M., 1995, J INT NEUROPSYCH SOC, V1, P163; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505	25	21	22	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1131	1136		10.1080/02699050701687326			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900004	17952713				2022-02-06	
J	Hoffmann, O; Mahrhofer, C; Rueter, N; Freyer, D; Bert, B; Fink, H; Weber, JR				Hoffmann, Olaf; Mahrhofer, Cordula; Rueter, Nina; Freyer, Dorette; Bert, Bettina; Fink, Heldrun; Weber, Joerg R.			Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis	INFECTION AND IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; NEGATIVE REGULATOR; BINDING-PROTEIN; MESSENGER-RNA; PROLIFERATION; EXPRESSION	Bacterial meningitis is a major infectious cause of neuronal degeneration in the hippocampus. Neurogenesis, a continuous process in the adult hippocampus, could ameliorate such loss. Yet the high rate of sequelae from meningitis suggests that this repair mechanism is inefficient. Here we used a mouse model of nonreplicative bacterial meningitis to determine the impact of transient intracranial inflammation on adult neurogenesis. Experimental meningitis resulted in a net loss of neurons, diminished volume, and impaired neurogenesis in the dentate gyrus for weeks following recovery from the insult. Inducible nitric oxide synthase (NOS) immunoreactivity was prominent in microglia in nonproliferating areas of the dentate gyrus and hilus region after meningitis induction. Treatment with the specific NOS inhibitor N6-(1-iminoethyl)-L-lysine restored neurogenesis in experimental meningitis. These data suggest that local central nervous system inflammation in and of itself suppresses adult neurogenesis by affecting both proliferation and neuronal differentiation. Repair of cognitive dysfunction following meningitis could be improved by intervention to interrupt these actively suppressive effects.	Charite Univmed Berlin, Dept Cell Biol, Ctr Anat, D-10117 Berlin, Germany; Charite Univmed Berlin, Dept Neurol, Ctr Anat, D-10117 Berlin, Germany; Free Univ Berlin, Inst Pharmacol & Toxicol Vet Med, Berlin, Germany		Weber, JR (corresponding author), Charite Univmed Berlin, Dept Cell Biol, Ctr Anat, Schumannstr 20-21, D-10117 Berlin, Germany.	joerg.weber@charite.de		Bert, Bettina/0000-0002-8202-9290			Bert B, 2005, NEUROBIOL LEARN MEM, V84, P57, DOI 10.1016/j.nlm.2005.03.005; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BOHR V, 1984, ARCH NEUROL-CHICAGO, V41, P1045, DOI 10.1001/archneur.1984.04050210043012; Boje KMK, 1996, BRAIN RES, V720, P75, DOI 10.1016/0006-8993(96)00142-4; BOJE KMK, 1995, EUR J PHARMACOL, V272, P297, DOI 10.1016/0014-2999(94)00715-J; Braun JS, 2002, J CLIN INVEST, V109, P19; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Champlin DT, 2000, DEVELOPMENT, V127, P3543; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DiGirolamo G, 2003, BRIT J PHARMACOL, V139, P1164, DOI 10.1038/sj.bjp.0705315; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Enikolopov G, 1999, CELL DEATH DIFFER, V6, P956, DOI 10.1038/sj.cdd.4400577; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; FISCHER H, 1984, J BACTERIOL, V157, P507, DOI 10.1128/JB.157.2.507-513.1984; GARCIABUSTOS JF, 1987, J BIOL CHEM, V262, P15400; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; Gibbs SM, 2003, MOL NEUROBIOL, V27, P107, DOI 10.1385/MN:27:2:107; Grandgirard D, 2007, DEV NEUROSCI-BASEL, V29, P134, DOI 10.1159/000096218; Hoffmann O, 2002, J CEREBR BLOOD F MET, V22, P988, DOI 10.1097/00004647-200208000-00010; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leib SL, 1998, J INFECT DIS, V177, P692, DOI 10.1086/514226; Li N, 2004, DRUG METAB DISPOS, V32, P1265, DOI 10.1124/dmd.32.11.1265; Liu JL, 1998, J NEUROSCI, V18, P7768; Mitchell L, 2004, J INFECT DIS, V190, P2039, DOI 10.1086/425520; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Parent JM, 1997, J NEUROSCI, V17, P3727; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Reilly CM, 2002, KIDNEY INT, V61, P839, DOI 10.1046/j.1523-1755.2002.00230.x; SCHELD WM, 1980, J CLIN INVEST, V66, P243, DOI 10.1172/JCI109850; Schneider O, 1999, NEUROLOGY, V53, P1584, DOI 10.1212/WNL.53.7.1584; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Suzuki Y, 1999, J CEREBR BLOOD F MET, V19, P1175, DOI 10.1097/00004647-199911000-00001; TAUBER MG, 1985, J INFECT DIS, V151, P528, DOI 10.1093/infdis/151.3.528; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; TOMASZ A, 1981, REV INFECT DIS, V3, P190; TOUMANEN E, 1985, J INFECT DIS, V151, P859; TUOMANEN E, 1985, J INFECT DIS, V151, P535, DOI 10.1093/infdis/151.3.535; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vermeire K, 2000, J LEUKOCYTE BIOL, V68, P119; VOITS M, 1995, J NEUROSCI METH, V57, P101, DOI 10.1016/0165-0270(94)00143-5; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; Winkler F, 2001, J INFECT DIS, V183, P1749, DOI 10.1086/320730; Yoshimura A, 1999, J IMMUNOL, V163, P1; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	57	21	22	0	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567			INFECT IMMUN	Infect. Immun.	SEP	2007	75	9					4289	4297		10.1128/IAI.01679-06			9	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	205RG	WOS:000249131700012	17591796	Green Published, Bronze			2022-02-06	
J	Mungan, NK				Mungan, Nils K.			Update on shaken baby syndrome: ophthalmology	CURRENT OPINION IN OPHTHALMOLOGY			English	Article						child abuse; inflicted traumatic brain injury; nonaccidental head injury; retinal hemorrhage; shaken baby syndrome	TRAUMATIC BRAIN-INJURY; INFLICTED CHILDHOOD NEUROTRAUMA; PERIMACULAR RETINAL FOLDS; HEAD-INJURY; SERUM BIOMARKERS; YOUNG-CHILDREN; AXONAL INJURY; HEMORRHAGES; INFANTS; NEUROPATHOLOGY	Purpose of review Shaken baby syndrome is a common problem with a high morbidity and mortality. Ophthalmologists help manage this condition and therefore must keep abreast of current advances. Recent findings Clinical updates include the discovery that retinal folds and traumatic retinoschisis can very rarely occur after crush head injury, but remain specific for shaken baby syndrome in other scenarios. Pathology updates include new studies on orbital histology and woodpecker anatomy that suggest the retinal and optic nerve hemorrhages in shaken baby syndrome are caused by shaking itself rather than secondary to intracranial pathology. Regarding this shaking injury, some primary prevention strategies have proven surprisingly effective. In the near future, serum biomarkers may be used as a screening tool for inflicted neurotrauma. Animal models such as the neonatal pig and computer models using finite element analysis are promising experimental techniques for studying shaken baby syndrome. Finally, child abuse recently became an accredited subspecialty of pediatrics, which will lead to further advances in patient care, education, research and prevention. Summary Ophthalmologists play a key role in the diagnosis of shaken baby syndrome. In addition, they are in a unique position to study ophthalmic aspects of the syndrome, which in turn furthers the overall understanding of this devastating condition.	Univ Mississippi, Med Ctr, Dept Ophthalmol, Jackson, MS 39216 USA		Mungan, NK (corresponding author), Univ Mississippi, Med Ctr, Dept Ophthalmol, 2500 N State St, Jackson, MS 39216 USA.	nmungan@ophth.umsmed.edu					Arlotti SA, 2007, J AAPOS, V11, P175, DOI 10.1016/j.jaapos.2006.09.023; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Betz P, 1996, FORENSIC SCI INT, V78, P71, DOI 10.1016/0379-0738(95)01866-2; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Biron DL, 2007, J PAEDIATR CHILD H, V43, P60, DOI 10.1111/j.1440-1754.2007.01004.x; Block RW, 2006, J PEDIATR-US, V148, P711, DOI 10.1016/j.jpeds.2006.01.033; Bonnier Christine, 2004, Pediatr Rehabil, V7, P165, DOI 10.1080/13638490410001703325; BUYS YM, 1992, OPHTHALMOLOGY, V99, P1718; COUPER Z, 2007, BIOMECH MODEL M 0302; Curtis TH, 2007, J AAPOS, V11, P509, DOI 10.1016/j.jaapos.2007.02.010; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Feldman KW, 1997, CHILD ABUSE NEGLECT, V21, P199, DOI 10.1016/S0145-2134(96)00145-7; Forbes BJ, 2004, J PEDIAT OPHTH STRAB, V41, P80, DOI 10.3928/0191-3913-20040301-07; Ganesh A, 2004, OPHTHALMOLOGY, V111, P1428, DOI 10.1016/j.ophtha.2003.10.028; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Ghatan S, 2002, NEUROSURG CLIN N AM, V13, P227, DOI 10.1016/S1042-3680(01)00002-X; GILLILAND MGF, 1993, AM J FOREN MED PATH, V14, P187, DOI 10.1097/00000433-199309000-00003; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; Goldman M, 2006, J PEDIATR-US, V148, P835, DOI 10.1016/j.jpeds.2005.12.052; GREENWALD MJ, 1986, OPHTHALMOLOGY, V93, P618; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Herr S, 2004, PEDIATRICS, V113, P1658, DOI 10.1542/peds.113.6.1658; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Levin AV, 2006, ARCH OPHTHALMOL-CHIC, V124, P1773, DOI 10.1001/archopht.124.12.1773; Levin AV, 2002, NEUROSURG CLIN N AM, V13, P201, DOI 10.1016/S1042-3680(02)00004-9; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; MINNS RA, 2005, EDINB, V35, P5; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Newton AW, 2005, CURR OPIN PEDIATR, V17, P246, DOI 10.1097/01.mop.0000158730.56669.b1; OBI E, 2007, J AAPOS, V11, P99, DOI DOI 10.1016/J.JAAPOS.2007.01.031; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; Ou JI, 2006, ARCH OPHTHALMOL-CHIC, V124, P913, DOI 10.1001/archopht.124.6.913; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; ROTH S, 2006, INT J LEGAL MED 0908; Schloff S, 2002, OPHTHALMOLOGY, V109, P1472, DOI 10.1016/S0161-6420(02)01086-2; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Simon J, 2005, J PEDIAT OPHTH STRAB, V42, P18; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Stoodley N, 2006, BRIT J RADIOL, V79, P550, DOI 10.1259/bjr/23921951; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Vinger PF, 2005, ARCH OPHTHALMOL-CHIC, V123, P833, DOI 10.1001/archopht.123.6.833; Wygnanski-Jaffe T, 2007, EYE, V21, P83, DOI 10.1038/sj.eye.6702163; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038	65	21	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-8738	1531-7021		CURR OPIN OPHTHALMOL	Curr. Opin. Ophthalmol.	SEP	2007	18	5					392	397		10.1097/ICU.0b013e3282a167f0			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	208EE	WOS:000249301800007	17700232				2022-02-06	
J	Chin, KR; Ahn, J				Chin, Kingsley R.; Ahn, Jaimo			Controlled cervical extension osteotomy for Ankylosing spondylitis utilizing the Jackson operating table - Technical note	SPINE			English	Article						pedicle subtraction; osteotomy; osteoclasis; ankylosing spondylitis; cervicothoracic kyphosis	SPINAL OSTEOTOMY; DEFORMITY	Study Design. Technical note. Objective. To demonstrate a controlled extension osteotomy technique of the cervical spine in a prone position and using the head elevator mechanism on the Jackson operating table to correct a chin-on-chest deformity in a patient with ankylosing spondylitis. Summary of Background Data. Catastrophic cord injury causing quadriplegia and death has been associated with correction of chin-on-chest deformity in patients with ankylosing spondylitis. Manual control of spinal column motion during and after osteoclasis or osteotomy can be difficult, inexact, and anxiety inducing. Methods. A 45-year-old woman with ankylosing spondylitis and severe chin-on-chest deformity underwent a posterior C7 pedicle subtraction osteotomy, deformity correction, and instrumented fusion in a prone position on the Jackson operating table. Results. By using the elevator mechanism attached to the head of the operating table and Mayfield tongs, the patient's cervicothoracic junction was placed into extension by over 30 in controlled increments. Conclusion. We present a technique for controlled extension osteotomy correction of chin-on-chest deformity in a prone position. Use of the operating table mechanism in conjunction with a closing-wedge osteotomy diminishes the risk of translation, decreases risk of air embolus associated with a sitting position, and promotes greater opportunity for fusion through the osteotomy, and the stability allows for placement of modern instrumentation.	Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Chin, KR (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 2 Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA.	kingsleychin@hotmail.com					Belanger TA, 2005, J BONE JOINT SURG AM, V87A, P1732, DOI 10.2106/JBJS.C.01472; Kubiak EN, 2005, J AM ACAD ORTHOP SUR, V13, P267, DOI 10.5435/00124635-200507000-00006; LAW WA, 1962, J BONE JOINT SURG AM, V41, P1119; Liew SM, 1998, ORTHOP CLIN N AM, V29, P779, DOI 10.1016/S0030-5898(05)70047-X; MASON C, 1953, Calif Med, V79, P244; MCMASTER MJ, 1985, J BONE JOINT SURG BR, V67, P204, DOI 10.1302/0301-620X.67B2.3980526; McMaster MJ, 1997, J BONE JOINT SURG BR, V79B, P197, DOI 10.1302/0301-620X.79B2.7095; SIMMONS EH, 1972, CLIN ORTHOP RELAT R, P132, DOI 10.1097/00003086-197207000-00019; URIST MR, 1958, J BONE JOINT SURG AM, V40, P833, DOI 10.2106/00004623-195840040-00007; Willems KF, 2005, SPINE, V30, P101, DOI 10.1097/00007632-200501010-00018	10	21	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	AUG 1	2007	32	17					1926	1929		10.1097/BRS.0b013e31811327fe			4	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	199LV	WOS:000248698200018	17762303				2022-02-06	
J	Cullen, N				Cullen, Nora			Canadian Healthcare Perspective in Traumatic Brain Injury Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury rehabilitation; Canadian healthcare; universal access		Brain injury rehabilitation is based on principles of universal access to healthcare in a publicly funded system and is available to all residents in Canada. However, a variability of resources exists because of the vastness of the country and differences in provincial funding. Rehabilitation is typically provided by an interprofessional team and is client centered, goal directed, evidence based, and aimed at improving quality of life for survivors of brain injury. Work is being done exploring different models of care including community treatment and the use of rehabilitation therapists. Patient education is an ongoing priority. Data collection is considered mandatory in many centers for program evaluation and quality improvement. There is a clear need for coordinated standards of care across the country.	[Cullen, Nora] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Cullen, Nora] Univ Toronto, Toronto, ON, Canada		Cullen, N (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	Cullen.Nora@TorontoRehab.on.ca		Cullen, Nora/0000-0001-6359-9418			Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; MAHABIR M, 2003, WORLD C BRAIN INJ MA; RYU A, 2006, 54 ANN M AAPM R NOV; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; WHITLOCK J A JR, 1992, Brain Injury, V6, P447, DOI 10.3109/02699059209008140; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	7	21	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2007	22	4					214	220		10.1097/01.HTR.0000281836.54602.6d			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	V87BQ	WOS:000205885400004	17667063				2022-02-06	
J	Maier, B; Lehnert, M; Laurer, HL; Marzi, I				Maier, Bernd; Lehnert, Mark; Laurer, Helmut L.; Marzi, Ingo			Biphasic elevation in cerebrospinal fluid and plasma concentrations of endothelin 1 after traumatic brain injury in human patients	SHOCK			English	Article						endothelin 1; microcirculatory disorder; subarachnoid hemorrhage; traumatic brain injury	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; SUPEROXIDE GENERATION; CEREBRAL VASOSPASM; HEAD-INJURY; DYSFUNCTION; IMPAIRMENT; EXPRESSION; ARTERY	Severe traumatic brain injury (TBI) is characterized by a high mortality and poor outcome. The pathomechanisms involved are cytokine-mediated proinflammatory and anti-inflammatory reactions and significant cerebral microcirculatory disorders. The role of endothelin 1 (ET-1), a very potent vasoconstrictive peptide, in the deterioration of cerebral perfusion after trauma is still unclear. The presented study investigated the changes in ET-1 in the cerebrospinal fluid (CSF) and plasma after TBI in humans, with special regard to the presence of subarachnoid hemorrhage (SAH) and clinical outcome. Twenty patients with TBI were consecutively enrolled into the study, 10 patients without SAH (TBI group) and 10 patients with SAH (TBI-H group). Paired samples of plasma and CSF were collected for 10 days after trauma. Analysis of the ET-1 concentrations showed that TBI is associated with initially increased ET-1 values in plasma (TBI, day 1; TBI-H, days 2-3) and significantly increased (P < 0.05, vs. control) CSF concentrations (TBI, days 1-2; TBI-H, days 1-3) in the first days after trauma. In the further time course, ET-1 values declined in both groups, reaching reference values in plasma. The CSF values remained significantly (P < 0.05 vs. control) elevated. Both groups showed a second peak on the beginning of the second week after trauma in plasma and CSF Whereas plasma concentrations failed to reach significance, CSF values showed a significant peak on day 7 in both groups. The TBI-H patients had significantly (P < 0.05) higher values in the secondary peak compared with patients of the TBI group. The kinetics of traumatic SAH-dependent ET-1 needs to be assessed in further investigations.	Univ Frankfurt, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany		Maier, B (corresponding author), Univ Frankfurt, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany.	bernd.maier@trauma.uni-frankfurt.de					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Armstead WM, 2004, CURR PHARM DESIGN, V10, P2185, DOI 10.2174/1381612043384178; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 2001, J NEUROTRAUM, V18, P1039, DOI 10.1089/08977150152693737; ASANO T, 1989, BIOCHEM BIOPH RES CO, V159, P1345, DOI 10.1016/0006-291X(89)92258-4; BEUTH W, 2001, NEUROL NEUROCHIR S5, V35, P5125; CARDOSO ER, 1985, ACTA NEUROCHIR, V76, P140, DOI 10.1007/BF01418477; CLOZEL M, 1993, LIFE SCI, V52, P825, DOI 10.1016/0024-3205(93)90081-D; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; IDE K, 1989, Neurological Research, V11, P101; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; LYSKO PG, 1995, DEV BRAIN RES, V88, P96, DOI 10.1016/0165-3806(95)00087-T; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Onoda K, 1996, J NEUROSURG, V85, P846, DOI 10.3171/jns.1996.85.5.0846; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zuccarello M, 1996, STROKE, V27, P1896, DOI 10.1161/01.STR.27.10.1896	25	21	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	JUN	2007	27	6					610	614		10.1097/shk.0b013e31802f9eaf			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	173FS	WOS:000246859500004	17505299				2022-02-06	
J	van Landeghem, FKH; Weiss, T; Oehmichen, M; von Deimling, A				van Landeghem, Frank K. H.; Weiss, Thorsten; Oehmichen, Manfred; von Deimling, Andreas			Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans	ACTA NEUROPATHOLOGICA			English	Article						astrocyte; human; oligodendrocyte; PACAP27; PACAP38; traumatic brain injury	GLUTAMATE TRANSPORTER PROTEINS; VASOACTIVE-INTESTINAL-PEPTIDE; CEREBELLAR GRANULE NEURONS; CULTURED RAT ASTROCYTES; POLYPEPTIDE PACAP; CORTICAL-NEURONS; NERVOUS-SYSTEM; REACTIVE ASTROCYTES; BASAL FOREBRAIN; UP-REGULATION	The pituitary adenylate cyclase-activating peptide (PACAP) is involved in many processes of the developing and mature central nervous system, such as proliferation, differentiation, apoptosis, neurotransmission, inflammation and neuroprotection. Alternative posttranslational processing of PACAP results in two biologically active, amidated 27- and 38-amino acid peptides termed PACAP27 and PACAP38. In the present study, we examined whether traumatic brain injury ( TBI) affects cellular immunopositivity for PACAP27 and PACAP38. Patients ( n = 55) were classified into three groups dependent on their survival time ( under 24 h, between 24 h and 7 days and between 7 days and 99 days postinjury). PACAP27 and PACAP38 were expressed by neurons and glial cells in normal human neocortex ( n = 10). Following TBI, the total number of PACAP27- and PACAP38- positive cells was significantly decreased for a prolonged survival period within the traumatized neocortex. In the pericontusional cortex, the number of cells expressing PACAP27 and PACAP38 was significantly increased at all survival times examined. Triple immunofluorescence examinations revealed a significant increase in the absolute numbers of GFAP-positive reactive astrocytes as well as a decrease in the CNP-positive oligodendrocytes, each coexpressing PACAP27 or PACAP38 in the contusional and pericontusional cortex. We hypothesize that the increase of glial PACAP immunoreactivity may be interpreted as part of a complex endogenous neuroprotective response in the pericontusional regions, but the precise role of PACAP following TBI is yet to be determined.	Charite Univ Med Berlin, CVK, Inst Neuropathol, D-13353 Berlin, Germany; Univ Klinikum Schleswig Holstein, Inst Med Legale, D-23562 Lubeck, Germany; Univ Klinikum Heidelberg, Dept Neuropathol, Fak Med, D-69120 Heidelberg, Germany		van Landeghem, FKH (corresponding author), Charite Univ Med Berlin, CVK, Inst Neuropathol, Charite Campus Virchow Klinikum,Augustenburger Pl, D-13353 Berlin, Germany.	frank.van_landeghem@charite.de	von Deimling, Andreas/F-7774-2013	von Deimling, Andreas/0000-0002-5863-540X			ARIMURA A, 1995, FRONT NEUROENDOCRIN, V16, P53, DOI 10.1006/frne.1995.1003; Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Ashur-Fabian O, 1997, J MOL NEUROSCI, V9, P211, DOI 10.1007/BF02800503; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Dai XD, 2003, J NEUROSCI, V23, P5846; Dai XD, 2001, GLIA, V34, P234, DOI 10.1002/glia.1057; Dejda A, 2005, PHARMACOL REP, V57, P307; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Figiel M, 2000, J NEUROSCI, V20, P3596, DOI 10.1523/JNEUROSCI.20-10-03596.2000; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Grimaldi M, 1999, EUR J NEUROSCI, V11, P2767, DOI 10.1046/j.1460-9568.1999.00693.x; Grimaldi M, 2000, ANN NY ACAD SCI, V921, P312; Jaworski DM, 2000, CELL TISSUE RES, V300, P219, DOI 10.1007/s004410000184; Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231; Kimura H, 2004, REGUL PEPTIDES, V123, P135, DOI 10.1016/j.regpep.2004.04.020; Kimura H, 2003, LARYNGOSCOPE, V113, P1000, DOI 10.1097/00005537-200306000-00016; Larsen JO, 1997, MOL BRAIN RES, V46, P109, DOI 10.1016/S0169-328X(96)00279-3; Lee M, 2001, J NEUROSCI, V21, P3849, DOI 10.1523/JNEUROSCI.21-11-03849.2001; Masmoudi O, 2003, FASEB J, V17, P17, DOI 10.1096/fj.02-0317com; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Moller K, 1997, BRAIN RES, V775, P166, DOI 10.1016/S0006-8993(97)00923-2; Morio H, 1996, BRAIN RES, V741, P82, DOI 10.1016/S0006-8993(96)00920-1; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; PALKOVITS M, 1995, BRAIN RES, V699, P116, DOI 10.1016/0006-8993(95)00869-R; Privat Alain, 1995, P3; Reglodi D, 2000, STROKE, V31, P1411, DOI 10.1161/01.STR.31.6.1411; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Schluter K, 2002, EUR J NEUROSCI, V16, P836, DOI 10.1046/j.1460-9568.2002.02130.x; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Suzuki R, 2003, MOL BRAIN RES, V115, P10, DOI 10.1016/S0169-328X(03)00172-4; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; TATSUNO I, 1990, BIOCHEM BIOPH RES CO, V168, P1027, DOI 10.1016/0006-291X(90)91132-C; Tatsuno I, 1996, ANN NY ACAD SCI, V805, P613; Uchida D, 1996, BRAIN RES, V736, P280, DOI 10.1016/0006-8993(96)00716-0; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2003, J NEUROSCI RES, V72, P303, DOI 10.1002/jnr.10530; Vaudry D, 2002, EUR J NEUROSCI, V15, P1451, DOI 10.1046/j.1460-9568.2002.01981.x; Vaudry D, 2002, P NATL ACAD SCI USA, V99, P6398, DOI 10.1073/pnas.082112699; Vermeiren C, 2005, J NEUROCHEM, V94, P405, DOI 10.1111/j.1471-4159.2005.03216.x; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Zhang YZ, 1996, NEUROSCIENCE, V74, P1099, DOI 10.1016/S0306-4522(96)00168-6; Zhou CJ, 2002, CURR PROTEIN PEPT SC, V3, P423, DOI 10.2174/1389203023380576; Zhou XR, 1999, J NEUROSCI RES, V57, P953, DOI 10.1002/(SICI)1097-4547(19990915)57:6<953::AID-JNR21>3.3.CO;2-I; [No title captured]	53	21	21	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JUN	2007	113	6					683	693		10.1007/s00401-007-0208-7			11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	171IO	WOS:000246729600007	17431645				2022-02-06	
J	Batista, CEA; Chugani, HT; Juhasz, C; Behen, ME; Shankaran, S				Batista, Carlos E. A.; Chugani, Harry T.; Juhasz, Csaba; Behen, Michael E.; Shankaran, Seetha			Transient hypertnetabolism of the basal ganglia following perinatal hypoxia	PEDIATRIC NEUROLOGY			English	Article							POSITRON EMISSION TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; CEREBRAL-PALSY; ISCHEMIC ENCEPHALOPATHY; ASPHYXIA; GLUTAMATE/GLUTAMINE	Positron emission tomography can tie used to evaluate brain function following perinatal hypoxia. This case report demonstrates transient hypermetabolism in the basal ganglia detected by glucose metabolism positron emission tomography study in a newborn who suffered hypoxic-ischemic encephalopathy and developed dystonic cerebral palsy later. A scan repeated at 4 years of age showed severe hypometabolism in the lentiform nuclei and thalami. Transient hypermetabolism in the basal ganglia following perinatal hypoxia may be related to excitotoxic damage causing permanent neurological symptoms in the form of dystonic cerebral palsy. Thus, positron emission tomography can help predict this form of cerebral palsy in neonates. (C) 2007 by Elsevier Inc. All rights reserved.	Wayne State Univ, Div Pediat Neurol, PET Ctr, Childrens Hosp Michigan, Detroit, MI 48201 USA; Wayne State Univ, Carman & Ann Adams Dept Pediat, Detroit, MI 48201 USA; Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA		Chugani, HT (corresponding author), Wayne State Univ, Div Pediat Neurol, PET Ctr, Childrens Hosp Michigan, 3901 Beaubien Blvd, Detroit, MI 48201 USA.	hchugani@pet.wayne.edu	Batista, Carlos Eduardo/G-1857-2010; Juhasz, Csaba/P-3665-2019	Batista, Carlos/0000-0003-1299-9934			Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BLENNOW M, 1995, ACTA PAEDIATR, V84, P1289, DOI 10.1111/j.1651-2227.1995.tb13551.x; COLAMARIA V, 1988, BRAIN DEV-JPN, V10, P57, DOI 10.1016/S0387-7604(88)80049-4; HASEGAWA M, 1992, BRAIN DEV-JPN, V14, P1; Johnston MV, 2005, BRAIN PATHOL, V15, P234; KERRIGAN JF, 1991, PEDIATR NEUROL, V7, P415, DOI 10.1016/0887-8994(91)90024-F; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; NELSON KB, 1988, J PEDIATR-US, V112, P572, DOI 10.1016/S0022-3476(88)80169-0; Perlman JM, 1997, PEDIATRICS, V99, P851, DOI 10.1542/peds.99.6.851; Pu YL, 2000, AM J NEURORADIOL, V21, P203; Rutherford M, 2006, PEDIATR RADIOL, V36, P582, DOI 10.1007/s00247-006-0164-8; SHEWMON DA, 1981, ANN NEUROL, V9, P358, DOI 10.1002/ana.410090408; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	16	21	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994			PEDIATR NEUROL	Pediatr. Neurol.	MAY	2007	36	5					330	333		10.1016/j.pediatrneurol.2007.01.004			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	172SM	WOS:000246824400008	17509466				2022-02-06	
J	Jantz, PB; Coulter, GA				Jantz, Paul; Coulter, Gail			Child and adolescent traumatic brain injury: academic, behavioural, and social consequences in the classroom	SUPPORT FOR LEARNING			English	Article						academic; behavioural; classroom teachers; social consequences; traumatic brain injury (TBI); United States	HEAD-INJURY; NEUROPSYCHOLOGICAL SEQUELAE; EPILEPSY	More than five million children suffer from brain injuries each year. While the majority of these children are treated and released without permanent consequences, many children return to the classroom with lasting effects. Symptoms of brain injury can be misconstrued as common behaviour or academic problems. Therefore, teachers need to recognize how traumatic brain injury can be manifested in the classroom. This paper presents information regarding the nature of brain injury for the educational professional. It describes types of brain injuries, introduces the consequences of brain injuries in school-age children and adolescents, and provides examples of common cognitive, physical, psycho-social, behavioural, and emotional manifestations.	[Coulter, Gail] Idaho State Univ, Pocatello, ID 83209 USA		Jantz, PB (corresponding author), Idaho State Univ, Coll Educ, Sch Psychol Program, Stop 8059, Pocatello, ID 83209 USA.	jantpaul@isu.edu					ALEXANDER M.P, 1984, NEUROL NEUROSURG, V5, p[20, 1]; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Annegers JF., 1996, TREATMENT EPILEPSY P, P165; Bakay L, 1980, HEAD INJURY; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Begali V., 1992, HEAD INJURY CHILDREN; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; Cooper P. R., 1982, HEAD INJURY, P185; DUFFY FH, 1985, DYSLEXIA NEUROSCIENT, P105; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gallagher D, 2002, EINSTEIN Q J BIOL ME, V19, P5; Haas David C., 1993, P629; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kraus MF, 1999, TRAUMATIC BRAIN INJU, V14, P173; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; LANGENDORF F, 1997, EPILEPSY COMPREHENSI; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MANDEL S, 1989, POSTGRAD MED, V85, P213; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; McIntosh G C, 1997, Appl Neuropsychol, V4, P62, DOI 10.1207/s15324826an0401_8; MEIROWSKY A.M., 1984, PENETRATING CRANIOCE; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; NOVACK T., 2000, WHAT EXPECT TRAUMATI; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pang D, 1985, HEAD INJURY REHABILI, P3; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RAICHLE ME, 1986, TRENDS NEUROSCI, V9, P525; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; Stavinoha PL, 2005, PREV SCH FAIL, V49, P11, DOI 10.3200/PSFL.49.4.11-16; TEASDALE G, 1974, LANCET, V2, P81; US DEPARTMENT OF EDUCATION/US CONGRESS, 1992, FED REG, V57, P44802; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VITAL M, 2002, NIH PUBLICATION; WEDDING D., 1997, NEUROPSYCHOLOGY HDB, V1, P91; WILLIAMS D, 1994, ED373476 ERIC DOC RE; WILLIAMSON J, 1996, ARCHIT DESIGN, P9; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; [No title captured]; [No title captured]	48	21	21	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-2141	1467-9604		SUPPORT LEARN	Support Learn.	MAY	2007	22	2					84	89		10.1111/j.1467-9604.2007.00452.x			6	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V57HK	WOS:000210618700007					2022-02-06	
J	Prause, G; Wildner, G; Kainz, J; Bossner, T; Gemes, G; Dacar, D; Magerl, S				Prause, G.; Wildner, G.; Kainz, J.; Boessner, T.; Gemes, G.; Dacar, D.; Magerl, S.			Strategies for quality assessment of emergency helicopter rescue systems - The Graz model	ANAESTHESIST			German	Article						emergency intervention; quality management; rescue helicopter; emergency medical doctor's experience	PREHOSPITAL ENDOTRACHEAL INTUBATION; TRAUMATIC BRAIN-INJURY; LIFE-SUPPORT; MEDICINE; EXPERIENCE; MORTALITY; SURVIVAL; EFFICACY; MODERATE	Purpose. Preclinical emergency medical treatment necessitates a comprehensive interdisciplinary knowledge by the emergency physician as well as a high level of manual dexterity. The quality of treatment therefore depends on the level of education and continuous training in emergency medical techniques. Based on an evaluation of the frequency of life-saving interventions by a physician-staffed rescue helicopter system, strategies for in-hospital training of relevant skills are suggested. Material and methods. At the outset, 10 important areas of treatment (e.g. intubation, chest tube etc.) and their frequency in emergency medical services were defined as the standard to be attained by emergency physicians within 1 year. The selection of the areas of treatment was based to some extent on international recommendations. The actual frequencies of the prehospital interventions were compared to the required minimum numbers by retrospective analysis of the helicopter rescue database (NACA-X). Results. During the observation period of 1 year, 20 emergency physicians responded to 956 prehospital emergency calls. A life-threatening condition requiring an on-site intervention occurred in only 521 (54.5%) patients, so that the majority of physicians did not perform the required minimum number of interventions. In order to maintain their level of skill, the emergency physicians were required to undertake additional training at the local university hospital. Conclusion. The frequency of on-site life-saving interventions in emergency medicine is insufficient to fulfill the quota necessary to maintain adequate training of emergency physicians. Only a link-up program at a hospital for primary care can ensure an adequate training level.	Med Univ Graz, Univ Klin Anasthesiol & Intens Med, Graz, Austria; Univ Klinikum Graz, Chirurg Univ Klin, Graz, Austria; Med Corps Grazer Rettung, Graz, Austria		Prause, G (corresponding author), Med Univ Graz, Univ Klin Anasthesiol & Intens Med, Graz, Austria.	gerhard.prause@meduni-graz.at					Birk Hans O, 2002, Prehosp Disaster Med, V17, P167; Cooke MW, 1999, BRIT MED J, V319, P1150, DOI 10.1136/bmj.319.7218.1150; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Fischer M, 2003, ANASTH INTENSIV NOTF, V38, P630; Garza AG, 2003, J EMERG MED, V25, P251, DOI 10.1016/S0736-4679(03)00198-7; Gries A, 2005, NOTFALL RETTUNGSMED, P391, DOI DOI 10.1007/s10049-005-0756-0; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; HUF R, 1993, INTENSIV MED NOTFALL, V30, P377; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Ljosland M, 2000, Tidsskr Nor Laegeforen, V120, P2247; Lockey D, 2001, BRIT MED J, V323, P141, DOI 10.1136/bmj.323.7305.141; Mitchell RG, 1997, J ACCID EMERG MED, V14, P274; Moecke H, 1997, ANAESTHESIST, V46, P787, DOI 10.1007/s001010050470; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; POHLMEUTHEN U, 1999, RETTUNGSDIENST STAAT; Prause G, 1991, Anaesthesiol Reanim, V16, P227; Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71; Ruchholtz S, 2002, J TRAUMA, V52, P879, DOI 10.1097/00005373-200205000-00010; RUCHHOLTZ S, 1994, UNFALLCHIRURG, V97, P285; SCHUSTER HP, 1994, ANAESTHESIST, V43, P30, DOI 10.1007/s001010050031; Schuttler J, 1995, ANAESTHESIST, V44, P850, DOI 10.1007/s001010050221; Shy Bradley D, 2004, Prehosp Emerg Care, V8, P394, DOI 10.1016/j.prehos.2004.06.013; TRIMMEL H, 1996, NOTARZT, V12, P47; Wang H E, 2001, Prehosp Emerg Care, V5, P10, DOI 10.1080/10903120190940254; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717	28	21	21	2	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	MAY	2007	56	5					461	465		10.1007/s00101-007-1174-0			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	171JF	WOS:000246731400008	17437072				2022-02-06	
J	Zulu, BMW; Mulaudzi, TV; Madiba, TE; Muckart, DJJ				Zulu, B. M. W.; Mulaudzi, T. V.; Madiba, T. E.; Muckart, D. J. J.			Outcome of head injuries in general surgical units with an off-site neurosurgical service	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article; Proceedings Paper	24th Biennal Congress of the Association-of-Surgeons-of-South-Africa	AUG 23, 2004	Cape Town, SOUTH AFRICA	Assoc Surg S Africa		head injury; neurosurgical unit; general surgical unit	BRAIN INJURY; TRAUMA; COMA; MORTALITY; SEVERITY; SCORE	Introduction: In order to cope with bed shortages in the only neurosurgical unit (NSU) in KwaZulu-Natal, it has become necessary to manage head injured patients in a general surgical unit (GSU) at the referral hospitals in consultation with the NSU. This study was undertaken to assess the outcome of patients with head injuries managed in a GSU in consultation with a regional NSU. Patients and methods: A prospective pilot study was carried out in a single surgical unit over an 18-month period (July 1997-December 1998), followed by a larger prospective study over a 6-month period (January-June 2001). All patients with head injuries severe enough to warrant admission to hospital (GCS <= 15 or 15 with localising signs) were included. Results: The pilot study comprised 86 patients and the subsequent study comprised 230 patients, giving a total of 316 patients in the whole study. The mean age was 31 12 years. Following consultation with the NSU, 265 (84%) patients were managed in the GSU and 51 (16%) required transfer to the NSU. Forty-one patients died giving a mortality rate of 13%. Twenty eight of the 42 patients with GCS <= 8 died (67%) compared to 13 out of 274 with GCS > 8 (5%) (p < 0.0001). Eleven of the 51 patients destined to the NSU died (22%) compared to 30 of 265 in the GSU (11%) (p = 0.046). The average hospital stay was 10 +/- 18 days. Forty surviving patients (17%) from the GSU and 20 from the NSU (51%) were discharged with neurological sequelae (p < 0.001). Conclusion: Head trauma is associated with high morbidity and mortality. Nonsurgical treatment of traumatic brain injury at the referral hospital by the GSU is acceptable practice. Outcome is determined primarily by the GCS on presentation. NSU patients had a significantly higher mortality rate. A delay before surgery did not seem to affect outcome. (c) 2007 Elsevier Ltd. All rights reserved.	Univ KwaZulu Natal, Dept Surg, ZA-4013 Congella, South Africa; King Edward VIII Hosp, Durban, South Africa		Madiba, TE (corresponding author), Univ KwaZulu Natal, Dept Surg, Private Bag 7, ZA-4013 Congella, South Africa.	madiba@ukzn.ac.za	Madiba, T E/N-6069-2013; Madiba, T E/ABI-8313-2020	Madiba, T E/0000-0002-0155-9143; Madiba, T E/0000-0002-0155-9143			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; BECKMANN V, 2004, INTENS CARE MED, V30, P1508; BOTO GR, 2006, J NEUROL NEUROSUR PS, V1, P1; Campbell NC, 1997, BRIT J SURG, V84, P1737, DOI 10.1046/j.1365-2168.1997.02819.x; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Jithoo R, 2003, J TELEMED TELECARE, V9, P63, DOI 10.1258/135763303321327894; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MUCKART DJJ, 1995, S AFR MED J, V85, P1172; MUCKART DJJ, 1991, S AFR MED J, V79, P93; Nadvi SS, 1997, S AFR MED J, V87, P1669; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; RaeGrant AD, 1996, J TRAUMA, V40, P401, DOI 10.1097/00005373-199603000-00013; TEASDALE G, 1974, LANCET, V2, P81; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A	21	21	21	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2007	38	5					576	583		10.1016/j.injury.2007.01.002			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	176AO	WOS:000247055300010	17472793				2022-02-06	
J	Henzler, D; Cooper, DJ; Tremayne, AB; Rossaint, R; Higgins, A				Henzler, Dietrich; Cooper, D. James; Tremayne, Ann B.; Rossaint, Rolf; Higgins, Alisa			Early modifiable factors associated with fatal outcome in patients with severe traumatic brain injury: A case control study	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; craniocerebral trauma; fatal outcome; intracranial pressure; multiple trauma; hypotension	ROAD TRAFFIC FATALITIES; MODERATE HYPOTHERMIA; OCCULT HYPOPERFUSION; MAJOR TRAUMA; MANAGEMENT; POLYTRAUMA; AUSTRALIA; VICTORIA; CARE; MORTALITY	Objective. Survival of patients with severe traumatic brain injury may be improved by minimizing secondary brain injury. We aimed to identify potentially modifiable contributors to secondary brain injury that may persist and adversely affect patient outcome. Design: Retrospective case control study. Nonsurviving patients with traumatic brain injury were selected and matched 1:1 for age, Glasgow Coma Scale score, Abbreviated Injury Scale: Head (AIS(HEAD)), Revised Trauma Score, and Injury Severity Score with survivors. Potentially modifiable contributors to secondary brain injury were examined and compared in both groups. Setting. A level I trauma center in Melbourne, Australia. Patients: Patients with traumatic brain injury caused by blunt trauma with an AIS(HEAD) >= 4 were identified from a prospective intensive care database. Interventions: None. Measurements and Main Results. Between January 1, 1999, and July 30, 2000, 74 patients, including 37 nonsurvivors, were identified. By design, the groups were well matched for injury severity and baseline conditions. In nonsurvivors, mean arterial pressure was similar to that of survivors at hospital arrival but was lower at 4 hrs after arrival (71 +/- 16 vs. 80 +/- 15 mm Hg, p =.016). A mean arterial pressure <= 65 mm Hg during this 4-hr period was associated with a four-fold increase in the odds of nonsurvival (95% confidence interval, 1.25-12.8). Intracranial pressure monitoring and intensive care unit admission tended to be initiated later in nonsurvivors, potentially delaying recognition and management of inadequate cerebral perfusion pressure. In nonsurvivors, hypothermia did not normalize during the first 24 hrs after injury. Conclusions: In patients with severe traumatic brain injury, lower blood pressure in the first 4 hrs after admission was associated with mortality and may have increased the rate of secondary brain injury. Outcomes of patients with severe traumatic brain injury may potentially be improved by early targeting of the higher mean arterial pressure observed in survivors (mean arterial pressure 80 mm Hg), which may facilitate improved cerebral perfusion. Slower initiation of intracranial pressure monitoring and of intensive care unit admission may also have adversely affected outcomes, whereas persistent hypothermia was associated with nonsurvival.	Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany; Monash Univ, Alfred Hosp, ICU, Dept Surg, Melbourne, Vic 3181, Australia; Monash Univ, Alfred Hosp, ICU, Dept Med, Melbourne, Vic 3181, Australia; Monash Univ, ANZIC RC, Dept Epidemiol & Prevent Med, Dept Med, Melbourne, Vic 3181, Australia		Cooper, DJ (corresponding author), Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany.	j.cooper@alfred.org.au	Higgins, Alisa/AAM-8088-2020; Cooper, D. James/G-7961-2013	Higgins, Alisa/0000-0001-8295-7559; Cooper, D. James/0000-0002-5872-9051; Henzler, Dietrich/0000-0001-5511-6885			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baltas I, 1998, J Neurosurg Sci, V42, P85; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; Claridge JA, 2000, J TRAUMA, V48, P8, DOI 10.1097/00005373-200001000-00003; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; Cooper DJ, 1998, J TRAUMA, V45, P772, DOI 10.1097/00005373-199810000-00027; Copes W. S., 1990, P 33 ANN M ASS ADV A, P205; Dereeper E, 1998, RESUSCITATION, V36, P15, DOI 10.1016/S0300-9572(97)00080-4; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Henzler D, 2001, Crit Care Resusc, V3, P153; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Krettek C, 1998, LANGENBECK ARCH SURG, V383, P220, DOI 10.1007/s004230050122; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McDermott FT, 1997, J TRAUMA, V43, P831, DOI 10.1097/00005373-199711000-00016; McDermott FT, 2001, BRIT J SURG, V88, P1099, DOI 10.1046/j.0007-1323.2001.01835.x; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Segers MJM, 1998, UNFALLCHIRURG, V101, P742, DOI 10.1007/s001130050332; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012	29	21	22	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	APR	2007	35	4					1027	1031		10.1097/01.CCM.0000259526.45894.08			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151PJ	WOS:000245302400004	17334255				2022-02-06	
J	Kremer, S; Oppenheim, C; Schmitt, E; Dietemann, JL				Kremer, S.; Oppenheim, C.; Schmitt, E.; Dietemann, J-L			Diffusion MRI: Technique and clinical applications	JOURNAL DE RADIOLOGIE			French	Article						diffusion MRI; brain; stroke; tumor	CREUTZFELDT-JAKOB-DISEASE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; REVERSIBLE ENCEPHALOPATHY SYNDROME; CLOSED-HEAD INJURY; IMAGING FINDINGS; WATER DIFFUSION; AXONAL INJURY; WEIGHTED MRI; BRAIN-TUMORS; COEFFICIENT	Diffusion MRI gives information that is not available with conventional MRI examinations. It can provide early diagnosis of stroke and helps in diagnosing cerebral lymphoma, cerebral bacterial abscess, and epidermoid cyst. It helps distinguish between vasogenic, edema and cytotoxic edema and has prognostic value. Acquisition is fast and should be performed in all neuroradiological examinations.	CHU Strasbourg, Serv Radiol 2, F-67098 Strasbourg, France; Hop St Anne, Serv Neuroradiol, F-75014 Paris, France; CHU Nancy, Serv Neuroradiol, F-54000 Nancy, France		Kremer, S (corresponding author), CHU Strasbourg, Serv Radiol 2, Ave Moliere, F-67098 Strasbourg, France.	stephane.kremer@chru-strasbourg.fr	Oppenheim, Catherine/N-1635-2018	Oppenheim, Catherine/0000-0003-3410-0862			Ahn KJ, 2004, NEURORADIOLOGY, V46, P978, DOI 10.1007/s00234-004-1276-1; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Briellmann RS, 2005, EPILEPSIA, V46, P760, DOI 10.1111/j.1528-1167.2005.47604.x; Chen S, 2001, AM J NEURORADIOL, V22, P1089; Chong-Han CH, 2003, AM J ROENTGENOL, V181, P1711, DOI 10.2214/ajr.181.6.1811711; Chua GC, 2002, CLIN RADIOL, V57, P800, DOI 10.1053/crad.2002.0977; Cole AJ, 2004, EPILEPSIA, V45, P72, DOI 10.1111/j.0013-9580.2004.04014.x; Collie DA, 2003, AM J NEURORADIOL, V24, P1560; Cosnard G, 2003, J NEURORADIOLOGY, V30, P146; Covarrubias DJ, 2002, AM J NEURORADIOL, V23, P1038; Dubrulle F, 2006, RADIOLOGY, V238, P604, DOI 10.1148/radiol.2381041649; Ducreux D, 2002, J NEURORADIOLOGY, V29, P39; Ducreux D, 2001, AM J NEURORADIOL, V22, P261; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Hakyemez B, 2005, EUR J RADIOL, V54, P214, DOI 10.1016/j.ejrad.2004.06.018; Heiner L, 2003, EUR J RADIOL, V45, P195, DOI 10.1016/S0720-048X(02)00306-6; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Kamal AK, 2003, AM J NEURORADIOL, V24, P895; Lamy C, 2006, EUR RADIOL, V16, P1090, DOI 10.1007/s00330-005-0049-5; Lamy C, 2004, J NEUROIMAGING, V14, P89, DOI 10.1177/1051228403258161; Leuthardt EC, 2002, SURG NEUROL, V58, P395, DOI 10.1016/S0090-3019(02)00929-1; Lovblad KO, 2006, EUR RADIOL, V16, P1253, DOI 10.1007/s00330-005-0103-3; Morita N, 2002, NEURORADIOLOGY, V44, P907, DOI 10.1007/s00234-002-0860-5; Mukherjee P, 2001, RADIOLOGY, V219, P756, DOI 10.1148/radiology.219.3.r01jn48756; Oppenheim C, 2005, J RADIOL, V86, P1069, DOI 10.1016/S0221-0363(05)81495-7; Oppenheim C, 2004, J NEUROL NEUROSUR PS, V75, P1066, DOI 10.1136/jnnp.2003.020172; Oppenheim C, 2001, STROKE, V32, P2486, DOI 10.1161/hs1101.098331; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Rees J, 2003, CURR OPIN NEUROL, V16, P643, DOI 10.1097/00019052-200312000-00001; Roberts TPL, 2003, EUR J RADIOL, V45, P185, DOI 10.1016/S0720-048X(02)00305-4; Rovira A, 2002, AM J NEURORADIOL, V23, P989; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Silvera S, 2005, AM J NEURORADIOL, V26, P236; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Tung GA, 2001, AM J ROENTGENOL, V177, P709, DOI 10.2214/ajr.177.3.1770709; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; Young GS, 2005, AM J NEURORADIOL, V26, P1551	40	21	24	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0221-0363			J RADIOL	J. Radiol.	MAR	2007	88	3	2				428	443		10.1016/S0221-0363(07)89845-3			16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	162DE	WOS:000246066200002	17457256				2022-02-06	
J	Nakabayashi, M; Suzaki, S; Tomita, H				Nakabayashi, Motoaki; Suzaki, Shinichiro; Tomita, Hiroki			Neural injury and recovery near cortical contusions: a clinical magnetic resonance spectroscopy study	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; contusion; choline; creatine; N-acetylaspartate; proton magnetic resonance spectroscopy	TRAUMATIC BRAIN-INJURY; N-ACETYL-ASPARTATE; CLOSED-HEAD INJURY; IN-VIVO; H-1 MRS; H-1-NMR SPECTROSCOPY; AXONAL INJURY; MITOCHONDRIAL DYSFUNCTION; CEREBRAL CONTUSIONS; METABOLIC-CHANGES	Object. Proton magnetic resonance (MR) spectroscopy can detect neural metabolic alterations noninvasively after traumatic brain injury (TBI) even in areas that appear normal. Unlike metabolic depression in diffuse TBI, focal metabolic alterations near cortical contusions in humans have not been previously investigated in a longitudinal study. The object of this study was to identify these alterations and examine their course. Methods. At 1 week and 1 month after mild to moderate TBI involving cortical contusion, 30 patients underwent H-1 MR spectroscopy examination that focused bilaterally on normal-appearing frontal and temporal white matter. Levels of N-acetylaspartate (NAA), choline (Cho) compounds, and creatine (Cr) were measured to obtain two metabolite ratios, NAA/Cr and Cho/Cr. The ratios were compared with those of 11 healthy individuals. At 1 week after TBI, the NAA/Cr ratio was significantly lower near cortical contusions than it was in white matter remote from the injury or in controls, while the Cho/Cr ratios did not differ significantly. At 1 month, the decreased NAA/Cr ratios near contusions had increased significantly from 1 week, as had the Cho/Cr ratio. Conclusions. Metabolic depression reflecting neural injury was apparent in subjacent normal-appearing white matter at I week after cortical contusion; this had normalized substantially at 1 month.	Musashino Red Cross Hosp, Dept Emergency Med, Musashino, Tokyo 1808610, Japan; Musashino Red Cross Hosp, Dept Neurosurg, Musashino, Tokyo 1808610, Japan		Nakabayashi, M (corresponding author), Musashino Red Cross Hosp, Dept Emergency Med, 1-26-1 Kyonan Cho, Musashino, Tokyo 1808610, Japan.	mnkb@mac.com					Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; Alessandri B, 2000, NEUROL RES, V22, P705; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Danielsen ER, 2003, NEURORADIOLOGY, V45, P722, DOI 10.1007/s00234-003-1068-z; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; JENNETT B, 1975, LANCET, V1, P480; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Son BC, 2000, ACT NEUR S, V76, P13; SUTTON LN, 1995, PEDIATR NEUROSURG, V22, P81, DOI 10.1159/000120881; TEASDALE G, 1974, LANCET, V2, P81; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Zampolini M, 1997, EUR J NEUROL, V4, P246, DOI 10.1111/j.1468-1331.1997.tb00343.x	42	21	22	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2007	106	3					370	377		10.3171/jns.2007.106.3.370			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	145KV	WOS:000244864700002	17367057				2022-02-06	
J	Zheng, WB; Liu, GR; Li, LP; Wu, RH				Zheng, W. B.; Liu, G. R.; Li, L. P.; Wu, R. H.			Prediction of recovery from a post-traumatic coma state by diffusion-weighted imaging (DWI) in patients with diffuse axonal injury	NEURORADIOLOGY			English	Article						diffuse axonal injury; magnetic resonance imaging; diffusion-weighted imaging; apparent diffusion coefficient	CLOSED-HEAD INJURY; TRAUMATIC BRAIN-INJURY; MR; DIAGNOSIS; STROKE; TISSUE; EDEMA; MODEL; WATER	Introduction To determine whether diffusion-weighted magnetic resonance (MR) imaging findings combined with initial clinical factors indicate the depth of shearing lesions in the brain structure and therefore relate to coma duration in diffuse axonal injury (DAI). Methods A total of 74 adult patients (48 male and 26 female) with DAI were examined with conventional MR imaging and diffusion-weighted MR imaging between 2 hours and 20 days after injury. Apparent diffusion coefficient (ADC) maps were obtained and the mean ADC values of each region of interest (ROI) were measured using MRI console software. The involvement of the brainstem, deep gray matter, and corpus callosum was determined for each sequence separately as well as for the combination of all sequences. The correlations between MR imaging findings indicating the presence of apparent brain injury combined with initial clinical factors were determined. Results Clinical characteristics, such as initial score on the Glasgow coma scale (GCS), age and number of all lesions, and ADC scores were predictive of the duration of coma. Conclusion It was possible to predict post-traumatic coma duration in DAI from cerebral MR imaging findings combined with clinical prognostic factors in the acute to subacute stage after head injury. Age, ADC scores, GCS score and number of lesions were highly significant in predicting coma duration. The technique presented here might provide a tool for in vivo detection of DAI to allow the prediction of the coma duration during the early stages in patients with traumatic brain injury.	Shantou Univ, Coll Med, Dept Radiol, Shantou 515041, Guangdong, Peoples R China; Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou 515031, Guangdong, Peoples R China		Zheng, WB (corresponding author), Shantou Univ, Coll Med, Dept Radiol, Shantou 515041, Guangdong, Peoples R China.	hwenb@21cn.com					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; *AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P573; [Anonymous], 2000, J Neurotrauma, V17, P563; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Brockstedt S, 1998, MAGN RESON IMAGING, V16, P877, DOI 10.1016/S0730-725X(98)00002-2; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHEN B, 2003, MED J W CHINA, V1, P185; Ebisu T, 1997, RADIOLOGY, V203, P823, DOI 10.1148/radiology.203.3.9169711; EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608; Filippi M, 1998, ANN NEUROL, V43, P809, DOI 10.1002/ana.410430616; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; GIDEON P, 1994, JMRI-J MAGN RESON IM, V4, P185, DOI 10.1002/jmri.1880040216; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Lai SM, 1999, STROKE, V30, P1840, DOI 10.1161/01.STR.30.9.1840; Lang P, 1998, Magn Reson Imaging Clin N Am, V6, P579; Le Bihan DJ, 1998, RADIOLOGY, V207, P305, DOI 10.1148/radiology.207.2.9577472; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; SRIVASTAVA MS, 1983, INTRO APPL MULTIVARI, P134; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Szafer A, 1995, NMR BIOMED, V8, P289, DOI 10.1002/nbm.1940080704; TEASDALE G, 1974, LANCET, V2, P81; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	41	21	28	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAR	2007	49	3					271	279		10.1007/s00234-006-0187-8			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	139SV	WOS:000244453800012	17203299				2022-02-06	
J	Cherubini, A; Luccichenti, G; Peran, P; Hagberg, GE; Barba, C; Formisano, R; Sabatini, U				Cherubini, Andrea; Luccichenti, Giacomo; Peran, Patrice; Hagberg, Gisela E.; Barba, Carmen; Formisano, Rita; Sabatini, Umberto			Multimodal MRI tractography in normal subjects and in clinically recovered traumatic brain injury patients	NEUROIMAGE			English	Article						probabilistic tractography; connectivity; functional MRI; motor pathways; motor-deficit; cortical plasticity	WHITE-MATTER TRACTOGRAPHY; MEDIAL FRONTAL-CORTEX; IN-VIVO; DIFFUSION TRACTOGRAPHY; PYRAMIDAL TRACTS; FUNCTIONAL MRI; HUMAN THALAMUS; MOTOR CORTEX; CONNECTIVITY; SYSTEM	In this study, we defined an operator-independent protocol for reconstructing the anatomical connections originating from fMRI activations in order to demonstrate that results obtained with this protocol are affected by alterations of functional activations. Seven healthy volunteers and two patients who sustained traumatic brain injury underwent an fMRI with a finger tapping task and a DTI scan. Cortical fMRI activations were used directly as seed mask for tractography for the reconstruction of individual motor pathways. On patients we observed a different motor network if compared to healthy subjects. However, when the activations of healthy subjects were used as seed masks for the tractography in patients, we observed for the patients a pattern of connectivity more similar to what was observed for healthy subjects. At the same time, when the activations of patients were used for the tractography on healthy subjects, we obtained patterns of connectivity similar to those obtained for patients. These results show the potential of the integration of fMR1 and tractography for clarifying the mechanisms of cortical plasticity in the recovery of motor functions. (c) 2006 Elsevier Inc. All rights reserved.	IRCCS, Fdn Santa Lucia, Neuroimaging Lab, I-00179 Rome, Italy		Cherubini, A (corresponding author), IRCCS, Fdn Santa Lucia, Neuroimaging Lab, Via Ardeatina 306, I-00179 Rome, Italy.	a.cherubini@hsantalucia.it	Cherubini, Andrea/D-1327-2009; Peran, Patrice/N-7561-2015; Sabatini, Umberto/A-8484-2010; Hagberg, Gisela E/A-2134-2010; barba, carmen/K-4942-2016; Sabatini, Umberto/K-4659-2016; Barba, Carmen/AAB-7162-2022	Cherubini, Andrea/0000-0002-5946-4390; Peran, Patrice/0000-0001-7200-0139; Hagberg, Gisela E/0000-0003-2176-7086; barba, carmen/0000-0001-5445-5842; Sabatini, Umberto/0000-0001-5321-8626; 			Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2006, NEUROIMAGE, V30, P220, DOI 10.1016/j.neuroimage.2005.09.036; Behrens TEJ, 2005, PHILOS T R SOC B, V360, P903, DOI 10.1098/rstb.2005.1640; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Celnik PA, 2004, RESTOR NEUROL NEUROS, V22, P261; Ciccarelli O, 2003, NEUROIMAGE, V19, P1545, DOI 10.1016/S1053-8119(03)00190-3; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Holodny AI, 2001, AM J NEURORADIOL, V22, P83; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Kamada K, 2005, NEUROSURGERY, V57, P121, DOI 10.1227/01.NEU.0000163526.60240.B6; Kamada Kyousuke, 2005, Neurosurgery, V56, P98; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Krings T, 2001, J NEUROSURG, V95, P816, DOI 10.3171/jns.2001.95.5.0816; Krings T, 2001, NEUROSCI LETT, V307, P192, DOI 10.1016/S0304-3940(01)01928-0; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; NOLODNY AI, 2005, ANN NY ACAD SCI, V1064, P88; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Parker GJM, 2003, LECT NOTES COMPUT SC, V2732, P684; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Tailarach J., 1988, COPLANAR STEREOTAXIC; Thottakara P, 2006, NEUROIMAGE, V29, P868, DOI 10.1016/j.neuroimage.2005.08.051; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022	35	21	23	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	FEB 15	2007	34	4					1331	1341		10.1016/j.neuroimage.2006.11.024			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	138GA	WOS:000244349900002	17197198				2022-02-06	
J	Hey, JG; Chu, XP; Seeds, J; Simon, RP; Xiong, ZG				Hey, Jessica G.; Chu, Xiang-Ping; Seeds, Joshua; Simon, Roger P.; Xiong, Zhi-Gang			Extracellular zinc protects against acidosis-induced injury of cells expressing Ca2+-permeable acid-sensing ion channels	STROKE			English	Article; Proceedings Paper	25th Princeton Conference on Cerebrovascular Disease	MAY 19-20, 2006	Portland, OR	AstraZeneca, Bayers, Cardinal Hlth, Johnson & Johnson, Legacy Hlth Syst, Merck, Neurobiol Technol, Novo Nordisk, Oregon Hlth & Sci, Univ Neurol, Pfizer Inc, Portland Dev Commiss, Renovious, Virogen & Wyeth		acid; cell injury; HEK293; zinc	METHYL-D-ASPARTATE; CORTICAL-NEURONS; HIPPOCAMPAL-NEURONS; DAMAGE; INHIBITION; RECEPTORS; ISCHEMIA; RELEASE; CALCIUM; STROKE	Acidosis is a common feature of neurological conditions including brain ischemia, epileptic seizures, and neurotrauma. Activation of Ca2+-permeable acid-sensing ion channels (ASIC1a) is involved in acidosis-mediated ischemic brain injury. Zn2+ is a divalent cation concentrated in nerve terminals in various brain regions, and is released into the extracellular space during excitatory stimulation. Our previous studies have demonstrated that the activities of ASIC1a containing channels and acid-induced increased intracellular Ca2+ concentrations are inhibited dramatically by the physiological concentration of extracellular Zn2+. In this report, we demonstrate that decreasing the concentration of the extracellular Zn2+ significantly enhances acid-induced injury of HEK 293 cells, a cell line expressing homomeric ASIC1a-like channels, whereas increasing the concentration of extracellular Zn2+ appears to be protective. Although increased concentrations of intracellular Zn2+ have been shown to be detrimental to neurons, our findings may suggest that the physiological concentration of extracellular Zn2+ might play a protective role in acidosis-induced, ASIC1a-mediated neuronal injury.	Legacy Clin Res Ctr, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA		Xiong, ZG (corresponding author), Legacy Clin Res Ctr, Robert S Dow Neurobiol Labs, 1225 NE 2nd Ave, Portland, OR 97232 USA.	zxiong@Downeurobiology.org		Chu, Xiang-Ping/0000-0002-6781-0468	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047506, R01NS049470] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS47506, R01NS049470] Funding Source: Medline		Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Benveniste M, 2005, NEW ENGL J MED, V352, P85, DOI 10.1056/NEJMcibr045010; Blasco-Ibanez JM, 2004, NEUROSCI LETT, V355, P101, DOI 10.1016/j.neulet.2003.10.053; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Huang YZ, 2004, CELL, V118, P665, DOI 10.1016/j.cell.2004.09.004; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Paoletti P, 1997, J NEUROSCI, V17, P5711; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Siesjo BK, 1996, ADV NEUROL, V71, P209; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	22	21	22	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	FEB	2007	38	2					670	673		10.1161/01.STR.0000251443.68897.99			4	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Cardiovascular System & Cardiology	134ZE	WOS:000244122600804	17261712	Bronze			2022-02-06	
J	Lenartova, L; Janciak, I; Wilbacher, I; Rusnak, M; Mauritz, W				Lenartova, Lucia; Janciak, Ivan; Wilbacher, Ingrid; Rusnak, Martin; Mauritz, Walter		Austrian Severe TBI Study Investig	Severe traumatic brain injury in Austria III: Prehospital status and treatment	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						brain injury; traumatic; outcome; prehospital; Glasgow Coma Scale; vital signs; fluid administration; transport	SEVERE HEAD-INJURY; RAPID-SEQUENCE INTUBATION; GLASGOW COMA SCALE; ENDOTRACHEAL INTUBATION; FLUID RESUSCITATION; SALINE; VENTILATION; PROGNOSIS; SURVIVAL; MODERATE	OBJECTIVES: The goal of this paper is to describe prehospital status and treatment of patients with severe TBI in Austria. PATIENTS AND METHODS: Data sets from 396 patients with severe TBI (Glasgow Coma Scale score < 9) included by 5 Austrian hospitals were available. The analysis focused on incidence and/or degree of severity of typical clinical signs, frequency of use of different management options, and association with outcomes for both. ICU mortality, 90-day mortality, final outcome (favorable = good recovery or moderate disability; unfavorable = severe disability, vegetative state, or death) after 6 or 12 months, and ratio of observed (90-day) to predicted mortality (O/E ratio) are reported for the selected parameters. Chi(2)-test, t-test, Fisher's exact test, and logistic regression were used to identify significant (p < 0.05) differences for association with survival and favorable outcome (both coded as 1). RESULTS: The majority of patients were male (72%), mean age was 49 +/- 21 years, mean injury severity score (ISS) was 27 +/- 17, mean first GCS score was 5.6 +/- 2.9, and expected hospital survival was 63 +/- 30%. ICU mortality was 32%, 90-day mortality was 37%, and final outcome was favorable in 35%, unfavorable in 53%, unknown in 12%. We found that age > 60 years, ISS > 50 points, GCS score < 4, bilateral changes in pupil size and reactivity, respiratory rate < 10/min, systolic blood pressure (SBP) < 90 mm Hg, and heart rate < 60/min were associated with significantly higher ICU and 90-day mortality rates, and lower rates of favorable outcome. With regard to prognostic value the GCS motor response score is identical to the full GCS score. Administration of > 1000 ml of fluid and helicopter transport were associated with better outcomes than expected, while endotracheal intubation in the field had neither a positive nor a negative effect on outcomes. Administration of no or < 500 ml of fluids was associated with worse outcomes than expected. Outcomes were better than expected in the few patients (5%) who received hypertonic saline. CONCLUSIONS: Age, ISS, and initial neuro status are the factors most closely associated with outcome. Hypotension must be avoided. Fluids should be given to restore and/or maintain SBP > 110 mm Hg. Helicopter transport should be arranged for more seriously injured patients.	INRO, Med Advisory Board, A-1080 Vienna, Austria; Trauma Hosp Lorenz Boehler, Dept Anesthesia & Crit Care Med, Vienna, Austria		Mauritz, W (corresponding author), INRO, Med Advisory Board, Molkergasse 4-3, A-1080 Vienna, Austria.	walter.mauritz@igeh.org	Rusnak, Martin/K-9349-2016	Rusnak, Martin/0000-0003-3321-1042; Mauritz, Walter/0000-0001-9043-3712			American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Lal Dave, 2003, Prehosp Disaster Med, V18, P20; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz Walter, 2002, Eur J Emerg Med, V9, P315; Neff TA, 2003, ANESTH ANALG, V96, P1453, DOI 10.1213/01.ANE.0000061582.09963.FD; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Soreide E, 2005, INJURY, V36, P1001, DOI 10.1016/j.injury.2005.01.002; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Werner C, 1997, ANAESTHESIST, V46, pS55, DOI 10.1007/PL00002466; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011	34	21	23	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	FEB	2007	119	1-2					35	45		10.1007/s00508-006-0762-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142GQ	WOS:000244637800009	17318749				2022-02-06	
J	Corrigan, JD; Bogner, J				Corrigan, John D.; Bogner, Jennifer			Interventions to promote retention in substance abuse treatment	BRAIN INJURY			English	Article						traumatic brain injury; substance abuse; premature termination	TRAUMATIC BRAIN-INJURY; DRUG-ABUSE; THERAPEUTIC ALLIANCE; ALCOHOL-ABUSE; READINESS; PREDICTOR; INCENTIVES; ATTENDANCE; FRAMEWORK; BEHAVIOR	Objectives: Compare two methods of improving retention in substance abuse treatment for persons with traumatic brain injury. Design: Randomized clinical trial with control group comparison. Interventions: Provision of a financial incentive and reduction of logistical barriers. Outcome measures: Treatment attendance, perceived therapeutic alliance, premature termination. Results: Provision of a financial incentive was highly effective for facilitating early attendance and appeared to promote eventual successful treatment completion. Reduction of logistical barriers did not significantly improve attendance or successful discharge. The hypothesized role of improved therapeutic alliance as a consequence of intervention and a mediator for preventing premature termination was not supported. However, results suggested that intervention, particularly financial incentives, promoted congruence between counsellor and client perceived therapeutic alliance. Conclusions: For clients with traumatic brain injuries, provision of a financial incentive at an early point in substance abuse treatment substantially improves attendance and reduces the likelihood of premature termination. The basis for this effect appears to involve more than enhancement of the therapeutic alliance. We posit that concrete incentives can provide an opportunity for successful rule- governed behaviour that may generalize to other areas of improved impulse control.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Bogner, Jennifer/E-2773-2011; Corrigan, John D./E-2921-2011				Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Barber JP, 2001, J CONSULT CLIN PSYCH, V69, P119, DOI 10.1037/0022-006X.69.1.119; Barber JP, 1999, PSYCHOTHER RES, V9, P54, DOI 10.1080/10503309912331332591; Bates ME, 2006, PSYCHOL ADDICT BEHAV, V20, P241, DOI 10.1037/0893-164X.20.3.241; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Becker M H, 1980, J Community Health, V6, P113, DOI 10.1007/BF01318980; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BEUTLER LE, 1991, J CONSULT CLIN PSYCH, V59, P1; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; BLAKELY E, 1987, BEHAV ANALYST, V10, P183, DOI 10.1007/BF03392428; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; CAREY KB, 1990, J BEHAV THER EXP PSY, V21, P205, DOI 10.1016/0005-7916(90)90008-9; Cicerone KD, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P246; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan J.D., 2005, REHABILITATION TRAUM, P133; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; CORRIGAN JD, 1999, REHABILITATION ADULT; *CTR SUBST AB TREA, 1998, SUBST US DIS TREATM; De Weert-Van Oene GH, 2001, J SUBST ABUSE TREAT, V20, P253, DOI 10.1016/S0740-5472(01)00160-X; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; EATHER N, 1993, READINESS CHANGE QUE; Fantino E, 2004, BEHAV PROCESS, V66, P279, DOI 10.1016/j.beproc.2004.03.009; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; Higgins S T, 1993, NIDA Res Monogr, V137, P97; Higgins ST, 2002, ADDICT BEHAV, V27, P887, DOI 10.1016/S0306-4603(02)00297-6; HIGGINS ST, 1994, ARCH GEN PSYCHIAT, V51, P568; HIGGINS ST, 1991, AM J PSYCHIAT, V148, P1218; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kudadjie-Gyamfi E, 2002, BEHAV PROCESS, V57, P29, DOI 10.1016/S0376-6357(01)00205-4; LANGLEY MJ, 1991, WORK WORTH DOING ADV; LEZAK MD, 1999, NEUROPSYCHOLOGICAL A; Luborsky L, 1996, J Psychother Pract Res, V5, P260; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McLellan AT., 1990, ADDICTION SEVERITY I, V5th; Meier P.S., 2006, J SUBST USE, V11, P73, DOI [10.1080/14659890500137004, DOI 10.1080/14659890500137004]; Meier PS, 2005, ADDICTION, V100, P304, DOI 10.1111/j.1360-0443.2004.00935.x; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Newman C F, 1997, NIDA Res Monogr, V165, P181; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Reitan RM, 2005, APPL NEUROPSYCHOL, V12, P181, DOI 10.1207/s15324826an1204_1; Rhodes GL, 2003, AM J DRUG ALCOHOL AB, V29, P759, DOI 10.1081/ADA-120026259; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; ROWANSZAL G, 1994, J SUBST ABUSE TREAT, V11, P217, DOI 10.1016/0740-5472(94)90078-7; Silverman K, 1996, DRUG ALCOHOL DEPEN, V41, P157, DOI 10.1016/0376-8716(96)01246-X; Simpson DD, 2004, J SUBST ABUSE TREAT, V27, P99, DOI 10.1016/j.jsat.2004.06.001; SIMPSON DD, 1981, ARCH GEN PSYCHIAT, V38, P875; Simpson DD, 1997, DRUG ALCOHOL DEPEN, V47, P227; SIMPSON DD, 1993, PSYCHOTHER, V30, P357, DOI 10.1037/0033-3204.30.2.357; Simpson DD, 1997, J SUBST ABUSE TREAT, V14, P565, DOI 10.1016/S0740-5472(97)00181-5; SNOW RE, 1991, J CONSULT CLIN PSYCH, V59, P205, DOI 10.1037/0022-006X.59.2.205; SOBELL MB, 1992, BEHAV THER, V23, P43, DOI 10.1016/S0005-7894(05)80307-7; Verdejo-Garcia A, 2004, NEUROPSYCHOL REV, V14, P1, DOI 10.1023/B:NERV.0000026647.71528.83; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604	63	21	21	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	4					343	356		10.1080/02699050701253103			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	168IY	WOS:000246518600001	17487633				2022-02-06	
J	Donat, CK; Schuhmann, MU; Voigt, C; Nieber, K; Schliebs, R; Brust, P				Donat, Cornelius Kurt; Schuhmann, Martin Ulrich; Voigt, Cornelia; Nieber, Karen; Schliebs, Reinhard; Brust, Peter			Alterations of acetylcholinesterase activity after traumatic brain injury in rats	BRAIN INJURY			English	Article						traumatic brain injury; acetylcholinesterase; cholinergic system; controlled cortical impact; histochemistry; rat	CONTROLLED CORTICAL IMPACT; REDUCED EVOKED RELEASE; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; CHOLINERGIC NEURONS; GENE-EXPRESSION; MOLECULAR-FORMS; DEFICITS; MEMORY; INHIBITION	Objective: The cholinergic system is highly vulnerable to traumatic brain injury (TBI). However, limited information is available to what extent the degrading enzyme acetylcholinesterase (AChE) is involved. The present study addresses this question. Method: Thirty-six anaesthetized Sprague-Dawley rats were subjected to sham operation or to TBI using controlled cortical impact (CCI). The AChE activity was histochemically determined in frozen brain slices at 2,24 and 72 hours after TBI. Results: High enzyme activity was observed in regions rich in cholinergic innervation such as the olfactory tubercle, basal forebrain, putamen and superior colliculi. Low activity was found in the cortex, cerebellum and particularly in the white matter. A decrease of AchE activity (20 - 35%) was found in the hippocampus and hypothalamus already at 2 hours after TBI. An increase of similar to 30% was found in the basal forebrain at 2 and 24 hours. No changes occurred at 72 hours. Conclusion: The findings are consistent with impairment of the cholinergic neurotransmission after TBI and suggest the involvement of the AChE in short-term regulatory mechanisms.	Inst Interdisciplinary Isotope Res, D-04318 Leipzig, Germany; Univ Leipzig, Dept Neurosurg, Leipzig, Germany; Univ Tubingen, Dept Neurosurg, D-72074 Tubingen, Germany; Univ Leipzig, Inst Pharm, Leipzig, Germany; Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany		Donat, CK (corresponding author), Inst Interdisciplinary Isotope Res, Permoserstr 15, D-04318 Leipzig, Germany.	donat@iif-leipzig.de		, Peter/0000-0001-5555-7058			ANDRA J, 1986, HISTOCHEMISTRY, V84, P575, DOI 10.1007/BF00482994; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; ATACK JR, 1986, J NEUROCHEM, V47, P263; Beeri R, 1997, J NEUROCHEM, V69, P2441; Bohnen NI, 2005, NEUROSCI LETT, V380, P127, DOI 10.1016/j.neulet.2005.01.031; Bohnen NI, 2005, J NEUROL NEUROSUR PS, V76, P315, DOI 10.1136/jnnp.2004.038729; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Darreh-Shori T, 2004, J NEUROCHEM, V88, P1102, DOI 10.1046/j.1471-4159.2003.02230.x; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fu AL, 2005, BRAIN RES, V1066, P10, DOI 10.1016/j.brainres.2005.09.063; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Hammond PI, 1996, ANAL BIOCHEM, V241, P82, DOI 10.1006/abio.1996.0381; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kaufer D, 1999, CHEM-BIOL INTERACT, V119, P349, DOI 10.1016/S0009-2797(99)00046-0; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Ma TG, 2001, ANAL BIOCHEM, V296, P18, DOI 10.1006/abio.2001.5208; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Perrier NA, 2005, J NEUROCHEM, V94, P629, DOI 10.1111/j.1471-4159.2005.03140.x; Perrier NA, 2006, J MOL NEUROSCI, V30, P75, DOI 10.1385/JMN:30:1:75; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Shinotoh H, 2004, CURR PHARM DESIGN, V10, P1505, DOI 10.2174/1381612043384763; Shohami E, 2000, J MOL MED-JMM, V78, P228, DOI 10.1007/s001090000104; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tenovuo OS, 2006, CURR DRUG THER, V1, P187, DOI 10.2174/157488506776930932; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8	53	21	22	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	10					1031	1037		10.1080/02699050701630359			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WU	WOS:000250329600005	17891565				2022-02-06	
J	Frey, KL; Rojas, DC; Anderson, CA; Arciniegas, DB				Frey, Kimberly L.; Rojas, Donald C.; Anderson, C. Alan; Arciniegas, David B.			Comparison of the O-Log and GOAT as measures of posttraumatic amnesia	BRAIN INJURY			English	Article						traumatic brain injury; posttraumatic amnesia; memory; rating scales	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; GALVESTON ORIENTATION; COGNITIVE ORIENTATION; PRACTICAL SCALE; REHABILITATION; RECOVERY; RESOLUTION; SEVERITY; DURATION	Primary objective: To compare PTA severity and duration assessments made by Orientation Log ( O-Log) and the Galveston Orientation and Amnesia Test ( GOAT) and the relationship of data yielded by these assessments to rehabilitation outcomes. Research design: Retrospective study. Methods and procedures: O-Log, GOAT, demographic, length of stay, and Functional Independence Measure ( FIM) data among 83 inpatient subjects with recent TBI requiring inpatient care were reviewed. Main outcomes and results: PTA severity and duration as assessed by the O-Log and the GOAT are statistically similar and correlate similarly with rehabilitation LOS and discharge total FIM score. Simple linear regression models suggest that O-Log scores better predict rehabilitation outcomes than GOAT scores. Conclusions: Although the O-Log and GOAT perform similarly as measures of PTA severity and duration, PTA assessments using the O-Log offers better prediction of rehabilitation outcomes. Further study of the O-Log as an alternate assessment of PTA is warranted.	Spalding Rehabil Hosp, Brain Injury Rehabil Unit, HealthONE, Aurora, CO 80011 USA; Univ Colorado, Sch Med, Dept Psychiat, Neuropsychiat Serv, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Neurol Behav Neurol Sect, Denver, CO USA; Denver Vet Affairs Med Ctr, Neurol Serv, Denver, CO USA		Frey, KL (corresponding author), Spalding Rehabil Hosp, Brain Injury Rehabil Unit, HealthONE, 900 Potomac St, Aurora, CO 80011 USA.	Kim.Frey@uchsc.edu	Rojas, Don/F-4296-2012; Rojas, Don/AAX-6678-2020; Arciniegas, David/A-3792-2009	Rojas, Don/0000-0001-6560-9616; 			Ahmed S, 2000, BRAIN INJURY, V14, P765; Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Baird A, 2005, BRAIN INJURY, V19, P811, DOI 10.1080/02699050500149213; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARROSSZEKY N, 1998, GUIDELINES USING WES; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; VONWOWERN F, 1966, ACTA NEUROL SCAND, V42, P373; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	29	21	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	5					513	520		10.1080/02699050701311026			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000008	17522991				2022-02-06	
J	Katz, N; Golstand, S; Bar-Ilan, RT; Parush, S				Katz, Noomi; Golstand, Sarina; Bar-Ilan, Ruthie Traub; Parush, Shula			The Dynamic Occupational Therapy Cognitive Assessment for Children (DOTCA-Ch): A new instrument for assessing learning potential	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						attention deficit hyperactivity disorder (ADHD); cognition; learning disability; pediatric; traumatic brain injury (TBI)	ECOLOGICAL VALIDITY; ASSESSMENT LOTCA; PERFORMANCE; BATTERY; SKILLS	OBJECTIVE. To describe the development and psychometric properties of the Dynamic Occupational Therapy Cognitive Assessment for Children (DOTCA-Ch), a dynamic criterion-referenced assessment of cognitive abilities and learning potential for children with cognitive and learning difficulties. METHOD. A series of studies analyzed the age standards, criterion cutoff scores, and percentage of mediation cues required for typically developing children 6-12 years of age, as well as reliability and validity. RESULTS. MANOVA analyses determined four age groups that best fit the outcome data: 6-6.11, 7-8.11, 9-10.11, and 11-12 years. Criterion cutoff scores of 25% for at-risk and under 10% for deficient performance were obtained for each age group. Dynamic percentage scores were determined. Significant high interrater reliability and moderate to high internal consistency reliability were found. Construct validity was supported by comparing children with traumatic brain injury and learning disabilities to typically developing children, and ecological validity of children with attention deficit hyperactivity disorder by comparing performance on the DOTCA-Ch to the School Function Assessment. CONCLUSIONS. The DOTCA-Ch is a reliable and valid assessment that provides learning potential and can facilitate intervention for cognitive difficulties that manifest themselves in daily functions among school-age children.	Hebrew Univ Jerusalem, Sch Occupat Therapy, POB 24026,Mt Scopus, IL-91240 Jerusalem, Israel		Katz, N (corresponding author), Hebrew Univ Jerusalem, Sch Occupat Therapy, POB 24026,Mt Scopus, IL-91240 Jerusalem, Israel.	noomi.katz@huji.ac.il					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Annes G, 1996, OCCUPATIONAL THERAPY, V3, P157; AVERBUCH S, 2005, COGNITION OCCUPATION, P113; AVERSA SML, 1999, CLIN LUNG CANCER, V1, P1; CERMAK S, 1984, SENSORY INTEGRATION, V7, P3; CERMAK SA, 1995, AM J OCCUP THER, V49, P500, DOI 10.5014/ajot.49.6.500; CERMAK SA, 2005, COGNITION OCCUPATION, P277; CERMAK SA, 1984, SENSORY INTEGRATION, V7, P1; Conners CK, 1997, CONNERS RATING SCALE; Coster W., 1998, SCH FUNCTION ASSESSM; Creedy Debra, 2004, Contemp Nurse, V18, P46; CROCKER L, 1986, INTRO VCLASSICAL MOD; DELAVEGA M, 2004, THESIS TEL AVIV U TE; Fabio RA, 2005, J GEN PSYCHOL, V132, P41, DOI 10.3200/GENP.132.1.41-66; Feuerstein R., 1980, INSTRUMENTAL ENRICHM; Feuerstein R., 1979, DYNAMIC ASSESSMENT R; Grigorenko EL, 1998, PSYCHOL BULL, V124, P75, DOI 10.1037/0033-2909.124.1.75; Guthke J, 2000, ADV COGN ED, V6, P17; HUNG SS, 1987, AM J OCCUP THER, V41, P790, DOI 10.5014/ajot.41.12.790; Itzkovich M., 1996, GERIATRIC VERSION LO; KATZ N, 1989, AM J OCCUP THER, V43, P184, DOI 10.5014/ajot.43.3.184; Katz N, 2000, OCCUP THER J RES, V20, P3, DOI 10.1177/153944920002000101; KATZ N, 2003, DYN OCC THER COGN AS; Katz N., 2000, LOEWENSTEIN OCCUPATI; Katz N, 2005, DYNAMIC OCCUPATIONAL; KATZ N, 2002, OCCUPATIONAL THERAPY, V22, P1; KIPKE MD, 1998, FOR NAT AC SCI NAT R; LAW M, 2001, MEASURING OCCUPATION, P287; Lezak MD, 1995, EUROPSYCHOLOGICAL AS; Lidz CS, 2000, ADV COGN ED, V6, P3; Long C.J., 1996, ECOLOGICAL VALIDITY; MISSIUNA C, 2004, PRCEIVED EFFICACY GO; MOZLIN R, 1995, J BEHAV OPTOMETRY, V6, P115; Parush S., 2000, OCCUPATIONAL THERAPY, V7, P216, DOI [10.1002/oti.124, DOI 10.1002/OTI.124]; Rosenblum S, 2000, PERCEPT MOTOR SKILL, V90, P587, DOI 10.2466/PMS.90.2.587-594; Roth Thomas, 2003, Clin Cornerstone, V5, P5, DOI 10.1016/S1098-3597(03)90031-7; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Solan H A, 1987, J Am Optom Assoc, V58, P88; Solan H A, 1986, J Am Optom Assoc, V57, P28; Sugden, 1992, MOVEMENT ASSESSMENT; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; TOGLIA JP, 1994, DYNAMIC ASSESSMENT C; Toglia JP, 2005, COGNITION OCCUPATION, P29; Vygotsky LS., 1978, MIND SOC DEV HIGHER; Williams Jane, 2004, J Child Health Care, V8, P34, DOI 10.1177/1367493504041852; YU P, 2004, USE DYNAMIC OCUPATIO; ZIVIANI J., 2004, NZ J OCCUPATIONAL TH, V51, P17	47	21	22	1	10	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2007	61	1					41	52		10.5014/ajot.61.1.41			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	130EM	WOS:000243782300005	17302104				2022-02-06	
J	Yang, TC; Lo, YL; Huang, YC; Yang, ST				Yang, Tao-Chieh; Lo, Yang-Lan; Huang, Yin-Chen; Yang, Shun-Tai			Traumatic anterior cerebral artery aneurysm following blunt craniofacial trauma	EUROPEAN NEUROLOGY			English	Article						traumatic anterior cerebral artery aneurysms; delayed-onset rebleeding; pericallosal artery; callosomarginal artery; transarterial embolization	INTRACRANIAL ANEURYSMS; HEMORRHAGE; CHILDHOOD; RUPTURE	Background: Traumatic aneurysms of the anterior cerebral artery ( ACA) were retrospectively reviewed in an effort to identify patients at high risk of ACA aneurysm. Methods: Blunt craniofacial trauma patients featuring vascular injuries over the region of the ACA were studied. Results: Six patients featuring eight ACA aneurysms were diagnosed between June 1992 and December 2005, inclusively. Seven aneurysms were located at nonbranched sites and one was located over the right ACA-anterior communicating artery junction. One patient died immediately of massive intracranial lobar hemorrhage (ICH). The other 5 patients experienced rebleeding during a period of from 1 to 29 days. Brain computed tomography revealed subarachnoid hemorrhage ( SAH) in 1 of these 6 patients, ICH over the medial frontal area or cingulated gyrus in 4 patients, intraventricular hemorrhage ( IVH) in 3 patients, and an interhemispheric subdural hematoma ( SDH) in 2 patients. Conclusion: Delayed-onset deterioration of neurological deficit is the most common clinical presentation of traumatic ACA aneurysms. Midline hemorrhage such as medial frontal hemorrhage or cingulate gyrus hemorrhage, and the presence of an interhemispheric SDH associated with SAH and IVH subsequent to blunt craniofacial trauma should be further evaluated, as they present a high risk of traumatic ACA aneurysms to patients. Copyright (c) 2007 S. Karger AG, Basel.	Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Kwei Shan Count, Taiwan		Yang, ST (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, 5 Fu Shin St, Tao Yuan, Kwei Shan Count, Taiwan.	yst0708@yahoo.com.tw					ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cummings TJ, 2000, NEUROL RES, V22, P165, DOI 10.1080/01616412.2000.11741055; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Ishibashi Akira, 1995, Neurologia Medico-Chirurgica, V35, P882, DOI 10.2176/nmc.35.882; Kumar M, 1998, NEUROSURG CLIN N AM, V9, P577; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PERLMUTTER D, 1978, J NEUROSURG, V49, P204, DOI 10.3171/jns.1978.49.2.0204; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Sasaoka Y, 1997, NEUROL SURG TOKYO, V25, P337; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; YOKOTA H, 1983, Neurological Surgery, V11, P521	15	21	22	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2007	58	4					239	245		10.1159/000107970			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	227KN	WOS:000250655700009	17851246				2022-02-06	
J	Greve, KW; Bianchini, KJ				Greve, Kevin W.; Bianchini, Kevin J.			Classification accuracy of the Portland Digit Recognition Test in traumatic brain injury: Results of a known-groups analysis	CLINICAL NEUROPSYCHOLOGIST			English	Article							MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; CARD SORTING TEST; MILD HEAD TRAUMA; COGNITIVELY INTACT; NORMATIVE DATA; RESPONSE BIAS; TOMM; PERFORMANCE; DEPRESSION	The present study used a known-groups design to examine the accuracy of the Portland Digit Recognition Test (PDRT) in the detection of malingering in traumatic brain injury (TBI). Data were derived from 262 TBI patients who were classified as not malingering, possibly malingering, and malingering based on the Slick, Sherman, and Iverson (1999) criteria. The original PDRT cutoffs detected between 20 and 50% of malingering TBI patients with a false positive error rate of 5% or less. When the false positive error rate was held at 5%, across all item sets, sensitivity was as high as 70%. The results show that the original PDRT cutoffs are conservative and that higher scores detect more MND patients without causing the false positive error rate to become unacceptably high. Clinical application and future research needs are discussed.	Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA; Jefferson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1993, PORTLAND DIGIT RECOG; BINDER LM, 2002, J FORENSIC NEUROPSYC, V2, P27; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Doane BM, 2005, CLIN NEUROPSYCHOL, V19, P99, DOI 10.1080/13854040490524100; Gouvier WD, 1998, CRIT ISS NE, P55; Greene R. L., 1991, MMPI 2 INTERPRETIVE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; GREVE KW, IN PRESS J CLIN EXPT; Gunstad J, 2001, CLIN NEUROPSYCHOL, V15, P397, DOI 10.1076/clin.15.3.397.10271; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Heaton SK, 1993, WISCONSIN CARD SORTI; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Ju D, 2000, Appl Neuropsychol, V7, P201, DOI 10.1207/S15324826AN0704_1; KAGEHIRO DK, 1990, PSYCHOL SCI, V1, P194, DOI 10.1111/j.1467-9280.1990.tb00197.x; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; *U MINN, 1989, MINN MULT PERS INV 2; Wechsler D., 1987, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	46	21	21	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2006	20	4					816	830		10.1080/13854040500346610			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	085IE	WOS:000240597000016	16980264				2022-02-06	
J	Hart, T; Dijkers, M; Fraser, R; Cicerone, K; Bogner, JA; Whyte, J; Malec, J; Waldron, B				Hart, Tessa; Dijkers, Marcel; Fraser, Robert; Cicerone, Keith; Bogner, Jennifer A.; Whyte, John; Malec, James; Waldron, Brigid			Vocational services for traumatic brain injury - Treatment definition and diversity within model systems of care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						measurement of treatment; traumatic brain injury; vocational rebabilitation	SUPPORTED EMPLOYMENT; BLACK-BOX; REHABILITATION; WORK; RETURN; SATISFACTION; INDIVIDUALS; LIFE	Objective: To examine characteristics and diversity among vocational treatment services in model programs for traumatic brain injury (TBI) rehabilitation. Setting: Vocational or postacute treatment components of 16 TBI Model System (TBIMS) centers. Participants: Vocational director/coordinator from each TBIMS surveyed in semistructured phone interview. Measure: Survey of vocational services for people with TBI, with about 100 closed and open-ended questions on vocational assessments; pre- and postjob placement treatments; program philosophies; funding; and integration of cognitive, behavioral, family, and medical rehabilitation interventions. Results: Great diversity was found among the vocational services of the 16 TBIMS. Programs fell into 3 clusters emphasizing medical rehabilitation services, supported employment, or a combination of these with an emphasis on case management. job coaching was identified as a key intervention, but there was great variability in intensity, availability, and funding of coaching services. Conclusion: Diversity in vocational services appears related to funding differences and "parallel evolution" rather than strong treatment philosophy or scientific evidence base. Multicenter research on effectiveness or establishment of best practices in vocational rehabilitation after TBI must deal with substantial existing variability in treatment models and specific interventions, and must examine the relationship of treatment variations to case-mix factors.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ USA; Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	thart@einstein.edu	Bogner, Jennifer/E-2773-2011; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W/0000-0003-2782-7326; Dijkers, Marcel/0000-0002-8362-5596; Whyte, John/0000-0002-4381-1474			ABRAMS D, 1993, J HEAD TRAUMA REHAB, V84, P59; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 1997, PSYCHIATR SERV, V48, P335; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; *COMM ACCR REH FAC, 2002, COMM ACCR REH FAC ST; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Crowther R, 1800, Cochrane Database Syst Rev, pCD003080, DOI 10.1002/14651858.CD003080; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; FRASER R, 1997, VOCAT REHABIL, V8, P371; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Keith RA, 1997, ARCH PHYS MED REHAB, V78, P1298, DOI 10.1016/S0003-9993(97)90300-2; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Malec JF, 2005, REHABILITATION TRAUM, P176; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Prigatano GP, 1985, NEUROPSYCHOLOGICAL R; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wall JR, 1998, BRAIN INJURY, V12, P215; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Wehman P, 1999, REHABILITATION ADULT, P326; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D	34	21	21	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2006	21	6					467	482		10.1097/00001199-200611000-00002			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	109UC	WOS:000242333400002	17122678				2022-02-06	
J	Jhanjee, R; van Dijk, JG; Sakaguchi, S; Benditt, DG				Jhanjee, Rajat; van Dijk, J. Gert; Sakaguchi, Scott; Benditt, David G.			Syncope in adults: Terminology, classification, and diagnostic strategy	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						syncope; unconsciousness; transient loss of consciousness	AMERICAN-HEART-ASSOCIATION; MANAGEMENT; GUIDELINES; HISTORY; RECOMMENDATIONS; STATEMENT; CRITERIA; COLLEGE; SOCIETY	Syncope is a relatively common clinical syndrome that is a subset of a broader range of conditions that cause transient loss of consciousness (TLOC). Other TLOC conditions include seizures, concussions, and intoxications. However, despite frequent confusion in the medical literature, syncope is and should be clearly distinguished from those other causes of TLOC by virtue of its pathophysiology; specifically, syncope is the result of self-terminating inadequacy of global cerebral nutrient perfusion, while the other forms of TLOC have different etiologies. Unfortunately, the diagnostic evaluation of syncope remains for the most part poorly managed and inefficient. Careful history-taking, physical examination, and judicious use of tests can not only increase the diagnostic yield of the evaluation, but also increase patient safety and reduced overall healthcare costs.	Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div,Cardiac Arrhythmia Ctr, Minneapolis, MN 55455 USA; Leiden Univ, Med Ctr, Dept Neurol & Clin Neurophysiol, Leiden, Netherlands		Benditt, DG (corresponding author), Mail Code 508,420 Delaware St SE, Minneapolis, MN 55455 USA.	bendi001@umn.edu					Alboni P, 2001, J AM COLL CARDIOL, V37, P1921, DOI 10.1016/S0735-1097(01)01241-4; Barton GM, 2004, NAT IMMUNOL, V5, P472, DOI 10.1038/ni0504-472; Benditt DG, 2005, CARDIAC ARRHYTHMIAS 2005, P655; Benditt DG, 2006, EUR HEART J, V27, P7, DOI 10.1093/eurheartj/ehi626; Benditt DG, 2003, J AM COLL CARDIOL, V41, P791, DOI 10.1016/S0735-1097(02)02928-5; Blanc JJ, 2002, EUR HEART J, V23, P815, DOI 10.1053/euhj.2001.2975; Brignole M, 2004, EUROPACE, V6, P467, DOI 10.1016/j.eupc.2004.08.008; Brignole M, 2006, EUR HEART J, V27, P76, DOI 10.1093/eurheartj/ehi647; Brignole M, 2003, EUROPACE, V5, P425, DOI 10.1016/S1099-5129(03)00088-6; Brignole M, 2003, EUROPACE, V5, P293, DOI 10.1016/S1099-5129(03)00047-3; BRIGNOLE M, 1995, AM J CARDIOL, V76, P273, DOI 10.1016/S0002-9149(99)80080-0; CALKINS H, 1995, AM J MED, V98, P365, DOI 10.1016/S0002-9343(99)80315-5; Chen-Scarabelli C, 2004, BMJ-BRIT MED J, V329, P336, DOI 10.1136/bmj.329.7461.336; Crawford MH, 1999, CIRCULATION, V100, P886, DOI 10.1161/01.CIR.100.8.886; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; Ermis C, 2003, AM J CARDIOL, V92, P815, DOI 10.1016/S0002-9149(03)00889-0; Fitzpatrick AP, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P63; Flecher E., 2005, Annales de Cardiologie et d'Angeiologie, V54, P141, DOI 10.1016/j.ancard.2005.04.007; Joshi AK, 2005, AM J CARDIOL, V95, P878, DOI 10.1016/j.amjcard.2004.12.015; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Kenny RA, 2002, AGE AGEING, V31, P272, DOI 10.1093/ageing/31.4.272; Krahn AD, 1999, CIRCULATION, V99, P406, DOI 10.1161/01.CIR.99.3.406; Krahn AD, 2003, J AM COLL CARDIOL, V42, P495, DOI 10.1016/S0735-1097(03)00659-4; Krahn AD, 2001, CIRCULATION, V104, P46, DOI 10.1161/01.CIR.104.1.46; Linzer M, 1997, ANN INTERN MED, V126, P989, DOI 10.7326/0003-4819-126-12-199706150-00012; Lu F, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P80; Moya A, 2001, CIRCULATION, V104, P1261, DOI 10.1161/hc3601.095708; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; ROSS D, 2003, CAN CARD SOC CONS C; Sheldon R, 2006, EUR HEART J, V27, P344, DOI 10.1093/eurheartj/ehi584; Sheldon R, 2002, J AM COLL CARDIOL, V40, P142, DOI 10.1016/S0735-1097(02)01940-X; Shen WK, 2004, CIRCULATION, V110, P3636, DOI 10.1161/01.CIR.0000149236.92822.07; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; SRA JS, 1991, ANN INTERN MED, V114, P1013, DOI 10.7326/0003-4819-114-12-1013; Strickberger SA, 2006, CIRCULATION, V113, P316, DOI 10.1161/CIRCULATIONAHA.105.170274; Sutton R, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P31; Thijs RD, 2004, CLIN AUTON RES, V14, P4, DOI 10.1007/s10286-004-1002-4; van Dijk JG, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P184; van Dijk JG, 2003, EVALUATION AND TREATMENT OF SYNCOPE: A HANDBOOK FOR CLINICAL PRACTICE, P102	39	21	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	OCT	2006	29	10					1160	1169		10.1111/j.1540-8159.2006.00508.x			10	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Engineering	104XY	WOS:000241995100015	17038147				2022-02-06	
J	Coronel, MF; Musolino, PL; Villar, MJ				Coronel, Maria Florencia; Musolino, Patricia Leonor; Villar, Marcelo Jose			Selective migration and engraftment of bone marrow mesenchymal stem cells in rat lumbar dorsal root ganglia after sciatic nerve constriction	NEUROSCIENCE LETTERS			English	Article						stem cell trafficking; primary afferent neurons; peripheral nerve lesion; peripheral neuropathies	STROMAL CELLS; SPINAL-CORD; ADHESION MOLECULE; SCHWANN-CELLS; DRG NEURONS; EXPRESSION; TRANSPLANTATION; DIFFERENTIATION; REGENERATION; RECEPTOR	Bone marrow mesenchymal stem cells (MSCs) preferentially migrate to the injured hemisphere when administered intravenously to rats with traumatic or ischemic brain injuries. In this study, we have investigated the localization of MSCs injected into the lumbar-4 dorsal root ganglion (L4-DRG) of rats with a sciatic nerve single ligature nerve constriction (SLNC). NISCs were isolated by their adherence to plastic, cultured until confluence and labelled with Hoechst. Animals with a unilateral injection of MSCs were subjected to an ipsilateral, bilateral or contralateral SLNC. After 9 days, they were perfused and the lumbar DRGs were dissected out, cut in a cryostat and observed with a fluorescence microscope. Large numbers of Hoechst-positive cells were observed in the injected L4-DRG, distributed around primary afferent neurons, resembling the anatomical localization of glial cells. In animals with an ipsilateral SLNC, some cells were detected in the ipsilateral L3, L5 or L6-DRGs but not in the contralateral ganglia. In animals with a bilateral lesion, NISCs migrated to both the ipsilateral and contralateral DRGs whereas in animals with a contralateral ligature, MSCs migrated to the contralateral DRGs. These results suggest that NISCs preferentially engraft in DRGs hosting primary sensory neurons affected by a lesion of their peripheral branches. Further studies should be carried out in order to elucidate the molecular mechanisms involved in this migration and homing, in order to evaluate the possible use of NISCs as a new therapeutic strategy for the treatment of peripheral nerve neuropathies. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Austral Univ, Sch Biomed Sci, RA-1629 Buenos Aires, DF, Argentina		Villar, MJ (corresponding author), Austral Univ, Sch Biomed Sci, Av Pte Peron 1500, RA-1629 Buenos Aires, DF, Argentina.	mvillar@cas.austral.edu.ar		Musolino, Patricia L./0000-0001-8724-5649			Abouelfetouh A, 2004, BRAIN RES, V1029, P114, DOI 10.1016/j.brainres.2004.07.092; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Brumovsky PR, 2004, BRAIN RES, V1006, P87, DOI 10.1016/j.brainres.2003.09.085; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Corti S, 2002, J NEUROSCI RES, V70, P721, DOI 10.1002/jnr.10455; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Hiroi S, 2003, FEBS LETT, V554, P311, DOI 10.1016/S0014-5793(03)01176-1; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Liu Li-Hui, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P417; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mimura T, 2004, J NEUROSURG, V101, P806, DOI 10.3171/jns.2004.101.5.0806; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; OWEN M, 1988, CIBA F SYMP, V136, P42; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; Soares S, 2005, EUR J NEUROSCI, V21, P1169, DOI 10.1111/j.1460-9568.2005.03961.x; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Wang Lei, 2002, Hematology, V7, P113; ZAMBONI L, 1967, J CELL BIOL, V35, pA148; Zhang PX, 2004, ARTIF CELL BLOOD SUB, V32, P509, DOI 10.1081/BIO-200039608	28	21	22	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 11	2006	405	1-2					5	9		10.1016/j.neulet.2006.06.018			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079IO	WOS:000240169500002	16806704				2022-02-06	
J	Farchi, S; Rossi, PG; Chini, F; Camilloni, L; Di Giorgio, M; Guasticchi, G; Borgia, P				Farchi, Sara; Rossi, Paolo Giorgi; Chini, Francesco; Camilloni, Laura; Di Giorgio, Maurizio; Guasticchi, Gabriella; Borgia, Piero			Unintentional home injuries reported by an emergency-based surveillance system: Incidence, hospitalisation rate and mortality	ACCIDENT ANALYSIS AND PREVENTION			English	Article						unintentional home injury; record linkage; surveillance; emergency department	TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVAL; US CHILDREN; RESIDENTIAL INJURIES; DEATH CERTIFICATES; NONFATAL INJURIES; UNITED-STATES; RISK-FACTORS; FALLS; EPIDEMIOLOGY	Objective: The aim of this study is to quantify the incidence of home injuries using an integrated surveillance system. It aims to estimate home accident mortality. Material and methods: The sources of data for this epidemiological descriptive study were the emergency information system, the hospital information system and the mortality registry of Lazio Region, 2000-2001. We selected all emergency department (ED) visits for unintentional traumas that occurred at home. We calculated incidence of ED visits, hospitalisation and mortality rates by sex and age. Results: In the year 2000, 145 101 persons visited the ED (2700/100 000), 8.1% of whom were then admitted to the hospital. Incidence was higher among children and older people. We observed 620 fatalities, a rate of 0.43%. The mortality registry reported 1042 deceased, a home accident-related mortality rate of 31.1/100 000. Conclusions: Unintentional injuries in the home are a relevant public health problem. Since none of the databases used in the study give a complete measure of the burden of home injuries, we combined the data from all of them to estimate the mortality and the burden of home injuries. Interventions for prevention must identify the specific accidents/injuries they are trying to reduce in order to focus their intervention on the appropriate population. (c) 2006 Elsevier Ltd. All rights reserved.	Publ Hlth Agcy Lazio Reg, I-00198 Rome, Italy		Farchi, S (corresponding author), Publ Hlth Agcy Lazio Reg, Via Santa Constanza, I-00198 Rome, Italy.	farchi@asplazio.it; giorgirossi@asplazio.it; chini@asplazio.it; camilloni@asplazio.it; digiorgio@asplazio.it; guasticchi@asplazio.it; borgia@asplazio.it	Rossi, Paolo Giorgi/K-6367-2016	Rossi, Paolo Giorgi/0000-0001-9703-2460			Ancona C, 2000, J EPIDEMIOL COMMUN H, V54, P930, DOI 10.1136/jech.54.12.930; Arkovitz MS, 1997, J TRAUMA, V42, P49, DOI 10.1097/00005373-199701000-00009; BALLARD JE, 1992, AM J EPIDEMIOL, V135, P26, DOI 10.1093/oxfordjournals.aje.a116198; Ballesteros MF, 2003, INJURY PREV, V9, P173, DOI 10.1136/ip.9.2.173; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bath PA, 1999, EUR J EPIDEMIOL, V15, P65, DOI 10.1023/A:1007531101765; Bienefeld M, 1996, Chronic Dis Can, V17, P21; BRENNAN J, 2003, OSTEOPOROS INT  0430; Cameron CM, 2005, J TRAUMA, V59, P639, DOI 10.1097/01.ta.0000183222.79685.23; D'Amico M, 1999, EUR J EPIDEMIOL, V15, P141, DOI 10.1023/A:1007570405888; Dedoukou X, 2004, ARCH PEDIAT ADOL MED, V158, P1002, DOI 10.1001/archpedi.158.10.1002; Dewar DJ, 2004, J BURN CARE REHABIL, V25, P224, DOI 10.1097/01.BCR.0000124821.22553.24; Geusens Piet, 2003, J Br Menopause Soc, V9, P101, DOI 10.1258/136218003100322314; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Gulliver P, 2005, AUST NZ J PUBL HEAL, V29, P29, DOI 10.1111/j.1467-842X.2005.tb00744.x; *HOM SAF COUNC, 2002, STAT HOM SAF AM FACT; Johansson LA, 2002, J EPIDEMIOL COMMUN H, V56, P301, DOI 10.1136/jech.56.4.301; Kopjar B, 1996, AM J EPIDEMIOL, V144, P456; Kron M, 2003, AM J EPIDEMIOL, V158, P645, DOI 10.1093/aje/kwg203; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; McGwin G, 2000, J TRAUMA, V49, P470, DOI 10.1097/00005373-200009000-00014; Migliaccio J, 2004, GENERATIONS, V28, P20; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Morrongiello BA, 2004, INJURY PREV, V10, P62, DOI 10.1136/ip.2003.003624; Mullins RJ, 1998, JAMA-J AM MED ASSOC, V279, P1727, DOI 10.1001/jama.279.21.1727; Nagaraja J, 2005, PEDIATRICS, V116, P454, DOI 10.1542/peds.2004-1415; Olson CJ, 2003, J TRAUMA, V55, P45, DOI 10.1097/01.TA.0000071291.17287.57; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Phelan KJ, 2005, PUBLIC HEALTH REP, V120, P63, DOI 10.1177/003335490512000111; Posner JC, 2004, PEDIATRICS, V113, P1603, DOI 10.1542/peds.113.6.1603; Powell EC, 2002, PEDIATRICS, V110, P792, DOI 10.1542/peds.110.4.792; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rogmans W, 2000, Sante Publique, V12, P283; Rossi PG, 2005, ANN EMERG MED, V46, P152, DOI 10.1016/j.annemergmed.2005.01.033; Rossi RG, 2004, INT J TUBERC LUNG D, V8, P528; Runyan CW, 2005, AM J PREV MED, V28, P80, DOI 10.1016/j.amepre.2004.09.017; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Rutledge R, 1997, J TRAUMA, V42, P477, DOI 10.1097/00005373-199703000-00016; Saluja Gitanjali, 2004, Inj Control Saf Promot, V11, P17, DOI 10.1076/icsp.11.1.17.26310; Shinoda-Tagawa T, 2003, INJURY PREV, V9, P214, DOI 10.1136/ip.9.3.214; Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4; Uitenbroek DG, 1996, RES Q EXERCISE SPORT, V67, P380, DOI 10.1080/02701367.1996.10607969; Villalba-Cota J, 2004, ANN TROP PAEDIATR, V24, P53, DOI 10.1179/027249304225013259; Weiss Steven J, 2003, Prehosp Emerg Care, V7, P79, DOI 10.1080/10903120390937148; Zuckerbraun NS, 2004, PEDIATR EMERG CARE, V20, P361, DOI 10.1097/01.pec.0000133609.04581.9f	46	21	21	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2006	38	5					843	853		10.1016/j.aap.2006.02.009			11	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	070NA	WOS:000239528200003	16574047				2022-02-06	
J	Witgen, BM; Lifshitz, J; Grady, MS				Witgen, Brent M.; Lifshitz, Jonathan; Grady, M. Sean			Inbred mouse strains as a tool to analyze hippocampal neuronal loss after brain injury: A stereological study	JOURNAL OF NEUROTRAUMA			English	Article						head injury; hippocampus; optical disector; optical fractionator; stereology; traumatic brain injury	ENRICHED-ENVIRONMENT; OPTICAL FRACTIONATOR; DENTATE GYRUS; HEAD-INJURY; CELL LOSS; NUMBER; RAT; MODEL; DEATH; MICE	Traumatic brain injury (TBI) damages the hippocampus both in experimental animal models and in humans. In particular, the mechanical injury in combination with the genetic susceptibility to injury may result in neuronal loss from the hippocampus. This report explores the time-course of neuronal loss in the four primary subregions of the mouse hippocampus after a lateral fluid percussion injury (FPI) to the brain, and how subtle genetic differences between C57BL/6J and C57BL/10J mouse strains influence the extent and time course of neuronal loss. Using design-based stereological procedures, our results indicate negligible neuronal loss ipsilateral to the injury at 2 days postinjury in C57BL/6J mice, whereas a significant number (30-40%) of neurons are lost across all subregions of the hippocampus (dentate, hilus, area CA3, and area CA1) by 1 week, which does not appear to progress at I month, compared to sham. Additionally, neuronal counts after lateral FPI in a genetically similar, yet kainic acid-sensitive, mouse strain (C57BL/10J) showed no statistically significant differences in neuron number compared to the C57BL/6J strain in response to brain injury. Hippocampal neuronal loss after lateral FPI and its consequent circuit disruption may depend more on factors related to the mechanics and secondary consequences of the injury, as opposed to subtle genetic variations between inbred mouse strains. The loss of neurons appears to be restricted to the first week post-injury, and the remaining neurons may serve as a substrate for recovery.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Grady, MS (corresponding author), 3 Silverstein Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	Sean.Grady@uphs.upenn.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD049343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32 HD-049343] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-05098, T32 NS-043126] Funding Source: Medline		Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; FERRARO TN, 1995, EPILEPSIA, V36, P301, DOI 10.1111/j.1528-1157.1995.tb00999.x; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hartman RE, 2002, J NEUROSCI, V22, P10083; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schauwecker PE, 2000, BRAIN RES, V884, P116, DOI 10.1016/S0006-8993(00)02888-2; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Shuttleworth CWR, 2001, J NEUROSCI, V21, P4225, DOI 10.1523/JNEUROSCI.21-12-04225.2001; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052	41	21	21	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1320	1329		10.1089/neu.2006.23.1320			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900004	16958584				2022-02-06	
J	Toczylowska, B; Chalimoniuk, M; Wodowska, M; Mayzner-Zawadzka, E				Toczylowska, Beata; Chalimoniuk, Malgorzata; Wodowska, Magdalena; Mayzner-Zawadzka, Ewa			Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury	BRAIN RESEARCH			English	Article						cerebrospinal fluid; brain trauma; nitric oxide; amino acid; proton NMR spectroscopy	MAGNETIC-RESONANCE SPECTROSCOPY; AMINO-ACIDS; GLUTAMATE; ISCHEMIA; EXCITOTOXICITY; DEGENERATION; BLOCKERS; GENDER; IMPACT; DAMAGE	Brain injury, like other central nervous system pathologies, causes changes in the composition of the cerebrospinal fluid (CSF). In this study, changes in the concentration of small molecules of the CSF, which are in the minimal micromolar concentration, were observed and monitored using high-resolution proton (NMR) spectroscopy. Twenty-two patients with isolated traumatic brain injuries (TBI) and 15 patients making up the control group were recruited for the study. CSF samples were collected by lumbar puncture from the lumbar subarachnoid space in the patients just before commencement of therapy and on the first, third, seventh and fourteenth days of therapy at the ICU. Forty-four signals of the NMR spectra and NO concentration of the CSF samples were analyzed. The analysis shows that the amino acid and organic acid concentrations change during the therapy and mostly are higher than in the control group. Significant differences in concentration of the analyzed CSF components between the TBI patients and the control group have been noted. The rate of the lactate to pyruvate conversion increased because the L/P ratio showed no significant differences between the TBI group and the control group, while the concentrations of both components were significantly higher in the TBI patients than in the control group. Citrulline, arginine and nitric oxide concentrations were the focus of the analysis. Citrulline concentration changes overlapped NO changes from 0 until 3rd day of therapy, while for the remaining days of observation the NO concentration stabilized at the control level, whereas citrulline concentration significantly decreased. (c) 2006 Elsevier B.V. All rights reserved.	Polish Acad Sci, Inst Biochem & Biophys, PL-02109 Warsaw, Poland; Polish Acad Sci, Inst Biocybernet & Biomed Engn, PL-02109 Warsaw, Poland; Polish Acad Sci, Med Res Ctr, Dept Cellular Signaling, PL-02109 Warsaw, Poland; Med Univ Warsaw, Dept Anaesthesia & Intens Therapy, PL-02005 Warsaw, Poland		Toczylowska, B (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, 5A Pawinskiego St, PL-02109 Warsaw, Poland.	beatat@ibib.waw.pl	Chalimoniuk, Malgorzata/Y-4440-2018	Chalimoniuk, Malgorzata/0000-0003-0361-8626; Toczylowska, Beata/0000-0002-5031-6228			Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; BARKER PB, 2001, FUNDAMENTALS CLIN MR, P168; Baumgartner WA, 1997, J CARDIAC SURG, V12, P300; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Calzada JI, 2002, NEUROCHEM RES, V27, P79, DOI 10.1023/A:1014854606309; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; Kalloniatis M, 1995, J Am Optom Assoc, V66, P750; Li W, 1999, J INTERF CYTOK RES, V19, P121, DOI 10.1089/107999099314261; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Martin RL, 1997, J CLIN NEUROSCI, V4, P290, DOI 10.1016/S0967-5868(97)90096-5; Mascalchi M, 1998, ANN NEUROL, V43, P244, DOI 10.1002/ana.410430215; McAdoo DJ, 2005, BRAIN RES, V1038, P92, DOI 10.1016/j.brainres.2005.01.024; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; ROSENBERG GA, 1980, AM J PHYSIOL, V238, pF42, DOI 10.1152/ajprenal.1980.238.1.F42; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; SADASIVUDU B, 1976, J NEUROCHEM, V27, P785, DOI 10.1111/j.1471-4159.1976.tb10409.x; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; SHUAIB A, 1994, BRAIN RES, V666, P99, DOI 10.1016/0006-8993(94)90287-9; Silberstein M, 2002, AM J NEURORADIOL, V23, P389; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Takahashi T, 1997, Nihon Shinkei Seishin Yakurigaku Zasshi, V17, P7; Tedeschi G, 1997, BRAIN, V120, P1541, DOI 10.1093/brain/120.9.1541; Vannucci RC, 1999, DEV BRAIN RES, V118, P147, DOI 10.1016/S0165-3806(99)00142-X; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; WEVERS RA, 1995, CLIN CHEM, V41, P744; WILLIAMS S, 2001, ISMRM EMSRMB JOINT A, P329; Yang CL, 2001, J PSYCHOLINGUIST RES, V30, P21, DOI 10.1023/A:1005252123299; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	32	21	22	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 9	2006	1104						183	189		10.1016/j.brainres.2006.05.057			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	082XR	WOS:000240421000018	16793028				2022-02-06	
J	Engstrom, M; Schott, U; Nordstrom, CH; Romner, B; Reinstrup, P				Engstrom, Martin; Schott, Ulf; Nordstrom, Carl-Henrik; Romner, Bertil; Reinstrup, Peter			Increased lactate levels impair the coagulation system - A potential contributing factor to progressive hemorrhage after traumatic brain injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						acidosis; coagulation; lactate; thromboelastography; trauma	CEREBRAL PERFUSION-PRESSURE; ACTIVATED FACTOR-VII; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; COAGULOPATHY; HYPOTHERMIA; TIME; THROMBOELASTOGRAPHY; THROMBELASTOGRAPHY; PREDICTORS	Progressive intracerebral contusions are a major problem in the management of patients with severe traumatic brain injury that is also linked to worse outcome. Microdialysis studies have revealed that lactate levels are very high inside contusions, corresponding to significant acidosis. The current study was performed in an effort to investigate whether the lactate accumulation inside cerebral contusions may be a contributing factor to the prolonged bleeding inside contusions. We have investigated the effects of lactic acidosis on the coagulation system with rotational thromboelastometry. It was a laboratory study involving 6 healthy volunteers. Blood was drawn and the pH was adjusted by addition of lactic acid in vitro. The pH levels studied were 7.4, 7.2, 7.0, and 6.8. The pH was also readjusted to 7.4 by addition the buffer THAM to blood initially adjusted to a pH of 6.8 to study the reversibility of potential adverse effects induced by the lactic acidosis. We found the coagulation to be significantly impaired by lactic acidosis (P = 0.0001). The impairment found was reversible after correction of the acidosis by a buffer. In conclusion, we found that lactic acidosis impaired the coagulation system. The impairment caused by lactic acidosis may be one factor causing the progressive hemorrhage in postraumatic cerebral contusions, known to have high levels of lactate and correspondingly low pH. It may also be important to consider in bleeding trauma patients.	Univ Lund Hosp, Dept Anaesthesia & Intens Care, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden; Halmstad Cty Hosp, Dept Anaesthesia & Intens Care, Halmstad, Sweden		Engstrom, M (corresponding author), Lund Univ, Dept Anaesthesia & Intens Care, S-22185 Lund, Sweden.	martin.engstrom@med.lu.se	Schott, Ulf/AAY-6982-2020				Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Armand R, 2003, TRANSFUS MED REV, V17, P223, DOI 10.1016/S0887-7963(03)00022-1; Bowbrick VA, 2003, PLATELETS, V14, P219, DOI 10.1080/0953710031000118849; Caprini JA, 1995, SEMIN THROMB HEMOST, V21, P91; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Engstrom Martin, 2005, BMC Blood Disord, V5, P3, DOI 10.1186/1471-2326-5-3; Gentilello LM, 2001, AM J RESP CRIT CARE, V163, P604, DOI 10.1164/ajrccm.163.3.2004106; Goh KYC, 1997, J NEUROL NEUROSUR PS, V63, P334, DOI 10.1136/jnnp.63.3.334; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Hendriks HGD, 2002, BLOOD COAGUL FIBRIN, V13, P309, DOI 10.1097/00001721-200206000-00006; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hutchinson PJA, 2002, ACT NEUR S, V81, P359; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kettner SC, 2003, ANESTH ANALG, V96, P1772, DOI 10.1213/01.ANE.0000062520.65192.C9; Krishna G, 1998, AUST NZ J SURG, V68, P826, DOI 10.1111/j.1445-2197.1998.tb04696.x; Lynn M, 2002, INTENS CARE MED, V28, pS241, DOI 10.1007/s00134-002-1471-7; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Metcalf K, 1990, Nurse Anesth, V1, P33; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; Murray DJ, 1997, J CARDIOTHOR VASC AN, V11, P24, DOI 10.1016/S1053-0770(97)90247-0; Nielsen VG, 2002, ANESTH ANALG, V95, P1503, DOI 10.1097/00000539-200212000-00008; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; TUMAN KJ, 1987, ANESTH ANALG, V66, P856; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; WONG CA, 1995, REGION ANESTH, V20, P521	42	21	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2006	18	3					200	204		10.1097/01.ana.0000211002.63774.8a			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	059FQ	WOS:000238719100007	16799348				2022-02-06	
J	Mangano, FT; Menendez, JA; Smyth, MD; Leonard, JR; Narayan, P; Park, TS				Mangano, Francesco T.; Menendez, Jose A.; Smyth, Matthew D.; Leonard, Jeffrey R.; Narayan, Prithvi; Park, Tae Sung			Pediatric neurosurgical injuries associated with all-terrain vehicle accidents: a 10-year experience at St. Louis Children's Hospital	JOURNAL OF NEUROSURGERY			English	Article						all-terrain vehicle; head trauma; spinal cord injury; pediatric neurosurgery	CRASHES; TRAUMA; MORTALITY; PATTERNS; HELMET; ATV	Object. All-terrain vehicles (ATVs) have been characterized as inherently unstable and are associated with significant pediatric injuries in the US. The authors performed a study to analyze data obtained in pediatric patients who had sustained neurological injuries in ATV-related accidents, identify potential risk factors, and propose preventive measures. The study is based on a 10-year experience at the St. Louis Children's Hospital. Methods. The authors retrospectively analyzed data obtained in all patients admitted to the St. Louis Children's Hospital between 1993 and 2003, limiting their focus to pediatric cases involving ATV-related accidents. A total of 185 patients were admitted with these criteria. Sixty-two patients (33.5%) suffered neurological injuries; there were 42 male and 20 female patients whose age ranged from 2 to 17 years. The most common injuries included skull fracture (37 cases) and closed head injury (30 cases). There were 39 cases of intracranial hemorrhage and 11 of spinal fracture. A total of 15 types of neurosurgical procedure were performed: six craniotomies for hematoma drainage, five craniotomies for elevation of depressed fractures, two procedures to allow placement of an intracranial pressure monitor, one to allow placement of an external ventricular drain, and one to allow the insertion of a ventriculoperitoneal shunt. Two patients had sustained spinal cord injury, and three procedures were performed for spinal decompression or stabilization. The duration of hospital stay ranged from I to 143 days (mean 6.6 days). Fifty-seven patients (30.8%) were eventually discharged from the hospital, three (1.6%) were transferred to another hospital, two (1.1%) died, and 123 (66.4%) required in-patient rehabilitation. Conclusions. Children suffered significant injuries due to ATV accidents. In passengers there was a statistically significant increased risk of neurological injury. The relative risk of neurological injury in patients not wearing helmets was higher than that in those who wore helmets, but the difference did not reach statistical significance. Further efforts must be made to improve the proper operation and safety of ATVs, both through the education of parents and children and through the creation of legislation requiring stricter laws concerning ATV use.	Washington Univ, St Louis Childrens Hosp, Dept Neurol Surg, St Louis, MO 63110 USA; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Neurol Surg, Cincinnati, OH USA		Park, TS (corresponding author), Washington Univ, St Louis Childrens Hosp, Dept Neurol Surg, 1 Childrens Pl,Suite 4S20, St Louis, MO 63110 USA.	park@nsurg.wustl.edu	Mangano, Francesco/AAG-6184-2019				[Anonymous], 1987, Pediatrics, V79, P306; Baruchin Abraham M., 1995, Harefuah, V129, P246; Bercher D L, 2001, J Ark Med Soc, V97, P351; Bhutta ST, 2004, PEDIATR RADIOL, V34, P130, DOI 10.1007/s00247-003-1085-4; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; DEMAS PN, 1992, J ORAL MAXIL SURG, V50, P1280, DOI 10.1016/0278-2391(92)90227-Q; Edmonson BC, 2004, OPHTHAL PLAST RECONS, V20, P99, DOI 10.1097/01.IOP.0000116381.80520.4E; Gibbs L, 1997, J La State Med Soc, V149, P276; HARGARTEN SW, 1991, AM J EMERG MED, V9, P149, DOI 10.1016/0735-6757(91)90178-M; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Lister DG, 1998, J PEDIATR SURG, V33, P1081, DOI 10.1016/S0022-3468(98)90535-8; Lynch JM, 1998, J PEDIATR SURG, V33, P329, DOI 10.1016/S0022-3468(98)90456-0; Mangus RS, 2004, INJURY PREV, V10, P56, DOI 10.1136/ip.2003.002626; MARGOLIS JL, 1988, J TRAUMA, V28, P395, DOI 10.1097/00005373-198803000-00017; Moroney P, 2003, INJURY, V34, P203, DOI 10.1016/S0020-1383(02)00317-0; Murphy N, 2004, J TRAUMA, V56, P1185, DOI 10.1097/01.TA.0000123038.94864.E2; POSTL BD, 1987, CAN MED ASSOC J, V137, P297; Rodgers GB, 1999, ACCIDENT ANAL PREV, V31, P409, DOI 10.1016/S0001-4575(98)00080-3; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; RODGERS GB, 1993, ACCIDENT ANAL PREV, V25, P335, DOI 10.1016/0001-4575(93)90027-T; Russell A, 1998, PEDIATR EMERG CARE, V14, P31, DOI 10.1097/00006565-199802000-00009; STEVENS WS, 1986, J PEDIATR-US, V109, P25, DOI 10.1016/S0022-3476(86)80566-2; Stueland D, 1991, Wis Med J, V90, P275; STUELAND D, 1991, WIS MED J, V90, P441; TerKonda S, 1990, Mo Med, V87, P89; TRAGER GW, 1986, ANN EMERG MED, V15, P1293, DOI 10.1016/S0196-0644(86)80612-6; Upperman JS, 2003, J PEDIATR SURG, V38, P1284, DOI 10.1016/S0022-3468(03)00383-X	29	21	21	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUL	2006	105	1		S			2	5		10.3171/ped.2006.105.1.2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	061EB	WOS:000238852900002	16871862				2022-02-06	
J	Snodgrass, C; Knott, F				Snodgrass, Clare; Knott, Fiona			Theory of mind in children with traumatic brain injury	BRAIN INJURY			English	Article						social cognition; theory of mind; paediatric traumatic brain injury; frontal lobes	CLOSED-HEAD-INJURY; STORY COMPREHENSION; ADOLESCENTS; CHILDHOOD; BEHAVIOR; EMOTION; DAMAGE; INHIBITION; IMPAIRMENT; ATTENTION	Objective: This study was designed to examine the existence of deficits in mentalizing or theory of mind (ToM) in children with traumatic brain injury (TBI). Research design: ToM functioning was assessed in 12 children aged 6-12 years with TBI and documented frontal lobe damage and compared to 12 controls matched for age, sex and verbal ability. Brief measures of attention and memory were also included. Main outcome and results: The TBI group was significantly impaired relative to controls on the advanced ToM measure and a measure of basic emotion recognition. No difference was found in a basic measure of ToM. Conclusion: Traumatic brain damage in childhood may disrupt the developmental acquisition of emotion recognition and advanced ToM skills. The clinical and theoretical importance of these findings is discussed and the implications for the assessment and treatment of children who have experienced TBI are outlined.	Old Sandy Rd Clin, Direct Access Serv, Glasgow G11 6HE, Lanark, Scotland; Univ Reading, Sch Psychol, Reading, Berks, England		Snodgrass, C (corresponding author), Old Sandy Rd Clin, Direct Access Serv, 12 Sandy Rd, Glasgow G11 6HE, Lanark, Scotland.	clare.snodgrass@glacomen.scot.nhs.uk		Knott, Fiona/0000-0002-5334-7206			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Baron-Cohen S., 2001, J DEV LEARN DISORD, V5, P47, DOI [10.1177/1362361303007002005, DOI 10.1177/1362361303007002005]; Baron-Cohen S., 2000, UNDERSTANDING OTHER, pUN; Baron-Cohen S., 2000, UNDERSTANDING OTHER, P3, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Burley, 1997, BRIT PICTURE VOCABUL; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Doody GA, 1998, PSYCHOL MED, V28, P397, DOI 10.1017/S003329179700648X; Ekman P., 1976, PICTURES FACIAL AFFE; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Fahie CM, 2003, J APPL DEV PSYCHOL, V24, P51, DOI 10.1016/S0193-3973(03)00024-8; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith ChrisD., 2000, UNDERSTANDING OTHER, P334; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Garth J, 1997, Pediatr Rehabil, V1, P99; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Hughes C, 1998, J CHILD PSYCHOL PSYC, V39, P981, DOI 10.1017/S0021963098003059; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; JENNETT B, 1986, DIS NERV SYST, P1282; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Leppanen JM, 2001, SCAND J PSYCHOL, V42, P429, DOI 10.1111/1467-9450.00255; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1984, AGING RECOVERY FUNCT, P314; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Siegal M, 1996, BRAIN LANG, V53, P40, DOI 10.1006/brln.1996.0035; Simonian SJ, 2001, CHILD PSYCHIAT HUM D, V32, P137, DOI 10.1023/A:1012298707253; SODIAN B, 1992, J CHILD PSYCHOL PSYC, V33, P591, DOI 10.1111/j.1469-7610.1992.tb00893.x; Stone V. E., 2000, UNDERSTANDING OTHER, P253; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; TEASDALE G, 1974, LANCET, V2, P81; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; TUKSTRA LS, 1998, J HEAD TRAUMA REHAB, V16, P469; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; Waterhouse L., 1997, HDB AUTISM PERVASIVE, P901; Weschler D, 1992, WECHSLER INTELLIGENC; Wilson B. A., 1990, CLIN PSYCHOL FORUM, V30, P8; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	61	21	21	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2006	20	8					825	833		10.1080/02699050600832585			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	081ZO	WOS:000240356300005	17060149				2022-02-06	
J	Urban, RJ				Urban, Randall J.			Hypopituitarism after acute brain injury	GROWTH HORMONE & IGF RESEARCH			English	Article; Proceedings Paper	19th Annual National Cooperative Growth Study/1st Annual National Cooperative Metabolic Study Investigator Meeting	NOV 03-05, 2005	San Francisco, CA			traumatic brain injury; anterior pituitary hormone deficiencies; screening	NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; PREVALENCE; SURVIVORS	Acute brain injury has many causes, but the most common is trauma. There are 1.5-2.0 million traumatic brain injuries (TBI) in the United States yearly, with an associated cost exceeding $10 billion. TBI is the most common cause of death and disability in young adults less than 35 years of age. The consequences of TBI can be severe, including disability in motor function, speech, cognition, and psychosocial and emotional skills. Recently, clinical studies have documented the occurrence of pituitary dysfunction after TBI and another cause of acute brain injury, subarachnoid hemorrhage (SAH). These studies have consistently demonstrated a 30-40% occurrence of pituitary dysfunction involving at least one anterior pituitary hormone following a moderate to severe TBI or SAH. Growth hormone (GH) deficiency is the most common pituitary hormone disorder, occurring in approximately 20% of patients when multiple tests of GH deficiency are used. Within 7-21 days of acute brain injury, adrenal insufficiency is the primary concern. Pituitary function can fluctuate over the first year after TBI, but it is well established by I year. Studies are ongoing to assess the effects of hormone replacement on motor function and cognition in TBI patients. Any subject with a moderate to severe acute brain injury should be screened for pituitary dysfunction. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA		Urban, RJ (corresponding author), Univ Texas, Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	rurban@utmb.edu					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G., 2005, J CLIN ENDOCRINOL ME; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Brazil K, 1992, Int J Rehabil Res, V15, P93, DOI 10.1097/00004356-199206000-00001; DANIEL PM, 1959, LANCET, V2, P927; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; RAY BS, 1969, J NEUROSURG, V30, P399, DOI 10.3171/jns.1969.30.4.0399; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; 1998, NIH CONSENSUS STATEM, V16, P1	22	21	27	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1096-6374	1532-2238		GROWTH HORM IGF RES	Growth Horm. IGF Res.	JUL	2006	16			A			S25	S29		10.1016/j.ghir.2006.03.017			5	Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cell Biology; Endocrinology & Metabolism	074OG	WOS:000239821100006	16697673				2022-02-06	
J	Tricco, AC; Colantonio, A; Chipman, M; Liss, G; McLellan, B				Tricco, Andrea C.; Colantonio, Angela; Chipman, Mary; Liss, Gary; McLellan, Barry			Work-related deaths and traumatic brain injury	BRAIN INJURY			English	Article						brain injury; mortality; accidents (occupational); coroners and medical examiners	MORTALITY; FATALITIES; OUTCOMES; CANADA; COUNTY	Background: Traumatic brain injury (TBI) at the workplace is a significant contributor to the number of work-related deaths that occur per year. This study aimed to quantify and characterize these deaths in Ontario. Methods: The study design was a case series with analytic and surveillance components. Data was obtained from the Chief Coroner's Office of Ontario from 1996 - 2000. Results: A total of 488 work-related injury fatalities were identified. Evidence of TBI was apparent in 45% of these cases (n = 211). Industries with the highest rate of work-related TBI mortality expressed per 100 000 working population included primary industry (59.1), agriculture (24.5), construction (20.0) and transportation/communications/utilities industries (13.9). Deaths involving TBI were more likely to be due to falls than non-TBI-related deaths among workers (p = 0.0001). Conclusions: Results from this research indicate that prevention programmes should focus on decreasing falls at all ages and increasing the use of personal protective equipment.	Univ Toronto, Toronto, ON, Canada; Toronto Rehabil Inst, Toronto, ON, Canada; Minist Labor, Toronto, ON, Canada; Off Chief Coroner Ontario, Toronto, ON, Canada		Colantonio, A (corresponding author), Saunderson Family Chair Acquired Brain Injury Res, Dept Occupat Sci & Occupat Therapy, 500 Univ Ave,Room 950, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Tricco, Andrea/B-9920-2011	Tricco, Andrea/0000-0002-4114-8971; Colantonio, Angela/0000-0003-2094-4765			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Band PR, 1996, AM J EPIDEMIOL, V143, P137; Baron J, 1998, OCCUP MED-OXFORD, V48, P199, DOI 10.1093/occmed/48.3.199; *BUR LAB STAT, 1997, FAT WORKPL INJ 1995; *BUR STAT, 1980, STAND IND CLASS; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Davis GG, 2000, J FORENSIC SCI, V45, P392; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; *GEN ACC OFF, 1998, TRAUM BRAIN INJ PROG; Gordis L, 2000, EPIDEMIOLOGY; GUIDOTTI TL, 1993, AM J IND MED, V23, P921, DOI 10.1002/ajim.4700230608; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Lett Ronald, 2002, Inj Control Saf Promot, V9, P199, DOI 10.1076/icsp.9.3.199.8708; Lipscomb H J, 2000, Appl Occup Environ Hyg, V15, P569; MCDOUGAL L, 1992, AM J IND MED, V21, P595, DOI 10.1002/ajim.4700210415; MCVITTIE DJ, 1995, OCCUP MED, V10, P285; Pickett W, 1999, CAN MED ASSOC J, V160, P1843; Pickett W, 1995, Inj Prev, V1, P97, DOI 10.1136/ip.1.2.97; Rivara FP, 2001, INJURY CONTROL GUIDE; *STAT CAN, 1996, LAB FORC SURV; *STAT CAN, 1993, STAND OCC CLASS; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; 1997, INT CLASSIFICATION D	25	21	23	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2006	20	7					719	724		10.1080/02699050600664640			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200006	16809204				2022-02-06	
J	Cunningham, MG; Goldstein, M; Katz, D; O'Neil, SQ; Joseph, A; Price, B				Cunningham, MG; Goldstein, M; Katz, D; O'Neil, SQ; Joseph, A; Price, B			Coalescence of psychiatry, neurology, and neuropsychology: From theory to practice	HARVARD REVIEW OF PSYCHIATRY			English	Article; Proceedings Paper	16th Annual Meeting of the American-Neuropsychiatry-Association	FEB-MAR -, 2005	Bal Harbour, FL	Amer Neuropsychiat Assoc		collaboration; cross-training; multidisciplinary; neurology; neuropsychiatry; psychiatry	TRAUMATIC BRAIN-INJURY; BORDERLINE PERSONALITY-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; MAJOR DEPRESSION; FUNCTIONAL NEUROANATOMY; INTELLECTUAL FRAMEWORK; HIPPOCAMPAL-NEURONS; CINGULATE CORTEX; METABOLIC-RATE; SCHIZOPHRENIA	In a climate of renewed interest in the synergy between neurology and psychiatry, practitioners are increasingly recognizing the importance of exchange and collaboration between these two disciplines. However, there are few working models of interdisciplinary teams that freely share expertise in real time, while providing clinical and academic training to future physicians who specialize in the central nervous system. Over the past 11 years, the McLean Hospital Neuropsychiatry and Behavioral Neurology service has provided proof-of-principle for such collaboration, demonstrating that a team comprising psychiatrists, neurologists, and neuropsychologists can function effectively as a unit while maintaining the autonomy of these three disciplines and also synthesizing their combined knowledge. In addition to delivering enhanced patient care and promoting medical research, this clinical service has provided enriched cross-specialty training for fellows, residents, and medical students. The practical functioning of the team is described, and case vignettes are presented to illustrate the team's collaborative synergism in practice.	McLean Hosp, Belmont, MA 02478 USA; Harvard Univ, Med Sch, Dept Psychiat, Cambridge, MA 02138 USA; Harvard Univ, Med Sch, Dept Neurol, Cambridge, MA 02138 USA; Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA		Cunningham, MG (corresponding author), McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	mcunningham@mclean.harvard.edu					Adachi N, 2002, EPILEPSIA, V43, P1574, DOI 10.1046/j.1528-1157.2002.22402.x; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Benes FM, 2001, BIOL PSYCHIAT, V50, P395, DOI 10.1016/S0006-3223(01)01084-8; BENES FM, 1992, CEREB CORTEX, V2, P503, DOI 10.1093/cercor/2.6.503; BRAGG TA, 1990, MCLEAN HOSP J, V15, P1; BRAUN AR, 1995, NEUROPSYCHOPHARMACOL, V13, P151, DOI 10.1016/0893-133X(95)00052-F; Chapman C B, 1974, Daedalus, V103, P105; Coyle JT, 1996, MOL PSYCHIATR, V1, P5; Cummings J. L., 1995, NEUROPSYCHIATRY BEHA; Detre T, 1997, ARCH GEN PSYCHIAT, V54, P201; Drevets WC, 2000, NUCL MED BIOL, V27, P499, DOI 10.1016/S0969-8051(00)00119-0; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; EISENBURG L, 2002, NEUROL TODAY, V12, P4; Filley CM, 2002, J NEUROPSYCH CLIN N, V14, P344, DOI 10.1176/appi.neuropsych.14.3.344; GORMAN J, 2001, CNS SPECTRUMS, V6, P740; Gorman J M, 2001, CNS Spectr, V6, P947; Gorman Jack M, 2002, CNS Spectr, V7, P261; Haase CG, 2003, BEHAV NEUROL, V14, P39, DOI 10.1155/2003/843760; Haznedar MM, 1997, AM J PSYCHIAT, V154, P682; Heckers S, 2002, J NEURAL TRANSM, V109, P891, DOI 10.1007/s007020200073; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kandel ER, 1998, AM J PSYCHIAT, V155, P457, DOI 10.1176/ajp.155.4.457; Kandel ER, 1999, AM J PSYCHIAT, V156, P505; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Leroi I, 2002, AM J PSYCHIAT, V159, P1306, DOI 10.1176/appi.ajp.159.8.1306; Martin JB, 2002, AM J PSYCHIAT, V159, P695, DOI 10.1176/appi.ajp.159.5.695; MAYBERG HS, 1994, J NUCL MED, V35, P929; MCCULLOUGH D, 2001, TOUCHSTONE; MCHENRY LC, 1969, GARRISONS HIST NEURO; Mitterschiffthaler MT, 2003, NEUROREPORT, V14, P177, DOI 10.1097/00001756-200302100-00003; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; PATERSON A, 1946, BRAIN, V69, P58, DOI 10.1093/brain/69.1.58; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; PRICE B, 2002, PSYCHIAT UPDATE; PRICE BH, 1999, HOSP NEUROLOGY, P619; Price BK, 2000, NEUROLOGY, V54, P8, DOI 10.1212/WNL.54.1.8; SACKEIM HA, 1990, ARCH GEN PSYCHIAT, V47, P60; Saxena S, 2003, AM J PSYCHIAT, V160, P522, DOI 10.1176/appi.ajp.160.3.522; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Soderstrom H, 2002, PSYCHIAT RES-NEUROIM, V114, P81, DOI 10.1016/S0925-4927(02)00006-9; Tiihonen J, 1997, AM J PSYCHIAT, V154, P239; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WATSON RI, 1953, PSYCHOL BULL, V50, P321, DOI 10.1037/h0062847	48	21	23	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1067-3229			HARVARD REV PSYCHIAT	Harv. Rev. Psychiatr.	MAY-JUN	2006	14	3					127	140		10.1080/10673220600748536			14	Psychiatry	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychiatry	058XH	WOS:000238697400001	16787885				2022-02-06	
J	Koponen, S; Taiminen, T; Kurki, T; Portin, R; Isoniemi, H; Himanen, L; Hinkka, S; Salokangas, RKR; Tenovuo, O				Koponen, S; Taiminen, T; Kurki, T; Portin, R; Isoniemi, H; Himanen, L; Hinkka, S; Salokangas, RKR; Tenovuo, O			MRI findings and Axis I and II psychiatric disorders after traumatic brain injury: A 30-year retrospective follow-up study	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						brain injuries; mental disorders; magnetic resonance imaging	ALZHEIMERS-DISEASE; HEAD TRAUMA; PERSONALITY-CHANGE; MILD; DEPRESSION; NEUROPSYCHIATRY; POPULATION; SECONDARY; HEALTH; RISK	We studied the association between psychiatric disorders and the presence and location of traumatic lesions on magnetic resonance imaging (MRI) in 58 patients, on average, 30 years after traumatic brain injury. Axis I psychiatric disorders that had begun after the injury were assessed with the Schedules for Clinical Assessment in Neuropsychiatry (version 2.1), and Axis 11 disorders with the Structured Clinical Interview for DSM-III-R Personality Disorders. A 1.5-Tesla MRI scanner was used. One-third of the subjects had traumatic lesions visible on MRI. Only three psychiatric disorders, that is, delusional disorder, dementia, and the disinhibited type of organic personality syndrome, were significantly more common in subjects with contusions. Concerning the location of contusions, organic personality syndrome and its disinhibited subtype were associated with frontal lesions, and major depression was, surprisingly, inversely associated with temporal lesions. These results, which should be interpreted with caution due to the limited size of the study group, suggest that the majority of psychiatric disorders after traumatic brain injury are not closely related to the specific location or even the presence of contusions detectable with post-acute MRI. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Turku Univ Hosp, Dept Psychiat, FI-20521 Turku, Finland; Turku Univ Hosp, Dept Radiol, FI-20521 Turku, Finland; Turku Univ Hosp, Dept Neurol, FI-20521 Turku, Finland; Univ Turku, Dept Biostat, Turku, Finland		Koponen, S (corresponding author), Turku Univ Hosp, Dept Psychiat, PL 52, FI-20521 Turku, Finland.	salla.koponen@utu.fi		Kurki, Timo/0000-0001-5532-3534; Hinkka-Yli-Salomaki, Susanna/0000-0001-7785-9196; Himanen, Leena/0000-0001-7261-8027			Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; HILLBOM E, 1960, ACT PSYCHIAT NEUROLO, V142, P35; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; O'Driscoll K, 1998, BRIT MED J, V317, P1673, DOI 10.1136/bmj.317.7174.1673a; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Spitzer R., 1989, STRUCTURED CLIN INTE; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	30	21	21	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927			PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	APR 30	2006	146	3					263	270		10.1016/j.pscychresns.2005.05.015			8	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	057ON	WOS:000238605200007	16507345				2022-02-06	
J	Greiffenstein, MF; Baker, WJ				Greiffenstein, MF; Baker, WJ			Miller was (mostly) right: Head injury severity inversely related to simulation	LEGAL AND CRIMINOLOGICAL PSYCHOLOGY			English	Article							COMPENSATION NEUROSIS; BRAIN-DAMAGE; BASE RATES; MMPI-2; SYMPTOMS; RECOVERY; DEFICITS; PERFORMANCE; CONCUSSION; SCORES	Purpose. British neurologist Henry Miller (196 1; Miller & Cartlidge, 1972) provoked controversy by asserting late post-concussion syndrome (LPCS) is explained by simulation. The present study examines Miller's inverse dose-response assertion; the more minor the compensable injury, the greater the likelihood of deficit simulation. Method. We examined the prevalence of three types of simulation (memory, motor, and psychiatric) in two archival cohorts of compensation seekers (N = 391 and 368) representing a broad range of cranio-cervical injury severity. A moderate-severe brain injured group provided two sets of performance floors to establish 'possible' or 'probable' pseudoabnormalities. Instruments included the Rey word recognition list, the Smedley dynamometer, the Test of Memory Malingering, and the MMPI-2 infrequency scale. Results. Chronic whiplash and minor head-injury litigants produced more invalid signs than severely injured persons on measures of simulated memory and motor deficits irrespective of definitional stringency. ANOVA revealed striking inverse linear trends as a function of severity. Under a 'possible' rule, at least one pseudoabnormality was present in 80% of LPCS claimants. Memory and motor pseudoabnormalities were more common than psychotic ones. Conclusions. These findings support Miller and Cartlidge's (1972) observations that embellishment rises as injury severity decreases in a compensable context. Simulating litigants may 'tailor' performance to fit aetiological expectations, as we found a low prevalence of psychosis simulation.	Psychol Syst Inc, Royal Oak, MI 48067 USA		Greiffenstein, MF (corresponding author), Psychol Syst Inc, Suite 103, Royal Oak, MI 48067 USA.	mfgreiff@yahoo.com					Albers JW, 2000, NEUROL CLIN, V18, P741, DOI 10.1016/S0733-8619(05)70221-8; Alexander, 1997, Semin Clin Neuropsychiatry, V2, P177; Alexander Michael P, 2003, Pain Res Manag, V8, P19; Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; BENTON AL, 1989, MILD HEAD INJURY, P1; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1991, J CLIN CONSULTING PS, V3, P171; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; BUTCHER J, 1989, MMMPI 2 MANUAL ADM S; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; FAUST D, 1995, NEUROL CLIN, V13, P255, DOI 10.1016/S0733-8619(18)30044-6; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 2001, NEUROREHABILITATION, V16, P237; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; GREENE R, 2000, MMMPI MMPI 2 INTERPR; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein M. F., 2000, BRAIN INJURY SOURCE, V4, P39; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GRONWALL D, 1974, LANCET, V2, P605; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; HAALAND KY, 1981, NEUROPSYCHOLOGIA, V19, P17; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Kanaya T, 2003, AM PSYCHOL, V58, P778, DOI 10.1037/0003-066X.58.10.778; KAY DWK, 1971, LANCET, V2, P1052; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; MENDELSON G, 1991, THEOR MED, V12, P227, DOI 10.1007/BF00489608; MENDELSON G, 1995, J PSYCHOSOM RES, V39, P695, DOI 10.1016/0022-3999(94)00154-W; MENDELSON G, 1982, MED J AUSTRALIA, V2, P132, DOI 10.5694/j.1326-5377.1982.tb124267.x; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1972, LANCET, V1, P580; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; OLSNES BT, 1989, ACTA NEUROL SCAND, V80, P584, DOI 10.1111/j.1600-0404.1989.tb03931.x; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; Peterson DI, 1998, NEUROLOGIST, V4, P131, DOI 10.1097/00127893-199805000-00004; Pliskin NH, 1998, J TRAUMA, V44, P709, DOI 10.1097/00005373-199804000-00027; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Reitan R, 1985, HALSTEAD REITAN NEUR; Rogers R., 1997, CLIN ASSESSMENT MALI; RUFF R, 1989, MILD HEAD INJURY, P179; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TOMBAUGH T, 1995, TESTS MEMORY MALINGE; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; Wechsler D, 1980, WECHSLER ADULT INTEL; WECHSLER D, 2000, MANUAL WECHSLER ABBR; WechslerD, 2001, WECHSLER TEST ADULT; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	69	21	21	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-3259	2044-8333		LEGAL CRIMINOL PSYCH	Legal Criminol. Psychol.	FEB	2006	11		1				131	145		10.1348/135532505X49828			15	Criminology & Penology; Law; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Government & Law; Psychology	010ZC	WOS:000235236400009					2022-02-06	
J	Anzai, K; Young, J; McCallum, J; Miller, B; Jongbloed, L				Anzai, K; Young, J; McCallum, J; Miller, B; Jongbloed, L			Factors influencing discharge location following high lesion spinal cord injury rehabilitation in British Columbia, Canada	SPINAL CORD			English	Article						high lesion spinal cord injury; social policy; discharge location; discharge planning	LENGTH-OF-STAY; LIFE SATISFACTION; SYSTEM	Study design: Retrospective chart review. Objective: To identify and describe factors that influence discharge location - extended care unit (nursing home) or other (private home, group home, or acute care) - following rehabilitation for individuals with a new high lesion spinal cord injury (SCI) (C1-C4) in British Columbia, Canada. Setting: GF Strong Rehabilitation Centre, Vancouver, British Columbia, Canada. Methods: Eligible clients were adults admitted to the GF Strong Rehabilitation Centre Spinal Cord Program between 1994 and 2003, with a new C1-4 lesion (traumatic or nontraumatic), and an ASIA score of A-C at time of discharge. Medical charts of 52 individuals were reviewed and data regarding individual characteristics, health-related characteristics, personal context, hospitalization factors, health resources, and other contextual factors were extracted. Results: In total, 40% of clients were discharged to extended care units post rehabilitation. Seven variables were associated at a univariate level: age, employment at the time of injury, preexisting medical conditions, social support, preinjury living situation, and insurance (worker's compensation or motor vehicle) or private funding for equipment. Four variables were associated at the multivariate level: age, preinjury living situation, and insurance or private funding for equipment. Conclusion: A range of individual, health-related, family and social policy variables influence discharge location following rehabilitation for high lesion SCI in British Columbia. The unique combination of variables presented by each individual should be considered by the rehabilitation team in the discharge planning process. Sponsorship: This study was funded by the BC Neurotrauma Fund.	GF Strong Rehabil Ctr, Vancouver, BC V5Z 2G9, Canada; Parkwood Hosp, Geriatr Rebabil Program, London, ON, Canada; Univ British Columbia, Sch Rehabil Sci, Vancouver, BC V5Z 1M9, Canada		Anzai, K (corresponding author), GF Strong Rehabil Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.						BACH JR, 1994, ARCH PHYS MED REHAB, V75, P626, DOI 10.1016/0003-9993(94)90183-X; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P785, DOI 10.1016/S0003-9993(99)90228-9; Dijkers M, 1996, AM REHABILITATION, P18; Dijkers Marcel P., 1995, P185; Fiedler RC, 1997, AM J PHYS MED REHAB, V76, P76, DOI 10.1097/00002060-199701000-00017; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; HAMMELL KR, 1998, THESIS U BRIT COLUMB; Hammell KW, 2004, SPINAL CORD, V42, P607, DOI 10.1038/sj.sc.3101662; Hammell KW, 2004, SPINAL CORD, V42, P491, DOI 10.1038/sj.sc.3101636; Inman C, 1999, CLIN REHABIL, V13, P25, DOI 10.1191/026921599674943310; Nieves C C, 1991, Rehabil Nurs, V16, P129; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Tooth L, 2003, SPINAL CORD, V41, P220, DOI 10.1038/sj.sc.3101433; World Health Organization, 2007, INT CLASS FUNCT DIS	15	21	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2006	44	1					11	18		10.1038/sj.sc.3101778			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	000WJ	WOS:000234492800003	16030516	Bronze			2022-02-06	
J	Cai, Y; Wu, P; Ozen, M; Yu, Y; Wang, J; Ittmann, M; Liu, M				Cai, Y; Wu, P; Ozen, M; Yu, Y; Wang, J; Ittmann, M; Liu, M			Gene expression profiling and analysis of signaling pathways involved in priming and differentiation of human neural stem cells	NEUROSCIENCE			English	Article						gene expression array; human neural stem cells; hNSCs; stem cell priming and differentiation; cell signaling pathways; GTP-binding proteins	DEPENDENT PROTEIN-KINASE; NEURONAL DIFFERENTIATION; GROWTH-FACTORS; EPH RECEPTORS; LYMPHOCYTE DEVELOPMENT; PHOSPHOLIPASES A(2); MICROARRAY ANALYSIS; NEURITE OUTGROWTH; PROGENITOR CELLS; NERVOUS-SYSTEM	Human neural stem cells have the ability to differentiate into all three major cell types in the CNS including neurons, astrocytes and oligodendrocytes. The multipotency of human neural stem cells shed a light on the possibility of using stem cells as a therapeutic tool for various neurological disorders including neurodegenerative diseases and neurotrauma that involve a loss of functional neurons. We have discovered previously a priming procedure to direct primarily cultured human neural stem cells to differentiate into almost pure neurons when grafted into adult CNS. However, the molecular mechanism underlying this phenomenon is still unknown. To unravel transcriptional changes of human neural stem cells upon priming, cDNA microarray was used to study temporal changes in human neural stem cell gene expression profile during priming and differentiation. As a result, transcriptional levels of 520 annotated genes were detected changed in at least at two time points during the priming process. In addition, transcription levels of more than 3000 hypothetical protein encoding genes and EST genes were modulated during the priming and differentiation processes of human neural stem cells. We further analyzed the named genes and grouped them into 14 functional categories. Of particular interest, key cell signal transduction pathways, including the G-protein-mediated signaling pathways (heterotrimeric and small monomeric GTPase pathways), the Wnt signaling pathway and the TGF-beta pathway, are modulated by the neural stem cell priming, suggesting important roles of these key signaling pathways in priming and differentiation of human neural stem cells. (c) 2005 IBRO. Published by Elsevier Ltd. All rights reserved.	Texas A&M Univ Syst, Ctr Sci, Alkek Inst Biosci & Technol, Houston, TX 77030 USA; Texas A&M Univ Syst, Ctr Sci, Dept Med Biochem & Genet, Houston, TX 77030 USA; Univ Texas, Med Branch, Dept Neurosci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Cell Biol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Michael E DeBakey Dept, Vet Affairs Med Ctr, Houston, TX 77030 USA		Liu, M (corresponding author), Texas A&M Univ Syst, Ctr Sci, Alkek Inst Biosci & Technol, 2121 W Holcombe, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	wu, Ping/G-8958-2011	Ozen, Mustafa/0000-0002-6142-5294	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064792] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5R01HL064792] Funding Source: Medline		Abu-Amer Y, 1999, J BONE MINER RES, V14, P1855, DOI 10.1359/jbmr.1999.14.11.1855; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Beyer C, 2000, J NEUROSCI RES, V59, P107, DOI 10.1002/(SICI)1097-4547(20000101)59:1<107::AID-JNR13>3.0.CO;2-W; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cai Y, 2005, ONCOGENE, V24, P4293, DOI 10.1038/sj.onc.1208593; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Devouassoux-Shisheboran M, 2003, APMIS, V111, P212, DOI 10.1034/j.1600-0463.2003.11101251.x; Drescher U, 2000, CELL, V103, P1005, DOI 10.1016/S0092-8674(00)00204-X; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Gurrieri S, 2003, J INVEST DERMATOL, V121, P156, DOI 10.1046/j.1523-1747.2003.12315.x; HEASLEY LE, 1991, CELL REGUL, V2, P479, DOI 10.1091/mbc.2.6.479; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Kawasoe T, 2000, CANCER RES, V60, P3354; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu JP, 1998, DEVELOPMENT, V125, P5055; Liu ZY, 2002, J BIOL CHEM, V277, P37832, DOI 10.1074/jbc.M205908200; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; McKay RD, 2004, PHILOS T R SOC B, V359, P851, DOI 10.1098/rstb.2004.1472; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Moroni E, 2002, J HEMATOTH STEM CELL, V11, P19, DOI 10.1089/152581602753448513; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakashima S, 2003, BIOCHEM J, V376, P655, DOI 10.1042/BJ20030830; Nosaka T, 2000, INT J HEMATOL, V71, P309; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Ohishi K, 2002, INT J HEMATOL, V75, P449, DOI 10.1007/BF02982106; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Piper DR, 2000, J NEUROPHYSIOL, V84, P534, DOI 10.1152/jn.2000.84.1.534; PUNT CJA, 1992, LEUKEMIA RES, V16, P551, DOI 10.1016/0145-2126(92)90001-N; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Reya T, 2003, RECENT PROG HORM RES, V58, P283, DOI 10.1210/rp.58.1.283; Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2; Ruscetti FW, 2001, INT J HEMATOL, V74, P18, DOI 10.1007/BF02982545; Sanchez S, 2004, NEUROCHEM INT, V44, P231, DOI 10.1016/S0197-0186(03)00150-5; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Schumann H, 2000, CARDIOVASC RES, V45, P720, DOI 10.1016/S0008-6363(99)00376-4; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Strubing C, 1997, EUR J NEUROSCI, V9, P824, DOI 10.1111/j.1460-9568.1997.tb01432.x; Svendsen C N, 2000, Prog Brain Res, V127, P13; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; Tago K, 2000, GENE DEV, V14, P1741; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tojima T, 2003, J NEUROSCI RES, V74, P829, DOI 10.1002/jnr.10754; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Wen TQ, 2002, CELL MOL NEUROBIOL, V22, P407, DOI 10.1023/A:1021059520618; WHITFIELD JF, 1995, J CELL BIOCHEM, P74; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu DM, 2003, EUR J NEUROSCI, V17, P1571, DOI 10.1046/j.1460-9568.2003.02591.x; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	70	21	24	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2006	138	1					133	148		10.1016/j.neuroscience.2005.11.041			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020XU	WOS:000235947400014	16414199				2022-02-06	
J	Fraser, R; Machamer, J; Temkin, N; Dikmen, S; Doctor, J				Fraser, R.; Machamer, J.; Temkin, N.; Dikmen, S.; Doctor, J.			Return to work in traumatic brain injury (TBI): A perspective on capacity for job complexity	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Work return; job complexity; job stability		In the traumatic brain injury (TBI) vocational literature there have been limited, but conflicting findings relative to job complexity and work reentry. This study follows 140 workers at the time of injury and examines return to work and maintenance within the context of job complexity at three to five years postinjury. Job complexity was examined as a function of US Department of Labor ratings of the Reasoning Development and Specific Vocational Preparation ratings required for each job held and hours worked. Subgroup comparisons were made across three subgroups: 1) job-maintainers, 2) those unable to sustain work after returning, and 3) those who could never return to work. The subgroup that was chiefly able to maintain complex work, according to U.S. Department of Labor ratings, was more likely to be of female gender, had fewer alcohol problems, was less severely injured and showed significantly better neuropsychological functioning. Those unable to sustain work had between 1.7 and 2.6 chance of holding a job with less complexity and hours at time of termination. There were no differences between these first two groups on involvement in the broader US Department of Labor occupational classification categories. The final subgroup, that was never able to work, showed both more severe injury and more neuropsychological impairment.	[Fraser, R.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Fraser, R.; Machamer, J.; Dikmen, S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fraser, R.; Temkin, N.; Doctor, J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Temkin, N.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Doctor, J.] Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; [Doctor, J.] Univ Washington, Hlth Serv, Seattle, WA 98195 USA		Fraser, R (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	RFRASER@u.washington.edu			DOE-NIDRR [H133A020508]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS19 643]; NIH-NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD33 677]	This study was supported by the following grants: DOE-NIDRR H133A020508, NIH-NINDS R01NS19 643 and NIH-NCMRR HD33 677.	Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Doctor J., 1994, J INT NEUROPSYCH SOC, V11, P1; Machamer J., J INT NEURO IN PRESS; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Orr M., 2003, ARCH PHYS MED REHAB, V84, P2; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; United States Department of Labor, 1991, DICT OCCUPATIONAL TI, VII; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001	11	21	21	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2006	25	3					141	148					8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V71OP	WOS:000211583800001					2022-02-06	
S	Sharma, HS; Lundstedt, T; Boman, A; Lek, P; Seifert, E; Wiklund, L; Ali, SF		Ali, SF; Fornai, F		Sharma, Hari S.; Lundstedt, Torbjorn; Boman, Arne; Lek, Per; Seifert, Elisabeth; Wiklund, Lars; Ali, Syed F.			A potent serotonin-modulating compound AP-267 attenuates morphine withdrawal-induced blood-brain barrier dysfunction in rats	CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Satellite Meeting on Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity - Cocaine, GHB and Substituted Amphetamines	AUG 16-19, 2005	Venice Int Univ, Venice, ITALY	Int Soc Neurochem, Neuromed Pozzilli, FDA, Natl Ctr Toxicol Res	Venice Int Univ	morphine; withdrawal symptoms; dependence; spontaneous withdrawal; AP-267; serotonin; 5-HT2c receptor; blood-brain barrier; Evans blue; radioiodine	5-HT3 RECEPTOR ANTAGONISTS; SPINAL-CORD; GUANYLATE-CYCLASE; ADENYLATE-CYCLASE; TRAUMATIC INJURY; NITRIC-OXIDE; PERMEABILITY; FLOW; 5-HYDROXYTRYPTAMINE; LEVEL	The possibility that a serotonin 5-HT2c receptor-modulating compound, AP-267, will influence spontaneous morphine withdrawal symptoms and the alterations in the brain fluid microenvironment was examined in a rat model. Daily administration of morphine (10 mg/kg, i.p.) for 10 days resulted in dependence of rats as seen by loss of analgesic response. On the 11th day, no morphine administration was given. This resulted in profound withdrawal symptoms 24 h after morphine withdrawal. The magnitude and severity of these symptoms were increased further 48 h after withdrawal. Measurement of the blood-brain barrier (BBB) permeability, a measure of perturbed brain fluid microenvironment showed leakage of Evans blue and radioiodine tracers in several parts of the brain in rats showing withdrawal symptoms. Whereas, rats treated with AP-267 either on the 1st day or 2nd day morphine withdrawal showed much less symptoms and leakage of the BBB. Taken together, these observations suggest that (a) stress associated with the withdrawal symptoms are sufficient enough to induce breakdown of the BBB function, and (b) modulation of serotonin 5-HT2c receptors may have some protective influence on the stress symptoms and the BBB disruption.	Uppsala Univ, Univ Hosp, Dept Surg Sci Anaesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden; US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Neurochem Lab, Jefferson, AR 72079 USA; Acure Pharma AB, SE-75643 Uppsala, Sweden; Uppsala Univ, Dept Organ & Pharmaceut Chem, SE-74123 Uppsala, Sweden		Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Dept Surg Sci Anaesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden.	Sharma@surgsci.uu.se					ANANTH US, 1987, J NEUROCHEM, V48, P253, DOI 10.1111/j.1471-4159.1987.tb13156.x; AUER LM, 1985, J CEREBR BLOOD F MET, V5, P517, DOI 10.1038/jcbfm.1985.78; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; AZMITIA EC, 1990, BRAIN RES, V510, P97, DOI 10.1016/0006-8993(90)90732-Q; BACA GM, 1978, BLOOD VESSELS, V15, P286; BARNES JM, 1990, NEUROPHARMACOLOGY, V29, P1037, DOI 10.1016/0028-3908(90)90110-D; BARNES NM, 1992, BRIT J PHARMACOL, V107, P233, DOI 10.1111/j.1476-5381.1992.tb14492.x; BLAUW GJ, 1988, LIFE SCI, V43, P1441, DOI 10.1016/0024-3205(88)90255-X; CARBONI E, 1988, EUR J PHARMACOL, V151, P159, DOI 10.1016/0014-2999(88)90710-8; CURZON G, 1990, TRENDS PHARMACOL SCI, V11, P181, DOI 10.1016/0165-6147(90)90109-L; Dawson VL, 1996, J NEUROSCI, V16, P2479; EDVINSSON L, 1976, PHARMACOL REV, V28, P275; GERZER R, 1986, BIOCHIM BIOPHYS ACTA, V886, P383, DOI 10.1016/0167-4889(86)90173-4; GIANUTSOS G, 1975, PSYCHOPHARMACOLOGIA, V43, P43, DOI 10.1007/BF00437613; GIANUTSOS G, 1975, METHODS NARCOTIC RES, P293; GUAN XM, 1989, BRAIN RES BULL, V23, P541, DOI 10.1016/0361-9230(89)90198-6; GULLIS RJ, 1975, BIOCHEM J, V148, P197, DOI 10.1042/bj1480197; HAUBRICH DR, 1973, BRIT J PHARMACOL, V48, P80, DOI 10.1111/j.1476-5381.1973.tb08224.x; HIGGINS GA, 1992, PSYCHOPHARMACOLOGY, V106, P315, DOI 10.1007/BF02245411; HOYER D, 1994, PHARMACOL REV, V46, P157; HUANG M, 1983, J NEUROCHEM, V40, P719, DOI 10.1111/j.1471-4159.1983.tb08038.x; HUI SCG, 1993, BRIT J PHARMACOL, V110, P1341, DOI 10.1111/j.1476-5381.1993.tb13966.x; JOO F, 1985, NEUROCHEM INT, V7, P1, DOI 10.1016/0197-0186(85)90002-6; JOO F, 1983, BRAIN RES, V278, P165, DOI 10.1016/0006-8993(83)90235-4; KARNUSHINA I, 1980, BRAIN RES, V189, P588, DOI 10.1016/0006-8993(80)90374-1; KILPATRICK GJ, 1987, NATURE, V330, P746, DOI 10.1038/330746a0; Lucaites VL, 1996, LIFE SCI, V59, P1081, DOI 10.1016/0024-3205(96)00423-7; MANYHAN WG, 1999, AM J PHYSIOL, V276, pC1148; MENGOD G, 1990, BRAIN RES, V524, P139, DOI 10.1016/0006-8993(90)90502-3; PALMER GC, 1983, PHYSL PHARM MICROCIR, V1, P1; PAZOS A, 1984, EUR J PHARMACOL, V106, P539, DOI 10.1016/0014-2999(84)90057-8; PERRY RJ, 1990, J AEROSOL MED, V3, P187, DOI 10.1089/jam.1990.3.187; RAY AK, 1980, ARCH INT PHARMACOD T, V246, P108; ROYCHOUDHURY M, 1986, METHOD FIND EXP CLIN, V18, P677; Sharma H. S., 2004, BLOOD SPINAL CORD BR, P437; Sharma H. S., 2004, BLOOD SPINAL CORD BR, P231; SHARMA HS, 1991, NEUROSCI RES, V10, P211; SHARMA HS, 1990, BRAIN RES, V517, P215, DOI 10.1016/0006-8993(90)91029-G; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P407, DOI 10.1196/annals.1344.036; Sharma HS, 1998, PROG BRAIN RES, V115, P351; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sharma HS, 2003, ACT NEUR S, V86, P383; SHARMA HS, 1987, NEUROPHARMACOLOGY, V26, P85, DOI 10.1016/0028-3908(87)90049-9; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; SHARMA HS, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P303; Sharma HS, 1998, PROG BRAIN RES, V115, P297; SHARMA HS, 1989, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1988, P317; SHARMA HS, 1990, NEUROSCIENCE, V36, P725, DOI 10.1016/0306-4522(90)90014-U; SHARMA HS, 1986, J NEUROL SCI, V72, P61, DOI 10.1016/0022-510X(86)90036-5; SHARMA HS, 1987, BRAIN RES, V424, P153, DOI 10.1016/0006-8993(87)91205-4; Sharma HS, 1996, BEHAV BRAIN RES, V72, P189; Sharma HS, 2004, BLOOD SPINAL CORD BR; SHARMA HS, ANN NY ACAD SCI; Sharma HS, 1999, ACTA U UPSAL, V830, P1; SHARMA HS, 2005, RECENT MODALITIES BR, P97; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109; WESTERGAARD E, 1975, ACTA NEUROPATHOL, V32, P27, DOI 10.1007/BF00686065; WESTERGAARD E, 1977, ACTA NEUROPATHOL, V39, P181, DOI 10.1007/BF00691695; Westergaard E, 1980, Adv Neurol, V28, P55; WINKLER T, 1995, NEUROSCIENCE, V68, P1097, DOI 10.1016/0306-4522(95)00194-N; YAGALOFF KA, 1985, J NEUROSCI, V5, P3178	61	21	22	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER STREET, HOBOKEN, NJ, UNITED STATES	0077-8923		1-57331-629-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2006	1074						482	496		10.1196/annals.1369.049			15	Cell Biology; Substance Abuse; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Substance Abuse; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BFJ04	WOS:000242168100049	17105947				2022-02-06	
J	Clark, RSB; Bayir, H; Jenkins, LW				Clark, RSB; Bayir, H; Jenkins, LW			Posttranslational protein modifications	CRITICAL CARE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; S-NITROSOTHIOLS; KINASE-C; MECHANISMS; QUANTITATION; ACETYLATION; SURVIVAL; PATHWAYS; ISCHEMIA		Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA.						Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Bayir H, 2003, J CEREBR BLOOD F MET, V23, P51, DOI 10.1097/01.WCB.0000040399.30600.E3; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Fu MF, 2004, BIOCHEM PHARMACOL, V68, P1199, DOI 10.1016/j.bcp.2004.05.037; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENKINS L, 2001, MO CL BI CC, V2, P163; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mendoza-Alvarez H, 1999, BIOCHEMISTRY-US, V38, P3948, DOI 10.1021/bi982148p; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Tyurin VA, 2002, METHOD ENZYMOL, V352, P347; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	32	21	22	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2005	33	12		S			S407	S409		10.1097/01.CCM.0000191712.96336.51			3	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000ZK	WOS:000234501300004	16340406				2022-02-06	
J	Lippert-Gruener, M; Weinert, U; Greisbach, T; Wedekind, C				Lippert-Gruener, M; Weinert, U; Greisbach, T; Wedekind, C			Foreign accent syndrome following traumatic brain injury	BRAIN INJURY			English	Article						FAS; traumatic temporal haemorrhage; rehabilitation; speech disorder		Foreign accent syndrome (FAS) is a very rare disorder, caused by lesions of the dominant brain hemisphere and defined as a loss of normal phonetic contrast when using the mother language. The pronounciation is perceived by native speakers as compromised by a foreign accent. This study reports about a 35-years old women, with a FAS following a brain injury with a traumatic left temporal haemorrhage, who experienced excellent remission after 2 years.	Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany; Univ Cologne, Dept Neurol, Cologne, Germany; Univ Cologne, Inst Phonet, Cologne, Germany		Wedekind, C (corresponding author), Univ Cologne, Dept Neurosurg, D-50924 Cologne, Germany.	drchrwedekind@web.de					BERTHIER ML, 1994, NEUROLOGY, V44, P990, DOI 10.1212/WNL.44.5.990-a; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; Carbary TJ, 2000, BRAIN COGNITION, V43, P78; Gonzalez-Alvarez J, 2003, REV NEUROLOGIA, V36, P227, DOI 10.33588/rn.3603.2002306; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; MATAS M, 1991, CAN J PSYCHIAT, V36, P363, DOI 10.1177/070674379103600509; Moonis M., 1996, NEUROLOGY, V43, P381; NEILSON JM, 1961, B LOS ANGELES NEUROL, V26, P157; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361	12	21	23	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2005	19	11					955	958		10.1080/02699050500109506			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983YY	WOS:000233269500011	16243750				2022-02-06	
J	Moran, C; Gillon, G				Moran, C; Gillon, G			Inference comprehension of adolescents with traumatic brain injury: A working memory hypothesis	BRAIN INJURY			English	Article						traumatic brain injury; language comprehension; adolescents	CLOSED-HEAD-INJURY; INDIVIDUAL-DIFFERENCES; SENTENCE COMPREHENSION; CHILDREN; LANGUAGE; CHILDHOOD; ADULTS; DAMAGE	This study investigated inference comprehension performance in adolescents who had suffered a traumatic brain injury (TBI). Using stimuli adapted from Lehman-Blake and Tompkins, participants listened to short paragraphs that varied according to the working memory demands of the task and answered comprehension questions that required inferences to be generated. Six adolescents, aged 12-16 years, who had suffered a TBI prior to the age of 10 years, were assessed and their performance was compared to six individually age-matched peers with typical development. Analysis revealed that individuals with TBI did not differ from non-injured peers in their understanding of inferences when the storage demands of the task were minimized. However, when storage demands were high, adolescents with TBI performed poorly compared to their age-matched peers. Results are discussed relative to a working-memory hypothesis of impairment following TBI.	Univ Canterbury, Fac Sci, Dept Speech & Language Therapy, Christchurch 1, New Zealand		Moran, C (corresponding author), Univ Canterbury, Fac Sci, Dept Speech & Language Therapy, Private Bag 4800, Christchurch 1, New Zealand.	catherine.moran@canterbury.ac.nz		Gillon, Gail/0000-0001-9501-8147			*ACC REH COMP INS, 1998, TRAUM BRAIN INJ REH; BEUKELMAN DR, 1991, COMMUNICATION DISORD; Cain K, 2001, MEM COGNITION, V29, P850, DOI 10.3758/BF03196414; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; Carpenter P. A., 1994, HDB PSYCHOLINGUISTIC, P1075; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DOSHER BA, 1982, MEM COGNITION, V10, P531, DOI 10.3758/BF03202435; ENGLE RW, 1992, J EXP PSYCHOL LEARN, V18, P972, DOI 10.1037/0278-7393.18.5.972; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Granier JP, 2000, APHASIOLOGY, V14, P501, DOI 10.1080/026870300401270; HAMMILL DD, 1994, TEST ADOLESCENT LANG; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; HARTLEY L, 1991, BRAIN INJURY, V6, P271; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Johnson, 1989, LANG SPEECH HEAR SER, V20, P420, DOI [10.1044/0161-1461.2004.420, DOI 10.1044/0161-1461.2004.420]; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Leathem JM, 1997, BRAIN INJURY, V11, P565, DOI 10.1080/026990597123269; Lehman MT, 2000, APHASIOLOGY, V14, P485, DOI 10.1080/026870300401261; Lehman-Blake MT, 2001, J SPEECH LANG HEAR R, V44, P639, DOI 10.1044/1092-4388(2001/052); LEINONEN E, 2000, CHILDRENS PRAGMETIC; Letts C, 2001, INT J LANG COMM DIS, V36, P307; MCDOWELL L, 1992, ANTIPODE, V24, P56, DOI 10.1111/j.1467-8330.1992.tb00428.x; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; MIYAKE A, 1994, COGNITIVE NEUROPSYCH, V11, P671, DOI 10.1080/02643299408251989; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; MORAN C, 2002, LANGUAGE COMPREHENSI; Nippold M., 1998, LATER LANGUAGE DEV S; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Swinney D., 1990, INFERENCES TEXT COMP, P17; TEASDALE G, 1974, LANCET, V2, P81; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137	44	21	22	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2005	19	10					743	751		10.1080/02699050500110199			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800001	16175835				2022-02-06	
J	Body, R; Parker, M				Body, R; Parker, M			Topic repetitiveness after traumatic brain injury: An emergent, jointly managed behaviour	CLINICAL LINGUISTICS & PHONETICS			English	Article						topic repetitiveness; traumatic brain injury; emergence; social cognition	COMMUNICATION BREAKDOWN; EXECUTIVE DYSFUNCTION; CONVERSATION; DISCOURSE; ABILITY; PEOPLE	Topic repetitiveness is a common component of pragmatic impairment and a powerful contributor to social exclusion. Despite this, description, characterization and intervention remain underdeveloped. This article explores the nature of repetitiveness in traumatic brain injury (TBI). A case study of one individual after TBI provides the basis for a conceptualization of topic repetitiveness in terms of two major strands of thinking in pragmatics. Firstly, it is viewed as an emergent response to underlying deficits in non-linguistic abilities. Secondly, it is described in terms of joint management of topic development between the person with TBI and his interlocutor.	Univ Sheffield, Dept Human Commun Sci, Sheffield S10 2TA, S Yorkshire, England; Head Injury Rehabil Ctr, Sheffield, S Yorkshire, England		Body, R (corresponding author), Univ Sheffield, Dept Human Commun Sci, 31 Claremont Crescent, Sheffield S10 2TA, S Yorkshire, England.	r.body@sheffield.ac.uk	Body, Richard/C-2736-2010	Body, Richard/0000-0001-9089-8130			ALDERMAN N, 1991, NEUROPSYCHOL REHABIL, V1, P65, DOI DOI 10.1080/09602019108401380; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Body R., 1999, BRAIN DAM B; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Brown Gillian., 1983, DISCOURSE ANAL; Burgess P, 1996, BEHAV ASSESSMENT DYS; BUTTON G, 1985, HUM STUD, V8, P3, DOI 10.1007/BF00143022; Clark Herbert H., 1996, USING LANGUAGE; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Croteau C, 2004, APHASIOLOGY, V18, P291, DOI 10.1080/02687030344000616; Damasio A., 1994, DESCARTES ERROR EMOT; DOBBINSON S, 2000, THESIS U SHEFFIELD; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; EDMONDS PE, 1988, J COMMUN DISORD, V21, P209, DOI 10.1016/0021-9924(88)90030-5; Ellmo W, 1995, MEASURE COGNITIVE LI; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HOTZ G, 1995, BRAIN INJURY, V9, P151, DOI 10.3109/02699059509008188; Lindsay J, 1999, APHASIOLOGY, V13, P305, DOI 10.1080/026870399402118; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; McDonald S., 1999, BRAIN DAM B; McDonald S., 2002, AWARENESS SOCIAL INF; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Park NW, 2001, NEUROPSYCHOLOGIA, V39, P7, DOI 10.1016/S0028-3932(00)00101-9; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Perkins L., 1997, CONVERSATION ANAL PR; Perkins M, 2002, INVESTIGATIONS IN CLINICAL PHONETICS AND LINGUISTICS, P1; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; Perkins MR, 2005, CLIN LINGUIST PHONET, V19, P367, DOI 10.1080/02699200400027155; POWELL JA, 1995, EUR J DISORDER COMM, V30, P65; Radford J, 2000, CLIN LINGUIST PHONET, V14, P387; SCHEUERMANN EA, 1979, ERNAHRUNGSWIRTSCHAFT, P23; Selting M, 2000, LANG SOC, V29, P477, DOI 10.1017/S0047404500004012; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Van Borsel J, 2001, CLIN LINGUIST PHONET, V15, P663; WALLESCH CW, 1990, APHASIOLOGY, V4, P133, DOI 10.1080/02687039008249066; WILLCOX A, 1995, CLIN LINGUIST PHONET, V9, P235, DOI 10.3109/02699209508985335; Ylvisaker M., 1998, COLLABORATIVE BRAIN	48	21	21	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	JUL-AUG	2005	19	5					379	392		10.1080/02699200400027189			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	935EB	WOS:000229761200003	16019782				2022-02-06	
J	Kompanje, EJO; Maas, AIR; Hilhorst, MT; Slieker, FJA; Teasdale, GM				Kompanje, EJO; Maas, AIR; Hilhorst, MT; Slieker, FJA; Teasdale, GM			Ethical considerations on consent procedures for emergency research in severe and moderate traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; proxy consent; waiver of consent; randomised controlled trails; European Union	SPINAL-CORD INJURY; INFORMED-CONSENT; CLINICAL-TRIALS; EUROPEAN-UNION; HEAD-INJURY; TIRILAZAD MESYLATE; METHYLPREDNISOLONE; RESUSCITATION; MORTALITY; EFFICACY	Therapeutic trials in TBI are subject to principles of Good Clinical Practice (GCP), to national legislation, and to international and European ethical concepts and regulations [e.g. 13]. The guiding principles underlying these investigations of treatment are respect for autonomy of research subjects, protection against discomfort, risk, harm and exploitation and the prospect of some benefit. Patients with significant TBI are mentally incapacitated, thus prohibiting obtaining consent directly from the subject. Various approaches to consent procedures are used as surrogate to subject consent: proxy consent, consent by an independent physician and waiver of consent. These approaches are reviewed. A questionnaire soliciting opinions was mailed to 148 EBIC (European Brain Injury Consortium) associated neuro-trauma centers in 19 European countries. 48% respondents believe that relatives were not able to make a balanced decision, 72% believed that consent procedures are a significant factor causing decrease in enrollment rate and 83% stated that consent procedures delay initiation of study treatment, resulting in possible harm if the agent has shown to be effective. 64% of the respondents considered TBI an emergency situation in which clinical research could be initiated under the emergency exception for consent. In new European legislation, emergency research under waiver of consent is not permitted. Nevertheless, we consider that randomising patients with TBI into carefully evaluated trial protocols without prior consent may be considered ethically justified.	Erasmus MC Univ Med Ctr Rotterdam, Dept Neurosurg, Rotterdam, Netherlands; Erasmus MC Univ Med Ctr Rotterdam, Dept Intens Care, Rotterdam, Netherlands; Erasmus MC Univ Med Ctr Rotterdam, Dept Med Eth, Rotterdam, Netherlands; Inst Neurol Sci, Dept Neurosurg, Glasgow, Lanark, Scotland		Kompanje, EJO (corresponding author), Erasmus Med Ctr Rotterdam, Dept Neurosurg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264			Agard A, 2001, HEART, V86, P632, DOI 10.1136/heart.86.6.632; Annane D, 2004, INTENS CARE MED, V30, P321, DOI 10.1007/s00134-003-2065-8; Arnold RM, 2003, CRIT CARE MED, V31, pS347, DOI 10.1097/01.CCM.0000065123.23736.12; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Clifton GL, 2002, J NEUROTRAUM, V19, P1121, DOI 10.1089/08977150260337930; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; CORTBUS F, 2002, NEUROTRAUMA, P69; DRUML C, 2003, EUROPEAN DIRECTIVE F; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Foex BA, 2001, EMERG MED J, V18, P198, DOI 10.1136/emj.18.3.198; Freeman BD, 2001, AM J RESP CRIT CARE, V164, P190, DOI 10.1164/ajrccm.164.2.2011028; Kompanje EJO, 2004, INTENS CARE MED, V30, P168, DOI 10.1007/s00134-003-2044-0; Kowey P, 2000, RESUSCITATION, V47, P307, DOI 10.1016/S0300-9572(00)00247-1; Lemaire F, 2002, INTENS CARE MED, V28, P660, DOI 10.1007/s00134-002-1280-z; Lindley RI, 1998, BRIT MED J, V316, P1005, DOI 10.1136/bmj.316.7136.1005; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PLOMER A, 2001, EUROPEAN J HLTH LAW, V8, P333; Roupie E, 2000, INTENS CARE MED, V26, P52, DOI 10.1007/s001340050011; Schats R, 2003, J NEUROL NEUROSUR PS, V74, P988, DOI 10.1136/jnnp.74.7.988; Sterz F, 2002, RESUSCITATION, V53, P237, DOI 10.1016/S0300-9572(02)00103-X; Stocchetti N, 2004, INTENS CARE MED, V30, P517, DOI 10.1007/s00134-003-2142-z; SULMASY DP, 1994, AM J MED, V96, P432, DOI 10.1016/0002-9343(94)90170-8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; VALADKA AB, 2001, CONTEMP NEUROSURG, V23, P1; van Olden GDJ, 2003, INJURY, V34, P191, DOI 10.1016/S0020-1383(02)00202-4; WRIGHT DW, 2001, ACAD EMERG MED, V8, P419	32	21	21	0	1	SPRINGER WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUN	2005	147	6					633	640		10.1007/s00701-005-0525-3			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933FM	WOS:000229614300019	15806325				2022-02-06	
J	Mathe, JF; Richard, I; Rome, J				Mathe, JF; Richard, I; Rome, J			Serious brain injury and public health, epidemiologic and financial considerations, comprehensive management and care	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						brain injury; traumatic coma; Glasgow Outcome Scale GOS; community reintegration; care network	HEAD-INJURY; CONSCIOUSNESS	The management of persons with traumatic brain injury affects a large spectrum of interventions from acute phase to the hospital discharge and the return to community. The incidence of brain injuries on mortality and morbidity constitutes a serious problem in front of the Health Administration. The traffic accidents remain the main cause but the falls in elderly are increasing. In the both cases preventive measures can be efficiency. In France, each year, there are about 150,000 new cases, 8000 of them will be dead and 4000 with coma. It is likely that 30,000 persons are living to day with important sequela of a brain injury. The management requires various types of interventions, each of them with specific and specialized techniques. It is necessary to have an overview of the problem and to work together in a comprehensive network. So French Health Ministery has just published an official note to precise some directives and co-ordination of the different interventions. (C) 2005 Elsevier SAS. Tous droits reserves.	CHU Nantes, Hop St Jacques, Serv Med Phys & Readaptat, F-44093 Nantes, France; CRRRF Les Capucins, Serv Med Phys & Readaptat, F-49024 Angers, France		Mathe, JF (corresponding author), CHU Nantes, Hop St Jacques, Serv Med Phys & Readaptat, F-44093 Nantes, France.	jeanfrancois.mathe@chu-nantes.fr					ALAOUI P, 1998, ANN READAPT MED PHYS, V43, P171; CHOI SC, 1996, NEUROTRAUMA, P779; ELOVIC E, 1996, MED REHABILITATION T, P1; FREREBEAU P, 1992, NEUROCHIRURGIE, V38, P35; JENNETT B, 1975, LANCET, V1, P480; Kraus J, 1996, NEUROTRAUMA, P13; LINDSAY JT, 1998, J NEUROTRAUM, V15, P573; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Masson F, 2000, ANN FR ANESTH, V19, P261; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; ODELL MW, 1996, MED REHABILITATION T, P103; PENTLAND B, 1988, BRIT J NEUROSURGERY, V2, P601; Ricard-Hibon A, 2000, ANN FR ANESTH, V19, P286; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Sosin DM, 1996, BRAIN INJURY, V10, P47; STEIN SC, 1996, NEUROTRAUMA, P755; TEASDALE G, 1974, LANCET, V2, P81; Tentillier E, 2000, ANN FR ANESTH, V19, P275; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Vigue B, 2003, NEUROCHIRURGIE, V49, P583; 2004, 280 DHOSSDO01DGSSD5D; 1999, ANN FR ANESTH REANIM, V18, P11; 2002, J NEUROTRAUMA, V19, P111; 2000, J NEUROTRAUMA, V17, P453; 2002, 96 DASDEDSSDH; 2002, 288 DHOSO2DGS2002DGA	27	21	24	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	JUN	2005	24	6					688	694		10.1016/j.annfar.2005.03.029			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	941QZ	WOS:000230230600022	15950118				2022-02-06	
J	Busch, RM; Booth, JE; McBride, A; Vanderploeg, RD; Curtiss, G; Duchnick, JJ				Busch, RM; Booth, JE; McBride, A; Vanderploeg, RD; Curtiss, G; Duchnick, JJ			Role of executive functioning in verbal and visual memory	NEUROPSYCHOLOGY			English	Article; Proceedings Paper	111th Annual Convention of the American-Psychological-Association	AUG 07-10, 2003	Toronto, CANADA	Amer Psychol Assoc		memory; material-specific memory; executive functions	DIFFUSE AXONAL INJURY; EPISODIC MEMORY; PREFRONTAL CORTEX; BRAIN-DAMAGE; SEX-DIFFERENCES; ATTENTION; PERFORMANCE; DYSFUNCTION; IMPAIRMENT; OLD	G. Tremont, S. Halpert, D. J. Javorsky, and R. A. Stern (2000) found that individuals with executive dysfunction were more impaired on less structured versus more structured verbal memory tasks. In the present study, the authors investigated the relationship between executive functions and memory in patients with a history of traumatic brain injury by examining the effect of executive functioning on more structured and less structured verbal and visual memory tasks at baseline and 1-year follow-up. Matched subgroups controlled for differences in severity of neuropsychological impairment unrelated to specific executive functions. The G. Tremont et al. (2000) findings were not replicated. Results showed that when acuteness and severity of injury were controlled, executive impairment played no significant role in performance on either more or less structured memory tasks. However, regardless of structure, executive functions played a role in visual memory performance, suggesting that visual memory may be a more fluid ability than verbal memory.	Univ S Florida, James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA; Univ Cincinnati, Cincinnati, OH 45221 USA; Univ Texas, Austin, TX 78712 USA		Vanderploeg, RD (corresponding author), Univ S Florida, James A Haley Vet Hosp, Psychol Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.Vanderploeg@med.va.gov					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; BARRON JH, 1992, ARCH CLIN NEUROPSYCH, V7, P175, DOI 10.1016/0887-6177(92)90011-B; BECKER JT, 1983, ALCOHOL CLIN EXP RES, V7, P213, DOI 10.1111/j.1530-0277.1983.tb05444.x; Benson D.F., 1986, FRONTAL LOBES; Delis DC, 1987, CALIFORNIA VERBAL LE; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; FABIAN MS, 1984, J NERV MENT DIS, V172, P16, DOI 10.1097/00005053-198401000-00005; Fitzpatrick MO, 1998, BRIT J NEUROSURG, V12, P313; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fletcher PC, 1998, BRAIN, V121, P1249, DOI 10.1093/brain/121.7.1249; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; Goldberg E., 1987, FRONTAL LOBES REVISI, P159; GOLDMANRAKIC PS, 1992, SCI AM, V267, P111; Hamsher K., 1989, MULTILINGUAL APHASIA; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1991, COMPREHENSIVE NORMS; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; HORN JL, 1976, ANNU REV PSYCHOL, V27, P437, DOI 10.1146/annurev.ps.27.020176.002253; INGLIS J, 1981, SCIENCE, V212, P693, DOI 10.1126/science.7221560; JONES B, 1971, ARCH GEN PSYCHIAT, V24, P71; Kaplan E, 1983, BOSTON NAMING TEST; KRAMER JH, 1989, J CONSULT CLIN PSYCH, V57, P257, DOI 10.1037/0022-006X.57.2.257; LEBER WR, 1981, J CLIN PSYCHOL, V37, P192, DOI 10.1002/1097-4679(198101)37:1<192::AID-JCLP2270370140>3.0.CO;2-M; Lezak M.D., 1987, NEUROPSYCHOL REHABIL, P41; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, VVol. 2; MALEC JF, 1991, PSYCHOL ASSESSMENT J, V3, P82; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCGLONE J, 1978, CORTEX, V14, P122, DOI 10.1016/S0010-9452(78)80015-X; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MIGLIOLI M, 1979, J NERV MENT DIS, V167, P212, DOI 10.1097/00005053-197904000-00003; NIXON SJ, 1987, J CLIN EXP NEUROPSYC, V9, P311, DOI 10.1080/01688638708405053; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; REITAN RM, 1958, HALSTEAD REITAN NEUR; RUSSELL EW, 1980, PERCEPT MOTOR SKILL, V51, P121, DOI 10.2466/pms.1980.51.1.121; RUSSELL EW, 1979, J CLIN PSYCHOL, V35, P611, DOI 10.1002/1097-4679(197907)35:3<611::AID-JCLP2270350325>3.0.CO;2-V; RUSSELL EW, 2000, CLIN GUIDE NEUROPSYC, P483; RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x; Shallice T, 1990, NEUROPSYCHOLOGY MENT; SHERER M, 1992, ARCH CLIN NEUROPSYCH, V7, P499, DOI 10.1016/0887-6177(92)90139-E; Stuss D., 2002, PR FRONTAL LOBE FUNC, P392, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0025; TEASDALE G, 1974, LANCET, V2, P81; Tong BSK, 2002, BRAIN INJURY, V16, P987, DOI 10.1080/02699050210147202; Trehub S., 1982, AGING COGNITIVE PROC, P237, DOI DOI 10.1007/978-1-4684-4178-9_14; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; WITTIG MA, 1979, SEX RELATED DIFFEREN; [No title captured], DOI DOI 10.1016/S0079-7421(08)60452-1	56	21	22	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2005	19	2					171	180		10.1037/0894-4105.19.2.171			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	906DE	WOS:000227619900004	15769201				2022-02-06	
J	Centonze, D; Palmieri, MG; Boffa, L; Pierantozzi, M; Stanzione, P; Brusa, L; Marciani, G; Siracusano, A; Bernardi, G; Caramia, D				Centonze, D; Palmieri, MG; Boffa, L; Pierantozzi, M; Stanzione, P; Brusa, L; Marciani, G; Siracusano, A; Bernardi, G; Caramia, D			Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Article						cortical excitability; hyperarousal; stress disorders; post-traumatic; transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM POTENTIATION; MOTOR CORTEX EXCITABILITY; HIPPOCAMPAL VOLUME; MATTER VOLUME; SEXUAL ABUSE; WHITE-MATTER; BRAIN; INJURY; PTSD	Objective: We applied paired transcranial magnetic stimulation (pTMS) to patients with post-traumatic stress disorder (PTSD) secondary to minor accidental head trauma. Our purpose was to determine the potential abnormality of motor cortex excitability in this pathologic condition. Methods: pTMS stimulation, according to the conditioning-test paradigm employing interstimulus intervals (ISIs) of 1-6 ms, was used to investigate intracortical inhibition in control subjects and patients with PTSD. The study population consisted of 14 patients who had developed PTSD following minor head trauma, 12 healthy volunteers without a clinical history of head trauma and 11 healthy subjects who had reported accidental minor head trauma 1-4 months before the study. This clinical electrophysiologic study was performed at the Department of Neuroscience, University of Rome "Tor Vergata." Results: All patients with PTSD exhibited a significantly lower motor evoked potential (MEP) inhibition than controls at 2 ms, 3 ms and 4 ms ISI. The statistical analysis of the pTMS protocol showed a significant effect (F-2,F-36 = 25.63, p < 0.001) of the factor "group," because patients with PTSD showed a mean conditioned MEP amplitude higher than that observed in both control groups for all 6 ISIs analyzed. The "ISI" factor was also significant (F-5,F-180 = 89.85, Greenhouse-Geisser epsilon = 0.35; p < 0.001), with the mean conditioned MEP amplitude increasing from 22.5% to 127.8% as the ISI increased from 1 ms to 6 ms. Finally, the interaction of group with ISI was also significant (F-10,F-180 = 8.97, p < 0.001), showing that the condition of PTSD secondary to head trauma was able to affect the MEP amplitude at different ISIs. Conclusions: Our results demonstrate that PTSD can give rise to abnormalities in intracortical inhibition. Our results provide further evidence that alterations in cortical inhibitory circuits may underlie specific forms of neuroticism in humans.	Univ Roma Tor Vergata, Dipartimento Neurosci, Neurol Clin, I-00133 Rome, Italy; Fdn Santa Lucia, Rome, Italy; Policlin Tor Vergata, Serv Neurofisiopatol, Rome, Italy; Univ Roma Tor Vergata, Dipartimento Neurosci, Clin Psichiatr, Rome, Italy		Centonze, D (corresponding author), Univ Roma Tor Vergata, Dipartimento Neurosci, Neurol Clin, Via Montpellier 1, I-00133 Rome, Italy.	centonze@uniroma2.it	Centonze, Diego/J-7767-2016	Centonze, Diego/0000-0002-8390-8545; SIRACUSANO, ALBERTO/0000-0001-8406-093X; maria grazia, marciani/0000-0001-6324-916X			Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blank T, 2002, J NEUROSCI, V22, P3788; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Caramia MD, 1996, ELECTROEN CLIN NEURO, V98, P14, DOI 10.1016/0013-4694(95)00150-6; Caramia MD, 2000, NEUROLOGY, V54, P58, DOI 10.1212/WNL.54.1.58; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; De Bellis MD, 2001, BIOL PSYCHIAT, V50, P305, DOI 10.1016/S0006-3223(01)01105-2; Evans R. W., 1996, NEUROLOGY TRAUMA, P91; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Greenberg BD, 2000, NEUROLOGY, V54, P142, DOI 10.1212/WNL.54.1.142; Grisaru N, 1998, BIOL PSYCHIAT, V44, P52, DOI 10.1016/S0006-3223(98)00016-X; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HATHAWAY RS, 1951, MANUAL MINNESOTA MUL; Hoffman RE, 2002, AM J PSYCHIAT, V159, P1093, DOI 10.1176/appi.ajp.159.7.1093; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; KUJIRAI T, 1993, J PHYSL, V473, P501; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; McCann UD, 1998, ARCH GEN PSYCHIAT, V55, P276, DOI 10.1001/archpsyc.55.3.276; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Pitman RK, 2001, J CLIN PSYCHIAT, V62, P47; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Ricker JH, 2000, J HEAD TRAUMA REHAB, V15, P859, DOI 10.1097/00001199-200004000-00007; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROSSINI PM, 1991, BRAIN RES, V567, P111, DOI 10.1016/0006-8993(91)91442-4; Rothwell JC, 1999, EEG CL N SU, P113; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Shaw ME, 2002, NEUROIMAGE, V15, P661, DOI 10.1006/nimg.2001.1024; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shin LM, 1997, ARCH GEN PSYCHIAT, V54, P233; Spielberg C. D., 1983, MANUAL STATE TRAIT A; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; vanderKolk BA, 1997, ANN NY ACAD SCI, V821, P99; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Villarreal G, 2002, CAN J PSYCHIAT, V47, P666, DOI 10.1177/070674370204700709; Villarreal G, 2001, Semin Clin Neuropsychiatry, V6, P131, DOI 10.1053/scnp.2001.21840; Wassermann EM, 2001, BIOL PSYCHIAT, V50, P377, DOI 10.1016/S0006-3223(01)01210-0; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	53	21	21	1	1	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	1180-4882	1488-2434		J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	MAR	2005	30	2					127	132					6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	899DO	WOS:000227125300007	15798788				2022-02-06	
J	Fink, EL; Marco, CD; Donovan, HA; Alexander, H; Dixon, CE; Jenkins, LW; Stange, CJ; Kochanek, PM; Clark, RSB				Fink, EL; Marco, CD; Donovan, HA; Alexander, H; Dixon, CE; Jenkins, LW; Stange, CJ; Kochanek, PM; Clark, RSB			Brief induced hypothermia improves outcome after asphyxial cardiopulmonary arrest in juvenile rats	DEVELOPMENTAL NEUROSCIENCE			English	Article						hypothermia; asphyxial cardiac arrest; neurodegeneration	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; WATER MAZE; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; RESUSCITATION; SURVIVAL; GENDER; ISCHEMIA; DAMAGE	The American Heart Association has endorsed the use of mild hypothermia for adults after cardiopulmonary arrest. However, there are no contemporary trials testing hypothermia in children after cardiopulmonary arrest and extrapolation from adult studies is problematic given differences in brain development and primary etiology (asphyxia in children vs. ventricular arrhythmia in adults). Accordingly, we tested the effects of mild postresuscitative hypothermia on functional and histopathological outcome after asphyxial cardiac arrest in juvenile rats. Postnatal day 17 rats were subjected to 8 min of asphyxia-induced cardiac arrest followed by resuscitation. Rats were randomized to normothermic (37 degrees C), hypothermic (32 degrees C), or unregulated temperature groups (n = 7-8/group) to begin after return of spontaneous circulation for a duration of 1 h. Brain temperature in the unregulated group dropped to 34.0 +/- 0.4 degrees C at 1 h. The hypothermic group had improved motor function assessed using beam balance and inclined plane tests vs. the normothermic group. The depth of hypothermia was associated with increased CA1 hippocampal neuron survival at 5 weeks. Neurodegeneration in the CA1 hippocampus assessed using Fluoro-Jade B labeling at 5 weeks was not detected in the 32 degrees C group, whereas 2/7 and 4/7 rats in the 34 and 37 degrees C groups, respectively, showed neurodegeneration. Brief treatment with moderate induced hypothermia improved functional outcome and prevented long-term neurodegeneration in a model that mimics the clinical and histopathological scenario of pediatric cardiac arrest. Similar to adults, infants and children may benefit from induced hypothermia after cardiopulmonary arrest, warranting further study. Copyright (c) 2005 S. Karger AG, Basel.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Clark, RSB (corresponding author), Pediat Crit Care Med, 3705 5th Ave, Pittsburgh, PA 15213 USA.	clarkrs@ccm.upmc.edu	Fink, Ericka/AAU-9792-2021; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Fink, Ericka/0000-0002-3683-4571	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD045968, 5T32 HD 40686] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38620, P50 NS30318] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P50NS030318] Funding Source: NIH RePORTER		Agnew DM, 2003, PEDIATR RES, V54, P253, DOI 10.1203/01.PDR.0000072783.22373.FF; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BIGGART MJ, 1990, J PEDIATR-US, V117, P179, DOI 10.1016/S0022-3476(05)80526-8; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Hachimi-Idrissi S, 2001, RESUSCITATION, V49, P73, DOI 10.1016/S0300-9572(00)00268-9; Hagberg H, 1997, ACTA PAEDIATR, V86, P85; Hickey RW, 1996, PEDIATR RES, V39, P77, DOI 10.1203/00006450-199601000-00011; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hurvitz E A, 1999, Pediatr Rehabil, V3, P43; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Loidl CF, 2000, PHYSIOL BEHAV, V68, P263, DOI 10.1016/S0031-9384(99)00125-0; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Nelson A, 1997, BEHAV BRAIN RES, V85, P93, DOI 10.1016/S0166-4328(96)00167-2; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Shukitt-Hale B, 2004, NEUROBIOL AGING, V25, P223, DOI 10.1016/S0197-4580(03)00041-1; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Vaagenes P, 1997, RESUSCITATION, V35, P41, DOI 10.1016/S0300-9572(97)01108-8; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Xiao F, 1998, AM J EMERG MED, V16, P17, DOI 10.1016/S0735-6757(98)90059-6; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; YOUNG R S K, 1983, Stroke, V14, P929	30	21	22	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2005	27	2-4			SI		191	199		10.1159/000085992			9	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	947XA	WOS:000230679400015	16046854				2022-02-06	
J	Hattiangadi, N; Pillion, JP; Slomine, B; Christensen, J; Trovato, MK; Speedie, LJ				Hattiangadi, N; Pillion, JP; Slomine, B; Christensen, J; Trovato, MK; Speedie, LJ			Characteristics of auditory agnosia in a child with severe traumatic brain injury: A case report	BRAIN AND LANGUAGE			English	Article						auditory agnosia; auditory perception; auditory brain stem response; verbal comprehension; language processing; complex sound processing; pure word deafness; temporal processing; traumatic brain injury; pediatric	PURE WORD DEAFNESS; ENVIRONMENTAL SOUNDS; SUBCORTICAL LESIONS; SPEECH-PERCEPTION; DISORDERS; DISSOCIATIONS; RECOGNITION; POTENTIALS	We present a case that is unusual in many respects from other documented incidences of auditory agnosia, including the mechanism of injury, age of the individual, and location of neurological insult. The clinical presentation is one of disturbance in the perception of spoken language, music, pitch, emotional prosody, and temporal auditory processing in the absence of significant deficits in the comprehension of written language, expressive language production, or peripheral auditory function. Furthermore, the patient demonstrates relatively preserved function in other aspects of audition such as sound localization, voice recognition, and perception of animal noises and environmental sounds. This case study demonstrates that auditory agnosia is possible following traumatic brain injury in a child, and illustrates the necessity of assessment with a wide variety of auditory stimuli to fully characterize auditory agnosia in a single individual. (C) 2004 Elsevier Inc. All rights reserved.	Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Audiol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA		Hattiangadi, N (corresponding author), Childrens Hosp Philadelphia, Dept Psychol, 3405 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	hattiangadi@email.chop.edu		Thomas, Nina/0000-0002-4452-3626			BOWERS D, 1992, FLORIDA AFFECT BATTE; BUCHMAN AS, 1986, J NEUROL NEUROSUR PS, V49, P489, DOI 10.1136/jnnp.49.5.489; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Elliott C. D., 1990, DIFFERENTIAL ABILITY; Elliott L., 1980, NW U CHILDRENS PERCE; Finitzo-Hieber T, 1977, SOUND EFFECTS RECOGN; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; FRANKLIN S, 1989, APHASIOLOGY, V3, P189, DOI 10.1080/02687038908248991; GOODGLASS H, 1978, ASSESSMENT APHASIA R; Griffiths TD, 1999, NEUROCASE, V5, P365, DOI 10.1080/13554799908402733; Griffiths TD, 2002, BRIT MED BULL, V63, P107, DOI 10.1093/bmb/63.1.107; HARMS MP, 1998, NEUROIMAGE, V7, pS365; Haskins, 1949, PHONETICALLY BALANCE; Johkura K, 1998, J NEUROL SCI, V161, P91, DOI 10.1016/S0022-510X(98)00261-5; Katz J, 1998, CENTRAL AUDITORY PRO, P215; Keith R, 2000, RANDOM GAP DETECTION; Kemp, 1998, NEPSY DEV NEUROPSYCH; LAMBERT J, 1989, CORTEX, V25, P71, DOI 10.1016/S0010-9452(89)80007-3; Liepmann H, 2001, CORTEX, V37, P547, DOI 10.1016/S0010-9452(08)70594-X; MENDEZ MF, 1988, J NEUROL NEUROSUR PS, V51, P1, DOI 10.1136/jnnp.51.1.1; Mesulam M., 1985, PRINCIPLES BEHAV NEU; MOTOMURA N, 1986, BRAIN, V109, P379, DOI 10.1093/brain/109.3.379; Musiek F E, 1994, J Am Acad Audiol, V5, P265; Noffsinger D, 1994, J Am Acad Audiol, V5, P248; Noffsinger D, 1994, J Am Acad Audiol, V5, P231; Pinard M, 2002, NEUROCASE, V8, P40, DOI 10.1076/neur.8.1.40.16243; RAPIN I, 1977, DEV MED CHILD NEUROL, V2, P197; Saygin AP, 2003, BRAIN, V126, P928, DOI 10.1093/brain/awg082; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Semel E., 1995, CLIN EVALUATION LANG, VThird; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Shivashankar N, 2001, CLIN NEUROL NEUROSUR, V103, P201, DOI 10.1016/S0303-8467(01)00136-6; SIDTIS JJ, 1981, NEUROPSYCHOLOGIA, V19, P103, DOI 10.1016/0028-3932(81)90050-6; Sidtis John J., 2003, Seminars in Speech and Language, V24, P93, DOI 10.1055/s-2003-38901; Simons J. S., 1999, NEUROCASE, V5, P379; Taniwaki T, 2000, CLIN NEUROL NEUROSUR, V102, P156, DOI 10.1016/S0303-8467(00)00090-1; TREHUB SE, 1995, J ACOUST SOC AM, V98, P2532, DOI 10.1121/1.414396; Vignolo LA, 2003, ANN NY ACAD SCI, V999, P50, DOI 10.1196/annals.1284.005; Vitte E, 2002, NEUROLOGY, V58, P970, DOI 10.1212/WNL.58.6.970; VONSTOCKERT TR, 1982, BRAIN LANG, V16, P133, DOI 10.1016/0093-934X(82)90077-3; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Wilson R H, 1996, J Am Acad Audiol, V7, P358; WOODCOCK RW, 1989, JOHNSON WOODCOCK JOH; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	47	21	22	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	JAN	2005	92	1					12	25		10.1016/j.bandl.2004.05.003			14	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	889NU	WOS:000226450500002	15582032				2022-02-06	
J	Iverson, GL; Lange, RT; Franzen, MD				Iverson, GL; Lange, RT; Franzen, MD			Effects of mild traumatic brain injury cannot be differentiated from substance abuse	BRAIN INJURY			English	Article; Proceedings Paper	21st Annual Conference of the National-Academy-of-Neuropsychology	OCT 31-NOV 03, 2001	SAN FRANCISCO, CA	Natl Acad Neuropsychol			NEUROPSYCHOLOGICAL TEST-PERFORMANCE; CHRONIC COCAINE ABUSERS; HEAD-INJURY; SOCIAL DRINKERS; LONG-TERM; COMPUTERIZED-TOMOGRAPHY; POLYSUBSTANCE ABUSE; CHRONIC-ALCOHOLISM; OLDER ADULTS; IMPAIRMENT	Primary objective: Patients involved in litigation relating to mild traumatic brain injury (MTBI) typically undergo a forensic neuropsychological evaluation. However, if cognitive problems are identified, it is difficult to know whether these are related to the MTBI or other factors such as pre- and/or post-injury substance abuse. The purpose of this study was to compare the neuropsychological test performances of 73 patients with acute, uncomplicated MTBIs to a sample of 73 patients from an inpatient substance abuse programme. Methods and procedures: Patients were perfectly matched on age, education and gender. Ten cognitive measures were used that included the Trail Making Test (TMT) and selected sub-tests from the Wechsler Memory Scale-Revised. Main outcomes and results: Patients with MTBI demonstrated poorer performances on Digits Backwards ( p < 0.028) and TMTA ( p < 0.032). There were no significant differences between the two groups on the remaining cognitive measures. The clinical usefulness of these measures to differentiate between the groups, using discriminant function analysis, was very poor. Conclusions: Patients with uncomplicated MTBIs could not be reliably differentiated from patients with substance abuse problems on these measures of concentration, memory and processing speed.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Riverview Hosp, Vancouver, BC, Canada; Allegheny Gen Hosp, Pittsburgh, PA 15212 USA		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Akshoomoff N A, 1989, Arch Clin Neuropsychol, V4, P275, DOI 10.1016/0887-6177(89)90018-8; ALTERMAN AI, 1985, INT J NEUROSCI, V28, P155, DOI 10.3109/00207458508985386; ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Bates ME, 1999, ASSESSMENT OF NEUROPSYCHOLOGICAL FUNCTIONS IN PSYCHIATRIC DISORDERS, P373; Beatty M. E., 1994, DRUG ALCOHOL DEPEN, V37, P247; BRANDT J, 1983, ARCH GEN PSYCHIAT, V40, P435; CARLIN AS, 1996, NEUROPSYCHOLOGICAL A, P486; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Drubach D A, 1993, Md Med J, V42, P989; EMMERSON RY, 1988, ALCOHOL CLIN EXP RES, V12, P625, DOI 10.1111/j.1530-0277.1988.tb00254.x; ERRICO AL, 1990, PSYCHOL ASSESSMENT, V2, P45, DOI DOI 10.1037/1040-3590.2.1.45; ERRICO AL, 1991, PSYCHOL ASSESSMENT, V3, P305; FABIAN MS, 1983, J ABNORM PSYCHOL, V92, P87, DOI 10.1037/0021-843X.92.1.87; Fein G, 1998, ALCOHOL CLIN EXP RES, V22, p196S, DOI 10.1111/j.1530-0277.1998.tb04000.x; FRENCH BN, 1977, SURG NEUROL, V7, P171; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GORDON SM, 1988, J SUBST ABUSE TREAT, V5, P99, DOI 10.1016/0740-5472(88)90019-0; GRANT I, 1987, J CLIN PSYCHIAT, V48, P319; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Heaton RK, 1991, COMPREHENSIVE NORMS; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; Hoff AL, 1996, PSYCHIAT RES, V60, P167, DOI 10.1016/0165-1781(96)02758-8; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 1999, ARCH CLIN NEUROPSYCH, V14, P781; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; IVERSON GL, 1997, J NEUROPSYCHIATRY CL, V9, P638; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; JERNIGAN T, 1992, IMAGING ALCOHOL RES, P121; KRAMER JH, 1989, ALCOHOL CLIN EXP RES, V13, P240, DOI 10.1111/j.1530-0277.1989.tb00320.x; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; LONG JA, 1974, Q J STUD ALCOHOL, V35, P1220; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MACVANE J, 1982, J STUD ALCOHOL, V43, P81, DOI 10.15288/jsa.1982.43.81; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; MORRIS JA, 1998, ALCOHOLISM TREATMENT, V16, P101; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; Nixon SJ, 1999, PSYCHOL SCI, V10, P181, DOI 10.1111/1467-9280.00130; OMALLEY S, 1992, AM J DRUG ALCOHOL AB, V18, P131, DOI 10.3109/00952999208992826; Paraherakis A, 2001, SUBST USE MISUSE, V36, P257, DOI 10.1081/JA-100102625; PARKER ES, 1982, ALCOHOL CLIN EXP RES, V6, P46, DOI 10.1111/j.1530-0277.1982.tb05380.x; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; PARSONS OA, 1993, NEUROL CLIN, V11, P205, DOI 10.1016/S0733-8619(18)30178-6; PARSONS OA, 1987, ACTA MED SCAND, P33; PARSONS OA, 1990, ADDICT BEHAV, V15, P297, DOI 10.1016/0306-4603(90)90073-7; PARSONS OA, 1990, ALCOHOL CLIN EXP RES, V14, P746, DOI 10.1111/j.1530-0277.1990.tb01239.x; PARSONS OA, 1996, NEUROPSYCHOLOGY CLIN, P175; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; POPE HG, 1995, DRUG ALCOHOL DEPEN, V38, P25, DOI 10.1016/0376-8716(95)01097-I; PRIFITERA CA, 1992, UNPUB NORMATIVE DELA; Reitan RM, 1992, TRAIL MAKING TEST MA; Reitan RM, 1985, HALSTEADREITAN NEURO; Rosselli M, 1996, J CLIN EXP NEUROPSYC, V18, P122, DOI 10.1080/01688639608408268; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ryan J. J., 1988, CLIN NEUROPSYCHOL, V2, P173; SACHS H, 1987, ARCH NEUROL-CHICAGO, V44, P1242, DOI 10.1001/archneur.1987.00520240024007; SANDER AM, 1989, J CONSULT CLIN PSYCH, V57, P705; Selby MJ, 1998, DRUG ALCOHOL DEPEN, V50, P39, DOI 10.1016/S0376-8716(98)00002-7; SLICK DJ, 2000, J INT NEUROPSYCH SOC, V6, P184; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STRANG J, 1989, BRIT J ADDICT, V84, P1011; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOHMAN JR, 1987, J NERV MENT DIS, V175, P219, DOI 10.1097/00005053-198704000-00005; YOHMAN JR, 1985, ALCOHOL CLIN EXP RES, V9, P114, DOI 10.1111/j.1530-0277.1985.tb05530.x; [No title captured]	74	21	21	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2005	19	1					11	18		10.1080/02699050410001720068			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Rehabilitation	875AS	WOS:000225392600002	15762097				2022-02-06	
S	Kulkarni, AP; Kellaway, LA; Kotwal, GJ		Kotwal, GJ; Lahiri, DK		Kulkarni, AP; Kellaway, LA; Kotwal, GJ			Herbal complement inhibitors in the treatment of neuroinflammation - Future strategy for neuroprotection	NATURAL PRODUCTS AND MOLECULAR THERAPY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	1st International Conference on Natural Products and Molecular Medicine	JAN 13-15, 2005	Univ Cape Town, Cape Town, SOUTH AFRICA		Univ Cape Town	neuroprotection; neurodegeneration; complement inhibitors; herbal ingredients; alternate pathway; classical pathway; cyclooxygenases; vaccinia virus complement control protein (VCP); Alzheimer's disease (AD); HIV-associated dementia (HAD); Parkinson's disease (PD)	SPINAL-CORD-INJURY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; IN-VITRO; CONTROL PROTEIN; ATNICOMPLEMENTARY ACTIVITY; ANTICOMPLEMENTARY ACTIVITY; IMMUNOMODULATORY ACTIVITY; ISOPYRUM-THALICTROIDES	The upregulated complement system plays a damaging role in disorders of the central nervous system (CNS). The classical and alternate pathways are two major pathways activated in neuroinflammatory disorders such as Alzheimer's disease, multiple sclerosis, traumatic brain injury, spinal cord injury, HIV-associated dementia, Parkinson's disease, and mad cow disease. Failure of currently available anti-inflammatory agents, especially cycloxygenase inhibitors, in offering significant neuroprotection in large epidemiologic clinical trials of CNS disorders suggests an urgent need for the development of new neuroprotective agents. The positive preclinical outcomes in treating CNS disorders by complement regulatory molecules, such as vaccinia virus complement control protein, suggest the possibility of using complement-inhibitory molecules as neuroprotective agents. Several active ingredients of herbal origin are found to have complement-inhibitory activity. These herbal ingredients along with other anti-inflammatory roles might be useful in treating neuroinflammation associated with CNS disorders. Active ingredients of herbal origin with complement inhibitory ingredients are summarized and classified according to their chemical nature and specificity towards the major pathways activating the complement system. The structure activity relationship of some specific examples is also discussed in this report. This information might be helpful in formulating a natural panacea against complement-mediated neuroinflammation.	Univ Cape Town, Med Sch, Div Med Virol, ZA-7925 Cape Town, South Africa; Univ Cape Town, Sch Med, Div Neurosci, ZA-7925 Cape Town, South Africa		Kotwal, GJ (corresponding author), Univ Cape Town, Med Sch, Div Med Virol, Anzio Rd, ZA-7925 Cape Town, South Africa.	gjkotw01@yahoo.com			Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Al-Sereiti M. R., 1999, Indian Journal of Experimental Biology, V37, P124; Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Apers S, 2002, PHYTOCHEM ANALYSIS, V13, P202, DOI 10.1002/pca.642; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x; Benencia F, 2000, J ETHNOPHARMACOL, V71, P293, DOI 10.1016/S0378-8741(00)00192-6; Blondin C, 1996, BIOMATERIALS, V17, P597, DOI 10.1016/0142-9612(96)88710-2; Bruder C, 2004, MOL IMMUNOL, V40, P949, DOI 10.1016/j.molimm.2003.10.016; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Chiou WF, 2003, PLANTA MED, V69, P9, DOI 10.1055/s-2003-37041; Cimanga K, 2003, J NAT PROD, V66, P97, DOI 10.1021/np020215h; CIMANGA K, 1995, J NAT PRODUCTS, V58, P372, DOI 10.1021/np50117a005; Davoust N, 1999, J IMMUNOL, V163, P6551; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Geetha T, 1999, GEN PHARMACOL-VASC S, V32, P495, DOI 10.1016/S0306-3623(98)00212-2; HART LA, 1988, J ETHNOPHARMACOL, V23, P61, DOI 10.1016/0378-8741(88)90115-8; HART LA, 1989, PLANTA MED, P509, DOI 10.1055/s-2006-962082; Henderson VW, 2005, J NEUROL NEUROSUR PS, V76, P103, DOI 10.1136/jnnp.2003.024927; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Ivanovska N, 1999, INT J IMMUNOPHARMACO, V21, P337, DOI 10.1016/S0192-0561(99)00015-6; Ivanovska N, 1999, INT J IMMUNOPHARMACO, V21, P325, DOI 10.1016/S0192-0561(99)00014-4; IVANOVSKA ND, 1995, J ETHNOPHARMACOL, V47, P135, DOI 10.1016/0378-8741(95)01273-G; Jauneau AC, 2003, FEBS LETT, V537, P17, DOI 10.1016/S0014-5793(03)00060-7; Kanatani K, 2004, J PHYSIOL PHARMACOL, V55, P207; Kapil A, 1997, J ETHNOPHARMACOL, V58, P89, DOI 10.1016/S0378-8741(97)00086-X; Kaplan Mariana, 2002, Curr Opin Investig Drugs, V3, P1017; Kawakami F, 2003, J BIOCHEM, V133, P231, DOI 10.1093/jb/mvg028; KIYOSHI N, 2000, J NEUROSCI, V20, P763; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; KOSASI S, 1989, J ETHNOPHARMACOL, V27, P81, DOI 10.1016/0378-8741(89)90080-9; Kotwal GJ, 2002, ANN NY ACAD SCI, V973, P317, DOI 10.1111/j.1749-6632.2002.tb04659.x; Kroes BH, 1997, IMMUNOLOGY, V90, P115, DOI 10.1046/j.1365-2567.1997.00131.x; KROES BH, 1993, J ETHNOPHARMACOL, V40, P117, DOI 10.1016/0378-8741(93)90056-B; Kulkarni AP, 2004, ANN NY ACAD SCI, V1035, P147, DOI 10.1196/annals.1332.010; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Manderson AP, 2001, J EXP MED, V194, P747, DOI 10.1084/jem.194.6.747; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Mead RJ, 2002, J IMMUNOL, V168, P458, DOI 10.4049/jimmunol.168.1.458; Min BS, 2003, BIOL PHARM BULL, V26, P1042, DOI 10.1248/bpb.26.1042; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Nicholl DS, 2001, J ETHNOPHARMACOL, V78, P39, DOI 10.1016/S0378-8741(01)00319-1; Nores MM, 1997, J ETHNOPHARMACOL, V55, P99, DOI 10.1016/S0378-8741(96)01480-8; Park SH, 1999, CHEM PHARM BULL, V47, P1484, DOI 10.1248/cpb.47.1484; PEAKE PW, 1991, INT J IMMUNOPHARMACO, V13, P853, DOI 10.1016/0192-0561(91)90036-7; Pieroni A, 1996, PHARMAZIE, V51, P765; Pieroni A, 2000, J ETHNOPHARMACOL, V70, P213, DOI 10.1016/S0378-8741(99)00169-5; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Reynolds DN, 2004, ANN NY ACAD SCI, V1035, P165, DOI 10.1196/annals.1332.011; Reynolds DN, 2003, ANN NY ACAD SCI, V1010, P534, DOI 10.1196/annals.1299.099; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Romi F, 2005, J NEUROIMMUNOL, V158, P191, DOI 10.1016/j.jneuroim.2004.08.002; Sahu A, 1999, BIOCHEM PHARMACOL, V57, P1439, DOI 10.1016/S0006-2952(99)00044-1; SANDERS ME, 1986, J IMMUNOL, V136, P4456; Sayah S, 2003, MOL BRAIN RES, V112, P53, DOI 10.1016/S0169-328X(03)00046-9; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Sellebjerg F, 1998, J NEUROL SCI, V157, P168, DOI 10.1016/S0022-510X(98)00086-0; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shahat AA, 2003, PLANTA MED, V69, P1153, DOI 10.1055/s-2003-818009; Shahat AA, 1996, PLANTA MED, V62, P10, DOI 10.1055/s-2006-957786; Shen Y, 1997, BRAIN RES PROTOC, V1, P186, DOI 10.1016/S1385-299X(96)00026-8; Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054; Spielman L, 2002, ACTA NEUROPATHOL, V103, P157, DOI 10.1007/s004010100447; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; STRUNK RC, 1979, PEDIATR RES, V13, P188, DOI 10.1203/00006450-197903000-00012; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Takahashi N, 2000, HEARTWEB, V5, pU1; Takano T, 2001, AM J PHYSIOL-RENAL, V281, pF841, DOI 10.1152/ajprenal.0048.2001; TEATHER LA, 2000, LEARN MEMORY, V9, P41; THABREW MI, 1991, J ETHNOPHARMACOL, V33, P63, DOI 10.1016/0378-8741(91)90162-7; THEOHARIDES TC, 1990, LIFE SCI, V46, P607, DOI 10.1016/0024-3205(90)90129-F; Thomet OAR, 2001, BIOCHEM PHARMACOL, V61, P1041, DOI 10.1016/S0006-2952(01)00552-4; VANDENBERG AJJ, 1995, FEBS LETT, V358, P215, DOI 10.1016/0014-5793(94)01405-P; VANDERNAT JM, 1989, J ETHNOPHARMACOL, V27, P15, DOI 10.1016/0378-8741(89)90073-1; Verrico MM, 2003, ANN PHARMACOTHER, V37, P1203, DOI 10.1345/aph.1A212; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319; Whiss Per A, 2002, Curr Opin Investig Drugs, V3, P870; Wolfe F, 2004, J RHEUMATOL, V31, P1143; Woolhiser MR, 2004, CLIN IMMUNOL, V110, P172, DOI 10.1016/j.clim.2003.11.007; YAMADA H, 1985, MOL IMMUNOL, V22, P295; ZHAO JF, 1993, PHYTOCHEMISTRY, V34, P719, DOI 10.1016/0031-9422(93)85346-S	87	21	21	0	8	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-595-8; 1-57331-594-X	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2005	1056						413	429		10.1196/annals.1352.020			17	Biochemistry & Molecular Biology; Integrative & Complementary Medicine; Medicine, Research & Experimental; Multidisciplinary Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Integrative & Complementary Medicine; Research & Experimental Medicine; Science & Technology - Other Topics	BDU43	WOS:000235433100035	16387706	Green Submitted			2022-02-06	
J	Ling, GSF; Neal, CJ				Ling, GSF; Neal, CJ			Maintaining cerebral perfusion pressure is a worthy clinical goal	NEUROCRITICAL CARE			English	Article						cerebral perfusion pressure; traumatic brain injury; critical care; intracranial pressure	SECONDARY ISCHEMIC INSULTS; TRAUMATIC BRAIN-INJURY; TISSUE OXYGEN; BLOOD-FLOW; THERAPY; AUTOREGULATION; HYPERTENSION; MANAGEMENT; VOLUME	Cerebral perfusion pressure (CPP) is one aspect of an all-encompassing approach in the management of traumatic brain injury (TBI). The clinical use of CPP is based on theoretical considerations that optimal cerebral blood flow is necessary to meet the metabolic needs of the injured brain. The goal is to preserve the ischemic penumbra and avoid secondary insults. Unfortunately, lack of objective measures of local tissue response and randomized controlled clinical trials prevents confirmation that these goals are being met when actively treating CPP. The present recommended threshold CPP for intervention in the literature is 70 mmHg. However, this specific CPP level is being challenged. There is increasing evidence that this and higher CPP thresholds are not necessary and that a lower CPP may be as clinically effective. There are clinical prospective, but not randomized, human trials showing that CPP 60 to 70 mmHg may be reasonable. Recently, the Brain Trauma Foundation updated their Web-based recommendation of a lower CPP goal of 60 mmHg. However, the lack of definitive data, such as from a randomized prospective intention-to-treat clinical trials, leaves this goal open to controversy. Therefore, for a variety of reasons, the physician may be most prudent to use the published CPP guideline of 70 mmHg until a consensus statement is published advocating a different value.	Uniformed Serv Univ Hlth Sci, Dept Neurol, Div Crit Care Med, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; Walter Reed Army Med Ctr, Natl Capital Neurosurg Consortium, Washington, DC 20307 USA		Ling, GSF (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Div Crit Care Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gling@usuhs.mil					*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P507; *AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P457; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 2001, J TRAUMA S, V51, pS3; *BRAIN TRAUM FDN, MAN PROGN SEV TRAUM; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHRISTER E, 1998, CRIT CARE MED, V26, P1881; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; Czosnyka M, 1996, CEREBROVAS BRAIN MET, V8, P273; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 2000, ACT NEUR S, V76, P483; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; Nordstrom CH, 2003, ACTA NEUROCHIR SUPPL, V86, P355; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Poon WS, 2002, ACT NEUR S, V81, P335; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Robertson C, 2000, CRIT CARE MED, V28, P3358, DOI 10.1097/00003246-200009000-00046; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 1991, Minerva Anestesiol, V57, P327; Thomson A D, 2000, Alcohol Alcohol Suppl, V35, P2; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; CEREBRAL PERFUSION P	36	21	24	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2005	2	1					75	81		10.1385/NCC:2:1:075			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945FU	WOS:000230489200015	16174974				2022-02-06	
J	Ng, YS; Chua, KSG				Ng, YS; Chua, KSG			States of Severely Altered Consciousness: Clinical characteristics, medical complications and functional outcome after rehabilitation	NEUROREHABILITATION			English	Article						rehabilitation; persistent vegetative state; minimally conscious state; traumatic brain injury; outcomes	PERSISTENT VEGETATIVE STATE; DISABILITY RATING-SCALE; TRAUMATIC BRAIN-INJURY; STROKE REHABILITATION; HEAD-INJURY; RECOVERY; DIAGNOSIS; COMA	Objective: To identify and characterize demographics, injury variables, complications, and functional outcomes in Asian patients presenting in States of Severely Altered Consciousness (SSAC). Design: Descriptive case series review. Setting/Subjects: Acute rehabilitation unit with intensive, comprehensive neurological rehabilitation program. Thirty consecutive patients diagnosed to be in persistent vegetative state (PVS) or minimally conscious (MCS) state over a 4-year period were included. Main Outcome Measures: Disability Rating Scale (DRS), Ranchos Los Amigos Scale (RLAS), Modified Barthel Index (MBI). Results: Seventeen (57%) were male, with a mean age of 31.8 years (median 25y, range 15-74, SD 16.3y). Twenty-one (70%) had traumatic brain injury, and median GCS on acute admission was 5. The mean length of stays (LOS) in acute and rehabilitation facilities was 90.1 days and 106.3 days respectively. Tracheostomized patients had longer acute LOS. (p = 0.03). All patients had improvement in their DRS scores upon rehabilitation discharge. The MBI was insensitive in identifying low-level changes; though paired analyses were significant for improvement. Seventeen (57%) patients were in PVS and the rest in MCS on admission to rehabilitation. Twelve patients progressed to a state of awareness, with eye responses as the most frequent first sign. There was a greater spread of higher RLAS categories on rehabilitation discharge. Urinary tract infection (16 patients, 53%) was the most common medical complication. Nineteen (63%) had central fever and this group was more functionally disabled (P = 0.045). The mean number of medications on discharge was 6. The majority of patients (22 patients, 73%) were discharged home, and patients continued to make functional progress post-discharge. Conclusions: Despite SSAC states, the majority improve, however profound disability persists. Possible predictors of a worse outcome include tracheostomy, severity of initial disability, initial RLAS II level and presence of central fever.	Singapore Gen Hosp, Dept Rehabil Med, Singapore 169608, Singapore; Tan Tock Seng Hosp, Dept Rehabil Med, Singapore, Singapore		Ng, YS (corresponding author), Singapore Gen Hosp, Dept Rehabil Med, Outram Rd, Singapore 169608, Singapore.	grunys@sgh.com.sg		Ng, Yee-Sien/0000-0003-1377-5852			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Chua KSG, 1999, INT J REHABIL RES, V22, P189, DOI 10.1097/00004356-199909000-00005; Clinchot DM, 1997, AM J PHYS MED REHAB, V76, P323, DOI 10.1097/00002060-199707000-00012; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hagen C., 1972, LEVELS COGNITIVE FUN; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kraus J. F., 1999, REHABILITATION ADULT, P3; Krimchansky BZ, 1999, BRAIN INJURY, V13, P899; LOMBARDI F, 2002, COCHRANE DATABASE, V2; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SIEGLER EL, 1994, ARCH INTERN MED, V154, P2185, DOI 10.1001/archinte.154.19.2185; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; 2000, SING DEP STAT	27	21	21	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2005	20	2					97	105					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	966EG	WOS:000232001800006	15920302				2022-02-06	
J	Bayly, PV; Ji, S; Song, SK; Okamoto, RJ; Massouros, P; Genin, GM				Bayly, PV; Ji, S; Song, SK; Okamoto, RJ; Massouros, P; Genin, GM			Measurement of strain in physical models of brain injury: A method based on HARP analysis of tagged magnetic resonance images (MRI)	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							DIFFUSE AXONAL INJURY; SPATIAL MODULATION; MECHANICAL STRETCH; MOTION; HEART; IMPACT; TRAUMA	Two-dimensional (2-D) strain fields were estimated non-invasively in two simple experimental models of closed-head brain injury. In the first experimental model, shear deformation of a gel was induced by angular acceleration of its spherical container. In the second model the brain of a euthanized rat pup was deformed by indentation of its skull. Tagged magnetic resonance images (MRI) were obtained by gated image acquisition during repeated motion. Harmonic phase (HARP) images corresponding to the spectral peaks of the original tagged MRI were obtained, following procedures proposed by Osman, McVeigh and Prince [1]. Two methods of HARP strain analysis were applied, one based on the displacement of tag line intersections, and the other based on the gradient of harmonic phase. Strain analysis procedures were also validated on simulated images of deformed grids. Results show that it is possible to visualize deformation and to quantify strain efficiently in animal models of closed head injury.	Washington Univ, St Louis, MO 63130 USA		Bayly, PV (corresponding author), Washington Univ, 1 Brookings Dr,Box 1185, St Louis, MO 63130 USA.	pvb@me.wustl.edu		Okamoto, Ruth/0000-0002-3085-3878; Bayly, Philip/0000-0003-4303-0704	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24CA083060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073315, R01HL042950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS045237] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24 CA083060] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL042950, R01 HL073315] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS045237-01A1, R21 NS045237, R21 NS045237-02, NS45237] Funding Source: Medline		Al-Bsharat AS, 1999, P 43 STAPP CAR CRASH; AXEL L, 1989, RADIOLOGY, V172, P349, DOI 10.1148/radiology.172.2.2748813; AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; Babuska I., 1991, FINITE ELEMENT ANAL; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy W.N., 1997, ASME PUBLICATION AMD, V225, P241; Holbourn AHS, 1943, LANCET, V2, P438; Kraitchman DL, 2003, CIRCULATION, V107, P2025, DOI 10.1161/01.CIR.0000062684.47526.47; Kuijer JPA, 2001, MAGN RESON MED, V46, P993; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Smith DH, 1999, J NEUROSCI, V19, P4263; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sosin DM, 1996, BRAIN INJURY, V10, P47; YOUNG AA, 1993, RADIOLOGY, V188, P101, DOI 10.1148/radiology.188.1.8511281; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283; ZHANG L, 2001, ASME BED, V50, P831	24	21	21	0	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	AUG	2004	126	4					523	528		10.1115/1.1785811			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	864YI	WOS:000224668800017	15543872	Green Accepted			2022-02-06	
J	Wennberg, R				Wennberg, R			Collision frequency in elite hockey on North American versus international size rinks	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							ICE HOCKEY; CONCUSSIONS; LEAGUE	Objective: Body impact or collision is the risk factor underlying all sports-related concussions. This study sought to determine whether collision rates in elite hockey differ between games played on North American size rinks as compared to games played on larger international size ice surfaces. Methods: Videotapes of games from the 2001 and 2002 National Hockey League Stanley Cup finals, World Junior championships and the 2002 Winter Olympics were analyzed, with all collisions counted and separated into various categories (player/player bodycheck, player/player into boards, player/boards, player/ice, head/stick, head/puck). Further subdivisions included collisions involving the head directly or indirectly. Twenty-two games were analyzed, 11 played on the small ice and 11 on the big ice. Results: Significantly more collisions of all types (in all categories and subdivisions within categories) were found to occur on the smaller North American ice surface (P value differences from 0.01 to 0.00001). Conclusions: The results of this study showed significantly fewer collisions of all types in elite hockey games played on the international size ice surface. The comparison groups studied here did differ in some aspects other than ice size and so replication of the findings with even more closely matched groups will be needed before definitive conclusions can be drawn. However, if these findings are replicable, it would suggest that a change to uniform usage of the larger international rinks, with no rule changes or other alterations in the game, could provide direct primary prevention to reduce the number of collisions, and, by extension, concussions, that occur in the sport.	Univ Toronto, Toronto Western Hosp, Div Neurol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Univ Hlth Network, Toronto, ON M5T 2S8, Canada		Wennberg, R (corresponding author), Univ Toronto, Toronto Western Hosp, Div Neurol, 399 Bathurst St,5W444, Toronto, ON M5T 2S8, Canada.						Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596	4	21	21	0	5	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	AUG	2004	31	3					373	377		10.1017/S0317167100003474			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849OZ	WOS:000223549600015	15376483	Bronze			2022-02-06	
J	Stocchetti, N; Canavesi, K; Magnoni, S; Valeriani, V; Conte, V; Rossi, S; Longhi, L; Zanier, ER; Colombo, A				Stocchetti, N; Canavesi, K; Magnoni, S; Valeriani, V; Conte, V; Rossi, S; Longhi, L; Zanier, ER; Colombo, A			Arterio-jugular difference of oxygen content and outcome after head injury	ANESTHESIA AND ANALGESIA			English	Article							TRAUMATIC BRAIN INJURY; CEREBRAL BLOOD-FLOW; INTRACRANIAL HYPERTENSION; SATURATION; METABOLISM; MANAGEMENT; HYPOXIA	This study investigated AJDo(2) (arterio-jugular difference of oxygen content) in a large sample of severely head-injured patients to identify its pattern during the first days after injury and to describe the relationship of AJDo(2) with acute neurological severity and with outcome 6 mo after trauma. In 229 comatose head-injured patients, we monitored intracranial pressure, cerebral perfusion pressure, and AJDo(2). Outcome was defined 6 mo after injury. Jugular hemoglobin oxygen saturation (Sjo(2)) averaged 68%. The mean AJDo(2) was 4.24 vol% (SD, 1.3 vol%). There were 80 measurements (4.6%) with Sjo(2) <55% and 304 (17.6%) with saturation >75%. AJDo(2) was higher than 8.7 vol% in 8 measurements (0.4%) and was lower than 3.9 vol% in 718 (42%) measurements. AJDo(2) was higher during the first tests and decreased steadily over the next few days. Cases with a favorable outcome had a higher mean AJDo(2) (4.3 vol%; SD, 0.3 vol%) than patients with severe disability or vegetative status (3.8 vol%; so, 1.3 vol%) and patients who died (3.6 vol%; so, 1 vol%). This difference was significant (P < 0.001). We conclude that low levels of AJDo(2) are correlated with a poor prognosis, whereas normal or high levels of AJDo(2) are predictive of better results.	Univ Milan, Ist Anestesia & Rianimaz, Policlin, Osped Maggiore Policlin,IRCCS, I-20122 Milan, Italy		Stocchetti, N (corresponding author), Univ Milan, Ist Anestesia & Rianimaz, Policlin, Osped Maggiore Policlin,IRCCS, Via F Sforza,35, I-20122 Milan, Italy.	stocchet@policlinico.mi.it	Stocchetti, Nino/O-7444-2017; Zanier, Elisa/AAA-8095-2020; Magnoni, Sandra/AAC-7479-2022	Stocchetti, Nino/0000-0003-3250-6834; Zanier, Elisa/0000-0002-3011-8718; Magnoni, Sandra/0000-0002-1723-0844; Rossi, Sandra/0000-0002-9963-8121			BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Cormio M, 1997, J CLIN NEUROSCI, V4, P132, DOI 10.1016/S0967-5868(97)90062-X; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Cruz J, 1996, CRIT CARE MED, V24, P953, DOI 10.1097/00003246-199606000-00013; CRUZ J, 1992, J NEUROSURG, V77, P162; CRUZ J, 1991, SNAAC NEWSLETT   SPR, P4; DESALLES AF, 1997, NEUROSURGERY, V21, P45; Gibbs EL, 1942, J BIOL CHEM, V144, P325; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Henson LC, 1998, ANESTHESIOLOGY, V88, P58, DOI 10.1097/00000542-199801000-00011; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; Latronico N, 2000, NEUROSURGERY, V46, P1131, DOI 10.1097/00006123-200005000-00021; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MEYER JS, 1965, NEUROLOGY, V15, P892, DOI 10.1212/WNL.15.10.892; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOODMAN T, 1996, NEUROTRAUMA, pCH36	24	21	26	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	JUL	2004	99	1					230	234		10.1213/01.ane.0000130393.08355.d4			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	832GW	WOS:000222256400044	15281535				2022-02-06	
J	Fee, DB; Sewell, DL; Andresen, K; Jacques, TJ; Piaskowski, S; Barger, BA; Hart, MN; Fabry, Z				Fee, DB; Sewell, DL; Andresen, K; Jacques, TJ; Piaskowski, S; Barger, BA; Hart, MN; Fabry, Z			Traumatic brain injury increases TGF beta RII expression on endothelial cells	BRAIN RESEARCH			English	Article						traumatic cerebral injury; TGF beta receptor; SMAD protein	CENTRAL-NERVOUS-SYSTEM; CEREBRAL MICROVESSELS; SIGNAL-TRANSDUCTION; IN-VITRO; RECEPTORS; ACTIVATION; PROTEINS; CULTURES	Transforming growth factor beta (TGFbeta) modulates a variety of growth related functions following traumatic injury. The cellular response to TGFbeta is predominantly mediated through TGFbeta receptor I (TGFbetaRI) and receptor II (TGFbetaRII) on the cell surface and SMAD proteins intracellularly. We investigated the expression of TGFbeta receptors in the acute and chronic phases of a traumatic cerebral injury (TCI) by immunohistochemistry and in cultures of murine brain microvascular endothelial (EN) cells using cytofluorimetry. Here, we report that TGFbetaRII expression significantly increases on brain endothelial cells in the chronic phase of TCI. SMAD3 and SMAD4 protein expression were also upregulated suggesting the activation of TGFbeta receptor intracellular signaling. When TGFbetaRI and TGFbetaRII expression was studied in in vitro cultures of murine brain microvessel EN cells, TGFbetaRII showed increased expression on proliferating cells that are incorporating BrdU. These data show a differential expression of TGFbetaRI and TGFbetaRII on brain microvessel EN cells in the acute and chronic phases of TO that might be associated with EN proliferation following injury. (C) 2004 Elsevier B.V. All rights reserved.	Univ Wisconsin, Hosp & Clin, Dept Pathol, Madison, WI 53706 USA; Univ Wisconsin, Hosp & Clin, Dept Neurol, Madison, WI USA; Univ Iowa, Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA		Fabry, Z (corresponding author), Univ Wisconsin, Hosp & Clin, Dept Pathol, 1300 Univ Ave,6130 MSC, Madison, WI 53706 USA.	zfabry@facstaff.wisc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS037570] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037570] Funding Source: NIH RePORTER		Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Cancilla P A, 1980, Adv Exp Med Biol, V131, P257; CANCILLA PA, 1972, LAB INVEST, V26, P376; CANCILLA PA, 1979, LAB INVEST, V40, P74; CANCILLA PA, 1992, J NEUROPATH EXP NEUR, V51, P560, DOI 10.1097/00005072-199209000-00011; Cowin AJ, 2001, EUR J DERMATOL, V11, P424; De Groot CJA, 1999, J NEUROPATH EXP NEUR, V58, P174, DOI 10.1097/00005072-199902000-00007; DeBault L E, 1980, Adv Exp Med Biol, V131, P69; DEBAULT LE, 1979, IN VITRO CELL DEV B, V15, P473; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DOREDUFFY P, 1994, MOL CHEM NEUROPATHOL, V22, P161, DOI 10.1007/BF03160103; FABRY Z, 1995, J IMMUNOL, V155, P325; FABRY Z, 1992, J NEUROIMMUNOL, V36, P1, DOI 10.1016/0165-5728(92)90026-H; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; HART MN, 1987, J NEUROPATH EXP NEUR, V46, P141, DOI 10.1097/00005072-198703000-00003; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hofstetter HH, 2003, J NEUROIMMUNOL, V134, P25, DOI 10.1016/S0165-5728(02)00358-2; KAPLAN MM, 1972, GASTROENTEROLOGY, V62, P452; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MOORE SA, 1988, AM J PHYSIOL, V254, P37; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Ngo M, 2001, PLAST RECONSTR SURG, V108, P1260, DOI 10.1097/00006534-200110000-00025; Rimaniol AC, 1995, NEUROREPORT, V7, P133, DOI 10.1097/00001756-199512290-00032; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Stark B, 2001, BRAIN RES, V913, P47, DOI 10.1016/S0006-8993(01)02757-3; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Vivien D, 1998, J NEUROCHEM, V70, P2296; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	33	21	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 25	2004	1012	1-2					52	59		10.1016/j.brainres.2004.03.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829QA	WOS:000222063500006	15158160				2022-02-06	
J	Slemmer, JE; Weber, JT; De Zeeuw, CI				Slemmer, JE; Weber, JT; De Zeeuw, CI			Cell death, glial protein alterations and elevated S-100 beta release in cerebellar cell cultures following mechanically induced trauma	NEUROBIOLOGY OF DISEASE			English	Article						NSE; Purkinje cell; stretch; GLAST; bergmann glia; in vitro injury; neuronal death	STRETCH-INDUCED INJURY; NEURON-SPECIFIC ENOLASE; BRAIN INJURY; FLUORESCENT PROTEIN; CORTICAL-NEURONS; DAMAGE; ASTROCYTES; MICE; RAT; ACTIVATION	Recent studies in vivo have shown that cells of the cerebellum, and particularly Purkinje neurons (PNs), are susceptible to damage following traumatic brain injury (TBI). To investigate more closely the effects of TBI at the cellular level, we subjected cerebellar cell cultures to injury using an in vitro model of stretch-induced mechanical trauma and found increased cell damage and neuronal loss with increasing levels of injury and time post-injury. The release of neuron-specific enolase and S-100beta were also elevated after injury. Compared to our previous findings in hippocampal cells, S-100beta levels were much higher in cerebellar cultures after injury, suggesting that cells from different brain regions show variable responses to mechanical trauma. Lastly, the addition of exogenous S-100beta to uninjured cerebellar cells caused no overt change in cell viability or overall neuronal number; there were, however, fewer calbindin-positive PNs, similar to findings after stretch injury. (C) 2004 Elsevier Inc. All rights reserved.	Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands		Weber, JT (corresponding author), Erasmus MC, Dept Neurosci, Dr Molenwaterpl 50, NL-3000 DR Rotterdam, Netherlands.	j.weber@erasmusmc.nl					Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Azmitia EC, 2002, PROG BRAIN RES, V136, P87; AZMITIA EC, 1990, BRAIN RES, V516, P354, DOI 10.1016/0006-8993(90)90942-5; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; CAJAL SR, 1933, CAJALS DEGENERATION, P91; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; DONATO R, 1991, CELL CALCIUM, V12, P713, DOI 10.1016/0143-4160(91)90040-L; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Lossi L, 1995, J ANAT, V187, P709; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; OHearn E, 1997, J NEUROSCI, V17, P8828; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Pinto SS, 2000, FEBS LETT, V486, P203, DOI 10.1016/S0014-5793(00)02301-2; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stepanova T, 2003, J NEUROSCI, V23, P2655; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Whitaker-Azmitia PM, 1997, BRAIN RES, V776, P51, DOI 10.1016/S0006-8993(97)01002-0; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Zhao XR, 2000, J CEREBR BLOOD F MET, V20, P550, DOI 10.1097/00004647-200003000-00014	37	21	22	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2004	15	3					563	572		10.1016/j.nbd.2003.11.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	811UL	WOS:000220796700015	15056464				2022-02-06	
J	Biberthaler, P; Mussack, T; Kanz, KG; Linsenmaier, U; Pfeifer, KJ; Mutschler, W; Jochum, M				Biberthaler, P; Mussack, T; Kanz, KG; Linsenmaier, U; Pfeifer, KJ; Mutschler, W; Jochum, M			Identification of high-risk patients after minor craniocerebral trauma. Measurement of nerve tissue protein S100	UNFALLCHIRURG			German	Article						minor head trauma; S100; neurotrauma; cranial computed tomography; CCT	CALCIUM-BINDING PROTEINS; SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; S-100B PROTEIN; WHOLE-BLOOD; SERUM; MARKER; S-100-BETA; S100-BETA; SURGERY	The indication for an initial cranial computed tomography (CCT) in minor head trauma (MHT) patients remains the subject of discussion. The aim of this study was to investigate whether a newly developed, rapid test system (ELECSYS S100, Roche Diagnostics) might allow a diagnostically valid, reproducible measurement of S 100 in MHT patients. Blood samples were drawn from 75 MHT patients, a CCT scan was performed, and those with a post-traumatic intracranial lesion counted as CCT+. Results were compared to a healthy control group (n=17). Of the 75 patients included in the study, 14 were stratified as CCT+. The systemic concentration of S 100 in these CCT+ patients was significantly increased (0.31 mug/l) compared to the healthy control group (0.04 mug/l) as well as to the CCT-negative patients (0.08 mug/l). The ELECSYS S100 system allows a rapid,valid,and reproducible assessment of S 100B in patient serum and this concentration is significantly elevated in patients suffering from intracranial lesions as shown by initial CCT scan. Hence,this study is the basis for a multicenter trial currently.	Univ Munich, Chirurg Klin & Poliklin Innesnstadt, D-80336 Munich, Germany; Univ Munich, Inst Radiol Diagnost Innestadt, Munich, Germany; Univ Munich, Abt Klin Chem & Biochem Innenstadt, Munich, Germany		Biberthaler, P (corresponding author), Univ Munich, Chirurg Klin & Poliklin Innesnstadt, Nussbaumstr 20, D-80336 Munich, Germany.	peter.biberthaler@med.uni-muenchen.de					Bergmann M, 1999, SHOCK, V12, P421, DOI 10.1097/00024382-199912000-00002; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; COCCHIA D, 1981, NATURE, V294, P85, DOI 10.1038/294085a0; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Ettinger A, 1999, ANN THORAC SURG, V68, P2196, DOI 10.1016/S0003-4975(99)00849-8; HAIMOTO H, 1987, LAB INVEST, V57, P489; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Pellegrini JD, 2000, J SURG RES, V88, P200, DOI 10.1006/jsre.1999.5797; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Ruchholtz S, 2002, CHIRURG, V73, P194, DOI 10.1007/s00104-002-0424-6; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TOENNIS W, 1953, AERZTL PRAXIS 5, V36, P13; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	27	21	24	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAR	2004	107	3					197	202		10.1007/s00113-004-0730-1			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	813GI	WOS:000220895200004	15042301				2022-02-06	
J	Gauggel, S; Heinemann, AW; Bocker, M; Lammler, G; Borchelt, M; Steinhagen-Thiessen, E				Gauggel, S; Heinemann, AW; Bocker, M; Lammler, G; Borchelt, M; Steinhagen-Thiessen, E			Patient-staff agreement on Barthel Index scores at admission and discharge in a sample of elderly stroke patients	REHABILITATION PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; IMPAIRED AWARENESS; INPATIENT REHABILITATION; SELF-AWARENESS; ADL INDEX; BEHAVIORAL LIMITATIONS; HEAD-INJURY; DISABILITY; RELATIVES	Objective: To investigate the congruence and influence of lesion side on staff and patient ratings of activity limitations. Study Design: Retrospective study of activity limitations at admission and discharge using the Rasch model and rating scale analysis. Participants: One-hundred twenty elderly stroke patients. Setting: Outpatient geriatric rehabilitation center. Main Outcome Measure: Barthel Index (BI). Results: High patient-staff agreement was found with the lowest agreement on the bathing item of the BI, Although staff rated the degree of activity limitations significantly higher than patients, the effect size was low at admission and discharge. The discrepancy between patient and staff reports did not change during rehabilitation and was equivalent between patients with right and patients with left hemisphere lesions. Conclusion: Patients with a stroke slightly overestimated their competency compared with rehabilitation staff and remained consistent during rehabilitation.	Univ Technol Chemnitz, Dept Psychol, D-09107 Chemnitz, Germany; Rehabil Inst Chicago, Chicago, IL 60611 USA; Geriatr Ctr Berlin, Berlin, Germany		Gauggel, S (corresponding author), Univ Technol Chemnitz, Dept Psychol, Wilhelm Raabe Str 43, D-09107 Chemnitz, Germany.	siegfried.gauggel@phil.tu-chemnitz.de	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326; Gauggel, Siegfried/0000-0002-2742-4917			BABINSKI MJ, 1914, REV NEUROL, V12, P845; BLONDER LX, 1994, NEUROPSY NEUROPSY BE, V7, P260; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; BOND TG, 2001, APPL RASCH MODE FUND; Collin C, 1988, Int Disabil Stud, V10, P61; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Embretson S.E., 2013, ITEM RESPONSE THEORY; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Gatterer G, 1990, ALTERS KONZENTRATION; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Gosman-Hedstrom G, 2000, DISABIL REHABIL, V22, P702, DOI 10.1080/09638280050191972; Harlacher R, 1999, Z GERONTOL GERIATR, V32, P200, DOI 10.1007/s003910050105; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LINACRE JM, 1999, WINSTEPS PC COMPATIB; Mahoney FI, 1995, MD STATE MED J, V14, P56; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Newman AC, 2000, BRAIN INJURY, V14, P333; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RANHOFF AH, 1993, AGE AGEING, V22, P171, DOI 10.1093/ageing/22.3.171; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Rose, 1982, CLIN GERONTOLOGIST, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Taylor JG, 1998, NEUROREPORT, V9, P1787, DOI 10.1097/00001756-199806010-00021; TENNANT A, 1996, CLIN REHABIL, V0010, P00301, DOI DOI 10.1177/026921559601000407; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; WAGNER MT, 1994, ARCH CLIN NEUROPSYCH, V9, P57, DOI 10.1016/0887-6177(94)90014-0; WATSON YI, 1993, J AM GERIATR SOC, V41, P1235, DOI 10.1111/j.1532-5415.1993.tb07308.x; WELLWOOD I, 1995, AGE AGEING, V24, P54, DOI 10.1093/ageing/24.1.54; Wright B, 1979, BEST TEST DESIGN; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; WYLLER TB, 1995, AGE AGEING, V24, P398, DOI 10.1093/ageing/24.5.398; Wyller TB, 1996, DISABIL REHABIL, V18, P454, DOI 10.3109/09638289609165909	48	21	21	0	1	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2004	49	1					21	27		10.1037/0090-5550.49.1.21			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	771RQ	WOS:000188800200004					2022-02-06	
J	af Geijerstam, JL; Britton, M; Marke, LA				af Geijerstam, JL; Britton, M; Marke, LA			Mild head injury: observation or computed tomography? Economic aspects by literature review and decision analysis	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN INJURY; MANAGEMENT; ADMISSION; RISK	Objectives: To compare the costs of two strategies for acute management of mild head injury: inhospital observation compared with acute computed tomography (CT) and home care. Methods: Studies comparing costs for the two strategies that seem to have similar outcomes for patients were systematically reviewed. A decision tree analysis to compare the costs was also constructed, based on Swedish national costs and the risks found in a recent review on mild head injury complications. Results: No studies were found that directly measured and compared risks, benefits, and costs of the two strategies. In the four studies retrieved, involving 4126 patients, the costs for hospital observation were factual, but a model was used to evaluate costs for the CT strategy. On average, costs were one third lower with CT. Also, the decision tree analysis demonstrated that the CT strategy was one third less expensive than inhospital observation. A sensitivity analysis showed this to be valid for nearly all cases. If these calculations hold true, a change of strategy could result in annual savings of pound280 000/million inhabitants. Conclusion: The CT strategy seems to cost one third less than hospital observation.	Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden		af Geijerstam, JL (corresponding author), Karolinska Hosp, Dept Med N4 01, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.	jean-luc.af.geijerstam@medks.ki.se					af Geijerstam JL, 2000, EUR J SURG, V166, P526; BAKER SR, 1985, RADIOLOGY, V156, P409, DOI 10.1148/radiology.156.2.4011903; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Brell M, 2001, NEUROCIRUGIA, V12, P105; *CTR EP, 1998, HOSP CAR 1996 PAT AD; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; JONES JJ, 1981, LANCET, V2, P850; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; *SO HLTH CAR DISTR, 1997, REG PRIC 1998; Stalhammar D, 1986, Acta Neurochir Suppl (Wien), V36, P63; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; *SWED COUNC TECHN, 2000, 153 SWED COUNC TECH; *SWED FED COUNT CO, 1999, COST ADM PAT 1996; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Von Wild K, 2001, BRAIN INJURY, V15, P273; VYDARENY KH, 1983, INVEST RADIOL, V18, P390, DOI 10.1097/00004424-198307000-00019; WILLIAMS RJL, 1994, J ROY SOC MED, V87, P83	31	21	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN 1	2004	21	1					54	58		10.1136/emj.2003.003178			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	765DC	WOS:000188251000016	14734377	Green Published, Bronze			2022-02-06	
J	Formisano, R; Voogt, RD; Buzzi, MG; Vinicola, V; Penta, F; Peppe, A; Stanzione, P				Formisano, R; Voogt, RD; Buzzi, MG; Vinicola, V; Penta, F; Peppe, A; Stanzione, P			Time interval of oral feeding recovery as a prognostic factor in severe traumatic brain injury	BRAIN INJURY			English	Article							KLUVER-BUCY-SYNDROME; HEAD-INJURY; ACUTE PREDICTORS; IMPROVEMENT; AMNESIA; RETURN	Primary objectives : To assess the outcome of severe traumatic brain injury at least 1 year after trauma, in relation to some early clinical prognostic factors occurring during coma recovery. Research design : Retrospective study conducted at the post-coma unit of a rehabilitation hospital. Methods and procedures : A total of 43 patients were included. All of the patients sustained severe traumatic brain injury and prolonged coma, i.e. coma lasting at least 15 days. Outcome was assessed by means of Glasgow Coma Scale, Barthel Index and Mini Mental State 1 year after trauma, in relation to some early clinical prognostic factors occurring during coma recovery. Main outcomes and results : At the 1 year follow-up, a statistically significant correlation was found with both the Glasgow Outcome Scale and the Barthel Index for the time interval from brain injury to recovery of the following clinical variables: optical fixation, ability to obey commands, spontaneous motor activity and first safe oral feeding. Psychomotor agitation and bulimia were also favourable prognostic factors for the final outcome. Conclusions : In the present study, first safe oral feeding during coma recovery represents the clinical feature that better predicts the final outcome of patients with severe traumatic brain injury and prolonged coma.	IRCCS, Fdn Santa Lucia, I-00179 Rome, Italy; Robert Voogt & Associates, Virginia Beach, VA USA; Univ Roma Tor Vergata, Neurol Clin, I-00173 Rome, Italy		Formisano, R (corresponding author), IRCCS, Fdn Santa Lucia, Via Ardeatina 306, I-00179 Rome, Italy.	r.formisano@hsantalucia.it	Buzzi, Maria Gabriella/K-5468-2016	Buzzi, Maria Gabriella/0000-0003-1307-8707			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARTHEL L, 1965, MD STATE MED J, V14, P61; Bates JB, 1997, J NEUROPSYCH CLIN N, V9, P626, DOI 10.1176/jnp.9.4.626; BRICOLO A, 1968, ACTA NEUROL SCAND, V44, P512, DOI 10.1111/j.1600-0404.1968.tb05589.x; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Childs A, 1987, Brain Inj, V1, P49, DOI 10.3109/02699058709034444; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; ESPERSEN JO, 1982, ACTA NEUROCHIR, V65, P81, DOI 10.1007/BF01405444; Finch M, 1997, BRAIN INJURY, V11, P713, DOI 10.1080/026990597123089; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORMISANO R, 1995, ACTA NEUROL SCAND, V91, P54; FROWEIN RA, 1989, ADV NEUROSURG, V17, P36; GERSTENBRAND F, 1983, NEUROSCI BIOBEHAV R, V7, P413, DOI 10.1016/0149-7634(83)90047-7; Goscinski I, 1997, ACTA NEUROCHIR, V139, P303, DOI 10.1007/BF01808825; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; OVERGAARD J, 1973, LANCET, V2, P631; PITTS LH, 1990, HDB CLIN NEUROLOGY, V13, P65; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; RICHARD KE, 1989, ADV NEUROSURG, V17, P81; RITWENDEN FJ, 1998, CLIN REHABILATION, V12, P53; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; STALHAMMAR JE, 1980, ACTA NEUROCHIR, V90, P73; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011	36	21	22	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2004	18	1					103	109		10.1080/0269905031000149470			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	749PB	WOS:000186928200007	14660239				2022-02-06	
J	Gunnarsson, T; Fehlings, MG				Gunnarsson, T; Fehlings, MG			Acute neurosurgical management of traumatic brain injury and spinal cord injury	CURRENT OPINION IN NEUROLOGY			English	Article						management; spinal cord injury; traumatic brain injury	SEVERE HEAD-INJURY; APOLIPOPROTEIN-E POLYMORPHISM; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; CERVICAL-SPINE; TISSUE OXYGEN; METHYLPREDNISOLONE; HYPOTHERMIA; HYPEROXIA; OUTCOMES	Purpose of review This review discusses some of the recent advances and current controversies in the acute clinical management of traumatic brain injury (TBI) and spinal cord injury (SCI). Recent findings Several key risk factors for adverse prognosis in TBI have been identified, including female sex. In the management of intracranial hypertension antibiotic impregnated intraventricular catheters have been found to reduce the risk for infection, and new studies have examined the roles of mannitol, hyperventilation, and hypothermia. Moderate hypothermia has also been found to improve outcome. Hyperoxia is now being explored as a treatment option for improving brain metabolism in TBI. That acute SCI continues to be a challenging diagnosis is supported by a recent study that showed that 9.1 % of SCIs are missed initially. The diagnosis and management of spinal instability has been studied in different patient groups. In SCI without radiographic abnormality, the presence of normal magnetic resonance imaging findings was associated with a good prognosis. New studies in the field of early decompression and the prevention of thromboembolism in SCI have also been published. Guidelines for the management of acute SCI recommend methylprednisolone and GM-1 ganglioside only as options. Summary In neurotrauma some established treatments have been reexamined and their efficacy proven, whereas others that were once considered the standard of care in SCI, such as methylprednisolone, have been questioned. Large multicenter trials are needed to assess treatments such as early decompression in SCI and decompressive craniectomy in TBI. A truly effective neuroprotective therapy in neurotrauma remains elusive.	Univ Toronto, Toronto Western Hosp, Spinal Program, Div Neurosurg, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada		Fehlings, MG (corresponding author), Univ Toronto, Toronto Western Hosp, Spinal Program, Div Neurosurg, 399 Bathurst St,W Wing,4W-499, Toronto, ON M5T 2S8, Canada.	michael@uhnres.utoronto.ca	Gunnarsson, Thorsteinn/AAA-1238-2019	Fehlings, Michael/0000-0002-5722-6364; Gunnarsson, Thorsteinn/0000-0001-6657-4187			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 2002, NEUROSURGERY S, V50, pS100; [Anonymous], 2002, NEUROSURGERY S, V50, pS36; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bosch PP, 2002, SPINE, V27, P2788, DOI 10.1097/00007632-200212150-00009; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRACKEN MB, 2002, NEUROSURGERY, V502, pS14; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P513; Bullock MR, 2003, J NEUROSURG, V98, P943, DOI 10.3171/jns.2003.98.5.0943; CHIANG MF, 2003, IN PRESS ACTA NEUROC; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; Dare AO, 2002, J NEUROSURG, V97, P33, DOI 10.3171/spi.2002.97.1.0033; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Dunn LT, 2003, J TRAUMA, V54, P497, DOI 10.1097/01.TA.0000030627.71453.CD; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Fehlings MG, 2001, SPINE, V26, pS101, DOI 10.1097/00007632-200112151-00017; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Guest J, 2002, J NEUROSURG, V97, P25, DOI 10.3171/spi.2002.97.1.0025; Hadley MN, 2002, NEUROSURGERY, V50, pS63; Hadley MN, 2002, NEUROSURGERY, V50, pS166; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hurlbert RJ, 2002, CAN J NEUROL SCI, V29, P236, DOI 10.1017/S0317167100002006; Insko EK, 2002, J TRAUMA, V53, P426, DOI 10.1097/00005373-200209000-00005; Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Merli G, 2003, J TRAUMA, V54, P1111, DOI 10.1097/01.TA.0000042159.90102.C2; Merli G, 2003, J TRAUMA, V54, P1116, DOI 10.1097/01.TA.0000066385.10596.71; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Molloy S, 2002, INJURY, V33, P575, DOI 10.1016/S0020-1383(02)00142-0; Mower WR, 2002, J TRAUMA, V53, P1198, DOI 10.1097/00005373-200212000-00039; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; POLLACK IF, 1988, J NEUROSURG, V69, P177, DOI 10.3171/jns.1988.69.2.0177; Poonnoose PM, 2002, J TRAUMA, V53, P314, DOI 10.1097/00005373-200208000-00021; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Schneider GH, 2002, ACT NEUR S, V81, P77; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; The Brain Trauma Foundation The American Association of Neurological Surgeons The Joint Section on Neurotrauma and Critical Care, 2000, J NEUROTRAUM, V17, P497; Thumbikat P, 2002, SPINAL CORD, V40, P416, DOI 10.1038/sj.sc.3101325; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vellman WP, 2003, SPINE, V28, P941; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725; 2002, NEUROSURGERY, V50, pS1	63	21	32	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2003	16	6					717	723		10.1097/00019052-200312000-00012			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	805MU	WOS:000220371200012	14624082				2022-02-06	
J	Lehnung, M; Leplow, B; Ekroll, V; Benz, B; Ritz, A; Mehdorn, M; Ferstl, R				Lehnung, M; Leplow, B; Ekroll, V; Benz, B; Ritz, A; Mehdorn, M; Ferstl, R			Recovery of spatial memory and persistence of spatial orientation deficits after traumatic brain injury during childhood	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; MORRIS WATER MAZE; 9-MONTH-OLD INFANTS; PLACE NAVIGATION; SCHOOL-CHILDREN; IMMATURE RAT; RADIAL MAZE; ONTOGENY; IMPAIRMENT; LOCALIZATION	The present study set out to examine the recovery of spatial learning and cognitive mapping skills after severe TBI in childhood. A prospective investigation was carried out with repeated measures. Children with TBI (n = 18) and healthy matched controls ( n = 18) were investigated while the children with TBI stayed in a rehabilitation facility (t(0)) and 4 years later (t(1)). Children were assessed with the Kiel Locomotor Maze, where they had to remember defined locations in an experimental chamber with completely controlled intra- and extra-maze cues until the learning criterion was reached. During probe trials, cognitive mapping strategies were assessed. Results showed (i) that spatial learning is functionally restituted 4 years post-trauma and (ii) that cognitive mapping skills are still impaired 4 years post-trauma. It was concluded that cognitive performance of children who survived a severe TBI may be overestimated, having far reaching consequences for the children.	Univ Kiel, Dept Psychol, D-24098 Kiel, Germany; Univ Kiel, Clin Neurosurg, D-24098 Kiel, Germany; Univ Halle Wittenberg, Dept Psychol, Halle An Der Saale, Germany; Childrens Rehabil Ctr, Bremen, Germany		Lehnung, M (corresponding author), Univ Kiel, Dept Psychol, Olshausenstr 62, D-24098 Kiel, Germany.	marialehnung@aol.com	Mehdorn, Maximilian/D-2495-2010	Ekroll, Vebjorn/0000-0002-9383-7322			AADLAND J, 1985, DEV PSYCHOBIOL, V18, P163, DOI 10.1002/dev.420180208; Achenbach T, 1983, MANUAL CHILD BEHAV C; ACREDOLO LP, 1979, DEV PSYCHOL, V15, P666, DOI 10.1037/0012-1649.15.6.666; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Bakker K, 1999, Pediatr Rehabil, V3, P149; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BENZ B, 1996, KINDH ENTWICK, V5, P201; BOHOT V, 1984, NEUR ABSTR, V20, P361; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BREMNER JG, 1978, DEV PSYCHOL, V14, P346, DOI 10.1037/0012-1649.14.4.346; Brown RW, 1997, DEV PSYCHOBIOL, V30, P329, DOI 10.1002/(SICI)1098-2302(199705)30:4<329::AID-DEV6>3.0.CO;2-Q; Bures J, 1997, P NATL ACAD SCI USA, V94, P343, DOI 10.1073/pnas.94.1.343; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 1999, Pediatr Rehabil, V3, P167; CHAPILLON P, 1995, DEV PSYCHOBIOL, V28, P429, DOI 10.1002/dev.420280805; Chapillon P, 1996, DEV PSYCHOBIOL, V29, P529; CORNELL EH, 1989, DEV PSYCHOL, V25, P755, DOI 10.1037/0012-1649.25.5.755; DALE PS, 1995, APPL PSYCHOLINGUIST, V16, P173, DOI 10.1017/S0142716400007074; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FOREMAN N, 1984, DEV PSYCHOBIOL, V17, P129, DOI 10.1002/dev.420170204; FOREMAN N, 1990, J GEN PSYCHOL, V117, P267; Geary DC, 2000, J EXP CHILD PSYCHOL, V77, P337, DOI 10.1006/jecp.2000.2594; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Jacobs WJ, 1997, LEARN MOTIV, V28, P521, DOI 10.1006/lmot.1997.0977; KERMOIAN R, 1988, CHILD DEV, V59, P908, DOI 10.1111/j.1467-8624.1988.tb03244.x; Lehnung M, 2001, CHILD NEUROPSYCHOL, V7, P59, DOI 10.1076/chin.7.2.59.3129; Lehnung M, 2001, PSYCHOL ERZ UNTERR, V48, P246; Lehnung M, 1998, BRIT J PSYCHOL, V89, P463, DOI 10.1111/j.2044-8295.1998.tb02697.x; LEHNUNG MM, 2000, ENNTWICKLUNG RAUMLIC; LEPLOW B, 1994, UNPUB NEUROPSYCHOLOG; LEPLOW B, 1998, LECT NOTES ARTIF INT, P9; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Morse S, 1999, Pediatr Rehabil, V3, P139; Nadel L., 1991, Hippocampus, V1, P221, DOI 10.1002/hipo.450010302; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1978, J COMP PHYSIOL PSYCH, V92, P609, DOI 10.1037/h0077492; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Overman WH, 1996, BEHAV NEUROSCI, V110, P1205, DOI 10.1037/0735-7044.110.6.1205; Piaget J., 1948, REPRESENTATION ESPAC; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Reid I., 1995, NEUR ABSTR, V21, P1446; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; THOMPSON NM, 1999, NEUROPSYCHOLOGY, V8, P333; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Verger K, 2000, BRAIN INJURY, V14, P495; Wilson PN, 1997, DISABIL REHABIL, V19, P213, DOI 10.3109/09638289709166530	61	21	21	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2003	17	10					855	869		10.1080/0269905031000089369			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	719CR	WOS:000185186500004	12963552				2022-02-06	
J	Vanderluit, JL; McPhail, LT; Fernandes, KJL; Kobayashi, NR; Tetzlaff, W				Vanderluit, JL; McPhail, LT; Fernandes, KJL; Kobayashi, NR; Tetzlaff, W			In vivo application of mitochondrial pore inhibitors blocks the induction of apoptosis in axotomized neonatal facial motoneurons	CELL DEATH AND DIFFERENTIATION			English	Article						facial; motoneurons; apoptosis; cell death; caspase-3; axotomy	CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; TRAUMATIC BRAIN-INJURY; ADENINE-NUCLEOTIDE TRANSLOCATOR; TRANSIENT CEREBRAL-ISCHEMIA; D-ASPARTATE RECEPTORS; CELL-DEATH; NEURONAL DEATH; BAX TRANSLOCATION; CYCLOSPORINE-A	Axotomy induces apoptosis in motoneurons of neonatal rodents. To identify the key players in motoneuron apoptosis, we assessed the progression of apoptosis at 4 h intervals following facial motoneuron axotomy. The mitochondrial release of cytochrome c, caspase-3 activation and nuclear condensation were first observed in the motoneuron cell bodies 16 h postaxotomy. In vivo application of inhibitors of the mitochondrial permeability transition pore, Bongkrekic acid and cyclosporin A prevented cytochrome c release as well as caspase-3 activation and attenuated motoneuron apoptosis. Similarly, in vivo application of RU360, an inhibitor of the mitochondrial calcium uniporter, also protected axotomized motoneurons from apoptosis. Taken together, our results show that cytochrome c release and subsequent caspase-3 activation are critical events that precipitate the apoptotic death of axotomized neonatal motoneurons in vivo. In addition, these results provide evidence that application of mitochondrial pore inhibitors in vivo can block the induction of apoptosis following motoneuron axotomy.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, ICORD, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z4, Canada		Tetzlaff, W (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.		Tetzlaff, Wolfram/AAY-4430-2020				Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403; BROEKEMEIER KM, 1994, MOL CELL BIOCHEM, V139, P33, DOI 10.1007/BF00944201; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Casanovas A, 1996, NEUROSCIENCE, V71, P313, DOI 10.1016/0306-4522(95)00461-0; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; GREENSMITH L, 1994, DEV BRAIN RES, V81, P162, DOI 10.1016/0165-3806(94)90302-6; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hamburger V, 1934, J EXP ZOOL, V68, P449, DOI 10.1002/jez.1400680305; IWASAKI Y, 1995, J NEUROL SCI, V134, P21, DOI 10.1016/0022-510X(95)00217-6; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kikuchi M, 2000, J NEUROSCI, V20, P5037; KLINGENBERG M, 1970, BIOCHEM BIOPH RES CO, V39, P344, DOI 10.1016/0006-291X(70)90582-6; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; Lawson SJ, 1998, NEUROSCIENCE, V87, P337, DOI 10.1016/S0306-4522(98)00120-1; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; MENTIS GZ, 1993, NEUROSCIENCE, V54, P283, DOI 10.1016/0306-4522(93)90253-C; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Rossiter JP, 1996, EXP NEUROL, V138, P33, DOI 10.1006/exnr.1996.0044; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Tapia R, 1997, NEUROCHEM INT, V30, P137, DOI 10.1016/S0197-0186(96)00056-3; Tong JXX, 1997, J NEUROCYTOL, V26, P339, DOI 10.1023/A:1018508819191; Vanderluit JL, 2000, EUR J NEUROSCI, V12, P3469, DOI 10.1046/j.1460-9568.2000.00241.x; Velasco I, 2000, J NEUROSCI RES, V60, P543, DOI 10.1002/(SICI)1097-4547(20000515)60:4<543::AID-JNR13>3.0.CO;2-Z; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	57	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047			CELL DEATH DIFFER	Cell Death Differ.	SEP	2003	10	9					969	976		10.1038/sj.cdd.4401258			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	717FE	WOS:000185075100005	12934071	Bronze			2022-02-06	
J	Ang, BT; Yap, E; Lim, J; Tan, WL; Ng, PY; Ng, I; Yeo, TT				Ang, BT; Yap, E; Lim, J; Tan, WL; Ng, PY; Ng, I; Yeo, TT			Poly(adenosine diphosphate-ribose) polymerase expression in human traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						poly(adenosine diphosphate-ribose) polymerase; human head injury; apoptosis	POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; APOPTOSIS; INHIBITION; ACTIVATION; PROTEIN; PARP; SYNTHETASE; ISCHEMIA; CLEAVAGE	Object. This study was designed to elucidate the pattern of expression of poly(adenosine diphosphate-ribose) polymerase (PARP) in human pericontusional brain tissue and to correlate these findings with commonly used clinical parameters. Methods. The expression of PARP was ascertained using immunohistochemical studies in eight specimens of human pericontusional brain tissue obtained when the patients underwent craniotomy for mass effect. The following demographic and clinical parameters were also analyzed for each patient: age, sex, postresuscitation Glasgow Coma Scale score (GCS), computerized tomography findings, intracranial pressure (ICP) recordings during the first 24 hours postsurgery, and the time interval from injury to surgery. The authors observed that PARP was present in neurons of pericontusional tissue and that it conformed to two patterns of subcellular localization; it was found either in the nucleus exclusively or in both nuclear and cytoplasmic compartments. They showed that a preponderance of cytoplasmic staining in neurons was significantly correlated with a short time interval from trauma to surgery (: 4 hours). There was no correlation, however, between the subcellular distribution of PARP and clinical parameters such as admission GCS score and ICP readings obtained intra- and postoperatively. Conclusions. As in earlier studies in which it has been suggested that caspase-cleaved PARP translocates to the cytoplasm during apoptosis, the authors' results indicate that apoptosis may predominate in the initial time frame after head injury. This information may well influence the timing of administration of antiapoptotic neuronal salvage agents for adjunctive therapy of head injury in the future.	Natl Univ Singapore, Natl Inst Neurosci, Dept Neurosurg, Sect Neurotrauma, Singapore 308433, Singapore; Natl Univ Singapore, Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Lab, Singapore 308433, Singapore		Ng, I (corresponding author), Natl Univ Singapore, Natl Inst Neurosci, Dept Neurosurg, Sect Neurotrauma, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.		Yeo, Tseng Tsai/U-8864-2017				BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cookson MR, 1999, BRAIN RES, V834, P182, DOI 10.1016/S0006-8993(99)01559-0; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Amours D, 2001, J CELL SCI, V114, P3771; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Jacobson MK, 1999, TRENDS BIOCHEM SCI, V24, P415, DOI 10.1016/S0968-0004(99)01481-4; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Lo EH, 1998, STROKE, V29, P830, DOI 10.1161/01.STR.29.4.830; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OLEINICK NL, 1985, RADIAT RES, V101, P29, DOI 10.2307/3576301; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Takahashi K, 1997, J CEREBR BLOOD F MET, V17, P1137, DOI 10.1097/00004647-199711000-00001; TEASDALE G, 1974, LANCET, V2, P81; Tentori L, 2002, PHARMACOL RES, V45, P73, DOI 10.1006/phrs.2001.0935; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	31	21	22	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUL	2003	99	1					125	130		10.3171/jns.2003.99.1.0125			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	696BN	WOS:000183865500020	12854754				2022-02-06	
J	Swift, EE; Taylor, HG; Kaugars, AS; Drotar, D; Yeates, KO; Wade, SL; Stancin, T				Swift, EE; Taylor, HG; Kaugars, AS; Drotar, D; Yeates, KO; Wade, SL; Stancin, T			Sibling relationships and behavior after pediatric traumatic brain injury	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						traumatic brain injury; sibling relationships	FAMILY RELATIONSHIPS; HEAD-INJURY; CHILDREN; ADAPTATION; CHILDHOOD; PREDICTORS; SCHOOL; ASSOCIATIONS; OUTCOMES; SEVERITY	To evaluate long-term outcomes for siblings of children with traumatic brain injury (TBI), measures of sibling relationships and sibling behavior were collected an average of 4 years postinjury. The study sample included participants in a larger longitudinal study who had school-aged siblings, including 34 with severe TBI, 30 with moderate TBI, and 39 with orthopedic injuries not involving brain insult (ORTHO group). Group comparisons revealed more negative sibling relationships in families of children with TBI than in families of children in the ORTHO group, but only for mixed-gender sibling pairings. Behavior problems in children with TBI predicted both sibling relationships and sibling behavior problems. The findings indicate a need to monitor the adjustment of siblings and sibling relationships after TBI and to include siblings in family interventions.	Rainbow Babies & Childrens Hosp, Div Behav Pediat & Psychol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; Univ Cincinnati, Sch Med, Childrens Hosp, Ctr Med,Dept Psychol, Cincinnati, OH USA; Metrohlth Med Ctr, Div Psychiat, Cleveland, OH 44109 USA		Taylor, HG (corresponding author), Rainbow Babies & Childrens Hosp, Div Behav Pediat & Psychol, 11100 Euclid Ave, Cleveland, OH 44106 USA.		Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-390611] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER		Achenbach TM, 1991, MANUAL CHILD BEHAV C; BOER F, 1992, CHILDRENS SIBLING RE; Bragg RM, 1992, J HEAD TRAUMA REHAB, V7, P94; BRODY GH, 1992, CHILD DEV, V63, P391, DOI 10.1111/j.1467-8624.1992.tb01635.x; BRODY GH, 1982, CHILD DEV, V53, P1364, DOI 10.2307/1129027; BRODY GH, 1985, DEV PSYCHOL, V21, P124, DOI 10.1037/0012-1649.21.1.124; BUHRMESTER D, 1987, CHILD DEV, V58, P1101, DOI 10.1111/j.1467-8624.1987.tb01444.x; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; COHEN D, 1995, J CLIN PSYCHOL, V50, P303; DROTAR D, 1985, J DEV BEHAV PEDIATR, V6, P355; DUNN J, 1994, DEV PSYCHOL, V30, P315, DOI 10.1037/0012-1649.30.3.315; Dunn J, 1999, J CHILD PSYCHOL PSYC, V40, P1025, DOI 10.1111/1469-7610.00521; DYSON LL, 1989, J PEDIATR PSYCHOL, V14, P215, DOI 10.1093/jpepsy/14.2.215; Fisman S, 2000, CAN J PSYCHIAT, V45, P369, DOI 10.1177/070674370004500406; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FURMAN W, 1985, CHILD DEV, V56, P448, DOI 10.1111/j.1467-8624.1985.tb00119.x; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; Hetherington E.M., 1988, REALTIONSHIPS FAMILI, P311; HETHERINGTON EM, 1993, J FAMILY PSYCHOL, V0007, P00039, DOI DOI 10.1037/0893-3200.7.1.39; HU Z, 1993, CAN MED ASSOC J, V149, P421; JENKINS J, 1992, CHILDRENS SIBLING RELATIONS, P125; JENNETT B, 1975, LANCET, V1, P480; KAISER HF, 1962, PSYCHOMETRIKA, V1, P83; Kim JE, 1999, CHILD DEV, V70, P1209, DOI 10.1111/1467-8624.00088; KRAUS JF, 1987, PEDIATRICS, V79, P501; Landgraf JM, 1996, CHILD HLTH QUESTIONN; LOEBER R, 1984, J CONSULT CLIN PSYCH, V52, P759, DOI 10.1037/0022-006X.52.5.759; LOEBER R, 1983, PSYCHOL BULL, V94, P68, DOI 10.1037/0033-2909.94.1.68; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Patterson G.R., 1984, ADV STUDY AGGRESSION, V1, P173; PATTERSON GR, 1986, DEV ANTISOCIAL PROSO; Peretti PO, 1995, INDIAN J CLIN PSYCHO, V22, P23; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RIVARA JB, 1994, PEDIATR ANN, V23, P38, DOI 10.3928/0090-4481-19940101-09; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; Sahler OJZ, 1997, J DEV BEHAV PEDIATR, V18, P233; SAHLER OJZ, 1994, J DEV BEHAV PEDIATR, V15, P353; Stormshak EA, 1996, DEV PSYCHOL, V32, P79, DOI 10.1037/0012-1649.32.1.79; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WILLER B, 1990, CAN J REHABIL, V3, P157; Williams PD, 1997, INT J NURS STUD, V34, P312, DOI 10.1016/S0020-7489(97)00019-9; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; [No title captured]	50	21	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0196-206X			J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	FEB	2003	24	1					24	31		10.1097/00004703-200302000-00007			8	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	645UF	WOS:000180997200006	12584482				2022-02-06	
J	Godfrey, HPD; Harnett, MA; Knight, RG; Marsh, NV; Kesel, DA; Partridge, FM; Robertson, RH				Godfrey, HPD; Harnett, MA; Knight, RG; Marsh, NV; Kesel, DA; Partridge, FM; Robertson, RH			Assessing distress in caregivers of people with a traumatic brain injury (TBI): a psychometric study of the Head Injury Behaviour Scale	BRAIN INJURY			English	Article							SELF-AWARENESS; FAMILY; REHABILITATION; PERSONALITY; STRESS; ADULTS	This study examined the psychometric properties of the Head Injury Behaviour Scale (HIBS) using responses from 242 caregivers. The HIBS is a 20-item, scale describing common behavioural problems following traumatic brain injury (TBI), which are typical of dysexecutive syndrome. A principal components analysis was conducted on caregiver distress ratings for the 20 items comprising the HIBS and produced a two-factor solution with 10 items loading on each factor. Consequently, two sub-scales were derived and labelled Emotional Regulation and Behavioural Regulation. The sub-scales were found to have good internal-consistency reliability. It is suggested that the Emotional Regulation sub-scale assesses behaviours reflecting impaired emotional control, occurring during interactions with caregivers. The Behavioural Regulation sub-scale assesses problems typical of dysexecutive syndrome, but which carry less emotional valence for caregivers. The clinical implications of these findings are discussed and normative data provided for the two sub-scales.	Univ Otago, Dept Psychol, Dunedin, New Zealand; Univ Teesside, Sch Hlth & Social Care, Middlesbrough, Tees Valley, England; Community Treatment Ctr Acquired Brain Damage, Glasgow, Lanark, Scotland; Psychol Associates, Dunedin, New Zealand		Knight, RG (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.	rknight@psy.otago.ac.nz	Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432; Fountain, Mairead/0000-0003-0575-5368			Bowen A, 2001, BRAIN INJURY, V15, P29, DOI 10.1080/02699050150209101; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1984, CLOSE HEAD INJURY PS; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; GODFREY HPD, 1987, NEW ZEAL J PSYCHOL, V16, P49; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Jennett B, 1981, MANAGEMENT HEAD INJU; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Minnes P, 2000, BRAIN INJURY, V14, P737; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PLATT SD, 1983, SOCIAL BEHAV ASSESSM; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; ROBERTSON RH, 2002, UNPUB EVALUATION SOC; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P88, DOI 10.1097/00001199-199608000-00011; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Smith LM, 1995, FAMILY SUPPORT PROGR	28	21	21	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	5					427	435		10.1080/0269905031000066201			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MQ	WOS:000181837300006	12745714				2022-02-06	
J	Hortobagyi, T; Gorlach, C; Benyo, Z; Lacza, Z; Hortobagyi, S; Wahl, M; Harkany, T				Hortobagyi, T; Gorlach, C; Benyo, Z; Lacza, Z; Hortobagyi, S; Wahl, M; Harkany, T			Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: Neuroprotection by 3-aminobenzamide	NEUROSCIENCE			English	Article						apoptosis; brain trauma; cerebral cortex; combined treatment; focal lesion; neuroprotection	ISCHEMIA-REPERFUSION; NERVOUS-SYSTEM; FOCAL ISCHEMIA; STRAND BREAKS; COLD-INJURY; RAT-BRAIN; IN-VITRO; DNA; SYNTHETASE; EXPRESSION	Focal traumatic injury to the cerebral cortex is associated with early activation of the neuronal isoform of nitric oxide synthase (nNOS), where high concentrations of nitric oxide-derived free radicals elicit extensive DNA damage. Subsequent activation of the nuclear repair enzyme poly(ADP-ribose) polymerase (PARP) causes a severe energy deficit leading to the ultimate demise of affected neurons. Little is known about the temporal relationship of nNOS and PARP activation and the neuroprotective efficacy of their selective blockade in traumatic brain injury. To determine the relationship of nNOS and PARP activation, brain injury was induced by cryogenic lesion to the somatosensory cortex applying a pre-cooled cylinder after trephination for 6 s to the intact dura mater. Pre-treatment with 3-bromo-7-nitroindazole (BrNI; 25 mg/kg, i.p.), and pre- or combined pre- and post-treatment with 3-aminobenzamide (AB; 10 mg/kg (i.c.v.) or 10 mg/kg/h (i.p.)) were used to inhibit nNOS and PARP, respectively. Cold lesion-induced changes in the somatosensory cortex and neuroprotection by BrNI and AB were determined using immunocytochemistry and immunodot-blot for detection of poly(ADP-ribose; PAR), the end-product of PARP activation, and the triphenyltetrazolium-chloride assay to assess lesion volume. PAR immunoreactivity reached its peak 30 min post-lesion and was followed by gradual reduction of PAR immunolabeling. BrNI pre-treatment significantly decreased the lesion-induced PAR concentration in damaged cerebral cortex. Pre-treatment by i.c.v. infusion of AB mark-edly diminished cortical PAR immunoreactivity and significantly reduced the lesion volume 24 h post-injury. In contrast, i.p. AB treatment remained largely ineffective. In conclusion, our data indicate early activation of PARP after cold lesion that is, at least in part, related to nNOS induction and supports the relevance of nNOS and/or PARP inhibition to therapeutic approaches of traumatic brain injury. (C) 2003 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Szeged, Dept Pathol, Szeged, Hungary; Univ Munich, Dept Physiol, D-8000 Munich, Germany; Semmelweis Univ, Inst Human Physiol & Expt Clin Res, H-1085 Budapest, Hungary; Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden		Hortobagyi, T (corresponding author), Inst Psychiat, Dept Neuropathol, POB 076,De Crespigny Pk, London SE5 8AF, England.	t.hortobagyi@iop.kcl.ac.uk	Benyo, Zoltan/C-9184-2009	Benyo, Zoltan/0000-0001-6015-0359			Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Affar EB, 1998, ANAL BIOCHEM, V259, P280, DOI 10.1006/abio.1998.2664; Benyo Z, 2000, BRAIN RES, V877, P79, DOI 10.1016/S0006-8993(00)02611-1; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burkle A, 1999, HISTOCHEM J, V31, P711, DOI 10.1023/A:1003944314206; Ciani E, 2001, BRAIN RES BULL, V56, P29, DOI 10.1016/S0361-9230(01)00589-5; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Endres M, 1998, NEUROSCI LETT, V248, P41, DOI 10.1016/S0304-3940(98)00224-9; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; ERISKAT J, 1994, ACTA NEUROCHIR, P425; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; Gorlach C, 2000, RESTOR NEUROL NEUROS, V17, P71; Gorlach C, 2000, PFLUG ARCH EUR J PHY, V440, P309; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Herceg Z, 1999, MOL CELL BIOL, V19, P5124; Hortobagyi T, 2000, PFLUG ARCH EUR J PHY, V441, P409, DOI 10.1007/s004240000441; IKAI K, 1980, J HISTOCHEM CYTOCHEM, V28, P670, DOI 10.1177/28.7.6993553; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; Koedel U, 1999, BRAIN PATHOL, V9, P57; Lacza Z, 2003, INT J MOL MED, V12, P153; LACZA Z, 2002, 2372 SOC NEUR; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Love S, 1998, NEUROREPORT, V9, P955, DOI 10.1097/00001756-199804200-00001; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; Muiras ML, 2000, EXP GERONTOL, V35, P703, DOI 10.1016/S0531-5565(00)00144-3; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pieper AA, 2000, P NATL ACAD SCI USA, V97, P1845, DOI 10.1073/pnas.97.4.1845; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Smith S, 1999, J CELL SCI, V112, P3649; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Tatsumi-Miyajima J, 1999, MOL CELL BIOCHEM, V193, P31, DOI 10.1023/A:1006935404987; Tokime T, 1998, J CEREBR BLOOD F MET, V18, P991, DOI 10.1097/00004647-199809000-00008; WALLIS RA, 1993, NEUROREPORT, V5, P245; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wiley CA, 2000, J NEUROPATH EXP NEUR, V59, P955, DOI 10.1093/jnen/59.11.955; Wright SC, 1996, J EXP MED, V183, P463, DOI 10.1084/jem.183.2.463; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	50	21	22	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2003	121	4					983	990		10.1016/S0306-4522(03)00482-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741QY	WOS:000186469800018	14580948				2022-02-06	
J	Onaya, M				Onaya, M			Neuropathological investigation of cerebral white matter lesions caused by closed head injury	NEUROPATHOLOGY			English	Article						axonal retraction ball; brain swelling; diffuse axonal injury; diffuse brain injury; head injury	DIFFUSE AXONAL INJURY; BETA-APP; MARKER	In order to ascertain whether there is widespread axonal disruption of cerebral white matter in the so-called 'diffuse axonal injury' (DAI), a type of closed head injury, proposed by Adams et al. the author investigated his own cases clinicopathologically. Twenty-six male autopsied cases of head injury, aged between 19 and 84, 15 of which had sustained road traffic accidents, were examined; the others were due to falling from heights and so on. The study group all belonged to non-missile head injuries and included 12 cases of diffuse brain injury, as well as 14 cases of focal brain injury, according to the classification of Gennarelli et al. The survival time ranged from 2 h to 21 years. Formalin-fixed brains were cut coronally so as to make paraffin-embedded hemispheric sections. Then these sections were stained conventionally (HE, Bodian, Kluver-Barrera and Holzer) and immunohistochemically (GFAP) to assess axonal decrease, myelin pallor and gliosis by the use of light microscopy. In the 13 chronic cases that died more than I month after the accidents, the intensities of gliosis, myelin pallor and axonal decrease tended to correlate with each other. In the 13 acute cases who died less than 1 month after their accident, the degree of axonal decrease in white matter seemed to correlate with the severity of myelin pallor. Regardless of types of trauma, however, axonal retraction balls, the so-called hallmark of DAI, were found only with myelin pallor suggesting the presence of brain swelling after the injury. Therefore these findings indicate that it may be difficult to accept the notion of DAI, that is, the presence of axonal retraction balls without brain swelling. In addition, diffuse vascular injury (2 cases) as well as rarefaction of subcortical white matter (6 cases) were presented and their pathogenesis individually discussed based on a literature review.	Shimofusa Natl Hosp, Midori Ku, Chiba 2660007, Japan		Onaya, M (corresponding author), Shimofusa Natl Hosp, Midori Ku, 578 Heta Cho, Chiba 2660007, Japan.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; ADAMS JH, 1992, GREENFIELDS NEUROPAT, P122; Akima M, 1993, NEUROPATHOLOGY, V13, P99; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P224; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; KIKUCHI T, 1992, NEUROTRAUMATOLOGY, V15, P125; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lubillo S, 2000, ACT NEUR S, V76, P415; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; ONAYA M, 1996, KEIO IGAKU, V73, P259; SEKINO H, 1995, INJURY BRAIN SPINAL, P55; SHIGEMORI M, 1991, NEUROTRAUMATOLOGY, V14, P133; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; SYMONDS C, 1962, LANCET, V1, P1; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; [No title captured]	25	21	23	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2002	22	4					243	251		10.1046/j.1440-1789.2002.00456.x			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	638KL	WOS:000180570100003	12564763	Green Submitted			2022-02-06	
J	Wilson, BM; Proctor, A				Wilson, BM; Proctor, A			Written discourse of adolescents with closed head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; CHILDREN; ADULTS	Written discourse of adolescents with closed head injury (CHI) was compared to that of normal controls. It was expected that the writing of adolescents with CHI would be disordered on one or more of the eight measurements used (productivity, efficiency, lexical, incomplete, or elliptic cohesion, global or local coherence, and maze use). Eight adolescents with closed head injury and matched controls provided written descriptions of a pictured activity. Analysis using t-tests indicated that adolescents with CHI used fewer words to express each idea in writing ( p = 0.05), and that the relationship between successive ideas was rated as less than that of controls ( p = 0.002). Implications are that written as well as oral discourse should be assessed after CHI. Writing is a more controlled process than speaking; and, therefore, may be used clinically to structure the development of ideas after CHI.	Eastern Illinois Univ, Charleston, IL 61920 USA; Univ Illinois, Urbana, IL 61801 USA		Wilson, BM (corresponding author), Eastern Illinois Univ, 600 Lincoln Ave, Charleston, IL 61920 USA.						Adamovich B. B., 1992, SCALES COGNITIVE ABI; BRASWELL D, 1992, PROFILE EXECUTIVE CO; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; ENTWISLE DR, 1994, CHILD DEV, V65, P1521, DOI 10.2307/1131278; ERLICH JS, 1988, J COMMUN DISORD, V21, P1; Glosser G., 1990, BRAIN LANG, V40, P67; GOLDMAN R, 1974, RECOGNITION MEMORY G; GOODCLASS H, 1983, BOSTON DIAGNOSTIC AP; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HARTLEY LL, 1995, DEV FUNCTIONAL APPRO, P10; HUGHES D, 1997, GUIDE NARRATIVE LANG, P207; HUNT K, 1993, DEV LANGUAGE, P370; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LOBAN W, 1997, GUIDE NARRATIVE LANG, P207; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; NELSON N, 1993, CHILDHOOD LANGUAGE D, P426; NIPPOLD MA, 1998, LATER LANGUAGE DEV S, P39; PAYNEJOHNSON JC, 1986, J COMMUN DISORD, V19, P237, DOI 10.1016/0021-9924(86)90030-4; RUBIN DL, 1987, TOP LANG DISORD, V7, P1, DOI 10.1097/00011363-198709000-00003; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; SPEAKER R, 1992, READ RES INSTRUCT, V31, P64; SPEIRS JC, 1990, POST GRAD COURS REH; Wilson BM, 2000, BRAIN COGNITION, V43, P425; WILSON BM, 1997, AM SPEECH LANG HEAR	28	21	21	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2002	16	11					1011	1024		10.1080/02699050210147248			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	609PQ	WOS:000178914500007	12443550				2022-02-06	
J	McCrory, P				McCrory, P			What advice should we give to athletes postconcussion?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CONCUSSION		Univ Melbourne, Ctr Sports Med Res & Educ, Melbourne, Vic 3052, Australia; Univ Melbourne, Inst Brain Res, Melbourne, Vic 3052, Australia		McCrory, P (corresponding author), POB 93, Shoreham, Vic 3916, Australia.	pmccrory@compuserve.com	McCrory, Paul/Q-8688-2019				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth J T, 2000, Dent Clin North Am, V44, P67; Barth JT, 1989, MILD HEAD INJURY, P257; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; GRONWALL D, 1974, LANCET, V2, P605; JENNETT B, 1975, LANCET, V1, P480; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Mayou R, 2002, BRIT MED J, V325, P426, DOI 10.1136/bmj.325.7361.426; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 2002, PHYSICIAN SPORTSMED, V30, P43, DOI 10.3810/psm.2002.08.403; RICE SG, 1995, SPORTS MED PRIM CARE, V1, P9; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x	15	21	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	OCT	2002	36	5					316	318		10.1136/bjsm.36.5.316			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	602RN	WOS:000178518400003	12351326	Green Published, Bronze			2022-02-06	
J	Kofler, M; Matzak, H; Saltuari, L				Kofler, M; Matzak, H; Saltuari, L			The impact of intrathecal baclofen on gastrointestinal function	BRAIN INJURY			English	Article; Proceedings Paper	4th World Congress on Brain Injury	2001	TURIN, ITALY				LOWER ESOPHAGEAL SPHINCTER; TRANSIENT LES RELAXATIONS; TRAUMATIC BRAIN INJURY; GABA(B) RECEPTORS; SPINAL-CORD; IMMUNOHISTOCHEMICAL DEMONSTRATION; NERVOUS-SYSTEM; IN-VITRO; NEURONS; MOTILITY	Intrathecal baclofen (ITB) application has become the first choice in the management of otherwise intractable generalized spasticity. The mechanism whereby ITB alleviates increased skeletal muscle tone is generally accepted; however, less is known about its effect on smooth muscles. The authors present two patients who developed a paralytic ileus during ITB infusion for supraspinal spasticity. In addition, they performed a retrospective chart analysis of another 12 patients receiving ITB with respect to their intestinal function. They calculated the cumulative sum of days without bowel movements plus the cumulative sum of interventions intended to promote intestinal peristalsis before and during ITB treatment. Intestinal function deteriorated in 10, remained unchanged in one, and improved in three patients compared to baseline, irrespective of concomitant oral baclofen medication. This is the first study addressing a previously unnoticed, but potentially deleterious side effect of ITB treatment. The findings suggest, however, that close observation of intestinal activity in conjunction with the generous use of prokinetic, laxantic or eubiotic drugs may allow for continuation of ITB treatment, even in particularly sensitive patients.	Hosp Hochzirl, Dept Neurol, A-6170 Zirl, Austria		Kofler, M (corresponding author), Hosp Hochzirl, Dept Neurol, Anna Dengel Haus, A-6170 Zirl, Austria.		Kofler, Markus/P-5585-2019	Kofler, Markus/0000-0002-2962-0903			ALLERTON CA, 1989, BRIT J PHARMACOL, V96, P29, DOI 10.1111/j.1476-5381.1989.tb11780.x; Altmayer T, 1996, ARCH PHYS MED REHAB, V77, P1093, DOI 10.1016/S0003-9993(96)90075-1; ANDREWS PLR, 1987, J PHYSIOL-LONDON, V388, P25, DOI 10.1113/jphysiol.1987.sp016599; ANDREWS PLR, 1986, BRIT J PHARMACOL, V89, P461, DOI 10.1111/j.1476-5381.1986.tb11145.x; ASHWORTH B, 1964, PRACTITIONER, V192, P540; AZOUVI P, 1993, J NEUROL NEUROSUR PS, V56, P515, DOI 10.1136/jnnp.56.5.515; BAETGE G, 1986, BRAIN RES BULL, V16, P421, DOI 10.1016/0361-9230(86)90066-3; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Bernards CM, 1999, SPINAL DRUG DELIVERY, P239; Bertrand S, 1999, EUR J NEUROSCI, V11, P583, DOI 10.1046/j.1460-9568.1999.00473.x; Blackshaw LA, 1999, AM J PHYSIOL-GASTR L, V277, pG867, DOI 10.1152/ajpgi.1999.277.4.G867; BOWERY NG, 1992, ARZNEIMITTELFORSCH, V42-1, P215; CURTIS DR, 1981, EXP BRAIN RES, V42, P158; DAVIDOFF RA, 1985, ANN NEUROL, V17, P107, DOI 10.1002/ana.410170202; DELHAAS EM, 1991, INT J CLIN PHARM TH, V29, P274; DRESSNANDT J, 1995, MUSCLE NERVE, V18, P103, DOI 10.1002/mus.880180114; FAIGLE JW, 1972, POSTGRAD MED J, V48, P9; FARGEAS MJ, 1988, EUR J PHARMACOL, V150, P163, DOI 10.1016/0014-2999(88)90763-7; FURNESS JB, 1995, GASTROENTEROLOGY, V108, P554, DOI 10.1016/0016-5085(95)90086-1; GENTILINI G, 1992, EUR J PHARMACOL, V217, P9, DOI 10.1016/0014-2999(92)90504-W; HEY JA, 1995, BRIT J PHARMACOL, V114, P735, DOI 10.1111/j.1476-5381.1995.tb13265.x; HILSON A, 1972, POSTGRAD MED J, V48, P25; HONG YG, 1991, EUR J PHARMACOL, V192, P55, DOI 10.1016/0014-2999(91)90068-2; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; JESSEN KR, 1986, J NEUROSCI, V6, P1628; KOFLER M, 1992, NEUROLOGY, V42, P864, DOI 10.1212/WNL.42.4.864; KOFLER M, 1994, NEUROLOGY, V44, P25, DOI 10.1212/WNL.44.1.25; Kroin JS, 1992, PARENTERAL DRUG THER, P67; Lehmann A, 1999, GASTROENTEROLOGY, V117, P1147, DOI 10.1016/S0016-5085(99)70400-2; Li Yu-Wen, 1996, American Journal of Physiology, V271, pR1304; Lidums I, 2000, GASTROENTEROLOGY, V118, P7, DOI 10.1016/S0016-5085(00)70408-2; Lin HH, 1998, NEUROSCIENCE, V86, P211, DOI 10.1016/S0306-4522(97)00688-X; M?ller H., 1988, LOCAL SPINAL THERAPY, P223; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; Nakajima K, 1996, NEUROCHEM RES, V21, P211, DOI 10.1007/BF02529137; NANNINGA JB, 1989, J UROLOGY, V142, P101, DOI 10.1016/S0022-5347(17)38673-1; NICHOLS K, 1995, J AUTONOM NERV SYST, V50, P253, DOI 10.1016/0165-1838(94)00096-3; ONG J, 1982, EUR J PHARMACOL, V86, P9, DOI 10.1016/0014-2999(82)90390-9; Page AJ, 1999, J NEUROSCI, V19, P8597; PENCHEVA N, 1991, GEN PHARMACOL, V22, P159, DOI 10.1016/0306-3623(91)90327-3; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PINTO ODS, 1972, POSTGRAD MED J, V48, P18; Ruggiero DA, 2000, J AUTONOM NERV SYST, V79, P181, DOI 10.1016/S0165-1838(99)00097-1; RUMPL E, 1985, INTENSIVBEHANDLUNG, V10, P92; SALTUARI L, 1990, NEW ENGL J MED, V322, P1533; SALTUARI L, 1992, LANCET, V339, P373, DOI 10.1016/0140-6736(92)91697-7; SANDERSON P, 1994, BRIT J ANAESTH, V73, P744, DOI 10.1093/bja/73.6.744; Schutter N, 1995, Ned Tijdschr Geneeskd, V139, P1891; Smid SD, 2000, BRIT J PHARMACOL, V131, P624, DOI 10.1038/sj.bjp.0703602; Staunton E, 2000, AM J PHYSIOL-GASTR L, V279, pG157, DOI 10.1152/ajpgi.2000.279.1.G157; STEERS WD, 1992, J UROLOGY, V148, P1849, DOI 10.1016/S0022-5347(17)37048-9; SUNDLER F, 1989, ACTA ONCOL, V28, P303, DOI 10.3109/02841868909111198; Takenaka K., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS48, DOI 10.1111/j.1440-1681.1995.tb02966.x; TONINI M, 1989, BRIT J PHARMACOL, V98, P1109, DOI 10.1111/j.1476-5381.1989.tb12654.x; TRIPPENBACH T, 1994, CAN J PHYSIOL PHARM, V72, P1200, DOI 10.1139/y94-170; Wang FB, 2000, J COMP NEUROL, V421, P302; Yuan CS, 1998, J PHARMACOL EXP THER, V286, P736; [No title captured]	58	21	21	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					825	836		10.1080/02699050210128898			12	Neurosciences; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800008	12217208				2022-02-06	
J	Burton, CL; Hultsch, DF; Strauss, E; Hunter, MA				Burton, CL; Hultsch, DF; Strauss, E; Hunter, MA			Intraindividual variability in physical and emotional functioning: Comparison of adults with traumatic brain injuries and healthy adults	CLINICAL NEUROPSYCHOLOGIST			English	Article							REACTION-TIME; PERFORMANCE; CONSISTENCY; DEMENTIA; TEXT	Recent research has shown that individuals with certain neurological conditions demonstrate greater intraindividual variability on cognitive tasks compared to healthy controls. The present study investigated intraindividual variability in the domains of physical functioning and affect/stress in three groups: adults with mild head injuries, adults with moderate/severe head injuries, and healthy adults. Participants were assessed on 10 occasions and results indicated that (a) individuals with head injuries demonstrated greater variability in dominant finger dexterity and right grip strength than the healthy controls; (b) increased variability tended to be associated with poorer performance/report both within and across tasks; and (c) increased variability on one task was associated with increased variability on other tasks. The findings suggest that increased variability in physical function, as well as cognitive function, represents an indicator of neurological compromise.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada		Burton, CL (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 3P5, Canada.	clburton@uvic.ca					Anstey KJ, 1999, AGING NEUROPSYCHOL C, V6, P84, DOI 10.1076/anec.6.2.84.786; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; BRUHN P, 1977, CORTEX, V13, P373, DOI 10.1016/S0010-9452(77)80018-X; Cohen J, 1977, STAT POWER ANAL BEHA; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; EYSENCK HJ, 1982, MODEL INTELLIGENCE, P151; FERRANDEZ AM, 1996, CHANGES SENSORY MOTO, P53; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Goldstein IB, 1998, STROKE, V29, P765, DOI 10.1161/01.STR.29.4.765; Hendrickson AE, 1982, MODEL INTELLIGENCE, P151, DOI DOI 10.1007/978-3-642-68664-1_6; HERTZOG C, 1992, BRAIN LANG, V42, P248, DOI 10.1016/0093-934X(92)90100-S; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; IVERSON G, 1998, RECOVERY, V9, P4; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; KNOTEK PC, 1990, BRAIN LANG, V38, P465, DOI 10.1016/0093-934X(90)90131-Y; Li SC, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P103; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; Nakamura T, 1997, ALZ DIS ASSOC DIS, V11, P132, DOI 10.1097/00002093-199709000-00005; NESSELROADE JR, 1991, VISIONS OF AESTHETICS, THE ENVIRONMENT & DEVELOPMENT : THE LEGACY OF JOACHIM F WOHLWILL, P213; NESSELROADE JR, 1992, BEST METHODS ANAL CH, P92; *PSYCH CORP, 1997, WAIS 3 TECHN MAN; Rabbitt P, 2001, Q J EXP PSYCHOL-A, V54, P981, DOI 10.1080/02724980042000534; Rabbitt PMA, 2000, DEBATES PSYCHOL, P160; SALTHOUSE TA, 1993, J GERONTOL, V48, pP263, DOI 10.1093/geronj/48.6.P263; SATTLER JM, 1999, ASSESSMENT CHILDREN; Slifkin AB, 1998, CURR DIR PSYCHOL SCI, V7, P170, DOI 10.1111/1467-8721.ep10836906; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STRAUSS E, IN PRESS J INT NEURO; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	35	21	22	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2002	16	3					264	279		10.1076/clin.16.3.264.13854			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	664UZ	WOS:000182081500006	12607140				2022-02-06	
J	Khan, S; Khan, A; Feyz, M				Khan, S; Khan, A; Feyz, M			Decreased length of stay, cost savings and descriptive findings of enhanced patient care resulting from an integrated traumatic brain injury programme	BRAIN INJURY			English	Article							MODERATE HEAD-INJURY; COMPUTED-TOMOGRAPHY; REHABILITATION; PROGNOSIS; MEMORY	Traumatic brain injury (TBI) has enormous economic consequences. The primary objective was to evaluate the effect of implementation of an integrated TBI programme on patient-care. The research design was a retrospective institutional review for which 1875 patient records were reviewed, healthcare professionals were interviewed, patient care was observed, and a literature review of the prognostic variables for mild, moderate and severe TBI was conducted. The implementation of an integrated TBI programme has reduced the average length of stay from 30.5 to 12 days and resulted in tremendous cost savings of $21.8 million over 6 years. 'Blueprinting' the continuum of TBI patients' care identified the weakest links to be the transfer of patients from the tertiary-care TBI programme to rehabilitation institutions and provision of long-term rehabilitative care due to information asymmetry. This was addressed by the development of comprehensive on-line TBI transfer documents. This study emphasizes the importance of comprehensive neurotrauma programmes.	Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada		Khan, S (corresponding author), 3477 Drummond St,Suite 205, Montreal, PQ H3G 1X6, Canada.						BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; *BRAIN TRAUM FDN A, 1995, GUID MAN SEV HEAD IN; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COLLINS JG, 1990, VITAL HLTH STAT, V10, P175; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; HARRISONFELIX C, 1996, J HEAD TRAUMA REHAB, V11, P225; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JANE JA, 1982, CLIN NEUR, V29, P346; JENNETT B, 1975, LANCET, V1, P480; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Miller JR, 1989, MILD MODERATE HEAD I, P125; Pitts L H, 1995, New Horiz, V3, P546; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1993, NEUROSURGERY, V32, P30; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1996, WESTERN J MED, V165, P192; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	31	21	21	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2002	16	6					537	554		10.1080/02699050110119862			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	569RK	WOS:000176615800008	12148505				2022-02-06	
J	Schlund, MW				Schlund, MW			Effects of acquired brain injury on adaptive choice and the role of reduced sensitivity to contingencies	BRAIN INJURY			English	Article							ANTICIPATORY BEHAVIOR DEFICITS; CLOSED-HEAD-INJURY; PREFRONTAL CORTEX; SELF-CONTROL; REINFORCEMENT; LESIONS; DENSITY; DAMAGE	The present investigation examined the proposal that brain injury reduces sensitivity to consequences. On a laboratory task, controls and subjects with brain injury made repeated choices between a small amount of money and a larger amount of money followed by a post-reinforcer delay of 3, 12, 18, or 24 seconds. Increasing delays lowered reinforcement densities (i.e. money available per minute) associated with large reinforcers. Consequently, choosing large reinforcers became less adaptive. Results showed subjects with brain injury made less adaptive choices and earned significantly less money than controls, because of a preference for large reinforcers with low reinforcement densities. Maladaptive choice was not attributable to deficits in discriminating reinforcer magnitudes or delays. Results suggest individuals with brain injury may remain sensitive to consequences but fail to discriminate among significant response-consequence relations (i.e. contingencies). This view, emphasizing basic learning processes, may account for some problems in skill acquisition and adaptive choice.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA		Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; [Anonymous], 1993, GUIDE UNIFORM DATA S; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; FLORA SR, 1992, J EXP ANAL BEHAV, V57, P201, DOI 10.1901/jeab.1992.57-201; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; HAYES SC, 1996, ADV PSYCHOL, P279; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Ito M, 1998, J EXP ANAL BEHAV, V69, P87, DOI 10.1901/jeab.1998.69-87; KOSMIDIS MH, 1995, J CLIN EXP NEUROPSYC, V17, P622, DOI 10.1080/01688639508405150; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Logue A. W., 1998, LEARNING BEHAV THERA, P252; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; *NO CA NEUR GROUP, 1995, MAN COGN; Reitan R., 1979, MANUAL ADM NEUROPSYC; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Schlund MW, 2000, BEHAV INTERVENT, V15, P155, DOI 10.1002/1099-078X(200007/09)15:3<155::AID-BIN53>3.0.CO;2-F; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Skinner BF, 1938, BEHAV ORGANISMS	24	21	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2002	16	6					527	535		10.1080/02699050110113679			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	569RK	WOS:000176615800007	12119088				2022-02-06	
J	Cahill, LM; Murdoch, BE; Theodoros, DG				Cahill, LM; Murdoch, BE; Theodoros, DG			Perceptual analysis of speech following traumatic brain injury in childhood	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; POSTERIOR-FOSSA SURGERY; DYSARTHRIC SPEAKERS; CEREBELLAR MUTISM; TRANSIENT MUTISM; CHILDREN; DISORDERS; PATTERNS; RECOVERY; TUMORS	Primary objective: To investigate perceptually the speech dimensions, oromotor function, and speech intelligibility of a group of individuals with traumatic brain injury (TBI) acquired in childhood. Research design: The speech of 24 children with TBI was analysed perceptually and compared with that of a group of non-neurologically impaired children matched for age and sex. Main outcome and results: The 16 dysarthric TBI subjects were significantly less intelligible than the control subjects, and demonstrated significant impairment in 12 of the 33 speech dimensions rated. In addition, the eight non-dysarthric TBI subjects were significantly impaired in many areas of oromotor function on the Frenchay Dysarthria Assessment, indicating some degree of pre-clinical speech impairment. Conclusion The results of the perceptual analysis are discussed in terms of the possible underlying pathophysiological bases of the deviant speech features identified, and the need for a comprehensive instrumental assessment, to more accurately determine the level of breakdown in the speech production mechanism in children following TBI.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia		Cahill, LM (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia.	l.cahill@mailbox.uq.edu.au	Cahill, Louise/C-7919-2012; Murdoch, Bruce E/C-1397-2012; Theodoros, Deborah/F-1362-2010	Cahill, Louise/0000-0003-3662-896X			ALJARALLAH A, 1994, J SURG ONCOL, V55, P126, DOI 10.1002/jso.2930550214; ALMATEEN M, 1988, NEUROLOGY, V38, P1155, DOI 10.1212/WNL.38.7.1155; ARAM DM, 1983, ARCH NEUROL-CHICAGO, V40, P614, DOI 10.1001/archneur.1983.04050090050007; ASAMOTO M, 1994, CHILD NERV SYST, V10, P275, DOI 10.1007/BF00301168; BAK E, 1983, DEV MED CHILD NEUROL, V25, P81; BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Brown J.R., 1975, MOTOR SPEECH DISORDE; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; Chenery H. J., 1988, AUSTR J HUMAN COMMUN, V16, P17, DOI [10.3109/asl2.1988.16.issue-2.02., DOI 10.3109/ASL2.1988.16.ISSUE-2.02]; Chenery H.J., 1990, AUST J HUMAN COMMUN, V18, p19 ; CHENERY HJ, 1992, AUSTR J HUMAN COMMUN, V16, P17; CORNWELL PL, 2001, ASIA PACIFIC J SPEEC, V6, P21; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; DANIELWHITNEY B, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P129; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; DARLEY FL, 1984, SEMINARS SPEECH LANG, V5, P267; DIETZE D, 1990, PEDIATR NEUROL, V4, P228; ENDERBY P, 1990, BRIT J DISORD COMMUN, V25, P341; Enderby P, 1983, FRENCHAY DYSARTHRIA; FERRANTE L, 1990, J NEUROSURG, V72, P959, DOI 10.3171/jns.1990.72.6.0959; FISHER H, 1971, FISHERLOGEMANN TEST; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Hartelius L., 1993, SCAN J LOGOP PHONIAT, V18, P131, DOI [10.3109/14015439309101359, DOI 10.3109/14015439309101359]; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; HERB E, 1992, NEUROPEDIATRICS, V23, P144, DOI 10.1055/s-2008-1071330; HOODIN RB, 1989, FOLIA PHONIATR, V41, P249, DOI 10.1159/000265976; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; KEARNS KP, 1988, J SPEECH HEAR RES, V31, P131, DOI 10.1044/jshr.3101.131; KENT R, 1975, J SPEECH HEAR DISORD, V40, P115, DOI 10.1044/jshd.4001.115; KENT RD, 1979, J SPEECH HEAR RES, V22, P627, DOI 10.1044/jshr.2203.627; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; Ludlow C., 1984, DYSARTHRIAS PHYSL AC, P163; Marquardt TP, 1990, TRAUMATIC BRAIN INJU, P181; MCHENRY MA, 1994, J SPEECH HEAR RES, V37, P1271, DOI 10.1044/jshr.3706.1271; McHenry MA, 1998, ARCH PHYS MED REHAB, V79, P545, DOI 10.1016/S0003-9993(98)90071-5; Murdoch B E, 1989, Brain Inj, V3, P41, DOI 10.3109/02699058909008072; Murdoch B E, 1999, Pediatr Rehabil, V3, P5; Murdoch B E, 1998, Motor Control, V2, P148; MURDOCH BE, 1991, J SPEECH HEAR RES, V34, P768, DOI 10.1044/jshr.3404.768; MURDOCH BE, 1994, EUR J DISORDER COMM, V29, P379; MURDOCH BE, 1993, BRAIN INJURY, V7, P295, DOI 10.3109/02699059309034956; Murdoch BE, 1997, INT CONGR SER, V1146, P621; MURDOCH BE, 1993, J MED SPEECH-LANG PA, V1, P107; MURDOCH BE, 1998, DYSARTHRIA PHYSL APP, P373; NAGATANI K, 1991, SURG NEUROL, V36, P307, DOI 10.1016/0090-3019(91)90094-P; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; ODELL K, 1991, J SPEECH HEAR RES, V34, P67, DOI 10.1044/jshr.3401.67; ORLIKOFF R F, 1992, Seminars in Speech and Language, V13, P25, DOI 10.1055/s-2008-1064184; POLLACK IF, 1995, NEUROSURGERY, V37, P885, DOI 10.1227/00006123-199511000-00006; PRANZATELLI MR, 1994, PEDIATR NEUROL, V10, P131, DOI 10.1016/0887-8994(94)90045-0; RAMIG LO, 1992, INTELLIGIBILITY SPEE, P355; Samuel C, 1998, J NEUROL NEUROSUR PS, V64, P482, DOI 10.1136/jnnp.64.4.482; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; THOMPSON B, 1995, WILDLIFE SOC B, V23, P1; THOMPSON EC, 1995, J COMMUN DISORD, V28, P261, DOI 10.1016/0021-9924(94)00013-P; van Mourik M, 1997, PEDIATR NEUROL, V17, P299; van Mourik M, 1998, PEDIATR NEUROL, V18, P411, DOI 10.1016/S0887-8994(97)00232-4; VANDONGEN HR, 1994, NEUROLOGY, V44, P2040, DOI 10.1212/WNL.44.11.2040; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; VOLCAN I, 1986, ARCH NEUROL-CHICAGO, V43, P313, DOI 10.1001/archneur.1986.00520040003002; Weismer Gary., 1984, SEMIN SPEECH LANG, V5, P293, DOI [10.1055/s-2008-1064291, DOI 10.1055/S-2008-1064291]; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; YORKSTON KM, 1989, ARCH PHYS MED REHAB, V70, P313; YORKSTON KM, 1984, DYSARTHRIA PHYSL ACO, P131; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; [No title captured]	81	21	22	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2002	16	5					415	446		10.1080/02699050110119871			32	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	553TX	WOS:000175692500005	12097225				2022-02-06	
J	Huh, JW; Laurer, HL; Raghupathi, R; Helfaer, MA; Saatman, KE				Huh, JW; Laurer, HL; Raghupathi, R; Helfaer, MA; Saatman, KE			Rapid loss and partial recovery of neurofilament immunostaining following focal brain injury in mice	EXPERIMENTAL NEUROLOGY			English	Article						neurofilament; controlled cortical impact; traumatic brain injury; cytoskeleton; phosphorylation; immunohistochemistry	SPINAL-CORD INJURY; MONOCLONAL-ANTIBODIES DISTINGUISH; GANGLION-CELL NEURONS; MEDIATED PROTEOLYSIS; AXONAL-TRANSPORT; CORTICAL IMPACT; NERVOUS-SYSTEM; PROTEINS; PHOSPHORYLATION; RAT	Neurofilaments (NF), the intermediate filaments of the neuronal cytoskeleton, provide mechanical stability to the cell. High-molecular-weight NF (NFH) comprises a heavily phosphorylated carboxyl terminal ("sidearm") domain which helps determine interfilament spacing distances. Experimental evidence suggests that dephosphorylation greatly increases the rate and extent of proteolysis of NFH. Because NF proteolysis has been implicated as one pathogenic mechanism underlying cell death following traumatic brain injury (TBI), we analyzed the patterns of acute NFH damage in relation to phosphorylation state following focal, concussive, controlled cortical impact (CCI) brain injury in mice. Brains from C57BL/6 male mice (n = 4 injured and n = 1 sham per time point) were evaluated 5 min, 15 min, 90 min, 4 h, and 24 h following CCI injury (1 min depth, 5 m/s). Immunohistochemistry was performed using antibodies that recognize epitopes on either dephosphorylated (d-NFH) or phosphorylated (p-NFH) sidearms or on the core (c-NFH) domain. As early as 5-15 min postinjury, immunoreactivity for d-, p-, and c-NFH decreased in the ipsilateral cortex, and hippocampal CA3, CA1, and dentate areas. This marked decrease of NFH labeling occurred in the absence of notable cell loss. Furthermore, partial recovery of NFH labeling was observed as early as 90 min postinjury in the cortex and by 24 h postinjury in hippocampal CA3 and dentate. The results of this study suggest that both phosphorylated and dephosphorylated NFH are vulnerable almost immediately following focal brain injury in mice, but that injured neurons may have an adaptive capability to partially restore this important cytoskeletal protein. (C) 2002 Elsevier Science (USA).	Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Huh, JW (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803] Funding Source: Medline		BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CARDEN MJ, 1985, J BIOL CHEM, V260, P9805; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Galvin JE, 2000, EXP NEUROL, V165, P77, DOI 10.1006/exnr.2000.7461; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; LEE V, 1982, P NATL ACAD SCI-BIOL, V79, P6089, DOI 10.1073/pnas.79.19.6089; LEE VMY, 1986, J NEUROSCI, V6, P2179; LEE VMY, 1986, J NEUROSCI, V6, P850; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1984, J NEUROCHEM, V42, P25, DOI 10.1111/j.1471-4159.1984.tb09692.x; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; MANSOUR H, 1989, J COMP NEUROL, V283, P481, DOI 10.1002/cne.902830404; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; *NAT RES COUNC, 1996, GUID CAR US LAB; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; NIXON RA, 1987, J NEUROSCI, V7, P1145; OBLINGER MM, 1987, J NEUROSCI, V7, P453; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pant HC, 1995, BIOCHEM CELL BIOL, V73, P575, DOI 10.1139/o95-063; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; Posmantur RM, 1998, NEUROCHEM RES, V23, P1265, DOI 10.1023/A:1020792132629; Raabe TD, 1996, J NEUROSCI, V16, P1605; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SAATMAN KE, 1999, J NEUROTRAUM, V16, P1002; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SCHMIDT ML, 1987, LAB INVEST, V56, P282; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; StraubeWest K, 1996, J CELL SCI, V109, P2319; TROJANOWSKI JQ, 1985, J HISTOCHEM CYTOCHEM, V33, P557, DOI 10.1177/33.6.3889140; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; YANG KY, 1994, J NEUROTRAUM, V11, P523, DOI 10.1089/neu.1994.11.523	47	21	23	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAY	2002	175	1					198	208		10.1006/exnr.2002.7880			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	550YN	WOS:000175532800018	12009772				2022-02-06	
J	Hawn, KL; Visser, MF; Sexton, PJ				Hawn, KL; Visser, MF; Sexton, PJ			Enforcement of mouthguard use and athlete compliance in National Collegiate Athletic Association Men's Collegiate Ice Hockey Competition	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; mild brain injury; injury prevention; protective equipment	INJURIES	Objective: To determine enforcement patterns and athlete compliance with the National Collegiate Athletic Association (NCAA) rule requiring the wearing of mouthguards in men's collegiate ice hockey games during a single competitive season. Design and Setting: We developed a questionnaire and sent it to certified athletic trainers (ATCs) directly responsible for men's varsity collegiate ice hockey at 127 NCAA-affiliated institutions. Then chi(2) analyses were conducted to determine whether significant differences existed in the pattern of responses by division of play (Division I, II, or III or independent). Subjects: A total of 104 ATCs responded. We obtained data from 94 questionnaires with complete answers to primary questions addressing program enforcement of the rule and mouthguard use. Measurements: Our questionnaire asked about types of mouthguards used, attitudes of the sports medicine and coaching staffs regarding the role of mouthguards in prevention of injury, enforcement of mouthguard use, and actual numbers of athletes wearing mouthguards in competition. Respondents also provided an estimate of the number of penalties assessed against their team for mouthguard violations during the previous season. Results: Most ATCs (93%) reported that they believed mouthguards play a role in injury prevention. Respondents indicated someone on the coaching or sports medicine staff enforced the rule at 74% of the institutions, with a trend toward greater enforcement at the Division II and III levels. Overall, ATCs reported 63% of athletes consistently wore mouthguards in competition, with significantly higher compliance at the Division II and III levels. A total of 19 penalties were reportedly assessed for violation of the mouthguard rule the previous season. Conclusions: Our data suggest that the use of mouthguards in competition is not consistently enforced by ATCs, coaches, or game officials and that mouthguards are not routinely worn by athletes. These results raise legitimate concerns for all physicians, athletic trainers, coaches, and governing bodies involved with men's collegiate ice hockey.	Minnesota State Univ, Mankato, MN 56001 USA; Univ Pittsburgh, Ctr Sports Med, Pittsburgh, PA USA		Visser, MF (corresponding author), Minnesota State Univ, 213 Morris Hall, Mankato, MN 56001 USA.						CASTALDI CR, 1993, SAFETY ICE HOCKEY, P164; Chapman P., 1985, AUST J SCI MED SPORT, P23; CHAPMAN PJ, 1989, AM J SPORT MED, V17, P690, DOI 10.1177/036354658901700518; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; DEYOUNG AK, 1994, J AM DENT ASSOC, V125, P1112, DOI 10.14219/jada.archive.1994.0121; DICK R, 1993, SAFETY ICE HOCKEY, P21; FARBER M, 1996, SPORTS ILLUSTRATED, V85, P100; Francis K T, 1991, Br J Sports Med, V25, P227; KERR IL, 1986, SPORTS MED, V3, P415, DOI 10.2165/00007256-198603060-00003; *NAT COLL ATHL ASS, 2001, 2001 MENS WOM IC HOC; *NAT COLL ATHL ASS, 1996, INJ SURV SYST 1997 9; NATT P, 1983, J ROY SOC HEALTH, V103, P180, DOI 10.1177/146642408310300506; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; Shaull K L, 1985, Trends Tech Contemp Dent Lab, V2, P12; Siegal S., 1988, NONPARAMETRIC STAT B; 2001, US TODAY COM SPORTS; [No title captured]	17	21	21	0	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	APR-JUN	2002	37	2					204	208					5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	558UA	WOS:000175983900015	12937436				2022-02-06	
J	Leong, B				Leong, B			The vegetative and minimally conscious states in children: spasticity, muscle contracture and issues for physiotherapy treatment	BRAIN INJURY			English	Article							INTRATHECAL BACLOFEN INFUSION; SELECTIVE POSTERIOR RHIZOTOMY; TRAUMATIC BRAIN-INJURY; BOTULINUM-TOXIN-A; UPPER EXTREMITY SPASTICITY; RECIPROCAL INHIBITION; PRESYNAPTIC INHIBITION; PHENOL BLOCK; DOUBLE-BLIND; FOREARM MUSCLES	The neuropathology of the vegetative (VS) and minimally conscious (MCS) states and the pathophysiology of spasticity are reviewed. Current treatment options available in the physical management of children in a low-level state and factors influencing the physiotherapy treatment of children in a low-level state will be discussed. The complex neuropathology of VS and MCS helps to explain the varied clinical presentations of children in VS and MCS. Spasticity and muscle contracture are common motor sequelae of VS and MCS. Loss of inhibition by descending motor pathways is thought to result in increased muscle tone or spasticity. However, secondary changes in muscle fibre structure and periarticular connective tissue may be an additional component to increased muscle tone. A multi-modal approach combining physical, pharmacological and surgical interventions is likely to be the most effective. Knowledge of the likelihood of recovery from VS and MCS can be helpful in determining the frequency and intensity of physiotherapy. Ethical issues in the management of children in a low-level state include a consideration of the benefits to the child and the child's family and the costs to the health care team and the medical institution.	Sunny Hill Hlth Ctr Children, Therapy Dept, Vancouver, BC V5M 3E8, Canada		Leong, B (corresponding author), Sunny Hill Hlth Ctr Children, Therapy Dept, 3644 Slocan St, Vancouver, BC V5M 3E8, Canada.	bnleong@cw.bc.cd					Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; ALBRIGHT AL, 1995, PEDIATR NEUROSURG, V23, P82; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; ARTIEDA J, 1991, NEUROLOGY, V41, P286, DOI 10.1212/WNL.41.2_Part_1.286; Ashford S, 2000, Physiother Res Int, V5, P202, DOI 10.1002/pri.199; ASHWAL S, 1994, PEDIATR NEUROL, V10, P27, DOI 10.1016/0887-8994(94)90063-9; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1992, ANN NEUROL, V32, P570, DOI 10.1002/ana.410320414; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Bogen JE, 1997, SEMIN NEUROL, V17, P95, DOI 10.1055/s-2008-1040918; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Burke D, 1988, Adv Neurol, V47, P401; CASTLE ME, 1979, CLIN ORTHOP RELAT R, P223; Chambers HG, 1997, MUSCLE NERVE, pS121; CHAPMAN CE, 1982, PHYSIOTHER CAN, V34, P125; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CONINE TA, 1990, ARCH PHYS MED REHAB, V71, P310; Corry IS, 1998, J PEDIATR ORTHOPED, V18, P304, DOI 10.1097/00004694-199805000-00006; DELWAIDE PJ, 1994, NEUROLOGY, V44, P21; DELWAIDE PJ, 1988, J NEUROL NEUROSUR PS, V51, P1546, DOI 10.1136/jnnp.51.12.1546; Desmedt JE., 1973, NEW DEV ELECTROMYOGR, P508; DIETZ V, 1981, BRAIN, V104, P431, DOI 10.1093/brain/104.3.431; DIETZ V, 1986, J NEUROL SCI, V75, P89, DOI 10.1016/0022-510X(86)90052-3; ENNEKING WF, 1972, J BONE JOINT SURG AM, VA 54, P973, DOI 10.2106/00004623-197254050-00003; FAIST M, 1994, BRAIN, V117, P1449, DOI 10.1093/brain/117.6.1449; Flett PJ, 1999, J PAEDIATR CHILD H, V35, P71, DOI 10.1046/j.1440-1754.1999.00330.x; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P243; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GIVEN JD, 1995, J NEUROL NEUROSUR PS, V59, P271, DOI 10.1136/jnnp.59.3.271; Gracies JM, 1997, MUSCLE NERVE, pS92; Gracies JM, 1997, MUSCLE NERVE, pS61; Harburn K L, 1995, Electromyogr Clin Neurophysiol, V35, P149; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HILL J, 1994, AM J OCCUP THER, V48, P219, DOI 10.5014/ajot.48.3.219; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; Ito J, 1996, BRAIN DEV-JPN, V18, P299, DOI 10.1016/0387-7604(96)00006-X; Jacobs HE, 1986, J HEAD TRAUMA REHAB, V1, P55, DOI DOI 10.1136/BMJ.M1815; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; KATZ R, 1982, BRAIN, V105, P103, DOI 10.1093/brain/105.1.103; Katz R, 1999, J PHYSIOLOGY-PARIS, V93, P379, DOI 10.1016/S0928-4257(00)80065-0; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P340, DOI 10.1016/0363-5023(90)90120-G; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Klepper H, 1997, CAMB Q HEALTHC ETHIC, V6, P306, DOI 10.1017/S0963180100008008; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LEHMKUHL LD, 1990, J HEAD TRAUMA REHAB, V5, P23, DOI DOI 10.1097/00001199-199012000-00005; LEONARD CT, 1990, DEV MED CHILD NEUROL, V32, P974; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lin JP, 1999, DEV MED CHILD NEUROL, V41, P534, DOI 10.1017/S0012162299001152; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P155, DOI 10.1053/apmr.2001.19246; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; NOTH J, 1991, J NEUROL, V238, P131, DOI 10.1007/BF00319679; ODwyer NJ, 1996, CURR OPIN NEUROL, V9, P451, DOI 10.1097/00019052-199612000-00010; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Okuma Y, 1996, CAN J NEUROL SCI, V23, P15, DOI 10.1017/S0317167100039135; On AY, 1999, AM J PHYS MED REHAB, V78, P344, DOI 10.1097/00002060-199907000-00010; PANIZZA M, 1995, AM J PHYS MED REHAB, V74, P357; Payne SK, 1997, SEMIN NEUROL, V17, P257, DOI 10.1055/s-2008-1040937; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; Peter KS, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199608000-00003; Pierrot-Deseilligny E, 1985, CLIN NEUROPHYSIOL, P63; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; POWERS RK, 1988, ANN NEUROL, V23, P115, DOI 10.1002/ana.410230203; POWERS RK, 1989, ANN NEUROL, V25, P32, DOI 10.1002/ana.410250106; ROSE J, 1994, J ORTHOP RES, V12, P758, DOI 10.1002/jor.1100120603; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; Sim J, 1997, Physiother Res Int, V2, P7, DOI 10.1002/pri.86; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Smyth MD, 2000, MUSCLE NERVE, V23, P153, DOI 10.1002/(SICI)1097-4598(200002)23:2<153::AID-MUS3>3.0.CO;2-4; Steinbok P, 1997, DEV MED CHILD NEUROL, V39, P178; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; TABARY JC, 1981, MUSCLE NERVE, V4, P198, DOI 10.1002/mus.880040305; THILMANN AF, 1991, J NEUROL NEUROSUR PS, V54, P134, DOI 10.1136/jnnp.54.2.134; TREMBLAY F, 1990, SCAND J REHABIL MED, V22, P171; Van Schaeybroeck P, 2000, NEUROSURGERY, V46, P603, DOI 10.1097/00006123-200003000-00017; WIESENDANGER M, 1985, CLIN NEUROPHYSIOL, P1; WILLIAMS PE, 1973, J ANAT, V116, P45; Wright FV, 1998, DEV MED CHILD NEUROL, V40, P239; WRIGHT J, 1990, CLIN ORTHOP RELAT R, V253, P12; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; YARKONY GM, 1987, CLIN ORTHOP RELAT R, P93; YOUNG RR, 1994, NEUROLOGY, V44, P12; YOUNG RR, 1987, CLIN ORTHOP RELAT R, V219, P50; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; [No title captured]; [No title captured]	100	21	21	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2002	16	3					217	230		10.1080/02699050110103283			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	526HP	WOS:000174124800004	11874615				2022-02-06	
J	Al-Abdulla, NA; Martin, LJ				Al-Abdulla, NA; Martin, LJ			Projection neurons and interneurons in the lateral geniculate nucleus undergo distinct forms of degeneration ranging from retrograde and transsynaptic apoptosis to transient atrophy after cortical ablation in rat	NEUROSCIENCE			English	Article						Alzheimer's disease; amyotrophic lateral sclerosis; axotomy; cell death; DNA damage; traumatic brain injury	FIMBRIA-FORNIX TRANSECTION; ACID DECARBOXYLASE GAD; CELL-DEATH; CAT; NEURODEGENERATION; IDENTIFICATION; CORTEX; SEPTUM; BRAIN	The cytological responses of thalamic interneurons to selective degeneration of thalamocortical projection neurons after cortical damage in the adult brain are poorly understood. We used a unilateral neocortical lesion model (occipital cortex ablation) in the adult rat to test the hypothesis that interneurons and projection neurons in the lateral geniculate nucleus undergo distinct forms of degeneration. In situ nuclear DNA fragmentation in neurons in the lateral geniculate occurs maximally at 7 days postlesion. Geniculocortical projection neurons that are identified by the retrograde tracer Fluorogold die primarily with a morphology of endstage apoptosis prominent at 7 days postlesion. In contrast, interneurons, identified by their particular nuclear ultrastructure and by glutamic acid decarboxylase immunoreactivity, undergo an atrophic vacuolar pathology starting early during the period of projection neuron death and peaking after the projection neuron death is complete. This degeneration of interneurons is transient, because these neurons exhibit structural recovery and their numbers are not changed significantly postlesion. A rare subset of interneurons (less than one in 100 interneurons and less than one in 100 apoptotic cells) undergoes apoptosis concurrently with the projection neurons. We conclude that different types of neurons within the same thalamic nucleus respond differently to focal cortical target deprivation. Unlike the apoptosis-prone projection neurons, most interneurons undergo transient transsynaptic atrophy and recovery rather than cell death. Nevertheless, a small subset of lateral geniculate interneurons undergoes transsynaptic apoptosis in response to projection neuron apoptosis. The pathological responses of thalamic neurons to cortical trauma vary depending on cell type. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neurosci, Baltimore, MD 21205 USA		Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, 558 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG016282] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG16282] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34100] Funding Source: Medline		Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; BARRON KD, 1967, J NEUROPATH EXP NEUR, V26, P300, DOI 10.1097/00005072-196704000-00007; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; FRY FJ, 1972, J COMP NEUROL, V144, P1, DOI 10.1002/cne.901440102; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; GIOLLI RA, 1971, J COMP NEUROL, V142, P351, DOI 10.1002/cne.901420306; Lashley KS, 1941, J COMP NEUROL, V75, P67, DOI 10.1002/cne.900750105; LEVAY S, 1979, BRAIN RES, V164, P304, DOI 10.1016/0006-8993(79)90026-X; MADARASZ M, 1983, EXP BRAIN RES, V52, P363; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin LJ, 2001, INT J MOL MED, V7, P455; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MONTERO VM, 1985, EXP BRAIN RES, V59, P151; OHARA PT, 1983, NEUROSCIENCE, V8, P189, DOI 10.1016/0306-4522(83)90060-X; POWELL TPS, 1952, BRAIN, V75, P571, DOI 10.1093/brain/75.4.571; Wang YZ, 1998, EXP NEUROL, V154, P389, DOI 10.1006/exnr.1998.6965; WEBER AJ, 1983, J COMP NEUROL, V220, P336, DOI 10.1002/cne.902200307	24	21	21	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2002	115	1					7	14	PII S0306-4522(02)00363-9	10.1016/S0306-4522(02)00363-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615DX	WOS:000179231500002	12401317				2022-02-06	
J	Lourido, J; Ederoth, P; Sundvall, N; Ungerstedt, U; Nordstrom, CH				Lourido, J; Ederoth, P; Sundvall, N; Ungerstedt, U; Nordstrom, CH			Correlation between blood glucose concentration and glucose concentration in subcutaneous adipose tissue evaluated with microdialysis during intensive care	SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION			English	Article						adipose tissue; glucose; glycerol; lactate; microdialysis	HUMAN SKELETAL-MUSCLE; INTRACEREBRAL MICRODIALYSIS; VOLUME REGULATION; HEAD-INJURY; HYPERGLYCEMIA; PRINCIPLES; LEVEL; METABOLISM; MORBIDITY; MORTALITY	Background: Hyper- as well as hypoglycemia may be detrimental for brain energy metabolism and even a moderate increase in blood glucose concentration can affect outcome adversely. During physiological conditions, glucose concentration obtained from microdialysis of subcutaneous adipose tissue adequately reflects plasma glucose concentration. This study examines whether this correlation is also obtained during intensive care in patients with severe injuries. Methods.. The study included 62 patients with severe traumatic brain injuries. All patients received one 30 mm microdialysis catheter (CMA 60, CMA Microdialysis) inserted into periumbilical subcutaneous adipose tissue. The probe was perfused (0.3 mul/min) with a Ringer solution from a microinfusion Pump and analyzed for glucose, lactate, and glycerol. The Study included 2.434 simultaneous analyses of glucose concentration in arterial blood and subcutaneous adipose tissue. Results.' The correlation coefficient for glucose concentration in blood and interstitial fluid was 0.743 for the whole material. The cot-relation was relatively poor for 1-6h after insertion of the probes, During this period. a continuous increase in the Subcutaneous level Of glucose and decreases in lactate and glycerol were noted. Conclusions: The correlation between blood glucose concentration and glucose Concentration in subcutaneous adipose tissue was not as good during intensive care as in normal humans. The poor correlation during the first 6h probably reflects a stress reaction (and possibly local vasoconstriction). Microdialysis of subcutaneous adipose tissue permits frequent bedside analyses of the biochemical composition of the extracellular fluid and may be of value during routine intensive care provided the methodological limitations are recognized.	Hosp Univ Canarias, Dept Neurosurg, Tenerife, Spain; Univ Lund Hosp, Dept Anesthesiol, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden		Nordstrom, CH (corresponding author), Univ Lund Hosp, Dept Neurosurg, SE-22185 Lund, Sweden.	carl-henrik.nordstrom@swipnet.se	Glasserman, Leonardo/AAO-6771-2021; Morales, Leonardo Glasserman/L-3139-2016	Morales, Leonardo Glasserman/0000-0001-7960-9537			ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BOLINDER J, 1993, LANCET, V342, P1080, DOI 10.1016/0140-6736(93)92063-Y; BOLINDER J, 1989, SCAND J CLIN LAB INV, V49, P465, DOI 10.3109/00365518909089123; BOLINDER J, 1992, DIABETOLOGIA, V35, P1177, DOI 10.1007/BF00401374; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; BUNGAY PM, 1990, LIFE SCI, V46, P105, DOI 10.1016/0024-3205(90)90043-Q; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; FELLANDER G, 1994, EUR J SURG, V160, P87; FELLANDER G, 1994, J CLIN ENDOCR METAB, V78, P150, DOI 10.1210/jc.78.1.150; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; HUTCHINSON PJ, 1999, ACTA NEUROCHIR SUPP, V75, P75; JANSSON PA, 1988, AM J PHYSIOL, V255, pE218, DOI 10.1152/ajpendo.1988.255.2.E218; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Moberg E, 1997, DIABETOLOGIA, V40, P1320, DOI 10.1007/s001250050827; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; PENTELENYI T, 1977, INJURY, V8, P264, DOI 10.1016/0020-1383(77)90099-7; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936, DOI 10.1152/ajpendo.1998.274.5.E936; ROSDAHL H, 1993, J PHYSIOL-LONDON, V471, P637, DOI 10.1113/jphysiol.1993.sp019920; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Ungerstedt U., 1974, B SCHWEIZ AKAD MED, V1278, P1; UNGERSTEDT U, 1999, J INTENSIVE CARE, V6, P102; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; WOO E, 1988, STROKE, V19, P185, DOI 10.1161/01.STR.19.2.185; WOO J, 1990, ARCH NEUROL-CHICAGO, V47, P1174, DOI 10.1001/archneur.1990.00530110028011; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	30	21	24	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0036-5513	1502-7686		SCAND J CLIN LAB INV	Scand. J. Clin. Lab. Invest.		2002	62	4					285	292		10.1080/003655102760145843			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	578WN	WOS:000177144200006	12476927				2022-02-06	
J	Johnson, SM; Johnson, AC; Barton, RG				Johnson, SM; Johnson, AC; Barton, RG			Avalanche trauma and closed head injury: adding insult to injury	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						avalanche; trauma; closed head injury; skiing; snowboarding; snowmobile		Objective.-The incidence of fatal closed head injury (CHI) and nonfatal CHI causing an altered level of consciousness in avalanche victims is unknown. The purpose of this study was to assess the incidence and potential significance of CHI in avalanche-related deaths. Methods.-The records of the state medical examiner and hospital records of all victims killed in avalanches in the state of Utah from October 1, 1992 through April 30, 1999 were reviewed for a cause of death and for the presence of CHI. Closed head injury was described as "present" or "severe," depending on whether the degree of CHI was sufficient to have caused or directly contributed to death, as determined by the medical examiner. Results.-In this review, 28 avalanche-related deaths were identified, of which 22 (79%) were due to asphyxia. Seventeen victims (61%) had evidence of some degree of CHI. Six victims (21%) had evidence of severe CHI. One of 7 snowmobile riders sustained a severe CHI, whereas 4 of 16 skiers or snowboarders sustained a severe CIE (P = not significant). Conclusion.-Although asphyxiation was the cause of death in most avalanche victims, evidence of CHI was present in 61% of the cases studied. While avalanche-associated CHI may not be sufficient to cause death in many cases, a depressed level of consciousness might render a victim incapable of self-rescue and predispose to asphyxia. Helmet use may help prevent avalanche-associated CHI and thus be a useful safety adjunct.	Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT USA		Johnson, SM (corresponding author), 426 10th Ave, Salt Lake City, UT 84103 USA.						Brugger H, 1996, RESUSCITATION, V31, P11, DOI 10.1016/0300-9572(95)00913-2; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; Grissom CK, 2000, JAMA-J AM MED ASSOC, V283, P2266, DOI 10.1001/jama.283.17.2266; GROSSMAN MD, 1989, J TRAUMA, V29, P1705, DOI 10.1097/00005373-198912000-00021; Page CE, 1999, WILD ENVIRON MED, V10, P146, DOI 10.1580/1080-6032(1999)010[0146:ADITUS]2.3.CO;2; Rostrup Morten, 1993, Tidsskrift for den Norske Laegeforening, V113, P1100; Tschirky F., 2000, AVALANCHE RESCUE SYS; WILLIAMS K, 1995, WILDERNESS MED MANAG, P617	8	21	21	0	0	WILDERNESS MEDICAL SOC	COLORADO SPRINGS	3595 E FOUNTAIN BLVD, STE A1, COLORADO SPRINGS, CO 80910 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	WIN	2001	12	4					244	247		10.1580/1080-6032(2001)012[0244:ATACHI]2.0.CO;2			4	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	505NR	WOS:000172919300006	11769920				2022-02-06	
J	Simpson, G; Tate, R; Ferry, K; Hodgkinson, A; Blaszczynski, A				Simpson, G; Tate, R; Ferry, K; Hodgkinson, A; Blaszczynski, A			Social, neuroradiologic, medical, and neuropsychologic correlates of sexually aberrant behavior after traumatic brain injury: A controlled study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						frontal lobe; paraphilias; sex offenses; traumatic brain injury	HEAD-INJURY; ADJUSTMENT; SEQUELAE	Objective: To identify social, neuroradiological, medical, and neuropsychological correlates of sexually aberrant behavior (SAB) after traumatic brain injury (TBI). Design: A controlled study using a retrospective file review. Setting: A brain injury unit providing inpatient and outpatient rehabilitation services. Participants: A sample of males (n = 25) exhibiting SABs and a control group (n = 25) matched for gender, severity of injury, age at injury, and time after injury. Main Outcome Measures: A protocol that recorded data on demographic, injury, radiological, medical, and neuropsychological variables. Results: The SAB group had a significantly higher incidence of postinjury psychosocial disturbance in areas of nonsexual crime and failure to return to work than the matched TBI group. There were no significant differences between the two groups in the incidence of premorbid psychosocial disturbance or postinjury radiological, medical, or neuropsychological variables. Conclusions: The study results caution against simplistic explanations of SAB as the product of damage to the frontal-lobe systems or premorbid psychosocial disturbance. Furthermore, the results suggest that a wide-ranging assessment of people with TBI who exhibit SABs is required, because results of neuropsychological examination alone cannot be considered conclusive. Future research into the etiology of SABs could examine additional factors such as lack of insight, lack of empathy, and premorbid history of family dysfunction.	Liverpool Hosp, Brain Injury Rehabil Unit, Liverpool, NSW 1871, Australia; Univ Sydney, Rehabil Studies Unit, Ryde, NSW, Australia; Univ Sydney, Westmead, NSW 2145, Australia; Dept Med Psychol, Westmead, NSW 2145, Australia		Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool, NSW 1871, Australia.		Blaszczynski, Alexander/G-2713-2013; Simpson, Grahame K/W-1074-2019	Blaszczynski, Alexander/0000-0003-1476-0791; Simpson, Grahame K/0000-0001-8156-9060			Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; Burgess INA., 1985, RAPE SEXUAL ASSAULT, P222; Crowe SF, 1999, BRAIN INJURY, V13, P347; EMORY LE, 1995, J HEAD TRAUMA REHAB, V10, P47; FAHY TJ, 1967, LANCET, V2, P475; Goldberg R L, 1982, Int J Psychiatry Med, V12, P275; GRABER B, 1982, J FORENSIC SCI, V27, P125; HALL HV, 1993, DISORDERS EXECUTIVE, P37; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY; HENN FA, 1976, AM J PSYCHIAT, V133, P694; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; Hucker S, 1988, ANN SEX RES, V1, P33, DOI DOI 10.1177/107906328800100104; JAMIESON KG, 1966, 13 NAT HLTH MED RES; KOZOL HL, 1946, ARCH NEURO PSYCHIATR, V56, P245, DOI 10.1001/archneurpsyc.1946.02300200002001; KOZOL HL, 1945, ARCH NEURO PSYCHIATR, V53, P358, DOI 10.1001/archneurpsyc.1945.02300050032004; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Langevin R, 1985, EROTIC PREFERENCE GE, P39; LEHNE G, 1986, SEX DISABIL, V7, P145; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Marshall W.L., 1990, HDB SEXUAL ASSAULT; Meyer W J 3rd, 1992, Bull Am Acad Psychiatry Law, V20, P249; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; MONEY J, 1990, AM J PSYCHOTHER, V44, P26, DOI 10.1176/appi.psychotherapy.1990.44.1.26; REGESTEIN QR, 1978, J NERV MENT DIS, V166, P794, DOI 10.1097/00005053-197811000-00007; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROSENTHAL M, 1990, REHABILITATION ADULT; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; SCOTT ML, 1984, J FORENSIC SCI, V29, P1114; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tate RL, 1998, NEUROPSYCHOL REHABIL, V8, P1, DOI 10.1080/713755554; WEINSTEIN EA, 1961, PSYCHIATR, V24, P69; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163; [No title captured]; [No title captured]	45	21	21	0	5	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2001	16	6					556	572		10.1097/00001199-200112000-00004			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	501AL	WOS:000172660800004	11732971				2022-02-06	
J	James, LE; MacKay, DG				James, LE; MacKay, DG			HM, word knowledge, and aging: Support for a new theory of long-term retrograde amnesia	PSYCHOLOGICAL SCIENCE			English	Article							CLOSED-HEAD-INJURY; HIPPOCAMPAL SYSTEM; OLDER ADULTS; MEMORY; CONSOLIDATION; RECOGNITION; DISEASE; BINDING; TONGUE; YOUNG	This study develops a new theory of long-term retrograde amnesia that encompasses episodic and semantic memory, including word knowledge. Under the theory, retrograde amnesia in both normal individuals and hippocampal amnesics reflects transmission deficits caused by aging, nonrecent use of connections, and infrequent use of connections over the life span. However, transmission deficits cause severe and irreversible retrograde amnesia only in amnesics who (unlike normal persons) cannot readily form new connections to replace nonfunctioning ones. The results of this study are consistent with this theory: For low-frequency but not high-frequency words, a famous "hippocampal amnesic" (H.M.) at age 71 performed worse than memory-normal control participants in a lexical decision experiment and a meaning-definition task (e.g., What does squander mean?). Also as predicted, H.M.'s lexical decision performance declined dramatically between ages 57 and 71 for low-frequency words, but was age invariant for high-frequency words.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA		MacKay, DG (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	mackay@psych.ucla.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG 09755] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG009755] Funding Source: NIH RePORTER		ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Corkin S, 1997, J NEUROSCI, V17, P3964; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; GABRIELI JDE, 1988, BRAIN COGNITION, V7, P157, DOI 10.1016/0278-2626(88)90027-9; GRAFMAN J, 1996, BASIC APPL MEMORY TH, P259; Helmuth LI, 1997, LEARN MEMORY, V3, P456, DOI 10.1101/lm.3.6.456; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; LACKNER JR, 1974, NEUROPSYCHOLOGIA, V12, P199, DOI 10.1016/0028-3932(74)90005-0; LAVER GD, 1993, PSYCHOL AGING, V8, P34, DOI 10.1037/0882-7974.8.1.34; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; MacKay DG, 1998, J MEM LANG, V38, P28, DOI 10.1006/jmla.1997.2544; MacKay DG, 1998, J COGNITIVE NEUROSCI, V10, P377, DOI 10.1162/089892998562807; MacKay DG, 2001, LANG COGNITIVE PROC, V16, P419, DOI 10.1080/01690960042000102; MacKay DG., 1990, RELATIONSHIPS PERCEP, P269, DOI [10.1007/978-3-642-75348-0_10, DOI 10.1007/978-3-642-75348-0_10]; MacKay DG., 1987, ORG PERCEPTION ACTIO; MACKAY DG, 1990, AGING COGNITION KNOW, P281, DOI DOI 10.1016/S0166-4115(08)60159-4; MACKAY DG, 1999, UNPUB HMS READING DE; MARSLENWILSON W, 1970, UNPUB RAW DATA; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; MCCLELLAND JL, 1985, ANN NY ACAD SCI, V444, P1, DOI 10.1111/j.1749-6632.1985.tb37576.x; METCALFE J, 1992, J COGNITIVE NEUROSCI, V4, P289, DOI 10.1162/jocn.1992.4.3.289; Milner B, 1975, Adv Neurol, V8, P299; Morris RGM, 1999, CURR BIOL, V9, pR890; Murre JMJ, 1996, HIPPOCAMPUS, V6, P675, DOI 10.1002/(SICI)1098-1063(1996)6:6<675::AID-HIPO10>3.0.CO;2-Y; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Ribot T., 1882, DIS MEMORY; WICKELGREN WA, 1979, PSYCHOL REV, V86, P44, DOI 10.1037/0033-295X.86.1.44; 1949, WEBSTERS NEW COLLEGI	34	21	21	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0956-7976	1467-9280		PSYCHOL SCI	Psychol. Sci.	NOV	2001	12	6					485	492		10.1111/1467-9280.00390			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	491MQ	WOS:000172112700009	11760136				2022-02-06	
J	Martin, C; Viguier, D; Deloche, G; Dellatolas, G				Martin, C; Viguier, D; Deloche, G; Dellatolas, G			Subjective experience after traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; DEPRESSED MOOD; RELATIVES; INDIVIDUALS; ADJUSTMENT; SEQUELAE; DISTRESS; DISORDER; CAREGIVERS	The present investigation aims to show which specific difficulties are reported with greater frequency in traumatic brain injury (TBI) patients than in controls, and in hetero-assessment than in self-assessment. Ninety-seven patients with severe TBI were compared to 97 controls matched for age and gender. The 63-item European Brain Injury Questionnaire (EBIQ) was completed by patients, close relatives and controls. A principal component analysis showed three main factors: 'depressive mood', 'cognitive difficulties', and 'difficulties in social interactions'. Relatives scored higher than patients for items concerning the three domains. Patients scored higher than controls for 'depressive mood' and 'cognitive difficulties', but not for 'difficulties in social interactions', which included items related to both self-assertion and lack of self-control. After TBI, emotional problems and, especially, depressive mood associated to cognitive difficulties have an important impact in everyday life and family functioning. Difficulties in social interactions are not specific of TBI patients.	INSERM, U472, F-94807 Villejuif, France		Dellatolas, G (corresponding author), INSERM, U472, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	dellatolas@vjf.inserm.fr	Dellatolas, Georges/AAW-1377-2021				Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; BORG I, 1987, MULTIDIMENSIONAL SIM; Deloche G., 1996, Annales de Readaptation et de Medecine Physique, V39, P1, DOI 10.1016/0168-6054(96)88044-5; DELOCHE G, 1997, HANDICAPS INADAPTATI, V75, P101; Derogatis LR., 1983, SCL 90 R ADM SCORING; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FAHY TJ, 1967, LANCET, V2, P475; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GURNS S, 1994, BRAIN INJURY, V8, P413, DOI 10.3109/02699059409150993; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kraus Jess F., 1994, P3; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LEVIN HS, 1989, HDB NEUROPSYCHOLOGY, P183; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; PANTING A, 1976, REHABILITATION, V82, P33; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, P55; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460	49	21	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2001	15	11					947	959		10.1080/02699050110065655			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	490VF	WOS:000172073900002	11689093				2022-02-06	
J	Weinstein, CS; Fucetola, R; Mollica, R				Weinstein, CS; Fucetola, R; Mollica, R			Neuropsychological issues in the assessment of refugees and victims of mass violence	NEUROPSYCHOLOGY REVIEW			English	Article						neuropsychology refugees/victims; mass violence	POSTTRAUMATIC-STRESS-DISORDER; WAR; TRAUMA; SURVIVORS; SEQUELAE; PRISONER; DEFICITS; TORTURE; MEMORY; PTSD	Brain injury, stressor severity, depression, premorbid vulnerabilities, and PTSD are frequently intertwined in trauma populations. This interaction is further complicated when the neuropsychologist evaluates refugees from other cultures. In addition, the observed psychiatric symptoms reported in refugees and victims of mass violence may in fact not be the primary features of PTSD and depression but psychiatric symptoms secondary to the effects of traumatic brain injury. This paper reviews the occurrence of starvation, torture, beatings, imprisonment, and other head injury experiences in refugee and POW populations to alert treators to the presence of chronic and persistent neuropsychiatric morbidity, with implications for psychosocial adjustment. The concept of fixed neural loss may also interact with environmental and emotional stresses, and a model of neuropsychological abnormalities triggered by traumatic events and influenced by subsequent stress will also be considered. Neuropsychologists working with refugees play an important role in assessing the possibility of traumatic brain injury with tools that are relatively culture-fair.	Harvard Univ, Dept Psychiat, Sch Med, Beth Israel Deaconess Hosp, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA; Harvard Univ, Sch Med, Harvard Refugee & Trauma Program, Boston, MA 02115 USA		Weinstein, CS (corresponding author), Harvard Univ, Dept Psychiat, Sch Med, Beth Israel Deaconess Hosp, East Campus,Rabb Bldg,2nd Floor, Boston, MA 02115 USA.						Adams J. H., 1992, GREENFIELDS NEUROPAT; ADAMS KM, 2000, M INT NEUR SOC DENV; Allden K, 1996, AM J PUBLIC HEALTH, V86, P1561, DOI 10.2105/AJPH.86.11.1561; [Anonymous], 1994, JAMA, V272, P391; Ardila A., 1992, HDB NEUROPSYCHOLOGIC, P181; Axelrod BN, 2000, CLIN NEUROPSYCHOL, V14, P344, DOI 10.1076/1385-4046(200008)14:3;1-P;FT344; Axelrod BN, 1997, J NEUROPSYCH CLIN N, V9, P23; Barona, 1991, SCHOOL PSYCHOL INT, V12, DOI [DOI 10.1177/0143034391121010, 10.1177/0143034391121010]; Bieliauskas LA, 2000, CLIN NEUROPSYCHOL, V14, P341, DOI 10.1076/1385-4046(200008)14:3;1-P;FT341; BREMNER JD, 1995, J TRAUMA STRESS, V8, P527, DOI 10.1002/jts.2490080403; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; BROWN L, 1990, TEST NONVERBAL INTEL; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; CASSIDAY KL, 1992, J TRAUMA STRESS, V5, P627, DOI 10.1007/BF00979230; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P443; CHRISTENSEN AL, 1998, J INT NEUROPSYCH SOC, V4, P212; CHRISTIANSON SA, 1984, SCAND J PSYCHOL, V25, P147, DOI 10.1111/j.1467-9450.1984.tb01007.x; CHRISTIANSON SA, 1991, COGNITION EMOTION, V5, P81, DOI 10.1080/02699939108411027; DELIA LF, 1996, TRAILS TEST PROFESSI; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A, P552; Dougherty D, 1997, HARVARD REV PSYCHIAT, V5, P138, DOI 10.3109/10673229709000299; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; EITENGER L, 1964, CONCENTRATION CAMP S; EITENGER L, 1973, MORTALITY MORBIDITY; FRIEDMAN MJ, 1989, J TRAUMATIC, V4, P67; FULD PA, 1982, FULD OBJECT MEMORY E; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Goodglass H, 1983, ASSESSMENT APHASIA R; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; GRONVIK O, 1962, J NEUROPSYCHIATRY, V4, P50; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; Hom J, 1997, ARCH CLIN NEUROPSYCH, V12, P531, DOI 10.1016/S0887-6177(97)00035-8; HOUGEN HP, 1988, FORENSIC SCI INT, V36, P153, DOI 10.1016/0379-0738(88)90229-0; JENSEN TS, 1982, NEW ENGL J MED, V307, P1341; KAPLAN E, 1991, WECHSLER ADULT INTEL; KEITEL MA, 1996, HDB MULTICULTURAL AS, P29; KING DA, 1996, NEUROPSYCHOLOGICAL A, P22; KLOVE H, 1974, CLIN NEUROPSYCHOLOGY; Krystal JH, 1995, MEMORY DISTORTION, P150; KRYSTAL JH, 1989, BEHAV THER, V20, P177, DOI 10.1016/S0005-7894(89)80068-1; Kulka RA, 1990, TRAUMA VIETNAM WAR G; LINDEM K, 2001, J INT NEUROPSYCH SOC, V7, P723; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MCGAUGH JL, 1989, ANNU REV NEUROSCI, V12, P255, DOI 10.1146/annurev.ne.12.030189.001351; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; MESULAM MM, 1985, PRINCIPLES BEHAVIORA, P86; Mollica RF, 1997, J AM ACAD CHILD PSY, V36, P1098, DOI 10.1097/00004583-199708000-00017; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; MOLLICA RF, 1997, J NERVOUS MENTAL S1, V180, P111; Nell V., 2000, CROSS CULTURAL NEURO; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PALUMBO C, 2001, J INT NEUROPSYCH SOC, V7, P723; PEREZARCE P, 1998, ECOLOGICAL VALIDITY, P283; PRIEBE S, 1997, J NERV MENT DIS, V185, P34; REITAN RM, 1969, UNPUB MANUAL ADM NEU; Rey A., 1941, EXAMEN CLIN PSYCHOL; Rosenstein LD, 1999, ARCH CLIN NEUROPSYCH, V14, P359, DOI 10.1016/S0887-6177(98)00026-2; Sack WH, 1997, J AM ACAD CHILD PSY, V36, P49, DOI 10.1097/00004583-199701000-00017; SAPOLSKY R, 1995, J NEUROSCI, V5, P1227; SAPOLSKY R, 1992, STRSS AGING BRAIN ME; SAPOLSKY RM, 1994, WHY ZEBRAS DONT GET, P172; SATZ P, 1997, 105 ANN CONV AM PSYC; Schacter D.L., 1995, MEMORY DISTORTION MI; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Shepherd I, 1999, J INT NEUROPSYCH SOC, V5, P83, DOI 10.1017/S1355617799511119; Shiang J, 1998, CLIN PSYCHOL-SCI PR, V5, P182, DOI 10.1111/j.1468-2850.1998.tb00143.x; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTIO; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; Sinnerbrink I, 1997, J PSYCHOL, V131, P463, DOI 10.1080/00223989709603533; Sue S., 1994, HDB PSYCHOTHERAPY BE, V12, P783; Sulway MR, 1996, NEUROLOGY, V46, P650, DOI 10.1212/WNL.46.3.650; SUTKER PB, 1990, PSYCHOL REP, V66, P912, DOI 10.2466/PR0.66.3.912-914; SUTKER PB, 1993, AM J PSYCHIAT, V150, P240; SUTKER PB, 1990, J PERS ASSESS, V54, P170, DOI 10.1207/s15327752jpa5401&2_17; SUTKER PB, 1989, J PSYCHOPATHOL BEHAV, V11, P185, DOI 10.1007/BF00960479; SUTKER PB, 1990, J CONSULT CLIN PSYCH, V58, P323, DOI 10.1037/0022-006X.58.3.323; THYGESEN P, 1970, DAN MED BULL, V17, P65; VANDERKOLK B, 1985, BIOL PSYCHIAT, V20, P314, DOI 10.1016/0006-3223(85)90061-7; VASTERLING J, 2001, J INT NEUROPSYCH SOC, V7, P155; Vasterling JJ, 1997, ASSESSMENT, V4, P51, DOI 10.1177/107319119700400107; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; VEGA WA, 1991, ANNU REV SOCIOL, V17, P351, DOI 10.1146/annurev.so.17.080191.002031; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; WAGENAAR WA, 1990, APPL COGNITIVE PSYCH, V4, P77, DOI 10.1002/acp.2350040202; WOLFE J, 1991, PSYCHOL ASSESSMENT J, V4, P573; Wolfson, 1993, HALSTEAD REITAN NEUR	98	21	21	1	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	SEP	2001	11	3					131	141		10.1023/A:1016650623996			11	Psychology, Clinical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	508TV	WOS:000173106400002	11795840				2022-02-06	
J	Laforce, R; Martin-MacLeod, L				Laforce, R; Martin-MacLeod, L			Symptom cluster associated with mild traumatic brain injury in university students	PERCEPTUAL AND MOTOR SKILLS			English	Article							HEAD-INJURY; POSTCONCUSSION SYNDROME; COLLEGE-STUDENTS; PREVALENCE; QUESTIONNAIRE; POPULATION; SAMPLE	There is growing recognition that even a minor blow to the head can have serious consequences on physical, cognitive, behavioral, and social well-being. Previous studies have indicated that such changes may in turn have a dramatic effect on the ability of university students to carry out their studies. This survey measured the prevalence of mild traumatic brain injury in a nonclinical population of 1,075 university students from all disciplines. In addition to surveying the nature, cause, and sex distribution, it further investigated the relationships between the physical, cognitive, behavioral, and social repercussions of the incidents. Results replicated earlier findings and indicated a prevalence rate of mild traumatic brain injury of 34.9% (n = 375). Moreover. significant correlations were found among the physical, cognitive, behavioral, and social changes reported by the students, suggesting a cluster of symptoms associated with such incidents, Altogether, these results suggest that even currently enrolled and active university students may face unique and subtle challenges related to a mild traumatic brain injury.	Univ New Brunswick, Dept Psychol, St John, NB E2L 4L5, Canada		Laforce, R (corresponding author), Univ New Brunswick, Dept Psychol, POB 5050, St John, NB E2L 4L5, Canada.			Laforce, Robert Jr/0000-0002-2031-490X			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Chan K M, 1984, Br J Sports Med, V18, P195; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CROVITZ HF, 1992, CORTEX, V28, P509, DOI 10.1016/S0010-9452(13)80160-8; FABIANO RJ, 1998, BRAIN INJURY, V14, P9; FITZGERALD DC, 1995, ARCH PHYS MED REHAB, V76, P1017, DOI 10.1016/S0003-9993(95)81041-2; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; HOLMES CB, 1991, PERCEPT MOTOR SKILL, V73, P497, DOI 10.2466/PMS.73.5.497-498; HOLMES CB, 1990, J POSTSECONDARY ED D, V8, P142; Hux D, 1998, BRAIN INJURY, V12, P667; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klonoff PS, 1998, CLIN NEUROPSYCHOL, V12, P31, DOI 10.1076/clin.12.1.31.1732; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MCBEATH JG, 1994, HEADACHE, V3, P148; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; POWELL BD, 1995, PERCEPT MOTOR SKILL, V81, P227, DOI 10.2466/pms.1995.81.1.227; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Triplett G, 1996, PERCEPT MOTOR SKILL, V83, P1344, DOI 10.2466/pms.1996.83.3f.1344; VARNEY NR, 1991, NEUROPSYCHOLOGY LAW, P24	29	21	21	0	1	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	AUG	2001	93	1					281	288		10.2466/PMS.93.5.281-288			8	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	484BF	WOS:000171669800043	11693696				2022-02-06	
J	Williams, KR; Galas, J; Light, D; Pepper, C; Ryan, C; Kleinmann, AE; Burright, R; Donovick, P				Williams, KR; Galas, J; Light, D; Pepper, C; Ryan, C; Kleinmann, AE; Burright, R; Donovick, P			Head injury and alexithymia: implications for family practice care	BRAIN INJURY			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Neuroscience	1998	NEW ORLEANS, LOUISIANA	Soc Neurosci			TRAUMATIC BRAIN INJURY; HEALTH-CARE; SCALE; PREVALENCE; DISORDERS; VALIDITY; DISEASE; ALCOHOL	Background: Alexithymia, a deficit in emotional information processing, and a history of head injury have both been found to be related to high rates of psychosomatic illness, substance abuse, depression, and utilization of primary care services. To date, no study has examined the potential comorbidity of alexithymia and head injury in a family practice setting, a necessary step in evaluating the aetiologic role of head injury in the development of alexithymia. The goals of this study are to establish prevalence of head injury and alexithymia in a family practice setting and to evaluate the relation, if present, between the two. Methods: Patients (n = 135) of a family practice residency facility were screened using the Traumatic Brain Injury Questionnaire and the Toronto Alexithymia Scale-20. Results: Forty-nine per cent of the participants reported a history of head injury and 18% were alexithymic. Those with a history of head injury had significantly higher scores of alexithymia. Chi-square analysis indicated a relation between head injury and alexithymia. Conclusions: The high rates of self-reported history of head injury in family practice settings, particularly in the context of alexithymia, may adversely affect a physician's ability to care for these patients. Increasing physicians' awareness of head injury and the potential mediating role of alexithymia in medical and psychological illness may facilitate effective diagnosis and patient-physician communication.	SUNY Binghamton, Dept Psychol, Mood & Depress Lab, Binghamton, NY 13902 USA; Wilson Family Practice Residency, New York, NY USA; SUNY Binghamton, Hlth Sci Ctr, Binghamton, NY USA		Williams, KR (corresponding author), SUNY Binghamton, Dept Psychol, Mood & Depress Lab, POB 6000, Binghamton, NY 13902 USA.						BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; BAGBY RM, 1988, PSYCHOTHER PSYCHOSOM, V50, P29; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLANCHARD EB, 1981, PSYCHOTHER PSYCHOSOM, V35, P64, DOI 10.1159/000287479; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Crane A. A., 1991, BEHAV RESIDENTIAL TR, V6, P65; *DEP ED, 1987, REHABILITATION TRAUM; DIRKS JF, 1981, PSYCHOTHER PSYCHOSOM, V36, P63, DOI 10.1159/000287527; ELLIOTT FA, 1984, NEUROL CLIN, V2, P113, DOI 10.1016/S0733-8619(18)31119-8; Gallacher JEJ, 1999, PSYCHOSOM MED, V61, P446, DOI 10.1097/00006842-199907000-00007; HAVILAND MG, 1996, J PEROSNAL ASSESSMEN, V66, P117; JESTE DV, 1988, BRIT J PSYCHIAT, V153, P444, DOI 10.1192/bjp.153.4.444; Joukamaa M, 1996, PSYCHOTHER PSYCHOSOM, V65, P199, DOI 10.1159/000289075; JOUKAMAA M, 1995, J PSYCHOSOM RES, V39, P833, DOI 10.1016/0022-3999(95)00020-1; KAPLAN SP, 1993, REHABIL COUNS BULL, V36, P151; Kauhanen J, 1996, J PSYCHOSOM RES, V41, P541, DOI 10.1016/S0022-3999(96)00226-7; KAUHANEN J, 1994, PSYCHOSOM MED, V56, P237, DOI 10.1097/00006842-199405000-00010; KENYON LW, 1991, CIRCULATION, V84, P1969, DOI 10.1161/01.CIR.84.5.1969; KRAUS JF, 1989, MILD HEAD INJURY, P8; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V13, P1; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Miller L., 1990, COGN REHABIL, V8, P14; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RYBAKOWSKI J, 1988, DRUG ALCOHOL DEPEN, V21, P133, DOI 10.1016/0376-8716(88)90058-0; Sifneos PE., 1994, NEW TRENDS EXP CLIN, V10, P193; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sosin DM, 1996, BRAIN INJURY, V10, P47; Taylor G. J., 1997, DISORDERS AFFECT REG; Taylor GJ, 1994, NEW TRENDS EXPT CLIN, V10, P61; WISE TN, 1988, PSYCHOTHER PSYCHOSOM, V50, P68, DOI 10.1159/000288102; [No title captured]	36	21	21	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2001	15	4					349	356		10.1080/026990501750111319			8	Neurosciences; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	420ZK	WOS:000168035000006	11299135				2022-02-06	
J	Glass, TF; Fabian, MJ; Schweitzer, JB; Weinberg, JA; Proctor, KG				Glass, TF; Fabian, MJ; Schweitzer, JB; Weinberg, JA; Proctor, KG			The impact of hypercarbia on the evolution of brain injury in a porcine model of traumatic brain injury and systemic hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Societies	MAY 01-04, 1999	SAN FRANCISCO, CA	Pediat Acad Soc		carbon dioxide; cerebral blood flow; cerebral metabolism; hemorrhagic shock; multiple trauma; resuscitation	CEREBRAL BLOOD-FLOW; HEAD-INJURY; RATS	Carbon dioxide is perhaps the most potent available modulator of cerebrovascular tone and thus cerebral blood flow (CBF). These experiments evaluate the impact of induced hypercarbia on the matching of blood flow and metabolism in the injured brain. We explore the hypothesis that hypercarbia will restore the relationship of CBF to metabolic demand, resulting in improved outcome following traumatic brain injury (TBI) and hemorrhage, A behavioral outcome score, hemodynamic, metabolic, and pathologic parameters were assessed in anesthetized and ventilated juvenile pigs, Animals were assigned to either normocarbia or hypercarbia and subdivided into TBI (via fluid percussion) with or without hemorrhage, The experimental groups were TBI; TBI + 40% hemorrhage (40%H); TBI + hypercarbia (CO2); and TBI + 40%H + CO2. Hemorrhaged animals were resuscitated with blood and crystalloid, Hypercarbia was induced immediately following TBI using 10% FiCO(2). The normocarbic group demonstrated disturbance of the matching of CBF to metabolism evidenced by statistically significant increases in cerebral oxygen and glucose extraction. Hypercarbic animals showed falls in the same parameters, demonstrating improvement in the matching of CBF to metabolic demand. Parenchymal injury was significantly decreased in hypercarbic animals: 3/10 hypercarbic versus 6/8 normocarbic animals showed cerebral contusions at the gray/white interface (p = 0.05). The hypercarbic group had significantly better behavioral outcome scores, 10.5, versus 7.3 for the normocarbic groups (p = 0.005). The decreased incidence of cerebral contusion and improved behavioral outcome scores in our experiments appear to be mediated by better matching of cerebral metabolism and blood flow, suggesting that manipulations modulating the balance of blood flow and metabolism in injured brain may improve outcomes from TBI.	Childrens Hosp, Med Ctr, Dept Pediat Emergency Med OSB4, Div Pediat Emergency Med, Cincinnati, OH 45229 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Anat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Neurobiol, Memphis, TN 38163 USA; Lebonheur Childrens Hosp & Med Ctr, Memphis, TN USA		Glass, TF (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat Emergency Med OSB4, Div Pediat Emergency Med, 3333 Burnett Ave, Cincinnati, OH 45229 USA.	glast0@chmcc.org	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628			Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Boswell WC, 1996, SOUTHERN MED J, V89, P218, DOI 10.1097/00007611-199602000-00012; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; DEDEYNE C, 1996, EUR J EMERG MED, V2, P69; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; HILTON DL, 1993, J NEUROTRAUM, V10, P121, DOI 10.1089/neu.1993.10.121; HOVDA DA, 1990, ACT NEUR S, V51, P331; KATSURA K, 1994, J CEREBR BLOOD F MET, V14, P243, DOI 10.1038/jcbfm.1994.31; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; KRISTIAN T, 1995, J CEREBR BLOOD F MET, V15, P78, DOI 10.1038/jcbfm.1995.9; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Marion D W, 1995, New Horiz, V3, P439; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856, DOI 10.1152/jappl.1980.49.5.856; MILLEN JE, 1983, J APPL PHYSIOL, V54, P666, DOI 10.1152/jappl.1983.54.3.666; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SIESJO BK, 1978, J NEURAL TRANSM-SUPP, V14, P17; SIKES PJ, 1994, CRIT CARE NURS Q, V1, P9; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Stoffel M, 1997, ACT NEUR S, V70, P91; UNTERBERG AW, 1997, J TRAUMA S, V5, pS32; Wei JN, 1998, BRAIN RES, V791, P146, DOI 10.1016/S0006-8993(98)00089-4	41	21	21	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2001	18	1					57	71		10.1089/089771501750055776			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	390EU	WOS:000166283400006	11200250				2022-02-06	
J	Rousseau, V; Sabel, BA				Rousseau, V; Sabel, BA			Restoration of vision IV: role of compensatory soma swelling of surviving retinal ganglion cells in recovery of vision after optic nerve crush	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						vision; plasticity; retinal ganglion cells; recovery of function; recovery of vision; ICON; contrast discrimination; neurotrauma; rat	AXONAL INJURY; CONTRAST-SENSITIVITY; SUBSEQUENT RECOVERY; TECTAL ABLATION; RESIDUAL VISION; VISUAL-CORTEX; BRAIN-DAMAGE; PLASTICITY; MODEL; RATS	Purpose: Diffuse axonal injury following partial optic nerve crush (ONC) leads to severe visual deficits from which rats can partially recover within 2-3 weeks, To evaluate the role of surviving retinal ganglion cells (RGCs) in recovery, we have observed their morphology repeatedly in vivo with ICON-microscopy and correlated cell size changes with recovery of vision which we observed in parallel in the same animals. Methods,, After rats had learned a visual contrast discrimination task using an automated, computer-based test, RGCs were labeled retrogradely with fluorescent beads. Animals then received either no lesion, a complete axotomy or bilateral mild, moderate or severe ONC, Before surgery and for 40 days post-operatively, RGC number and soma size was repeatedly quantified every five days with the in vivo confocal neuroimaging method (Sabel et al., Nature med, 3, 1997, p. 244). In parallel, visual function was quantified with the contrast-discrimination task, Results: After ONC about 70 % of the RGCs died after having undergone a fast and massive soma swelling. The extent of cell death was independend of crush severity, RGCs surviving the injury did not change their body size over time in the severe group and these animals also did not recover their vision, In contrast, after a mild or moderate crush, about half of the surviving RGCs experienced a slow and moderate, "compensatory" cell soma swelling and the rats showed partial recovery of vision. Both the number of RGC showing such compensatory soma swelling and the extent of the swelling correlated highly (r = 0.96) with recovery of contrast discrimination performance at post-operative days 23 and 38, Conclusions: Depending on the time course and extent, soma swelling after neurotrauma may be associated either with cell death or recovery of function, Because of the very high correlation between extent of recovery and amount of soma swelling, moderate soma swelling contributes in a prominent way to recovery of vision. We believe that these cells provide an important structural substrate for neuronal tissue repair and therefore term these cells "compensatory neurons".	Otto Von Guericke Univ, Inst Med Psychol, D-39120 Magdeburg, Germany		Sabel, BA (corresponding author), Otto Von Guericke Univ, Inst Med Psychol, Leipzigerstr 44, D-39120 Magdeburg, Germany.	Bernhard.Sabel@Medizin.Uni-Magdeburg.de	Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543			Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Berardi N, 1999, RESTOR NEUROL NEUROS, V15, P125; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; CASTANEDA E, 1990, J NEUROSCI, V10, P1847; Chino YM, 1999, RESTOR NEUROL NEUROS, V15, P165; Chino YM, 1995, CAN J PHYSIOL PHARM, V73, P1323, DOI 10.1139/y95-187; CHOW KL, 1972, EXP NEUROL, V34, P409, DOI 10.1016/0014-4886(72)90038-6; COWEY A, 1982, EXP BRAIN RES, V48, P149; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; Eysel UT, 1999, RESTOR NEUROL NEUROS, V15, P153; EYSEL UT, 1985, EXP NEUROL, V88, P757, DOI 10.1016/0014-4886(85)90086-X; FENDRICH R, 1992, SCIENCE, V258, P1489, DOI 10.1126/science.1439839; Finger S., 1982, BRAIN DAMAGE RECOVER; FLOHR AP, 1988, POST LESION NEURAL P; Freund HJ, 1997, BRAIN PLASTICITY; Frost DO, 1999, RESTOR NEUROL NEUROS, V15, P107; Galuske RAW, 1999, RESTOR NEUROL NEUROS, V15, P115; Gennarelli T.A., 1986, MECHANISMS SECONDARY, P15; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Grafstein B, 1978, NEURONAL PLASTICITY, P155; HARVEY LO, 1997, BEHAV RES METH INSTR, V18, P623; HEYWOD CA, 1988, EXP BRAIN RES, V70, P513; Innocenti GM, 1999, RESTOR NEUROL NEUROS, V15, P219; Inoue T, 2000, RESTOR NEUROL NEUROS, V17, P23; Kasten E, 1998, NAT MED, V4, P1083, DOI 10.1038/2079; Kasten E, 1999, RESTOR NEUROL NEUROS, V15, P273; Keller J, 2000, J NEUROSCI METH, V97, P103, DOI 10.1016/S0165-0270(00)00173-4; Kerkhoff G, 1999, RESTOR NEUROL NEUROS, V15, P255; Kreutz MR, 1998, J NEUROSCI, V18, P8278; Lashley KS, 1939, J COMP NEUROL, V70, P45, DOI 10.1002/cne.900700104; LAU KC, 1991, RESTOR NEUROL NEUROS, V3, P235, DOI 10.3233/RNN-1991-3502; LINDEN R, 1983, EXP BRAIN RES, V51, P368; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moore S, 1996, NEUROSCI LETT, V207, P117, DOI 10.1016/0304-3940(96)12500-3; MOORE T, 1995, P NATL ACAD SCI USA, V92, P8215, DOI 10.1073/pnas.92.18.8215; Payne BR, 1999, RESTOR NEUROL NEUROS, V15, P81; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Quan MZ, 1999, INVEST OPHTH VIS SCI, V40, P2360; Rousseau V, 1999, NEUROREPORT, V10, P3387, DOI 10.1097/00001756-199911080-00024; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P177; Sabel BA, 1997, NEUROSCIENTIST, V3, P366, DOI 10.1177/107385849700300609; Sabel BA, 1997, NAT MED, V3, P244, DOI 10.1038/nm0297-244; Sabel BA, 1997, ADV NEUROL, V73, P251; SABEL BA, 1995, EXP BRAIN RES, V106, P93; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; Schmitt U, 1996, J NEUROTRAUM, V13, P791, DOI 10.1089/neu.1996.13.791; Schmitt U, 1996, EXP NEUROL, V139, P17, DOI 10.1006/exnr.1996.0076; STEIN DG, 1983, BEHAV NEURAL BIOL, V37, P185, DOI 10.1016/S0163-1047(83)91216-5; STEWARD O, 1982, INT REV NEUROBIOL, V23, P197, DOI 10.1016/S0074-7742(08)60626-1; TABATA T, 1992, NEUROREPORT, V3, P709, DOI 10.1097/00001756-199208000-00015; THANOS S, 1995, J NEUROSCI, V15, P1057, DOI 10.1523/jneurosci.15-02-01057.1995; Werth R, 1999, RESTOR NEUROL NEUROS, V15, P229; Wessinger CM, 1999, RESTOR NEUROL NEUROS, V15, P243; Worgotter F, 1999, RESTOR NEUROL NEUROS, V15, P137	55	21	21	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2001	18	4					177	189					13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	525CK	WOS:000174049500005	11847441				2022-02-06	
J	Harry, GJ; d'Hellencourt, CL; Bruccoleri, A; Schmechel, D				Harry, GJ; d'Hellencourt, CL; Bruccoleri, A; Schmechel, D			Age-dependent cytokine responses: Trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						apolipoprotein E; GFAP; EB22; TNF alpha; MIP-1 alpha; TGF-beta 1	E-DEFICIENT MICE; NECROSIS-FACTOR-ALPHA; APOLIPOPROTEIN-E POLYMORPHISM; MOLECULE-1 GENE-EXPRESSION; ALZHEIMERS-DISEASE CERAD; DIFFERENT PLAQUE TYPES; CLOSED-HEAD INJURY; INTERFERON-GAMMA; MESSENGER-RNA; NERVOUS-SYSTEM	In this study, the hippocampal neurotoxicant trimethyltin (TMT) was used to examine possible differential susceptibility associated with the apolipoprotein E genotype. Mice-wild type (C57BL6J), APOE knockout, and APOE4 transgenic-received either saline or TMT (2 mg/kg, ip) at either 21 days or 8 months of age. At both ages, similar mRNA levels were seen in the hippocampus across genotypes for ICAM-1, A20, and MAC-I. GFAP mRNA was higher in the APOE knockouts and APOE4 as compared to wild-type mice. Within 24 h, TMT produced cell death of hippocampal dentate granule neurons and mild astrogliosis in all animals. In 21-day-old mice, TMT exposure significantly increased mRNA levels for ICAM-1 and MIP-1 alpha in all genotypes. EB-22, GFAP, TNF alpha, and TGF-beta1 levels were significantly elevated in both wild-type and APOE knockout mice following TMT. At 8 months of age, genotype specific differences were observed. mRNA levels for GFAP, TNF beta, TNF alpha, and MIP-1 alpha were increased in both APOE knockout and APOE4 mice compared to wild-type mice. TMT exposure significantly increased mRNA levels for GFAP and MIP-1 alpha in all animals. TNF alpha mRNA levels were increased in wild-type and APOE4 mice while EB22 mRNA levels were increased in both the APOE knockout and APOE4 mice but not wild-type mice. These data suggest an age-dependent effect on both microglia early inflammatory responses to injury associated with the APOE genotype. (C) 2000 Academic Press.	NIEHS, Neurotoxicol Grp, Toxicol Lab, Res Triangle Pk, NC 27709 USA; Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Dept Med Neurol, Durham, NC 27710 USA		Harry, GJ (corresponding author), NIEHS, Neurotoxicol Grp, Toxicol Lab, POB 12233, Res Triangle Pk, NC 27709 USA.		Harry, Gaylia Jean/AAC-1171-2022	Harry, Gaylia Jean/0000-0002-0829-7318	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES021154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005128] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5P50 AG-05128] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Y01-ES-40290] Funding Source: Medline		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ABRAHAM CR, 1992, RES IMMUNOL, V143, P631, DOI 10.1016/0923-2494(92)80047-O; Arvin B, 1995, ANN NY ACAD SCI, V765, P62, DOI 10.1111/j.1749-6632.1995.tb16561.x; Baskin F, 1997, J NEUROL SCI, V148, P15, DOI 10.1016/S0022-510X(96)05335-X; BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Boschert U, 1999, NEUROBIOL DIS, V6, P508, DOI 10.1006/nbdi.1999.0251; Bruccoleri A, 1999, J NEUROSCI RES, V57, P916, DOI 10.1002/(SICI)1097-4547(19990915)57:6<916::AID-JNR17>3.3.CO;2-A; Bruccoleri A, 1998, J NEUROCHEM, V71, P1577; BUTCHER EC, 1990, AM J PATHOL, V136, P3; Cacabelos R, 1996, ACTA NEUROL SCAND, V93, P72; CACABELOS R, 1996, METH FIND EXP CLI SA, V18, P161; CAMPBELL IL, 1994, J IMMUNOL, V152, P716; CHANG LW, 1982, NEUROBEH TOXICOL TER, V4, P149; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruts M, 1998, ANN MED, V30, P560, DOI 10.3109/07853899809002605; de Bont N, 1999, J LIPID RES, V40, P680; DELACOURTE A, 1990, NEUROLOGY, V40, P33, DOI 10.1212/WNL.40.1.33; DELREE P, 1993, BRAIN RES BULL, V30, P231, DOI 10.1016/0361-9230(93)90249-B; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Egensperger R, 1998, BRAIN PATHOL, V8, P439; EIKELENBOOM P, 1994, TRENDS PHARMACOL SCI, V15, P447, DOI 10.1016/0165-6147(94)90057-4; FINSEN BR, 1993, GLIA, V7, P41, DOI 10.1002/glia.440070109; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; FROHMAN EM, 1989, J NEUROIMMUNOL, V23, P117, DOI 10.1016/0165-5728(89)90030-1; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Higgins GA, 1997, PHARMACOL BIOCHEM BE, V56, P675, DOI 10.1016/S0091-3057(96)00420-0; HOBBS MV, 1993, J IMMUNOL, V150, P3602; Hogan B., 1994, MANIPULATING MOUSE E, V2nd ed.; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; Hull M, 1996, EUR ARCH PSY CLIN N, V246, P124, DOI 10.1007/BF02189112; Hyman BT, 1997, NEUROBIOL AGING, V18, pS27, DOI 10.1016/S0197-4580(97)00066-3; INGLIS JD, 1991, GENE, V106, P213, DOI 10.1016/0378-1119(91)90201-L; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; Kerr M E, 1998, AACN Clin Issues, V9, P524, DOI 10.1097/00044067-199811000-00007; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; LEFEBVRE PP, 1992, NEUROREPORT, V3, P295, DOI 10.1097/00001756-199204000-00001; Licastro F, 1998, J NEUROIMMUNOL, V88, P105, DOI 10.1016/S0165-5728(98)00096-4; Licastro F, 1999, AM J PATHOL, V155, P869, DOI 10.1016/S0002-9440(10)65186-3; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; MURPHY GM, 1995, J NEUROSCI RES, V40, P755, DOI 10.1002/jnr.490400607; Nakai M, 1996, NEUROSCI LETT, V211, P41, DOI 10.1016/0304-3940(96)12716-6; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; REUHL KR, 1983, NEUROTOXICOLOGY, V4, P19; ROGISTER B, 1993, J NEUROSCI RES, V34, P32, DOI 10.1002/jnr.490340105; Roselaar SE, 1998, J LIPID RES, V39, P1740; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; Saitoh T, 1997, GERONTOLOGY, V43, P109; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHMECHEL DE, 1999, ADV NEUROCHEM, V9, P215; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Sheng JG, 1996, NEUROPATH APPL NEURO, V22, P334, DOI 10.1111/j.1365-2990.1996.tb01112.x; SHRIKANT P, 1994, J NEUROIMMUNOL, V51, P209, DOI 10.1016/0165-5728(94)90083-3; SHRIKANT P, 1995, J IMMUNOL, V155, P1489; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TARDIFF B, 1994, CIRCULATION, V90, P201; Trieu VN, 2000, BIOCHEM BIOPH RES CO, V268, P835, DOI 10.1006/bbrc.2000.2205; UCHIHARA T, 1995, NEUROSCI LETT, V195, P5, DOI 10.1016/0304-3940(95)11763-M; Unger JW, 1998, MICROSC RES TECHNIQ, V43, P24, DOI 10.1002/(SICI)1097-0029(19981001)43:1<24::AID-JEMT4>3.0.CO;2-P; Xu PT, 1998, NEUROSCI LETT, V246, P65, DOI 10.1016/S0304-3940(98)00247-X; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023	80	21	21	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	DEC	2000	14	4					288	304		10.1006/brbi.2000.0606			17	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	388HE	WOS:000166174100005	11120597				2022-02-06	
J	Leoni, MJ; Chen, XH; Mueller, AL; Cheney, J; McIntosh, TK; Smith, DH				Leoni, MJ; Chen, XH; Mueller, AL; Cheney, J; McIntosh, TK; Smith, DH			NPS 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat	EXPERIMENTAL NEUROLOGY			English	Article						brain trauma; fluid percussion; hippocampus; memory; NMDA; NPS 1506	CONTROLLED CORTICAL IMPACT; REGIONAL CEREBRAL EDEMA; D-ASPARTATE RECEPTORS; CLOSED-HEAD INJURY; SELECTIVE VULNERABILITY; NMDA ANTAGONIST; DAMAGE; HYPOTHERMIA; ISCHEMIA; MK-801	Although several noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists have been shown to be substantially efficacious in experimental models of brain trauma, side effects associated with this class of compounds have impeded clinical application. Therefore, new noncompetitive NMDA receptor antagonists have been developed, including NPS 1506, that appear to be nontoxic but retain efficacy. In the present study, we evaluated the efficacy of NPS 1506 in a model of parasagittal fluid percussion brain trauma in the anesthetized rat. Administration of 1 mg/kg NPS 1506 at both 10 min and 4 h posttrauma induced no changes in brain temperature, mean arterial pressure, pulse, or arterial blood gasses. At 1 week postinjury, animals treated with the same dosing regimen of NPS 1506 demonstrated a dramatic attenuation of memory dysfunction evaluated by a water maze task (P < 0.02) and had greatly reduced neuron death in the CA3 subfield of the hippocampus (P < 0.01). However, NPS 1506 treatment did not significantly affect the extent of cortical tissue loss following injury. Since memory dysfunction and hippocampal damage are common and potentially related consequences of brain trauma in humans, our results suggest that NPS 1506 treatment may have clinical utility. (C) 2000 Academic Press.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; NPS Pharmaceut Inc, Salt Lake City, UT USA		Leoni, MJ (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.		smith, douglas/A-1321-2007		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, P01NS008803, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, NS38104] Funding Source: Medline		Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Brady EM, 1998, NEUROLOGY, V50, pA346; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BUCHAN A, 1990, J NEUROSCI, V10, P311; CHOI DW, 1987, J NEUROSCI, V7, P369; CORBETT D, 1990, BRAIN RES, V514, P300, DOI 10.1016/0006-8993(90)91424-F; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; FADEN AI, 1989, SCIENCE, V244, P789; GRAHAM DI, 1993, HEAD INJURY, P91; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KIMELBERG HK, 1982, HEAD INJURY BASIC CL, P31; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; LEVIN HS, 1985, STATUS REPORT CENTRA, P281; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1986, NEUROSCI LETT, V68, P29, DOI 10.1016/0304-3940(86)90224-7; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P316; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Smith D H, 1995, New Horiz, V3, P562; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SMITH SA, 1993, P AQUACULTURE ASS CA, V10, P62; Soares HD, 1995, J NEUROSCI, V15, P8223; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	57	21	21	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	DEC	2000	166	2					442	449		10.1006/exnr.2000.7513			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	380PB	WOS:000165709300024	11085909				2022-02-06	
J	Maughan, PH; Scholten, KJ; Schmidt, RH				Maughan, PH; Scholten, KJ; Schmidt, RH			Recovery of water maze performance in aged versus young rats after brain injury with the impact acceleration model	JOURNAL OF NEUROTRAUMA			English	Article						aging; cholinergic neurons; impact acceleration injury; traumatic brain injury; water maze	SPATIAL MEMORY PERFORMANCE; CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION INJURY; LONG-TERM POTENTIATION; FOREBRAIN CHOLINERGIC NEURONS; COGNITIVE IMPAIRMENT; ANTICHOLINERGIC SENSITIVITY; ACETYLCHOLINE SYNTHESIS; GLUTAMATE RECEPTORS; EVOKED RELEASE	Clinically, elderly patients have a higher cognitive morbidity from head trauma than young patients. We have modeled injury in aged rats in an effort to elucidate the pathophysiology of this enhanced sensitivity and, in particular, to determine if there are susceptibility differences in forebrain cholinergic innervation in young versus aged rats. Aged (20-23 months) and young (2-3 months) rats were subjected to injury under halothane anesthesia using the Marmarou impact acceleration model. Injury parameters required adjustment downward for the aged rats (323 g at 1.61 m versus 494 g at 2.06 m) to provide equivalent mortality (30% versus 20%) and loss of righting-reflex times (10-12 min average). At 1 week following injury, the aged animals were markedly more impaired in water maze performance than were young rats, and this difference persisted at least up to 5 weeks following injury, The extent of improvement in performance from 1 to 5 weeks was markedly worse for aged animals compared to young animals, Forebrain synaptosomal choline uptake was decreased in aged injured rats by 8-14% at 1, 3, and 5 weeks postinjury, but not decreased in young injured rats. No differences were noted in entorhinal cortex or hippocampal choline uptake. This model effectively demonstrates the markedly increased susceptibility of older animals to head injury and their decreased capacity for recovery. The neurophysiological basis for this difference is presently unknown, but the differences in cognitive dysfunction between young and aged rats appears to be much greater than would seem to be explained by the small differences in forebrain cholinergic innervation.	Univ Utah, Dept Neurosurg, Salt Lake City, UT 84132 USA		Schmidt, RH (corresponding author), Univ Utah, Dept Neurosurg, 50 N Med Dr, Salt Lake City, UT 84132 USA.	rhs@suzy.med.utah.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 01866] Funding Source: Medline		ABDULLA FA, 1995, NEUROBIOL AGING, V16, P41, DOI 10.1016/0197-4580(95)80006-D; Baxter MG, 1999, NEUROSCIENCE, V89, P771, DOI 10.1016/S0306-4522(98)00374-1; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Colombo PJ, 1998, NEUROBIOL LEARN MEM, V70, P314, DOI 10.1006/nlme.1998.3857; COOPER JR, 1994, J NEUROCHEM, V63, P395; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dawson R, 1999, BRAIN RES BULL, V48, P319, DOI 10.1016/S0361-9230(99)00003-9; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; FISCHER W, 1992, NEUROBIOL AGING, V13, P9, DOI 10.1016/0197-4580(92)90003-G; Flood JF, 1998, MECH AGEING DEV, V105, P173, DOI 10.1016/S0047-6374(98)00098-0; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Granger R, 1996, SYNAPSE, V22, P332, DOI 10.1002/(SICI)1098-2396(199604)22:4<332::AID-SYN4>3.0.CO;2-C; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hersi AI, 2000, MOL BRAIN RES, V76, P336, DOI 10.1016/S0169-328X(00)00015-2; INGRAM DK, 1994, LIFE SCI, V55, P2037, DOI 10.1016/0024-3205(94)00384-X; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JOPE RS, 1979, BRAIN RES REV, V1, P313, DOI 10.1016/0165-0173(79)90009-2; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lanahan A, 1997, J NEUROSCI, V17, P2876; LAPCHAK PA, 1988, J NEUROCHEM, V50, P58, DOI 10.1111/j.1471-4159.1988.tb13229.x; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Magnusson KR, 1998, MECH AGEING DEV, V104, P227, DOI 10.1016/S0047-6374(98)00076-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; MEYER EM, 1984, NEUROBIOL AGING, V5, P315, DOI 10.1016/0197-4580(84)90008-3; Meyer RC, 1998, ANN NY ACAD SCI, V854, P307, DOI 10.1111/j.1749-6632.1998.tb09911.x; NILSSON OG, 1993, NEUROBIOL AGING, V14, P487, DOI 10.1016/0197-4580(93)90107-M; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Sarter M, 1998, BRAIN RES REV, V27, P143, DOI 10.1016/S0165-0173(98)00003-4; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shukitt-Hale B, 1998, EXP GERONTOL, V33, P615, DOI 10.1016/S0531-5565(98)00024-2; SIMON JR, 1976, J NEUROCHEM, V26, P909, DOI 10.1111/j.1471-4159.1976.tb06472.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stemmelin J, 2000, NEUROSCIENCE, V96, P275, DOI 10.1016/S0306-4522(99)00561-8; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	60	21	22	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2000	17	12					1141	1153		10.1089/neu.2000.17.1141			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	379MB	WOS:000165644900003	11186228				2022-02-06	
J	Feinstein, A; Rapoport, M				Feinstein, A; Rapoport, M			Mild traumatic brain injury: The silent epidemic	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article							RANDOMIZED CONTROLLED TRIAL; ROUTINE FOLLOW-UP		Univ Toronto, Sunnybrook & Womens Coll, Ctr Hlth Sci, Dept Psychiat,Dept Neuropsychiat, Toronto, ON M4N 3M5, Canada		Feinstein, A (corresponding author), Univ Toronto, Sunnybrook & Womens Coll, Ctr Hlth Sci, Dept Psychiat,Dept Neuropsychiat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.		Rapoport, Mark/AAD-8581-2020				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BERROL S, 1992, PHYSICAL MED REHABIL, V6, P1; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; GRONWALL D, 1975, LANCET, V2, P995; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; MCCULLAGH S, 2000, IN PRESS ANN M AM PS; *SMART RISK MIN HL, 1999, EC BURD UN INJ ONT; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; [No title captured]	12	21	21	0	0	CANADIAN PUBLIC HEALTH ASSOC	OTTAWA	1565 CARLING AVE, SUITE 400, OTTAWA, ONTARIO K1Z 8R1, CANADA	0008-4263			CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	SEP-OCT	2000	91	5					325	326		10.1007/BF03404799			2	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	373JN	WOS:000165286000002	11089281	Green Published, Bronze			2022-02-06	
J	Bauman, RA; Widholm, JJ; Petras, JM; McBride, K; Long, JB				Bauman, RA; Widholm, JJ; Petras, JM; McBride, K; Long, JB			Secondary hypoxemia exacerbates the reduction of visual discrimination accuracy and neuronal cell density in the dorsal lateral geniculate nucleus resulting from fluid percussion injury	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion injury; secondary hypoxemia; visual discrimination	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; COGNITIVE DEFICITS; MEMORY DYSFUNCTION; OXIDATIVE STRESS; NERVOUS-SYSTEM; RATS; HYPOXIA; HIPPOCAMPUS	The purpose of this study was to determine the impact of secondary hypoxemia on visual discrimination accuracy after parasagittal fluid percussion injury (FPI). Rats lived singly in test cages, where they were trained to repeatedly execute a flicker-frequency visual discrimination for food. After learning was complete, all rats were surgically prepared and then retested over the following 4-5 days to ensure recovery to presurgery levels of performance. Rats were then assigned to one of three groups [FPI + Hypoxia (IPI), FPI + Normoxia (IN), or Sham Injury + Hypoxia (SH)] and were anesthetized with halothane delivered by compressed air. Immediately after injury or sham injury, rats in groups IH and SH were switched to a 13% O-2 source to continue halothane anesthesia for 30 min before being returned to their test cages. Anesthesia for rats in group IN was maintained using compressed air for 30 min after injury. FPI significantly reduced visual discrimination accuracy and food intake, and increased incorrect choices. Thirty minutes of immediate posttraumatic hypoxemia significantly (1) exacerbated the PBI-induced reductions of visual discrimination accuracy and food intake, (2) further increased numbers of incorrect choices, and (3) delayed the progressive recovery of visual discrimination accuracy. Thionine stains of midbrain coronal sections revealed that, in addition to the loss of neurons seen in several thalamic nuclei following FPI, cell loss in the ipsilateral dorsal lateral geniculate nucleus (dLG) was significantly greater after FPI and hypoxemia than after FPI alone. In contrast, neuropathological changes were not evident following hypoxemia alone. These results show that, although hypoxemia alone was without effect, posttraumatic hypoxemia exacerbates FPI-induced reductions in visual discrimination accuracy and secondary hypoxemia interferes with control of the rat's choices by flicker frequency, perhaps in part as a result of neuronal loss and fiber degeneration in the dLG. These results additionally confirm the utility of this visual discrimination procedure as a sensitive, noninvasive means of assessing behavioral function after experimental traumatic brain injury.	Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Div Neurosci, Washington, DC 20307 USA; Univ Illinois, Dept Vet Med, Urbana, IL 61801 USA; American Univ, Dept Psychol, Washington, DC 20016 USA		Bauman, RA (corresponding author), Dept Neurobehav Assessment, Div Neurosci, Washington, DC 20307 USA.	richard.bauman@na.amedd.army.mil					Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BAUMAN R, 1991, J EXP ANAL BEHAV, V56, P33, DOI 10.1901/jeab.1991.56-33; Bauman RA, 1996, J EXP ANAL BEHAV, V65, P401, DOI 10.1901/jeab.1996.65-401; Bauman RA, 1998, PHYSIOL BEHAV, V64, P507, DOI 10.1016/S0031-9384(98)00102-4; BAUMAN RA, 1995, PHYSIOL BEHAV, V57, P1187, DOI 10.1016/0031-9384(95)00038-K; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1997, NEUROL EMERG, V15, P581; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; COHEN N, 1994, MEMORY AMNESIA HIPPO; Cooper R M, 1995, Int J Neurosci, V81, P27, DOI 10.3109/00207459509015296; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Fix AS, 1996, TOXICOL PATHOL, V24, P291, DOI 10.1177/019262339602400305; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KITA H, 1994, ACTA NEUROCHIR, P452; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; LAEMLE LK, 1986, NEUROSCI LETT, V63, P207, DOI 10.1016/0304-3940(86)90357-5; LEMAGNEN J, 1983, PHYSIOL REV, V63, P314, DOI 10.1152/physrev.1983.63.1.314; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McIntosh TK, 1996, LAB INVEST, V74, P315; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Ross JF, 1996, BRAIN RES, V725, P137; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SWANSON LW, 1996, BRAIN MAPS STRUCTURE; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Tobe EH, 1999, J NEUROPSYCH CLIN N, V11, P504, DOI 10.1176/jnp.11.4.504; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	59	21	21	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2000	17	8					679	693		10.1089/089771500415427			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	347WF	WOS:000088951600005	10972244				2022-02-06	
J	Hegel, MT; Ferguson, RJ				Hegel, MT; Ferguson, RJ			Differential reinforcement of other behavior (DRO) to reduce aggressive behavior following traumatic brain injury	BEHAVIOR MODIFICATION			English	Article								Severe brain injury can result in significant neurobehavioral and social functioning impairment. In rehabilitation settings, behavioral problems of aggression and nonadherence to therapeutic activities can pose barriers to maximal recovery of function. Behavioral interventions seem to be effective in reducing problem behavior among individuals recovering from severe brain trauma. but well-controlled studies examining the efficacy of such interventions are sparse. This article presents a single-case. multiple-baseline study of a differential reinforcement of other behavior (DRO) procedure in a 28-year-old, brain-injured male with aggressive behavior problems. The procedure successfully reduced the frequency of problem behavior by up to 74%, maintained at 1-month follow-up. Implications of this intervention for individuals with brain injury are discussed, and testing of this procedure using a between-group design seems indicated.	Dartmouth Med Sch, Lebanon, NH 03756 USA		Hegel, MT (corresponding author), Dartmouth Med Sch, Lebanon, NH 03756 USA.						Annoni J M, 1992, Disabil Rehabil, V14, P23; CALLON EB, 1995, HDB HLTH REHABILITAT; Chambless DL, 1996, CLIN PSYCHOL-SCI PR, V3, P230, DOI 10.1111/j.1468-2850.1996.tb00074.x; CHAMBLESS DL, 1994, TREATMENT PANIC DISO, P248; FOSTER K, 1988, COGNITIVE REHABILITA, V6, P16; GOLDSTEIN LH, 1985, BRIT J CLIN PSYCHOL, V24, P13, DOI 10.1111/j.2044-8260.1985.tb01309.x; GOUVIER WD, 1985, ARCH PHYS MED REHAB, V66, P113; Hegel M T, 1988, Brain Inj, V2, P333, DOI 10.3109/02699058809150904; HERSEN M, 1983, SINGLE CASE EXPT DES; *MED DIS SOC GREAT, 1988, MAN TRAUM BRAIN INJ; PAGE TJ, 1992, BEHAV RES TREAT, V7, P169; Van Hasselt V. B., 1996, SOURCEBOOK PSYCHOL T	12	21	21	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0145-4455			BEHAV MODIF	Behav. Modificat.	JAN	2000	24	1					94	101		10.1177/0145445500241005			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	271TM	WOS:000084609600005	10641369				2022-02-06	
J	Jiang, XB; Ohno, K; Qian, L; Tominaga, B; Kuroiwa, T; Nariai, T; Hirakawa, K				Jiang, XB; Ohno, K; Qian, L; Tominaga, B; Kuroiwa, T; Nariai, T; Hirakawa, K			Changes in local cerebral blood flow, glucose utilization, and mitochondrial function following traumatic brain injury in rats	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						brain injury; cerebral blood flow; cerebral glucose utilization; lateral fluid percussion injury; mitochondria; succinate dehydrogenase	TOMOGRAPHY	The pathophysiology of secondary brain damage following experimental traumatic brain injury was investigated by measuring local cerebral blood flow (ICBF), local cerebral glucose utilization (lCGU), and activity of succinate dehydrogenase (SDH), which Is a mitochondrial enzyme of the tricarboxylic acid cycle, in the rat brain after moderate lateral fluid percussion injury. Measurements used autoradiography for lCBF and lCGU with [C-14]iodoantipyrine and [C-14]2-deoxyglucose, respectively. Regional SDH activity was determined using quantitative imaging of formazan produced from 2,3,5-triphenyl tetrazolium chloride by SDH. lCBF decreased at 1 hour after injury and was significantly lower than the preinjury level in almost all regions of both hemispheres at 6 and 24 hours, and remained low at 2 weeks. lCGU increased 1 hour after injury but was significantly decreased at 6 and 24 hours, and at 2 weeks in most regions of both hemispheres. The ipsilateral hemisphere showed a significant decrease in the activity of SDH in the cortices, hippocampus, thalamus, and caudate/putamen, most conspicuously 72 hours after injury, whereas no significant decrease was observed in the contralateral hemisphere at any time. Necrosis in the injured cortex and reduction of the number of neurons in the ipsilateral hippocampus were observed 2 weeks after injury. The present study showed that a decrease in lCBF and mitochondrial dysfunction occur with glucose hypermetabolism around 1 hour after lateral fluid percussion injury, and that lCBF, lCGU, and mitochondrial function all deteriorate after 6 hours. This suggests that ICBF and cellular metabolism may change dynamically during the several hours following traumatic brain injury, and afterwards neuronal damage may result in an irreversible change in the areas with depressed glucose hypermetabolism in the early period after injury in combination with mitochondrial dysfunction.	Tokyo Med & Dent Univ, Dept Neurosurg, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Dept Neuropathol, Bunkyo Ku, Tokyo 1138519, Japan		Ohno, K (corresponding author), Tokyo Med & Dent Univ, Dept Neurosurg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DEWITT DS, 1992, J NEUROSURG, V67, P110; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1995, J NEUROSURG, V82, pA376; INGLIS FM, 1990, ACT NEUR S, V51, P277; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; Kuroiwa T, 1996, NEUROSCI LETT, V206, P117, DOI 10.1016/S0304-3940(96)12439-3; LEWEN A, 1988, J NEUROTRAUM, V15, P521; MATHEW P, 1994, ACTA NEUROCHIR, P428; Nakamura T, 1987, Neurol Med Chir (Tokyo), V27, P396, DOI 10.2176/nmc.27.396; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Qian Liang, 1996, Bulletin of Tokyo Medical and Dental University, V43, P53; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SHAR K, 1983, NEUROSCI LETT, V40, P287; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	32	21	21	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2000	40	1					16	28		10.2176/nmc.40.16			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	275WX	WOS:000084844100002	10721252	Bronze			2022-02-06	
J	Kolakowsky-Hayner, SA; Kreutzer, JS; Miner, KD				Kolakowsky-Hayner, SA; Kreutzer, JS; Miner, KD			Validation of the Service Obstacles Scale for the traumatic brain injury population	NEUROREHABILITATION			English	Article						service obstacles; traumatic brain injury; family needs; life quality	FAMILY NEEDS; RELATIVES; LIFE	Traumatic brain injury is a leading cause of death and disability iii the United States. Limited access to specialized medical and rehabilitation services has been linked to poor outcomes. Literature provides little guidance for assessment of service obstacles and satisfaction with community resources. The present investigation describes the development of a specialized scale to evaluate caregivers' perceptions of brain injury services in the community. Results indicate good internal consistency and criterion-related validity of the Service Obstacles Scale. Lack of money for services and lack of adequate community resources were the greatest concerns voiced by respondents, while lack of transportation was the least problematic. Comparisons are made with regard to family needs and respondents' post-injury life quality. Implications for future research are discussed.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Kolakowsky-Hayner, SA (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			BARNES BL, 1997, INDIAN J PSYCHOMETRY, V26, P1; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BUNTING K, 1997, RATIONAL DISABILITY; Campbell C H, 1988, Rehabil Nurs, V13, P320; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Engli M, 1993, J Neurosci Nurs, V25, P78; Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; MARWITZ JH, SERVICE OBSTACLES SC; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MINTZ MC, 1995, BRAIN INJURY, V9, P173, DOI 10.3109/02699059509008190; MOLTER NC, 1979, HEART LUNG, V8, P332; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; 2000, J HEAD TRAUMA REHABI, V15, P750	25	21	21	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2000	14	3					151	158					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357PD	WOS:000089509300004	11455077				2022-02-06	
J	Prieto, M; Chauvet, N; Alonso, G				Prieto, M; Chauvet, N; Alonso, G			Tanycytes transplanted into the adult rat spinal cord support the regeneration of lesioned axons	EXPERIMENTAL NEUROLOGY			English	Article						glial cells; cell culture; regeneration; astrocyte; immunocytochemistry	ENSHEATHING GLIA TRANSPLANTS; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; MEDIOBASAL HYPOTHALAMUS; NEURITE OUTGROWTH; ASTROCYTES; CELLS; NEURONS; INJURY; BRAIN	During past years a number of therapeutic strategies have been developed in order to stimulate axonal regeneration after traumatic injuries of the spinal cord. Recently, encouraging data have been obtained by grafting specific glial cells such as Schwann cells or olfactory ensheathing glial cells, known to support the regeneration of peripheral or central axons, respectively. In a recent series of studies, we have shown that tanycytes, a particular glial cell type present in the mediobasal hypothalamus, were able to support the regeneration of a variety of axons innervating this region. The aim of the present study was to determine whether tanycytes could also support the regeneration of lesioned spinal axons. Cultured hypothalamic tanycytes and cortical astrocytes were prelabeled with Fast blue (FB) and grafted into the thoracic spinal cord of adult rats. Three weeks after the transplantation, the animals were fixed and spinal cord sections treated for multiple fluorescence detection of the FB-labeled transplanted cells on the one hand and of various glial and neuronal markers on the other hand. We show here that in all the spinal cords examined, transplanted tanycytes or astrocytes formed large spherical clusters of about 0.5 mm in diameter, located in the mediolateral spinal cord layer. The immunodetection of glial markers showed that transplanted astrocytes exhibited intense immunostaining for both glial fibrillary acidic protein (GFAP) and vimentin (VIM), whereas transplanted tanycytes were intensely immunostained for VIM, but GFAP negative. The immunodetection of axonal markers showed that contrasting with astrocyte transplants, tanycyte transplants were invaded by numerous axonal fibers. These data indicate that tanycyte transplants may represent a useful therapeutic tool for the reparation of the lesioned spinal axons. (C) Academic Press.	Univ Montpellier, INSERM, U336, Montpellier 5, France		Prieto, M (corresponding author), Univ Montpellier, INSERM, U336, Montpellier 5, France.		Chauvet, Norbert/D-7333-2016	Chauvet, Norbert/0000-0003-4388-6422			Aguado A, 1982, ADV CELL NEUROBIOL, V3, P215; ALONSO G, 1993, J NEUROSCI RES, V34, P510, DOI 10.1002/jnr.490340504; BODEGA G, 1990, ANAT EMBRYOL, V181, P567; Carbonetto S, 1991, Curr Opin Neurobiol, V1, P407, DOI 10.1016/0959-4388(91)90062-C; CHAUVET N, 1995, J NEUROSCI RES, V41, P129, DOI 10.1002/jnr.490410115; Chauvet N, 1996, GLIA, V18, P211, DOI 10.1002/(SICI)1098-1136(199611)18:3<211::AID-GLIA5>3.0.CO;2-1; Chauvet N, 1998, EXP NEUROL, V151, P1, DOI 10.1006/exnr.1998.6784; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; DANIEL PM, 1970, ACTA ENDOCRINOL-COP, V64, P696, DOI 10.1530/acta.0.0640696; DELLMANN HD, 1973, INT REV CYTOL, V36, P215, DOI 10.1016/S0074-7696(08)60219-3; GIBSON SJ, 1984, J NEUROSCI, V4, P3101, DOI 10.1523/jneurosci.04-12-03101.1984; GUENARD V, 1992, J NEUROSCI, V12, P3310; HOKFELT T, 1976, MED BIOL, V54, P427; Kikuchi Kenji, 1993, Neurologia Medico-Chirurgica, V33, P682, DOI 10.2176/nmc.33.682; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 1998, J NEUROSCI, V18, P10514; Martin D, 1996, J NEUROSCI RES, V45, P588; MILLER RH, 1986, J NEUROCYTOL, V15, P187, DOI 10.1007/BF01611655; NONA SN, 1995, J NEUROSCI RES, V42, P350, DOI 10.1002/jnr.490420309; ONTENIENTE B, 1983, J COMP NEUROL, V215, P427, DOI 10.1002/cne.902150407; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Prieto M, 1999, EXP NEUROL, V155, P118, DOI 10.1006/exnr.1998.6970; RAISMAN G, 1973, J COMP NEUROL, V147, P181, DOI 10.1002/cne.901470204; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Reier P., 1983, SPINAL CORD RECONSTR, P163; REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302; REIER PJ, 1983, DEV BRAIN RES, V10, P201, DOI 10.1016/0165-3806(83)90137-2; REIER PJ, 1988, ADV NEUROLOGY FUNCTI, P163; SASAKI H, 1981, J COMP NEUROL, V198, P13, DOI 10.1002/cne.901980104; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; SMITH GM, 1990, DEV BIOL, V138, P377, DOI 10.1016/0012-1606(90)90204-V; SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; WUNDERLICH G, 1994, GLIA, V10, P49, DOI 10.1002/glia.440100107; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; YAMADA H, 1995, ZOOL SCI, V12, P325, DOI 10.2108/zsj.12.325; ZEMAN W, 1963, CRAIGIES NEUROANATOM, P50; Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479; ZOTTOLI SJ, 1994, NEURAL REGEN, P219	44	21	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2000	161	1					27	37		10.1006/exnr.1999.7223			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	290FU	WOS:000085666300003	10683271				2022-02-06	
J	Goksoy, EO; McKinstry, LJ; Wilkins, LJ; Parkman, I; Phillips, A; Richardson, RI; Anil, MH				Goksoy, EO; McKinstry, LJ; Wilkins, LJ; Parkman, I; Phillips, A; Richardson, RI; Anil, MH			Broiler stunning and meat quality	POULTRY SCIENCE			English	Article						electrical stunning; concussion stunning; broiler meat quality	BROKEN BONES; CHICKENS; BREAST; TENDERNESS	The effects of electrical and concussion stunning on meat and carcass quality of broilers were compared. Broiler chickens (n = 165) were subjected to treatments: 1) electrical stunning with no fibrillation, 2) electrical stunning with fibrillation, 3) concussion stunning with restraint, or 4) concussion stunning with no restraint. Electrical stunning (100 V, 80 mA, 50 Hz sinusoidal waveform alternating current) was applied for 3 s. Concussion was applied using a nonpenetrative captive bolt gun with or without restraint. We assessed broken bones, hemorrhages, meat quality defects, blood loss, pH at 10 min and 24 h, and texture from breasts filleted 3 h and 24 h postmortem. Electrically stunned birds showed a significantly higher incidence of broken bones (P < 0.0001), coracoid and furculum bone hemorrhages (P < 0.0001), and nonbone hemorrhages (P < 0.0001) than birds stunned by concussion. However, the incidence of red wing tips (P < 0.005) and shoulder hemorrhages was significantly higher (P < 0.05) in concussion-stunned birds than electrically stunned birds. Electrically stunned and nonfibrillated birds had the fastest blood loss rate. The pH value at 10 min was the lowest in concussion-stunned and unrestrained birds. Breast muscles from concussion-stunned birds that were filleted at 3 h postmortem were more tender than those from birds stunned electrically (P < 0.05). We concluded that concussion stunning could be advantageous for early filleting.	Univ Bristol, Dept Vet Clin Sci, Bristol BS40 5DU, Avon, England		Anil, MH (corresponding author), Univ Bristol, Dept Vet Clin Sci, Bristol BS40 5DU, Avon, England.		Goksoy, Ergun O/J-7267-2013; Goksoy, Ergun/AAX-9668-2021	Goksoy, Ergun O/0000-0001-9165-5894; 			BILGILI SF, 1992, J APPL POULTRY RES, V1, P135; BLACKMORE DK, 1979, VET REC, V20, P372; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; DAVIS LL, 1954, POULTRY SCI, V33, P616, DOI 10.3382/ps.0330616; GREGORY NG, 1989, J SCI FOOD AGR, V47, P13, DOI 10.1002/jsfa.2740470103; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P59, DOI 10.1080/00071669008417231; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P53, DOI 10.1080/00071669008417230; GREGORY NG, 1990, VET REC, V126, P570; GREGORY NG, 1989, VET REC, V124, P530, DOI 10.1136/vr.124.20.530; GREGORY NG, 1987, TURKEYS, V35, P19; GREGORY NG, 1989, PROCESSING POULTRY, P31; HARRIS CE, 1977, POULTRY SCI, V56, P1827, DOI 10.3382/ps.0561827; Hillebrand SJW, 1996, POULTRY SCI, V75, P664, DOI 10.3382/ps.0750664; KETTLEWELL PJ, 1990, J AGR ENG RES, V47, P139, DOI 10.1016/0021-8634(90)80036-T; KHAN AW, 1970, J FOOD SCI, V35, P266, DOI 10.1111/j.1365-2621.1970.tb12157.x; KOTULA AW, 1966, POULTRY SCI, V45, P404, DOI 10.3382/ps.0450404; LYON CE, 1985, POULTRY SCI, V64, P307, DOI 10.3382/ps.0640307; NEWELL GW, 1950, POULTRY SCI, V29, P271, DOI 10.3382/ps.0290271; PAPINAHO PA, 1995, POULTRY SCI, V74, P1533, DOI 10.3382/ps.0741533; RAJ ABM, 1992, VET REC, V130, P325, DOI 10.1136/vr.130.15.325; SMITH MC, 1969, J FOOD SCI, V34, P42, DOI 10.1111/j.1365-2621.1969.tb14358.x; VEERKAMP CH, 1988, POULT MISSET     JUN, P30; Wabeck C., 1988, Poultry International, V27, P50; *WASK, 1955, WELF AN SLAUGHT KILL; Wilkins L. J., 1987, Meat Hygienist, P31	25	21	22	0	7	POULTRY SCIENCE ASSOC INC	SAVOY	1111 NORTH DUNLAP AVE, SAVOY, IL 61874 USA	0032-5791			POULTRY SCI	Poult. Sci.	DEC	1999	78	12					1796	1800		10.1093/ps/78.12.1796			5	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	268KV	WOS:000084413600022	10626658	hybrid			2022-02-06	
J	Munte, TF; Troger, MC; Nusser, I; Wieringa, BM; Matzke, M; Johannes, S; Dengler, R				Munte, TF; Troger, MC; Nusser, I; Wieringa, BM; Matzke, M; Johannes, S; Dengler, R			Abnormalities of visual search behaviour in ALS patients detected with event-related brain potentials	AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS			English	Article						ALS; visual search; event-related potential; P3; attention	AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR NEURON DISEASE; MULTIMODALITY EVOKED-POTENTIALS; POSITRON EMISSION TOMOGRAPHY; FRONTAL-LOBE FUNCTION; CLOSED-HEAD-INJURY; SELECTIVE ATTENTION; PRESENILE-DEMENTIA; ELECTROPHYSIOLOGICAL EVIDENCE; PARALLEL	A number of recent reports have emphasized neuropyschological symptoms in ALS, including frontal functions, memory and attention. We investigated visual search behaviour of ALS in two types of tasks: a simple, relatively effortless parallel search task and a more complex attention-demanding serial search task. Behavioural parameters and cognitive event-related potentials (ERP) from 19 scalp channels were obtained from 13 ALS patients and 13 matched controls during task performance. ALS patients showed the same target detection rates as controls in the parallel task but were significantly impaired in the serial task. Performance was slower in the patients than in the controls. This slowing could be attributed to cognitive rather than motor impairments, by inspection of the latency of the P3 component, which was delayed by 120 ms in the patients. In addition, the ERPs in the serial task showed a grossly reduced P3 amplitude, indicating disturbed stimulus evaluation in the patients under these conditions. Changes of an early attention-sensitive ERP component suggest an attention deficit underlying the disturbances in search behaviour.	Hannover Med Sch, Dept Neurol, D-30693 Hannover, Germany; Otto von Guericke Univ, Dept Neuropsychol, Magdeburg, Germany		Munte, TF (corresponding author), Hannover Med Sch, Dept Neurol, D-30693 Hannover, Germany.		Munte, Thomas/C-2077-2014				ABRAHAMS S, 1995, J NEUROL SCI, V129, P44, DOI 10.1016/0022-510X(95)00060-F; Abrahams S, 1997, J NEUROL NEUROSUR PS, V62, P464, DOI 10.1136/jnnp.62.5.464; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; CAVALLERI F, 1994, ACTA NEUROL SCAND, V89, P391; DALAKAS MC, 1987, ANN NEUROL, V22, P580, DOI 10.1002/ana.410220504; DAVID AS, 1986, PSYCHOSOMATICS, V27, P441, DOI 10.1016/S0033-3182(86)72673-X; Delay J, 1959, REV NEUROL, V100, P191; DEYMEER F, 1989, NEUROLOGY, V39, P58, DOI 10.1212/WNL.39.1.58; Frank B, 1997, CLIN NEUROL NEUROSUR, V99, P79, DOI 10.1016/S0303-8467(96)00598-7; GALLASSI R, 1985, ACTA NEUROL SCAND, V71, P480; GALLASSI R, 1989, EUR NEUROL, V29, P115, DOI 10.1159/000116391; GHEZZI A, 1989, ACTA NEUROL SCAND, V79, P353, DOI 10.1111/j.1600-0404.1989.tb03799.x; GIL R, 1995, ARCH NEUROL-CHICAGO, V52, P890, DOI 10.1001/archneur.1995.00540330068017; HATAZAWA J, 1988, J COMPUT ASSIST TOMO, V12, P630, DOI 10.1097/00004728-198807000-00019; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; HOROUPIAN DS, 1984, ANN NEUROL, V16, P305, DOI 10.1002/ana.410160306; HUDSON AJ, 1981, BRAIN, V104, P217, DOI 10.1093/brain/104.2.217; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Johannes S, 1997, EUR J NEUROL, V4, P152, DOI 10.1111/j.1468-1331.1997.tb00321.x; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; KEW JJM, 1993, BRAIN, V116, P1001; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LUCK SJ, 1990, PERCEPT PSYCHOPHYS, V48, P603, DOI 10.3758/BF03211606; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; MATHESON JK, 1986, ARCH NEUROL-CHICAGO, V43, P338, DOI 10.1001/archneur.1986.00520040026013; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; MITSUYAMA Y, 1984, J NEUROL NEUROSUR PS, V47, P953, DOI 10.1136/jnnp.47.9.953; MITSUYAMA Y, 1979, ARCH NEUROL-CHICAGO, V36, P592, DOI 10.1001/archneur.1979.00500450086021; MORITA K, 1987, ARCH GERONTOL GERIAT, V6, P263, DOI 10.1016/0167-4943(87)90026-4; Munte TF, 1998, J NEUROL, V245, P206, DOI 10.1007/s004150050206; Munte TF, 1998, ACTA NEUROL SCAND, V98, P110; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; Munte TF, 1997, ARCH NEUROL-CHICAGO, V54, P1089, DOI 10.1001/archneur.1997.00550210027009; PALMA V, 1983, ELECTROMYOGR CLIN NE, V33, P167; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; RADTKE RA, 1986, NEUROLOGY, V36, P796, DOI 10.1212/WNL.36.6.796; Regan D., 1988, HDB ELECTROENCEPHALO, V3, P159; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; VIEREGGE P, 1994, COGNITIVE BRAIN RES, V2, P117, DOI 10.1016/0926-6410(94)90008-6; WIKSTROM J, 1982, ARCH NEUROL-CHICAGO, V39, P681, DOI 10.1001/archneur.1982.00510230007002; Ziegler LH, 1930, ARCH NEURO PSYCHIATR, V24, P930, DOI 10.1001/archneurpsyc.1930.02220170050006	49	21	21	0	1	MARTIN DUNITZ LTD	LONDON	LIVERY HOUSE, 7-9 PRATT ST, LONDON NW1 0AE, ENGLAND	1466-0822			AMYOTROPH LATERAL SC	Amyotroph. Lateral. Scler. Mot. Neuron Disord.	DEC	1999	1	1					21	27					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	366TJ	WOS:000090020400005	12365064				2022-02-06	
J	Chorny, I; Bsorai, R; Artru, AA; Talmor, D; Benkoviz, V; Roytblat, L; Shapira, Y				Chorny, I; Bsorai, R; Artru, AA; Talmor, D; Benkoviz, V; Roytblat, L; Shapira, Y			Albumin or hetastarch improves neurological outcome and decreases volume of brain tissue necrosis but not brain edema following closed-head trauma in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain edema; brain protection; closed-head trauma; hemodilution; neurological outcome; rat	FOCAL CEREBRAL-ISCHEMIA; CROSS-LINKED HEMOGLOBIN; COLLOID ONCOTIC PRESSURE; MOLECULAR-WEIGHT DEXTRAN; HYPERVOLEMIC HEMODILUTION; 5-PERCENT DEXTROSE; LACTATED RINGERS; RAPID INFUSION; CANINE MODEL; BLOOD-FLOW	The present study examined whether hemodilution with 20% human serum albumin (HSA) or 10% hydroxyethyl starch (HES) improved the outcome from closed-head trauma (CHT) in rats. Rats anesthetized with halothane were given one of three hemodilution solutions (i.e., 20% HSA, 10% HES, or control [0.9% saline]) after CHT or sham surgery. CHT was delivered using a weight drop impact of 0.5 J onto the closed cranium. The hemodilution solution (volume = 1% of body weight) was given just after determining the neurological severity score (NSS) at 1 hour following CHT. The NSS was determined again at 24, 48, and 72 hours following CHT. At 72 hours, brains were removed, and brain edema and brain tissue necrosis volume were determined. Solutions of 20% HSA and 10% HES significantly improved brain tissue necrosis volume (143 +/- 72 mm(3) and 104 +/- 53 mm(3) as compared to 271 +/- 65 mm(3) in controls, mean +/- SD) and NSS (12 +/- 2 and 9 +/- 2 as compared to 15 +/- 2 in controls at 72 hours, median +/- range) but not brain edema. The hematocrit decreased similarly in all groups during hemodilution. Hemodilution with 20% HSA and 10% HES following CHT in rats did not decrease brain edema but did decrease brain tissue necrosis volume and NSS (improved neurological function), suggesting that the beneficial effect of hemodilution resulted not from decreased edema formation but rather from effects not measured in this study such as improved perfusion of the salvageable brain tissue surrounding the core injury.	Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol,Div Anesthesiol, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Orthoped Surg, IL-84101 Beer Sheva, Israel; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA		Shapira, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol,Div Anesthesiol, IL-84101 Beer Sheva, Israel.						ARTRU AA, 1997, TXB NEUROANESTHESIA, P61; ASPLUND K, 1987, STROKE, V18, P691; ASPLUND K, 1988, STROKE, V19, P464; BARNETT HJM, 1987, CEREBRAL BLOOD FLOW, P593; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; CANDELISE L, 1988, LANCET, V1, P318; Cole DJ, 1996, ANESTH ANALG, V83, P342, DOI 10.1097/00000539-199608000-00024; COLE DJ, 1993, ANESTHESIOLOGY, V78, P335, DOI 10.1097/00000542-199302000-00018; COLE DJ, 1990, AM J PHYSIOL, V259, pH211, DOI 10.1152/ajpheart.1990.259.1.H211; COLE DJ, 1990, STROKE, V21, P1333, DOI 10.1161/01.STR.21.9.1333; COLE DJ, 1994, ARTIF CELL BLOOD SUB, V22, P813, DOI 10.3109/10731199409117915; Dixon CE, 1996, NEUROTRAUMA, P1337; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Edvinsson L, 1993, CEREBRAL BLOOD FLOW, P3; EWING JR, 1987, CEREBRAL BLOOD FLOW, P202; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; GOSLINGA H, 1992, STROKE, V23, P181, DOI 10.1161/01.STR.23.2.181; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KEE DB, 1987, CEREBRAL BLOOD FLOW, P173; KOLLER M, 1990, STROKE, V21, P1429, DOI 10.1161/01.STR.21.10.1429; LEE SH, 1994, J NEUROSURG, V80, P469, DOI 10.3171/jns.1994.80.3.0469; MARMAROU A, 1978, J NEUROSURG, V49, P503; MATSUI T, 1993, NEUROSURGERY, V33, P293, DOI 10.1227/00006123-199308000-00017; MILDE LN, 1998, CLIN NEUROANAESTHESI, P177; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; Povlishock JT., 1996, NEUROTRAUMA, P1325; Rosner M., 1987, CEREBRAL BLOOD FLOW, P425; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014; TODD M M, 1984, Anesthesiology (Hagerstown), V61, pA123, DOI 10.1097/00000542-198409001-00123; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; WOOD JH, 1984, NEUROLOGY, V34, P24, DOI 10.1212/WNL.34.1.24; WOOD JH, 1983, J NEUROSURG, V59, P500, DOI 10.3171/jns.1983.59.3.0500; Yanaka K, 1996, STROKE, V27, P906, DOI 10.1161/01.STR.27.5.906; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010; Zornow MH, 1997, TXB NEUROANESTHESIA, P117; ZORNOW MH, 1994, ANESTHESIA NEUROSURG, P247	47	21	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	1999	11	4					273	281		10.1097/00008506-199910000-00008			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	241LL	WOS:000082884700008	10527147				2022-02-06	
J	Armstead, WM				Armstead, WM			Age-dependent impairment of K-ATP channel function following brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral circulation; cyclic nucleotides; endothelin; K+ channel; newborn	CEREBRAL BLOOD-FLOW; POTASSIUM CHANNELS; METABOLISM; CATS; RAT; HEMORRHAGE; NEWBORN; ARTERY; ADULT; TONE	Previous studies observed that endothelin-l (ET-1) contributed to ATP-sensitive K+ (K-ATP) channel impairment 1 h following fluid percussion brain injury (FPI) in the newborn pig. The present study was designed to determine the effect of FPI on KATP channel activity as a function of time in newborn (1-5 days old) and juvenile (3-4 weeks old) pigs equipped with a closed cranial window. FPI of moderate severity (1.9-2.1 atm) was produced by using a pendulum to strike a piston on a saline-filled cylinder that was fluid coupled to the brain via a hollow screw inserted through the cranium. Cromakalim, a K-ATP agonist, produced dilation that was blunted for at least 72 h post FPI, but dilator responsiveness was restored within 168 h post FPI in the newborn pig (15 +/- 1% and 27 +/- 2% vs. 5 +/- 1% and 11 +/- 1% vs. 13 +/- 1% and 26 +/- 2% for responses to 10(-8), 10(-6) M cromakalim before, and 72 and 168 h after FPI). Similar inhibited responses were observed for calcitonin gene-related peptide, 8-Bromo cGMP, and the nitric oxide (NO) releasers SNP and SNAP. In contrast, cromakalim-induced dilation was blunted for at least 4 h, but dilator responsiveness was restored within 8 h post FPI in the juvenile pig (15 +/- 1% and 27 +/- 1% vs. 9 +/- 1% and 15 +/- 2% vs. 18 +/- 1% and 28 +/- 1% for 10(-8), 10(-6) M cromakalim before, and 4 and 8 h post FPI). Similar inhibition of dilations of other agonists also occurred in the juvenile. CSF ET-1 increased to a greater level and remained elevated for a longer period of time in the newborn compared to the juvenile pig. BQ123, an ET-1 antagonist, pretreatment partially restored decremented agonist induced dilation following FPI in the newborn and juvenile pig (5 +/- 1% and 11 +/- 1% vs. 11 +/- 1% and 21 +/- 1% for responses to 10(-8), 10-6 M cromakalim 72 h post FPI in the newborn in the absence and presence of BQ123). These data indicate that K-ATP channel function is impaired to a greater extent and for a longer time period in the newborn versus the juvenile pig. These data also show that ET-1 contributes to such impaired vascular responsiveness to a greater extent in the newborn versus the juvenile pig. These data furthermore suggest that the newborn is more sensitive to traumatic vascular injury than the juvenile.	Childrens Hosp Philadelphia, Dept Anesthesia, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesia, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.						Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH1272; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH423, DOI 10.1152/ajpheart.1996.270.2.H423; Bari F, 1996, J CEREBR BLOOD F MET, V16, P1158, DOI 10.1097/00004647-199611000-00010; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; CLOZEL M, 1993, LIFE SCI, V52, P825, DOI 10.1016/0024-3205(93)90081-D; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; KITAZONO T, 1993, AM J PHYSIOL, V265, pH581, DOI 10.1152/ajpheart.1993.265.2.H581; Kontos HA, 1996, AM J PHYSIOL-HEART C, V271, pH1498, DOI 10.1152/ajpheart.1996.271.4.H1498; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P223; MIYOSHI Y, 1992, CIRC RES, V70, P612, DOI 10.1161/01.RES.70.3.612; NELSON MT, 1993, TRENDS CARDIOVAS MED, V3, P54, DOI 10.1016/1050-1738(93)90037-7; NELSON MT, 1995, AM J PHYSIOL, V268, P799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Satoh H, 1995, GEN PHARMACOL, V26, P1549, DOI 10.1016/0306-3623(95)00046-1; SHANKAR V, 1995, AM J PHYSIOL-HEART C, V269, pH997, DOI 10.1152/ajpheart.1995.269.3.H997; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Tepas J J 3rd, 1995, Semin Pediatr Surg, V4, P120; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	31	21	21	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	1999	16	5					391	402		10.1089/neu.1999.16.391			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	200WC	WOS:000080562200005	10369559				2022-02-06	
J	Sasaki, S; Iwata, M				Sasaki, S; Iwata, M			Immunoreactivity of beta-amyloid precursor protein in amyotrophic lateral sclerosis	ACTA NEUROPATHOLOGICA			English	Article						amyotrophic lateral sclerosis; beta-amyloid precursor protein; immunohistochemistry; fast axonal transport; anterior horn neuron	TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; AXONAL DAMAGE; CORTICAL-NEURONS; GOLGI-APPARATUS; SECRETED FORMS; MOTOR-NEURONS; SPINAL-CORD; RAT; CYTOSKELETON	We investigated the localization and extent of beta-amyloid precursor protein (beta-APP(695)) immunoreactivity as a sensitive marker for impairment of fast axonal transport in the spinal cords of 21 patients with amyotrophic lateral sclerosis (ALS), paying special attention to anterior horn neurons. Specimens from 18 patients without neurological disease served as controls. Increased beta-APP immunoreactivity was frequently recognized in the anterior hems of the ALS patients with short clinical courses or with mild depletion of anterior horn cells, while no beta-APP immunoreactivity was demonstrated in those with severe depletion of anterior horn neurons or with long-standing clinical courses. Increased beta-APP immunoreactivity in the anterior horn neurons was mainly confined to the perikarya and no immunoreactivity was recognized in the dendrites or proximal axons directly emanating from the somata, except some spheroids (proximal axonal swellings) which showed increased immunoreactivity of beta-APP. Increased beta-APP immunoreactivity was spotted or focally aggregated in the perikarya of normal-looking large anterior horn neurons, while it was frequently diffuse in that of degenerative neurons such as central chromatolytic cells and or those with simple atrophy. On the other hand, the controls showed no immunostaining with beta-APP in the spinal cord. These findings suggest that increased immunoreactivity of beta-APP in neuronal perikarya of the anterior horn cells and in some proximal axonal swellings is an early change of ALS, and may be a response of the increased synthesis of beta-APP resulting from neuronal damage, or the impairment of fast axonal transport.	Tokyo Womens Med Coll, Neurol Inst, Dept Neurol, Shinjuku Ku, Tokyo 162, Japan		Sasaki, S (corresponding author), Tokyo Womens Med Coll, Neurol Inst, Dept Neurol, Shinjuku Ku, 8-1 Kawadacho, Tokyo 162, Japan.						ALLINQUANT B, 1994, J NEUROSCI, V14, P6842; AMARATUNGA A, 1995, J NEUROCHEM, V64, P2374; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Giometto B, 1997, ANN NEUROL, V42, P34, DOI 10.1002/ana.410420108; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GONATAS NK, 1992, AM J PATHOL, V140, P731; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; MURAKAMI S, 1995, NEUROPATHOLOGY, V15, P289; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Pierce JES, 1996, J NEUROSCI, V16, P1083; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; REFOLO LM, 1991, J NEUROSCI, V11, P3888; ROBERTS GW, 1992, LANCET, V338, P131; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; SASAKI S, 1992, ACTA NEUROPATHOL, V83, P598, DOI 10.1007/BF00299408; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; SUENAGA T, 1994, ACTA NEUROPATHOL, V87, P450; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95	34	21	21	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	MAY	1999	97	5					463	468		10.1007/s004010051015			6	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	189TU	WOS:000079922900005	10334483				2022-02-06	
J	Seif-Naraghi, AH; Herman, RM				Seif-Naraghi, AH; Herman, RM			A novel method for locomotion training	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						body weight support; central pattern generator; cerebral palsy; cerebrovascular accident; gait training; partial weight bearing; sensory stimulation; spinal cord injury; traumatic brain injury; treadmill training	SPINAL-CORD INJURY; BODY-WEIGHT SUPPORT; RECOVERY; REFLEXES; CATS; GAIT; CYPROHEPTADINE; MICTURITION; MODULATION; GENERATOR	This article describes a novel therapeutic system for locomotion training and learning for patients with a wide range of neurological and musculoskeletal disorders. The technique embraces che notion that loco motion therapy should be goal oriented and task specific. The task specificity Includes a partial weightbearing device that permits the posture/equilibrium, movement, and weight-bearing components of gait function to operate concurrently, even in patients with serious deficits. In addition, it allows interaction with therapists and others to facilitate locomotion control, particularly during the early stages of gait therapy. Neurobiological bases for this technique and early clinical results are discussed, and two case studies of patients with traumatic brain injury (TBI) are presented. Although well-designed efficacy studies are needed, clearly this therapeutic approach to locomotor disorders among TBI patients meets the various criteria for recovery of gait function established in this article.	Mobil Res LLC, Tempe, AZ 85281 USA; Arizona State Univ, Chem Biol & Mat Engn Dept, Tempe, AZ USA; Arizona State Univ, Dept Pharmacol, Tempe, AZ USA		Seif-Naraghi, AH (corresponding author), Mobil Res LLC, 2209 W 1st St,105, Tempe, AZ 85281 USA.						BAJD T, 1994, GAIT POSTURE, V2, P5, DOI 10.1016/0966-6362(94)90011-6; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; BARBEAU H, 1994, CURR OPIN NEUROL, V7, P517, DOI 10.1097/00019052-199412000-00008; BUSSEL B, 1989, BRAIN RES B, V58, P1168; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; Chau C, 1998, J NEUROPHYSIOL, V79, P2941, DOI 10.1152/jn.1998.79.6.2941; DIETZ V, 1995, ANN NEUROL, V37, P574, DOI 10.1002/ana.410370506; Dobkin BH, 1996, NEUROLOGIST, V2, P239; Dobkin BH, 1995, J NEUROL REHABIL, V9, P183; FINCH L, 1986, Physiotherapy Canada, V38, P36; FUNG J, 1990, J NEUROL SCI, V100, P85, DOI 10.1016/0022-510X(90)90017-H; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; HERMAN R, 1985, SPINE, V10, P1, DOI 10.1097/00007632-198501000-00001; HERMAN R, 1973, CONTROL POSTURE LOCO; HERMAN RM, 1991, ARCH PHYS MED REHAB, V72, P539; HERMAN RM, 1988, ANESTHESIOLOGY, V69, P313, DOI 10.1097/00000542-198809000-00005; HERMAN RM, 1970, SPINAL CORD DYSFUNCT; HERMAN RM, 1988, SOC NEUR ABSTR, V14, P1302; HERMAN RM, 1991, RESTORATIVE NEUROLOG, P5; HERMAN RM, 1986, NEUROBIOLOGY VERTEBR; HESSE S, 1994, ARCH PHYS MED REHAB, V75, P1087, DOI 10.1016/0003-9993(94)90083-3; IWAHARA T, 1991, BRAIN RES B, V28, P99; Kojima N, 1998, EXP BRAIN RES, V120, P139, DOI 10.1007/s002210050387; LOVELY RG, 1990, BRAIN RES, V514, P206, DOI 10.1016/0006-8993(90)91417-F; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; MANN R, 1979, J BONE JOINT SURG, V2, P232; MASSION J, 1988, NEWS PHYSIOL SCI, V3, P88; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Nicol DJ, 1998, MED ENG PHYS, V20, P182, DOI 10.1016/S1350-4533(98)00012-5; PEARSON KG, 1992, J NEUROSCI METH, V42, P75, DOI 10.1016/0165-0270(92)90137-3; PRINCE F, 1994, GAIT POSTURE, V2, P19, DOI 10.1016/0966-6362(94)90013-2; Richards CL, 1997, PEDIAT PHYS THER, V9, P158, DOI DOI 10.1097/00001577-199700940-00002; Rossignol S, 1993, J Am Paraplegia Soc, V16, P190; THOR KB, 1983, J UROLOGY, V129, P202, DOI 10.1016/S0022-5347(17)51984-9; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; WAINBERG M, 1990, J NEUROL NEUROSUR PS, V53, P754, DOI 10.1136/jnnp.53.9.754; WERNIG A, 1991, RESTORATIVE NEUROLOG, P5; YANG YF, 1998, J PHYSL, V507, P927	38	21	21	0	8	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1999	14	2					146	162		10.1097/00001199-199904000-00005			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	187DN	WOS:000079771800005	10191373				2022-02-06	
J	Shreiber, DI; Smith, DH; Meaney, DF				Shreiber, DI; Smith, DH; Meaney, DF			Immediate in vivo response of the cortex and the blood-brain barrier following dynamic cortical deformation in the rat	NEUROSCIENCE LETTERS			English	Article						blood-brain barrier; cerebral contusion; brain injury; biomechanics	FLUID-PERCUSSION MODEL; IMPACT HEAD-INJURY; PERMEABILITY; DISRUPTION	Although it is known that the brain can be injured by mechanical forces initiated at the moment of impact during trauma, it is not clear how the physical response of the brain dictates the injury patterns that occur in experimental models of traumatic brain injury. In this study, we investigated the mechanical response of the brain to a technique that creates a focal injury in the rat brain. Using a transient vacuum pulse applied to the exposed cortical surface, we found that the displacement of the cortex and the extent of in vivo blood-brain barrier breakdown were related significantly to the vacuum pressure level. The relationship between the response of the cortex and injury pattern points towards a new opportunity for control of the distribution and extent of injury patterns in animal models through a precise understanding of the model biomechanics, as well as potential improvements in means of preventing traumatic brain injury. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 120 Hayden Hall, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu	Shreiber, David/ABE-8254-2021; smith, douglas/A-1321-2007	Shreiber, David/0000-0001-8248-419X; Meaney, David/0000-0002-0954-4122	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS-08803] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR312712, R01 35712] Funding Source: Medline		Chan M., 1980, P 24 STAPP CAR CRASH, P347; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; MATHEW P, 1994, ACTA NEUROCHIR, P428; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; MOOS T, 1993, NEUROPATH APPL NEURO, V19, P120, DOI 10.1111/j.1365-2990.1993.tb00416.x; NAWASHIRO H, 1994, ACTA NEUROCHIR, P440; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Schreiber DI, 1997, 41 STAPP CAR CRASH C, P277; Smith, 1996, EXPT MODELS TRAUMATI, V1996, P5, DOI 10.1002/tl.37219966604; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; STEINWALL O, 1996, J NEUROPATHOL EXP NE, V25, P542; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695	19	21	21	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 4	1999	259	1					5	8		10.1016/S0304-3940(98)00853-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160RC	WOS:000078243900002	10027542				2022-02-06	
J	Raabe, A; Czosnyka, M; Piper, I; Seifert, V				Raabe, A; Czosnyka, M; Piper, I; Seifert, V			Monitoring of intracranial compliance: Correction for a change in body position	ACTA NEUROCHIRURGICA			English	Article						intracranial compliance; pressure-volume index; constant term; body position	PRESSURE-VOLUME INDEX; FLUID PRESSURE; HEAD-INJURY	The objectives of our study were 1. to investigate whether the intracranial compliance changes with body position; 2. to test if the pressure-volume index (PVI) calculation is affected by different body positions; 3. to define the optimal parameter to correct PVI for changes in body position and 4. to investigate the physiological meaning of the constant term (P-0) in the model of the intracranial volume-pressure relationship. Thirteen patients were included in this study. All patients were subjected to 2 to 3 different body positions. In each position, either classic bolus injection was performed for measurement of intracranial compliance and calculation of PVI or the new Spiegelberg compliance monitor was used to calculate PVI continuously. Four different models were used for calculating the constant pressure term P-0 and the P-0 corrected PVI values. Pressure volume index not corrected for the constant term P-0 significantly decreased with elevating the patients head (r = 0.70. p < 0.0001). In contrast, volume-pressure response and ICP pulse amplitude did not change with position. Using the constant term P-0 to correct the PVI we found no changes between the different body positions. Our results suggest that during the variation in body position there is no change in intracranial compliance but a change in hydrostatic offset pressure which causes a shifting of the volume-pressure curve along the pressure axis without its shape being affected. PVI measurements should either be performed only with the patient in the 0 degrees recumbent position or that the PVI calculation should be corrected for the hydrostatic difference between the level of the ICP transducer and the hydrostatic indifference point of the craniospinal system close to the third thoracic vertebra.	Univ Leipzig, Dept Neurosurg, D-04103 Leipzig, Germany; Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Glasgow, So Gen Hosp, Dept Neurosurg, Glasgow, Lanark, Scotland		Raabe, A (corresponding author), Univ Leipzig, Dept Neurosurg, Johannisallee 34, D-04103 Leipzig, Germany.						Avezaat C, 1984, CEREBROSPINAL FLUID; AVEZAAT CJJ, 1976, INTRACRANIAL PRESSUR, P308; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; GJERRIS F, 1989, OUTFLOW CEREBROSPINA; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1099, DOI 10.1136/jnnp.37.10.1099; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1105, DOI 10.1136/jnnp.37.10.1105; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P599; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; OTT EO, 1974, NEUROLOGY, V24, P1117, DOI 10.1212/WNL.24.12.1117; PIPER IR, 1990, ACT NEUR S, V51, P387; Raabe A, 1998, NEUROSURGERY, V42, P74, DOI 10.1097/00006123-199801000-00015; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SULLIVAN HG, 1978, SURG NEUROL, V9, P47; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810	20	21	22	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1999	141	1					31	35		10.1007/s007010050263			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	166AW	WOS:000078554900011	10071684				2022-02-06	
J	Cherian, L; Goodman, JC; Robertson, CS				Cherian, L; Goodman, JC; Robertson, CS			Effect of glucose administration on contusion volume after moderate cortical impact injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						contusional change; neuronal loss; rats; systemic hyperglycemia; traumatic brain injury	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; BRAIN INJURY; PARENTERAL-NUTRITION; HYPERGLYCEMIC RATS; VASOGENIC EDEMA; ISCHEMIA; DAMAGE; VELOCITY; INCREASE	Previous studies had shown that pre- and postinjury glucose administration increased brain injury caused by a mild cortical impact injury only when the traumatic injury was complicated by a secondary ischemic insult. The purpose of this study was to examine the effect of pre- and postinjury glucose administration on a more severe cortical impact injury, where primary ischemia occurs at the site of the impact, Long Evans rats who were fasted overnight and anesthetized with isoflurane were subjected to a 5-m/sec, 2.5-mm impact injury. The animals were randomly assigned one of the following treatments: (1) 2.2 g/kg glucose in 4 mi of saline, 20 min prior to injury; (2) 2.0 g/kg glucose in 4 mi of saline, 20 min after injury; or (3) 4 mi of saline either 20 min before injury or 20 min after the injury, At 2 weeks, the animals were sacrificed and the brains were examined for contusion volume and for neuronal loss in CA1 and CA3 regions of the hippocampus. Contusion volume was increased from a median value of 23 mm(3) in the saline-infused animals to 34 mm(3) in the preimpact glucose infusion animals (p = 0.005), Postimpact glucose infusion had no effect on contusion volume, Neuron density in CA1 and CA3 regions of the hippocampus was similar in all three treatment groups. These studies support the hypothesis that glucose administration adversely affects experimental traumatic brain injury in those circumstances where the trauma is complicated by primary cerebral ischemia, such as around cortical contusions.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA		Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		BACK T, 1995, J CEREBR BLOOD F MET, V15, P566, DOI 10.1038/jcbfm.1995.70; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI KT, 1994, BRAIN RES, V642, P104; COMBS DJ, 1989, J NEUROSURG, V70, P623, DOI 10.3171/jns.1989.70.4.0623; Duckrow RB, 1995, BRAIN RES, V703, P145, DOI 10.1016/0006-8993(95)01077-7; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; HSU SSF, 1991, AM J PHYSIOL, V261, pH398, DOI 10.1152/ajpheart.1991.261.2.H398; Katsura K, 1996, BRAIN RES, V726, P57, DOI 10.1016/S0006-8993(96)00317-4; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SIEMKOWICZ E, 1978, ACTA NEUROL SCAND, V58, P1; Siesjo BK, 1996, ACT NEUR S, V66, P8; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; WATERS DC, 1986, J NEUROSURG, V64, P460, DOI 10.3171/jns.1986.64.3.0460; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	35	21	21	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1998	15	12					1059	1066		10.1089/neu.1998.15.1059			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	148FW	WOS:000077495200006	9872462				2022-02-06	
